PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Trapani, L; Melli, L; Segatto, M; Trezza, V; Campolongo, P; Jozwiak, A; Swiezewska, E; Pucillo, LP; Moreno, S; Fanelli, F; Linari, M; Pallottini, V				Trapani, Laura; Melli, Luca; Segatto, Marco; Trezza, Viviana; Campolongo, Patrizia; Jozwiak, Adam; Swiezewska, Ewa; Pucillo, Leopoldo Paolo; Moreno, Sandra; Fanelli, Francesca; Linari, Marco; Pallottini, Valentina			Effects of myosin heavy chain (MHC) plasticity induced by HMGCoA-reductase inhibition on skeletal muscle functions	FASEB JOURNAL			English	Article						cholesterol; statins	COENZYME-A REDUCTASE; SHORTENING VELOCITY; PLASMA-CHOLESTEROL; STATIN THERAPY; COA REDUCTASE; OLDER-ADULTS; BODY-SIZE; RAT; SIMVASTATIN; FIBERS	The rate-limiting step of cholesterol bio-synthetic pathway is catalyzed by 3-hydroxy-3-methylglutaryl coenzyme reductase (HGMR), whose inhibitors, the statins, widely used in clinical practice to treat hypercholesterolemia, often cause myopathy, and rarely rhabdomyolysis. All studies to date are limited to the definition of statin-induced myotoxicity omitting to investigate whether and how HMGR inhibition influences muscle functions. To this end, 3-mo-old male rats (Rattus norvegicus) were treated for 3 wk with a daily intraperitoneal injection of simvastatin (1.5 mg/kg/d), and biochemical, morphological, mechanical, and functional analysis were performed on extensor digitorum longus (EDL) muscle. Our results show that EDL muscles from simvastatin-treated rats exhibited reduced HMGR activity; a 15% shift from the fastest myosin heavy-chain (MHC) isoform IIb to the slower IIa/x; and reduced power output and unloaded shortening velocity, by 41 and 23%, respectively, without any change in isometric force and endurance. Moreover, simvastatin-treated rats showed a decrease of maximum speed reached and the latency to fall off the rotaroad (similar to = 30%). These results indicate that the molecular mechanism of the impaired muscle function following statin treatment could be related to the plasticity of fast MHC isoform expression.-Trapani, L., Melli, L., Segatto, M., Trezza, V., Campolongo, P., Jozwiak, A., Swiezewska, E., Pucillo, L. P., Moreno, S., Fanelli, F., Linari, M., Pallottini, V. Effects of myosin heavy chain (MHC) plasticity induced by HMGCoA-reductase inhibition on skeletal muscle functions. FASEB J. 25, 4037-4047 (2011). www.fasebj.org	[Trapani, Laura; Segatto, Marco; Trezza, Viviana; Moreno, Sandra; Fanelli, Francesca; Pallottini, Valentina] Univ Roma Tre, Dept Biol, I-00146 Rome, Italy; [Melli, Luca; Linari, Marco] Univ Florence, Dept Evolutionary Biol, Florence, Italy; [Campolongo, Patrizia] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy; [Jozwiak, Adam; Swiezewska, Ewa] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Pucillo, Leopoldo Paolo] Natl Inst Infect Dis, Rome, Italy	Roma Tre University; University of Florence; Sapienza University Rome; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Pallottini, V (corresponding author), Univ Roma Tre, Dept Biol, Viale Marconi 446, I-00146 Rome, Italy.	vpallott@uniroma3.it	Segatto, Marco/AHD-3607-2022; Trezza, Viviana/K-4418-2016; Moreno, Sandra/D-4254-2014; Jozwiak, Adam/E-7717-2011; Campolongo, Patrizia/D-4628-2009; Pallottini, Valentina/AAA-3218-2021	Jozwiak, Adam/0000-0002-7666-7747; Campolongo, Patrizia/0000-0002-2827-8755; Pallottini, Valentina/0000-0003-2511-6168; moreno, sandra/0000-0002-1079-3222; LINARI, MARCO/0000-0001-6512-4897; Swiezewska, Ewa/0000-0002-3439-8948; Segatto, Marco/0000-0003-0465-9470				Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; BOTTINELLI R, 1994, J PHYSIOL-LONDON, V478, P341, DOI 10.1113/jphysiol.1994.sp020254; Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7; Bozzo C, 2003, AM J PHYSIOL-CELL PH, V285, pC575, DOI 10.1152/ajpcell.00441.2002; Brown MS, 2004, ATHEROSCLEROSIS SUPP, V5, P57, DOI 10.1016/j.atherosclerosissup.2004.08.024; BRUSCALUPI G, 1985, CELL MOL BIOL, V31, P365; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Carter R J, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0812s15; CHAO Y, 1991, EUR J CLIN PHARMACOL, V40, pS11, DOI 10.1007/BF01409400; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Dirks AJ, 2006, AM J PHYSIOL-CELL PH, V291, pC1208, DOI 10.1152/ajpcell.00226.2006; Draeger A, 2006, J PATHOL, V210, P94, DOI 10.1002/path.2018; Dubroca C, 2007, CARDIOVASC RES, V73, P190, DOI 10.1016/j.cardiores.2006.10.020; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Ginsberg HN, 1998, AM J CARDIOL, V81, p32B, DOI 10.1016/S0002-9149(98)00035-6; Istvan ES, 2000, BBA-MOL CELL BIOL L, V1529, P9, DOI 10.1016/S1388-1981(00)00134-7; Izumo N, 2001, METHOD FIND EXP CLIN, V23, P389, DOI 10.1358/mf.2001.23.7.662123; Kou R, 2009, J BIOL CHEM, V284, P14734, DOI 10.1074/jbc.M808664200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martini C, 2009, J CELL PHYSIOL, V220, P524, DOI 10.1002/jcp.21810; Ogura Takeharu, 2007, Journal of Toxicological Sciences, V32, P57, DOI 10.2131/jts.32.57; Payne AM, 2003, J APPL PHYSIOL, V95, P2554, DOI 10.1152/japplphysiol.00758.2003; Pellegrino MA, 2003, J PHYSIOL-LONDON, V546, P677, DOI 10.1113/jphysiol.2002.027375; Pette D, 1990, Rev Physiol Biochem Pharmacol, V116, P1; Puthoff ML, 2007, PHYS THER, V87, P1334, DOI 10.2522/ptj.20060176; ROME LC, 1990, J PHYSIOL-LONDON, V431, P173, DOI 10.1113/jphysiol.1990.sp018325; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Schreiber DH, 2006, J EMERG MED, V31, P177, DOI 10.1016/j.jemermed.2005.08.020; Scott D, 2009, QJM-INT J MED, V102, P625, DOI 10.1093/qjmed/hcp093; Sirvent P, 2005, BIOCHEM BIOPH RES CO, V338, P1426, DOI 10.1016/j.bbrc.2005.10.108; Tang PH, 2001, CLIN CHEM, V47, P256; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Viccica G, 2007, J Endocrinol Invest, V30, P8; von Tresckow B, 2007, HAEMATOL-HEMATOL J, V92, P682, DOI 10.3324/haematol.11020; Voss J, 2003, EUR J PHARMACOL, V482, P215, DOI 10.1016/j.ejphar.2003.10.007; Wang WX, 2010, J MOL MED, V88, P309, DOI 10.1007/s00109-009-0561-1; Westwood FR, 2005, TOXICOL PATHOL, V33, P246, DOI 10.1080/01926230590908213; Yokoyama M, 2007, J LIPID RES, V48, P646, DOI 10.1194/jlr.M600301-JLR200	39	17	19	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2011	25	11					4037	4047		10.1096/fj.11-184218	http://dx.doi.org/10.1096/fj.11-184218			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21798954	Green Submitted			2022-12-25	WOS:000296723100027
J	Verpelli, C; Dvoretskova, E; Vicidomini, C; Rossi, F; Chiappalone, M; Schoen, M; Di Stefano, B; Mantegazza, R; Broccoli, V; Bockers, TM; Dityatev, A; Sala, C				Verpelli, Chiara; Dvoretskova, Elena; Vicidomini, Cinzia; Rossi, Francesca; Chiappalone, Michela; Schoen, Michael; Di Stefano, Bruno; Mantegazza, Renato; Broccoli, Vania; Boeckers, Tobias M.; Dityatev, Alexander; Sala, Carlo			Importance of Shank3 Protein in Regulating Metabotropic Glutamate Receptor 5 (mGluR5) Expression and Signaling at Synapses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; POSTSYNAPTIC DENSITY PROTEINS; DENDRITIC SPINE MORPHOLOGY; 22Q13.3 DELETION SYNDROME; POSITIVE ALLOSTERIC MODULATOR; X MENTAL-RETARDATION; HIPPOCAMPAL AREA CA1; SYNAPTIC PLASTICITY; SCAFFOLD PROTEINS; DNA METHYLATION	Shank3/PROSAP2 gene mutations are associated with cognitive impairment ranging from mental retardation to autism. Shank3 is a large scaffold postsynaptic density protein implicated in dendritic spines and synapse formation; however, its specific functions have not been clearly demonstrated. We have used RNAi to knockdown Shank3 expression in neuronal cultures and showed that this treatment specifically reduced the synaptic expression of the metabotropic glutamate receptor 5 (mGluR5), but did not affect the expression of other major synaptic proteins. The functional consequence of Shank3 RNAi knockdown was impaired signaling via mGluR5, as shown by reduction in ERK1/2 and CREB phosphorylation induced by stimulation with (S)-3,5-dihydroxyphenylglycine (DHPG) as the agonist of mGluR5 receptors, impaired mGluR5-dependent synaptic plasticity (DHPG-induced long-term depression), and impaired mGluR5-dependent modulation of neural network activity. We also found morphological abnormalities in the structure of synapses (spine number, width, and length) and impaired glutamatergic synaptic transmission, as shown by reduction in the frequency of miniature excitatory postsynaptic currents (mEPSC). Notably, pharmacological augmentation of mGluR5 activity using 3-cyano-N-(1,3-diphenyl-1H- pyrazol-5-yl)-benzamide as the positive allosteric modulator of these receptors restored mGluR5-dependent signaling (DHPG-induced phosphorylation of ERK1/2) and normalized the frequency of mEPSCs in Shank3-knocked down neurons. These data demonstrate that a deficit in mGluR5-mediated intracellular signaling in Shank3 knockdown neurons can be compensated by 3-cyano-N-(1,3-diphenyl- 1H-pyrazol-5-yl)-benzamide; this raises the possibility that pharmacological augmentation of mGluR5 activity represents a possible new therapeutic approach for patients with Shank3 mutations.	[Verpelli, Chiara; Vicidomini, Cinzia; Rossi, Francesca; Sala, Carlo] Univ Milan, Dept Pharmacol, CNR Inst Neurosci, I-20129 Milan, Italy; [Verpelli, Chiara; Mantegazza, Renato; Sala, Carlo] Neurol Inst Fdn Carlo Besta, Dept Neuromuscular Dis & Neuroimmunol, I-20133 Milan, Italy; [Dvoretskova, Elena; Chiappalone, Michela; Dityatev, Alexander] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy; [Schoen, Michael; Boeckers, Tobias M.] Univ Ulm, Fac Med, Inst Anat & Cell Biol, D-89081 Ulm, Germany; [Di Stefano, Bruno; Broccoli, Vania] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Milan; IRCCS Istituto Neurologico Besta; Istituto Italiano di Tecnologia - IIT; Ulm University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Sala, C (corresponding author), Via Vanvitelli 32, I-20129 Milan, Italy.	c.sala@in.cnr.it	Broccoli, Vania/K-3464-2016; Verpelli, Chiara/K-6673-2016; Cabrera, Mariel/GMX-2706-2022; Di Stefano, Bruno/H-7232-2015; Verpelli, Chiara/AAH-1140-2020; Sala, Carlo/A-2493-2009; Dityatev, Alexander/A-4034-2008; Di Stefano, Bruno/K-5020-2017; Mantegazza, Renato/AAB-7569-2019	Broccoli, Vania/0000-0003-4050-0926; Verpelli, Chiara/0000-0003-2949-9725; Di Stefano, Bruno/0000-0003-2532-3087; Verpelli, Chiara/0000-0003-2949-9725; Sala, Carlo/0000-0003-0662-9523; Dityatev, Alexander/0000-0002-0472-0553; Di Stefano, Bruno/0000-0003-2532-3087; Mantegazza, Renato/0000-0002-9810-5737; Chiappalone, Michela/0000-0003-1427-5147	Telethon-Italy [GGP09196]; Fondazione CARIPLO [2009.264]; Regione Lombardia [SAL-50-16983]; Italian Institute of Technology; San Paolo Foundation	Telethon-Italy(Fondazione Telethon); Fondazione CARIPLO(Fondazione Cariplo); Regione Lombardia(Regione Lombardia); Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); San Paolo Foundation(Compagnia di San Paolo)	This work was supported in part by Telethon-Italy Grant GGP09196, Fondazione CARIPLO Project number 2009.264, RSTL-CNR, Regione Lombardia Project number SAL-50-16983 TERDISMENTAL, and an Italian Institute of Technology, Seed Grant (to C. S. and V. B.).; Supported by a grant from the San Paolo Foundation and the Italian Institute of Technology.	Bangash MA, 2011, CELL, V145, P758, DOI 10.1016/j.cell.2011.03.052; Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Beri S, 2007, J NEUROCHEM, V101, P1380, DOI 10.1111/j.1471-4159.2007.04539.x; Berry-Kravis E, 2009, J MED GENET, V46, P266, DOI 10.1136/jmg.2008.063701; Blau A, 2009, J BIOSCIENCES, V34, P59, DOI 10.1007/s12038-009-0009-3; Bockmann J, 2002, J NEUROCHEM, V83, P1013, DOI 10.1046/j.1471-4159.2002.01204.x; Boeckers TM, 1999, BIOCHEM BIOPH RES CO, V264, P247, DOI 10.1006/bbrc.1999.1489; Boeckers TM, 2005, J NEUROCHEM, V92, P519, DOI 10.1111/j.1471-4159.2004.02910.x; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; Bologna LL, 2010, NEUROSCIENCE, V165, P692, DOI 10.1016/j.neuroscience.2009.11.018; Bonaglia MC, 2006, J MED GENET, V43, P822, DOI 10.1136/jmg.2005.038604; Bonaglia MC, 2001, AM J HUM GENET, V69, P261, DOI 10.1086/321293; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Delahaye A, 2009, EUR J MED GENET, V52, P328, DOI 10.1016/j.ejmg.2009.05.004; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Durand CM, 2012, MOL PSYCHIATR, V17, P71, DOI 10.1038/mp.2011.57; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Gong YS, 2009, BRAIN RES, V1292, P191, DOI 10.1016/j.brainres.2009.07.056; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Grabrucker AM, 2011, EMBO J, V30, P569, DOI 10.1038/emboj.2010.336; Hagerman RJ, 2009, PEDIATRICS, V123, P378, DOI 10.1542/peds.2008-0317; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Hough CD, 1997, GENE DEV, V11, P3242, DOI 10.1101/gad.11.23.3242; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; Jo J, 2006, NAT NEUROSCI, V9, P170, DOI 10.1038/nn1637; Kim SM, 2009, J NEUROCHEM, V109, P1106, DOI 10.1111/j.1471-4159.2009.06039.x; Kinney GG, 2005, J PHARMACOL EXP THER, V313, P199, DOI 10.1124/jpet.104.079244; Lu YM, 1997, J NEUROSCI, V17, P5196; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Maccione A, 2009, J NEUROSCI METH, V177, P241, DOI 10.1016/j.jneumeth.2008.09.026; Manahan-Vaughan D, 2005, CEREB CORTEX, V15, P1703, DOI 10.1093/cercor/bhi047; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Moriyoshi K, 2004, P NATL ACAD SCI USA, V101, P8614, DOI 10.1073/pnas.0403042101; Moult PR, 2006, J NEUROSCI, V26, P2544, DOI 10.1523/JNEUROSCI.4322-05.2006; Naie K, 2004, CEREB CORTEX, V14, P189, DOI 10.1093/cercor/bhg118; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Pasquale V, 2010, J COMPUT NEUROSCI, V29, P213, DOI 10.1007/s10827-009-0175-1; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Piccoli G, 2007, J PROTEOME RES, V6, P3203, DOI 10.1021/pr0701308; Proepper C, 2007, EMBO J, V26, P1397, DOI 10.1038/sj.emboj.7601569; Qualmann B, 2004, J NEUROSCI, V24, P2481, DOI 10.1523/JNEUROSCI.5479-03.2004; Quitsch A, 2005, J NEUROSCI, V25, P479, DOI 10.1523/JNEUROSCI.2699-04.2005; Romorini S, 2004, J NEUROSCI, V24, P9391, DOI 10.1523/JNEUROSCI.3314-04.2004; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Sala C, 2005, J NEUROSCI, V25, P4587, DOI 10.1523/JNEUROSCI.4822-04.2005; Sala C, 2003, J NEUROSCI, V23, P6327; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Schmeisser MJ, 2009, J BIOL CHEM, V284, P29146, DOI 10.1074/jbc.M109.020628; Seeburg DP, 2008, J NEUROSCI, V28, P6583, DOI 10.1523/JNEUROSCI.1853-08.2008; Sheng M, 2000, J CELL SCI, V113, P1851; Shiraishi-Yamaguchi Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-25; Simonyi A, 2010, EUR J PHARMACOL, V639, P17, DOI 10.1016/j.ejphar.2009.12.039; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Uslaner JM, 2009, NEUROPHARMACOLOGY, V57, P531, DOI 10.1016/j.neuropharm.2009.07.022; Verpelli C, 2010, J NEUROSCI, V30, P5830, DOI 10.1523/JNEUROSCI.0119-10.2010; Volk LJ, 2006, J NEUROPHYSIOL, V95, P2427, DOI 10.1152/jn.00383.2005; Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212; Wilson CA, 2003, J NEUROSCI RES, V74, P361, DOI 10.1002/jnr.10776; Wilson HL, 2008, EUR J HUM GENET, V16, P1301, DOI 10.1038/ejhg.2008.107; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575	70	132	137	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34839	34850		10.1074/jbc.M111.258384	http://dx.doi.org/10.1074/jbc.M111.258384			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21795692	Green Published, hybrid			2022-12-25	WOS:000295406300038
J	Zhu, XJ; Cha, BY; Zachos, NC; Sarker, R; Chakraborty, M; Chen, TE; Kovbasnjuk, O; Donowitz, M				Zhu, Xinjun; Cha, Boyoung; Zachos, Nicholas C.; Sarker, Rafiquel; Chakraborty, Molee; Chen, Tian-e; Kovbasnjuk, Olga; Donowitz, Mark			Elevated Calcium Acutely Regulates Dynamic Interactions of NHERF2 and NHE3 Proteins in Opossum Kidney (OK) Cell Microvilli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORDER NA+/H+ EXCHANGER; INTESTINAL EPITHELIAL NHE3; ILEAL BRUSH-BORDER; PROXIMAL TUBULE; CA2+-DEPENDENT INHIBITION; INTRACELLULAR CALCIUM; STIMULATES NHE3; APICAL SURFACE; BASAL ACTIVITY; PKC-ALPHA	The brush border (BB) Na+H+ exchanger NHE3 is rapidly activated or inhibited by changes in trafficking, which mimics renal and intestinal physiology. However, there is a paradox in that NHE3 has limited mobility in the BB due to its binding to the multi-PDZ domain containing the NHERF family. To allow increased endocytosis, as occurs with elevated intracellular Ca2+, we hypothesized that NHE3 had to be, at least transiently, released from the BB cytoskeleton. BecauseNHERF1 and -2 are localized at the BB, where they bind NHE3 as well as the cytoskeleton, we tested whether either or both might dynamically interact with NHE3 as part of Ca2+ signaling. We employed FRET to study close association of NHE3 and these NHERFs and fluorescence recovery after photobleaching to monitor NHE3 mobility in the apical domain in polarized opossum kidney cells. Under basal conditions, NHERF2 and NHE3 exhibited robust FRET signaling. Within 1 min of A23187 (0.5 mu M) exposure, the NHERF2-NHE3 FRET signal was abolished, and BB NHE3 mobility was transiently increased. The dynamics in FRET signal and NHE3 mobility correlated well with a change in co-precipitation of NHE3 and NHERF2 but not NHERF1. We conclude the following. 1) Under basal conditions, NHE3 closely associates with NHERF2 in opossum kidney cell microvilli. 2) Within 1 min of elevated Ca2+, the close association of NHE3-NHERF2 is abolished but is re-established in similar to 60 min. 3) The change in NHE3-NHERF2 association is accompanied by an increased BB mobile fraction of NHE3, which contributes to inhibition of NHE3 transport activity via increased endocytosis.	[Donowitz, Mark] Johns Hopkins Univ, Div Gastroenterol & Hepatol, Dept Med, Sch Med, Baltimore, MD 21205 USA; [Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol, Div Gastroenterol, Baltimore, MD 21205 USA; [Zhu, Xinjun] Albany Med Coll, Gastrointestinal Div, Albany, NY 12008 USA	Johns Hopkins University; Johns Hopkins University; Albany Medical College	Donowitz, M (corresponding author), Johns Hopkins Univ, Div Gastroenterol & Hepatol, Dept Med, Sch Med, 925 Ross Res Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.	mdonowit@jhmi.edu	Zachos, Nicholas/GWC-7914-2022		National Institutes of Health [R01DK26523, RO1DK61765, PO1 DK072084, R24DK64388]; NIDDK [KO8DK088950, T32DK2007632]; Johns Hopkins Center for Epithelial Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK091482, R24DK064388, P01DK072084, R01DK061765, K08DK088950, R01DK026523] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Johns Hopkins Center for Epithelial Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK26523, RO1DK61765, PO1 DK072084, and R24DK64388 (Johns Hopkins Basic Research Digestive Diseases Development Core Center) and KO8DK088950 and T32DK2007632 from NIDDK. This work was also supported by the Johns Hopkins Center for Epithelial Biology.	Akhter S, 2002, AM J PHYSIOL-CELL PH, V283, pC927, DOI 10.1152/ajpcell.00613.2001; Alexander RT, 2009, J EXP BIOL, V212, P1630, DOI 10.1242/jeb.027375; Alexander RT, 2005, P NATL ACAD SCI USA, V102, P12253, DOI 10.1073/pnas.0409197102; Banday AA, 2011, AM J PHYSIOL-RENAL, V301, pF364, DOI 10.1152/ajprenal.00121.2011; Biemesderfer D, 2001, J BIOL CHEM, V276, P10161, DOI 10.1074/jbc.M008098200; Bobulescu IA, 2006, SEMIN NEPHROL, V26, P334, DOI 10.1016/j.semnephrol.2006.07.001; Bobulescu IA, 2009, PFLUG ARCH EUR J PHY, V458, P5, DOI 10.1007/s00424-008-0595-1; Cha BY, 2010, J CELL SCI, V123, P2434, DOI 10.1242/jcs.056713; Cha BY, 2004, J CELL SCI, V117, P3353, DOI 10.1242/jcs.01180; Choi JW, 2004, BBA-MOL CELL BIOL L, V1683, P59, DOI 10.1016/j.bbalip.2004.04.005; Di Sole F, 2003, J AM SOC NEPHROL, V14, P1720, DOI 10.1097/01.ASN.0000072743.97583.DB; DONOWITZ M, 1989, J CLIN INVEST, V83, P1953, DOI 10.1172/JCI114104; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Donowitz M, 2009, J EXP BIOL, V212, P1638, DOI 10.1242/jeb.028605; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Gill RK, 2005, GASTROENTEROLOGY, V128, P962, DOI 10.1053/j.gastro.2005.02.011; Hayashi H, 2004, J GEN PHYSIOL, V123, P491, DOI 10.1085/jgp.200308979; Janecki AJ, 2000, J BIOL CHEM, V275, P8133, DOI 10.1074/jbc.275.11.8133; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; Lee-Kwon W, 2003, AM J PHYSIOL-CELL PH, V285, pC1527, DOI 10.1152/ajpcell.00017.2003; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; Li XH, 2004, J PHYSIOL-LONDON, V556, P791, DOI 10.1113/jphysiol.2004.060921; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; Lin R, 2011, GASTROENTEROLOGY, V140, P560, DOI 10.1053/j.gastro.2010.10.042; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; McDonough AA, 2003, CURR OPIN NEPHROL HY, V12, P533, DOI 10.1097/00041552-200309000-00009; Morris AP, 2001, AM J PHYSIOL-GASTR L, V281, pG303, DOI 10.1152/ajpgi.2001.281.2.G303; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Murtazina R, 2011, AM J PHYSIOL-CELL PH, V301, pC126, DOI 10.1152/ajpcell.00311.2010; Musch MW, 2007, AM J PHYSIOL-GASTR L, V292, pG1549, DOI 10.1152/ajpgi.00388.2006; Musch MW, 2010, AM J PHYSIOL-GASTR L, V298, pG203, DOI 10.1152/ajpgi.00379.2009; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Riquier ADM, 2009, AM J PHYSIOL-CELL PH, V296, pC900, DOI 10.1152/ajpcell.00526.2008; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Sarker R, 2008, MOL BIOL CELL, V19, P3859, DOI 10.1091/mbc.E08-01-0019; Sarker R, 2011, AM J PHYSIOL-CELL PH, V300, pC771, DOI 10.1152/ajpcell.00119.2010; Weinman EJ, 2001, AM J PHYSIOL-RENAL, V281, pF374, DOI 10.1152/ajprenal.2001.281.2.F374; Yang LE, 2005, J AM SOC NEPHROL, V16, P2890, DOI 10.1681/ASN.2005040366; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004; Zachos NC, 2009, J BIOL CHEM, V284, P23708, DOI 10.1074/jbc.M109.012641; Zachos NC, 2009, ANN NY ACAD SCI, V1165, P240, DOI 10.1111/j.1749-6632.2009.04055.x; Zachos NC, 2008, CELL PHYSIOL BIOCHEM, V22, P693, DOI 10.1159/000185553	45	15	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34486	34496		10.1074/jbc.M111.230219	http://dx.doi.org/10.1074/jbc.M111.230219			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21799002	Green Published, hybrid			2022-12-25	WOS:000295406300002
J	Wan, XY; Hu, B; Liu, JX; Feng, X; Xiao, WH				Wan, Xiaoyang; Hu, Bo; Liu, Jing-xia; Feng, Xi; Xiao, Wuhan			Zebrafish mll Gene Is Essential for Hematopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTO-ONCOPROTEIN MLL; HOX GENES; STEM-CELL; DROSOPHILA-TRITHORAX; 11Q23 TRANSLOCATIONS; DNA METHYLATION; HISTONE; MII; MAINTENANCE; EXPRESSION	Studies implicate an important role for the mixed lineage leukemia (Mll) gene in hematopoiesis, mainly through maintaining Hox gene expression. However, the mechanisms underlying Mll-mediated hematopoiesis during embryogenesis remain largely unclear. Here, we investigate the role of mll during zebrafish embryogenesis, particularly hematopoiesis. Mll depletion caused severe defects in hematopoiesis as indicated by a lack of blood flow and mature blood cells as well as a significant reduction in expression of hematopoietic progenitor and mature blood cell markers. Furthermore, mll depletion prevented the differentiation of hematopoietic progenitors. In addition, we identified the N-terminal mini-peptide of Mll that acted as a dominant negative form to disrupt normal function of mll during embryogenesis. As expected, mll knockdown altered the expression of a subset of Hox genes. However, overexpression of these down-regulated Hox genes only partially rescued the blood deficiency, suggesting that mll may target additional genes to regulate hematopoiesis. In the mll morphants, microarray analysis revealed a dramatic up-regulation of gadd45 alpha a. Multiple assays indicate that mll inhibited gadd45 alpha a expression and that overexpression of gadd45 alpha a mRNA led to a phenotype similar to the one seen in the mll morphants. Taken together, these findings demonstrate that zebrafish mll plays essential roles in hematopoiesis and that gadd45 alpha a may serve as a potential downstream target for mediating the function of mll in hematopoiesis.	[Wan, Xiaoyang; Hu, Bo; Liu, Jing-xia; Feng, Xi; Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan 430072, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Xiao, WH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan 430072, Peoples R China.	w-xiao@ihb.ac.cn	Feng, Xi/N-7160-2016; hu, bo/ABC-3810-2021; Xiao, Wuhan/GLU-7352-2022	Feng, Xi/0000-0002-6920-1519; hu, bo/0000-0001-5656-9632; Wan, Xiaoyang/0000-0002-8871-2015	National Science Foundation of China [30971667, 31071212, 91019008, 20890113]; National Transgene Project [2009ZX08010-021B]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgene Project	Supported by "973" Grants 2010CB126306 and 2007CB815705, National Science Foundation of China Grants 30971667, 31071212, 91019008, and 20890113, and National Transgene Project Grant 2009ZX08010-021B.	Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Ayton P, 2001, GENESIS, V30, P201, DOI 10.1002/gene.1066; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; de Jong JLO, 2005, ANNU REV GENET, V39, P481, DOI 10.1146/annurev.genet.39.073003.095931; Diehl F, 2007, BLOOD, V109, P1472, DOI 10.1182/blood-2006-08-039651; DJABALI M, 1992, NAT GENET, V2, P113, DOI 10.1038/ng1092-113; Dobson CL, 2000, EMBO J, V19, P843, DOI 10.1093/emboj/19.5.843; Dorshkind K, 2004, MOL CELL, V13, P765, DOI 10.1016/S1097-2765(04)00159-5; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Engel N, 2009, EPIGENETICS-US, V4, P98, DOI 10.4161/epi.4.2.7858; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hess JL, 1997, BLOOD, V90, P1799, DOI 10.1182/blood.V90.5.1799; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; KRAUSS S, 1991, NATURE, V353, P267, DOI 10.1038/353267a0; Krishnaraju K, 1997, BLOOD, V90, P1840, DOI 10.1182/blood.V90.5.1840; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lee P, 2002, P NATL ACAD SCI USA, V99, P10470, DOI 10.1073/pnas.162366299; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Liu H, 2010, NATURE, V467, P343, DOI 10.1038/nature09350; MAGLI MC, 1991, P NATL ACAD SCI USA, V88, P6348, DOI 10.1073/pnas.88.14.6348; Marschalek R, 2011, BRIT J HAEMATOL, V152, P141, DOI 10.1111/j.1365-2141.2010.08459.x; MCCABE NR, 1992, P NATL ACAD SCI USA, V89, P11794, DOI 10.1073/pnas.89.24.11794; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; Mende M, 2008, MECH DEVELOP, V125, P947, DOI 10.1016/j.mod.2008.08.005; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Muntean AG, 2008, BLOOD, V112, P4690, DOI 10.1182/blood-2008-01-134056; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Robinson BW, 2011, BRIT J HAEMATOL, V152, P307, DOI 10.1111/j.1365-2141.2010.08398.x; Schilling TF, 2001, PHILOS T R SOC B, V356, P1599, DOI 10.1098/rstb.2001.0918; Siafakas AR, 2009, INT J BIOCHEM CELL B, V41, P986, DOI 10.1016/j.biocel.2008.06.018; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Tittle RK, 2011, DEV BIOL, V350, P50, DOI 10.1016/j.ydbio.2010.11.009; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Tu CT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004249; Wan XY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009118; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yagi H, 1998, BLOOD, V92, P108, DOI 10.1182/blood.V92.1.108.413k11_108_117; Yamashita M, 2006, IMMUNITY, V24, P611, DOI 10.1016/j.immuni.2006.03.017; Yang ZG, 2001, DEV BIOL, V231, P138, DOI 10.1006/dbio.2000.0139; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599; Zhou JG, 2009, J BIOL CHEM, V284, P19142, DOI 10.1074/jbc.M109.010439; ZIEMINVANDERPOEL S, 1991, P NATL ACAD SCI USA, V88, P10735, DOI 10.1073/pnas.88.23.10735	54	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33345	33357		10.1074/jbc.M111.253252	http://dx.doi.org/10.1074/jbc.M111.253252			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21784840	Green Published, hybrid			2022-12-25	WOS:000294968800053
J	Deb, DK; Wang, YL; Zhang, ZY; Nie, HG; Huang, XS; Yuan, ZW; Chen, YZ; Zhao, Q; Li, YC				Deb, Dilip K.; Wang, Youli; Zhang, Zhongyi; Nie, Hongguang; Huang, Xueshi; Yuan, Zhengwei; Chen, Yunzi; Zhao, Qun; Li, Yan Chun			Molecular Mechanism Underlying 1,25-Dihydroxyvitamin D Regulation of Nephrin Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; CHRONIC KIDNEY-DISEASE; DIABETIC-NEPHROPATHY; D ANALOG; ALBUMINURIA; ACTIVATION; PODOCYTES; D-3; IDENTIFICATION; TRANSCRIPTION	Nephrin plays a key role in maintaining the structure of the slit diaphragm in the glomerular filtration barrier. Our previous studies have demonstrated potent renoprotective activity for 1,25-dihydroxyvitamin D (1,25(OH)(2)D-3). Here we showed that in podocytes 1,25(OH)(2)D-3 markedly stimulated nephrin mRNA and protein expression. ChIP scan of the 6-kb 5' upstream region of the mouse nephrin gene identified several putative vitamin D response elements (VDREs), and EMSA confirmed that the VDRE at -312 (a DR4-type VDRE) could be bound by vitamin D receptor (VDR)/retinoid X receptor. Luciferase reporter assays of the proximal nephrin promoter fragment (-427 to +173) showed strong induction of luciferase activity upon 1,25(OH)(2)D-3 treatment, and the induction was abolished by mutations within -312VDRE. ChIP assays showed that, upon 1,25(OH)(2)D-3 activation, VDR bound to this VDRE leading to recruitment of DRIP205 and RNA polymerase II and histone 4 acetylation. Treatment of mice with a vitamin D analog induced nephrin mRNA and protein in the kidney, accompanied by increased VDR binding to the -312VDRE and histone 4 acetylation. 1,25(OH)(2)D-3 reversed high glucose-induced nephrin reduction in podocytes, and vitamin D analogs prevented nephrin decline in both type 1 and 2 diabetic mice. Together these data demonstrate that 1,25(OH)(2)D-3 stimulates nephrin expression in podocytes by acting on a VDRE in the proximal nephrin promoter. Nephrin up-regulation likely accounts for part of the renoprotective activity of vitamin D.	[Yuan, Zhengwei; Zhao, Qun] China Med Univ, Shengjing Hosp, Minist Hlth, Key Lab Congenital Malformat, Shenyang, Peoples R China; [Deb, Dilip K.; Wang, Youli; Zhang, Zhongyi; Chen, Yunzi; Li, Yan Chun] Univ Chicago, Dept Med, Div Biol Sci, Chicago, IL 60637 USA; [Nie, Hongguang; Huang, Xueshi; Li, Yan Chun] China Med Univ, Lab Metab Dis Res & Drug Dev, Shenyang, Peoples R China	China Medical University; University of Chicago; China Medical University	Zhao, Q (corresponding author), China Med Univ, Shengjing Hosp, Minist Hlth, Key Lab Congenital Malformat, 36 Sanhao St, Shenyang, Peoples R China.	rezh2001@yahoo.com; cyan@medicine.bsd.uchicago.edu	聂, 宏光/GYJ-8253-2022	聂, 宏光/0000-0002-9973-6354	National Institutes of Health [R01HL085793]; Genzyme renal research fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genzyme renal research fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL085793. This work was also supported by a Genzyme renal research fellowship.	Alborzi P, 2008, HYPERTENSION, V52, P249, DOI 10.1161/HYPERTENSIONAHA.108.113159; CARLBERG C, 1993, NATURE, V361, P657, DOI 10.1038/361657a0; de Boer IH, 2007, AM J KIDNEY DIS, V50, P69, DOI 10.1053/j.ajkd.2007.04.015; de Zeeuw D, 2010, LANCET, V376, P1543, DOI 10.1016/S0140-6736(10)61032-X; Deb DK, 2010, KIDNEY INT, V77, P1000, DOI 10.1038/ki.2010.22; Deb DK, 2009, AM J PHYSIOL-RENAL, V296, pF1212, DOI 10.1152/ajprenal.00002.2009; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Li YC, 2011, CURR DIABETES REV, V7, P35, DOI 10.2174/157339911794273964; Li YC, 2010, KIDNEY INT, V78, P134, DOI 10.1038/ki.2009.175; Li YC, 2001, AM J PHYSIOL-ENDOC M, V281, pE558, DOI 10.1152/ajpendo.2001.281.3.E558; Meyer MB, 2007, J BIOL CHEM, V282, P22344, DOI 10.1074/jbc.M703475200; MOGENSEN CE, 1984, NEW ENGL J MED, V311, P89, DOI 10.1056/NEJM198407123110204; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Qi XM, 2002, J BIOL CHEM, V277, P25884, DOI 10.1074/jbc.M203039200; Quack M, 2000, J MOL BIOL, V296, P743, DOI 10.1006/jmbi.2000.3499; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; SCHRADER M, 1994, NATURE, V370, P382, DOI 10.1038/370382a0; Sutton ALM, 2003, MOL ENDOCRINOL, V17, P777, DOI 10.1210/me.2002-0363; Takano Y, 2007, AM J PHYSIOL-RENAL, V292, pF1573, DOI 10.1152/ajprenal.00423.2006; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; VIBERTI GC, 1982, LANCET, V1, P1430; Wang Y, 2006, KIDNEY INT, V70, P882, DOI 10.1038/sj.ki.5001624; Yamauchi K, 2006, KIDNEY INT, V70, P892, DOI 10.1038/sj.ki.5001625; Yuan WH, 2007, J BIOL CHEM, V282, P29821, DOI 10.1074/jbc.M705495200; Zhang Y, 2009, AM J PHYSIOL-RENAL, V297, pF791, DOI 10.1152/ajprenal.00247.2009; Zhang Z, 2008, KIDNEY INT, V73, P163, DOI 10.1038/sj.ki.5002572; Zhang Z, 2008, P NATL ACAD SCI USA, V105, P15896, DOI 10.1073/pnas.0803751105	32	31	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32011	32017		10.1074/jbc.M111.269118	http://dx.doi.org/10.1074/jbc.M111.269118			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21803771	hybrid, Green Published			2022-12-25	WOS:000294726800010
J	Li, X; Lu, DF; He, FJ; Zhou, HB; Liu, Q; Wang, Y; Shao, CS; Gong, YQ				Li, Xi; Lu, Defen; He, Fengjuan; Zhou, Haibin; Liu, Qiao; Wang, Yu; Shao, Changshun; Gong, Yaoqin			Cullin 4B Protein Ubiquitin Ligase Targets Peroxiredoxin III for Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED MENTAL-RETARDATION; DNA-DAMAGE; HUMAN HOMOLOG; STEM-CELLS; S-PHASE; COMPLEX; UBIQUITYLATION; SUBSTRATE; APOPTOSIS; RECEPTOR	Cullin 4B (CUL4B) is a scaffold protein that assembles cullin-RING ubiquitin ligase (E3) complexes. Recent studies have revealed that germ-line mutations in CUL4B can cause mental retardation, short stature, and many other abnormalities in humans. Identifying specific CUL4B substrates will help to better understand the physiological functions of CUL4B. Here, we report the identification of peroxiredoxin III (PrxIII) as a novel substrate of the CUL4B ubiquitin ligase complex. Two-dimensional gel electrophoresis coupled with mass spectrometry showed that PrxIII was among the proteins up-regulated in cells after RNAi-mediated CUL4B depletion. The impaired degradation of PrxIII observed in CUL4B knockdown cells was confirmed by Western blot. We further demonstrated that DDB1 and ROC1 in the DDB1-CUL4B-ROC1 complex are also indispensable for the proteolysis of PrxIII. In addition, the degradation of PrxIII is independent of CUL4A, a cullin family member closely related to CUL4B. In vitro and in vivo ubiquitination assays revealed that CUL4B promoted the polyubiquitination of PrxIII. Furthermore, we observed a significant decrease in cellular reactive oxygen species (ROS) production in CUL4B-silenced cells, which was associated with increased resistance to hypoxia and H2O2-induced apoptosis. These findings are discussed with regard to the known function of PrxIII as a ROS scavenger and the high endogenous ROS levels required for neural stem cell proliferation. Together, our study has identified a specific target substrate of CUL4B ubiquitin ligase that may have significant implications for the pathogenesis observed in patients with mutations in CUL4B.	[Li, Xi; Lu, Defen; He, Fengjuan; Zhou, Haibin; Liu, Qiao; Wang, Yu; Shao, Changshun; Gong, Yaoqin] Shandong Univ, Sch Med, Inst Med Genet, Key Lab Expt Teratol,Minist Educ, Jinan 250012, Shandong, Peoples R China	Shandong University	Gong, YQ (corresponding author), 44 Wen Hua Xi Lu, Jinan 250012, Shandong, Peoples R China.	yxg8@sdu.edu.cn	Shao, Changshun/AAD-8977-2022	Shao, Changshun/0000-0003-2618-9342	National Natural Science Foundation of China [30830065, 30800614, 81070223, 60974117, 30901987]; National Basic Research Program of China [2007CB512001, 2011CB966201]; Science Foundation of Shandong Province [ZR2010HM038]; Science Foundation for the Excellent Youth Scholars of Ministry of Education of China [200804221067]; Scientific Research Foundation for the Returned Overseas Chinese Scholars	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Science Foundation for the Excellent Youth Scholars of Ministry of Education of China; Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by National Natural Science Foundation of China Grants 30830065, 30800614, 81070223, 60974117, and 30901987, National Basic Research Program of China Grants 2007CB512001 and 2011CB966201, Science Foundation of Shandong Province Grant ZR2010HM038, Science Foundation for the Excellent Youth Scholars of Ministry of Education of China Grant 200804221067, and the Scientific Research Foundation for the Returned Overseas Chinese Scholars.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Baier M, 1997, PLANT J, V12, P179, DOI 10.1046/j.1365-313X.1997.12010179.x; Bernhardt A, 2006, PLANT J, V47, P591, DOI 10.1111/j.1365-313X.2006.02810.x; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Chen LC, 1998, CANCER RES, V58, P3677; Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Kong L, 2007, J BIOL CHEM, V282, P26381, DOI 10.1074/jbc.M702195200; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lehtonen ST, 2005, AM J PHYSIOL-LUNG C, V288, pL997, DOI 10.1152/ajplung.00432.2004; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Li BH, 2002, MOL CELL BIOL, V22, P4997, DOI 10.1128/MCB.22.14.4997-5005.2002; Li Y, 2004, J BIOL CHEM, V279, P11074, DOI 10.1074/jbc.M312301200; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Mauro C, 2006, J BIOL CHEM, V281, P2631, DOI 10.1074/jbc.M502181200; Miranda-Carboni GA, 2008, GENE DEV, V22, P3121, DOI 10.1101/gad.1692808; Monteiro G, 2007, P NATL ACAD SCI USA, V104, P4886, DOI 10.1073/pnas.0700481104; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Nasu J, 2010, J CELL BIOCHEM, V111, P676, DOI 10.1002/jcb.22752; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Nonn L, 2003, MOL CANCER RES, V1, P682; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Schindl M, 2007, ANTICANCER RES, V27, P949; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Tu SC, 2001, ANTIOXID REDOX SIGN, V3, P881, DOI 10.1089/15230860152665046; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489; Zou YX, 2009, J BIOL CHEM, V284, P33320, DOI 10.1074/jbc.M109.050427	53	41	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32344	32354		10.1074/jbc.M111.249003	http://dx.doi.org/10.1074/jbc.M111.249003			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795677	hybrid, Green Published			2022-12-25	WOS:000294726800044
J	Nho, RS; Peterson, M				Nho, Richard Seonghun; Peterson, Mark			Eukaryotic Translation Initiation Factor 4E Binding Protein 1 (4EBP-1) Function Is Suppressed by Src and Protein Phosphatase 2A (PP2A) on Extracellular Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; CELL-SURFACE RECEPTORS; PHAS-I; TYROSINE PHOSPHORYLATION; SIGNALING PATHWAY; EPITHELIAL-CELLS; KINASE; STIMULATION; ACTIVATION; REPRESSOR	Human lung fibroblasts utilize integrins to attach and proliferate on type I collagen. beta 1 integrin is the major integrin subunit for this attachment. Integrins coordinate cellular responses to cell-cell and cell-extracellular matrix interactions that regulate a variety of biological processes. Although beta 1 integrin-mediated signaling pathways in lung fibroblasts have been studied, a detailed molecular mechanism regulating translational control of gene expression by 4EBP-1 is not understood. 4EBP-1 inhibits cap-dependent translation by binding to the eIF4E translation initiation factor. We found that when lung fibroblasts attach to collagen via beta 1 integrin, high Src activity suppresses 4EBP-1 expression via PP2A, and the decrease of 4EBP-1 is due to protein degradation. The inhibition of Src activity dramatically increases PP2A and 4EBP-1 expression. Furthermore ectopic expression of PP2A, or PP2A silencing using PP2A siRNA confirmed that 4EBP-1 is regulated by PP2A. In addition, we found that 4EBP-1 inhibition by fibroblast attachment to collagen increases cap-dependent translation. Our study showed that when lung fibroblasts are attached to collagen matrix, the beta 1 integrin/Src/PP2A-mediated 4EBP-1 regulatory pathway is activated. We suggest that beta 1 integrin-mediated signaling pathway may be a crucial event in regulating fibroblast translational control machinery on collagen matrix.	[Nho, Richard Seonghun; Peterson, Mark] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Nho, RS (corresponding author), Univ Minnesota, Dept Med, Box 276,420 Delaware St SE, Minneapolis, MN 55455 USA.	nhoxx002@umn.edu			American Heart Association; American Lung Association	American Heart Association(American Heart Association); American Lung Association	This work was supported by the Scientist Development grant and the Pulmonary Fibrosis Research grant from the American Heart Association and the American Lung Association (to R. S. N.).	AKIYAMA SK, 1990, BIOCHIM BIOPHYS ACTA, V1031, P91, DOI 10.1016/0304-4157(90)90004-V; Barisic S, 2010, BIOCHEM PHARMACOL, V80, P439, DOI 10.1016/j.bcp.2010.04.028; BEAULIEU JF, 1999, FRONT BIOSCI, V4, P310; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; CHEN J, 1994, J BIOL CHEM, V269, P7957; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Das F, 2008, CELL SIGNAL, V20, P409, DOI 10.1016/j.cellsig.2007.10.027; Fadden P, 1997, J BIOL CHEM, V272, P10240; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Hu XH, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-74; HUNTER T, 1987, CELL, V49, P1, DOI 10.1016/0092-8674(87)90745-8; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Jiang H, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-2; Lantry LE, 1999, CARCINOGENESIS, V20, P343, DOI 10.1093/carcin/20.2.343; Lawrence JC, 1997, TRENDS BIOCHEM SCI, V22, P345, DOI 10.1016/S0968-0004(97)01101-8; Li YK, 2010, NEOPLASIA, V12, P848, DOI 10.1593/neo.10704; Lynch M, 2004, J BIOL CHEM, V279, P3327, DOI 10.1074/jbc.M310872200; Marastoni S, 2008, CONNECT TISSUE RES, V49, P203, DOI 10.1080/03008200802143190; Mendez R, 1996, MOL CELL BIOL, V16, P2857; Nho RS, 2006, J BIOL CHEM, V281, P33291, DOI 10.1074/jbc.M606450200; Nho RS, 2010, J BIOL CHEM, V285, P14195, DOI 10.1074/jbc.M109.052845; Nho RS, 2005, J BIOL CHEM, V280, P26630, DOI 10.1074/jbc.M411798200; Park KW, 2005, ARTERIOSCL THROM VAS, V25, P742, DOI 10.1161/01.ATV.0000156288.70849.26; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Rousseau D, 1996, ONCOGENE, V13, P2415; RUOSLAHTI E, 1989, CANCER CELL-MON REV, V1, P119; Takada Y, 1997, MATRIX BIOL, V16, P143, DOI 10.1016/S0945-053X(97)90002-0; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Walsh D, 2004, GENE DEV, V18, P660, DOI 10.1101/gad.1185304; WERA S, 1995, BIOCHEM J, V311, P17, DOI 10.1042/bj3110017; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Xu Q, 2003, BLOOD, V102, P972, DOI 10.1182/blood-2002-11-3429; Yeh CJ, 2011, VIRCHOWS ARCH, V458, P171, DOI 10.1007/s00428-010-0994-5	38	14	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					31953	31965		10.1074/jbc.M111.222299	http://dx.doi.org/10.1074/jbc.M111.222299			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784851	Green Published, hybrid			2022-12-25	WOS:000294726800004
J	Wassef, L; Quadro, L				Wassef, Lesley; Quadro, Loredana			Uptake of Dietary Retinoids at the Maternal-Fetal Barrier IN VIVO EVIDENCE FOR THE ROLE OF LIPOPROTEIN LIPASE AND ALTERNATIVE PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; HIGH-DENSITY-LIPOPROTEIN; RETINYL ESTER; VITAMIN-A; BINDING-PROTEIN; CHYLOMICRON METABOLISM; LIPID-METABOLISM; APOLIPOPROTEIN-E; HEPATIC-UPTAKE; LDL RECEPTOR	Dietary retinoids (vitamin A and its derivatives) contribute to normal embryonic development. However, the mechanism(s) involved in the transfer of recently ingested vitamin A from mother to embryo is not fully understood. We investigated in vivo whether lipoprotein lipase (LPL) facilitates the placental uptake of dietary retinyl ester incorporated in chylomicrons and their remnants and its transfer to the embryo. We examined the effects of both genetic ablation (MCK-L0 mice) and pharmacological inhibition (P-407) of LPL by maintaining wild type and MCK-L0 mice on diets with different vitamin A content or administering them an oral gavage dose of [H-3]retinol with or without P-407 treatment. We showed that LPL expressed in placenta facilitates uptake of retinoids by this organ and their transfer to the embryo, mainly through its catalytic activity. In addition, through its "bridging function," LPL can mediate the acquisition of nascent chylomicrons by the placenta, although less efficiently. Quantitative real-time PCR and Western blot analysis showed that placental LPL acts in concert with LDL receptor and LRP1. Finally, by knocking out the retinol-binding protein (RBP) gene in the MCK-L0 background (MCK-L0-RBP-/- mice) we demonstrated that the placenta acquires dietary retinoids also via the maternal circulating RBP-retinol complex. RBP expressed in the placenta facilitate the transfer of postprandial retinoids across the placental layers toward the embryo.	[Quadro, Loredana] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Quadro, L (corresponding author), Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA.	quadro@aesop.rutgers.edu			National Institutes of Health [R01HD057493, R01HD057493-02S1]; United States Department of Agriculture Cooperative State Research, Education, and Extension Service, Bioactive Food Component for Optimal Health [2006-35200-16580, 31.0]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture Cooperative State Research, Education, and Extension Service, Bioactive Food Component for Optimal Health(United States Department of Agriculture (USDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HD057493 and R01HD057493-02S1 (to L. Q.). This work was also supported by National Research Initiative Award 2006-35200-16580 from the United States Department of Agriculture Cooperative State Research, Education, and Extension Service, Bioactive Food Component for Optimal Health (31.0) (to L. Q.)	BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; Bharadwaj KG, 2010, J BIOL CHEM, V285, P37976, DOI 10.1074/jbc.M110.174458; BLANER WS, 1994, J BIOL CHEM, V269, P16559; BLOMHOFF R, 1982, P NATL ACAD SCI-BIOL, V79, P7326, DOI 10.1073/pnas.79.23.7326; BONET B, 1992, METABOLISM, V41, P596, DOI 10.1016/0026-0495(92)90051-B; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Campbell FM, 1998, PLACENTA, V19, P409, DOI 10.1016/S0143-4004(98)90081-9; CHAPPELL DA, 1993, J BIOL CHEM, V268, P14168; Clagett-Dame M, 2002, ANNU REV NUTR, V22, P347, DOI 10.1146/annurev.nutr.22.010402.102745E; Council N. R, 1996, GUID CAR US LAB AN; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; Goldberg IJ, 2009, J LIPID RES, V50, pS86, DOI 10.1194/jlr.R800085-JLR200; GOODMAN DS, 1965, J LIPID RES, V6, P390; Harrison EH, 2005, ANNU REV NUTR, V25, P87, DOI 10.1146/annurev.nutr.25.050304.092614; HARRISON EH, 1995, J LIPID RES, V36, P1498; Hatzopoulos AK, 1998, J LIPID RES, V39, P495; Herrera E, 2002, ENDOCRINE, V19, P43, DOI 10.1385/ENDO:19:1:43; Hu LH, 2008, J LIPID RES, V49, P1553, DOI 10.1194/jlr.M800130-JLR200; Hultin M, 1996, J LIPID RES, V37, P1022; Johnston TP, 2010, J PHARM PHARMACOL, V62, P1807, DOI 10.1111/j.2042-7158.2010.01138.x; JOHNSTON TP, 1993, BIOCHEM PHARMACOL, V46, P1037, DOI 10.1016/0006-2952(93)90668-M; Kim YK, 2010, METHODS MOL BIOL, V652, P263, DOI 10.1007/978-1-60327-325-1_15; KIRCHGESSNER TG, 1989, J BIOL CHEM, V264, P1473; Lafond J, 1999, PLACENTA, V20, P583, DOI 10.1053/plac.1999.0412; Lassiter TL, 1999, TOXICOL SCI, V52, P92, DOI 10.1093/toxsci/52.1.92; LevakFrank S, 1997, J BIOL CHEM, V272, P17182, DOI 10.1074/jbc.272.27.17182; Lindegaard MLS, 2006, J LIPID RES, V47, P2581, DOI 10.1194/jlr.M600236-JLR200; Lindegaard MLS, 2005, J LIPID RES, V46, P2339, DOI 10.1194/jlr.M500277-JLR200; Linke T, 2005, J BIOL CHEM, V280, P23287, DOI 10.1074/jbc.M413585200; Magnusson-Olsson AL, 2006, J LIPID RES, V47, P2551, DOI 10.1194/jlr.M600098-JLR200; Merkel M, 1998, P NATL ACAD SCI USA, V95, P13841, DOI 10.1073/pnas.95.23.13841; Merkel M, 1998, J CLIN INVEST, V102, P893, DOI 10.1172/JCI2912; Morriss-Kay GM, 1999, INT REV CYTOL, V188, P73; O'Byrne SM, 2010, AM J PHYSIOL-ENDOC M, V298, pE862, DOI 10.1152/ajpendo.00491.2009; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; OVERBERGH L, 1995, J LIPID RES, V36, P1774; Quadro L, 2005, ENDOCRINOLOGY, V146, P4479, DOI 10.1210/en.2005-0158; Quadro L, 2004, J LIPID RES, V45, P1975, DOI 10.1194/jlr.M400137-JLR200; Quadro L, 2004, AM J PHYSIOL-ENDOC M, V286, pE844, DOI 10.1152/ajpendo.00556.2003; Quadro L, 2003, MOL ASPECTS MED, V24, P421, DOI 10.1016/S0098-2997(03)00038-4; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sapin V, 1997, DEV DYNAM, V208, P199, DOI 10.1002/(SICI)1097-0177(199702)208:2<199::AID-AJA7>3.0.CO;2-D; Savonen R, 1999, J LIPID RES, V40, P1336; Schaiff WT, 2007, ENDOCRINOLOGY, V148, P3625, DOI 10.1210/en.2007-0211; Soprano Dianne Robert, 1994, P257; Strom K, 2009, FASEB J, V23, P2307, DOI 10.1096/fj.08-120923; van Bennekum AM, 1999, J LIPID RES, V40, P565; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Waterman IJ, 1998, BBA-LIPID LIPID MET, V1394, P169, DOI 10.1016/S0005-2760(98)00105-2; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; World Health Organization (WHO), 1998, SAF VIT DOS PREGN LA; Yan B, 1999, PLACENTA, V20, P599, DOI 10.1053/plac.1999.0407; Zhang WH, 2002, APPL IMMUNOHISTO M M, V10, P374, DOI 10.1097/00022744-200212000-00015; Zile MH, 1998, J NUTR, V128, p455S, DOI 10.1093/jn/128.2.455S	57	34	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32198	32207		10.1074/jbc.M111.253070	http://dx.doi.org/10.1074/jbc.M111.253070			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795711	hybrid, Green Published			2022-12-25	WOS:000294726800030
J	Wojcik-Stanaszek, L; Sypecka, J; Szymczak, P; Ziemka-Nalecz, M; Khrestchatisky, M; Rivera, S; Zalewska, T				Wojcik-Stanaszek, Luiza; Sypecka, Joanna; Szymczak, Patrycja; Ziemka-Nalecz, Malgorzata; Khrestchatisky, Michel; Rivera, Santiago; Zalewska, Teresa			The Potential Role of Metalloproteinases in Neurogenesis in the Gerbil Hippocampus Following Global Forebrain Ischemia	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; MATRIX METALLOPROTEINASES; SUBVENTRICULAR ZONE; CELL-MIGRATION; NEURONAL DEATH; BRAIN ISCHEMIA; GROWTH-FACTOR; MATRIX-METALLOPROTEINASE-9; INVOLVEMENT	Background: Matrix metalloproteinases (MMPs) have recently been considered to be involved in the neurogenic response of adult neural stem/progenitor cells. However, there is a lack of information showing direct association between the activation of MMPs and the development of neuronal progenitor cells involving proliferation and/or further differentiation in vulnerable (Cornus Ammoni-CA1) and resistant (dentate gyrus-DG) to ischemic injury areas of the brain hippocampus. Principal Findings: We showed that dynamics of MMPs activation in the dentate gyrus correlated closely with the rate of proliferation and differentiation of progenitor cells into mature neurons. In contrast, in the damaged CA1 pyramidal cells layer, despite the fact that some proliferating cells exhibited antigen specific characteristic of newborn neuronal cells, these did not attain maturity. This coincides with the low, near control-level, activity of MMPs. The above results are supported by our in vitro study showing that MMP inhibitors interfered with both the proliferation and differentiation of the human neural stem cell line derived from umbilical cord blood (HUCB-NSCs) toward the neuronal lineage. Conclusion: Taken together, the spatial and temporal profiles of MMPs activity suggest that these proteinases could be an important component in neurogenesis-associated processes in post-ischemic brain hippocampus.	[Wojcik-Stanaszek, Luiza; Sypecka, Joanna; Szymczak, Patrycja; Ziemka-Nalecz, Malgorzata; Zalewska, Teresa] Polish Acad Sci, Mossakowski Med Res Ctr, NeuroRepair Dept, Warsaw, Poland; [Khrestchatisky, Michel; Rivera, Santiago] Aix Marseille Univ, CNRS, UMR 6184, Marseille, France	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Wojcik-Stanaszek, L (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, NeuroRepair Dept, Warsaw, Poland.	terezal@cmdik.pan.pl	Stanaszek, Luiza/GQZ-3242-2022	Stanaszek, Luiza/0000-0003-3205-5949; Ziemka-Nalecz, Malgorzata/0000-0001-8412-995X; Teresa, Zalewska/0000-0002-4301-9495; Khrestchatisky, Michel/0000-0003-4797-8332	MSHE [1266/P01/2006/31, 0154/B/P01/2010/38]; Letten Foundation	MSHE; Letten Foundation	This work was supported by MSHE grants: 1266/P01/2006/31 and 0154/B/P01/2010/38, and by the Letten Foundation grant to MK and SR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantea D, 2008, NEUROSCIENCE, V152, P8, DOI 10.1016/j.neuroscience.2007.12.030; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Bendel O, 2005, J CEREBR BLOOD F MET, V25, P1586, DOI 10.1038/sj.jcbfm.9600153; Bovetti S, 2007, EUR J NEUROSCI, V25, P2021, DOI 10.1111/j.1460-9568.2007.05441.x; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Buzanska L, 2006, STEM CELLS DEV, V15, P391, DOI 10.1089/scd.2006.15.391; Domanska-Janik K, 1999, J NEUROSCI RES, V57, P840, DOI 10.1002/(SICI)1097-4547(19990915)57:6<840::AID-JNR9>3.0.CO;2-Z; Dzwonek J, 2004, FEBS LETT, V567, P129, DOI 10.1016/j.febslet.2004.03.070; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Frolichsthal-Schoeller P, 1999, NEUROREPORT, V10, P345; Gasche Y, 2006, FRONT BIOSCI-LANDMRK, V11, P1289, DOI 10.2741/1883; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Gonthier B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005099; JABLONSKA A, 7 INT STEM CELL SCH; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kang SS, 2008, BRAIN RES, V1228, P20, DOI 10.1016/j.brainres.2008.06.056; Kato H, 2003, BRAIN RES BULL, V60, P215, DOI 10.1016/S0361-9230(03)00036-4; Lee CZ, 2004, STROKE, V35, P1715, DOI 10.1161/01.STR.0000129334.05181.b6; Lee SR, 2006, J NEUROSCI, V26, P3491, DOI 10.1523/JNEUROSCI.4085-05.2006; Liu JL, 1998, J NEUROSCI, V18, P7768; Lu L, 2008, HIPPOCAMPUS, V18, P1074, DOI 10.1002/hipo.20466; Mannello F, 2006, STEM CELLS, V24, P475, DOI 10.1634/stemcells.2005-0333; MORRIS DC, 2006, ACAD EMERG MED, V13, pS194; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Ogier C, 2006, GLIA, V54, P272, DOI 10.1002/glia.20349; Ould-yahoui A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008289; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Rivera S, 2002, EUR J NEUROSCI, V15, P19, DOI 10.1046/j.0953-816x.2001.01838.x; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Sbai O, 2010, GLIA, V58, P344, DOI 10.1002/glia.20927; SZYMCZAK P, 2009, ACTA NEUROBIOL EXP W, V69, P293; Tonchev AB, 2003, MOL CELL NEUROSCI, V23, P292, DOI 10.1016/S1044-7431(03)00058-7; Tsukatani T, 2003, NEUROREPORT, V14, P1135, DOI 10.1097/00001756-200306110-00007; Wojcik L, 2009, ACTA NEUROBIOL EXP, V69, P52; Wurmser AE, 2004, SCIENCE, V304, P1253, DOI 10.1126/science.1099344; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111; Yang Y, 2010, J NEUROCHEM, V112, P134, DOI 10.1111/j.1471-4159.2009.06433.x; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Zalewska T, 2002, ACTA NEUROBIOL EXP, V62, P53; Ziemka-Nalecz M, 2003, NEUROCHEM INT, V42, P205, DOI 10.1016/S0197-0186(02)00096-7	46	29	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22465	10.1371/journal.pone.0022465	http://dx.doi.org/10.1371/journal.pone.0022465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799862	Green Published, gold, Green Submitted			2022-12-25	WOS:000293172900034
J	Cronin, JT				Cronin, James T.			Spatial Ecology of the Palm-Leaf Skeletonizer, Homaledra sabelella (Lepidoptera: Coleophoridae)	PLOS ONE			English	Article							DISPERSAL LIMITATION; POPULATION; MOVEMENT; COMMUNITIES; PATTERNS; INSECT; AUTOCORRELATION; EXTINCTION; HERBIVORY; ONTOGENY	Understanding the processes that determine the distribution of populations is a fundamental goal in ecology. In this study, I determined the relative contribution of space and the biotic and abiotic environment to the distribution of the palm-leaf skeletonizer Homaledra sabalella (PLS; Lepidoptera: Coleophoridae) among patchily distributed dwarf palmettos (Sabal minor; Arecaceae). Based on surveys conducted at two sites in the Sherburne Wildlife Management Area, Louisiana, I found that the distribution of the PLS was primarily related to local environmental conditions - number of PLS increased with palmetto height, was greater in dry versus wet habitats, and varied in an inconsistent way with the type of understory cover. Spatial structure of the forest and isolation of the host plant were of minor importance to the distribution of the PLS. Based on a series of experiments, the mechanisms underlying the effects of these environmental variables on PLS abundance were elucidated. Tall palmettos have a greater abundance of PLS because they are 2.5 times more likely to be colonized than small palmettos. Tall palmettos do not represent better hosts (in terms of PLS survival to pupation, pupal length, or risk of parasitism). Similarly, an open understory increased colonization by two-fold, relative to a shrub understory, but understory type had no effect on host quality. Wet soils greatly reduced palmetto quality as a host (survival and pupal length), but only for the smallest palmettos (<0.75 m height). Finally, corroborating the survey data, my dispersal experiment revealed that the PLS is a strong flier and that local PLS populations (i.e., infested palmettos) are likely well connected by dispersal. I conclude by discussing how landscape-level changes at Sherburne Wildlife Management Area, owing to recent hurricane activity, could affect the risk of palmetto infestation by the PLS.	Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Cronin, JT (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jcronin@lsu.edu	Cronin, James/V-2781-2019	Cronin, James/0000-0001-7111-6412	National Science Foundation [DEB-0211359, DEB-0515764]; REU Supplements; Direct For Biological Sciences [1020867] Funding Source: National Science Foundation; Division Of Environmental Biology [1021203] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); REU Supplements; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by The National Science Foundation grants DEB-0211359 and DEB-0515764 and three REU Supplements. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton KE, 2010, AM NAT, V175, P481, DOI 10.1086/650722; Bellier E, 2007, ECOGRAPHY, V30, P385, DOI [10.1111/j.2007.0906-7590.04911.x, 10.1111/j.0906-7590.2007.04911.x]; Boege K, 2005, TRENDS ECOL EVOL, V20, P441, DOI 10.1016/j.tree.2005.05.001; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Cappuccino N, 1997, OECOLOGIA, V110, P69, DOI 10.1007/s004420050134; Chase J.M., 2009, ECOLOGICAL NICHES LI; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Cottenie K, 2003, ECOLOGY, V84, P991, DOI 10.1890/0012-9658(2003)084[0991:ZMSRVL]2.0.CO;2; Creighton JT, 1937, J ECON ENTOMOL, V30, P590, DOI 10.1093/jee/30.4.590; Cronin JT, 2007, ECOLOGY, V88, P2966, DOI 10.1890/07-0070.1; Cronin JT, 2005, P ROY SOC B-BIOL SCI, V272, P2225, DOI 10.1098/rspb.2005.3286; Cronin JT, 2004, ECOLOGY, V85, P2772, DOI 10.1890/04-0303; Cronin JT, 2004, OECOLOGIA, V139, P503, DOI 10.1007/s00442-004-1549-8; Cronin JT, 2000, OIKOS, V90, P127, DOI 10.1034/j.1600-0706.2000.900113.x; Cronin JT, 2009, EDGE EFFECT IN PRESS; DOBZHANSKY T, 1974, PROC R SOC SER B-BIO, V187, P281, DOI 10.1098/rspb.1974.0075; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dover J, 2009, J INSECT CONSERV, V13, P3, DOI 10.1007/s10841-008-9135-8; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Fraser DF, 2001, AM NAT, V158, P124, DOI 10.1086/321307; Fric Z, 2007, BASIC APPL ECOL, V8, P377, DOI 10.1016/j.baae.2006.06.005; Fuentes-Montemayor E, 2009, J ANIM ECOL, V78, P857, DOI 10.1111/j.1365-2656.2009.01551.x; Gilbert B, 2010, J APPL ECOL, V47, P1071, DOI 10.1111/j.1365-2664.2010.01861.x; Gilbert M, 2004, J ANIM ECOL, V73, P459, DOI 10.1111/j.0021-8790.2004.00820.x; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; Hanski I., 1999, METAPOPULATION ECOLO; Hanski Ilkka, 1995, P149, DOI 10.1016/B978-012159270-7/50009-9; Harrison Susan, 1997, P27, DOI 10.1016/B978-012323445-2/50004-3; Haynes KJ, 2003, ECOLOGY, V84, P2856, DOI 10.1890/02-0611; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hovestadt T, 2001, P ROY SOC B-BIOL SCI, V268, P385, DOI 10.1098/rspb.2000.1379; Howard F.W., 2001, INSECTS PALMS, V131, DOI [10.1079/9780851993263.0000, DOI 10.1079/9780851993263.0000]; Howard FW, 2004, ENCY ENTOMOLOGY, P1622; Hubbell Stephen P., 2001, V32, pi; HUFFAKER C. B., 1958, HILGARDIA, V27, P343; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Johnson DM, 2004, ECOLOGY, V85, P2037, DOI 10.1890/03-0508; Karst J, 2005, ECOLOGY, V86, P2473, DOI 10.1890/04-1420; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Krebs C. J., 1999, ECOLOGICAL METHODOLO; Legendre P, 2002, ECOGRAPHY, V25, P601, DOI 10.1034/j.1600-0587.2002.250508.x; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; MAC ARTHUR ROBERT H., 1967; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; Marsh DM, 2004, ECOL APPL, V14, P1882, DOI 10.1890/03-5179; MARTORELL L. F., 1976, ANNOTATED FOOD PLANT; Matter SF, 2004, ECOL APPL, V14, P1526, DOI 10.1890/03-5164; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.1890/0012-9658(2002)083[1131:SCMISE]2.0.CO;2; Nabout JC, 2009, ACTA OECOL, V35, P720, DOI 10.1016/j.actao.2009.07.002; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Peres-Neto PR, 2010, GLOBAL ECOL BIOGEOGR, V19, P174, DOI 10.1111/j.1466-8238.2009.00506.x; Pinto SM, 2010, AM NAT, V175, P675, DOI 10.1086/652467; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; Prugh LR, 2009, ECOL APPL, V19, P1300, DOI 10.1890/08-1524.1; Ramette A, 2007, P NATL ACAD SCI USA, V104, P2761, DOI 10.1073/pnas.0610671104; Roland J, 2007, P NATL ACAD SCI USA, V104, P13702, DOI 10.1073/pnas.0705511104; Santos SM, 2009, CAN J ZOOL, V87, P1227, DOI 10.1139/Z09-108; Sattler T, 2010, ECOLOGY, V91, P3343, DOI 10.1890/09-1810.1; SCHMUTTERER H, 1990, PLAGAS PLANTAS CULTI; Schneider JC, 1999, ECOLOGY, V80, P2740, DOI 10.2307/177254; Shurin JB, 2009, OECOLOGIA, V159, P151, DOI 10.1007/s00442-008-1174-z; Skalski GT, 2000, ECOLOGY, V81, P1685, DOI 10.2307/177317; Tripp EA, 2006, CASTANEA, V71, P172, DOI 10.2179/05-12.1; Tscharntke T, 2005, ANN ZOOL FENN, V42, P421; Tscharntke T, 2004, ANNU REV ENTOMOL, V49, P405, DOI 10.1146/annurev.ento.49.061802.123339; Turchin Peter, 1998; Urban MC, 2006, DIVERS DISTRIB, V12, P337, DOI 10.1111/j.1366-9516.2005.00226.x; Watling JI, 2007, DIVERS DISTRIB, V13, P372, DOI 10.1111/j.1472-4642.2007.00331.x; Westcott DA, 2000, OECOLOGIA, V122, P249, DOI 10.1007/PL00008853; Wiens John A., 1997, P43, DOI 10.1016/B978-012323445-2/50005-5; WOLCOTT GEORGE N., 1936, JOUR AGRIC UNIV PUERTO RICO, V20, P1; ZHANG B-C., 1994, INDEX EC IMPORTANT L; ZONA S, 1990, Aliso, V12, P583; Zona S., 1997, HARVARD PAPERS BOT, P71	76	0	0	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22331	10.1371/journal.pone.0022331	http://dx.doi.org/10.1371/journal.pone.0022331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799826	Green Submitted, Green Published, gold			2022-12-25	WOS:000293097300033
J	Gehrmann, U; Qazi, KR; Johansson, C; Hultenby, K; Karlsson, M; Lundeberg, L; Gabrielsson, S; Scheynius, A				Gehrmann, Ulf; Qazi, Khaleda Rahman; Johansson, Catharina; Hultenby, Kjell; Karlsson, Maria; Lundeberg, Lena; Gabrielsson, Susanne; Scheynius, Annika			Nanovesicles from Malassezia sympodialis and Host Exosomes Induce Cytokine Responses - Novel Mechanisms for Host-Microbe Interactions in Atopic Eczema	PLOS ONE			English	Article							CELL-DERIVED EXOSOMES; PEPTIDE-BASED VACCINE; CD8(+) CTL RESPONSES; PATCH TEST REACTION; CD4(+) T-CELLS; DENDRITIC CELLS; IN-VITRO; TRANSFERRIN RECEPTOR; SHEEP RETICULOCYTES; CONSENSUS REPORT	Background: Intercellular communication can occur via the release of membrane vesicles. Exosomes are nanovesicles released from the endosomal compartment of cells. Depending on their cell of origin and their cargo they can exert different immunoregulatory functions. Recently, fungi were found to produce extracellular vesicles that can influence host-microbe interactions. The yeast Malassezia sympodialis which belongs to our normal cutaneous microbial flora elicits specific IgE- and T-cell reactivity in approximately 50% of adult patients with atopic eczema (AE). Whether exosomes or other vesicles contribute to the inflammation has not yet been investigated. Objective: To investigate if M. sympodialis can release nanovesicles and whether they or endogenous exosomes can activate PBMC from AE patients sensitized to M. sympodialis. Methods: Extracellular nanovesicles isolated from M. sympodialis, co-cultures of M. sympodialis and dendritic cells, and from plasma of patients with AE and healthy controls (HC) were characterised using flow cytometry, sucrose gradient centrifugation, Western blot and electron microscopy. Their ability to stimulate IL-4 and TNF-alpha responses in autologous CD14, CD34 depleted PBMC was determined using ELISPOT and ELISA, respectively. Results: We show for the first time that M. sympodialis releases extracellular vesicles carrying allergen. These vesicles can induce IL-4 and TNF-alpha responses with a significantly higher IL-4 production in patients compared to HC. Exosomes from dendritic cell and M. sympodialis co-cultures induced IL-4 and TNF-alpha responses in autologous CD14, CD34 depleted PBMC of AE patients and HC while plasma exosomes induced TNF-alpha but not IL-4 in undepleted PBMC. Conclusions: Extracellular vesicles from M. sympodialis, dendritic cells and plasma can contribute to cytokine responses in CD14, CD34 depleted and undepleted PBMC of AE patients and HC. These novel observations have implications for understanding host-microbe interactions in the pathogenesis of AE.	[Gehrmann, Ulf; Qazi, Khaleda Rahman; Johansson, Catharina; Gabrielsson, Susanne; Scheynius, Annika] Karolinska Inst, Dept Med Solna, Clin Allergy Res Unit, Stockholm, Sweden; [Hultenby, Kjell] Karolinska Univ Hosp Huddinge, Dept Lab Med, Huddinge, Sweden; [Karlsson, Maria; Lundeberg, Lena] Karolinska Univ Hosp, Dermatol & Venereol Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Gehrmann, U (corresponding author), Karolinska Inst, Dept Med Solna, Clin Allergy Res Unit, Stockholm, Sweden.	ulf.gehrmann@ki.se	Gabrielsson, S./E-4145-2014	Gabrielsson, S./0000-0003-1771-1346	Swedish Research Council; Center for Allergy Research Karolinska Institutet; Hesselman Foundation; Swedish Heart and Lung Association; Groshinsky Memory Foundation; Swedish Society for Medical Research (SSMF); Cancer and Allergy Association; Swedish Asthma and Allergy Association's Research Foundation; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Center for Allergy Research Karolinska Institutet(Karolinska Institutet); Hesselman Foundation; Swedish Heart and Lung Association(Swedish Heart-Lung Foundation); Groshinsky Memory Foundation; Swedish Society for Medical Research (SSMF); Cancer and Allergy Association; Swedish Asthma and Allergy Association's Research Foundation; Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Research Council (www.vr.se), Center for Allergy Research Karolinska Institutet (ki.se/ki/jsp/polopoly.jsp?d = 4477&l = en), the Hesselman Foundation, the Swedish Heart and Lung Association (http://www.hjart-lungfonden.se), the Groshinsky Memory Foundation, the Swedish Society for Medical Research (SSMF, www.ssmf.se), the Cancer and Allergy Association, the Swedish Asthma and Allergy Association's Research Foundation (www.astmaoallergiforbundet.se), and through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and the Karolinska Institutet (ki.se/ki/jsp/polopoly.jsp;jsessionid = a3fQhAvJt7chzjc6I5?l = en&d = 7121). U. G. holds a PhD grant from Karolinska Institutet (ki.se/ki/jsp/polopoly.jsp?l = en&d = 13467). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admyre C, 2008, ALLERGY, V63, P404, DOI 10.1111/j.1398-9995.2007.01600.x; Admyre C, 2003, EUR RESPIR J, V22, P578, DOI 10.1183/09031936.03.00041703; Admyre C, 2007, J ALLERGY CLIN IMMUN, V120, P1418, DOI 10.1016/j.jaci.2007.06.040; Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Akdis CA, 2006, J ALLERGY CLIN IMMUN, V118, P152, DOI 10.1016/j.jaci.2006.03.045; Albuquerque PC, 2008, CELL MICROBIOL, V10, P1695, DOI 10.1111/j.1462-5822.2008.01160.x; Almqvist N, 2008, IMMUNOLOGY, V125, P21, DOI 10.1111/j.1365-2567.2008.02812.x; Andre F, 2004, J IMMUNOL, V172, P2126, DOI 10.4049/jimmunol.172.4.2126; ASHBEE HR, 2010, PATHOGENIC YEASTS YE, P209; Beauvillain C, 2007, MICROBES INFECT, V9, P1614, DOI 10.1016/j.micinf.2007.07.002; Beauvillain C, 2009, VACCINE, V27, P1750, DOI 10.1016/j.vaccine.2009.01.022; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Bhatnagar S, 2007, J BIOL CHEM, V282, P25779, DOI 10.1074/jbc.M702277200; Bieber T, 2009, CURR ALLERGY ASTHM R, V9, P291, DOI 10.1007/s11882-009-0041-2; Buentke E, 2000, CLIN EXP ALLERGY, V30, P1759, DOI 10.1046/j.1365-2222.2000.00937.x; Buentke E, 2001, CLIN EXP ALLERGY, V31, P1583, DOI 10.1046/j.1365-2222.2001.01199.x; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Casadevall A, 2009, TRENDS MICROBIOL, V17, P158, DOI 10.1016/j.tim.2008.12.005; Chaput N, 2004, J IMMUNOL, V172, P2137, DOI 10.4049/jimmunol.172.4.2137; Esser J, 2010, J ALLERGY CLIN IMMUN, V126, P1032, DOI 10.1016/j.jaci.2010.06.039; Gafvelin G, 2005, INT ARCH ALLERGY IMM, V138, P59, DOI 10.1159/000087358; Gaitanis G, 2010, MALASSEZIA AND THE SKIN: SCIENCE AND CLINICAL PRACTICE, P201, DOI 10.1007/978-3-642-03616-3; Hao SG, 2007, J LEUKOCYTE BIOL, V82, P829, DOI 10.1189/jlb.0407249; Hao SG, 2007, J IMMUNOL, V179, P2731, DOI 10.4049/jimmunol.179.5.2731; Hood JL, 2009, LAB INVEST, V89, P1317, DOI 10.1038/labinvest.2009.94; Johansson C, 2002, J INVEST DERMATOL, V118, P1044, DOI 10.1046/j.1523-1747.2002.01758.x; Johansson C, 2009, INT ARCH ALLERGY IMM, V150, P51, DOI 10.1159/000210380; Johansson SM, 2008, IMMUNOLOGY, V123, P491, DOI 10.1111/j.1365-2567.2007.02714.x; Kesavan S, 1998, MED MYCOL, V36, P97, DOI 10.1080/02681219880000161; Kim SH, 2007, J IMMUNOL, V179, P2235, DOI 10.4049/jimmunol.179.4.2235; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Kunz B, 1997, DERMATOLOGY, V195, P10, DOI 10.1159/000245677; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; OLIVEIRA DL, INFECT IMMUN, V78, P1601; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Pfeiffer JR, 2011, MOL CELL BIOL, V31, P277, DOI 10.1128/MCB.00775-10; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rippke F, 2004, AM J CLIN DERMATOL, V5, P217, DOI 10.2165/00128071-200405040-00002; Rodrigues ML, 2007, EUKARYOT CELL, V6, P48, DOI 10.1128/EC.00318-06; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Selander C, 2006, ALLERGY, V61, P1002, DOI 10.1111/j.1398-9995.2006.01108.x; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vilhelmsson M, 2007, INT ARCH ALLERGY IMM, V143, P155, DOI 10.1159/000099082	48	90	94	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e21480	10.1371/journal.pone.0021480	http://dx.doi.org/10.1371/journal.pone.0021480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799736	gold, Green Published, Green Submitted			2022-12-25	WOS:000293097300003
J	Lau, WKH; Chow, AWM; Au, SCL; Ko, WH				Lau, Wendy Ka-hoi; Chow, Alison Wai-ming; Au, Simon Chak-leung; Ko, Wing-hung			Differential Inhibitory Effects of CysLT(1) Receptor Antagonists on P2Y(6) Receptor-Mediated Signaling and Ion Transport in Human Bronchial Epithelia	PLOS ONE			English	Article							CL-SECRETION; EXTRACELLULAR NUCLEOTIDES; LEUKOTRIENE RECEPTOR; CHLORIDE SECRETION; P2 RECEPTORS; MAST-CELLS; CAMP; EPAC; ACTIVATION; RELEASE	Background: Cysteinyl leukotriene (CysLT) is one of the proinflammatory mediators released by the bronchi during inflammation. CysLTs exert their biological effects via specific G-protein-coupled receptors. CysLT(1) receptor antagonists are available for clinical use for the treatment of asthma. Recently, crosstalk between CysLT(1) and P2Y(6) receptors has been delineated. P2Y receptors are expressed in apical and/or basolateral membranes of virtually all polarized epithelia to control the transport of fluid and electrolytes. Previous research suggests that CysLT(1) receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors. However, the detailed molecular mechanism underlying the inhibition remains unresolved. Methodology/Principal Findings: In this study, western blot analysis confirmed that both CysLT(1) and P2Y(6) receptors were expressed in the human bronchial epithelial cell line 16HBE14o-. All three CysLT(1) antagonists inhibited the uridine diphosphate (UDP)-evoked I-SC, but only montelukast inhibited the UDP-evoked [Ca2+](i) increase. In the presence of forskolin or 8-bromoadenosine 3'5' cyclic monophosphate (8-Br-cAMP), the UDP-induced I-SC was potentiated but was reduced by pranlukast and zafirlukast but not montelukast. Pranlukast inhibited the UDP-evoked I-SC potentiated by an Epac activator, 8-(4-Chlorophenylthio)-2'-O-methyladenosine-3',5'-cyclic monophosphate (8-CPT-2'-O-Me-cAMP), while montelukast and zafirlukast had no such effect. Pranlukast inhibited the real-time increase in cAMP changes activated by 8-CPT-2'-O-Me-cAMP as monitored by fluorescence resonance energy transfer imaging. Zafirlukast inhibited the UDP-induced I-SC potentiated by N-6-Phenyladenosine-3', 5'-cyclic monophosphorothioate, Sp-isomer (Sp-6-Phe-cAMP; a PKA activator) and UDP-activated PKA activity. Conclusions/Significance: In summary, our data strongly suggest for the first time that in human airway epithelia, the three specific CysLT(1) receptor antagonists exert differential inhibitory effects on P2Y(6) receptor-coupled Ca2+ signaling pathways and the potentiating effect on I-SC mediated by cAMP and Epac, leading to the modulation of ion transport activities across the epithelia.	[Lau, Wendy Ka-hoi; Chow, Alison Wai-ming; Au, Simon Chak-leung; Ko, Wing-hung] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong	Lau, WKH (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	whko@cuhk.edu.hk	Ko, Hung/R-1802-2018	Ko, Hung/0000-0002-2041-402X	Chinese University of Hong Kong [2041539]; Research Grant Council [2140595]	Chinese University of Hong Kong(Chinese University of Hong Kong); Research Grant Council(Hong Kong Research Grants Council)	The work was supported by a Direct Grant for Research, The Chinese University of Hong Kong (# 2041539) and a Research Grant Council General Research Fund (#2140595) awarded to W.H. Ko. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson RH, 2008, AM J PHYSIOL-HEART C, V294, pH1188, DOI 10.1152/ajpheart.00937.2007; Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; Borland G, 2009, BRIT J PHARMACOL, V158, P70, DOI 10.1111/j.1476-5381.2008.00087.x; Brink C, 2003, PHARMACOL REV, V55, P195, DOI 10.1124/pr.55.1.8; Brunschweiger A, 2006, CURR MED CHEM, V13, P289, DOI 10.2174/092986706775476052; Bucheimer RE, 2004, J PHYSIOL-LONDON, V555, P311, DOI 10.1113/jphysiol.2003.056697; Burnstock Geoffrey, 2006, Novartis Found Symp, V276, P26; Capra V, 2005, J CELL SCI, V118, P5625, DOI 10.1242/jcs.02668; Capra V, 2007, MED RES REV, V27, P469, DOI 10.1002/med.20071; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Chow AWM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012091; Costanzi S, 2004, J MED CHEM, V47, P5393, DOI 10.1021/jm049914c; Cox MA, 2005, BIOCHEM BIOPH RES CO, V330, P467, DOI 10.1016/j.bbrc.2005.03.004; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Drazen JM, 2003, ADV EXP MED BIOL, V525, P1; Dulong S, 2007, CELL PHYSIOL BIOCHEM, V20, P483, DOI 10.1159/000107532; Garcia-Marcos L, 1999, PEDIAT ALLERG IMM-UK, V10, P77, DOI 10.1034/j.1399-3038.1999.00006.x; Grbic DM, 2008, J IMMUNOL, V180, P2659, DOI 10.4049/jimmunol.180.4.2659; Hoque KM, 2010, J GEN PHYSIOL, V135, P43, DOI 10.1085/jgp.200910339; Hu QH, 1999, J BIOL CHEM, V274, P33995, DOI 10.1074/jbc.274.48.33995; Jame AJ, 2007, CLIN EXP ALLERGY, V37, P880, DOI 10.1111/j.1365-2222.2007.02733.x; Jiang YF, 2009, J IMMUNOL, V182, P1129, DOI 10.4049/jimmunol.182.2.1129; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kottgen M, 2003, J CLIN INVEST, V111, P371, DOI 10.1172/JCI200316711; Lazarowski ER, 1997, P NATL ACAD SCI USA, V94, P2599, DOI 10.1073/pnas.94.6.2599; Lefkimmiatis K, 2009, NAT CELL BIOL, V11, P433, DOI 10.1038/ncb1850; Leipziger J, 2003, AM J PHYSIOL-RENAL, V284, pF419, DOI 10.1152/ajprenal.00075.2002; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Li J, 2007, MOL ENDOCRINOL, V21, P159, DOI 10.1210/me.2006-0340; Liu GD, 2009, NEUROSCI BULL, V25, P161, DOI 10.1007/s12264-009-0120-3; Mamedova L, 2005, BIOCHEM PHARMACOL, V71, P115, DOI 10.1016/j.bcp.2005.10.003; Marcet B, 2007, J CELL PHYSIOL, V211, P716, DOI 10.1002/jcp.20979; Mellor EA, 2001, P NATL ACAD SCI USA, V98, P7964, DOI 10.1073/pnas.141221498; Nicosia S, 2001, PULM PHARMACOL THER, V14, P3, DOI 10.1006/pupt.2000.0262; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Profita M, 2008, J PHARMACOL EXP THER, V325, P1024, DOI 10.1124/jpet.107.131649; Relvas LJM, 2009, INVEST OPHTH VIS SCI, V50, P1241, DOI 10.1167/iovs.08-1902; Riccioni G, 2007, CURR MED CHEM, V14, P1966; Rovati GE, 2007, THESCIENTIFICWORLDJO, V7, P1375, DOI 10.1100/tsw.2007.185; SAMUELSSON B, 1983, ADV PROSTAG THROMB L, V11, P1; Sarau HM, 1999, MOL PHARMACOL, V56, P657, DOI 10.1124/mol.56.3.657; Schreiber R, 2005, CELL PHYSIOL BIOCHEM, V16, P99, DOI 10.1159/000087736; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; von Kugelgen I, 2000, N-S ARCH PHARMACOL, V362, P310, DOI 10.1007/s002100000310; Wong AM, 2009, AM J RESP CELL MOL, V40, P733, DOI 10.1165/rcmb.2008-0020OC; Wong CHY, 2002, J BIOL CHEM, V277, P9016, DOI 10.1074/jbc.M111917200; Yue GGL, 2004, J BIOL CHEM, V279, P39310, DOI 10.1074/jbc.M406787200	50	15	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22363	10.1371/journal.pone.0022363	http://dx.doi.org/10.1371/journal.pone.0022363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799837	Green Published, gold, Green Submitted			2022-12-25	WOS:000293097300040
J	Shin, JY; Gupta, MK; Jung, YH; Uhm, SJ; Lee, HT				Shin, Ji Young; Gupta, Mukesh Kumar; Jung, Yoon Hee; Uhm, Sang Jun; Lee, Hoon Taek			Differential Genomic Imprinting and Expression of Imprinted microRNAs in Testes-Derived Male Germ-Line Stem Cells in Mouse	PLOS ONE			English	Article							NONCODING RNAS; SELF-RENEWAL; CHROMOSOME 12QF1; GENE-EXPRESSION; CONTROL REGION; IDENTIFICATION; PLURIPOTENCY; CLUSTER; GROWTH; LOCUS	Background: Testis-derived male germ-line stem (GS) cells, the in vitro counterpart of spermatogonial stem cells (SSC), can acquire multipotency under appropriate culture conditions to become multipotent adult germ-line stem (maGS) cells, which upon testicular transplantation, produce teratoma instead of initiating spermatogenesis. Consequently, a molecular marker that can distinguish GS cells from maGS cells would be of potential value in both clinical and experimental research settings. Methods and Findings: Using mouse as a model system, here we show that, similar to sperm, expression of imprinted and paternally expressed miRNAs (miR-296-3p, miR-296-5p, miR-483) were consistently higher (P<0.001), while those of imprinted and maternally expressed miRNA (miR-127, miR-127-5p) were consistently lower (P<0.001) in GS cells than in control embryonic stem (ES) cells. DNA methylation analyses of imprinting control regions (ICR), that control the expression of all imprinted miRNAs in respective gene clusters (Gnas-Nespas DMR, Igf2-H19 ICR and Dlk1-Dio3 IG-DMR), confirmed that imprinted miRNAs were androgenetic in GS cells. On the other hand, DNA methylation of imprinted miRNA genes in maGS cells resembled those of ES cells but the expression pattern of the imprinted miRNAs was intermediate between those of GS and ES cells. The expression of imprinted miRNAs in GS and maGS cells were also altered during their in vitro differentiation and varied both with the differentiation stage and the miRNA. Conclusions: Our data suggest that GS cells have androgenetic DNA methylation and expression of imprinted miRNAs which changes to ES cell-like pattern upon their conversion to maGS cells. Differential genomic imprinting of imprinted miRNAs may thus, serve as epigenetic miRNA signature or molecular marker to distinguish GS cells from maGS cells.	[Shin, Ji Young; Gupta, Mukesh Kumar; Jung, Yoon Hee; Uhm, Sang Jun; Lee, Hoon Taek] Konkuk Univ, Dept Anim Biotechnol, Bioorgan Res Ctr, Anim Resources Res Ctr, Seoul, South Korea	Konkuk University	Shin, JY (corresponding author), Konkuk Univ, Dept Anim Biotechnol, Bioorgan Res Ctr, Anim Resources Res Ctr, Seoul, South Korea.	goops@konkuk.ac.kr; htl3675@konkuk.ac.kr	Gupta, Mukesh/M-8140-2019; Jung, Yoonhee/AAK-3414-2021; liang, yan/H-3894-2011	Gupta, Mukesh/0000-0002-0125-0381; 	Rural Development Administration, Republic of Korea [PJ007188]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from BioGreen 21 Program (#PJ007188), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Ciaudo C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000620; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; de Rooij DG, 2006, P NATL ACAD SCI USA, V103, P7939, DOI 10.1073/pnas.0602432103; Gabory A, 2010, BIOESSAYS, V32, P473, DOI 10.1002/bies.200900170; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Hagan JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004352; Han SY, 2009, ASIAN AUSTRAL J ANIM, V22, P187, DOI 10.5713/ajas.2009.80324; Hiura H, 2007, FEBS LETT, V581, P1255, DOI 10.1016/j.febslet.2007.02.034; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Ju JY, 2008, FERTIL STERIL, V89, P1314, DOI 10.1016/j.fertnstert.2006.11.203; Jung YH, 2010, MOL HUM REPROD, V16, P804, DOI 10.1093/molehr/gaq058; Jung YH, 2010, EXP CELL RES, V316, P747, DOI 10.1016/j.yexcr.2009.11.021; Kanatsu-Shinohara M, 2005, DEVELOPMENT, V132, P4155, DOI 10.1242/dev.02004; Kanatsu-Shinohara M, 2003, BIOL REPROD, V68, P167, DOI 10.1095/biolreprod.102.008516; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P681, DOI 10.1095/biolreprod.107.066068; Kanatsu-Shinohara M, 2007, BIOL REPROD, V76, P55, DOI 10.1095/biolreprod.106.055863; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Lakshmipathy U, 2007, STEM CELLS DEV, V16, P1003, DOI 10.1089/scd.2007.0026; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Liu J, 2005, P NATL ACAD SCI USA, V102, P5513, DOI 10.1073/pnas.0408262102; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; NOGUERDANCE M, 2010, HUM MOL GENET; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Oh SH, 2009, MOL CELLS, V27, P635, DOI 10.1007/s10059-009-0084-1; Peters J, 2008, MAMM GENOME, V19, P493, DOI 10.1007/s00335-008-9139-4; Ren JQ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-20; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Royo H, 2006, CYTOGENET GENOME RES, V113, P99, DOI 10.1159/000090820; Royo H, 2008, BIOL CELL, V100, P149, DOI 10.1042/BC20070126; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sasaki H, 1995, DEVELOPMENT, V121, P4195; Schmidt JA, 2009, BIOL REPROD, V81, P56, DOI 10.1095/biolreprod.108.075358; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Seitz H, 2004, BIOL CHEM, V385, P905, DOI 10.1515/BC.2004.118; Shamanski FL, 1999, HUM REPROD, V14, P1050, DOI 10.1093/humrep/14.4.1050; Shang EY, 2004, GENE EXPR PATTERNS, V4, P513, DOI 10.1016/j.modgep.2004.03.002; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Tarantino C, 2010, FASEB J, V24, P3255, DOI 10.1096/fj.09-152207; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tripathi R, 2011, GENE EXPR PATTERNS, V11, P334, DOI 10.1016/j.gep.2011.03.004; Veronese A, 2010, CANCER RES, V70, P3140, DOI 10.1158/0008-5472.CAN-09-4456; Wei JX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005382; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Williamson CM, 2006, NAT GENET, V38, P350, DOI 10.1038/ng1731; Wroe SF, 2000, P NATL ACAD SCI USA, V97, P3342, DOI 10.1073/pnas.050015397; Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106; Wurdinger T, 2008, CANCER CELL, V14, P382, DOI 10.1016/j.ccr.2008.10.005; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Yan NH, 2007, REPRODUCTION, V134, P73, DOI 10.1530/REP-07-0056; Zechner U, 2009, MOL HUM REPROD, V15, P345, DOI 10.1093/molehr/gap023; Zovoilis A, 2008, MOL HUM REPROD, V14, P521, DOI 10.1093/molehr/gan044; Zovoilis A, 2010, MOL HUM REPROD, V16, P793, DOI 10.1093/molehr/gaq053; Zovoilis A, 2009, DIFFERENTIATION, V78, P69, DOI 10.1016/j.diff.2009.06.003	60	13	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22481	10.1371/journal.pone.0022481	http://dx.doi.org/10.1371/journal.pone.0022481			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799869	Green Submitted, gold, Green Published			2022-12-25	WOS:000293097300052
J	Cheng, Z; Zhang, HT; Chen, MZQ; Zhou, T; Valeyev, NV				Cheng, Zhao; Zhang, Hai-Tao; Chen, Michael Z. Q.; Zhou, Tao; Valeyev, Najl V.			Aggregation Pattern Transitions by Slightly Varying the Attractive/Repulsive Function	PLOS ONE			English	Article							MULTIAGENT SYSTEMS; SENSOR NETWORKS; CONSENSUS; COORDINATION; AGENTS; BEHAVIOR	Among collective behaviors of biological swarms and flocks, the attractive/repulsive (A/R) functional links between particles play an important role. By slightly changing the cutoff distance of the A/R function, a drastic transition between two distinct aggregation patterns is observed. More precisely, a large cutoff distance yields a liquid-like aggregation pattern where the particle density decreases monotonously from the inside to the outwards within each aggregated cluster. Conversely, a small cutoff distance produces a crystal-like aggregation pattern where the distance between each pair of neighboring particles remains constant. Significantly, there is an obvious spinodal in the variance curve of the inter-particle distances along the increasing cutoff distances, implying a legible transition pattern between the liquid-like and crystal-like aggregations. This work bridges the aggregation phenomena of physical particles and swarming of organisms in nature upon revealing some common mechanism behind them by slightly varying their inter-individual attractive/repulsive functions, and may find its potential engineering applications, for example, in the formation design of multi-robot systems and unmanned aerial vehicles (UAVs).	[Cheng, Zhao; Zhang, Hai-Tao] Huazhong Univ Sci & Technol, State Key Lab Digital Mfg Equipments & Technol, Wuhan 430074, Peoples R China; [Cheng, Zhao; Zhang, Hai-Tao] Huazhong Univ Sci & Technol, Key Lab Image Proc & Intelligent Control, Dept Control Sci & Engn, Wuhan 430074, Peoples R China; [Cheng, Zhao] Temple Univ, Dept Elect & Comp Engn, Philadelphia, PA 19122 USA; [Chen, Michael Z. Q.] Univ Hong Kong, Dept Mech Engn, Pokfulam, Hong Kong, Peoples R China; [Chen, Michael Z. Q.] Nanjing Univ Sci & Technol, Sch Automat, Nanjing, Peoples R China; [Zhou, Tao] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu 610054, Peoples R China; [Valeyev, Najl V.] Univ Kent, Sch Engn & Digital Arts, Ctr Mol Proc, Canterbury CT2 7NZ, Kent, England	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Hong Kong; Nanjing University of Science & Technology; University of Electronic Science & Technology of China; University of Kent	Cheng, Z (corresponding author), Huazhong Univ Sci & Technol, State Key Lab Digital Mfg Equipments & Technol, Wuhan 430074, Peoples R China.	zht@mail.hust.edu.cn			National Natural Science Foundation of China (NNSFC) [60704041, 10635040]; Research Fund for the Doctoral Program of Higher Education (RFDP) [20070487090]; University of Hong Kong	National Natural Science Foundation of China (NNSFC)(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education (RFDP)(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); University of Hong Kong(University of Hong Kong)	H.T.Z. acknowledges the support of National Natural Science Foundation of China (NNSFC) under Grant No. 60704041, and the Research Fund for the Doctoral Program of Higher Education (RFDP) under Grant No. 20070487090. T.Z. acknowledges the support of NNSFC under Grant No. 10635040. M.Z.Q.C. acknowledges the CRCG Grant by The University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyildiz IF, 2002, COMPUT NETW, V38, P393, DOI 10.1016/S1389-1286(01)00302-4; Aldana M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.095702; Arai T, 2002, IEEE T ROBOTIC AUTOM, V18, P655, DOI 10.1109/TRA.2002.806024; Archer AJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031501; Bertsekas DP, 2007, IEEE T AUTOMAT CONTR, V52, P968, DOI 10.1109/TAC.2007.895885; BREDER CM, 1954, ECOLOGY, V35, P361, DOI 10.2307/1930099; Chuang YL, 2007, PHYSICA D, V232, P33, DOI 10.1016/j.physd.2007.05.007; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; D'Orsogna MR, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.104302; Gregoire G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.025702; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; Helbing D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083005; Helbing D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.057104; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Jadbabaie A, 2003, IEEE T AUTOMAT CONTR, V48, P988, DOI 10.1109/TAC.2003.812781; Jones JE, 1924, P R SOC LOND A-CONTA, V106, P441, DOI 10.1098/rspa.1924.0081; Juanico DEO, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/48004; Lev BI, 1998, PHYS REV E, V58, pR2681, DOI 10.1103/PhysRevE.58.R2681; Li W, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.021920; Liu M, 2007, PHYSICA A, V383, P733, DOI 10.1016/j.physa.2007.05.030; Melzer A, 1999, PHYS REV LETT, V83, P3194, DOI 10.1103/PhysRevLett.83.3194; Moreau L, 2005, IEEE T AUTOMAT CONTR, V50, P169, DOI 10.1109/TAC.2004.841888; Moussaid M, 2011, P NATL ACAD SCI USA, V108, P6884, DOI 10.1073/pnas.1016507108; Olfati-Saber R, 2006, IEEE T AUTOMAT CONTR, V51, P401, DOI 10.1109/TAC.2005.864190; Olfati-Saber R, 2004, IEEE T AUTOMAT CONTR, V49, P1520, DOI 10.1109/TAC.2004.834113; Peng LQ, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026113; Perc M, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/1/003; Ren W, 2005, IEEE T AUTOMAT CONTR, V50, P655, DOI 10.1109/TAC.2005.846556; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; RIGBY M, 1986, FORCES MOL; SCHLOTTMANN P, 1992, PHYS REV LETT, V68, P1916, DOI 10.1103/PhysRevLett.68.1916; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; Tanner HG, 2003, 42ND IEEE CONFERENCE ON DECISION AND CONTROL, VOLS 1-6, PROCEEDINGS, P2010; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; VICSEK T, 2008, P 2 IEEE INT C SELF, V1, P3; WARBURTON K, 1991, J THEOR BIOL, V150, P473, DOI 10.1016/S0022-5193(05)80441-2; Zhang HT, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/40011; Zhang HT, 2008, IEEE CIRC SYST MAG, V8, P67, DOI 10.1109/MCAS.2008.928446; Zhang HT, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/40003; Zhang HT, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016113	44	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22123	10.1371/journal.pone.0022123	http://dx.doi.org/10.1371/journal.pone.0022123			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799776	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000292931200026
J	Middlebrooks, ML; Pierce, SK; Bell, SS				Middlebrooks, Michael L.; Pierce, Sidney K.; Bell, Susan S.			Foraging Behavior under Starvation Conditions Is Altered via Photosynthesis by the Marine Gastropod, Elysia clarki	PLOS ONE			English	Article							SACOGLOSSAN OPISTHOBRANCHS; SYMBIOTIC CHLOROPLASTS; MOLLUSCA; PREDATION; RISK; AUTOTROPHY; HERBIVORES; DISPERSAL; PRODUCTS; CRISPATA	It has been well documented that nutritional state can influence the foraging behavior of animals. However, photosynthetic animals, those capable of both heterotrophy and symbiotic photosynthesis, may have a delayed behavioral response due to their ability to photosynthesize. To test this hypothesis we subjected groups of the kleptoplastic sea slug, Elysia clarki, to a gradient of starvation treatments of 4, 8, and 12 weeks plus a satiated control. Compared to the control group, slugs starved 8 and 12 weeks displayed a significant increase in the proportion of slugs feeding and a significant decrease in photosynthetic capability, as measured in maximum quantum yield and [chl a]. The 4 week group, however, showed no significant difference in feeding behavior or in the metrics of photosynthesis compared to the control. This suggests that photosynthesis in E. clarki, thought to be linked to horizontally-transferred algal genes, delays a behavioral response to starvation. This is the first demonstration of a link between photosynthetic capability in an animal and a modification of foraging behavior under conditions of starvation.	[Middlebrooks, Michael L.; Pierce, Sidney K.; Bell, Susan S.] Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Middlebrooks, ML (corresponding author), Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA.	mlmiddle@mail.usf.edu		Middlebrooks, Michael/0000-0002-8612-1801	Lerner-Grey Fund for Marine Research; Tharp Fellowship	Lerner-Grey Fund for Marine Research; Tharp Fellowship	Financial support was provided by the Lerner-Grey Fund for Marine Research and the Tharp Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Avila C, 1998, MAR FRESHW BEHAV PHY, V31, P1, DOI 10.1080/10236249809387059; Biesinger Z, 2005, ANIM BEHAV, V69, P235, DOI 10.1016/j.anbehav.2004.02.023; Bonte D, 2008, BASIC APPL ECOL, V9, P308, DOI 10.1016/j.baae.2007.03.004; Casalduero FG, 2008, J EXP MAR BIOL ECOL, V357, P181, DOI 10.1016/j.jembe.2008.01.020; CLARK KB, 1990, VELIGER, V33, P339; Cronin G, 1996, ECOLOGY, V77, P1531, DOI 10.2307/2265549; Curtis NE, 2004, INTEGR COMP BIOL, V44, P686; Curtis NE, 2007, MAR BIOL, V150, P797, DOI 10.1007/s00227-006-0398-x; GREENE RW, 1972, MAR BIOL, V14, P253; GREENE RW, 1970, MAR BIOL, V7, P138, DOI 10.1007/BF00354917; Hader DP, 1997, AQUAT BOT, V56, P253, DOI 10.1016/S0304-3770(96)01107-2; Handeler K, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-28; HART LJ, 1990, J EXP MAR BIOL ECOL, V135, P99, DOI 10.1016/0022-0981(90)90009-2; HOEGHGULDBERG O, 1986, PROC R SOC SER B-BIO, V228, P493, DOI 10.1098/rspb.1986.0066; HOUSTON AI, 1991, J EXP ANAL BEHAV, V56, P585, DOI 10.1901/jeab.1991.56-585; Imafuku M, 2000, MAR FRESHW BEHAV PHY, V33, P221, DOI 10.1080/10236240009387094; JACOME I, 1995, J INSECT PHYSIOL, V41, P1079, DOI 10.1016/0022-1910(95)00067-5; JENSEN KR, 1993, BIOL J LINN SOC, V48, P135, DOI 10.1111/j.1095-8312.1993.tb00883.x; Jeschke JM, 2005, ETHOLOGY, V111, P187, DOI 10.1111/j.1439-0310.2004.01052.x; Jeschke JM, 2007, OECOLOGIA, V152, P357, DOI 10.1007/s00442-006-0654-2; JOYARD J, 1987, METHOD ENZYMOL, V148, P195; MARIN A, 1993, J MOLLUS STUD, V59, P95, DOI 10.1093/mollus/59.1.95; Mondy WL, 2003, INVERTEBR BIOL, V122, P126; Pierce SK, 2008, J SHELLFISH RES, V27, P1042; Pierce SK, 2006, MOLLUSCAN RES, V26, P23; Pierce SK, 2009, SYMBIOSIS, V49, P121, DOI 10.1007/s13199-009-0044-8; Pierce SK, 1996, J EXP BIOL, V199, P2323; Piniak GA, 2002, MAR BIOL, V141, P449, DOI 10.1007/s00227-002-0825-6; Prop J, 2003, OIKOS, V103, P403, DOI 10.1034/j.1600-0706.2003.12042.x; ROCHETTE R, 1994, MAR ECOL PROG SER, V106, P93, DOI 10.3354/meps106093; Soto RE, 2005, ETHOLOGY, V111, P1044, DOI 10.1111/j.1439-0310.2005.01107.x; STEPHENS DW, 1981, ANIM BEHAV, V29, P628, DOI 10.1016/S0003-3472(81)80128-5; STIRTS HM, 1980, J EXP MAR BIOL ECOL, V43, P39, DOI 10.1016/0022-0981(80)90145-8; STOECKER DK, 1989, MAR ECOL PROG SER, V58, P41, DOI 10.3354/meps058041; Titlyanov EA, 2000, SYMBIOSIS, V29, P263; Torres JB, 2002, J APPL ENTOMOL, V126, P326, DOI 10.1046/j.1439-0418.2002.00653.x; TRENCH RK, 1976, NEW PHYTOL, V76, P99, DOI 10.1111/j.1469-8137.1976.tb01442.x; TROWBRIDGE CD, 1994, MAR ECOL PROG SER, V105, P61, DOI 10.3354/meps105061; VADAS RL, 1994, OECOLOGIA, V100, P439, DOI 10.1007/BF00317866; Venn AA, 2008, J EXP BOT, V59, P1069, DOI 10.1093/jxb/erm328; Wagele H, 2001, ORG DIVERS EVOL, V1, P193, DOI 10.1078/1439-6092-00016; Williams SI, 1999, OCEANOGR MAR BIOL, V37, P87; Wojdak JM, 2009, ACTA OECOL, V35, P746, DOI 10.1016/j.actao.2009.08.001	44	21	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22162	10.1371/journal.pone.0022162	http://dx.doi.org/10.1371/journal.pone.0022162			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799783	Green Published, gold, Green Submitted			2022-12-25	WOS:000292931200029
J	Chen, XM; Whissell, P; Orser, BA; MacDonald, JF				Chen, Xuanmao; Whissell, Paul; Orser, Beverley A.; MacDonald, John F.			Functional Modifications of Acid-Sensing Ion Channels by Ligand-Gated Chloride Channels	PLOS ONE			English	Article							EPITHELIAL NA+ CHANNEL; RECEPTORS; DESENSITIZATION; CONTRIBUTES; ACTIVATION; CFTR; ION-CHANNEL-1; REGULATOR; ISCHEMIA; NEURONS	Together, acid-sensing ion channels (ASICs) and epithelial sodium channels (ENaC) constitute the majority of voltage-independent sodium channels in mammals. ENaC is regulated by a chloride channel, the cystic fibrosis transmembrane conductance regulator (CFTR). Here we show that ASICs were reversibly inhibited by activation of GABA(A) receptors in murine hippocampal neurons. This inhibition of ASICs required opening of the chloride channels but occurred with both outward and inward GABA(A) receptor-mediated currents. Moreover, activation of the GABA(A) receptors modified the pharmacological features and kinetic properties of the ASIC currents, including the time course of activation, desensitization and deactivation. Modification of ASICs by open GABA(A) receptors was also observed in both nucleated patches and outside-out patches excised from hippocampal neurons. Interestingly, ASICs and GABA(A) receptors interacted to regulate synaptic plasticity in CA1 hippocampal slices. The activation of glycine receptors, which are similar to GABA(A) receptors, also modified ASICs in spinal neurons. We conclude that GABA(A) receptors and glycine receptors modify ASICs in neurons through mechanisms that require the opening of chloride channels.	[Chen, Xuanmao; Whissell, Paul; Orser, Beverley A.; MacDonald, John F.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Chen, Xuanmao; MacDonald, John F.] Univ Western Ontario, Robarts Res Inst, London, ON, Canada; [Orser, Beverley A.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Anesthesia, Toronto, ON, Canada	University of Toronto; Western University (University of Western Ontario); University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Chen, XM (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	beverley.orser@utoronto.ca; j.macdonald@utoronto.ca	chen, xuanmao/I-7576-2013	Chen, Xuanmao/0000-0002-0057-8510	Canadian Institutes of Health Research [15514, 38028]; Canadian Stroke Network; Heart and Stroke Foundation in Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Stroke Network; Heart and Stroke Foundation in Canada	This work was supported by grants (grant number 15514 to J.F.M., grant number 38028 to B.A.O.) from the Canadian Institutes of Health Research Grants and a Canadian Stroke Network Grant to J.F. M. X. C. was supported by a postdoctoral research fellowship from the Heart and Stroke Foundation in Canada and by Canadian Stroke Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Bai DL, 1999, J NEUROSCI, V19, P10635, DOI 10.1523/JNEUROSCI.19-24-10635.1999; Berdiev BK, 2009, MOL BIOSYST, V5, P123, DOI 10.1039/b810471a; Betz H, 1999, ANN NY ACAD SCI, V868, P667, DOI 10.1111/j.1749-6632.1999.tb11343.x; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Chen XM, 2007, J BIOL CHEM, V282, P30406, DOI 10.1074/jbc.M702229200; Chen XM, 2010, NEUROPHARMACOLOGY, V58, P1045, DOI 10.1016/j.neuropharm.2010.01.011; Cheng VY, 2006, J NEUROSCI, V26, P3713, DOI 10.1523/JNEUROSCI.5024-05.2006; Cho JH, 2008, J NEUROPHYSIOL, V99, P426, DOI 10.1152/jn.00940.2007; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Gentzsch M, 2010, J BIOL CHEM, V285, P32227, DOI 10.1074/jbc.M110.155259; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Kusama N, 2010, J BIOL CHEM, V285, P17425, DOI 10.1074/jbc.M109.091561; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Matsumoto K, 1996, J CEREBR BLOOD F MET, V16, P114, DOI 10.1097/00004647-199601000-00014; Reddy MM, 1999, NATURE, V402, P301, DOI 10.1038/46297; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Weng JY, 2010, J NEUROSCI, V30, P6548, DOI 10.1523/JNEUROSCI.0582-10.2010; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132	30	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e21970	10.1371/journal.pone.0021970	http://dx.doi.org/10.1371/journal.pone.0021970			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789198	gold, Green Published, Green Submitted			2022-12-25	WOS:000292812400022
J	Liu, SL; Lei, SF; Yang, F; Li, X; Liu, R; Nie, S; Liu, XG; Yang, TL; Guo, Y; Deng, FY; Tian, Q; Li, J; Liu, YZ; Liu, YJ; Shen, H; Deng, HW				Liu, Shan-Lin; Lei, Shu-Feng; Yang, Fang; Li, Xi; Liu, Rong; Nie, Shan; Liu, Xiao-Gang; Yang, Tie-Lin; Guo, Yan; Deng, Fei-Yan; Tian, Qing; Li, Jian; Liu, Yao-Zhong; Liu, Yong-Jun; Shen, Hui; Deng, Hong-Wen			Copy Number Variation in CNP267 Region May Be Associated with Hip Bone Size	PLOS ONE			English	Article							MINERAL DENSITY; ANDROGEN RECEPTOR; ETHNIC DIFFERENCE; CANDIDATE GENES; PROTEIN FHL2; OSTEOPOROSIS; SPINE; POLYMORPHISM; CHINESE; DIFFERENTIATION	Osteoporotic hip fracture (HF) is a serious global public health problem associated with high morbidity and mortality. Hip bone size (BS) has been identified as one of key measurable risk factors for HF, independent of bone mineral density (BMD). Hip BS is highly genetically determined, but genetic factors underlying BS variation are still poorly defined. Here, we performed an initial genome-wide copy number variation (CNV) association analysis for hip BS in 1,627 Chinese Han subjects using Affymetrix GeneChip Human Mapping SNP 6.0 Array and a follow-up replicate study in 2,286 unrelated US Caucasians sample. We found that a copy number polymorphism (CNP267) located at chromosome 2q12.2 was significantly associated with hip BS in both initial Chinese and replicate Caucasian samples with p values of 4.73E-03 and 5.66E-03, respectively. An important candidate gene, four and a half LIM domains 2 (FHL2), was detected at the downstream of CNP267, which plays important roles in bone metabolism by binding to several bone formation regulator, such as insulin-like growth factor-binding protein 5 (IGFBP-5) and androgen receptor (AR). Our findings suggest that CNP267 region may be associated with hip BS which might influence the FHL2 gene downstream.	[Liu, Shan-Lin; Lei, Shu-Feng; Yang, Fang; Li, Xi; Liu, Rong; Nie, Shan; Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Minist Educ, Lab Mol & Stat Genet, Changsha, Hunan, Peoples R China; [Liu, Shan-Lin; Lei, Shu-Feng; Yang, Fang; Li, Xi; Liu, Rong; Nie, Shan; Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China; [Deng, Fei-Yan; Tian, Qing; Li, Jian; Liu, Yao-Zhong; Liu, Yong-Jun; Shen, Hui; Deng, Hong-Wen] Tulane Univ, Sch Publ Hlth & Trop Med, Ctr Bioinformat & Genom, New Orleans, LA USA; [Liu, Xiao-Gang; Yang, Tie-Lin; Guo, Yan; Shen, Hui; Deng, Hong-Wen] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Xian 710049, Shanxi, Peoples R China; [Deng, Hong-Wen] Shanghai Univ Sci & Technol, Ctr Systemat Biomed Res, Shanghai 201800, Peoples R China	Hunan Normal University; Hunan Normal University; Tulane University; Xi'an Jiaotong University; University of Shanghai for Science & Technology	Liu, SL (corresponding author), Hunan Normal Univ, Coll Life Sci, Minist Educ, Lab Mol & Stat Genet, Changsha, Hunan, Peoples R China.	lei@hunnu.edu.cn; hdeng2@tulane.edu	Li, Jian/G-4445-2015; Liu, Shanlin/HGA-2841-2022; Liu, Yaozhong/ABD-5544-2020; Liu, Shanlin/GNH-3256-2022; Guo, Yan/G-8742-2014; Liu, Yong/GWQ-6163-2022; Yang, Tie-Lin/G-8365-2014	Liu, Shanlin/0000-0001-8118-8313; Liu, Shanlin/0000-0001-8118-8313; Guo, Yan/0000-0002-7364-2392; Yang, Tie-Lin/0000-0001-7062-3025; Deng, Hong-Wen/0000-0002-0387-8818	Natural Science Foundation of China (NSFC) [31071097, 30600364, 30771222, 30900810]; NSFC-Canadian Institutes of Health Research (CIHR) Joint Health Research Initiative Proposal [30811120436]; NSFC/Research Grants Council [30731160618]; Shanghai Leading Academic Discipline Project [S30501]; Shanghai University of Science and Technology; National Institutes of Health [P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, R03TW008221]; Franklin D. Dickson/Missouri Endowment; FOGARTY INTERNATIONAL CENTER [R03TW008221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050496, P50AR055081, R01AR057049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564] Funding Source: NIH RePORTER	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC-Canadian Institutes of Health Research (CIHR) Joint Health Research Initiative Proposal(Canadian Institutes of Health Research (CIHR)); NSFC/Research Grants Council(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai University of Science and Technology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Franklin D. Dickson/Missouri Endowment; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was partially supported by Natural Science Foundation of China (NSFC) (31071097, 30600364, 30771222 and 30900810), NSFC-Canadian Institutes of Health Research (CIHR) Joint Health Research Initiative Proposal (30811120436), NSFC/Research Grants Council Joint Research Scheme (30731160618), Shanghai Leading Academic Discipline Project (S30501) and startup fund from Shanghai University of Science and Technology. H-WD was partially supported by grants from National Institutes of Health (P50AR055081, R01AG026564, R01AR050496, RC2DE020756, R01AR057049, and R03TW008221) and Franklin D. Dickson/Missouri Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter MP, 1998, CALCIFIED TISSUE INT, V63, P442, DOI 10.1007/s002239900554; Amaar YG, 2002, J BIOL CHEM, V277, P12053, DOI 10.1074/jbc.M110872200; Andress DL, 2001, AM J PHYSIOL-ENDOC M, V281, pE283, DOI 10.1152/ajpendo.2001.281.2.E283; Bai ST, 2005, J CLIN INVEST, V115, P2742, DOI 10.1172/JCI24921; Bi WM, 2002, GENOME RES, V12, P713, DOI 10.1101/gr.73702; Boniotto M, 2004, GENET TEST, V8, P325, DOI 10.1089/gte.2004.8.325; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Chang XL, 2011, J NEUROL SCI, V302, P68, DOI 10.1016/j.jns.2010.11.023; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Czarnomska A, 2003, CANCER RES, V63, P4533; Deng FY, 2010, OSTEOPOROSIS INT, V21, P579, DOI 10.1007/s00198-009-0998-7; Deng HW, 2002, J BONE MINER METAB, V20, P358, DOI 10.1007/s007740200052; Deng HW, 2002, J CLIN DENSITOM, V5, P45, DOI 10.1385/JCD:5:1:045; Dvornyk V, 2005, CHINESE MED J-PEKING, V118, P1235; Dvornyk V, 2003, ANN HUM GENET, V67, P216, DOI 10.1046/j.1469-1809.2003.00037.x; Eder W, 2005, J ALLERGY CLIN IMMUN, V116, P601, DOI 10.1016/j.jaci.2005.05.003; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Fang Y, 2007, J CLIN ENDOCR METAB, V92, P1491, DOI 10.1210/jc.2006-1134; Fisher KA, 2008, J ACOUST SOC AM, V123, P1862, DOI 10.1121/1.2839140; GILSANZ V, 1994, RADIOLOGY, V190, P678, DOI 10.1148/radiology.190.3.8115610; Gong G, 1999, OSTEOPOROSIS INT, V9, P307, DOI 10.1007/s001980050152; Govoni KE, 2006, CALCIFIED TISSUE INT, V79, P112, DOI 10.1007/s00223-006-0074-7; Govoni KE, 2005, PEDIATR NEPHROL, V20, P261, DOI 10.1007/s00467-004-1658-y; Gunther T, 2005, EMBO J, V24, P3049, DOI 10.1038/sj.emboj.7600773; Jian WX, 2004, J HUM GENET, V49, P87, DOI 10.1007/s10038-003-0113-4; Kawano H, 2003, P NATL ACAD SCI USA, V100, P9416, DOI 10.1073/pnas.1533500100; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Labalette C, 2004, MOL CELL BIOL, V24, P10689, DOI 10.1128/MCB.24.24.10689-10702.2004; Lei S. F., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P36; Lei SF, 2005, BONE, V36, P533, DOI 10.1016/j.bone.2004.11.002; Liu YJ, 2006, J BONE MINER RES, V21, P1511, DOI 10.1359/JBMR.051002; Liu ZH, 2002, J BONE MINER METAB, V20, P181, DOI 10.1007/s007740200026; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Martin B, 2002, J CELL BIOL, V159, P113, DOI 10.1083/jcb.200202075; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Miao XP, 2010, J PEDIATR SURG, V45, P709, DOI 10.1016/j.jpedsurg.2009.07.067; MOHAN S, 1995, J BIOL CHEM, V270, P20424, DOI 10.1074/jbc.270.35.20424; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Need AG, 1996, EUR J CLIN INVEST, V26, P793, DOI 10.1046/j.1365-2362.1996.2080554.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Reneland RH, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-9; Reymond A, 2007, CURR OPIN GENET DEV, V17, P381, DOI 10.1016/j.gde.2007.08.009; Richman C, 1999, ENDOCRINOLOGY, V140, P4699, DOI 10.1210/en.140.10.4699; Seeman E, 2001, J BONE MINER RES, V16, P120, DOI 10.1359/jbmr.2001.16.1.120; Shao W, 2007, GENES IMMUN, V8, P224, DOI 10.1038/sj.gene.6364378; Sharp AJ, 2009, HUM MUTAT, V30, P135, DOI 10.1002/humu.20843; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; Zmuda JM, 2001, J BONE MINER RES, V16, P911, DOI 10.1359/jbmr.2001.16.5.911	50	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22035	10.1371/journal.pone.0022035	http://dx.doi.org/10.1371/journal.pone.0022035			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789208	gold, Green Published, Green Submitted			2022-12-25	WOS:000292811700016
J	Nance, HA; Klimley, P; Galvan-Magana, F; Martinez-Ortiz, J; Marko, PB				Nance, Holly A.; Klimley, Peter; Galvan-Magana, Felipe; Martinez-Ortiz, Jimmy; Marko, Peter B.			Demographic Processes Underlying Subtle Patterns of Population Structure in the Scalloped Hammerhead Shark, Sphyrna lewini	PLOS ONE			English	Article							GENETIC DIVERSITY; MICROSATELLITE LOCI; MUTATION-RATES; GLOBAL PHYLOGEOGRAPHY; STATISTICAL TESTS; TROPICAL PACIFIC; STOCK ASSESSMENT; MIGRATION RATES; BLACKTIP SHARK; ATLANTIC-OCEAN	Genetic diversity (theta), effective population size (N-e), and contemporary levels of gene flow are important parameters to estimate for species of conservation concern, such as the globally endangered scalloped hammerhead shark, Sphyrna lewini. Therefore, we have reconstructed the demographic history of S. lewini across its Eastern Pacific (EP) range by applying classical and coalescent population genetic methods to a combination of 15 microsatellite loci and mtDNA control region sequences. In addition to significant population genetic structure and isolation-by-distance among seven coastal sites between central Mexico and Ecuador, the analyses revealed that all populations have experienced a bottleneck and that all current values of h are at least an order of magnitude smaller than ancestral theta, indicating large decreases in N-e (theta= 4N(e)mu), where mu is the mutation rate. Application of the isolation-with-migration (IM) model showed modest but significant genetic connectivity between most sampled sites (point estimates of Nm= 0.1-16.7), with divergence times (t) among all populations significantly greater than zero. Using a conservative (i.e., slow) fossil-based taxon-specific phylogenetic calibration for mtDNA mutation rates, posterior probability distributions (PPDs) for the onset of the decline in N-e predate modern fishing in this region. The cause of decline over the last several thousand years is unknown but is highly atypical as a post-glacial demographic history. Regardless of the cause, our data and analyses suggest that S. lewini was far more abundant throughout the EP in the past than at present.	[Nance, Holly A.; Marko, Peter B.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Klimley, Peter] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Galvan-Magana, Felipe] IPN, CICIMAR, La Paz, Mexico; [Martinez-Ortiz, Jimmy] EPESPO, Manta, Ecuador	Clemson University; University of California System; University of California Davis; Instituto Politecnico Nacional - Mexico	Nance, HA (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	hnance@hboi.fau.edu			National Science Foundation [DEB03-44419, OCE05-50526]; Cooperative State Research, Education, and Extension Service/United States Department of Agriculture [SC-1700342]; University of North Carolina; Instituto Politecnico Nacional	National Science Foundation(National Science Foundation (NSF)); Cooperative State Research, Education, and Extension Service/United States Department of Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); University of North Carolina; Instituto Politecnico Nacional	Funds for this work were provided by National Science Foundation (http://www.nsf.gov/) grants DEB03-44419 and OCE05-50526 to Peter B. Marko, a Cooperative State Research, Education, and Extension Service/United States Department of Agriculture grant under project number SC-1700342, and a University of North Carolina Smith Graduate Research grant (http://gradschool.unc.edu/funding/) to Holly A. Nance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are extremely grateful to M. Hoyos, Y. Torres, M. Garcia, A. Polanco, I. Zanella, D. Chacon-Rojas, A. Vega, H. Guzman, P. Ahuja, O. Escobar, S. Jorgensen, S. Torres, L. Mejia, V. Alatorre, D. Ramirez, L. Castillo, M. Angel, and Chuy, Coochie, and other fishermen who generously cooperated with us and were instrumental in sample collection. All sequencing was done at CUGI - we thank J. Troutman, K. Brown, and R. Ackerman. S. Emme, the Marko Lab, and M. Marsh provided valuable technical support. F. Galvan-Magana thanks Instituto Politecnico Nacional (COFAA and EDI) for their support. This is a technical contribution no. 5942 of the Clemson University Experiment Station.	Allen Melinda S., 2002, Asian Perspectives, V41, P195, DOI 10.1353/asi.2003.0001; Allen MS, 2001, INT J OSTEOARCHAEOL, V11, P56, DOI 10.1002/oa.546; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Ashley MV, 2009, COMPUTATIONAL BIOLOGY: NEW RESEARCH, P231; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Beaumont MA, 1999, GENETICS, V153, P2013; Becquet C, 2007, GENOME RES, V17, P1505, DOI 10.1101/gr.6409707; Becquet C, 2009, EVOLUTION, V63, P2547, DOI 10.1111/j.1558-5646.2009.00662.x; Beerli P, 2004, MOL ECOL, V13, P827, DOI 10.1111/j.1365-294X.2004.02101.x; Bradshaw CJA, 2008, BIOL CONSERV, V141, P1894, DOI 10.1016/j.biocon.2008.05.007; BRANSTETTER S, 1987, ENVIRON BIOL FISH, V19, P161, DOI 10.1007/BF00005346; Bulut Z, 2009, GENETICA, V136, P501, DOI 10.1007/s10709-008-9341-z; Butler VL, 2001, INT J OSTEOARCHAEOL, V11, P88, DOI 10.1002/oa.548; Cappetta H., 1987, HDB PALEOICHTHYOLO B, V3B; Castro ALF, 2007, MOL ECOL, V16, P5183, DOI 10.1111/j.1365-294X.2007.03597.x; Chapman Demian D., 2010, Endangered Species Research, V9, P221, DOI 10.3354/esr00241; Chevolot M, 2008, HEREDITY, V101, P120, DOI 10.1038/hdy.2008.36; Clarke SC, 2006, CONSERV BIOL, V20, P201, DOI 10.1111/j.1523-1739.2005.00247.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Compagno LJV., 1984, FAO FISH SYNOP, P20; Cook T, 1998, ESTUAR COAST SHELF S, V46, P587, DOI 10.1006/ecss.1997.0283; COOKE R, 1992, J WORLD PREHIST, V6, P1, DOI 10.1007/BF00997584; Cornuet JM, 1996, GENETICS, V144, P2001; Cortes E, 2010, AQUAT LIVING RESOUR, V23, P25, DOI 10.1051/alr/2009044; CROW GL, 1995, J WILDLIFE DIS, V31, P562, DOI 10.7589/0090-3558-31.4.562; DALLAS JF, 1992, MAMM GENOME, V3, P452, DOI 10.1007/BF00356155; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dudgeon CL, 2009, MOL ECOL, V18, P248, DOI 10.1111/j.1365-294X.2008.04025.x; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Duncan KM, 2006, MOL ECOL, V15, P2239, DOI 10.1111/j.1365-294X.2006.02933.x; Torres-Rojas YE, 2010, AQUAT ECOL, V44, P301, DOI 10.1007/s10452-009-9245-8; ELLEGREN H, 1995, MAMM GENOME, V6, P376, DOI 10.1007/BF00364807; Erlandson JM, 2005, ANNU REV MAR SCI, V2, P231; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1971, GENETICS, V68, P581; Fitzpatrick SM, 2007, CORAL REEFS, V26, P915, DOI 10.1007/s00338-007-0226-x; Fong QSW, 2002, ECOL ECON, V40, P117, DOI 10.1016/S0921-8009(01)00273-7; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1996, GENETICS, V143, P557; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Gonser R, 2000, GENETICS, V154, P1793; HASTINGS A, 1993, ECOLOGY, V74, P1362, DOI 10.2307/1940066; Hayes CG, 2009, N AM J FISH MANAGE, V29, P1406, DOI 10.1577/M08-026.1; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Hoelzel AR, 2010, CONSERV GENET, V11, P655, DOI 10.1007/s10592-010-0045-4; Holt T, 2001, CERTIFICATION REPORT; Hu YB, 2010, GENETICA, V138, P1297, DOI 10.1007/s10709-010-9532-2; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; JORDE PE, 1995, GENETICS, V139, P1077; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Karl SA, 2011, CONSERV GENET, V12, P371, DOI 10.1007/s10592-010-0145-1; Keeney DB, 2003, MOL ECOL NOTES, V3, P501, DOI 10.1046/j.1471-8286.2003.00492.x; Koutavas A, 2002, SCIENCE, V297, P226, DOI 10.1126/science.1072376; Kraus SD, 2005, SCIENCE, V309, P561, DOI 10.1126/science.1111200; Lamy F, 2001, EARTH PLANET SC LETT, V185, P369, DOI 10.1016/S0012-821X(00)00381-2; Lavery S, 1996, MOL BIOL EVOL, V13, P1106, DOI 10.1093/oxfordjournals.molbev.a025672; LESSIOS HA, 1984, CORAL REEFS, V3, P173, DOI 10.1007/BF00288252; Lim DD, 2010, MOL PHYLOGENET EVOL, V55, P572, DOI 10.1016/j.ympev.2010.01.037; Liu JX, 2006, MOL PHYLOGENET EVOL, V40, P712, DOI 10.1016/j.ympev.2006.04.019; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; MacKenzie BR, 2007, FISH RES, V87, P229, DOI 10.1016/j.fishres.2007.01.013; Marko PB, 2010, MOL ECOL, V19, P146, DOI 10.1111/j.1365-294X.2009.04417.x; MARTIN AP, 1992, NATURE, V357, P153, DOI 10.1038/357153a0; Martin AP, 1999, MOL BIOL EVOL, V16, P996, DOI 10.1093/oxfordjournals.molbev.a026189; Martinez-Ortiz J., 2007, TIBURONES ECUADOR CA, P9; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nance HA, 2009, MOL ECOL RESOUR, V9, P955, DOI 10.1111/j.1755-0998.2008.02510.x; Olivieri GL, 2008, BIOL CONSERV, V141, P1257, DOI 10.1016/j.biocon.2008.02.025; Ovenden JR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-40; Palumbi SR, 2003, ECOL APPL, V13, pS146; Pardini AT, 2001, NATURE, V412, P139, DOI 10.1038/35084125; Peakall R, 2005, GENALEX 6 GENETIC AN; Pereyra S, 2010, FISH RES, V106, P468, DOI 10.1016/j.fishres.2010.09.022; Piercy AN, 2007, MAR FRESHWATER RES, V58, P34, DOI 10.1071/MF05195; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; Porch CE, 2006, FISH B-NOAA, V104, P89; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Quattro JM, 2006, MAR BIOL, V148, P1143, DOI 10.1007/s00227-005-0151-x; Rambaut A, 2014, TRACER V1 6; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rick TC, 2001, AM ANTIQUITY, V66, P595, DOI 10.2307/2694175; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Roman J, 2003, SCIENCE, V301, P508, DOI 10.1126/science.1084524; Rose GA, 2000, CAN J FISH AQUAT SCI, V57, P644, DOI 10.1139/cjfas-57-3-644; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Hoelzel AR, 2006, BIOL LETTERS, V2, P639, DOI 10.1098/rsbl.2006.0513; Schug MD, 1997, NAT GENET, V15, P99, DOI 10.1038/ng0197-99; Schultz JK, 2008, MOL ECOL, V17, P5336, DOI 10.1111/j.1365-294X.2008.04000.x; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; SMITH AG, 1989, J MED VET MYCOL, V27, P83; Stoskopf M., 1993, FISH MED; Strasburg JL, 2010, MOL BIOL EVOL, V27, P297, DOI 10.1093/molbev/msp233; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; TEMPLETON AR, 1992, GENETICS, V132, P619; Torres-Huerta AM, 1999, OBSERVACIONES BIOL R; Uthicke S, 2003, MOL ECOL, V12, P2635, DOI 10.1046/j.1365-294X.2003.01954.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Walsh CJ, 2006, INTEGR COMP BIOL, V46, P1072, DOI 10.1093/icb/icl041; Wang JL, 2009, MOL ECOL, V18, P2148, DOI 10.1111/j.1365-294X.2009.04175.x; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Wares JP, 2001, EVOLUTION, V55, P2455; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; Yue GH, 2007, GENETICA, V129, P329, DOI 10.1007/s10709-006-0003-8; Yue GH, 2002, GENETICA, V114, P113, DOI 10.1023/A:1015189921578; Zanella I, 2008, THESIS U NACL COSTA	114	55	57	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21459	10.1371/journal.pone.0021459	http://dx.doi.org/10.1371/journal.pone.0021459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21789171	gold, Green Submitted, Green Published			2022-12-25	WOS:000292811300009
J	Hellsten, R; Johansson, M; Dahlman, A; Sterner, O; Bjartell, A				Hellsten, Rebecka; Johansson, Martin; Dahlman, Anna; Sterner, Olov; Bjartell, Anders			Galiellalactone Inhibits Stem Cell-Like ALDH-Positive Prostate Cancer Cells	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; ALDEHYDE DEHYDROGENASE 1; DRUG DISCOVERY; STAT3; MARKER; EXPRESSION; PATHWAY; IDENTIFICATION; PROGRESSION; PREDICTOR	Galiellalactone is a potent and specific inhibitor of STAT3 signaling which has been shown to possess growth inhibitory effects on prostate cancer cells expressing active STAT3. In this study we aimed to investigate the effect of galiellalactone on prostate cancer stem cell-like cells. We explored the expression of aldehyde dehydrogenase (ALDH) as a marker for cancer stem cell-like cells in different human prostate cancer cell lines and the effects of galiellalactone on ALDH expressing (ALDH+) prostate cancer cells. ALDH+ subpopulations were detected and isolated from the human prostate cancer cell lines DU145 and long-term IL-6 stimulated LNCaP cells using ALDEFLUOR (R) assay and flow cytometry. In contrast to ALDH- cells, ALDH+ prostate cancer cells showed cancer stem cell-like characteristics such as increased self-renewing and colony forming capacity and tumorigenicity. In addition, ALDH+ cells showed an increased expression of putative prostate cancer stem cell markers (CD44 and integrin alpha 2 beta 1). Furthermore, ALDH+ cells expressed phosphorylated STAT3. Galiellalactone treatment decreased the proportion of ALDH+ prostate cancer cells and induced apoptosis of ALDH+ cells. The gene expression of ALDH1A1 was downregulated in vivo in galiellalactone treated DU145 xenografts. These findings emphasize that targeting the STAT3 pathway in prostate cancer cells, including prostate cancer stem cell-like cells, is a promising therapeutic approach and that galiellalactone is an interesting compound for the development of future prostate cancer drugs.	[Hellsten, Rebecka; Dahlman, Anna; Bjartell, Anders] Lund Univ, Dept Clin Sci, Div Urol Cancers, Malmo, Sweden; [Johansson, Martin; Sterner, Olov] Lund Univ, Dept Chem, Div Organ Chem, Lund, Sweden	Lund University; Lund University	Hellsten, R (corresponding author), Lund Univ, Dept Clin Sci, Div Urol Cancers, Malmo, Sweden.	rebecka.hellsten@med.lu.se			Swedish Cancer Society; Swedish Research Council; MAS Cancer Foundation; Holger Knud Christensens Donation; Percy Falck Foundation; Gunnar Nilsson Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); MAS Cancer Foundation; Holger Knud Christensens Donation; Percy Falck Foundation; Gunnar Nilsson Foundation	The Swedish Cancer Society, The Swedish Research Council, MAS Cancer Foundation, Holger Knud Christensens Donation, Percy Falck Foundation and Gunnar Nilsson Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulghani J, 2008, AM J PATHOL, V172, P1717, DOI 10.2353/ajpath.2008.071054; Birnie R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r83; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Costantino L, 2008, CURR MED CHEM, V15, P834, DOI 10.2174/092986708783955464; Deng JX, 2007, CURR CANCER DRUG TAR, V7, P91, DOI 10.2174/156800907780006922; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hellsten R, 2008, PROSTATE, V68, P269, DOI 10.1002/pros.20699; Hobisch A, 2001, CLIN CANCER RES, V7, P2941; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; Johansson M, 2002, J ANTIBIOT, V55, P663, DOI 10.7164/antibiotics.55.663; Kakarala M, 2010, BREAST CANCER RES TR, V122, P777, DOI 10.1007/s10549-009-0612-x; Kawasaki BT, 2009, PROSTATE, V69, P827, DOI 10.1002/pros.20931; Kelly K, 2008, CELL RES, V18, P528, DOI 10.1038/cr.2008.50; Lang SH, 2009, J PATHOL, V217, P299, DOI 10.1002/path.2478; Li GR, 2010, J BIOL CHEM, V285, P5461, DOI 10.1074/jbc.M109.037127; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Lindgren D, 2011, AM J PATHOL, V178, P828, DOI 10.1016/j.ajpath.2010.10.026; Maitland NJ, 2008, J CLIN ONCOL, V26, P2862, DOI 10.1200/JCO.2007.15.1472; Maitland NJ, 2008, J CELL BIOCHEM, V105, P931, DOI 10.1002/jcb.21843; Pfeiffer MJ, 2010, EUR UROL, V57, P246, DOI 10.1016/j.eururo.2009.01.015; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Saini V, 2010, CANCER SCI, V101, P16, DOI 10.1111/j.1349-7006.2009.01371.x; Sengupta A, 2010, J CELL PHYSIOL, V225, P7, DOI 10.1002/jcp.22213; Su Y, 2010, CANCER EPIDEM BIOMAR, V19, P327, DOI 10.1158/1055-9965.EPI-09-0865; Tam L, 2007, BRIT J CANCER, V97, P378, DOI 10.1038/sj.bjc.6603871; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Tang Y, 2010, INT J CLIN EXP PATHO, V3, P128; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Villalva C, 2011, INT J CANCER, V128, P826, DOI 10.1002/ijc.25416; Wei C, 2007, CANCER BIOL THER, V6, P763, DOI 10.4161/cbt.6.5.3996; Weidler M, 2000, FEBS LETT, V484, P1, DOI 10.1016/S0014-5793(00)02115-3; Zhang KX, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-319; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	40	72	73	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e22118	10.1371/journal.pone.0022118	http://dx.doi.org/10.1371/journal.pone.0022118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779382	Green Published, Green Submitted, gold			2022-12-25	WOS:000292680900030
J	Kisiela, DI; Kramer, JJ; Tchesnokova, V; Aprikian, P; Yarov-Yarovoy, V; Clegg, S; Sokurenko, EV				Kisiela, Dagmara I.; Kramer, Jeremy J.; Tchesnokova, Veronika; Aprikian, Pavel; Yarov-Yarovoy, Vladimir; Clegg, Steven; Sokurenko, Evgeni V.			Allosteric Catch Bond Properties of the FimH Adhesin from Salmonella enterica Serovar Typhimurium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; TYPE-1 FIMBRIAE; BINDING SPECIFICITIES; DIFFERENTIAL BINDING; BACTERIAL ADHESION; PROTEIN-STRUCTURE; STRUCTURAL BASIS; MOLECULAR-BASIS; CELLS; COLONIZATION	Despite sharing the name and the ability to mediate mannose-sensitive adhesion, the type 1 fimbrial FimH adhesins of Salmonella Typhimurium and Escherichia coli share only 15% sequence identity. In the present study, we demonstrate that even with this limited identity in primary sequence, these two proteins share remarkable similarity of complex receptor binding and structural properties. In silico simulations suggest that, like E. coli FimH, Salmonella FimH has a two-domain tertiary structure topology, with a mannose-binding pocket located on the apex of a lectin domain. Structural analysis of mutations that enhance S. Typhimurium FimH binding to eukaryotic cells and mannose-BSA demonstrated that they are not located proximal to the predicted mannose-binding pocket but rather occur in the vicinity of the predicted interface between the lectin and pilin domains of the adhesin. This implies that the functional effect of such mutations is indirect and probably allosteric in nature. By analogy with E. coli FimH, we suggest that Salmonella FimH functions as an allosteric catch bond adhesin, where shear-induced separation of the lectin and pilin domains results in a shift from a low affinity to a high affinity binding conformation of the lectin domain. Indeed, we observed shear-enhanced binding of whole bacteria expressing S. Typhimurium type 1 fimbriae. In addition, we observed that anti-FimH antibodies activate rather than inhibit S. Typhimurium FimH mannose binding, consistent with the allosteric catch bond properties of this adhesin.	[Kisiela, Dagmara I.; Kramer, Jeremy J.; Tchesnokova, Veronika; Aprikian, Pavel; Yarov-Yarovoy, Vladimir; Sokurenko, Evgeni V.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Clegg, Steven] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Washington; University of Washington Seattle; University of Iowa	Sokurenko, EV (corresponding author), Univ Washington, Dept Microbiol, Rm J267A HSB,Box 357242, Seattle, WA 98195 USA.	evs@u.washington.edu	Yarov-Yarovoy, Vladimir/ABE-5454-2020	Yarov-Yarovoy, Vladimir/0000-0002-2325-4834	National Institutes of Health [RO1 GM084318, RO1 AI050940, RO1 AI74693]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050940, R01AI074693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM084318, RO1 AI050940, and RO1 AI74693.	Althouse C, 2003, INFECT IMMUN, V71, P6446, DOI 10.1128/IAI.71.11.6446-6452.2003; Anderson BN, 2007, J BACTERIOL, V189, P1794, DOI 10.1128/JB.00899-06; Aprikian P, 2007, J BIOL CHEM, V282, P23437, DOI 10.1074/jbc.M702037200; Aprikian P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000617; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baumler AJ, 1997, ADV EXP MED BIOL, V412, P149; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; BHATTACHARJEE JW, 1978, J GEN MICROBIOL, V107, P407, DOI 10.1099/00221287-107-2-407; Boddicker JD, 2002, MOL MICROBIOL, V45, P1255, DOI 10.1046/j.1365-2958.2002.03121.x; Boyd EF, 1999, J BACTERIOL, V181, P1301, DOI 10.1128/JB.181.4.1301-1308.1999; Bullitt E, 1998, BIOPHYS J, V74, P623, DOI 10.1016/S0006-3495(98)77821-X; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; CLEGG S, 1985, INFECT IMMUN, V48, P275, DOI 10.1128/IAI.48.2.275-279.1985; Collinson SK, 1996, GENE, V169, P75, DOI 10.1016/0378-1119(95)00763-6; Duguid J. L., 1980, BACTERIAL ADHERENCE, V6, P185; Duncan MJ, 2005, J BIOL CHEM, V280, P37707, DOI 10.1074/jbc.M501249200; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Ewen SWB, 1997, FEMS IMMUNOL MED MIC, V18, P185, DOI 10.1016/S0928-8244(97)00038-2; Forero M, 2006, PLOS BIOL, V4, P1509, DOI 10.1371/journal.pbio.0040298; FU DT, 1994, CARBOHYD RES, V261, P173, DOI 10.1016/0008-6215(94)84015-6; GERLACH GF, 1989, INFECT IMMUN, V57, P764, DOI 10.1128/IAI.57.3.764-770.1989; Guo AZ, 2007, MICROBIOL-SGM, V153, P1059, DOI 10.1099/mic.0.2006/000331-0; Guo AZ, 2009, MICROBIOL-SGM, V155, P1623, DOI 10.1099/mic.0.026286-0; Hancox LS, 1997, FEMS IMMUNOL MED MIC, V19, P289, DOI 10.1016/S0928-8244(97)00095-3; Hung CS, 2002, MOL MICROBIOL, V44, P903, DOI 10.1046/j.1365-2958.2002.02915.x; Imberty A, 2004, MICROBES INFECT, V6, P221, DOI 10.1016/j.micinf.2003.10.016; Kisiela D, 2005, INFECT IMMUN, V73, P6187, DOI 10.1128/IAI.73.9.6187-6190.2005; Korea CG, 2010, ENVIRON MICROBIOL, V12, P1957, DOI 10.1111/j.1462-2920.2010.02202.x; KORHONEN TK, 1980, J BACTERIOL, V144, P800, DOI 10.1128/JB.144.2.800-805.1980; Langermann S, 2003, ADV EXP MED BIOL, V539, P635; Langermann S, 2000, J INFECT DIS, V181, P774, DOI 10.1086/315258; Le Trong I, 2010, J STRUCT BIOL, V172, P380, DOI 10.1016/j.jsb.2010.06.002; MADISON B, 1994, INFECT IMMUN, V62, P843, DOI 10.1128/IAI.62.3.843-848.1994; Merckel MC, 2003, J MOL BIOL, V331, P897, DOI 10.1016/S0022-2836(03)00841-6; Naughton PJ, 2001, J MED MICROBIOL, V50, P191, DOI 10.1099/0022-1317-50-2-191; Nilsson LM, 2007, MOL MICROBIOL, V65, P1158, DOI 10.1111/j.1365-2958.2007.05858.x; Nilsson LM, 2006, APPL ENVIRON MICROB, V72, P3005, DOI 10.1128/AEM.72.4.3005-3010.2006; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; OFEK I, 1977, NATURE, V265, P623, DOI 10.1038/265623a0; Pettigrew D, 2004, J BIOL CHEM, V279, P46851, DOI 10.1074/jbc.M409284200; Poggio TV, 2006, CAN J MICROBIOL, V52, P1093, DOI 10.1139/W06-065; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sambrook J, 2001, MOL CLONING LAB MANU; Sevier CS, 2006, ANTIOXID REDOX SIGN, V8, P797, DOI 10.1089/ars.2006.8.797; Sokurenko EV, 1997, J BIOL CHEM, V272, P17880, DOI 10.1074/jbc.272.28.17880; SOKURENKO EV, 1995, J BACTERIOL, V177, P3680, DOI 10.1128/jb.177.13.3680-3686.1995; Sokurenko EV, 1998, P NATL ACAD SCI USA, V95, P8922, DOI 10.1073/pnas.95.15.8922; Stahlhut SG, 2009, J BACTERIOL, V191, P6592, DOI 10.1128/JB.00786-09; Sung YH, 2001, J BIOL CHEM, V276, P44229, DOI 10.1074/jbc.M104239200; Tchesnokova V., 2011, INFECT IMMU IN PRESS; Tchesnokova V, 2008, J BIOL CHEM, V283, P7823, DOI 10.1074/jbc.M707804200; Tchesnokova V, 2010, MOL MICROBIOL, V76, P489, DOI 10.1111/j.1365-2958.2010.07116.x; Thankavel K, 1999, J BIOL CHEM, V274, P5797, DOI 10.1074/jbc.274.9.5797; Thomas WE, 2004, MOL MICROBIOL, V53, P1545, DOI 10.1111/j.1365-2958.2004.04226.x; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200	57	19	21	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38136	38147		10.1074/jbc.M111.237511	http://dx.doi.org/10.1074/jbc.M111.237511			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21795699	hybrid, Green Published			2022-12-25	WOS:000296594200027
J	Engel, D; Beckers, L; Wijnands, E; Seijkens, T; Lievens, D; Drechsler, M; Gerdes, N; Soehnlein, O; Daemen, MJAP; Stan, RV; Biessen, EAL; Lutgens, E				Engel, David; Beckers, Linda; Wijnands, Erwin; Seijkens, Tom; Lievens, Dirk; Drechsler, Maik; Gerdes, Norbert; Soehnlein, Oliver; Daemen, Mat J. A. P.; Stan, Radu V.; Biessen, Erik A. L.; Lutgens, Esther			Caveolin-1 deficiency decreases atherosclerosis by hampering leukocyte influx into the arterial wall and generating a regulatory T-cell response	FASEB JOURNAL			English	Article						cholesterol; lipoproteins; endothelial cells; hematopoietic and nonhematopoietic compartment	NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE-CELLS; NEOINTIMA FORMATION; GENETIC ABLATION; IMMUNE-RESPONSE; IN-VIVO; EXPRESSION; DEFECTS; MICE; ACTIVATION	Caveolin-1 plays a crucial role in atherosclerosis, which is mainly attributed to its effects on low-density-lipoprotein (LDL) transcytosis. However, caveolin-1 has also been implicated in the regulation of inflammation. We investigated the effects of caveolin-1 deficiency in atherosclerosis with its accompanying changes in plaque- and lymphoid-related immunology and inflammation. Cav1(-/-)Apoe(-/-) mice exhibited a 15-fold reduction in plaque size with plaques containing fewer macrophages, T cells, and neutrophils. Intravital microscopy revealed 83% less leukocyte adhesion to the vessel wall in Cav1(-/-)Apoe(-/-) mice, which could be attributed to reduced endothelial chemokine ligand-2 (CCL-2/MCP-1) and vascular cell adhesion molecule-1 (VCAM-1) expression. Caveolin-1 deficiency resulted in a 57% increase in regulatory T cells and a 4% decrease in CD4(+) effector T cells in lymphoid organs. Bone marrow transplantations revealed that Cav1(-/-)Apoe(-/-) mice receiving Cav1(+/+)Apoe(-/-) or Cav1(-/-)Apoe(-/-) bone marrow presented 4- to 4.5-fold smaller plaques with no additional phenotypic changes. In contrast, atherosclerosis was not affected in Cav1(+/+) Apoe(-/-) recipients receiving Cav1(-/-)Apoe(-/-) or Cav1(+/+) Apoe(-/-) bone marrow. However, the presence of Cav1(-/-) Apoe(-/-) bone marrow was associated with an anti-inflammatory T-cell profile. Our study reveals that nonhematopoietic caveolin-1 determines plaque size, whereas hematopoietic caveolin-1 regulates lymphoid immune-modulation. However, both are required for phenotypic modulation of plaques.-Engel, D., Beckers, L., Wijnands, E., Seijkens, T., Lievens, D., Drechsler, M., Gerdes, N., Soehnlein, O., Daemen, M. J. A. P., Stan, R. V., Biessen, E. A. L., Lutgens, E. Caveolin-1 deficiency decreases atherosclerosis by hampering leukocyte influx into the arterial wall and generating a regulatory T-cell response. FASEB J. 25, 3838-3848 (2011). www.fasebj.org	[Engel, David; Beckers, Linda; Wijnands, Erwin; Seijkens, Tom; Gerdes, Norbert; Soehnlein, Oliver; Biessen, Erik A. L.; Lutgens, Esther] Univ Maastricht, Dept Pathol, Cardiovasc Res Inst Maastricht CARIM, NL-6229 HX Maastricht, Netherlands; [Lievens, Dirk; Drechsler, Maik; Gerdes, Norbert; Soehnlein, Oliver; Lutgens, Esther] Univ Munich, Inst Cardiovasc Prevent, Munich, Germany; [Daemen, Mat J. A. P.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Stan, Radu V.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Pathol, Hanover, NH 03756 USA	Maastricht University; University of Munich; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Dartmouth College	Engel, D (corresponding author), Univ Maastricht, Dept Pathol, Cardiovasc Res Inst Maastricht CARIM, P Debyelaan 25, NL-6229 HX Maastricht, Netherlands.	david.engel@maastrichtuniversity.nl	Gerdes, Norbert/E-2787-2010; Lutgens, Esther/E-2919-2010; Stan, Radu/AAE-7574-2021; Drechsler, Maik/C-3829-2008	Gerdes, Norbert/0000-0002-4546-7208; Lutgens, Esther/0000-0002-2609-5744; Stan, Radu/0000-0003-2969-1725; Daemen, Mat/0000-0003-1076-199X; Seijkens, Tom/0000-0001-6370-1267; Biessen, Erik/0000-0002-6454-8548	Netherlands Organization for Scientific Research; Netherlands Heart Foundation; Humboldt Foundation; Deutsche Forschungsgemeinschaft (DFG) [SO873/3-1]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092085, R01HL065418, R01HL083249] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Heart Foundation(Netherlands Heart Foundation); Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Netherlands Organization for Scientific Research (VIDI grant to E.L.), the Netherlands Heart Foundation (established investigator grant to E.L.), the Humboldt Foundation (Sofja Kovalevskaja grant to E.L.), and the Deutsche Forschungsgemeinschaft (DFG grant SO873/3-1).	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Chang SH, 2009, AM J PATHOL, V175, P1768, DOI 10.2353/ajpath.2009.090171; Chen SF, 2010, J CELL BIOCHEM, V109, P356, DOI 10.1002/jcb.22407; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Donners MMPC, 2008, BLOOD, V111, P4596, DOI 10.1182/blood-2007-05-088906; Donners MMPC, 2005, AM J TRANSPLANT, V5, P1204, DOI 10.1111/j.1600-6143.2005.00821.x; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Engelman JA, 1998, FEBS LETT, V428, P205, DOI 10.1016/S0014-5793(98)00470-0; Fernandez-Hernando C, 2010, AM J PATHOL, V177, P998, DOI 10.2353/ajpath.2010.091287; Fernandez-Hernando C, 2009, CELL METAB, V10, P48, DOI 10.1016/j.cmet.2009.06.003; Feron O, 2001, CIRCULATION, V103, P113; Feron O, 1999, J CLIN INVEST, V103, P897, DOI 10.1172/JCI4829; Frank PG, 2004, ARTERIOSCL THROM VAS, V24, P98, DOI 10.1161/01.ATV.0000101182.89118.E5; Frank PG, 2008, AM J PHYSIOL-CELL PH, V295, pC242, DOI 10.1152/ajpcell.00185.2008; Frank PG, 2006, AM J PHYSIOL-HEART C, V291, pH677, DOI 10.1152/ajpheart.01092.2005; Fu CL, 2010, BBA-MOL CELL BIOL L, V1801, P702, DOI 10.1016/j.bbalip.2010.04.001; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; Gargalovic P, 2003, J LIPID RES, V44, P1622, DOI 10.1194/jlr.M300140-JLR200; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Han SG, 2010, TOXICOL APPL PHARM, V246, P74, DOI 10.1016/j.taap.2010.04.009; Harris J, 2002, IMMUNOLOGY, V105, P190, DOI 10.1046/j.1365-2567.2002.01362.x; Harris J, 2002, TRENDS IMMUNOL, V23, P158, DOI 10.1016/S1471-4906(01)02161-5; Hassan GS, 2006, AM J PHYSIOL-HEART C, V290, pH2393, DOI 10.1152/ajpheart.01161.2005; Hassan GS, 2004, BIOCHEMISTRY-US, V43, P8312, DOI 10.1021/bi049609t; Hnasko Robert, 2003, Mol Interv, V3, P445, DOI 10.1124/mi.3.8.445; Hu GC, 2008, AM J PHYSIOL-LUNG C, V294, pL178, DOI 10.1152/ajplung.00263.2007; Lin WW, 2006, J HISTOCHEM CYTOCHEM, V54, P897, DOI 10.1369/jhc.5A6869.2006; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; Medina FA, 2006, INFECT IMMUN, V74, P6665, DOI 10.1128/IAI.00949-06; Mercier I, 2009, AM J PATHOL, V174, P1172, DOI 10.2353/ajpath.2009.080882; Murata T, 2007, J BIOL CHEM, V282, P16631, DOI 10.1074/jbc.M607948200; Oh YS, 2008, DIABETOLOGIA, V51, P1025, DOI 10.1007/s00125-008-0993-0; Ohnuma Kei, 2006, Mod Rheumatol, V16, P3; Park DS, 2002, AM J PATHOL, V160, P2207, DOI 10.1016/S0002-9440(10)61168-6; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Rodriguez-Feo JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002612; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Schwencke C, 2005, CARDIOVASC RES, V68, P128, DOI 10.1016/j.cardiores.2005.05.004; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wang XM, 2009, J IMMUNOL, V182, P3809, DOI 10.4049/jimmunol.0712437; Wang XM, 2006, AM J RESP CELL MOL, V34, P434, DOI 10.1165/rcmb.2005-0376OC; Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799; Zulli A, 2006, J HISTOCHEM CYTOCHEM, V54, P151, DOI 10.1369/jhc.5A6677.2005	49	35	37	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2011	25	11					3838	3848		10.1096/fj.11-183350	http://dx.doi.org/10.1096/fj.11-183350			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21795505	Green Published			2022-12-25	WOS:000296723100009
J	Ariza, A; Eklof, JM; Spadiut, O; Offen, WA; Roberts, SM; Besenmatter, W; Friis, EP; Skjot, M; Wilson, KS; Brumer, H; Davies, G				Ariza, Antonio; Eklof, Jens M.; Spadiut, Oliver; Offen, Wendy A.; Roberts, Shirley M.; Besenmatter, Werner; Friis, Esben P.; Skjot, Michael; Wilson, Keith S.; Brumer, Harry; Davies, Gideon			Structure and Activity of Paenibacillus polymyxa Xyloglucanase from Glycoside Hydrolase Family 44	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDO-TRANSGLYCOSYLASES; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; CELL-WALLS; K-I; PROTEINS; ENDO-BETA-1,4-GLUCANASE; ENDOGLUCANASES; CEL44C-MAN26A; ISOFAGOMINE	The enzymatic degradation of plant polysaccharides is emerging as one of the key environmental goals of the early 21st century, impacting on many processes in the textile and detergent industries as well as biomass conversion to biofuels. One of the well known problems with the use of nonstarch (nonfood)-based substrates such as the plant cell wall is that the cellulose fibers are embedded in a network of diverse polysaccharides, including xyloglucan, that renders access difficult. There is therefore increasing interest in the "accessory enzymes," including xyloglucanases, that may aid biomass degradation through removal of "hemicellulose" polysaccharides. Here, we report the biochemical characterization of the endo-beta-1,4-(xylo)glucan hydrolase from Paenibacillus polymyxa with polymeric, oligomeric, and defined chromogenic aryl-oligosaccharide substrates. The enzyme displays an unusual specificity on defined xyloglucan oligosaccharides, cleaving the XXXG-XXXG repeat into XXX and GXXXG. Kinetic analysis on defined oligosaccharides and on aryl-glycosides suggests that both the -4 and +1 subsites show discrimination against xylose-appended glucosides. The three-dimensional structures of PpXG44 have been solved both in apo-form and as a series of ligand complexes that map the -3 to -1 and +1 to +5 subsites of the extended ligand binding cleft. Complex structures are consistent with partial intolerance of xylosides in the -4' subsites. The atypical specificity of PpXG44 may thus find use in industrial processes involving xyloglucan degradation, such as biomass conversion, or in the emerging exciting applications of defined xyloglucans in food, pharmaceuticals, and cellulose fiber modification.	[Ariza, Antonio; Offen, Wendy A.; Roberts, Shirley M.; Wilson, Keith S.; Davies, Gideon] Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Eklof, Jens M.; Spadiut, Oliver; Brumer, Harry] Royal Inst Technol, Sch Biotechnol, Div Glycosci, SE-10691 Stockholm, Sweden; [Spadiut, Oliver; Brumer, Harry] Royal Inst Technol, Wallenberg Wood Sci Ctr, SE-10691 Stockholm, Sweden; [Besenmatter, Werner; Friis, Esben P.; Skjot, Michael] Novozymes AS, DK-2880 Bagsvaerd, Denmark	University of York - UK; Royal Institute of Technology; Royal Institute of Technology; Novozymes	Wilson, KS (corresponding author), Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England.	keith@ysbl.york.ac.uk; harry@biotech.kth.se; davies@ysbl.york.ac.uk	Davies, Gideon J/A-9042-2011; Ariza, Antonio/H-7830-2019	Davies, Gideon J/0000-0002-7343-776X; Ariza, Antonio/0000-0003-4364-823X; Wilson, Keith/0000-0002-3581-2194	Biotechnology and Biological Sciences Research Council; Swedish Research Council; Swedish Center for Biomimetic Fiber Engineering (Biomime); Novozymes A/S; Royal Society; Biotechnology and Biological Sciences Research Council [BB/D522511/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Center for Biomimetic Fiber Engineering (Biomime); Novozymes A/S; Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Biotechnology and Biological Sciences Research Council, the Swedish Research Council, the Swedish Center for Biomimetic Fiber Engineering (Biomime), and by Novozymes A/S. W. B., E. P. S., and M. S. are employed by Novozymes A/S.; Recipient of a Royal Society/Wolfson research merit award. To whom correspondence may be addressed. E-mail: davies@ysbl.york.ac.uk.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baumann MJ, 2007, PLANT CELL, V19, P1947, DOI 10.1105/tpc.107.051391; Brumer H, 2004, J AM CHEM SOC, V126, P5715, DOI 10.1021/ja0316770; Brzozowski AM, 2000, BIOCHEMISTRY-US, V39, P9099, DOI 10.1021/bi0000317; Buckeridge MS, 2000, PLANT PHYSIOL BIOCH, V38, P141, DOI 10.1016/S0981-9428(00)00162-5; Burlingham BT, 2003, J CHEM EDUC, V80, P214, DOI 10.1021/ed080p214; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Cho KM, 2006, APPL MICROBIOL BIOT, V73, P618, DOI 10.1007/s00253-006-0523-2; Cho KM, 2008, BIOTECHNOL LETT, V30, P1061, DOI 10.1007/s10529-008-9640-6; CLAEYSSENS M, 1992, PROTEIN SCI, V1, P1293, DOI 10.1002/pro.5560011008; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; FRY SC, 1993, PHYSIOL PLANTARUM, V89, P1; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Gloster TM, 2007, J BIOL CHEM, V282, P19177, DOI 10.1074/jbc.M700224200; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hilz H, 2007, CARBOHYD RES, V342, P170, DOI 10.1016/j.carres.2006.12.005; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hoffman M, 2005, CARBOHYD RES, V340, P1826, DOI 10.1016/j.carres.2005.04.016; Hsieh YSY, 2009, MOL PLANT, V2, P943, DOI 10.1093/mp/ssp061; Ibatullin FM, 2008, BIOCHEMISTRY-US, V47, P7762, DOI 10.1021/bi8009168; Juhasz T, 2005, PROCESS BIOCHEM, V40, P3519, DOI 10.1016/j.procbio.2005.03.057; Kitago Y, 2007, J BIOL CHEM, V282, P35703, DOI 10.1074/jbc.M706835200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumar CS, 2008, CRIT REV FOOD SCI, V48, P1, DOI 10.1080/10408390600948600; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Macdonald JM, 2002, AUST J CHEM, V55, P747, DOI 10.1071/CH02165; Maris A, 2011, J EXP BOT, V62, P261, DOI 10.1093/jxb/erq263; Mark P, 2009, PROTEINS, V75, P820, DOI 10.1002/prot.22291; Martinez-Fleites C, 2006, J BIOL CHEM, V281, P24922, DOI 10.1074/jbc.M603583200; MCFEETERS RF, 1980, ANAL BIOCHEM, V103, P302, DOI 10.1016/0003-2697(80)90614-4; Meloncelli PJ, 2007, AUST J CHEM, V60, P549, DOI 10.1071/CH07188; Mishra A, 2009, J MATER CHEM, V19, P8528, DOI 10.1039/b911150f; MOPPER K, 1973, ANAL BIOCHEM, V56, P440, DOI 10.1016/0003-2697(73)90210-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Nam KH, 2009, BIOCHEM BIOPH RES CO, V383, P183, DOI 10.1016/j.bbrc.2009.03.149; Nishikubo N, 2007, PLANT CELL PHYSIOL, V48, P843, DOI 10.1093/pcp/pcm055; Pauly M, 1999, PLANT J, V20, P629, DOI 10.1046/j.1365-313X.1999.00630.x; Pena MJ, 2008, GLYCOBIOLOGY, V18, P891, DOI 10.1093/glycob/cwn078; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Powlowski J, 2009, CARBOHYD RES, V344, P1175, DOI 10.1016/j.carres.2009.04.020; Saura-Valls M, 2008, J BIOL CHEM, V283, P21853, DOI 10.1074/jbc.M803058200; Schnorr K., 2004, U. S. Patent, Patent No. 6815192; Sevcik J, 1998, ACTA CRYSTALLOGR D, V54, P854, DOI 10.1107/S0907444998002005; Sinitsyna OA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P41, DOI 10.1134/S0006297910010062; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Tailford LE, 2007, J BIOL CHEM, V282, P11291, DOI 10.1074/jbc.M610964200; Vincken JP, 1997, CARBOHYD RES, V298, P299, DOI 10.1016/S0008-6215(96)00325-4; VINCKEN JP, 1994, PLANT PHYSIOL, V104, P99, DOI 10.1104/pp.104.1.99; Vlasenko E, 2010, BIORESOURCE TECHNOL, V101, P2405, DOI 10.1016/j.biortech.2009.11.057; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Warner CD, 2011, ENZYME MICROB TECH, V48, P27, DOI 10.1016/j.enzmictec.2010.08.009; Warner CD, 2010, APPL ENVIRON MICROB, V76, P338, DOI 10.1128/AEM.02026-09; Wong DDWS, 2010, PROTEIN PEPTIDE LETT, V17, P803; Wong DDWS, 2010, APPL MICROBIOL BIOT, V86, P1463, DOI 10.1007/s00253-009-2364-2; Yaoi K, 2005, APPL ENVIRON MICROB, V71, P7670, DOI 10.1128/AEM.71.12.7670-7678.2005; Yaoi K, 2004, STRUCTURE, V12, P1209, DOI 10.1016/j.str.2004.04.020; Yaoi K, 2007, J MOL BIOL, V370, P53, DOI 10.1016/j.jmb.2007.04.035; Yaoi K, 2009, FEBS J, V276, P5094, DOI 10.1111/j.1742-4658.2009.07205.x; Zhao MS, 2010, SCIENCE, V329, P940, DOI [10.1126/science.1192666, 10.1126/science.1189590]	65	29	30	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33890	33900		10.1074/jbc.M111.262345	http://dx.doi.org/10.1074/jbc.M111.262345			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21795708	hybrid, Green Published			2022-12-25	WOS:000295159200021
J	Barros, MH; Rak, M; Paulela, JA; Tzagoloff, A				Barros, Mario H.; Rak, Malgorzata; Paulela, Janaina A.; Tzagoloff, Alexander			Characterization of Gtf1p, the Connector Subunit of Yeast Mitochondrial tRNA-dependent Amidotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; ELONGATION-FACTOR TU; SACCHAROMYCES-CEREVISIAE; INNER MEMBRANE; ATP SYNTHASE; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; PROTEIN-SYNTHESIS; GENE; EXPRESSION	The bacterial GatCAB operon for tRNA-dependent amidotransferase (AdT) catalyzes the transamidation of mischarged glutamyl-tRNA(Gln) to glutaminyl-tRNA(Gln). Here we describe the phenotype of temperature-sensitive (ts) mutants of GTF1, a gene proposed to code for subunit F of mitochondrial AdT in Saccharomyces cerevisiae. The ts gtf1 mutants accumulate an electrophoretic variant of the mitochondrially encoded Cox2p subunit of cytochrome oxidase and an unstable form of the Atp8p subunit of the F-1-F-0 ATP synthase that is degraded, thereby preventing assembly of the F-0 sector. Allotopic expression of recoded ATP8 and COX2 did not significantly improve growth of gtf1 mutants on respiratory substrates. However, ts gft1 mutants are partially rescued by overexpression of PET112 and HER2 that code for the yeast homologues of the catalytic subunits of bacterial AdT. Additionally, B66, a her2 point mutant has a phenotype similar to that of gtf1 mutants. These results provide genetic support for the essentiality, in vivo, of the GatF subunit of the heterotrimeric AdT that catalyzes formation of glutaminyl-tRNA(Gln) (Frechin, M., Senger, B., Braye, M., Kern, D., Martin, R. P., and Becker, H. D. (2009) Genes Dev. 23, 1119-1130).	[Rak, Malgorzata; Tzagoloff, Alexander] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Barros, Mario H.; Paulela, Janaina A.] Univ Sao Paulo, Dept Microbiol, BR-05508900 Sao Paulo, Brazil	Columbia University; Universidade de Sao Paulo	Tzagoloff, A (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	spud@columbia.edu	Barros, Mario H/B-8118-2012; Barros, Mario/Q-6358-2019	Barros, Mario/0000-0003-2977-9815	National Institutes of Health [GM 50187]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL022174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 50187 (to A. T.). This work was also supported by a Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grant (to M. H. B.).	Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Barros MH, 2006, J BIOL CHEM, V281, P3743, DOI 10.1074/jbc.M510778200; Barros MH, 2002, J BIOL CHEM, V277, P9997, DOI 10.1074/jbc.M112025200; Becker HD, 1998, P NATL ACAD SCI USA, V95, P12832, DOI 10.1073/pnas.95.22.12832; BROACH JR, 1979, GENE, V8, P121, DOI 10.1016/0378-1119(79)90012-X; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; DIECKMANN CL, 1994, INT REV CYTOL, V152, P145, DOI 10.1016/S0074-7696(08)62556-5; FAYE G, 1974, J MOL BIOL, V88, P105, DOI 10.1016/0022-2836(74)90304-0; Feng L, 2005, J BIOL CHEM, V280, P8150, DOI 10.1074/jbc.M411098200; Frechin M, 2009, GENE DEV, V23, P1119, DOI 10.1101/gad.518109; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Green-Willms NS, 2001, J BIOL CHEM, V276, P6392, DOI 10.1074/jbc.M009856200; He SC, 1997, MOL BIOL CELL, V8, P1449, DOI 10.1091/mbc.8.8.1449; He SC, 1999, MOL CELL BIOL, V19, P6598; Hell K, 1997, FEBS LETT, V418, P367, DOI 10.1016/S0014-5793(97)01412-9; Hell K, 2000, J BIOL CHEM, V275, P4571, DOI 10.1074/jbc.275.7.4571; Herrmann J. M., 1994, CELL BIOL LAB HDB, VI, P538; HERRMANN JM, 1995, J BIOL CHEM, V270, P27079, DOI 10.1074/jbc.270.45.27079; Jan PS, 2000, MOL GEN GENET, V263, P483, DOI 10.1007/s004380051192; Kim SI, 1997, J BACTERIOL, V179, P5625, DOI 10.1128/jb.179.17.5625-5627.1997; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPOINTE J, 1986, J BACTERIOL, V165, P88, DOI 10.1128/jb.165.1.88-93.1986; LAW RHP, 1988, FEBS LETT, V236, P501, DOI 10.1016/0014-5793(88)80086-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Min B, 2003, J BACTERIOL, V185, P3524, DOI 10.1128/JB.185.12.3524-3526.2003; MULERO JJ, 1994, CURR GENET, V25, P299, DOI 10.1007/BF00351481; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Nagao A, 2009, P NATL ACAD SCI USA, V106, P16209, DOI 10.1073/pnas.0907602106; Nagao Asuteka, 2007, Nucleic Acids Symp Ser (Oxf), P41; NAKAGAWA K, 1991, J BIOL CHEM, V266, P1977; Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156; Paul MF, 2000, J BIOL CHEM, V275, P29238, DOI 10.1074/jbc.M004546200; Pelchat M, 1998, CAN J MICROBIOL, V44, P378, DOI 10.1139/cjm-44-4-378; PELISSIER P, 1995, CURR GENET, V27, P409, DOI 10.1007/BF00311209; POUTRE CG, 1987, GENETICS, V115, P637; Pujol C, 2008, P NATL ACAD SCI USA, V105, P6481, DOI 10.1073/pnas.0712299105; Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200; Rak M, 2009, P NATL ACAD SCI USA, V106, P18509, DOI 10.1073/pnas.0910351106; Rinehart J, 2005, GENE DEV, V19, P583, DOI 10.1101/gad.1269305; Roy H, 2007, NUCLEIC ACIDS RES, V35, P3420, DOI 10.1093/nar/gkm211; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SCHNEIDER A, 1991, EMBO J, V10, P247, DOI 10.1002/j.1460-2075.1991.tb07944.x; SCHON A, 1988, BIOCHIMIE, V70, P391, DOI 10.1016/0300-9084(88)90212-X; SIMON M, 1984, MOL GEN GENET, V196, P266, DOI 10.1007/BF00328059; Soto IC, 2009, BBA-MOL CELL RES, V1793, P1776, DOI 10.1016/j.bbamcr.2009.09.002; STANZEL M, 1994, EUR J BIOCHEM, V219, P435, DOI 10.1111/j.1432-1033.1994.tb19956.x; Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253; Supekova L, 2010, P NATL ACAD SCI USA, V107, P5047, DOI 10.1073/pnas.1000735107; TERPSTRA P, 1979, J BIOL CHEM, V254, P2662; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TZAGOLOFF A, 1969, J BIOL CHEM, V244, P5020; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; TZAGOLOFF A, 1975, J BIOL CHEM, V250, P8228; WILCOX M, 1969, EUR J BIOCHEM, V11, P405, DOI 10.1111/j.1432-1033.1969.tb00788.x; WILCOX M, 1968, P NATL ACAD SCI USA, V61, P229, DOI 10.1073/pnas.61.1.229	59	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32937	32947		10.1074/jbc.M111.265371	http://dx.doi.org/10.1074/jbc.M111.265371			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21799017	hybrid, Green Published			2022-12-25	WOS:000294968800012
J	Hsu, FN; Chen, MC; Chiang, MC; Lin, E; Lee, YT; Huang, PH; Lee, GS; Lin, H				Hsu, Fu-Ning; Chen, Mei-Chih; Chiang, Ming-Ching; Lin, Eugene; Lee, Yueh-Tsung; Huang, Pao-Hsuan; Lee, Guan-Shun; Lin, Ho			Regulation of Androgen Receptor and Prostate Cancer Growth by Cyclin-dependent Kinase 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR-LOCALIZATION; TRANSCRIPTIONAL ACTIVITY; PHOSPHORYLATION SITES; SIGNAL TRANSDUCER; INDUCED APOPTOSIS; CDK5; CELLS; PROTEIN; ACTIVATION; NEURODEGENERATION	Prostate cancer is the most frequently diagnosed male malignancy. The normal prostate development and prostate cancer progression are mediated by androgen receptor (AR). Recently, the roles of cyclin-dependent kinase 5 (Cdk5) and its activator, p35, in cancer biology are explored one after another. We have previously demonstrated that Cdk5 may regulate proliferation of thyroid cancer cells. In addition, we also identify that Cdk5 overactivation can be triggered by drug treatments and leads to apoptosis of prostate cancer cells. The aim of this study is to investigate how Cdk5 regulates AR activation and growth of prostate cancer cells. At first, the data show that Cdk5 enables phosphorylation of AR at Ser-81 site through direct biochemical interaction and, therefore, results in the stabilization of AR proteins. The Cdk5-dependent AR stabilization causes accumulation of AR proteins and subsequent activation. Besides, the positive regulations of Cdk5-AR on cell growth are also determined in vitro and in vivo. S81A mutant of AR diminishes its interaction with Cdk5, reduces its nuclear localization, fails to stabilize its protein level, and therefore, decreases prostate cancer cell proliferation. Prostate carcinoma specimens collected from 177 AR-positive patients indicate the significant correlations between the protein levels of AR and Cdk5 or p35. These findings demonstrate that Cdk5 is an important modulator of AR and contributes to prostate cancer growth. Therefore, Cdk5-p35 may be suggested as diagnostic and therapeutic targets for prostate cancer in the near future.	[Hsu, Fu-Ning; Chen, Mei-Chih; Chiang, Ming-Ching; Lin, Eugene; Lee, Yueh-Tsung; Huang, Pao-Hsuan; Lee, Guan-Shun; Lin, Ho] Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan; [Lin, Ho] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 402, Taiwan; [Lin, Ho] China Med Univ, Grad Inst Rehabil Sci, Taichung 404, Taiwan; [Lin, Eugene] Chang Bing Show Chwan Mem Hosp, Dept Urol, Changhua 505, Taiwan; [Lee, Yueh-Tsung] Chang Bing Show Chwan Mem Hosp, Dept Surg, Changhua 505, Taiwan; [Lin, Ho] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 701, Taiwan	National Chung Hsing University; National Chung Hsing University; China Medical University Taiwan; Chang Bing Show Chwan Memorial Hospital; Chang Bing Show Chwan Memorial Hospital; National Cheng Kung University	Lin, H (corresponding author), 250 Kuokuang Rd, Taichung 402, Taiwan.	hlin@dragon.nchu.edu.tw		Lin, Ho/0000-0001-7849-9137	National Science Council [NSC97-2320-B-005-002-MY3, NSC96-2628-B-005-013-MY3]; Taiwan Ministry of Education	National Science Council(Ministry of Science and Technology, Taiwan); Taiwan Ministry of Education(Ministry of Education, Taiwan)	This work was supported by National Science Council Grants NSC97-2320-B-005-002-MY3 and NSC96-2628-B-005-013-MY3 and in part by the Taiwan Ministry of Education under the Aiming for the Top University plan.	Berger R, 2006, CANCER RES, V66, P5723, DOI 10.1158/0008-5472.CAN-05-3928; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Chen MC, 2010, AM J PHYSIOL-CELL PH, V299, pC516, DOI 10.1152/ajpcell.00534.2009; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Chen SY, 2009, J BIOL CHEM, V284, P25576, DOI 10.1074/jbc.M109.043133; Choi HS, 2009, J HUM GENET, V54, P298, DOI 10.1038/jhg.2009.29; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Feldmann G, 2010, CANCER RES, V70, P4460, DOI 10.1158/0008-5472.CAN-09-1107; Fu AKY, 2004, P NATL ACAD SCI USA, V101, P6728, DOI 10.1073/pnas.0307606100; Fu XR, 2006, J BIOL CHEM, V281, P39014, DOI 10.1074/jbc.M512663200; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Gioeli D, 2006, MOL ENDOCRINOL, V20, P503, DOI 10.1210/me.2005-0351; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Goodyear S, 2007, EXP MOL PATHOL, V82, P25, DOI 10.1016/j.yexmp.2006.09.002; Gordon V, 2010, MOL ENDOCRINOL, V24, P2267, DOI 10.1210/me.2010-0238; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; Hsu FN, 2011, AM J PHYSIOL-ENDOC M, V300, pE902, DOI 10.1152/ajpendo.00610.2010; Isaacs JT, 2004, NAT MED, V10, P26, DOI 10.1038/nm0104-26; Kesler CT, 2007, MOL ENDOCRINOL, V21, P2071, DOI 10.1210/me.2007-0240; Kim E, 2006, INT J ONCOL, V28, P191; Kino T, 2007, MOL ENDOCRINOL, V21, P1552, DOI 10.1210/me.2006-0345; Kuo HS, 2009, CHINESE J PHYSIOL, V52, P23, DOI 10.4077/CJP.2009.AMG067; Lilja L, 2001, J BIOL CHEM, V276, P34199, DOI 10.1074/jbc.M103776200; Lin H, 2007, CELL DEATH DIFFER, V14, P607, DOI 10.1038/sj.cdd.4402033; Lin H, 2004, J BIOL CHEM, V279, P29302, DOI 10.1074/jbc.M403664200; Lin H, 2009, ADAPT MED, V1, P22; Lin H, 2007, J BIOL CHEM, V282, P2776, DOI 10.1074/jbc.M607234200; Lin H, 2009, ENDOCRINOLOGY, V150, P396, DOI 10.1210/en.2008-0496; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Liu JL, 2011, MED ONCOL, V28, P673, DOI 10.1007/s12032-010-9510-7; Liu SC, 2010, BIOCHEM BIOPH RES CO, V394, P297, DOI 10.1016/j.bbrc.2010.02.164; Lockwood WW, 2008, ONCOGENE, V27, P4615, DOI 10.1038/onc.2008.98; Mellinghoff IK, 2004, CANCER CELL, V6, P517, DOI 10.1016/j.ccr.2004.09.031; Nawaz Z, 1999, MOL CELL BIOL, V19, P1182; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Rhim JS, 1997, CRIT REV ONCOGENESIS, V8, P305, DOI 10.1615/CritRevOncog.v8.i4.20; Selvendiran K, 2006, CANCER RES, V66, P4826, DOI 10.1158/0008-5472.CAN-05-4062; Sheflin L, 2000, BIOCHEM BIOPH RES CO, V276, P144, DOI 10.1006/bbrc.2000.3424; Shigemura K, 2009, PROSTATE, V69, P949, DOI 10.1002/pros.20944; Strock CJ, 2006, CANCER RES, V66, P7509, DOI 10.1158/0008-5472.CAN-05-3048; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Upadhyay AK, 2008, CURR CANCER DRUG TAR, V8, P741, DOI 10.2174/156800908786733405	45	70	70	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33141	33149		10.1074/jbc.M111.252080	http://dx.doi.org/10.1074/jbc.M111.252080			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21799006	Green Published, hybrid			2022-12-25	WOS:000294968800033
J	Sharma, NM; Kochenova, OV; Shcherbakova, PV				Sharma, Neeru M.; Kochenova, Olga V.; Shcherbakova, Polina V.			The Non-canonical Protein Binding Site at the Monomer-Monomer Interface of Yeast Proliferating Cell Nuclear Antigen (PCNA) Regulates the Rev1-PCNA Interaction and Pol zeta/Rev1-dependent Translesion DNA Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYCYTIDYL TRANSFERASE-ACTIVITY; DAMAGE-INDUCED MUTAGENESIS; REV1 PROTEIN; POLYMERASE-ETA; SACCHAROMYCES-CEREVISIAE; UBIQUITIN-BINDING; COMPLEX-FORMATION; DCMP TRANSFERASE; POL32 SUBUNIT; LESION-BYPASS	Rev1 and DNA polymerase zeta (Pol zeta) are involved in the tolerance of DNA damage by translesion synthesis (TLS). The proliferating cell nuclear antigen (PCNA), the auxiliary factor of nuclear DNA polymerases, plays an important role in regulating the access of TLS polymerases to the primer terminus. Both Rev1 and Pol zeta lack the conserved hydrophobic motif that is used by many proteins for the interaction with PCNA at its interdomain connector loop. We have previously reported that the interaction of yeast Pol zeta with PCNA occurs at an unusual site near the monomer-monomer interface of the trimeric PCNA. Using GST pull-down assays, PCNA-coupled affinity beads pull-down and gel filtration chromatography, we show that the same region is required for the physical interaction of PCNA with the polymerase-associated domain (PAD) of Rev1. The interaction is disrupted by the pol30-113 mutation that results in a double amino acid substitution at the monomer-monomer interface of PCNA. Genetic analysis of the epistatic relationship of the pol30-113 mutation with an array of DNA repair and damage tolerance mutations indicated that PCNA-113 is specifically defective in the Rev1/Pol zeta-dependent TLS pathway. Taken together, the data suggest that Pol zeta and Rev1 are unique among PCNA-interacting proteins in using the novel binding site near the intermolecular interface of PCNA. The new mode of Rev1-PCNA binding described here suggests a mechanism by which Rev1 adopts a catalytically inactive configuration at the replication fork.	[Sharma, Neeru M.; Kochenova, Olga V.; Shcherbakova, Polina V.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Shcherbakova, PV (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 986805 Nebraska Med Ctr, Omaha, NE 68198 USA.	pshcherb@unmc.edu		Sharma, Neeru/0000-0002-8477-7065	Nebraska DHHS [LB506]; National Institutes of Health [ES011644, ES015869]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015869, K22ES011644] Funding Source: NIH RePORTER	Nebraska DHHS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by Nebraska DHHS Grant LB506, and National Institutes of Health Grants ES011644 and ES015869 (to P. V. S.).	Acharya N, 2005, MOL CELL BIOL, V25, P9734, DOI 10.1128/MCB.25.21.9734-9740.2005; Acharya N, 2009, P NATL ACAD SCI USA, V106, P9631, DOI 10.1073/pnas.0902175106; Acharya N, 2007, MOL CELL BIOL, V27, P8401, DOI 10.1128/MCB.01478-07; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Broyde S, 2008, TRENDS BIOCHEM SCI, V33, P209, DOI 10.1016/j.tibs.2008.02.004; Bunting KA, 2003, EMBO J, V22, P5883, DOI 10.1093/emboj/cdg568; D'Souza S, 2008, DNA REPAIR, V7, P1455, DOI 10.1016/j.dnarep.2008.05.009; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Fortune JM, 2006, NUCLEIC ACIDS RES, V34, P4335, DOI 10.1093/nar/gkl403; Freudenthal BD, 2009, ACTA CRYSTALLOGR D, V65, P560, DOI 10.1107/S0907444909011329; Freudenthal BD, 2008, BIOCHEMISTRY-US, V47, P13354, DOI 10.1021/bi8017762; Fukuda H, 2009, J BIOL CHEM, V284, P25585, DOI 10.1074/jbc.M109.037259; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; Garg P, 2005, J BIOL CHEM, V280, P23446, DOI 10.1074/jbc.C500173200; Gilljam KM, 2009, J CELL BIOL, V186, P645, DOI 10.1083/jcb.200903138; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Haracska L, 2006, P NATL ACAD SCI USA, V103, P6477, DOI 10.1073/pnas.0510924103; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; Haracska L, 2002, J BIOL CHEM, V277, P15546, DOI 10.1074/jbc.M112146200; Haracska L, 2002, MOL CELL BIOL, V22, P784, DOI 10.1128/MCB.22.3.784-791.2002; Haracska L, 2001, P NATL ACAD SCI USA, V98, P14256, DOI 10.1073/pnas.261560798; Haracska L, 2001, MOL CELL BIOL, V21, P7199, DOI 10.1128/MCB.21.21.7199-7206.2001; Haracska L, 2001, MOL CELL, V8, P407, DOI 10.1016/S1097-2765(01)00319-7; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Johansson E, 2004, J BIOL CHEM, V279, P1907, DOI 10.1074/jbc.M310362200; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Lin WS, 1999, NUCLEIC ACIDS RES, V27, P4468, DOI 10.1093/nar/27.22.4468; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Masuda Y, 2002, J BIOL CHEM, V277, P3040, DOI 10.1074/jbc.M110149200; Masuda Y, 2001, J BIOL CHEM, V276, P15051, DOI 10.1074/jbc.M008082200; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Northam MR, 2006, EMBO J, V25, P4316, DOI 10.1038/sj.emboj.7601320; Northam MR, 2010, GENETICS, V184, P27, DOI 10.1534/genetics.109.107482; Ogi T, 2005, J CELL SCI, V118, P129, DOI 10.1242/jcs.01603; Parker JL, 2007, NUCLEIC ACIDS RES, V35, P881, DOI 10.1093/nar/gkl1102; Plosky BS, 2006, EMBO J, V25, P2847, DOI 10.1038/sj.emboj.7601178; Ross AL, 2005, NUCLEIC ACIDS RES, V33, P1280, DOI 10.1093/nar/gki279; Shcherbakova PV, 1999, MOL CELL BIOL, V19, P3177; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Vidal AE, 2004, J BIOL CHEM, V279, P48360, DOI 10.1074/jbc.M406511200; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Wood A, 2007, J BIOL CHEM, V282, P20256, DOI 10.1074/jbc.M702366200; Yang W, 2005, FEBS LETT, V579, P868, DOI 10.1016/j.febslet.2004.11.047; Yang W, 2003, CURR OPIN STRUC BIOL, V13, P23, DOI 10.1016/S0959-440X(02)00003-9; Zhang HS, 2006, GENETICS, V173, P1983, DOI 10.1534/genetics.106.058545; Zhang YB, 2002, NUCLEIC ACIDS RES, V30, P1630, DOI 10.1093/nar/30.7.1630; Zhou Y, 2010, NUCLEIC ACIDS RES, V38, P5036, DOI 10.1093/nar/gkq225	51	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33557	33566		10.1074/jbc.M110.206680	http://dx.doi.org/10.1074/jbc.M110.206680			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21799021	Green Published, hybrid			2022-12-25	WOS:000294968800072
J	Maruyama, S; Shibata, R; Ohashi, K; Ohashi, T; Daida, H; Walsh, K; Murohara, T; Ouchi, N				Maruyama, Sonomi; Shibata, Rei; Ohashi, Koji; Ohashi, Taiki; Daida, Hiroyuki; Walsh, Kenneth; Murohara, Toyoaki; Ouchi, Noriyuki			Adiponectin Ameliorates Doxorubicin-induced Cardiotoxicity through Akt Protein-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; CARDIAC MYOCYTE SURVIVAL; SPHINGOSINE 1-PHOSPHATE; MYOCARDIAL ISCHEMIA/REPERFUSION; CARDIOVASCULAR-DISEASE; INDUCED CARDIOMYOPATHY; ADIPOSE-TISSUE; APOPTOSIS; MICE; RECEPTORS	Accumulating evidence shows that obesity is associated with doxorubicin cardiac toxicity in the heart, but the molecular mechanisms that contribute to this pathological response are not understood. Adiponectin is an adipose-derived, cardioprotective factor that is down-regulated in obesity. Here, we investigated the effect of adiponectin on doxorubicin (DOX)-induced cardiotoxicity and assessed the mechanisms of this effect. A single dose of DOX was intraperitoneally injected into the abdomen of adiponectin knock-out (APN-KO) and wild-type (WT) mice. APN-KO mice had increased mortality and exacerbated contractile dysfunction of left ventricle compared with WT mice. APN-KO mice also showed increased apoptotic activity and diminished Akt signaling in the failing myocardium. Systemic delivery of adenoviral vector expressing adiponectin improved left ventricle dysfunction and myocardial apoptosis following DOX injection in WT and APN-KO mice but not in Akt1 heterozygous KO mice. In cultured rat neonatal cardiomyocytes, adiponectin stimulated Akt phosphorylation and inhibited DOX-stimulated apoptosis. Treatment with sphingosine kinase-1 inhibitor or sphingosine 1-phosphate receptor antagonist diminished adiponectin-induced Akt phosphorylation and reversed the inhibitory effects of adiponectin on myocyte apoptosis. Pretreatment with anti-calreticulin antibody reduced the binding of adiponectin to cardiac myocytes and blocked the adiponectin-stimulated increase in Akt activation and survival in cardiomyocytes. Interference of the LRP1/calreticulin co-receptor system by siRNA or blocking antibodies diminished the stimulatory actions of adiponectin on Akt activation and myocyte survival. These data show that adiponectin protects against DOX-induced cardiotoxicity by its ability to promote Akt signaling.	[Shibata, Rei] Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Ohashi, Koji; Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Nagoya, Aichi 4668550, Japan; [Maruyama, Sonomi; Daida, Hiroyuki] Juntendo Univ, Sch Med, Dept Cardiol, Tokyo 1138421, Japan; [Walsh, Kenneth] Boston Univ, Sch Med, Boston, MA 02118 USA	Nagoya University; Nagoya University; Juntendo University; Boston University	Shibata, R (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	rshibata@med.nagoya-u.ac.jp	OHASHI, Koji/I-7307-2014; Murohara, Toyoaki/M-4958-2014; OUCHI, Noriyuki/I-7306-2014		Uehara Memorial Foundation; Japan Heart Foundation/Novartis; NATIONAL INSTITUTE ON AGING [R37AG015052] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Heart Foundation/Novartis; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by a grant-in-aid for young scientists B, the Uehara Memorial Foundation, and the Japan Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology 2011 (to R. S.).	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Arola OJ, 2000, CANCER RES, V60, P1789; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bian Y, 2009, AM J PHYSIOL-HEART C, V297, pH1974, DOI 10.1152/ajpheart.01010.2008; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; de Azambuja E, 2010, BREAST CANCER RES TR, V119, P145, DOI 10.1007/s10549-009-0512-0; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Fujioka D, 2006, AM J PHYSIOL-HEART C, V290, pH2409, DOI 10.1152/ajpheart.00987.2005; Gonon AT, 2008, CARDIOVASC RES, V78, P116, DOI 10.1093/cvr/cvn017; Gonzalez E, 2006, J BIOL CHEM, V281, P3210, DOI 10.1074/jbc.M510434200; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Ikeda Y, 2008, FEBS LETT, V582, P1147, DOI 10.1016/j.febslet.2008.03.002; Ikeda Y, 2010, MOL ENDOCRINOL, V24, P1338, DOI 10.1210/me.2009-0402; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Kondo K, 2010, CIRC-CARDIOVASC INTE, V3, P166, DOI 10.1161/CIRCINTERVENTIONS.109.872044; Konishi M, 2011, CARDIOVASC RES, V89, P309, DOI 10.1093/cvr/cvq335; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mitra MS, 2008, TOXICOL APPL PHARM, V231, P413, DOI 10.1016/j.taap.2008.05.006; Mitra MS, 2007, TOXICOL APPL PHARM, V225, P90, DOI 10.1016/j.taap.2007.07.018; Negoro S, 2001, CIRCULATION, V103, P555, DOI 10.1161/01.CIR.103.4.555; Ohashi K, 2006, HYPERTENSION, V47, P1108, DOI 10.1161/01.HYP.0000222368.43759.a1; Ohashi K, 2009, MOL CELL BIOL, V29, P3487, DOI 10.1128/MCB.00126-09; Orr AW, 2004, J BIOL CHEM, V279, P48983, DOI 10.1074/jbc.M404881200; Osawa Y, 2001, J IMMUNOL, V167, P173, DOI 10.4049/jimmunol.167.1.173; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shibata R, 2007, J MOL CELL CARDIOL, V42, P1065, DOI 10.1016/j.yjmcc.2007.03.808; Shibata R, 2009, CIRC J, V73, P608, DOI 10.1253/circj.CJ-09-0057; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Taniyama Y, 2002, J MOL CELL CARDIOL, V34, P1241, DOI 10.1006/jmcc.2002.2068; Tao L, 2007, CIRCULATION, V115, P1408, DOI 10.1161/CIRCULATIONAHA.106.666941; Weinstein DM, 2000, J PHARMACOL EXP THER, V294, P396; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Zhang JQ, 2007, AM J PHYSIOL-HEART C, V293, pH3150, DOI 10.1152/ajpheart.00587.2006	44	69	70	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32790	32800		10.1074/jbc.M111.245985	http://dx.doi.org/10.1074/jbc.M111.245985			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784858	hybrid, Green Published			2022-12-25	WOS:000294726800086
J	Buhnerkempe, MG; Eisen, RJ; Goodell, B; Gage, KL; Antolin, MF; Webb, CT				Buhnerkempe, Michael G.; Eisen, Rebecca J.; Goodell, Brandon; Gage, Kenneth L.; Antolin, Michael F.; Webb, Colleen T.			Transmission Shifts Underlie Variability in Population Responses to Yersinia pestis Infection	PLOS ONE			English	Article							EARLY-PHASE TRANSMISSION; TAILED PRAIRIE DOGS; PLAGUE EPIZOOTICS; CYNOMYS-LUDOVICIANUS; DISEASE TRANSMISSION; UNBLOCKED FLEAS; SIPHONAPTERA; PERSISTENCE; THRESHOLDS; ABUNDANCE	Host populations for the plague bacterium, Yersinia pestis, are highly variable in their response to plague ranging from near deterministic extinction (i.e., epizootic dynamics) to a low probability of extinction despite persistent infection (i.e., enzootic dynamics). Much of the work to understand this variability has focused on specific host characteristics, such as population size and resistance, and their role in determining plague dynamics. Here, however, we advance the idea that the relative importance of alternative transmission routes may vary causing shifts from epizootic to enzootic dynamics. We present a model that incorporates host and flea ecology with multiple transmission hypotheses to study how transmission shifts determine population responses to plague. Our results suggest enzootic persistence relies on infection of an off-host flea reservoir and epizootics rely on transiently maintained flea infection loads through repeated infectious feeds by fleas. In either case, early-phase transmission by fleas (i.e., transmission immediately following an infected blood meal) has been observed in laboratory studies, and we show that it is capable of driving plague dynamics at the population level. Sensitivity analysis of model parameters revealed that host characteristics (e. g., population size and resistance) vary in importance depending on transmission dynamics, suggesting that host ecology may scale differently through different transmission routes enabling prediction of population responses in a more robust way than using either host characteristics or transmission shifts alone.	[Buhnerkempe, Michael G.; Goodell, Brandon; Antolin, Michael F.; Webb, Colleen T.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Buhnerkempe, Michael G.; Eisen, Rebecca J.; Gage, Kenneth L.] Ctr Dis Control, Div Vector Borne Infect Dis, Ft Collins, CO 80522 USA	Colorado State University	Buhnerkempe, MG (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	michael.buhnerkempe@colostate.edu	Antolin, Michael Franc/AAT-5971-2021; Buhnerkempe, Michael G./N-2411-2019	Buhnerkempe, Michael G./0000-0002-5996-8927	Centers for Disease Control and Prevention; Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Funding from the Centers for Disease Control and Prevention provided partial support for M.G.B. C.T.W. acknowledges funding from the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; ANDERSON RM, 1986, PHILOS T ROY SOC B, V314, P533, DOI 10.1098/rstb.1986.0072; Bacot A W, 1914, J Hyg (Lond), V13, P423; Barnes A.M., 1982, Symposia of the Zoological Society of London, V50, P237; BARTLETT MS, 1960, J R STAT SOC SER A-G, V123, P37, DOI 10.2307/2343186; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; BAZANOVA LP, 1996, MED PARASITOL, V2, P45; Begon M, 2003, J ANIM ECOL, V72, P343, DOI 10.1046/j.1365-2656.2003.00705.x; Ber R, 2003, APPL ENVIRON MICROB, V69, P5787, DOI 10.1128/AEM.69.10.5787-5792.2003; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Collinge SK, 2005, LANDSCAPE ECOL, V20, P941, DOI 10.1007/s10980-005-4617-5; Craft ME, 2011, J R SOC INTERFACE, V8, P776, DOI 10.1098/rsif.2010.0511; Cully JF, 2001, J MAMMAL, V82, P894, DOI 10.1644/1545-1542(2001)082&lt;0894:ICOSPI&gt;2.0.CO;2; Davis RM, 2002, J VECTOR ECOL, V27, P107; Davis S, 2008, NATURE, V454, P634, DOI 10.1038/nature07053; Davis S, 2004, SCIENCE, V304, P736, DOI 10.1126/science.1095854; Eisen RJ, 2008, J MED ENTOMOL, V45, P1160, DOI 10.1603/0022-2585(2008)45[1160:DOETOY]2.0.CO;2; Eisen RJ, 2008, AM J TROP MED HYG, V78, P949, DOI 10.4269/ajtmh.2008.78.949; Eisen RJ, 2008, EMERG INFECT DIS, V14, P941, DOI 10.3201/eid1406.080029; Eisen RJ, 2007, J MED ENTOMOL, V44, P678, DOI 10.1603/0022-2585(2007)44[678:ETOYPB]2.0.CO;2; Eisen RJ, 2007, J MED ENTOMOL, V44, P672, DOI 10.1603/0022-2585(2007)44[672:TDOETO]2.0.CO;2; Eisen RJ, 2006, P NATL ACAD SCI USA, V103, P15380, DOI 10.1073/pnas.0606831103; Eisen RJ, 2009, VET RES, V40, DOI 10.1051/vetres:2008039; Engelthaler DM, 2000, AM J TROP MED HYG, V62, P552, DOI 10.4269/ajtmh.2000.62.552; Eskey CR., 1940, PUB HLTH B, V254, P1; Evans F. C., 1943, JOUR MAMMAL, V24, P231, DOI 10.2307/1374808; GAGE KL, 1995, J MAMMAL, V76, P695, DOI 10.2307/1382741; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; GEORGE DB, 2011, P NATL ACAD IN PRESS; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GOLOV DA, 1928, P 1 ALL RUSS ANT C S, P102; Gulland FMD, 1996, J WILDLIFE DIS, V32, P572, DOI 10.7589/0090-3558-32.4.572; HARTWELL WV, 1958, SCIENCE, V127, P814, DOI 10.1126/science.127.3302.814; Hoogland J. L., 1995, BLACK TAILED PRAIRIE; KARIMI PY, 1963, B SOC PATHOL EXOT, V56, P1183; KARTMAN LEO, 1962, ZOONOSES RES, V1, P201; Keeling MJ., 2008, MODELING INFECT DIS, DOI [DOI 10.1515/9781400841035, 10.1515/9781400841035]; LANG J D, 1991, Bulletin of the Society for Vector Ecology, V16, P183; Linsdale J. M., 1946, P475; Lorange EA, 2005, J INFECT DIS, V191, P1907, DOI 10.1086/429931; MAY RM, 1979, NATURE, V280, P455, DOI 10.1038/280455a0; Nasci RS, 2001, EMERG INFECT DIS, V7, P742; PIESMAN J, 1988, J MED ENTOMOL, V25, P336, DOI 10.1093/jmedent/25.5.336; Poland J. D., 1979, CRC Handbook Series in Zoonoses. Section A: bacterial, rickettsial, and mycotic diseases. Volume I., P515; QUAN TJ, 1985, J WILDLIFE DIS, V21, P205, DOI 10.7589/0090-3558-21.3.205; Rocke TE, 2010, VECTOR-BORNE ZOONOT, V10, P53, DOI 10.1089/vbz.2009.0050; Salkeld DJ, 2008, J PARASITOL, V94, P616, DOI 10.1645/GE-1368.1; Salkeld DJ, 2010, P NATL ACAD SCI USA, V107, P14247, DOI 10.1073/pnas.1002826107; SHARETS AS, 1958, MONOGR ALMATY, P145; Stenseth NC, 2006, P NATL ACAD SCI USA, V103, P13110, DOI 10.1073/pnas.0602447103; SULKIN SE, 1962, AM J PUBLIC HEALTH N, V52, P489, DOI 10.2105/AJPH.52.3.489; Swinton J, 1998, J ANIM ECOL, V67, P54, DOI 10.1046/j.1365-2656.1998.00176.x; Swinton J., 2002, P83; THOMAS RE, 1988, J WILDLIFE DIS, V24, P327, DOI 10.7589/0090-3558-24.2.327; Tripp DW, 2009, VECTOR-BORNE ZOONOT, V9, P313, DOI 10.1089/vbz.2008.0194; Webb CT, 2006, P NATL ACAD SCI USA, V103, P6236, DOI 10.1073/pnas.0510090103; Wilder AP, 2008, ECOHEALTH, V5, P205, DOI 10.1007/s10393-008-0165-1; Wilder AP, 2008, VECTOR-BORNE ZOONOT, V8, P359, DOI 10.1089/vbz.2007.0181; WILLIAMS JE, 1979, J INFECT DIS, V140, P618, DOI 10.1093/infdis/140.4.618; Wilson A, 2008, PLOS BIOL, V6, P1612, DOI 10.1371/journal.pbio.0060210; Wimsatt J, 2009, J VECTOR DIS, V46, P85	61	31	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22498	10.1371/journal.pone.0022498	http://dx.doi.org/10.1371/journal.pone.0022498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799873	Green Published, Green Submitted, gold			2022-12-25	WOS:000293172900038
J	Kanemoto, Y; Matsuzaki, M; Morita, S; Hayama, T; Noguchi, J; Senda, N; Momotake, A; Arai, T; Kasai, H				Kanemoto, Yuya; Matsuzaki, Masanori; Morita, Susumu; Hayama, Tatsuya; Noguchi, Jun; Senda, Naoko; Momotake, Atsuya; Arai, Tatsuo; Kasai, Haruo			Spatial Distributions of GABA Receptors and Local Inhibition of Ca2+ Transients Studied with GABA Uncaging in the Dendrites of CA1 Pyramidal Neurons	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; HIPPOCAMPAL; PLASTICITY; GEOMETRY; INPUTS	GABA(gamma-amino-butylic acid)-mediated inhibition in the dendrites of CA1 pyramidal neurons was characterized by two-photon uncaging of a caged-GABA compound, BCMACM-GABA, and one-photon uncaging of RuBi-GABA in rat hippocampal slice preparations. Although we found that GABA(A)-mediated currents were diffusely distributed along the dendrites, currents elicited at the branch points of the apical dendritic trunk were approximately two times larger than those elsewhere in the dendrite. We examined the inhibitory action of the GABA-induced currents on Ca2+ transients evoked with a single back-propagating action potential (bAP) in oblique dendrites. We found that GABA uncaging selectively inhibited the Ca2+ transients in the region adjacent (<20 mu m) to the uncaging site, and that GABA uncaging was effective only within a short period after bAP (<20 ms). The strength of inhibition was linearly related to the amplitudes of the GABA currents, suggesting that the currents inhibited a sustained, subthreshold after-depolarization without preventing propagation of bAP. GABA uncaging at the dendritic branch points inhibited Ca2+ transients farther into dendritic branches (>20 mu m). Our data indicate that GABA inhibition results in spatially confined inhibition of Ca2+ transients shortly after bAP, and suggest that this effect is particularly potent at the dendritic branch points where GABA receptors cluster.	[Kanemoto, Yuya; Matsuzaki, Masanori; Morita, Susumu; Hayama, Tatsuya; Noguchi, Jun; Kasai, Haruo] Univ Tokyo, Grad Sch Med, Lab Struct Physiol, Ctr Dis Biol & Integrat Med, Tokyo, Japan; [Matsuzaki, Masanori; Kasai, Haruo] Japan Sci & Technol Agcy, CREST, Saitama, Japan; [Senda, Naoko; Momotake, Atsuya; Arai, Tatsuo] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki, Japan	University of Tokyo; Japan Science & Technology Agency (JST); University of Tsukuba	Kanemoto, Y (corresponding author), UCL, Wolfson Inst Biomed Res, London, England.	hkasai@m.u-tokyo.ac.jp	Momotake, Atsuya/O-7062-2017; Momotake, Atsuya/R-8321-2016	Momotake, Atsuya/0000-0002-1040-0468; Momotake, Atsuya/0000-0002-1040-0468; Noguchi, Jun/0000-0002-8350-791X; Matsuzaki, Masanori/0000-0003-3872-4322; Kasai, Haruo/0000-0003-2327-9027	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [2000009, 20021008, 471, 19680020, 22750143, 21500367]; Mitsubishi Foundation; Human Frontier Science Program; Grants-in-Aid for Scientific Research [21500367, 21000009] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Human Frontier Science Program(Human Frontier Science Program); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Specially Promoted Area (No. 2000009 to H.K.), Scientific Research on Priority Areas (Elucidation of neural network function in the brain, No. 20021008 to M.M., New Frontiers in Photochromism No. 471 to TA), Young Scientist (A) (No. 19680020 to M.M.), Young Scientist (B) (No. 22750143 to AM), Scientific Research (C) (No. 21500367 to J.N.), and the Global COE Program (Integrative Life Science based on the study of Biosignaling Mechanisms to H.K.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). This work was also supported by a Mitsubishi Foundation grant to M.M. and a Research Grant from the Human Frontier Science Program to H.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Hao J, 2009, P NATL ACAD SCI USA, V106, P21906, DOI 10.1073/pnas.0912022106; Kantevari S, 2010, NAT METHODS, V7, P123, DOI [10.1038/NMETH.1413, 10.1038/nmeth.1413]; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Koch Christof, 1999, P1; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matsuzaki M, 2010, NAT CHEM BIOL, V6, P255, DOI [10.1038/nchembio.321, 10.1038/NCHEMBIO.321]; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Senda N, 2007, B CHEM SOC JPN, V80, P2384, DOI 10.1246/bcsj.80.2384; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Verde EMR, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.002.2008	21	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22652	10.1371/journal.pone.0022652	http://dx.doi.org/10.1371/journal.pone.0022652			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799926	Green Submitted, Green Published, gold			2022-12-25	WOS:000293172900062
J	Ohri, CM; Shikotra, A; Green, RH; Waller, DA; Bradding, P				Ohri, Chandra M.; Shikotra, Aarti; Green, Ruth H.; Waller, David A.; Bradding, Peter			The Tissue Microlocalisation and Cellular Expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 Is Correlated to Clinical Outcome in NSCLC	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; ENDOTHELIAL GROWTH-FACTOR; BINDING PROTEINS MRP8; LUNG-CANCER; NITRIC-OXIDE; HUMAN-MONOCYTES; SURVIVAL ADVANTAGE; SCAVENGER RECEPTOR; ISLETS CONFERS; CELLS	Background: We have previously investigated the microlocalisation of M1 and M2 macrophages in NSCLC. This study investigated the non-macrophage (NM) expression of proteins associated with M1 and M2 macrophages in NSCLC. Methods: Using immunohistochemistry, CD68(+) macrophages and proteins associated with either a cytotoxic M1 phenotype (HLA-DR, iNOS, and MRP 8/14), or a non-cytotoxic M2 phenotype (CD163 and VEGF) were identified. NM expression of the markers was analysed in the islets and stroma of surgically resected tumours from 20 patients with extended survival (ES) (median 92.7 months) and 20 patients with poor survival (PS) (median 7.7 months). Results: The NM expression of NM-HLA-DR (p<0.001), NM-iNOS (p = 0.02) and NM-MRP 8/14 (p = 0.02) was increased in ES compared to PS patients in the tumour islets. The tumour islet expression of NM-VEGF, was decreased in ES compared to PS patients (p<0.001). There was more NM-CD163 expression (p = 0.04) but less NM-iNOS (p = 0.002) and MRP 8/14 (p = 0.01) expression in the stroma of ES patients compared with PS patients. The 5-year survival for patients with above and below median NM expression of the markers in the islets was 74.9% versus 4.7% (NM-HLA-DR p<0.001), 65.0% versus 14.6% (NM-iNOS p = 0.003), and 54.3% versus 22.2% (NM-MRP 8/14 p = 0.04), as opposed to 34.1% versus 44.4% (NM-CD163 p = 0.41) and 19.4% versus 59.0% (NM-VEGF p = 0.001). Conclusions: Cell proteins associated with M1 and M2 macrophages are also expressed by other cell types in the tumour islets and stroma of patients with NSCLC. Their tissue and cellular microlocalisation is associated with important differences in clinical outcome.	[Ohri, Chandra M.; Shikotra, Aarti; Bradding, Peter] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Ohri, Chandra M.; Green, Ruth H.; Bradding, Peter] Glenfield Gen Hosp, Inst Lung Hlth, Dept Resp Med, Leicester LE3 9QP, Leics, England; [Waller, David A.] Glenfield Gen Hosp, Dept Thorac Surg, Leicester LE3 9QP, Leics, England	University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Ohri, CM (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England.	cohri@doctors.org.uk		Bradding, Peter/0000-0001-8403-0319	Royal College of Physicians, London, United Kingdom	Royal College of Physicians, London, United Kingdom	Funding for this study was provided by the James Maxwell Grant Prophit Fellowship awarded to Dr. Chandra Ohri by the Royal College of Physicians, London, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CF, 2002, J LEUKOCYTE BIOL, V72, P101; Baj-Krzyworzeka M, 2007, IMMUNOL LETT, V113, P76, DOI 10.1016/j.imlet.2007.07.014; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; BHARDWAJ RS, 1992, EUR J IMMUNOL, V22, P1891, DOI 10.1002/eji.1830220732; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Binion DG, 1998, AM J PHYSIOL-GASTR L, V275, pG592, DOI 10.1152/ajpgi.1998.275.3.G592; Bogdan C, 1998, J EXP MED, V187, P1361, DOI 10.1084/jem.187.9.1361; Bradbury PA, 2008, J THORAC ONCOL, V3, pS164, DOI 10.1097/JTO.0b013e318174e9a7; Carrega P, 2008, CANCER-AM CANCER SOC, V112, P863, DOI 10.1002/cncr.23239; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Endress H, 1997, LUNG CANCER-J IASLC, V18, P35, DOI 10.1016/S0169-5002(97)00042-1; Eue I, 2000, INT IMMUNOL, V12, P1593, DOI 10.1093/intimm/12.11.1593; Fabriek BO, 2005, IMMUNOBIOLOGY, V210, P153, DOI 10.1016/j.imbio.2005.05.010; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Ferrara N, 1997, EXS, V79, P209; Foukas PG, 2001, ANTICANCER RES, V21, P2609; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Kim DW, 2008, BRIT J CANCER, V98, P1118, DOI 10.1038/sj.bjc.6604256; Perez-Gracia JL, 2010, CLIN TRANSL ONCOL, V12, P174, DOI 10.1007/s12094-010-0487-7; Luoma JS, 1998, ARTERIOSCL THROM VAS, V18, P157, DOI 10.1161/01.ATV.18.2.157; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MAHNKE K, 1995, J LEUKOCYTE BIOL, V57, P63, DOI 10.1002/jlb.57.1.63; Maniecki MB, 2006, IMMUNOBIOLOGY, V211, P407, DOI 10.1016/j.imbio.2006.05.019; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; O'Byrne KJ, 2001, BRIT J CANCER, V85, P473, DOI 10.1054/bjoc.2001.1943; Ohri CM, 2009, EUR RESPIR J, V33, P118, DOI 10.1183/09031936.00065708; Ohri CM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-323; Ohri CM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-172; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perez-Gracia JL, 2002, CANCER-AM CANCER SOC, V95, P1605, DOI 10.1002/cncr.10877; Poncet P, 1999, J LEUKOCYTE BIOL, V66, P105, DOI 10.1002/jlb.66.1.105; Puhakka A, 2003, APMIS, V111, P1137, DOI 10.1111/j.1600-0463.2003.apm1111210.x; Robinson MJ, 2000, BIOCHEM BIOPH RES CO, V275, P865, DOI 10.1006/bbrc.2000.3407; Schaer DJ, 2006, BLOOD, V107, P373, DOI 10.1182/blood-2005-03-1014; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Tran TA, 1998, CANCER, V83, P276, DOI 10.1002/(SICI)1097-0142(19980715)83:2<276::AID-CNCR11>3.3.CO;2-5; Van den Heuvel MM, 1999, J LEUKOCYTE BIOL, V66, P858, DOI 10.1002/jlb.66.5.858; Veikkola T, 2000, CANCER RES, V60, P203; Welsh TJ, 2005, J CLIN ONCOL, V23, P8959, DOI 10.1200/JCO.2005.01.4910; Xie KP, 1996, J LEUKOCYTE BIOL, V59, P797, DOI 10.1002/jlb.59.6.797; ZWADLO G, 1986, J IMMUNOL, V137, P512	42	37	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e21874	10.1371/journal.pone.0021874	http://dx.doi.org/10.1371/journal.pone.0021874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799753	Green Submitted, Green Published, gold			2022-12-25	WOS:000293097300007
J	Laguna, MF; Risau-Gusman, S				Fabiana Laguna, Mara; Risau-Gusman, Sebastian			Of Lice and Math: Using Models to Understand and Control Populations of Head Lice	PLOS ONE			English	Article							HUMAN-BODY LOUSE; PEDICULUS-HUMANUS; MATHEMATICAL-MODEL; CAPITIS ANOPLURA; PRIMARY-SCHOOL; TRANSMISSION; IMMUNIZATION; RESISTANCE; EFFICACY; EXTRACT	In this paper we use detailed data about the biology of the head louse (pediculus humanus capitis) to build a model of the evolution of head lice colonies. Using theory and computer simulations, we show that the model can be used to assess the impact of the various strategies usually applied to eradicate head lice, both conscious (treatments) and unconscious (grooming). In the case of treatments, we study the difference in performance that arises when they are applied in systematic and non-systematic ways. Using some reasonable simplifying assumptions (as random mixing of human groups and the same mobility for all life stages of head lice other than eggs) we model the contagion of pediculosis using only one additional parameter. It is shown that this parameter can be tuned to obtain collective infestations whose characteristics are compatible with what is given in the literature on real infestations. We analyze two scenarios: One where group members begin treatment when a similar number of lice are present in each head, and another where there is one individual who starts treatment with a much larger threshold ("superspreader"). For both cases we assess the impact of several collective strategies of treatment.	[Fabiana Laguna, Mara] Consejo Nacl Invest Cient & Tecn, San Carlos De Bariloche, Rio Negro, Argentina; Ctr Atom Bariloche, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche	Laguna, MF (corresponding author), Consejo Nacl Invest Cient & Tecn, San Carlos De Bariloche, Rio Negro, Argentina.	lagunaf@cab.cnea.gov.ar		Laguna, Maria Fabiana/0000-0003-4311-8802				ALLMAN ES, 2004, MATH MODELS BIOL; Anderson AL, 2009, INT J ENV RES PUB HE, V6, P592, DOI 10.3390/ijerph6020592; ANDERSON R M, 1991; Bacot A., 1917, Parasitology Cambridge, V9, DOI 10.1017/S0031182000006065; Begon M., 2009, ECOLOGY INDIVIDUALS; BENYAKIR D, 1994, MED VET ENTOMOL, V8, P114, DOI 10.1111/j.1365-2915.1994.tb00149.x; Beugnet F, 2004, PARASITE, V11, P387, DOI 10.1051/parasite/2004114387; Beugnet F, 1998, VET PARASITOL, V77, P277, DOI 10.1016/S0304-4017(98)00116-2; Burgess IF, 2010, MED VET ENTOMOL, V24, P55, DOI 10.1111/j.1365-2915.2009.00845.x; Burgess IE, 2004, ANNU REV ENTOMOL, V49, P457, DOI 10.1146/annurev.ento.49.061802.123253; Burkhart CN, 2007, J AM ACAD DERMATOL, V56, P1044, DOI 10.1016/j.jaad.2006.10.979; Buxton P A, 1941, Proc R Soc Med, V34, P193; Canyon D. V., 2010, OPEN DERMATOL J, V4, P72; Canyon DV, 2002, J INVEST DERMATOL, V119, P629, DOI 10.1046/j.1523-1747.2002.00540.x; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Chouela E, 1997, INT J DERMATOL, V36, P819, DOI 10.1046/j.1365-4362.1997.00177.x; EVANS FC, 1983, AM NAT, V86, P299; Falagas ME, 2008, EMERG INFECT DIS, V14, P1493, DOI 10.3201/eid1409.080368; Hansen RC, 2004, CLIN PEDIATR, V43, P523, DOI 10.1177/000992280404300603; Heukelbach J, 2008, MED VET ENTOMOL, V22, P264, DOI 10.1111/j.1365-2915.2008.00738.x; Krasnov B.R., 2008, FUNCTIONAL EVOLUTION; Lebwohl M, 2007, PEDIATRICS, V119, P965, DOI 10.1542/peds.2006-3087; LEFKOVITCH LP, 1965, BIOMETRICS, V21, P1, DOI 10.2307/2528348; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Li WJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000641; Light JE, 2008, MOL PHYLOGENET EVOL, V47, P1203, DOI 10.1016/j.ympev.2008.03.014; Maunder J W, 1993, Health Visit, V66, P317; MCLAURY P, 1983, AM J NURS, V83, P1300, DOI 10.2307/3463414; MEINKING TL, 1999, CURRENT PROBLEMS DER, V11, P75; MUMCUOGLU KY, 1990, INT J DERMATOL, V29, P502, DOI 10.1111/j.1365-4362.1990.tb04845.x; Mumcuoglu KY, 1997, MED VET ENTOMOL, V11, P315, DOI 10.1111/j.1365-2915.1997.tb00415.x; Mumcuoglu KY, 2001, PEDIATR DERMATOL, V18, P9, DOI 10.1046/j.1525-1470.2001.018001009.x; PINDER JE, 1978, ECOLOGY, V59, P175; Revie CW, 2005, J FISH DIS, V28, P603, DOI 10.1111/j.1365-2761.2005.00665.x; Sonnberg S, 2010, OPEN DERMATOLOGY J, V4, P82; Speare R, 2006, INT J DERMATOL, V45, P543, DOI 10.1111/j.1365-4632.2005.02520.x; Speare R, 2002, AUST NZ J PUBL HEAL, V26, P208, DOI 10.1111/j.1467-842X.2002.tb00675.x; Speare R, 1999, INT J DERMATOL, V38, P285, DOI 10.1046/j.1365-4362.1999.00680.x; Stone P, 2008, J MATH BIOL, V56, P743, DOI 10.1007/s00285-007-0136-0; Takano-Lee M, 2005, INT J DERMATOL, V44, P811, DOI 10.1111/j.1365-4632.2005.02418.x; Takano-Lee M, 2003, J MED ENTOMOL, V40, P628, DOI 10.1603/0022-2585-40.5.628; VANDERSTICHELE RH, 1995, BMJ-BRIT MED J, V311, P604, DOI 10.1136/bmj.311.7005.604; Vermaak Z, 1996, PUBLIC HEALTH, V110, P283, DOI 10.1016/S0033-3506(96)80090-4; Watt KEF, 1966, SYSTEMS ANAL ECOLOGY	44	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e21848	10.1371/journal.pone.0021848	http://dx.doi.org/10.1371/journal.pone.0021848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799752	gold, Green Published, Green Submitted			2022-12-25	WOS:000292931200015
J	Nituch, LA; Bowman, J; Beauclerc, KB; Schulte-Hostedde, AI				Nituch, Larissa A.; Bowman, Jeff; Beauclerc, Kaela B.; Schulte-Hostedde, Albrecht I.			Mink Farms Predict Aleutian Disease Exposure in Wild American Mink	PLOS ONE			English	Article							MUSTELA-VISON; PARVOVIRUS; ANTIBODIES; CARNIVORES; IMPACTS; VIRUS	Background: Infectious diseases can often be of conservation importance for wildlife. Spillover, when infectious disease is transmitted from a reservoir population to sympatric wildlife, is a particular threat. American mink (Neovison vison) populations across Canada appear to be declining, but factors thus far explored have not fully explained this population trend. Recent research has shown, however, that domestic mink are escaping from mink farms and hybridizing with wild mink. Domestic mink may also be spreading Aleutian disease (AD), a highly pathogenic parvovirus prevalent in mink farms, to wild mink populations. AD could reduce fitness in wild mink by reducing both the productivity of adult females and survivorship of juveniles and adults. Methods: To assess the seroprevalence and geographic distribution of AD infection in free-ranging mink in relation to the presence of mink farms, we conducted both a large-scale serological survey, across the province of Ontario, and a smaller-scale survey, at the interface between a mink farm and wild mink. Conclusions/Significance: Antibodies to AD were detected in 29% of mink (60 of 208 mink sampled); however, seroprevalence was significantly higher in areas closer to mink farms than in areas farther from farms, at both large and small spatial scales. Our results indicate that mink farms act as sources of AD transmission to the wild. As such, it is likely that wild mink across North America may be experiencing increased exposure to AD, via disease transmission from mink farms, which may be affecting wild mink demographics across their range. In light of declining mink populations, high AD seroprevalence within some mink farms, and the large number of mink farms situated across North America, improved biosecurity measures on farms are warranted to prevent continued disease transmission at the interface between mink farms and wild mink populations.	[Nituch, Larissa A.; Bowman, Jeff] Trent Univ, Ontario Minist Nat Resources, Peterborough, ON K9J 7B8, Canada; [Beauclerc, Kaela B.; Schulte-Hostedde, Albrecht I.] Laurentian Univ, Dept Biol, Sudbury, ON P3E 2C6, Canada	Ministry of Natural Resources & Forestry; Trent University; Laurentian University	Nituch, LA (corresponding author), Trent Univ, Ontario Minist Nat Resources, DNA Bldg, Peterborough, ON K9J 7B8, Canada.	larissanituch@trentu.ca	Schulte-Hostedde, Albrecht/C-2007-2009; Bowman, Jeff/B-4147-2009	Bowman, Jeff/0000-0002-1892-4469	Natural Sciences and Engineering Research Council of Canada; Wildlife Research and Development Section of the Ontario Ministry of Natural Resources	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Wildlife Research and Development Section of the Ontario Ministry of Natural Resources	Support for this research was provided by the Natural Sciences and Engineering Research Council of Canada (www.nserc.ca), the Wildlife Research and Development Section of the Ontario Ministry of Natural Resources (http://www.mnr.gov.on.ca/en/Business/Wildlife). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasted B, 1998, VACCINE, V16, P1158, DOI 10.1016/S0264-410X(98)80114-X; ALEXANDERSEN S, 1994, VET PATHOL, V31, P216, DOI 10.1177/030098589403100209; ALEXANDERSEN S, 1990, SCANDINAVICA, V98, P1; BLOOM ME, 1994, INFECT AGENT DIS, V3, P279; Bonesi L, 2007, BIOL CONSERV, V134, P470, DOI 10.1016/j.biocon.2006.09.006; Bowman J, 2007, BIOL CONSERV, V139, P12, DOI 10.1016/j.biocon.2007.05.020; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CHO HJ, 1978, J CLIN MICROBIOL, V7, P18; CHRIEL M, 2000, P 9 S INT SOC VET EP; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; Dunstone N., 1993, MINK; Eagle T.C., 1987, P614; Ferreras P, 1999, J APPL ECOL, V36, P701, DOI 10.1046/j.1365-2664.1999.00431.x; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Fournier-Chambrillon C, 2004, J WILDLIFE DIS, V40, P394, DOI 10.7589/0090-3558-40.3.394; Frolich K, 2002, ANN NY ACAD SCI, V969, P4, DOI 10.1111/j.1749-6632.2002.tb04343.x; Funk SM, 2001, CONSERV BIOL SER, V5, P443; Gerell R., 1967, VILTREVY, V5, P1; Gorman, 2007, THESIS TRENT U; HADLOW WJ, 1983, INFECT IMMUN, V41, P1016, DOI 10.1128/IAI.41.3.1016-1023.1983; Haffner GD, 1998, J GREAT LAKES RES, V24, P880, DOI 10.1016/S0380-1330(98)70869-X; Halliwell EC, 1996, BIOL CONSERV, V76, P51, DOI 10.1016/0006-3207(95)00072-0; Hartsough G. R., 1956, NAT FUR NEWS, V28, P10; Henson J B, 1976, Front Biol, V44, P175; Hunter D. B., 2008, Scientifur, V32, P200; Joergensen G., 1985, MINK PRODUCTION; Kidd AG, 2009, MOL ECOL, V18, P1175, DOI 10.1111/j.1365-294X.2009.04100.x; Knuuttila A, 2009, VET MICROBIOL, V133, P229, DOI 10.1016/j.vetmic.2008.07.003; Kock RA, 1999, VET REC, V145, P275, DOI 10.1136/vr.145.10.275; Kruska DCT, 2003, MAMM BIOL, V68, P257, DOI 10.1078/1616-5047-00095; LARSEN AE, 1975, INFECT IMMUN, V11, P92, DOI 10.1128/IAI.11.1.92-94.1975; Macdonald DW, 2003, NEW ZEAL J ZOOL, V30, P421, DOI 10.1080/03014223.2003.9518350; Macdonald DW, 1996, NATURE, V379, P400, DOI 10.1038/379400a0; Manas S, 2001, J WILDLIFE DIS, V37, P138, DOI 10.7589/0090-3558-37.1.138; Medina G, 1997, J ZOOL, V242, P291; Newman S. J., 2006, Scientifur, V30, P33; Ontario Animal Research and Services Committee (OARSC), 2004, ONT FUR RES SERV SUB; Otterstatter MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002771; R Core Development Team, 2008, R LANG ENV STAT COMP; RACEY GD, 1983, J APPL ECOL, V20, P387, DOI 10.2307/2403515; Randall DA, 2006, BIOL CONSERV, V131, P151, DOI 10.1016/j.biocon.2006.04.004; Statistics Canada, 2006, CENS AGR FARM DAT FA; Wildhaagen A., 1956, Journal of Mammalogy, V37, P116, DOI 10.2307/1375544; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Yamaguchi N, 2001, VET REC, V149, P485, DOI 10.1136/vr.149.16.485	45	32	33	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e21693	10.1371/journal.pone.0021693	http://dx.doi.org/10.1371/journal.pone.0021693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789177	gold, Green Submitted, Green Published			2022-12-25	WOS:000292812400013
J	Foreman, KW; Brown, M; Park, F; Emtage, S; Harriss, J; Das, C; Zhu, L; Crew, A; Arnold, L; Shaaban, S; Tucker, P				Foreman, Kenneth W.; Brown, Mark; Park, Frances; Emtage, Spencer; Harriss, June; Das, Chhaya; Zhu, Li; Crew, Andy; Arnold, Lee; Shaaban, Salam; Tucker, Philip			Structural and Functional Profiling of the Human Histone Methyltransferase SMYD3	PLOS ONE			English	Article							TANDEM REPEATS POLYMORPHISM; TRITHORAX-GROUP PROTEIN; SET DOMAIN; CANCER-CELLS; LYSINE METHYLTRANSFERASE; MOLECULAR-MECHANISMS; CRYSTAL-STRUCTURE; DNA METHYLATION; VARIABLE NUMBER; ACTIVE-SITE	The SET and MYND Domain (SMYD) proteins comprise a unique family of multi-domain SET histone methyltransferases that are implicated in human cancer progression. Here we report an analysis of the crystal structure of the full length human SMYD3 in a complex with an analog of the S-adenosyl methionine (SAM) methyl donor cofactor. The structure revealed an overall compact architecture in which the "split-SET" domain adopts a canonical SET domain fold and closely assembles with a Zn-binding MYND domain and a C-terminal superhelical 9 alpha-helical bundle similar to that observed for the mouse SMYD1 structure. Together, these structurally interlocked domains impose a highly confined binding pocket for histone substrates, suggesting a regulated mechanism for its enzymatic activity. Our mutational and biochemical analyses confirm regulatory roles of the unique structural elements both inside and outside the core SET domain and establish a previously undetected preference for trimethylation of H4K20.	[Foreman, Kenneth W.; Crew, Andy] OSI Pharmaceut Inc, Farmingdale, NY USA; [Brown, Mark; Harriss, June; Das, Chhaya; Zhu, Li; Tucker, Philip] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Park, Frances] AltheaDx Inc, San Diego, CA USA; [Emtage, Spencer] Eli Lilly & Co, San Diego, CA USA; [Arnold, Lee] DiscoverElucidations LLC, Mt Sinai, NY USA; [Shaaban, Salam] Abbott Biores Ctr, Worcester, MA USA	Astellas Pharmaceuticals; OSI Pharmaceuticals; University of Texas System; University of Texas Austin; Eli Lilly	Foreman, KW (corresponding author), Coferon Inc, New York, NY USA.	kforeman@coferon.com	Foreman, Kenneth/AAI-2249-2020		NIH [CA31534]; Marie Betzner Morrow endowment; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA031534] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Betzner Morrow endowment; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support was provided to PT by the NIH (CA31534; http://www.nih.gov/) and by the Marie Betzner Morrow endowment (http://www.biosci.utexas.edu/mgm/events/kelley.htm). Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Use of the LRL Collaborative Access Team (LRL-CAT) beamline facilities at Sector 31 of the Advanced Photon Source was provided by Eli Lilly & Company, which operates the facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Benetti R, 2007, J CELL BIOL, V178, P925, DOI 10.1083/jcb.200703081; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Brown MA, 2007, BIOCHEM BIOPH RES CO, V363, P241, DOI 10.1016/j.bbrc.2007.08.054; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Byrd KN, 2003, P NATL ACAD SCI USA, V100, P11535, DOI 10.1073/pnas.1933593100; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Collard RL, 2006, PROSTATE, V66, P687, DOI 10.1002/pros.20371; Congdon LM, 2010, J CELL BIOCHEM, V110, P609, DOI 10.1002/jcb.22570; Conway KE, 2000, CANCER RES, V60, P6236; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Cui LW, 2008, INT J PARASITOL, V38, P1083, DOI 10.1016/j.ijpara.2008.01.002; Ducasse M, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-60; ERICKSON P, 1992, BLOOD, V80, P1825; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hamamoto R, 2006, CANCER SCI, V97, P113, DOI 10.1111/j.1349-7006.2006.00146.x; Jacobs SA, 2002, NAT STRUCT BIOL, V9, P833, DOI 10.1038/nsb861; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kapoor-Vazirani P, 2008, CANCER RES, V68, P6810, DOI 10.1158/0008-5472.CAN-08-0141; Kapoor-Vazirani P, 2011, MOL CELL BIOL, V31, P1594, DOI 10.1128/MCB.00524-10; Kwon T, 2003, EMBO J, V22, P292, DOI 10.1093/emboj/cdg025; Liu YZ, 2007, CANCER CELL, V11, P483, DOI 10.1016/j.ccr.2007.04.010; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Marmorstein R, 2003, TRENDS BIOCHEM SCI, V28, P59, DOI 10.1016/S0968-0004(03)00007-0; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; McConnell BB, 2004, APOPTOSIS, V9, P5, DOI 10.1023/B:APPT.0000012117.32430.0c; MCREE D, 1993, STRUCT BIOL, V125, P156; Mehta IS, 2007, ANN NY ACAD SCI, V1100, P250, DOI 10.1196/annals.1395.027; Min JR, 2002, NAT STRUCT BIOL, V9, P828, DOI 10.1038/nsb860; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Silva FP, 2008, ONCOGENE, V27, P2686, DOI 10.1038/sj.onc.1210929; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Sirinupong N, 2011, J MOL BIOL, V406, P149, DOI 10.1016/j.jmb.2010.12.014; Sirinupong N, 2010, J BIOL CHEM, V285, P40635, DOI 10.1074/jbc.M110.168187; Spadaccini R, 2006, J MOL BIOL, V358, P498, DOI 10.1016/j.jmb.2006.01.087; Srivastava D, 2002, COLD SPRING HARB SYM, V67, P121, DOI 10.1101/sqb.2002.67.121; Stone AR, 2004, AM J PATHOL, V165, P1151, DOI 10.1016/S0002-9440(10)63376-7; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Tanaka Y, 2007, GENE, V397, P161, DOI 10.1016/j.gene.2007.04.027; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Trievel RC, 2003, NAT STRUCT BIOL, V10, P545, DOI 10.1038/nsb946; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; Tsuge M, 2005, NAT GENET, V37, P1104, DOI 10.1038/ng1638; Venters Bryan J, 2007, Genome Biol, V8, P319, DOI 10.1186/gb-2007-8-11-319; Veraksa A, 2002, GENESIS, V33, P67, DOI 10.1002/gene.10090; Wang HJ, 2008, CANCER SCI, V99, P787, DOI 10.1111/j.1349-7006.2008.00729.x; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; XU S, 2011, NUCL ACIDS RES; Yang HB, 2008, J BIOL CHEM, V283, P12085, DOI 10.1074/jbc.M707974200; Yang HB, 2009, BIOCHEM CELL BIOL, V87, P151, DOI 10.1139/O08-131; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; ZHOU COA, 2006, CELLULAR MOL LIFE SC, V68, P9	65	72	74	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22290	10.1371/journal.pone.0022290	http://dx.doi.org/10.1371/journal.pone.0022290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779408	gold, Green Published, Green Submitted			2022-12-25	WOS:000292811300061
J	Tho, LM; Libertini, S; Rampling, R; Sansom, O; Gillespie, DA				Tho, L. M.; Libertini, S.; Rampling, R.; Sansom, O.; Gillespie, D. A.			Chk1 is essential for chemical carcinogen-induced mouse skin tumorigenesis	ONCOGENE			English	Article						checkpoints; carcinogenesis; DNA damage; genome stability; apoptosis; senescence	ONCOGENE-INDUCED SENESCENCE; DNA-DAMAGE; STEM-CELLS; TUMOR-FORMATION; HAIR FOLLICLE; CANCER; CHECKPOINT; EPIDERMIS; MICE; ATR	Chk1 is a key regulator of DNA damage checkpoint responses and genome stability in eukaryotes. To better understand how checkpoint proficiency relates to cancer development, we investigated the effects of genetic ablation of Chk1 in the mouse skin on tumors induced by chemical carcinogens. We found that homozygous deletion of Chk1 immediately before carcinogen exposure strongly suppressed benign tumor (papilloma) formation, and that the few, small lesions that formed in the ablated skin always retained Chk1 expression. Remarkably, Chk1 deletion rapidly triggered spontaneous cell proliferation, gamma-H2AX staining and apoptosis within the hair follicle, a principal site of origin for carcinogen-induced tumors. At later times, the ablated skin was progressively repopulated by non-recombined Chk1-expressing cells and ultimately normal sensitivity to tumor induction was restored when carcinogen treatment was delayed. In marked contrast, papillomas formed normally in Chk1 hemizygous skin but showed an increased propensity to progress to carcinoma. Thus, complete loss of Chk1 is incompatible with epithelial tumorigenesis, whereas partial loss of function (haploinsufficiency) fosters benign malignant tumor progression. Oncogene (2012) 31, 1366-1375; doi:10.1038/onc.2011.326; published online 1 August 2011	[Tho, L. M.; Libertini, S.; Sansom, O.; Gillespie, D. A.] Univ Glasgow, Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Tho, L. M.; Rampling, R.; Sansom, O.; Gillespie, D. A.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute; University of Glasgow; University of Glasgow	Gillespie, DA (corresponding author), Univ Glasgow, Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	d.gillespie@beatson.gla.ac.uk	Tho, Lye Mun/A-1232-2011; Tho, Lye Mun/X-1745-2019; Gillespie, David/R-4771-2019; Libertini, Silvana/A-3531-2011	Gillespie, David/0000-0002-6338-0544; Libertini, Silvana/0000-0003-2633-1564; Sansom, Owen J./0000-0001-9540-3010	Cancer Research UK (CR-UK); Marie Curie EU; Royal College of Radiologists; CRUK: Royal College of Radiologists; Marie Curie fellowship; Cancer Research UK [12481] Funding Source: researchfish	Cancer Research UK (CR-UK)(Cancer Research UK); Marie Curie EU(European Commission); Royal College of Radiologists; CRUK: Royal College of Radiologists; Marie Curie fellowship(European Commission); Cancer Research UK(Cancer Research UK)	We thank Cancer Research UK (CR-UK), Marie Curie EU and the Royal College of Radiologists for financial support, Drs S Elledge, J Rosen and M Lam for the kind gift of reagents, as well as Dr G Inman for constructive comments on the manuscript. LMT was the recipient of a joint CRUK: Royal College of Radiologists fellowship and SL was the recipient of a Marie Curie fellowship.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Ashwell S, 2008, EXPERT OPIN INV DRUG, V17, P1331, DOI [10.1517/13543784.17.9.1331, 10.1517/13543784.17.9.1331 ]; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bolderson E, 2009, CLIN CANCER RES, V15, P6314, DOI 10.1158/1078-0432.CCR-09-0096; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Fishler T, 2010, ONCOGENE, V29, P4007, DOI 10.1038/onc.2010.163; Greenow KR, 2009, ONCOGENE, V28, P1443, DOI 10.1038/onc.2008.482; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kangsamaksin T, 2007, MOL CARCINOGEN, V46, P579, DOI 10.1002/mc.20355; Kemp CJ, 2005, SEMIN CANCER BIOL, V15, P460, DOI 10.1016/j.semcancer.2005.06.003; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Liu QH, 2000, GENE DEV, V14, P1448; McLean GW, 2004, GENE DEV, V18, P2998, DOI 10.1101/gad.316304; Mulherkar R, 2003, ONCOGENE, V22, P1936, DOI 10.1038/sj.onc.1206229; Niida H, 2010, EMBO J, V29, P3558, DOI 10.1038/emboj.2010.218; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Takai H, 2000, GENE DEV, V14, P1439; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Zaugg K, 2007, P NATL ACAD SCI USA, V104, P3805, DOI 10.1073/pnas.0611584104	26	31	33	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	11					1366	1375		10.1038/onc.2011.326	http://dx.doi.org/10.1038/onc.2011.326			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	912FL	21804609				2022-12-25	WOS:000301780000004
J	Rakotomamonjy, J; Levenes, C; Baulieu, EE; Schumacher, M; Ghoumari, AM				Rakotomamonjy, Jennifer; Levenes, Carole; Baulieu, Etienne Emile; Schumacher, Michael; Ghoumari, Abdel M.			Novel protective effect of mifepristone on detrimental GABA(A) receptor activity to immature Purkinje neurons	FASEB JOURNAL			English	Article						resting potential; neuroprotection; ionotropic receptor; RU486	TEMPORAL-LOBE EPILEPSY; CELL-DEATH; HIPPOCAMPAL-NEURONS; IN-VITRO; EXCITATORY ACTIONS; CUSHINGS-SYNDROME; CLIMBING FIBERS; RAT; APOPTOSIS; SURVIVAL	Immature Purkinje neurons are particularly vulnerable cells. They survive in cerebellar slice cultures under treatment by the synthetic steroid mifepristone (RU486) that depolarizes them at this age. The present study aims at understanding the mechanism underlying this neuroprotective effect. In the developing cerebellum, the role of gamma-aminobutyric acid (GABA) in neuron survival is unknown. In 3-d-old mouse cerebellar slice cultures, we show that GABA(A) receptor activation is depolarizing and excitatory. Antagonists of GABA(A) receptors rescue Purkinje neurons, demonstrating that GABA is endogenously released in this preparation and is toxic. Mifepristone likely protects these neurons by reversing GABA(A) receptor-mediated chloride fluxes and reducing their driving force. Neuroprotection by mifepristone is dose-dependently decreased by the agonist of GABA(A) receptors muscimol and by caffeine, an agonist of internal calcium store release. Moreover, the survival induced by neomycin, an inhibitor of calcium release, is partially reversed by muscimol. The p38 mitogen-activated protein kinase (MAPK) inhibitor SB239063 also rescues Purkinje neurons. In summary, we propose that when GABA is depolarizing, mifepristone protects Purkinje neurons by shunting GABA responses and probably chloride fluxes, by inhibiting p38 MAPK activity and likely internal calcium store release. A new and nonhormonal effect of mifepristone is thus revealed.-Rakotomamonjy, J., Levenes, C., Baulieu, E. E., Schumacher, M., Ghoumari, A. M. Novel protective effect of mifepristone on detrimental GABA(A) receptor activity to immature Purkinje neurons. FASEB J. 25, 3999-4010 (2011). www.fasebj.org	[Rakotomamonjy, Jennifer; Baulieu, Etienne Emile; Schumacher, Michael; Ghoumari, Abdel M.] INSERM, UMR 788, F-94276 Le Kremlin Bicetre, France; [Rakotomamonjy, Jennifer; Baulieu, Etienne Emile; Schumacher, Michael; Ghoumari, Abdel M.] Univ Paris 11, F-94276 Le Kremlin Bicetre, France; [Levenes, Carole] Univ Paris 05, Inst Neurosci Cognit IMC, CNRS, UMR8119, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Ghoumari, AM (corresponding author), INSERM, UMR 788, 80 Rue Gen Leclerc, F-94276 Le Kremlin Bicetre, France.	abdel.ghoumari@inserm.fr	Schumacher, Michael/G-3581-2013	Schumacher, Michael/0000-0001-6117-5371; Rakotomamonjy, Jennifer/0000-0002-6375-0920; Levenes, Carole/0000-0002-1345-180X				BAULIEU EE, 1989, SCIENCE, V245, P1351, DOI 10.1126/science.2781282; Behl C, 1997, EUR J NEUROSCI, V9, P912, DOI 10.1111/j.1460-9568.1997.tb01442.x; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bosman LWJ, 2009, NEUROSCIENCE, V162, P612, DOI 10.1016/j.neuroscience.2009.01.032; Castinetti F, 2009, EUR J ENDOCRINOL, V160, P1003, DOI 10.1530/EJE-09-0098; Cerminara NL, 2004, J NEUROSCI, V24, P4510, DOI 10.1523/JNEUROSCI.4530-03.2004; Chen G, 1996, J PHYSIOL-LONDON, V494, P451, DOI 10.1113/jphysiol.1996.sp021505; CHERUBINI E, 1990, INT J DEV NEUROSCI, V8, P481, DOI 10.1016/0736-5748(90)90080-L; Cohen I, 2003, BIOL CELL, V95, P329, DOI 10.1016/S0248-4900(03)00081-9; Conti R, 2004, J NEUROSCI, V24, P6946, DOI 10.1523/JNEUROSCI.1397-04.2004; DRENGLER SM, 1993, BRAIN RES, V615, P175, DOI 10.1016/0006-8993(93)91129-G; Dusart I, 1997, J NEUROSCI, V17, P3710; Eilers J, 2001, J PHYSIOL-LONDON, V536, P429, DOI 10.1111/j.1469-7793.2001.0429c.xd; Fredriksson A, 2007, ANESTHESIOLOGY, V107, P427, DOI 10.1097/01.anes.0000278892.62305.9c; Ghoumari AM, 2006, FASEB J, V20, P1377, DOI 10.1096/fj.05-5832com; Ghoumari AM, 2000, EUR J NEUROSCI, V12, P2935, DOI 10.1046/j.1460-9568.2000.00186.x; Ghoumari AM, 2003, P NATL ACAD SCI USA, V100, P7953, DOI 10.1073/pnas.1332667100; Harper SJ, 2001, CELL SIGNAL, V13, P299, DOI 10.1016/S0898-6568(01)00148-6; Honegger P, 1998, DEV BRAIN RES, V105, P219, DOI 10.1016/S0165-3806(97)00194-6; Ikonomidou C, 2009, BRAIN DEV-JPN, V31, P488, DOI 10.1016/j.braindev.2009.02.006; Jankowski J, 2009, CEREBELLUM, V8, P277, DOI 10.1007/s12311-009-0093-9; Johanssen S, 2007, EUR J ENDOCRINOL, V157, P561, DOI 10.1530/EJE-07-0458; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kahraman S, 2008, J NEUROSURG ANESTH, V20, P233, DOI 10.1097/ANA.0b013e31817ec34d; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Khawaled R, 1999, PFLUG ARCH EUR J PHY, V438, P314, DOI 10.1007/s004240050915; Kim DY, 2008, EPILEPSIA, V49, P861, DOI 10.1111/j.1528-1167.2007.01455.x; Lukasiuk K, 2000, J NEUROCHEM, V74, P2445, DOI 10.1046/j.1471-4159.2000.0742445.x; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; Meldrum BS, 2007, NEUROTHERAPEUTICS, V4, P18, DOI 10.1016/j.nurt.2006.11.010; Nunez JL, 2003, EXP NEUROL, V181, P258, DOI 10.1016/S0014-4886(03)00053-0; Oomen CA, 2007, EUR J NEUROSCI, V26, P3395, DOI 10.1111/j.1460-9568.2007.05972.x; Palma E, 2006, P NATL ACAD SCI USA, V103, P8465, DOI 10.1073/pnas.0602979103; Repici M, 2011, CEREBELLUM, V10, P281, DOI 10.1007/s12311-010-0244-z; SERAFINI R, 1995, J PHYSIOL-LONDON, V488, P371, DOI 10.1113/jphysiol.1995.sp020973; Sotelo C, 2008, J COMP NEUROL, V506, P240, DOI 10.1002/cne.21501; Subramaniam S, 2010, FEBS J, V277, P22, DOI 10.1111/j.1742-4658.2009.07367.x; Watt AJ, 2009, NAT NEUROSCI, V12, P463, DOI 10.1038/nn.2285; Wei L, 2004, PFLUG ARCH EUR J PHY, V448, P325, DOI 10.1007/s00424-004-1277-2; Young AH, 2004, NEUROPSYCHOPHARMACOL, V29, P1538, DOI 10.1038/sj.npp.1300471; Yu SP, 2000, P NATL ACAD SCI USA, V97, P9360, DOI 10.1073/pnas.97.17.9360; Yuzaki M, 1996, J NEUROSCI, V16, P4651	42	9	10	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2011	25	11					3999	4010		10.1096/fj.11-183384	http://dx.doi.org/10.1096/fj.11-183384			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21795502				2022-12-25	WOS:000296723100024
J	Sun, Z; Singh, N; Mullican, SE; Everett, LJ; Li, L; Yuan, LJ; Liu, X; Epstein, JA; Lazar, MA				Sun, Zheng; Singh, Nikhil; Mullican, Shannon E.; Everett, Logan J.; Li, Li; Yuan, Lijun; Liu, Xi; Epstein, Jonathan A.; Lazar, Mitchell A.			Diet-induced Lethality Due to Deletion of the Hdac3 Gene in Heart and Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; FATTY-ACID OXIDATION; ERR-ALPHA; OBESITY CARDIOMYOPATHY; COREPRESSOR COMPLEX; DIABETIC HEART; CARDIAC-MUSCLE; RECEPTOR; METABOLISM	Many human diseases result from the influence of the nutritional environment on gene expression. The environment interacts with the genome by altering the epigenome, including covalent modification of nucleosomal histones. Here, we report a novel and dramatic influence of diet on the phenotype and survival of mice in which histone deacetylase 3 (Hdac3) is deleted postnatally in heart and skeletal muscle. Although embryonic deletion of myocardial Hdac3 causes major cardiomyopathy that reduces survival, we found that excision of Hdac3 in heart and muscle later in development leads to a much milder phenotype and does not reduce survival when mice are fed normal chow. Remarkably, upon switching to a high fat diet, the mice begin to die within weeks and display signs of severe hypertrophic cardiomyopathy and heart failure. Down-regulation of myocardial mitochondrial bioenergetic genes, specifically those involved in lipid metabolism, precedes the full development of cardiomyopathy, suggesting that HDAC3 is important in maintaining proper mitochondrial function. These data suggest that loss of the epigenomic modifier HDAC3 causes dietary lethality by compromising the ability of cardiac mitochondria to respond to changes of nutritional environment. In addition, this study provides a mouse model for diet-inducible heart failure.	[Sun, Zheng; Mullican, Shannon E.; Everett, Logan J.; Lazar, Mitchell A.] Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; [Sun, Zheng; Mullican, Shannon E.; Everett, Logan J.; Lazar, Mitchell A.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Sun, Zheng; Mullican, Shannon E.; Everett, Logan J.; Lazar, Mitchell A.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Singh, Nikhil; Li, Li; Yuan, Lijun; Liu, Xi; Epstein, Jonathan A.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Singh, Nikhil; Li, Li; Yuan, Lijun; Liu, Xi; Epstein, Jonathan A.] Univ Penn, Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Lazar, MA (corresponding author), 3400 Civ Ctr Blvd,12-102 TRC, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Everett, Logan/AAK-1523-2021; Lazar, Mitchell A/AAF-3738-2019; Sun, Zheng/C-1146-2012; singh, Nikhil/AAX-5380-2020	Sun, Zheng/0000-0002-6858-0633; Epstein, Jonathan/0000-0001-8637-4465; Singh, Nikhil/0000-0002-5269-8469	National Institutes of Health [DK43806, R01 HL071546]; Cox Institute for Medical Research; Medical Scientist Training Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043806, R37DK043806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cox Institute for Medical Research; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK43806 (to M. A. L.) and R01 HL071546 (to J. A. E.). This work was also supported by the Cox Institute for Medical Research (to M. A. L.) and a Medical Scientist Training Program grant (to N. S.).	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Alpert MA, 2001, AM J MED SCI, V321, P225, DOI 10.1097/00000441-200104000-00003; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bugger H, 2010, CARDIOVASC RES, V88, P229, DOI 10.1093/cvr/cvq239; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Carafa V, 2011, RECENT PAT ANTI-CANC, V6, P131, DOI 10.2174/157489211793980088; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Duncan JG, 2011, BBA-MOL CELL RES, V1813, P1351, DOI 10.1016/j.bbamcr.2011.01.014; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Guenther MG, 2000, GENE DEV, V14, P1048; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; He YJ, 2010, J BIOL CHEM, V285, P9516, DOI 10.1074/jbc.M109.092429; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Kolwicz SC, 2009, TRENDS CARDIOVAS MED, V19, P201, DOI 10.1016/j.tcm.2009.12.005; Larsen TS, 2008, CARDIOVASC DRUG THER, V22, P91, DOI 10.1007/s10557-008-6083-1; Lehman JJ, 2008, AM J PHYSIOL-HEART C, V295, pH185, DOI 10.1152/ajpheart.00081.2008; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tessari A, 2008, CIRC RES, V102, P813, DOI 10.1161/CIRCRESAHA.107.163188; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; WEYDERT A, 1987, CELL, V49, P121, DOI 10.1016/0092-8674(87)90762-8; Wong C, 2007, NAT CLIN PRACT CARD, V4, P436, DOI 10.1038/ncpcardio0943; Wright JJ, 2009, CARDIOVASC RES, V82, P351, DOI 10.1093/cvr/cvp017; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	58	72	74	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33301	33309		10.1074/jbc.M111.277707	http://dx.doi.org/10.1074/jbc.M111.277707			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21808063	Green Published, hybrid			2022-12-25	WOS:000294968800049
J	Meng, QY; Cai, DS				Meng, Qingyuan; Cai, Dongsheng			Defective Hypothalamic Autophagy Directs the Central Pathogenesis of Obesity via the I kappa B Kinase beta (IKK beta)/NF-kappa B Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; N-TERMINAL KINASE; HIGH-FAT DIET; INSULIN-RESISTANCE; LEPTIN RESISTANCE; CELL MASS; ER STRESS; MICE; INFLAMMATION; DISEASE	Autophagy has been recently demonstrated to control cell and tissue homeostasis, including the functions of various metabolic tissues. However, it remains unclear whether autophagy is critical for the central nervous system and particularly the hypothalamus for exerting metabolic regulation. Using autophagy-related protein 7 (Atg7) as an autophagic marker, this work showed that autophagy was highly active in the mediobasal hypothalamus of normal mice. In contrast, chronic development of dietary obesity was associated with autophagic decline in the mediobasal hypothalamus. To investigate the potential role of autophagy in the hypothalamic control of metabolic physiology, a mouse model was developed with autophagic inhibition in the mediobasal hypothalamus using site-specific delivery of lentiviral shRNA against Atg7. This model revealed that hypothalamic inhibition of autophagy increased energy intake and reduced energy expenditure. These metabolic changes were sufficient to increase body weight gain under normal chow feeding and exacerbate the progression of obesity and whole-body insulin resistance under high-fat diet feeding. To explore the underlying mechanism, this study found that defective hypothalamic autophagy led to hypothalamic inflammation, including the activation of proinflammatory I kappa B kinase beta pathway. Using brain-specific I kappa B kinase beta knockout mice, it was found that the effects of defective hypothalamic autophagy in promoting obesity were reversed by I kappa B kinase beta inhibition in the brain. In conclusion, hypothalamic autophagy is crucial for the central control of feeding, energy, and body weight balance. Conversely, decline of hypothalamic autophagy under conditions of chronic caloric excess promotes hypothalamic inflammation and thus impairs hypothalamic control of energy balance, leading to accelerated development of obesity and comorbidities.	[Cai, Dongsheng] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cai, DS (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	dongsheng.cai@einstein.yu.edu			National Institutes of Health [R01 DK078750, R01 AG031774]; Albert Einstein College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK078750 and R01 AG031774 (to D.C.). This work was also supported by the internal support of the Albert Einstein College of Medicine (to D.C.). Part of this work was presented in 71st Annual Meeting of the American Diabetes Association.	Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Choi SJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE1122, DOI 10.1152/ajpendo.00006.2010; Crisan TO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018666; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Elmquist JK, 2004, SCIENCE, V304, P63, DOI 10.1126/science.1096746; Fujishima Y, 2011, ARCH BIOCHEM BIOPHYS, V506, P223, DOI 10.1016/j.abb.2010.12.009; Fujitani Y, 2009, AUTOPHAGY, V5, P280, DOI 10.4161/auto.5.2.7656; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kim JS, 2008, HEPATOLOGY, V47, P1725, DOI 10.1002/hep.22187; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Le Gouill E, 2007, DIABETES, V56, P2690, DOI 10.2337/db06-1228; Lee JA, 2009, J NEUROSCI, V29, P8506, DOI 10.1523/JNEUROSCI.0924-09.2009; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Oh-I S, 2010, AM J PHYSIOL-ENDOC M, V299, pE47, DOI 10.1152/ajpendo.00026.2010; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Purkayastha S, 2011, P NATL ACAD SCI USA, V108, P2939, DOI 10.1073/pnas.1006875108; Sabio G, 2010, GENE DEV, V24, P256, DOI 10.1101/gad.1878510; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Unger EK, 2010, ENDOCRINOLOGY, V151, P671, DOI 10.1210/en.2009-0711; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yin XM, 2008, HEPATOLOGY, V47, P1773, DOI 10.1002/hep.22146; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106	49	184	187	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32324	32332		10.1074/jbc.M111.254417	http://dx.doi.org/10.1074/jbc.M111.254417			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784844	Green Published, hybrid			2022-12-25	WOS:000294726800042
J	Choi, JY; Eoff, RL; Pence, MG; Wang, J; Martin, MV; Kim, EJ; Folkmann, LM; Guengerich, FP				Choi, Jeong-Yun; Eoff, Robert L.; Pence, Matthew G.; Wang, Jian; Martin, Martha V.; Kim, Eun-Jin; Folkmann, Lindsay M.; Guengerich, F. Peter			Roles of the Four DNA Polymerases of the Crenarchaeon Sulfolobus solfataricus and Accessory Proteins in DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROSOMAL CYTOCHROME-P-450; SLIDING-CLAMP; UV DAMAGE; FIDELITY; GENOME; BYPASS; GENE; PCNA; DPO4; P2	The hyperthermophilic crenarchaeon Sulfolobus solfataricus P2 encodes three B-family DNA polymerase genes, B1 (Dpo1), B2 (Dpo2), and B3 (Dpo3), and one Y-family DNA polymerase gene, Dpo4, which are related to eukaryotic counterparts. Both mRNAs and proteins of all four DNA polymerases were constitutively expressed in all growth phases. Dpo2 and Dpo3 possessed very low DNA polymerase and 3' to 5' exonuclease activities in vitro. Steady-state kinetic efficiencies (k(cat)/K-m) for correct nucleotide insertion by Dpo2 and Dpo3 were several orders of magnitude less than Dpo1 and Dpo4. Both the accessory proteins proliferating cell nuclear antigen and the clamp loader replication factor C facilitated DNA synthesis with Dpo3, as with Dpo1 and Dpo4, but very weakly with Dpo2. DNA synthesis by Dpo2 and Dpo3 was remarkably decreased by single-stranded binding protein, in contrast to Dpo1 and Dpo4. DNA synthesis in the presence of proliferating cell nuclear antigen, replication factor C, and single-stranded binding protein was most processive with Dpo1, whereas DNA lesion bypass was most effective with Dpo4. Both Dpo2 and Dpo3, but not Dpo1, bypassed hypoxanthine and 8-oxoguanine. Dpo2 and Dpo3 bypassed uracil and cis-syn cyclobutane thymine dimer, respectively. High concentrations of Dpo2 or Dpo3 did not attenuate DNA synthesis by Dpo1 or Dpo4. We conclude that Dpo2 and Dpo3 are much less functional and more thermolabile than Dpo1 and Dpo4 in vitro but have bypass activities across hypoxanthine, 8-oxoguanine, and either uracil or cis-syn cyclobutane thymine dimer, suggesting their catalytically limited roles in translesion DNA synthesis past deaminated, oxidized base lesions and/or UV-induced damage.	[Choi, Jeong-Yun; Eoff, Robert L.; Pence, Matthew G.; Wang, Jian; Martin, Martha V.; Folkmann, Lindsay M.; Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Choi, Jeong-Yun; Eoff, Robert L.; Pence, Matthew G.; Wang, Jian; Martin, Martha V.; Folkmann, Lindsay M.; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA; [Choi, Jeong-Yun; Kim, Eun-Jin] Sungkyunkwan Univ, Dept Mol Cell Biol, Div Pharmacol, Sch Med, Suwon 440746, Gyeonggi Do, South Korea; [Choi, Jeong-Yun; Kim, Eun-Jin] Samsung Biomed Res Inst, Suwon 440746, Gyeonggi Do, South Korea	Vanderbilt University; Vanderbilt University; Sungkyunkwan University (SKKU)	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	Pence, Matthew/J-1379-2012	Pence, Matthew/0000-0003-2271-789X	National Institutes of Health [R01 ES010375, F32 CA119776, K99 GM084460, T32 ES007028, P30 ES000267]; Ministry of Education, Science and Technology [2010-0006538]; Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A084187]; NATIONAL CANCER INSTITUTE [F32CA119776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, T32ES007028, R01ES010375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM084460] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES010375 (to F. P. G.), F32 CA119776 (to R. L. E.), K99 GM084460 (to R. L. E.), T32 ES007028 (to F. P. G. and M. G. P.), and P30 ES000267 (to F. P. G.). This work was also supported by the Basic Science Research Program of the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology Grant 2010-0006538 (to J.-Y. C.) and a grant of the Korea Healthcare Technology R & D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea, Grant A084187 (to J.-Y. C.).	Bohlke K, 2002, EXTREMOPHILES, V6, P1, DOI 10.1007/s007920100222; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Choi JY, 2004, J BIOL CHEM, V279, P19217, DOI 10.1074/jbc.M313759200; Connolly BA, 2009, BIOCHEM SOC T, V37, P65, DOI 10.1042/BST0370065; Dionne I, 2003, MOL CELL, V11, P275, DOI 10.1016/S1097-2765(02)00824-9; Dionne I, 2008, MOL MICROBIOL, V68, P216, DOI 10.1111/j.1365-2958.2008.06150.x; Duggin IG, 2006, J BIOL CHEM, V281, P15029, DOI 10.1074/jbc.R500029200; Edgell DR, 1997, J BACTERIOL, V179, P2632, DOI 10.1128/jb.179.8.2632-2640.1997; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Frols S, 2009, BIOCHEM SOC T, V37, P36, DOI 10.1042/BST0370036; Frols S, 2007, J BACTERIOL, V189, P8708, DOI 10.1128/JB.01016-07; Gotz D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r220; Gruz P, 2003, NUCLEIC ACIDS RES, V31, P4024, DOI 10.1093/nar/gkg447; Guengerich F. P., 2007, PRINCIPLES METHODS T, P1981; GUENGERICH FP, 1982, BIOCHEMISTRY-US, V21, P1698, DOI 10.1021/bi00536a035; GUENGERICH FP, 1991, J PHARMACOL EXP THER, V256, P1189; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Indiani C, 2005, MOL CELL, V19, P805, DOI 10.1016/j.molcel.2005.08.011; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kornberg A., 1992, DNA REPLICATION; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Pisani FM, 2000, J MOL BIOL, V301, P61, DOI 10.1006/jmbi.2000.3964; PRANGISHVILI D, 1993, NUCLEIC ACIDS RES, V21, P2768, DOI 10.1093/nar/21.11.2768; Rivera MC, 2004, NATURE, V431, P152, DOI 10.1038/nature02848; ROBB FT, 1995, ARCHAEA LAB MANUAL, V3, P167; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Savino C, 2004, STRUCTURE, V12, P2001, DOI 10.1016/j.str.2004.09.007; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Soucek P, 1995, BIOCHEMISTRY-US, V34, P16013, DOI 10.1021/bi00049a015; van Passel M. W. J., 2007, Archaea, V2, P137, DOI 10.1155/2007/165723; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; Wong JHY, 2010, EMBO J, V29, P2059, DOI 10.1038/emboj.2010.101; Wu ZL, 2006, ARCH BIOCHEM BIOPHYS, V445, P138, DOI 10.1016/j.abb.2005.11.002; Yutin N, 2008, MOL BIOL EVOL, V25, P1619, DOI 10.1093/molbev/msn108; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zaparty M, 2010, EXTREMOPHILES, V14, P119, DOI 10.1007/s00792-009-0280-0; Zhang LK, 2009, BIOCHEMISTRY-US, V48, P7492, DOI 10.1021/bi900532w	42	50	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31180	31193		10.1074/jbc.M111.258038	http://dx.doi.org/10.1074/jbc.M111.258038			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21784862	Green Published, hybrid			2022-12-25	WOS:000294487500013
J	Than, NG; Romero, R; Meiri, H; Erez, O; Xu, Y; Tarquini, F; Barna, L; Szilagyi, A; Ackerman, R; Sammar, M; Fule, T; Karaszi, K; Kovalszky, I; Dong, Z; Kim, CJ; Zavodszky, P; Papp, Z; Gonen, R				Nandor Gabor Than; Romero, Roberto; Meiri, Hamutal; Erez, Offer; Xu, Yi; Tarquini, Federica; Barna, Laszlo; Szilagyi, Andras; Ackerman, Ron; Sammar, Marei; Fule, Tibor; Karaszi, Katalin; Kovalszky, Ilona; Dong, Zhong; Kim, Chong Jai; Zavodszky, Peter; Papp, Zoltan; Gonen, Ron			PP13, Maternal ABO Blood Groups and the Risk Assessment of Pregnancy Complications	PLOS ONE			English	Article							PLACENTAL PROTEIN 13; VON-WILLEBRAND-FACTOR; FACTOR-VIII; SERUM PP-13; PREECLAMPSIA; WOMEN; PLACENTAL-PROTEIN-13; POPULATION; GALECTINS; MARKERS	Background: Placental Protein 13 (PP13), an early biomarker of preeclampsia, is a placenta-specific galectin that binds beta-galactosides, building-blocks of ABO blood-group antigens, possibly affecting its bioavailability in blood. Methods and Findings: We studied PP13-binding to erythrocytes, maternal blood-group effect on serum PP13 and its performance as a predictor of preeclampsia and intrauterine growth restriction (IUGR). Datasets of maternal serum PP13 in Caucasian (n = 1078) and Hispanic (n = 242) women were analyzed according to blood groups. In vivo, in vitro and in silico PP13-binding to ABO blood-group antigens and erythrocytes were studied by PP13-immunostainings of placental tissue-microarrays, flow-cytometry of erythrocyte-bound PP13, and model-building of PP13-blood-group H antigen complex, respectively. Women with blood group AB had the lowest serum PP13 in the first trimester, while those with blood group B had the highest PP13 throughout pregnancy. In accordance, PP13-binding was the strongest to blood-group AB erythrocytes and weakest to blood-group B erythrocytes. PP13-staining of maternal and fetal erythrocytes was revealed, and a plausible molecular model of PP13 complexed with blood-group H antigen was built. Adjustment of PP13 MoMs to maternal ABO blood group improved the prediction accuracy of first trimester maternal serum PP13 MoMs for preeclampsia and IUGR. Conclusions: ABO blood group can alter PP13-bioavailability in blood, and it may also be a key determinant for other lectins' bioavailability in the circulation. The adjustment of PP13 MoMs to ABO blood group improves the predictive accuracy of this test.	[Nandor Gabor Than; Karaszi, Katalin; Papp, Zoltan] Semmelweis Univ, Dept Obstet & Gynecol 1, H-1085 Budapest, Hungary; [Nandor Gabor Than; Romero, Roberto; Erez, Offer; Xu, Yi; Tarquini, Federica; Dong, Zhong; Kim, Chong Jai] Wayne State Univ, Detroit, MI USA; [Meiri, Hamutal; Ackerman, Ron; Sammar, Marei] Diagnost Technol Ltd, Yokneam, Israel; [Meiri, Hamutal] TeleMarpeh Ltd, Tel Aviv, Israel; [Erez, Offer] Ben Gurion Univ Negev, Soroka Univ, Med Ctr, Dept Obstet & Gynecol B, IL-84105 Beer Sheva, Israel; [Barna, Laszlo; Szilagyi, Andras; Zavodszky, Peter] Hungarian Acad Sci, Inst Enzymol, Budapest, Hungary; [Sammar, Marei] ORT Braude Coll, Dept Biotechnol Engn, Karmiel, Israel; [Fule, Tibor; Karaszi, Katalin; Kovalszky, Ilona] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Gonen, Ron] Technion Israel Inst Technol, Dept Obstet & Gynecol, Fac Med, Bnai Zion Med Ctr, Haifa, Israel	Semmelweis University; Wayne State University; Ben Gurion University; Soroka Medical Center; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Semmelweis University; Bnai Zion Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Than, NG (corresponding author), Semmelweis Univ, Dept Obstet & Gynecol 1, H-1085 Budapest, Hungary.	nthan@med.wayne.edu	Kovalszky, Ilona/ABH-2832-2020; Than, Nandor G/N-1442-2016; Szilagyi, Andras/A-3561-2008; Romero, Roberto/A-5268-2019	Kovalszky, Ilona/0000-0002-0179-3378; Barna, Laszlo/0000-0002-3856-5774; Szilagyi, Andras/0000-0002-1773-6861; Romero, Roberto/0000-0002-4448-5121	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH, DHHS, USA); Hungarian research grants [OTKA T/046473, OTKA NK77978, OTKA PD73096, OM00075/2007, OMFB-00253/2010]; European Union [037244-Pregenesys]; Israel Chief Scientist research grants [31851, 37324, 14128]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002400] Funding Source: NIH RePORTER	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH, DHHS, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Hungarian research grants; European Union(European Commission); Israel Chief Scientist research grants; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded in part by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH, DHHS, USA); Hungarian research grants OTKA T/046473 (to NGT), OTKA NK77978 (to PZ), OTKA PD73096 (to AS), OM00075/2007 (to PZ), and OMFB-00253/2010 (to PZ); European Union FP6 research grant 037244-Pregenesys (to HM and NGT); and Israel Chief Scientist research grants 31851, 37324 and 14128 (to HM). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolekar R, 2009, PRENATAL DIAG, V29, P1103, DOI 10.1002/pd.2375; Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Balogh A, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.023; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; BOHN H, 1983, ONCODEV BIOL MED, V4, P343; BRATOSIN D, 1995, GLYCOCONJUGATE J, V12, P258, DOI 10.1007/BF00731328; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Burger O, 2004, PLACENTA, V25, P608, DOI 10.1016/j.placenta.2003.12.009; Burton GJ, 2009, PLACENTA, V30, pS43, DOI 10.1016/j.placenta.2008.11.003; Buzas EI, 2006, AUTOIMMUNITY, V39, P691, DOI 10.1080/08916930601061470; Chafetz I, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.02.025; Cohen M, 2009, BLOOD, V114, P3668, DOI 10.1182/blood-2009-06-227041; Cowans N, 2011, PLACENTA, V32, pS37, DOI 10.1016/j.placenta.2010.08.014; Cummings R.D., 2009, ESSENTIALS GLYCOBIOL, Vsecond, P475; Dollberg S, 2005, ISRAEL MED ASSOC J, V7, P311; Gabius HJ, 2002, BBA-GEN SUBJECTS, V1572, P165, DOI 10.1016/S0304-4165(02)00306-9; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; GILL JC, 1987, BLOOD, V69, P1691; Gonen R, 2008, BJOG-INT J OBSTET GY, V115, P1465, DOI 10.1111/j.1471-0528.2008.01902.x; Hiltunen LM, 2009, THROMB RES, V124, P167, DOI 10.1016/j.thromres.2008.11.012; Horlacher T, 2010, CHEMBIOCHEM, V11, P1563, DOI 10.1002/cbic.201000020; Huppertz B, 2008, FETAL DIAGN THER, V24, P230, DOI 10.1159/000151344; Johnson MR, 2002, BJOG-INT J OBSTET GY, V109, P836, DOI 10.1016/S1470-0328(02)01045-5; Khalil A, 2010, ULTRASOUND OBST GYN, V35, P671, DOI 10.1002/uog.7559; Khalil A, 2009, PRENATAL DIAG, V29, P781, DOI 10.1002/pd.2287; Kliman H, 2008, HYPERTENS PREGNANCY, V27, P578; KOSTER T, 1995, LANCET, V345, P152, DOI 10.1016/S0140-6736(95)90166-3; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; Larsen TB, 2005, J THROMB HAEMOST, V3, P300, DOI 10.1111/j.1538-7836.2005.01195.x; Lenting PJ, 2010, HAEMOPHILIA, V16, P194, DOI 10.1111/j.1365-2516.2010.02320.x; Lin J, 2005, OBSTET GYNECOL, V105, P182, DOI 10.1097/01.AOG.0000146250.85561.e9; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; MAYHEW TM, 1994, J ANAT, V184, P535; MEADE TW, 1994, BRIT J HAEMATOL, V88, P601, DOI 10.1111/j.1365-2141.1994.tb05079.x; MEDALIE JH, 1971, NEW ENGL J MED, V285, P1348, DOI 10.1056/NEJM197112092852404; Nicolaides KH, 2006, ULTRASOUND OBST GYN, V27, P13, DOI 10.1002/uog.2686; O'Donnell J, 2001, TRANSFUSION MED, V11, P343, DOI 10.1046/j.1365-3148.2001.00315.x; PAPP C, 1991, Orvosi Hetilap, V132, P1865; Paterson AD, 2009, ARTERIOSCL THROM VAS, V29, P1958, DOI 10.1161/ATVBAHA.109.192971; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Reid M E, 1990, Transfus Med Rev, V4, P47, DOI 10.1016/S0887-7963(90)70247-7; Roberts JM, 2009, PLACENTA, V30, pS32, DOI 10.1016/j.placenta.2008.11.009; Romero R., 1996, PRENAT NEONAT MED, V1, P8; Romero R, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.01.013; Sekizawa A, 2009, REPROD SCI, V16, P408, DOI 10.1177/1933719108328615; SHARON R, 1991, CYTOMETRY, V12, P545, DOI 10.1002/cyto.990120611; Shimizu H, 2009, PRENATAL DIAG, V29, P1231, DOI 10.1002/pd.2380; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Spencer K, 2007, ULTRASOUND OBST GYN, V29, P128, DOI 10.1002/uog.3876; SPINILLO A, 1995, J HUM HYPERTENS, V9, P623; SPINILLO A, 1994, J HUM HYPERTENS, V8, P771; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Than G.N., 1993, ADV PREGNANCY RELATE; Than NG, 2008, P NATL ACAD SCI USA, V105, P15819, DOI 10.1073/pnas.0807606105; Than NG, 2008, VIRCHOWS ARCH, V453, P387, DOI 10.1007/s00428-008-0658-x; Than NG, 2009, P NATL ACAD SCI USA, V106, P9731, DOI 10.1073/pnas.0903568106; Than NG, 2004, EUR J BIOCHEM, V271, P1065, DOI 10.1111/j.1432-1033.2004.04004.x; Than NG, 1999, PLACENTA, V20, P703, DOI 10.1053/plac.1999.0436; Varki A., 2008, ESSENTIALS GLYCOBIOL; Varkonyi T, 2011, PLACENTA, V32, pS21, DOI 10.1016/j.placenta.2010.04.014; Visegrady B, 2001, PROTEIN ENG, V14, P875, DOI 10.1093/protein/14.11.875; Walser PJ, 2004, STRUCTURE, V12, P689, DOI 10.1016/j.str.2004.03.002; Watkins WM, 2001, TRANSFUSION MED, V11, P243, DOI 10.1046/j.1365-3148.2001.00321.x; Wortelboer EJ, 2010, BJOG-INT J OBSTET GY, V117, P1384, DOI 10.1111/j.1471-0528.2010.02690.x; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0	68	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e21564	10.1371/journal.pone.0021564	http://dx.doi.org/10.1371/journal.pone.0021564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799738	Green Published, gold, Green Submitted			2022-12-25	WOS:000293172900004
J	Marquet, F; Tung, YS; Teichert, T; Ferrera, VP; Konofagou, EE				Marquet, Fabrice; Tung, Yao-Sheng; Teichert, Tobias; Ferrera, Vincent P.; Konofagou, Elisa E.			Noninvasive, Transient and Selective Blood-Brain Barrier Opening in Non-Human Primates In Vivo	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; FOCUSED ULTRASOUND; ALZHEIMERS-DISEASE; LOW-FREQUENCY; GENE-THERAPY; THROMBOLYSIS; SKULL; MICROBUBBLES; DISRUPTION; CAVITATION	The blood-brain barrier (BBB) is a specialized vascular system that impedes entry of all large and the vast majority of small molecules including the most potent central nervous system (CNS) disease therapeutic agents from entering from the lumen into the brain parenchyma. Microbubble-enhanced, focused ultrasound (ME-FUS) has been previously shown to disrupt noninvasively, selectively, and transiently the BBB in small animals in vivo. For the first time, the feasibility of transcranial ME-FUS BBB opening in non-human primates is demonstrated with subsequent BBB recovery. Sonications were combined with two different types of microbubbles (customized 4-5 mu m and Definity (R)). 3T MRI was used to confirm the BBB disruption and to assess brain damage.	[Marquet, Fabrice; Tung, Yao-Sheng; Konofagou, Elisa E.] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Teichert, Tobias; Ferrera, Vincent P.] Columbia Univ, Dept Neurosci, New York, NY USA; [Ferrera, Vincent P.] Columbia Univ, Dept Psychiat, New York, NY USA; [Konofagou, Elisa E.] Columbia Univ, Dept Radiol, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University	Marquet, F (corresponding author), Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.	ek2191@columbia.edu	Teichert, Tobias/F-6295-2014	Teichert, Tobias/0000-0001-6500-9573; Ferrera, Vincent/0000-0002-6599-7740	National Institutes of Health (NIH) [R01EB009041, R01MH059244]; National Science Foundation (NSF) [0644713]; Kavli Foundation; DFG [819/1-1]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059244] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Kavli Foundation; DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported in part by the National Institutes of Health (NIH) R01EB009041 (E. E. K.) and National Science Foundation (NSF) CAREER 0644713 (E. E. K.), NIH R01MH059244 (V. P. F.) and the Kavli Foundation (E. E. K. and V. P. F.). Additional support came from DFG 819/1-1 to T. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Aubry JF, 2010, IRBM, V31, P87, DOI 10.1016/j.irbm.2010.02.013; Azuma T, 2005, JPN J APPL PHYS 1, V44, P4625, DOI 10.1143/JJAP.44.4625; Baron C, 2009, ULTRASOUND MED BIOL, V35, P1148, DOI 10.1016/j.ultrasmedbio.2008.11.014; Baseri B, 2010, ULTRASOUND MED BIOL, V36, P1445, DOI 10.1016/j.ultrasmedbio.2010.06.005; Behrens S, 1999, ULTRASOUND MED BIOL, V25, P269, DOI 10.1016/S0301-5629(98)00158-6; Berti V, 2010, NEURODEGENER DIS, V7, P131, DOI 10.1159/000289222; Chen H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.034301; Choi JJ, 2007, ULTRASOUND MED BIOL, V33, P95, DOI 10.1016/j.ultrasmedbio.2006.07.018; Clement GT, 2002, PHYS MED BIOL, V47, P1219, DOI 10.1088/0031-9155/47/8/301; Clement GT, 2000, PHYS MED BIOL, V45, P3707, DOI 10.1088/0031-9155/45/12/314; Cobbold R. S. C., 2007, FDN BIOMEDICAL ULTRA; CRUM LA, 1975, J ACOUST SOC AM, V57, P1363, DOI 10.1121/1.380614; Daffertshofer M, 2005, STROKE, V36, P1441, DOI 10.1161/01.STR.0000170707.86793.1a; Datta S, 2006, ULTRASOUND MED BIOL, V32, P1257, DOI 10.1016/j.ultrasmedbio.2006.04.008; Deffieux T, 2010, IEEE T ULTRASON FERR, V57, P2637, DOI 10.1109/TUFFC.2010.1738; Doolittle ND, 2000, CANCER, V88, P637, DOI 10.1002/(SICI)1097-0142(20000201)88:3<637::AID-CNCR22>3.0.CO;2-Y; Dove A, 2008, NAT BIOTECHNOL, V26, P1213, DOI 10.1038/nbt1108-1213; Everbach EC, 2000, ULTRASOUND MED BIOL, V26, P1153, DOI 10.1016/S0301-5629(00)00250-7; Feshitan JA, 2009, J COLLOID INTERF SCI, V329, P316, DOI 10.1016/j.jcis.2008.09.066; Fiske BK, 2008, EXP NEUROL, V209, P28, DOI 10.1016/j.expneurol.2007.09.006; Fortin D, 2007, CANCER-AM CANCER SOC, V109, P751, DOI 10.1002/cncr.22450; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; FRY F J, 1977, Ultrasound in Medicine and Biology, V3, P179, DOI 10.1016/0301-5629(77)90069-2; FRY WJ, 1954, J NEUROSURG, V11, P471, DOI 10.3171/jns.1954.11.5.0471; Habgood MD, 2000, CELL MOL NEUROBIOL, V20, P231, DOI 10.1023/A:1007001923498; Hynynen K, 1998, ULTRASOUND MED BIOL, V24, P275, DOI 10.1016/S0301-5629(97)00269-X; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Jordao JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010549; Mandel RJ, 2010, CURR OPIN MOL THER, V12, P240; Marquet F, 2009, PHYS MED BIOL, V54, P2597, DOI 10.1088/0031-9155/54/9/001; Marquet F, 2011, FEASIBILITY STUDY SI; Martin E, 2009, ANN NEUROL, V66, P858, DOI 10.1002/ana.21801; McDannold N, 2006, PHYS MED BIOL, V51, P793, DOI 10.1088/0031-9155/51/4/003; McDannold N, 2010, TRANSCRANIAL MAGNETI; McDannold N, 2008, ULTRASOUND MED BIOL, V34, P834, DOI 10.1016/j.ultrasmedbio.2007.10.016; Mychaskiw G, 2000, ANESTH ANALG, V91, P798, DOI 10.1097/00000539-200010000-00007; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Pardridge William M, 2005, NeuroRx, V2, P3; Sheikov N, 2004, ULTRASOUND MED BIOL, V30, P979, DOI 10.1016/j.ultrasmedbio.2004.04.010; Tanter M, 1998, J ACOUST SOC AM, V103, P2403, DOI 10.1121/1.422759; Ter Haar G, 2007, INT J HYPERTHER, V23, P85, DOI 10.1080/02656730601185924; Tung YS, 2010, PHYS MED BIOL, V55, P6141, DOI 10.1088/0031-9155/55/20/007; Tuszynski MH, 2007, ALZ DIS ASSOC DIS, V21, P179, DOI 10.1097/WAD.0b013e318068d6d2; Vlachos F, 2010, PHYS MED BIOL, V55, P5451, DOI 10.1088/0031-9155/55/18/012	45	97	99	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22598	10.1371/journal.pone.0022598	http://dx.doi.org/10.1371/journal.pone.0022598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799913	Green Published, Green Submitted, gold			2022-12-25	WOS:000293097300072
J	Geschka, S; Kretschmer, A; Sharkovska, Y; Evgenov, OV; Lawrenz, B; Hucke, A; Hocher, B; Stasch, JP				Geschka, Sandra; Kretschmer, Axel; Sharkovska, Yuliya; Evgenov, Oleg V.; Lawrenz, Bettina; Hucke, Andreas; Hocher, Berthold; Stasch, Johannes-Peter			Soluble Guanylate Cyclase Stimulation Prevents Fibrotic Tissue Remodeling and Improves Survival in Salt-Sensitive Dahl Rats	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; PULMONARY ARTERIAL-HYPERTENSION; CHRONIC HEART-FAILURE; NITRIC-OXIDE; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; OSTEOPONTIN; FIBROSIS; RIOCIGUAT; PRESSURE	Background: A direct pharmacological stimulation of soluble guanylate cyclase (sGC) is an emerging therapeutic approach to the management of various cardiovascular disorders associated with endothelial dysfunction. Novel sGC stimulators, including riociguat (BAY 63-2521), have a dual mode of action: They sensitize sGC to endogenously produced nitric oxide (NO) and also directly stimulate sGC independently of NO. Little is known about their effects on tissue remodeling and degeneration and survival in experimental malignant hypertension. Methods and Results: Mortality, hemodynamics and biomarkers of tissue remodeling and degeneration were assessed in Dahl salt-sensitive rats maintained on a high salt diet and treated with riociguat (3 or 10 mg/kg/d) for 14 weeks. Riociguat markedly attenuated systemic hypertension, improved systolic heart function and increased survival from 33% to 85%. Histological examination of the heart and kidneys revealed that riociguat significantly ameliorated fibrotic tissue remodeling and degeneration. Correspondingly, mRNA expression of the pro-fibrotic biomarkers osteopontin (OPN), tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) and plasminogen activator inhibitor-1 (PAI-1) in the myocardium and the renal cortex was attenuated by riociguat. In addition, riociguat reduced plasma and urinary levels of OPN, TIMP-1, and PAI-1. Conclusions: Stimulation of sGC by riociguat markedly improves survival and attenuates systemic hypertension and systolic dysfunction, as well as fibrotic tissue remodeling in the myocardium and the renal cortex in a rodent model of pressure and volume overload. These findings suggest a therapeutic potential of sGC stimulators in diseases associated with impaired cardiovascular and renal functions.	[Geschka, Sandra; Hucke, Andreas; Stasch, Johannes-Peter] Bayer HealthCare, Cardiol Res, Wuppertal, Germany; [Kretschmer, Axel] Bayer HealthCare, Global Biomarker, Wuppertal, Germany; [Sharkovska, Yuliya; Hocher, Berthold] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany; [Sharkovska, Yuliya; Hocher, Berthold] Charite, Cardiovasc Res Ctr, Inst Pharmacol & Toxicol, Berlin, Germany; [Evgenov, Oleg V.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA USA; [Lawrenz, Bettina] Bayer HealthCare, Pathol, Wuppertal, Germany; [Stasch, Johannes-Peter] Univ Halle Wittenberg, Inst Pharm, Halle, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Harvard Medical School; Massachusetts General Hospital; Bayer AG; Bayer Healthcare Pharmaceuticals; Martin Luther University Halle Wittenberg	Geschka, S (corresponding author), Bayer HealthCare, Cardiol Res, Wuppertal, Germany.	johannes-peter.stasch@bayer.com	Hocher, Berthold/AAC-3510-2020	Hocher, Berthold/0000-0001-8143-0579				Arikan H, 2007, RENAL FAILURE, V29, P713, DOI 10.1080/08860220701460129; Brown L, 2005, DEV CARDIOVASC MED, V253, P275; CAREY RM, 2007, HYPERTENSION HORMONE, P91; Chandramohan G, 2008, AM J NEPHROL, V28, P158, DOI 10.1159/000110021; CHEN PY, 1991, J CLIN INVEST, V88, P1559, DOI 10.1172/JCI115467; CHEN PY, 1993, LAB INVEST, V68, P174; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Frantz S, 2008, EUR J HEART FAIL, V10, P388, DOI 10.1016/j.ejheart.2008.02.015; Ghofrani HA, 2010, EUR RESPIR J, V36, P792, DOI 10.1183/09031936.00182909; Grimminger F, 2009, EUR RESPIR J, V33, P785, DOI 10.1183/09031936.00039808; Ha H, 2009, NAT REV NEPHROL, V5, P203, DOI 10.1038/nrneph.2009.15; Haffner D, 2005, J HYPERTENS, V23, P1067, DOI 10.1097/01.hjh.0000166849.72721.1c; Hocher B, 2000, J HYPERTENS, V18, P1807, DOI 10.1097/00004872-200018120-00015; Hocher B, 1999, HYPERTENSION, V33, P816, DOI 10.1161/01.HYP.33.3.816; Johnson RJ, 2000, J HYPERTENS, V18, P1497, DOI 10.1097/00004872-200018100-00019; Joseph J, 2009, J HYPERTENS, V27, P1317, DOI 10.1097/HJH.0b013e328329fc20; Kim NH, 2010, EUR RESPIR REV, V19, P68, DOI 10.1183/09059180.00007909; Lorenzen J, 2010, EUR J CLIN INVEST, V40, P294, DOI 10.1111/j.1365-2362.2010.02271.x; Lorenzen JM, 2011, CHEST, V139, P1010, DOI 10.1378/chest.10-1146; Majid DSA, 2007, CLIN EXP PHARMACOL P, V34, P946, DOI 10.1111/j.1440-1681.2007.04642.x; Manning RD, 2005, AM J NEPHROL, V25, P311, DOI 10.1159/000086411; Manning RD, 2003, ACTA PHYSIOL SCAND, V179, P243, DOI 10.1046/j.0001-6772.2003.01204.x; Masuyama H, 2009, HYPERTENS RES, V32, P597, DOI 10.1038/hr.2009.64; Mittendorf J, 2009, CHEMMEDCHEM, V4, P853, DOI 10.1002/cmdc.200900014; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Perco P, 2008, J CELL MOL MED, V12, P1177, DOI 10.1111/j.1582-4934.2008.00280.x; Rosenberg M, 2008, CIRC-HEART FAIL, V1, P43, DOI 10.1161/CIRCHEARTFAILURE.107.746172; Schermuly RT, 2008, EUR RESPIR J, V32, P881, DOI 10.1183/09031936.00114407; Schwarz ER, 1998, BASIC RES CARDIOL, V93, P477, DOI 10.1007/s003950050118; Sharkovska Y, 2010, J HYPERTENS, V28, P1666, DOI 10.1097/HJH.0b013e32833b558c; Stasch Johannes-Peter, 2009, V191, P277, DOI 10.1007/978-3-540-68964-5_13; Stasch JP, 2002, BRIT J PHARMACOL, V135, P333, DOI 10.1038/sj.bjp.0704484; Stasch JP, 1997, ARZNEIMITTELFORSCH, V47, P1016; STASCH JP, 1990, CLIN EXP HYPERTENS A, V12, P1419, DOI 10.3109/10641969009073528; STASCH JP, CIRCULATION; STLEZIN E, 1992, HYPERTENSION, V19, P419, DOI 10.1161/01.HYP.19.5.419; Tamaki K, 1996, J AM SOC NEPHROL, V7, P2578; Waller AH, 2010, CARDIOL REV, V18, P125, DOI 10.1097/CRD.0b013e3181cfb646; Wang YR, 2006, AM J PHYSIOL-RENAL, V290, pF167, DOI 10.1152/ajprenal.00197.2005	39	82	88	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e21853	10.1371/journal.pone.0021853	http://dx.doi.org/10.1371/journal.pone.0021853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789188	Green Published, gold, Green Submitted			2022-12-25	WOS:000292812400018
J	van Gelder, MMHJ; Roeleveld, N; Nordeng, H				van Gelder, Marleen M. H. J.; Roeleveld, Nel; Nordeng, Hedvig			Exposure to Non-Steroidal Anti-Inflammatory Drugs during Pregnancy and the Risk of Selected Birth Defects: A Prospective Cohort Study	PLOS ONE			English	Article							VENTRICULAR SEPTAL-DEFECTS; POPULATION-BASED COHORT; CYCLOOXYGENASE-2; REGISTRY; NORWAY; ORGANOGENESIS; MALFORMATIONS; PRESCRIPTION; MISCARRIAGE; TOXICITY	Background: Since use of non-steroidal anti-inflammatory drugs (NSAIDs) during pregnancy is common, small increases in the risk of birth defects may have significant implications for public health. Results of human studies on the teratogenic risks of NSAIDs are inconsistent. Therefore, we evaluated the risk of selected birth defects after prenatal exposure to prescribed and over-the-counter NSAIDs. Methods and Findings: We used data on 69,929 women enrolled in the Norwegian Mother and Child Cohort Study between 1999 and 2006. Data on NSAID exposure were available from a self-administered questionnaire completed around gestational week 17. Information on pregnancy outcome was obtained from the Medical Birth Registry of Norway. Only birth defects suspected to be associated with NSAID exposure based upon proposed teratogenic mechanisms and previous studies were included in the multivariable logistic regression analyses. A total of 3,023 women used NSAIDs in gestational weeks 0-12 and 64,074 women did not report NSAID use in early pregnancy. No associations were observed between overall exposure to NSAIDs during pregnancy and the selected birth defects separately or as a group (adjusted odds ratio 0.7, 95% confidence interval 0.4-1.1). Associations between maternal use of specific types of NSAIDs and the selected birth defects were not found either, although an increased risk was seen for septal defects and exposure to multiple NSAIDs based on small numbers (2 exposed cases; crude odds ratio 3.9, 95% confidence interval 0.9-15.7). Conclusions: Exposure to NSAIDs during the first 12 weeks of gestation does not seem to be associated with an increased risk of the selected birth defects. However, due to the small numbers of NSAID-exposed infants for the individual birth defect categories, increases in the risks of specific birth defects could not be excluded.	[van Gelder, Marleen M. H. J.; Roeleveld, Nel] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands; [Nordeng, Hedvig] Univ Oslo, Sch Pharm, Oslo, Norway; [Nordeng, Hedvig] Norwegian Inst Publ Hlth, Div Mental Hlth, Oslo, Norway	Radboud University Nijmegen; University of Oslo; Norwegian Institute of Public Health (NIPH)	van Gelder, MMHJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands.	M.vanGelder@ebh.umcn.nl	van Gelder, Marleen/P-9473-2015	van Gelder, Marleen/0000-0003-4853-4434	Norwegian Ministry of Health; NIH/NIEHS [NO1-ES-85433]; NIH/NINDS [1 UO1 NS 047537-01]; Norwegian Research Council/FUGE [151918/S10]; Netherlands Organisation for Scientific Research/NWO [021.001.008]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [N01ES085433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	Norwegian Ministry of Health; NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Norwegian Research Council/FUGE(Research Council of Norway); Netherlands Organisation for Scientific Research/NWO(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health, NIH/NIEHS (grant no. NO1-ES-85433), NIH/NINDS (grant no. 1 UO1 NS 047537-01), and the Norwegian Research Council/FUGE (grant no. 151918/S10). MMHJvG is supported by the Netherlands Organisation for Scientific Research/NWO (grant no. 021.001.008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman DN, 2004, EUR J CLIN PHARMACOL, V60, P635, DOI 10.1007/s00228-004-0829-x; Briggs GG, 2008, DRUGS PREGNANCY LACT; Cappon GD, 2003, BIRTH DEFECTS RES B, V68, P47, DOI 10.1002/bdrb.10008; Cassina M, 2010, REPROD TOXICOL, V30, P401, DOI 10.1016/j.reprotox.2010.04.010; Cleves MA, 2004, BIRTH DEFECTS RES A, V70, P107, DOI 10.1002/bdra.20005; Cook JC, 2003, BIRTH DEFECTS RES B, V68, P5, DOI 10.1002/bdrb.10005; Damase-Michel C, 2009, PHARMACOEPIDEM DR S, V18, P1034, DOI 10.1002/pds.1817; Engeland A, 2008, BRIT J CLIN PHARMACO, V65, P653, DOI 10.1111/j.1365-2125.2008.03102.x; Ericson A, 2001, REPROD TOXICOL, V15, P371, DOI 10.1016/S0890-6238(01)00137-X; Eriksson UJ, 2003, REV ENDOCR METAB DIS, V4, P79, DOI 10.1023/A:1021879504372; Glover DD, 2003, AM J OBSTET GYNECOL, V188, P1039, DOI 10.1067/mob.2003.223; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Kallen BAJ, 2003, REPROD TOXICOL, V17, P255, DOI 10.1016/S0890-6238(03)00012-1; Koren G, 2006, ANN PHARMACOTHER, V40, P824, DOI 10.1345/aph.1G428; Kubon C, 2007, ACTA OBSTET GYN SCAN, V86, P1453, DOI 10.1080/08037050701645090; Lamers WH, 2002, CIRC RES, V91, P93, DOI 10.1161/01.RES.0000027135.63141.89; Li DK, 2003, BRIT MED J, V327, P368, DOI 10.1136/bmj.327.7411.368; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Melve KK, 2008, ACTA OBSTET GYN SCAN, V87, P824, DOI 10.1080/00016340802217184; Nielsen GL, 2001, BRIT MED J, V322, P266, DOI 10.1136/bmj.322.7281.266; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60; Ofori B, 2006, BIRTH DEFECTS RES B, V77, P268, DOI 10.1002/bdrb.20085; Olesen C, 1999, EUR J CLIN PHARMACOL, V55, P139, DOI 10.1007/s002280050608; Rasmussen SA, 2003, BIRTH DEFECTS RES A, V67, P193, DOI 10.1002/bdra.10012; Sheffield JS, 2002, OBSTET GYNECOL, V100, P925, DOI 10.1016/S0029-7844(02)02242-1; Stanfield KM, 2003, BIRTH DEFECTS RES A, V67, P54, DOI 10.1002/bdra.10032; Streck RD, 2003, BIRTH DEFECTS RES B, V68, P57, DOI 10.1002/bdrb.10006; van Gelder MMHJ, 2010, HUM REPROD UPDATE, V16, P378, DOI 10.1093/humupd/dmp052; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Vroom F, 2008, BRIT J CLIN PHARMACO, V65, P275, DOI 10.1111/j.1365-2125.2007.02994.x; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Werler MM, 2009, AM J MED GENET A, V149A, P1399, DOI 10.1002/ajmg.a.32897; Werler MM, 2009, BIRTH DEFECTS RES A, V85, P52, DOI 10.1002/bdra.20524; WHO Collaborating Center for Drug Statistics Methodology, ATC DDD IND 2010; World Health Organization, INT STAT CLASS DIS R	36	36	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22174	10.1371/journal.pone.0022174	http://dx.doi.org/10.1371/journal.pone.0022174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789231	Green Published, gold, Green Submitted			2022-12-25	WOS:000292812400035
J	Alvi, A; Ansari, SA; Ehtesham, NZ; Rizwan, M; Devi, S; Sechi, LA; Qureshi, IA; Hasnain, SE; Ahmed, N				Alvi, Ayesha; Ansari, Suhail A.; Ehtesham, Nasreen Z.; Rizwan, Mohammed; Devi, Savita; Sechi, Leonardo A.; Qureshi, Insaf A.; Hasnain, Seyed E.; Ahmed, Niyaz			Concurrent Proinflammatory and Apoptotic Activity of a Helicobacter pylori Protein (HP986) Points to Its Role in Chronic Persistence	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; GASTRIC EPITHELIAL-CELLS; INTERLEUKIN-8 SECRETION; VACUOLATING CYTOTOXIN; PLASTICITY REGION; ULCER DISEASE; PEPTIC-ULCER; WEB SERVER; IN-VIVO	Helicobacter pylori induces cytokine mediated changes in gastroduodenal pathophysiology, wherein, the activated macrophages at the sub-mucosal space play a central role in mounting innate immune response against the antigens. The bacterium gains niche through persistent inflammation and local immune-suppression causing peptic ulcer disease or chronic gastritis; the latter being a significant risk factor for the development of gastric adenocarcinoma. What favors persistence of H. pylori in the gastric niches is not clearly understood. We report detailed characterization of a functionally unknown gene (HP986), which was detected in patient isolates associated with peptic ulcer and gastric carcinoma. Expression and purification of recombinant HP986 (rHP986) revealed a novel, similar to 29 kDa protein in biologically active form which associates with significant levels of humoral immune responses in diseased individuals (p < 0.001). Also, it induced significant levels of TNF-alpha and Interleukin-8 in cultured human macrophages concurrent to the translocation of nuclear transcription factor-kappa B (NF-kappa B). Further, the rHP986 induced apoptosis of cultured macrophages through a Fas mediated pathway. Dissection of the underlying signaling mechanism revealed that rHP986 induces both TNFR1 and Fas expression to lead to apoptosis. We further demonstrated interaction of HP986 with TNFR1 through computational and experimental approaches. Independent proinflammatory and apoptotic responses triggered by rHP986 as shown in this study point to its role, possibly as a survival strategy to gain niche through inflammation and to counter the activated macrophages to avoid clearance.	[Alvi, Ayesha; Ehtesham, Nasreen Z.; Rizwan, Mohammed; Hasnain, Seyed E.; Ahmed, Niyaz] Univ Hyderabad Campus, Inst Life Sci, Hyderabad, Andhra Pradesh, India; [Ansari, Suhail A.; Devi, Savita; Ahmed, Niyaz] Univ Hyderabad, Sch Life Sci, Pathogen Biol Lab, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India; [Ehtesham, Nasreen Z.] Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India; [Sechi, Leonardo A.] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Hasnain, Seyed E.] Indian Inst Technol, Sch Biol Sci, New Delhi, India; [Ahmed, Niyaz] Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia	University of Hyderabad; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); University of Sassari; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Universiti Malaya	Alvi, A (corresponding author), Univ Hyderabad Campus, Inst Life Sci, Hyderabad, Andhra Pradesh, India.	niyazSL@uohyd.ernet.in	EHTESHAM, NASREEN ZAFAR/AAI-3169-2020; Qureshi, Insaf Ahmed/W-1957-2019; Ansari, Suhail Akhtar/AAF-4904-2020; Ahmed, Niyaz/D-2589-2010; Sechi, Leonardo Antonio/Y-3109-2018	Qureshi, Insaf Ahmed/0000-0001-7720-7067; Ahmed, Niyaz/0000-0001-6425-7583; Hasnain, Seyed/0000-0002-2967-0791; sechi, leonardo antonio/0000-0003-0566-2049	University of Hyderabad [GRK 1673]; German Research Foundation (DFG); Council for Scientific and Industrial Research (CSIR), India	University of Hyderabad(University of Hyderabad); German Research Foundation (DFG)(German Research Foundation (DFG)); Council for Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	Part of this work was carried out under the umbrella of the Indo-German International Research Training Group - functional molecular infection epidemiology (GRK 1673) funded by the University of Hyderabad and the German Research Foundation (DFG). SAA acknowledges award of a Junior Research Fellowship of the Council for Scientific and Industrial Research (CSIR), India. NA is the Fellow of the European Helicobacter Study Group. SEH is a J. C. Bose National Fellow and Robert Koch fellow, Robert Koch Institute, Berlin, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvi A, 2007, J CLIN MICROBIOL, V45, P4039, DOI 10.1128/JCM.01631-07; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Backert S, 2004, INFECT IMMUN, V72, P1043, DOI 10.1128/IAI.72.2.1043-1056.2004; Banerjee S, 2004, P NATL ACAD SCI USA, V101, P12652, DOI 10.1073/pnas.0404347101; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Boyle JJ, 2003, ARTERIOSCL THROM VAS, V23, P1553, DOI 10.1161/01.ATV.0000086961.44581.B7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao P, 1998, INFECT IMMUN, V66, P2984, DOI 10.1128/IAI.66.6.2984-2986.1998; CRABTREE JE, 1994, J CLIN PATHOL, V47, P945, DOI 10.1136/jcp.47.10.945; DECKER T, 1987, J IMMUNOL, V138, P957; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Eswar N, 2006, CURRENT PROTOCOLS S, P561; Fan XJ, 2000, J IMMUNOL, V165, P1918, DOI 10.4049/jimmunol.165.4.1918; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Ge ZM, 1999, ANNU REV MICROBIOL, V53, P353, DOI 10.1146/annurev.micro.53.1.353; Gebert B, 2003, SCIENCE, V301, P1099, DOI 10.1126/science.1086871; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grossmann J, 1998, AM J PHYSIOL-GASTR L, V274, pG1117, DOI 10.1152/ajpgi.1998.274.6.G1117; Hagimoto N, 1999, AM J RESP CELL MOL, V21, P436, DOI 10.1165/ajrcmb.21.3.3397; Harris PR, 1998, J INFECT DIS, V178, P1516, DOI 10.1086/314426; Houghton J, 2000, INFECT IMMUN, V68, P1189, DOI 10.1128/IAI.68.3.1189-1195.2000; Hussain MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001481; Israel DA, 2001, J CLIN INVEST, V107, P611, DOI 10.1172/JCI11450; Janssen PJ, 2001, NUCLEIC ACIDS RES, V29, P4395, DOI 10.1093/nar/29.21.4395; Jones NL, 1999, INFECT IMMUN, V67, P4237, DOI 10.1128/IAI.67.8.4237-4242.1999; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Keates S, 1999, J IMMUNOL, V163, P5552; KELLEY LA, 2009, 3D2GO PROTEIN 3D STR; Kuck D, 2001, INFECT IMMUN, V69, P5080, DOI 10.1128/IAI.69.8.5080-5087.2001; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Lee SY, 2007, INFECT IMMUN, V75, P1291, DOI 10.1128/IAI.01700-06; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Maeda S, 2000, GASTROENTEROLOGY, V119, P97, DOI 10.1053/gast.2000.8540; Manna SK, 2000, CANCER RES, V60, P3838; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; Occhialini A, 2000, INFECT IMMUN, V68, P6240, DOI 10.1128/IAI.68.11.6240-6249.2000; Peek RM, 1995, LAB INVEST, V73, P760; Prouzet-Mauleon V, 2005, J CLIN MICROBIOL, V43, P4237, DOI 10.1128/JCM.43.8.4237-4241.2005; Rad R, 2003, J INFECT DIS, V188, P272, DOI 10.1086/376458; Rizwan M, 2008, J BACTERIOL, V190, P1146, DOI 10.1128/JB.01309-07; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Segal ED, 1996, P NATL ACAD SCI USA, V93, P1259, DOI 10.1073/pnas.93.3.1259; Sharma SA, 1998, J IMMUNOL, V160, P2401; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Torok AM, 2005, INFECT IMMUN, V73, P1523, DOI 10.1128/IAI.73.3.1523-1531.2005; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Varfolomeev EE, 1996, J EXP MED, V183, P1271, DOI 10.1084/jem.183.3.1271; VISVANATHAN KV, 1989, EMBO J, V8, P1129, DOI 10.1002/j.1460-2075.1989.tb03483.x; Wang J, 2001, J IMMUNOL, V167, P926, DOI 10.4049/jimmunol.167.2.926; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; WEIH F, 1994, ONCOGENE, V9, P3289; Yamaoka Y, 1999, J CLIN MICROBIOL, V37, P2274, DOI 10.1128/JCM.37.7.2274-2279.1999; Zheng Y, 2001, J IMMUNOL, V166, P4949, DOI 10.4049/jimmunol.166.8.4949	58	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22530	10.1371/journal.pone.0022530	http://dx.doi.org/10.1371/journal.pone.0022530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789261	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811700045
J	Soboleski, MR; Gabbard, JD; Price, GE; Misplon, JA; Lo, CY; Perez, DR; Ye, JQ; Tompkins, SM; Epstein, SL				Soboleski, Mark R.; Gabbard, Jon D.; Price, Graeme E.; Misplon, Julia A.; Lo, Chia-Yun; Perez, Daniel R.; Ye, Jianqiang; Tompkins, S. Mark; Epstein, Suzanne L.			Cold-Adapted Influenza and Recombinant Adenovirus Vaccines Induce Cross-Protective Immunity against pH1N1 Challenge in Mice	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; A VIRUS; HETEROSUBTYPIC IMMUNITY; EXTRACELLULAR DOMAIN; MATRIX PROTEIN-2; M2 PROTEIN; CELL; NUCLEOPROTEIN; VACCINATION; RESPONSES	Background: The rapid spread of the 2009 H1N1 pandemic influenza virus (pH1N1) highlighted problems associated with relying on strain-matched vaccines. A lengthy process of strain identification, manufacture, and testing is required for current strain-matched vaccines and delays vaccine availability. Vaccines inducing immunity to conserved viral proteins could be manufactured and tested in advance and provide cross-protection against novel influenza viruses until strain-matched vaccines became available. Here we test two prototype vaccines for cross-protection against the recent pandemic virus. Methodology/Principal Findings: BALB/c and C57BL/6 mice were intranasally immunized with a single dose of cold-adapted (ca) influenza viruses from 1977 or recombinant adenoviruses (rAd) expressing 1934 nucleoprotein (NP) and consensus matrix 2 (M2) (NP+M2-rAd). Antibodies against the M2 ectodomain (M2e) were seen in NP+M2-rAd immunized BALB/c but not C57BL/6 mice, and cross-reacted with pH1N1 M2e. The ca-immunized mice did not develop antibodies against M2e. Despite sequence differences between vaccine and challenge virus NP and M2e epitopes, extensive cross-reactivity of lung T cells with pH1N1 peptides was detected following immunization. Both ca and NP+M2-rAd immunization protected BALB/c and C57BL/6 mice against challenge with a mouse-adapted pH1N1 virus. Conclusion/Significance: Cross-protective vaccines such as NP+M2-rAd and ca virus are effective against pH1N1 challenge within 3 weeks of immunization. Protection was not dependent on recognition of the highly variable external viral proteins and could be achieved with a single vaccine dose. The rAd vaccine was superior to the ca vaccine by certain measures, justifying continued investigation of this experimental vaccine even though ca vaccine is already available. This study highlights the potential for cross-protective vaccines as a public health option early in an influenza pandemic.	[Soboleski, Mark R.; Price, Graeme E.; Misplon, Julia A.; Lo, Chia-Yun; Epstein, Suzanne L.] US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Gabbard, Jon D.; Tompkins, S. Mark] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Perez, Daniel R.; Ye, Jianqiang] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA	US Food & Drug Administration (FDA); University System of Georgia; University of Georgia; University System of Maryland; University of Maryland College Park	Soboleski, MR (corresponding author), US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	suzanne.epstein@fda.hhs.gov	ye, jianqiang/ABH-8988-2020; Perez, Daniel R./D-5044-2016; Tompkins, Stephen/A-3317-2008	Perez, Daniel R./0000-0002-6569-5689; Tompkins, Stephen/0000-0002-1523-5588; Epstein, Suzanne/0000-0002-6311-6890; Misplon, Julia/0000-0001-9614-5922	National Institute of Allergy and Infectious Diseases Trans-National Institutes of Health/Food and Drug Administration (FDA); FDA's Center for Biologics Evaluation and Research pandemic influenza initiative	National Institute of Allergy and Infectious Diseases Trans-National Institutes of Health/Food and Drug Administration (FDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FDA's Center for Biologics Evaluation and Research pandemic influenza initiative	This work was supported by grants from the National Institute of Allergy and Infectious Diseases Trans-National Institutes of Health/Food and Drug Administration (FDA) Intramural Biodefense Program and the FDA's Center for Biologics Evaluation and Research pandemic influenza initiative. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW ME, 1986, MICROB PATHOGENESIS, V1, P443, DOI 10.1016/0882-4010(86)90006-9; Barefoot B, 2008, VACCINE, V26, P6108, DOI 10.1016/j.vaccine.2008.09.007; Benton KA, 2001, J IMMUNOL, V166, P7437, DOI 10.4049/jimmunol.166.12.7437; Brown LE, 2009, IMMUNOL CELL BIOL, V87, P300, DOI 10.1038/icb.2009.16; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Deng YP, 1997, J IMMUNOL, V158, P1507; ENNIS FA, 1982, J GEN VIROL, V58, P273, DOI 10.1099/0022-1317-58-2-273; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Epstein SL, 2010, EXPERT REV VACCINES, V9, P1325, DOI 10.1586/ERV.10.123; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Ge XH, 2010, J VIROL, V84, P3312, DOI 10.1128/JVI.02226-09; Graham MB, 1997, J EXP MED, V186, P2063, DOI 10.1084/jem.186.12.2063; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Haanen JBAG, 1999, J EXP MED, V190, P1319, DOI 10.1084/jem.190.9.1319; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Kedzierska K, 2008, P NATL ACAD SCI USA, V105, P19408, DOI 10.1073/pnas.0810274105; Kobinger GP, 2010, J INFECT DIS, V201, P1000, DOI 10.1086/651171; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; LaMere MW, 2011, J VIROL, V85, P5027, DOI 10.1128/JVI.00150-11; LaMere MW, 2011, J IMMUNOL, V186, P4331, DOI 10.4049/jimmunol.1003057; Lau YF, 2011, J VIROL, V85, P76, DOI 10.1128/JVI.01564-10; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Lo CY, 2008, VACCINE, V26, P2062, DOI 10.1016/j.vaccine.2008.02.047; Misplon JA, 2010, VACCINE, V28, P5817, DOI 10.1016/j.vaccine.2010.06.069; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; Murphy BR, 2002, VIRAL IMMUNOL, V15, P295, DOI 10.1089/08828240260066242; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Oukka M, 1996, J IMMUNOL, V157, P3039; Powell TJ, 2007, J IMMUNOL, V178, P1030, DOI 10.4049/jimmunol.178.2.1030; Price GE, 2000, J EXP MED, V191, P1853, DOI 10.1084/jem.191.11.1853; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roy S, 2007, VACCINE, V25, P6845, DOI 10.1016/j.vaccine.2007.07.035; SLEPUSHKIN VA, 1995, VACCINE, V13, P1399, DOI 10.1016/0264-410X(95)92777-Y; Sun K, 2011, J IMMUNOL, V186, P987, DOI 10.4049/jimmunol.1002664; TANNOCK GA, 1987, ARCH VIROL, V92, P121, DOI 10.1007/BF01310067; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Thorner AR, 2006, J VIROL, V80, P12009, DOI 10.1128/JVI.01749-06; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; Townsend ARM, 2006, J IMMUNOL, V176, P5141; Tu WW, 2010, J VIROL, V84, P6527, DOI 10.1128/JVI.00519-10; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Vitiello A, 1996, J IMMUNOL, V157, P5555; Webby RJ, 2003, P NATL ACAD SCI USA, V100, P7235, DOI 10.1073/pnas.1232449100; Wesley RD, 2004, VACCINE, V22, P3427, DOI 10.1016/j.vaccine.2004.02.040; Ye JQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001145; Zhou DM, 2010, MOL THER, V18, P2182, DOI 10.1038/mt.2010.202	48	37	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e21937	10.1371/journal.pone.0021937	http://dx.doi.org/10.1371/journal.pone.0021937			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789196	Green Submitted, gold, Green Published			2022-12-25	WOS:000292811700011
J	Emmanouilidou, E; Elenis, D; Papasilekas, T; Stranjalis, G; Gerozissis, K; Ioannou, PC; Vekrellis, K				Emmanouilidou, Evangelia; Elenis, Dimitris; Papasilekas, Themis; Stranjalis, Georgios; Gerozissis, Kyriaki; Ioannou, Penelopi C.; Vekrellis, Kostas			Assessment of alpha-Synuclein Secretion in Mouse and Human Brain Parenchyma	PLOS ONE			English	Article							AMYLOID-BETA DYNAMICS; FLUORO-JADE-C; PARKINSONS-DISEASE; CEREBROSPINAL-FLUID; INTRACEREBRAL MICRODIALYSIS; HUMAN PLASMA; LEWY BODIES; IN-VIVO; NEURONS; MICE	Genetic, biochemical, and animal model studies strongly suggest a central role for alpha-synuclein in the pathogenesis of Parkinson's disease. alpha-synuclein lacks a signal peptide sequence and has thus been considered a cytosolic protein. Recent data has suggested that the protein may be released from cells via a non-classical secretory pathway and may therefore exert paracrine effects in the extracellular environment. However, proof that alpha-synuclein is actually secreted into the brain extracellular space in vivo has not been obtained. We developed a novel highly sensitive ELISA in conjugation with an in vivo microdialysis technique to measure alpha-synuclein in brain interstitial fluid. We show for the first time that alpha-synuclein is readily detected in the interstitial fluid of both alpha-synuclein transgenic mice and human patients with traumatic brain injury. Our data suggest that alpha-synuclein is physiologically secreted by neurons in vivo. This interstitial fluid pool of the protein may have a role in the propagation of synuclein pathology and progression of Parkinson's disease.	[Emmanouilidou, Evangelia; Vekrellis, Kostas] Acad Athens, Biomed Res Fdn, Div Basic Neurosci, Athens, Greece; [Elenis, Dimitris; Ioannou, Penelopi C.] Univ Athens, Dept Chem, GR-10680 Athens, Greece; [Papasilekas, Themis; Stranjalis, Georgios] Univ Athens, Evaggelismos Gen Hosp, Dept Neurosurg, Athens, Greece; [Gerozissis, Kyriaki] CNRS, Ctr Neurosci, UMR 8195, F-91405 Orsay, France; [Gerozissis, Kyriaki] Univ Paris 11, UMR 8195, Orsay, France; [Gerozissis, Kyriaki] Univ Paris 11, INSERM, F-91405 Orsay, France	Academy of Athens; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Emmanouilidou, E (corresponding author), Acad Athens, Biomed Res Fdn, Div Basic Neurosci, Athens, Greece.	vekrellis@bioacademy.gr	Emmanouilidou, Evangelia/ACP-6562-2022	Ioannou, Penelope/0000-0002-2595-1385	Michael J. Fox Foundation; MEFOPA FP7	Michael J. Fox Foundation; MEFOPA FP7	This work was supported by a Rapid Innovation Response Award from the Michael J. Fox Foundation to EE and KV. Partial support was obtained from MEFOPA FP7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Bian GL, 2007, BRAIN RES, V1150, P55, DOI 10.1016/j.brainres.2007.02.078; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Chaurasia CS, 2007, PHARM RES, V24, P1014, DOI 10.1007/s11095-006-9206-z; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; DYKSTRA KH, 1992, J NEUROCHEM, V58, P931, DOI 10.1111/j.1471-4159.1992.tb09346.x; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; EMMANOUILIDOU E, J NEUROSCI, V30, P6838; Engstrom ER, 2001, EPILEPSY RES, V43, P135, DOI 10.1016/S0920-1211(00)00191-1; GEROZISSIS K, 1993, BRAIN RES, V611, P258, DOI 10.1016/0006-8993(93)90511-K; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; HANSEN C, 2011, J CLIN INVEST; Hillman J, 2006, ACTA NEUROCHIR, V148, P319, DOI 10.1007/s00701-005-0670-8; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kim TD, 2000, PROTEIN SCI, V9, P2489, DOI 10.1110/ps.9.12.2489; Kordower JH, 2008, MOVEMENT DISORD, V23, P2303, DOI 10.1002/mds.22369; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Lindberger M, 2001, EPILEPSIA, V42, P256, DOI 10.1046/j.1528-1157.2001.4220256.x; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Moussa CEH, 2004, NEUROSCI LETT, V371, P239, DOI 10.1016/j.neulet.2004.09.004; Ohrfelt A, 2009, NEUROSCI LETT, V450, P332, DOI 10.1016/j.neulet.2008.11.015; Olanow CW, 2004, LANCET NEUROL, V3, P496, DOI 10.1016/S1474-4422(04)00827-0; Perrin RJ, 2003, NEUROSCI LETT, V349, P133, DOI 10.1016/S0304-3940(03)00781-X; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; Roodveldt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013481; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; SOTIRIOU E, NEUROBIOL AGING, V31, P2103; Specht CG, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-11; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Su XM, 2008, NEUROBIOL AGING, V29, P1690, DOI 10.1016/j.neurobiolaging.2007.04.006; Sung JY, 2005, J BIOL CHEM, V280, P25216, DOI 10.1074/jbc.M503341200; TOKUDA T, NEUROLOGY, V75, P1766; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Vekrellis K, 2004, MOL NEUROBIOL, V30, P1, DOI 10.1385/MN:30:1:001; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Winter CD, 2002, J NEUROSCI METH, V119, P45, DOI 10.1016/S0165-0270(02)00153-X; WOODS SC, 1977, AM J PHYSIOL, V233, pE331, DOI 10.1152/ajpendo.1977.233.4.E331	48	121	128	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22225	10.1371/journal.pone.0022225	http://dx.doi.org/10.1371/journal.pone.0022225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779395	gold, Green Published, Green Submitted			2022-12-25	WOS:000292811300049
J	Dubois, D; Baron, O; Cougnoux, A; Delmas, J; Pradel, N; Boury, M; Bouchon, B; Bringer, MA; Nougayrede, JP; Oswald, E; Bonnet, R				Dubois, Damien; Baron, Olivier; Cougnoux, Antony; Delmas, Julien; Pradel, Nathalie; Boury, Michele; Bouchon, Bernadette; Bringer, Marie-Agnes; Nougayrede, Jean-Philippe; Oswald, Eric; Bonnet, Richard			ClbP Is a Prototype of a Peptidase Subgroup Involved in Biosynthesis of Nonribosomal Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENICILLIN-BINDING PROTEINS; SERINE BETA-LACTAMASES; ESCHERICHIA-COLI; CATALYTIC MECHANISM; MOLECULAR-GRAPHICS; SPECIFICITY; INHIBITION; POLYKETIDE; EVOLUTION; SUBSTRATE	The pks genomic island of Escherichia coli encodes polyketide (PK) and nonribosomal peptide (NRP) synthases that allow assembly of a putative hybrid PK-NRP compound named colibactin that induces DNA double-strand breaks in eukaryotic cells. The pks-encoded machinery harbors an atypical essential protein, ClbP. ClbP crystal structure and mutagenesis experiments revealed a serine-active site and original structural features compatible with peptidase activity, which was detected by biochemical assays. Ten ClbP homologs were identified in silico in NRP genomic islands of closely and distantly related bacterial species. All tested ClbP homologs were able to complement a clbP-deficient E. coli mutant. ClbP is therefore a prototype of a new subfamily of extracytoplasmic peptidases probably involved in the maturation of NRP compounds. Such peptidases will be powerful tools for the manipulation of NRP biosynthetic pathways.	[Baron, Olivier; Boury, Michele; Nougayrede, Jean-Philippe; Oswald, Eric] INSERM, U1043, F-31076 Toulouse, France; [Dubois, Damien; Delmas, Julien; Bonnet, Richard] Ctr Hosp Clermont Ferrand, Lab Bacteriol Clin, F-63003 Clermont Ferrand, France; [Dubois, Damien; Cougnoux, Antony; Delmas, Julien; Pradel, Nathalie; Bringer, Marie-Agnes; Bonnet, Richard] Univ Clermont Ferrand 2, Inst Natl Rech Agron, JE Univ Auvergne 2526, Unite Contrat 2018, F-63001 Clermont Ferrand, France; [Bouchon, Bernadette] INSERM, U990, Clermont Ferrand, France; [Baron, Olivier; Boury, Michele; Nougayrede, Jean-Philippe; Oswald, Eric] CNRS, U5282, F-31076 Toulouse, France; [Baron, Olivier; Boury, Michele; Nougayrede, Jean-Philippe; Oswald, Eric] INRA, Unite Contrat, F-31076 Toulouse, France; [Baron, Olivier; Boury, Michele; Nougayrede, Jean-Philippe; Oswald, Eric] Univ Toulouse 3, Ctr Physiopathol Toulouse Purpan, F-31076 Toulouse, France; [Baron, Olivier; Oswald, Eric] Hop Purpan, Ctr Hosp Univ Toulouse, Serv Bacteriol Hyg, F-31059 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse	Oswald, E (corresponding author), INSERM, U1043, F-31076 Toulouse, France.	e.oswald@envt.fr; rbonnet@chu-clermontferrand.fr	Bringer, Marie-Agnès/Q-1752-2018; Bouchon, Bernadette/L-5698-2015; Bonnet, Richard/C-8544-2015; Nougayrede, Jean-Philippe/I-6362-2019	Bringer, Marie-Agnès/0000-0002-3746-4998; Nougayrede, Jean-Philippe/0000-0002-6802-1890; Oswald, Eric/0000-0002-3017-0081; Cougnoux, Antony/0000-0001-9407-7540	le Ministere Francais de l'Education Nationale, de la Recherche, et de la Technologie [JE2526]; l'Institut National de la Recherche Agronomique [USC-2018]; National Institutes of Health [P41 RR-01081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	le Ministere Francais de l'Education Nationale, de la Recherche, et de la Technologie; l'Institut National de la Recherche Agronomique; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by le Ministere Francais de l'Education Nationale, de la Recherche, et de la Technologie Grant JE2526 and l'Institut National de la Recherche Agronomique Grant USC-2018. Molecular graphics images were produced using the University of California, San Francisco Chimera package (National Institutes of Health Grant P41 RR-01081).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bauvois C, 2005, ANTIMICROB AGENTS CH, V49, P4240, DOI 10.1128/AAC.49.10.4240-4246.2005; Beadle BM, 2002, ANTIMICROB AGENTS CH, V46, P3978, DOI 10.1128/AAC.46.12.3978-3980.2002; Beadle BM, 2002, STRUCTURE, V10, P413, DOI 10.1016/S0969-2126(02)00725-6; Bompard-Gilles G, 2000, STRUCTURE, V8, P971, DOI 10.1016/S0969-2126(00)00188-X; Chen Y, 2006, J AM CHEM SOC, V128, P2970, DOI 10.1021/ja056806m; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; Delfosse V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004712; Delmarcelle M, 2005, PROTEIN SCI, V14, P2296, DOI 10.1110/ps.051475305; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Donadio S, 2007, NAT PROD REP, V24, P1073, DOI 10.1039/b514050c; Drawz SM, 2010, BIOCHEMISTRY-US, V49, P329, DOI 10.1021/bi9015988; Dubois D, 2010, J CLIN MICROBIOL, V48, P2122, DOI 10.1128/JCM.02365-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GALLENI M, 1995, BIOCHEM PHARMACOL, V49, P1171, DOI 10.1016/0006-2952(94)00502-D; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Johnson JR, 2008, J CLIN MICROBIOL, V46, P3906, DOI 10.1128/JCM.00949-08; Kevany BM, 2009, APPL ENVIRON MICROB, V75, P1144, DOI 10.1128/AEM.02518-08; Komatsuzawa H, 2000, FEMS MICROBIOL LETT, V188, P35, DOI 10.1016/S0378-1097(00)00194-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu YW, 2008, J BACTERIOL, V190, P6903, DOI 10.1128/JB.00865-08; Matagne A, 1998, BIOCHEM J, V330, P581, DOI 10.1042/bj3300581; MATAGNE A, 1993, BIOCHEM J, V295, P705, DOI 10.1042/bj2950705; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meroueh SO, 2003, J AM CHEM SOC, V125, P9612, DOI 10.1021/ja034861u; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Okazaki S, 2008, J SYNCHROTRON RADIAT, V15, P250, DOI 10.1107/S0909049507064655; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Pratt RF, 2008, CELL MOL LIFE SCI, V65, P2138, DOI 10.1007/s00018-008-7591-7; Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Sattely ES, 2008, NAT PROD REP, V25, P757, DOI 10.1039/b801747f; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; SCHMITT CK, 1994, J BACTERIOL, V176, P368, DOI 10.1128/JB.176.2.368-377.1994; Steiner RA, 2003, ACTA CRYSTALLOGR D, V59, P2114, DOI 10.1107/S0907444903018675; Wagner UG, 2002, PROTEIN SCI, V11, P467, DOI 10.1110/ps.33002	40	70	72	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35562	35570		10.1074/jbc.M111.221960	http://dx.doi.org/10.1074/jbc.M111.221960			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21795676	Green Published, hybrid			2022-12-25	WOS:000295927100028
J	Chen, VP; Choi, RCY; Chan, WKB; Leung, KW; Guo, AJY; Chan, GKL; Luk, WKW; Tsim, KWK				Chen, Vicky P.; Choi, Roy C. Y.; Chan, Wallace K. B.; Leung, K. Wing; Guo, Ava J. Y.; Chan, Gallant K. L.; Luk, Wilson K. W.; Tsim, Karl W. K.			The Assembly of Proline-rich Membrane Anchor (PRiMA)-linked Acetylcholinesterase Enzyme GLYCOSYLATION IS REQUIRED FOR ENZYMATIC ACTIVITY BUT NOT FOR OLIGOMERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED CHICK MYOTUBES; ASYMMETRIC ACETYLCHOLINESTERASE; ALZHEIMERS-DISEASE; ATTACHMENT DOMAIN; GOLGI-APPARATUS; CYCLIC-AMP; PRIMA; EXPRESSION; MUSCLE; PROTEIN	Acetylcholinesterase (AChE) anchors onto cell membranes by a transmembrane protein PRiMA (proline-rich membrane anchor) as a tetrameric form in vertebrate brain. The assembly of AChE tetramer with PRiMA requires the C-terminal "t-peptide" in AChE catalytic subunit (AChE(T)). Although mature AChE is well known N-glycosylated, the role of glycosylation in forming the physiologically active PRiMA-linked AChE tetramer has not been studied. Here, several lines of evidence indicate that the N-linked glycosylation of AChET plays a major role for acquisition of AChE full enzymatic activity but does not affect its oligomerization. The expression of the AChET mutant, in which all N-glycosylation sites were deleted, together with PRiMA in HEK293T cells produced a glycan-depleted PRiMA-linked AChE tetramer but with a much higher K-m value as compared with the wild type. This glycan-depleted enzyme was assembled in endoplasmic reticulum but was not transported to Golgi apparatus or plasma membrane.	[Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Ctr Chinese Med, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay Rd, Hong Kong, Hong Kong, Peoples R China.	botsim@ust.hk	CHEN, VICKY/C-9223-2016	CHEN, VICKY/0000-0003-3753-7170; Tsim, Karl/0000-0003-4808-1674; Leung, Ka Wing/0000-0002-6137-3877	Research Grants Council of Hong Kong [662407, 660409, 662911, F-HK21/06T]; Croucher Foundation [CAS-CF07/08.SC03]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Croucher Foundation	This work was supported by grants from the Research Grants Council of Hong Kong (662407, 660409, 662911, F-HK21/06T) and the Croucher Foundation (CAS-CF07/08.SC03) (to K. W. K. T. and R. C. Y. C.).	Bon S, 1997, J BIOL CHEM, V272, P3016, DOI 10.1074/jbc.272.5.3016; CHATEL JM, 1993, P NATL ACAD SCI USA, V90, P2476, DOI 10.1073/pnas.90.6.2476; Chen VP, 2010, J BIOL CHEM, V285, P27265, DOI 10.1074/jbc.M110.113647; Choi RCY, 1998, J NEUROCHEM, V71, P152; Choi RCY, 2001, MOL CELL NEUROSCI, V17, P732, DOI 10.1006/mcne.2001.0968; Choi RCY, 1996, NEUROSCI LETT, V217, P165, DOI 10.1016/0304-3940(96)13102-5; Dobbertin A, 2009, J NEUROSCI, V29, P4519, DOI 10.1523/JNEUROSCI.3863-08.2009; Dvir H, 2004, EMBO J, V23, P4394, DOI 10.1038/sj.emboj.7600425; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; GOUGH NR, 1995, J NEUROCHEM, V65, P2734; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; Krejci E, 1997, J BIOL CHEM, V272, P22840, DOI 10.1074/jbc.272.36.22840; Liang D, 2009, FEBS J, V276, P94, DOI 10.1111/j.1742-4658.2008.06756.x; LIAO J, 1991, EUR J BIOCHEM, V198, P59, DOI 10.1111/j.1432-1033.1991.tb15986.x; LIAO J, 1992, J NEUROCHEM, V58, P1230, DOI 10.1111/j.1471-4159.1992.tb11333.x; Luzikov VN, 2002, BIOCHEMISTRY-MOSCOW+, V67, P171, DOI 10.1023/A:1014457813037; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Massoulie J, 2009, CURR OPIN PHARMACOL, V9, P316, DOI 10.1016/j.coph.2009.04.004; MEFLAH K, 1984, BIOCHIMIE, V66, P59, DOI 10.1016/0300-9084(84)90192-5; Meyer-Schaller N, 2009, P NATL ACAD SCI USA, V106, P12365, DOI 10.1073/pnas.0812528106; Mimori Y, 1997, BEHAV BRAIN RES, V83, P25, DOI 10.1016/S0166-4328(97)86041-X; Mok MKW, 2009, NEUROSCI LETT, V461, P202, DOI 10.1016/j.neulet.2009.06.015; Morel N, 2001, J BIOL CHEM, V276, P37379, DOI 10.1074/jbc.M103192200; Noureddine H, 2008, J BIOL CHEM, V283, P20722, DOI 10.1074/jbc.M801364200; Noureddine H, 2007, J BIOL CHEM, V282, P3487, DOI 10.1074/jbc.M607221200; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; Santos SCR, 2007, J BIOL CHEM, V282, P25597, DOI 10.1074/jbc.M700569200; ROTUNDO RL, 1988, J BIOL CHEM, V263, P19398; ROTUNDO RL, 1984, P NATL ACAD SCI-BIOL, V81, P479, DOI 10.1073/pnas.81.2.479; ROTUNDO RL, 1989, J BIOL CHEM, V264, P3146; Ruiz CA, 2009, J BIOL CHEM, V284, P21488, DOI 10.1074/jbc.M109.030049; Saez-Valero J, 2000, J NEUROL NEUROSUR PS, V69, P664, DOI 10.1136/jnnp.69.5.664; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TSIM KWK, 1988, J NEUROCHEM, V51, P95, DOI 10.1111/j.1471-4159.1988.tb04840.x; Tung EKK, 2004, MOL PHARMACOL, V66, P794, DOI 10.1124/mol.104.003269; VELAN B, 1993, BIOCHEM J, V296, P649, DOI 10.1042/bj2960649; Xie HQ, 2007, J BIOL CHEM, V282, P11765, DOI 10.1074/jbc.M608265200; Xie HDQ, 2010, J BIOL CHEM, V285, P11537, DOI 10.1074/jbc.M109.038711	41	41	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32948	32961		10.1074/jbc.M111.261248	http://dx.doi.org/10.1074/jbc.M111.261248			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795704	Green Published, hybrid			2022-12-25	WOS:000294968800013
J	Nguyen, TTA; Nishitani, M; Harada, S; Yamaguchi, M; Kamei, K				Nguyen Thi Tu Anh; Nishitani, Maiko; Harada, Shigeharu; Yamaguchi, Masamitsu; Kamei, Kaeko			Essential Role of Duox in Stabilization of Drosophila Wing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL OXIDASE; REACTIVE OXYGEN; GUT IMMUNITY; CELL-DEATH; MELANOGASTER; FAMILY; GENE; PATHOPHYSIOLOGY; PHYSIOLOGY; ENZYMES	NADPH oxidase produces reactive oxygen species (ROS). Drosophila melanogaster has two homologs of NADPH oxidase, dNox and dDuox, with functions that remain unclear in vivo. To clarify these functions, two independent transgenic fly lines expressing dsRNA targeted for different portions of dDuox mRNA were used. In both flies, en-GAL4> UAS-dDuoxIR(976-1145) and en-GAL4> UAS-dDuoxIR(370-518), in which dDuox was knocked down selectively in the posterior area of the wing disc, the posterior compartment of the adult wings became paler and more fragile with wing veins that were indistinct by comparison with the anterior one. Fluorescence staining of the en-GAL4> UAS-dDuoxIR(976-1145) adult wings revealed that the ROS concentration in the posterior compartment was significantly lower than that in the anterior compartment. Moreover, in these flies, the posterior compartment of the wing imaginal disc showed a greater number of apoptotic cells detected by immunostaining with anti-cleaved caspase-3 antibody than those in the anterior compartment. Respective knockdown of tyrosine hydroxylase or dopa-decarboxylase showed paler wing blades in the posterior compartment similar to the phenotype of dDuox-knockdown files. Along with this observation, analysis of the catecholic and dityrosine components in the wings of adult flies proved that dDuox plays important roles in the stabilization of the cuticle structure of the wings via tyrosine cross-linking, the sclerotization and melanization processes possibly through ROS production. These dDuox-knockdown fly lines would be useful tools for further studying dDuox functions during the development of Drosophila.	[Kamei, Kaeko] Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan; [Nguyen Thi Tu Anh; Nishitani, Maiko; Harada, Shigeharu; Yamaguchi, Masamitsu] Kyoto Inst Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan	Kyoto Institute of Technology; Kyoto Institute of Technology	Kamei, K (corresponding author), Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan.	kame@kit.ac.jp		Yamaguchi, Masamitsu/0000-0002-6321-9750	Scientific Research [22570140]	Scientific Research	This work was supported by Grant-in-aid for Scientific Research (C) 22570140 and Grant-in-aid for Scientific Research (A) 22241052.	Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Groeger G, 2009, ANTIOXID REDOX SIGN, V11, P2655, DOI 10.1089/ARS.2009.2728; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Jane SM, 2005, CURR OPIN GENET DEV, V15, P447, DOI 10.1016/j.gde.2005.05.005; Kato Y, 2000, BIOCHEM BIOPH RES CO, V275, P11, DOI 10.1006/bbrc.2000.3265; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Lambeth JD, 2000, TRENDS BIOCHEM SCI, V25, P459, DOI 10.1016/S0968-0004(00)01658-3; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Milan M, 1997, P NATL ACAD SCI USA, V94, P5691, DOI 10.1073/pnas.94.11.5691; Moreno JC, 2002, NEW ENGL J MED, V347, P95, DOI 10.1056/NEJMoa012752; Phelps CB, 1998, METHODS, V14, P367, DOI 10.1006/meth.1998.0592; RIOUX C, 1983, ANAL BIOCHEM, V133, P163, DOI 10.1016/0003-2697(83)90238-5; Ris-Stalpers C, 2006, ANTIOXID REDOX SIGN, V8, P1563, DOI 10.1089/ars.2006.8.1563; Ritsick DR, 2007, FREE RADICAL BIO MED, V43, P31, DOI 10.1016/j.freeradbiomed.2007.03.006; ROBERTSON HM, 1988, GENETICS, V118, P461; Wong JL, 2004, DEV CELL, V7, P801, DOI 10.1016/j.devcel.2004.10.014; Xie XJ, 2010, INT J BIOL SCI, V6, P252	27	40	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33244	33251		10.1074/jbc.M111.263178	http://dx.doi.org/10.1074/jbc.M111.263178			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21808060	hybrid, Green Published			2022-12-25	WOS:000294968800043
J	Shim, JY; Bertalovitz, AC; Kendall, DA				Shim, Joong-Youn; Bertalovitz, Alexander C.; Kendall, Debra A.			Identification of Essential Cannabinoid-binding Domains STRUCTURAL INSIGHTS INTO EARLY DYNAMIC EVENTS IN RECEPTOR ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA(2) ADRENERGIC-RECEPTOR; ANGSTROM CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; CB1 RECEPTOR; INVERSE AGONIST; HIGH-AFFINITY; BETA(2)-ADRENERGIC RECEPTOR; CONSTITUTIVE ACTIVATION; FORCE-FIELD	The classical cannabinoid agonist HU210, a structural analog of (-)-Delta(9)-tetrahydrocannabinol, binds to brain cannabinoid (CB1) receptors and activates signal transduction pathways. To date, an exact molecular description of the CB1 receptor is not yet available. Utilizing the minor binding pocket of the CB1 receptor as the primary ligand interaction site, we explored HU210 binding using lipid bilayer molecular dynamics (MD) simulations. Among the potential ligand contact residues, we identified residues Phe-174(2.61), Phe-177(2.64), Leu-193(3.29), and Met-363(6.55) as being critical for HU210 binding by mutational analysis. Using these residues to guide the simulations, we determined essential cannabinoid-binding domains in the CB1 receptor, including the highly sought after hydrophobic pocket important for the binding of the C3 alkyl chain of classical and nonclassical cannabinoids. Analyzing the simulations of the HU210-CB1 receptor complex, the CP55940-CB1 receptor complex, and the (-)-Delta(9)-tetrahydrocannabinol-CB1 receptor complex, we found that the positioning of the C3 alkyl chain and the aromatic stacking between Trp-356(6.48) and Trp-279(5.43) is crucial for the Trp-356(6.48) rotamer change toward receptor activation through the rigid-body movement of H6. The functional data for the mutant receptors demonstrated reductions in potency for G protein activation similar to the reductions seen in ligand binding affinity for HU210.	[Shim, Joong-Youn] N Carolina Cent Univ, JL Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA; [Bertalovitz, Alexander C.; Kendall, Debra A.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA	University of North Carolina; North Carolina Central University; University of Connecticut	Shim, JY (corresponding author), N Carolina Cent Univ, JL Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA.	jyshim@nccu.edu			National Institutes of Health [5K01 DA020663, DA020763]; National Science Foundation through TeraGrid resources; TACC and Indiana University; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020763, K01DA020663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation through TeraGrid resources(National Science Foundation (NSF)); TACC and Indiana University; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants 5K01 DA020663 (to J.-Y. S.) and DA020763 (to D. A. K.). This work was also supported in part by the National Science Foundation through TeraGrid resources provided by TACC and Indiana University.	Abadji V, 1999, J NEUROCHEM, V72, P2032, DOI 10.1046/j.1471-4159.1999.0722032.x; ADAMS R, 1949, J AM CHEM SOC, V71, P1624, DOI 10.1021/ja01173a023; Ahn KH, 2009, MOL PHARMACOL, V76, P833, DOI 10.1124/mol.109.057356; Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; [Anonymous], [No title captured]; Ashton JC, 2008, CURR MED CHEM, V15, P1428, DOI 10.2174/092986708784567716; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bouaboula M, 1997, J BIOL CHEM, V272, P22330, DOI 10.1074/jbc.272.35.22330; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Busch-Petersen J, 1996, J MED CHEM, V39, P3790, DOI 10.1021/jm950934b; Cai K, 2001, P NATL ACAD SCI USA, V98, P4877, DOI 10.1073/pnas.051632898; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen JH, 2006, J AM CHEM SOC, V128, P3728, DOI 10.1021/ja057216r; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chin CN, 1998, J NEUROCHEM, V70, P366; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978; DEVANE WA, 1992, J MED CHEM, V35, P2065, DOI 10.1021/jm00089a018; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fay JF, 2005, BIOCHEMISTRY-US, V44, P8757, DOI 10.1021/bi0472651; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Glass M, 1999, MOL PHARMACOL, V56, P1362, DOI 10.1124/mol.56.6.1362; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Henin J, 2004, J CHEM PHYS, V121, P2904, DOI 10.1063/1.1773132; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hornak V, 2010, J MOL BIOL, V396, P510, DOI 10.1016/j.jmb.2009.12.003; HOWLETT AC, 1988, MOL PHARMACOL, V33, P297; Howlett AC, 2010, CURR MED CHEM, V17, P1382, DOI 10.2174/092986710790980023; Huffman JW, 1996, J MED CHEM, V39, P3875, DOI 10.1021/jm960394y; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Javitch JA, 1997, J BIOL CHEM, V272, P18546, DOI 10.1074/jbc.272.30.18546; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Kapur A, 2007, MOL PHARMACOL, V71, P1512, DOI 10.1124/mol.107.034645; Kimura T, 2009, BIOPHYS J, V96, P4916, DOI 10.1016/j.bpj.2009.03.033; Klein-Seetharaman J, 2004, P NATL ACAD SCI USA, V101, P3409, DOI 10.1073/pnas.0308713101; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; LOEV B, 1973, J MED CHEM, V16, P1200, DOI 10.1021/jm00269a002; MacCallum JL, 2008, BIOPHYS J, V94, P3393, DOI 10.1529/biophysj.107.112805; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martin BR, 1999, J PHARMACOL EXP THER, V290, P1065; McAllister SD, 2004, J BIOL CHEM, V279, P48024, DOI 10.1074/jbc.M406648200; McAllister SD, 2003, J MED CHEM, V46, P5139, DOI 10.1021/jm0302647; McAllister SD, 2002, BIOCHEM PHARMACOL, V63, P2121, DOI 10.1016/S0006-2952(02)01031-6; MELVIN LS, 1993, MOL PHARMACOL, V44, P1008; Meschler JP, 2000, BIOCHEM PHARMACOL, V60, P1315, DOI 10.1016/S0006-2952(00)00447-0; Meyer EA, 2003, ANGEW CHEM INT EDIT, V42, P1210, DOI 10.1002/anie.200390319; Murphy JW, 2003, BIOCHEM PHARMACOL, V65, P1623, DOI 10.1016/S0006-2952(03)00155-2; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Picone RP, 2005, MOL PHARMACOL, V68, P1623, DOI 10.1124/mol.105.014407; Rahn EJ, 2009, NEUROTHERAPEUTICS, V6, P713, DOI 10.1016/j.nurt.2009.08.002; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenkilde MM, 2010, TRENDS PHARMACOL SCI, V31, P567, DOI 10.1016/j.tips.2010.08.006; Saam J, 2002, BIOPHYS J, V83, P3097, DOI 10.1016/S0006-3495(02)75314-9; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Scotter EL, 2010, BRIT J PHARMACOL, V160, P480, DOI 10.1111/j.1476-5381.2010.00735.x; Shen CP, 2006, EUR J PHARMACOL, V531, P41, DOI 10.1016/j.ejphar.2005.12.026; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Shim JY, 2011, PROTEINS, V79, P581, DOI 10.1002/prot.22907; Shim JY, 2010, CURR TOP MED CHEM, V10, P779, DOI 10.2174/156802610791164210; Shim JY, 2009, BIOPHYS J, V96, P3251, DOI 10.1016/j.bpj.2008.12.3934; Shim JY, 2004, J CHEM INF COMP SCI, V44, P1466, DOI 10.1021/ci040040c; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Song ZH, 1999, MOL PHARMACOL, V56, P834; Song ZH, 1996, MOL PHARMACOL, V49, P891; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Stone JE, 2007, J COMPUT CHEM, V28, P2618, DOI 10.1002/jcc.20829; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Walsh D, 2003, SUPPORT CARE CANCER, V11, P137, DOI 10.1007/s00520-002-0387-7; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Zajicek J, 2003, LANCET, V362, P1517, DOI 10.1016/S0140-6736(03)14738-1	91	28	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33422	33435		10.1074/jbc.M111.261651	http://dx.doi.org/10.1074/jbc.M111.261651			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795705	hybrid, Green Published			2022-12-25	WOS:000294968800060
J	Zuo, T; Shi, XL; Liu, ZH; Guo, LL; Zhao, Q; Guan, TX; Pan, XM; Jia, N; Cao, WC; Zhou, BP; Goldin, M; Zhang, LQ				Zuo, Teng; Shi, Xuanling; Liu, Zhonghua; Guo, Linlin; Zhao, Qing; Guan, Tianxia; Pan, Xianming; Jia, Na; Cao, Wuchun; Zhou, Boping; Goldin, Mark; Zhang, Linqi			Comprehensive Analysis of Pathogen-specific Antibody Response in Vivo Based on an Antigen Library Displayed on Surface of Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; HUMAN MONOCLONAL-ANTIBODIES; B-CELLS; SITES; IDENTIFICATION; GENERATION; DIVERSITY; MOLECULE; MEMORY; MICE	Host antibody response is a crucial defense against pathogenic infection. Here, we report a novel technique allowing quantitative measurement of polyclonal antibody response in vivo. This involves expression of a combinatorial library of target proteins from a candidate pathogen on the surface of yeast Saccharomyces cerevisiae. After mixing with serum/plasma from infected or immunized subjects, positive yeast clones were isolated via fluorescence-activated cell sorting (FACS). Using this technique, we have studied mouse immunized serum with recombinant hemagglutinin (HA) protein from a human influenza H5N1 strain (A/Anhui/1/2005) and convalescent plasma from an infected human in China. Our technique has identified novel antigenic domains targeted by serum/plasma and allowed calculation of the relative proportion of the antibody response against each domain. We believe such systematic measurement of an antibody response is unprecedented, and applying this method to different pathogens will improve understanding of protective immunity and guide development of vaccines and therapeutics.	[Zuo, Teng; Shi, Xuanling; Liu, Zhonghua; Guo, Linlin; Zhao, Qing; Guan, Tianxia; Pan, Xianming; Goldin, Mark; Zhang, Linqi] Tsinghua Univ, Comprehens AIDS Res Ctr, Sch Med, Beijing 100084, Peoples R China; [Jia, Na; Cao, Wuchun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Zhou, Boping] Shenzhen Donghu Hosp, Shenzhen 518020, Peoples R China	Tsinghua University; Beijing Institute of Microbiology & Epidemiology	Zhang, LQ (corresponding author), Tsinghua Univ, Comprehens AIDS Res Ctr, Sch Med, Beijing 100084, Peoples R China.	zhanglinqi@tsinghua.edu.cn	Guan, Tianxia/B-5559-2017; ZHANG, LIN/GYD-9123-2022	Guan, Tianxia/0000-0001-6187-5431; Zhao, Qing/0000-0003-2862-3886	National Institutes of Health CIPRA [U19 AI51915]; National Science and Technology Major [2008ZX10001-011, 2009ZX10004-016]; National Basic Research Program (973 Program) [2006CB504200]; National Outstanding Youth Award [30825035]; Tsinghua University Initiative Scientific Research; Tsinghua Yue-Yuen Medical Sciences Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER	National Institutes of Health CIPRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science and Technology Major; National Basic Research Program (973 Program)(National Basic Research Program of China); National Outstanding Youth Award; Tsinghua University Initiative Scientific Research; Tsinghua Yue-Yuen Medical Sciences Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health CIPRA Grant U19 AI51915. This work was also supported by National Science and Technology Major Projects 2008ZX10001-011 and 2009ZX10004-016, National Basic Research Program (also called the 973 Program) Grant 2006CB504200, the National Outstanding Youth Award 30825035, Tsinghua University Initiative Scientific Research Program, and Tsinghua Yue-Yuen Medical Sciences Fund.	Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Janeway CA, 2001, IMMUNOBIOLOGY; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Lin Zhanglin, 2009, V515, P261, DOI 10.1007/978-1-59745-559-6_18; PHILPOTT M, 1989, J VIROL, V63, P3453, DOI 10.1128/JVI.63.8.3453-3458.1989; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shu YL, 2006, NEW ENGL J MED, V354, P1421, DOI 10.1056/NEJMc053524; SMITH CA, 1991, J EXP MED, V173, P953, DOI 10.1084/jem.173.4.953; STAUDT LM, 1983, J EXP MED, V157, P687, DOI 10.1084/jem.157.2.687; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359	30	17	21	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33511	33519		10.1074/jbc.M111.270553	http://dx.doi.org/10.1074/jbc.M111.270553			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795672	Green Published, hybrid			2022-12-25	WOS:000294968800068
J	Chaudhuri, A; Xie, MH; Yang, B; Mahapatra, K; Liu, JF; Marsters, S; Bodepudi, S; Ashkenazi, A				Chaudhuri, Amitabha; Xie, Ming-Hong; Yang, Becky; Mahapatra, Kaushiki; Liu, Jinfeng; Marsters, Scot; Bodepudi, Sweta; Ashkenazi, Avi			Distinct Involvement of the Gab1 and Grb2 Adaptor Proteins in Signal Transduction by the Related Receptor Tyrosine Kinases RON and MET	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; MACROPHAGE-STIMULATING PROTEIN; CELL-TRANSFORMATION; DOCKING PROTEIN; SCATTER-FACTOR; C-MET; PATHWAYS DOWNSTREAM; SCAFFOLDING PROTEIN; REGULATED KINASE; BINDING-SITES	Although the signal transduction mechanisms of the receptor tyrosine kinase MET are well defined, less is known about its close relative RON. MET initiates intracellular signaling by autophosphorylation on specific cytoplasmic tyrosines that form docking sites for the adaptor proteins Grb2 and Gab1. Grb2 binds directly and is essential for all of the biological activities of MET. Gab1 docks either directly or indirectly via Grb2 and controls only a subset of MET functions. Because MET and RON possess similar adaptor binding sites, it was anticipated that their adaptor interactions would be conserved. Here we show that in contrast to MET, RON relies primarily on Gab1 for signal transmission. Surprisingly, disruption of the Grb2 docking site of RON or Grb2 depletion augments activity, whereas enhancement of Grb2 binding attenuates Gab1 recruitment and signaling. Hence, RON and MET differ in their adaptor interactions; furthermore, Grb2 performs a novel antagonistic role in the context of RON signaling.	[Chaudhuri, Amitabha; Xie, Ming-Hong; Yang, Becky; Mahapatra, Kaushiki; Liu, Jinfeng; Marsters, Scot; Bodepudi, Sweta; Ashkenazi, Avi] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Chaudhuri, A (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	amitabha@gene.com; aa@gene.com	Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589; Liu, Jinfeng/0000-0002-0343-8222				Bardelli A, 1997, ONCOGENE, V15, P3103, DOI 10.1038/sj.onc.1201561; Chan EL, 2005, ONCOGENE, V24, P479, DOI 10.1038/sj.onc.1208231; Cowin AJ, 2001, CELL TISSUE RES, V306, P239, DOI 10.1007/s004410100443; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; Eulenfeld R, 2009, J CELL SCI, V122, P55, DOI 10.1242/jcs.037226; FIXMAN ED, 1995, ONCOGENE, V10, P237; Fixman ED, 1996, J BIOL CHEM, V271, P13116, DOI 10.1074/jbc.271.22.13116; Fixman ED, 1997, J BIOL CHEM, V272, P20167, DOI 10.1074/jbc.272.32.20167; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; GAUDINO G, 1994, EMBO J, V13, P3524, DOI 10.1002/j.1460-2075.1994.tb06659.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giordano S, 1997, P NATL ACAD SCI USA, V94, P13868, DOI 10.1073/pnas.94.25.13868; Haber DA, 2007, NATURE, V446, P145, DOI 10.1038/446145a; Harris TJR, 2010, NAT REV CLIN ONCOL, V7, P251, DOI 10.1038/nrclinonc.2010.41; HolgadoMadruga M, 1996, NATURE, V379, P560, DOI 10.1038/379560a0; HUFF JL, 1993, P NATL ACAD SCI USA, V90, P6140, DOI 10.1073/pnas.90.13.6140; Kiyatkin A, 2006, J BIOL CHEM, V281, P19925, DOI 10.1074/jbc.M600482200; Kondo A, 2008, J BIOL CHEM, V283, P1428, DOI 10.1074/jbc.M704999200; Kretschmann KL, 2010, CURR DRUG TARGETS, V11, P1157; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Leonard E J, 1979, Adv Exp Med Biol, V121B, P181; Lew ED, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000021; Lock LS, 2003, J BIOL CHEM, V278, P30083, DOI 10.1074/jbc.M302675200; Lock LS, 2002, MOL BIOL CELL, V13, P2132, DOI 10.1091/mbc.02-02-0031; Maroun CR, 2000, MOL CELL BIOL, V20, P8513, DOI 10.1128/MCB.20.22.8513-8525.2000; Maroun CR, 2003, MOL BIOL CELL, V14, P1691, DOI 10.1091/mbc.E02-06-0352; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matsumura I, 2008, CANCER SCI, V99, P479, DOI 10.1111/j.1349-7006.2007.00717.x; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; Morrison AC, 2004, J IMMUNOL, V172, P1825, DOI 10.4049/jimmunol.172.3.1825; Morrison AC, 2002, J IMMUNOL, V168, P853, DOI 10.4049/jimmunol.168.2.853; Nguyen L, 1997, J BIOL CHEM, V272, P20811, DOI 10.1074/jbc.272.33.20811; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Park CY, 1999, J BIOL CHEM, V274, P7583, DOI 10.1074/jbc.274.11.7583; PARK M, 1987, P NATL ACAD SCI USA, V84, P6379, DOI 10.1073/pnas.84.18.6379; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Pawson T, 2009, CURR OPIN CELL BIOL, V21, P147, DOI 10.1016/j.ceb.2009.02.005; Peace BE, 2005, CANCER RES, V65, P1285, DOI 10.1158/0008-5472.CAN-03-3580; Ponzetto C, 1996, J BIOL CHEM, V271, P14119, DOI 10.1074/jbc.271.24.14119; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; RONSIN C, 1993, ONCOGENE, V8, P1195; Rosario M, 2003, TRENDS CELL BIOL, V13, P328, DOI 10.1016/S0962-8924(03)00104-1; Sachs M, 2000, J CELL BIOL, V150, P1375, DOI 10.1083/jcb.150.6.1375; Saucier C, 2002, ONCOGENE, V21, P1800, DOI 10.1038/sj.onc.1205261; Schaeper U, 2000, J CELL BIOL, V149, P1419, DOI 10.1083/jcb.149.7.1419; Schaeper U, 2007, P NATL ACAD SCI USA, V104, P15376, DOI 10.1073/pnas.0702555104; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Seiden-Long I, 2008, CARCINOGENESIS, V29, P647, DOI 10.1093/carcin/bgn009; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Waltz SE, 2001, J CLIN INVEST, V108, P567, DOI 10.1172/JCI11881; Ward CW, 1996, J BIOL CHEM, V271, P5603, DOI 10.1074/jbc.271.10.5603; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Zhou YQ, 2003, ONCOGENE, V22, P186, DOI 10.1038/sj.onc.1206075; ZHU H, 1994, J BIOL CHEM, V269, P29943	58	22	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32762	32774		10.1074/jbc.M111.239384	http://dx.doi.org/10.1074/jbc.M111.239384			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784853	Green Published, hybrid			2022-12-25	WOS:000294726800084
J	Munkvik, M; Lunde, PK; Aronsen, JM; Birkeland, JAK; Sjaastad, I; Sejersted, OM				Munkvik, Morten; Lunde, Per Kristian; Aronsen, Jan Magnus; Birkeland, Jon Arne Kro; Sjaastad, Ivar; Sejersted, Ole M.			Attenuated Fatigue in Slow Twitch Skeletal Muscle during Isotonic Exercise in Rats with Chronic Heart Failure	PLOS ONE			English	Article							EXTENSOR DIGITORUM LONGUS; ISOMETRIC CONTRACTIONS; SHORTENING VELOCITY; SINGLE FIBERS; MOUSE MUSCLE; RELAXATION; METABOLISM; PHOSPHATE; PH; ABNORMALITIES	During isometric contractions, slow twitch soleus muscles (SOL) from rats with chronic heart failure (chf) are more fatigable than those of sham animals. However, a muscle normally shortens during activity and fatigue development is highly task dependent. Therefore, we examined the development of skeletal muscle fatigue during shortening (isotonic) contractions in chf and sham-operated rats. Six weeks following coronary artery ligation, infarcted animals were classified as failing (chf) if left ventricle end diastolic pressure was >15mmHg. During isoflurane anaesthesia, SOL with intact blood supply was stimulated (1s on 1s off) at 30Hz for 15 min and allowed to shorten isotonically against a constant afterload. Muscle temperature was maintained at 37 degrees C. In resting muscle, maximum isometric force (F-max) and the concentrations of ATP and CrP were not different in the two groups. During stimulation, F-max and the concentrations declined in parallel sham and chf. Fatigue, which was evident as reduced shortening during stimulation, was also not different in the two groups. The isometric force decline was fitted to a bi-exponential decay equation. Both time constants increased transiently and returned to initial values after approximately 200 s of the fatigue protocol. This resulted in a transient rise in baseline tension between stimulations, although this effect which was less prominent in chf than sham. Myosin light chain 2s phosphorylation declined in both groups after 100 s of isotonic contractions, and remained at this level throughout 15 min of stimulation. In spite of higher energy demand during isotonic than isometric contractions, both shortening capacity and rate of isometric force decline were as well or better preserved in fatigued SOL from chf rats than in sham. This observation is in striking contrast to previous reports which have employed isometric contractions to induce fatigue.	[Munkvik, Morten; Lunde, Per Kristian; Aronsen, Jan Magnus; Birkeland, Jon Arne Kro; Sjaastad, Ivar; Sejersted, Ole M.] Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway; [Munkvik, Morten; Lunde, Per Kristian; Aronsen, Jan Magnus; Birkeland, Jon Arne Kro; Sjaastad, Ivar; Sejersted, Ole M.] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Sjaastad, Ivar] Oslo Univ Hosp, Dept Cardiol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Munkvik, M (corresponding author), Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway.	o.m.sejersted@medisin.uio.no			Norwegian Foundation for Health and Rehabilitation; University of Oslo; Oslo University Hospital; Ulleval and Anders Jahre's fund for the Promotion of Science, Oslo, Norway	Norwegian Foundation for Health and Rehabilitation; University of Oslo; Oslo University Hospital; Ulleval and Anders Jahre's fund for the Promotion of Science, Oslo, Norway	The study was funded by grants from the Norwegian Foundation for Health and Rehabilitation, University of Oslo, Oslo University Hospital, Ulleval and Anders Jahre's fund for the Promotion of Science, Oslo, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; AMEREDES BT, 1992, J APPL PHYSIOL, V73, P2105, DOI 10.1152/jappl.1992.73.5.2105; Beltman JGM, 2004, ACTA PHYSIOL SCAND, V182, P179, DOI 10.1111/j.1365-201X.2004.01338.x; BRISTOW MR, 1982, NEW ENGL J MED, V307, P205, DOI 10.1056/NEJM198207223070401; CHASE PB, 1988, BIOPHYS J, V53, P935, DOI 10.1016/S0006-3495(88)83174-6; Cheng AJ, 2010, MED SCI SPORT EXER, V42, P1651, DOI 10.1249/MSS.0b013e3181d6c5b5; COOKE R, 1985, BIOPHYS J, V48, P789, DOI 10.1016/S0006-3495(85)83837-6; DANTZIG JA, 1992, J PHYSIOL-LONDON, V451, P247, DOI 10.1113/jphysiol.1992.sp019163; de Tombe PP, 2007, AM J PHYSIOL-REG I, V292, pR1129, DOI 10.1152/ajpregu.00630.2006; Fitts RH, 2008, J APPL PHYSIOL, V104, P551, DOI 10.1152/japplphysiol.01200.2007; Hamdani N, 2008, CARDIOVASC RES, V77, P649, DOI 10.1093/cvr/cvm079; Harrington D, 1997, EUR HEART J, V18, P1865; HASTIE T, 2009, SPRINGER SERIES STAT; HENNIG R, 1985, NATURE, V314, P164, DOI 10.1038/314164a0; Hettrick DA, 1996, ANESTHESIOLOGY, V85, P403, DOI 10.1097/00000542-199608000-00023; Karatzaferi C, 2008, AM J PHYSIOL-REG I, V294, pR948, DOI 10.1152/ajpregu.00541.2007; Kemp GJ, 1996, HEART, V76, P35, DOI 10.1136/hrt.76.1.35; Knuth ST, 2006, J PHYSIOL-LONDON, V575, P887, DOI 10.1113/jphysiol.2006.106732; LAMB GD, 1992, J PHYSIOL-LONDON, V448, P211, DOI 10.1113/jphysiol.1992.sp019037; Lowry O. H., 1972, FLEXIBLE SYSTEM ENZY, P146; Lunde PK, 2006, CIRC RES, V98, P1514, DOI 10.1161/01.RES.0000226529.66545.e5; Lunde PK, 2002, J PHYSIOL-LONDON, V540, P571, DOI 10.1113/jphysiol.2001.013324; Macdonald WA, 2001, J PHYSIOL-LONDON, V532, P499, DOI 10.1111/j.1469-7793.2001.0499f.x; MANCINI DM, 1992, CIRCULATION, V85, P1364, DOI 10.1161/01.CIR.85.4.1364; Mark Allyn L., 1995, Clinical Cardiology, V18, pI3; MCMAHON AT, 1984, MUSCLES REFLEXES LOC; MINOTTI JR, 1992, CHEST, V101, pS333; MOORE RL, 1984, AM J PHYSIOL, V247, pC462, DOI 10.1152/ajpcell.1984.247.5.C462; Mulligan IP, 1999, PFLUG ARCH EUR J PHY, V437, P393, DOI 10.1007/s004240050793; Munkvik M, 2010, MED SCI SPORT EXER, V42, P847, DOI 10.1249/MSS.0b013e3181c29ec1; Munkvik M, 2009, AM J PHYSIOL-REG I, V297, pR900, DOI 10.1152/ajpregu.91043.2008; Pedersen TH, 2004, SCIENCE, V305, P1144, DOI 10.1126/science.1101141; Potma EJ, 1996, J PHYSIOL-LONDON, V496, P1; Roots H, 2009, J APPL PHYSIOL, V106, P378, DOI 10.1152/japplphysiol.90883.2008; Schaufelberger M, 1996, HEART, V76, P29, DOI 10.1136/hrt.76.1.29; SELLEVOLD OFM, 1986, J MOL CELL CARDIOL, V18, P517, DOI 10.1016/S0022-2828(86)80917-8; Simonini A, 1996, J MOL CELL CARDIOL, V28, P1683, DOI 10.1006/jmcc.1996.0158; Sjaastad I, 2003, ACTA PHYSIOL SCAND, V177, P449, DOI 10.1046/j.1365-201X.2003.01063.x; Sjaastad I, 2000, J APPL PHYSIOL, V89, P1445, DOI 10.1152/jappl.2000.89.4.1445; Slettalokken G, 2012, SCAND J MED SCI SPOR, V22, P199, DOI 10.1111/j.1600-0838.2010.01226.x; Solaro RJ, 2008, CARDIOVASC RES, V77, P616, DOI 10.1093/cvr/cvn004; Soukup T, 2002, ACTA HISTOCHEM, V104, P399, DOI 10.1078/0065-1281-00660; SULLIVAN MJ, 1991, CIRCULATION, V84, P1597, DOI 10.1161/01.CIR.84.4.1597; Sweeney HL, 2004, PHILOS T R SOC B, V359, P1829, DOI 10.1098/rstb.2004.1576; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; THOMPSON CH, 1994, CLIN SCI, V87, P403, DOI 10.1042/cs0870403; Thorud HMS, 2004, ACTA PHYSIOL SCAND, V181, P173, DOI 10.1111/j.1365-201X.2004.01285.x; Tonnessen T, 1997, CARDIOVASC RES, V33, P601, DOI 10.1016/S0008-6363(96)00266-0; Vedsted P, 2003, ACTA PHYSIOL SCAND, V178, P175, DOI 10.1046/j.1365-201X.2003.01123.x; Ventura-Clapier R, 2004, J PHYSIOL-LONDON, V555, P1, DOI 10.1113/jphysiol.2003.055095; Vollestad NK, 1997, J APPL PHYSIOL, V83, P1557; VOLLESTAD NK, 1990, J APPL PHYSIOL, V68, P1150, DOI 10.1152/jappl.1990.68.3.1150; WESTERBLAD H, 1991, J PHYSIOL-LONDON, V434, P323, DOI 10.1113/jphysiol.1991.sp018472; WESTERBLAD H, 1993, J PHYSIOL-LONDON, V468, P729, DOI 10.1113/jphysiol.1993.sp019797; WESTERBLAD H, 1993, J PHYSIOL-LONDON, V466, P611; Westerblad H, 1998, ACTA PHYSIOL SCAND, V162, P253, DOI 10.1046/j.1365-201X.1998.0301f.x; Zhi G, 2005, P NATL ACAD SCI USA, V102, P17519, DOI 10.1073/pnas.0506846102	57	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22695	10.1371/journal.pone.0022695	http://dx.doi.org/10.1371/journal.pone.0022695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799933	Green Submitted, Green Published, gold			2022-12-25	WOS:000293172900067
J	Pettersson, US; Christoffersson, G; Massena, S; Ahl, D; Jansson, L; Henriksnas, J; Phillipson, M				Pettersson, Ulrika Sofia; Christoffersson, Gustaf; Massena, Sara; Ahl, David; Jansson, Leif; Henriksnas, Johanna; Phillipson, Mia			Increased Recruitment but Impaired Function of Leukocytes during Inflammation in Mouse Models of Type 1 and Type 2 Diabetes	PLOS ONE			English	Article							ENDOTHELIAL INTERACTION; INSULIN-RESISTANCE; ADHESION; EMIGRATION; NEUTROPHILS; DYSFUNCTION; EXPRESSION; GENERATION; INFECTION; MELLITUS	Background: Patients suffering from diabetes show defective bacterial clearance. This study investigates the effects of elevated plasma glucose levels during diabetes on leukocyte recruitment and function in established models of inflammation. Methodology/Principal Findings: Diabetes was induced in C57Bl/6 mice by intravenous alloxan (causing severe hyperglycemia), or by high fat diet (moderate hyperglycemia). Leukocyte recruitment was studied in anaesthetized mice using intravital microscopy of exposed cremaster muscles, where numbers of rolling, adherent and emigrated leukocytes were quantified before and during exposure to the inflammatory chemokine MIP-2 (0.5 nM). During basal conditions, prior to addition of chemokine, the adherent and emigrated leukocytes were increased in both alloxan-(62 +/- 18% and 85 +/- 21%, respectively) and high fat diet-induced (77 +/- 25% and 86 +/- 17%, respectively) diabetes compared to control mice. MIP-2 induced leukocyte emigration in all groups, albeit significantly more cells emigrated in alloxan-treated mice (15.3 +/- 1.0) compared to control (8.0 +/- 1.1) mice. Bacterial clearance was followed for 10 days after subcutaneous injection of bioluminescent S. aureus using non-invasive IVIS imaging, and the inflammatory response was assessed by Myeloperoxidase-ELISA and confocal imaging. The phagocytic ability of leukocytes was assessed using LPS-coated fluorescent beads and flow cytometry. Despite efficient leukocyte recruitment, alloxan-treated mice demonstrated an impaired ability to clear bacterial infection, which we found correlated to a 50% decreased phagocytic ability of leukocytes in diabetic mice. Conclusions/Significance: These results indicate that reduced ability to clear bacterial infections observed during experimentally induced diabetes is not due to reduced leukocyte recruitment since sustained hyperglycemia results in increased levels of adherent and emigrated leukocytes in mouse models of type 1 and type 2 diabetes. Instead, decreased phagocytic ability observed for leukocytes isolated from diabetic mice might account for the impaired bacterial clearance.	[Pettersson, Ulrika Sofia; Christoffersson, Gustaf; Massena, Sara; Ahl, David; Jansson, Leif; Henriksnas, Johanna; Phillipson, Mia] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	Uppsala University	Pettersson, US (corresponding author), Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.	Mia.phillipson@mcb.uu.se	Christoffersson, Gustaf/ABC-7939-2020; Christoffersson, Gustaf/I-3756-2012	Christoffersson, Gustaf/0000-0002-9640-9702; Phillipson, Mia/0000-0002-2387-0266	Swedish Medical Research Council [57X-20675]; Royal Swedish Academy of Sciences; Swedish Diabetes Foudation [DIA2010-063]; Magnus Bergvalls Foundation; Swedish Society for Medical Research; Lars Hiertas Foundation; Harald and Greta Jeanssons Foundation; Family Ernfors Foundation	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Royal Swedish Academy of Sciences; Swedish Diabetes Foudation; Magnus Bergvalls Foundation; Swedish Society for Medical Research; Lars Hiertas Foundation; Harald and Greta Jeanssons Foundation; Family Ernfors Foundation	This study was supported by grants from the Swedish Medical Research Council (57X-20675), the Royal Swedish Academy of Sciences, Swedish Diabetes Foudation (DIA2010-063), Magnus Bergvalls Foundation, the Swedish Society for Medical Research, Lars Hiertas Foundation, Harald and Greta Jeanssons Foundation, and the Family Ernfors Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Bohman S, 2008, BIOCHEM BIOPH RES CO, V377, P729, DOI 10.1016/j.bbrc.2008.10.059; Calhoun Jason H, 2002, Adv Skin Wound Care, V15, P31, DOI 10.1097/00129334-200201000-00011; Cara DC, 2001, J IMMUNOL, V167, P6552, DOI 10.4049/jimmunol.167.11.6552; Cruz JWMC, 2000, EUR J PHARMACOL, V391, P163, DOI 10.1016/S0014-2999(00)00057-1; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; FORTES ZB, 1991, DIABETES, V40, P1267, DOI 10.2337/diabetes.40.10.1267; FREEDMAN SF, 1992, EXP EYE RES, V55, P767, DOI 10.1016/0014-4835(92)90181-Q; Gupta A, 2007, INDIAN J BIOCHEM BIO, V44, P373; Hadi HAR, 2007, VASC HEALTH RISK MAN, V3, P853; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Jakelic J, 1995, Med Arh, V49, P9; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; Mohanty P, 2000, J CLIN ENDOCR METAB, V85, P2970, DOI 10.1210/jc.85.8.2970; Panes J, 1996, CIRCULATION, V93, P161, DOI 10.1161/01.CIR.93.1.161; Petri B, 2008, J IMMUNOL, V180, P6439, DOI 10.4049/jimmunol.180.10.6439; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Ptak W, 1998, CLIN EXP IMMUNOL, V114, P13; RAYFIELD EJ, 1982, AM J MED, V72, P439, DOI 10.1016/0002-9343(82)90511-3; RERUP C, 1969, EUR J PHARMACOL, V7, P89, DOI 10.1016/0014-2999(69)90169-1; Rich J, 2005, DIABETES, V54, P2904, DOI 10.2337/diabetes.54.10.2904; Sampson MJ, 2002, ARTERIOSCL THROM VAS, V22, P1187, DOI 10.1161/01.ATV.0000021759.08060.63; Sannomiya P, 1997, BRIT J PHARMACOL, V122, P894, DOI 10.1038/sj.bjp.0701448; SHAHIN RD, 1987, J IMMUNOL, V138, P3475; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sjoholm A, 2006, DIABETES-METAB RES, V22, P4, DOI 10.1002/dmrr.568; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; WHEAT LJ, 1980, DIABETES CARE, V3, P187, DOI 10.2337/diacare.3.1.187; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	33	35	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22480	10.1371/journal.pone.0022480	http://dx.doi.org/10.1371/journal.pone.0022480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799868	Green Published, gold, Green Submitted			2022-12-25	WOS:000293172900037
J	Peng, Y; Ang, M; Foo, S; Lee, WS; Ma, Z; Venkatraman, SS; Wong, TT				Peng, Yan; Ang, Marcus; Foo, Selin; Lee, Wing Sum; Ma, Zhen; Venkatraman, Subbu S.; Wong, Tina T.			Biocompatibility and Biodegradation Studies of Subconjunctival Implants in Rabbit Eyes	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; OCULAR DRUG-DELIVERY; ANTERIOR SEGMENT; BETAMETHASONE PHOSPHATE; INTRAOCULAR DELIVERY; SUSTAINED DELIVERY; CONTROLLED-RELEASE; PLGA NANOSPHERES; POLYMER; PHARMACOKINETICS	Sustained ocular drug delivery is difficult to achieve. Most drugs have poor penetration due to the multiple physiological barriers of the eye and are rapidly cleared if applied topically. Biodegradable subconjunctival implants with controlled drug release may circumvent these two problems. In our study, two microfilms (poly [d, l-lactide-co-glycolide] PLGA and poly[d,l-lactide-co-caprolactone] PLC were developed and evaluated for their degradation behavior in vitro and in vivo. We also evaluated the biocompatibility of both microfilms. Eighteen eyes (9 rabbits) were surgically implanted with one type of microfilm in each eye. Serial anterior-segment optical coherence tomography (AS-OCT) scans together with serial slit-lamp microscopy allowed us to measure thickness and cross-sectional area of the microfilms. In vitro studies revealed bulk degradation kinetics for both microfilms, while in vivo studies demonstrated surface erosion kinetics. Serial slit-lamp microscopy revealed no significant inflammation or vascularization in both types of implants (mean increase in vascularity grade PLGA50/50 12 +/- 0.5% vs. PLC70/30 15 +/- 0.6%; P = 0.91) over a period of 6 months. Histology, immunohistochemistry and immuno-fluorescence also revealed no significant inflammatory reaction from either of the microfilms, which confirmed that both microfilms are biocompatible. The duration of the drug delivery can be tailored by selecting the materials, which have different degradation kinetics, to suit the desired clinical therapeutic application.	[Peng, Yan; Venkatraman, Subbu S.; Wong, Tina T.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore, Singapore; [Ang, Marcus; Lee, Wing Sum; Wong, Tina T.] Singapore Natl Eye Ctr, Singapore, Singapore; [Ang, Marcus; Foo, Selin; Ma, Zhen; Wong, Tina T.] Singapore Eye Res Inst, Singapore, Singapore; [Wong, Tina T.] Natl Univ Singapore, Dept Ophthalmol, Yong Yoo Lin Sch Med, Singapore 117548, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore National Eye Center; National University of Singapore; Singapore National Eye Center; National University of Singapore	Peng, Y (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore, Singapore.	assubbu@ntu.edu.sg; tina.wong.t.l@snec.com.sg	Venkatraman, Subramanian/A-2228-2011	Venkatraman, Subramanian/0000-0002-8693-1070	National Research Foundation [NMRC/TCR/002 - SERI/2008 - TCR 621/41/2008]	National Research Foundation	This work was supported by National Research Foundation-Funded Translational & Clinical Research (TCR) Programme Grant [NMRC/TCR/002 - SERI/2008 - TCR 621/41/2008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri SM, 2009, NANOMED-NANOTECHNOL, V5, P90, DOI 10.1016/j.nano.2008.07.003; Ali Y, 2006, ADV DRUG DELIVER REV, V58, P1258, DOI 10.1016/j.addr.2006.07.022; Araujo J, 2009, COLLOID SURFACE B, V72, P48, DOI 10.1016/j.colsurfb.2009.03.028; Barar J, 2008, EXPERT OPIN DRUG DEL, V5, P567, DOI 10.1517/17425247.5.5.567 ; Barbu E, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/22/225108; Beeley NRF, 2006, J BIOMED MATER RES A, V76A, P690, DOI 10.1002/jbm.a.30567; Beeley NRF, 2005, J BIOMED MATER RES A, V73A, P437, DOI 10.1002/jbm.a.30294; Duong-Hong D, 2010, CATHETER CARDIO INTE, V76, P711, DOI 10.1002/ccd.22735; Frank A, 2005, J CONTROL RELEASE, V102, P333, DOI 10.1016/j.jconrel.2004.10.019; Gaudana R, 2009, PHARM RES-DORDR, V26, P1197, DOI 10.1007/s11095-008-9694-0; Ghate Deepta, 2006, Expert Opin Drug Deliv, V3, P275, DOI 10.1517/17425247.3.2.275; GIORDANO GG, 1993, INVEST OPHTH VIS SCI, V34, P2743; HITCHINGS RA, 1983, T OPHTHAL SOC UK, V103, P84; Houchin ML, 2008, J PHARM SCI-US, V97, P2395, DOI 10.1002/jps.21176; Hughes PM, 2005, ADV DRUG DELIVER REV, V57, P2010, DOI 10.1016/j.addr.2005.09.004; Jaffe GJ, 2000, INVEST OPHTH VIS SCI, V41, P3569; Kato A, 2004, INVEST OPHTH VIS SCI, V45, P238, DOI 10.1167/iovs.02-1258; Kim H, 2004, INVEST OPHTH VIS SCI, V45, P2722, DOI 10.1167/iovs.04-0091; Koevary SB, 2003, CURR DRUG METAB, V4, P213, DOI 10.2174/1389200033489488; Kreuter J, 1996, J ANAT, V189, P503; KREUTER J, 1995, J DRUG TARGET, V3, P171, DOI 10.3109/10611869509015940; Kunou N, 2000, J BIOMED MATER RES, V51, P635, DOI 10.1002/1097-4636(20000915)51:4<635::AID-JBM11>3.0.CO;2-O; Lewis KJ, 1998, J DRUG TARGET, V5, P291, DOI 10.3109/10611869808995882; Loo SCJ, 2008, INT J PHARMACEUT, V360, P228, DOI 10.1016/j.ijpharm.2008.04.017; Munger RJ, 2002, VET OPHTHALMOL, V5, P167, DOI 10.1046/j.1463-5224.2002.00243.x; Nomoto H, 2009, INVEST OPHTH VIS SCI, V50, P4807, DOI 10.1167/iovs.08-3148; Okabe J, 2003, INVEST OPHTH VIS SCI, V44, P740, DOI 10.1167/iovs.02-0375; Okabe K, 2003, INVEST OPHTH VIS SCI, V44, P2702, DOI 10.1167/iovs.02-0956; Ramos JLB, 2009, CLIN EXP OPHTHALMOL, V37, P81, DOI 10.1111/j.1442-9071.2008.01823.x; Singh M, 2007, OPHTHALMOLOGY, V114, P47, DOI 10.1016/j.ophtha.2006.05.078; Singh M, 2009, CLIN EXP OPHTHALMOL, V37, P345, DOI 10.1111/j.1442-9071.2009.02066.x; Souto EB, 2010, CURR EYE RES, V35, P537, DOI 10.3109/02713681003760168; Vega E, 2008, J PHARM SCI-US, V97, P5306, DOI 10.1002/jps.21383; Wang XT, 2006, BIOMATERIALS, V27, P5588, DOI 10.1016/j.biomaterials.2006.07.016; Weijtens O, 1999, AM J OPHTHALMOL, V128, P192, DOI 10.1016/S0002-9394(99)00129-4; Wells AP, 2004, J GLAUCOMA, V13, P454, DOI 10.1097/00061198-200412000-00005; Zhang WS, 2004, J CONTROL RELEASE, V99, P241, DOI 10.1016/j.jconrel.2004.07.001	37	42	46	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22507	10.1371/journal.pone.0022507	http://dx.doi.org/10.1371/journal.pone.0022507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799878	Green Published, gold, Green Submitted			2022-12-25	WOS:000293097300056
J	Ying, XM; Cao, Y; Wu, JY; Liu, Q; Cha, L; Li, WJ				Ying, Xiaomin; Cao, Yuan; Wu, Jiayao; Liu, Qian; Cha, Lei; Li, Wuju			sTarPicker: A Method for Efficient Prediction of Bacterial sRNA Targets Based on a Two-Step Model for Hybridization	PLOS ONE			English	Article							SMALL NONCODING RNAS; SITE ACCESSIBILITY; MICRORNA; SIRNA; CONSTRUCTION; TOOL; HFQ	Background: Bacterial sRNAs are a class of small regulatory RNAs involved in regulation of expression of a variety of genes. Most sRNAs act in trans via base-pairing with target mRNAs, leading to repression or activation of translation or mRNA degradation. To date, more than 1,000 sRNAs have been identified. However, direct targets have been identified for only approximately 50 of these sRNAs. Computational predictions can provide candidates for target validation, thereby increasing the speed of sRNA target identification. Although several methods have been developed, target prediction for bacterial sRNAs remains challenging. Results: Here, we propose a novel method for sRNA target prediction, termed sTarPicker, which was based on a two-step model for hybridization between an sRNA and an mRNA target. This method first selects stable duplexes after screening all possible duplexes between the sRNA and the potential mRNA target. Next, hybridization between the sRNA and the target is extended to span the entire binding site. Finally, quantitative predictions are produced with an ensemble classifier generated using machine-learning methods. In calculations to determine the hybridization energies of seed regions and binding regions, both thermodynamic stability and site accessibility of the sRNAs and targets were considered. Comparisons with the existing methods showed that sTarPicker performed best in both performance of target prediction and accuracy of the predicted binding sites. Conclusions: sTarPicker can predict bacterial sRNA targets with higher efficiency and determine the exact locations of the interactions with a higher accuracy than competing programs. sTarPicker is available at http://ccb.bmi.ac.cn/starpicker/.	[Ying, Xiaomin; Wu, Jiayao; Liu, Qian; Cha, Lei; Li, Wuju] Beijing Inst Basic Med Sci, Ctr Computat Biol, Beijing, Peoples R China; [Cao, Yuan] 90th Hosp Jinan, Dept Clin Lab, Jinan, Shandong, Peoples R China	Academy of Military Medical Sciences - China	Ying, XM (corresponding author), Beijing Inst Basic Med Sci, Ctr Computat Biol, Beijing, Peoples R China.	liwj@nic.bmi.ac.cn	Li, Wu/AHA-4320-2022	/0000-0002-2681-8711; Li, Wuju/0000-0003-4613-9692	National Natural Science Foundation of China [31071157]; National Key Basic Research and Development Program [2010CB912801]; Chinese Key Project for the Infectious Diseases [2008ZX10002-016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program(National Basic Research Program of China); Chinese Key Project for the Infectious Diseases	This work was supported by grants from the National Natural Science Foundation of China (31071157, http://www.nsfc.gov.cn/Portal0/default106.htm), the National Key Basic Research and Development Program (2010CB912801, http://www.973.gov.cn/English/Index.aspx), and the Chinese Key Project for the Infectious Diseases (2008ZX10002-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2006, J COMPUT BIOL, V13, P267, DOI 10.1089/cmb.2006.13.267; Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Busch A, 2008, BIOINFORMATICS, V24, P2849, DOI 10.1093/bioinformatics/btn544; Cao YA, 2010, RNA, V16, P2051, DOI 10.1261/rna.2193110; Cao Y, 2009, BIOINFORMATION, V3, P364, DOI 10.6026/97320630003364; Far RKK, 2003, NUCLEIC ACIDS RES, V31, P4417, DOI 10.1093/nar/gkg649; Gerlach W, 2006, BIOINFORMATICS, V22, P762, DOI 10.1093/bioinformatics/btk041; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guillier M, 2006, MOL MICROBIOL, V59, P231, DOI 10.1111/j.1365-2958.2005.04929.x; Huang HY, 2009, NUCLEIC ACIDS RES, V37, pD150, DOI 10.1093/nar/gkn852; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Koberle C, 2006, NAT PROTOC, V1, P1832, DOI 10.1038/nprot.2006.206; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lenz DH, 2005, MOL MICROBIOL, V58, P1186, DOI 10.1111/j.1365-2958.2005.04902.x; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Lu ZJ, 2008, NUCLEIC ACIDS RES, V36, P640, DOI 10.1093/nar/gkm920; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; Muckstein U, 2008, COMM COM INF SC, V13, P114; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Richter AS, 2010, BIOINFORMATICS, V26, P1, DOI 10.1093/bioinformatics/btp609; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Schubert S, 2005, J MOL BIOL, V348, P883, DOI 10.1016/j.jmb.2005.03.011; Shao Y, 2007, RNA, V13, P1631, DOI 10.1261/rna.546207; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Storz G, 2004, CURR OPIN MICROBIOL, V7, P140, DOI 10.1016/j.mib.2004.02.015; Sun XG, 2002, NUCLEIC ACIDS RES, V30, P3662, DOI 10.1093/nar/gkf508; Tafer H, 2008, BIOINFORMATICS, V24, P2657, DOI 10.1093/bioinformatics/btn193; Tjaden B, 2008, NUCLEIC ACIDS RES, V36, pW109, DOI 10.1093/nar/gkn264; Tjaden B, 2006, NUCLEIC ACIDS RES, V34, P2791, DOI 10.1093/nar/gkl356; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Tu KC, 2007, GENE DEV, V21, P221, DOI 10.1101/gad.1502407; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Vogel J, 2005, BIOL CHEM, V386, P1219, DOI 10.1515/BC.2005.140; Wu BL, 2007, BIOCHEM BIOPH RES CO, V354, P498, DOI 10.1016/j.bbrc.2007.01.002; Wuju L, 2002, BIOINFORMATICS, V18, P325, DOI 10.1093/bioinformatics/18.2.325; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Zhang Y, 2006, BIOCHEM BIOPH RES CO, V343, P950, DOI 10.1016/j.bbrc.2006.02.196; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao YL, 2008, BIOCHEM BIOPH RES CO, V372, P346, DOI 10.1016/j.bbrc.2008.05.046	42	35	39	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22705	10.1371/journal.pone.0022705	http://dx.doi.org/10.1371/journal.pone.0022705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799937	Green Published, Green Submitted, gold			2022-12-25	WOS:000293097300081
J	Bowers, JS; Pleydell-Pearce, CW				Bowers, Jeffrey S.; Pleydell-Pearce, Christopher W.			Swearing, Euphemisms, and Linguistic Relativity	PLOS ONE			English	Article							LANGUAGE; HYPOTHESIS; THINKING; THOUGHT	Participants read aloud swear words, euphemisms of the swear words, and neutral stimuli while their autonomic activity was measured by electrodermal activity. The key finding was that autonomic responses to swear words were larger than to euphemisms and neutral stimuli. It is argued that the heightened response to swear words reflects a form of verbal conditioning in which the phonological form of the word is directly associated with an affective response. Euphemisms are effective because they replace the trigger (the offending word form) by another word form that expresses a similar idea. That is, word forms exert some control on affect and cognition in turn. We relate these findings to the linguistic relativity hypothesis, and suggest a simple mechanistic account of how language may influence thinking in this context.	[Bowers, Jeffrey S.; Pleydell-Pearce, Christopher W.] Univ Bristol, Dept Expt Psychol, Bristol, Avon, England	University of Bristol	Bowers, JS (corresponding author), Univ Bristol, Dept Expt Psychol, Bristol, Avon, England.	j.bowers@bris.ac.uk		Bowers, Jeffrey/0000-0001-9558-5010				Bloom P, 2001, MIND LANG, V16, P351, DOI 10.1111/1468-0017.00175; BOND MH, 1986, J SOC PSYCHOL, V126, P179; Boroditsky L, 2001, COGNITIVE PSYCHOL, V43, P1, DOI 10.1006/cogp.2001.0748; Boroditsky L., 2006, ENCY COGNITIVE SCI, P917, DOI DOI 10.1002/0470018860.500567; Boroditsky L, 2010, PSYCHOL SCI, V21, P1635, DOI 10.1177/0956797610386621; Brown P., 1978, POLITENESS SOME UNIV; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; Damian MF, 2001, J EXP PSYCHOL HUMAN, V27, P154, DOI 10.1037/0096-1523.27.1.154; de Divitiis E, 1977, Acta Neurochir (Wien), P73; Dewaele J.-M., 2004, J MULTILING MULTICUL, V25, P204; Fausey CM, 2010, PSYCHON B REV, V17, P644, DOI 10.3758/PBR.17.5.644; FERENCZI S, 1916, CONTRIBUTIONS PSYCHO; Gilbert AL, 2006, P NATL ACAD SCI USA, V103, P489, DOI 10.1073/pnas.0509868103; GonzalezReigosa F., 1976, CROSS CULTURAL ANXIE, P89; Greenson RR, 1950, INT J PSYCHOANAL, V31, P18; Harris CL, 2003, APPL PSYCHOLINGUIST, V24, P561, DOI 10.1017/S0142716403000286; Hudson, 1980, SOCIOLINGUISTICS; HUNT E, 1991, PSYCHOL REV, V98, P377, DOI 10.1037/0033-295X.98.3.377; Javier R.A, 1989, PSYCHOANAL PSYCHOL, V6, P87, DOI DOI 10.1037/0736-9735.6.1.87; KWOK H, 1972, GEN LINGUIST, V12, P63; LAZARUS RS, 1982, AM PSYCHOL, V37, P1019, DOI 10.1037/0003-066X.37.9.1019; LeDoux J.E., 1989, COGNITION EMOTION, V3, P267, DOI [10.1080/02699938908412709, DOI 10.1080/02699938908412709]; Lee JJ, 2010, PSYCHOL REV, V117, P785, DOI 10.1037/a0019688; Levelt, 1993, SPEAKING INTENTION A; Levinson SC, 2002, COGNITION, V84, P155, DOI 10.1016/S0010-0277(02)00045-8; Li P, 2002, COGNITION, V83, P265, DOI 10.1016/S0010-0277(02)00009-4; Liberzon I, 2000, NEUROPSYCHOPHARMACOL, V23, P508, DOI 10.1016/S0893-133X(00)00157-3; Lim CL, 1997, INT J PSYCHOPHYSIOL, V25, P97, DOI 10.1016/S0167-8760(96)00713-1; Majid A, 2004, TRENDS COGN SCI, V8, P108, DOI 10.1016/j.tics.2004.01.003; McGlone MS, 2003, J COMMUN, V53, P251, DOI 10.1093/joc/53.2.251; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; PILGER J, 1998, HIDDEN AGENDAS; Pinker Steven, 1994, LANGUAGE INSTINCT; Ramscar M, 2010, LANG COGNITIVE PROC, V25, P589, DOI 10.1080/01690960903381166; Roberson D, 2000, J EXP PSYCHOL GEN, V129, P369, DOI 10.1037//0096-3445.129.3.369; ROBERTSON M, 1990, J NEUROL NEUROSUR PS, V53, P691, DOI 10.1136/jnnp.53.8.691; ROBINSON BW, 1976, ANN NY ACAD SCI, V280, P761, DOI 10.1111/j.1749-6632.1976.tb25539.x; Slobin D., 1987, P 13 ANN M BERK LING, V13, P435; Slobin DI, 2003, BRADFORD BOOKS, P157; TAILARACH J, 1973, ELECTROENCEPHALOGR C, V34, P45; Van Lancker D, 1999, BRAIN RES REV, V31, P83, DOI 10.1016/S0165-0173(99)00060-0; Widdowson H., 1990, ASPECTS LANGUAGE TEA; ZAJONC RB, 1984, AM PSYCHOL, V39, P117, DOI 10.1037/0003-066X.39.2.117; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	45	29	29	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22341	10.1371/journal.pone.0022341	http://dx.doi.org/10.1371/journal.pone.0022341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	794WE	21799832	Green Published, gold, Green Submitted			2022-12-25	WOS:000292931200049
J	Patterson, EM; Mann, J				Patterson, Eric M.; Mann, Janet			The Ecological Conditions That Favor Tool Use and Innovation in Wild Bottlenose Dolphins (Tursiops sp.)	PLOS ONE			English	Article							ACOUSTIC TARGET STRENGTH; SWIM-BLADDER; PREY DETECTION; LIVE FISH; SWIMBLADDER; EVOLUTION; BEHAVIOR; SCATTERING; PRIMATES; CULTURE	Dolphins are well known for their exquisite echolocation abilities, which enable them to detect and discriminate prey species and even locate buried prey. While these skills are widely used during foraging, some dolphins use tools to locate and extract prey. In the only known case of tool use in free-ranging cetaceans, a subset of bottlenose dolphins (Tursiops sp.) in Shark Bay, Western Australia habitually employs marine basket sponge tools to locate and ferret prey from the seafloor. While it is clear that sponges protect dolphins' rostra while searching for prey, it is still not known why dolphins probe the substrate at all instead of merely echolocating for buried prey as documented at other sites. By 'sponge foraging' ourselves, we show that these dolphins target prey that both lack swimbladders and burrow in a rubble-littered substrate. Delphinid echolocation and vision are critical for hunting but less effective on such prey. Consequently, if dolphins are to access this burrowing, swimbladderless prey, they must probe the seafloor and in turn benefit from using protective sponges. We suggest that these tools have allowed sponge foraging dolphins to exploit an empty niche inaccessible to their non-tool-using counterparts. Our study identifies the underlying ecological basis of dolphin tool use and strengthens our understanding of the conditions that favor tool use and innovation in the wild.	[Patterson, Eric M.; Mann, Janet] Georgetown Univ, Dept Biol, Washington, DC 20057 USA	Georgetown University	Patterson, EM (corresponding author), Georgetown Univ, Dept Biol, Washington, DC 20057 USA.	emp46@georgetown.edu	Mann, Janet/L-2311-2019	Mann, Janet/0000-0003-0664-175X	National Geographic Society; Explorers Club Exploration Fund; National Science Foundation [0918303, 0847922, 0316800, OCE0526065]; Division Of Integrative Organismal Systems [0918308] Funding Source: National Science Foundation	National Geographic Society(National Geographic Society); Explorers Club Exploration Fund; National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support for this study was provided by The National Geographic Society Young Explorers Grant (http://www.nationalgeographic.com/field/grantsprograms/young-explorers/) and The Explorers Club Exploration Fund Grant (http://www.explorers.org/index.php/expeditions/funding/expedition_grants) to EMP and the National Science Foundation (http://www.nsf.gov/) 0918303, 0847922, 0316800 to JM. Field gear was supplied at discounted rates by Airline Supply by J. Sink (http://www.airlinebyjsink.com/) and Splash Dive Center of Alexandria, VA (http://www.splashdivecenter.com/). The orthophoto in Figure 2 was supported by NSF grant OCE0526065 to Dr. Mike Heithaus and DEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlettaz R, 2001, NATURE, V414, P742, DOI 10.1038/414742a; Au WWL, 2009, J ACOUST SOC AM, V126, P460, DOI 10.1121/1.3147497; Au WWL, 2004, AIP CONF PROC, V728, P247, DOI 10.1063/1.1843019; Bacher K, 2010, BEHAV GENET, V40, P706, DOI 10.1007/s10519-010-9375-8; BATTAGLENE SC, 1994, AQUACULTURE, V128, P177, DOI 10.1016/0044-8486(94)90112-0; Bentley-Condit VK, 2010, BEHAVIOUR, V147, P185, DOI 10.1163/000579509X12512865686555; Bird CD, 2009, P NATL ACAD SCI USA, V106, P10370, DOI 10.1073/pnas.0901008106; Boonman AM, 1998, BEHAV ECOL SOCIOBIOL, V44, P99, DOI 10.1007/s002650050521; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1053, DOI 10.1098/rstb.1996.0093; Cole RG, 2003, FISH RES, V60, P381, DOI 10.1016/S0165-7836(02)00133-9; COLLETTE B, 1986, P ACAD NAT SCI PHILA, P250; DENTON EJ, 1972, J MAR BIOL ASSOC UK, V52, P727, DOI 10.1017/S0025315400021676; dos Santos Manuel Eduardo, 2007, Revista Brasileira de Zoociencias, V9, P31; EDWARDS J, 1983, INT COUNC EXPLOR SEA, V23, P1; Edwards J.I., 1983, FAO FISH, V300, P69; Eleftheriou A., 2005, METHODS STUDY MARINE, V3rd ed, DOI DOI 10.1111/maec.12189; FANGE R, 1983, REV PHYSIOL BIOCH P, V97, P111, DOI 10.1007/BFb0035347; Fish M. P., 1970, SOUNDS W N ATLANTIC; FOOTE K G, 1985, Fiskeridirektoratets Skrifter Serie Havundersokelser, V18, P1; FOOTE KG, 1986, J CONSEIL, V42, P212; FOOTE KG, 1980, J ACOUST SOC AM, V67, P2084, DOI 10.1121/1.384452; Froese R, 2010, FISHBASE WORLD WIDE; GIBSON K, 1995, TOOLS LANGUAGE COGNI; Gibson K.R., 1986, P93; GODDARD GC, 1986, J CONSEIL, V42, P197; GREEN SL, 1984, CELL TISSUE RES, V237, P277, DOI 10.1007/BF00217146; Hansell M, 2008, TRENDS ECOL EVOL, V23, P73, DOI 10.1016/j.tree.2007.10.006; HASLETT RWG, 1962, P PHYS SOC LOND, V79, P559, DOI 10.1088/0370-1328/79/3/313; Herman LM., 2010, INT J COMP PSYCHOL, V23, P310; Hill JJ, 2004, METHODS ECOLOGICAL M; InoueNakamura N, 1997, J COMP PSYCHOL, V111, P159, DOI 10.1037/0735-7036.111.2.159; JONES FRH, 1953, BIOL REV, V28, P16, DOI 10.1111/j.1469-185X.1953.tb01370.x; Krutzen M, 2005, P NATL ACAD SCI USA, V102, P8939, DOI 10.1073/pnas.0500232102; LANCASTER JB, 1968, AM ANTHROPOL, V70, P56, DOI 10.1525/aa.1968.70.1.02a00060; Lefebvre L, 2004, BRAIN BEHAV EVOLUT, V63, P233, DOI 10.1159/000076784; Madsen PT, 2007, AQUAT BIOL, V1, P141, DOI 10.3354/ab00014; Mann Janet, 2003, P236, DOI 10.1017/CBO9780511584022.010; Mann J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003868; Matsuzawa T, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P3; MCCARTNEY BS, 1971, J SOUND VIB, V15, P397, DOI 10.1016/0022-460X(71)90433-0; McCosker JE, 2001, REV BIOL TROP, V49, P13; McCune AR, 2004, EVOL DEV, V6, P246, DOI 10.1111/j.1525-142X.2004.04030.x; McKay R.J., 1992, FAO SPECIES CATALOGU; MOORE P, 1997, P SOC PHOTO-OPT INS, P2; Moravec F, 2007, FOLIA PARASIT, V54, P293, DOI 10.14411/fp.2007.038; Norman J. R., 1975, HIST FISHES; ONA E, 1990, J MAR BIOL ASSOC UK, V70, P107, DOI 10.1017/S002531540003424X; Roitblat HL, 1995, NEURAL NETWORKS, V8, P1263, DOI 10.1016/0893-6080(95)00052-6; ROPER CFE, 1975, VERTICAL DISTRIBUTIO, P51; Rossbach KA, 1997, MAR MAMMAL SCI, V13, P498, DOI 10.1111/j.1748-7692.1997.tb00658.x; Rutz C, 2010, SCIENCE, V329, P1523, DOI 10.1126/science.1192053; Sargeant BL, 2007, BEHAV ECOL SOCIOBIOL, V61, P679, DOI 10.1007/s00265-006-0296-8; Schoning C, 2008, J HUM EVOL, V55, P48, DOI 10.1016/j.jhevol.2007.12.002; Seed A, 2010, CURR BIOL, V20, pR1032, DOI 10.1016/j.cub.2010.09.042; Sen SN., 1990, ACOUSTICS WAVES OSCI; Smolker R, 1997, ETHOLOGY, V103, P454, DOI 10.1111/j.1439-0310.1997.tb00160.x; Szczucka J, 2002, ACTA ACUST UNITED AC, V88, P735; Tebbich S, 2004, ANIM BEHAV, V67, P689, DOI 10.1016/j.anbehav.2003.08.003; Thomas JA, 2004, ECHOLOCATION BATS DO; Tominaga Y., 1996, POSTERIOR EXTENSION; Treasurer JW, 1997, J FISH BIOL, V50, P895, DOI 10.1006/jfbi.1996.0342; TURL CW, 1991, J ACOUST SOC AM, V89, P896, DOI 10.1121/1.1894651; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; Whitehead H, 2003, MAR MAMMAL SCI, V19, P400, DOI 10.1111/j.1748-7692.2003.tb01118.x; WITTENBERG JB, 1964, J GEN PHYSIOL, V48, P337, DOI 10.1085/jgp.48.2.337	65	52	52	5	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22243	10.1371/journal.pone.0022243	http://dx.doi.org/10.1371/journal.pone.0022243			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799801	Green Submitted, Green Published, gold			2022-12-25	WOS:000292931200037
J	Taube, C; Tertilt, C; Gyulveszi, G; Dehzad, N; Kreymborg, K; Schneeweiss, K; Michel, E; Reuter, S; Renauld, JC; Arnold-Schild, D; Schild, H; Buhl, R; Becher, B				Taube, Christian; Tertilt, Christine; Gyuelveszi, Gabor; Dehzad, Nina; Kreymborg, Katharina; Schneeweiss, Kristin; Michel, Erich; Reuter, Sebastian; Renauld, Jean-Christophe; Arnold-Schild, Danielle; Schild, Hansjoerg; Buhl, Roland; Becher, Burkhard			IL-22 Is Produced by Innate Lymphoid Cells and Limits Inflammation in Allergic Airway Disease	PLOS ONE			English	Article							ROR-GAMMA-T; ACTIVATION-REGULATED CHEMOKINE; EPITHELIAL-CELLS; INDUCIBLE FACTOR; NEGATIVE REGULATOR; IL-TIF; INTERLEUKIN-22; ASTHMA; CYTOKINE; EXPRESSION	Interleukin (IL)-22 is an effector cytokine, which acts primarily on epithelial cells in the skin, gut, liver and lung. Both pro- and anti-inflammatory properties have been reported for IL-22 depending on the tissue and disease model. In a murine model of allergic airway inflammation, we found that IL-22 is predominantly produced by innate lymphoid cells in the inflamed lungs, rather than TH cells. To determine the impact of IL-22 on airway inflammation, we used allergen-sensitized IL-22-deficient mice and found that they suffer from significantly higher airway hyperreactivity upon airway challenge. IL-22-deficiency led to increased eosinophil infiltration lymphocyte invasion and production of CCL17 (TARC), IL-5 and IL-13 in the lung. Mice treated with IL-22 before antigen challenge displayed reduced expression of CCL17 and IL-13 and significant amelioration of airway constriction and inflammation. We conclude that innate IL-22 limits airway inflammation, tissue damage and clinical decline in allergic lung disease.	[Taube, Christian; Dehzad, Nina; Reuter, Sebastian; Buhl, Roland] Johannes Gutenberg Univ Mainz, Med Clin 3, Mainz, Germany; [Tertilt, Christine; Schneeweiss, Kristin; Arnold-Schild, Danielle; Schild, Hansjoerg] Johannes Gutenberg Univ Mainz, Inst Immunol, D-6500 Mainz, Germany; [Tertilt, Christine] Johannes Gutenberg Univ Mainz, Dept Pediat, D-6500 Mainz, Germany; [Gyuelveszi, Gabor; Kreymborg, Katharina; Becher, Burkhard] Univ Zurich Hosp, Inst Expt Immunol, Dept Pathol, Neuroimmunol Div, CH-8091 Zurich, Switzerland; [Michel, Erich] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Renauld, Jean-Christophe] Catholic Univ Louvain, Ludwig Inst Canc Res Ltd, Expt Med Unit, B-1348 Louvain, Belgium	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; Ludwig Institute for Cancer Research; Universite Catholique Louvain	Taube, C (corresponding author), Johannes Gutenberg Univ Mainz, Med Clin 3, Mainz, Germany.	taube@3-med.klinik.uni-mainz.de; tertilt@kinder.klinik.uni-mainz.de	Reuter, Sebastian/L-1804-2013; Becher, Burkhard/ABE-4225-2020; Renauld, Jean-Christophe/B-7268-2012	Becher, Burkhard/0000-0002-1541-7867; Renauld, Jean-Christophe/0000-0003-1736-2131; Reuter, Sebastian/0000-0002-1784-0124	Deutsche Forschungsgemeinschaft (DFG) [Ta 275/4-1, Ta 275/5-1]; FZI Mainz; Swiss National Science Foundation; Swiss Cancer League; Koetser Foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); FZI Mainz; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; Koetser Foundation	The study was funded by Deutsche Forschungsgemeinschaft (DFG; Ta 275/4-1 and Ta 275/5-1 to C. T.), by Asthma Core Facility of FZI Mainz (to C. T.), the Swiss National Science Foundation (to B. B.), the Swiss Cancer League (to B. B.), and the Koetser Foundation (to B. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Barrett NA, 2009, IMMUNITY, V31, P425, DOI 10.1016/j.immuni.2009.08.014; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Bopp T, 2009, J IMMUNOL, V182, P4017, DOI 10.4049/jimmunol.0803310; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Demello DE, 2002, IN VITRO CELL DEV-AN, V38, P154; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Dumoutier L, 2011, EUR J IMMUNOL, V41, P1075, DOI 10.1002/eji.201040878; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Guo HL, 2010, J VIROL, V84, P7750, DOI 10.1128/JVI.00187-10; Hahn YS, 2003, J IMMUNOL, V171, P3170, DOI 10.4049/jimmunol.171.6.3170; Kawasaki S, 2001, J IMMUNOL, V166, P2055, DOI 10.4049/jimmunol.166.3.2055; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P679, DOI 10.1016/j.intimp.2004.01.008; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Pan HN, 2004, CELL MOL IMMUNOL, V1, P43; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Reuter S, 2008, EUR RESPIR J, V31, P773, DOI 10.1183/09031936.00058907; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Schnyder B, 2010, CYTOKINE, V50, P220, DOI 10.1016/j.cyto.2010.02.003; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Sekiya T, 2000, J IMMUNOL, V165, P2205, DOI 10.4049/jimmunol.165.4.2205; Simonian PL, 2010, J EXP MED, V207, P2239, DOI 10.1084/jem.20100061; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JCI33194, 10.1172/JC133194]; Taube C, 2004, INT ARCH ALLERGY IMM, V135, P173, DOI 10.1159/000080899; Taube C, 2002, J IMMUNOL, V169, P6482, DOI 10.4049/jimmunol.169.11.6482; Veldhoen M, 2010, SCIENCE, V330, P594, DOI 10.1126/science.1198298; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Whittington HA, 2004, AM J RESP CELL MOL, V31, P220, DOI 10.1165/rcmb.2003-0285OC; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zenewicz LA, 2008, EUR J IMMUNOL, V38, P3265, DOI 10.1002/eji.200838655; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Ziesche E, 2007, J BIOL CHEM, V282, P16006, DOI 10.1074/jbc.M611040200	54	97	106	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e21799	10.1371/journal.pone.0021799	http://dx.doi.org/10.1371/journal.pone.0021799			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789181	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000292812400015
J	Park, E; Dvorak, D; Fenton, AA				Park, EunHye; Dvorak, Dino; Fenton, Andre A.			Ensemble Place Codes in Hippocampus: CA1, CA3, and Dentate Gyrus Place Cells Have Multiple Place Fields in Large Environments	PLOS ONE			English	Article							COMPLEX-SPIKE CELLS; SPATIAL REPRESENTATION	Previously we reported that the hippocampus place code must be an ensemble code because place cells in the CA1 region of hippocampus have multiple place fields in a more natural, larger-than-standard enclosure with stairs that permitted movements in 3-D. Here, we further investigated the nature of hippocampal place codes by characterizing the spatial firing properties of place cells in the CA1, CA3, and dentate gyrus (DG) hippocampal subdivisions as rats foraged in a standard 76-cm cylinder as well as a larger-than-standard box (1.8 mx1.4 m) that did not have stairs or any internal structure to permit movements in 3-D. The rats were trained to forage continuously for 1 hour using computer-controlled food delivery. We confirmed that most place cells have single place fields in the standard cylinder and that the positional firing pattern remapped between the cylinder and the large enclosure. Importantly, place cells in the CA1, CA3 and DG areas all characteristically had multiple place fields that were irregularly spaced, as we had reported previously for CA1. We conclude that multiple place fields are a fundamental characteristic of hippocampal place cells that simplifies to a single field in sufficiently small spaces. An ensemble place code is compatible with these observations, which contradict any dedicated coding scheme.	[Park, EunHye; Fenton, Andre A.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Dvorak, Dino] Suny Downstate Med Ctr, Joint Program Biomed Engn, NYU Poly, Brooklyn, NY 11203 USA; [Fenton, Andre A.] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neurosci, Brooklyn, NY 11203 USA; [Fenton, Andre A.] NYU, Ctr Neural Sci, New York, NY 10003 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; New York University; New York University Tandon School of Engineering; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; New York University	Park, E (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA.	afenton@nyu.edu		Fenton, Andre/0000-0002-5063-1156	Korea Government (MOHERD) [KRF-2007-357-H0005]; National Science Foundation [IOS-0725001]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084038] Funding Source: NIH RePORTER	Korea Government (MOHERD)(Korean Government); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was supported by a Korea Research Foundation grant to EHP funded by Korea Government (MOHERD) KRF-2007-357-H0005, and National Science Foundation grant IOS-0725001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alme CB, 2010, HIPPOCAMPUS, V20, P1109, DOI 10.1002/hipo.20810; DEALMEIDA L, 2010, HIPPOCAMPUS; Fenton AA, 2008, J NEUROSCI, V28, P11250, DOI 10.1523/JNEUROSCI.2862-08.2008; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; HENRIKSEN EJ, 2009, NEUR M PLANN CHIC SO; Henriksen EJ, 2010, NEURON, V68, P127, DOI 10.1016/j.neuron.2010.08.042; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lever C, 2002, BIOL CYBERN, V87, P356, DOI 10.1007/s00422-002-0360-z; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1989, J NEUROSCI, V9, P4101; MULLER RU, 1987, J NEUROSCI, V7, P1935; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030	19	62	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22349	10.1371/journal.pone.0022349	http://dx.doi.org/10.1371/journal.pone.0022349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789250	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811700041
J	Riera, M; Irar, S; Velez-Bermudez, IC; Carretero-Paulet, L; Lumbreras, V; Pages, M				Riera, Marta; Irar, Sami; Velez-Bermudez, Isabel C.; Carretero-Paulet, Lorenzo; Lumbreras, Victoria; Pages, Montserrat			Role of Plant-Specific N-Terminal Domain of Maize CK2 beta 1 Subunit in CK2 beta Functions and Holoenzyme Regulation	PLOS ONE			English	Article							PROTEIN-KINASE CK2; MULTIPLE SEQUENCE ALIGNMENT; ALPHA-SUBUNIT; BETA-SUBUNIT; SUBCELLULAR-LOCALIZATION; CRYSTAL-STRUCTURE; CASEIN KINASE-2; ZEA-MAYS; ARABIDOPSIS; PHOSPHORYLATION	Protein kinase CK2 is a highly pleiotropic Ser/Thr kinase ubiquituous in eukaryotic organisms. CK2 is organized as a heterotetrameric enzyme composed of two types of subunits: the catalytic (CK2 alpha) and the regulatory (CK2 beta). The CK2 beta subunits enhance the stability, activity and specificity of the holoenzyme, but they can also perform functions independently of the CK2 tetramer. CK2 beta regulatory subunits in plants differ from their animal or yeast counterparts, since they present an additional specific N-terminal extension of about 90 aminoacids that shares no homology with any previously characterized functional domain. Sequence analysis of the N-terminal domain of land plant CK2 beta subunit sequences reveals its arrangement through short, conserved motifs, some of them including CK2 autophosphorylation sites. By using maize CK2 beta 1 and a deleted version (Delta NCK2 beta 1) lacking the N-terminal domain, we have demonstrated that CK2 beta 1 is autophosphorylated within the N-terminal domain. Moreover, the holoenzyme composed with CK2 alpha 1/Delta NCK2 beta 1 is able to phosphorylate different substrates more efficiently than CK2 alpha 1/CK2 beta 1 or CK2 alpha alone. Transient overexpression of CK2 beta 1 and Delta NCK2 beta 1 fused to GFP in different plant systems show that the presence of N-terminal domain enhances aggregation in nuclear speckles and stabilizes the protein against proteasome degradation. Finally, bimolecular fluorescence complementation (BiFC) assays show the nuclear and cytoplasmic location of the plant CK2 holoenzyme, in contrast to the individual CK2 alpha/beta subunits mainly observed in the nucleus. All together, our results support the hypothesis that the plant-specific N-terminal domain of CK2 beta subunits is involved in the down-regulation of the CK2 holoenzyme activity and in the stabilization of CK2 beta 1 protein. In summary, the whole amount of data shown in this work suggests that this domain was acquired by plants for regulatory purposes.	[Riera, Marta; Irar, Sami; Velez-Bermudez, Isabel C.; Carretero-Paulet, Lorenzo; Lumbreras, Victoria; Pages, Montserrat] CSIC IRTA UAB, CRAG, Dept Mol Genet, Barcelona, Spain; [Carretero-Paulet, Lorenzo] Univ Almeria, Dept Appl Biol, Area Genet, Almeria, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; Universidad de Almeria	Riera, M (corresponding author), CSIC IRTA UAB, CRAG, Dept Mol Genet, Barcelona, Spain.	montse.pages@cid.csic.es	Carretero-Paulet, Lorenzo/Z-2744-2019; Torrens, Montserrat Pages/B-6329-2012; Pages, Montserrat/ABA-6448-2021; Riera, Marta/M-7082-2015	Carretero-Paulet, Lorenzo/0000-0001-6697-827X; Torrens, Montserrat Pages/0000-0001-8431-5605; Riera, Marta/0000-0003-1007-5324	MICINN (Spain) [I3P-CSIC2006, FPI2007, BIO2009-13044-CO2-01]; CONSOLIDER-INGENIO, MEC [CSD2007-00057]	MICINN (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONSOLIDER-INGENIO, MEC(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	MR was financed by I3P-CSIC2006, ICV-B by predoctoral fellowship FPI2007 from MICINN (Spain) and LC-P by Juan de la Cierva Programme, MICINN (Spain). This work was also supported by grant BIO2009-13044-CO2-01 from MICINN (Spain) and CONSOLIDER-INGENIO 2010 MEC (CSD2007-00057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bibby AC, 2005, INT J BIOL SCI, V1, P67; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bolanos-Garcia VM, 2006, TRENDS BIOCHEM SCI, V31, P654, DOI 10.1016/j.tibs.2006.10.005; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Dennis MD, 2009, J BIOL CHEM, V284, P20602, DOI 10.1074/jbc.M109.006692; DOBROWOLSKA G, 1991, BIOCHIM BIOPHYS ACTA, V1129, P139, DOI 10.1016/0167-4781(91)90230-J; Durbin R., 1998, BIOL SEQUENCE ANAL P; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Espunya MC, 1999, PLANT J, V19, P655, DOI 10.1046/j.1365-313x.1999.00563.x; Faust M, 2000, CELL TISSUE RES, V301, P329, DOI 10.1007/s004410000256; Ferrando A, 2000, PLANT J, V22, P553, DOI 10.1046/j.1365-313x.2000.00763.x; Filhol O, 2003, MOL CELL BIOL, V23, P975, DOI 10.1128/MCB.23.3.975-987.2003; Graham KC, 2000, J BIOL CHEM, V275, P5003, DOI 10.1074/jbc.275.7.5003; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hidalgo P, 2001, PLANT PHYSIOL, V125, P396, DOI 10.1104/pp.125.1.396; Holland Z, 2009, EUKARYOT CELL, V8, P388, DOI 10.1128/EC.00334-08; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Lassot I, 2005, J BIOL CHEM, V280, P41537, DOI 10.1074/jbc.M505294200; Lebska M, 2009, PHYSIOL PLANTARUM, V136, P251, DOI 10.1111/j.1399-3054.2009.01238.x; Lee Y, 1999, PLANT PHYSIOL, V119, P989, DOI 10.1104/pp.119.3.989; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; LITCHFIELD DW, 1991, J BIOL CHEM, V266, P20380; LUSCHER B, 1994, EUR J BIOCHEM, V220, P521, DOI 10.1111/j.1432-1033.1994.tb18651.x; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MEGGIO F, 1992, EUR J BIOCHEM, V204, P293, DOI 10.1111/j.1432-1033.1992.tb16636.x; Moreno-Romero J, 2008, PLANT J, V55, P118, DOI 10.1111/j.1365-313X.2008.03494.x; Niefind K, 2009, CELL MOL LIFE SCI, V66, P1800, DOI 10.1007/s00018-009-9149-8; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; Niefind K, 1998, EMBO J, V17, P2451, DOI 10.1093/emboj/17.9.2451; Peracchia G, 1999, PLANT MOL BIOL, V40, P199, DOI 10.1023/A:1006196530079; Perales M, 2006, PLANT J, V46, P849, DOI 10.1111/j.1365-313X.2006.02744.x; Portoles S, 2007, PLANT J, V51, P966, DOI 10.1111/j.1365-313X.2007.03186.x; Pyerin W, 2003, PROG NUCLEIC ACID RE, V74, P239, DOI 10.1016/S0079-6603(03)01015-8; Riera M, 2004, P NATL ACAD SCI USA, V101, P9879, DOI 10.1073/pnas.0306154101; Riera M, 2003, PROTEIN EXPRES PURIF, V29, P24, DOI 10.1016/S1046-5928(03)00005-6; Riera M, 2001, MOL CELL BIOCHEM, V227, P119, DOI 10.1023/A:1013141713277; Riera M, 2001, PLANT J, V25, P365, DOI 10.1046/j.1365-313x.2001.00973.x; Rodriguez FA, 2008, P NATL ACAD SCI USA, V105, P5693, DOI 10.1073/pnas.0802065105; Salinas P, 2006, PLANT CELL PHYSIOL, V47, P1295, DOI 10.1093/pcp/pcj100; Sano M, 2007, J BIOL CHEM, V282, P25970, DOI 10.1074/jbc.M703634200; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075	52	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e21909	10.1371/journal.pone.0021909	http://dx.doi.org/10.1371/journal.pone.0021909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789193	Green Published, gold			2022-12-25	WOS:000292811700010
J	Garca-Penarrubia, P; Galvez, JJ; Galvez, J				Garca-Penarrubia, Pilar; Galvez, Juan J.; Galvez, Jesus			Spatio-Temporal Dependence of the Signaling Response in Immune-Receptor Trafficking Networks Regulated by Cell Density: A Theoretical Model	PLOS ONE			English	Article							SUPPORTED BILAYERS; LATERAL MOBILITY; STEM-CELLS; ACTIVATION; PROTEINS; DIFFERENTIATION; TRANSDUCTION; INHIBITION; KINASES; BIOLOGY	Cell signaling processes involve receptor trafficking through highly connected networks of interacting components. The binding of surface receptors to their specific ligands is a key factor for the control and triggering of signaling pathways. In most experimental systems, ligand concentration and cell density vary within a wide range of values. Dependence of the signal response on cell density is related with the extracellular volume available per cell. This dependence has previously been studied using non-spatial models which assume that signaling components are well mixed and uniformly distributed in a single compartment. In this paper, a mathematical model that shows the influence exerted by cell density on the spatio-temporal evolution of ligands, cell surface receptors, and intracellular signaling molecules is developed. To this end, partial differential equations were used to model ligand and receptor trafficking dynamics through the different domains of the whole system. This enabled us to analyze several interesting features involved with these systems, namely: a) how the perturbation caused by the signaling response propagates through the system; b) receptor internalization dynamics and how cell density affects the robustness of dose-response curves upon variation of the binding affinity; and c) that enhanced correlations between ligand input and system response are obtained under conditions that result in larger perturbations of the equilibrium ligand surface receptor reversible arrow igand receptor complex. Finally, the results are compared with those obtained by considering that the above components are well mixed in a single compartment.	[Garca-Penarrubia, Pilar] Univ Murcia, Sch Med, Dept Biochem & Mol Biol & Immunol, Murcia, Spain; [Galvez, Juan J.] Univ Murcia, Fac Comp Sci, Dept Informat & Commun Engn, Murcia, Spain; [Galvez, Jesus] Univ Murcia, Fac Chem, Dept Phys Chem, Murcia, Spain	University of Murcia; University of Murcia; University of Murcia	Garca-Penarrubia, P (corresponding author), Univ Murcia, Sch Med, Dept Biochem & Mol Biol & Immunol, Murcia, Spain.	jgalvez@um.es	García-Peñarrubia, Pilar/ABH-2427-2020	García-Peñarrubia, Pilar/0000-0002-2922-4804	Research Office of Murcia University	Research Office of Murcia University	This work was supported by the Research Office of Murcia University (ACI funds, www.um.es/investigacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Brown GC, 1999, FEBS LETT, V457, P452, DOI 10.1016/S0014-5793(99)01058-3; Chakraborty AK, 2010, NAT REV IMMUNOL, V10, P59, DOI 10.1038/nri2688; Chang TC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009187; Childress JL, 2006, CURR BIOL, V16, P2228, DOI 10.1016/j.cub.2006.09.031; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; FEIN M, 1993, J MEMBRANE BIOL, V135, P83, DOI 10.1007/BF00234654; Ghosh S, 2010, EXP CELL RES, V316, P2087, DOI 10.1016/j.yexcr.2010.04.015; Goldstein B, 2004, NAT REV IMMUNOL, V4, P445, DOI 10.1038/nri1374; Groves JT, 1996, BIOPHYS J, V71, P2716, DOI 10.1016/S0006-3495(96)79462-6; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hsieh MY, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-57; Incardona JP, 2002, CURR BIOL, V12, P983, DOI 10.1016/S0960-9822(02)00895-3; Jacobson KA, 1997, BBA-BIOMEMBRANES, V1330, P138, DOI 10.1016/S0005-2736(97)00128-4; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kreis S, 2007, MOL CANCER RES, V5, P1331, DOI 10.1158/1541-7786.MCR-07-0317; Li AK, 2003, J BIOL CHEM, V278, P2799, DOI 10.1074/jbc.M205067200; Ma WZ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100111; Madshus IH, 2009, J CELL SCI, V122, P3433, DOI 10.1242/jcs.050260; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Resat H, 2003, BIOPHYS J, V85, P730, DOI 10.1016/S0006-3495(03)74516-0; Shankaran H, 2007, PLOS COMPUT BIOL, V3, P986, DOI 10.1371/journal.pcbi.0030101; Slepchenko BM, 2003, TRENDS CELL BIOL, V13, P570, DOI 10.1016/j.tcb.2003.09.002; Swat A, 2009, MOL CELL BIOL, V29, P3332, DOI 10.1128/MCB.01955-08; Tophkhane C, 2009, INT J ONCOL, V35, P1429, DOI 10.3892/ijo_00000461; Wang J, 2005, BIOCHEM J, V392, P383, DOI 10.1042/BJ20050492; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Xu GZ, 2005, MOL CELL PROTEOMICS, V4, P1959, DOI 10.1074/mcp.M500095-MCP200; Zi Z, 2007, FEBS LETT, V581, P4589, DOI 10.1016/j.febslet.2007.08.047	32	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21786	10.1371/journal.pone.0021786	http://dx.doi.org/10.1371/journal.pone.0021786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21789180	Green Submitted, Green Published, gold			2022-12-25	WOS:000292811300014
J	Holahan, MR; Madularu, D; McConnell, EM; Walsh, R; DeRosa, MC				Holahan, Matthew R.; Madularu, Dan; McConnell, Erin M.; Walsh, Ryan; DeRosa, Maria C.			Intra-Accumbens Injection of a Dopamine Aptamer Abates MK-801-Induced Cognitive Dysfunction in a Model of Schizophrenia	PLOS ONE			English	Article							IN-VITRO SELECTION; NICOTINIC ACETYLCHOLINE-RECEPTOR; INCREASES FOOD-INTAKE; NUCLEUS-ACCUMBENS; MK-801 INCREASES; DIZOCILPINE MK-801; RNA LIGANDS; RATS; EXTINCTION; ANTAGONISTS	Systemic administration of the noncompetitive NMDA-receptor antagonist, MK-801, has been proposed to model cognitive deficits similar to those seen in patients with schizophrenia. The present work investigated the ability of a dopamine-binding DNA aptamer to regulate these MK-801-induced cognitive deficits when injected into the nucleus accumbens. Rats were trained to bar press for chocolate pellet rewards then randomly assigned to receive an intra-accumbens injection of a DNA aptamer (200 nM; n = 7), tris buffer (n = 6) or a randomized DNA oligonucleotide (n = 7). Animals were then treated systemically with MK-801 (0.1 mg/kg) and tested for their ability to extinguish their bar pressing response. Two control groups were also included that did not receive MK-801. Data revealed that injection of Tris buffer or the random oligonucleotide sequence into the nucleus accumbens prior to treatment with MK-801 did not reduce the MK-801-induced extinction deficit. Animals continued to press at a high rate over the entire course of the extinction session. Injection of the dopamine aptamer reversed this MK-801-induced elevation in lever pressing to levels as seen in rats not treated with MK-801. Tests for activity showed that the aptamer did not impair locomotor activity. Results demonstrate the in vivo utility of DNA aptamers as tools to investigate neurobiological processes in preclinical animal models of mental health disease.	[Holahan, Matthew R.; Madularu, Dan] Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada; [McConnell, Erin M.; Walsh, Ryan; DeRosa, Maria C.] Carleton Univ, Dept Chem, Ottawa, ON K1S 5B6, Canada	Carleton University; Carleton University	Holahan, MR (corresponding author), Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada.	matthew_holahan@carleton.ca; maria_derosa@carleton.ca	Walsh, Ryan/C-8683-2011; Walsh, Ryan/K-6714-2019; Holahan, Matthew/GZK-5814-2022	Walsh, Ryan/0000-0002-3794-4721; Holahan, Matthew/0000-0001-7653-9262	National Science and Engineering Research Council of Canada; Canadian Foundation for Innovation Leaders	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation Leaders	This research was supported by separate National Science and Engineering Research Council of Canada Discovery grants and separate Canadian Foundation for Innovation Leaders Opportunity Fund awards to Matthew R. Holahan and Maria C. DeRosa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2007, PSYCHOPHARMACOLOGY, V191, P641, DOI 10.1007/s00213-006-0526-9; ALI SF, 1994, NEUROTOXICOL TERATOL, V16, P335, DOI 10.1016/0892-0362(94)90021-3; Bassareo V, 1999, EUR J NEUROSCI, V11, P4389, DOI 10.1046/j.1460-9568.1999.00843.x; Burns GA, 1997, PHARMACOL BIOCHEM BE, V56, P145, DOI 10.1016/S0091-3057(96)00171-2; Carlsson A, 1999, BIOL PSYCHIAT, V46, P1388, DOI 10.1016/S0006-3223(99)00117-1; Carlsson A, 2001, ANNU REV PHARMACOL, V41, P237, DOI 10.1146/annurev.pharmtox.41.1.237; Covasa M, 2004, AM J PHYSIOL-REG I, V287, pR1462, DOI 10.1152/ajpregu.00471.2004; DANYSZ W, 1994, PHARMACOL BIOCHEM BE, V48, P111, DOI 10.1016/0091-3057(94)90506-1; de Franciscis V, 2009, CNS NEUROL DISORD-DR, V8, P393, DOI 10.2174/187152709789542023; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; GOLDSTEIN M, 1984, ANN NY ACAD SCI, V430, P1, DOI 10.1111/j.1749-6632.1984.tb14495.x; Hess GP, 2000, P NATL ACAD SCI USA, V97, P13895, DOI 10.1073/pnas.240459497; Hironaka N, 2004, ANN NY ACAD SCI, V1025, P140, DOI 10.1196/annals.1316.018; Holahan MR, 2007, LEARN MEMORY, V14, P407, DOI 10.1101/lm.581907; HOLAHAN MR, 2010, PSYCHOPHARMACOLOGY; Li YH, 2006, J PSYCHOPHARMACOL, V20, P40, DOI [10.1177/02698881105057250, 10.1177/0269881105057250]; Linden DEJ, 2007, NEUROSCIENTIST, V13, P257, DOI 10.1177/1073858406298480; LOSCHER W, 1992, EUR J PHARMACOL, V215, P199, DOI 10.1016/0014-2999(92)90029-4; Mannironi C, 1997, BIOCHEMISTRY-US, V36, P9726, DOI 10.1021/bi9700633; Matsugami A, 2003, STRUCTURE, V11, P533, DOI 10.1016/S0969-2126(03)00069-8; Mayer G, 2009, ANGEW CHEM INT EDIT, V48, P2672, DOI 10.1002/anie.200804643; Meltzer HY, 2011, PSYCHOPHARMACOLOGY, V213, P289, DOI 10.1007/s00213-010-2137-8; Mendonsa SD, 2005, J AM CHEM SOC, V127, P9382, DOI 10.1021/ja052406n; MURASE S, 1993, J NEURAL TRANSM-GEN, V91, P13, DOI 10.1007/BF01244915; Murschall A, 2005, PSYCHOPHARMACOLOGY, V182, P290, DOI 10.1007/s00213-005-0073-9; Neill JC, 2010, PHARMACOL THERAPEUT, V128, P419, DOI 10.1016/j.pharmthera.2010.07.004; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; la Torre MP, 2008, ANN NY ACAD SCI, V1139, P259, DOI 10.1196/annals.1432.038; Pitts RC, 2006, PSYCHOPHARMACOLOGY, V189, P135, DOI 10.1007/s00213-006-0538-5; Port RL, 1998, PHYSIOL BEHAV, V64, P391, DOI 10.1016/S0031-9384(98)00095-X; Ragozzino ME, 2007, ANN NY ACAD SCI, V1121, P355, DOI 10.1196/annals.1401.013; Reichenberg Abraham, 2010, Dialogues Clin Neurosci, V12, P383; Rentmeister A, 2006, RNA, V12, P1650, DOI 10.1261/rna.126306; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Ulrich H, 1998, P NATL ACAD SCI USA, V95, P14051, DOI 10.1073/pnas.95.24.14051; van der Meulen JAJ, 2003, NEUROREPORT, V14, P2225, DOI 10.1097/00001756-200312020-00018; Waford RN, 2010, SCHIZOPHR RES, V118, P128, DOI 10.1016/j.schres.2010.01.031; Walsh R, 2009, BIOCHEM BIOPH RES CO, V388, P732, DOI 10.1016/j.bbrc.2009.08.084; Wang JA, 2010, ANALYST, V135, P2826, DOI 10.1039/c0an00365d; Wang YX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009726; Willuhn I, 2010, CURR TOP BEHAV NEURO, V3, P29, DOI 10.1007/7854_2009_27; WOZNIAK DF, 1990, PSYCHOPHARMACOLOGY, V101, P47, DOI 10.1007/BF02253717; Yan QS, 1997, BRAIN RES, V765, P149, DOI 10.1016/S0006-8993(97)00568-4; ZHANG J, 1992, BRAIN RES, V590, P153, DOI 10.1016/0006-8993(92)91091-R	45	18	18	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22239	10.1371/journal.pone.0022239	http://dx.doi.org/10.1371/journal.pone.0022239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21779401	gold, Green Submitted, Green Published			2022-12-25	WOS:000292781500042
J	Cao, XX; Xue, LX; Han, LM; Ma, LW; Chen, TD; Tong, TJ				Cao, Xiaoxiao; Xue, Lixiang; Han, Limin; Ma, Liwei; Chen, Tianda; Tong, Tanjun			WW Domain-containing E3 Ubiquitin Protein Ligase 1 (WWP1) Delays Cellular Senescence by Promoting p27(Kip1) Degradation in Human Diploid Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR; CAENORHABDITIS-ELEGANS; BREAST-CANCER; PATHWAY; TARGET; TRANSCRIPTION; BINDING; CELLS; RB	WW domain-containing E3 ubiquitin protein ligase 1 (WWP1) plays an important role in the proliferation of tumor cells and the lifespan of Caenorhabditis elegans. However, the role of WWP1 in cellular senescence is still unknown. Here, we show that the expression patterns of p27(Kip1) and WWP1 are inversely correlated during cellular senescence. Moreover, the overexpression of WWP1 delayed senescence, whereas the knockdown of WWP1 led to premature senescence in human fibroblasts. Furthermore, we demonstrate that WWP1 repressed endogenous p27(Kip1) expression through ubiquitin-proteasome-mediated degradation. Additionally, WWP1 had a strong preference for catalyzing the Lys-48-linked polyubiquitination of p27(Kip1) in vitro. Finally, we demonstrate that WWP1 markedly inhibited the replicative senescence induced by p27(Kip1) by promoting p27(Kip1) degradation. Therefore, our study provides a new molecular mechanism for the regulation of cellular senescence.	[Cao, Xiaoxiao; Xue, Lixiang; Han, Limin; Ma, Liwei; Chen, Tianda; Tong, Tanjun] Peking Univ, Res Ctr Aging, Dept Biochem & Mol Biol, Hlth Sci Ctr, Beijing 100191, Peoples R China	Peking University	Tong, TJ (corresponding author), Peking Univ, Res Ctr Aging, Dept Biochem & Mol Biol, Hlth Sci Ctr, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	ttj@bjmu.edu.cn			Special Funds for Major State Basis Research of China [2007CB507400]; National Natural Science Foundation of China [30973146]	Special Funds for Major State Basis Research of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Special Funds for Major State Basis Research of China (Grant 2007CB507400) and the National Natural Science Foundation of China (Grant 30973146).	Alexander K, 2001, MOL CELL BIOL, V21, P3616, DOI 10.1128/MCB.21.11.3616-3631.2001; BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Carrano AC, 2009, NATURE, V460, P396, DOI 10.1038/nature08130; Chen C, 2007, ONCOGENE, V26, P2386, DOI 10.1038/sj.onc.1210021; Chen CS, 2007, INT J CANCER, V121, P80, DOI 10.1002/ijc.22653; Chen CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009494; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Conkright MD, 2001, J BIOL CHEM, V276, P29299, DOI 10.1074/jbc.M103670200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Galinier R, 2002, BIOCHEMISTRY-US, V41, P14299, DOI 10.1021/bi020125b; Gan Q, 2008, J CELL SCI, V121, P2235, DOI 10.1242/jcs.026633; Huang K, 2000, GENE, V252, P137, DOI 10.1016/S0378-1119(00)00216-X; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; Li Y, 2008, CELL DEATH DIFFER, V15, P1941, DOI 10.1038/cdd.2008.134; Li Y, 2009, ONCOGENE, V28, P2948, DOI 10.1038/onc.2009.162; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; MCGLADE CJ, 1992, MOL CELL BIOL, V12, P991, DOI 10.1128/MCB.12.3.991; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Peschiaroli A, 2010, BIOCHEM BIOPH RES CO, V402, P425, DOI 10.1016/j.bbrc.2010.10.050; Schulz L, 2005, MOL CELL, V17, P168, DOI 10.1016/j.molcel.2005.01.003; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Yew TL, 2011, AGING CELL, V10, P349, DOI 10.1111/j.1474-9726.2011.00676.x; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699; Zeng JP, 2009, J PATHOL, V218, P419, DOI 10.1002/path.2530; Zhang H, 2004, GENE DEV, V18, P3028, DOI 10.1101/gad.1253004; Zhang XL, 2004, BIOCHEM BIOPH RES CO, V316, P139, DOI 10.1016/j.bbrc.2004.02.033; Zhou R, 2009, NUCLEIC ACIDS RES, V37, P5183, DOI 10.1093/nar/gkp533	35	33	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33447	33456		10.1074/jbc.M111.225565	http://dx.doi.org/10.1074/jbc.M111.225565			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795702	Green Published, hybrid			2022-12-25	WOS:000294968800062
J	Jokela, TA; Makkonen, KM; Oikari, S; Karna, R; Koli, E; Hart, GW; Tammi, RH; Carlberg, C; Tammi, MI				Jokela, Tiina A.; Makkonen, Katri M.; Oikari, Sanna; Karna, Riikka; Koli, Elina; Hart, Gerald W.; Tammi, Raija H.; Carlberg, Carsten; Tammi, Markku I.			Cellular Content of UDP-N-acetylhexosamines Controls Hyaluronan Synthase 2 Expression and Correlates with O-Linked N-Acetylglucosamine Modification of Transcription Factors YY1 and SP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; SKIN ORGAN-CULTURE; GENE-EXPRESSION; RETINOIC ACID; KERATINOCYTE ACTIVATION; INSULIN-RESISTANCE; BINDING PROTEIN; DOWN-REGULATION; MESSENGER-RNA	Hyaluronan, a high molecular mass polysaccharide on the vertebrate cell surface and extracellular matrix, is produced at the plasma membrane by hyaluronan synthases using UDP-GlcNAc and UDP-GlcUA as substrates. The availability of these UDP-sugar substrates can limit the synthesis rate of hyaluronan. In this study, we show that the cellular level of UDP-HexNAc also controls hyaluronan synthesis by modulating the expression of HAS2 (hyaluronan synthase 2). Increasing UDP-HexNAc in HaCaT keratinocytes by adding glucosamine down-regulated HAS2 gene expression, whereas a decrease in UDP-HexNAc, realized by mannose treatment or siRNA for GFAT1 (glutamine: fructose-6-phosphate amidotransferase 1), enhanced expression of the gene. Tracing the UDP-HexNAc-initiated signal to the HAS2 promoter revealed no change in the binding of STAT3, NF-kappa B, and cAMP response element-binding protein, shown previously to mediate growth factor and cytokine signals on HAS2 expression. Instead, altered binding of SP1 and YY1 to the promoter correlated with cellular UDP-HexNAc content and inhibition of HAS2 expression. siRNA silencing of YY1 and SP1 confirmed their inhibitory effects on HAS2 expression. Reduced and increased levels of O-GlcNAc-modified SP1 and YY1 proteins were associated with stimulation or inhibition of HAS2 expression, respectively. Our data are consistent with the hypothesis that, by regulating the level of protein O-GlcNAc modifications, cellular UDP-HexNAc content controls HAS2 transcription and decreases the effects on hyaluronan synthesis that would result from cellular fluctuations of this substrate.	[Jokela, Tiina A.; Makkonen, Katri M.; Oikari, Sanna; Karna, Riikka; Koli, Elina; Tammi, Raija H.; Tammi, Markku I.] Univ Eastern Finland, Inst Biomed, Ctr Canc, FIN-70211 Kuopio, Finland; [Makkonen, Katri M.; Carlberg, Carsten] Univ Eastern Finland, Inst Biosci, Ctr Canc, FIN-70211 Kuopio, Finland; [Makkonen, Katri M.] Univ Eastern Finland, Inst Dent, Ctr Canc, FIN-70211 Kuopio, Finland; Univ Eastern Finland, Bioctr Kuopio, FIN-70211 Kuopio, Finland; [Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Johns Hopkins University	Tammi, MI (corresponding author), Univ Eastern Finland, Inst Biomed, Ctr Canc, POB 1627, FIN-70211 Kuopio, Finland.	tammi@uef.fi	Jokela, Tiina/O-9206-2015; Tammi, Markku/AAQ-7878-2021; Carlberg, Carsten/C-9075-2011	Jokela, Tiina/0000-0002-7521-3866; Carlberg, Carsten/0000-0003-2633-0684; Hart, Gerald/0000-0001-7812-4351	Academy of Finland; Sigrid Juselius Foundation; Cancer Center of the University of Eastern Finland; Kuopio University Hospital; Mizutani Foundation; National Glycoscience Graduate School; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Center of the University of Eastern Finland; Kuopio University Hospital; Mizutani Foundation; National Glycoscience Graduate School; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Academy of Finland (to M. I. T. and C. C.), the Sigrid Juselius Foundation and the Cancer Center of the University of Eastern Finland (to M. I. T. and R. H. T.), the EVO (Erityisvaltionosuus) Funds of the Kuopio University Hospital and the Mizutani Foundation (to M. I. T.), and the National Glycoscience Graduate School.	AGREN UM, 1995, J CELL PHYSIOL, V164, P240, DOI 10.1002/jcp.1041640204; BADEN HP, 1983, J INVEST DERMATOL, V81, P558, DOI 10.1111/1523-1747.ep12523220; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Chalkley RJ, 2009, P NATL ACAD SCI USA, V106, P8894, DOI 10.1073/pnas.0900288106; Comer FI, 1999, BBA-GEN SUBJECTS, V1473, P161, DOI 10.1016/S0304-4165(99)00176-2; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; Dunlop TW, 2004, J STEROID BIOCHEM, V89-90, P257, DOI 10.1016/j.jsbmb.2004.03.079; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Hazel M, 2004, ENDOCRINOLOGY, V145, P2118, DOI 10.1210/en.2003-0812; Hiromura M, 2003, J BIOL CHEM, V278, P14046, DOI 10.1074/jbc.M300789200; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Kuroda K, 2001, J DERMATOL SCI, V26, P156, DOI 10.1016/S0923-1811(00)00155-9; Maier KG, 2010, J VASC SURG, V51, P1238, DOI 10.1016/j.jvs.2009.11.073; Majumdar G, 2006, J BIOL CHEM, V281, P3642, DOI 10.1074/jbc.M511223200; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Monslow J, 2006, J BIOL CHEM, V281, P18043, DOI 10.1074/jbc.M510467200; Ozcan S, 2010, BBA-GENE REGUL MECH, V1799, P353, DOI 10.1016/j.bbagrm.2010.02.005; Pasonen-Seppanen S, 2003, J INVEST DERMATOL, V120, P1038, DOI 10.1046/j.1523-1747.2003.12249.x; Pasonen-Seppanen SM, 2008, J INVEST DERMATOL, V128, P797, DOI 10.1038/sj.jid.5701098; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; Richards JS, 2005, MOL CELL ENDOCRINOL, V234, P75, DOI 10.1016/j.mce.2005.01.004; Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141; Rilla K, 2004, J INVEST DERMATOL, V123, P708, DOI 10.1111/j.0022-202X.2004.23409.x; Saavalainen K, 2005, J BIOL CHEM, V280, P14636, DOI 10.1074/jbc.M500206200; Saavalainen K, 2007, J BIOL CHEM, V282, P11530, DOI 10.1074/jbc.M607871200; Sainio A, 2010, GLYCOBIOLOGY, V20, P1117, DOI 10.1093/glycob/cwq076; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; Schleicher ED, 2000, KIDNEY INT, V58, pS13, DOI 10.1046/j.1523-1755.2000.07703.x; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Solomon SS, 2008, LIFE SCI, V83, P305, DOI 10.1016/j.lfs.2008.06.024; Sugiura K, 2009, MOL REPROD DEV, V76, P537, DOI 10.1002/mrd.20971; Taguchi S, 2011, J INVEST DERMATOL, V131, P37, DOI 10.1038/jid.2010.229; TAMMI R, 1985, ARCH DERMATOL RES, V277, P276, DOI 10.1007/BF00509080; TAMMI R, 1988, J INVEST DERMATOL, V90, P412, DOI 10.1111/1523-1747.ep12456530; Tammi RH, 2009, J INVEST DERMATOL, V129, P1858, DOI 10.1038/jid.2009.91; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Yamada Y, 2004, J INVEST DERMATOL, V122, P631, DOI 10.1111/j.0022-202X.2004.22332.x; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678	53	51	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33632	33640		10.1074/jbc.M111.265637	http://dx.doi.org/10.1074/jbc.M111.265637			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795679	Green Published, hybrid			2022-12-25	WOS:000294968800079
J	Frankel, MB; Hendrickx, APA; Missiakas, DM; Schneewind, O				Frankel, Matthew B.; Hendrickx, Antoni P. A.; Missiakas, Dominique M.; Schneewind, Olaf			LytN, a Murein Hydrolase in the Cross-wall Compartment of Staphylococcus aureus, Is Involved in Proper Bacterial Growth and Envelope Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; CELL-WALL; SURFACE-PROTEINS; N-ACETYLGLUCOSAMINIDASE; MOLECULAR CHARACTERIZATION; PEPTIDOGLYCAN HYDROLASE; LACTOCOCCUS-LACTIS; ANCHOR STRUCTURE; RESISTANCE GENE; MAJOR AUTOLYSIN	Cell cycle progression for the spherical microbe Staphylococcus aureus requires the coordinated synthesis and remodeling of peptidoglycan. The majority of these rearrangements takes place at the mid-cell, in a compartment designated the cross-wall. Secreted polypeptides endowed with a YSIRK-G/S signal peptide are directly delivered to the cross-wall compartment. One such YSIRK-containing protein is the murein hydrolase LytN. lytN mutations precipitate structural damage to the cross-wall and interfere with staphylococcal growth. Overexpression of lytN also affects growth and triggers rupture of the cross-wall. The lytN phenotype can be reversed by the controlled expression of lytN but not by adding purified LytN to staphylococcal cultures. LytN harbors LysM and CHAP domains, the latter of which functions as both an N-acetylmuramoyl-L-alanine amidase and D-alanyl-glycine endopeptidase. Thus, LytN secretion into the cross-wall promotes peptidoglycan separation and completion of the staphylococcal cell cycle.	[Frankel, Matthew B.; Hendrickx, Antoni P. A.; Missiakas, Dominique M.; Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	University of Chicago	Schneewind, O (corresponding author), 920 E 58th St, Chicago, IL 60637 USA.	oschnee@bsd.uchicago.edu	Hendrickx, Antoni/AAN-1789-2021	Hendrickx, Antoni P.A./0000-0003-4431-9323	National Institutes of Health, Infectious Disease Branch, NIAID [AI038897]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, F32AI085709, R01AI038897] Funding Source: NIH RePORTER	National Institutes of Health, Infectious Disease Branch, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)NIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI038897 from Infectious Disease Branch, NIAID (to O. S.).	Baba T, 1998, EMBO J, V17, P4639, DOI 10.1093/emboj/17.16.4639; Baba T, 1998, TRENDS MICROBIOL, V6, P66, DOI 10.1016/S0966-842X(97)01196-7; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Bae T, 2003, J BACTERIOL, V185, P2910, DOI 10.1128/JB.185.9.2910-2919.2003; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Bateman A, 2003, TRENDS BIOCHEM SCI, V28, P234, DOI 10.1016/S0968-0004(03)00061-6; Berger-Bachi Brigitte, 1994, Trends in Microbiology, V2, P389, DOI 10.1016/0966-842X(94)90617-3; BERGERBACHI B, 1989, MOL GEN GENET, V219, P263; BUIST G, 1995, J BACTERIOL, V177, P1554, DOI 10.1128/jb.177.6.1554-1563.1995; Carroll SA, 2003, J BACTERIOL, V185, P6801, DOI 10.1128/JB.185.23.6801-6808.2003; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; CHATTERJEE AN, 1964, P NATL ACAD SCI USA, V51, P9, DOI 10.1073/pnas.51.1.9; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; DeDent A, 2008, EMBO J, V27, P2656, DOI 10.1038/emboj.2008.185; DeDent AC, 2007, J BACTERIOL, V189, P4473, DOI 10.1128/JB.00227-07; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Donovan DM, 2006, APPL ENVIRON MICROB, V72, P5108, DOI 10.1128/AEM.03065-05; Frankel MB, 2010, MOL MICROBIOL, V78, P238, DOI 10.1111/j.1365-2958.2010.07334.x; GHUYSEN JM, 1968, BACTERIOL REV, V32, P425, DOI 10.1128/MMBR.32.4_Pt_2.425-464.1968; Giesbrecht P, 1998, MICROBIOL MOL BIOL R, V62, P1371, DOI 10.1128/MMBR.62.4.1371-1414.1998; GIESBRECHT P, 1976, INT REV CYTOL, V44, P225, DOI 10.1016/S0074-7696(08)61651-4; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; Kajimura J, 2005, MOL MICROBIOL, V58, P1087, DOI 10.1111/j.1365-2958.2005.04881.x; Klevens RM, 2008, CLIN INFECT DIS, V47, P927, DOI 10.1086/591698; Komatsuzawa H, 1997, MICROBIOL IMMUNOL, V41, P469, DOI 10.1111/j.1348-0421.1997.tb01880.x; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; LEE CY, 1991, GENE, V103, P101, DOI 10.1016/0378-1119(91)90399-V; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mesnage S, 2008, J BIOL CHEM, V283, P19845, DOI 10.1074/jbc.M802323200; Navarre WW, 1999, J BIOL CHEM, V274, P15847, DOI 10.1074/jbc.274.22.15847; Navarre WW, 1998, J BIOL CHEM, V273, P29135, DOI 10.1074/jbc.273.44.29135; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; OSHIDA T, 1995, P NATL ACAD SCI USA, V92, P285, DOI 10.1073/pnas.92.1.285; Rigden DJ, 2003, TRENDS BIOCHEM SCI, V28, P230, DOI 10.1016/S0968-0004(03)00062-8; SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; Steen A, 2005, FEBS J, V272, P2854, DOI 10.1111/j.1742-4658.2005.04706.x; STROMINGER JL, 1967, FED PROC, V26, P9; Sugai M, 1997, J BACTERIOL, V179, P2958, DOI 10.1128/jb.179.9.2958-2962.1997; Sugai M, 1998, GENE, V224, P67, DOI 10.1016/S0378-1119(98)00508-3; TIPPER DJ, 1965, P NATL ACAD SCI USA, V54, P1133, DOI 10.1073/pnas.54.4.1133; TIPPER DJ, 1968, J BIOL CHEM, V243, P3169; TonThat H, 1997, J BIOL CHEM, V272, P22285, DOI 10.1074/jbc.272.35.22285; TZAGOLOFF H, 1977, J BACTERIOL, V129, P343, DOI 10.1128/JB.129.1.343-350.1977; Yamada S, 1996, J BACTERIOL, V178, P1565, DOI 10.1128/jb.178.6.1565-1571.1996; YOKOGAWA K, 1974, ANTIMICROB AGENTS CH, V6, P156, DOI 10.1128/AAC.6.2.156	53	47	47	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32593	32605		10.1074/jbc.M111.258863	http://dx.doi.org/10.1074/jbc.M111.258863			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784864	Green Published, hybrid			2022-12-25	WOS:000294726800069
J	Talwar, S; Jin, JF; Carroll, B; Liu, AG; Gillespie, MB; Palanisamy, V				Talwar, Sudha; Jin, Junfei; Carroll, Brittany; Liu, Angen; Gillespie, Marion Boyd; Palanisamy, Viswanathan			Caspase-mediated Cleavage of RNA-binding Protein HuR Regulates c-Myc Protein Expression after Hypoxic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; CELL CARCINOMA; TRANSLATION; CANCER; CYTOPLASM; PHOSPHORYLATION; STABILIZATION; BIOGENESIS	Altered expression of RNA-binding proteins modulates gene expression in association with mRNAs encoding many proto-oncogenes, cytokines, chemokines, and proinflammatory factors. Huantigen R (HuR), a ubiquitously expressed protein, controls a range of cellular functions such as tumor progression, apoptosis, invasion, and metastasis by stabilizing the AU-rich element located at the 3'-untranslated region (UTR) of target mRNAs. Although significant progress has been made in understanding HuR regulation in gene expression, little is known about how HuR undergoes post-translational modifications and recruits target mRNAs during hypoxic stress. Here, we report that during CoCl2-induced hypoxic stress, HuR is significantly overexpressed and undergoes caspase-dependent cleavage in head and neck squamous cell carcinoma cells. Unexpectedly, the HuR-cleavage product 1 (HuR-CP1) was found to strongly associate with the 3'-UTR of c-myc mRNA and block mRNA translation. The binding efficiency of HuR to the 3'-UTR of c-myc mRNA was confirmed using ribonucleoprotein immunoprecipitation and site-directed mutagenesis at the AU-rich element sequences of the c-myc mRNA. Overexpression of a non-cleavable isoform, HuR-D226A, revealed a potent dominant-negative effect, repressing cleavage of endogenous HuR and promoting cell viability. Surprisingly, under hypoxia, siRNA knockdown of HuR elevated c-Myc protein expression. These findings suggest an important role for HuR in hypoxia, and we may have revealed a novel post-transcriptional mechanism that controls c-Myc expression in oral cancer progression.	[Talwar, Sudha; Jin, Junfei; Carroll, Brittany; Palanisamy, Viswanathan] Med Univ S Carolina, Coll Dent Med, Dept Craniofacial Biol, Charleston, SC 29425 USA; [Liu, Angen] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Gillespie, Marion Boyd] Med Univ S Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA; [Palanisamy, Viswanathan] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Palanisamy, V (corresponding author), Med Univ S Carolina, Coll Dent Med, Dept Craniofacial Biol, Charleston, SC 29425 USA.	visu@musc.edu		Palanisamy, Viswanathan/0000-0001-5128-2878; Jin, Junfei/0000-0002-9237-9024	National Institutes of Health [R00DE018165]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R00DE018165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R00DE018165 (to V.P.).	Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299; Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Abdelmohsen K, 2009, EMBO J, V28, P1271, DOI 10.1038/emboj.2009.67; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Atasoy U, 1998, J CELL SCI, V111, P3145; Balasubramanian S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011470; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Beauchamp P, 2010, CELL DEATH DIFFER, V17, P1588, DOI 10.1038/cdd.2010.34; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Brunelle JK, 2004, J BIOL CHEM, V279, P4305, DOI 10.1074/jbc.M312241200; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Chen JL, 2009, AUTOPHAGY, V5, P244, DOI 10.4161/auto.5.2.7549; Chung J, 2002, J CELL BIOL, V158, P165, DOI 10.1083/jcb.200112015; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Corn PG, 2005, CANCER BIOL THER, V4, P1285, DOI 10.4161/cbt.4.11.2299; Costantino CL, 2009, CANCER RES, V69, P4567, DOI 10.1158/0008-5472.CAN-09-0371; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Fernau NS, 2010, J BIOL CHEM, V285, P3896, DOI 10.1074/jbc.M109.081430; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hasegawa H, 2009, BRIT J CANCER, V100, P1943, DOI 10.1038/sj.bjc.6605084; Janssen HL, 2005, HEAD NECK-J SCI SPEC, V27, P622, DOI 10.1002/hed.20223; Kakuguchi W, 2010, MOL CANCER RES, V8, P520, DOI 10.1158/1541-7786.MCR-09-0367; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Kurokawa T, 2003, BRIT J CANCER, V89, P1042, DOI 10.1038/sj.bjc.6601186; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Lafon I, 1998, ONCOGENE, V16, P3413, DOI 10.1038/sj.onc.1201895; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Leandersson K, 2006, NUCLEIC ACIDS RES, V34, P3988, DOI 10.1093/nar/gkl571; Leo C, 2004, SEMIN RADIAT ONCOL, V14, P207, DOI 10.1016/j.semradonc.2004.04.007; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Li HW, 2002, J BIOL CHEM, V277, P44623, DOI 10.1074/jbc.M206187200; Li Q, 2009, BIOCHIMIE, V91, P1307, DOI 10.1016/j.biochi.2009.07.001; Masuda K, 2009, J CELL MOL MED, V13, P2759, DOI 10.1111/j.1582-4934.2009.00842.x; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Meng Z, 2005, NUCLEIC ACIDS RES, V33, P2962, DOI 10.1093/nar/gki603; Millard SS, 2000, MOL CELL BIOL, V20, P5947, DOI 10.1128/MCB.20.16.5947-5959.2000; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	50	47	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32333	32343		10.1074/jbc.M111.255927	http://dx.doi.org/10.1074/jbc.M111.255927			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795698	Green Published, hybrid			2022-12-25	WOS:000294726800043
J	Taneike, M; Mizote, I; Morita, T; Watanabe, T; Hikoso, S; Yamaguchi, O; Takeda, T; Oka, T; Tamai, T; Oyabu, J; Murakawa, T; Nakayama, H; Nishida, K; Takeda, J; Mochizuki, N; Komuro, I; Otsu, K				Taneike, Manabu; Mizote, Isamu; Morita, Takashi; Watanabe, Tetsuya; Hikoso, Shungo; Yamaguchi, Osamu; Takeda, Toshihiro; Oka, Takafumi; Tamai, Takahito; Oyabu, Jota; Murakawa, Tomokazu; Nakayama, Hiroyuki; Nishida, Kazuhiko; Takeda, Junji; Mochizuki, Naoki; Komuro, Issei; Otsu, Kinya			Calpain Protects the Heart from Hemodynamic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCES INFARCT SIZE; SMALL-SUBUNIT GENE; PLASMA-MEMBRANE; CONTRACTILE DYSFUNCTION; EMBRYONIC-DEVELOPMENT; UBIQUITOUS CALPAINS; PRESSURE-OVERLOAD; RAT-HEART; DISRUPTION; REPAIR	Calpains make up a family of Ca2+-dependent intracellular cysteine proteases that include ubiquitously expressed mu- and m-calpains. Both are heterodimers consisting of a distinct large catalytic subunit (calpain 1 for mu-calpain and calpain 2 for m-calpain) and a common regulatory subunit (calpain 4). The physiological roles of calpain remain unclear in the organs, including the heart, but it has been suggested that calpain is activated by Ca2+ overload in diseased hearts, resulting in cardiac dysfunction. In this study, cardiac-specific calpain 4-deficient mice were generated to elucidate the role of calpain in the heart in response to hemodynamic stress. Cardiac-specific deletion of calpain 4 resulted in decreased protein levels of calpains 1 and 2 and showed no cardiac phenotypes under base-line conditions but caused left ventricle dilatation, contractile dysfunction, and heart failure with interstitial fibrosis 1 week after pressure overload. Pressure-overloaded calpain 4-deficient hearts took up a membrane-impermeant dye, Evans blue, indicating plasma membrane disruption. Membrane repair assays using a two-photon laser-scanning microscope revealed that calpain 4-deficient cardiomyocytes failed to reseal a plasma membrane that had been disrupted by laser irradiation. Thus, the data indicate that calpain protects the heart from hemodynamic stresses, such as pressure overload.	[Takeda, Toshihiro; Oka, Takafumi; Tamai, Takahito; Oyabu, Jota; Murakawa, Tomokazu; Otsu, Kinya] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Takeda, Junji] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka 5650871, Japan; [Nakayama, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol & Pharmacogen, Suita, Osaka 5650871, Japan; [Mochizuki, Naoki] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Cell Biol, Osaka 5658565, Japan	Osaka University; Osaka University; Osaka University; National Cerebral & Cardiovascular Center - Japan	Otsu, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kotsu@medone.med.osaka-u.ac.jp	Hikoso, Shungo/R-4281-2018	Yamaguchi, Osamu/0000-0002-7461-369X; Hikoso, Shungo/0000-0003-2284-1970	Ministry of Education, Culture, Sports, Science, and Technology	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology.	Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bertoli C, 2009, ONCOGENE, V28, P721, DOI 10.1038/onc.2008.425; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; Chen M, 2002, J BIOL CHEM, V277, P29181, DOI 10.1074/jbc.M204951200; Demarchi F, 2006, J CELL BIOL, V175, P595, DOI 10.1083/jcb.200601024; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Dutt P, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-3; Galvez AS, 2007, CIRC RES, V100, P1071, DOI 10.1161/01.RES.0000261938.28365.11; Gao WD, 1997, CIRC RES, V80, P393, DOI 10.1161/01.res.0000435855.49359.47; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Greyson CR, 2008, J MOL CELL CARDIOL, V44, P59, DOI 10.1016/j.yjmcc.2007.10.010; Han R, 2007, J CLIN INVEST, V117, P1805, DOI 10.1172/JCI30848; Hikoso S, 2009, CIRC RES, V105, P70, DOI 10.1161/CIRCRESAHA.108.193318; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Iwamoto H, 1999, J CARDIOVASC PHARM, V33, P580, DOI 10.1097/00005344-199904000-00010; Khalil PN, 2005, EUR J PHARMACOL, V528, P124, DOI 10.1016/j.ejphar.2005.10.032; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Larsen AK, 2008, BIOCHEM J, V411, P657, DOI 10.1042/BJ20070522; Mani SK, 2008, AM J PHYSIOL-HEART C, V295, pH314, DOI 10.1152/ajpheart.00085.2008; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; McNeil PL, 2001, NAT CELL BIOL, V3, pE124, DOI 10.1038/35074652; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Molinari M, 1997, J MEMBRANE BIOL, V156, P1, DOI 10.1007/s002329900181; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Papp Z, 2000, CARDIOVASC RES, V45, P981, DOI 10.1016/S0008-6363(99)00374-0; Shao HS, 2006, MOL CELL BIOL, V26, P5481, DOI 10.1128/MCB.02243-05; Shimada M, 2008, J BIOL CHEM, V283, P21002, DOI 10.1074/jbc.M710354200; Singh RB, 2004, J MOL CELL CARDIOL, V37, P101, DOI 10.1016/j.yjmcc.2004.04.009; Suryakumar G, 2010, J CARDIOVASC PHARM, V55, P567, DOI 10.1097/FJC.0b013e3181d9f5d4; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Tan Y, 2006, GENESIS, V44, P297, DOI 10.1002/dvg.20216; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Tsuji T, 2001, AM J PHYSIOL-HEART C, V281, pH1286, DOI 10.1152/ajpheart.2001.281.3.H1286; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Zimmerman UJP, 2000, IUBMB LIFE, V50, P63	40	39	39	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32170	32177		10.1074/jbc.M111.248088	http://dx.doi.org/10.1074/jbc.M111.248088			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795695	Green Published, hybrid			2022-12-25	WOS:000294726800027
J	Thomas, SV; Kathpalia, PP; Rajagopal, M; Charlton, C; Zhang, JN; Eaton, DC; Helms, MN; Pao, AC				Thomas, Sheela V.; Kathpalia, Paru P.; Rajagopal, Madhumitha; Charlton, Carol; Zhang, Jianning; Eaton, Douglas C.; Helms, My N.; Pao, Alan C.			Epithelial Sodium Channel Regulation by Cell Surface-associated Serum- and Glucocorticoid-regulated Kinase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLECTING DUCT CELLS; ALDOSTERONE-INDUCED KINASE; INDUCIBLE PROTEIN-KINASE; NA+ CHANNEL; LIDDLES-SYNDROME; MOUSE MODEL; MINERALOCORTICOID REGULATION; UBIQUITIN LIGASE; APICAL MEMBRANE; PLASMA-MEMBRANE	Serum- and glucocorticoid-regulated kinase 1 (sgk1) participates in diverse biological processes, including cell growth, apoptosis, and sodium homeostasis. In the cortical collecting duct of the kidney, sgk1 regulates sodium transport by stimulating the epithelial sodium channel (ENaC). Control of subcellular localization of sgk1 may be an important mechanism for modulating specificity of sgk1 function; however, which subcellular locations are required for sgk1-regulated ENaC activity in collecting duct cells has yet to be established. Using cell surface biotinylation studies, we detected endogenous sgk1 at the apical cell membrane of aldosterone-stimulated mpkCCD(c14) collecting duct cells. The association of sgk1 with the cell membrane was enhanced when ENaC was co-transfected with sgk1 in kidney cells, suggesting that ENaC brings sgk1 to the cell surface. Furthermore, association of endogenous sgk1 with the apical cell membrane of mpkCCD(c14) cells could be modulated by treatments that increase or decrease ENaC expression at the apical membrane; forskolin increased the association of sgk1 with the apical surface, whereas methyl-beta-cyclodextrin decreased the association of sgk1 with the apical surface. Single channel recordings of excised inside-out patches from the apical membrane of aldosterone-stimulated A6 collecting duct cells revealed that the open probability of ENaC was sensitive to the sgk1 inhibitor GSK650394, indicating that endogenous sgk1 is functionally active at the apical cell membrane. We propose that the association of sgk1 with the apical cell membrane, where it interacts with ENaC, is a novel means by which sgk1 specifically enhances ENaC activity in aldosterone-stimulated collecting duct cells.	[Thomas, Sheela V.; Kathpalia, Paru P.; Rajagopal, Madhumitha; Charlton, Carol; Pao, Alan C.] Stanford Univ, Dept Med, Div Nephrol, Stanford, CA 94305 USA; [Zhang, Jianning] Univ Texas SW Med Ctr Dallas, Div Nephrol, Dept Med, Dallas, TX 75390 USA; [Eaton, Douglas C.; Helms, My N.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA	Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University	Pao, AC (corresponding author), 780 Welch Rd,Ste 106, Palo Alto, CA 94304 USA.	paoman@stanford.edu		Eaton, Douglas/0000-0002-2686-6692	National Institutes of Health [K08-DK-073487, R00-HL-09222601, P30-DK-079328, T32-DK07357-26A1]; Stanford University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL092226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079328, T32DK007357, K08DK073487] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford University(Stanford University); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K08-DK-073487 (to A. C. P.), R00-HL-09222601 (to M. N. H.), P30-DK-079328 (to J. Z.), and T32-DK07357-26A1 (to P. P. K.). This work was also supported by Stanford University Dean's Fellowship award (to S. V. T.).	Arteaga MF, 2008, P NATL ACAD SCI USA, V105, P4459, DOI 10.1073/pnas.0800958105; Arteaga MF, 2007, MOL BIOL CELL, V18, P2072, DOI 10.1091/mbc.E06-10-0968; Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; Auberson M, 2003, AM J PHYSIOL-RENAL, V285, pF459, DOI 10.1152/ajprenal.00071.2003; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bertog M, 2008, J PHYSIOL-LONDON, V586, P459, DOI 10.1113/jphysiol.2007.140459; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bogusz AM, 2006, FEBS J, V273, P2913, DOI 10.1111/j.1742-4658.2006.05304.x; Brickley DR, 2002, J BIOL CHEM, V277, P43064, DOI 10.1074/jbc.M207604200; Buse P, 1999, J BIOL CHEM, V274, P7253, DOI 10.1074/jbc.274.11.7253; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Cordas E, 2007, AM J PHYSIOL-CELL PH, V292, pC1971, DOI 10.1152/ajpcell.00399.2006; Dahlmann A, 2003, AM J PHYSIOL-RENAL, V285, pF310, DOI 10.1152/ajprenal.00016.2003; de la Rosa DA, 2006, AM J PHYSIOL-CELL PH, V290, pC492, DOI 10.1152/ajpcell.00556.2004; de la Rosa DA, 2003, J PHYSIOL-LONDON, V551, P455, DOI 10.1113/jphysiol.2003.042903; de la Rosa DA, 1999, J BIOL CHEM, V274, P37834, DOI 10.1074/jbc.274.53.37834; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; Engelsberg A, 2006, BIOCHEM J, V399, P69, DOI 10.1042/BJ20060386; Flores SY, 2005, J AM SOC NEPHROL, V16, P2279, DOI 10.1681/ASN.2004100828; Hill WG, 2007, J BIOL CHEM, V282, P37402, DOI 10.1074/jbc.M704084200; Hill WG, 2002, J BIOL CHEM, V277, P33541, DOI 10.1074/jbc.C200309200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Krueger B, 2009, CELL PHYSIOL BIOCHEM, V24, P605, DOI 10.1159/000257516; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lee IH, 2009, J BIOL CHEM, V284, P12663, DOI 10.1074/jbc.M809737200; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; Loffing J, 2001, AM J PHYSIOL-RENAL, V280, pF675, DOI 10.1152/ajprenal.2001.280.4.F675; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Maiyar AC, 2003, MOL BIOL CELL, V14, P1221, DOI 10.1091/mbc.E02-03-0170; Morris RG, 2002, J GEN PHYSIOL, V120, P71, DOI 10.1085/jgp.20018547; Naray-Fejes-Toth A, 2004, MOL CELL ENDOCRINOL, V217, P197, DOI 10.1016/j.mce.2003.10.043; Naray-Fejes-Toth A, 1999, J BIOL CHEM, V274, P16973, DOI 10.1074/jbc.274.24.16973; Pao AC, 2007, AM J PHYSIOL-RENAL, V292, pF1741, DOI 10.1152/ajprenal.00027.2007; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Pradervand S, 2003, J AM SOC NEPHROL, V14, P2219, DOI 10.1097/01.ASN.0000080204.65527.E6; Raikwar NS, 2008, AM J PHYSIOL-RENAL, V295, pF1440, DOI 10.1152/ajprenal.90239.2008; Rajagopal M., 2011, AM J PHYSL IN PRESS; Rajagopal M, 2010, HYPERTENSION, V55, P1123, DOI 10.1161/HYPERTENSIONAHA.109.143404; Setiawan I, 2002, PFLUG ARCH EUR J PHY, V444, P426, DOI 10.1007/s00424-002-0823-z; Sherk AB, 2008, CANCER RES, V68, P7475, DOI 10.1158/0008-5472.CAN-08-1047; Shigaev A, 2000, AM J PHYSIOL-RENAL, V278, pF613, DOI 10.1152/ajprenal.2000.278.4.F613; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Snyder PM, 2000, J CLIN INVEST, V105, P45, DOI 10.1172/JCI7869; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; Wang J, 2001, AM J PHYSIOL-RENAL, V280, pF303, DOI 10.1152/ajprenal.2001.280.2.F303; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200; Zecevic M, 2004, PFLUG ARCH EUR J PHY, V448, P29, DOI 10.1007/s00424-003-1222-9; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	54	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32074	32085		10.1074/jbc.M111.278283	http://dx.doi.org/10.1074/jbc.M111.278283			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784856	hybrid, Green Published			2022-12-25	WOS:000294726800017
J	Yoshida, S; Hong, SK; Suzuki, T; Nada, S; Mannan, AM; Wang, JY; Okada, M; Guan, KL; Inoki, K				Yoshida, Sei; Hong, Sungki; Suzuki, Tsukasa; Nada, Shigeyuki; Mannan, Aristotle M.; Wang, Junying; Okada, Masato; Guan, Kun-Liang; Inoki, Ken			Redox Regulates Mammalian Target of Rapamycin Complex 1 (mTORC1) Activity by Modulating the TSC1/TSC2-Rheb GTPase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS COMPLEX; AMINO-ACID SUFFICIENCY; TSC2 GAP ACTIVITY; CELL-GROWTH; AFFINITY-CHROMATOGRAPHY; PROTEIN-KINASE; PHENYLARSINE OXIDE; GENE-PRODUCTS; RAG GTPASES; S6 KINASE	Mammalian target of rapamycin (mTOR) is a kinase that plays a key role in a wide array of cellular processes and exists in two distinct functional complexes, mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). Although mTORC2 is primarily activated by growth factors, mTORC1 is regulated by numerous extracellular and intracellular signals such as nutrients, growth factors, and cellular redox. Previous study has shown that cysteine oxidants sufficiently activate mTORC1 activity under amino acid-depleted conditions and that a reducing agent effectively suppresses amino acid-induced mTORC1 activity, thereby raising the possibility that redox-sensitive mechanisms underlie amino acid-dependent mTORC1 regulation. However, the molecular mechanism by which redox regulates mTORC1 activity is not well understood. In this study, we show that the redox-sensitive regulation of mTORC1 occurs via Rheb but not the Rag small GTPase. Enhancing cellular redox potential with cysteine oxidants significantly increases Rheb GTP levels. Importantly, modulation of the cellular redox potential with a cysteine oxidant or reducing agent failed to alter mTORC1 activity in TSC1(-/-) or TSC2(-/-) mouse embryonic fibroblast cells. Furthermore, a cysteine oxidant has little effect on mTOR localization but sufficiently activates mTORC1 activity in both p18(-/-) and control mouse embryonic fibroblast cells, suggesting that the redox-sensitive regulation of mTORC1 occurs independent of the Ragulator.Rag complex. Taken together, our results suggest that the TSC complex plays an important role in redox-sensitive mTORC1 regulation and argues for the activation of mTORC1 in places other than the lysosome upon inhibition of the TSC complex.	[Yoshida, Sei; Hong, Sungki; Suzuki, Tsukasa; Mannan, Aristotle M.; Wang, Junying; Inoki, Ken] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Inoki, Ken] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Inoki, Ken] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Nada, Shigeyuki; Okada, Masato] Osaka Univ, Dept Oncogene Res, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, Moores Canc Ctr, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Osaka University; University of California System; University of California San Diego	Inoki, K (corresponding author), 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	inokik@umich.edu	Guan, Kun-Liang/ADK-7088-2022	Yoshida, Sei/0000-0002-4771-3900	National Institutes of Health [DK083491]; NATIONAL CANCER INSTITUTE [R01CA108941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK083491 (to K. I.).	Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Bogumil R, 2002, METHOD ENZYMOL, V348, P271, DOI 10.1016/S0076-6879(02)48645-4; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; FROST SC, 1990, BIOCHEM J, V269, P589, DOI 10.1042/bj2690589; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hipkiss AR, 2006, ANN NY ACAD SCI, V1067, P361, DOI 10.1196/annals.1354.051; HOFFMAN RD, 1992, J BIOL CHEM, V267, P14005; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; KALEF E, 1994, METHOD ENZYMOL, V233, P395; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; KOSOWER EM, 1995, METHOD ENZYMOL, V251, P133, DOI 10.1016/0076-6879(95)51117-2; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sarkar S, 2011, MOL CELL, V43, P19, DOI 10.1016/j.molcel.2011.04.029; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Takahashi T, 2000, GENES CELLS, V5, P765, DOI 10.1046/j.1365-2443.2000.00365.x; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Urano J, 2001, METHOD ENZYMOL, V333, P217; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; vonManteuffel SR, 1996, P NATL ACAD SCI USA, V93, P4076, DOI 10.1073/pnas.93.9.4076; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zheng M, 2011, NAT CELL BIOL, V13, P263, DOI 10.1038/ncb2168; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	55	109	112	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32651	32660		10.1074/jbc.M111.238014	http://dx.doi.org/10.1074/jbc.M111.238014			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784859	Green Published, hybrid			2022-12-25	WOS:000294726800074
J	DeMaso, CR; Kovacevic, I; Uzun, A; Cram, EJ				DeMaso, Christina R.; Kovacevic, Ismar; Uzun, Alper; Cram, Erin J.			Structural and Functional Evaluation of C. elegans Filamins FLN-1 and FLN-2	PLOS ONE			English	Article							A ABP-280 MOLECULES; ACTIN CROSS-LINKING; SEIZURE SUPPRESSION; DROSOPHILA FILAMIN; CELL MOTILITY; BINDING; MODEL; MUTATIONS; DOMAIN; GENE	Filamins are long, flexible, multi-domain proteins composed of an N-terminal actin-binding domain (ABD) followed by multiple immunoglobulin-like repeats (IgFLN). They function to organize and maintain the actin cytoskeleton, to provide scaffolds for signaling components, and to act as mechanical force sensors. In this study, we used transcript sequencing and homology modeling to characterize the gene and protein structures of the C. elegans filamin orthologs fln-1 and fln-2. Our results reveal that C. elegans FLN-1 is well conserved at the sequence level to vertebrate filamins, particularly in the ABD and several key IgFLN repeats. Both FLN-1 and the more divergent FLN-2 colocalize with actin in vivo. FLN-2 is poorly conserved, with at least 23 IgFLN repeats interrupted by large regions that appear to be nematode-specific. Our results indicate that many of the key features of vertebrate filamins are preserved in C. elegans FLN-1 and FLN-2, and suggest the nematode may be a very useful model system for further study of filamin function.	[DeMaso, Christina R.; Kovacevic, Ismar; Cram, Erin J.] Northeastern Univ, Dept Biol, Ctr Interdisciplinary Res Complex Syst, Boston, MA 02115 USA; [Uzun, Alper] Brown Univ, Dept Pediat, Women & Infants Hosp Rhode Isl, Ctr Computat Mol Biol,Brown Alpert Med Sch, Providence, RI 02912 USA	Northeastern University; Brown University; Women & Infants Hospital Rhode Island	DeMaso, CR (corresponding author), Northeastern Univ, Dept Biol, Ctr Interdisciplinary Res Complex Syst, Boston, MA 02115 USA.	e.cram@neu.edu		Uzun, Alper/0000-0001-6489-8591	National Institutes of Health (NIH) [R01 GM85077]; Northeastern University, Boston, Massachusetts; National Center for Research Resources, National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085077] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeastern University, Boston, Massachusetts; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health (NIH) R01 GM85077 to E.J. Cram partially supported this study (www.nih.gov). Other funding came from internal startup funds provided by Northeastern University, Boston, Massachusetts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; C. elegans strain N2 was provided by the Caenorhabditis Genetic Center, which is funded by the National Center for Research Resources, National Institutes of Health. We thank Hiba Tannoury, Melissa LaBonty, and Jose Orozco for critical reading of the manuscript, and Valentin Ilyin for helpful discussions.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Bicknell LS, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029967; Blumenthal Thomas, 2005, WormBook, P1, DOI 10.1895/wormbook.1.5.1; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bosher JM, 2003, J CELL BIOL, V161, P757, DOI 10.1083/jcb.200302151; BRENNER S, 1974, GENETICS, V77, P71; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CONRAD R, 1991, MOL CELL BIOL, V11, P1921, DOI 10.1128/MCB.11.4.1921; Corsi AK, 2006, ANAL BIOCHEM, V359, P1, DOI 10.1016/j.ab.2006.07.033; Cox EA, 2004, J CELL SCI, V117, P1885, DOI 10.1242/jcs.01176; Cram EJ, 2003, J CELL SCI, V116, P3871, DOI 10.1242/jcs.00705; DAVIES PJA, 1980, BIOCHEMISTRY-US, V19, P1366, DOI 10.1021/bi00548a015; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; FURUHASHI K, 1992, BIOCHEM BIOPH RES CO, V184, P1261, DOI 10.1016/S0006-291X(05)80018-X; Furuike S, 2001, FEBS LETT, V498, P72, DOI 10.1016/S0014-5793(01)02497-8; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; GETTNER SN, 1995, J CELL BIOL, V129, P1127, DOI 10.1083/jcb.129.4.1127; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Heikkinen OK, 2009, J BIOL CHEM, V284, P25450, DOI 10.1074/jbc.M109.019661; Hekmat-Scafe DS, 2006, J NEUROSCI, V26, P8943, DOI 10.1523/JNEUROSCI.4998-05.2006; Hekmat-Scafe DS, 2005, GENETICS, V169, P1477, DOI 10.1534/genetics.104.036558; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hidalgo-Bravo A, 2005, AM J MED GENET A, V136A, P190, DOI 10.1002/ajmg.a.30792; Ithychanda SS, 2009, J BIOL CHEM, V284, P35113, DOI 10.1074/jbc.M109.060954; Jeon YJ, 2008, MOL BIOL CELL, V19, P5116, DOI 10.1091/mbc.E08-06-0576; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kesner BA, 2010, MOL BIOL EVOL, V27, P283, DOI 10.1093/molbev/msp236; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kovacevic I, 2010, DEV BIOL, V347, P247, DOI 10.1016/j.ydbio.2010.08.005; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; LEBART MC, 1994, J BIOL CHEM, V269, P4279; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li MG, 1999, J CELL BIOL, V146, P1061, DOI 10.1083/jcb.146.5.1061; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; Lundquist Erik A, 2006, WormBook, P1; Marti A, 1997, J BIOL CHEM, V272, P2620, DOI 10.1074/jbc.272.5.2620; McCoy AJ, 1999, NAT STRUCT BIOL, V6, P836; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nakamura F, 2005, J BIOL CHEM, V280, P32426, DOI 10.1074/jbc.M502203200; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Olguin P, 2011, CURR BIOL, V21, P236, DOI 10.1016/j.cub.2011.01.001; Onoprishvili I, 2003, MOL PHARMACOL, V64, P1092, DOI 10.1124/mol.64.5.1092; PENTIKAINEN U, 2011, J BIOL CHEM IN PRESS; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Popowicz GM, 2004, J MOL BIOL, V342, P1637, DOI 10.1016/j.jmb.2004.08.017; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sawyer GM, 2009, J MOL BIOL, V390, P1030, DOI 10.1016/j.jmb.2009.06.009; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sjekloca L, 2007, J MOL BIOL, V368, P1011, DOI 10.1016/j.jmb.2007.02.018; Sokol NS, 1999, CURR BIOL, V9, P1221, DOI 10.1016/S0960-9822(99)80502-8; Sokol NS, 2003, DEV BIOL, V260, P260, DOI 10.1016/S0012-1606(03)00248-3; Song J, 2006, J NEUROPHYSIOL, V95, P627, DOI 10.1152/jn.01059.2004; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Tigges U, 2003, J BIOL CHEM, V278, P23561, DOI 10.1074/jbc.M302302200; WEIHING RR, 1988, BIOCHEMISTRY-US, V27, P1865, DOI 10.1021/bi00406a011; WINDER SJ, 1995, J CELL SCI, V108, P63; Yamazaki M, 2002, J MUSCLE RES CELL M, V23, P525, DOI 10.1023/A:1023418725001; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	69	12	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22428	10.1371/journal.pone.0022428	http://dx.doi.org/10.1371/journal.pone.0022428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799850	Green Published, Green Submitted, gold			2022-12-25	WOS:000293172900029
J	Liu, P; Chen, ZC; Jones, JA; Huang, DF; Liu, HJ				Liu, Peng; Chen, Zhaocong; Jones, Jeffery A.; Huang, Dongfeng; Liu, Hanjun			Auditory Feedback Control of Vocal Pitch during Sustained Vocalization: A Cross-Sectional Study of Adult Aging	PLOS ONE			English	Article							AGE-RELATED-CHANGES; VOICE FUNDAMENTAL-FREQUENCY; EVENT-RELATED POTENTIALS; NEURAL REPRESENTATION; SPEECH PRODUCTION; F-0 RESPONSES; PERTURBATIONS; TRACT; SPEAKING; CHILDREN	Background: Auditory feedback has been demonstrated to play an important role in the control of voice fundamental frequency (F(0)), but the mechanisms underlying the processing of auditory feedback remain poorly understood. It has been well documented that young adults can use auditory feedback to stabilize their voice F(0) by making compensatory responses to perturbations they hear in their vocal pitch feedback. However, little is known about the effects of aging on the processing of audio-vocal feedback during vocalization. Methodology/Principal Findings: In the present study, we recruited adults who were between 19 and 75 years of age and divided them into five age groups. Using a pitch-shift paradigm, the pitch of their vocal feedback was unexpectedly shifted +/- 50 or +/- 100 cents during sustained vocalization of the vowel sound/u/. Compensatory vocal F(0) response magnitudes and latencies to pitch feedback perturbations were examined. A significant effect of age was found such that response magnitudes increased with increasing age until maximal values were reached for adults 51-60 years of age and then decreased for adults 61-75 years of age. Adults 51-60 years of age were also more sensitive to the direction and magnitude of the pitch feedback perturbations compared to younger adults. Conclusion: These findings demonstrate that the pitch-shift reflex systematically changes across the adult lifespan. Understanding aging-related changes to the role of auditory feedback is critically important for our theoretical understanding of speech production and the clinical applications of that knowledge.	[Liu, Peng; Chen, Zhaocong; Huang, Dongfeng; Liu, Hanjun] Sun Yat Sen Univ, Dept Rehabil Med, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Jones, Jeffery A.] Wilfrid Laurier Univ, Dept Psychol, Waterloo, ON N2L 3C5, Canada; [Jones, Jeffery A.] Wilfrid Laurier Univ, Laurier Ctr Cognit Neurosci, Waterloo, ON N2L 3C5, Canada	Sun Yat Sen University; Wilfrid Laurier University; Wilfrid Laurier University	Liu, P (corresponding author), Sun Yat Sen Univ, Dept Rehabil Med, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.	lhanjun@mail.sysu.edu.cn		Liu, Hanjun/0000-0003-1466-4193; Chen, Zhaocong/0000-0002-0144-2754	National Natural Science Foundation of China [30970965, 31070990]; Natural Science Foundation of Guangdong Province [9151008901000053]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by National Natural Science Foundation of China (30970965 and 31070990) and Natural Science Foundation of Guangdong Province (9151008901000053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenedo E, 1998, BIOL PSYCHIAT, V43, P210, DOI 10.1016/S0006-3223(97)00255-2; Baker KK, 1998, NEUROLOGY, V51, P1592, DOI 10.1212/WNL.51.6.1592; Ballard KJ, 2001, J SPEECH LANG HEAR R, V44, P763, DOI 10.1044/1092-4388(2001/060); Bellis TJ, 2000, J NEUROSCI, V20, P791, DOI 10.1523/JNEUROSCI.20-02-00791.2000; Boersma P, 2001, GLOT INT, V5, P341; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; Chen SH, 2007, J ACOUST SOC AM, V121, P1157, DOI 10.1121/1.2404624; Chen ZC, 2010, J ACOUST SOC AM, V128, pEL355, DOI 10.1121/1.3509124; Cowie R., 1992, POSTLINGUALLY ACQUIR; DASILVA PT, J VOICE IN PRESS; Decoster W., 1997, Acta Oto-Rhino-Laryngologica Belgica, V51, P105; Elliott L., 1970, INT AUDIOL, VIX, P47; ENOKI H, 1993, COGNITIVE BRAIN RES, V1, P161, DOI 10.1016/0926-6410(93)90023-X; Geal-Dor M, 2006, CLIN NEUROPHYSIOL, V117, P1974, DOI 10.1016/j.clinph.2006.05.024; Gorham-Rowan MM, 2006, J COMMUN DISORD, V39, P171, DOI 10.1016/j.jcomdis.2005.11.005; Hain TC, 2000, EXP BRAIN RES, V130, P133, DOI 10.1007/s002219900237; HOLLIEN H, 1972, J SPEECH HEAR RES, V15, P155, DOI 10.1044/jshr.1501.155; Huber JE, 2008, J SPEECH LANG HEAR R, V51, P651, DOI 10.1044/1092-4388(2008/047); Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Jones JA, 2002, J PHONETICS, V30, P303, DOI 10.1006/jpho.2001.0160; Kiran S, 2001, J SPEECH LANG HEAR R, V44, P975, DOI 10.1044/1092-4388(2001/076); Kovacevic S, 2005, NEUROREPORT, V16, P1075, DOI 10.1097/00001756-200507130-00009; Larson CR, 2008, EXP BRAIN RES, V187, P613, DOI 10.1007/s00221-008-1330-z; Larson CR, 2001, J ACOUST SOC AM, V110, P2845, DOI 10.1121/1.1417527; Linville SE, 2001, J VOICE, V15, P323, DOI 10.1016/S0892-1997(01)00034-0; Liu HJ, 2007, J ACOUST SOC AM, V122, P3671, DOI 10.1121/1.2800254; Liu HJ, 2011, J ACOUST SOC AM, V129, P3946, DOI 10.1121/1.3575593; Liu HJ, 2010, J ACOUST SOC AM, V128, P3739, DOI 10.1121/1.3500675; Liu HJ, 2010, J ACOUST SOC AM, V127, P1042, DOI 10.1121/1.3273880; Liu P, 2010, J ACOUST SOC AM, V128, P1306, DOI 10.1121/1.3467773; Matilainen LE, 2010, CLIN NEUROPHYSIOL, V121, P902, DOI 10.1016/j.clinph.2010.01.007; Murbe D, 2002, J VOICE, V16, P44, DOI 10.1016/S0892-1997(02)00071-1; Natke U, 2003, J ACOUST SOC AM, V113, P1587, DOI 10.1121/1.1543928; Natke U, 2001, J SPEECH LANG HEAR R, V44, P577, DOI 10.1044/1092-4388(2001/045); Ramig LO, 2001, FOLIA PHONIATR LOGO, V53, P252, DOI 10.1159/000052680; RASTATTER MP, 1990, FOLIA PHONIATR, V42, P312, DOI 10.1159/000266088; Russo N, 2008, EXP BRAIN RES, V188, P111, DOI 10.1007/s00221-008-1348-2; Sataloff RT, 1997, J VOICE, V11, P156, DOI 10.1016/S0892-1997(97)80072-0; Schneider BA, 2005, PSYCHOL AGING, V20, P261, DOI 10.1037/0882-7974.20.2.261; SMITH KU, 1962, DELAYED SENSORY FEED; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Stephen JM, 2010, NEUROSCI LETT, V484, P76, DOI 10.1016/j.neulet.2010.08.023; SVIRSKY MA, 1992, J ACOUST SOC AM, V92, P1284, DOI 10.1121/1.403923; Torre P, 2009, J COMMUN DISORD, V42, P324, DOI 10.1016/j.jcomdis.2009.03.001; Tremblay KL, 2002, NEUROREPORT, V13, P1865, DOI 10.1097/00001756-200210280-00007; Xue SA, 2003, J SPEECH LANG HEAR R, V46, P689, DOI 10.1044/1092-4388(2003/054)	46	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22791	10.1371/journal.pone.0022791	http://dx.doi.org/10.1371/journal.pone.0022791			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	798AP	21799942	Green Published, gold, Green Submitted			2022-12-25	WOS:000293172900073
J	Nishijima, T; Komatsu, H; Gatanaga, H; Aoki, T; Watanabe, K; Kinai, E; Honda, H; Tanuma, J; Yazaki, H; Tsukada, K; Honda, M; Teruya, K; Kikuchi, Y; Oka, S				Nishijima, Takeshi; Komatsu, Hirokazu; Gatanaga, Hiroyuki; Aoki, Takahiro; Watanabe, Koji; Kinai, Ei; Honda, Haruhito; Tanuma, Junko; Yazaki, Hirohisa; Tsukada, Kunihisa; Honda, Miwako; Teruya, Katsuji; Kikuchi, Yoshimi; Oka, Shinichi			Impact of Small Body Weight on Tenofovir-Associated Renal Dysfunction in HIV-Infected Patients: A Retrospective Cohort Study of Japanese Patients	PLOS ONE			English	Article							ANTIRETROVIRAL-NAIVE PATIENTS; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; CALCULATED CREATININE CLEARANCE; CHRONIC KIDNEY-DISEASE; DISOPROXIL FUMARATE; TUBULAR DYSFUNCTION; RISK-FACTORS; FUNCTION DECLINE; FANCONI-SYNDROME; THERAPY	Background: Treatment with tenofovir is sometimes associated with renal dysfunction. Limited information is available on this side effect in patients with small body weight, although the use of tenofovir will spread rapidly in Asia and Africa, where patients are likely to be of smaller body weight. Methods: In a single-center cohort, Japanese patients with HIV infection who started tenofovir-containing antiretroviral therapy were retrospectively analyzed. The incidence of tenofovir-associated renal dysfunction, defined as more than 25% decrement of estimated glomerular filtration rate (eGFR) from the baseline, was determined. The effects of small body weight and body mass index (BMI) on tenofovir-associated renal dysfunction, respectively, were estimated in univariate and multivariate Cox hazards models as the primary exposure. Other possible risk factors were evaluated by univariate analysis and those found significant were entered into the multivariate analysis. Results: The median weight of 495 patients was 63 kg. Tenofovir-related renal dysfunction occurred in 97 (19.6%) patients (incidence: 10.5 per 100 person-years). Univariate analysis showed that the incidence of tenofovir-related renal dysfunction was significantly associated with smaller body weight and BMI, respectively (per 5 kg decrement, HR = 1.23; 95% CI, 1.10-1.37; p<0.001)(per 1 kg/m(2) decrement, HR = 1.14; 95% CI, 1.05-1.23; p = 0.001). Old age, high baseline eGFR, low serum creatinine, low CD4 count, high HIV viral load, concurrent nephrotoxic drugs, hepatitis C infection, and current smoking were also associated with tenofovir-related renal dysfunction. Multivariate analysis identified small body weight as a significant risk (adjusted HR = 1.13; 95% CI, 1.01-1.27; p = 0.039), while small BMI had marginal significance (adjusted HR = 1.07; 95% CI 1.00-1.16; p = 0.058). Conclusion: The incidence of tenofovir-associated renal dysfunction in Japanese patients was high. Small body weight was identified as an independent risk factor for tenofovir-associated renal dysfunction. Close monitoring of renal function is advocated for patients with small body weight treated with tenofovir.	[Nishijima, Takeshi; Gatanaga, Hiroyuki; Aoki, Takahiro; Watanabe, Koji; Kinai, Ei; Honda, Haruhito; Tanuma, Junko; Yazaki, Hirohisa; Tsukada, Kunihisa; Honda, Miwako; Teruya, Katsuji; Kikuchi, Yoshimi; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Komatsu, Hirokazu] Saku Cent Hosp, Dept Community Care, Nagano, Japan; [Nishijima, Takeshi; Gatanaga, Hiroyuki; Watanabe, Koji; Oka, Shinichi] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan	National Center for Global Health & Medicine - Japan; Kumamoto University	Nishijima, T (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	tnishiji@acc.ncgm.go.jp	Tanuma, Junko/AAE-5395-2020	Oka, Shinichi/0000-0002-9283-2167	Ministry of Health, Labor, and Welfare of Japan [H20-AIDS-002]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for AIDS Research from the Ministry of Health, Labor, and Welfare of Japan (H20-AIDS-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou T, 2005, HIV MED, V6, P284, DOI 10.1111/j.1468-1293.2005.00308.x; Arribas JR, 2008, JAIDS-J ACQ IMM DEF, V47, P74, DOI 10.1097/QAI.0b013e31815acab8; Bash LD, 2009, AM J EPIDEMIOL, V170, P414, DOI 10.1093/aje/kwp151; Baxmann AC, 2008, CLIN J AM SOC NEPHRO, V3, P348, DOI 10.2215/CJN.02870707; Chaisiri K, 2010, CURR HIV RES, V8, P504, DOI 10.2174/157016210793499259; CHUE CD, 2011, NEPHROL DIAL TRANSPL, DOI DOI 10.1093/NDT/GFQ78; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Fux CA, 2007, ANTIVIR THER, V12, P1165; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gallant JE, 2008, AIDS, V22, P2155, DOI 10.1097/QAD.0b013e3283112b8e; Gatanaga H, 2006, AIDS RES HUM RETROV, V22, P744, DOI 10.1089/aid.2006.22.744; Gayet-Ageron A, 2007, J ANTIMICROB CHEMOTH, V59, P1034, DOI 10.1093/jac/dkm064; Goicoechea M, 2008, J INFECT DIS, V197, P102, DOI 10.1086/524061; Gupta SK, 2005, CLIN INFECT DIS, V40, P1559, DOI 10.1086/430257; Horberg M, 2010, JAIDS-J ACQ IMM DEF, V53, P62, DOI 10.1097/QAI.0b013e3181be6be2; Izzedine H, 2005, NEPHROL DIAL TRANSPL, V20, P743, DOI 10.1093/ndt/gfh658; Jullien V, 2005, ANTIMICROB AGENTS CH, V49, P3361, DOI 10.1128/AAC.49.8.3361-3366.2005; Kinai E, 2009, AIDS RES HUM RETROV, V25, P387, DOI 10.1089/aid.2008.0202; Kiser JJ, 2008, ANTIMICROB AGENTS CH, V52, P631, DOI 10.1128/AAC.00761-07; Kohler JJ, 2009, LAB INVEST, V89, P513, DOI 10.1038/labinvest.2009.14; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lomaestro BM, 2000, DRUG SAFETY, V22, P479, DOI 10.2165/00002018-200022060-00006; Nelson MR, 2007, AIDS, V21, P1273, DOI 10.1097/QAD.0b013e3280b07b33; Peyriere H, 2004, JAIDS-J ACQ IMM DEF, V35, P269, DOI 10.1097/00126334-200403010-00007; Post FA, 2010, JAIDS-J ACQ IMM DEF, V55, P49, DOI 10.1097/QAI.0b013e3181dd911e; Post FA, 2009, CURR OPIN INFECT DIS, V22, P43, DOI 10.1097/QCO.0b013e328320ffec; Reid A, 2008, CLIN INFECT DIS, V46, P1271, DOI 10.1086/533468; Rodriguez-Novoa S, 2009, CLIN INFECT DIS, V48, pE108, DOI 10.1086/598507; Rollot F, 2003, CLIN INFECT DIS, V37, pE174, DOI 10.1086/379829; Schaaf B, 2003, CLIN INFECT DIS, V37, pE41, DOI 10.1086/376643; Szczech LA, 2004, CLIN INFECT DIS, V39, P1199, DOI 10.1086/424013; Van Rompay KKA, 2008, ANTIMICROB AGENTS CH, V52, P3144, DOI 10.1128/AAC.00350-08; Verhelst D, 2002, AM J KIDNEY DIS, V40, P1331, DOI 10.1053/ajkd.2002.36924; Wever K, 2010, JAIDS-J ACQ IMM DEF, V55, P78, DOI 10.1097/QAI.0b013e3181d05579; Winston A, 2006, HIV MED, V7, P105, DOI 10.1111/j.1468-1293.2006.00349.x	36	78	85	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22661	10.1371/journal.pone.0022661	http://dx.doi.org/10.1371/journal.pone.0022661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799928	gold, Green Submitted, Green Published			2022-12-25	WOS:000293172900064
J	Pedroza, M; Schneider, DJ; Karmouty-Quintana, H; Coote, J; Shaw, S; Corrigan, R; Molina, JG; Alcorn, JL; Galas, D; Gelinas, R; Blackburn, MR				Pedroza, Mesias; Schneider, Daniel J.; Karmouty-Quintana, Harry; Coote, Julie; Shaw, Stevan; Corrigan, Rebecca; Molina, Jose G.; Alcorn, Joseph L.; Galas, David; Gelinas, Richard; Blackburn, Michael R.			Interleukin-6 Contributes to Inflammation and Remodeling in a Model of Adenosine Mediated Lung Injury	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIRWAY INFLAMMATION; IL-6; RECEPTOR; FIBROSIS; EXPRESSION; IMMUNITY; CELLS; MICE; SUSCEPTIBILITY	Background: Chronic lung diseases are the third leading cause of death in the United States due in part to an incomplete understanding of pathways that govern the progressive tissue remodeling that occurs in these disorders. Adenosine is elevated in the lungs of animal models and humans with chronic lung disease where it promotes air-space destruction and fibrosis. Adenosine signaling increases the production of the pro-fibrotic cytokine interleukin-6 (IL-6). Based on these observations, we hypothesized that IL-6 signaling contributes to tissue destruction and remodeling in a model of chronic lung disease where adenosine levels are elevated. Methodology/Principal Findings: We tested this hypothesis by neutralizing or genetically removing IL-6 in adenosine deaminase (ADA)-deficient mice that develop adenosine dependent pulmonary inflammation and remodeling. Results demonstrated that both pharmacologic blockade and genetic removal of IL-6 attenuated pulmonary inflammation, remodeling and fibrosis in this model. The pursuit of mechanisms involved revealed adenosine and IL-6 dependent activation of STAT-3 in airway epithelial cells. Conclusions/Significance: These findings demonstrate that adenosine enhances IL-6 signaling pathways to promote aspects of chronic lung disease. This suggests that blocking IL-6 signaling during chronic stages of disease may provide benefit in halting remodeling processes such as fibrosis and air-space destruction.	[Pedroza, Mesias; Schneider, Daniel J.; Karmouty-Quintana, Harry; Corrigan, Rebecca; Molina, Jose G.; Blackburn, Michael R.] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX USA; [Pedroza, Mesias; Schneider, Daniel J.; Corrigan, Rebecca; Alcorn, Joseph L.; Blackburn, Michael R.] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX USA; [Coote, Julie; Shaw, Stevan] UCB Celltech, Slough, Berks, England; [Alcorn, Joseph L.] Univ Texas Med Sch Houston, Dept Pediat, Houston, TX USA; [Galas, David; Gelinas, Richard] Inst Syst Biol, Seattle, WA USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Celltech Group Ltd; University of Texas System; University of Texas Health Science Center Houston; Institute for Systems Biology (ISB)	Pedroza, M (corresponding author), Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX USA.	michael.r.blackburn@uth.tmc.edu	Karmouty-Quintana, Harry/ABC-9144-2020	Karmouty-Quintana, Harry/0000-0003-4753-9823; Blackburn, Michael/0000-0002-1394-9966	National Institutes of Health (NIH) [HL70952, HL095401]; Ford Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL095401, R01HL070952] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ford Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grant numbers HL70952 and HL095401 to Michael R. Blackburn and a Ford Foundation Fellowship to Mesias Pedroza. Julie Coote and Stevan Shaw are employees of UCB Celltech Inc., and contributed IL-6 neutralizing antibodies for use in this study, but no other financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; BELIKOFF BG, J LEUKOC BIOL, V64, P2444; Blackburn MR, 2000, J EXP MED, V192, P159, DOI 10.1084/jem.192.2.159; Blackburn MR, 2003, J CLIN INVEST, V112, P332, DOI 10.1172/JCI200316815; Blackburn MR, 1998, J BIOL CHEM, V273, P5093, DOI 10.1074/jbc.273.9.5093; CHAN ES, MOD RHEUMATOL, V20, P114; Chaouat A, 2009, CHEST, V136, P678, DOI 10.1378/chest.08-2420; Chunn JL, 2005, J IMMUNOL, V175, P1937, DOI 10.4049/jimmunol.175.3.1937; Chunn JL, 2001, J IMMUNOL, V167, P4676, DOI 10.4049/jimmunol.167.8.4676; Ding CH, 2009, EXPERT OPIN INV DRUG, V18, P1457, DOI 10.1517/13543780903203789; Doganci A, 2005, CLIN REV ALLERG IMMU, V28, P257, DOI 10.1385/CRIAI:28:3:257; Donaldson GC, 2005, CHEST, V128, P1995, DOI 10.1378/chest.128.4.1995; DRIVER AG, 1993, AM REV RESPIR DIS, V148, P91, DOI 10.1164/ajrccm/148.1.91; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eddahibi Saadia, 2006, Proc Am Thorac Soc, V3, P475; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Hasegawa M, 1999, RHEUMATOLOGY, V38, P612, DOI 10.1093/rheumatology/38.7.612; Hasko G, 1998, EUR J PHARMACOL, V358, P261, DOI 10.1016/S0014-2999(98)00619-0; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; HIRANO T, 1992, RES IMMUNOL, V143, P723, DOI 10.1016/0923-2494(92)80010-I; Hokuto I, 2004, J CLIN INVEST, V113, P28, DOI 10.1172/JCI200419491; Ikegami M, 2008, J APPL PHYSIOL, V104, P1753, DOI 10.1152/japplphysiol.00875.2007; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Knight DA, 2003, PHARMACOL THERAPEUT, V99, P327, DOI 10.1016/S0163-7258(03)00095-0; Konno S, 1996, INT ARCH ALLERGY IMM, V109, P73, DOI 10.1159/000237234; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsumoto S, 2010, J IMMUNOL, V184, P1543, DOI 10.4049/jimmunol.0801217; Matsuzaki Y, 2008, AM J RESP CELL MOL, V38, P551, DOI 10.1165/rcmb.2007-0311OC; Matsuzaki Y, 2006, J IMMUNOL, V177, P527, DOI 10.4049/jimmunol.177.1.527; MIHARA M, 1995, BRIT J RHEUMATOL, V34, P321; Mohsenin A, 2007, FASEB J, V21, P1026, DOI 10.1096/fj.06-7301com; Moodley YP, 2003, AM J PATHOL, V163, P345, DOI 10.1016/S0002-9440(10)63658-9; Pantelidis P, 2001, AM J RESP CRIT CARE, V163, P1432, DOI 10.1164/ajrccm.163.6.2006064; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Saito F, 2008, AM J RESP CELL MOL, V38, P566, DOI 10.1165/rcmb.2007-0299OC; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; SCHNEIDER DJ, 2009, FASEB J; Senior RM, 1998, FISHMANS PULMONARY D, P659; Shapiro SD, 1999, AM J RESP CRIT CARE, V160, pS29, DOI 10.1164/ajrccm.160.supplement_1.9; Sime PJ, 2001, CLIN IMMUNOL, V99, P308, DOI 10.1006/clim.2001.5008; Smith RE, 1998, J LEUKOCYTE BIOL, V64, P528, DOI 10.1002/jlb.64.4.528; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; Varani K, 2006, AM J RESP CRIT CARE, V173, P398, DOI 10.1164/rccm.200506-869OC; VESTBO J, 1997, LANCET, V350, P1431; Volmer JB, 2006, J IMMUNOL, V176, P4449, DOI 10.4049/jimmunol.176.7.4449; Young HWJ, 2004, J IMMUNOL, V173, P1380, DOI 10.4049/jimmunol.173.2.1380; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhong HY, 2005, AM J RESP CELL MOL, V32, P2, DOI 10.1165/rcmb.2004-0103OC; Zhou Y, 2011, J IMMUNOL, V186, P1097, DOI 10.4049/jimmunol.1002907; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009224; Zhou Y, 2009, PHARMACOL THERAPEUT, V123, P105, DOI 10.1016/j.pharmthera.2009.04.003; Zhou Y, 2009, J IMMUNOL, V182, P8037, DOI 10.4049/jimmunol.0900515	59	77	90	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22667	10.1371/journal.pone.0022667	http://dx.doi.org/10.1371/journal.pone.0022667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799929	Green Submitted, Green Published, gold			2022-12-25	WOS:000293172900065
J	Svensson, J; Sjogren, K; Faldt, J; Andersson, N; Isaksson, O; Jansson, JO; Ohlsson, C				Svensson, Johan; Sjogren, Klara; Faldt, Jenny; Andersson, Niklas; Isaksson, Olle; Jansson, John-Olov; Ohlsson, Claes			Liver-Derived IGF-I Regulates Mean Life Span in Mice	PLOS ONE			English	Article							GROWTH-FACTOR-I; INSULIN-RECEPTOR; OXIDATIVE STRESS; DWARF MICE; LONGEVITY; LONG; GENE; HORMONE; MUTANT; EXTENSION	Background: Transgenic mice with low levels of global insulin-like growth factor-I (IGF-I) throughout their life span, including pre- and postnatal development, have increased longevity. This study investigated whether specific deficiency of liver-derived, endocrine IGF-I is of importance for life span. Methods and Findings: Serum IGF-I was reduced by approximately 80% in mice with adult, liver-specific IGF-I inactivation (LI-IGF-I-/- mice), and body weight decreased due to reduced body fat. The mean life span of LI-IGF-I-/- mice (n = 84) increased 10% vs. control mice (n = 137) (Cox's test, p<0.01), mainly due to increased life span (16%) of female mice [LI-IGF-I-/- mice (n = 31): 26.7 +/- 1.1 vs. control (n = 67): 23.0 +/- 0.7 months, p<0.001]. Male LI-IGF-I-/- mice showed only a tendency for increased longevity (p = 0.10). Energy expenditure, measured as oxygen consumption during and after submaximal exercise, was increased in the LI-IGF-I-/- mice. Moreover, microarray and RT-PCR analyses showed consistent regulation of three genes (heat shock protein 1A and 1B and connective tissue growth factor) in several body organs in the LI-IGF-I-/- mice. Conclusions: Adult inactivation of liver-derived, endocrine IGF-I resulted in moderately increased mean life span. Body weight and body fat decreased in LI-IGF-I-/- mice, possibly due to increased energy expenditure during exercise. Genes earlier reported to modulate stress response and collagen aging showed consistent regulation, providing mechanisms that could underlie the increased mean life span in the LI-IGF-I-/- mice.	[Svensson, Johan; Sjogren, Klara; Faldt, Jenny; Isaksson, Olle; Ohlsson, Claes] Sahlgrens Univ Hosp, Dept Internal Med, Gothenburg, Sweden; [Andersson, Niklas; Jansson, John-Olov] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden; [Andersson, Niklas] Chalmers Univ Technol, Dept Chem & Biol Engn, Food Sci Unit, S-41296 Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Chalmers University of Technology	Svensson, J (corresponding author), Sahlgrens Univ Hosp, Dept Internal Med, Gothenburg, Sweden.	johan.svensson@medic.gu.se	Ohlsson, Claes/AGP-3544-2022	Ohlsson, Claes/0000-0002-9633-2805; Sjogren, Klara/0000-0001-5776-7278; Andersson, Niklas/0000-0002-3493-7358; Svensson, Johan/0000-0002-4487-6405	Swedish Research Council; Swedish Foundation for Strategic Research; ALF/LUA research grant in Gothenburg; Lundberg Foundation; Torsten and Ragnar Soderberg's Foundation; Novo Nordisk Foundation; Swedish Strategic Foundation [A305:188]; European Union [FP7/2007-2013]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); ALF/LUA research grant in Gothenburg; Lundberg Foundation(European Commission); Torsten and Ragnar Soderberg's Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Strategic Foundation; European Union(European Commission)	This work was supported by grants from the Swedish Research Council, the Swedish Foundation for Strategic Research, the ALF/LUA research grant in Gothenburg, the Lundberg Foundation, the Torsten and Ragnar Soderberg's Foundation, the Novo Nordisk Foundation, Sahlgrenska Center for Cardiovascular and Metabolic Research (CMR, no. A305:188), which is supported by the Swedish Strategic Foundation, and from the European Union Seventh Framework Programme (FP7/2007-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avogaro A, 2010, PFLUG ARCH EUR J PHY, V459, P301, DOI 10.1007/s00424-009-0721-8; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Conover CA, 2007, AGING CELL, V6, P727, DOI 10.1111/j.1474-9726.2007.00328.x; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Drake WM, 2001, ENDOCR REV, V22, P425, DOI 10.1210/er.22.4.425; Faldt J, 2004, ENDOCRINOLOGY, V145, P2680, DOI 10.1210/en.2003-1319; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Kaletsky R, 2010, DIS MODEL MECH, V3, P415, DOI 10.1242/dmm.001040; Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254; Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Li Q, 2007, REJUV RES, V10, P501, DOI 10.1089/rej.2007.0552; Lindberg MK, 2006, BONE, V38, P85, DOI 10.1016/j.bone.2005.07.027; Liu JL, 1998, MOL ENDOCRINOL, V12, P1452, DOI 10.1210/me.12.9.1452; Maynard SP, 2006, AGING CELL, V5, P89, DOI 10.1111/j.1474-9726.2006.00187.x; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Norry FM, 2003, EXP GERONTOL, V38, P673, DOI 10.1016/S0531-5565(03)00057-3; Ohlsson C, 1998, ENDOCR REV, V19, P55, DOI 10.1210/er.19.1.55; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Panici JA, 2010, FASEB J, V24, P5073, DOI 10.1096/fj.10-163253; Piriz J, 2011, EXP GERONTOL, V46, P96, DOI 10.1016/j.exger.2010.08.022; Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040; Raffaello A, 2011, BBA-MOL CELL RES, V1813, P260, DOI 10.1016/j.bbamcr.2010.10.007; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Sjogren K, 2002, J BONE MINER RES, V17, P1977, DOI 10.1359/jbmr.2002.17.11.1977; Sjogren K, 2001, DIABETES, V50, P1539, DOI 10.2337/diabetes.50.7.1539; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051; Svensson J, 2006, J ENDOCRINOL, V189, P617, DOI 10.1677/joe.1.06631; Svensson J, 2005, AM J PHYSIOL-ENDOC M, V289, pE466, DOI 10.1152/ajpendo.00425.2004; Svensson J, 2007, J ENDOCRINOL, V193, P359, DOI 10.1677/JOE-07-0024; Svensson J, 2008, J ENDOCRINOL, V199, P489, DOI 10.1677/JOE-08-0406; Svensson PA, 2006, ATHEROSCLEROSIS, V185, P32, DOI 10.1016/j.atherosclerosis.2005.05.007; Swindell WR, 2009, MECH AGEING DEV, V130, P393, DOI 10.1016/j.mad.2009.03.004; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tatar M, 1997, NATURE, V390, P30, DOI 10.1038/36237; Tivesten A, 2002, ENDOCRINOLOGY, V143, P4235, DOI 10.1210/en.2002-220524; Tower J, 2009, TRENDS ENDOCRIN MET, V20, P216, DOI 10.1016/j.tem.2008.12.005; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Wallenius K, 2001, ENDOCRINOLOGY, V142, P4762, DOI 10.1210/en.142.11.4762; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wang CX, 2004, MECH AGEING DEV, V125, P629, DOI 10.1016/j.mad.2004.07.003; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; Yakar S, 2009, J BONE MINER RES, V24, P1481, DOI [10.1359/JBMR.090226, 10.1359/jbmr.090226]; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x	61	40	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22640	10.1371/journal.pone.0022640	http://dx.doi.org/10.1371/journal.pone.0022640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799924	Green Submitted, gold, Green Published			2022-12-25	WOS:000293172900060
J	Xu, XB; Pantakani, DVK; Luhrig, S; Tan, XY; Khromov, T; Nolte, J; Dressel, R; Zechner, U; Engel, W				Xu, Xingbo; Pantakani, D. V. Krishna; Luehrig, Sandra; Tan, Xiaoying; Khromov, Tatjana; Nolte, Jessica; Dressel, Ralf; Zechner, Ulrich; Engel, Wolfgang			Stage-Specific Germ-Cell Marker Genes Are Expressed in All Mouse Pluripotent Cell Types and Emerge Early during Induced Pluripotency	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GENERATION; DERIVATION; CHROMATIN; LINEAGE; FATE	Embryonic stem cells (ESCs) generated from the in-vitro culture of blastocyst stage embryos are known as equivalent to blastocyst inner cell mass (ICM) in-vivo. Though several reports have shown the expression of germ cell/pre-meiotic (GC/PrM) markers in ESCs, their functional relevance for the pluripotency and germ line commitment are largely unknown. In the present study, we used mouse as a model system and systematically analyzed the RNA and protein expression of GC/PrM markers in ESCs and found them to be comparable to the expression of cultured pluripotent cells originated from the germ line. Further, siRNA knockdown experiments have demonstrated the parallel maintenance and independence of pluripotent and GC/PrM networks in ESCs. Through chromatin immunoprecipitation experiments, we observed that pluripotent cells exhibit active chromatin states at GC marker genes and a bivalent chromatin structure at PrM marker genes. Moreover, gene expression analysis during the time course of iPS cells generation revealed that the expression of GC markers precedes pluripotency markers. Collectively, through our observations we hypothesize that the chromatin state and the expression of GC/PrM markers might indicate molecular parallels between in-vivo germ cell specification and pluripotent stem cell generation.	[Xu, Xingbo; Pantakani, D. V. Krishna; Luehrig, Sandra; Tan, Xiaoying; Khromov, Tatjana; Nolte, Jessica; Engel, Wolfgang] Univ Goettingen, Inst Human Genet, Gottingen, Germany; [Dressel, Ralf] Univ Goettingen, Dept Cellular & Mol Immunol, Gottingen, Germany; [Zechner, Ulrich] Johannes Gutenberg Univ Mainz, Inst Human Genet, Mainz, Germany	University of Gottingen; University of Gottingen; Johannes Gutenberg University of Mainz	Xu, XB (corresponding author), Univ Goettingen, Inst Human Genet, Gottingen, Germany.	krishna.if1@gmail.com; wengel@gwdg.de	Zechner, Ulrich/G-2116-2010; Dressel, Ralf/R-7065-2016	Dressel, Ralf/0000-0002-1651-1214; Xu, Xingbo/0000-0002-8249-5507	German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG SPP1356, EN 84/22-1, ZE 442/4-1, DFG FOR 1041, EN 84/23-1, ZE 442/5-1]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was partly supported by the German Research Foundation (Deutsche Forschungsgemeinschaft) DFG SPP1356 (EN 84/22-1; ZE 442/4-1) and DFG FOR 1041 (EN 84/23-1; ZE 442/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bowles J, 2007, DEVELOPMENT, V134, P3401, DOI 10.1242/dev.001107; Carter MG, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r61; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Cox JL, 2010, EXP BIOL MED, V235, P148, DOI 10.1258/ebm.2009.009267; Dressel R, 2010, FASEB J, V24, P2164, DOI 10.1096/fj.09-134957; Dressel R, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-31; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; KAHAN BW, 1970, J NATL CANCER I, V44, P1015; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; KHROMOV T, 2010, MOL HUM REPROD; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Matsui Y, 2010, J ANDROL, V31, P61, DOI 10.2164/jandrol.109.008094; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mise N, 2008, GENES CELLS, V13, P863, DOI 10.1111/j.1365-2443.2008.01211.x; Nayernia K, 2006, LAB INVEST, V86, P654, DOI 10.1038/labinvest.3700429; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Okamura D, 2003, DEVELOPMENT, V130, P6423, DOI 10.1242/dev.00870; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Qing TT, 2007, DIFFERENTIATION, V75, P902, DOI 10.1111/j.1432-0436.2007.00181.x; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Saiti D, 2007, BIOMARK INSIGHTS, V2, P241; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Saitou M, 2009, CURR OPIN GENET DEV, V19, P386, DOI 10.1016/j.gde.2009.06.003; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Voss AK, 1997, EXP CELL RES, V230, P45, DOI 10.1006/excr.1996.3418; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Zechner U, 2009, MOL HUM REPROD, V15, P345, DOI 10.1093/molehr/gap023; Zwaka TP, 2005, DEVELOPMENT, V132, P227, DOI 10.1242/dev.01586	41	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22413	10.1371/journal.pone.0022413	http://dx.doi.org/10.1371/journal.pone.0022413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799849	gold, Green Published, Green Submitted			2022-12-25	WOS:000293172900028
J	Childs, KL; Davidson, RM; Buell, CR				Childs, Kevin L.; Davidson, Rebecca M.; Buell, C. Robin			Gene Coexpression Network Analysis as a Source of Functional Annotation for Rice Genes	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; EXPRESSION ATLAS; CLUSTER-ANALYSIS; DATABASE; PROTEINS; DEFENSE; BIOLOGY; MODULES; BIOINFORMATICS; SUPERFAMILY	With the existence of large publicly available plant gene expression data sets, many groups have undertaken data analyses to construct gene coexpression networks and functionally annotate genes. Often, a large compendium of unrelated or condition-independent expression data is used to construct gene networks. Condition-dependent expression experiments consisting of well-defined conditions/treatments have also been used to create coexpression networks to help examine particular biological processes. Gene networks derived from either condition-dependent or condition-independent data can be difficult to interpret if a large number of genes and connections are present. However, algorithms exist to identify modules of highly connected and biologically relevant genes within coexpression networks. In this study, we have used publicly available rice (Oryza sativa) gene expression data to create gene coexpression networks using both condition-dependent and condition-independent data and have identified gene modules within these networks using the Weighted Gene Coexpression Network Analysis method. We compared the number of genes assigned to modules and the biological interpretability of gene coexpression modules to assess the utility of condition-dependent and condition-independent gene coexpression networks. For the purpose of providing functional annotation to rice genes, we found that gene modules identified by coexpression analysis of condition-dependent gene expression experiments to be more useful than gene modules identified by analysis of a condition-independent data set. We have incorporated our results into the MSU Rice Genome Annotation Project database as additional expression-based annotation for 13,537 genes, 2,980 of which lack a functional annotation description. These results provide two new types of functional annotation for our database. Genes in modules are now associated with groups of genes that constitute a collective functional annotation of those modules. Additionally, the expression patterns of genes across the treatments/conditions of an expression experiment comprise a second form of useful annotation.	[Childs, Kevin L.; Davidson, Rebecca M.; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University	Childs, KL (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	kchilds@plantbiology.msu.edu	Childs, Kevin/C-9513-2014	Childs, Kevin/0000-0002-3680-062X; Buell, C Robin/0000-0002-6727-4677	National Science Foundation [DBI-0834043]; DOE [DE-FG02-08ER64631]; Division Of Integrative Organismal Systems [0834043] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funds to support this work were provided through a grant to CRB from the National Science Foundation (DBI-0834043) and a grant to KLC and CRB from the DOE (DE-FG02-08ER64631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borghi L, 2010, PLANT CELL, V22, P1792, DOI 10.1105/tpc.110.074591; Buschiazzo A, 2004, EMBO J, V23, P3196, DOI 10.1038/sj.emboj.7600324; Chang XA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012126; Cosgrove EJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-454; Dunwell JM, 1998, BIOTECHNOL GENET ENG, V15, P1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Ficklin SP, 2010, PLANT PHYSIOL, V154, P13, DOI 10.1104/pp.110.159459; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fukushima A, 2009, PLANT BIOTECHNOL-NAR, V26, P485, DOI 10.5511/plantbiotechnology.26.485; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hamada K, 2011, PLANT CELL PHYSIOL, V52, P220, DOI 10.1093/pcp/pcq195; Hirose N, 2007, PLANT CELL PHYSIOL, V48, P523, DOI 10.1093/pcp/pcm022; Huang S, 2009, PLANT PHYSIOL, V149, P719, DOI 10.1104/pp.108.131300; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Iancu OD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-585; Ivliev AE, 2010, CANCER RES, V70, P10060, DOI 10.1158/0008-5472.CAN-10-2465; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Kauffmann A, 2009, BIOINFORMATICS, V25, P2092, DOI 10.1093/bioinformatics/btp354; Kojima M, 2009, PLANT CELL PHYSIOL, V50, P1201, DOI 10.1093/pcp/pcp057; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Lee TH, 2009, PLANT PHYSIOL, V151, P16, DOI 10.1104/pp.109.139030; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; Mao LY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-346; Marcel S, 2010, PLANT CELL, V22, P3177, DOI 10.1105/tpc.110.078048; Mumford JA, 2010, NEUROIMAGE, V52, P1465, DOI 10.1016/j.neuroimage.2010.05.047; Mutwil M, 2010, PLANT PHYSIOL, V152, P29, DOI 10.1104/pp.109.145318; Narsai R, 2009, PLANT PHYSIOL, V151, P306, DOI 10.1104/pp.109.142026; Nilsson EE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011637; Norton GJ, 2008, J EXP BOT, V59, P2267, DOI 10.1093/jxb/ern097; Obayashi T, 2007, NUCLEIC ACIDS RES, V35, pD863, DOI 10.1093/nar/gkl783; Ogata Y, 2010, BIOINFORMATICS, V26, P1267, DOI 10.1093/bioinformatics/btq121; Ogata Yoshiyuki, 2009, Genome Inform, V23, P117; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Peng Y, 2010, RICE, V3, P36, DOI 10.1007/s12284-010-9039-6; Ren GD, 2010, J INTEGR PLANT BIOL, V52, P496, DOI 10.1111/j.1744-7909.2010.00945.x; Rico M, 1996, BIOCHEMISTRY-US, V35, P15672, DOI 10.1021/bi961748q; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Steinhauser D, 2004, BIOINFORMATICS, V20, P3647, DOI 10.1093/bioinformatics/bth398; Swarbrick PJ, 2008, NEW PHYTOL, V179, P515, DOI 10.1111/j.1469-8137.2008.02484.x; Toh H, 2002, BIOINFORMATICS, V18, P287, DOI 10.1093/bioinformatics/18.2.287; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1633, DOI 10.1111/j.1365-3040.2009.02040.x; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Wurtele ES, 2003, COMP FUNCT GENOM, V4, P239, DOI 10.1002/cfg.285; Xin ZY, 2009, PLANT PHYSIOL, V149, P434, DOI 10.1104/pp.108.130583; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Yuan JS, 2008, PLANT J, V55, P491, DOI 10.1111/j.1365-313X.2008.03524.x; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zheng LQ, 2009, PLANT PHYSIOL, V151, P262, DOI 10.1104/pp.109.141051; Zhou YL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-78; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	64	99	103	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22196	10.1371/journal.pone.0022196	http://dx.doi.org/10.1371/journal.pone.0022196			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799793	gold, Green Submitted, Green Published			2022-12-25	WOS:000293097300021
J	Falin, LJ; Tyler, BM				Falin, Lee J.; Tyler, Brett M.			Using Interpolation to Estimate System Uncertainty in Gene Expression Experiments	PLOS ONE			English	Article							QUANTIFICATION	The widespread use of high-throughput experimental assays designed to measure the entire complement of a cell's genes or gene products has led to vast stores of data that are extremely plentiful in terms of the number of items they can measure in a single sample, yet often sparse in the number of samples per experiment due to their high cost. This often leads to datasets where the number of treatment levels or time points sampled is limited, or where there are very small numbers of technical and/or biological replicates. Here we introduce a novel algorithm to quantify the uncertainty in the unmeasured intervals between biological measurements taken across a set of quantitative treatments. The algorithm provides a probabilistic distribution of possible gene expression values within unmeasured intervals, based on a plausible biological constraint. We show how quantification of this uncertainty can be used to guide researchers in further data collection by identifying which samples would likely add the most information to the system under study. Although the context for developing the algorithm was gene expression measurements taken over a time series, the approach can be readily applied to any set of quantitative systems biology measurements taken following quantitative (i.e. non-categorical) treatments. In principle, the method could also be applied to combinations of treatments, in which case it could greatly simplify the task of exploring the large combinatorial space of future possible measurements.	[Falin, Lee J.; Tyler, Brett M.] Virginia Polytech & State Univ, Virginia Bioinformat Inst, Blacksburg, VA USA; [Tyler, Brett M.] Virginia Polytech & State Univ, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Falin, LJ (corresponding author), Virginia Polytech & State Univ, Virginia Bioinformat Inst, Blacksburg, VA USA.	btyler@vbi.vt.edu		Falin, Lee/0000-0002-7776-2519	National Science Foundation [DBI-0211863]; Agriculture and Food Research Initiative of the National Institute of Food and Agriculture of the USDA [2005-35604-15525]; Virginia Bioinformatics Institute; Virginia Tech Graduate Program in Genetics, Bioinformatics and Computational Biology	National Science Foundation(National Science Foundation (NSF)); Agriculture and Food Research Initiative of the National Institute of Food and Agriculture of the USDA; Virginia Bioinformatics Institute; Virginia Tech Graduate Program in Genetics, Bioinformatics and Computational Biology	This work was supported in part by grants from the National Science Foundation #DBI-0211863, from the Agriculture and Food Research Initiative of the National Institute of Food and Agriculture of the USDA #2005-35604-15525, by the Virginia Bioinformatics Institute, and by the Virginia Tech Graduate Program in Genetics, Bioinformatics and Computational Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Joseph Z, 2003, J COMPUT BIOL, V10, P341, DOI 10.1089/10665270360688057; Brock GN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-12; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; Challinor AJ, 2005, PHILOS T ROY SOC B, V360, P2085, DOI 10.1098/rstb.2005.1740; Christie M, 2006, J COMPUT PHYS, V217, P143, DOI 10.1016/j.jcp.2006.01.026; Culbertson MR, 2003, CURR OPIN GENET DEV, V13, P207, DOI 10.1016/S0959-437X(03)00014-5; DURSTENFELD R, 1964, COMMUN ACM, V7, P420, DOI 10.1145/364520.364540; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guan YF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s3; Huang YB, 2008, J COMPUT INF SCI ENG, V8, DOI 10.1115/1.2904931; Hutter M., 2005, TEXT THEORET COMP S; Lermusiaux PFJ, 2006, J COMPUT PHYS, V217, P176, DOI 10.1016/j.jcp.2006.02.010; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Oberkampf WL, 2002, RELIAB ENG SYST SAFE, V75, P333, DOI 10.1016/S0951-8320(01)00120-X; Palmer TN, 2000, REP PROG PHYS, V63, P71, DOI 10.1088/0034-4885/63/2/201; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; SINGH R, 2005, P 22 INT C MACH LEAR, P832; Team R, 2008, R LANG ENV STAT COMP; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yu PS, 2001, J HYDROL, V244, P43, DOI 10.1016/S0022-1694(01)00328-6	20	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22071	10.1371/journal.pone.0022071	http://dx.doi.org/10.1371/journal.pone.0022071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799771	Green Published, gold, Green Submitted			2022-12-25	WOS:000293097300014
J	Karunakaran, K; Mehlitz, A; Rudel, T				Karunakaran, Karthika; Mehlitz, Adrian; Rudel, Thomas			Evolutionary Conservation of Infection-Induced Cell Death Inhibition among Chlamydiales	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; NF-KAPPA-B; SIMKANIA-NEGEVENSIS; APOPTOSIS RESISTANCE; PARACHLAMYDIA-ACANTHAMOEBAE; CHLAMYDOPHILA-PNEUMONIAE; INTRACELLULAR BACTERIA; PROAPOPTOTIC PROTEINS; SEROLOGICAL EVIDENCE; CYTOCHROME-C	Control of host cell death is of paramount importance for the survival and replication of obligate intracellular bacteria. Among these, human pathogenic Chlamydia induces the inhibition of apoptosis in a variety of different host cells by directly interfering with cell death signaling. However, the evolutionary conservation of cell death regulation has not been investigated in the order Chlamydiales, which also includes Chlamydia-like organisms with a broader host spectrum. Here, we investigated the apoptotic response of human cells infected with the Chlamydia-like organism Simkania negevensis (Sn). Simkania infected cells exhibited strong resistance to apoptosis induced by intrinsic stress or by the activation of cell death receptors. Apoptotic signaling was blocked upstream of mitochondria since Bax translocation, Bax and Bak oligomerisation and cytochrome c release were absent in these cells. Infected cells turned on pro-survival pathways like cellular Inhibitor of Apoptosis Protein 2 (cIAP-2) and the Akt/PI3K pathway. Blocking any of these inhibitory pathways sensitized infected host cell towards apoptosis induction, demonstrating their role in infection-induced apoptosis resistance. Our data support the hypothesis of evolutionary conserved signaling pathways to apoptosis resistance as common denominators in the order Chlamydiales.	[Karunakaran, Karthika; Mehlitz, Adrian; Rudel, Thomas] Univ Wurzburg, Dept Microbiol, Bioctr, Wurzburg, Germany	University of Wurzburg	Karunakaran, K (corresponding author), Univ Wurzburg, Dept Microbiol, Bioctr, Wurzburg, Germany.	thomas.rudel@biozentrum.uni-wuerzburg.de			Federal Ministry of Education, Science, Research and Technology [BMBF NGFN: 01GS08200]; German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg	Federal Ministry of Education, Science, Research and Technology; German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg	This work was supported by the Federal Ministry of Education, Science, Research and Technology [BMBF NGFN: 01GS08200] and the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantel H, 2001, J CELL BIOL, V155, P637, DOI 10.1083/jcb.200105081; Bohme L, 2010, CELL MICROBIOL, V12, P1340, DOI 10.1111/j.1462-5822.2010.01473.x; Bohme L, 2009, MICROBES INFECT, V11, P1063, DOI 10.1016/j.micinf.2009.08.014; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Clifton DR, 1998, P NATL ACAD SCI USA, V95, P4646, DOI 10.1073/pnas.95.8.4646; Coombes BK, 2002, CELL MICROBIOL, V4, P447, DOI 10.1046/j.1462-5822.2002.00203.x; Corsarol D, 2006, CLIN MICROBIOL REV, V19, P283, DOI 10.1128/CMR.19.2.283-297.2006; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dong F, 2005, INFECT IMMUN, V73, P1861, DOI 10.1128/IAI.73.3.1861-1864.2005; Downward J, 1999, NAT CELL BIOL, V1, pE33, DOI 10.1038/10026; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Fischer SE, 2004, J EXP MED, V200, P905, DOI 10.1084/jem.20040402; Fischer SF, 2004, INFECT IMMUN, V72, P1107, DOI 10.1128/IAI.72.2.1107-1115.2004; Fischer SF, 2001, INFECT IMMUN, V69, P7121, DOI 10.1128/IAI.69.11.7121-7129.2001; Gagnon V, 2003, INT J ONCOL, V23, P803; Greenberg D, 2003, SCAND J INFECT DIS, V35, P506, DOI 10.1080/00365540310014648; Greub G, 2009, CLIN MICROBIOL INFEC, V15, P18, DOI 10.1111/j.1469-0691.2008.02633.x; Greub G, 2004, EMERG INFECT DIS, V10, P470, DOI 10.3201/eid1003.020792; Greub G, 2003, INFECT IMMUN, V71, P5979, DOI 10.1128/IAI.71.10.5979-5985.2003; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Heiskanen-Kosma T, 2008, SCAND J INFECT DIS, V40, P127, DOI 10.1080/00365540701558680; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Husain S, 2007, TRANSPLANTATION, V83, P138, DOI 10.1097/01.tp.0000250477.65139.02; Kahane S, 1998, J INFECT DIS, V177, P1425, DOI 10.1086/517830; Kahane S, 2002, MICROBIOL-SGM, V148, P735, DOI 10.1099/00221287-148-3-735; KAHANE S, 1993, FEMS MICROBIOL LETT, V109, P329, DOI 10.1016/0378-1097(93)90041-Y; Kahane S, 1999, INT J SYST BACTERIOL, V49, P815, DOI 10.1099/00207713-49-2-815; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lamoth F, 2010, EXPERT REV ANTI-INFE, V8, P775, DOI [10.1586/eri.10.52, 10.1586/ERI.10.52]; Lieberman D, 1997, AM J RESP CRIT CARE, V156, P578, DOI 10.1164/ajrccm.156.2.9608081; Lieberman D, 2002, EUR J CLIN MICROBIOL, V21, P307, DOI 10.1007/s10096-002-0703-7; Lieberman D, 1997, AGE AGEING, V26, P69, DOI 10.1093/ageing/26.2.69; Matsuo J, 2008, APPL ENVIRON MICROB, V74, P6397, DOI 10.1128/AEM.00841-08; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; Muller A, 2000, EMBO J, V19, P5332, DOI 10.1093/emboj/19.20.5332; Nascimento-Carvalho CM, 2009, J INFECTION, V58, P250, DOI 10.1016/j.jinf.2009.01.008; Paland N, 2006, CELL MICROBIOL, V8, P1643, DOI 10.1111/j.1462-5822.2006.00739.x; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Prakash H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006519; Rajalingam K, 2001, INFECT IMMUN, V69, P7880, DOI 10.1128/IAI.69.12.7880-7888.2001; Rajalingam K, 2006, PLOS PATHOG, V2, P1013, DOI 10.1371/journal.ppat.0020114; Rajalingam K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003102; Schoier J, 2001, MICROB PATHOGENESIS, V31, P173, DOI 10.1006/mpat.2001.0460; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Sharma M, 2009, FEMS IMMUNOL MED MIC, V55, P154, DOI 10.1111/j.1574-695X.2008.00515.x; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Verbeke Philippe, 2006, PLoS Pathog, V2, pe45, DOI 10.1371/journal.ppat.0020045; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Ying SM, 2005, INFECT IMMUN, V73, P1399, DOI 10.1128/IAI.73.3.1399-1403.2005; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yuasa T, 1998, J BIOL CHEM, V273, P22681, DOI 10.1074/jbc.273.35.22681; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0; Zychlinsky A, 1997, J CLIN INVEST, V100, P493, DOI 10.1172/JCI119557	65	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22528	10.1371/journal.pone.0022528	http://dx.doi.org/10.1371/journal.pone.0022528			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799887	gold, Green Published, Green Submitted			2022-12-25	WOS:000293097300061
J	Piras, A; Gianetto, D; Conte, D; Bosone, A; Vercelli, A				Piras, Antonio; Gianetto, Daniele; Conte, Daniele; Bosone, Alex; Vercelli, Alessandro			Activation of Autophagy in a Rat Model of Retinal Ischemia following High Intraocular Pressure	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; GANGLION-CELL DEATH; CHICK-EMBRYOS; DYING NEURONS; ACID-PHOSPHATASE; OXIDATIVE STRESS; SELF-DIGESTION; IN-VIVO; APOPTOSIS; ENDOCYTOSIS	Acute primary open angle glaucoma is an optic neuropathy characterized by the elevation of intraocular pressure, which causes retinal ischemia and neuronal death. Rat ischemia/reperfusion enhances endocytosis of both horseradish peroxidase (HRP) or fluorescent dextran into ganglion cell layer (GCL) neurons 24 h after the insult. We investigated the activation of autophagy in GCL-neurons following ischemia/reperfusion, using acid phosphatase (AP) histochemistry and immunofluorescence against LC3 and LAMP1. Retinal I/R lead to the appearance of AP-positive granules and LAMP1-positive vesicles 12 and 24 h after the insult, and LC3 labelling at 24 h, and induced a consistent retinal neuron death. At 48 h the retina was negative for autophagic markers. In addition, Western Blot analysis revealed an increase of LC3 levels after damage: the increase in the conjugated, LC3-II isoform is suggestive of autophagic activity. Inhibition of autophagy by 3-methyladenine partially prevented death of neurons and reduces apoptotic markers, 24 h post-lesion. The number of neurons in the GCL decreased significantly following I/R (I/R 12.21 +/- 1.13 vs controls 19.23 +/- 1.12 cells/500 mu m); this decrease was partially prevented by 3-methyladenine (17.08 +/- 1.42 cells/500 mu m), which potently inhibits maturation of autophagosomes. Treatment also prevented the increase in glial fibrillary acid protein immunoreactivity elicited by I/R. Therefore, targeting autophagy could represent a novel and promising treatment for glaucoma and retinal ischemia.	[Piras, Antonio; Gianetto, Daniele; Conte, Daniele; Vercelli, Alessandro] Cavalieri Ottolenghi Fdn, Inst Neurosci, Turin, Italy; [Piras, Antonio; Gianetto, Daniele; Bosone, Alex; Vercelli, Alessandro] Univ Turin, Dept Anat Pharmacol & Forens Med, Neurosci Inst Turin, Turin, Italy; [Conte, Daniele] Univ Turin, Italy Dept Oncol Sci, Inst Canc Res & Treatment IRCC, Turin, Italy	University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin	Piras, A (corresponding author), Cavalieri Ottolenghi Fdn, Inst Neurosci, Turin, Italy.	antonio.piras@unito.it	Vercelli, Alessandro E/A-1926-2012	Vercelli, Alessandro E/0000-0002-5909-2128; Piras, Antonio/0000-0003-3052-1715	MIUR, the Italian Ministry of Health; Compagnia di San Paolo and Regione Piemonte; Regione Autonoma della Sardegna - Progetto Master and Back	MIUR, the Italian Ministry of Health(Ministry of Education, Universities and Research (MIUR)Ministry of Health, Italy); Compagnia di San Paolo and Regione Piemonte(Compagnia di San Paolo); Regione Autonoma della Sardegna - Progetto Master and Back	This study was supported by MIUR (PRIN 2007), the Italian Ministry of Health and Compagnia di San Paolo and Regione Piemonte grants awarded to Dr. Vercelli. Dr. Piras is the recipient of a fellowship from Regione Autonoma della Sardegna - Progetto Master and Back 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Adhami F, 2007, AUTOPHAGY, V3, P42, DOI 10.4161/auto.3412; Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; AMES A, 1983, STROKE, V14, P233, DOI 10.1161/01.STR.14.2.233; ANDERSON DH, 1986, INVEST OPHTH VIS SCI, V27, P168; Arnold A C, 1995, Semin Ophthalmol, V10, P221, DOI 10.3109/08820539509060976; Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; BARKA T, 1962, J HISTOCHEM CYTOCHEM, V10, P741, DOI 10.1177/10.6.741; Bessero AC, 2010, J NEUROCHEM, V113, P1307, DOI 10.1111/j.1471-4159.2010.06705.x; Borsello T, 2003, J COMP NEUROL, V465, P286, DOI 10.1002/cne.10834; Bringmann A, 2001, FRONT BIOSCI-LANDMRK, V6, pE77, DOI 10.2741/Bringman; BUCHI ER, 1991, OPHTHALMOLOGICA, V203, P138; Bursch W, 2000, J CELL SCI, V113, P1189; Buschini E, PROGR NEURO IN PRESS; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; CLARKE PGH, 1992, TRENDS NEUROSCI, V15, P211, DOI 10.1016/0166-2236(92)90036-8; CLARKE PGH, 1984, HISTOCHEM J, V16, P955, DOI 10.1007/BF01003851; CLARKE PGH, 1982, NEUROSCI LETT, V30, P223, DOI 10.1016/0304-3940(82)90403-7; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Garcia-Sevilla JA, 2004, NEUROPHARMACOLOGY, V46, P519, DOI 10.1016/j.neuropharm.2003.10.006; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; Guimaraes CA, 2003, J BIOL CHEM, V278, P41938, DOI 10.1074/jbc.M306547200; HORNUNG JP, 1989, J COMP NEUROL, V283, P425, DOI 10.1002/cne.902830310; Huang Y, 2007, EXP EYE RES, V85, P659, DOI 10.1016/j.exer.2007.07.020; Janen SB, 2010, GLIA, V58, P1766, DOI 10.1002/glia.21047; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kent D, 2000, EYE, V14, P313, DOI 10.1038/eye.2000.79; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Koenekoop RK, 2009, OPHTHALMIC GENET, V30, P152, DOI 10.1080/13816810902788974; Komatsu M, 2007, CELL DEATH DIFFER, V14, P887, DOI 10.1038/sj.cdd.4402120; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kunchithapautham K, 2007, AUTOPHAGY, V3, P433, DOI 10.4161/auto.4294; Lafuente MP, 2002, NEUROSCIENCE, V109, P157, DOI 10.1016/S0306-4522(01)00458-4; Lee JA, 2009, J NEUROSCI, V29, P8506, DOI 10.1523/JNEUROSCI.0924-09.2009; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Morrison JC, 1998, INVEST OPHTH VIS SCI, V39, P526; Munafo DB, 2002, TRAFFIC, V3, P472, DOI 10.1034/j.1600-0854.2002.30704.x; Palanza L, 2002, ACTA OPHTHALMOL SCAN, V80, P47, DOI 10.1034/j.1600-0420.80.s236.27.x; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Puyal J, 2009, ANN NEUROL, V66, P378, DOI 10.1002/ana.21714; Qin AP, 2010, AUTOPHAGY, V6, P738, DOI 10.4161/auto.6.6.12573; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Rosenbaum DM, 2010, J NEUROSCI RES, V88, P1569, DOI 10.1002/jnr.22314; Roth S, 2003, INVEST OPHTH VIS SCI, V44, P5383, DOI 10.1167/iovs.03-0451; Sadasivan S, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-21; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; SellesNavarro I, 1996, INVEST OPHTH VIS SCI, V37, P2002; Shacka JJ, 2008, FRONT BIOSCI-LANDMRK, V13, P718, DOI 10.2741/2714; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; SMITH GG, 1952, AM J OPHTHALMOL, V35, P133, DOI 10.1016/0002-9394(52)90266-3; Stromhaug PE, 2001, TRAFFIC, V2, P524, DOI 10.1034/j.1600-0854.2001.20802.x; TAKAHASHI K, 1992, ARCH OPHTHALMOL-CHIC, V110, P862, DOI 10.1001/archopht.1992.01080180134041; Uchiyama Y, 2001, ARCH HISTOL CYTOL, V64, P233, DOI 10.1679/aohc.64.233; Ueda M, 2004, J PHARMACOL EXP THER, V309, P200, DOI 10.1124/jpet.103.061127; Vaslin A, 2007, J NEUROCHEM, V102, P789, DOI 10.1111/j.1471-4159.2007.04564.x; Wang Y, 2009, EUR J NEUROSCI, V30, P2258, DOI 10.1111/j.1460-9568.2009.07025.x; Wang YS, 2004, J BIOL CHEM, V279, P41267, DOI 10.1074/jbc.C400199200; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; YOFFE JR, 1980, HISTOCHEM J, V12, P537, DOI 10.1007/BF01011927; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; ZAKERI Z, 1995, CELL DEATH DIFFER, V2, P87; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510	78	89	94	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22514	10.1371/journal.pone.0022514	http://dx.doi.org/10.1371/journal.pone.0022514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799881	gold, Green Submitted, Green Published			2022-12-25	WOS:000293097300058
J	Hoffmann, D; Garcia, AD; Harrigan, PR; Johnston, ICD; Nakasone, T; Garcia-Lerma, JG; Heneine, W				Hoffmann, Dieter; Garcia, Albert D.; Harrigan, P. Richard; Johnston, Ian C. D.; Nakasone, Tadashi; Garcia-Lerma, J. Gerardo; Heneine, Walid			Measuring Enzymatic HIV-1 Susceptibility to Two Reverse Transcriptase Inhibitors as a Rapid and Simple Approach to HIV-1 Drug-Resistance Testing	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PHENOTYPIC RESISTANCE; MUTATIONS; EMTRICITABINE; EFAVIRENZ; TENOFOVIR; PLASMA; ASSAY	Simple and cost-effective approaches for HIV drug-resistance testing are highly desirable for managing increasingly expanding HIV-1 infected populations who initiate antiretroviral therapy (ART), particularly in resource-limited settings. Non-nucleoside reverse trancriptase inhibitor (NNRTI)-based regimens with an NRTI backbone containing lamivudine (3TC) or emtricitabine (FTC) are preferred first ART regimens. Failure with these drug combinations typically involves the selection of NNRTI- and/or 3TC/FTC- resistant viruses. Therefore, the availability of simple assays to measure both types of drug resistance is critical. We have developed a high throughput screening test for assessing enzymatic resistance of the HIV-1 RT in plasma to 3TC/FTC and NNRTIs. The test uses the sensitive "Amp-RT" assay with a newly-developed real-time PCR format to screen biochemically for drug resistance in single reactions containing either 3TC-triphosphate (3TC-TP) or nevirapine (NVP). Assay cut-offs were defined based on testing a large panel of subtype B and non-subtype B clinical samples with known genotypic profiles. Enzymatic 3TC resistance correlated well with the presence of M184I/V, and reduced NVP susceptibility was strongly associated with the presence of K103N, Y181C/I, Y188L, and G190A/Q. The sensitivity and specificity for detecting resistance were 97.0% and 96.0% in samples with M184V, and 97.4% and 96.2% for samples with NNRTI mutations, respectively. We further demonstrate the utility of an HIV capture method in plasma by using magnetic beads coated with CD44 antibody that eliminates the need for ultracentifugation. Thus our results support the use of this simple approach for distinguishing WT from NNRTI- or 3TC/FTC-resistant viruses in clinical samples. This enzymatic testing is subtype-independent and can assist in the clinical management of diverse populations particularly in resource-limited settings.	[Hoffmann, Dieter; Garcia, Albert D.; Garcia-Lerma, J. Gerardo; Heneine, Walid] Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; [Harrigan, P. Richard] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Johnston, Ian C. D.] Miltenyi Biotec, Bergisch Gladbach, Germany; [Nakasone, Tadashi] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan	Centers for Disease Control & Prevention - USA; B.C. Centre for Excellence in HIV/AIDS; Miltenyi Biotec; National Institute of Infectious Diseases (NIID)	Hoffmann, D (corresponding author), Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA.	hoffmann@virologie.med.tum.de			CDC	CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by intramural CDC funds. Dieter Hoffmann was partially supported by an International Emerging Infectious Diseases Fellowship from CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bacheler L, 2001, J VIROL, V75, P4999, DOI 10.1128/JVI.75.11.4999-5008.2001; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Cheung PK, 2004, AIDS REV, V6, P107; Deeks SG, 2003, LANCET, V362, P2002, DOI 10.1016/S0140-6736(03)15022-2; Delaugerre C, 2001, J MED VIROL, V65, P445, DOI 10.1002/jmv.2055; Galli RA, 2003, J CLIN MICROBIOL, V41, P2900, DOI 10.1128/JCM.41.7.2900-2907.2003; Girouard M, 2003, J BIOL CHEM, V278, P34403, DOI 10.1074/jbc.M303528200; HENEINE W, 1995, J INFECT DIS, V171, P1210, DOI 10.1093/infdis/171.5.1210; Johnson Victoria A, 2009, Top HIV Med, V17, P138; Lerma JGG, 1998, J INFECT DIS, V177, P1221, DOI 10.1086/515272; Lerma JGG, 1999, ANTIMICROB AGENTS CH, V43, P264, DOI 10.1128/AAC.43.2.264; Lerma JGG, 2000, J CLIN MICROBIOL, V38, P402; Lopez CA, 2010, ARCH VIROL, V155, P895, DOI 10.1007/s00705-010-0659-3; Margot NA, 2006, ANTIMICROB AGENTS CH, V50, P4087, DOI 10.1128/AAC.00816-06; MARGOT NA, 2009, J ACQUIR IMMUNE DEFI; Miller V, 2001, AIDS, V15, P309, DOI 10.1097/00002030-200102160-00003; Napravnik S, 2010, J CLIN VIROL, V47, P18, DOI 10.1016/j.jcv.2009.10.001; Piantadosi A, 2009, J VIROL, V83, P7805, DOI 10.1128/JVI.00280-09; Pozniak AL, 2006, JAIDS-J ACQ IMM DEF, V43, P535; Richman DD, 2001, NATURE, V410, P995, DOI 10.1038/35073673; Romano L, 2002, J INFECT DIS, V185, P898, DOI 10.1086/339706; Tremblay MJ, 1998, IMMUNOL TODAY, V19, P346, DOI 10.1016/S0167-5699(98)01286-9; Vazquez-Rosales G, 1999, AIDS RES HUM RETROV, V15, P1191, DOI 10.1089/088922299310287; Wainberg MA, 1996, AIDS, V10, pS3, DOI 10.1097/00002030-199612005-00002; Wallis CL, 2010, JAIDS-J ACQ IMM DEF, V53, P480, DOI 10.1097/QAI.0b013e3181bc478b; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335	26	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22019	10.1371/journal.pone.0022019	http://dx.doi.org/10.1371/journal.pone.0022019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799767	gold, Green Published			2022-12-25	WOS:000292931200021
J	Hontelez, JAC; de Vlas, SJ; Tanser, F; Bakker, R; Barnighausen, T; Newell, ML; Baltussen, R; Lurie, MN				Hontelez, Jan A. C.; de Vlas, Sake J.; Tanser, Frank; Bakker, Roel; Baernighausen, Till; Newell, Marie-Louise; Baltussen, Rob; Lurie, Mark N.			The Impact of the New WHO Antiretroviral Treatment Guidelines on HIV Epidemic Dynamics and Cost in South Africa	PLOS ONE			English	Article							VIRAL LOAD; SEXUAL-BEHAVIOR; RISK BEHAVIOR; THERAPY; TRANSMISSION; PREVALENCE; MORTALITY; MODEL; INITIATION; COMMUNITY	Background: Since November 2009, WHO recommends that adults infected with HIV should initiate antiretroviral therapy (ART) at CD4+ cell counts of <= 350 cells/mu l rather than <= 200 cells/mu l. South Africa decided to adopt this strategy for pregnant and TB co-infected patients only. We estimated the impact of fully adopting the new WHO guidelines on HIV epidemic dynamics and associated costs. Methods and Finding: We used an established model of the transmission and control of HIV in specified sexual networks and healthcare settings. We quantified the model to represent Hlabisa subdistrict, KwaZulu-Natal, South Africa. We predicted the HIV epidemic dynamics, number on ART and program costs under the new guidelines relative to treating patients at <= 200 cells/mu l for the next 30 years. During the first five years, the new WHO treatment guidelines require about 7% extra annual investments, whereas 28% more patients receive treatment. Furthermore, there will be a more profound impact on HIV incidence, leading to relatively less annual costs after seven years. The resulting cumulative net costs reach a break-even point after on average 16 years. Conclusions: Our study strengthens the WHO recommendation of starting ART at <= 350 cells/mu l for all HIV-infected patients. Apart from the benefits associated with many life-years saved, a modest frontloading appears to lead to net savings within a limited time-horizon. This finding is robust to alternative assumptions and foreseeable changes in ART prices and effectiveness. Therefore, South Africa should aim at rapidly expanding its healthcare infrastructure to fully embrace the new WHO guidelines.	[Hontelez, Jan A. C.; de Vlas, Sake J.; Bakker, Roel] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [Hontelez, Jan A. C.; Tanser, Frank; Baernighausen, Till; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [Hontelez, Jan A. C.; Baltussen, Rob] Radboud Univ Nijmegen, Dept Primary & Community Care, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Baernighausen, Till] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Lurie, Mark N.] Brown Univ, Dept Epidemiol, Warren Alpert Med Sch, Providence, RI 02912 USA; [Lurie, Mark N.] Brown Univ, Int Hlth Inst, Warren Alpert Med Sch, Providence, RI 02912 USA	Erasmus University Rotterdam; Erasmus MC; University of Kwazulu Natal; Radboud University Nijmegen; Harvard University; Harvard T.H. Chan School of Public Health; Brown University; Brown University	Hontelez, JAC (corresponding author), Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands.	j.hontelez@erasmusmc.nl	Bärnighausen, Till/Y-2388-2019; Baltussen, R.M.P.M./L-4181-2015; Lurie, Mark N/I-3133-2014; Newell, Marie-Louise/AAE-8222-2019; Tanser, Frank/ABE-8326-2021	Newell, Marie-Louise/0000-0002-1074-7699; de Vlas, Sake J./0000-0002-1830-5668; Tanser, Frank/0000-0001-9797-0000	NIH [1R01MH083539-01]; Wellcome Trust; President's Emergency Plan (PEPFAR) [674-A-00-08-0001-00]; University of KwaZulu-Natal, South Africa [082384/Z/07/Z]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083539] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); President's Emergency Plan (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); University of KwaZulu-Natal, South Africa; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by an NIH R-01 grant to Dr. Lurie (1R01MH083539-01) and grants from the Wellcome Trust to the Africa Centre for Health and Population Studies, University of KwaZulu-Natal, South Africa 082384/Z/07/Z. The funding organizations had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review or approval of the manuscript. In addition, this study is made possible by the generous support of the American people through the United States Agency for International Development (USAID) and the President's Emergency Plan (PEPFAR) under the terms of Award No. 674-A-00-08-0001-00 for the Hlabisa Treatment and Care Programme. The opinions expressed herein are those of the authors and do not necessarily reflect the views of USAID or the United States Government.	Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V41, P632, DOI 10.1097/01.qai.0000194234.31078.bf; [Anonymous], 2008, EP FACT SHEET HIV AI; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; Barnighausen T, 2009, AIDS RES HUM RETROV, V25, P405, DOI 10.1089/aid.2008.0211; Baggaley RF, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-9; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Bartlett JA, 2009, LANCET INFECT DIS, V9, P637, DOI 10.1016/S1473-3099(09)70227-0; Blower S, 2005, AIDS, V19, P1, DOI 10.1097/00002030-200501030-00001; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; CARAEL M, 1991, AIDS, V5, pS65; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Harling G, 2007, JAIDS-J ACQ IMM DEF, V45, P348; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; Kennedy C, 2007, AIDS CARE, V19, P707, DOI 10.1080/09540120701203261; Lees S, 2010, SEX TRANSM DIS, V37, P497, DOI 10.1097/OLQ.0b013e3181d4722d; Leisegang R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000189; *MED SANSFRONTIERE, 2010, UNT WEB ARV PRIC RED; MUHWAVA W, 2007, ACDIS MONOGRAPH, V2; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Ndirangu J, 2010, AIDS, V24, P593, DOI 10.1097/QAD.0b013e328335cff5; Nnko S, 2004, SOC SCI MED, V59, P299, DOI 10.1016/j.socscimed.2003.10.031; Orroth KK, 2007, SEX TRANSM INFECT, V83, pI5, DOI 10.1136/sti.2006.023531; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; *SANAC, 2010, MED STAT OUTL NAT HI; *SANAC, 2010, S AFR ANT TREATM GUI; *STAT S AFR, 2010, HIST PPI KEY IND; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Todd J, 2009, SEX TRANSM INFECT, V85, pI72, DOI 10.1136/sti.2008.033985; *US FED RESERVEBOA, 2010, FOR EXCH RAT S AFR H; Van der Ploeg CPB, 1998, INTERFACES, V28, P84, DOI 10.1287/inte.28.3.84; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; Waning B, 2009, B WORLD HEALTH ORGAN, V87, P520, DOI 10.2471/BLT.08.058925; Weinhardt LS, 1998, ARCH SEX BEHAV, V27, P155, DOI 10.1023/A:1018682530519; White RG, 2008, SEX TRANSM INFECT, V84, P528, DOI 10.1136/sti.2008.032011; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; World Health Organisation, 2003, MAK CHOIC HLTH WHO G; World Health Organization, 2009, RAP ADV ANT THER HIV	48	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e21919	10.1371/journal.pone.0021919	http://dx.doi.org/10.1371/journal.pone.0021919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	794WE	21799755	gold, Green Published, Green Submitted			2022-12-25	WOS:000292931200016
J	McKeever, T; Saha, S; Fogarty, AW				McKeever, Tricia; Saha, Shiron; Fogarty, Andrew W.			The Association between Systemic Inflammatory Cellular Levels and Lung Function: A Population-Based Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; C-REACTIVE PROTEIN; LEUKOCYTE COUNT; AIRWAY INFLAMMATION; CIGARETTE-SMOKE; MORTALITY; DECLINE	Background: Lower lung function is associated with an elevated systemic white cell count in men. However, these observations have not been demonstrated in a representative population that includes females and may be susceptible to confounding by recent airway infections or recent cigarette smoking. We tested the hypothesis that lung function is inversely associated with systemic white cell count in a population-based study. Methods: The study population consisted adults aged 17-90+ years who participated in the Third National Health and Nutrition Examination Survey who did not report a recent cough, cold or acute illness in a non-smoking and smoking population. Results: In non-smoking adults with the highest quintile of the total white cell count had a FEV1 125.3 ml lower than those in the lowest quintile (95% confidence interval CI: -163.1 to -87.5). Adults with the highest quintile of the total white cell count had a FVC 151.1 ml lower than those in the lowest quintile (95% confidence interval CI: -195.0 to -107.2). Similar associations were observed for granulocytes, mononuclear cells and lymphocytes. In current smokers, similar smaller associations observed for total white cell count, granulocytes and mononuclear cells. Conclusions: Systemic cellular inflammation levels are inversely associated with lung function in a population of both nonsmokers and smokers without acute illnesses. This may contribute to the increased mortality observed in individuals with a higher baseline white cell count.	[McKeever, Tricia; Fogarty, Andrew W.] Univ Nottingham, Nottingham Resp Biomed Res Unit, Div Epidemiol & Publ Hlth, City Hosp, Nottingham NG7 2RD, England; [Saha, Shiron] Sheffield Teaching Hosp NHS Trust, Dept Resp Med, No Gen Hosp, Sheffield, S Yorkshire, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; Northern General Hospital; University of Sheffield	McKeever, T (corresponding author), Univ Nottingham, Nottingham Resp Biomed Res Unit, Div Epidemiol & Publ Hlth, City Hosp, Nottingham NG7 2RD, England.	andrew.fogarty@nottingham.ac.uk						Aronson D, 2006, AM J RESP CRIT CARE, V174, P626, DOI 10.1164/rccm.200602-243OC; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Barnes Peter J, 2004, COPD, V1, P59, DOI 10.1081/COPD-120028701; Barnes PJ, 2004, PLOS MED, V1, P25, DOI 10.1371/journal.pmed.0010020; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Benowitz NL, 2009, AM J EPIDEMIOL, V169, P236, DOI 10.1093/aje/kwn301; CAREL RS, 1988, CHEST, V93, P1137, DOI 10.1378/chest.93.6.1137; Donaldson GC, 2005, CHEST, V128, P1995, DOI 10.1378/chest.128.4.1995; Fogarty AW, 2007, THORAX, V62, P515, DOI 10.1136/thx.2006.066969; FRETTE C, 1991, AM REV RESPIR DIS, V143, P987, DOI 10.1164/ajrccm/143.5_Pt_1.987; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Gunter EW, 1996, LAB PROCEDURES USED; Hancox RJ, 2007, THORAX, V62, P1064, DOI 10.1136/thx.2006.076877; Jiang R, 2008, AM J EPIDEMIOL, V168, P602, DOI 10.1093/aje/kwn174; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; KAUFFMANN F, 1986, AM REV RESPIR DIS, V134, P1172; Lewis SA, 2001, CHEST, V119, P105, DOI 10.1378/chest.119.1.105; NADEL JA, 1961, J APPL PHYSIOL, V16, P713, DOI 10.1152/jappl.1961.16.4.713; National Center for Health Statistics, 1994, PLAN OP 3 NAT HLTH N; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Pinto-Plata VM, 2006, THORAX, V61, P23, DOI 10.1136/thx.2005.042200; Quint JK, 2007, J ALLERGY CLIN IMMUN, V119, P1065, DOI 10.1016/j.jaci.2006.12.640; Ruggiero C, 2007, J AM COLL CARDIOL, V49, P1841, DOI 10.1016/j.jacc.2007.01.076; Shaw DE, 2007, CHEST, V132, P1871, DOI 10.1378/chest.07-1047; SPARROW D, 1984, CHEST, V86, P383, DOI 10.1378/chest.86.3.383; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; WEISS ST, 1995, AM J EPIDEMIOL, V142, P493, DOI 10.1093/oxfordjournals.aje.a117665; YEUNG MC, 1984, AM J MED, V76, P31, DOI 10.1016/0002-9343(84)90741-1; Young RP, 2007, EUR RESPIR J, V30, P616, DOI 10.1183/09031936.00021707	30	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e21593	10.1371/journal.pone.0021593	http://dx.doi.org/10.1371/journal.pone.0021593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799739	Green Published, Green Submitted, gold			2022-12-25	WOS:000292931200008
J	Schwarzer, J; Misof, B; Ifuta, SN; Schliewen, UK				Schwarzer, Julia; Misof, Bernhard; Ifuta, Seraphin N.; Schliewen, Ulrich K.			Time and Origin of Cichlid Colonization of the Lower Congo Rapids	PLOS ONE			English	Article							ADAPTIVE RADIATION; PHYLOGENETIC ANALYSIS; SPECIES FLOCK; FISH; TELEOSTEI; EVOLUTION; MORMYRIDAE; SPECIATION; BASIN	Most freshwater diversity is arguably located in networks of rivers and streams, but, in contrast to lacustrine systems riverine radiations, are largely understudied. The extensive rapids of the lower Congo River is one of the few river stretches inhabited by a locally endemic cichlid species flock as well as several species pairs, for which we provide evidence that they have radiated in situ. We use more that 2,000 AFLP markers as well as multilocus sequence datasets to reconstruct their origin, phylogenetic history, as well as the timing of colonization and speciation of two Lower Congo cichlid genera, Steatocranus and Nanochromis. Based on a representative taxon sampling and well resolved phylogenetic hypotheses we demonstrate that a high level of riverine diversity originated in the lower Congo within about 5 mya, which is concordant with age estimates for the hydrological origin of the modern lower Congo River. A spatial genetic structure is present in all widely distributed lineages corresponding to a trisection of the lower Congo River into major biogeographic areas, each with locally endemic species assemblages. With the present study, we provide a phylogenetic framework for a complex system that may serve as a link between African riverine cichlid diversity and the megadiverse cichlid radiations of the East African lakes. Beyond this we give for the first time a biologically estimated age for the origin of the lower Congo River rapids, one of the most extreme freshwater habitats on earth.	[Schwarzer, Julia; Schliewen, Ulrich K.] Bavarian State Collect Zool, Munich, Germany; [Schwarzer, Julia; Misof, Bernhard] Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Ifuta, Seraphin N.] ISP GOMBE, Dept Biol, Kinshasa, DEM REP CONGO	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Schwarzer, J (corresponding author), Bavarian State Collect Zool, Munich, Germany.	j.schwarzer.zfmk@uni-bonn.de			Deutsche Forschungsgemeinschaft [DFG MI649/8-1, SCHL567/4-1]; University of Bonn; Zoologisches Forschungsmuseum Alexander Koenig	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Bonn; Zoologisches Forschungsmuseum Alexander Koenig	This work was supported by grants from the Deutsche Forschungsgemeinschaft to B.M. (DFG MI649/8-1) and U.K.S. (SCHL567/4-1) and a graduate student grant of the University of Bonn as well as a travel grant from the supporters of the Zoologisches Forschungsmuseum Alexander Koenig to J.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-215; Boulenger G. A, 1899, ANN MUSEE CONGO ZO 1, V1, P39; Carnevale G, 2003, J VERTEBR PALEONTOL, V23, P508, DOI 10.1671/1858; Chow S, 1998, MOL ECOL, V7, P1255; COLYN M, 1991, IMPORTANCE ZOOGEOGRA; Coyne JA, 2004, SPECIATION, V37; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ferry JN, 2004, GEODIN ACTA, V17, P241, DOI 10.3166/ga.17.241-251; Feulner PGD, 2007, J EVOLUTION BIOL, V20, P403, DOI 10.1111/j.1420-9101.2006.01181.x; Feulner PGD, 2008, J PHYSIOLOGY-PARIS, V102, P340, DOI 10.1016/j.jphysparis.2008.10.002; Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050; Greenwood P.H., 1984, P13; Herder F, 2006, P R SOC B, V273, P2209, DOI 10.1098/rspb.2006.3558; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JACKSON PR, 2009, P IAHR S RIV COAST E, P1007; Joyce DA, 2005, NATURE, V435, P90, DOI 10.1038/nature03489; Katongo C, 2005, HYDROBIOLOGIA, V542, P221, DOI 10.1007/s10750-004-1389-x; Katongo C, 2007, MOL PHYLOGENET EVOL, V45, P326, DOI 10.1016/j.ympev.2007.02.011; Kocher TD, 1995, MOL PHYLOGENET EVOL, V4, P420, DOI 10.1006/mpev.1995.1039; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Konings A., 2016, MALAWI CICHLIDS THEI; Kullander SO, 2010, J ZOOL SYST EVOL RES, V48, P248, DOI 10.1111/j.1439-0469.2009.00557.x; Lavier LL, 2001, MAR GEOL, V178, P63, DOI 10.1016/S0025-3227(01)00175-X; LETURMY P, 2003, J GEOPHYS RES SOL EA, V108; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; LINK W, 1995, THEOR APPL GENET, V90, P27, DOI 10.1007/BF00220992; Lucazeau F, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001928; LUCAZEAU F, 2003, J GEOPHYS RES SOL EA, V108; MARKERT JA, 2010, BMC EVOL BIOL, V10; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; NUMRICH R, 2003, AQUARISTIK FACHMAGAZ, V171, P44; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Rambaut A, TRACER VERSION 1 4; RIBBINK AJ, 1983, S AFR J ZOOL, V18, P149; Robert M., 1946, CONGO PHYS, V3; ROBERTS T R, 1976, Bulletin of the Museum of Comparative Zoology, V147, P239; Ruber L, 2001, J EVOLUTION BIOL, V14, P325, DOI 10.1046/j.1420-9101.2001.00269.x; Runge J., 2008, LARGE RIVERS GEOMORP, P293; Salzburger W, 2004, NATURWISSENSCHAFTEN, V91, P277, DOI 10.1007/s00114-004-0528-6; Schliewen UK, 2006, ZOOTAXA, P33; Schliewen Uli, 2005, P58; Schwarzer J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-186; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Snoeks J., 1991, CHECK LIST FRESHWATE, V4, P100; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sullivan JP, 2002, EVOLUTION, V56, P597; Sullivan JP, 2004, EVOLUTION, V58, P825; TEUGELS GG, 1994, BIOL DIVERSITY AFRIC, P67; Turner GF, 2001, MOL ECOL, V10, P793, DOI 10.1046/j.1365-294x.2001.01200.x; VANDEPEER Y, 1993, COMPUT APPL BIOSCI, V9, P177; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vreven EJ, 2009, ICHTHYOL EXPLOR FRES, V20, P213	53	46	46	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22380	10.1371/journal.pone.0022380	http://dx.doi.org/10.1371/journal.pone.0022380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799840	Green Published, gold, Green Submitted			2022-12-25	WOS:000292931200050
J	Souiai, O; Becker, E; Prieto, C; Benkahla, A; De Las Rivas, J; Brun, C				Souiai, Ouissem; Becker, Emmanuelle; Prieto, Carlos; Benkahla, Alia; De Las Rivas, Javier; Brun, Christine			Functional Integrative Levels in the Human Interactome Recapitulate Organ Organization	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORK; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; COMPLEXES; MODULARITY; ONTOLOGY; MAP; PERIPHERY; SELECTION; CONTEXT	Interactome networks represent sets of possible physical interactions between proteins. They lack spatio-temporal information by construction. However, the specialized functions of the differentiated cell types which are assembled into tissues or organs depend on the combinatorial arrangements of proteins and their physical interactions. Is tissue-specificity, therefore, encoded within the interactome? In order to address this question, we combined protein-protein interactions, expression data, functional annotations and interactome topology. We first identified a subnetwork formed exclusively of proteins whose interactions were observed in all tested tissues. These are mainly involved in housekeeping functions and are located at the topological center of the interactome. This 'Largest Common Interactome Network' represents a 'functional interactome core'. Interestingly, two types of tissue-specific interactions are distinguished when considering function and network topology: tissue-specific interactions involved in regulatory and developmental functions are central whereas tissue-specific interactions involved in organ physiological functions are peripheral. Overall, the functional organization of the human interactome reflects several integrative levels of functions with housekeeping and regulatory tissue-specific functions at the center and physiological tissue-specific functions at the periphery. This gradient of functions recapitulates the organization of organs, from cells to organs. Given that several gradients have already been identified across interactomes, we propose that gradients may represent a general principle of protein-protein interaction network organization.	[Souiai, Ouissem; Becker, Emmanuelle; Brun, Christine] INSERM, U928, TAGC, F-13258 Marseille, France; [Souiai, Ouissem; Becker, Emmanuelle; Brun, Christine] Univ Aix Marseille 2, UMR S928, Marseille, France; [Souiai, Ouissem; Benkahla, Alia] Inst Pasteur, Tunis, Tunisia; [Prieto, Carlos; De Las Rivas, Javier] CSIC USAL, Bioinformat & Funct Genom Res Grp, Canc Res Ctr, IBMCC CIC, Salamanca, Spain; [Brun, Christine] CNRS, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Centre National de la Recherche Scientifique (CNRS)	Souiai, O (corresponding author), INSERM, U928, TAGC, F-13258 Marseille, France.	brun@tagc.univ-mrs.fr	Prieto, Carlos/G-2382-2016; Brun, Christine/B-4922-2008; Becker, Emmanuelle/H-2523-2015; De Las Rivas, Javier/G-5936-2014	Prieto, Carlos/0000-0001-8178-9768; Brun, Christine/0000-0002-5563-6765; Becker, Emmanuelle/0000-0002-7673-0582; De Las Rivas, Javier/0000-0002-0984-9946; oussama, souiai/0000-0003-2443-114X; Benkahla, Alia/0000-0001-9988-3250	Fondation Merieux; French Cooperation Institute; ANR [R09127AA]; ANR under EU	Fondation Merieux; French Cooperation Institute; ANR(French National Research Agency (ANR)); ANR under EU(French National Research Agency (ANR))	OS is the recipient of a Fondation Merieux and a French Cooperation Institute fellowship. This work is funded by an ANR grant to CB (ANR Piribio R09127AA) and by the ANR, partner of the ERASysbio+ initiative supported under the EU ERANET Plus scheme in FP7 (ModHeart Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000817; [Anonymous], O M ALGORITHM CORES; [Anonymous], K CORE DECOMPOSITION; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Herrmann C, 2009, BIOINFORMATICS, V25, P3197, DOI 10.1093/bioinformatics/btp553; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kim PM, 2007, P NATL ACAD SCI USA, V104, P20274, DOI 10.1073/pnas.0710183104; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; Lehner B, 2004, TRENDS GENET, V20, P468, DOI 10.1016/j.tig.2004.08.002; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Martin D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r101; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Park SG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-241; Ponten F, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.93; Prieto C, 2006, NUCLEIC ACIDS RES, V34, pW298, DOI 10.1093/nar/gkl128; Rachlin J, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100103; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SEIDMAN SB, 1983, SOC NETWORKS, V5, P269, DOI 10.1016/0378-8733(83)90028-X; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vinogradov AE, 2008, BIOINFORMATICS, V24, P2814, DOI 10.1093/bioinformatics/btn555; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Yeung KY, 2001, BIOINFORMATICS, V17, P309, DOI 10.1093/bioinformatics/17.4.309; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	41	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22051	10.1371/journal.pone.0022051	http://dx.doi.org/10.1371/journal.pone.0022051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799769	Green Published, gold, Green Submitted			2022-12-25	WOS:000292931200022
J	Whiteside, HM; Dawson, DA; Soulsbury, CD; Harris, S				Whiteside, Helen M.; Dawson, Deborah A.; Soulsbury, Carl D.; Harris, Stephen			Mother Knows Best: Dominant Females Determine Offspring Dispersal in Red Foxes (Vulpes vulpes)	PLOS ONE			English	Article							SARCOPTIC MANGE; ALLELIC DROPOUT; POPULATION; FITNESS; ASSIGNMENT; EVOLUTION; PATERNITY; PARENTAGE; BEHAVIOR	Background: Relatedness between group members is central to understanding the causes of animal dispersal. In many group-living mammals this can be complicated as extra-pair copulations result in offspring having varying levels of relatedness to the dominant animals, leading to a potential conflict between male and female dominants over offspring dispersal strategies. To avoid resource competition and inbreeding, dominant males might be expected to evict unrelated males and related females, whereas the reverse strategy would be expected for dominant females. Methodology/Principal Findings: We used microsatellites and long-term data from an urban fox (Vulpes vulpes) population to compare dispersal strategies between offspring with intra-and extra-group fathers and mothers of differing social status in red foxes. Relatedness to the dominant male had no effect on dispersal in offspring of either sex, whereas there was a strong effect of relatedness to resident females on offspring dispersal independent of population density. Males with dominant mothers dispersed significantly more often than males with subordinate mothers, whereas dispersing females were significantly more likely to have subordinate mothers compared to philopatric females. Conclusions/Significance: This is the first study to demonstrate that relatedness to resident females is important in juvenile dispersal in group-living mammals. Male dispersal may be driven by inbreeding avoidance, whereas female dispersal appears to be influenced by the fitness advantages associated with residing with the same-sex dominant parent. Selection pressure for paternal influence on offspring dispersal is low due to the limited costs associated with retaining unrelated males and the need for alternative inbreeding avoidance mechanisms between the dominant male and his female offspring. These findings have important implications for the evolution of dispersal and group living in social mammals, and our understanding of a key biological process.	[Whiteside, Helen M.; Soulsbury, Carl D.; Harris, Stephen] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Dawson, Deborah A.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Bristol; University of Sheffield	Whiteside, HM (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	Helen.Whiteside@Bristol.ac.uk	Soulsbury, Carl D./F-3137-2010; Soulsbury, Carl/P-1492-2019; Whiteside, Helen/GPK-0368-2022	Soulsbury, Carl D./0000-0001-8808-5210; Soulsbury, Carl/0000-0001-8808-5210; Whiteside, Helen/0000-0001-5168-1131	Dulverton Trust; Natural Environment Research Council, United Kingdom; NERC [NBAF010001] Funding Source: UKRI; Natural Environment Research Council [NBAF010001] Funding Source: researchfish	Dulverton Trust; Natural Environment Research Council, United Kingdom(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Long-term funding for this study was provided by the Dulverton Trust, and the molecular work was supported by the Natural Environment Research Council, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker PJ, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P207; Baker PJ, 2004, BEHAV ECOL, V15, P766, DOI 10.1093/beheco/arh077; Baker PJ, 1998, ANIM BEHAV, V56, P1411, DOI 10.1006/anbe.1998.0950; Baker PJ, 2001, J APPL ECOL, V38, P823, DOI 10.1046/j.1365-2664.2001.00637.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; DOBSON FS, 1985, AM NAT, V126, P855, DOI 10.1086/284457; Duckworth RA, 2009, PHILOS T R SOC B, V364, P1075, DOI 10.1098/rstb.2008.0294; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; HALPIN ZT, 1991, KIN RECOGNITION, P220; HARRIS S, 1988, J APPL ECOL, V25, P409, DOI 10.2307/2403833; HARRIS S, 1978, J ZOOL, V184, P91, DOI 10.1111/j.1469-7998.1978.tb03268.x; HARRIS S, 1992, ANIM BEHAV, V44, P1085, DOI 10.1016/S0003-3472(05)80320-3; Honer OP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1059; Iossa G, 2009, BEHAV ECOL, V20, P385, DOI 10.1093/beheco/arn149; Johnson PCD, 2007, GENETICS, V175, P827, DOI 10.1534/genetics.106.064618; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kenta T, 2008, MOL ECOL RESOUR, V8, P1230, DOI 10.1111/j.1755-0998.2008.02190.x; Kukekova AV, 2004, J HERED, V95, P185, DOI 10.1093/jhered/esh033; Lambin Xavier, 2001, P110; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Newman TJ, 2002, CAN J ZOOL, V80, P154, DOI [10.1139/z01-216, 10.1139/Z01-216]; Nicholls JA, 2000, J AVIAN BIOL, V31, P165, DOI 10.1034/j.1600-048X.2000.310208.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richardson DS, 2001, MOL ECOL, V10, P2263, DOI 10.1046/j.0962-1083.2001.01355.x; Roemer GW, 2001, J ZOOL, V255, P1, DOI 10.1017/S0952836901001066; SilleroZubiri C, 1996, BEHAV ECOL SOCIOBIOL, V38, P331, DOI 10.1007/s002650050249; Soulsbury CD, 2008, BEHAV ECOL SOCIOBIOL, V62, P1289, DOI 10.1007/s00265-008-0557-9; Soulsbury CD, 2007, MAMMAL REV, V37, P278, DOI 10.1111/j.1365-2907.2007.00101.x; Soulsbury CD, 2007, CONSERV GENET, V8, P733, DOI 10.1007/s10592-006-9194-x; Tschirren B, 2007, AM NAT, V169, P87, DOI 10.1086/509945; Wandeler P, 2006, MOL ECOL NOTES, V6, P98, DOI 10.1111/j.1471-8286.2005.01152.x; Wang J, 2009, GENETICS, V181, P1579, DOI 10.1534/genetics.108.100214; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; WOLFF JO, 1993, OIKOS, V68, P173, DOI 10.2307/3545324; [No title captured]	37	7	7	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22145	10.1371/journal.pone.0022145	http://dx.doi.org/10.1371/journal.pone.0022145			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799780	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000292931200028
J	Yu, Y; Zhao, C; Lv, Z; Chen, W; Tong, M; Guo, XJ; Wang, L; Liu, JY; Zhou, ZM; Zhu, H; Zhou, Q; Sha, JH				Yu, Yang; Zhao, Chun; Lv, Zhuo; Chen, Wen; Tong, Man; Guo, Xuejiang; Wang, Liu; Liu, Jiayin; Zhou, Zuomin; Zhu, Hui; Zhou, Qi; Sha, Jiahao			Microinjection Manipulation Resulted in the Increased Apoptosis of Spermatocytes in Testes from Intracytoplasmic Sperm Injection (ICSI) Derived Mice	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGIES; ENDOPLASMIC-RETICULUM STRESS; IN-VITRO FERTILIZATION; BLASTOMERE BIOPSY; BIRTH-DEFECTS; MOUSE; EMBRYOS; CULTURE; RISK; SPERMATOGENESIS	The invention of intracytoplasmic sperm injection (ICSI) has possibly been the most important development in reproductive medicine, one that has given hope to thousands of infertile couples worldwide. However, concerns remain regarding the safety of this method since it is a more invasive procedure than in vitro fertilization (IVF), since a spermatozoon is injected into the oocyte cytoplasm. Using mice derived from IVF technology as a control, we assessed the influence of invasive microinjection in the process of transferring sperm into oocyte cytoplasm in ICSI procedure on the development and physiologic function of resultant offspring. Our results demonstrated that mice produced from ICSI and IVF had no significant difference in phenotypic indices including body weight, forelimb physiology, and learning and memory ability. However, increased spermatocyte apoptosis was observed in the testis of adult ICSI mice, when compared with IVF mice. And, decreased testis weight and marked damage of spermatogenic epithelia were found in aged ICSI mice. Furthermore, proteomic analysis verified that most of the differentiated proteins in testes between adult ICSI and IVF mice were those involved in regulation of apoptosis pathways. Our results demonstrated that the microinjection manipulation used in the ICSI procedure might pose potential risks to the fertility of male offspring. The changed expression of a series of proteins relating to apoptosis or proliferation might contribute to it. Further studies are necessary to better understand all the risks of ICSI.	[Yu, Yang; Lv, Zhuo; Tong, Man; Wang, Liu; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Zhao, Chun; Chen, Wen; Guo, Xuejiang; Liu, Jiayin; Zhou, Zuomin; Zhu, Hui; Sha, Jiahao] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Peoples R China; [Lv, Zhuo; Tong, Man] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Nanjing Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yu, Y (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	njzhuhui@njmu.edu.cn; qzhou@ioz.ac.cn	Lu, Zhuo/D-4517-2014; Guo, Xuejiang/J-9600-2014	Guo, Xuejiang/0000-0002-0475-5705	973 program [2007CB948103]; National Science Foundation of China [90919060]	973 program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from 973 program (No. 2007CB948103) and from the National Science Foundation of China (No. 90919060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bavister BD, 1995, HUM REPROD UPDATE, V1, P91, DOI 10.1093/humupd/1.2.91; Bonduelle M, 2002, HUM REPROD, V17, P671, DOI 10.1093/humrep/17.3.671; Caperton L, 2007, P NATL ACAD SCI USA, V104, P5085, DOI 10.1073/pnas.0611642104; CHATOT CL, 1990, BIOL REPROD, V42, P432, DOI 10.1095/biolreprod42.3.432; Chen Y, 2007, PROTEOMICS, V7, P3097, DOI 10.1002/pmic.200700019; Corazzari M, 2007, BRIT J CANCER, V96, P1062, DOI 10.1038/sj.bjc.6603672; de Mouzon J, 2009, HUM REPROD, V24, P2310, DOI 10.1093/humrep/dep098; Ecker DJ, 2004, P NATL ACAD SCI USA, V101, P1595, DOI 10.1073/pnas.0306846101; Hansen M, 2002, NEW ENGL J MED, V346, P725, DOI 10.1056/NEJMoa010035; Hansen M, 2005, HUM REPROD, V20, P328, DOI 10.1093/humrep/deh593; HIKIM APS, 1988, BIOL REPROD, V39, P1225, DOI 10.1095/biolreprod39.5.1225; HOWARDS SS, 1995, NEW ENGL J MED, V332, P312, DOI 10.1056/NEJM199502023320507; Hu XY, 2007, PROSTATE CANCER P D, V10, P104, DOI 10.1038/sj.pcan.4500919; Jain T, 2007, NEW ENGL J MED, V357, P251, DOI 10.1056/NEJMsa070707; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kurinczuk JJ, 2003, HUM REPROD, V18, P925, DOI 10.1093/humrep/deg217; Lawrence LT, 2008, SEMIN REPROD MED, V26, P143, DOI 10.1055/s-2008-1042953; Liebaers I, 2010, HUM REPROD, V25, P275, DOI 10.1093/humrep/dep298; Liu HR, 2005, CIRCULATION, V111, P90, DOI 10.1161/01.CIR.0000151613.90994.17; Lizama C, 2007, APOPTOSIS, V12, P499, DOI 10.1007/s10495-006-0012-1; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Mandal M, 2001, J BIOL CHEM, V276, P9699, DOI 10.1074/jbc.M008514200; Mandic A, 2003, J BIOL CHEM, V278, P9100, DOI 10.1074/jbc.M210284200; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Munne S, 1998, FERTIL STERIL, V69, P904, DOI 10.1016/S0015-0282(98)00039-9; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Notari M, 2006, BLOOD, V107, P2507, DOI 10.1182/blood-2005-09-3732; Oldereid Nan B, 2003, Tidsskr Nor Laegeforen, V123, P2696; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Romundstad LB, 2008, LANCET, V372, P737, DOI 10.1016/S0140-6736(08)61041-7; Shaha Chandrima, 2007, Soc Reprod Fertil Suppl, V63, P173; Shiota Kohei, 2005, Congenital Anomalies, V45, P39, DOI 10.1111/j.1741-4520.2005.00061.x; Suzuki Y, 2004, CELL DEATH DIFFER, V11, P208, DOI 10.1038/sj.cdd.4401343; Verpoest Willem, 2006, Hum Fertil (Camb), V9, P81, DOI 10.1080/14647270500422158; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Watkins AJ, 2007, P NATL ACAD SCI USA, V104, P5449, DOI 10.1073/pnas.0610317104; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; Yu Y, 2009, MOL CELL PROTEOMICS, V8, P1490, DOI 10.1074/mcp.M800273-MCP200; ZHENGWEI Y, 1990, BIOL REPROD, V43, P629, DOI 10.1095/biolreprod43.4.629	40	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22172	10.1371/journal.pone.0022172	http://dx.doi.org/10.1371/journal.pone.0022172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799787	Green Published, Green Submitted, gold			2022-12-25	WOS:000292931200031
J	Li, T; Xiao, JH; Xu, ZH; Murphy, RW; Huang, DW				Li, Tong; Xiao, Jin-Hua; Xu, Zhao-Huan; Murphy, Robert W.; Huang, Da-Wei			Cellular Tropism, Population Dynamics, Host Range and Taxonomic Status of an Aphid Secondary Symbiont, SMLS (Sitobion miscanthi L Type Symbiont)	PLOS ONE			English	Article							ACYRTHOSIPHON-PISUM INSECTA; PEA APHID; HORIZONTAL TRANSFER; ENDOSYMBIOTIC BACTERIUM; RICKETTSIA; INFERENCE; BUCHNERA; STRAINS; FITNESS; MRBAYES	SMLS (Sitobion miscanthi L type symbiont) is a newly reported aphid secondary symbiont. Phylogenetic evidence from molecular markers indicates that SMLS belongs to the Rickettsiaceae and has a sibling relationship with Orientia tsutsugamushi. A comparative analysis of coxA nucleotide sequences further supports recognition of SMLS as a new genus in the Rickettsiaceae. In situ hybridization reveals that SMLS is housed in both sheath cells and secondary bacteriocytes and it is also detected in aphid hemolymph. The population dynamics of SMLS differ from those of Buchnera aphidicola and titer levels of SMLS increase in older aphids. A survey of 13 other aphids reveals that SMLS only occurs in wheat-associated species.	[Li, Tong; Xiao, Jin-Hua; Huang, Da-Wei] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Li, Tong] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Xu, Zhao-Huan] Shandong Agr Univ, Coll Plant Protect, Tai An, Shandong, Peoples R China; [Murphy, Robert W.] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Murphy, Robert W.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Huang, Da-Wei] Hebei Univ, Coll Life Sci, Baoding, Hebei, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shandong Agricultural University; Chinese Academy of Sciences; Kunming Institute of Zoology; Royal Ontario Museum; Hebei University	Li, T (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	huangdw@ioz.ac.cn		Li, Tong/0000-0001-6269-5117; Murphy, Robert/0000-0001-8555-2338	Ministry of Agriculture of the People's Republic of China [200803002]; Key Laboratory of Zoological Systematics and Evolution, the Chinese Academy of Sciences [O529YX5105]; National Natural Science Foundation of China (NSFC) [31090253, 30900137]; Special Fund for Agro-Scientific Research in the Public Interest of China [201103022]; Chinese Academy of Sciences	Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs); Key Laboratory of Zoological Systematics and Evolution, the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-Scientific Research in the Public Interest of China; Chinese Academy of Sciences(Chinese Academy of Sciences)	This project was supported by a Research and Demonstration of Aphid Prevention and Management Technology grant from the Ministry of Agriculture of the People's Republic of China (No. 200803002) and by grant No. O529YX5105 from the Key Laboratory of Zoological Systematics and Evolution, the Chinese Academy of Sciences. This research is partially supported by National Natural Science Foundation of China (NSFC grant No. 31090253, 30900137) and by the Special Fund for Agro-Scientific Research in the Public Interest of China (grant No. 201103022). Manuscript preparation was supported by a Visiting Professorship for Senior International Scientists from the Chinese Academy of Sciences to R. W. Murphy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], [No title captured]; Chen DQ, 1996, CURR MICROBIOL, V33, P123, DOI 10.1007/s002849900086; Chen DQ, 2000, ENTOMOL EXP APPL, V95, P315, DOI 10.1023/A:1004083324807; Clark MA, 2000, EVOLUTION, V54, P517, DOI 10.1111/j.0014-3820.2000.tb00054.x; Darby AC, 2001, FEMS MICROBIOL ECOL, V36, P43, DOI 10.1111/j.1574-6941.2001.tb00824.x; Davis MJ, 1998, CURR MICROBIOL, V36, P80, DOI 10.1007/s002849900283; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Fukatsu T, 2000, APPL ENVIRON MICROB, V66, P2748, DOI 10.1128/AEM.66.7.2748-2758.2000; Fukatsu T, 1998, APPL ENVIRON MICROB, V64, P3599; Fukatsu T, 2001, APPL ENVIRON MICROB, V67, P1284, DOI 10.1128/AEM.67.3.1284-1291.2001; Guay JF, 2009, J INSECT PHYSIOL, V55, P919, DOI 10.1016/j.jinsphys.2009.06.006; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Koga R, 2003, P ROY SOC B-BIOL SCI, V270, P2543, DOI 10.1098/rspb.2003.2537; Koga R, 2009, APPL ENTOMOL ZOOL, V44, P281, DOI 10.1303/aez.2009.281; Li T, 2011, J INVERTEBR PATHOL, V106, P418, DOI 10.1016/j.jip.2010.12.003; Min CK, 2008, COMP FUNCT GENOM, DOI 10.1155/2008/623145; Mitsuhashi W, 2002, INSECT MOL BIOL, V11, P577, DOI 10.1046/j.1365-2583.2002.00368.x; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rozen S, 2000, Methods Mol Biol, V132, P365; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; Sandstrom JP, 2001, MOL ECOL, V10, P217, DOI 10.1046/j.1365-294X.2001.01189.x; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Sintupachee S, 2006, MICROB ECOL, V51, P294, DOI 10.1007/s00248-006-9036-x; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tsuchida T, 2005, MICROB ECOL, V49, P126, DOI 10.1007/s00248-004-0216-2; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; UNTERMAN BM, 1989, J BACTERIOL, V171, P2970, DOI 10.1128/jb.171.6.2970-2974.1989; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07	40	14	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e21944	10.1371/journal.pone.0021944	http://dx.doi.org/10.1371/journal.pone.0021944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789197	gold, Green Published, Green Submitted			2022-12-25	WOS:000292811700012
J	Staal, JA; Alexander, SR; Liu, Y; Dickson, TD; Vickers, JC				Staal, Jerome A.; Alexander, Samuel R.; Liu, Yao; Dickson, Tracey D.; Vickers, James C.			Characterization of Cortical Neuronal and Glial Alterations during Culture of Organotypic Whole Brain Slices from Neonatal and Mature Mice	PLOS ONE			English	Article							NEUROFILAMENT TRIPLET; SYNAPTIC DEVELOPMENT; HIPPOCAMPAL; PROTEINS; SYSTEM; GROWTH; CORTEX; CELLS; TIME; LTP	Background: Organotypic brain slice culturing techniques are extensively used in a wide range of experimental procedures and are particularly useful in providing mechanistic insights into neurological disorders or injury. The cellular and morphological alterations associated with hippocampal brain slice cultures has been well established, however, the neuronal response of mouse cortical neurons to culture is not well documented. Methods: In the current study, we compared the cell viability, as well as phenotypic and protein expression changes in cortical neurons, in whole brain slice cultures from mouse neonates (P4-6), adolescent animals (P25-28) and mature adults (P50+). Cultures were prepared using the membrane interface method. Results: Propidium iodide labeling of nuclei (due to compromised cell membrane) and AlamarBlue (TM) (cell respiration) analysis demonstrated that neonatal tissue was significantly less vulnerable to long-term culture in comparison to the more mature brain tissues. Cultures from P6 animals showed a significant increase in the expression of synaptic markers and a decrease in growth-associated proteins over the entire culture period. However, morphological analysis of organotypic brain slices cultured from neonatal tissue demonstrated that there were substantial changes to neuronal and glial organization within the neocortex, with a distinct loss of cytoarchitectural stratification and increased GFAP expression (p<0.05). Additionally, cultures from neonatal tissue had no glial limitans and, after 14 DIV, displayed substantial cellular protrusions from slice edges, including cells that expressed both glial and neuronal markers. Conclusion: In summary, we present a substantial evaluation of the viability and morphological changes that occur in the neocortex of whole brain tissue cultures, from different ages, over an extended period of culture.	[Staal, Jerome A.; Alexander, Samuel R.; Liu, Yao; Dickson, Tracey D.; Vickers, James C.] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia	University of Tasmania; Menzies Institute for Medical Research	Staal, JA (corresponding author), Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia.	Jastaal@utas.edu.au	Vickers, James C/J-7464-2014	Vickers, James C/0000-0001-5671-4879; Dickson, Tracey/0000-0002-9196-1661	National Health and Medical Research Council [31469]; Tasmanian Motor Accident Insurance Board [S0018815]; Alzhiemer's Australia Fellowship	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Tasmanian Motor Accident Insurance Board; Alzhiemer's Australia Fellowship	This work was supported by research grants from the National Health and Medical Research Council (ID# 31469), The Tasmanian Motor Accident Insurance Board (not-for-profit government organization; #S0018815). JAS holds a Masonic Medical Research Foundation and Alzhiemer's Australia Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUCHS PA, 1993, DEV BRAIN RES, V71, P81, DOI 10.1016/0165-3806(93)90108-M; Cater HL, 2007, J NEUROCHEM, V101, P434, DOI 10.1111/j.1471-4159.2006.04379.x; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Chung RS, 2003, J NEUROSCI, V23, P3336; Colbert Costa M., 2006, V337, P117; Collin C, 1997, J NEUROPHYSIOL, V77, P1614, DOI 10.1152/jn.1997.77.3.1614; De Simoni A, 2006, NAT PROTOC, V1, P1439, DOI 10.1038/nprot.2006.228; Finley M, 2004, BRAIN RES, V1001, P125, DOI 10.1016/j.brainres.2003.12.009; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; GAHWILER BH, 1981, JAMA-J AM MED ASSOC, V245, P1858, DOI 10.1001/jama.245.18.1858; Ghanem N, 2007, J NEUROSCI, V27, P5012, DOI 10.1523/JNEUROSCI.4725-06.2007; Gutierrez R, 1999, BRAIN RES, V815, P304, DOI 10.1016/S0006-8993(98)01101-9; Kirkcaldie MTK, 2002, J CHEM NEUROANAT, V24, P163, DOI 10.1016/S0891-0618(02)00043-1; Klugmann M, 1997, NEURON, V18, P59, DOI 10.1016/S0896-6273(01)80046-5; Kristensen BW, 2001, BRAIN RES, V917, P21, DOI 10.1016/S0006-8993(01)02900-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leutgeb JK, 2003, J NEUROSCI METH, V130, P19, DOI 10.1016/S0165-0270(03)00228-0; Lossi L, 2009, PROG NEUROBIOL, V88, P221, DOI 10.1016/j.pneurobio.2009.01.002; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; McManus T, 2004, J NEUROCHEM, V91, P327, DOI 10.1111/j.1471-4159.2004.02711.x; Mielke JG, 2005, DEV BRAIN RES, V160, P275, DOI 10.1016/j.devbrainres.2005.09.009; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; MIYOSHI G, 2010, CEREB CORTEX; Morrison B, 2002, BRIT J PHARMACOL, V137, P1255, DOI 10.1038/sj.bjp.0704986; MULLER D, 1993, DEV BRAIN RES, V71, P93, DOI 10.1016/0165-3806(93)90109-N; MULLER M, 1993, BRAIN RES, V619, P157, DOI 10.1016/0006-8993(93)91607-T; Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; Pena F, 2010, CURR MED CHEM, V17, P987, DOI 10.2174/092986710790820679; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Staal JA, 2009, J NEUROTRAUM, V26, P781, DOI 10.1089/neu.2008.0669; Stachniak TJE, 2006, AM J PHYSIOL-REG I, V291, pR68, DOI 10.1152/ajpregu.00830.2005; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Taniguchi H, 2007, J NEUROSCI, V27, P2815, DOI 10.1523/JNEUROSCI.0032-07.2007; Thompson SM, 1996, J COMP NEUROL, V372, P515; Tom VJ, 2004, J NEUROSCI, V24, P9282, DOI 10.1523/JNEUROSCI.2120-04.2004; VICKERS JC, 1992, NEUROSCIENCE, V49, P73, DOI 10.1016/0306-4522(92)90077-F; Xiang ZM, 2000, BRAIN RES, V881, P77, DOI 10.1016/S0006-8993(00)02795-5; Xiang ZM, 2000, J NEUROSCI METH, V98, P145, DOI 10.1016/S0165-0270(00)00197-7; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009	42	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22040	10.1371/journal.pone.0022040	http://dx.doi.org/10.1371/journal.pone.0022040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789209	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811700017
J	Iizuka, R; Ueno, T; Morone, N; Funatsu, T				Iizuka, Ryo; Ueno, Taro; Morone, Nobuhiro; Funatsu, Takashi			Single-Molecule Fluorescence Polarization Study of Conformational Change in Archaeal Group II Chaperonin	PLOS ONE			English	Article							THERMOCOCCUS STRAIN KS-1; EUKARYOTIC CHAPERONIN; CRYSTAL-STRUCTURE; FOLDING CHAMBER; ATP BINDING; MECHANISM; STATE; SUBUNITS; CLOSURE; HYDROLYSIS	Group II chaperonins found in archaea and in eukaryotic cytosol mediate protein folding without a GroES-like cofactor. The function of the cofactor is substituted by the helical protrusion at the tip of the apical domain, which forms a built-in lid on the central cavity. Although many studies on the change in lid conformation coupled to the binding and hydrolysis of nucleotides have been conducted, the molecular mechanism of lid closure remains poorly understood. Here, we performed a single-molecule polarization modulation to probe the rotation of the helical protrusion of a chaperonin from a hyperthermophilic archaeum, Thermococcus sp. strain KS-1. We detected approximately 35 degrees rotation of the helical protrusion immediately after photorelease of ATP. The result suggests that the conformational change from the open lid to the closed lid state is responsible for the approximately 35 degrees rotation of the helical protrusion.	[Iizuka, Ryo; Ueno, Taro; Funatsu, Takashi] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Morone, Nobuhiro] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Tokyo, Japan; [Funatsu, Takashi] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	University of Tokyo; National Center for Neurology & Psychiatry - Japan; Japan Science & Technology Agency (JST)	Iizuka, R (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan.	funatsu@mail.ecc.u-tokyo.ac.jp	Funatsu, Takashi/Q-1404-2015	Funatsu, Takashi/0000-0002-9656-8308; Morone, Nobuhiro/0000-0002-7672-158X; Iizuka, Ryo/0000-0002-9328-5628	Ministry of Education, Culture, Sports, Science and Technology of Japan [21370065, 21121004, 21118523, 18770126, 18031008, 22020006]; Health Labor Science Research Grant [Nano-001]; Japan Society for the Promotion of Science (JSPS) [18.10141]; Grants-in-Aid for Scientific Research [23310087] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health Labor Science Research Grant; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research (B) (21370065 to TF), Grant-in-Aid for Scientific Research on Innovative Areas (21121004 to TF, 21118523 to NM), Grant-in-Aid for Young Scientists (18770126 to TU), and Grant-in-Aid for Scientific Research on Priority Areas (18031008 to TU; 22020006 to RI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was supported in part by a Health Labor Science Research Grant (Nano-001 to NM). This research was also supported by the Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program). RI received a Research Fellowship from the Japan Society for the Promotion of Science for Young Scientists (18.10141). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2000, P NATL ACAD SCI USA, V97, P7243, DOI 10.1073/pnas.120174297; Booth CR, 2008, NAT STRUCT MOL BIOL, V15, P746, DOI 10.1038/nsmb.1436; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Clare DK, 2008, STRUCTURE, V16, P528, DOI 10.1016/j.str.2008.01.016; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Gutsche I, 1999, J MOL BIOL, V293, P295, DOI 10.1006/jmbi.1999.3008; Ha T, 1999, J PHYS CHEM B, V103, P6839, DOI 10.1021/jp990948j; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Huo YW, 2010, STRUCTURE, V18, P1270, DOI 10.1016/j.str.2010.07.009; Iizuka R, 2005, J BIOL CHEM, V280, P40375, DOI 10.1074/jbc.M506785200; Iizuka R, 2004, J BIOL CHEM, V279, P18834, DOI 10.1074/jbc.M400839200; Iizuka R, 2003, J BIOL CHEM, V278, P44959, DOI 10.1074/jbc.M305484200; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Kanzaki T, 2008, J BIOL CHEM, V283, P34773, DOI 10.1074/jbc.M805303200; KIM S, 1994, TRENDS BIOCHEM SCI, V19, P543, DOI 10.1016/0968-0004(94)90058-2; Llorca O, 1999, NAT STRUCT BIOL, V6, P639; Llorca O, 2001, EMBO J, V20, P4065, DOI 10.1093/emboj/20.15.4065; Llorca O, 1998, J BIOL CHEM, V273, P10091, DOI 10.1074/jbc.273.17.10091; Masaike T, 2008, NAT STRUCT MOL BIOL, V15, P1326, DOI 10.1038/nsmb.1510; Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Nitsch M, 1998, NAT STRUCT BIOL, V5, P855, DOI 10.1038/2296; PENZKOFER A, 1980, OPT COMMUN, V35, P81, DOI 10.1016/0030-4018(80)90364-8; Pereira JH, 2010, J BIOL CHEM, V285, P27958, DOI 10.1074/jbc.M110.125344; Schoehn G, 2000, J MOL BIOL, V301, P323, DOI 10.1006/jmbi.2000.3952; Schoehn G, 2000, J MOL BIOL, V296, P813, DOI 10.1006/jmbi.2000.3505; Shomura Y, 2004, J MOL BIOL, V335, P1265, DOI 10.1016/j.jmb.2003.11.028; Toprak E, 2007, ANNU REV BIOPH BIOM, V36, P349, DOI 10.1146/annurev.biophys.36.040306.132700; Velonia K, 2005, ANGEW CHEM INT EDIT, V44, P560, DOI 10.1002/anie.200460625; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yoshida T, 2000, J MOL BIOL, V299, P1399, DOI 10.1006/jmbi.2000.3847; Yoshida T, 2002, J MOL BIOL, V315, P73, DOI 10.1006/jmbi.2001.5220; Yoshida T, 1997, J MOL BIOL, V273, P635, DOI 10.1006/jmbi.1997.1337; Zhang JJ, 2010, NATURE, V463, P379, DOI 10.1038/nature08701	35	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22253	10.1371/journal.pone.0022253	http://dx.doi.org/10.1371/journal.pone.0022253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779405	Green Submitted, Green Published, gold			2022-12-25	WOS:000292811300058
J	Welnowska, E; Sanz, MA; Redondo, N; Carrasco, L				Welnowska, Ewelina; Angel Sanz, Miguel; Redondo, Natalia; Carrasco, Luis			Translation of Viral mRNA without Active eIF2: The Case of Picornaviruses	PLOS ONE			English	Article							INITIATION FACTOR-II; INTERNAL RIBOSOMAL ENTRY; SITE-MEDIATED TRANSLATION; 68,000-MR PROTEIN-KINASE; ENCEPHALOMYOCARDITIS VIRUS; POLIOVIRUS RNA; ALPHA-SUBUNIT; INDEPENDENT TRANSLATION; INFECTED CELLS; SINDBIS VIRUS	Previous work by several laboratories has established that translation of picornavirus RNA requires active eIF2 alpha for translation in cell free systems or after transfection in culture cells. Strikingly, we have found that encephalomyocarditis virus protein synthesis at late infection times is resistant to inhibitors that induce the phosphorylation of eIF2 alpha whereas translation of encephalomyocarditis virus early during infection is blocked upon inactivation of eIF2 alpha by phosphorylation induced by arsenite. The presence of this compound during the first hour of infection leads to a delay in the appearance of late protein synthesis in encephalomyocarditis virus-infected cells. Depletion of eIF2 alpha also provokes a delay in the kinetics of encephalomyocarditis virus protein synthesis, whereas at late times the levels of viral translation are similar in control or eIF2 alpha-depleted HeLa cells. Immunofluorescence analysis reveals that eIF2 alpha, contrary to eIF4GI, does not colocalize with ribosomes or with encephalomyocarditis virus 3D polymerase. Taken together, these findings support the novel idea that eIF2 is not involved in the translation of encephalomyocarditis virus RNA during late infection. Moreover, other picornaviruses such as foot-and-mouth disease virus, mengovirus and poliovirus do not require active eIF2 alpha when maximal viral translation is taking place. Therefore, translation of picornavirus RNA may exhibit a dual mechanism as regards the participation of eIF2. This factor would be necessary to translate the input genomic RNA, but after viral RNA replication, the mechanism of viral RNA translation switches to one independent of eIF2.	[Welnowska, Ewelina; Angel Sanz, Miguel; Redondo, Natalia; Carrasco, Luis] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Welnowska, E (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain.	masanz@cbm.uam.es	Carrasco, Luis/E-2435-2012; Sanz, Miguel A/H-1914-2015; sanz-gomez, miguel/Y-6244-2019; Carrasco, Luis/H-3001-2017	Sanz, Miguel A/0000-0001-6573-883X; sanz-gomez, miguel/0000-0002-5761-9010; Carrasco, Luis/0000-0003-3833-8835; REDONDO, NATALIA/0000-0001-9356-8102	Direccion General de Investigacion Cientifica y Tecnica (DGICYT) [BFU2009-07352]; Fundacion Ramon Areces	Direccion General de Investigacion Cientifica y Tecnica (DGICYT)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces	This study was supported by a Grant from Direccion General de Investigacion Cientifica y Tecnica (DGICYT) (BFU2009-07352) and the Institutional Grant awarded to the Centro de Biologia Molecular "Severo Ochoa" by the Fundacion Ramon Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agol Vadim I., 2002, P127; ALDABE R, 1995, BIOCHEM BIOPH RES CO, V215, P928, DOI 10.1006/bbrc.1995.2553; ANDINO R, 1993, EMBO J, V12, P3587, DOI 10.1002/j.1460-2075.1993.tb06032.x; Sanz MA, 2010, J MOL BIOL, V402, P101, DOI 10.1016/j.jmb.2010.07.014; Sanz MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004772; Belov GA, 2007, CELL CYCLE, V6, P36, DOI 10.4161/cc.6.1.3683; Belsham GJ, 2009, VIRUS RES, V139, P183, DOI 10.1016/j.virusres.2008.07.001; BLACK TL, 1993, J VIROL, V67, P791, DOI 10.1128/JVI.67.2.791-800.1993; BLACK TL, 1989, J VIROL, V63, P2244, DOI 10.1128/JVI.63.5.2244-2251.1989; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; Burgui I, 2007, J VIROL, V81, P12427, DOI 10.1128/JVI.01105-07; Castello A, 2006, J MOL BIOL, V355, P942, DOI 10.1016/j.jmb.2005.11.024; Castello A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000562; CHEN JJ, 1995, TRENDS BIOCHEM SCI, V20, P105, DOI 10.1016/S0968-0004(00)88975-6; Deniz N, 2009, RNA, V15, P932, DOI 10.1261/rna.1315109; DESTEFANO J, 1990, J VIROL, V64, P4445, DOI 10.1128/JVI.64.9.4445-4453.1990; Dmitriev SE, 2010, J BIOL CHEM, V285, P26779, DOI 10.1074/jbc.M110.119693; Fata-Hartley CL, 2005, J VIROL, V79, P11062, DOI 10.1128/JVI.79.17.11062-11070.2005; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Fernandez J, 2002, J BIOL CHEM, V277, P2050, DOI 10.1074/jbc.M109199200; Garrey JL, 2010, J VIROL, V84, P1124, DOI 10.1128/JVI.02006-09; Gerlitz G, 2002, EUR J BIOCHEM, V269, P2810, DOI 10.1046/j.1432-1033.2002.02974.x; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; HERSHEY JWB, 1989, J BIOL CHEM, V264, P20823; Hogle JM, 2002, ANNU REV MICROBIOL, V56, P677, DOI 10.1146/annurev.micro.56.012302.160757; Katsafanas GC, 2007, CELL HOST MICROBE, V2, P221, DOI 10.1016/j.chom.2007.08.005; KERR IM, 1971, J VIROL, V7, P438, DOI 10.1128/JVI.7.4.438-447.1971; Kolupaeva VG, 2003, MOL CELL BIOL, V23, P687, DOI 10.1128/MCB.23.2.687-698.2003; Lancaster AM, 2006, RNA, V12, P894, DOI 10.1261/rna.2342306; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; MEURS EF, 1992, J VIROL, V66, P5805, DOI 10.1128/JVI.66.10.5805-5814.1992; Mir MA, 2008, EMBO J, V27, P3129, DOI 10.1038/emboj.2008.228; ONEILL RE, 1989, J VIROL, V63, P5069, DOI 10.1128/JVI.63.12.5069-5075.1989; Paul Aniko V., 2002, P227; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Pestova TV, 2004, EMBO REP, V5, P906, DOI 10.1038/sj.embor.7400240; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; RANSONE LJ, 1987, J VIROL, V61, P1781, DOI 10.1128/JVI.61.6.1781-1787.1987; RANSONE LJ, 1988, J VIROL, V62, P3551, DOI 10.1128/JVI.62.10.3551-3557.1988; RICE AP, 1985, J VIROL, V54, P894, DOI 10.1128/JVI.54.3.894-898.1985; Rieder Elizabeth, 2002, P61; Sanz MA, 2007, J VIROL, V81, P7061, DOI 10.1128/JVI.02529-06; SCHEPER GC, 1991, BIOCHIM BIOPHYS ACTA, V1089, P220, DOI 10.1016/0167-4781(91)90011-A; SCHREIER MH, 1973, NATURE-NEW BIOL, V242, P35, DOI 10.1038/newbio242035a0; Shatsky IN, 2010, MOL CELLS, V30, P285, DOI 10.1007/s10059-010-0149-1; Shimoike T, 2009, ANTIVIR RES, V83, P228, DOI 10.1016/j.antiviral.2009.05.004; Skabkin MA, 2010, GENE DEV, V24, P1787, DOI 10.1101/gad.1957510; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; SVITKIN YV, 1994, J VIROL, V68, P1544, DOI 10.1128/JVI.68.3.1544-1550.1994; Terenin IM, 2008, NAT STRUCT MOL BIOL, V15, P836, DOI 10.1038/nsmb.1445; Thomas AAM, 1996, J GEN VIROL, V77, P265, DOI 10.1099/0022-1317-77-2-265; Ventoso I, 2006, GENE DEV, V20, P87, DOI 10.1101/gad.357006; VILELLA MD, 1991, EUR J BIOCHEM, V196, P407, DOI 10.1111/j.1432-1033.1991.tb15831.x; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Xi QR, 2004, GENE DEV, V18, P1997, DOI 10.1101/gad.1212504	60	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22230	10.1371/journal.pone.0022230	http://dx.doi.org/10.1371/journal.pone.0022230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779397	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811300050
J	Weise, LD; Nash, MP; Panfilov, AV				Weise, Louis D.; Nash, Martyn P.; Panfilov, Alexander V.			A Discrete Model to Study Reaction-Diffusion-Mechanics Systems	PLOS ONE			English	Article							SPIRAL WAVES; CHANNELS; TISSUE; EXCITATION; HEART	This article introduces a discrete reaction-diffusion-mechanics (dRDM) model to study the effects of deformation on reaction-diffusion (RD) processes. The dRDM framework employs a FitzHugh-Nagumo type RD model coupled to a mass-lattice model, that undergoes finite deformations. The dRDM model describes a material whose elastic properties are described by a generalized Hooke's law for finite deformations (Seth material). Numerically, the dRDM approach combines a finite difference approach for the RD equations with a Verlet integration scheme for the equations of the mass-lattice system. Using this framework results were reproduced on self-organized pacemaking activity that have been previously found with a continuous RD mechanics model. Mechanisms that determine the period of pacemakers and its dependency on the medium size are identified. Finally it is shown how the drift direction of pacemakers in RDM systems is related to the spatial distribution of deformation and curvature effects.	[Weise, Louis D.] Univ Utrecht, Dept Theoret Biol, Utrecht, Netherlands; [Nash, Martyn P.] Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand; [Nash, Martyn P.] Univ Auckland, Dept Engn Sci, Auckland 1, New Zealand; [Panfilov, Alexander V.] Univ Ghent, Dept Phys & Astron, B-9000 Ghent, Belgium	Utrecht University; University of Auckland; University of Auckland; Ghent University	Weise, LD (corresponding author), Univ Utrecht, Dept Theoret Biol, Utrecht, Netherlands.	L.D.Weise@uu.nl	Nash, Martyn P/F-6982-2012; Panfilov, Alexander/G-8459-2016	Nash, Martyn P/0000-0002-6466-4936; Panfilov, Alexander/0000-0003-2643-642X; Breakspear, Michael/0000-0003-4943-3969	Netherlands Organization for Scientific Research (NWO) of the research Council for Physical Sciences (EW) [613.000.604]; James Cook Fellowship	Netherlands Organization for Scientific Research (NWO) of the research Council for Physical Sciences (EW)(Netherlands Organization for Scientific Research (NWO)); James Cook Fellowship	LDW is funded by the Netherlands Organization for Scientific Research (http://www.nwo.nl) (NWO Grant No. 613.000.604) of the research Council for Physical Sciences (EW). MPN is supported by a James Cook Fellowship administered by the Royal Society of New Zealand (http://www.royalsociety.org.nz/) on behalf of the New Zealand Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliev RR, 1996, CHAOS SOLITON FRACT, V7, P293, DOI 10.1016/0960-0779(95)00089-5; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bourguignon D, 2000, SPRING COMP SCI, P113; Caillerie D, 2003, ESAIM-MATH MODEL NUM, V37, P681, DOI 10.1051/m2an:2003054; DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; Delingette H, 1998, P IEEE, V86, P512, DOI 10.1109/5.662876; FEYNMAN R, 1969, FEYNMAN LECT PHYS MA, P592; FRITZ T, 2009, EUR C INT FED MED BI; Gerisch G., 1965, Wilhelm Roux Archiv fur Entwicklungsmechanik der Organismen, V156, P127, DOI 10.1007/BF00573870; GORELOVA NA, 1983, J NEUROBIOL, V14, P353, DOI 10.1002/neu.480140503; Hu H, 1997, J MOL CELL CARDIOL, V29, P1511, DOI 10.1006/jmcc.1997.0392; IMBIHL R, 1995, CHEM REV, V95, P697, DOI 10.1021/cr00035a012; Keener J., 1998, MATH PHYSL; Kohl P, 1999, PROG BIOPHYS MOL BIO, V71, P91, DOI 10.1016/S0079-6107(98)00038-8; KRIVTSOV A, 1999, Z ANGEW MATH MECH, V79, P19; LEGRICE IJ, 1995, AM J PHYSIOL-HEART C, V269, pH571, DOI 10.1152/ajpheart.1995.269.2.H571; Mohr M., 2003, BIOMEDICAL ENG, V48, P6, DOI DOI 10.1515/bmte.2003.48.s1.6; Nash MP, 2004, PROG BIOPHYS MOL BIO, V85, P501, DOI 10.1016/j.pbiomolbio.2004.01.016; Nash MP, 2000, J ELASTICITY, V61, P113, DOI 10.1023/A:1011084330767; Nealen A, 2006, COMPUT GRAPH FORUM, V25, P809, DOI 10.1111/j.1467-8659.2006.01000.x; OSTERMEYER G, 1999, PHYS MESOMECH, V2, P31; Panfilov AV, 2007, P NATL ACAD SCI USA, V104, P7922, DOI 10.1073/pnas.0701895104; Panfilov AV, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.258104; Panfilov AV, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118101; POPOV VL, 2001, PHYS MESOMECH, V4, P15; Schargott M, 2007, TRIBOL INT, V40, P937, DOI 10.1016/j.triboint.2006.02.036; Seth BR, 1934, PHILOS T R SOC S-A, V234, P231; Trayanova N, 2004, HEART RHYTHM, V1, P67, DOI 10.1016/j.hrthm.2004.01.002; VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98; Vetter FJ, 2001, ANN BIOMED ENG, V29, P414, DOI 10.1114/1.1366670; Weijer CJ, 2004, CURR OPIN GENET DEV, V14, P392, DOI 10.1016/j.gde.2004.06.006; WINFREE AT, 1984, NATURE, V311, P611, DOI 10.1038/311611a0; Yoshida R, 1996, J AM CHEM SOC, V118, P5134, DOI 10.1021/ja9602511; ZAIKIN AN, 1970, NATURE, V225, P535, DOI 10.1038/225535b0; Zhang YH, 2000, J PHYSIOL-LONDON, V523, P607, DOI 10.1111/j.1469-7793.2000.00607.x; Zykov V. S., 1980, Biophysics, V25, P906	36	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e21934	10.1371/journal.pone.0021934	http://dx.doi.org/10.1371/journal.pone.0021934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21804911	gold, Green Published, Green Submitted			2022-12-25	WOS:000292680900018
J	Obel, N; Omland, LH; Kronborg, G; Larsen, CS; Pedersen, C; Pedersen, G; Sorensen, HT; Gerstoft, J				Obel, Niels; Omland, Lars Haukali; Kronborg, Gitte; Larsen, Carsten S.; Pedersen, Court; Pedersen, Gitte; Sorensen, Henrik Toft; Gerstoft, Jan			Impact of Non-HIV and HIV Risk Factors on Survival in HIV-Infected Patients on HAART: A Population-Based Nationwide Cohort Study	PLOS ONE			English	Article							COMBINATION ANTIRETROVIRAL THERAPY; MORTALITY; DANISH; RATES; DEATH	Background: We determined the impact of three factors on mortality in HIV-infected patients who had been on highly active antiretroviral therapy (HAART) for at least one year: (1) insufficient response to (HAART) and presence of AIDS-defining diseases, (2) comorbidity, and (3) drug and alcohol abuse and compared the mortality to that of the general population. Methodology/Principal Findings: In a Danish nationwide, population-based cohort study, we used population based registries to identify (1) all Danish HIV-infected patients who started HAART in the period 1 January 1998-1 July 2009, and (2) a comparison cohort of individuals matched on date of birth and gender (N = 2,267 and 9,068, respectively). Study inclusion began 1 year after start of HAART. Patients were categorised hierarchically in four groups according to the three risk factors, which were identified before study inclusion. The main outcome measure was probability of survival from age 25 to 65 years. The probability of survival from age 25 to age 65 was substantially lower in HIV patients [0.48 (95% confidence interval (CI) 0.42-0.55)] compared to the comparison cohort [0.88 (0.86 to 0.90)]. However, in HIV patients with no risk factors (N = 871) the probability of survival was equivalent to that of the general population [0.86 (95% CI 0.77-0.92)]. In contrast, the probability of survival was 0.58 in patients with HIV risk factors (N = 704), 0.30 in patients with comorbidities (N = 479), and 0.03 in patients with drug or alcohol abuse (N = 313). Conclusions: The increased risk of death in HIV-infected individuals is mainly attributable to risk factors that can be identified prior to or in the initial period of antiretroviral treatment. Mortality in patients without risk factors on a successful HAART is almost identical to that of the non-HIV-infected population.	[Obel, Niels; Omland, Lars Haukali; Gerstoft, Jan] Rigshosp, Dept Infect Dis, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Kronborg, Gitte] Univ Copenhagen, Hvidovre Hosp, Copenhagen Univ Hosp, Dept Infect Dis, DK-2650 Hvidovre, Denmark; [Larsen, Carsten S.; Pedersen, Gitte] Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus N, Denmark; [Pedersen, Court] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense C, Denmark; [Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus N, Denmark; [Sorensen, Henrik Toft] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Rigshospitalet; University of Copenhagen; University of Copenhagen; Aarhus University; University of Southern Denmark; Odense University Hospital; Aarhus University; Boston University	Obel, N (corresponding author), Rigshosp, Dept Infect Dis, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark.	omland@dadlnet.dk	Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Omland, Lars Haukali/0000-0002-5338-8948; Obel, Niels/0000-0002-5031-0045	Preben and Anna Simonsen's Foundation; AIDS Foundation; NOVO Nordisk Foundation; Clinical Institute of Copenhagen University; Roche; Bristol-Myers Squibb; Merck Sharp Dohme; GlaxoSmithKline; Abbott; Boehringer Ingelheim; Janssen-Cilag; Swedish Orphan; Gilead and Tibotec; Pharmasia	Preben and Anna Simonsen's Foundation; AIDS Foundation; NOVO Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Clinical Institute of Copenhagen University; Roche(Roche Holding); Bristol-Myers Squibb(Bristol-Myers Squibb); Merck Sharp Dohme(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Swedish Orphan; Gilead and Tibotec; Pharmasia	The authors thank Preben and Anna Simonsen's Foundation, the AIDS Foundation, the NOVO Nordisk Foundation, and the Clinical Institute of Copenhagen University for financial support. No funding sources were involved in study design, data collection, analysis, report writing, or the decision to submit the paper.; N. Obel has received research funding from Roche, Bristol-Myers Squibb, Merck Sharp & Dohme, GlaxoSmithKline, Abbott, Boehringer Ingelheim, Janssen-Cilag, and Swedish Orphan. L. H. Omland has received honoraria for speaking at meetings (Tibotec and Merck Sharp & Dohme). C. Pedersen has received research funding from Abbott, Roche, Bristol-Myers Squibb, Merck Sharp & Dohme, GlaxoSmithKline, Swedish Orphan, Boehringer Ingelheim, Gilead and Tibotec. J. Gerstoft has received research funding from Abbott, Roche, Bristol-Myers Squibb, Mecrk Sharp & Dohme, Pharmasia, GlaxoSmithKline, Swedish Orphan, and Boehringer Ingelheim. G. Kronborg is a board member GlaxoSmithKline. The funding organisations played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. Dr. Sorensen did not report receiving fees, honoraria, grants or consultancies. Department of Clinical Epidemiology is, however, involved in studies with funding from various companies as research grants to (and administered by) Aarhus University. None of these studies have relation to the present study. CS Larsen reports no conflicts of interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andersen TF, 1999, DAN MED BULL, V46, P263; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Jaggy C, 2003, LANCET, V362, P877, DOI 10.1016/S0140-6736(03)14307-3; Larsen MV, 2010, SCAND J INFECT DIS, V42, P917, DOI 10.3109/00365548.2010.511258; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Lodwick RK, 2010, LANCET, V376, P340, DOI 10.1016/S0140-6736(10)60932-4; Lohse N, 2006, CLIN INFECT DIS, V42, P136, DOI 10.1086/498515; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Obel N, 2009, INT J EPIDEMIOL, V38, P1202, DOI 10.1093/ije/dyn192; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; ROTHMAN KJ, 2002, BIASES STUDY DESIGN, P94; ROTHMAN KJ, 2002, ANAL SIMPLE EPIDEMIO, P130; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Saves M, 2003, CLIN INFECT DIS, V37, P292, DOI 10.1086/375844; Weis N, 2006, CLIN INFECT DIS, V42, P1481, DOI 10.1086/503569; Zavascki AP, 2007, J CLIN EPIDEMIOL, V60, P867, DOI 10.1016/j.jclinepi.2006.11.004	20	107	108	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22698	10.1371/journal.pone.0022698	http://dx.doi.org/10.1371/journal.pone.0022698			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799935	Green Published, gold, Green Submitted			2022-12-25	WOS:000293172900068
J	Devine, MJ; Kaganovich, A; Ryten, M; Mamais, A; Trabzuni, D; Manzoni, C; McGoldrick, P; Chan, D; Dillman, A; Zerle, J; Horan, S; Taanman, JW; Hardy, J; Marti-Masso, JF; Healey, D; Schapira, AH; Wolozin, B; Bandopadhyay, R; Cookson, MR; van der Brug, MP; Lewis, PA				Devine, Michael J.; Kaganovich, Alice; Ryten, Mina; Mamais, Adamantios; Trabzuni, Daniah; Manzoni, Claudia; McGoldrick, Philip; Chan, Diane; Dillman, Allissa; Zerle, Julia; Horan, Susannah; Taanman, Jan-Willem; Hardy, John; Marti-Masso, Jose-Felix; Healey, Daniel; Schapira, Anthony H.; Wolozin, Benjamin; Bandopadhyay, Rina; Cookson, Mark R.; van der Brug, Marcel P.; Lewis, Patrick A.			Pathogenic LRRK2 Mutations Do Not Alter Gene Expression in Cell Model Systems or Human Brain Tissue	PLOS ONE			English	Article							PARKINSONS-DISEASE; PHOSPHORYLATION; PROTEINS; HEALTH; 4E-BP	Point mutations in LRRK2 cause autosomal dominant Parkinson's disease. Despite extensive efforts to determine the mechanism of cell death in patients with LRRK2 mutations, the aetiology of LRRK2 PD is not well understood. To examine possible alterations in gene expression linked to the presence of LRRK2 mutations, we carried out a case versus control analysis of global gene expression in three systems: fibroblasts isolated from LRRK2 mutation carriers and healthy, non-mutation carrying controls; brain tissue from G2019S mutation carriers and controls; and HEK293 inducible LRRK2 wild type and mutant cell lines. No significant alteration in gene expression was found in these systems following correction for multiple testing. These data suggest that any alterations in basal gene expression in fibroblasts or cell lines containing mutations in LRRK2 are likely to be quantitatively small. This work suggests that LRRK2 is unlikely to play a direct role in modulation of gene expression, although it remains possible that this protein can influence mRNA expression under pathogenic cicumstances.	[Devine, Michael J.; Ryten, Mina; Mamais, Adamantios; Trabzuni, Daniah; Manzoni, Claudia; Zerle, Julia; Hardy, John; Bandopadhyay, Rina; Lewis, Patrick A.] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Kaganovich, Alice; Dillman, Allissa; Cookson, Mark R.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Mamais, Adamantios; Bandopadhyay, Rina] UCL Inst Neurol, Rita Lila Weston Inst, London, England; [Mamais, Adamantios; Bandopadhyay, Rina] UCL Inst Neurol, Queen Sq Brain Bank, London, England; [McGoldrick, Philip] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London, England; [Chan, Diane; Wolozin, Benjamin] Boston Univ, Sch Med, Dept Pharmacol, Boston, MA 02118 USA; [Horan, Susannah; Taanman, Jan-Willem; Healey, Daniel; Schapira, Anthony H.] UCL Inst Neurol, Dept Clin Neurosci, London, England; [Marti-Masso, Jose-Felix] Hosp Donastia, San Sebastian, Spain; [van der Brug, Marcel P.] Scripps Res Inst, Jupiter, FL USA	University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; University of London; University College London; University of London; University College London; Boston University; University of London; University College London; Scripps Research Institute	Devine, MJ (corresponding author), UCL Inst Neurol, Dept Mol Neurosci, London, England.	mvanderb@scripps.edu; p.lewis@ion.ucl.ac.uk	Trabzuni, Daniah/AAI-2037-2021; Taanman, Jan W/A-5379-2011; Schapira, Anthony H V/A-1245-2010; Hardy, John/C-2451-2009; Lewis, Patrick A./C-3674-2009; Trabzuni, Daniah M/C-4034-2012; manzoni, claudia/F-4831-2014; Cookson, Mark/AAW-2516-2021; Ryten, Mina/Q-8419-2016; Bandopadhyay, Rina/C-7926-2009; Marti Masso, Jose Felix/D-8619-2013	Trabzuni, Daniah/0000-0003-4826-9570; Taanman, Jan W/0000-0002-5476-9785; Schapira, Anthony H V/0000-0002-3018-3966; Hardy, John/0000-0002-3122-0423; Trabzuni, Daniah M/0000-0003-4826-9570; Cookson, Mark/0000-0002-1058-3831; Marti Masso, Jose Felix/0000-0001-8428-4386; Lewis, Patrick/0000-0003-4537-0489; Chan, Diane/0000-0003-3765-190X; Mamais, Adamantios/0000-0002-5546-7084; Devine, Mike/0000-0001-6076-3382; Manzoni, Claudia/0000-0001-5367-4023	Medical Research Council [G0800437]; Parkinson's UK [F-1002]; Brain Research Trust; Michael J. Fox foundation; Wellcome/MRC Parkinson's Disease Consortium; National Institute on Aging; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060872] Funding Source: NIH RePORTER; Alzheimers Research UK [ART-PPG2011A-14] Funding Source: researchfish; Medical Research Council [MC_G1000735, G0802462, G0701075] Funding Source: researchfish; Parkinson&quot;s UK [F-1002, G-0506] Funding Source: researchfish; MRC [MC_G1000735, G0701075, G0802462, G0800437] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parkinson's UK(Parkinson's UK); Brain Research Trust; Michael J. Fox foundation; Wellcome/MRC Parkinson's Disease Consortium(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council (fellowship G0800437, MJD), Parkinson's UK (fellowship F-1002, PAL), Brain Research Trust and the Michael J. Fox foundation. It was supported in part by the Wellcome/MRC Parkinson's Disease Consortium grant and by the intramural program of the National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beach TG, 2008, CELL TISSUE BANK, V9, P229, DOI 10.1007/s10561-008-9067-2; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Cookson MR, 2008, INT J CLIN EXP PATHO, V1, P217; Dachsel JC, 2010, ARCH NEUROL-CHICAGO, V67, P542, DOI 10.1001/archneurol.2010.79; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hsu CH, 2010, NEURODEGENER DIS, V7, P68, DOI 10.1159/000285509; Hsu CH, 2010, J NEUROCHEM, V112, P1593, DOI 10.1111/j.1471-4159.2010.06568.x; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008730; Lewis PA, 2009, BIOL CELL, V101, P183, DOI 10.1042/BC20080053; Mortiboys H, 2010, NEUROLOGY, V75, P2017, DOI 10.1212/WNL.0b013e3181ff9685; Mutez E, 2010, NEUROBIOL AGING; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sharma S, 2011, NEUROPATHOL APPL NEU; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Sly W S, 1979, Methods Enzymol, V58, P444; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105	24	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22489	10.1371/journal.pone.0022489	http://dx.doi.org/10.1371/journal.pone.0022489			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799870	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000293097300053
J	Calero, O; Bullido, MJ; Clarimon, J; Frank-Garcia, A; Martinez-Martin, P; Lleo, A; Rey, MJ; Rabano, A; Blesa, R; Gomez-Isla, T; Valdivieso, F; de Pedro-Cuesta, J; Ferrer, I; Calero, M				Calero, Olga; Bullido, Maria J.; Clarimon, Jordi; Frank-Garcia, Ana; Martinez-Martin, Pablo; Lleo, Alberto; Jesus Rey, Maria; Rabano, Alberto; Blesa, Rafael; Gomez-Isla, Teresa; Valdivieso, Fernando; de Pedro-Cuesta, Jesus; Ferrer, Isidro; Calero, Miguel			Genetic Cross-Interaction between APOE and PRNP in Sporadic Alzheimer's and Creutzfeldt-Jakob Diseases	PLOS ONE			English	Article							PRION PROTEIN GENE; APOLIPOPROTEIN-E; CODON-129 POLYMORPHISM; RISK-FACTOR; ONSET; ALLELE; GENOTYPE; ASSOCIATION; IMPAIRMENT; EPISTASIS	Alzheimer's disease (AD) and Creutzfeldt-Jakob disease (CJD) represent two distinct clinical entities belonging to a wider group, generically named as conformational disorders that share common pathophysiologic mechanisms. It is well-established that the APOE epsilon 4 allele and homozygosity at polymorphic codon 129 in the PRNP gene are the major genetic risk factors for AD and human prion diseases, respectively. However, the roles of PRNP in AD, and APOE in CJD are controversial. In this work, we investigated for the first time, APOE and PRNP genotypes simultaneously in 474 AD and 175 sporadic CJD (sCJD) patients compared to a common control population of 335 subjects. Differences in genotype distribution between patients and control subjects were studied by logistic regression analysis using age and gender as covariates. The effect size of risk association and synergy factors were calculated using the logistic odds ratio estimates. Our data confirmed that the presence of APOE epsilon 4 allele is associated with a higher risk of developing AD, while homozygosity at PRNP gene constitutes a risk for sCJD. Opposite, we found no association for PRNP with AD, nor for APOE with sCJD. Interestingly, when AD and sCJD patients were stratified according to their respective main risk genes (APOE for AD, and PRNP for sCJD), we found statistically significant associations for the other gene in those strata at higher previous risk. Synergy factor analysis showed a synergistic age-dependent interaction between APOE and PRNP in both AD (SF = 3.59, p = 0.027), and sCJD (SF = 7.26, p = 0.005). We propose that this statistical epistasis can partially explain divergent data from different association studies. Moreover, these results suggest that the genetic interaction between APOE and PRNP may have a biological correlate that is indicative of shared neurodegenerative pathways involved in AD and sCJD.	[Calero, Olga; Bullido, Maria J.; Clarimon, Jordi; Frank-Garcia, Ana; Martinez-Martin, Pablo; Lleo, Alberto; Blesa, Rafael; Gomez-Isla, Teresa; Valdivieso, Fernando; de Pedro-Cuesta, Jesus; Ferrer, Isidro; Calero, Miguel] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Calero, Olga; Calero, Miguel] Inst Salud Carlos III CNM ISCIII, Unidad Encefalopatias Espongiformes, Ctr Nacl Microbiol, Madrid, Spain; [Bullido, Maria J.; Valdivieso, Fernando] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Bullido, Maria J.; Frank-Garcia, Ana; Valdivieso, Fernando] Inst Sanit Res Hosp la Paz IdIPaz, Madrid, Spain; [Clarimon, Jordi; Lleo, Alberto; Blesa, Rafael; Gomez-Isla, Teresa] Univ Autonoma Barcelona, Dept Neurol, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain; [Frank-Garcia, Ana] Hosp Univ La Paz UAM, Neurol Serv, Madrid, Spain; [Martinez-Martin, Pablo] Alzheimer Ctr Reina Sofia Fdn, Alzheimer Dis Res Unit, CIEN Fdn, Carlos III Inst Hlth, Madrid, Spain; [Jesus Rey, Maria] Banco Tejidos Neurol Univ Barcelona Hosp Clin, Barcelona, Spain; [Rabano, Alberto] Alzheimer Ctr Reina Sofia Fdn, Banco Tejidos Fdn CIEN, CIEN Fdn, Carlos III Inst Hlth, Madrid, Spain; [de Pedro-Cuesta, Jesus] Inst Salud Carlos III CNM ISCIII, Area Epidemiol Aplicada, Ctr Nacl Epidemiol, Madrid, Spain; [Ferrer, Isidro] Univ Barcelona, Fac Med, Inst Neuropathol INP, IDIBELL Hosp Univ Bellvitge, Barcelona 08907, Spain	CIBERNED; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Hospital Universitario La Paz; Instituto de Salud Carlos III; Instituto de Salud Carlos III; Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE); CIBERNED; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Calero, O (corresponding author), Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.	mcalero@isciii.es	Martinez-Martin, Pablo/N-9909-2019; Martinez-Martin, Pablo/E-1329-2013; García, Ana Frank/I-5159-2015; Lleó, Alberto/K-5783-2019; Bullido, maria j/C-8509-2014; Calero, Miguel/H-5691-2015	Martinez-Martin, Pablo/0000-0003-0837-5280; García, Ana Frank/0000-0003-3858-9116; Bullido, maria j/0000-0002-6477-1117; Calero, Miguel/0000-0001-5366-3324; Clarimon, Jordi/0000-0002-6824-6942	Ministerio de Ciencia e Innovacion [FIS 05/0912]; Ministerio de Sanidad, Politica Social e Igualdad; Spanish CIBERNED network	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Sanidad, Politica Social e Igualdad(Spanish Government); Spanish CIBERNED network	This work was supported by grants FIS 05/0912 from the Ministerio de Ciencia e Innovacion, DGSP from Ministerio de Sanidad, Politica Social e Igualdad (MC), and the Spanish CIBERNED network (AL, FV, JdP, IF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348; AMOUYEL P, 1994, LANCET, V344, P1315, DOI 10.1016/S0140-6736(94)90691-2; Armstrong RA, 2005, NEUROPATHOLOGY, V25, P111, DOI 10.1111/j.1440-1789.2005.00605.x; Barnham KJ, 2006, TRENDS BIOCHEM SCI, V31, P465, DOI 10.1016/j.tibs.2006.06.006; Berr C, 1998, NEUROLOGY, V51, P734, DOI 10.1212/WNL.51.3.734; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Calero O, 2009, J NEUROSCI METH, V183, P238, DOI 10.1016/j.jneumeth.2009.06.033; Calero O, 2009, PRION, V3, P146, DOI 10.4161/pri.3.3.9339; Casadei VM, 2001, J NEUROL NEUROSUR PS, V71, P279, DOI 10.1136/jnnp.71.2.279; CERF E, 2011, FASEB J         0125; Chapman J, 2001, NEUROLOGY, V57, P1482, DOI 10.1212/WNL.57.8.1482; Checler F, 2002, TRENDS NEUROSCI, V25, P616, DOI 10.1016/S0166-2236(02)02263-4; Chiesa R, 2008, J NEUROSCI, V28, P13258, DOI 10.1523/JNEUROSCI.3109-08.2008; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Combarros O, 2000, NEUROLOGY, V55, P593, DOI 10.1212/WNL.55.4.593; Combarros O, 2009, NEUROBIOL AGING, V30, P1333, DOI 10.1016/j.neurobiolaging.2007.11.027; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cortina-Borja Mario, 2009, BMC Res Notes, V2, P105, DOI 10.1186/1756-0500-2-105; COUSIN E, 2009, NEUROBIOL AGING 1102; de Pedro-Cuesta J, 2011, J NEUROL NEUROSUR PS, V82, P204, DOI 10.1136/jnnp.2009.188425; Debatin L, 2008, NEURODEGENER DIS, V5, P347, DOI 10.1159/000121389; Del Bo R, 2006, NEUROBIOL AGING, V27, DOI 10.1016/j.neurobiolaging.2005.05.025; Dermaut B, 2003, ANN NEUROL, V53, P409, DOI 10.1002/ana.10507; Eisenberg DTA, 2010, AM J PHYS ANTHROPOL, V143, P100, DOI 10.1002/ajpa.21298; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P49; Friedman G, 1997, ARCH GERONTOL GERIAT, V24, P175, DOI 10.1016/S0167-4943(96)00750-9; Gacia M, 2006, J NEURAL TRANSM, V113, P1747, DOI 10.1007/s00702-006-0540-4; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Gambetti P, 1998, NEPHROL DIAL TRANSPL, V13, P33, DOI 10.1093/ndt/13.suppl_7.33; Gavin R, 2010, NEUROBIOL DIS, V37, P324, DOI 10.1016/j.nbd.2009.10.010; Gavin R, 2008, NEUROBIOL DIS, V30, P243, DOI 10.1016/j.nbd.2008.02.001; Giannattasio C, 2008, DEMENT GERIATR COGN, V25, P354, DOI 10.1159/000119730; Gilch S, 2006, MOL CELL NEUROSCI, V31, P346, DOI 10.1016/j.mcn.2005.10.008; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Golanska E, 2004, NEUROLOGY, V62, P313, DOI 10.1212/01.WNL.0000103290.74549.DC; Golanska E, 2009, J ALZHEIMERS DIS, V17, P359, DOI 10.3233/JAD-2009-1055; Gunther EC, 2010, J MOL MED, V88, P331, DOI 10.1007/s00109-009-0568-7; Hainfellner JA, 1998, ACTA NEUROPATHOL, V96, P116, DOI 10.1007/s004010050870; Hill AF, 2003, BRAIN, V126, P1333, DOI 10.1093/brain/awg125; Hoe HS, 2005, J NEUROCHEM, V93, P145, DOI 10.1111/j.1471-4159.2004.03007.x; Huang YD, 2010, TRENDS MOL MED, V16, P287, DOI 10.1016/j.molmed.2010.04.004; Kellett KAB, 2009, PRION, V3, P190, DOI 10.4161/pri.3.4.9980; KESANIEMI YA, 1987, J CLIN INVEST, V80, P578, DOI 10.1172/JCI113107; Kim D, 2009, CELL, V137, P997, DOI 10.1016/j.cell.2009.05.042; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kovacs GG, 2002, NEUROSCI LETT, V329, P269, DOI 10.1016/S0304-3940(02)00668-7; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li XH, 2005, ANN NEUROL, V58, P858, DOI 10.1002/ana.20646; Mahley RW, 1999, CURR OPIN LIPIDOL, V10, P207, DOI 10.1097/00041433-199906000-00003; Martinez-Garcia A, 2004, MOL CELL PROBE, V18, P211, DOI 10.1016/j.mcp.2004.03.003; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Minaki H, 2009, NEUROPATHOLOGY, V29, P536, DOI 10.1111/j.1440-1789.2009.01007.x; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010; Nygaard HB, 2009, ARCH NEUROL-CHICAGO, V66, P1325, DOI 10.1001/archneurol.2009.223; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Petrlova J, 2011, PROTEINS, V79, P402, DOI 10.1002/prot.22891; PICKERINGBROWN SM, 1995, NEUROSCI LETT, V187, P127, DOI 10.1016/0304-3940(95)11353-3; Poleggi A, 2008, EUR J NEUROL, V15, P173, DOI 10.1111/j.1468-1331.2007.02021.x; PRICE DL, 1993, P NATL ACAD SCI USA, V90, P6381, DOI 10.1073/pnas.90.14.6381; Riemenschneider M, 2004, NEUROLOGY, V63, P364, DOI 10.1212/01.WNL.0000130198.72589.69; RUSHWORTH JV, 2010, INT J ALZHEIMERS DIS; SALVATORE M, 1995, NEUROSCI LETT, V199, P95, DOI 10.1016/0304-3940(95)12030-8; SAUNDERS AM, 1993, LANCET, V342, P710, DOI 10.1016/0140-6736(93)91709-U; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schjeide BM, 2009, NEUROGENETICS, V10, P19, DOI 10.1007/s10048-008-0151-3; Schmidt C, 2010, DEMENT GERIATR COGN, V29, P371, DOI 10.1159/000278692; Sharman MJ, 2010, J ALZHEIMERS DIS, V21, P403, DOI 10.3233/JAD-2010-100141; Soldevila M, 2006, GENOME RES, V16, P231, DOI 10.1101/gr.4345506; TAKAHASHI RH, 2010, NEUROPATHOLOGY  1109; Van Everbroeck B, 2001, NEUROSCI LETT, V313, P69, DOI 10.1016/S0304-3940(01)02264-9; Varges D, 2011, J ALZHEIMERS DIS, V23, P717, DOI 10.3233/JAD-2010-101527; Voigtlander T, 2001, ACTA NEUROPATHOL, V101, P417; Wade MJ, 2001, GENETICA, V112, P59, DOI 10.1023/A:1013316611768; Zerr I, 1996, ARCH NEUROL-CHICAGO, V53, P1233, DOI 10.1001/archneur.1996.00550120041014; ZERR I, 1995, LANCET, V345, P68	81	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22090	10.1371/journal.pone.0022090	http://dx.doi.org/10.1371/journal.pone.0022090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799773	Green Published, gold, Green Submitted			2022-12-25	WOS:000292931200025
J	Mancini, R; Giarnieri, E; De Vitis, C; Malanga, D; Roscilli, G; Noto, A; Marra, E; Laudanna, C; Zoppoli, P; De Luca, P; Affuso, A; Ruco, L; Di Napoli, A; Mesiti, G; Aurisicchio, L; Ricci, A; Mariotta, S; Pisani, L; Andreetti, C; Viglietto, G; Rendina, EA; Giovagnoli, MR; Ciliberto, G				Mancini, Rita; Giarnieri, Enrico; De Vitis, Claudia; Malanga, Donatella; Roscilli, Giuseppe; Noto, Alessia; Marra, Emanuele; Laudanna, Carmelo; Zoppoli, Pietro; De Luca, Pasquale; Affuso, Andrea; Ruco, Luigi; Di Napoli, Arianna; Mesiti, Giuseppe; Aurisicchio, Luigi; Ricci, Alberto; Mariotta, Salvatore; Pisani, Lara; Andreetti, Claudio; Viglietto, Giuseppe; Rendina, Erino A.; Giovagnoli, Maria Rosaria; Ciliberto, Gennaro			Spheres Derived from Lung Adenocarcinoma Pleural Effusions: Molecular Characterization and Tumor Engraftment	PLOS ONE			English	Article							CANCER STEM-CELLS; ALDEHYDE DEHYDROGENASE; MARKER; IDENTIFICATION; PREVENTION; MANAGEMENT; DIAGNOSIS; BIOLOGY; ORIGIN	Malignant pleural effusions (MPEs) could represent an excellent source to culture a wide variety of cancer cells from different donors. In this study, we set up culture conditions for cancer cells deriving from MPEs of several patients affected by the most frequent form of lung cancer, namely the subset of non small cell lung cancers (NSCLC) classified as Lung Adenocarcinomas (AdenoCa) which account for approximately 40% of lung cancer cases. AdenoCa malignant pleural effusions gave rise to in vitro cultures both in adherent and/or in spheroid conditions in almost all cases analyzed. We characterized in greater detail two samples which showed the most efficient propagation in vitro. In these samples we also compared gene profiles of spheroid vs adherent cultures and identified a set of differentially expressed genes. Finally we achieved efficient tumor engraftment in recipient NOD/SCID mice, also upon inoculation of small number of cells, thus suggesting indirectly the presence of tumor initiating cells.	[Mancini, Rita; Giarnieri, Enrico; De Vitis, Claudia; Roscilli, Giuseppe; Noto, Alessia; Marra, Emanuele; Ruco, Luigi; Di Napoli, Arianna; Ricci, Alberto; Mariotta, Salvatore; Pisani, Lara; Giovagnoli, Maria Rosaria] Univ Roma La Sapienza, Dept Clin & Mol Med, S Andrea Hosp, Rome, Italy; [De Vitis, Claudia; Malanga, Donatella; Roscilli, Giuseppe; Marra, Emanuele; Laudanna, Carmelo; De Luca, Pasquale; Affuso, Andrea; Aurisicchio, Luigi; Viglietto, Giuseppe] Biogem SCARL, Ariano Irpino, AV, Italy; [Viglietto, Giuseppe; Ciliberto, Gennaro] Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, Catanzaro, Italy; [Andreetti, Claudio; Rendina, Erino A.] Univ Roma La Sapienza, Dept Thorac Surg, S Andrea Hosp, Rome, Italy; [Mesiti, Giuseppe] Charles River Labs, Res Model & Serv, Lecce, Italy; [Malanga, Donatella; Zoppoli, Pietro] Univ Sannio, Dept Biol & Bioenvironm Study, Benevento, Italy; [Giarnieri, Enrico] Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA	Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Magna Graecia University of Catanzaro; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; University of Sannio; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Mancini, R (corresponding author), Univ Roma La Sapienza, Dept Clin & Mol Med, S Andrea Hosp, Rome, Italy.	rita.mancini@uniroma1.it	Zoppoli, Pietro/J-9954-2018; Malanga, Donatella/J-4877-2018; Rendina, Erino Angelo/AAG-7598-2021; Ciliberto, Gennaro/J-4131-2017; De Vitis, Claudia/K-4726-2016; Di Napoli, Arianna/AAB-3210-2022; De Luca, Pasquale/AAL-5673-2021; Viglietto, Giuseppe/AAC-2852-2019	Zoppoli, Pietro/0000-0002-7860-9655; Malanga, Donatella/0000-0002-0491-7698; Ciliberto, Gennaro/0000-0003-2851-8605; De Vitis, Claudia/0000-0001-8899-2347; Di Napoli, Arianna/0000-0002-3159-5380; De Luca, Pasquale/0000-0003-4289-6784; Viglietto, Giuseppe/0000-0003-2327-7515; Pisani, Lara/0000-0001-9224-8158; Ricci, Alberto/0000-0002-1718-1587; LAUDANNA, Carmelo/0000-0002-0397-6020; Aurisicchio, Luigi/0000-0003-3110-4534; Giarnieri, Enrico/0000-0002-2046-5505	Associazione Italiana Ricerca sul Cancro (AIRC) [IG 5836, IG 10334]	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	Funded by Associazione Italiana Ricerca sul Cancro (AIRC) grant IG 5836 to G. Viglietto and by AIRC grant IG 10334 to G. Ciliberto. This funder played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Basak SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005884; BAYLIN SB, 2008, STEM CELLS CANC EPIG; Borczuk Alain C, 2009, Proc Am Thorac Soc, V6, P152, DOI 10.1513/pats.200807-076LC; Cioce M, 2010, CELL CYCLE, V9, P2878, DOI 10.4161/cc.9.14.12371; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Collins LG, 2007, AM FAM PHYSICIAN, V75, P56; Dontu G, 2005, J MAMMARY GLAND BIOL, V10, P75, DOI 10.1007/s10911-005-2542-5; Dontu G, 2005, STEM CELL REV, V1, P207, DOI 10.1385/SCR:1:3:207; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Heffner JE, 2008, MAYO CLIN PROC, V83, P235, DOI 10.4065/83.2.235; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Lambert MP, 2007, 2 IARC M LYON FRANC, V2, P33; Lee YCG, 2004, RESPIROLOGY, V9, P148, DOI 10.1111/j.1440-1843.2004.00566.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Moreb JS, 2008, CURR STEM CELL RES T, V3, P237, DOI 10.2174/157488808786734006; Nardone A, 2009, CELL TISSUE BANK, V10, P301, DOI 10.1007/s10561-009-9124-5; Pallini R, 2008, CLIN CANCER RES, V14, P8205, DOI 10.1158/1078-0432.CCR-08-0644; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci A, 2010, GROWTH FACTORS, V28, P221, DOI 10.3109/08977191003677402; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rozen S, 2000, Methods Mol Biol, V132, P365; Scaglia N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006812; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Spillane JB, 2007, ANZ J SURG, V77, P464, DOI 10.1111/j.1445-2197.2007.04096.x; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Subramaniam D, 2010, MINI-REV MED CHEM, V10, P359, DOI 10.2174/138955710791330954; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Teng Y, 2010, BIOCHEM BIOPH RES CO, V392, P373, DOI 10.1016/j.bbrc.2010.01.028; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Woodward WA, 2008, CANCER METAST REV, V27, P459, DOI 10.1007/s10555-008-9130-2; Wu XZ, 2008, ANN SURG ONCOL, V15, P407, DOI 10.1245/s10434-007-9695-y; Zou GM, 2008, J CELL PHYSIOL, V217, P598, DOI 10.1002/jcp.21541	39	51	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e21320	10.1371/journal.pone.0021320	http://dx.doi.org/10.1371/journal.pone.0021320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789168	Green Published, Green Submitted, gold			2022-12-25	WOS:000292812400006
J	Putluri, N; Shojaie, A; Vasu, VT; Nalluri, S; Vareed, SK; Putluri, V; Vivekanandan-Giri, A; Byun, J; Pennathur, S; Sana, TR; Fischer, SM; Palapattu, GS; Creighton, CJ; Michailidis, G; Sreekumar, A				Putluri, Nagireddy; Shojaie, Ali; Vasu, Vihas T.; Nalluri, Srilatha; Vareed, Shaiju K.; Putluri, Vasanta; Vivekanandan-Giri, Anuradha; Byun, Jeman; Pennathur, Subramaniam; Sana, Theodore R.; Fischer, Steven M.; Palapattu, Ganesh S.; Creighton, Chad J.; Michailidis, George; Sreekumar, Arun			Metabolomic Profiling Reveals a Role for Androgen in Activating Amino Acid Metabolism and Methylation in Prostate Cancer Cells	PLOS ONE			English	Article							RECEPTOR GENE; DNA METHYLATION; EARLY EVENT; CPG ISLAND; PROGRESSION; EXPRESSION; PROMOTER; LNCAP; CONTAINS; MUTATION	Prostate cancer is the second leading cause of cancer related death in American men. Development and progression of clinically localized prostate cancer is highly dependent on androgen signaling. Metastatic tumors are initially responsive to anti-androgen therapy, however become resistant to this regimen upon progression. Genomic and proteomic studies have implicated a role for androgen in regulating metabolic processes in prostate cancer. However, there have been no metabolomic profiling studies conducted thus far that have examined androgen-regulated biochemical processes in prostate cancer. Here, we have used unbiased metabolomic profiling coupled with enrichment-based bioprocess mapping to obtain insights into the biochemical alterations mediated by androgen in prostate cancer cell lines. Our findings indicate that androgen exposure results in elevation of amino acid metabolism and alteration of methylation potential in prostate cancer cells. Further, metabolic phenotyping studies confirm higher flux through pathways associated with amino acid metabolism in prostate cancer cells treated with androgen. These findings provide insight into the potential biochemical processes regulated by androgen signaling in prostate cancer. Clinically, if validated, these pathways could be exploited to develop therapeutic strategies that supplement current androgen ablative treatments while the observed androgen-regulated metabolic signatures could be employed as biomarkers that presage the development of castrate-resistant prostate cancer.	[Putluri, Nagireddy; Vasu, Vihas T.; Nalluri, Srilatha; Vareed, Shaiju K.; Putluri, Vasanta; Sreekumar, Arun] Med Coll Georgia, Ctr Canc, Augusta, GA 30912 USA; [Putluri, Nagireddy; Vasu, Vihas T.; Nalluri, Srilatha; Vareed, Shaiju K.; Putluri, Vasanta; Sreekumar, Arun] Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Sreekumar, Arun] Med Coll Georgia, Dept Urol, Augusta, GA 30912 USA; [Sreekumar, Arun] Med Coll Georgia, Dept Surg, Augusta, GA 30912 USA; [Shojaie, Ali; Michailidis, George] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA; [Vivekanandan-Giri, Anuradha; Byun, Jeman; Pennathur, Subramaniam] Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA; [Sana, Theodore R.; Fischer, Steven M.] Agilent Technol, Metabol Lab Applicat Grp, Santa Clara, CA USA; [Palapattu, Ganesh S.] Methodist Hosp, Dept Urol, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Agilent Technologies; The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine	Putluri, N (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem, Dept Cellular & Mol Biol, Houston, TX 77030 USA.	sreekuma@bcm.edu	Vasu, Vihas T/G-7303-2012; Vasu, Vihas T/D-6673-2014	Vasu, Vihas T/0000-0003-2275-2476; Vasu, Vihas T/0000-0003-2275-2476; Putluri, Nagireddy/0000-0003-4488-7400; nalluri, srilatha/0000-0002-7265-8165	National Cancer Institute [RO1CA133458-04, 1 R03 CA139489-01, RCA145444A]; Doris Duke Foundation and Molecular Phenotyping Core [DK089503]; Georgia Cancer Research; Agilent Technologies; NATIONAL CANCER INSTITUTE [P30CA125123, R03CA139489, T32CA083654, RC1CA145444, R01CA133458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Doris Duke Foundation and Molecular Phenotyping Core; Georgia Cancer Research; Agilent Technologies; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported in part by the National Cancer Institute grants RO1CA133458-04 (AS), 1 R03 CA139489-01 (AS) and RCA145444A (AS), the Doris Duke Foundation and Molecular Phenotyping Core and DK089503 (all to SP). AS is supported by Georgia Cancer Research Distinguished Scientist award. The project was also supported by Agilent Technologies who provided guidance on methodology. TS and SF are employed with Agilent Technologies. No additional external funding received for this study.	DePrimo SE, 2002, GENOME BIOL, V3; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; ELO JP, 1995, J CLIN ENDOCR METAB, V80, P3494, DOI 10.1210/jc.80.12.3494; Feng ZH, 2010, TRENDS CELL BIOL, V20, P427, DOI 10.1016/j.tcb.2010.03.004; Fernandez SV, 2010, MUTAT RES-FUND MOL M, V688, P28, DOI 10.1016/j.mrfmmm.2010.02.007; GADDIPATI JP, 1994, CANCER RES, V54, P2861; Huggins C, 1972, CA Cancer J Clin, V22, P232, DOI 10.3322/canjclin.22.4.232; Hurtubise A, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-16; Jarrard DF, 1998, CANCER RES, V58, P5310; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kaarbo M, 2010, CELL ONCOL, V32, P11, DOI 10.3233/CLO-2009-0487; Kamikihara T, 2005, INT J CANCER, V115, P690, DOI 10.1002/ijc.20971; Kim HC, 2005, J GASTROEN HEPATOL, V20, P1920, DOI 10.1111/j.1440-1746.2005.03943.x; Kinoshita H, 2000, CANCER RES, V60, P3623; Kobayashi T, 2010, PROSTATE, V70, P866, DOI 10.1002/pros.21120; Lin BY, 2005, CANCER RES, V65, P3081, DOI 10.1158/0008-5472.CAN-04-3218; Linja MJ, 2001, CANCER RES, V61, P3550; Martin DB, 2004, CANCER RES, V64, P347, DOI 10.1158/0008-5472.CAN-03-2062; Meehan KL, 2004, PROTEOMICS, V4, P1116, DOI 10.1002/pmic.200300649; Mishra DK, 2010, MOL CANCER THER, V9, P33, DOI 10.1158/1535-7163.MCT-09-0486; Monge A, 2006, CELL MOL LIFE SCI, V63, P487, DOI 10.1007/s00018-005-5471-y; Montgomery JS, 2001, J PATHOL, V195, P138, DOI 10.1002/1096-9896(200109)195:2<138::AID-PATH961>3.0.CO;2-Y; Nelson PS, 2000, ELECTROPHORESIS, V21, P1823; Noda H, 2005, ONCOLOGY-BASEL, V69, P354, DOI 10.1159/000089768; Perry AS, 2010, NAT REV UROL, V7, P668, DOI 10.1038/nrurol.2010.185; Petrylak DP, 2005, UROLOGY, V65, P3, DOI 10.1016/j.urology.2005.03.053; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Recchia AG, 2009, INT J BIOCHEM CELL B, V41, P603, DOI 10.1016/j.biocel.2008.07.004; Rhodes DR, 2007, NEOPLASIA, V9, P443, DOI 10.1593/neo.07292; RIEGMAN PHJ, 1991, MOL ENDOCRINOL, V5, P1921, DOI 10.1210/mend-5-12-1921; Sana TR, 2008, J CHROMATOGR B, V871, P314, DOI 10.1016/j.jchromb.2008.04.030; Sasaki M, 2002, J NATL CANCER I, V94, P384; Schayek H, 2010, EXP CELL RES, V316, P1479, DOI 10.1016/j.yexcr.2010.03.007; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Segawa T, 2002, ONCOGENE, V21, P8749, DOI 10.1038/sj.onc.1205992; SHARRARD RM, 1992, BRIT J CANCER, V65, P667, DOI 10.1038/bjc.1992.142; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; VELDSCHOLTE J, 1992, J STEROID BIOCHEM, V41, P665, DOI 10.1016/0960-0760(92)90401-4; Vellaichamy A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010936; Vellaichamy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007075; Waghray A, 2001, PROTEOMICS, V1, P1327, DOI 10.1002/1615-9861(200110)1:10<1327::AID-PROT1327>3.3.CO;2-2; Watts GS, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-47; Wright Michael E, 2003, Genome Biol, V5, pR4, DOI 10.1186/gb-2003-5-1-r4; Wu Y, 2010, ANTICANCER RES, V30, P3895	47	65	67	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e21417	10.1371/journal.pone.0021417	http://dx.doi.org/10.1371/journal.pone.0021417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789170	Green Published, gold, Green Submitted			2022-12-25	WOS:000292812400008
J	Saslis-Lagoudakis, CH; Klitgaard, BB; Forest, F; Francis, L; Savolainen, V; Williamson, EM; Hawkins, JA				Saslis-Lagoudakis, C. Haris; Klitgaard, Bente B.; Forest, Felix; Francis, Louise; Savolainen, Vincent; Williamson, Elizabeth M.; Hawkins, Julie A.			The Use of Phylogeny to Interpret Cross-Cultural Patterns in Plant Use and Guide Medicinal Plant Discovery: An Example from Pterocarpus (Leguminosae)	PLOS ONE			English	Article							SECONDARY METABOLITES; ANTIMALARIAL ACTIVITY; HYPOGLYCEMIC ACTIVITY; ANGIOSPERM PHYLOGENY; NONCODING REGIONS; BLOOD-GLUCOSE; DNA BARCODE; EVOLUTION; BIOGEOGRAPHY; ETHNOBOTANY	Background: The study of traditional knowledge of medicinal plants has led to discoveries that have helped combat diseases and improve healthcare. However, the development of quantitative measures that can assist our quest for new medicinal plants has not greatly advanced in recent years. Phylogenetic tools have entered many scientific fields in the last two decades to provide explanatory power, but have been overlooked in ethnomedicinal studies. Several studies show that medicinal properties are not randomly distributed in plant phylogenies, suggesting that phylogeny shapes ethnobotanical use. Nevertheless, empirical studies that explicitly combine ethnobotanical and phylogenetic information are scarce. Methodology/Principal Findings: In this study, we borrowed tools from community ecology phylogenetics to quantify significance of phylogenetic signal in medicinal properties in plants and identify nodes on phylogenies with high bioscreening potential. To do this, we produced an ethnomedicinal review from extensive literature research and a multi-locus phylogenetic hypothesis for the pantropical genus Pterocarpus (Leguminosae: Papilionoideae). We demonstrate that species used to treat a certain conditions, such as malaria, are significantly phylogenetically clumped and we highlight nodes in the phylogeny that are significantly overabundant in species used to treat certain conditions. These cross-cultural patterns in ethnomedicinal usage in Pterocarpus are interpreted in the light of phylogenetic relationships. Conclusions/Significance: This study provides techniques that enable the application of phylogenies in bioscreening, but also sheds light on the processes that shape cross-cultural ethnomedicinal patterns. This community phylogenetic approach demonstrates that similar ethnobotanical uses can arise in parallel in different areas where related plants are available. With a vast amount of ethnomedicinal and phylogenetic information available, we predict that this field, after further refinement of the techniques, will expand into similar research areas, such as pest management or the search for bioactive plant-based compounds.	[Saslis-Lagoudakis, C. Haris; Hawkins, Julie A.] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Saslis-Lagoudakis, C. Haris; Savolainen, Vincent] Imperial Coll London, Div Biol, Ascot, Berks, England; [Klitgaard, Bente B.] Royal Bot Gardens, Herbarium, Richmond, Surrey, England; [Forest, Felix; Francis, Louise; Savolainen, Vincent] Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England; [Williamson, Elizabeth M.] Univ Reading, Sch Pharm, Reading, Berks, England	University of Reading; Imperial College London; Royal Botanic Gardens, Kew; Royal Botanic Gardens, Kew; University of Reading	Saslis-Lagoudakis, CH (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	C.SaslisLagoudakis@pgr.reading.ac.uk	Williamson, Elizabeth/D-4679-2011; Saslis-Lagoudakis, C. Haris/F-9372-2011	Williamson, Elizabeth/0000-0003-2034-7063; Saslis-Lagoudakis, C. Haris/0000-0002-2909-5459; Francis, Louise/0000-0002-8700-6055; Savolainen, Vincent/0000-0001-5350-9984	John Spedan Lewis Fellowship award	John Spedan Lewis Fellowship award	The study was funded through a John Spedan Lewis Fellowship award to CHSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque U. P. de, 1998, Anales del Jardin Botanico de Madrid, V56, P107; Amiguet VT, 2006, ECON BOT, V60, P24, DOI 10.1663/0013-0001(2006)60[24:ARAOQM]2.0.CO;2; Ankli A, 1999, ECON BOT, V53, P144, DOI 10.1007/BF02866493; Arthur W, 2002, NATURE, V415, P757, DOI 10.1038/415757a; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Baker E.G., 1929, LEGUMINOSAE TROPICAL; Baum BR, 2001, PHYTOCHEMISTRY, V56, P543, DOI 10.1016/S0031-9422(00)00425-8; Bay-Smidt MGK, 2011, S AFR J BOT, V77, P175, DOI 10.1016/j.sajb.2010.07.016; Bennett BC, 2008, J ETHNOPHARMACOL, V116, P422, DOI 10.1016/j.jep.2007.12.006; Bennett BC, 2007, ECON BOT, V61, P246, DOI 10.1663/0013-0001(2007)61[246:DOSAEO]2.0.CO;2; Bentham G, 1860, J P LINNEAN SOC BO S, VIV, P1, DOI DOI 10.1111/J.1095-8339.1860.TB02464.X; Bertani S, 2005, J ETHNOPHARMACOL, V98, P45, DOI 10.1016/j.jep.2004.12.020; Bisby FA, 1980, CHEMOSYSTEMATICS PRI; BLETTER N, 2000, CROSS CULT PHYL MED; Bletter N, 2007, J ETHNOBIOL ETHNOMED, V3, DOI 10.1186/1746-4269-3-36; Chakraborty A, 2010, TOXICOL IN VITRO, V24, P1215, DOI 10.1016/j.tiv.2010.02.007; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Clarkson C, 2004, J ETHNOPHARMACOL, V92, P177, DOI 10.1016/j.jep.2004.02.011; Cook F. E. M., 1995, Economic botany data collection standard.; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Csiba L, 2006, DNA TISSUE BANKING B, P114; De Candolle AP., 1825, MEMOIRES FAMILLE LEG; Dhanabal SP, 2006, PHYTOTHER RES, V20, P4, DOI 10.1002/ptr.1819; Donoghue MJ, 2008, P NATL ACAD SCI USA, V105, P11549, DOI 10.1073/pnas.0801962105; Douwes E, 2008, J ETHNOPHARMACOL, V119, P356, DOI 10.1016/j.jep.2008.07.040; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; ETKIN NL, 1988, ANNU REV ANTHROPOL, V17, P23, DOI 10.1146/annurev.an.17.100188.000323; Fabricant DS, 2001, ENVIRON HEALTH PERSP, V109, P69, DOI 10.2307/3434847; FAIRBROTHERS DE, 1975, ANN MO BOT GARD, V62, P765, DOI 10.2307/2395273; Farnsworth N.R., 1991, CONSERV MED PLANTS, V26, P25, DOI DOI 10.1017/CBO9780511753312.005; Fay MF, 1998, TAXON, V47, P43, DOI 10.2307/1224017; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Firn RD, 2003, BIODIVERS CONSERV, V12, P207, DOI 10.1023/A:1021928209813; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Gibbs R.D., 1974, CHEMOTAXONOMY FLOWER, DOI [10.2307/j.ctt1w0ddx8, DOI 10.2307/J.CTT1W0DDX8]; Grover JK, 2002, J ETHNOPHARMACOL, V81, P81, DOI 10.1016/S0378-8741(02)00059-4; Harborne J. B., 1984, PLANT CHEMOSYSTEMATI; Harborne J. B., 1970, PHYTOCHEMICAL PHYLOG; HARMS H, 1915, VEGETATION ERDE; Hilu KW, 2003, AM J BOT, V90, P1758, DOI 10.3732/ajb.90.12.1758; Hughes CE, 2004, SYST BOT, V29, P366, DOI 10.1600/036364404774195557; IUCN, 2014, IUCN RED LIST THREAT; Jain A, 2005, J ETHNOPHARMACOL, V102, P143, DOI 10.1016/j.jep.2005.05.047; Kar A, 2003, J ETHNOPHARMACOL, V84, P105, DOI 10.1016/S0378-8741(02)00144-7; Karou D, 2003, J ETHNOPHARMACOL, V89, P291, DOI 10.1016/j.jep.2003.09.010; Kelchner SA, 2000, ANN MO BOT GARD, V87, P482, DOI 10.2307/2666142; Klitgaard B. B., 2000, Kew Bulletin, V55, P989, DOI 10.2307/4113648; Klitgaard B.B., 2005, LEGUMES WORLD, P307; Kondeti VK, 2010, FOOD CHEM TOXICOL, V48, P1281, DOI 10.1016/j.fct.2010.02.023; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lans C., 2007, J ETHNOBIOL ETHNOMED, V3, P1, DOI DOI 10.1186/1746-4269-3-3; Larsen MM, 2010, BIOCHEM SYST ECOL, V38, P1026, DOI 10.1016/j.bse.2010.10.005; Lavin M, 2001, AM J BOT, V88, P503, DOI 10.2307/2657116; Leonti M, 2003, ECON BOT, V57, P218, DOI 10.1663/0013-0001(2003)057[0218:MFOTPM]2.0.CO;2; Lewis G.P., 1987, LEGUMES BAHIA; LEWIS WH, 1995, ANN MO BOT GARD, V82, P16, DOI 10.2307/2399976; Li RW, 2003, J ETHNOPHARMACOL, V85, P25, DOI 10.1016/S0378-8741(02)00336-7; Lock J. M., 1999, Kew Bulletin, V54, P208, DOI 10.2307/4111040; Lukhoba CW, 2006, J ETHNOPHARMACOL, V103, P1, DOI 10.1016/j.jep.2005.09.011; McClatchey WC, 2009, PHARMACOL THERAPEUT, V123, P239, DOI 10.1016/j.pharmthera.2009.04.002; MENDONCA FA, 1968, B SOC BROTERIANA, V42, P269; Moerman DE, 2007, J ETHNOPHARMACOL, V112, P451, DOI 10.1016/j.jep.2007.04.001; Moerman Daniel E., 1999, Journal of Ethnobiology, V19, P49; MOERMAN DE, 1991, J ETHNOPHARMACOL, V31, P1, DOI 10.1016/0378-8741(91)90141-Y; Muellner AN, 2005, AM J BOT, V92, P534, DOI 10.3732/ajb.92.3.534; Munoz V, 2000, J ETHNOPHARMACOL, V69, P127, DOI 10.1016/S0378-8741(99)00148-8; MURTHY YLN, 2004, J TROPICAL MED PLANT, V4; Mustofa, 2000, J ETHNOPHARMACOL, V73, P145; Nadkarni AK, 1976, INDIAN MATERIA MED; NAGARAJU N, 1990, J ETHNOPHARMACOL, V29, P137, DOI 10.1016/0378-8741(90)90051-T; NAGARAJU N, 1991, PHARM BIOL, V29, P141; Newmaster SG, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-2; Pacharawongsakda E, 2009, APPL MICROBIOL BIOT, V82, P579, DOI 10.1007/s00253-008-1847-x; Paton AJ, 2004, MOL PHYLOGENET EVOL, V31, P277, DOI 10.1016/j.ympev.2003.08.002; Pennington RT, 2006, NEW PHYTOL, V172, P605, DOI 10.1111/j.1469-8137.2006.01902.x; Pirie MD, 2009, SYST BOT, V34, P345, DOI 10.1600/036364409788606262; POLHILL R M, 1969, Kew Bulletin, V23, P483, DOI 10.2307/4117194; PRANCE G T, 1987, Conservation Biology, V1, P296, DOI 10.1111/j.1523-1739.1987.tb00050.x; Prinzing A, 2001, P ROY SOC B-BIOL SCI, V268, P2383, DOI 10.1098/rspb.2001.1801; Proches S, 2008, BIOSCIENCE, V58, P151, DOI 10.1641/B580209; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Rambaut A, 2001, NATURE, V410, P1047, DOI 10.1038/35074179; Rao BK, 2001, J ETHNOPHARMACOL, V74, P69, DOI 10.1016/S0378-8741(00)00344-5; Reyes-Garcia V, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-32; Reynolds T, 2007, PHYTOCHEMISTRY, V68, P2887, DOI 10.1016/j.phytochem.2007.06.027; Ribeiro RA, 2007, SYST BOT, V32, P762, DOI 10.1600/036364407783390700; Roersch CMFB, 2010, J ETHNOPHARMACOL, V131, P522, DOI 10.1016/j.jep.2010.07.045; Rojo J.P., 1972, PTEROCARPUS LEGUMINO; Ronsted N, 2008, BIOCHEM SYST ECOL, V36, P417, DOI 10.1016/j.bse.2007.12.010; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Saslis-Lagoudakis CH, 2011, J ETHNOPHARMACOL, V135, P476, DOI 10.1016/j.jep.2011.03.044; Saslis-Lagoudakis C, 2008, AM J BOT, V95, P1270, DOI 10.3732/ajb.0800101; Savolainen V., 2000, Kew Bulletin, V55, P257, DOI 10.2307/4115644; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Soejarto DD, 2005, J ETHNOPHARMACOL, V100, P15, DOI 10.1016/j.jep.2005.05.031; SPECHT CD, 1997, M INT SOC ETHN LOND; Specht CD, 1996, JOINT M SOC EC BOT I; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tao J, 2009, BIOCHEM GENET, V47, P8, DOI 10.1007/s10528-008-9201-7; Taubert P. H.W., 1894, NATURL PFLANZ, V3, P70, DOI DOI 10.5962/BHL.TITLE.4635; Taylor JLS, 2001, PLANT GROWTH REGUL, V34, P23, DOI 10.1023/A:1013310809275; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trotter R.T., 1986, PLANTS INDIGENOUS ME, P91, DOI DOI 10.4324/9781315060385-6; Uprety Y, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-3; Vats V, 2002, J ETHNOPHARMACOL, V79, P95, DOI 10.1016/S0378-8741(01)00374-9; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Weete JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010899; Wink M, 2003, BIOCHEM SYST ECOL, V31, P897, DOI 10.1016/S0305-1978(03)00085-1; Wink M, 2003, PHYTOCHEMISTRY, V64, P3, DOI 10.1016/S0031-9422(03)00300-5; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846; Wright CI, 2007, J ETHNOPHARMACOL, V114, P1, DOI 10.1016/j.jep.2007.07.023; Zamora N, 2000, NOVON, V10, P175, DOI 10.2307/3393023	119	84	86	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22275	10.1371/journal.pone.0022275	http://dx.doi.org/10.1371/journal.pone.0022275			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789247	gold, Green Accepted, Green Published			2022-12-25	WOS:000292812400044
J	Gu, ZP; Zhou, LR; Gao, S; Wang, ZX				Gu, Zhongping; Zhou, Liran; Gao, Shen; Wang, Zhengxin			Nuclear Transport Signals Control Cellular Localization and Function of Androgen Receptor Cofactor p44/WDR77	PLOS ONE			English	Article							RNA HELICASE-A; NUCLEOLAR ACCUMULATION; PROSTATE; PROTEIN; EXPORT; IDENTIFICATION; COMPLEX; IMPORT; TRANSCRIPTION; METHYLATION	The androgen receptor (AR) cofactor p44/WDR77, which regulates expression of a set of androgen target genes, is required for differentiation of prostate epithelium. Aberrant localization of p44/WDR77 in the cytoplasm is associated with prostate tumorigenesis. Here, we describe studies that used the mouse prostate and human prostate cancer cells as model systems to investigate signals that control subcellular localization of p44/WDR77. We observed distinct subcellular location of p44/WDR77 during prostate development. p44/WDR77 localizes in the cytoplasm at the early stage of prostate development, when prostate epithelial cells are rapidly proliferating, and in the nucleus in adult prostate, when epithelial cells are fully differentiated. Subcellular localization assays designed to span the entire open-reading frame of p44/WDR77 protein revealed the presence of two nuclear exclusion signal (NES) and three nuclear localization signal (NLS) sequences in the p44/WDR77 protein. Site-directed mutagenesis of critical residues within an NLS led to loss of nuclear localization and transcriptional activity of p44/WDR77, suggesting that nuclear localization of p44/WDR77 is essential for its function as a transcriptional cofactor for AR. Three identified NLS were not functional in AR-positive prostate cancer (LNCaP and 22RV1) cells, which led to localization of p44/WDR77 in cytoplasm. The function of NLS in LNCaP cells could be restored by factor(s) from Cos 7 or PC3 cells. Mass spectrometric (MALDI-TOF/TOF) analysis identified proteins associated with an NLS and an NES in prostate cancer cells. These results provide a basis for understanding subcellular transport of p44/WDR77 during prostate development and tumorigenesis.	[Gu, Zhongping; Zhou, Liran; Gao, Shen; Wang, Zhengxin] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Gu, Zhongping] Fourth Mil Med Univ, Dept Thorac Surg, Tangdu Hosp, Xian 710032, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Air Force Military Medical University	Gu, ZP (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	zhenwang@mdanderson.org			National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [1R01 DK065156 01]; National Cancer Institute, National Institutes of Health [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065156] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Grant 1R01 DK065156 01 from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (to Z.W.) and by Cancer Center Support (Core) Grant CA16672 from the National Cancer Institute, National Institutes of Health to The University of Texas MD Anderson Cancer Center. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Aratani S, 2001, MOL CELL BIOL, V21, P4460, DOI 10.1128/MCB.21.14.4460-4469.2001; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Gao S, 2005, MOL ENDOCRINOL, V19, P1792, DOI 10.1210/me.2004-0445; Gao S, 2004, PROSTATE, V59, P214, DOI 10.1002/pros.10375; Gao S, 2006, J MOL ENDOCRINOL, V36, P463, DOI 10.1677/jme.1.01991; Gao S, 2010, ENDOCRINOLOGY, V151, P3941, DOI 10.1210/en.2009-1080; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hayward SW, 1996, ACTA ANAT, V155, P81; Hood JK, 2000, BBA-REV CANCER, V1471, pM31, DOI 10.1016/S0304-419X(00)00018-4; Hosohata K, 2003, MOL CELL BIOL, V23, P7019, DOI 10.1128/MCB.23.19.7019-7029.2003; Kahle J, 2009, J BIOL CHEM, V284, P9382, DOI 10.1074/jbc.M805694200; KELLOKUMPULEHTINEN P, 1985, BIOL NEONATE, V48, P157; Liu GZ, 2003, J BIOL CHEM, V278, P14956, DOI 10.1074/jbc.M212229200; McLane LM, 2009, IUBMB LIFE, V61, P697, DOI 10.1002/iub.194; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2002, EMBO J, V21, P5853, DOI 10.1093/emboj/cdf585; MESSMER B, 1993, EUR J CELL BIOL, V61, P369; MICHAEL WM, 1995, CELL, V83, P415; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; Peng Y, 2008, P NATL ACAD SCI USA, V105, P5236, DOI 10.1073/pnas.0712262105; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Rivera J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006433; Schalken JA, 2003, UROLOGY, V62, P11, DOI 10.1016/S0090-4295(03)00758-1; SCHMIDTZACHMANN MS, 1993, CELL, V74, P493, DOI 10.1016/0092-8674(93)80051-F; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; Stoldt S, 2007, BIOL CELL, V99, P541, DOI 10.1042/BC20060117; Storck Sebastien, 2007, Subcell Biochem, V41, P125; SUGIMURA Y, 1986, BIOL REPROD, V34, P961, DOI 10.1095/biolreprod34.5.961; Tetsuka T, 2004, EUR J BIOCHEM, V271, P3741, DOI 10.1111/j.1432-1033.2004.04314.x; TIMMS BG, 1994, J UROLOGY, V151, P1427, DOI 10.1016/S0022-5347(17)35273-4; Wang ZX, 1997, GENE DEV, V11, P1315, DOI 10.1101/gad.11.10.1315; Westermarck J, 2002, EMBO J, V21, P451, DOI 10.1093/emboj/21.3.451; Xue Y, 1998, PROSTATE, V34, P292, DOI 10.1002/(SICI)1097-0045(19980301)34:4<292::AID-PROS7>3.0.CO;2-J; Xue Zhixiong, 1994, Trends in Cell Biology, V4, P414, DOI 10.1016/0962-8924(94)90095-7; Yu X, 2001, MOL CELL BIOL, V21, P4614, DOI 10.1128/MCB.21.14.4614-4625.2001; Zhou LR, 2006, J MOL ENDOCRINOL, V37, P283, DOI 10.1677/jme.1.02062	43	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22395	10.1371/journal.pone.0022395	http://dx.doi.org/10.1371/journal.pone.0022395			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789256	Green Submitted, Green Published, gold			2022-12-25	WOS:000292811700044
J	Head, BP; Hu, Y; Finley, JC; Saldana, MD; Bonds, JA; Miyanohara, A; Niesman, IR; Ali, SS; Murray, F; Insel, PA; Roth, DM; Patel, HH; Patel, PM				Head, Brian P.; Hu, Yue; Finley, J. Cameron; Saldana, Michelle D.; Bonds, Jacqueline A.; Miyanohara, Atsushi; Niesman, Ingrid R.; Ali, Sameh S.; Murray, Fiona; Insel, Paul A.; Roth, David M.; Patel, Hemal H.; Patel, Piyush M.			Neuron-targeted Caveolin-1 Protein Enhances Signaling and Promotes Arborization of Primary Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; NEUROTROPHIC FACTOR; DENDRITIC SPINES; NERVOUS-SYSTEM; GROWTH CONE; ACTIVATION; GANGLIOSIDES; KINASE; LOCALIZATION; REGENERATION	Decreased expression of prosurvival and progrowth-stimulatory pathways, in addition to an environment that inhibits neuronal growth, contribute to the limited regenerative capacity in the central nervous system following injury or neurodegeneration. Membrane/lipid rafts, plasmalemmal microdomains enriched in cholesterol, sphingolipids, and the protein caveolin (Cav) are essential for synaptic development/stabilization and neuronal signaling. Cav-1 concentrates glutamate and neurotrophin receptors and prosurvival kinases and regulates cAMP formation. Here, we show that primary neurons that express a synapsin-driven Cav-1 vector (SynCav1) have increased raft formation, neurotransmitter and neurotrophin receptor expression, NMDA- and BDNF-mediated prosurvival kinase activation, agonist-stimulated cAMP formation, and dendritic growth. Moreover, expression of SynCav1 in Cav-1 KO neurons restores NMDA- and BDNF-mediated signaling and enhances dendritic growth. The enhanced dendritic growth occurred even in the presence of inhibitory cytokines (TNF alpha, IL-1 beta) and myelin-associated glycoproteins (MAG, Nogo). Targeting of Cav-1 to neurons thus enhances prosurvival and progrowth signaling and may be a novel means to repair the injured and neurodegenerative brain.	[Head, Brian P.; Hu, Yue; Finley, J. Cameron; Saldana, Michelle D.; Bonds, Jacqueline A.; Niesman, Ingrid R.; Roth, David M.; Patel, Hemal H.; Patel, Piyush M.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Ali, Sameh S.; Murray, Fiona; Insel, Paul A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Miyanohara, Atsushi] Univ Calif San Diego, Gene Therapy Program, La Jolla, CA 92093 USA; [Head, Brian P.; Hu, Yue; Finley, J. Cameron; Saldana, Michelle D.; Bonds, Jacqueline A.; Niesman, Ingrid R.; Roth, David M.; Patel, Hemal H.; Patel, Piyush M.] Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Head, BP (corresponding author), Vet Affairs Med Ctr 125, Dept Anesthesiol, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	bhead@ucsd.edu		Murray, Fiona/0000-0002-5572-4810; Niesman, Ingrid/0000-0001-9767-6629; Ali, Sameh Saad/0000-0002-0339-6106	National Institutes of Health [RO1 HL091071, RO1 GM085179]; Veterans Affairs Career Development Award; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL091061, R01HL091071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM085179] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Career Development Award; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL091071 (to H. H. P.) and RO1 GM085179 (to P. M. P.). This work was also supported by Veterans Affairs Career Development Award 2 (to B. P. H.) and a Merit Award from the Department of Veterans Affairs (to D. M. R.).	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; Assaife-Lopes N, 2010, J NEUROSCI, V30, P8468, DOI 10.1523/JNEUROSCI.5695-09.2010; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Besshoh S, 2005, J NEUROCHEM, V93, P186, DOI 10.1111/j.1471-4159.2004.03009.x; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bilderback TR, 1999, J BIOL CHEM, V274, P257, DOI 10.1074/jbc.274.1.257; Bist A, 2000, BIOCHEMISTRY-US, V39, P1966, DOI 10.1021/bi991721h; Bjork K, 2010, EXP CELL RES, V316, P1351, DOI 10.1016/j.yexcr.2010.02.034; Calabrese B, 2006, PHYSIOLOGY, V21, P38, DOI 10.1152/physiol.00042.2005; Carmichael ST, 2008, STROKE, V39, P1380, DOI 10.1161/STROKEAHA.107.499962; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V284, pC457, DOI 10.1152/ajpcell.00380.2002; DERRY DM, 1967, SCIENCE, V158, P1450, DOI 10.1126/science.158.3807.1450; Francesconi A, 2009, J NEUROSCI, V29, P3590, DOI 10.1523/JNEUROSCI.5824-08.2009; Gioiosa L, 2008, BEHAV BRAIN RES, V188, P255, DOI 10.1016/j.bbr.2007.11.002; Grider MH, 2009, J NEUROSCI RES, V87, P3033, DOI 10.1002/jnr.22140; Guirland C, 2007, ADV EXP MED BIOL, V621, P144, DOI 10.1007/978-0-387-76715-4_11; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hassan GS, 2004, BIOCHEMISTRY-US, V43, P8312, DOI 10.1021/bi049609t; Hattiangady B, 2005, EXP NEUROL, V195, P353, DOI 10.1016/j.expneurol.2005.05.014; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Head BP, 2008, FASEB J, V22, P828, DOI 10.1096/fj.07-9299com; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Head BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015697; Hering H, 2003, J NEUROSCI, V23, P3262; Hibbert AP, 2006, MOL CELL NEUROSCI, V32, P387, DOI 10.1016/j.mcn.2006.06.001; Hicks RR, 1998, MOL BRAIN RES, V59, P264, DOI 10.1016/S0169-328X(98)00158-2; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jasmin JF, 2007, CIRC RES, V100, P721, DOI 10.1161/01.RES.0000260180.42709.29; Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106; Lemkuil BP, 2011, ANESTHESIOLOGY, V114, P49, DOI 10.1097/ALN.0b013e318201dcb3; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; Lim ST, 2011, NEUROPHARMACOLOGY, V60, P1160, DOI 10.1016/j.neuropharm.2010.10.012; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; MacDonald E, 2007, NEUROREHAB NEURAL RE, V21, P486, DOI 10.1177/1545968307305521; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Mermelstein PG, 2009, J NEUROENDOCRINOL, V21, P257, DOI 10.1111/j.1365-2826.2009.01838.x; Murray AJ, 2009, J NEUROSCI, V29, P15434, DOI 10.1523/JNEUROSCI.3071-09.2009; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Oshikawa J, 2003, AM J PHYSIOL-CELL PH, V285, pC567, DOI 10.1152/ajpcell.00422.2002; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Renner M, 2009, J NEUROSCI, V29, P2926, DOI 10.1523/JNEUROSCI.4445-08.2009; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Sotgia F, 2006, AM J PATHOL, V168, P292, DOI 10.2353/ajpath.2006.050429; SPARROW JR, 1984, J NEUROSCI RES, V12, P233, DOI 10.1002/jnr.490120211; Stern CM, 2010, CELL MOL LIFE SCI, V67, P3785, DOI 10.1007/s00018-010-0447-y; SUZUKI K, 1965, J NEUROCHEM, V12, P629, DOI 10.1111/j.1471-4159.1965.tb04256.x; Suzuki S, 2007, J NEUROSCI, V27, P6417, DOI 10.1523/JNEUROSCI.0690-07.2007; Suzumura A, 2006, ANN NY ACAD SCI, V1088, P219, DOI 10.1196/annals.1366.012; SVENNERHOLM L, 1956, NATURE, V177, P524, DOI 10.1038/177524b0; Takayasu Y, 2010, P NATL ACAD SCI USA, V107, P21778, DOI 10.1073/pnas.1015553107; Toescu EC, 2004, TRENDS NEUROSCI, V27, P614, DOI 10.1016/j.tins.2004.07.010; Trushina E, 2006, BEHAV BRAIN RES, V172, P24, DOI 10.1016/j.bbr.2006.04.024; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Willmann R, 2006, EMBO J, V25, P4050, DOI 10.1038/sj.emboj.7601288; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558; Yamashita T, 2005, P NATL ACAD SCI USA, V102, P2725, DOI 10.1073/pnas.0407785102; YEE JK, 1994, METHOD CELL BIOL, V43, P99	62	66	72	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33310	33321		10.1074/jbc.M111.255976	http://dx.doi.org/10.1074/jbc.M111.255976			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21799010	Green Published, hybrid			2022-12-25	WOS:000294968800050
J	Rombouts, Y; Alibaud, L; Carrere-Kremer, S; Maes, E; Tokarski, C; Elass, E; Kremer, L; Guerardel, Y				Rombouts, Yoann; Alibaud, Laeticia; Carrere-Kremer, Severine; Maes, Emmanuel; Tokarski, Caroline; Elass, Elisabeth; Kremer, Laurent; Guerardel, Yann			Fatty Acyl Chains of Mycobacterium marinum Lipooligosaccharides STRUCTURE, LOCALIZATION AND ACYLATION BY PapA4 (MMAR_2343) PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TREHALOSE-CONTAINING LIPOOLIGOSACCHARIDES; MODULAR POLYKETIDE SYNTHASES; TUBERCULOSIS; BIOSYNTHESIS; ACYLTRANSFERASES; IDENTIFICATION; VIRULENCE; ENVELOPE; COMPLEX; DOMAIN	We have recently established the fine structure of the glycan backbone of lipooligosaccharides (LOS-I to LOS-IV) isolated from Mycobacterium marinum, a close relative of Mycobacterium tuberculosis. These studies culminated with the description of an unusual terminal N-acylated monosaccharide that confers important biological functions to LOS-IV, such as macrophage activation, that may be relevant to granuloma formation. It was, however, also suggested that the lipid moiety was required for LOSs to exert their immunomodulatory activity. Herein, using highly purified LOSs from M. marinum, we have determined through a combination of mass spectrometric and NMR techniques, the structure and localization of the fatty acids composing the lipid moiety. The occurrence of two distinct polymethyl-branched fatty acids presenting specific localizations is consistent with the presence of two highly related polyketide synthases (Pks5 and Pks5.1) in M. marinum and presumably involved in the synthesis of these fatty acyl chains. In addition, a bioinformatic search permitted us to identify a set of enzymes potentially involved in the biosynthesis or transfer of these lipids to the LOS trehalose unit. These include MMAR_2343, a member of the Pap (polyketide-associated protein) family, that acylates trehalose-based glycolipids in M. marinum. The participation of MMAR_2343 to LOS assembly was demonstrated using a M. marinum mutant carrying a transposon insertion in the MMAR_2343 gene. Disruption of MMAR_2343 resulted in a severe LOS breakdown, indicating that MMAR_2343, here-after designated PapA4, fulfills the requirements for LOS acylation and assembly.	[Alibaud, Laeticia; Carrere-Kremer, Severine; Kremer, Laurent] Univ Montpellier 2 & 1, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, F-34095 Montpellier 05, France; [Elass, Elisabeth; Guerardel, Yann] Univ Lille 1, Unite Glycobiol Struct & Fonct, F-59650 Villeneuve Dascq, France; [Rombouts, Yoann; Maes, Emmanuel; Elass, Elisabeth; Guerardel, Yann] CNRS, UMR 8576, F-59650 Villeneuve Dascq, France; [Kremer, Laurent] DIMNP, INSERM, F-34095 Montpellier 05, France; [Tokarski, Caroline] Univ Lille 1 Sci & Technol, USR CNRS 3290, IFR 147, F-59655 Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Lille - ISITE; Universite de Lille	Kremer, L (corresponding author), Univ Montpellier 2 & 1, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, Case 107,Pl Eugene Bataillon, F-34095 Montpellier 05, France.	laurent.kremer@univ-montp2.fr; yann.guerardel@univ-lille1.fr	Kremer, Laurent/M-4935-2017	Kremer, Laurent/0000-0002-6604-4458; Rombouts, Yoann/0000-0003-4482-2199; Guerardel, Yann/0000-0003-4967-9512; elass, elisabeth/0000-0002-2573-2959	French National Research Agency [ANR-05-MIIM-025, ANR-10-MIDI010]; Ministere de l'Enseignement Superieur; Centre Commun de Mesure RMN (Resonance Magnetique Nucleaire) de l'Universite de Lille 1; European Union; Region Nord-Pas de Calais; CNRS; Institut Pasteur de Lille; European community; Region Nord-Pas de Calais (France); Infrastructures en Biologie Sante et Agronomie network; Universite Lille 1 Sciences et Technologies; TGE FT-ICR (Tres Grand Equipement Fourier Transform Ion Cyclotron Resonance)	French National Research Agency(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur; Centre Commun de Mesure RMN (Resonance Magnetique Nucleaire) de l'Universite de Lille 1; European Union(European Commission); Region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur de Lille; European community(European Commission); Region Nord-Pas de Calais (France)(Region Hauts-de-France); Infrastructures en Biologie Sante et Agronomie network; Universite Lille 1 Sciences et Technologies; TGE FT-ICR (Tres Grand Equipement Fourier Transform Ion Cyclotron Resonance)	This work was supported by French National Research Agency Grant ANR-05-MIIM-025 (to Y. G. and L. K.), ZebraFlam Grant ANR-10-MIDI010 (to L. K.), and a grant from the Ministere de l'Enseignement Superieur (to Y. R.). The 400-MHz facility was funded by the Centre Commun de Mesure RMN (Resonance Magnetique Nucleaire) de l'Universite de Lille 1. The 600-MHz facility used in this study was funded by the European Union, Region Nord-Pas de Calais, CNRS, and Institut Pasteur de Lille. The mass spectrometry facilities used for this study are funded by the European community (Fonds Europeen de Developpement Regional), the Region Nord-Pas de Calais (France), the Infrastructures en Biologie Sante et Agronomie network, the CNRS, the Universite Lille 1 Sciences et Technologies, and the TGE FT-ICR (Tres Grand Equipement Fourier Transform Ion Cyclotron Resonance).	Alibaud L, 2011, MOL MICROBIOL, V80, P919, DOI 10.1111/j.1365-2958.2011.07618.x; Anand S, 2010, NUCLEIC ACIDS RES, V38, pW487, DOI 10.1093/nar/gkq340; BELISLE JT, 1989, J BACTERIOL, V171, P3465, DOI 10.1128/jb.171.6.3465-3470.1989; Bergendahl V, 2002, EUR J BIOCHEM, V269, P620, DOI 10.1046/j.0014-2956.2001.02691.x; BESRA GS, 1993, BIOCHEMISTRY-US, V32, P12705, DOI 10.1021/bi00210a020; BESRA GS, 1994, CARBOHYD RES, V251, P99, DOI 10.1016/0008-6215(94)84279-5; Bhatt K, 2007, MICROBIOL-SGM, V153, P513, DOI 10.1099/mic.0.2006/003103-0; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Buglino J, 2004, J BIOL CHEM, V279, P30634, DOI 10.1074/jbc.M404011200; Burguiere A, 2005, J BIOL CHEM, V280, P42124, DOI 10.1074/jbc.M507500200; CAMPHAUSEN RT, 1987, J BACTERIOL, V169, P5473, DOI 10.1128/jb.169.12.5473-5480.1987; Chopra T, 2009, METHOD ENZYMOL, V459, P259, DOI 10.1016/S0076-6879(09)04612-6; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; COLLINS FM, 1981, INFECT IMMUN, V32, P614, DOI 10.1128/IAI.32.2.614-624.1981; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; DAFFE M, 1991, RES MICROBIOL, V142, P405, DOI 10.1016/0923-2508(91)90110-V; DAFFE M, 1991, BIOCHEMISTRY-US, V30, P378, DOI 10.1021/bi00216a011; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Etienne G, 2009, J BACTERIOL, V191, P2613, DOI 10.1128/JB.01235-08; GILLERON M, 1993, J BIOL CHEM, V268, P3168; GOREN MB, 1970, BIOCHIM BIOPHYS ACTA, V210, P127, DOI 10.1016/0005-2760(70)90068-8; Hatzios SK, 2009, J BIOL CHEM, V284, P12745, DOI 10.1074/jbc.M809088200; HUNTER SW, 1984, J BIOL CHEM, V259, P9729; HUNTER SW, 1983, J BIOL CHEM, V258, P481; JARLIER V, 1990, J BACTERIOL, V172, P1418, DOI 10.1128/jb.172.3.1418-1423.1990; Karakousis PC, 2004, CELL MICROBIOL, V6, P105, DOI 10.1046/j.1462-5822.2003.00351.x; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Kumar P, 2007, P NATL ACAD SCI USA, V104, P11221, DOI 10.1073/pnas.0611649104; Kwan DH, 2010, ACS CHEM BIOL, V5, P829, DOI 10.1021/cb100175a; Kwan DH, 2008, CHEM BIOL, V15, P1231, DOI 10.1016/j.chembiol.2008.09.012; Larsen Michelle H, 2007, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/9780471729259.mc10a02s6; LEMASSU A, 1992, J GEN MICROBIOL, V138, P1535, DOI 10.1099/00221287-138-7-1535; LEWENDON A, 1988, BIOCHEMISTRY-US, V27, P7385, DOI 10.1021/bi00419a032; McAdam RA, 2002, MICROBIOL-SGM, V148, P2975, DOI 10.1099/00221287-148-10-2975; MCNEIL M, 1989, METHOD ENZYMOL, V179, P215; Munoz M, 1998, MICROBIOL-SGM, V144, P137, DOI 10.1099/00221287-144-1-137; Neyrolles O, 2011, TUBERCULOSIS, V91, P187, DOI 10.1016/j.tube.2011.01.002; Onwueme KC, 2004, P NATL ACAD SCI USA, V101, P4608, DOI 10.1073/pnas.0306928101; Ren HP, 2007, MOL MICROBIOL, V63, P1345, DOI 10.1111/j.1365-2958.2007.05603.x; Rombouts Y, 2010, J AM CHEM SOC, V132, P16073, DOI 10.1021/ja105807s; Rombouts Y, 2009, J BIOL CHEM, V284, P20975, DOI 10.1074/jbc.M109.011429; RYHAGE RAGNAR, 1960, JOUR LIPID RES, V1, P361; Sarkar D, 2011, J BACTERIOL, V193, P2336, DOI 10.1128/JB.00065-11; Schmidt Y, 2010, ORG LETT, V12, P2218, DOI 10.1021/ol1005399; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; van der Sar AM, 2004, INFECT IMMUN, V72, P6306, DOI 10.1128/IAI.72.11.6306-6312.2004; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8	49	25	25	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33678	33688		10.1074/jbc.M111.273920	http://dx.doi.org/10.1074/jbc.M111.273920			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21803773	Green Published, hybrid			2022-12-25	WOS:000294968800084
J	Kuningas, M; McQuillan, R; Wilson, JF; Hofman, A; van Duijn, CM; Uitterlinden, AG; Tiemeier, H				Kuningas, Maris; McQuillan, Ruth; Wilson, James F.; Hofman, Albert; van Duijn, Cornelia M.; Uitterlinden, Andre G.; Tiemeier, Henning			Runs of Homozygosity Do Not Influence Survival to Old Age	PLOS ONE			English	Article							EXTENDED TRACTS; POPULATIONS; IDENTIFY	Runs of homozygosity (ROH) are extended tracts of adjacent homozygous single nucleotide polymorphisms (SNPs) that are more common in unrelated individuals than previously thought. It has been proposed that estimating ROH on a genome-wide level, by making use of the genome-wide single nucleotide polymorphism (SNP) data, will enable to indentify recessive variants underlying complex traits. Here, we examined ROH larger than 1.5 Mb individually and in combination for association with survival in 5974 participants of the Rotterdam Study. In addition, we assessed the role of overall homozygosity, expressed as a percentage of the autosomal genome that is in ROH longer than 1.5 Mb, on survival during a mean follow-up period of 12 years. None of these measures of homozygosity was associated with survival to old age.	[Kuningas, Maris; Hofman, Albert; van Duijn, Cornelia M.; Uitterlinden, Andre G.; Tiemeier, Henning] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [McQuillan, Ruth; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Hofman, Albert; van Duijn, Cornelia M.; Uitterlinden, Andre G.; Tiemeier, Henning] Netherlands Consortium Healthy Aging, Netherlands Genom Initiat, Leiden, Netherlands; [Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Tiemeier, Henning] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Edinburgh; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Kuningas, M (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands.	M.Kuningas@erasmusmc.nl	Wilson, James F/A-5704-2009; Tiemeier, Henning/H-6534-2019	Wilson, James F/0000-0001-5751-9178; Tiemeier, Henning/0000-0002-4395-1397; Van Duijn, Cornelia/0000-0002-2374-9204	Research Institute for Diseases in the Elderly [014-93-015, RIDE2]; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) [050-060-810 NCHA, 175.010.2005.011, 911-03-012, 017-106-370 VIDI]; Erasmus Medical Center and Erasmus University; Netherlands Organization for the Health Research and Development (ZonMw); Ministries of Education, Culture and Science, and Health, Welfare and Sports; European Commission (DGXII); Municipality of Rotterdam; Royal Society; Chief Scientist Office of the Scottish Government	Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Erasmus Medical Center and Erasmus University; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Ministries of Education, Culture and Science, and Health, Welfare and Sports; European Commission (DGXII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Royal Society(Royal Society of London); Chief Scientist Office of the Scottish Government	The study was supported by the Research Institute for Diseases in the Elderly (grant-number 014-93-015; RIDE2); the Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) (grant-numbers 050-060-810 NCHA; 175.010.2005.011; 911-03-012; 017-106-370 VIDI to HT); Erasmus Medical Center and Erasmus University; Netherlands Organization for the Health Research and Development (ZonMw); the Ministries of Education, Culture and Science, and Health, Welfare and Sports; the European Commission (DGXII); and the Municipality of Rotterdam. JFW is supported by the Royal Society and RM by the Chief Scientist Office of the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gibson J, 2006, HUM MOL GENET, V15, P789, DOI 10.1093/hmg/ddi493; Hofman A, 2009, EUR J EPIDEMIOL, V24, P553, DOI 10.1007/s10654-009-9386-z; Hosking FJ, 2010, BLOOD, V115, P4472, DOI 10.1182/blood-2009-09-244483; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Nalls MA, 2009, NEUROGENETICS, V10, P183, DOI 10.1007/s10048-009-0182-4; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Spain SL, 2009, CANCER RES, V69, P7422, DOI 10.1158/0008-5472.CAN-09-0659; Vine AE, 2009, PSYCHIAT GENET, V19, P165, DOI 10.1097/YPG.0b013e32832a4faa; Yang TL, 2010, J CLIN ENDOCR METAB, V95, P3777, DOI 10.1210/jc.2009-1715	10	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22580	10.1371/journal.pone.0022580	http://dx.doi.org/10.1371/journal.pone.0022580			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799906	Green Published, Green Submitted, gold			2022-12-25	WOS:000293172900052
J	Trinh, XB; Tjalma, WAA; Dirix, LY; Vermeulen, PB; Peeters, DJ; Bachvarov, D; Plante, M; Berns, EM; Helleman, J; Van Laere, SJ; van Dam, PA				Trinh, Xuan Bich; Tjalma, Wiebren A. A.; Dirix, Luc Y.; Vermeulen, Peter B.; Peeters, Dieter J.; Bachvarov, Dimcho; Plante, Marie; Berns, Els M.; Helleman, Jozien; Van Laere, Steven J.; van Dam, Peter A.			Microarray-Based Oncogenic Pathway Profiling in Advanced Serous Papillary Ovarian Carcinoma	PLOS ONE			English	Article							GENE-EXPRESSION PROFILE; POSITIVE BREAST-CANCER; PHASE-II TRIAL; ESTROGEN-RECEPTOR; BETA-CATENIN; PROGESTERONE-RECEPTOR; CLINICAL-RELEVANCE; E2F FAMILY; PROGNOSIS; SIGNATURE	Introduction: The identification of specific targets for treatment of ovarian cancer patients remains a challenge. The objective of this study is the analysis of oncogenic pathways in ovarian cancer and their relation with clinical outcome. Methodology: A meta-analysis of 6 gene expression datasets was done for oncogenic pathway activation scores: AKT, beta-Catenin, BRCA, E2F1, EGFR, ER, HER2, INF alpha, INF gamma, MYC, p53, p63, PI3K, PR, RAS, SRC, STAT3, TNF alpha, and TGF beta and VEGF-A. Advanced serous papillary tumours from uniformly treated patients were selected (N = 464) to find differences independent from stage-, histology- and treatment biases. Survival and correlations with documented prognostic signatures (wound healing response signature WHR/genomic grade index GGI/invasiveness gene signature IGS) were analysed. Results: The GGI, WHR, IGS score were unexpectedly increased in chemosensitive versus chemoresistant patients. PR and RAS activation score were associated with survival outcome (p = 0.002; p = 0.004). Increased activations of beta-Catenin (p = 0.0009), E2F1 (p = 0.005), PI3K (p = 0.003) and p63 (p = 0.05) were associated with more favourable clinical outcome and were consistently correlated with three prognostic gene signatures. Conclusions: Oncogenic pathway profiling of advanced serous ovarian tumours revealed that increased beta-Catenin, E2F1, p63, PI3K, PR and RAS -pathway activation scores were significantly associated with favourable clinical outcome. WHR, GGI and IGS scores were unexpectedly increased in chemosensitive tumours. Earlier studies have shown that WHR, GGI and IGS are strongly associated with proliferation and that high-proliferative ovarian tumours are more chemosensitive. These findings may indicate opposite confounding of prognostic versus predictive factors when studying biomarkers in epithelial ovarian cancer.	[Trinh, Xuan Bich; Dirix, Luc Y.; Vermeulen, Peter B.; Peeters, Dieter J.; Van Laere, Steven J.; van Dam, Peter A.] St Augustinus GZA Hosp, Translat Canc Res Unit, Antwerp, Belgium; [Trinh, Xuan Bich; Tjalma, Wiebren A. A.] Univ Antwerp Hosp, Dept Gynaecol Oncol, Antwerp, Belgium; [Bachvarov, Dimcho; Plante, Marie] Ctr Hosp Univ Quebec CHUQ, Hop Hotel Dieu Quebec, Canc Res Ctr, Quebec City, PQ, Canada; [Berns, Els M.; Helleman, Jozien] Erasmus MC Josephine Nefkens Inst, Dept Med Oncol, Rotterdam, Netherlands	University of Antwerp; Laval University; Erasmus University Rotterdam; Erasmus MC	Trinh, XB (corresponding author), St Augustinus GZA Hosp, Translat Canc Res Unit, Antwerp, Belgium.	peter.vandam@gza.be	Van Laere, Steven/GQA-8872-2022; Dirix, Luc/AAI-8880-2020	Van Laere, Steven/0000-0002-2640-0040; Peeters, Dieter/0000-0002-6943-2675; Bachvarov, Dimcho/0000-0001-6509-9599	GZA-Hospitals St. Augustinus, Antwerp, Belgium	GZA-Hospitals St. Augustinus, Antwerp, Belgium	Financial support for this analysis was provided by the GZA-Hospitals St. Augustinus, Antwerp, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, J CLIN ONCOL, V28, P5229; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Bachvarov D, 2006, INT J ONCOL, V29, P919; Baggerly KA, 2008, J CLIN ONCOL, V26, P1186, DOI 10.1200/JCO.2007.15.1951; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bonnefoi H, 2011, LANCET ONCOL, V12, P116, DOI 10.1016/S1470-2045(11)70011-0; Burger RA, 2007, J CLIN ONCOL, V25, P5165, DOI 10.1200/JCO.2007.11.5345; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Cannistra SA, 2007, J CLIN ONCOL, V25, P5180, DOI 10.1200/JCO.2007.12.0782; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; del Carmen MG, 2003, GYNECOL ONCOL, V91, P596, DOI 10.1016/j.ygyno.2003.08.021; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; Faleiro-Rodrigues C, 2004, INT J GYNECOL PATHOL, V23, P337, DOI 10.1097/01.pgp.0000139711.22158.14; Fattet S, 2009, J PATHOL, V218, P86, DOI 10.1002/path.2514; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; Hogdall EVS, 2007, ONCOL REP, V18, P1051; Hu ZY, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-9; Irving JA, 2005, HUM PATHOL, V36, P605, DOI 10.1016/j.humpath.2005.03.005; Itamochi H, 2002, OBSTET GYNECOL, V100, P281, DOI 10.1016/S0029-7844(02)02040-9; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Konstantinopoulos PA, 2010, J CLIN ONCOL, V28, P3555, DOI 10.1200/JCO.2009.27.5719; Lauss M, 2010, CLIN CANCER RES, V16, P4421, DOI 10.1158/1078-0432.CCR-10-0606; Lee P, 2005, GYNECOL ONCOL, V96, P671, DOI 10.1016/j.ygyno.2004.11.010; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Loi S, 2010, P NATL ACAD SCI USA, V107, P10208, DOI 10.1073/pnas.0907011107; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Mostertz W, 2010, JAMA-J AM MED ASSOC, V303, P535, DOI 10.1001/jama.2010.80; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Papadimitriou CA, 2004, ONCOLOGY-BASEL, V66, P112, DOI 10.1159/000077436; Potti A, 2011, NAT MED, V17, P135, DOI 10.1038/nm0111-135; Reimer D, 2006, ANN NY ACAD SCI, V1091, P270, DOI 10.1196/annals.1378.073; Reimer D, 2007, CLIN CANCER RES, V13, P144, DOI 10.1158/1078-0432.CCR-06-0780; Rosen DG, 2010, MODERN PATHOL, V23, P113, DOI 10.1038/modpathol.2009.141; Smyth JF, 2007, CLIN CANCER RES, V13, P3617, DOI 10.1158/1078-0432.CCR-06-2878; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stawerski P, 2008, POL J PATHOL, V59, P27; Tangjitgamol S, 2009, INT J GYNECOL CANCER, V19, P620, DOI 10.1111/IGC.0b013e3181a44b62; Teoh DGK, 2011, CANCER CONTROL, V18, P31, DOI 10.1177/107327481101800105; Tetu B, 2008, MODERN PATHOL, V21, P1002, DOI 10.1038/modpathol.2008.80; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Voutilainen KA, 2006, J CLIN PATHOL, V59, P460, DOI 10.1136/jcp.2005.029876; Williams C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001034.pub2; Williams CJ, 2001, COCHRANE DB SYST REV; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Yang XY, 2009, GYNECOL ONCOL, V113, P99, DOI 10.1016/j.ygyno.2008.12.018; Yoshihara K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009615; 2010, J CLIN ONCOL, V25, P4350	50	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22469	10.1371/journal.pone.0022469	http://dx.doi.org/10.1371/journal.pone.0022469			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799864	Green Published, gold, Green Submitted			2022-12-25	WOS:000293172900035
J	Zhao, XL; Sun, YP; Pu, J; Fan, LH; Shi, WM; Hu, YX; Yang, J; Xu, Q; Wang, JJ; Hou, DJ; Ma, GP; Liu, JH				Zhao, Xueli; Sun, Yipeng; Pu, Juan; Fan, Lihong; Shi, Weimin; Hu, Yanxin; Yang, Jun; Xu, Qi; Wang, Jingjing; Hou, Dongjun; Ma, Guangpeng; Liu, Jinhua			Characterization of an Artificial Swine-Origin Influenza Virus with the Same Gene Combination as H1N1/2009 Virus: A Genesis Clue of Pandemic Strain	PLOS ONE			English	Article							A VIRUS; H1N1 VIRUS; TRANSMISSION; EMERGENCE; PATHOGENESIS; PATHOGENICITY; COMPATIBILITY; REPLICATION; RESIDUES; HUMANS	Pandemic H1N1/2009 influenza virus, derived from a reassortment of avian, human, and swine influenza viruses, possesses a unique gene segment combination that had not been detected previously in animal and human populations. Whether such a gene combination could result in the pathogenicity and transmission as H1N1/2009 virus remains unclear. In the present study, we used reverse genetics to construct a reassortant virus (rH1N1) with the same gene combination as H1N1/2009 virus (NA and M genes from a Eurasian avian-like H1N1 swine virus and another six genes from a North American triple-reassortant H1N2 swine virus). Characterization of rH1N1 in mice showed that this virus had higher replicability and pathogenicity than those of the seasonal human H1N1 and Eurasian avian-like swine H1N1 viruses, but was similar to the H1N1/2009 and triple-reassortant H1N2 viruses. Experiments performed on guinea pigs showed that rH1N1 was not transmissible, whereas pandemic H1N1/2009 displayed efficient transmissibility. To further determine which gene segment played a key role in transmissibility, we constructed a series of reassortants derived from rH1N1 and H1N1/2009 viruses. Direct contact transmission studies demonstrated that the HA and NS genes contributed to the transmission of H1N1/2009 virus. Second, the HA gene of H1N1/2009 virus, when combined with the H1N1/2009 NA gene, conferred efficient contact transmission among guinea pigs. The present results reveal that not only gene segment reassortment but also amino acid mutation were needed for the generation of the pandemic influenza virus.	[Zhao, Xueli; Sun, Yipeng; Pu, Juan; Fan, Lihong; Shi, Weimin; Hu, Yanxin; Yang, Jun; Xu, Qi; Wang, Jingjing; Hou, Dongjun; Liu, Jinhua] China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Zoonosis, Beijing 100094, Peoples R China; [Ma, Guangpeng] China Rural Technol Dev Ctr, Beijing, Peoples R China; [Liu, Jinhua] Shandong Anim Dis Control Ctr, Jinan, Shandong, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Zhao, XL (corresponding author), China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Zoonosis, Beijing 100094, Peoples R China.	maguangpeng1977@163.com; ljh@cau.edu.cn			National Basic Research Program (973 Program) [2011CB504702]; National Natural Science Foundation of China; National Key Technologies RD Program [2010BAD04B01]; Program for Cheung Kong Scholars and Innovative Research Teams in Chinese Universities [IRT0866]; Taishan Scholar Foundation	National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies RD Program(National Key Technology R&D Program); Program for Cheung Kong Scholars and Innovative Research Teams in Chinese Universities; Taishan Scholar Foundation	This work was supported by the National Basic Research Program (973 Program) (No. 2011CB504702), the National Natural Science Foundation of China, the National Key Technologies R&D Program (2010BAD04B01), and the Program for Cheung Kong Scholars and Innovative Research Teams in Chinese Universities (No. IRT0866). The corresponding author was funded by Taishan Scholar Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr IG, 2010, EURO SURVEILL, V15; Belser JA, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001705; Belser JA, 2010, J VIROL, V84, P4194, DOI 10.1128/JVI.02742-09; Bi YH, 2010, EMERG INFECT DIS, V16, P1162, DOI 10.3201/eid1607.091881; Brookes SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009068; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Vries RP, 2011, J BIOL CHEM, V286, P5868, DOI 10.1074/jbc.M110.193557; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Imai H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001106; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Liu JH, 2009, J CLIN MICROBIOL, V47, P2643, DOI 10.1128/JCM.00262-09; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Ma WJ, 2010, J VIROL, V84, P2122, DOI 10.1128/JVI.01668-09; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Octaviani CP, 2010, J VIROL, V84, P10918, DOI 10.1128/JVI.01140-10; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; PENSAERT M, 1981, B WORLD HEALTH ORGAN, V59, P75; *PREV CFDCA, 2010, 2009 HINI FLU INT SI; *PREV CFDCA, 2009, MMWR-MORBID MORTAL W, V58, P400; Pu JA, 2010, VIRUS RES, V151, P200, DOI 10.1016/j.virusres.2010.05.007; REED L. J., 1938, AMER JOUR HYG, V27, P493; SCHAFER JR, 1993, VIROLOGY, V194, P781, DOI 10.1006/viro.1993.1319; Scholtissek C, 1997, ARCH VIROL, P99; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Steel J, 2010, J VIROL, V84, P21, DOI 10.1128/JVI.01732-09; Sun YP, 2011, P NATL ACAD SCI USA, V108, P4164, DOI 10.1073/pnas.1019109108; Trifonov V, 2009, NEW ENGL J MED, V361, P115, DOI 10.1056/NEJMp0904572; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106	38	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22091	10.1371/journal.pone.0022091	http://dx.doi.org/10.1371/journal.pone.0022091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799774	gold, Green Published, Green Submitted			2022-12-25	WOS:000293172900011
J	Baker, J; Gatton, ML; Peters, J; Ho, MF; McCarthy, JS; Cheng, Q				Baker, Joanne; Gatton, Michelle L.; Peters, Jennifer; Ho, Mei-Fong; McCarthy, James S.; Cheng, Qin			Transcription and Expression of Plasmodium falciparum Histidine-Rich Proteins in Different Stages and Strains: Implications for Rapid Diagnostic Tests	PLOS ONE			English	Article							MALARIA PARASITES; VAR GENE; LIFE; PERFORMANCE; RESISTANCE; DIVERSITY; SECRETION	Background: Although rapid diagnostic tests (RDTs) for Plasmodium falciparum infection that target histidine rich protein 2 (PfHRP2) are generally sensitive, their performance has been reported to be variable. One possible explanation for variable test performance is differences in expression level of PfHRP in different parasite isolates. Methods: Total RNA and protein were extracted from synchronised cultures of 7 P. falciparum lines over 5 time points of the life cycle, and from synchronised ring stages of 10 falciparum lines. Using quantitative real-time polymerase chain reaction, Western blot analysis and ELISA we investigated variations in the transcription and protein levels of pfhrp2, pfhrp3 and PfHRP respectively in the different parasite lines, over the parasite intraerythrocytic life cycle. Results: Transcription of pfhrp2 and pfhrp3 in different parasite lines over the parasite life cycle was observed to vary relative to the control parasite K1. In some parasite lines very low transcription of these genes was observed. The peak transcription was observed in ring-stage parasites. Pfhrp2 transcription was observed to be consistently higher than pfhrp3 transcription within parasite lines. The intraerythrocytic lifecycle stage at which the peak level of protein was present varied across strains. Total protein levels were more constant relative to total mRNA transcription, however a maximum 24 fold difference in expression at ring-stage parasites relative to the K1 strain was observed. Conclusions: The levels of transcription of pfhrp2 and pfhrp3, and protein expression of PfHRP varied between different P. falciparum strains. This variation may impact on the detection sensitivity of PfHRP2-detecting RDTs.	[Baker, Joanne; Peters, Jennifer; Cheng, Qin] Australian Army Malaria Inst, Dept Drug Resistance & Diagnost, Enoggera, Qld, Australia; [Gatton, Michelle L.; Peters, Jennifer; Cheng, Qin] Queensland Inst Med Res, Malaria Drug Resistance & Chemotherapy Lab, Brisbane, Qld 4006, Australia; [Ho, Mei-Fong; McCarthy, James S.] Queensland Inst Med Res, Clin Trop Med Lab, Brisbane, Qld 4006, Australia; [McCarthy, James S.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Baker, Joanne; Cheng, Qin] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland	Baker, J (corresponding author), Australian Army Malaria Inst, Dept Drug Resistance & Diagnost, Enoggera, Qld, Australia.	qin.cheng@defence.gov.au	McCarthy, James S/C-1681-2009; Cheng, Qin/AAO-2198-2020; Gatton, Michelle/H-3139-2019	Cheng, Qin/0000-0001-7776-4437; Gatton, Michelle/0000-0003-1188-609X; McCarthy, James/0000-0001-6596-9718	NHMRC	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	JSM is supported by the NHMRC, an Australia and a Queensland Government Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, PLASMODB PLASMODIUM; Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Baker J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-129; Biosystems PEA, 2001, US B BIOS PEA; Birku Y, 1999, ETHIOPIAN MED J, V37, P173; Biswas S, 2005, ANN TROP MED PARASIT, V99, P553, DOI 10.1179/136485905X51463; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Daily JP, 2007, NATURE, V450, P1091, DOI 10.1038/nature06311; Desakorn V, 2005, T ROY SOC TROP MED H, V99, P517, DOI 10.1016/j.trstmh.2004.11.014; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Gatton ML, 2006, AM J TROP MED HYG, V75, P212, DOI 10.4269/ajtmh.2006.75.212; Gonzales JM, 2008, PLOS BIOL, V6, P2016, DOI 10.1371/journal.pbio.0060238; Gopalakrishnan AM, 2010, PARASITOL RES, V106, P833, DOI 10.1007/s00436-010-1738-9; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hayward RE, 2000, EXP PARASITOL, V96, P139, DOI 10.1006/expr.2000.4557; Horrocks P, 2009, MOL BIOCHEM PARASIT, V164, P9, DOI 10.1016/j.molbiopara.2008.11.010; HOWARD RJ, 1986, J CELL BIOL, V103, P1269, DOI 10.1083/jcb.103.4.1269; Jiang HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002484; Kidgell C, 2006, PLOS PATHOG, V2, P562, DOI 10.1371/journal.ppat.0020057; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; MURRAY CK, 2009, INTERDISCIP PERSPECT; Noedl H, 2002, EXP PARASITOL, V102, P157, DOI 10.1016/S0014-4894(03)00051-1; Noland GS, 2003, MOL BIOCHEM PARASIT, V130, P91, DOI 10.1016/S0166-6851(03)00163-4; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; PANTON LJ, 1989, MOL BIOCHEM PARASIT, V35, P149, DOI 10.1016/0166-6851(89)90117-5; Pava Z, 2010, AM J TROP MED HYG, V83, P834, DOI 10.4269/ajtmh.2010.10-0075; Ponts N, INFECT GENET EVOL; ROCK EP, 1987, PARASITOLOGY, V95, P209, DOI 10.1017/S0031182000057681; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Scherf A, 1996, SEMIN CELL DEV BIOL, V7, P49, DOI 10.1006/scdb.1996.0008; SHARMA YD, 1988, INT J BIOCHEM, V20, P471, DOI 10.1016/0020-711X(88)90495-8; SHIFF CJ, 1993, T ROY SOC TROP MED H, V87, P646, DOI 10.1016/0035-9203(93)90273-S; Shock JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r134; Sims JS, 2009, EUKARYOT CELL, V8, P327, DOI 10.1128/EC.00340-08; Teuscher F, 2010, J INFECT DIS, V202, P1362, DOI 10.1086/656476; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; WELLEMS TE, 1987, CELL, V49, P633, DOI 10.1016/0092-8674(87)90539-3; WELLEMS TE, 1986, P NATL ACAD SCI USA, V83, P6065, DOI 10.1073/pnas.83.16.6065; WELLEMS TE, 1991, P NATL ACAD SCI USA, V88, P3382, DOI 10.1073/pnas.88.8.3382; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Wongsrichanalai C, 1999, ACTA TROP, V73, P263, DOI 10.1016/S0001-706X(99)00040-6; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130	49	44	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22593	10.1371/journal.pone.0022593	http://dx.doi.org/10.1371/journal.pone.0022593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799910	Green Published, gold, Green Submitted			2022-12-25	WOS:000293097300070
J	Breitling, LP; Koenig, W; Fischer, M; Mallat, Z; Hengstenberg, C; Rothenbacher, D; Brenner, H				Breitling, Lutz P.; Koenig, Wolfgang; Fischer, Marcus; Mallat, Ziad; Hengstenberg, Christian; Rothenbacher, Dietrich; Brenner, Hermann			Type II Secretory Phospholipase A(2) and Prognosis in Patients with Stable Coronary Heart Disease: Mendelian Randomization Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; ARTERY-DISEASE; EPIC-NORFOLK; SERUM-LEVELS; HEALTHY-MEN; EVENTS; ASSOCIATION; RISK; ATHEROGENESIS	Background: Serum type II secretory phospholipase A(2) (sPLA(2)-IIa) has been found to be predictive of adverse outcomes in patients with stable coronary heart disease. Compounds targeting sPLA(2)-IIa are already under development. This study investigated if an association of sPLA(2)-IIa with secondary cardiovascular disease (CVD) events may be of causal nature or mainly a matter of confounding by correlated cardiovascular risk markers. Methodology/Principal Findings: Eight-year follow-up data of a prospective cohort study (KAROLA) of patients who underwent in-patient rehabilitation after an acute cardiovascular event were analysed. Associations of polymorphisms (SNP) in the sPLA(2)-IIa-coding gene PLA2G2A with serum sPLA(2)-IIa and secondary fatal or non-fatal CVD events were examined by multiple regression. Hazard ratios (HR) were compared with those expected if the association between sPLA(2)-IIa and CVD were causal. The strongest determinants of sPLA(2)-IIa (rs4744 and rs10732279) were associated with an increase of serum concentrations by 81% and 73% per variant allele. HRs (95% confidence intervals) estimating the associations of the SNPs with secondary CVD events were increased, but not statistically significant (1.16 [0.89-1.51] and 1.18 [0.91-1.52] per variant allele, respectively). However, these estimates were very similar to those expected when assuming causality (1.18 and 1.17), based on an association of natural log-transformed sPLA(2)-IIa concentration with secondary events with HR = 1.33 per unit. Conclusion: The present findings regarding genetic polymorphisms, determination of serum sPLA(2)-IIa, and prognosis in CVD patients are consistent with a genuine causal relationship and thus might point to a valid drug target for prevention of secondary CVD events.	[Breitling, Lutz P.; Rothenbacher, Dietrich; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res C070, Heidelberg, Germany; [Koenig, Wolfgang] Univ Ulm, Dept Internal Med Cardiol 2, Med Ctr, Ulm, Germany; [Fischer, Marcus; Hengstenberg, Christian] Univ Regensburg, Klin & Poliklin Innere Med 2, Regensburg, Germany; [Mallat, Ziad] Addenbrookes Hosp, Div Cardiovasc Med, Cambridge, England; [Rothenbacher, Dietrich] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; University of Regensburg; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Ulm University	Breitling, LP (corresponding author), German Canc Res Ctr, Div Clin Epidemiol & Aging Res C070, Heidelberg, Germany.	l.breitling@fkfz-heidelberg.de	Brenner, Hermann/B-4627-2017; Brenner, Hermann/ABE-6383-2020; Mallat, Ziad/D-4041-2012; Hengstenberg, Christian/U-5485-2019	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Mallat, Ziad/0000-0003-0443-7878; Koenig, Wolfgang/0000-0002-2064-9603	German Federal Ministry of Education and Research [01GD9820/0]; Pitzer Foundation (Bad Nauheim, Germany); German Research Foundation [Br1704/11-1]; German National Genome Research Network [NGFN-2 01GS0417, 01GS0832, 01GS0834]; University Hospital of Regensburg, Germany; British Heart Foundation [RG/10/001/27643] Funding Source: researchfish	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Pitzer Foundation (Bad Nauheim, Germany); German Research Foundation(German Research Foundation (DFG)); German National Genome Research Network; University Hospital of Regensburg, Germany; British Heart Foundation(British Heart Foundation)	The study was supported in parts by the German Federal Ministry of Education and Research (#01GD9820/0), the Pitzer Foundation (Bad Nauheim, Germany), and the German Research Foundation priority programme SPP1226 (#Br1704/11-1). Part of this work was financed by the German National Genome Research Network (NGFN-2 01GS0417 and NGFNplus Atherogenomics 01GS0832, as well as 01GS0834), and by the University Hospital of Regensburg, Germany. Reagents for sPLA2 mass measurements were kindly provided by Anthera Co., United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boekholdt SM, 2005, ARTERIOSCL THROM VAS, V25, P839, DOI 10.1161/01.ATV.0000157933.19424.b7; Brunner EJ, 2008, PLOS MED, V5, P1278, DOI 10.1371/journal.pmed.0050155; Casas JP, 2005, LANCET, V365, P224, DOI 10.1016/S0140-6736(05)70152-5; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Jonsson-Rylander AC, 2008, CURR ATHEROSCLER REP, V10, P252, DOI 10.1007/s11883-008-0039-6; Koenig W, 2009, EUR HEART J, V30, P2742, DOI 10.1093/eurheartj/ehp302; Koenig WG, 2009, CARDIOVASC DRUG THER, V23, P85, DOI 10.1007/s10557-008-6135-6; Kugiyama K, 1999, CIRCULATION, V100, P1280, DOI 10.1161/01.CIR.100.12.1280; Lee M, 2010, STROKE, V41, P1205, DOI 10.1161/STROKEAHA.109.573410; Mallat Z, 2005, J AM COLL CARDIOL, V46, P1249, DOI 10.1016/j.jacc.2005.06.056; Mallat Z, 2007, ARTERIOSCL THROM VAS, V27, P1177, DOI 10.1161/ATVBAHA.107.139352; Mallat Z, 2010, CIRCULATION, V122, P2183, DOI 10.1161/CIRCULATIONAHA.110.936393; R Foundation of Statistical Computing, 2007, R V2 6 1; Rosenson Robert S, 2009, Curr Cardiol Rep, V11, P445; Rosenson RS, 2009, CARDIOVASC DRUG THER, V23, P93, DOI 10.1007/s10557-008-6148-1; Rothenbacher D, 2006, ARCH INTERN MED, V166, P2455, DOI 10.1001/archinte.166.22.2455; SAS Institute, 2008, STAT ANAL SOFTW REL; Schunkert H, 2008, NEW ENGL J MED, V359, P1953, DOI 10.1056/NEJMe0807235; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tietge UJF, 2005, J LIPID RES, V46, P1604, DOI 10.1194/jlr.M400469-JLR200; Wootton PTE, 2006, HUM MOL GENET, V15, P355, DOI 10.1093/hmg/ddi453; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	28	15	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22318	10.1371/journal.pone.0022318	http://dx.doi.org/10.1371/journal.pone.0022318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799821	Green Published, Green Submitted, gold			2022-12-25	WOS:000293097300031
J	Feng, HC; Kwun, HJ; Liu, X; Gjoerup, O; Stolz, DB; Chang, Y; Moore, PS				Feng, Huichen; Kwun, Hyun Jin; Liu, Xi; Gjoerup, Ole; Stolz, Donna B.; Chang, Yuan; Moore, Patrick S.			Cellular and Viral Factors Regulating Merkel Cell Polyomavirus Replication	PLOS ONE			English	Article							DNA-REPLICATION; KAPOSIS-SARCOMA; T-ANTIGENS; MIDDLE-T; CARCINOMA; VIRUS; EXPRESSION; GENE; MCV; RESTRICTION	Merkel cell polyomavirus (MCV), a previously unrecognized component of the human viral skin flora, was discovered as a mutated and clonally-integrated virus inserted into Merkel cell carcinoma (MCC) genomes. We reconstructed a replicating MCV clone (MCV-HF), and then mutated viral sites required for replication or interaction with cellular proteins to examine replication efficiency and viral gene expression. Three days after MCV-HF transfection into 293 cells, although replication is not robust, encapsidated viral DNA and protein can be readily isolated by density gradient centrifugation and typical similar to 40 nm diameter polyomavirus virions are identified by electron microscopy. The virus has an orderly gene expression cascade during replication in which large T (LT) and 57kT proteins are first expressed by day 2, followed by expression of small T (sT) and VP1 proteins. VP1 and sT proteins are not detected, and spliced 57kT is markedly diminished, in the replication-defective virus suggesting that early gene splicing and late gene transcription may be dependent on viral DNA replication. MCV replication and encapsidation is increased by overexpression of MCV sT, consistent with sT being a limiting factor during virus replication. Mutation of the MCV LT vacuolar sorting protein hVam6p (Vps39) binding site also enhances MCV replication while exogenous hVam6p overexpression reduces MCV virion production by >90%. Although MCV-HF generates encapsidated wild-type MCV virions, we did not find conditions for persistent transmission to recipient cell lines suggesting that MCV has a highly restricted tropism. These studies identify and highlight the role of polyomavirus DNA replication in viral gene expression and show that viral sT and cellular hVam6p are important factors regulating MCV replication. MCV-HF is a molecular clone that can be readily manipulated to investigate factors affecting MCV replication.	[Feng, Huichen; Kwun, Hyun Jin; Liu, Xi; Gjoerup, Ole; Chang, Yuan; Moore, Patrick S.] Univ Pittsburgh, Canc Virol Program, Inst Canc, Pittsburgh, PA 15260 USA; [Stolz, Donna B.] Univ Pittsburgh, Dept Cell Biol & Physiol, Ctr Biol Imaging, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Feng, HC (corresponding author), Univ Pittsburgh, Canc Virol Program, Inst Canc, Pittsburgh, PA 15260 USA.	yc70@pitt.edu; psm9@pitt.edu	Feng, Huichen/F-5502-2011; Kwun, Hyun Jin/AAH-2706-2020; Kwun, Hyun Jin/F-5511-2011; Chang, Yuan/F-4146-2011; Kwun, Hyun jin/AAJ-3365-2020; Moore, Patrick S./F-3960-2011; Moore, Patrick/GVR-8294-2022	Feng, Huichen/0000-0003-3069-8174; Kwun, Hyun Jin/0000-0002-8926-746X; Chang, Yuan/0000-0003-1125-4041; Kwun, Hyun jin/0000-0002-8926-746X; Moore, Patrick S./0000-0002-8132-858X; 	National Institutes of Health (NIH) [CA136363, CA120726, AI078926]; Al Copeland Foundation; University of Pittsburgh; NATIONAL CANCER INSTITUTE [R01CA136363, R33CA120726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078926] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Al Copeland Foundation; University of Pittsburgh(University of Pittsburgh); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) CA136363, CA120726, the Al Copeland Foundation, and University of Pittsburgh EXPLORER grants to Patrick S. Moore and Yuan Chang, who are American Cancer Society Research Professors; and by NIH AI078926 to Ole Gjoerup. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caplan S, 2001, J CELL BIOL, V154, P109, DOI 10.1083/jcb.200102142; Carter JJ, 2009, JNCI-J NATL CANCER I, V101, P1510, DOI 10.1093/jnci/djp332; Chen L, 2006, J VIROL, V80, P7295, DOI 10.1128/JVI.00679-06; Chen TT, 2011, J CLIN VIROL, V50, P125, DOI 10.1016/j.jcv.2010.10.015; CRAWFORD LV, 1962, VIROLOGY, V18, P170, DOI 10.1016/0042-6822(62)90002-8; Fanning E, 2009, VIROLOGY, V384, P352, DOI 10.1016/j.virol.2008.11.038; Felici A, 2003, EMBO J, V22, P4465, DOI 10.1093/emboj/cdg428; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Feng HC, 2007, J VIROL, V81, P11332, DOI 10.1128/JVI.00875-07; Goh S, 2009, EMERG INFECT DIS, V15, P489, DOI 10.3201/eid1503.081206; Guerin JL, 2000, J VIROL, V74, P4523, DOI 10.1128/JVI.74.10.4523-4529.2000; Guerin JL, 2003, DIS POULTRY; Hausen HZ, 2008, P NATL ACAD SCI USA, V105, P16063, DOI 10.1073/pnas.0808973105; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kassem A, 2008, CANCER RES, V68, P5009, DOI 10.1158/0008-5472.CAN-08-0949; Katano H, 2009, J MED VIROL, V81, P1951, DOI 10.1002/jmv.21608; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Kwun HJ, 2009, J VIROL, V83, P12118, DOI 10.1128/JVI.01336-09; Li L, 2009, MOL CELL, V35, P543, DOI 10.1016/j.molcel.2009.08.010; Liu X, 2011, J BIOL CHEM; LIU Z, 1993, P NATL ACAD SCI USA, V90, P8494, DOI 10.1073/pnas.90.18.8494; Loyo M, 2010, INT J CANCER, V126, P2991, DOI 10.1002/ijc.24737; Moore PS, 2010, NAT REV CANCER, V10, P878, DOI 10.1038/nrc2961; OSBORN JE, 1974, J VIROL, V13, P614, DOI 10.1128/JVI.13.3.614-622.1974; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Pastrana DV, 2010, VIROLOGY, V405, P20, DOI 10.1016/j.virol.2010.06.022; Pastrana DV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000578; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Prins C, 2001, J NEUROVIROL, V7, P250; Sarid R, 1998, J VIROL, V72, P1005, DOI 10.1128/JVI.72.2.1005-1012.1998; Sastre-Garau X, 2009, J PATHOL, V218, P48, DOI 10.1002/path.2532; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Shuda M, J CLIN INVE IN PRESS; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Shuda M, 2009, INT J CANCER, V125, P1243, DOI 10.1002/ijc.24510; Tolstov YL, 2009, INT J CANCER, V125, P1250, DOI 10.1002/ijc.24509; Tolstov YL, EMERG INFEC IN PRESS; Touze A, 2010, J CLIN MICROBIOL, V48, P1767, DOI 10.1128/JCM.01691-09; YAMAGUCHI M, 1989, J BIOL CHEM, V264, P16887	40	67	67	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22468	10.1371/journal.pone.0022468	http://dx.doi.org/10.1371/journal.pone.0022468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799863	gold, Green Published, Green Accepted			2022-12-25	WOS:000293097300050
J	Huang, XF; Guo, YZ; Bao, CD; Shen, N				Huang, Xinfang; Guo, Yanzhi; Bao, Chunde; Shen, Nan			Multidimensional Single Cell Based STAT Phosphorylation Profiling Identifies a Novel Biosignature for Evaluation of Systemic Lupus Erythematosus Activity	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; CYCLIN D1 PROMOTER; FLOW-CYTOMETRY; RHEUMATOID-ARTHRITIS; SIGNALING PATHWAY; REVISED CRITERIA; DISEASE-ACTIVITY; CANCER-CELLS; ACTIVATION; BROMOCRIPTINE	Introduction: Dysregulated cytokine action on immune cells plays an important role in the initiation and progress of systemic lupus erythematosus (SLE), a complex autoimmune disease. Comprehensively quantifying basal STATs phosphorylation and their signaling response to cytokines should help us to better understand the etiology of SLE. Methods: Phospho-specific flow cytometry was used to measure the basal STAT signaling activation in three immune cell types of peripheral-blood mononuclear cells from 20 lupus patients, 9 rheumatoid arthritis (RA) patients and 13 healthy donors (HDs). A panel of 27 cytokines, including inflammatory cytokines, was measured with Bio-Plex (TM) Human Cytokine Assays. Serum Prolactin levels were measured with an immunoradiometric assay. STAT signaling responses to inflammatory cytokines (interferon alpha [IFN alpha], IFN gamma, interleukin 2 [IL2], IL6, and IL10) were also monitored. Results: We observed the basal activation of STAT3 in SLE T cells and monocytes, and the basal activation of STAT5 in SLE T cells and B cells. The SLE samples clustered into two main groups, which were associated with the SLE Disease Activity Index 2000, their erythrocyte sedimentation rate, and their hydroxychloroquine use. The phosphorylation of STAT5 in B cells was associated with cytokines IL2, granulocyte colony-stimulating factor (G-CSF), and IFN gamma, whereas serum prolactin affected STAT5 activation in T cells. The responses of STAT1, STAT3, and STAT5 to IFN alpha were greatly reduced in SLE T cells, B cells, and monocytes, except for the STAT1 response to IFN alpha in monocytes. The response of STAT3 to IL6 was reduced in SLE T cells. Conclusions: The basal activation of STATs signaling and reduced response to cytokines may be helpful us to identify the activity and severity of SLE.	[Huang, Xinfang; Guo, Yanzhi; Bao, Chunde; Shen, Nan] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Huang, XF (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai 200030, Peoples R China.	baochunde_1678@yahoo.com.cn; nanshensibs@gmail.com	Shen, Nan/AGK-6807-2022	Shen, Nan/0000-0002-5875-4417	National Basic Research Program of China (973 Program) [2007CB947900]; National High Technology Research and Development Program of China (863 Program) [2007AA02Z123]; National Natural Science Foundation of China [30801026]; Shanghai Commission of Science and Technology [06JC14050]; Shanghai Jiao Tong University School of Medicine [BXJ201020]; Program of Shanghai Subject Chief Scientist [07XD14021]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); Shanghai Jiao Tong University School of Medicine; Program of Shanghai Subject Chief Scientist	This work was supported in part by the National Basic Research Program of China (973 Program) (No. 2007CB947900), the National High Technology Research and Development Program of China (863 Program) (No. 2007AA02Z123), the National Natural Science Foundation of China (No. 30801026), the Key Basic Program of the Shanghai Commission of Science and Technology (No. 06JC14050), the Doctoral Innovation Fund of Shanghai Jiao Tong University School of Medicine (BXJ201020), and the Program of Shanghai Subject Chief Scientist (No. 07XD14021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Nemegyei J, 1998, LUPUS, V7, P414, DOI 10.1191/096120398678920334; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Brockman JL, 2005, MOL CELL ENDOCRINOL, V239, P45, DOI 10.1016/j.mce.2005.04.006; Brockman JL, 2002, MOL ENDOCRINOL, V16, P774, DOI 10.1210/me.16.4.774; Capper ER, 2004, CLIN EXP IMMUNOL, V138, P348, DOI 10.1111/j.1365-2249.2004.02607.x; Chang RL, 2010, CURR DRUG TARGETS, V11, P994; CHRISTIAN W, 2002, CLIN INVESTIGATOR, V109, P1133; Crow Mary K, 2005, Curr Rheumatol Rep, V7, P463, DOI 10.1007/s11926-005-0053-4; Dong J, 2007, LUPUS, V16, P101, DOI 10.1177/0961203306075383; Fleenor D, 2006, HORM RES, V66, P101, DOI 10.1159/000093667; Galligan CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006703; Gladman DD, 2002, J RHEUMATOL, V29, P288; Gutierrez MA, 1996, INT ARCH ALLERGY IMM, V109, P229, DOI 10.1159/000237242; Hale MB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006756; Harada T, 2007, AUTOIMMUNITY, V40, P1, DOI 10.1080/08916930601095148; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Jacobi AM, 2001, LUPUS, V10, P554, DOI 10.1191/096120301701549688; Karonitsch T, 2009, ARTHRITIS RHEUM, V60, P1463, DOI 10.1002/art.24449; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; Krutzik PO, 2011, METHODS MOL BIOL, V699, P179, DOI 10.1007/978-1-61737-950-5_9; Lee AW, 2008, J VIROL, V82, P3702, DOI 10.1128/JVI.01582-07; Lewis RS, 2008, EXPERT REV MOL DIAGN, V8, P73, DOI 10.1586/14737159.8.1.73; Lin CC, 2010, CYTOM PART A, V77A, P1008, DOI 10.1002/cyto.a.20965; LINKERISRAELI M, 1991, J IMMUNOL, V147, P117; Martinez-Lostao L, 2007, LUPUS, V16, P483, DOI 10.1177/0961203307079618; Nevalainen MT, 2004, J CLIN ONCOL, V22, P2053, DOI 10.1200/JCO.2004.11.046; Perez OD, 2006, IMMUNOL REV, V210, P208, DOI 10.1111/j.0105-2896.2006.00364.x; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Seo J, 2002, COMPUTER, V35, P80; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Walker SE, 2000, LUPUS, V9, P527, DOI 10.1177/096120330000900709; Walker SE, 2001, LUPUS, V10, P762, DOI 10.1191/096120301717165010	32	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e21671	10.1371/journal.pone.0021671	http://dx.doi.org/10.1371/journal.pone.0021671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799742	Green Published, Green Submitted, gold			2022-12-25	WOS:000293097300005
J	Ma, YJ; Yang, MN; Fan, Y; Wu, J; Ma, Y; Xu, JN				Ma, Yajun; Yang, Manni; Fan, Yong; Wu, Jing; Ma, Ying; Xu, Jiannong			Population Structure of the Malaria Vector Anopheles sinensis (Diptera: Culicidae) in China: Two Gene Pools Inferred by Microsatellites	PLOS ONE			English	Article							REPUBLIC-OF-KOREA; ALLELE FREQUENCY; PLASMODIUM-VIVAX; HYRCANUS GROUP; SOUTH-AMERICA; WEST-AFRICA; GAMBIAE; FLOW; DIFFERENTIATION; FUNESTUS	Background: Anopheles sinensis is a competent malaria vector in China. An understanding of vector population structure is important to the vector-based malaria control programs. However, there is no adequate data of A. sinensis population genetics available yet. Methodology/Principal Findings: This study used 5 microsatellite loci to estimate population genetic diversity, genetic differentiation and demographic history of A. sinensis from 14 representative localities in China. All 5 microsatellite loci were highly polymorphic across populations, with high allelic richness and heterozygosity. Hardy-Weinberg disequilibrium was found in 12 populations associated with heterozygote deficits, which was likely caused by the presence of null allele and the Wahlund effect. Bayesian clustering analysis revealed two gene pools, grouping samples into two population clusters; one includes six and the other includes eight populations. Out of 14 samples, six samples were mixed with individuals from both gene pools, indicating the coexistence of two genetic units in the areas sampled. The overall differentiation between two genetic pools was moderate (F-ST = 0.156). Pairwise differentiation between populations were lower within clusters (F-ST = 0.008-0.028 in cluster I and F-ST = 0.004-0.048 in cluster II) than between clusters (F-ST = 0.120-0.201). A reduced gene flow (Nm = 1-1.7) was detected between clusters. No evidence of isolation by distance was detected among populations neither within nor between the two clusters. There are differences in effective population size (Ne = 14.3-infinite) across sampled populations. Conclusions/Significance: Two genetic pools with moderate genetic differentiation were identified in the A. sinensis populations in China. The population divergence was not correlated with geographic distance or barrier in the range. Variable effective population size and other demographic effects of historical population perturbations could be the factors affecting the population differentiation. The structured populations may limit the migration of genes under pressures/selections, such as insecticides and immune genes against malaria.	[Ma, Yajun; Yang, Manni; Fan, Yong; Wu, Jing; Ma, Ying] Second Mil Med Univ, Dept Pathogen Biol, Shanghai, Peoples R China; [Xu, Jiannong] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA	Naval Medical University; New Mexico State University	Ma, YJ (corresponding author), Second Mil Med Univ, Dept Pathogen Biol, Shanghai, Peoples R China.	yajunm@yahoo.com.cn; jxu@nmsu.edu	Xu, Jiannong/N-1583-2019	Xu, Jiannong/0000-0001-7332-4370	National Natural Science Foundation of China [U0932604]; National Basic Research Program of China (973 Program) [2007CB513100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China-Yunnan Joint Fund (U0932604) to Yajun Ma and Jiannong Xu, and National Basic Research Program of China (973 Program 2007CB513100) to Yajun Ma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonio-Nkondjio C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-120; BAIMAI V, 1993, J AM MOSQUITO CONTR, V9, P59; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Carnahan J, 2002, J HERED, V93, P249, DOI 10.1093/jhered/93.4.249; CHOW C. Y., 1970, Southeast Asian Journal of Tropical Medicine and Public Health, V1, P40; Christophides GK, 2005, CELL MICROBIOL, V7, P325, DOI 10.1111/j.1462-5822.2005.00495.x; Coleman RE, 2002, J MED ENTOMOL, V39, P244, DOI 10.1603/0022-2585-39.1.244; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Cornuet JM, 1996, GENETICS, V144, P2001; Donnelly MJ, 2002, TRENDS PARASITOL, V18, P75, DOI 10.1016/S1471-4922(01)02198-5; Donnelly MJ, 2001, MOL BIOL EVOL, V18, P1353, DOI 10.1093/oxfordjournals.molbev.a003919; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gaggiotti OE, 1999, MOL ECOL, V8, P1513, DOI 10.1046/j.1365-294x.1999.00730.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gutierrez LA, 2010, AM J TROP MED HYG, V83, P38, DOI 10.4269/ajtmh.2010.09-0381; Gutierrez LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-259; HARRISON B A, 1975, Contributions of the American Entomological Institute, V12, P1; Jung J, 2006, MOL ECOL NOTES, V6, P1272, DOI 10.1111/j.1471-8286.2006.01512.x; Jung J, 2007, AM J TROP MED HYG, V77, P310, DOI 10.4269/ajtmh.2007.77.310; Lee WJ, 2007, J MED ENTOMOL, V44, P1086, DOI 10.1603/0022-2585(2007)44[1086:AKAPAA]2.0.CO;2; Lehmann T, 1999, J HERED, V90, P613, DOI 10.1093/jhered/90.6.613; Lehmann T, 1997, MOL ECOL, V6, P243, DOI 10.1046/j.1365-294X.1997.00177.x; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; LU BL, 1997, COMMUN FAUNA SINICA, V9, P12; Ma Y, 1990, J GUIYANG MED COLL, V15, P45; Ma Ya-jun, 2000, Chinese Journal of Parasitology and Parasitic Diseases, V18, P325; Ma Ya-jun, 2001, Acta Entomologica Sinica, V44, P33; Ma YJ, 2008, MOL ECOL RESOUR, V8, P1059, DOI 10.1111/j.1755-0998.2008.02154.x; MANTEL N, 1967, CANCER RES, V27, P209; Michel AP, 2006, GENETICS, V173, P1389, DOI 10.1534/genetics.106.059667; Michel AP, 2005, MOL ECOL, V14, P4235, DOI 10.1111/j.1365-294X.2005.02754.x; Michel AP, 2005, INSECT MOL BIOL, V14, P375, DOI 10.1111/j.1365-2583.2005.00568.x; Min GS, 2002, MOL CELLS, V14, P198; Mirabello Lisa, 2008, BMC Ecology, V8, P3, DOI 10.1186/1472-6785-8-3; Molina-Cruz A, 2004, AM J TROP MED HYG, V71, P350, DOI 10.4269/ajtmh.2004.71.350; Moreno M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-137; Ndo C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-161; Nei M., 1987, MOL EVOLUTIONARY GEN; Peel D., 2004, NEESTIMATOR SOFTWARE; Pritchard JK, 2000, GENETICS, V155, P945; Qian Huilin, 1994, Chinese Journal of Parasitology & Parasitic Diseases, V12, P265; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ree HI, 2001, J AM MOSQUITO CONTR, V17, P67; Rongsriyam Yupha, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P159; Rueda LM, 2005, J AM MOSQUITO CONTR, V21, P458, DOI 10.2987/8756-971X(2006)21[458:HADOAS]2.0.CO;2; Scarpassa VM, 2007, MEM I OSWALDO CRUZ, V102, P319, DOI 10.1590/S0074-02762007005000045; SCHNEIDER S., 2000, ARLEQUIN VERSION 2 0; SLATKIN M, 1995, GENETICS, V139, P457; Somboon P., 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P766; Sun Y, 1993, CHINESE BULL ENTOMOL, V30, P56; TANAKA K, 1979, Contributions of the American Entomological Institute, V16, P1; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Xu S. B., 1991, Journal of Medical Colleges of PLA, V6, P286; [周水森 ZHOU Shui-sen], 2009, [中国寄生虫学与寄生虫病杂志, Chinese Journal of Parasitology & Parasitic Diseases], V27, P455	54	22	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22219	10.1371/journal.pone.0022219	http://dx.doi.org/10.1371/journal.pone.0022219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799796	gold, Green Submitted, Green Published			2022-12-25	WOS:000293097300022
J	Roeber, U; Veser, S; Schroger, E; O'Shea, RP				Roeber, Urte; Veser, Sandra; Schroeger, Erich; O'Shea, Robert P.			On the Role of Attention in Binocular Rivalry: Electrophysiological Evidence	PLOS ONE			English	Article							BISTABLE PERCEPTION; VISUAL AWARENESS; HUMAN BRAIN; POTENTIALS; SELECTION; COLOR	During binocular rivalry visual consciousness fluctuates between two dissimilar monocular images. We investigated the role of attention in this phenomenon by comparing event-related potentials (ERPs) when binocular-rivalry stimuli were attended with when they were unattended. Stimuli were dichoptic, orthogonal gratings that yielded binocular rivalry and dioptic, identically oriented gratings that yielded binocular fusion. Events were all possible orthogonal changes in orientation of one or both gratings. We had two attention conditions: In the attend-to-grating condition, participants had to report changes in perceived orientation, focussing their attention on the gratings. In the attend-to-fixation condition participants had to report changes in a central fixation target, taking attention away from the gratings. We found, surprisingly, that attending to rival gratings yielded a smaller ERP component (the N1, from 160-210 ms) than attending to the fixation target. To explain this paradoxical effect of attention, we propose that rivalry occurs in the attend-to-fixation condition (we found an ERP signature of rivalry in the form of a sustained negativity from 210-300 ms) but that the mechanism processing the stimulus changes is more adapted in the attend-to-grating condition than in the attend-to-fixation condition. This is consistent with the theory that adaptation gives rise to changes of visual consciousness during binocular rivalry.	[Roeber, Urte; Veser, Sandra; Schroeger, Erich; O'Shea, Robert P.] Univ Leipzig, Inst Psychol, Leipzig, Germany; [Roeber, Urte] So Cross Univ, Discipline Psychol, Sch Hlth & Human Sci, Coffs Harbour, NSW, Australia; [Roeber, Urte] Univ Sydney, Sydney, NSW 2006, Australia; [Veser, Sandra] Univ Tubingen, Inst Med Psychol, Tubingen, Germany; [O'Shea, Robert P.] Univ Otago, Dept Psychol, Dunedin, New Zealand; [O'Shea, Robert P.] So Cross Univ, Discipline Psychol & Cognit Neurosci Res Cluster, Sch Hlth & Human Sci, Coffs Harbour, NSW, Australia	Leipzig University; Southern Cross University; University of Sydney; Eberhard Karls University of Tubingen; University of Otago; Southern Cross University	Roeber, U (corresponding author), Univ Leipzig, Inst Psychol, Leipzig, Germany.	urte@uni-leipzig.de	Schröger, Erich/C-3079-2009; O'Shea, Robert P./C-5723-2008	Schröger, Erich/0000-0002-8321-6629; O'Shea, Robert P./0000-0003-3132-7199; Roeber, Urte/0000-0002-6631-5828	German Research Foundation (DFG) [RO 3061/1-2]	German Research Foundation (DFG)(German Research Foundation (DFG))	This research was supported by the German Research Foundation (DFG grant no. RO 3061/1-2 awarded to Urte Roeber, DFG website: http://www.dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2010, CURR BIOL, V20, P1362, DOI 10.1016/j.cub.2010.06.015; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; CIGANEK L, 1961, ELECTROEN CLIN NEURO, V13, P165, DOI 10.1016/0013-4694(61)90132-8; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DONCHIN E, 1967, ELECTROEN CLIN NEURO, V22, P537, DOI 10.1016/0013-4694(67)90061-2; Du Tour EF., 1760, MIM MATH PHYS ACAD R, V3, P514; Eimer M, 1997, BIOL PSYCHOL, V44, P143, DOI 10.1016/S0301-0511(96)05217-9; GARCIAAUSTT E, 1964, ELECTROEN CLIN NEURO, V17, P136, DOI 10.1016/0013-4694(64)90145-2; Gruber T, 2005, CEREB CORTEX, V15, P109, DOI 10.1093/cercor/bhh113; HARTER MR, 1972, ELECTROEN CLIN NEURO, V32, P605; He X, 2008, BRAIN RES, V1245, P116, DOI 10.1016/j.brainres.2008.09.092; Helmholtz H., 1925, TREATISE PHYSL OPTIC; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Kaernbach C, 1999, NEUROREPORT, V10, P713, DOI 10.1097/00001756-199903170-00010; KENEMANS JL, 1989, BIOL PSYCHOL, V28, P199, DOI 10.1016/0301-0511(89)90001-X; Khoe W, 2008, J VISION, V8, DOI 10.1167/8.3.18; Kornmeier J, 2005, VISION RES, V45, P955, DOI 10.1016/j.visres.2004.10.006; Kornmeier J, 2006, INT J PSYCHOPHYSIOL, V62, P345, DOI 10.1016/j.ijpsycho.2006.04.007; Lack L.C., 1978, SELECTIVE ATTENTION; Lee SH, 2007, NAT NEUROSCI, V10, P1048, DOI 10.1038/nn1939; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; Luck S.J., 2005, INTRO EVENT RELATED; MATSUOKA K, 1984, BIOL CYBERN, V49, P201, DOI 10.1007/BF00334466; McDougall W., 1901, BRAIN, V24, P579, DOI DOI 10.1093/BRAIN/24.4.579; Meng M, 2004, J VISION, V4, P539, DOI 10.1167/4.7.2; Mishra J, 2009, VISION RES, V49, P1073, DOI 10.1016/j.visres.2008.02.018; NAATANEN R, 2002, STEVENS HDB EXPT PSY, V4, P601; Noest AJ, 2007, J VISION, V7, DOI 10.1167/7.8.10; OSHEA RP, 1987, VISION RES, V27, P781, DOI 10.1016/0042-6989(87)90075-7; Paffen CLE, 2006, PSYCHOL SCI, V17, P752, DOI 10.1111/j.1467-9280.2006.01777.x; Pastukhov A, 2007, J VISION, V7, DOI 10.1167/7.10.5; PERRIN F, 1990, ELECTROEN CLIN NEURO, V76, P565; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Pitts MA, 2007, J VISION, V7, DOI 10.1167/7.1.6; Pitts MA, 2010, J VISION, V10, DOI 10.1167/10.14.25; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Regan D., 1989, HUMAN BRAIN ELECTROP; Roeber U, 2004, NEUROSCI LETT, V371, P51, DOI 10.1016/j.neulet.2004.08.038; Roeber U, 2008, J VISION, V8, DOI 10.1167/8.3.21; RUGG MD, 1987, NEUROPSYCHOLOGIA, V25, P85, DOI 10.1016/0028-3932(87)90045-5; Sherrington Charles Scott, 1911, INTEGRATIVE ACTION N; Stoner GR, 2005, PROG BRAIN RES, V149, P227, DOI 10.1016/S0079-6123(05)49016-0; Valle-Inclan F, 1999, NEUROREPORT, V10, P21, DOI 10.1097/00001756-199901180-00004; Veser S, 2008, VISION RES, V48, P2359, DOI 10.1016/j.visres.2008.07.024; Wade N J, 1998, Laterality, V3, P97, DOI 10.1080/135765098397313; WASTELL DG, 1980, PHYSIOL BEHAV, V25, P93, DOI 10.1016/0031-9384(80)90187-0; Zhang P, 2009, J VISION, V9, P291	48	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22612	10.1371/journal.pone.0022612	http://dx.doi.org/10.1371/journal.pone.0022612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799918	gold, Green Published			2022-12-25	WOS:000293097300073
J	Shende, VR; Goldrick, MM; Ramani, S; Earnest, DJ				Shende, Vikram R.; Goldrick, Marianna M.; Ramani, Suchitra; Earnest, David J.			Expression and Rhythmic Modulation of Circulating MicroRNAs Targeting the Clock Gene Bmal1 in Mice	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; PERIOD HOMOLOGS; DENDRITIC CELLS; SCN2.2 CELLS; PLASMA; TRANSCRIPTOME; RIBONUCLEASE; MECHANISMS; PACEMAKER; MIRBASE	MicroRNAs (miRNAs) interact with 3' untranslated region (UTR) elements of target genes to regulate mRNA stability or translation and thus play a role in regulating many different biological processes, including circadian rhythms. However, specific miRNAs mediating the regulation of essential clock genes remain largely unknown. Because vesicles containing membrane-bound miRNAs are present in the circulatory system, we examined miRNAs predicted to target the clock gene, Bmal1, for evidence of rhythmic fluctuations in circulating levels and modulatory effects on the 3' UTR activity of Bmal1. A number of miRNAs with Bmal1 as a predicted target were expressed in the serum of mice exposed to LD 12:12 and of these miRNAs, miR-152 and miR-494 but not miR-142-3p were marked by diurnal oscillations with bimodal peaks in expression occurring near the middle of the day and 8 or 12 hr later during the night. Co-transfection of pre-miR over-expression constructs for miR-494 and miR-142-3p in HEK293 cells had significant effects in repressing luciferase-reported Bmal1 3' UTR activity by as much as 60%, suggesting that these miRNAs may function as post-transcriptional modulators of Bmal1. In conjunction with previous studies implicating miRNAs as extracellular regulatory signals, our results suggest that circulating miRNAs may play a role in the regulation of the molecular clockworks in peripheral circadian oscillators.	[Shende, Vikram R.; Earnest, David J.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Shende, Vikram R.; Earnest, David J.] Texas A&M Univ, Ctr Biol Clocks Res, College Stn, TX 77843 USA; [Earnest, David J.] Texas A&M Univ, Hlth Sci Ctr, Dept Neurosci & Expt Therapeut, Coll Med, College Stn, TX 77843 USA; [Goldrick, Marianna M.; Ramani, Suchitra] BIOO Sci, Austin, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Shende, VR (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	dearnest@tamu.edu	Shende, Vikram/M-2816-2017	Earnest, David/0000-0003-4433-6481	National Institutes of Health [PO1 NS39546]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Program Project Grant PO1 NS39546 (to D.J.E.) and employees at BIOO Scientific Corp. The primary funder (NIH) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Despite their role as an employer of several co-authors, BIOO Scientific Corp. was only involved in data collection/analysis and review of the final manuscript, but played no role in study design, decision to publish, or preparation of the manuscript.	Allen GC, 2004, NEUROSCIENCE, V127, P989, DOI 10.1016/j.neuroscience.2004.06.003; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartram AK, 2009, BIOTECHNIQUES, V47, P1016, DOI 10.2144/000113276; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; DEBOER SF, 1987, PHYSIOL BEHAV, V40, P323, DOI 10.1016/0031-9384(87)90054-0; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Farnell YZ, 2008, ALCOHOL CLIN EXP RES, V32, P544, DOI 10.1111/j.1530-0277.2007.00598.x; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo YF, 2003, AM HEART J, V145, P779, DOI 10.1016/S0002-8703(02)94797-6; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kadener S, 2009, GENE DEV, V23, P2179, DOI 10.1101/gad.1819509; Kim SM, 2009, FASEB J, V23, P3226, DOI 10.1096/fj.09-132019; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li P, 1999, AM J PHYSIOL-REG I, V276, pR500, DOI 10.1152/ajpregu.1999.276.2.R500; LUCAS LA, 1980, J ENDOCRINOL, V87, P37, DOI 10.1677/joe.0.0870037; Menger GJ, 2005, PHYSIOL GENOMICS, V21, P370, DOI 10.1152/physiolgenomics.00224.2004; Menger GJ, 2007, PHYSIOL GENOMICS, V29, P280, DOI 10.1152/physiolgenomics.00199.2006; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nolte-'t Hoen ENM, 2009, BLOOD, V113, P1977, DOI 10.1182/blood-2008-08-174094; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Perera RF, 2007, BIODRUGS, V21, P97, DOI 10.2165/00063030-200721020-00004; REDDI KK, 1976, P NATL ACAD SCI USA, V73, P2308, DOI 10.1073/pnas.73.7.2308; Segura E, 2007, J IMMUNOL, V179, P1489, DOI 10.4049/jimmunol.179.3.1489; Shaw E, 2009, CURR ATHEROSCLER REP, V11, P289, DOI 10.1007/s11883-009-0044-4; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shi LH, 2009, J BIOL CHEM, V284, P25791, DOI 10.1074/jbc.M109.033993; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; TASAKA Y, 1980, ENDOCRINOL JAPON, V27, P495; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; WIRZJUSTICE A, 1987, PROG NEUROBIOL, V29, P219, DOI 10.1016/0301-0082(87)90022-0; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yamamoto T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-18; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	55	84	91	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22586	10.1371/journal.pone.0022586	http://dx.doi.org/10.1371/journal.pone.0022586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799909	Green Published, Green Submitted, gold			2022-12-25	WOS:000293097300069
J	Sousa-Ferreira, L; Garrido, M; Nascimento-Ferreira, I; Nobrega, C; Santos-Carvalho, A; Alvaro, AR; Rosmaninho-Salgado, J; Kaster, M; Kugler, S; de Almeida, LP; Cavadas, C				Sousa-Ferreira, Ligia; Garrido, Manuel; Nascimento-Ferreira, Isabel; Nobrega, Clevio; Santos-Carvalho, Ana; Alvaro, Ana Rita; Rosmaninho-Salgado, Joana; Kaster, Manuella; Kuegler, Sebastian; de Almeida, Luis Pereira; Cavadas, Claudia			Moderate Long-Term Modulation of Neuropeptide Y in Hypothalamic Arcuate Nucleus Induces Energy Balance Alterations in Adult Rats	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; DIET-INDUCED OBESITY; CENTRAL LEPTIN INFUSION; AGOUTI-RELATED PROTEIN; FA/FA ZUCKER RATS; GENE-EXPRESSION; PARAVENTRICULAR NUCLEUS; FOOD-INTAKE; GENETICALLY-OBESE; FEEDING-BEHAVIOR	Neuropeptide Y (NPY) produced by arcuate nucleus (ARC) neurons has a strong orexigenic effect on target neurons. Hypothalamic NPY levels undergo wide-ranging oscillations during the circadian cycle and in response to fasting and peripheral hormones (from 0.25 to 10-fold change). The aim of the present study was to evaluate the impact of a moderate long-term modulation of NPY within the ARC neurons on food consumption, body weight gain and hypothalamic neuropeptides. We achieved a physiological overexpression (3.6-fold increase) and down-regulation (0.5-fold decrease) of NPY in the rat ARC by injection of AAV vectors expressing NPY and synthetic microRNA that target the NPY, respectively. Our work shows that a moderate overexpression of NPY was sufficient to induce diurnal over-feeding, sustained body weight gain and severe obesity in adult rats. Additionally, the circulating levels of leptin were elevated but the immunoreactivity (ir) of ARC neuropeptides was not in accordance (POMC-ir was unchanged and AGRP-ir increased), suggesting a disruption in the ability of ARC neurons to response to peripheral metabolic alterations. Furthermore, a dysfunction in adipocytes phenotype was observed in these obese rats. In addition, moderate down-regulation of NPY did not affect basal feeding or normal body weight gain but the response to food deprivation was compromised since fasting-induced hyperphagia was inhibited and fasting-induced decrease in locomotor activity was absent. These results highlight the importance of the physiological ARC NPY levels oscillations on feeding regulation, fasting response and body weight preservation, and are important for the design of therapeutic interventions for obesity that include the NPY.	[Sousa-Ferreira, Ligia; Garrido, Manuel; Nascimento-Ferreira, Isabel; Nobrega, Clevio; Santos-Carvalho, Ana; Alvaro, Ana Rita; Rosmaninho-Salgado, Joana; Kaster, Manuella; de Almeida, Luis Pereira; Cavadas, Claudia] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Garrido, Manuel; Kuegler, Sebastian] Univ Med Gottingen, Viral Vectors Lab, Dept Neurol, Gottingen, Germany; [Alvaro, Ana Rita] Univ Tras Os Montes & Alto Douro, Dept Biol & Environm, Vila Real, Portugal; [Sousa-Ferreira, Ligia; Nascimento-Ferreira, Isabel; Santos-Carvalho, Ana; de Almeida, Luis Pereira; Cavadas, Claudia] Univ Coimbra, Fac Pharm, Coimbra, Portugal	Universidade de Coimbra; University of Gottingen; University of Tras-os-Montes & Alto Douro; Universidade de Coimbra	Sousa-Ferreira, L (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	ccavadas@ff.uc.pt	de Almeida, Luis Pereira/O-8196-2019; Cavadas, Claudia/K-8271-2014; Kaster, Manuella P/D-5028-2013; Santos-Carvalho, Ana/M-7044-2016; Cavadas, Claudia/AAB-6904-2021; Rosmaninho-salgado, Joana/A-7673-2014; Sousa-Ferreira, Lígia/M-4181-2013; Nobrega, Clévio/M-6047-2013; Alvaro, Ana Rita/A-8168-2013; de Almeida, Luis Pereira/A-4605-2009	de Almeida, Luis Pereira/0000-0001-5831-3307; Cavadas, Claudia/0000-0001-8020-9266; Kaster, Manuella P/0000-0003-0258-6204; Santos-Carvalho, Ana/0000-0003-4718-5666; Cavadas, Claudia/0000-0001-8020-9266; Rosmaninho-salgado, Joana/0000-0002-6781-8515; Sousa-Ferreira, Lígia/0000-0002-7169-9491; Nobrega, Clévio/0000-0002-8312-5292; Alvaro, Ana Rita/0000-0002-2387-374X; de Almeida, Luis Pereira/0000-0001-5831-3307; Garrido, Manuel/0000-0003-0421-0681	Portuguese Foundation for Science and Technology; FEDER; COMPETE [PTDC/SAU-FCF/099082/2008, PTDC/SAU-FCF/70384/2006, PTDC/SAU/NEU/73119/2006, SFRH/BD/30608/2006, SFRH/BD/29479/2006, SFRH/BPD/62945/2009, SFRH/BD/45311/2008, SFRH/BPD/49079/2008, SFRH/BPD/46086/2008, SFRH/BPD/31547/2006]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); FEDER(European Commission); COMPETE	This work was supported by the Portuguese Foundation for Science and Technology, FEDER and COMPETE [PTDC/SAU-FCF/099082/2008; PTDC/SAU-FCF/70384/2006; PTDC/SAU/NEU/73119/2006; SFRH/BD/30608/2006; SFRH/BD/29479/2006; SFRH/BPD/62945/2009; SFRH/BD/45311/2008, SFRH/BPD/49079/2008; SFRH/BPD/46086/2008; SFRH/BPD/31547/2006]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Goycolea C, 2005, J NEUROSCI, V25, P10510, DOI 10.1523/JNEUROSCI.2552-05.2005; BAGDADE JD, 1967, J CLIN INVEST, V46, P1549, DOI 10.1172/JCI105646; Baskin DG, 1999, DIABETES, V48, P828, DOI 10.2337/diabetes.48.4.828; BECK B, 1992, INT J OBESITY, V16, P295; BECK B, 1990, BRAIN RES, V528, P245, DOI 10.1016/0006-8993(90)91664-3; Bi S, 2003, AM J PHYSIOL-REG I, V285, pR1030, DOI 10.1152/ajpregu.00734.2002; BRADY LS, 1990, NEUROENDOCRINOLOGY, V52, P441, DOI 10.1159/000125626; Bray MS, 2007, OBES REV, V8, P169, DOI 10.1111/j.1467-789X.2006.00277.x; Broberger C, 1999, NEUROENDOCRINOLOGY, V70, P295, DOI 10.1159/000054490; CHRONWALL BM, 1985, NEUROSCIENCE, V15, P1159, DOI 10.1016/0306-4522(85)90260-X; CHUA SC, 1991, MOL BRAIN RES, V11, P291, DOI 10.1016/0169-328X(91)90038-Y; CLARK JT, 1985, ENDOCRINOLOGY, V117, P2435, DOI 10.1210/endo-117-6-2435; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; Davy KP, 2009, NEUROSCI BIOBEHAV R, V33, P116, DOI 10.1016/j.neubiorev.2008.05.024; Dhillo WS, 2002, J NEUROENDOCRINOL, V14, P725, DOI 10.1046/j.1365-2826.2002.00832.x; Dhillon H, 2001, MOL THER, V4, P139, DOI 10.1006/mthe.2001.0427; Dryden S, 1999, CLIN SCI, V96, P307, DOI [10.1042/CS19980226, 10.1042/cs0960307]; DRYDEN S, 1995, BRAIN RES, V690, P185, DOI 10.1016/0006-8993(95)00628-4; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Elias CF, 2000, J COMP NEUROL, V423, P261; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Froy O, 2007, FRONT NEUROENDOCRIN, V28, P61, DOI 10.1016/j.yfrne.2007.03.001; Gardiner JV, 2005, BIOCHEM BIOPH RES CO, V327, P1088, DOI 10.1016/j.bbrc.2004.12.113; Ghamari-Langroudi M, 2005, CELL METAB, V2, P191, DOI 10.1016/j.cmet.2005.08.003; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Hansen MJ, 2004, J NEUROCHEM, V88, P909, DOI 10.1046/j.1471-4159.2003.02217.x; Huang XF, 2003, MOL BRAIN RES, V115, P21, DOI 10.1016/S0169-328X(03)00174-8; KALRA SP, 1991, P NATL ACAD SCI USA, V88, P10931, DOI 10.1073/pnas.88.23.10931; Keen-Rhinehart E, 2009, HORM BEHAV, V56, P275, DOI 10.1016/j.yhbeh.2009.05.006; King PJ, 1999, J NEUROCHEM, V73, P641, DOI 10.1046/j.1471-4159.1999.0730641.x; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Kugler S, 2003, GENE THER, V10, P337, DOI 10.1038/sj.gt.3301905; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Kurreck J, 2003, EUR J BIOCHEM, V270, P1628, DOI 10.1046/j.1432-1033.2003.03555.x; Laposky AD, 2008, AM J PHYSIOL-REG I, V295, pR2059, DOI 10.1152/ajpregu.00026.2008; LEVINE AS, 1984, PEPTIDES, V5, P1025, DOI 10.1016/0196-9781(84)90165-7; Li G, 2005, DIABETOLOGIA, V48, P2376, DOI 10.1007/s00125-005-1943-8; Li G, 2003, DIABETES, V52, P1951, DOI 10.2337/diabetes.52.8.1951; Lin S, 2000, BRAIN RES, V875, P89, DOI 10.1016/S0006-8993(00)02580-4; LUNDBERG JM, 1985, BIOCHEM BIOPH RES CO, V133, P30, DOI 10.1016/0006-291X(85)91837-6; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Malik JMI, 2005, MOL THER, V11, P373, DOI 10.1016/j.ymthe.2004.11.014; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Mercer JG, 1996, J NEUROENDOCRINOL, V8, P733, DOI 10.1046/j.1365-2826.1996.05161.x; Mizuno TM, 1998, DIABETES, V47, P294, DOI 10.2337/diabetes.47.2.294; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P814, DOI 10.1210/en.140.2.814; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010; Raposinho PD, 2001, MOL CELL ENDOCRINOL, V185, P195, DOI 10.1016/S0303-7207(01)00620-7; Raposinho PD, 2000, ENDOCRINOLOGY, V141, P4419, DOI 10.1210/en.141.12.4419; Roseberry AG, 2004, NEURON, V41, P711, DOI 10.1016/S0896-6273(04)00074-1; SAHU A, 1992, MOL BRAIN RES, V15, P15, DOI 10.1016/0169-328X(92)90145-2; Sahu A, 2002, J NEUROENDOCRINOL, V14, P796, DOI 10.1046/j.1365-2826.2002.00840.x; Sahu A, 2008, NEUROSCI LETT, V440, P125, DOI 10.1016/j.neulet.2008.05.083; SANACORA G, 1990, ENDOCRINOLOGY, V127, P730, DOI 10.1210/endo-127-2-730; Sanchez E, 2008, ENDOCRINOLOGY, V149, P4329, DOI 10.1210/en.2008-0411; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; SCHWARTZ MW, 1992, ENDOCRINOLOGY, V130, P3608, DOI 10.1210/en.130.6.3608; Shevtsova Z, 2005, EXP PHYSIOL, V90, P53, DOI 10.1113/expphysiol.2004.028159; SIPOLS AJ, 1995, DIABETES, V44, P147, DOI 10.2337/diabetes.44.2.147; STANLEY BG, 1985, P NATL ACAD SCI USA, V82, P3940, DOI 10.1073/pnas.82.11.3940; Stricker-Krongrad A, 1997, AM J PHYSIOL-REG I, V273, pR2112, DOI 10.1152/ajpregu.1997.273.6.R2112; Thornton JE, 1997, ENDOCRINOLOGY, V138, P5063, DOI 10.1210/en.138.11.5063; Tiesjema B, 2007, J NEUROSCI, V27, P14139, DOI 10.1523/JNEUROSCI.3280-07.2007; Tiesjema B, 2007, OBESITY, V15, P2424, DOI 10.1038/oby.2007.288; Tiesjema B, 2009, OBESITY, V17, P1448, DOI 10.1038/oby.2008.670; Wang B, 2008, J ENDOCRINOL, V198, P127, DOI 10.1677/JOE-08-0156; Wang J, 1998, BRAIN RES, V802, P75, DOI 10.1016/S0006-8993(98)00551-4; WHITE J D, 1990, Molecular and Cellular Neuroscience, V1, P41; WILDING JPH, 1993, ENDOCRINOLOGY, V132, P1939, DOI 10.1210/en.132.5.1939; Wolak ML, 2003, J COMP NEUROL, V464, P285, DOI 10.1002/cne.10823; Xu B, 1999, ENDOCRINOLOGY, V140, P2868, DOI 10.1210/en.140.6.2868; Yamamoto Y, 1999, MOL BRAIN RES, V65, P14, DOI 10.1016/S0169-328X(98)00320-9; Yang L, 2009, J NEUROSCI, V29, P179, DOI 10.1523/JNEUROSCI.4379-08.2009; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yin J, 2009, AM J PHYSIOL-ENDOC M, V296, pE333, DOI 10.1152/ajpendo.90760.2008; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; ZARJEVSKI N, 1993, ENDOCRINOLOGY, V133, P1753, DOI 10.1210/en.133.4.1753; Ziotopoulou M, 2000, AM J PHYSIOL-ENDOC M, V279, pE838, DOI 10.1152/ajpendo.2000.279.4.E838	88	32	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22333	10.1371/journal.pone.0022333	http://dx.doi.org/10.1371/journal.pone.0022333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799827	gold, Green Published, Green Submitted			2022-12-25	WOS:000293097300034
J	Thomas, M; Lischka, P; Muller, R; Stamminger, T				Thomas, Marco; Lischka, Peter; Mueller, Regina; Stamminger, Thomas			The Cellular DExD/H-Box RNA-Helicases UAP56 and URH49 Exhibit a CRM1-Independent Nucleocytoplasmic Shuttling Activity	PLOS ONE			English	Article							NUCLEAR EXPORT SIGNAL; REGULATORY PROTEIN UL69; DEPENDENT MESSENGER-RNA; HUMAN CYTOMEGALOVIRUS; TRANSACTIVATOR PROTEIN; SCHIZOSACCHAROMYCES-POMBE; SR PROTEINS; TRANSLATION INITIATION; UNSPLICED RNA; TAP BINDING	Cellular DExD/H-box RNA-helicases perform essential functions during mRNA biogenesis. The closely related human proteins UAP56 and URH49 are members of this protein family and play an essential role for cellular mRNA export by recruiting the adaptor protein REF to spliced and unspliced mRNAs. In order to gain insight into their mode of action, we aimed to characterize these RNA-helicases in more detail. Here, we demonstrate that UAP56 and URH49 exhibit an intrinsic CRM1-independent nucleocytoplasmic shuttling activity. Extensive mapping studies identified distinct regions within UAP56 or URH49 required for (i) intranuclear localization (UAP56 aa81-381) and (ii) interaction with REF (UAP56 aa51-428). Moreover, the region conferring nucleocytoplasmic shuttling activity was mapped to the C-terminus of UAP56, comprising the amino acids 195-428. Interestingly, this region coincides with a domain within Uap56p of S. pombe that has been reported to be required for both Rae1p-interaction and nucleocytoplasmic shuttling. However, in contrast to this finding we report that human UAP56 shuttles independently from Rae1. In summary, our results reveal nucleocytoplasmic shuttling as a conserved feature of yeast and human UAP56, while their export receptor seems to have diverged during evolution.	[Thomas, Marco; Lischka, Peter; Mueller, Regina; Stamminger, Thomas] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, Erlangen, Germany	University of Erlangen Nuremberg	Thomas, M (corresponding author), Univ Erlangen Nurnberg, Inst Clin & Mol Virol, Erlangen, Germany.	thomas.stamminger@viro.med.uni-erlangen.de		Stamminger, Thomas/0000-0001-9878-3119	Deutsche Forschungsgemeinschaft [SFB796]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (subproject B3 of the SFB796 "Reprogramming of host cells by microbial effectors''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bedard KM, 2007, EMBO J, V26, P459, DOI 10.1038/sj.emboj.7601494; Blevins MB, 2003, J BIOL CHEM, V278, P20979, DOI 10.1074/jbc.M302061200; Boyne JR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000194; Braun IC, 2001, J BIOL CHEM, V276, P20536, DOI 10.1074/jbc.M100400200; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Cavaloc Y, 1999, RNA, V5, P468, DOI 10.1017/S1355838299981967; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Cole CN, 2006, NAT CELL BIOL, V8, P645, DOI 10.1038/ncb0706-645; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Fukuda S, 2002, BIOCHEM BIOPH RES CO, V292, P593, DOI 10.1006/bbrc.2002.6680; Gatfield D, 2002, J CELL BIOL, V159, P579, DOI 10.1083/jcb.200207128; Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gross T, 2007, SCIENCE, V315, P646, DOI 10.1126/science.1134641; Hargous Y, 2006, EMBO J, V25, P5126, DOI 10.1038/sj.emboj.7601385; Hautbergue GM, 2008, P NATL ACAD SCI USA, V105, P5154, DOI 10.1073/pnas.0709167105; Herold A, 2003, EMBO J, V22, P2472, DOI 10.1093/emboj/cdg233; Herold A, 2001, RNA, V7, P1768; Hofmann H, 2000, J VIROL, V74, P2510, DOI 10.1128/JVI.74.6.2510-2524.2000; Hofmann H, 2002, J VIROL, V76, P5769, DOI 10.1128/JVI.76.11.5769-5783.2002; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Hung ML, 2010, NUCLEIC ACIDS RES, V38, P3351, DOI 10.1093/nar/gkq033; Kapadia F, 2006, GENE, V384, P37, DOI 10.1016/j.gene.2006.07.010; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Lai MC, 2008, MOL BIOL CELL, V19, P3847, DOI 10.1091/mbc.E07-12-1264; Leaw CL, 2004, CELL MOL LIFE SCI, V61, P2264, DOI 10.1007/s00018-004-4205-x; Lei EP, 2001, GENE DEV, V15, P1771, DOI 10.1101/gad.892401; Linder P, 2001, CURR BIOL, V11, pR961, DOI 10.1016/S0960-9822(01)00574-7; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Lischka P, 2001, EMBO J, V20, P7271, DOI 10.1093/emboj/20.24.7271; Lischka P, 2006, MOL CELL BIOL, V26, P1631, DOI 10.1128/MCB.26.5.1631-1643.2006; Lischka P, 2007, J GEN VIROL, V88, P405, DOI 10.1099/vir.0.82480-0; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; MacMorris M, 2003, RNA, V9, P847, DOI 10.1261/rna.5480803; Malik P, 2004, J BIOL CHEM, V279, P33001, DOI 10.1074/jbc.M313008200; Masuda S, 2005, GENE DEV, V19, P1512, DOI 10.1101/gad.1302205; Meignin C, 2008, DEV BIOL, V315, P89, DOI 10.1016/j.ydbio.2007.12.004; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Momose F, 2001, J VIROL, V75, P1899, DOI 10.1128/JVI.75.4.1899-1908.2001; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Pritchard CEJ, 1999, J CELL BIOL, V145, P237, DOI 10.1083/jcb.145.2.237; Pryor A, 2004, NUCLEIC ACIDS RES, V32, P1857, DOI 10.1093/nar/gkh347; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Roth J, 1997, J VIROL, V71, P8933, DOI 10.1128/JVI.71.11.8933-8939.1997; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Shen HH, 2008, GENE DEV, V22, P1796, DOI 10.1101/gad.1657308; Shen JP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702304200; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stamminger T, 2008, CURR TOP MICROBIOL, V325, P167; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Sugiura T, 2007, EXP CELL RES, V313, P782, DOI 10.1016/j.yexcr.2006.11.014; Thakurta AG, 2004, J BIOL CHEM, V279, P17434, DOI 10.1074/jbc.M309731200; Thakurta AG, 2005, EMBO J, V24, P2512, DOI 10.1038/sj.emboj.7600713; Thakurta AG, 2007, J BIOL CHEM, V282, P17507, DOI 10.1074/jbc.M609727200; Tintaru AM, 2007, EMBO REP, V8, P756, DOI 10.1038/sj.embor.7401031; Toth Z, 2006, NUCLEIC ACIDS RES, V34, P1237, DOI 10.1093/nar/gkl007; Toth Z, 2008, FRONT BIOSCI-LANDMRK, V13, P2939, DOI 10.2741/2899; WINKLER M, 1994, J VIROL, V68, P3943, DOI 10.1128/JVI.68.6.3943-3954.1994; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yoon JH, 2000, MOL CELL BIOL, V20, P8767, DOI 10.1128/MCB.20.23.8767-8782.2000; Zhao R, 2004, STRUCTURE, V12, P1373, DOI 10.1016/j.str.2004.06.006; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	72	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22671	10.1371/journal.pone.0022671	http://dx.doi.org/10.1371/journal.pone.0022671			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799930	Green Published, Green Submitted, gold			2022-12-25	WOS:000293097300078
J	Kost, C; Tremmel, M; Wirth, R				Kost, Christian; Tremmel, Martin; Wirth, Rainer			Do Leaf Cutting Ants Cut Undetected? Testing the Effect of Ant-Induced Plant Defences on Foraging Decisions in Atta colombica	PLOS ONE			English	Article							L HYMENOPTERA-FORMICIDAE; TROPICAL RAIN-FOREST; CEPHALOTES L; SPODOPTERA-LITTORALIS; VOLATILE EMISSION; LEAFCUTTING ANT; INDUCTION; HERBIVORY; BIOSYNTHESIS; RESPONSES	Leaf-cutting ants (LCAs) are polyphagous, yet highly selective herbivores. The factors that govern their selection of food plants, however, remain poorly understood. We hypothesized that the induction of anti-herbivore defences by attacked food plants, which are toxic to either ants or their mutualistic fungus, should significantly affect the ants' foraging behaviour. To test this "induced defence hypothesis," we used lima bean (Phaseolus lunatus), a plant that emits many volatile organic compounds (VOCs) upon herbivore attack with known anti-fungal or ant-repellent effects. Our results provide three important insights into the foraging ecology of LCAs. First, leaf-cutting by Atta ants can induce plant defences: Lima bean plants that were repeatedly exposed to foraging workers of Atta colombica over a period of three days emitted significantly more VOCs than undamaged control plants. Second, the level to which a plant has induced its anti-herbivore defences can affect the LCAs' foraging behaviour: In dual choice bioassays, foragers discriminated control plants from plants that have been damaged mechanically or by LCAs 24 h ago. In contrast, strong induction levels of plants after treatment with the plant hormone jasmonic acid or three days of LCA feeding strongly repelled LCA foragers relative to undamaged control plants. Third, the LCA-specific mode of damaging leaves allows them to remove larger quantities of leaf material before being recognized by the plant: While leaf loss of approximately 15% due to a chewing herbivore (coccinelid beetle) was sufficient to significantly increase VOC emission levels after 24 h, the removal of even 20% of a plant's leaf area within 20 min by LCAs did not affect its VOC emission rate after 24 h. Taken together, our results support the "induced defence hypothesis" and provide first empirical evidence that the foraging behaviour of LCAs is affected by the induction of plant defence responses.	[Kost, Christian] Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Germany; [Tremmel, Martin; Wirth, Rainer] Univ Kaiserslautern, Dept Plant Ecol & Systemat, Kaiserslautern, Germany	Max Planck Society; University of Kaiserslautern	Kost, C (corresponding author), Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Germany.	christiankost@gmail.com	Kost, Christian/N-1553-2014; Wirth, Rainer/I-1552-2013	Kost, Christian/0000-0002-7870-7343; Wirth, Rainer/0000-0001-8042-3123	Deutsche Forschungsgemeinschaft [WI 1959/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Financial support was provided by the Deutsche Forschungsgemeinschaft (grant No. WI 1959/1-2) to RW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura G, 2005, BBA-MOL CELL BIOL L, V1734, P91, DOI 10.1016/j.bbalip.2005.03.001; BARRER PM, 1972, J ENTOMOL SER A-GEN, V47, P15; Bernasconi ML, 1998, ENTOMOL EXP APPL, V87, P133, DOI 10.1023/A:1003200108763; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; CHEN TK, 1984, NATURWISSENSCHAFTEN, V71, P97, DOI 10.1007/BF01156359; CHERRETT JM, 1972, J ANIM ECOL, V41, P647, DOI 10.2307/3200; CHERRETT JM, 1968, J ANIM ECOL, V37, P387, DOI 10.2307/2955; CHERRETT JM, 1983, ECOLOGY MANAGEMENT, V2, P253; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; de Oliveira HG, 2004, PESQUI AGROPECU BRAS, V39, P285, DOI 10.1590/S0100-204X2004000300012; DICKE M, 1986, PHYSIOL ENTOMOL, V11, P251, DOI 10.1111/j.1365-3032.1986.tb00412.x; Dicke M, 2000, ENTOMOL EXP APPL, V97, P237, DOI 10.1023/A:1004111624780; DONATH J, 1995, PHYTOCHEMISTRY, V39, P785, DOI 10.1016/0031-9422(95)00082-I; FOWLER H G, 1980, Sociobiology, V5, P25; Gols R, 2003, J CHEM ECOL, V29, P2651, DOI 10.1023/B:JOEC.0000008010.40606.b0; Gouinguene S, 2003, J CHEM ECOL, V29, P145, DOI 10.1023/A:1021984715420; Hammer KA, 2003, J APPL MICROBIOL, V95, P853, DOI 10.1046/j.1365-2672.2003.02059.x; Harborne J. B., 1988, INTRO ECOLOGICAL BIO; Haukioja E., 1990, ANNU REV ENTOMOL, V36, P25; HILL DS, 2008, PESTS CROPS WARMER C, P511; Howard JJ, 2001, BEHAV ECOL SOCIOBIOL, V49, P348, DOI 10.1007/s002650000314; HOWARD JJ, 1990, OECOLOGIA, V82, P394, DOI 10.1007/BF00317488; HOWARD JJ, 1988, J CHEM ECOL, V14, P59, DOI 10.1007/BF01022531; HOWARD JJ, 1991, ANT - PLANT INTERACTIONS, P42; HUBBELL SP, 1983, OECOLOGIA, V60, P321, DOI 10.1007/BF00376846; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Koch T, 1999, PLANT PHYSIOL, V121, P153, DOI 10.1104/pp.121.1.153; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; Kost C, 2005, J TROP ECOL, V21, P677, DOI 10.1017/S0266467405002592; Kost C, 2008, J CHEM ECOL, V34, P2, DOI 10.1007/s10886-007-9404-0; LITTLEDYKE M, 1976, B ENTOMOL RES, V66, P205, DOI 10.1017/S0007485300006647; Meyer ST, 2006, FUNCT ECOL, V20, P973, DOI 10.1111/j.1365-2435.2006.01178.x; Mithofer A, 2005, PLANT PHYSIOL, V137, P1160, DOI 10.1104/pp.104.054460; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; R Development Core Team, 2007, R LANG ENV STAT COMP; Reymond P, 1998, CURR OPIN PLANT BIOL, V1, P404, DOI 10.1016/S1369-5266(98)80264-1; ROCKWOOD LL, 1987, OECOLOGIA, V74, P55, DOI 10.1007/BF00377345; Takabayashi J, 1996, TRENDS PLANT SCI, V1, P109, DOI 10.1016/S1360-1385(96)90004-7; TAUTZ J, 1995, SCIENCE, V267, P84, DOI 10.1126/science.267.5194.84; TURLINGS TCJ, 1991, FLA ENTOMOL, V74, P42, DOI 10.2307/3495238; Urbas P, 2007, BIOTROPICA, V39, P489, DOI 10.1111/j.1744-7429.2007.00285.x; van Poecke RMP, 2004, PLANT BIOLOGY, V6, P387, DOI 10.1055/s-2004-820887; Vasconcelos HL, 1997, OECOLOGIA, V112, P370, DOI 10.1007/s004420050322; VASCONCELOS HL, 1990, APPL MYRMECOLOGY WOR, P411; VIEIRA RF, 1992, PESQUI AGROPECU BRAS, V27, P841; Wirth R, 2003, HERBIVORY LEAF CUTTI; Wu JQ, 2009, PLANT CELL ENVIRON, V32, P1161, DOI 10.1111/j.1365-3040.2009.01943.x; Zhang ZZ, 2006, J AGR FOOD CHEM, V54, P3936, DOI 10.1021/jf060017m	49	14	14	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22340	10.1371/journal.pone.0022340	http://dx.doi.org/10.1371/journal.pone.0022340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799831	Green Published, gold, Green Submitted			2022-12-25	WOS:000292931200048
J	Lindell, DM; Morris, SB; White, MP; Kallal, LE; Lundy, PK; Hamouda, T; Baker, JR; Lukacs, NW				Lindell, Dennis M.; Morris, Susan B.; White, Maria P.; Kallal, Lara E.; Lundy, Phillip K.; Hamouda, Tarek; Baker, James R., Jr.; Lukacs, Nicholas W.			A Novel Inactivated Intranasal Respiratory Syncytial Virus Vaccine Promotes Viral Clearance without Th2 Associated Vaccine-Enhanced Disease	PLOS ONE			English	Article							CD8 T-CELLS; IN-VITRO; SURFACTANT NANOEMULSION; INTERFERON-GAMMA; IMMUNE-RESPONSE; FUSION PROTEIN; HOST-DEFENSE; RSV VACCINE; TH17 CELLS; IMMUNIZATION	Background: Respiratory syncytial virus (RSV) is a leading cause of bronchiolitis and pneumonia in young children worldwide, and no vaccine is currently available. Inactivated RSV vaccines tested in the 1960's led to vaccine-enhanced disease upon viral challenge, which has undermined RSV vaccine development. RSV infection is increasingly being recognized as an important pathogen in the elderly, as well as other individuals with compromised pulmonary immunity. A safe and effective inactivated RSV vaccine would be of tremendous therapeutic benefit to many of these populations. Principal Findings: In these preclinical studies, a mouse model was utilized to assess the efficacy of a novel, nanoemulsion-adjuvanted, inactivated mucosal RSV vaccine. Our results demonstrate that NE-RSV immunization induced durable, RSV-specific humoral responses, both systemically and in the lungs. Vaccinated mice exhibited increased protection against subsequent live viral challenge, which was associated with an enhanced Th1/Th17 response. In these studies, NE-RSV vaccinated mice displayed no evidence of Th2 mediated immunopotentiation, as has been previously described for other inactivated RSV vaccines. Conclusions: These studies indicate that nanoemulsion-based inactivated RSV vaccination can augment viral-specific immunity, decrease mucus production and increase viral clearance, without evidence of Th2 immune mediated pathology.	[Lindell, Dennis M.; White, Maria P.] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA USA; [Morris, Susan B.; Kallal, Lara E.; Lundy, Phillip K.; Lukacs, Nicholas W.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Hamouda, Tarek] NanoBio Corp, Ann Arbor, MI USA; [Baker, James R., Jr.] Univ Michigan, Michigan Nanotechnol Inst Med & Biol Sci, Ann Arbor, MI 48109 USA	Seattle Children's Hospital; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lindell, DM (corresponding author), Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA USA.	nlukacs@umich.edu	Lukacs, Nicholas W/ABH-5583-2020		NanoBio;  [R01AI073876];  [R01AI036302];  [K22AI077712]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073876, R01AI036302, K22AI077712] Funding Source: NIH RePORTER	NanoBio; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by R01AI073876 (Nicholas W. Lukacs), R01AI036302 (Nicholas W. Lukacs), K22AI077712 (Dennis M. Lindell) and in part by a grant from NanoBio. Tarek Hamouda and James Baker, Jr., have financial interest due to their affiliation to Nanobio. They participated in the study by providing material goods and technical expertise for formulating and administration of the vaccine in the study. James Baker, Jr. also contributed in part by grammatically editing the manuscript.	Aujla SJ, 2007, EXP LUNG RES, V33, P507, DOI 10.1080/01902140701756604; Berlin AA, 2006, LAB INVEST, V86, P557, DOI 10.1038/labinvest.3700419; Bielinska AU, 2008, CLIN VACCINE IMMUNOL, V15, P348, DOI 10.1128/CVI.00440-07; Bielinska AU, 2008, AIDS RES HUM RETROV, V24, P271, DOI 10.1089/aid.2007.0148; Bielinska AU, 2007, INFECT IMMUN, V75, P4020, DOI 10.1128/IAI.00070-07; BLACK CP, 2003, RESP CARE, V48, P231; Black Craig Patrick, 2003, Respir Care, V48, P209; Boelen A, 2000, VACCINE, V19, P982, DOI 10.1016/S0264-410X(00)00213-9; Brewer JM, 1999, J IMMUNOL, V163, P6448; Byrd LG, 1997, CLIN INFECT DIS, V25, P1363, DOI 10.1086/516152; Castilow EM, 2008, FUTURE VIROL, V3, P445, DOI 10.2217/17460794.3.5.445; Castilow EM, 2007, IMMUNOL RES, V39, P225, DOI 10.1007/s12026-007-0071-6; Chepurnov AA, 2003, ACTA TROP, V87, P315, DOI 10.1016/S0001-706X(03)00120-7; Crowe JE, 2001, VACCINE, V20, pS32, DOI 10.1016/S0264-410X(01)00287-0; Dardalhon V, 2008, J AUTOIMMUN, V31, P252, DOI 10.1016/j.jaut.2008.04.017; Ding J, 2009, J INNATE IMMUN, V1, P413, DOI 10.1159/000226256; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; GRAHAM BS, 1995, AM J RESP CRIT CARE, V152, pS63, DOI 10.1164/ajrccm/152.4_Pt_2.S63; GRAHAM BS, 1993, J IMMUNOL, V151, P2032; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hamouda T, 2001, MICROBIOL RES, V156, P1, DOI 10.1078/0944-5013-00069; Hamouda T, 1999, J INFECT DIS, V180, P1939, DOI 10.1086/315124; Herlocher ML, 1999, VACCINE, V17, P172, DOI 10.1016/S0264-410X(98)00155-8; Jaffar Z, 2009, J IMMUNOL, V182, P4507, DOI 10.4049/jimmunol.0900237; John AE, 2005, AM J PATHOL, V166, P345, DOI 10.1016/S0002-9440(10)62258-4; John AE, 2005, EUR J IMMUNOL, V35, P108, DOI 10.1002/eji.200425439; Kohyama S, 2007, J IMMUNOL, V179, P3917, DOI 10.4049/jimmunol.179.6.3917; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kovacs-Nolan J, 2009, J GEN VIROL, V90, P1892, DOI 10.1099/vir.0.011684-0; Lindell DM, 2008, EUR J IMMUNOL, V38, P2168, DOI 10.1002/eji.200838155; Lindell DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003129; LiPuma JJ, 2009, ANTIMICROB AGENTS CH, V53, P249, DOI 10.1128/AAC.00691-08; Lukacs NW, 2006, AM J PATHOL, V169, P977, DOI 10.2353/ajpath.2006.051055; Lukacs NW, 2010, J IMMUNOL, V185, P2231, DOI 10.4049/jimmunol.1000733; Lundy SK, 2005, J IMMUNOL, V174, P2054, DOI 10.4049/jimmunol.174.4.2054; Makidon PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002954; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; Meyer G, 2008, COMP IMMUNOL MICROB, V31, P191, DOI 10.1016/j.cimid.2007.07.008; Miller AL, 2004, J INFECT DIS, V189, P1419, DOI 10.1086/382958; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Moore ML, 2009, J VIROL, V83, P4185, DOI 10.1128/JVI.01853-08; Moschen AR, 2008, IMMUNOBIOLOGY, V213, P779, DOI 10.1016/j.imbio.2008.07.022; MURPHY BR, 1988, J CLIN MICROBIOL, V26, P1595, DOI 10.1128/JCM.26.8.1595-1597.1988; Myc A, 2003, VACCINE, V21, P3801, DOI 10.1016/S0264-410X(03)00381-5; Myc A, 2002, MYCOPATHOLOGIA, V155, P195, DOI 10.1023/A:1021129710316; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Newcomb DC, 2009, J IMMUNOL, V182, P5317, DOI 10.4049/jimmunol.0803868; Openshaw PJM, 2003, PEDIATR INFECT DIS J, V22, pS58, DOI 10.1097/00006454-200302001-00009; Perkins SM, 2005, J CLIN MICROBIOL, V43, P2356, DOI 10.1128/JCM.43.5.2356-2362.2005; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Polack FP, 2004, PEDIATR INFECT DIS J, V23, pS65, DOI 10.1097/01.inf.0000108194.71892.95; SCHALLER MA, 2005, EUR J IMMUNOL; Schaller MA, 2008, AM J PATHOL, V172, P386, DOI 10.2353/ajpath.2008.070537; Smit JJ, 2007, AM J PATHOL, V171, P1944, DOI 10.2353/ajpath.2007.070578; SNAPPER CM, 1988, J EXP MED, V167, P183, DOI 10.1084/jem.167.1.183; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; SNAPPER CM, 1987, J IMMUNOL, V139, P10; Stegmann T, 2010, VACCINE, V28, P5543, DOI 10.1016/j.vaccine.2010.06.041; Stensballe LG, 2003, PEDIATR INFECT DIS J, V22, pS21, DOI 10.1097/00006454-200302001-00004; Tripp Ralph A, 2005, Proc Am Thorac Soc, V2, P147, DOI 10.1513/pats.200502-014AW; Welliver RC, 2003, J PEDIATR-US, V143, pS112, DOI 10.1067/S0022-3476(03)00508-0; Welliver RC, 2003, PEDIATR INFECT DIS J, V22, pS6, DOI 10.1097/00006454-200302001-00002; Wiehler S, 2007, AM J PHYSIOL-LUNG C, V293, pL505, DOI 10.1152/ajplung.00066.2007; Yang D, 2001, CELL MOL LIFE SCI, V58, P978, DOI 10.1007/PL00000914; Yeh N, 2010, J IMMUNOL, V185, P2089, DOI 10.4049/jimmunol.1000818	69	52	60	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e21823	10.1371/journal.pone.0021823	http://dx.doi.org/10.1371/journal.pone.0021823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789184	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811700003
J	Stuart, K; Paderi, J; Snyder, PW; Freeman, L; Panitch, A				Stuart, Kate; Paderi, John; Snyder, Paul W.; Freeman, Lynetta; Panitch, Alyssa			Collagen-Binding Peptidoglycans Inhibit MMP Mediated Collagen Degradation and Reduce Dermal Scarring	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LEUCINE-RICH PROTEOGLYCANS; WOUND REPAIR; TGF-BETA; DECORIN; FIBRILLOGENESIS; FIBROBLASTS; SKIN; FIBRILS; INJURY	Scarring of the skin is a large unmet clinical problem that is of high patient concern and impact. Wound healing is complex and involves numerous pathways that are highly orchestrated, leaving the skin sealed, but with abnormal organization and composition of tissue components, namely collagen and proteoglycans, that are then remodeled over time. To improve healing and reduce or eliminate scarring, more rapid restoration of healthy tissue composition and organization offers a unique approach for development of new therapeutics. A synthetic collagen-binding peptidoglycan has been developed that inhibits matrix metalloproteinase-1 and 13 (MMP-1 and MMP-13) mediated collagen degradation. We investigated the synthetic peptidoglycan in a rat incisional model in which a single dose was delivered in a hyaluronic acid (HA) vehicle at the time of surgery prior to wound closure. The peptidoglycan treatment resulted in a significant reduction in scar tissue at 21 days as measured by histology and visual analysis. Improved collagen architecture of the treated wounds was demonstrated by increased tensile strength and transmission electron microscopy (TEM) analysis of collagen fibril diameters compared to untreated and HA controls. The peptidoglycan's mechanism of action includes masking existing collagen and inhibiting MMP-mediated collagen degradation while modulating collagen organization. The peptidoglycan can be synthesized at low cost with unique design control, and together with demonstrated preclinical efficacy in reducing scarring, warrants further investigation for dermal wound healing.	[Stuart, Kate; Paderi, John; Freeman, Lynetta; Panitch, Alyssa] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Snyder, Paul W.; Freeman, Lynetta] Purdue Univ, Sch Vet Med, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Stuart, K (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	apanitch@purdue.edu	Panitch, Alyssa/F-4413-2012	Freeman, Lynetta/0000-0002-4077-1497	NIH (NIGMS) [1R43GM093414-01A1]; Alfred Mann Institute at Purdue University (AMIPurdue); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM093414] Funding Source: NIH RePORTER	NIH (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Alfred Mann Institute at Purdue University (AMIPurdue); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for the present work was provided by the NIH (NIGMS Phase I SBIR award 1R43GM093414-01A1) and the Alfred Mann Institute at Purdue University (AMIPurdue). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DG, 2002, J AM PODIAT MED ASSN, V92, P12, DOI 10.7547/87507315-92-1-12; BEAUSANG E, 1997, NEW QUANTITATIVE SCA, P1954; Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2; Brunner G, 2004, THROMB HAEMOSTASIS, V92, P253, DOI 10.1160/TH04-05-0324; Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; David-Raoudi M, 2008, WOUND REPAIR REGEN, V16, P274, DOI 10.1111/j.1524-475X.2007.00342.x; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Douglas T, 2006, BIOMACROMOLECULES, V7, P2388, DOI 10.1021/bm0603746; FERGUSON MWJ, 1994, J INTERFERON RES, V14, P303, DOI 10.1089/jir.1994.14.303; Geng YQ, 2006, MATRIX BIOL, V25, P484, DOI 10.1016/j.matbio.2006.08.259; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Jarvelainen H, 2006, WOUND REPAIR REGEN, V14, P443, DOI 10.1111/j.1743-6109.2006.00150.x; Jarvinen TAH, 2009, WOUND REPAIR REGEN, V17, pA69; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Khorramizadeh MR, 1999, MOL CELL BIOCHEM, V194, P99, DOI 10.1023/A:1006909021352; LAURENT GJ, 1987, AM J PHYSIOL, V252, P1; Mutsaers SE, 1997, INT J BIOCHEM CELL B, V29, P5, DOI 10.1016/S1357-2725(96)00115-X; OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3; Paderi JE, 2008, BIOMACROMOLECULES, V9, P2562, DOI 10.1021/bm8006852; Paderi JE, 2009, TISSUE ENG PT A, V15, P2991, DOI [10.1089/ten.tea.2009.0014, 10.1089/ten.TEA.2009.0014]; Paderi JE, 2011, BIOMATERIALS, V32, P2516, DOI 10.1016/j.biomaterials.2010.12.025; PARRY DAD, 1988, BIOPHYS CHEM, V29, P195, DOI 10.1016/0301-4622(88)87039-X; PARRY DAD, 1982, FEBS LETT, V149, P1, DOI 10.1016/0014-5793(82)81060-0; Penc SF, 1998, J BIOL CHEM, V273, P28116, DOI 10.1074/jbc.273.43.28116; Puig A., 2008, International Journal of Cosmetic Science, V30, P97, DOI 10.1111/j.1468-2494.2008.00429.x; Radek KA, 2009, WOUND REPAIR REGEN, V17, P118, DOI 10.1111/j.1524-475X.2008.00449.x; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Robson MC, 2003, SURG CLIN N AM, V83, P557, DOI 10.1016/S0039-6109(02)00197-4; Schonherr E, 1998, ARCH BIOCHEM BIOPHYS, V355, P241, DOI 10.1006/abbi.1998.0720; SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313; Scott PG, 1996, CLIN SCI, V90, P417, DOI 10.1042/cs0900417; Scott PG, 2000, HAND CLIN, V16, P271; Shah M, 1999, AM J PATHOL, V154, P1115, DOI 10.1016/S0002-9440(10)65364-3; SHAH M, 1995, J CELL SCI, V108, P985; SHAH M, 1994, J CELL SCI, V107, P1137; Simhon D, 2001, LASER SURG MED, V29, P265, DOI 10.1002/lsm.1118; Trowbridge JM, 2002, J BIOL CHEM, V277, P42815, DOI 10.1074/jbc.M204959200; VOGEL KG, 1987, COLLAGEN REL RES, V7, P105; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; Wang JF, 2008, LAB INVEST, V88, P1278, DOI 10.1038/labinvest.2008.101; Widgerow AD, 2009, AESTHET PLAST SURG, V33, P533, DOI 10.1007/s00266-008-9276-x; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Zhang Z, 2007, BURNS, V33, P634, DOI 10.1016/j.burns.2006.08.018	44	44	48	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e22139	10.1371/journal.pone.0022139	http://dx.doi.org/10.1371/journal.pone.0022139			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779387	Green Published, Green Submitted, gold			2022-12-25	WOS:000292680900032
J	Indovina, P; Giorgi, F; Rizzo, V; Khadang, B; Schenone, S; Di Marzo, D; Forte, IM; Tomei, V; Mattioli, E; D'Urso, V; Grilli, B; Botta, M; Giordano, A; Pentimalli, F				Indovina, P.; Giorgi, F.; Rizzo, V.; Khadang, B.; Schenone, S.; Di Marzo, D.; Forte, I. M.; Tomei, V.; Mattioli, E.; D'Urso, V.; Grilli, B.; Botta, M.; Giordano, A.; Pentimalli, F.			New pyrazolo[3,4-d] pyrimidine SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization	ONCOGENE			English	Article						SRC inhibitors; meso thelioma; apoptosis; p27; AKT; cyclin D1	CANCER CELLS; CYCLE INHIBITORS; MICE LACKING; KINASE; EXPRESSION; P27(KIP1); OVEREXPRESSION; HYPERPLASIA; ACTIVATION; MIGRATION	Malignant mesothelioma (MM) is a highly aggressive tumor of the serous membranes for which there is currently no effective curative modality. Recent data suggest that hyperactivation of the tyrosine kinase SRC has a key role in MM development and therefore this kinase represents an important molecular target for MM therapy. We tested new pyrazolo[3,4-d] pyrimidine SRC inhibitors on a panel of MM cell lines expressing the active form of SRC. These SRC inhibitors exerted a significant proapoptotic effect on MM cells without affecting the normal mesothelial cell line MET-5A, supporting a possible use of these SRC inhibitors for a safe treatment of MM. We also showed that SRC inhibitor-induced apoptosis occurred concomitantly with an increase in the nuclear stability of the cyclin-dependent kinase inhibitor p27. This finding is remarkable considering that loss of nuclear p27 expression is a well-established adverse prognostic factor in MM, and p27 nuclear localization is crucial for its tumor-suppressive function. Consistently, SRC inhibition seems to promote the increase in p27 nuclear level also by inactivating the AKT kinase and downregulating cyclin D1, which would otherwise delay p27 nuclear import and provoke its cytoplasmic accumulation. To determine whether p27 stabilization has a direct role in apoptosis induced by SRC inhibition, we stably silenced the CDKN1B gene, encoding p27, in MSTO-211H and REN mesothelioma cells by transduction with lentiviral vectors expressing short hairpin RNAs against the CDKN1B transcript. Strikingly, p27 silencing was able to suppress the apoptosis induced by these SRC inhibitors in both MM cell lines, suggesting that p27 has a crucial proapoptotic role in MM cells treated with SRC inhibitors. Our findings reveal a new mechanism, dependent on p27 nuclear stabilization, by which SRC inhibition can induce apoptosis in MM cells and provide a new rationale for the use of SRC inhibitors in MM therapy. Oncogene (2012) 31, 929-938; doi: 10.1038/onc.2011.286; published online 25 July 2011	[Di Marzo, D.; Forte, I. M.; D'Urso, V.; Giordano, A.; Pentimalli, F.] Pascale Fdn, INT CROM, Natl Canc Inst, Canc Res Ctr, Mercogliano, Italy; [Indovina, P.; Giorgi, F.; Rizzo, V.; Khadang, B.; Forte, I. M.; Tomei, V.; Mattioli, E.; Giordano, A.] Univ Siena, Dept Human Pathol & Oncol, I-53100 Siena, Italy; [Indovina, P.; Tomei, V.; Grilli, B.; Giordano, A.] Temple Univ, Coll Sci & Technol, Ctr Biotechnol, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA; [Schenone, S.] Univ Genoa, Dept Pharmaceut Sci, Genoa, Italy; [D'Urso, V.] Univ Sassari, Dept Biomed Sci, Natl Inst Biostruct & Biosyst, Div Biochem & Biophys, I-07100 Sassari, Italy; [Botta, M.] Univ Siena, Dept Pharmaceut & Appl Chem, I-53100 Siena, Italy	IRCCS Fondazione Pascale; University of Siena; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Genoa; University of Sassari; University of Siena	Pentimalli, F (corresponding author), Pascale Fdn, INT CROM, Natl Canc Inst, Canc Res Ctr, Via Ammiraglio Bianco, I-83013 Avellino, Italy.	francesca.pentimalli@gmail.com	Mattioli, Eliseo/AAC-5018-2022; Pentimalli, Francesca/K-4936-2014; Forte, Iris Maria/K-7588-2016; Giordano, Antonio/F-1927-2010	Mattioli, Eliseo/0000-0002-2456-7867; Pentimalli, Francesca/0000-0003-4740-6801; Forte, Iris Maria/0000-0001-9490-5844; Giordano, Antonio/0000-0002-5959-016X; Indovina, Paola/0000-0001-8416-435X; Grilli, Bruna/0000-0003-3698-9503	Human Health Foundation; Sbarro Health Research Organization	Human Health Foundation; Sbarro Health Research Organization	We thank Giuseppe Viglietto for providing lentiviral vectors and Giovanni Gaudino for providing REN cells. PI, FG and VR are the recipients of Human Health Foundation fellowships. FP is also Adjunct Assistant Professor at Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA. This work was funded by Sbarro Health Research Organization (http://www.shro.org) and Human Health Foundation (http://www.hhfonlus.org).	Altomare DA, 2005, ONCOGENE, V24, P6080, DOI 10.1038/sj.onc.1208744; Baldi A, 2004, THORAX, V59, P428, DOI 10.1136/thx.2003.008912; Beer TW, 2001, HISTOPATHOLOGY, V38, P535, DOI 10.1046/j.1365-2559.2001.01136.x; Bertino P, 2008, CLIN CANCER RES, V14, P541, DOI 10.1158/1078-0432.CCR-07-1388; Blagosklonny MV, 2002, CELL CYCLE, V1, P391, DOI 10.4161/cc.1.6.262; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Bongiovanni M, 2001, CANCER-AM CANCER SOC, V92, P1245, DOI 10.1002/1097-0142(20010901)92:5<1245::AID-CNCR1444>3.0.CO;2-G; Bravo SB, 2003, ONCOGENE, V22, P7819, DOI 10.1038/sj.onc.1207029; Carraro F, 2006, J MED CHEM, V49, P1549, DOI 10.1021/jm050603r; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; Chiappetta G, 2007, ENDOCR-RELAT CANCER, V14, P405, DOI 10.1677/ERC-06-0030; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Faraonio R, 2006, ANTIOXID REDOX SIGN, V8, P365, DOI 10.1089/ars.2006.8.365; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Karni R, 1999, ONCOGENE, V18, P4654, DOI 10.1038/sj.onc.1202835; Katayose Y, 1997, CANCER RES, V57, P5441; Kettunen E, 2001, INT J CANCER, V91, P492, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1094>3.0.CO;2-M; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kudo Y, 2000, CLIN CANCER RES, V6, P916; Lee AY, 2007, CANCER-AM CANCER SOC, V109, P1454, DOI 10.1002/cncr.22552; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masuda A, 2001, AM J PATHOL, V158, P87, DOI 10.1016/S0002-9440(10)63947-8; Menges Craig W, 2010, Genes Cancer, V1, P493; Mezquita B, 2010, J CELL BIOCHEM, V110, P732, DOI 10.1002/jcb.22584; Mikami I, 2010, ONCOL REP, V24, P1677, DOI 10.3892/or_00001033; Motti ML, 2005, AM J PATHOL, V166, P737, DOI 10.1016/S0002-9440(10)62295-X; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Schenone S, 2004, BIOORG MED CHEM LETT, V14, P2511, DOI 10.1016/j.bmcl.2004.03.013; Schenone S, 2010, EXPERT OPIN INV DRUG, V19, P931, DOI 10.1517/13543784.2010.499898; Schenone S, 2008, EUR J MED CHEM, V43, P2665, DOI 10.1016/j.ejmech.2008.01.034; Schweppe RE, 2009, J CLIN ENDOCR METAB, V94, P2199, DOI 10.1210/jc.2008-2511; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shor AC, 2007, CANCER RES, V67, P2800, DOI 10.1158/0008-5472.CAN-06-3469; Sinibaldi D, 2000, ONCOGENE, V19, P5419, DOI 10.1038/sj.onc.1203947; Spreafico A, 2008, FASEB J, V22, P1560, DOI 10.1096/fj.07-9873com; Tsao AS, 2007, MOL CANCER THER, V6, P1962, DOI 10.1158/1535-7163.MCT-07-0052; Tsao AS, 2009, J CLIN ONCOL, V27, P2081, DOI 10.1200/JCO.2008.19.8523; Wang XT, 1997, ONCOGENE, V15, P2991, DOI 10.1038/sj.onc.1201450; Wang Z, 2005, CELL DEATH DIFFER, V12, P98, DOI 10.1038/sj.cdd.4401515; Xiao GH, 2005, MOL CELL BIOL, V25, P2384, DOI 10.1128/MCB.25.6.2384-2394.2005; Yamaguchi H, 2008, J BIOL CHEM, V283, P19112, DOI 10.1074/jbc.M709882200; Yang H, 2006, ONCOGENE, V25, P4585, DOI 10.1038/sj.onc.1209481; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	50	36	36	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	7					929	938		10.1038/onc.2011.286	http://dx.doi.org/10.1038/onc.2011.286			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	897BL	21785466				2022-12-25	WOS:000300615800011
J	Hoog, G; Zarrizi, R; von Stedingk, K; Jonsson, K; Alvarado-Kristensson, M				Hoog, Greta; Zarrizi, Reihaneh; von Stedingk, Kristoffer; Jonsson, Kristina; Alvarado-Kristensson, Maria			Nuclear localization of gamma-tubulin affects E2F transcriptional activity and S-phase progression	FASEB JOURNAL			English	Article						cell cycle progression; signal transduction; cell signaling	CELL-CYCLE; CENTROSOME; EXPRESSION; PROLIFERATION; COMPLEXES; FAMILY; GENES; PHOSPHORYLATION; IDENTIFICATION; PROTEINS	We show that the centrosome- and microtubule-regulating protein gamma-tubulin interacts with E2 promoter binding factors (E2Fs) to modulate E2F transcriptional activity and thereby control cell cycle progression. gamma-Tubulin contains a C-terminal signal that results in its translocation to the nucleus during late G(1) to early S phase. gamma-Tubulin mutants showed that the C terminus interacts with the transcription factor E2F1 and that the E2F1-gamma-tubulin complex is formed during the G(1)/S transition, when E2F1 is transcriptionally active. Furthermore, E2F transcriptional activity is altered by reduced expression of gamma-tubulin or by complex formation between gamma-tubulin and E2F1, E2F2, or E2F3, but not E2F6. In addition, the gamma-tubulin C terminus encodes a DNA-binding domain that interacts with E2F-regulated promoters, resulting in gamma-tubulin-mediated transient activation of E2Fs. Thus, we report a novel mechanism regulating the activity of E2Fs, which can help explain how these proteins affect cell cycle progression in mammalian cells.-Hoog, G., Zarrizi, R., von Stedingk, K., Jonsson, K., Alvarado-Kristensson, M. Nuclear localization of gamma-tubulin affects E2F transcriptional activity and S-phase progression. FASEB J. 25, 3815-3827 (2011). www.fasebj.org	[Hoog, Greta; Zarrizi, Reihaneh; von Stedingk, Kristoffer; Jonsson, Kristina; Alvarado-Kristensson, Maria] Lund Univ, Ctr Mol Pathol, Dept Lab Med, Skane Univ Hosp, SE-20502 Malmo, Sweden	Lund University; Skane University Hospital	Alvarado-Kristensson, M (corresponding author), Lund Univ, Ctr Mol Pathol, SUS, Entrance 78,Floor 2, SE-20502 Malmo, Sweden.	maria.alvarado-kristensson@med.lu.se	Alvarado-Kristensson, Maria T./C-4543-2014	Eklund, Greta/0000-0002-2498-7765; Alvarado Kristensson, Maria Teresa/0000-0003-0598-7986	Royal Physiographic Society (Lund, Sweden); Ake Wiberg Foundations; Thelma Zoegas Foundation; Per-Eric Foundation; Ulla Schyberg Foundation; O. E. and Edla Johansson Foundation; Gradfordska, H. and G. Jeassons Foundation; O. and E. Ericsson Foundation; Gyllenstiernska Krapperupsstiftelsen; Universitetssjukhuset Malmo Allmana Sjukhus (U-MAS); U-MAS Cancer Research Fund; Swedish Research Council; Swedish Society for Medical Research	Royal Physiographic Society (Lund, Sweden); Ake Wiberg Foundations; Thelma Zoegas Foundation; Per-Eric Foundation; Ulla Schyberg Foundation; O. E. and Edla Johansson Foundation; Gradfordska, H. and G. Jeassons Foundation; O. and E. Ericsson Foundation; Gyllenstiernska Krapperupsstiftelsen; Universitetssjukhuset Malmo Allmana Sjukhus (U-MAS); U-MAS Cancer Research Fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society for Medical Research	The authors thank Jiri Bartek (Institute of Cancer Biology, Danish Cancer Society, Yang Shi (Harvard Medical School, Boston, MA, USA), Kristian Helin (Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark), Marc van de Wetering (Hubrecht Laboratory, Centre for Biomedical Genetics, Utrecht, The Netherlands), Joseph R. Nevins (Duke University, Durham, NC, USA), Robert A. Weinberg (Massachusetts Institute of Technology, Cambridge, MA, USA), and David M. Livingston (Dana-Farber Cancer Institute, Boston, MA, USA) for reagents, and P. Odman for editorial assistance. This work was supported by grants from the Royal Physiographic Society (Lund, Sweden); the Ake Wiberg, Thelma Zoegas, Per-Eric and Ulla Schyberg, O. E. and Edla Johansson, Gradfordska, H. and G. Jeassons, and O. and E. Ericsson Foundations; Gyllenstiernska Krapperupsstiftelsen; Universitetssjukhuset Malmo Allmana Sjukhus (U-MAS) and the U-MAS Cancer Research Fund; and the Swedish Research Council. A fellowship from the Swedish Society for Medical Research provided additional support. The authors declare no conflicts of interest.	Alvarado-Kristensson M, 2004, J EXP MED, V199, P449, DOI 10.1084/jem.20031771; Alvarado-Kristensson M, 2001, FASEB J, V15, P129, DOI 10.1096/fj.01-0817fje; Alvarado-Kristensson M, 2009, NAT CELL BIOL, V11, P1081, DOI 10.1038/ncb1921; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; [Anonymous], Q01094 E2F1 HUMAN UN; Black EP, 2005, P NATL ACAD SCI USA, V102, P15948, DOI 10.1073/pnas.0504300102; Carrera AC, 2009, CELL CYCLE, V8, P4005, DOI 10.4161/cc.8.24.10178; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Gaubatz S, 1998, P NATL ACAD SCI USA, V95, P9190, DOI 10.1073/pnas.95.16.9190; Geng Y, 1996, ONCOGENE, V12, P1173; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; HIEBERT SW, 1992, GENE DEV, V6, P177, DOI 10.1101/gad.6.2.177; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jamshidi-Parsian A, 2005, GENE, V344, P67, DOI 10.1016/j.gene.2004.09.030; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Korver W, 2003, INT J CANCER, V104, P283, DOI 10.1002/ijc.10945; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; Lesca C, 2005, ONCOGENE, V24, P5165, DOI 10.1038/sj.onc.1208723; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Moudjou M, 1996, J CELL SCI, V109, P875; MUDRYJ M, 1990, EMBO J, V9, P2179, DOI 10.1002/j.1460-2075.1990.tb07387.x; Muller H, 2006, SCIENCE, V314, P654, DOI 10.1126/science.1132834; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schiebel E, 2000, CURR OPIN CELL BIOL, V12, P113, DOI 10.1016/S0955-0674(99)00064-2; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10321, DOI 10.1073/pnas.93.19.10321; Wan ZH, 2010, J CLIN INVEST, V120, P3530, DOI 10.1172/JCI41805; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3	36	43	43	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2011	25	11					3815	3827		10.1096/fj.11-187484	http://dx.doi.org/10.1096/fj.11-187484			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21788450	Green Published, hybrid			2022-12-25	WOS:000296723100007
J	Banerjee, P; Basu, A; Datta, D; Gasser, M; Waaga-Gasser, AM; Pal, S				Banerjee, Pallavi; Basu, Aninda; Datta, Dipak; Gasser, Martin; Waaga-Gasser, Ana Maria; Pal, Soumitro			The Heme Oxygenase-1 Protein Is Overexpressed in Human Renal Cancer Cells following Activation of the Ras-Raf-ERK Pathway and Mediates Anti-Apoptotic Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; GENE-EXPRESSION; EPITHELIAL-CELLS; KINASE PATHWAYS; MOLECULAR-MECHANISMS; ANTICANCER TREATMENT; ONCOGENIC RAS; RHO KINASE; NRF2; INHIBITION	The stress-inducible cytoprotective enzyme heme oxygenase-1 (HO-1) may play a critical role in the growth and metastasis of tumors. We demonstrated that overexpressed HO-1 promotes the survival of renal cancer cells by inhibiting cellular apoptosis; we also showed that the proto-oncogene H-Ras becomes activated in these cells under stress following treatment with immunosuppressive agents. However, it is not known if there is an association between Ras activation and HO-1 overexpression. Here, we examined if the activation of H-Ras pathway could induce HO-1, and promote the survival of renal cancer cells (786-0 and Caki-1). In co-transfection assays, using HO-1 promoter-luciferase construct, we found that the activated H-Ras, H-Ras(12V), promoted HO-1 transcriptional activation. The inhibition of endogenous H-Ras by specific dominant-negative mutant/siRNA markedly ablated the HO-1 promoter activity. Active H-Ras increased HO-1 mRNA and protein expression. Moreover, transfection with effector domain mutant constructs of active H-Ras showed that H-Ras-induced HO-1 overexpression was primarily mediated through the Raf signaling pathway. Using pharmacological inhibitor, we observed that ERK is a critical intermediary molecule for Ras-Raf-induced HO-1 expression. Activation of H-Ras and ERK promoted nuclear translocation of the transcription factor Nrf2 for its binding to the specific sequence of HO-1 promoter. The knockdown of Nrf2 significantly inhibited H-Ras-induced HO-1 transcription. Finally, by FACS analysis using Annexin-V staining, we demonstrated that the H-Ras-ERK-induced and HO-1-mediated pathway could protect renal cancer cells from apoptosis. Thus, targeting the Ras-Raf-ERK pathway for HO-1 overexpression may serve as novel therapeutics for the treatment of renal cancer.	[Banerjee, Pallavi; Basu, Aninda; Datta, Dipak; Pal, Soumitro] Harvard Univ, Div Nephrol, Childrens Hosp Boston, Sch Med, Boston, MA 02115 USA; [Banerjee, Pallavi; Basu, Aninda; Datta, Dipak; Pal, Soumitro] Harvard Univ, Dept Pediat, Sch Med, Boston, MA 02115 USA; [Gasser, Martin; Waaga-Gasser, Ana Maria] Univ Wurzburg, Dept Surg Mol Oncol & Immunol 1, D-97080 Wurzburg, Germany	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of Wurzburg	Pal, S (corresponding author), Childrens Hosp, Div Nephrol, 300 Longwood Ave, Boston, MA 02115 USA.	soumitro.pal@childrens.harvard.edu			National Institutes of Health [R01 CA131145]; NATIONAL CANCER INSTITUTE [R01CA131145] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA131145 (to S. P.).	Agarwal A, 2000, J AM SOC NEPHROL, V11, P965, DOI 10.1681/ASN.V115965; Akagi R, 2005, CONTRIB NEPHROL, V148, P70, DOI 10.1159/000086044; Alam J, 2000, J BIOL CHEM, V275, P27694; Alaoui-Jamali MA, 2009, CANCER RES, V69, P8017, DOI 10.1158/0008-5472.CAN-09-0419; Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Datta D, 2006, CANCER RES, V66, P9509, DOI 10.1158/0008-5472.CAN-05-4345; Datta D, 2010, J BIOL CHEM, V285, P36842, DOI 10.1074/jbc.M110.170324; Datta D, 2009, CANCER RES, V69, P8902, DOI 10.1158/0008-5472.CAN-09-1404; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Durante W, 1999, ARTERIOSCL THROM VAS, V19, P2666, DOI 10.1161/01.ATV.19.11.2666; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Ekman S, 1999, ONCOGENE, V18, P2481, DOI 10.1038/sj.onc.1202606; Fang J, 2004, APOPTOSIS, V9, P27, DOI 10.1023/B:APPT.0000012119.83734.4e; Fang J, 2009, ADV DRUG DELIVER REV, V61, P290, DOI 10.1016/j.addr.2009.02.005; Ferrandiz ML, 2008, CURR PHARM DESIGN, V14, P473, DOI 10.2174/138161208783597399; Goodman AI, 1997, P SOC EXP BIOL MED, V214, P54; Hock TD, 2007, J BIOL CHEM, V282, P6875, DOI 10.1074/jbc.M608456200; Jo M, 2002, J BIOL CHEM, V277, P12479, DOI 10.1074/jbc.M111147200; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; KHOSRAVIFAR R, 1994, MOL CELL BIOL, V14, P6848, DOI 10.1128/MCB.14.10.6848; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Kim T. H., 2011, CANC RES, V71; Kivela AM, 2008, J NUTR, V138, P1263, DOI 10.1093/jn/138.7.1263; LAVROVSKY Y, 1994, P NATL ACAD SCI USA, V91, P5987, DOI 10.1073/pnas.91.13.5987; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Miyake M, 2011, ONCOL REP, V25, P653, DOI 10.3892/or.2010.1125; Mo L, 2007, J CLIN INVEST, V117, P314, DOI 10.1172/JCI30062; Naidu S, 2009, J IMMUNOL, V182, P7048, DOI 10.4049/jimmunol.0900006; Nath KA, 2006, KIDNEY INT, V70, P432, DOI 10.1038/sj.ki.5001565; Omerovic J, 2008, ONCOGENE, V27, P2754, DOI 10.1038/sj.onc.1210925; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Papaiahgari S, 2004, J BIOL CHEM, V279, P42302, DOI 10.1074/jbc.M408275200; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Roberts RE, 2004, J PHARMACOL EXP THER, V311, P742, DOI 10.1124/jpet.104.071100; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Rojo AI, 2006, FREE RADICAL BIO MED, V41, P247, DOI 10.1016/j.freeradbiomed.2006.04.002; Rushworth SA, 2008, BLOOD, V111, P3793, DOI 10.1182/blood-2007-07-104042; Rushworth SA, 2010, CANCER RES, V70, P2973, DOI 10.1158/0008-5472.CAN-09-3407; Ryter SW, 2005, ANTIOXID REDOX SIGN, V7, P80, DOI 10.1089/ars.2005.7.80; Ryter SW, 2002, ANTIOXID REDOX SIGN, V4, P625, DOI 10.1089/15230860260220120; Sass G, 2008, INT J CANCER, V123, P1269, DOI 10.1002/ijc.23695; Satoh T, 2006, P NATL ACAD SCI USA, V103, P768, DOI 10.1073/pnas.0505723102; SCHLESSINGER J, 1993, TRENDS BIOCHEM SCI, V18, P273, DOI 10.1016/0968-0004(93)90031-H; SETTLEMAN J, 1992, NATURE, V359, P153, DOI 10.1038/359153a0; Shen GX, 2004, J BIOL CHEM, V279, P23052, DOI 10.1074/jbc.M401368200; Srisook K, 2005, ANTIOXID REDOX SIGN, V7, P1674, DOI 10.1089/ars.2005.7.1674; Stacy DR, 2006, HEAD NECK-J SCI SPEC, V28, P813, DOI 10.1002/hed.20430; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Was H, 2010, CURR DRUG TARGETS, V11, P1551, DOI 10.2174/1389450111009011551; Xu L, 2005, CANCER RES, V65, P5711, DOI 10.1158/0008-5472.CAN-04-4313; Yu R, 2000, J BIOL CHEM, V275, P39907, DOI 10.1074/jbc.M004037200; Zipper LM, 2000, BIOCHEM BIOPH RES CO, V278, P484, DOI 10.1006/bbrc.2000.3830	54	53	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33580	33590		10.1074/jbc.M111.248401	http://dx.doi.org/10.1074/jbc.M111.248401			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21808062	Green Published, hybrid			2022-12-25	WOS:000294968800074
J	Shi, XJ; Sun, XO; Liu, M; Li, DW; Aneja, R; Zhou, J				Shi, Xingjuan; Sun, Xiaoou; Liu, Min; Li, Dengwen; Aneja, Ritu; Zhou, Jun			CEP70 Protein Interacts with gamma-Tubulin to Localize at the Centrosome and Is Critical for Mitotic Spindle Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR CYLD; CHROMOSOMAL INSTABILITY; MICROTUBULE DYNAMICS; MECHANISMS; DISEASE; CANCER; CELL; MISORIENTATION; ORIENTATION; MOTOR	Deregulation of the mitotic spindle has been implicated in genomic instability, an important aspect of tumorigenesis and malignant transformation. To ensure the fidelity of chromosome transmission, the mitotic spindle is assembled by exquisite mechanisms and orchestrated by centrosomes in animal cells. Centrosomal proteins especially are thought to act coordinately to ensure accurate spindle formation, but the molecular details remain to be investigated. In this study, we report the molecular characterization and functional analysis of a novel centrosomal protein, Cep70. Our data show that Cep70 localizes to the centrosome throughout the cell cycle and binds to the key centrosomal component, gamma-tubulin, through the peptide fragments that contain the coiled-coil domains. Our data further reveal that the centrosomal localization pattern of Cep70 is dependent on its interaction with gamma-tubulin. Strikingly, Cep70 plays a significant role in the organization of both preexisting and nascent microtubules in interphase cells. In addition, Cep70 is necessary for the organization and orientation of the bipolar spindle during mitosis. These results thus report for the first time the identification of Cep70 as an important centrosomal protein that interacts with gamma-tubulin and underscore its critical role in the regulation of mitotic spindle assembly.	[Shi, Xingjuan; Sun, Xiaoou; Li, Dengwen; Zhou, Jun] Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China; [Liu, Min] Tianjin Med Univ, Dept Biochem, Key Lab Immune Microenvironm & Dis, Minist Educ,Basic Med Coll, Tianjin 300070, Peoples R China; [Aneja, Ritu] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	Nankai University; Tianjin Medical University; University System of Georgia; Georgia State University	Zhou, J (corresponding author), Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, Tianjin Key Lab Prot Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China.	junzhou@nankai.edu.cn	Zhou, Jun/D-4654-2017	Zhou, Jun/0000-0001-7858-8260	National Natural Science Foundation of China [30825022, 90913021, 30801407]; National Basic Research Program of China [2007CB914503, 2010CB912204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30825022, 90913021, and 30801407 and National Basic Research Program of China Grants 2007CB914503 and 2010CB912204.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; Delaval B, 2010, J CELL BIOL, V188, P181, DOI 10.1083/jcb.200908114; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gao JM, 2008, J BIOL CHEM, V283, P8802, DOI 10.1074/jbc.M708470200; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Godinho S, 2009, CANCER METAST REV, V28, P85, DOI 10.1007/s10555-008-9163-6; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Liu M, 2010, J PATHOL, V221, P221, DOI 10.1002/path.2706; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Pease JC, 2011, J CELL SCI, V124, P1007, DOI 10.1242/jcs.081406; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Sun L, 2010, J PATHOL, V221, P425, DOI 10.1002/path.2723; Tanenbaum ME, 2010, DEV CELL, V19, P797, DOI 10.1016/j.devcel.2010.11.011; Thoma CR, 2009, NAT CELL BIOL, V11, P994, DOI 10.1038/ncb1912; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Wilkinson CJ, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-17; Zhou J, 2002, J BIOL CHEM, V277, P17200, DOI 10.1074/jbc.M110369200	23	30	35	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33401	33408		10.1074/jbc.M111.252262	http://dx.doi.org/10.1074/jbc.M111.252262			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795687	hybrid, Green Published			2022-12-25	WOS:000294968800058
J	Jung, WS; Lee, J; Kim, MI; Ma, J; Nagamatsu, T; Goo, E; Kim, H; Hwang, I; Han, J; Rhee, S				Jung, Woo-Suk; Lee, Jeehyun; Kim, Myung-Il; Ma, Jun; Nagamatsu, Tomohisa; Goo, Eunhye; Kim, Hongsup; Hwang, Ingyu; Han, Jaehong; Rhee, Sangkee			Structural and Functional Analysis of Phytotoxin Toxoflavin-Degrading Enzyme	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; TRANSFORMATION; FERVENULIN	Pathogenic bacteria synthesize and secrete toxic low molecular weight compounds as virulence factors. These microbial toxins play essential roles in the pathogenicity of bacteria in various hosts, and are emerging as targets for antivirulence strategies. Toxoflavin, a phytotoxin produced by Burkholderia glumae BGR1, has been known to be the key factor in rice grain rot and wilt in many field crops. Recently, toxoflavin-degrading enzyme (TxDE) was identified from Paenibacillus polymyxa JH2, thereby providing a possible antivirulence strategy for toxoflavin-mediated plant diseases. Here, we report the crystal structure of TxDE in the substrate-free form and in complex with toxoflavin, along with the results of a functional analysis. The overall structure of TxDE is similar to those of the vicinal oxygen chelate superfamily of metalloenzymes, despite the lack of apparent sequence identity. The active site is located at the end of the hydrophobic channel, 9 angstrom in length, and contains a Mn(II) ion interacting with one histidine residue, two glutamate residues, and three water molecules in an octahedral coordination. In the complex, toxoflavin binds in the hydrophobic active site, specifically the Mn(II)-coordination shell by replacing a ligating water molecule. A functional analysis indicated that TxDE catalyzes the degradation of toxoflavin in a manner dependent on oxygen, Mn(II), and the reducing agent dithiothreitol. These results provide the structural features of TxDE and the early events in catalysis.	[Jung, Woo-Suk; Lee, Jeehyun; Kim, Myung-Il; Goo, Eunhye; Kim, Hongsup; Hwang, Ingyu; Rhee, Sangkee] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Ma, Jun; Nagamatsu, Tomohisa] Okayama Univ, Div Pharmaceut Sci, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Han, Jaehong] Chung Ang Univ, Dept Biotechnol, Anseong, South Korea; [Rhee, Sangkee] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul, South Korea	Seoul National University (SNU); Okayama University; Chung Ang University; Seoul National University (SNU)	Jung, WS (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	srheesnu@snu.ac.kr	Han, Jaehong/C-9230-2011; Goo, Eunhye/ERO-2624-2022	Han, Jaehong/0000-0002-5328-3927; 	Next-Generation BioGreen 21 Program [PJ008059]; Rural Development Administration; Crop Functional Genomics Center; Ministry of Education, Science and Technology, Republic of Korea [R11-2008-062-01002-0, 2010-0025883]	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Crop Functional Genomics Center; Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center No. PJ008059), Rural Development Administration, and from Crop Functional Genomics Center of the 21st Century Frontier Research Program, and from National Research Foundation (R11-2008-062-01002-0 and 2010-0025883) funded by the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRIOS GN, 2005, PLANT PATHOL, P190; Armstrong RN, 2000, BIOCHEMISTRY-US, V39, P13625, DOI 10.1021/bi001814v; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bergdoll M, 1998, PROTEIN SCI, V7, P1661, DOI 10.1002/pro.5560070801; Block A, 2008, CURR OPIN PLANT BIOL, V11, P396, DOI 10.1016/j.pbi.2008.06.007; Bokhove M, 2010, P NATL ACAD SCI USA, V107, P686, DOI 10.1073/pnas.0911839107; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cameron AD, 1997, EMBO J, V16, P3386, DOI 10.1093/emboj/16.12.3386; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Dong YH, 2007, PHILOS T R SOC B, V362, P1201, DOI 10.1098/rstb.2007.2045; Fenwick MK, 2011, BIOCHEMISTRY-US, V50, P1091, DOI 10.1021/bi101741v; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HAN S, 1995, SCIENCE, V270, P976, DOI 10.1126/science.270.5238.976; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim J, 2004, MOL MICROBIOL, V54, P921, DOI 10.1111/j.1365-2958.2004.04338.x; Koh S, 2011, PLANT BIOTECHNOL J, V9, P348, DOI 10.1111/j.1467-7652.2010.00557.x; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; LATUASAN HE, 1961, BIOCHIM BIOPHYS ACTA, V52, P502, DOI 10.1016/0006-3002(61)90408-5; Lee SH, 2003, HETEROCYCLES, V60, P47; Mobius N, 2009, CURR OPIN PLANT BIOL, V12, P390, DOI 10.1016/j.pbi.2009.06.004; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; MULLER F, 1987, FREE RADICAL BIO MED, V3, P215, DOI 10.1016/0891-5849(87)90009-8; NAGAMATSU T, 1982, CHEM LETT, P1309, DOI 10.1246/cl.1982.1309; Nagamatsu T, 2001, RRD ORG BIOORG CHEM, V4, P97; Nagamatsu T, 2009, HETEROCYCLES, V77, P849, DOI 10.3987/COM-08-S(F)111; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Vaillancourt FH, 2006, CRIT REV BIOCHEM MOL, V41, P241, DOI 10.1080/10409230600817422; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; YONEDA F, 1973, TETRAHEDRON LETT, P1577	36	17	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22443	10.1371/journal.pone.0022443	http://dx.doi.org/10.1371/journal.pone.0022443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799856	gold, Green Published, Green Submitted			2022-12-25	WOS:000293172900031
J	Khanani, MR; Somani, M; Rehmani, SS; Veras, NMC; Salemi, M; Ali, SH				Khanani, Muhammad R.; Somani, Mehreen; Rehmani, Sadiq S.; Veras, Nazle M. C.; Salemi, Marco; Ali, Syed H.			The Spread of HIV in Pakistan: Bridging of the Epidemic between Populations	PLOS ONE			English	Article							INJECTION-DRUG USERS; RISK; PREVALENCE; SEX; TRANSMISSION; INFECTIONS; PREVENTION; LIKELIHOOD; BEHAVIORS; ACCURATE	In the last two decades, 'concentrated epidemics' of human immunodeficiency virus (HIV) have established in several high risk groups in Pakistan, including Injecting Drug Users (IDUs) and among men who have sex with men (MSM). To explore the transmission patterns of HIV infection in these major high-risk groups of Pakistan, 76 HIV samples were analyzed from MSM, their female spouses and children, along with 26 samples from a previously studied cohort of IDUs. Phylogenetic analysis of HIV gag gene sequences obtained from these samples indicated a substantial degree of intermixing between the IDU and MSM populations, suggesting a bridging of HIV infection from IDUs, via MSM, to the MSM spouses and children. HIV epidemic in Pakistan is now spreading to the female spouses and offspring of bisexual MSM. HIV control and awareness programs must be refocused to include IDUs, MSM, as well as bisexual MSM, and their spouses and children.	[Khanani, Muhammad R.; Ali, Syed H.] Dow Univ Hlth Sci, Dept Microbiol, Karachi, Pakistan; [Somani, Mehreen; Rehmani, Sadiq S.; Ali, Syed H.] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan; [Veras, Nazle M. C.; Salemi, Marco] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Jacksonville, FL USA; [Veras, Nazle M. C.; Salemi, Marco] Emerging Pathogens Inst, Jacksonville, FL USA	Dow University of Health Sciences; Aga Khan University; State University System of Florida; University of Florida	Khanani, MR (corresponding author), Dow Univ Hlth Sci, Dept Microbiol, Karachi, Pakistan.	syed.ali@aku.edu	Abidi, Syed Hani/G-9457-2013	Abidi, Syed Hani/0000-0001-9497-0902; Khanani, Rafiq/0000-0002-5787-2366	Higher Education Commission, Pakistan [20-775]; Pakistan Science Foundation, Pakistan [232]	Higher Education Commission, Pakistan(Higher Education Commission of Pakistan); Pakistan Science Foundation, Pakistan	This study was partly funded by the Higher Education Commission, Pakistan, grant 20-775, and Pakistan Science Foundation, Pakistan, grant 232. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arroyo MA, 2010, AIDS RES HUM RETROV, V26, P5, DOI 10.1089/aid.2009.0150; Bokhari A, 2007, INT J STD AIDS, V18, P486, DOI 10.1258/095646207781147201; Choi KH, 2004, AIDS EDUC PREV, V16, P19, DOI 10.1521/aeap.16.1.19.27721; Emmanuel F, 2008, INT J DRUG POLICY, V19, pS59, DOI 10.1016/j.drugpo.2007.12.012; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haque N, 2004, INT J STD AIDS, V15, P601, DOI 10.1258/0956462041724172; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2009, AIDS EP UPD 2009; Khan AA, 2008, INT J STD AIDS, V19, P817, DOI 10.1258/ijsa.2008.008135; Khanani MR, 2010, J INFECTION, V61, P507, DOI 10.1016/j.jinf.2010.09.035; KHANANI RM, 1988, AIDS RES HUM RETROV, V4, P149, DOI 10.1089/aid.1988.4.149; Khoja S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003191; Niccolai LM, 2009, J URBAN HEALTH, V86, pS131, DOI 10.1007/s11524-009-9369-0; *PROGR NAC, 2007, PROGR REP DECL COMM; Rai MA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-7; Rajabali A, 2008, LANCET INFECT DIS, V8, P511, DOI 10.1016/S1473-3099(08)70183-X; Shah SA, 2004, INT J STD AIDS, V15, P209, DOI 10.1258/095646204322916713; Toussova O, 2009, J URBAN HEALTH, V86, pS121, DOI 10.1007/s11524-009-9364-5; 2009, PHYLOGENETIC HDB PRA, P267	19	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22449	10.1371/journal.pone.0022449	http://dx.doi.org/10.1371/journal.pone.0022449			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799857	Green Published, gold, Green Submitted			2022-12-25	WOS:000293172900032
J	Lebedeva, IV; Pande, P; Patton, WF				Lebedeva, Irina V.; Pande, Praveen; Patton, Wayne F.			Sensitive and Specific Fluorescent Probes for Functional Analysis of the Three Major Types of Mammalian ABC Transporters	PLOS ONE			English	Article							CANCER RESISTANCE PROTEIN; GLYCOPROTEIN-MEDIATED RESISTANCE; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; CYCLOSPORINE-A; CELL-LINES; EXPRESSION; PHENOTYPE; LEUKEMIA; EFFLUX	An underlying mechanism for multi drug resistance (MDR) is up-regulation of the transmembrane ATP-binding cassette (ABC) transporter proteins. ABC transporters also determine the general fate and effect of pharmaceutical agents in the body. The three major types of ABC transporters are MDR1 (P-gp, P-glycoprotein, ABCB1), MRP1/2 (ABCC1/2) and BCRP/MXR (ABCG2) proteins. Flow cytometry (FCM) allows determination of the functional expression levels of ABC transporters in live cells, but most dyes used as indicators (rhodamine 123, DiOC(2)(3), calcein-AM) have limited applicability as they do not detect all three major types of ABC transporters. Dyes with broad coverage (such as doxorubicin, daunorubicin and mitoxantrone) lack sensitivity due to overall dimness and thus may yield a significant percentage of false negative results. We describe two novel fluorescent probes that are substrates for all three common types of ABC transporters and can serve as indicators of MDR in flow cytometry assays using live cells. The probes exhibit fast internalization, favorable uptake/efflux kinetics and high sensitivity of MDR detection, as established by multidrug resistance activity factor (MAF) values and Kolmogorov-Smirnov statistical analysis. Used in combination with general or specific inhibitors of ABC transporters, both dyes readily identify functional efflux and are capable of detecting small levels of efflux as well as defining the type of multidrug resistance. The assay can be applied to the screening of putative modulators of ABC transporters, facilitating rapid, reproducible, specific and relatively simple functional detection of ABC transporter activity, and ready implementation on widely available instruments.	[Lebedeva, Irina V.; Pande, Praveen; Patton, Wayne F.] ENZO Life Sci Inc, Farmingdale, NY USA		Lebedeva, IV (corresponding author), ENZO Life Sci Inc, Farmingdale, NY USA.	ilebedeva@enzolifesciences.com	Lebedeva, Irina V/A-3156-2008	Lebedeva, Irina V/0000-0002-1693-9392	ENZO Life Sciences, Inc.	ENZO Life Sciences, Inc.	The study was funded by ENZO Life Sciences, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ M, 1995, J CLIN INVEST, V95, P2205, DOI 10.1172/JCI117910; Beck WT, 1996, CANCER RES, V56, P3010; Broxterman HJ, 1997, LEUKEMIA, V11, P1110, DOI 10.1038/sj.leu.2400685; Broxterman HJ, 1996, BLOOD, V87, P4809, DOI 10.1182/blood.V87.11.4809.bloodjournal87114809; Cantz T, 2000, AM J PHYSIOL-GASTR L, V278, pG522, DOI 10.1152/ajpgi.2000.278.4.G522; COLLINGTON GK, 1992, BIOCHEM PHARMACOL, V44, P417, DOI 10.1016/0006-2952(92)90431-H; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; GUPTA RS, 1988, BIOCHEM BIOPH RES CO, V153, P598, DOI 10.1016/S0006-291X(88)81137-9; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; HARKER WG, 1989, CANCER RES, V49, P4542; Hollo Z, 1996, FEBS LETT, V383, P99, DOI 10.1016/0014-5793(96)00237-2; HOLLO Z, 1994, BBA-BIOMEMBRANES, V1191, P384, DOI 10.1016/0005-2736(94)90190-2; HOMOLYA L, 1993, J BIOL CHEM, V268, P21493; HUNTER J, 1991, BRIT J CANCER, V64, P437, DOI 10.1038/bjc.1991.328; Koshiba S, 2008, XENOBIOTICA, V38, P863, DOI [10.1080/00498250801986944, 10.1080/00498250801986944 ]; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; LIMINGA G, 1994, EXP CELL RES, V212, P291, DOI 10.1006/excr.1994.1146; LING V, 1983, CANCER TREAT REP, V67, P869; Litman T, 2001, CELL MOL LIFE SCI, V58, P931, DOI 10.1007/PL00000912; Litman T, 2000, J CELL SCI, V113, P2011; McCollum AK, 2008, CANCER RES, V68, P7419, DOI 10.1158/0008-5472.CAN-07-5175; Minderman H, 1996, CYTOMETRY, V25, P14, DOI 10.1002/(SICI)1097-0320(19960901)25:1<14::AID-CYTO2>3.0.CO;2-E; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NEYFAKH AA, 1988, EXP CELL RES, V174, P168, DOI 10.1016/0014-4827(88)90152-8; Qadir M, 2005, CLIN CANCER RES, V11, P2320, DOI 10.1158/1078-0432.CCR-04-1725; Rabindran SK, 2000, CANCER RES, V60, P47; Robey RW, 2004, CANCER RES, V64, P1242, DOI 10.1158/0008-5472.CAN-03-3298; Roelofsen H, 1997, GASTROENTEROLOGY, V112, P511, DOI 10.1053/gast.1997.v112.pm9024305; Ross DD, 1999, J NATL CANCER I, V91, P429, DOI 10.1093/jnci/91.5.429; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Sauna ZE, 2007, MOL CANCER THER, V6, P13, DOI 10.1158/1535-7163.MCT-06-0155; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; Tiberghien F, 1996, ANTI-CANCER DRUG, V7, P568, DOI 10.1097/00001813-199607000-00012; van der Heijden JW, 2009, ARTHRITIS RHEUM-US, V60, P669, DOI 10.1002/art.24354; YOUNG IT, 1977, J HISTOCHEM CYTOCHEM, V25, P935, DOI 10.1177/25.7.894009	37	68	72	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22429	10.1371/journal.pone.0022429	http://dx.doi.org/10.1371/journal.pone.0022429			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799851	Green Submitted, gold, Green Published			2022-12-25	WOS:000293097300045
J	Steffens, DC; Taylor, WD; Denny, KL; Bergman, SR; Wang, LH				Steffens, David C.; Taylor, Warren D.; Denny, Kevin L.; Bergman, Sara R.; Wang, Lihong			Structural Integrity of the Uncinate Fasciculus and Resting State Functional Connectivity of the Ventral Prefrontal Cortex in Late Life Depression	PLOS ONE			English	Article							EMOTION REGULATION; BRAIN; NETWORK	Background: Neuroimaging studies in late life depression have reported decreased structural integrity of white matter tracts in the prefrontal cortex. Functional studies have identified changes in functional connectivity among several key areas involved in mood regulation. Few studies have combined structural and functional imaging. In this study we sought to examine the relationship between the uncinate fasciculus, a key fronto-temporal tract and resting state functional connectivity between the ventral prefrontal cortex ((PFC) and limbic and striatal areas. Methods: The sample consisted of 24 older patients remitted from unipolar major depression. Each participant had a magnetic resonance imaging brain scan using standardized protocols to obtain both diffusion tensor imaging and resting state functional connectivity data. Our statistical approach compared structural integrity of the uncinate fasciculus and functional connectivity data. Results: We found positive correlations between left uncinate fasciculus (UF) fractional anisotropy (FA) and resting state functional connectivity (rsFC) between the left ventrolateral PFC and left amygdala and between the left ventrolateral PFC and the left hippocampus. In addition, we found a significant negative correlation between left ventromedial PFC-caudate rsFC and left UF FA. The right UF FA did not correlate with any of the seed region based connectivity. Conclusions: These results support the notion that resting state functional connectivity reflects structural integrity, since the ventral PFC is structurally connected to temporal regions by the UF. Future studies should include larger samples of patients and healthy comparison subjects in which both resting state and task-based functional connectivity are examined.	[Steffens, David C.; Taylor, Warren D.; Denny, Kevin L.; Bergman, Sara R.; Wang, Lihong] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27706 USA	Duke University	Steffens, DC (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27706 USA.	steff001@mc.duke.edu	Wang, Lihong/D-8960-2011; Taylor, Warren D/J-3687-2014		National Institutes of Health [R01 MH054846, P50 MH060451, K24 MH070027, K23 AG028982]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054846, P50MH060451, K24MH070027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG028982] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01 MH054846, P50 MH060451, K24 MH070027, and K23 AG028982. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Duda JT, 2010, LECT NOTES COMPUT SC, V6362, P282; EBELING U, 1992, ACTA NEUROCHIR, V115, P143, DOI 10.1007/BF01406373; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; LIAO W, 2010, HUM BRAIN MAPP; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Ochsner KN, 2008, CURR DIR PSYCHOL SCI, V17, P153, DOI 10.1111/j.1467-8721.2008.00566.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Phillips ML, 2008, MOL PSYCHIATR, V13, DOI 829833-857; Price JL, 2005, J COMP NEUROL, V493, P132, DOI 10.1002/cne.20750; Sharp D, 2010, J NEUROL NEUROSUR PS, V81, pE23, DOI 10.1136/jnnp.2010.226340.25; Sheline YI, 2008, AM J PSYCHIAT, V165, P524, DOI 10.1176/appi.ajp.2007.07010175; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Steffens DC, 2004, J GERIATR PSYCH NEUR, V17, P202, DOI 10.1177/0891988704269819; Taylor WD, 2007, AM J ROENTGENOL, V188, P1695, DOI 10.2214/AJR.06.1163; Taylor Warren D, 2007, Neuropsychiatr Dis Treat, V3, P669; Taylor WD, 2003, PROG NEURO-PSYCHOPH, V27, P539, DOI 10.1016/S0278-5846(02)00358-5; Upadhyay J, 2010, BRAIN, V133, P2098, DOI 10.1093/brain/awq138; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Versace A, 2010, BIOL PSYCHIAT, V68, P560, DOI 10.1016/j.biopsych.2010.04.036; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006	24	57	60	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22697	10.1371/journal.pone.0022697	http://dx.doi.org/10.1371/journal.pone.0022697			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799934	Green Submitted, Green Published, gold			2022-12-25	WOS:000293097300080
J	Bloom, JD; Nayak, JS; Baltimore, D				Bloom, Jesse D.; Nayak, Jagannath S.; Baltimore, David			A Computational-Experimental Approach Identifies Mutations That Enhance Surface Expression of an Oseltamivir-Resistant Influenza Neuraminidase	PLOS ONE			English	Article							PROTEIN STABILITY; MAXIMUM-LIKELIHOOD; EVOLUTIONARY TREES; BAYESIAN-INFERENCE; VIRUSES RESISTANT; FOLDING KINETICS; GENETIC-ANALYSIS; A(H1N1) VIRUSES; T4 LYSOZYME; A VIRUS	The His274-->Tyr (H274Y) oseltamivir (Tamiflu) resistance mutation causes a substantial decrease in the total levels of surface-expressed neuraminidase protein and activity in early isolates of human seasonal H1N1 influenza, and in the swine-origin pandemic H1N1. In seasonal H1N1, H274Y only became widespread after the occurrence of secondary mutations that counteracted this decrease. H274Y is currently rare in pandemic H1N1, and it remains unclear whether secondary mutations exist that might similarly counteract the decreased neuraminidase surface expression associated with this resistance mutation in pandemic H1N1. Here we investigate the possibility of predicting such secondary mutations. We first test the ability of several computational approaches to retrospectively identify the secondary mutations that enhanced levels of surface-expressed neuraminidase protein and activity in seasonal H1N1 shortly before the emergence of oseltamivir resistance. We then use the most successful computational approach to predict a set of candidate secondary mutations to the pandemic H1N1 neuraminidase. We experimentally screen these mutations, and find that several of them do indeed partially counteract the decrease in neuraminidase surface expression caused by H274Y. Two of the secondary mutations together restore surface-expressed neuraminidase activity to wildtype levels, and also eliminate the very slight decrease in viral growth in tissue-culture caused by H274Y. Our work therefore demonstrates a combined computational-experimental approach for identifying mutations that enhance neuraminidase surface expression, and describes several specific mutations with the potential to be of relevance to the spread of oseltamivir resistance in pandemic H1N1.	[Bloom, Jesse D.; Nayak, Jagannath S.; Baltimore, David] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Bloom, JD (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu	Bloom, Jesse D/C-6837-2013; Bloom, Jesse D/K-3695-2019	Bloom, Jesse D/0000-0003-1267-3408; 	Beckman Institute at the California Institute of Technology; Amgen; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI093789] Funding Source: NIH RePORTER	Beckman Institute at the California Institute of Technology; Amgen(Amgen); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JDB was funded by a Beckman Institute postdoctoral fellowship at the California Institute of Technology. JSN was funded by an Amgen undergraduate summer research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2004, ANTIVIR THER, V9, P577; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Baranovich T, 2010, J CLIN VIROL, V47, P23, DOI 10.1016/j.jcv.2009.11.003; Baz M, 2010, J INFECT DIS, V201, P740, DOI 10.1086/650464; Besenmatter W, 2007, PROTEINS, V66, P500, DOI 10.1002/prot.21227; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Bloom JD, 2007, GENETICS, V175, P255, DOI 10.1534/genetics.106.061754; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Bloom JD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000349; Bogner P, 2006, NATURE, V442, P981, DOI 10.1038/442981a; Brookes DW, 2011, J ANTIMICROB CHEMOTH, V66, P466, DOI 10.1093/jac/dkq486; Calloni G, 2005, J BIOL CHEM, V280, P10607, DOI 10.1074/jbc.M412951200; Cao A, 2002, BIOCHEM BIOPH RES CO, V291, P795, DOI 10.1006/bbrc.2002.6526; Casalegno JS, 2010, ANTIVIR RES, V87, P242, DOI 10.1016/j.antiviral.2010.05.010; Chen Z, 2002, NEURAL COMPUT, V14, P2791, DOI 10.1162/089976602760805296; Chen ZY, 2010, J VIROL, V84, P44, DOI 10.1128/JVI.02106-09; Chiti F, 2000, EMBO J, V19, P1441, DOI 10.1093/emboj/19.7.1441; Ciancio BC, 2009, EUROSURVEILLANCE, V14, P13; Collins PJ, 2009, VACCINE, V27, P6317, DOI 10.1016/j.vaccine.2009.07.017; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; da Silva J, 2010, GENETICS, V185, P293, DOI 10.1534/genetics.109.112458; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Duan SS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001022; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fasan R, 2008, J MOL BIOL, V383, P1069, DOI 10.1016/j.jmb.2008.06.060; FELSENSTEIN J, 1973, SYST ZOOL, V22, P240, DOI 10.2307/2412304; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Felsenstein J, 2009, PHYLIP PHYLOGENY INF; Fersht AR, 2000, P NATL ACAD SCI USA, V97, P1525, DOI 10.1073/pnas.97.4.1525; Godoy-Ruiz R, 2004, J MOL BIOL, V336, P313, DOI 10.1016/j.jmb.2003.12.048; Godoy-Ruiz R, 2006, J MOL BIOL, V362, P966, DOI 10.1016/j.jmb.2006.07.065; GOLUB GH, 1986, SIAM J ALGEBRA DISCR, V7, P273, DOI 10.1137/0607031; Govindarajan S, 2003, J MOL BIOL, V328, P1061, DOI 10.1016/S0022-2836(03)00357-7; Gribenko AV, 2009, P NATL ACAD SCI USA, V106, P2601, DOI 10.1073/pnas.0808220106; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hamelin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001015; Hensley SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015190; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Huelsenbeck JP, 2002, SYST BIOL, V51, P673, DOI 10.1080/10635150290102366; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; KALBFLEISCH JD, 1985, J AM STAT ASSOC, V80, P863, DOI 10.2307/2288545; Kiso M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001079; Lehmann M, 2002, PROTEIN ENG, V15, P403, DOI 10.1093/protein/15.5.403; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; Matsuzaki Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-53; Memoli MJ, 2011, J INFECT DIS, V203, P348, DOI 10.1093/infdis/jiq067; MEYER CD, 1975, SIAM REV, V17, P443, DOI 10.1137/1017044; MITRAKI A, 1991, SCIENCE, V253, P54, DOI 10.1126/science.1648264; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; PAKULA AA, 1989, ANNU REV GENET, V23, P289, DOI 10.1146/annurev.ge.23.120189.001445; PANTOLIANO MW, 1989, BIOCHEMISTRY-US, V28, P7205, DOI 10.1021/bi00444a012; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Pizzorno A, 2011, J INFECT DIS, V203, P25, DOI 10.1093/infdis/jiq010; Poteete AR, 1997, PROTEIN SCI, V6, P2418; Rameix-Welti MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000103; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; SANDBERG WS, 1993, P NATL ACAD SCI USA, V90, P8367, DOI 10.1073/pnas.90.18.8367; Sato S, 2001, J MOL BIOL, V312, P569, DOI 10.1006/jmbi.2001.4968; Seibert CW, 2010, J VIROL, V84, P11219, DOI 10.1128/JVI.01424-10; SERRANO L, 1993, J MOL BIOL, V233, P305, DOI 10.1006/jmbi.1993.1508; SHORTLE D, 1985, GENETICS, V110, P539; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; STEIPE B, 1994, J MOL BIOL, V240, P188, DOI 10.1006/jmbi.1994.1434; Taverna DM, 2002, PROTEINS, V46, P105, DOI 10.1002/prot.10016; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; *WHO, 2010, IN UPD 20 OCT 2010; WHO (World Health Organization), 2010, WEEKL UPD OS RES PAN; World Health Organization, 2010, WKLY EPIDEMIOL REC, V6, P37; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08; Yang JR, 2010, ANTIVIR RES, V88, P256, DOI 10.1016/j.antiviral.2010.09.014; Yeh WW, 2006, J VIROL, V80, P8168, DOI 10.1128/JVI.00068-06; Zeldovich KB, 2007, P NATL ACAD SCI USA, V104, P16152, DOI 10.1073/pnas.0705366104; Zhang XJ, 1995, PROTEIN ENG, V8, P1017, DOI 10.1093/protein/8.10.1017	81	41	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22201	10.1371/journal.pone.0022201	http://dx.doi.org/10.1371/journal.pone.0022201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799795	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000292931200034
J	Deghorain, M; Pages, C; Meile, JC; Stouf, M; Capiaux, H; Mercier, R; Lesterlin, C; Hallet, B; Cornet, F				Deghorain, Marie; Pages, Carine; Meile, Jean-Christophe; Stouf, Mathieu; Capiaux, Herve; Mercier, Romain; Lesterlin, Christian; Hallet, Bernard; Cornet, Francois			A Defined Terminal Region of the E-coli Chromosome Shows Late Segregation and High FtsK Activity	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; TOPOISOMERASE-IV ACTIVITY; CELL-DIVISION PROTEIN; XER RECOMBINATION; DIMER RESOLUTION; DNA TRANSLOCATION; FUNCTIONAL INTERACTION; NUCLEOID ORGANIZATION; DIF; DOMAIN	Background: The FtsK DNA-translocase controls the last steps of chromosome segregation in E. coli. It translocates sister chromosomes using the KOPS DNA motifs to orient its activity, and controls the resolution of dimeric forms of sister chromosomes by XerCD-mediated recombination at the dif site and their decatenation by TopoIV. Methodology: We have used XerCD/dif recombination as a genetic trap to probe the interaction of FtsK with loci located in different regions of the chromosome. This assay revealed that the activity of FtsK is restricted to a similar to 400 kb terminal region of the chromosome around the natural position of the dif site. Preferential interaction with this region required the tethering of FtsK to the division septum via its N-terminal domain as well as its translocation activity. However, the KOPS-recognition activity of FtsK was not required. Displacement of replication termination outside the FtsK high activity region had no effect on FtsK activity and deletion of a part of this region was not compensated by its extension to neighbouring regions. By observing the fate of fluorescent-tagged loci of the ter region, we found that segregation of the FtsK high activity region is delayed compared to that of its adjacent regions. Significance: Our results show that a restricted terminal region of the chromosome is specifically dedicated to the last steps of chromosome segregation and to their coupling with cell division by FtsK.	[Deghorain, Marie; Pages, Carine; Meile, Jean-Christophe; Stouf, Mathieu; Capiaux, Herve; Mercier, Romain; Lesterlin, Christian; Cornet, Francois] CNRS, Lab Microbiol & Genet Mol, Toulouse, France; [Deghorain, Marie; Pages, Carine; Meile, Jean-Christophe; Stouf, Mathieu; Capiaux, Herve; Mercier, Romain; Lesterlin, Christian; Cornet, Francois] Univ Toulouse 3, Univ Toulouse, F-31062 Toulouse, France; [Deghorain, Marie; Hallet, Bernard] Catholic Univ Louvain, Inst Sci Vie, Unite Genet, B-1348 Louvain, Belgium	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Catholique Louvain	Deghorain, M (corresponding author), Univ Libre Bruxelles, Inst Biol & Med Mol, Gosselies, Belgium.	Francois.Cornet@ibcg.biotoul.fr	Cornet, Francois/A-9201-2008; Mercier, Romain/E-3642-2012	Cornet, Francois/0000-0001-8576-7451; Stouf, Mathieu/0000-0001-9287-3551; Meile, Jean-Christophe/0000-0002-6747-2104; Lesterlin, Christian/0000-0002-9108-0848	CNRS; Universite Paul Sabatier; Universite de Toulouse; ACI [JC5010]; ANR [BLAN06-2 134012]; Fondation pour la Recherche Medicale	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paul Sabatier; Universite de Toulouse; ACI; ANR(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was funded by the CNRS, Universite Paul Sabatier, Universite de Toulouse, ACI contract JC5010, ANR contract BLAN06-2 134012 and the Fondation pour la Recherche Medicale (to MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aussel L, 2002, CELL, V108, P195, DOI 10.1016/S0092-8674(02)00624-4; Barre FX, 2000, GENE DEV, V14, P2976, DOI 10.1101/gad.188700; Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; Bigot S, 2005, EMBO J, V24, P3770, DOI 10.1038/sj.emboj.7600835; Bigot S, 2004, MOL MICROBIOL, V54, P876, DOI 10.1111/j.1365-2958.2004.04335.x; Bigot S, 2007, MOL MICROBIOL, V64, P1434, DOI 10.1111/j.1365-2958.2007.05755.x; Bigot S, 2006, NAT STRUCT MOL BIOL, V13, P1026, DOI 10.1038/nsmb1159; Bigot S, 2010, NUCLEIC ACIDS RES, V38, P3031, DOI 10.1093/nar/gkp1243; Bonne L, 2009, NUCLEIC ACIDS RES, V37, P2371, DOI 10.1093/nar/gkp104; Capiaux H, 2002, EMBO REP, V3, P532, DOI 10.1093/embo-reports/kvf116; Cornet F, 1996, GENE DEV, V10, P1152, DOI 10.1101/gad.10.9.1152; CORNET F, 1994, J BACTERIOL, V176, P3188, DOI 10.1128/jb.176.11.3188-3195.1994; Corre J, 2005, MOL MICROBIOL, V56, P1539, DOI 10.1111/j.1365-2958.2005.04633.x; Dubarry N, 2010, MOL MICROBIOL, V78, P1088, DOI 10.1111/j.1365-2958.2010.07412.x; Dubarry N, 2010, EMBO J, V29, P597, DOI 10.1038/emboj.2009.381; Duggin IG, 2009, J MOL BIOL, V387, P532, DOI 10.1016/j.jmb.2009.02.027; Espeli O, 2004, MOL MICROBIOL, V52, P925, DOI 10.1111/j.1365-2958.2004.04047.x; Espeli O, 2003, J BIOL CHEM, V278, P44639, DOI 10.1074/jbc.M308926200; Espeli O, 2003, MOL CELL, V11, P189, DOI 10.1016/S1097-2765(03)00013-3; Espeli O, 2008, MOL MICROBIOL, V68, P1418, DOI 10.1111/j.1365-2958.2008.06239.x; Graham JE, 2010, P NATL ACAD SCI USA, V107, P20263, DOI 10.1073/pnas.1007518107; Graham JE, 2010, NUCLEIC ACIDS RES, V38, P72, DOI 10.1093/nar/gkp843; Grainge I, 2007, EMBO J, V26, P4228, DOI 10.1038/sj.emboj.7601849; Grainge I, 2011, NUCLEIC ACIDS RES, V39, P5140, DOI 10.1093/nar/gkr078; Grenga L, 2008, FEMS MICROBIOL LETT, V287, P163, DOI 10.1111/j.1574-6968.2008.01317.x; Hashimoto M, 2005, MOL MICROBIOL, V55, P137, DOI 10.1111/j.1365-2958.2004.04386.x; HENSON JM, 1985, P NATL ACAD SCI USA, V82, P3766, DOI 10.1073/pnas.82.11.3766; Hojgaard A, 1999, MOL MICROBIOL, V33, P1027, DOI 10.1046/j.1365-2958.1999.01545.x; Joshi MC, 2011, P NATL ACAD SCI USA, V108, P2765, DOI 10.1073/pnas.1019593108; Kaimer C, 2009, MOL MICROBIOL, V74, P810, DOI 10.1111/j.1365-2958.2009.06894.x; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Le Bourgeois P, 2007, PLOS GENET, V3, P1190, DOI 10.1371/journal.pgen.0030117; Lesterlin C, 2004, MOL MICROBIOL, V54, P1151, DOI 10.1111/j.1365-2958.2004.04356.x; Levy O, 2005, P NATL ACAD SCI USA, V102, P17618, DOI 10.1073/pnas.0508932102; Li YF, 2003, MOL MICROBIOL, V50, P825, DOI 10.1046/j.1365-2958.2003.03746.x; Li YF, 2002, MOL MICROBIOL, V46, P63, DOI 10.1046/j.1365-2958.2002.03156.x; LOUARN J, 1994, J BACTERIOL, V176, P7524, DOI 10.1128/JB.176.24.7524-7531.1994; Lowe J, 2008, MOL CELL, V31, P498, DOI 10.1016/j.molcel.2008.05.027; Massey TH, 2004, EMBO REP, V5, P399, DOI 10.1038/sj.embor.7400116; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Nielsen HJ, 2006, MOL MICROBIOL, V61, P383, DOI 10.1111/j.1365-2958.2006.05245.x; Niki H, 2000, GENE DEV, V14, P212; Nolivos S, 2010, NUCLEIC ACIDS RES, V38, P6477, DOI 10.1093/nar/gkq507; Perals K, 2000, MOL MICROBIOL, V36, P33, DOI 10.1046/j.1365-2958.2000.01847.x; Perals K, 2001, MOL MICROBIOL, V39, P904, DOI 10.1046/j.1365-2958.2001.02277.x; Ptacin JL, 2006, NAT STRUCT MOL BIOL, V13, P1023, DOI 10.1038/nsmb1157; Reyes-Larnothe R, 2008, TRENDS MICROBIOL, V16, P238, DOI 10.1016/j.tim.2008.02.003; Rocha EPC, 2008, ANNU REV GENET, V42, P211, DOI 10.1146/annurev.genet.42.110807.091653; Sherratt DJ, 2010, BIOCHEM SOC T, V38, P395, DOI 10.1042/BST0380395; Sivanathan V, 2006, NAT STRUCT MOL BIOL, V13, P965, DOI 10.1038/nsmb1158; Sivanathan V, 2009, MOL MICROBIOL, V71, P1031, DOI 10.1111/j.1365-2958.2008.06586.x; Steiner WW, 1998, MOL MICROBIOL, V27, P257, DOI 10.1046/j.1365-2958.1998.00651.x; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; Val ME, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000201; Wang LL, 1998, MOL MICROBIOL, V29, P731, DOI 10.1046/j.1365-2958.1998.00958.x; Wang SCE, 2006, J BACTERIOL, V188, P1497, DOI 10.1128/JB.188.4.1497-1508.2006; Wang XD, 2005, GENE DEV, V19, P2367, DOI 10.1101/gad.345305; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Wu LJ, 2009, MOL MICROBIOL, V74, P773, DOI 10.1111/j.1365-2958.2009.06892.x; Yates J, 2006, MOL MICROBIOL, V59, P1754, DOI 10.1111/j.1365-2958.2005.05033.x; Yates J, 2003, MOL MICROBIOL, V49, P241, DOI 10.1046/j.1365-2958.2003.03574.x; Yu XC, 1998, J BACTERIOL, V180, P1296, DOI 10.1128/JB.180.5.1296-1304.1998	62	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22164	10.1371/journal.pone.0022164	http://dx.doi.org/10.1371/journal.pone.0022164			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799784	Green Published, Green Submitted, gold			2022-12-25	WOS:000292931200030
J	Liu, XY; Fernandes, R; Gertsenstein, M; Perumalsamy, A; Lai, I; Chi, M; Moley, KH; Greenblatt, E; Jurisica, I; Casper, RF; Sun, Y; Jurisicova, A				Liu, Xinyu; Fernandes, Roxanne; Gertsenstein, Marina; Perumalsamy, Alagammal; Lai, Ingrid; Chi, Maggie; Moley, Kelle H.; Greenblatt, Ellen; Jurisica, Igor; Casper, Robert F.; Sun, Yu; Jurisicova, Andrea			Automated Microinjection of Recombinant BCL-X into Mouse Zygotes Enhances Embryo Development	PLOS ONE			English	Article							CELL-DEATH; MATHEMATICAL-MODELS; BCL-X(L) PREVENTS; OXIDATIVE STRESS; CLEAVAGE-STAGE; IN-VITRO; MITOCHONDRIAL; APOPTOSIS; EXPRESSION; ARREST	Progression of fertilized mammalian oocytes through cleavage, blastocyst formation and implantation depends on successful implementation of the developmental program, which becomes established during oogenesis. The identification of ooplasmic factors, which are responsible for successful embryo development, is thus crucial in designing possible molecular therapies for infertility intervention. However, systematic evaluation of molecular targets has been hampered by the lack of techniques for efficient delivery of molecules into embryos. We have developed an automated robotic microinjection system for delivering cell impermeable compounds into preimplantation embryos with a high post-injection survival rate. In this paper, we report the performance of the system on microinjection of mouse embryos. Furthermore, using this system we provide the first evidence that recombinant BCL-XL (recBCL-XL) protein is effective in preventing early embryo arrest imposed by suboptimal culture environment. We demonstrate that microinjection of recBCL-XL protein into early-stage embryos repairs mitochondrial bioenergetics, prevents reactive oxygen species (ROS) accumulation, and enhances preimplantation embryo development. This approach may lead to a possible treatment option for patients with repeated in vitro fertilization (IVF) failure due to poor embryo quality.	[Liu, Xinyu; Sun, Yu] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON, Canada; [Liu, Xinyu; Sun, Yu] McGill Univ, Inst Biomat & Biomed Engn, Montreal, PQ, Canada; [Fernandes, Roxanne; Gertsenstein, Marina; Perumalsamy, Alagammal; Lai, Ingrid; Casper, Robert F.; Jurisicova, Andrea] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Chi, Maggie; Moley, Kelle H.] Washington Univ, Dept Obstet & Gynecol, St Louis, MO USA; [Greenblatt, Ellen; Casper, Robert F.; Jurisicova, Andrea] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Jurisica, Igor] Univ Toronto, Ontario Canc Inst, Dept Comp Sci, Univ Hlth Network, Toronto, ON, Canada; [Jurisica, Igor] Univ Toronto, Dept Med Biophys, Ontario Canc Inst, Univ Hlth Network, Toronto, ON, Canada; [Jurisica, Igor] Univ Toronto, Campbell Family Inst Canc Res, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; McGill University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Washington University (WUSTL); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Liu, XY (corresponding author), McGill Univ, Dept Mech Engn, Montreal, PQ, Canada.	sun@mie.utoronto.ca; jurisicova@lunenfeld.ca	Jurisicova, Andrea/E-4580-2013; Casper, Robert F./E-3775-2013; Greenblatt, Ellen/C-1437-2016; Liu, Xinyu/B-5529-2009	Casper, Robert F./0000-0002-6249-462X; Liu, Xinyu/0000-0001-5705-9765; Sun, Yu/0000-0001-7895-0741	Canadian Institutes of Health Research (CIHR) [MOP 14058, 84328]; Ferring; Natural Sciences and Engineering Research Council (NSERC) [104105, 458099]; Canada Foundation for Innovation (CFI) [12301, 203383, 203771]; Ontario Ministry of Research and Innovation (MRI) [482193]; National Institutes of Health (NIH) [HD040390, HD065435]; Canada Research Chairs Program; Ontario Graduate Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040390, R01HD065435] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ferring(Ferring Pharmaceuticals); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Ministry of Research and Innovation (MRI)(Ministry of Research and Innovation, Ontario); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chairs Program(Canada Research Chairs); Ontario Graduate Scholarship(Ontario Graduate Scholarship); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Grants from Canadian Institutes of Health Research to AJ and RFC (CIHR MOP 14058, 84328 and research grant from Ferring), Natural Sciences and Engineering Research Council and the Canada Foundation for Innovation to IJ (NSERC #104105, CFI #12301 and CFI #203383) and AJ (CFI#203771), Natural Sciences and Engineering Research Council and Ontario Ministry of Research and Innovation to YS (NSERC #458099, MRI #482193) and the National Institutes of Health to KHM (NIH HD040390 and HD065435). IJ, YS and AJ are supported by the Canada Research Chairs Program. XYL was supported by the Ontario Graduate Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton BM, 2007, BIOL REPROD, V77, P569, DOI 10.1095/biolreprod.107.060806; Acton BM, 2004, MOL HUM REPROD, V10, P23, DOI 10.1093/molehr/gah004; [Anonymous], INTEROLOGOUS INTERAC; Autret A, 2009, MOL CELL, V36, P355, DOI 10.1016/j.molcel.2009.10.011; Barritt JA, 2001, HUM REPROD UPDATE, V7, P428, DOI 10.1093/humupd/7.4.428; Barritt JA, 2001, HUM REPROD, V16, P513, DOI 10.1093/humrep/16.3.513; Berman SB, 2009, J CELL BIOL, V184, P707, DOI 10.1083/jcb.200809060; Betts DH, 2008, MOL HUM REPROD, V14, P445, DOI 10.1093/molehr/gan035; Brown KR, 2009, BIOINFORMATICS, V25, P3327, DOI 10.1093/bioinformatics/btp595; Brown KV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r95; Chi MMY, 2002, AM J PHYSIOL-ENDOC M, V283, pE226, DOI 10.1152/ajpendo.00046.2002; Civico S, 2008, FERTIL STERIL, V89, P1557, DOI 10.1016/j.fertnstert.2007.06.003; Cohen J, 1997, LANCET, V350, P186, DOI 10.1016/S0140-6736(05)62353-7; Cornell E, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2827516; Dumollard R, 2007, DEVELOPMENT, V134, P455, DOI 10.1242/dev.02744; Favetta LA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-132; Favetta LA, 2007, FREE RADICAL BIO MED, V42, P1201, DOI 10.1016/j.freeradbiomed.2007.01.018; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; GARDNER DK, 1986, HUM REPROD, V1, P25, DOI 10.1093/oxfordjournals.humrep.a136336; GODDARD MJ, 1983, J EMBRYOL EXP MORPH, V73, P111; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Guillemin Y, 2009, J MOL MED, V87, P923, DOI 10.1007/s00109-009-0495-7; Haga S, 2008, J HEPATOL, V48, P422, DOI 10.1016/j.jhep.2007.11.018; Hardy K, 2001, P NATL ACAD SCI USA, V98, P1655, DOI 10.1073/pnas.98.4.1655; Hardy K, 2002, APOPTOSIS, V7, P373, DOI 10.1023/A:1016183731694; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Jurisicova A, 2003, MOL HUM REPROD, V9, P133, DOI 10.1093/molehr/gag016; Jurisicova A, 1998, MOL REPROD DEV, V51, P243, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;243::AID-MRD3&gt;3.0.CO;2-P; Kasai S, 2003, DEV BIOL, V264, P202, DOI 10.1016/S0012-1606(03)00400-7; Kim DH, 2005, J BIOMECH, V38, P1359, DOI 10.1016/j.jbiomech.2004.07.014; Kowaltowski AJ, 2004, FREE RADICAL BIO MED, V37, P1845, DOI 10.1016/j.freeradbiomed.2004.09.005; Kumar R, 2003, IEEE INT C INT ROB S; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Liu X, 2009, IEEE INT C ROB AUT I; Liu XY, 2009, BIOMED MICRODEVICES, V11, P1169, DOI 10.1007/s10544-009-9333-5; Maleszewski M, 1999, MOL REPROD DEV, V54, P303, DOI 10.1002/(SICI)1098-2795(199911)54:3&lt;303::AID-MRD11&gt;3.0.CO;2-0; Mattos LS, 2009, IEEE T INF TECHNOL B, V13, P822, DOI 10.1109/TITB.2009.2023664; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; MUGGLETONHARRIS A, 1982, NATURE, V299, P460, DOI 10.1038/299460a0; MUGGLETONHARRIS AL, 1988, HUM REPROD, V3, P1020, DOI 10.1093/oxfordjournals.humrep.a136815; Perez GI, 2007, CELL DEATH DIFFER, V14, P524, DOI 10.1038/sj.cdd.4402050; Perumalsamy A, 2010, FEBS J, V277, P1219, DOI 10.1111/j.1742-4658.2010.07554.x; Riedlinger G, 2002, BIOL REPROD, V66, P438, DOI 10.1095/biolreprod66.2.438; Ruder EH, 2008, HUM REPROD UPDATE, V14, P345, DOI 10.1093/humupd/dmn011; Sun Y, 2002, INT J ROBOT RES, V21, P861, DOI 10.1177/0278364902021010833; Suzuki O, 1996, REPROD FERT DEVELOP, V8, P975, DOI 10.1071/RD9960975; Vander Heiden MG, 2002, J BIOL CHEM, V277, P44870, DOI 10.1074/jbc.M204888200; Vander Heiden MG, 1999, MOL CELL, V3, P159; Wang WH, 2007, INT J ROBOT RES, V26, P821, DOI 10.1177/0278364907080254; Wang WH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000862; Wang WH, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.3006000; Wilding M, 2001, HUM REPROD, V16, P909, DOI 10.1093/humrep/16.5.909; Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686; Ziebe S, 1997, HUM REPROD, V12, P1545, DOI 10.1093/humrep/12.7.1545	54	30	37	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e21687	10.1371/journal.pone.0021687	http://dx.doi.org/10.1371/journal.pone.0021687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799744	Green Published, gold, Green Submitted			2022-12-25	WOS:000292931200010
J	Tucker, MA; Tang, SX; Uzoh, A; Morgan, A; Stickgold, R				Tucker, Matthew A.; Tang, Sunny X.; Uzoh, Amaka; Morgan, Alexandra; Stickgold, Robert			To Sleep, to Strive, or Both: How Best to Optimize Memory	PLOS ONE			English	Article							SLOW-WAVE SLEEP; CONSOLIDATION; NEUROSCIENCE; ACTIVATION; SCALE	While numerous studies have shown that a night of sleep profits memory relative to wake, we still have little understanding about what factors mediate this effect of sleep. A clear understanding of the dynamics of this effect of sleep beyond the initial night of sleep is also lacking. Here, we examined the effect of extrinsic rewards on sleep-dependent declarative memory processing across 12 and 24 hr training-retest intervals. Subjects were either paid based on their performance at retest ($1 for each correct answer), or received a flat fee for participation. After a 12 hr interval we observed pronounced benefits of both sleep and reward on memory. Over an extended 24 hr interval we found 1) that an initial night of sleep partially protects memories from subsequent deterioration during wake, and 2) that sleep blocks further deterioration, and may even have a restorative effect on memory, when it follows a full day of wake. Interestingly, the benefit imparted to rewarded (relative to unrewarded) stimuli was equal for sleep and wake subjects, suggesting that the sleeping brain may not differentially process rewarded information, relative to wake. However, looking at the overall impact of sleep relative to reward in this protocol, it was apparent that sleep both imparted a stronger mnemonic boost than reward, and provided a benefit to memory regardless of whether it occurred in the first or the second 12 hrs following task training.	[Tucker, Matthew A.; Stickgold, Robert] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Tang, Sunny X.; Uzoh, Amaka; Stickgold, Robert] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Tucker, Matthew A.; Morgan, Alexandra; Stickgold, Robert] Ctr Sleep & Cognit, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University	Tucker, MA (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA.	mtucker1@bidmc.harvard.edu		Tang, Sunny/0000-0002-4001-8120	National Institutes of Health [R01-MH48832]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048832, R01MH092638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding: National Institutes of Health R01-MH48832. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; Backhaus J, 2008, NEUROBIOL LEARN MEM, V89, P76, DOI 10.1016/j.nlm.2007.08.010; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Drosopoulos S, 2007, J EXP PSYCHOL GEN, V136, P169, DOI 10.1037/0096-3445.136.2.169; Ellenbogen JM, 2006, CURR OPIN NEUROBIOL, V16, P716, DOI 10.1016/j.conb.2006.10.006; Eschenko O, 2008, LEARN MEMORY, V15, P222, DOI 10.1101/lm.726008; Fenn KM, 2003, NATURE, V425, P614, DOI 10.1038/nature01951; Fischer S, 2009, J EXP PSYCHOL LEARN, V35, P1586, DOI 10.1037/a0017256; Gais S, 2004, P NATL ACAD SCI USA, V101, P2140, DOI 10.1073/pnas.0305404101; Gais S, 2002, J NEUROSCI, V22, P6830; Gais S, 2006, LEARN MEMORY, V13, P259, DOI 10.1101/lm.132106; HODDES E, 1972, PSYCHOPHYSIOLOGY, V9, P150; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; LOFTUS GR, 1970, J EXP PSYCHOL, V85, P141, DOI 10.1037/h0029537; Maquet P., 2003, SLEEP BRAIN PLASTICI; Nielson KA, 2005, NEUROBIOL LEARN MEM, V84, P42, DOI 10.1016/j.nlm.2005.03.004; PAYNE JD, 2010, J COGN NEUROSCI; Payne JD, 2008, PSYCHOL SCI, V19, P781, DOI 10.1111/j.1467-9280.2008.02157.x; Schabus M, 2004, SLEEP, V27, P1479, DOI 10.1093/sleep/27.7.1479; Talamini LM, 2008, LEARN MEMORY, V15, P233, DOI 10.1101/lm.771608; WEINER B, 1966, J EXP PSYCHOL, V71, P190, DOI 10.1037/h0022848; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555	25	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e21737	10.1371/journal.pone.0021737	http://dx.doi.org/10.1371/journal.pone.0021737			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	794WE	21799746	Green Published, gold, Green Submitted			2022-12-25	WOS:000292931200012
J	Ha, LA; Ponnamperuma, RM; Jay, S; Ricci, MS; Weinberg, WC				Ha, Linan; Ponnamperuma, Roshini M.; Jay, Steven; Ricci, M. Stacey; Weinberg, Wendy C.			Dysregulated Delta Np63 alpha Inhibits Expression of Ink4a/arf, Blocks Senescence, and Promotes Malignant Conversion of Keratinocytes	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; P63 ISOFORMS; TUMOR-SUPPRESSOR; P53 HOMOLOG; EPIDERMAL DEVELOPMENT; DIFFERENTIATION; APOPTOSIS; ARREST; CANCER; MICE	p63 is critical for squamous epithelial development, and elevated levels of the Delta Np63 alpha isoform are seen in squamous cell cancers of various organ sites. However, significant controversy exists regarding the role of p63 isoforms as oncoproteins or tumor suppressors. Here, lentiviruses were developed to drive long-term overexpression of Delta Np63 alpha in primary keratinocytes. Elevated levels of Delta Np63 alpha in vitro promote long-term survival and block both replicative and oncogene-induced senescence in primary keratinocytes, as evidenced by the expression of SA-beta-gal and the presence of nuclear foci of heterochromatin protein 1 gamma. The contribution of Delta Np63 alpha to cancer development was assessed using an in vivo grafting model of experimental skin tumorigenesis that allows distinction between benign and malignant tumors. Grafted lenti-Delta Np63 alpha keratinocytes do not form tumors, whereas lenti-GFP/v-ras(Ha) keratinocytes develop well-differentiated papillomas. Lenti-Delta Np63 alpha/v-ras(Ha) keratinocytes form undifferentiated carcinomas. The average volume of lenti-Delta Np63 alpha/v-ras(Ha) tumors was significantly higher than those in the lenti-GFP/v-ras(Ha) group, consistent with increased BrdU incorporation detected by immunohistochemistry. The block in oncogene-induced senescence corresponds to sustained levels of E2F1 and phosphorylated AKT, and is associated with loss of induction of p16(ink4a)/p19(arf). The relevance of p16(ink4a)/p19(arf) loss was demonstrated in grafting studies of p19(arf)-null keratinocytes, which develop malignant carcinomas in the presence of v-ras(Ha) similar to those arising in wildtype keratinocytes that express lenti-Delta Np63 alpha and v-ras(Ha). Our findings establish that Delta Np63 alpha has oncogenic activity and its overexpression in human squamous cell carcinomas contributes to the malignant phenotype, and implicate its ability to regulate p16(ink4a)/p19(arf) in the process.	[Ha, Linan; Ponnamperuma, Roshini M.; Ricci, M. Stacey; Weinberg, Wendy C.] US FDA, Div Monoclonal Antibodies, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA; [Jay, Steven] SAIC Frederick Inc, Frederick, MD USA	US Food & Drug Administration (FDA); Science Applications International Corporation (SAIC); SAIC-Frederick	Ha, LA (corresponding author), US FDA, Div Monoclonal Antibodies, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA.	wendy.weinberg@fda.hhs.gov			Interagency Oncology Task Force Fellowship Program	Interagency Oncology Task Force Fellowship Program	Supported by intramural funding to the Food and Drug Administration (FDA) and the National Cancer Institute (NCI). LH and MSR were fellows of the Interagency Oncology Task Force Fellowship Program. These funding providers had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Steven Jay is an employee of SAIC-Frederick Inc. and helped perform the experiments.	Boldrup L, 2009, J PATHOL, V218, P428, DOI 10.1002/path.2560; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Candi E, 2006, CELL DEATH DIFFER, V13, P1037, DOI 10.1038/sj.cdd.4401926; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Chen YK, 2004, INT J ORAL MAX SURG, V33, P493, DOI 10.1016/j.ijom.2003.10.023; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Frost SJ, 1999, MOL ENDOCRINOL, V13, P1801, DOI 10.1210/me.13.11.1801; Ghioni P, 2002, MOL CELL BIOL, V22, P8659, DOI 10.1128/MCB.22.24.8659-8668.2002; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Ha L, 2007, P NATL ACAD SCI USA, V104, P10968, DOI 10.1073/pnas.0611638104; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Helton ES, 2006, J BIOL CHEM, V281, P2533, DOI 10.1074/jbc.M507964200; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Keyes WM, 2006, P NATL ACAD SCI USA, V103, P8435, DOI 10.1073/pnas.0602477103; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; King KE, 2008, CANCER RES, V68, P5122, DOI 10.1158/0008-5472.CAN-07-6123; King KE, 2006, CARCINOGENESIS, V27, P53, DOI 10.1093/carcin/bgi200; King KE, 2003, ONCOGENE, V22, P3635, DOI 10.1038/sj.onc.1206536; Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160; Koster MI, 2007, P NATL ACAD SCI USA, V104, P3255, DOI 10.1073/pnas.0611376104; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Koster MI, 2006, CANCER RES, V66, P3981, DOI 10.1158/0008-5472.CAN-06-0027; Koster MI, 2002, J INVEST DERM SYMP P, V7, P41, DOI 10.1046/j.1523-1747.2002.19639.x; Leontieva OV, 2010, AGING-US, V2, P924, DOI 10.18632/aging.100265; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lin Z, 2006, INT J GYNECOL CANCER, V16, P1643, DOI 10.1111/j.1525-1438.2006.00638.x; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Nylander K, 2002, J PATHOL, V198, P417, DOI 10.1002/path.1231; Nylander K, 2000, INT J CANCER, V87, P368, DOI 10.1002/1097-0215(20000801)87:3<368::AID-IJC9>3.3.CO;2-A; Perez CA, 2007, CELL CYCLE, V6, P246, DOI 10.4161/cc.6.3.3801; Ponnamperuma RM, 2009, J PATHOL, V219, P263, DOI 10.1002/path.2600; Pozzi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005008; Pruneri G, 2002, LAB INVEST, V82, P1327, DOI 10.1097/01.LAB.0000032373.99569.73; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Romano RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005623; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Su XH, 2009, EMBO J, V28, P1904, DOI 10.1038/emboj.2009.151; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Tremain R, 2000, ONCOGENE, V19, P1698, DOI 10.1038/sj.onc.1203471; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Weinberg WC, 1997, ONCOGENE, V15, P685, DOI 10.1038/sj.onc.1201230; Wrone DA, 2004, DERMATOL SURG, V30, P1299, DOI 10.1111/j.1524-4725.2004.30403.x; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zhu L, 2007, J INVEST DERMATOL, V127, P1980, DOI 10.1038/sj.jid.5700797	50	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e21877	10.1371/journal.pone.0021877	http://dx.doi.org/10.1371/journal.pone.0021877			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789189	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811700007
J	Guedj, M; Marisa, L; de Reynies, A; Orsetti, B; Schiappa, R; Bibeau, F; MacGrogan, G; Lerebours, F; Finetti, P; Longy, M; Bertheau, P; Bertrand, F; Bonnet, F; Martin, AL; Feugeas, JP; Bieche, I; Lehmann-Che, J; Lidereau, R; Birnbaum, D; Bertucci, F; de The, H; Theillet, C				Guedj, M.; Marisa, L.; de Reynies, A.; Orsetti, B.; Schiappa, R.; Bibeau, F.; MacGrogan, G.; Lerebours, F.; Finetti, P.; Longy, M.; Bertheau, P.; Bertrand, F.; Bonnet, F.; Martin, A. L.; Feugeas, J. P.; Bieche, I.; Lehmann-Che, J.; Lidereau, R.; Birnbaum, D.; Bertucci, F.; de The, H.; Theillet, C.			A refined molecular taxonomy of breast cancer	ONCOGENE			English	Article						breast cancer; molecular classification; taxonomy; transcriptome; CGH-array, outcome	ANDROGEN RECEPTOR; SUBTYPES; TUMORS; METASTASIS; PROGENITORS; PREDICTORS; GRADE	The current histoclinical breast cancer classification is simple but imprecise. Several molecular classifications of breast cancers based on expression profiling have been proposed as alternatives. However, their reliability and clinical utility have been repeatedly questioned, notably because most of them were derived from relatively small initial patient populations. We analyzed the transcriptomes of 537 breast tumors using three unsupervised classification methods. A core subset of 355 tumors was assigned to six clusters by all three methods. These six subgroups overlapped with previously defined molecular classes of breast cancer, but also showed important differences, notably the absence of an ERBB2 subgroup and the division of the large luminal ER+ group into four subgroups, two of them being highly proliferative. Of the six subgroups, four were ER+/PR+/AR+, one was ER-PR-/AR+ and one was triple negative (AR-/ER-/PR-). ERBB2-amplified tumors were split between the ER-/PR-/AR+ subgroup and the highly proliferative ER+ LumC subgroup. Importantly, each of these six molecular subgroups showed specific copy-number alterations. Gene expression changes were correlated to specific signaling pathways. Each of these six subgroups showed very significant differences in tumor grade, metastatic sites, relapse-free survival or response to chemotherapy. All these findings were validated on large external datasets including more than 3000 tumors. Our data thus indicate that these six molecular subgroups represent well-defined clinico-biological entities of breast cancer. Their identification should facilitate the detection of novel prognostic factors or therapeutical targets in breast cancer. Oncogene (2012) 31, 1196-1206; doi:10.1038/onc.2011.301; published online 25 July 2011	[Theillet, C.] CRLC Val dAurelle Paul Lamarque, Inst Rech Canc Montpellier, INSERM, U896, F-34298 Montpellier 5, France; [Guedj, M.; Marisa, L.; de Reynies, A.; Schiappa, R.] Ligue Natl Canc, Cartes Identite Tumeurs Program, Paris, France; [Bibeau, F.] CRLC Val dAurelle Paul Lamarque, Dept Pathol, F-34298 Montpellier 5, France; [MacGrogan, G.; Longy, M.; Bonnet, F.] Univ Bordeaux 2, EA 3669, F-33076 Bordeaux, France; [MacGrogan, G.; Longy, M.; Bonnet, F.] Inst Bergonie, Dept Pathol, Bordeaux, France; [Lerebours, F.; Bertrand, F.; Bieche, I.; Lidereau, R.] Inst Curie Hop Ctr Rene Huguenin, Oncogenet Lab, INSERM, U735, St Cloud, France; [Finetti, P.; Birnbaum, D.; Bertucci, F.] Inst J Paoli I Calmettes, Dept Mol Oncol, CRCM, Ctr Rech Canc Marseille, F-13009 Marseille, France; [Bertheau, P.] Univ Paris, Hop St Louis, APHP, Dept Pathol, F-75252 Paris, France; [Martin, A. L.] Federat Natl Ctr Lutte Canc, Paris, France; [Feugeas, J. P.; Lehmann-Che, J.; de The, H.] Hop St Louis, APHP, Dept Biochem, Paris, France; [Feugeas, J. P.; Lehmann-Che, J.; de The, H.] CNRS, INSERM, UMR 944 7212, Paris, France; [Feugeas, J. P.; Lehmann-Che, J.; de The, H.] Univ Paris 07, Univ Hematol Inst, Paris, France; [Theillet, C.] Univ Montpellier 1, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; Institut National de la Sante et de la Recherche Medicale (Inserm); Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier	Theillet, C (corresponding author), CRLC Val dAurelle Paul Lamarque, Inst Rech Canc Montpellier, INSERM, U896, F-34298 Montpellier 5, France.	charles.theillet@inserm.fr	SCHIAPPA, Renaud/K-8192-2019; Feillet, Francois/A-3648-2017; de Reyniès, Aurélien/Q-8640-2017; Bièche, Ivan/O-7399-2017; Theillet, Charles/O-7634-2018; Finetti, Pascal/O-8669-2017	Feillet, Francois/0000-0002-8717-469X; de Reyniès, Aurélien/0000-0002-1328-5290; Bièche, Ivan/0000-0002-2430-5429; Theillet, Charles/0000-0001-5555-2759; MacGrogan, Gaetan/0000-0002-3483-9758; SCHIAPPA, Renaud/0000-0001-5104-9507; Finetti, Pascal/0000-0002-2674-3123; Lehmann-Che, jacqueline/0000-0001-6685-3354	Ligue Nationale Contre le Cancer	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by the Carte d'Identite des Tumeurs Program from the Ligue Nationale Contre le Cancer. We thank Pr Jacqueline Godet and Dr Jacqueline Metral for their constant support during the course of this work. The expertize of the personnel serving the RNA extraction and qualification (Saint-Louis Hospital, Paris), Affymetrix expression array (IGBMC, Strasbourg), CIT database and array-CGH (IRCM, Montpellier) CIT platforms is gratefully acknowledged. We further thank Dr Stan du Manoir for critical reading of the manuscript, Vessela N Kristensen and Peter Van Loo for making their data available to us.	Bertheau P, 2007, PLOS MED, V4, P585, DOI 10.1371/journal.pmed.0040090; Bertucci F, 2008, ONCOGENE, V27, P5359, DOI 10.1038/onc.2008.158; Bertucci F, 2006, OMICS, V10, P429, DOI 10.1089/omi.2006.10.429; Bonnefoi Herve, 2007, Lancet Oncol, V8, P1071, DOI 10.1016/S1470-2045(07)70345-5; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; de Reynies A, 2009, J CLIN ONCOL, V27, P1108, DOI 10.1200/JCO.2008.18.5678; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gusterson B, 2009, NAT REV CANCER, V9, P128, DOI 10.1038/nrc2571; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; ISOLA JJ, 1993, J PATHOL, V170, P31, DOI 10.1002/path.1711700106; Jonsson G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2596; Kapp AV, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-231; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Naderi A, 2008, NEOPLASIA, V10, P542, DOI 10.1593/neo.08274; Natrajan R, 2009, CLIN CANCER RES, V15, P2711, DOI 10.1158/1078-0432.CCR-08-1878; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Staaf J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2568; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; van 't Veer LJ, 2003, BREAST CANCER RES, V5, P57, DOI 10.1186/bcr562; Weigelt B, 2010, LANCET ONCOL, V11, P339, DOI 10.1016/S1470-2045(10)70008-5; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	35	184	193	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	9					1196	1206		10.1038/onc.2011.301	http://dx.doi.org/10.1038/onc.2011.301			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	901EW	21785460	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000300945900013
J	Helman, E; Naxerova, K; Kohane, IS				Helman, E.; Naxerova, K.; Kohane, I. S.			DNA hypermethylation in lung cancer is targeted at differentiation-associated genes	ONCOGENE			English	Article						Hypermethylation; development; non-small cell lung cancer; gene expression	TUMOR-SUPPRESSOR GENE; CPG-ISLAND METHYLATION; EMBRYONIC STEM-CELLS; EARLY EVENT; GENOME; MARKERS; GERM; HYPOMETHYLATION; CARDIOMYOCYTES; RETINOBLASTOMA	Aberrant DNA hypermethylation of tumor suppressor genes is thought to be an early event in tumorigenesis. Many studies have reported the methylation status of individual genes with known involvement in cancer, but an unbiased assessment of the biological function of the collective of hypermethylated genes has not been conducted so far. Based on the observation that a variety of human cancers recapitulate developmental gene expression patterns ( that is activate genes normally expressed in early development and suppress late developmental genes), we hypothesized that the silencing of differentiation-associated genes in cancer could be attributed in part to DNA hypermethylation. To this end, we investigated the developmental expression patterns of genes with hypermethylated CpG islands in primary human lung carcinomas and lung cancer cell lines. We found that DNA hypermethylation primarily affects genes that are expressed in late stages of murine lung development. Gene ontology characterization of these genes shows that they are almost exclusively involved in morphogenetic differentiation processes. Our results indicate that DNA hypermethylation in cancer functions as a selective silencing mechanism of genes that are required for the maintenance of a differentiated state. The process of cellular de-differentiation that is evident on both the microscopic and transcriptional level in cancer might at least partly be mediated by these epigenetic events. Our observations provide a mechanistic explanation for induction of differentiation upon treatment with DNA methyltransferase inhibitors. Oncogene (2012) 31, 1181-1188; doi:10.1038/onc.2011.307; published online 1 August 2011	[Kohane, I. S.] Childrens Hosp, Informat Program, Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA; [Naxerova, K.] Harvard Univ, Sch Med, Boston, MA USA; [Naxerova, K.] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Kohane, IS (corresponding author), Childrens Hosp, Informat Program, Harvard Mit Div Hlth Sci & Technol, 300 Longwood Ave,Enders 6L, Boston, MA 02115 USA.	Isaac_Kohane@hms.harvard.edu	Kohane, Isaac Kohane/K-3716-2012	Kohane, Isaac Kohane/0000-0003-2192-5160; Naxerova, Kamila/0000-0001-7744-5110				ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; Armstrong L, 2006, STEM CELLS, V24, P805, DOI 10.1634/stemcells.2005-0350; Banerjee S, 2010, EXP CELL RES, V316, P172, DOI 10.1016/j.yexcr.2009.08.011; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Baylin SB, 1998, ADV CANCER RES, V72, P141; Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Borczuk AC, 2003, AM J PATHOL, V163, P1949, DOI 10.1016/S0002-9440(10)63553-5; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Delgado S, 1998, EMBO J, V17, P2426, DOI 10.1093/emboj/17.8.2426; Esteller M, 2005, ANNU REV PHARMACOL, V45, P629, DOI 10.1146/annurev.pharmtox.45.120403.095832; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Esteller M, 2001, CANCER RES, V61, P3225; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531; GREGER V, 1989, HUM GENET, V83, P155, DOI 10.1007/BF00286709; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hayslip J, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-44; Heller G, 2010, CANCER METAST REV, V29, P95, DOI 10.1007/s10555-010-9203-x; HERMAN JG, 1995, CANCER RES, V55, P4525; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KESHET I, 1986, CELL, V44, P535, DOI 10.1016/0092-8674(86)90263-1; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Liu HY, 2006, PLOS MED, V3, P1090, DOI 10.1371/journal.pmed.0030232; Marchevsky AM, 2004, J MOL DIAGN, V6, P28, DOI 10.1016/S1525-1578(10)60488-6; McLaren A, 2000, MOL CELL ENDOCRINOL, V163, P3, DOI 10.1016/S0303-7207(99)00234-8; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; MOMPARLER RL, 1985, LEUKEMIA RES, V9, P1361, DOI 10.1016/0145-2126(85)90123-7; Naxerova K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r108; Nephew KP, 2003, CANCER LETT, V190, P125, DOI 10.1016/S0304-3835(02)00511-6; Nuovo GJ, 1999, P NATL ACAD SCI USA, V96, P12754, DOI 10.1073/pnas.96.22.12754; Pfeifer GP, 2009, SEMIN CANCER BIOL, V19, P181, DOI 10.1016/j.semcancer.2009.02.008; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; Rauch TA, 2008, P NATL ACAD SCI USA, V105, P252, DOI 10.1073/pnas.0710735105; Safar AM, 2005, CLIN CANCER RES, V11, P4400, DOI 10.1158/1078-0432.CCR-04-2378; SAKAI T, 1991, AM J HUM GENET, V48, P880; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Tsou JA, 2002, ONCOGENE, V21, P5450, DOI 10.1038/sj.onc.1205605; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Wang Y, 2004, BIOINFORMATICS, V20, P1170, DOI 10.1093/bioinformatics/bth059; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Yoon BS, 2006, DIFFERENTIATION, V74, P149, DOI 10.1111/j.1432-0436.2006.00063.x	49	19	19	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	9					1181	1188		10.1038/onc.2011.307	http://dx.doi.org/10.1038/onc.2011.307			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	901EW	21804601				2022-12-25	WOS:000300945900011
J	Molina, JR; Agarwal, NK; Morales, FC; Hayashi, Y; Aldape, KD; Cote, G; Georgescu, MM				Molina, J. R.; Agarwal, N. K.; Morales, F. C.; Hayashi, Y.; Aldape, K. D.; Cote, G.; Georgescu, M-M			PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma	ONCOGENE			English	Article						glioblastoma; PTEN; NHERF1; PHLPP; Akt	MEMBRANE ASSOCIATION; BREAST-CANCER; PDZ DOMAIN; PROTEIN; BINDING; GROWTH; AKT; PHOSPHATASE; RECEPTOR; CELLS	The phosphatidylinositol-3-OH kinase (PI3K)-Akt pathway is activated in cancer by genetic or epigenetic events and efforts are under way to develop targeted therapies. phosphatase and tensin homolog deleted on chromosome 10 (PTEN) tumor suppressor is the major brake of the pathway and a common target for inactivation in glioblastoma, one of the most aggressive and therapy-resistant cancers. To achieve potent inhibition of the PI3K-Akt pathway in glioblastoma, we need to understand its mechanism of activation by investigating the interplay between its regulators. We show here that PTEN modulates the PI3K-Akt pathway in glioblastoma within a tumor suppressor network that includes Na+/H+ exchanger regulatory factor 1 (NHERF1) and pleckstrin-homology domain leucine-rich repeat protein phosphatases 1 (PHLPP1). The NHERF1 adaptor, previously characterized by our group as a PTEN ligand and regulator, shows also PTEN-independent Akt-modulating effects that led us to identify the PHLPP1/PHLPP2 Akt phosphatases as NHERF1 ligands. NHERF1 interacts via its PDZ domains with PHLPP1/PHLPP2 and scaffolds heterotrimeric complexes with PTEN. Functionally, PHLPP1 requires NHERF1 for membrane localization and growth-suppressive effects. PHLPP1 loss boosts Akt phosphorylation only in PTEN-negative cells and cooperates with PTEN loss for tumor growth. In a panel of low-grade and high-grade glioma patient samples, we show for the first time a significant disruption of all three members of the PTEN-NHERF1-PHLPP1 tumor suppressor network in high-grade tumors, correlating with Akt activation and patient's abysmal survival. We thus propose a PTEN-NHERF1-PHLPP PI3K-Akt pathway inhibitory network that relies on molecular interactions and can undergo parallel synergistic hits in glioblastoma. Oncogene (2012) 31, 1264-1274; doi:10.1038/onc.2011.324; published online 1 August 2011	[Molina, J. R.; Agarwal, N. K.; Morales, F. C.; Hayashi, Y.; Georgescu, M-M] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Aldape, K. D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Cote, G.] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Georgescu, MM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, 6767 Bertner Ave, Houston, TX 77030 USA.	mgeorges@mdanderson.org	Georgescu, Maria-Magdalena/AAJ-6359-2020		 [NCI-CA107201];  [NCI-CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA107201] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank NCI-CA107201 and the corresponding ARRA supplement (M-M. Georgescu), and NCI-CA16672 that partially supported the DNA sequencing and animal breeding.	Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Cardone RA, 2007, MOL BIOL CELL, V18, P1768, DOI 10.1091/mbc.E06-07-0617; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Fouassier L, 2000, J BIOL CHEM, V275, P25039, DOI 10.1074/jbc.C000092200; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Georgescu MM, 2008, CURR MOL MED, V8, P459, DOI 10.2174/156652408785748031; Georgescu Maria-Magdalena, 2010, Genes Cancer, V1, P1170, DOI 10.1177/1947601911407325; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Hall RA, 1998, P NATL ACAD SCI USA, V95, P8496, DOI 10.1073/pnas.95.15.8496; Hayashi Y, 2010, NEOPLASIA, V12, P1013, DOI 10.1593/neo.10780; Kreimann EL, 2007, ONCOGENE, V26, P5290, DOI 10.1038/sj.onc.1210336; Lazar CS, 2004, MOL BIOL CELL, V15, P5470, DOI 10.1091/mbc.E04-03-0239; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Molina JR, 2010, CANCER RES, V70, P6697, DOI 10.1158/0008-5472.CAN-10-1271; Molina JR, 2010, NEOPLASIA, V12, P453, DOI 10.1593/neo.10126; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Murthy A, 1998, J BIOL CHEM, V273, P1273, DOI 10.1074/jbc.273.3.1273; Pan Y, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1846; Qiao M, 2010, MOL CELL, V38, P512, DOI 10.1016/j.molcel.2010.03.017; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shenolikar S, 2001, FEBS LETT, V489, P233, DOI 10.1016/S0014-5793(01)02109-3; Shibata T, 2003, HEPATOLOGY, V38, P178, DOI 10.1053/jhep.2003.50270; Shimizu K, 1999, FEBS LETT, V458, P363, DOI 10.1016/S0014-5793(99)01190-4; Song J, 2007, HISTOPATHOLOGY, V51, P40, DOI 10.1111/j.1365-2559.2007.02730.x; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Walker SM, 2004, BIOCHEM J, V379, P301, DOI 10.1042/BJ20031839; Weinman EJ, 1998, J CLIN INVEST, V101, P2199, DOI 10.1172/JCI204	40	131	133	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	10					1264	1274		10.1038/onc.2011.324	http://dx.doi.org/10.1038/onc.2011.324			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	906KS	21804599	Green Accepted			2022-12-25	WOS:000301344600006
J	Orr, B; Riddick, ACP; Stewart, GD; Anderson, RA; Franco, OE; Hayward, SW; Thomson, AA				Orr, B.; Riddick, A. C. P.; Stewart, G. D.; Anderson, R. A.; Franco, O. E.; Hayward, S. W.; Thomson, A. A.			Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostate	ONCOGENE			English	Article						prostate; stromal/epithelial interactions; cancer-associated fibroblasts; cancer microenvironment; Tag profiling	GENE-EXPRESSION; BREAST-CANCER; TUMOR MICROENVIRONMENT; REACTIVE STROMA; GROWTH-FACTOR; CELLS; CARCINOGENESIS; PROGRESSION; MESENCHYME; BETA	The stromal microenvironment has key roles in prostate development and cancer, and cancer-associated fibroblasts (CAFs) stimulate tumourigenesis via several mechanisms including the expression of pro-tumourigenic factors. Mesenchyme (embryonic stroma) controls prostate organogenesis, and in some circumstances can re-differentiate prostate tumours. We have applied next-generation Tag profiling to fetal human prostate, normal human prostate fibroblasts (NPFs) and CAFs to identify molecules expressed in prostatic stroma. Comparison of gene expression profiles of a patient-matched pair of NPFs vs CAFs identified 671 transcripts that were enriched in CAFs and 356 transcripts whose levels were decreased, relative to NPFs. Gene ontology analysis revealed that CAF-enriched transcripts were associated with prostate morphogenesis and CAF-depleted transcripts were associated with cell cycle. We selected mRNAs to follow-up by comparison of our data sets with published prostate cancer fibroblast microarray profiles as well as by focusing on transcripts encoding secreted and peripheral membrane proteins, as well as mesenchymal transcripts identified in a previous study from our group. We confirmed differential transcript expression between CAFs and NPFs using QrtPCR, and defined protein localization using immunohistochemistry in fetal prostate, adult prostate and prostate cancer. We demonstrated that ASPN, CAV1, CFH, CTSK, DCN, FBLN1, FHL1, FN, NKTR, OGN, PARVA, S100A6, SPARC, STC1 and ZEB1 proteins showed specific and varied expression patterns in fetal human prostate and in prostate cancer. Colocalization studies suggested that some stromally expressed molecules were also expressed in subsets of tumour epithelia, indicating that they may be novel markers of EMT. Additionally, two molecules (ASPN and STC1) marked overlapping and distinct subregions of stroma associated with tumour epithelia and may represent new CAF markers. Oncogene (2012) 31, 1130-1142; doi:10.1038/onc.2011.312; published online 1 August 2011	[Orr, B.; Thomson, A. A.] Queens Med Res Inst, Med Res Council Human Reprod Sci Unit, Edinburgh EH16 4TJ, Midlothian, Scotland; [Riddick, A. C. P.; Stewart, G. D.] Western Gen Hosp, Dept Urol, Edinburgh EH4 2XU, Midlothian, Scotland; [Anderson, R. A.] Univ Edinburgh, Reprod & Dev Sci Sect, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Franco, O. E.; Hayward, S. W.] Vanderbilt Univ, Med Ctr, Dept Urol Surg, Nashville, TN USA; [Franco, O. E.; Hayward, S. W.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA	University of Edinburgh; University of Edinburgh; University of Edinburgh; Vanderbilt University; Vanderbilt University	Thomson, AA (corresponding author), Queens Med Res Inst, Med Res Council Human Reprod Sci Unit, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	a.thomson@hrsu.mrc.ac.uk	Thomson, Axel/A-7893-2013	Stewart, Grant D./0000-0003-3188-9140; Hayward, Simon/0000-0002-6059-6550	MRC WBSe [1276.00.003.00004.01]; NCI [CA126505]; MRC; Prostate Cancer Charity; Medical Research Council [G1002033, MC_U127684421, G1100357, G1002118] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U54CA126505] Funding Source: NIH RePORTER; MRC [G1002033, MC_U127684421, G1002118, G1100357] Funding Source: UKRI	MRC WBSe(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Prostate Cancer Charity; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank Ted Pinner for help with the figure preparation, Donald Dunbar for Bio-informatic advice and Sheila Macpherson for help with colocalization. This work was funded by the MRC WBSe 1276.00.003.00004.01 to AAT and NCI CA126505 to SWH. The MRC Human Reproductive Sciences Unit closed on 31 March 2011. AAT was supported by the MRC and The Prostate Cancer Charity.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Augsten M, 2009, P NATL ACAD SCI USA, V106, P3414, DOI 10.1073/pnas.0813144106; Ayala G, 2003, CLIN CANCER RES, V9, P4792; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Cunha GR, 2002, DIFFERENTIATION, V70, P473, DOI 10.1046/j.1432-0436.2002.700902.x; Dakhova O, 2009, CLIN CANCER RES, V15, P3979, DOI 10.1158/1078-0432.CCR-08-1899; Di Vizio D, 2009, CELL CYCLE, V8, P2420, DOI 10.4161/cc.8.15.9116; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Franco OE, 2011, CANCER RES, V71, P1272, DOI 10.1158/0008-5472.CAN-10-3142; Gregg JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-165; HAYASHI N, 1991, CANCER RES, V51, P4924; Hayward SW, 1996, ANN NY ACAD SCI, V784, P50, DOI 10.1111/j.1749-6632.1996.tb16227.x; Hayward SW, 2001, CANCER RES, V61, P8135; Joensuu K, 2008, CANCER LETT, V265, P76, DOI 10.1016/j.canlet.2008.02.022; Joesting MS, 2005, CANCER RES, V65, P10423, DOI 10.1158/0008-5472.CAN-05-0824; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kiskowski MA, 2011, CANCER RES, V71, P3459, DOI 10.1158/0008-5472.CAN-10-2999; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Lesniak W, 2009, BIOCHEM BIOPH RES CO, V390, P1087, DOI 10.1016/j.bbrc.2009.10.150; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Madar S, 2009, CARCINOGENESIS, V30, P20, DOI 10.1093/carcin/bgn232; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pascal LE, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-317; Placencio VR, 2008, CANCER RES, V68, P4709, DOI 10.1158/0008-5472.CAN-07-6289; Pritchard C, 2009, CANCER RES, V69, P1739, DOI 10.1158/0008-5472.CAN-07-6817; Rehman I, 2005, PROSTATE, V65, P322, DOI 10.1002/pros.20302; Schaeffer EM, 2008, ONCOGENE, V27, P7180, DOI 10.1038/onc.2008.327; Stasko SE, 2001, DEV DYNAM, V220, P49, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1086>3.0.CO;2-5; Stolovitzky GA, 2005, P NATL ACAD SCI USA, V102, P1402, DOI 10.1073/pnas.0406555102; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Thalmann GN, 2010, EUR UROL, V58, P162, DOI 10.1016/j.eururo.2009.08.026; Thomson AA, 1999, DEVELOPMENT, V126, P3693; TIMMS BG, 1995, MICROSC RES TECHNIQ, V30, P319, DOI 10.1002/jemt.1070300407; Tuxhorn JA, 2002, CANCER RES, V62, P3298; Vanpoucke G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r213; Watson JEV, 2004, PROSTATE, V61, P192, DOI 10.1002/pros.20100; Whitaker HC, 2010, PROSTATE, V70, P333, DOI 10.1002/pros.21059; Witkiewicz AK, 2009, CELL CYCLE, V8, P1654, DOI 10.4161/cc.8.11.8544; Yanagisawa N, 2007, HUM PATHOL, V38, P1611, DOI 10.1016/j.humpath.2007.04.008; Zhao HJ, 2007, J CELL PHYSIOL, V210, P111, DOI 10.1002/jcp.20828	42	83	85	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	9					1130	1142		10.1038/onc.2011.312	http://dx.doi.org/10.1038/onc.2011.312			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	901EW	21804603	Green Published, hybrid			2022-12-25	WOS:000300945900006
J	Westendorf, C; Schmidt, A; Coin, I; Furkert, J; Ridelis, I; Zampatis, D; Rutz, C; Wiesner, B; Rosenthal, W; Beyermann, M; Schulein, R				Westendorf, Carolin; Schmidt, Antje; Coin, Irene; Furkert, Jens; Ridelis, Ingrid; Zampatis, Dimitris; Rutz, Claudia; Wiesner, Burkhard; Rosenthal, Walter; Beyermann, Michael; Schuelein, Ralf			Inhibition of Biosynthesis of Human Endothelin B Receptor by the Cyclodepsipeptide Cotransin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-PEPTIDE; COTRANSLATIONAL TRANSLOCATION; PROTEINS; PREDICTION; SEQUENCES; CLEAVAGE	The specific inhibition of the biosynthesis of target proteins is a relatively novel strategy in pharmacology and is based mainly on antisense approaches (e.g. antisense oligonucleotides or RNA interference). Recently, a novel class of substances was described acting at a later step of protein biosynthesis. The cyclic heptadepsipeptides CAM741 and cotransin were shown to inhibit selectively the biosynthesis of a small subset of secretory proteins by preventing stable insertion of the nascent chains into the Sec61 translocon complex at the endoplasmic reticulum membrane (Besemer, J., Harant, H., Wang, S., Oberhauser, B., Marquardt, K., Foster, C. A., Schreiner, E. P., de Vries, J. E., Dascher-Nadel, C., and Lindley, I. J. (2005) Nature 436, 290-293; Garrison, J. L., Kunkel, E. J., Hegde, R. S., and Taunton, J. (2005) Nature 436, 285-289). These peptides act in a signal sequence-discriminatory manner, which explains their selectivity. Here, we have analyzed the cotransin sensitivity of various G protein-coupled receptors in transfected HEK 293 cells. We show that the biosynthesis of the human endothelin B receptor (ETBR) is highly sensitive to cotransin, in contrast to that of the other G protein-coupled receptors analyzed. Using a novel biosynthesis assay based on fusions with the photoconvertible Kaede protein, we show that the IC50 value of cotransin action on ETBR biosynthesis is 5.4 mu M and that ETBR signaling could be completely blocked by treating cells with 30 mu M cotransin. Taken together, our data add an integral membrane protein, namely the ETBR, to the small group of cotransin-sensitive proteins.	[Westendorf, Carolin; Furkert, Jens; Ridelis, Ingrid; Zampatis, Dimitris; Rutz, Claudia; Wiesner, Burkhard; Beyermann, Michael; Schuelein, Ralf] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Schmidt, Antje; Rosenthal, Walter] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Coin, Irene] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Ridelis, Ingrid; Rosenthal, Walter] Charite, Bereich Mol Pharmakol & Zellbiol, D-14195 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Salk Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schulein, R (corresponding author), Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany.	schuelein@fmp-berlin.de			Deutsche Forschungsgemeinschaft [SFB 449, SCHU 1116/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft Grant SFB 449 and Grant SCHU 1116/2-1.	Alken M, 2005, BIOCHEM J, V390, P455, DOI 10.1042/BJ20050113; Alken M, 2009, MOL PHARMACOL, V75, P801, DOI 10.1124/mol.108.051581; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; AUDIGIER Y, 1987, P NATL ACAD SCI USA, V84, P5783, DOI 10.1073/pnas.84.16.5783; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Besemer J, 2005, NATURE, V436, P290, DOI 10.1038/nature03670; Boger DL, 1999, J AM CHEM SOC, V121, P6197, DOI 10.1021/ja990918u; Coin I, 2008, ORG LETT, V10, P3857, DOI 10.1021/ol800855p; Coin I, 2007, NAT PROTOC, V2, P3247, DOI 10.1038/nprot.2007.454; Garrison JL, 2005, NATURE, V436, P285, DOI 10.1038/nature03821; Grantcharova E, 2002, J BIOL CHEM, V277, P43933, DOI 10.1074/jbc.M208407200; Harant H, 2007, MOL PHARMACOL, V71, P1657, DOI 10.1124/mol.107.034249; Harant H, 2006, J BIOL CHEM, V281, P30492, DOI 10.1074/jbc.M607243200; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; Kochl R, 2002, J BIOL CHEM, V277, P16131, DOI 10.1074/jbc.M111674200; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; MacKinnon AL, 2007, J AM CHEM SOC, V129, P14560, DOI 10.1021/ja076250y; Mizuno H, 2003, MOL CELL, V12, P1051, DOI 10.1016/S1097-2765(03)00393-9; Moller T, 1997, NEUROREPORT, V8, P2127; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; Rutz C, 2006, J BIOL CHEM, V281, P24910, DOI 10.1074/jbc.M601554200; Sambrook J, 2001, MOL CLONING LAB MANU; Schmidt A, 2009, TRAFFIC, V10, P2, DOI 10.1111/j.1600-0854.2008.00843.x; Schreiner EP, 2004, BIOORG MED CHEM LETT, V14, P5003, DOI 10.1016/j.bmcl.2004.07.012; von Heijne G, 1990, CURR OPIN CELL BIOL, V2, P604, DOI 10.1016/0955-0674(90)90100-S; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WATAKABE T, 1992, BIOCHEM BIOPH RES CO, V185, P867, DOI 10.1016/0006-291X(92)91707-W; Wietfeld D, 2004, J BIOL CHEM, V279, P38386, DOI 10.1074/jbc.M405335200	29	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35588	35600		10.1074/jbc.M111.239244	http://dx.doi.org/10.1074/jbc.M111.239244			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21808059	Green Published, hybrid			2022-12-25	WOS:000295927100031
J	Sakurai, A; Jian, XY; Lee, CJ; Manavski, Y; Chavakis, E; Donaldson, J; Randazzo, PA; Gutkind, JS				Sakurai, Atsuko; Jian, Xiaoying; Lee, Charity J.; Manavski, Yosif; Chavakis, Emmanouil; Donaldson, Julie; Randazzo, Paul A.; Gutkind, J. Silvio			Phosphatidylinositol-4-phosphate 5-Kinase and GEP100/Brag2 Protein Mediate Antiangiogenic Signaling by Semaphorin 3E-Plexin-D1 through Arf6 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE PROTEIN; POSTSYNAPTIC DENSITY; ACTIN CYTOSKELETON; TUMOR ANGIOGENESIS; CELL-ADHESION; MEMBRANE; DOMAIN; ALPHA; 4,5-BISPHOSPHATE; ENDOCYTOSIS	The semaphorins are a family of secreted or membrane-bound proteins that are known to guide axons in the developing nervous system. Genetic evidence revealed that a class III semaphorin, semaphorin 3E (Sema3E), and its receptor Plexin-D1 also control the vascular patterning during development. At the molecular level, we have recently shown that Sema3E acts on Plexin-D1 expressed in endothelial cells, thus initiating a novel antiangiogenic signaling pathway that results in the retraction of filopodia in endothelial tip cells. Sema3E induces the rapid disassembly of integrin-mediated adhesive structures, thereby inhibiting endothelial cell adhesion to the extracellular matrix. This process requires the activation of small GTPase Arf6 (ADP-ribosylation factor 6), which regulates intracellular trafficking of beta 1 integrin. However, the molecular mechanisms by which Sema3E-Plexin-D1 activates Arf6 remained to be identified. Here we show that GEP100 (guanine nucleotide exchange protein 100)/Brag2, a guanine nucleotide exchange factor for Arf6, mediates Sema3E-induced Arf6 activation in endothelial cells. We provide evidence that upon activation by Sema3E, Plexin-D1 recruits phosphatidylinositol-4-phosphate 5-kinase, and its enzymatic lipid product, phosphatidylinositol 4,5-bisphosphate, binds to the pleckstrin homology domain of GEP100. Phosphatidylinositol 4,5-bisphosphate binding to GEP100 enhances its guanine nucleotide exchange factor activity toward Arf6, thus resulting in the disassembly of integrin-mediated focal adhesions and endothelial cell collapse. Our present study reveals a novel phospholipid-regulated antiangiogenic signaling pathway whereby Sema3E activates Arf6 through Plexin-D1 and consequently controls integrin-mediated endothelial cell attachment to the extracellular matrix and migration.	[Sakurai, Atsuko; Lee, Charity J.; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Jian, Xiaoying; Randazzo, Paul A.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Manavski, Yosif; Chavakis, Emmanouil] Goethe Univ, Inst Cardiovasc Regenerat, Ctr Mol Med, Frankfurt, Germany; [Chavakis, Emmanouil] Goethe Univ Frankfurt, Dept Internal Med 3, D-6000 Frankfurt, Germany; [Donaldson, Julie] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Goethe University Frankfurt; Goethe University Frankfurt; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Gutkind, JS (corresponding author), Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, 30 Convent Dr,Rm 211, Bethesda, MD 20892 USA.	sg39v@nih.gov	Gutkind, J. Silvio/A-1053-2009; Gutkind, J. Silvio/J-1201-2016	Gutkind, J. Silvio/0000-0002-5150-4482	National Institute of Dental and Craniofacial Research; Japan Society for the Promotion of Science; Deutsche Forschungsgemeinschaft [TR-SFB23, A2]; NATIONAL CANCER INSTITUTE [ZIABC007365] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by a National Institutes of the extracellular matrix and causing the retraction of filopodia Health grant from Intramural Research Program of the National Institute of Dental and Craniofacial Research.; Supported by Japan Society for the Promotion of Science postdoctoral fellowships for research abroad.; Supported by Deutsche Forschungsgemeinschaft Grant TR-SFB23, Project A2.	Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; Bhatt A, 2002, J CELL SCI, V115, P3415; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Campa F, 2009, J BIOL CHEM, V284, P28069, DOI 10.1074/jbc.M109.028266; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Chao WT, 2010, MOL CELL BIOL, V30, P4463, DOI 10.1128/MCB.01207-09; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Derrien V, 2002, J CELL SCI, V115, P2867; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gay CM, 2011, DEV BIOL, V349, P1, DOI 10.1016/j.ydbio.2010.09.008; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Ha VL, 2005, METHOD ENZYMOL, V404, P164, DOI 10.1016/S0076-6879(05)04016-4; Hiroi T, 2006, P NATL ACAD SCI USA, V103, P10672, DOI 10.1073/pnas.0604091103; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Inaba Y, 2004, J NEUROCHEM, V89, P1347, DOI 10.1111/j.1471-4159.2004.02440.x; Jian XY, 2010, TRAFFIC, V11, P732, DOI 10.1111/j.1600-0854.2010.01054.x; Kessler O, 2004, CANCER RES, V64, P1008, DOI 10.1158/0008-5472.CAN-03-3090; Kwiatkowska K, 2010, CELL MOL LIFE SCI, V67, P3927, DOI 10.1007/s00018-010-0432-5; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Moriya J, 2010, CIRC RES, V106, P391, DOI 10.1161/CIRCRESAHA.109.210815; Murphy JA, 2006, BRAIN RES, V1120, P35, DOI 10.1016/j.brainres.2006.08.096; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; RANDAZZO PA, 1995, J BIOL CHEM, V270, P14809, DOI 10.1074/jbc.270.24.14809; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Sakurai A, 2010, MOL CELL BIOL, V30, P3086, DOI 10.1128/MCB.01652-09; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Someya A, 2001, P NATL ACAD SCI USA, V98, P2413, DOI 10.1073/pnas.051634798; Someya A, 2010, J BIOL CHEM, V285, P30698, DOI 10.1074/jbc.M110.107458; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; Tolias KF, 1998, J BIOL CHEM, V273, P18040, DOI 10.1074/jbc.273.29.18040; Tolias KF, 2000, CURR BIOL, V10, P153, DOI 10.1016/S0960-9822(00)00315-8; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang YF, 2008, J CLIN INVEST, V118, P812, DOI 10.1172/JCI34239; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	45	35	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34335	34345		10.1074/jbc.M111.259499	http://dx.doi.org/10.1074/jbc.M111.259499			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21795701	hybrid, Green Published			2022-12-25	WOS:000295159200062
J	Gardsvoll, H; Jacobsen, B; Kriegbaum, MC; Behrendt, N; Engelholm, L; Ostergaard, S; Ploug, M				Gardsvoll, Henrik; Jacobsen, Benedikte; Kriegbaum, Mette C.; Behrendt, Niels; Engelholm, Lars; Ostergaard, Soren; Ploug, Michael			Conformational Regulation of Urokinase Receptor Function IMPACT OF RECEPTOR OCCUPANCY AND EPITOPE-MAPPED MONOCLONAL ANTIBODIES ON LAMELLIPODIA INDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN ACTIVATION SYSTEM; VITRONECTIN-BINDING; CELL-MIGRATION; ENDOTHELIAL-CELLS; LIGAND-BINDING; UPA RECEPTOR; DOMAIN; ADHESION; CANCER; EXPRESSION	The urokinase-type plasminogen activator receptor ( uPAR) is a glycolipid-anchored membrane protein with an established role in focalizing uPA-mediated plasminogen activation on cell surfaces. Distinct from this function, uPAR also modulates cell adhesion and migration on vitronectin-rich matrices. Although uPA and vitronectin engage structurally distinct binding sites on uPAR, they nonetheless cooperate functionally, as uPA binding potentiates uPAR-dependent induction of lamellipodia on vitronectin matrices. We now present data advancing the possibility that it is the burial of the beta-hairpin in uPA per se into the hydrophobic ligand binding cavity of uPAR that modulates the function of this receptor. Based on these data, we now propose a model in which the inherent interdomain mobility in uPAR plays a major role in modulating its function. Particularly one uPAR conformation, which is stabilized by engagement of the beta-hairpin in uPA, favors the proper assembly of an active, compact receptor structure that stimulates lamellipodia induction on vitronectin. This molecular model has wide implications for drug development targeting uPAR function.	[Gardsvoll, Henrik; Jacobsen, Benedikte; Kriegbaum, Mette C.; Behrendt, Niels; Engelholm, Lars; Ploug, Michael] Rigshosp, Finsen Lab, Sect 3735, Copenhagen Bioctr, DK-2200 Copenhagen, Denmark; [Ostergaard, Soren] Novo Nordisk AS, DK-2760 Malov, Denmark; [Gardsvoll, Henrik; Jacobsen, Benedikte; Behrendt, Niels; Ploug, Michael] Danish Chinese Ctr Proteases & Canc, Aarhus, Denmark	Rigshospitalet; University of Copenhagen; Novo Nordisk	Ploug, M (corresponding author), Rigshosp, Finsen Lab, Sect 3735, Copenhagen Bioctr, Rm 3-3-31,Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	m-ploug@finsenlab.dk	Ostergaard, Soren/B-8123-2019	Ostergaard, Soren/0000-0002-9415-3352; Behrendt, Niels/0000-0003-1833-3922; Engelholm, Lars/0000-0002-6616-1232; Ploug, Michael/0000-0003-2215-4265	Danish National Research Foundation (Centre for Proteases and Cancer); Lundbeck Foundation	Danish National Research Foundation (Centre for Proteases and Cancer)(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from The Danish National Research Foundation (Centre for Proteases and Cancer) and The Lundbeck Foundation.	Chang AW, 1998, ARTERIOSCL THROM VAS, V18, P1855, DOI 10.1161/01.ATV.18.12.1855; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; ELLIS V, 1989, J BIOL CHEM, V264, P2185; Fazioli F, 1997, EMBO J, V16, P7279, DOI 10.1093/emboj/16.24.7279; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Galat A, 2008, CELL MOL LIFE SCI, V65, P3481, DOI 10.1007/s00018-008-8473-8; Gardsvoll H, 1999, J BIOL CHEM, V274, P37995, DOI 10.1074/jbc.274.53.37995; Gardsvoll H, 2004, PROTEIN EXPRES PURIF, V34, P284, DOI 10.1016/j.pep.2003.12.002; Gardsvoll H, 2007, J BIOL CHEM, V282, P13561, DOI 10.1074/jbc.M610184200; Gardsvoll H, 2006, J BIOL CHEM, V281, P19260, DOI 10.1074/jbc.M513583200; Hillig T, 2008, J BIOL CHEM, V283, P15217, DOI 10.1074/jbc.C700214200; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; Jacobsen B, 2008, CURR MED CHEM, V15, P2559, DOI 10.2174/092986708785909012; Jorgensen TJD, 2004, BIOCHEMISTRY-US, V43, P15044, DOI 10.1021/bi048706j; Kanse SM, 1996, EXP CELL RES, V224, P344, DOI 10.1006/excr.1996.0144; Kjaergaard M, 2008, FRONT BIOSCI-LANDMRK, V13, P5441, DOI 10.2741/3092; Kjaergaard M, 2007, PROTEIN SCI, V16, P1934, DOI 10.1110/ps.072949607; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Kriegbaum M., 2011, CURRENT DRU IN PRESS, V12; Lin L, 2010, J BIOL CHEM, V285, P10982, DOI 10.1074/jbc.M109.093492; List K, 1999, J IMMUNOL METHODS, V222, P125, DOI 10.1016/S0022-1759(98)00189-6; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Magdolen V, 2001, BIOL CHEM, V382, P1197, DOI 10.1515/BC.2001.150; NUSRAT AR, 1991, J CLIN INVEST, V87, P1091, DOI 10.1172/JCI115070; Pass J, 2007, THROMB HAEMOSTASIS, V97, P1013, DOI 10.1160/TH06-11-0644; PLOUG M, 1995, BIOCHEMISTRY-US, V34, P12524, DOI 10.1021/bi00039a006; Ploug M, 2001, BIOCHEMISTRY-US, V40, P12157, DOI 10.1021/bi010662g; PLOUG M, 1991, J BIOL CHEM, V266, P1926; Pluskota E, 2003, BLOOD, V101, P1582, DOI 10.1182/blood-2002-06-1842; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; RONNE E, 1991, FEBS LETT, V288, P233, DOI 10.1016/0014-5793(91)81042-7; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Salasznyk RM, 2007, MATRIX BIOL, V26, P359, DOI 10.1016/j.matbio.2007.01.009; Sato S, 2002, FEBS LETT, V528, P212, DOI 10.1016/S0014-5793(02)03311-2; Schmiedeberg N, 2002, J MED CHEM, V45, P4984, DOI 10.1021/jm020254q; Sidenius N, 2000, FEBS LETT, V470, P40, DOI 10.1016/S0014-5793(00)01282-5; Sidenius N, 2002, J BIOL CHEM, V277, P27982, DOI 10.1074/jbc.M111736200; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Stahl A, 1997, INT J CANCER, V71, P116, DOI 10.1002/(SICI)1097-0215(19970328)71:1<116::AID-IJC19>3.3.CO;2-Z; STRATTONTHOMAS JR, 1995, PROTEIN ENG, V8, P463, DOI 10.1093/protein/8.5.463; WALTZ DA, 1994, J BIOL CHEM, V269, P14746; WALTZ DA, 1993, J CLIN INVEST, V91, P1541, DOI 10.1172/JCI116360; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; WEI Y, 1994, J BIOL CHEM, V269, P32380; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551	48	49	50	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33544	33556		10.1074/jbc.M111.220087	http://dx.doi.org/10.1074/jbc.M111.220087			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21799009	Green Published, hybrid			2022-12-25	WOS:000294968800071
J	Candela, T; Maes, E; Garenaux, E; Rombouts, Y; Krzewinski, F; Gohar, M; Guerardel, Y				Candela, Thomas; Maes, Emmanuel; Garenaux, Estelle; Rombouts, Yoann; Krzewinski, Frederic; Gohar, Michel; Guerardel, Yann			Environmental and Biofilm-dependent Changes in a Bacillus cereus Secondary Cell Wall Polysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR DNA; NMR-SPECTROSCOPY; ANTHRACIS; PROTEINS; SUBTILIS; STRAINS; STAPHYLOCOCCUS; PEPTIDOGLYCAN; THURINGIENSIS; SPORULATION	Bacterial species from the Bacillus genus, including Bacillus cereus and Bacillus anthracis, synthesize secondary cell wall polymers (SCWP) covalently associated to the peptidoglycan through a phospho-diester linkage. Although such components were observed in a wide panel of B. cereus and B. anthracis strains, the effect of culture conditions or of bacterial growth state on their synthesis has never been addressed. Herein we show that B. cereus ATCC 14579 can synthesize not only one, as previously reported, but two structurally unrelated secondary cell wall polymers (SCWP) polysaccharides. The first of these SCWP, -> 4)[GlcNAc(beta 1-3)]GlcNAc(beta 1-6)[Glc(beta 1-3)][ManNAc(alpha 1-4)]GalNAc(alpha 1-4) ManNAc(beta 1 ->, although presenting an original sequence, fits to the already described the canonical sequence motif of SCWP. In contrast, the second polysaccharide was made up by a totally original sequence, -> 6)-Gal(alpha 1-2)(2-R-hydroxyglutar-5-ylamido) Fuc2NAc4N(alpha 1-6) GlcNAc(beta 1 ->, which no equivalent has ever been identified in the Bacillus genus. In addition, we established that the syntheses of these two polysaccharides were differently regulated. The first one is constantly expressed at the surface of the bacteria, whereas the expression of the second is tightly regulated by culture conditions and growth states, planktonic, or biofilm.	[Maes, Emmanuel; Garenaux, Estelle; Rombouts, Yoann; Krzewinski, Frederic; Guerardel, Yann] Univ Lille 1, Unite Glycobiol Struct & Fonct, F-59650 Villeneuve Dascq, France; [Maes, Emmanuel; Garenaux, Estelle; Rombouts, Yoann; Krzewinski, Frederic; Guerardel, Yann] CNRS, UMR 8576, F-59650 Villeneuve Dascq, France; [Candela, Thomas; Gohar, Michel] INRA, UMR1319, F-78352 Jouy En Josas, France	Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Guerardel, Y (corresponding author), Univ Lille 1, Unite Glycobiol Struct & Fonct, F-59650 Villeneuve Dascq, France.	yann.guerardel@univ-lille1.fr	Candela, Thomas/ABA-6367-2021; Candela, Thomas/AAC-9583-2021	GOHAR, Michel/0000-0001-8341-3297; Guerardel, Yann/0000-0003-4967-9512; Krzewinski, Frederic/0000-0003-1491-6899; Candela, thomas/0000-0002-4686-2533; Rombouts, Yoann/0000-0003-4482-2199	Conseil Regional Nord-Pas de Calais ARCir; Ministere de l'Enseignement Superieur; Region Ile de France; TGE RMN THC [Fr3050]; Region Nord-Pas de Calais; European Union; Ministere Francais de la Recherche; Universite Lille1-Sciences and Technologies; CNRS; Centre Commun de Mesure RMN de l'Universite de Lille1	Conseil Regional Nord-Pas de Calais ARCir(Region Hauts-de-FranceRegion Ile-de-France); Ministere de l'Enseignement Superieur; Region Ile de France(Region Ile-de-France); TGE RMN THC; Region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission); European Union(European Commission); Ministere Francais de la Recherche(Ministry of Research, France); Universite Lille1-Sciences and Technologies; CNRS(Centre National de la Recherche Scientifique (CNRS)); Centre Commun de Mesure RMN de l'Universite de Lille1	This work was supported by the Conseil Regional Nord-Pas de Calais ARCir (to Y. G.), the Ministere de l'Enseignement Superieur (to Y. R.), and the Region Ile de France (to T. C.). Research on the 800 and 900 MHz spectrometers was supported by the TGE RMN THC Fr3050.; We thank I. G. Boneca from the Institut Pasteur for the analysis of peptidoglycans by HPLC, B. Coddeville from Unite de Glycobiologie Structurale et Fonctionnelle for helping in the MS/MS analysis of polysaccharides, and Prof. A. Dell for providing access to mass spectrometry facility (Division of Molecular Biosciences, Faculty of Natural Sciences, Imperial College London). The 800- and 900-MHz spectrometers were funded by Region Nord-Pas de Calais, European Union (FEDER), Ministere Francais de la Recherche, Universite Lille1-Sciences and Technologies, and CNRS. The 400 MHz facility was funded by the Centre Commun de Mesure RMN de l'Universite de Lille1.	Antikainen J, 2002, MOL MICROBIOL, V46, P381, DOI 10.1046/j.1365-2958.2002.03180.x; Archibald A. R., 1993, P381; Auger S, 2009, APPL ENVIRON MICROB, V75, P6616, DOI 10.1128/AEM.00155-09; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; BRADBURY JH, 1984, CARBOHYD RES, V126, P125, DOI 10.1016/0008-6215(84)85131-9; Candela T, 2005, MOL MICROBIOL, V57, P717, DOI 10.1111/j.1365-2958.2005.04718.x; Chitlaru T, 2004, PROTEOMICS, V4, P677, DOI 10.1002/pmic.200300575; Choudhury B, 2006, J BIOL CHEM, V281, P27932, DOI 10.1074/jbc.M605768200; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Forsberg LS, 2011, GLYCOBIOLOGY, V21, P934, DOI 10.1093/glycob/cwr026; Gohar M, 2005, PROTEOMICS, V5, P3696, DOI 10.1002/pmic.200401225; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Guerardel Y, 2004, J BIOL CHEM, V279, P15591, DOI 10.1074/jbc.M308928200; Houry A, 2010, MICROBIOL-SGM, V156, P1009, DOI 10.1099/mic.0.034827-0; Hsueh YH, 2006, APPL ENVIRON MICROB, V72, P5089, DOI 10.1128/AEM.00573-06; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; KOERNER TAW, 1987, METHOD ENZYMOL, V138, P38; Kolter R, 2005, TRENDS MICROBIOL, V13, P1, DOI 10.1016/j.tim.2004.11.003; Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0; LANG WK, 1982, J BACTERIOL, V151, P367, DOI 10.1128/JB.151.1.367-375.1982; Lebeer S, 2007, APPL ENVIRON MICROB, V73, P6768, DOI 10.1128/AEM.01393-07; LECADET MM, 1980, J GEN MICROBIOL, V121, P203; Lee K, 2007, MICROBIOL-SGM, V153, P1693, DOI 10.1099/mic.0.2006/003376-0; Lee REB, 2005, GLYCOBIOLOGY, V15, P139, DOI 10.1093/glycob/cwh150; Leoff C, 2008, J BIOL CHEM, V283, P29812, DOI 10.1074/jbc.M803234200; Leoff C, 2008, J BACTERIOL, V190, P112, DOI 10.1128/JB.01292-07; Leoff C, 2009, GLYCOBIOLOGY, V19, P665, DOI 10.1093/glycob/cwp036; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Maes E, 2009, J BIOCHEM, V145, P413, DOI 10.1093/jb/mvp008; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Peng JS, 2002, INT J FOOD MICROBIOL, V77, P11, DOI 10.1016/S0168-1605(02)00060-0; Ren DC, 2004, BIOTECHNOL BIOENG, V86, P344, DOI 10.1002/bit.20053; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; STIMSON E, 1995, MOL MICROBIOL, V17, P1201, DOI 10.1111/j.1365-2958.1995.mmi_17061201.x; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Vinogradov E, 2003, EUR J BIOCHEM, V270, P1810, DOI 10.1046/j.1432-1033.2003.03543.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Weidenmaier C, 2005, J INFECT DIS, V191, P1771, DOI 10.1086/429692; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wijman JGE, 2007, APPL ENVIRON MICROB, V73, P1481, DOI 10.1128/AEM.01781-06; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	45	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31250	31262		10.1074/jbc.M111.249821	http://dx.doi.org/10.1074/jbc.M111.249821			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21784857	Green Published, hybrid			2022-12-25	WOS:000294487500020
J	Sharma, P; Dube, D; Sinha, M; Mishra, B; Dey, S; Mal, G; Pathak, KML; Kaur, P; Sharma, S; Singh, TP				Sharma, Pradeep; Dube, Divya; Sinha, Mau; Mishra, Biswajit; Dey, Sharmistha; Mal, Gorakh; Pathak, Krishan M. L.; Kaur, Punit; Sharma, Sujata; Singh, Tej P.			Multiligand Specificity of Pathogen-associated Molecular Pattern-binding Site in Peptidoglycan Recognition Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; EXPRESSION; FAMILY; GENE; PGRP	The peptidoglycan recognition protein PGRP-S is an innate immunity molecule that specifically interacts with microbial peptidoglycans and other pathogen-associated molecular patterns. We report here two structures of the unique tetrameric camel PGRP-S (CPGRP-S) complexed with (i) muramyl dipeptide (MDP) at 2.5 angstrom resolution and (ii) GlcNAc and beta-maltose at 1.7 angstrom resolution. The binding studies carried out using surface plasmon resonance indicated that CPGRP-S binds to MDP with a dissociation constant of 10(-7) M, whereas the binding affinities for GlcNAc and beta-maltose separately are in the range of 10(-4) M to 10(-5) M, whereas the dissociation constant for the mixture of GlcNAc and maltose was estimated to be 10(-6) M. The data from bacterial suspension culture experiments showed a significant inhibition of the growth of Staphylococcus aureus cells when CPGRP-S was added to culture medium. The ELISA experiment showed that the amount of MDP-induced production of TNF-alpha and IL-6 decreased considerably after the introduction of CPGRP-S. The crystal structure determinations of (i) a binary complex with MDP and (ii) a ternary complex with GlcNAc and beta-maltose revealed that MDP, GlcNAc, and beta-maltose bound to CPGRP-S in the ligand binding cleft, which is situated at the interface of molecules C and D of the homotetramer formed by four protein molecules A, B, C, and D. In the binary complex, the muramyl moiety of MDP is observed at the C-D interface, whereas the peptide chain protrudes into the center of tetramer. In the ternary complex, GlcNAc and beta-maltose occupy distinct non-overlapping positions belonging to different subsites.	[Sharma, Pradeep; Dube, Divya; Sinha, Mau; Mishra, Biswajit; Dey, Sharmistha; Kaur, Punit; Sharma, Sujata; Singh, Tej P.] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; [Mal, Gorakh; Pathak, Krishan M. L.] Natl Res Ctr Camel, Bikaner 334001, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Camel	Singh, TP (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	tpsingh.aiims@gmail.com		SINHA, MAU/0000-0003-3011-9160	Departments of Science and Technology; Department of Biotechnology, Ministry of Science and Technology (government of India, New Delhi); Council of Scientific and Industrial Research, New Delhi	Departments of Science and Technology; Department of Biotechnology, Ministry of Science and Technology (government of India, New Delhi)(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Departments of Science and Technology and Department of Biotechnology, Ministry of Science and Technology (government of India, New Delhi) and the Council of Scientific and Industrial Research, New Delhi (to P. S. and M. S.).	BAO ZZ, 1992, J BIOL CHEM, V267, P4974; Brunger AT, 1997, STRUCTURE, V5, P325, DOI 10.1016/S0969-2126(97)00190-1; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Dziarski R, 2005, J ENDOTOXIN RES, V11, P304, DOI 10.1179/096805105X67256; Guan RJ, 2005, J MOL BIOL, V347, P683, DOI 10.1016/j.jmb.2005.01.070; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kappeler SR, 2004, J DAIRY SCI, V87, P2660, DOI 10.3168/jds.S0022-0302(04)73392-5; KINI RM, 1995, BIOCHEM BIOPH RES CO, V212, P1115, DOI 10.1006/bbrc.1995.2084; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Lo D, 2003, CELL IMMUNOL, V224, P8, DOI 10.1016/S0008-8749(03)00155-2; Lu XF, 2006, J BIOL CHEM, V281, P5895, DOI 10.1074/jbc.M511631200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen T, 2000, INFECT IMMUN, V68, P2061, DOI 10.1128/IAI.68.4.2061-2068.2000; Ochiai M, 1999, J BIOL CHEM, V274, P11854, DOI 10.1074/jbc.274.17.11854; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Sharma P, 2008, J MOL BIOL, V378, P923, DOI 10.1016/j.jmb.2008.03.018; Sharma P, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.228163; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Xu XN, 2002, J IMMUNOL METHODS, V268, P21, DOI 10.1016/S0022-1759(02)00196-5	24	11	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31723	31730		10.1074/jbc.M111.264374	http://dx.doi.org/10.1074/jbc.M111.264374			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21784863	Green Published, hybrid			2022-12-25	WOS:000294487500065
J	Murphy, DA; Diaz, B; Bromann, PA; Tsai, JH; Kawakami, Y; Maurer, J; Stewart, RA; Izpisua-Belmonte, JC; Courtneidge, SA				Murphy, Danielle A.; Diaz, Begona; Bromann, Paul A.; Tsai, Jeff H.; Kawakami, Yasuhiko; Maurer, Jochen; Stewart, Rodney A.; Izpisua-Belmonte, Juan Carlos; Courtneidge, Sara A.			A Src-Tks5 Pathway Is Required for Neural Crest Cell Migration during Embryonic Development	PLOS ONE			English	Article							VERTEBRATE GASTRULATION; PODOSOME FORMATION; HUMAN MELANOCYTES; KINASE INHIBITOR; IN-VIVO; ZEBRAFISH; PROTEIN; GROWTH; INVADOPODIA; FAMILY	In the adult organism, cell migration is required for physiological processes such as angiogenesis and immune surveillance, as well as pathological events such as tumor metastasis. The adaptor protein and Src substrate Tks5 is necessary for cancer cell migration through extracellular matrix in vitro and tumorigenicity in vivo. However, a role for Tks5 during embryonic development, where cell migration is essential, has not been examined. We used morpholinos to reduce Tks5 expression in zebrafish embryos, and observed developmental defects, most prominently in neural crest-derived tissues such as craniofacial structures and pigmentation. The Tks5 morphant phenotype was rescued by expression of mammalian Tks5, but not by a variant of Tks5 in which the Src phosphorylation sites have been mutated. We further evaluated the role of Tks5 in neural crest cells and neural crest-derived tissues and found that loss of Tks5 impaired their ventral migration. Inhibition of Src family kinases also led to abnormal ventral patterning of neural crest cells and their derivatives. We confirmed that these effects were likely to be cell autonomous by shRNA-mediated knockdown of Tks5 in a murine neural crest stem cell line. Tks5 was required for neural crest cell migration in vitro, and both Src and Tks5 were required for the formation of actin-rich structures with similarity to podosomes. Additionally, we observed that neural crest cells formed Src-Tks5-dependent cell protrusions in 3-D culture conditions and in vivo. These results reveal an important and novel role for the Src-Tks5 pathway in neural crest cell migration during embryonic development. Furthermore, our data suggests that this pathway regulates neural crest cell migration through the generation of actin-rich pro-migratory structures, implying that similar mechanisms are used to control cell migration during embryogenesis and cancer metastasis.	[Murphy, Danielle A.; Diaz, Begona; Bromann, Paul A.; Maurer, Jochen; Courtneidge, Sara A.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Tsai, Jeff H.; Izpisua-Belmonte, Juan Carlos] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Kawakami, Yasuhiko] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Stewart, Rodney A.] Huntsman Canc Inst, Salt Lake City, UT USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; Salk Institute; Huntsman Cancer Institute	Murphy, DA (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA USA.	courtneidge@sanfordburnham.org	Maurer, Jochen/G-4832-2018; Stewart, Rodney/ABA-6757-2020	Maurer, Jochen/0000-0003-3962-3128; Stewart, Rodney/0000-0003-1220-1830; Kawakami, Yasuhiko/0000-0002-0043-9705; Diaz, Begona/0000-0002-7892-6319	National Cancer Institute of the National Institutes of Health (NIH); Mather's Foundation; American Cancer Society North Texas; NIH [ROO-NSO5860i];  [T32 CA121949];  [T32 CA121938]; NATIONAL CANCER INSTITUTE [T32CA121938, T32CA121949] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mather's Foundation; American Cancer Society North Texas; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute of the National Institutes of Health (NIH) and the Mather's Foundation. D.A.M. was supported by training grant T32 CA121949 and the American Cancer Society North Texas Postdoctoral Fellowship, 2008, North Texans Creating Tomorrow's Miracles. J.H.T. was supported by training grant T32 CA121938. R.A.S. was supported by NIH # ROO-NSO5860i. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Alfandari D, 1997, DEV BIOL, V182, P314, DOI 10.1006/dbio.1996.8458; Baas D, 2009, MATRIX BIOL, V28, P490, DOI 10.1016/j.matbio.2009.07.004; Berndt JD, 2008, DEV BIOL, V324, P236, DOI 10.1016/j.ydbio.2008.09.013; Berzat A, 2010, EMBO J, V29, P2734, DOI 10.1038/emboj.2010.170; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Block MR, 2008, EUR J CELL BIOL, V87, P491, DOI 10.1016/j.ejcb.2008.02.012; Blouw B, 2008, EUR J CELL BIOL, V87, P555, DOI 10.1016/j.ejcb.2008.02.008; BRONNERFRASER M, 1995, EXP CELL RES, V218, P405, DOI 10.1006/excr.1995.1173; Buschman MD, 2009, MOL BIOL CELL, V20, P1302, DOI 10.1091/mbc.E08-09-0949; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Chan KT, 2009, J CELL BIOL, V185, P357, DOI 10.1083/jcb.200809110; Coyle RC, 2008, EXP CELL RES, V314, P2150, DOI 10.1016/j.yexcr.2008.03.010; DELANNET M, 1992, DEVELOPMENT, V116, P275; Epperlein HH, 1996, INT J DEV BIOL, V40, P229; ERICKSON CA, 1992, DEV BIOL, V151, P251, DOI 10.1016/0012-1606(92)90231-5; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gilmour DT, 2002, NEURON, V34, P577, DOI 10.1016/S0896-6273(02)00683-9; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; HERLYN M, 1988, EXP CELL RES, V179, P322, DOI 10.1016/0014-4827(88)90271-6; Iqbal Z, 2010, AM J HUM GENET, V86, P254, DOI 10.1016/j.ajhg.2010.01.009; Jesuthasan S, 1996, DEVELOPMENT, V122, P381; Jopling C, 2005, EMBO REP, V6, P426, DOI 10.1038/sj.embor.7400386; Kelsh RN, 1996, DEVELOPMENT, V123, P369; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kucenas S, 2008, NAT NEUROSCI, V11, P143, DOI 10.1038/nn2025; LALLIER T, 1992, J CELL BIOL, V119, P1335, DOI 10.1083/jcb.119.5.1335; Le Douarin NM, 1999, NEURAL CREST, V2; Lock P, 1998, EMBO J, V17, P4346, DOI 10.1093/emboj/17.15.4346; MARTINSGREEN M, 1987, DEVELOPMENT, V101, P517; Maurer J, 2007, DIFFERENTIATION, V75, P580, DOI 10.1111/j.1432-0436.2007.00164.x; McCusker C, 2009, MOL BIOL CELL, V20, P78, DOI 10.1091/mbc.E08-05-0535; Moustakas A, 2008, FEBS LETT, V582, P2051, DOI 10.1016/j.febslet.2008.03.027; Neuner R, 2009, MECH DEVELOP, V126, P240, DOI 10.1016/j.mod.2008.10.010; OCONNOR TJ, 1992, CELL GROWTH DIFFER, V3, P435; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; RAIBLE DW, 1992, DEV DYNAM, V195, P29, DOI 10.1002/aja.1001950104; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Sauka-Spengler T, 2006, CURR OPIN GENET DEV, V16, P360, DOI 10.1016/j.gde.2006.06.006; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Sharma D, 2005, DEV BIOL, V285, P462, DOI 10.1016/j.ydbio.2005.07.018; Steventon B, 2005, SEMIN CELL DEV BIOL, V16, P647, DOI 10.1016/j.semcdb.2005.06.001; Stewart RA, 2006, DEV BIOL, V292, P174, DOI 10.1016/j.ydbio.2005.12.035; Stewart RA, 2010, DEV CELL, V18, P750, DOI [10.1016/j.devcel.2010.03.009, 10.1016/j.devce1.2010.03.009]; Stoller JZ, 2005, SEMIN CELL DEV BIOL, V16, P704, DOI 10.1016/j.semcdb.2005.06.004; Stylli SS, 2009, J CELL SCI, V122, P2727, DOI 10.1242/jcs.046680; Takatsuka A, 2008, DEV BIOL, V315, P474, DOI 10.1016/j.ydbio.2008.01.004; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Tobin JL, 2008, P NATL ACAD SCI USA, V105, P6714, DOI 10.1073/pnas.0707057105; VALINSKY JE, 1985, EMBO J, V4, P1403, DOI 10.1002/j.1460-2075.1985.tb03793.x; Westerfield M, 1993, ZEBRAFISH BOOK; Yin CY, 2009, CURR TOP DEV BIOL, V89, P163, DOI 10.1016/S0070-2153(09)89007-8	56	62	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22499	10.1371/journal.pone.0022499	http://dx.doi.org/10.1371/journal.pone.0022499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799874	Green Published, Green Submitted, gold			2022-12-25	WOS:000293172900039
J	Redrejo-Rodriguez, M; Saint-Pierre, C; Couve, S; Mazouzi, A; Ishchenko, AA; Gasparutto, D; Saparbaev, M				Redrejo-Rodriguez, Modesto; Saint-Pierre, Christine; Couve, Sophie; Mazouzi, Abdelghani; Ishchenko, Alexander A.; Gasparutto, Didier; Saparbaev, Murat			New Insights in the Removal of the Hydantoins, Oxidation Product of Pyrimidines, via the Base Excision and Nucleotide Incision Repair Pathways	PLOS ONE			English	Article							ESCHERICHIA-COLI; ENDONUCLEASE-III; FANCONI-ANEMIA; DNA-DAMAGE; IONIZING-RADIATION; NTH; RECOGNITION; LESIONS; GENE; APE1	Background: Oxidative damage to DNA, if not repaired, can be both miscoding and blocking. These genetic alterations can lead to mutations and/or cell death, which in turn cause cancer and aging. Oxidized DNA bases are substrates for two overlapping repair pathways: base excision (BER) and nucleotide incision repair (NIR). Hydantoin derivatives such as 5-hydroxyhydantoin (5OH-Hyd) and 5-methyl-5-hydroxyhydantoin (5OH-5Me-Hyd), major products of cytosine and thymine oxidative degradation pathways, respectively, have been detected in cancer cells and ancient DNA. Hydantoins are blocking lesions for DNA polymerases and excised by bacterial and yeast DNA glycosylases in the BER pathway. However little is known about repair of pyrimidine-derived hydantoins in human cells. Methodology/Principal Findings: Here, using both denaturing PAGE and MALDI-TOF MS analyses we report that the bacterial, yeast and human AP endonucleases can incise duplex DNA 59 next to 5OH-Hyd and 5OH-5Me-Hyd thus initiating the NIR pathway. We have fully reconstituted the NIR pathway for these lesions in vitro using purified human proteins. Depletion of Nfo in E. coli and APE1 in HeLa cells abolishes the NIR activity in cell-free extracts. Importantly, a number of redundant DNA glycosylase activities can excise hydantoin residues, including human NTH1, NEIL1 and NEIL2 and the former protein being a major DNA glycosylase activity in HeLa cells extracts. Conclusions/Significance: This study demonstrates that both BER and NIR pathways can compete and/or back-up each other to remove hydantoin DNA lesions in vivo.	[Redrejo-Rodriguez, Modesto; Couve, Sophie; Mazouzi, Abdelghani; Ishchenko, Alexander A.; Saparbaev, Murat] Univ Paris 11, Inst Cancerol Gustave Roussy, CNRS, Grp Reparat ADN,UMR8200, Villejuif, France; [Saint-Pierre, Christine; Gasparutto, Didier] CEA, INAC, Lab Les Acides Nucl, SCIB,CEA UJF,UMR E3, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Redrejo-Rodriguez, M (corresponding author), Univ Paris 11, Inst Cancerol Gustave Roussy, CNRS, Grp Reparat ADN,UMR8200, Villejuif, France.	didier.gasparutto@cea.fr; smurat@igr.fr	Ishchenko, Alexander/D-4133-2013; Saparbaev, Murat K/N-3225-2015; Saparbaev, Murat/AAC-5478-2020; Redrejo Rodríguez, Modesto/D-7247-2012	Ishchenko, Alexander/0000-0002-0488-8858; Saparbaev, Murat K/0000-0002-4630-1074; Saparbaev, Murat/0000-0002-4630-1074; Redrejo Rodríguez, Modesto/0000-0003-0014-4162; Mazouzi, Abdelghani/0000-0003-0298-6304	Fondation pour la Recherche Medicale; Centre National de la Recherche Scientifique [PICS N5479-Russie]; CNRS-INCA-MSHE Franco-Pologne [3037987]; Electricite de France; Contrat Radioprotection; Fondation de France [00012091]; Association pour la Recherche sur le Cancer	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); CNRS-INCA-MSHE Franco-Pologne; Electricite de France; Contrat Radioprotection; Fondation de France(Fondation de France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by grants from Fondation pour la Recherche Medicale(http://www.frm.org) [EQUIPES FRM 2007 to M. S.]; Centre National de la Recherche Scientifique( http://www.cnrs.fr) [PICS N5479-Russie, and CNRS-INCA-MSHE Franco-Pologne # 3037987 to M. S.]; Electricite de France(http://www.edf.fr) Contrat Radioprotection [RB 2010 to M. S. and D. G.]; Fondation de France http://www.fondationdefrance.org) [# 00012091 to A. A. I.]. M. R.-R. and S. C. were supported by postdoctoral fellowships from the Association pour la Recherche sur le Cancer( http://www.arc-cancer.net) and Fondation pour la Recherche Medicale, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandaru V, 2007, DNA REPAIR, V6, P1629, DOI 10.1016/j.dnarep.2007.05.011; Banerjee D, 2011, J BIOL CHEM, V286, P6006, DOI 10.1074/jbc.M110.198796; Beernink PT, 2001, J MOL BIOL, V307, P1023, DOI 10.1006/jmbi.2001.4529; BREIMER LH, 1984, J BIOL CHEM, V259, P5543; BREIMER LH, 1985, MUTAT RES, V150, P85, DOI 10.1016/0027-5107(85)90104-6; Breslin C, 2009, MOL CELL BIOL, V29, P4653, DOI 10.1128/MCB.00677-09; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Cadet J, 2003, MUTAT RES-FUND MOL M, V531, P5, DOI 10.1016/j.mrfmmm.2003.09.001; CHAN E, 1987, P NATL ACAD SCI USA, V84, P3189, DOI 10.1073/pnas.84.10.3189; d'Abbadie M, 2007, NAT BIOTECHNOL, V25, P939, DOI 10.1038/nbt1321; D'Ham C, 1998, J CHROMATOGR B, V710, P67, DOI 10.1016/S0378-4347(98)00133-9; Daviet S, 2007, DNA REPAIR, V6, P8, DOI 10.1016/j.dnarep.2006.08.001; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Dizdaroglu M, 2000, BIOCHEMISTRY-US, V39, P5586, DOI 10.1021/bi9927787; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Dubey I, 2001, NUCLEOS NUCLEOT NUCL, V20, P1463, DOI 10.1081/NCN-100105241; Fortini P, 1999, J BIOL CHEM, V274, P15230, DOI 10.1074/jbc.274.21.15230; Fromme JC, 2004, CURR OPIN STRUC BIOL, V14, P43, DOI 10.1016/j.sbi.2004.01.003; Gasparutto D, 2000, CHEM RES TOXICOL, V13, P575, DOI 10.1021/tx000005+; Gasparutto D, 2009, BBA-GEN SUBJECTS, V1790, P16, DOI 10.1016/j.bbagen.2008.10.001; Gelin A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012241; Georg J, 2006, NUCLEIC ACIDS RES, V34, P5325, DOI 10.1093/nar/gkl604; Golan G, 2010, MUTAT RES-FUND MOL M, V685, P70, DOI 10.1016/j.mrfmmm.2009.08.017; Gorman MA, 1997, EMBO J, V16, P6548, DOI 10.1093/emboj/16.21.6548; Gros L, 2004, NUCLEIC ACIDS RES, V32, P73, DOI 10.1093/nar/gkh165; GUY A, 1990, TETRAHEDRON LETT, V31, P5745, DOI 10.1016/S0040-4039(00)97947-4; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; IDE H, 1994, BIOCHEMISTRY-US, V33, P7842, DOI 10.1021/bi00191a011; Ischenko AA, 2002, NATURE, V415, P183, DOI 10.1038/415183a; Ishchenko AA, 2006, P NATL ACAD SCI USA, V103, P2564, DOI 10.1073/pnas.0508582103; Ishchenko AA, 2004, BIOCHEMISTRY-US, V43, P15210, DOI 10.1021/bi049214+; Ishchenko AA, 2003, NUCLEIC ACIDS RES, V31, P6344, DOI 10.1093/nar/gkg812; Jiang DY, 1997, J BACTERIOL, V179, P3773, DOI 10.1128/jb.179.11.3773-3782.1997; Jurado J, 1998, BIOCHEMISTRY-US, V37, P7757, DOI 10.1021/bi972982z; Katafuchi A, 2004, J BIOL CHEM, V279, P14464, DOI 10.1074/jbc.M400393200; KOW YW, 1985, P NATL ACAD SCI USA, V82, P8354, DOI 10.1073/pnas.82.24.8354; LEBIHAN YV, 2011, NUCL ACIDS RES; MACEAIME G, 2010, ENV MOL MUTAGEN; McDonald JP, 2006, NUCLEIC ACIDS RES, V34, P1102, DOI 10.1093/nar/gkj512; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; MULLER E, 2001, EUR J ORG CHEM   JUN, P2091; OLINSKI R, 1992, FEBS LETT, V309, P193, DOI 10.1016/0014-5793(92)81093-2; Olinski R, 1996, CANCER LETT, V106, P207, DOI 10.1016/0304-3835(96)04320-0; Prasad A, 2007, MOL CELL BIOL, V27, P8442, DOI 10.1128/MCB.00791-07; REDREJORODRIGUE.M, 2009, VIROLOGY; Riviere J, 2005, CHEM RES TOXICOL, V18, P1332, DOI 10.1021/tx050121i; Riviere J, 2004, J AM CHEM SOC, V126, P6548, DOI 10.1021/ja049438f; Saito Y, 1997, J BACTERIOL, V179, P3783, DOI 10.1128/jb.179.11.3783-3785.1997; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Senturker S, 1997, FEBS LETT, V416, P286, DOI 10.1016/S0014-5793(97)01226-X; Suzuki T, 2010, DNA REPAIR, V9, P542, DOI 10.1016/j.dnarep.2010.02.004; TEOULE R, 1977, RADIAT RES, V72, P190, DOI 10.2307/3574690; Toga T, 2009, TETRAHEDRON LETT, V50, P723, DOI 10.1016/j.tetlet.2008.12.001; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wagner JR, 2010, ACCOUNTS CHEM RES, V43, P564, DOI 10.1021/ar9002637; Wagner JR, 1999, J AM CHEM SOC, V121, P4101, DOI 10.1021/ja982461e; WALSH CE, 1994, BLOOD, V84, P453; Wang D, 2004, MOL CANCER THER, V3, P679; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; Zanier R, 2004, ONCOGENE, V23, P5004, DOI 10.1038/sj.onc.1207677; Zhao XB, 2010, BIOCHEMISTRY-US, V49, P1658, DOI 10.1021/bi901852q; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	64	31	31	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e21039	10.1371/journal.pone.0021039	http://dx.doi.org/10.1371/journal.pone.0021039			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799731	Green Published, gold, Green Submitted			2022-12-25	WOS:000293172900001
J	Rogers, GW; Brand, MD; Petrosyan, S; Ashok, D; Elorza, AA; Ferrick, DA; Murphy, AN				Rogers, George W.; Brand, Martin D.; Petrosyan, Susanna; Ashok, Deepthi; Elorza, Alvaro A.; Ferrick, David A.; Murphy, Anne N.			High Throughput Microplate Respiratory Measurements Using Minimal Quantities Of Isolated Mitochondria	PLOS ONE			English	Article							RAT LIVER MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; DISEASE; DYSFUNCTION; TARGET; RESPIROMETRY; INHIBITION; MEMBRANES; CAPACITY	Recently developed technologies have enabled multi-well measurement of O(2) consumption, facilitating the rate of mitochondrial research, particularly regarding the mechanism of action of drugs and proteins that modulate metabolism. Among these technologies, the Seahorse XF24 Analyzer was designed for use with intact cells attached in a monolayer to a multi-well tissue culture plate. In order to have a high throughput assay system in which both energy demand and substrate availability can be tightly controlled, we have developed a protocol to expand the application of the XF24 Analyzer to include isolated mitochondria. Acquisition of optimal rates requires assay conditions that are unexpectedly distinct from those of conventional polarography. The optimized conditions, derived from experiments with isolated mouse liver mitochondria, allow multi-well assessment of rates of respiration and proton production by mitochondria attached to the bottom of the XF assay plate, and require extremely small quantities of material (1-10 mu g of mitochondrial protein per well). Sequential measurement of basal, State 3, State 4, and uncoupler-stimulated respiration can be made in each well through additions of reagents from the injection ports. We describe optimization and validation of this technique using isolated mouse liver and rat heart mitochondria, and apply the approach to discover that inclusion of phosphatase inhibitors in the preparation of the heart mitochondria results in a specific decrease in rates of Complex I-dependent respiration. We believe this new technique will be particularly useful for drug screening and for generating previously unobtainable respiratory data on small mitochondrial samples.	[Rogers, George W.; Elorza, Alvaro A.; Ferrick, David A.] Seahorse Biosci, N Billerica, MA USA; [Brand, Martin D.; Ashok, Deepthi] Buck Inst Age Res, Novato, CA USA; [Petrosyan, Susanna; Murphy, Anne N.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Buck Institute for Research on Aging; University of California System; University of California San Diego	Rogers, GW (corresponding author), Seahorse Biosci, N Billerica, MA USA.	anmurphy@ucsd.edu	Brand, Martin D/A-9423-2012; Murphy, Anne N/H-3217-2016	Brand, Martin D/0000-0003-4418-6153; Elorza, Alvaro A./0000-0003-1570-9832; Ashok, Deepthi/0000-0003-0252-4716; Murphy, Anne N/0000-0002-5222-9902	American Diabetes Association [1-08-RA-139]; National Institutes of Health [2 P01 DK054441-09, P01 AG025901, PL1 AG032118]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG025901, PL1AG032118] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by the American Diabetes Association 1-08-RA-139, National Institutes of Health 2 P01 DK054441-09 (ANM) and National Institutes of Health P01 AG025901 and PL1 AG032118 (MDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boja ES, 2009, J PROTEOME RES, V8, P4665, DOI 10.1021/pr900387b; BRAND MD, 1993, BIOCHEM J, V291, P739, DOI 10.1042/bj2910739; Burchell VS, 2010, EXPERT OPIN THER TAR, V14, P497, DOI 10.1517/14728221003730434; Burchell VS, 2010, EXPERT OPIN THER TAR, V14, P369, DOI 10.1517/14728221003652489; Camara AKS, 2010, ANTIOXID REDOX SIGN, V13, P279, DOI 10.1089/ars.2009.2788; CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65; Chappell J. B., 1972, SUBCELLULAR COMPONEN, P77; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; DENG N, 2011, MOL CELL PR IN PRESS; Dykens James A., 2008, DRUG INDUCED MITOCHO; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Guarino RD, 2004, BIOTECHNOL BIOENG, V86, P775, DOI 10.1002/bit.20072; HARRIS RA, 1995, J NUTR, V125, pS1758; HEIDRICH HG, 1970, J CELL BIOL, V46, P137, DOI 10.1083/jcb.46.1.137; Huttemann M, 2007, BBA-MOL CELL RES, V1773, P1701, DOI 10.1016/j.bbamcr.2007.10.001; Hutter E, 2006, EXP GERONTOL, V41, P103, DOI 10.1016/j.exger.2005.09.011; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Labbe G, 2008, FUND CLIN PHARMACOL, V22, P335, DOI 10.1111/j.1472-8206.2008.00608.x; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Moreira PI, 2009, CNS NEUROL DISORD-DR, V8, P492, DOI 10.2174/187152709789824651; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Nicholls D.G., 1992, BIOENERGETICS, V2, P22; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pagliarini DJ, 2005, MOL CELL, V19, P197, DOI 10.1016/j.molcel.2005.06.008; PARCE JW, 1989, SCIENCE, V246, P243, DOI 10.1126/science.2799384; PORTER RK, 1993, NATURE, V362, P628, DOI 10.1038/362628a0; RANGANATHAN S, 1989, TOXICOL APPL PHARM, V99, P81, DOI 10.1016/0041-008X(89)90113-0; Rardin MJ, 2008, J BIOL CHEM, V283, P15440, DOI 10.1074/jbc.M709547200; ROSCA M, 2011, BIOCH BIOPH IN PRESS; Salvi M, 2005, FREE RADICAL BIO MED, V38, P1267, DOI 10.1016/j.freeradbiomed.2005.02.006; Samavati L, 2008, J BIOL CHEM, V283, P21134, DOI 10.1074/jbc.M801954200; SCHNAITMAN C, 1968, J CELL BIOL, V38, P158, DOI 10.1083/jcb.38.1.158; Schon EA, 2010, TRENDS MOL MED, V16, P268, DOI 10.1016/j.molmed.2010.04.007; Shertzer HG, 2010, INT J TOXICOL, V29, P40, DOI 10.1177/1091581809352885; Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x; Sordahl LA, 1984, METHODS STUDYING CAR, P65; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Will Y, 2006, NAT PROTOC, V1, P2563, DOI 10.1038/nprot.2006.351; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xie H, 2009, MOL CANCER THER, V8, P626, DOI 10.1158/1535-7163.MCT-08-1049; ZHAO X, 2011, MOL CELL PR IN PRESS	43	325	327	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e21746	10.1371/journal.pone.0021746	http://dx.doi.org/10.1371/journal.pone.0021746			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799747	Green Published, gold, Green Submitted			2022-12-25	WOS:000293172900006
J	Son, JS; Chae, CS; Hwang, JS; Park, ZY; Im, SH				Son, Jun-Seock; Chae, Chang-Suk; Hwang, Ji-Sun; Park, Zee Yong; Im, Sin-Hyeog			Enhanced Chromatin Accessibility and Recruitment of JUNB Mediate the Sustained IL-4 Expression in NFAT1 Deficient T Helper 2 Cells	PLOS ONE			English	Article							ACTIVATED T-CELLS; GENE-EXPRESSION; NUCLEAR FACTOR; NF-AT; TRANSCRIPTION; DIFFERENTIATION; ELEMENTS; SATB1; DEACTIVATION; CALCINEURIN	Nuclear factor of activated T cells (NFAT) is a family of transcription factors composed of five proteins. Among them, NFAT1 is a predominant NFAT protein in CD4(+) T cells. NFAT1 positively regulates transcription of a large number of inducible cytokine genes including IL-2, IL-4, IL-5 and other cytokines. However, disruption of NFAT1 results in an unexpected increase of IL-4. In this study, we have investigated the role of NFAT1 in regulation of IL-4 gene expression in T helper 2 cells (Th2) from an epigenetic viewpoint. NFAT1 deficient Th2 cells showed a sustained IL-4 expression while wild type (WT) cells reduced its expression. We tested whether epigenetic maintenance and changes in the chromatin architecture of IL-4 promoter locus play a role in differential IL-4 transcription between in WT and NFAT1 deficient Th2 cells. Compared with WT, NFAT1 deficient CD4+ Th2 cells exhibited enhanced chromatin accessibility with permissive histone modification and DNA demethylation in the IL-4 promoter region. Transcription factors bound to IL-4 promoter region in the absence of NFAT1 were identified by Micro-LC/LC-MS/MS analysis. Among the candidates, preferential recruitment of JUNB to the IL-4 promoter was confirmed by chromatin immunoprecipitation analysis. Overexpression of JUNB together with SATB1 synergistically upregulated IL-4 promoter activity, while knockdown JUNB significantly reduced IL-4 expression. Our results suggest that the prolonged IL-4 expression in NFAT1 deficient Th2 cells is mediated by preferential binding of JUNB/SATB1 to the IL-4 promoter with permissive chromatin architecture.	[Son, Jun-Seock] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea; Gwangju Inst Sci & Technol, Immune Synapse Res Ctr, Kwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Son, JS (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea.	imsh@gist.ac.kr	Im, Sin-Hyeog/AAM-9586-2021; Im, Sin-Hyeog/E-6811-2013	Im, Sin-Hyeog/0000-0002-3173-1856; Im, Sin-Hyeog/0000-0002-3173-1856	NRF (National Research Foundation, KOREA) [2011-0000126]; MEST (Ministry of Education, Science and Technology, KOREA) [2010-0028102]; GIST	NRF (National Research Foundation, KOREA); MEST (Ministry of Education, Science and Technology, KOREA)(Ministry of Education, Science & Technology (MEST), Republic of Korea); GIST	This research was supported by grants from Mid-career Researcher Program through NRF (National Research Foundation, KOREA) (2011-0000126), grant funded by the MEST (Ministry of Education, Science and Technology, KOREA) (2010-0028102) and by a Systems Biology Infrastructure Establishment Grant provided by GIST in 2011. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Feske S, 2007, N COMP BIOC, V41, P365; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; GARRITY PA, 1994, MOL CELL BIOL, V14, P2159, DOI 10.1128/MCB.14.3.2159; Guo LY, 2004, IMMUNITY, V20, P193, DOI 10.1016/S1074-7613(04)00025-1; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Im SH, 2004, MOL CELLS, V18, P1; Im SH, 2004, J BIOL CHEM, V279, P46818, DOI 10.1074/jbc.M401722200; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; KAI S, 1998, EUROPEAN J IMMUNOLOG, V28, P2456; Kaneko T, 2007, MOL IMMUNOL, V44, P2249, DOI 10.1016/j.molimm.2006.11.004; Kass SU, 1997, TRENDS GENET, V13, P444, DOI 10.1016/S0168-9525(97)01268-7; Kiani A, 1997, IMMUNITY, V7, P849, DOI 10.1016/S1074-7613(00)80403-3; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LiWeber M, 1997, GENE, V188, P253, DOI 10.1016/S0378-1119(96)00820-7; Loh C, 1996, MOL CELL BIOL, V16, P3945; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; Park J, 2010, J CELL SCI, V123, P1742, DOI 10.1242/jcs.064170; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Ranger AM, 2000, J EXP MED, V191, P9, DOI 10.1084/jem.191.1.9; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; Rengarajan J, 2002, NAT IMMUNOL, V3, P48, DOI 10.1038/ni744; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Sahoo A, 2008, J BIOL CHEM, V283, P28860, DOI 10.1074/jbc.M802510200; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; SZABO SJ, 1993, MOL CELL BIOL, V13, P4793, DOI 10.1128/MCB.13.8.4793; Takemoto N, 1997, INT IMMUNOL, V9, P1329, DOI 10.1093/intimm/9.9.1329; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323	45	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22042	10.1371/journal.pone.0022042	http://dx.doi.org/10.1371/journal.pone.0022042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799768	Green Published, Green Submitted, gold			2022-12-25	WOS:000293172900010
J	Gasparini, C; Pilastro, A; Evans, JP				Gasparini, Clelia; Pilastro, Andrea; Evans, Jonathan P.			Male Genital Morphology and Its Influence on Female Mating Preferences and Paternity Success in Guppies	PLOS ONE			English	Article							SEXUAL SELECTION; POECILIA-RETICULATA; MATE CHOICE; FERTILIZATION SUCCESS; BEHAVIOR PATTERNS; TRINIDADIAN GUPPY; AQUARIUS-REMIGIS; EVOLUTION; POPULATION; ORNAMENTS	In internally fertilizing species male genitalia often show a higher degree of elaboration than required for simply transferring sperm to females. Among the hypotheses proposed to explain such diversity, sexual selection has received the most empirical support, with studies revealing that genital morphology can be targeted by both pre-and postcopulatory sexual selection. Until now, most studies have focused on these two episodes of selection independently. Here, we take an alternative approach by considering both components simultaneously in the livebearing fish, Poecilia reticulata. We allowed females to mate successively (and cooperatively) with two males and determined whether male genital length influenced the female's propensity to mate with a male (precopulatory selection, via female choice) and whether male genital size and shape predicted the relative paternity share of subsequent broods (postcopulatory selection, via sperm competition/cryptic female choice). We found no evidence that either episode of sexual selection targets male genital size or shape. These findings, in conjunction with our recent work exposing a role of genital morphology in mediating unsolicited (forced) matings in guppies, further supports our prior speculation that sexual conflict may be an important broker of genital evolution in this species.	[Gasparini, Clelia; Pilastro, Andrea] Univ Padua, Dept Biol, Padua, Italy; [Evans, Jonathan P.] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, Australia	University of Padua; University of Western Australia	Gasparini, C (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	clelia.gasparini@unipd.it	Pilastro, Andrea/G-3868-2011; Gasparini, Clelia/F-2159-2011; Evans, Jonathan/A-1992-2011	Pilastro, Andrea/0000-0001-9803-6308; 	University of Padova; Australian Research Council	University of Padova; Australian Research Council(Australian Research Council)	This work was funded by University of Padova (Progetto di Eccellenza CARIPARO 2007) and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 1999, EVOLUTION, V53, P147, DOI [10.2307/2640927, 10.1111/j.1558-5646.1999.tb05340.x]; Arnqvist G, 1997, BIOL J LINN SOC, V60, P365; Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; Bertin A, 2005, J EVOLUTION BIOL, V18, P949, DOI 10.1111/j.1420-9101.2005.00913.x; BROOKS R, 1995, ANIM BEHAV, V50, P301, DOI 10.1006/anbe.1995.0246; Brooks R, 2002, GENETICA, V116, P343, DOI 10.1023/A:1021228308636; Cheng YY, 2004, THESIS U TORONTO; CLARK E, 1954, B AM MUS NAT HIST, V103, P141; Cohen, 1988, J STAT POWER ANAL BE; Eberhard WG, 1985, SEXUAL SELECTION ANI; Eberhard W, 2010, GENETICA, V138, P5, DOI 10.1007/s10709-009-9358-y; Evans JP, 2001, P ROY SOC B-BIOL SCI, V268, P719, DOI 10.1098/rspb.2000.1577; Evans JP, 2011, P ROY SOC B BIOL SCI; FARR JA, 1980, BEHAVIOUR, V74, P38, DOI 10.1163/156853980X00311; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gasparini C, 2010, J EVOLUTION BIOL, V23, P124, DOI 10.1111/j.1420-9101.2009.01889.x; Holwell GI, 2010, BEHAV ECOL SOCIOBIOL, V64, P617, DOI 10.1007/s00265-009-0879-2; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Houde A.E., 1997, SEX COLOR MATE CHOIC; HOUDE AE, 1987, EVOLUTION, V41, P1, DOI 10.1111/j.1558-5646.1987.tb05766.x; House CM, 2003, P ROY SOC B-BIOL SCI, V270, P447, DOI 10.1098/rspb.2002.2266; Kahn AT, 2010, BIOL LETTERS, V6, P55, DOI 10.1098/rsbl.2009.0637; Kelly CD, 2000, CAN J ZOOL, V78, P1674, DOI 10.1139/cjz-78-9-1674; Kuckuck Constanze, 1997, Zeitschrift fuer Fischkunde, V4, P73; Langerhans RB, 2005, P NATL ACAD SCI USA, V102, P7618, DOI 10.1073/pnas.0500935102; Martin SB, 2010, VIVIPAROUS FISHES; NICOLETTO PF, 1993, ANIM BEHAV, V46, P441, DOI 10.1006/anbe.1993.1213; PATWARY MU, 1994, J SHELLFISH RES, V13, P547; Pitcher TE, 2003, P ROY SOC B-BIOL SCI, V270, P1623, DOI 10.1098/rspb.2002.2280; Preziosi RF, 1996, J EVOLUTION BIOL, V9, P317, DOI 10.1046/j.1420-9101.1996.9030317.x; ROSEN DE, 1961, COPEIA, P201, DOI 10.2307/1439999; ROSEN DONN ERIC, 1953, ZOOLOGICA [NEW YORK], V38, P1; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WILLIAMS DA, 1982, J R STAT SOC C-APPL, V31, P144; Zelditch ML, 2007, GEOMETRIC MORPHOMETR	35	20	21	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22329	10.1371/journal.pone.0022329	http://dx.doi.org/10.1371/journal.pone.0022329			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799825	gold, Green Published, Green Submitted			2022-12-25	WOS:000293097300032
J	Li, L; Zhang, JX; Jiang, T				Li, Ling; Zhang, Jin-Xiang; Jiang, Tao			Visual Working Memory Load-Related Changes in Neural Activity and Functional Connectivity	PLOS ONE			English	Article							SHORT-TERM-MEMORY; GRAPH-THEORETICAL ANALYSIS; SMALL-WORLD; PHASE SYNCHRONIZATION; EEG ALPHA; NETWORKS; OSCILLATIONS; CAPACITY; REPRESENTATIONS; RETENTION	Background: Visual working memory (VWM) helps us store visual information to prepare for subsequent behavior. The neuronal mechanisms for sustaining coherent visual information and the mechanisms for limited VWM capacity have remained uncharacterized. Although numerous studies have utilized behavioral accuracy, neural activity, and connectivity to explore the mechanism of VWM retention, little is known about the load-related changes in functional connectivity for hemi-field VWM retention. Methodology/Principal Findings: In this study, we recorded electroencephalography (EEG) from 14 normal young adults while they performed a bilateral visual field memory task. Subjects had more rapid and accurate responses to the left visual field (LVF) memory condition. The difference in mean amplitude between the ipsilateral and contralateral event-related potential (ERP) at parietal-occipital electrodes in retention interval period was obtained with six different memory loads. Functional connectivity between 128 scalp regions was measured by EEG phase synchronization in the theta-(4-8 Hz), alpha-(8-12 Hz), beta-(12-32 Hz), and gamma-(32-40 Hz) frequency bands. The resulting matrices were converted to graphs, and mean degree, clustering coefficient and shortest path length was computed as a function of memory load. The results showed that brain networks of theta-, alpha-, beta-, and gamma-frequency bands were load-dependent and visual-field dependent. The networks of theta-and alpha-bands phase synchrony were most predominant in retention period for right visual field (RVF) WM than for LVF WM. Furthermore, only for RVF memory condition, brain network density of theta-band during the retention interval were linked to the delay of behavior reaction time, and the topological property of alpha-band network was negative correlation with behavior accuracy. Conclusions/Significance: We suggest that the differences in theta-and alpha-bands between LVF and RVF conditions in functional connectivity and topological properties during retention period may result in the decline of behavioral performance in RVF task.	[Li, Ling; Zhang, Jin-Xiang; Jiang, Tao] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China	University of Electronic Science & Technology of China	Li, L (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	liling@uestc.edu.cn	Li, Ling/F-3433-2015		Natural Science Foundation of China [30800242]; Program for Changjiang Scholars and Innovative Research Team in University; Fundamental Research Funds for the Central Universities	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	LL, J-XZ, and TJ were supported by the Natural Science Foundation of China, grant no. 30800242, by the Program for Changjiang Scholars and Innovative Research Team in University, and by the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Babiloni C, 2006, CEREB CORTEX, V16, P1690, DOI 10.1093/cercor/bhj104; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Doesburg SM, 2008, CEREB CORTEX, V18, P386, DOI 10.1093/cercor/bhm073; Eimer M, 2010, PSYCHOPHYSIOLOGY, V47, P197, DOI 10.1111/j.1469-8986.2009.00879.x; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Hwa RC, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021901; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Kayser J, 2006, CLIN NEUROPHYSIOL, V117, P348, DOI 10.1016/j.clinph.2005.08.034; Klimesch W, 1999, COGNITIVE BRAIN RES, V7, P493, DOI 10.1016/S0926-6410(98)00056-1; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Linden DEJ, 2003, NEUROIMAGE, V20, P1518, DOI 10.1016/j.neuroimage.2003.07.021; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Masuda N, 2004, BIOL CYBERN, V90, P302, DOI 10.1007/s00422-004-0471-9; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Palva JM, 2010, P NATL ACAD SCI USA, V107, P7580, DOI 10.1073/pnas.0913113107; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Palva S, 2010, NEUROIMAGE, V49, P3257, DOI 10.1016/j.neuroimage.2009.11.031; PECORA LM, 1990, PHYS REV LETT, V64, P821, DOI 10.1103/PhysRevLett.64.821; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Quiroga RQ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041903; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rosenblum MG, 1996, PHYS REV LETT, V76, P1804, DOI 10.1103/PhysRevLett.76.1804; RUCHKIN DS, 1990, ELECTROEN CLIN NEURO, V76, P419, DOI 10.1016/0013-4694(90)90096-3; RUCHKIN DS, 1992, COGNITIVE BRAIN RES, V1, P53, DOI 10.1016/0926-6410(92)90005-C; Scheeringa R, 2009, NEUROIMAGE, V44, P1224, DOI 10.1016/j.neuroimage.2008.08.041; Smith EE, 1996, CEREB CORTEX, V6, P11, DOI 10.1093/cercor/6.1.11; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Song JH, 2006, NEUROIMAGE, V30, P963, DOI 10.1016/j.neuroimage.2005.10.006; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Xu YD, 2002, PERCEPT PSYCHOPHYS, V64, P1260, DOI 10.3758/BF03194770	60	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22357	10.1371/journal.pone.0022357	http://dx.doi.org/10.1371/journal.pone.0022357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789253	Green Published, gold, Green Submitted			2022-12-25	WOS:000292812400047
J	Dahiya, N; Becker, KG; Wood, WH; Zhang, YQ; Morin, PJ				Dahiya, Neetu; Becker, Kevin G.; Wood, William H., III; Zhang, Yongqing; Morin, Patrice J.			Claudin-7 Is Frequently Overexpressed in Ovarian Cancer and Promotes Invasion	PLOS ONE			English	Article							JUNCTION PROTEIN CLAUDIN-7; PROSTATE-SPECIFIC ANTIGEN; SQUAMOUS-CELL CARCINOMA; REDUCED EXPRESSION; EPITHELIAL-CELLS; BARRIER FUNCTION; GENE-EXPRESSION; TIGHT JUNCTIONS; E-CADHERIN; EPCAM	Background: Claudins are tight junction proteins that are involved in tight junction formation and function. Previous studies have shown that claudin-7 is frequently upregulated in epithelial ovarian cancer (EOC) along with claudin-3 and claudin-4. Here, we investigate in detail the expression patterns of claudin-7, as well as its possible functions in EOC. Methodology/Principal Findings: A total of 95 ovarian tissue samples (7 normal ovarian tissues, 65 serous carcinomas, 11 clear cell carcinomas, 8 endometrioid carcinomas and 4 mucinous carcinomas) were studied for claudin-7 expression. In real-time RT-PCR analysis, the gene for claudin-7, CLDN7, was found to be upregulated in all the tumor tissue samples studied. Similarly, immunohistochemical analysis and western blotting showed that claudin-7 protein was significantly overexpressed in the vast majority of EOCs. Small interfering RNA-mediated knockdown of claudin-7 in ovarian cancer cells led to significant changes in gene expression as measured by microarrays and validated by RT-PCR and immunoblotting. Analyses of the genes differentially expressed revealed that the genes altered in response to claudin-7 knockdown were associated with pathways implicated in various molecular and cellular functions such as cell cycle, cellular growth and proliferation, cell death, development, and cell movement. Through functional experiments in vitro, we found that both migration and invasion were altered in cells where CLDN7 had been knocked down or overexpressed. Interestingly, claudin-7 expression was associated with a net increase in invasion, but also with a decrease in migration. Conclusion/Significance: Our work shows that claudin-7 is significantly upregulated in EOC and that it may be functionally involved in ovarian carcinoma invasion. CLDN7 may therefore represent potential marker for ovarian cancer detection and a target for therapy.	[Dahiya, Neetu; Morin, Patrice J.] NIA, Lab Cellular & Mol Biol, Baltimore, MD 21224 USA; [Becker, Kevin G.; Wood, William H., III; Zhang, Yongqing] NIA, Res Resource Branch, Baltimore, MD 21224 USA; [Morin, Patrice J.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins Medicine	Dahiya, N (corresponding author), NIA, Lab Cellular & Mol Biol, Baltimore, MD 21224 USA.	morinp@mail.nih.gov	Dahiya, Neetu/E-5208-2011	Becker, Kevin/0000-0002-6794-6656	National Institutes of Health, National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZICAG000616, ZIAAG000397] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported entirely by the Intramural Research Program of the National Institutes of Health, National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2005, CANCER RES, V65, P7378, DOI 10.1158/0008-5472.CAN-05-1036; Al Moustafa AE, 2002, ONCOGENE, V21, P2634, DOI 10.1038/sj.onc.1205351; Albini A, 1998, Pathol Oncol Res, V4, P230; Banz C, 2010, FERTIL STERIL, V94, P1212, DOI 10.1016/j.fertnstert.2009.06.039; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; D'Souza T, 2005, J BIOL CHEM, V280, P26233, DOI 10.1074/jbc.M502003200; D'Souza T, 2007, EXP CELL RES, V313, P3364, DOI 10.1016/j.yexcr.2007.06.026; Darido C, 2008, CANCER RES, V68, P4258, DOI 10.1158/0008-5472.CAN-07-5805; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; Erdogan M, 2007, J BIOL CHEM, V282, P27713, DOI 10.1074/jbc.M703037200; Erin N, 2009, INT J CANCER, V124, P1503, DOI 10.1002/ijc.24131; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Garcia M, 2007, GLOBAL CANC FACTS FI; Gleichmann M., 2010, NEUROBIOL AGING; Gregoire L, 1998, IN VITRO CELL DEV-AN, V34, P636; HAMILTON TC, 1983, CANCER RES, V43, P5379; Ip YC, 2007, MOL CANCER THER, V6, P2858, DOI 10.1158/1535-7163.MCT-07-0453; Johnson AH, 2005, AM J PATHOL, V167, P577, DOI 10.1016/S0002-9440(10)62999-9; Keely PJ, 1999, J CELL BIOL, V145, P1077, DOI 10.1083/jcb.145.5.1077; Kim CJ, 2011, EUR J CANCER, V47, P918, DOI 10.1016/j.ejca.2010.11.007; Kleinberg L, 2008, HUM PATHOL, V39, P747, DOI 10.1016/j.humpath.2007.10.002; Kleinberg L, 2007, AM J CLIN PATHOL, V127, P928, DOI 10.1309/V025QRN3R9CJGNPX; Kominsky Scott L., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000056; Kominsky SL, 2003, ONCOGENE, V22, P2021, DOI 10.1038/sj.onc.1206199; Kuhn S, 2007, MOL CANCER RES, V5, P553, DOI 10.1158/1541-7786.MCR-06-0384; Kurman RJ, 2008, INT J GYNECOL PATHOL, V27, P151, DOI 10.1097/PGP.0b013e318161e4f5; Ladwein M, 2005, EXP CELL RES, V309, P345, DOI 10.1016/j.yexcr.2005.06.013; Lal-Nag M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-235; Le Naour F, 2008, FRONT BIOSCI-LANDMRK, V13, P5847, DOI 10.2741/3121; Leng J, 1999, J BIOL CHEM, V274, P37855, DOI 10.1074/jbc.274.53.37855; Lioni M, 2007, AM J PATHOL, V170, P709, DOI 10.2353/ajpath.2007.060343; Michl P, 2003, CANCER RES, V63, P6265; Miyamori H, 2001, J BIOL CHEM, V276, P28204, DOI 10.1074/jbc.M103083200; Mok SC, 2001, J NATL CANCER I, V93, P1458, DOI 10.1093/jnci/93.19.1458; Morin PJ, 2007, DIS MARKERS, V23, P453, DOI 10.1155/2007/674058; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Nubel T, 2009, MOL CANCER RES, V7, P285, DOI 10.1158/1541-7786.MCR-08-0200; Oshima T, 2008, ONCOL REP, V19, P953; Park D, 2007, APMIS, V115, P52, DOI 10.1111/j.1600-0463.2007.apm_524.x; PAULI BU, 1977, LAB INVEST, V37, P609; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Rangel LBA, 2003, CLIN CANCER RES, V9, P2567; Santin AD, 2004, INT J CANCER, V112, P14, DOI 10.1002/ijc.20408; Sauer T, 2005, CYTOPATHOLOGY, V16, P193, DOI 10.1111/j.1365-2303.2005.00257.x; Sheehan GM, 2007, HUM PATHOL, V38, P564, DOI 10.1016/j.humpath.2006.11.007; Soini Y, 2006, INT J GYNECOL PATHOL, V25, P330, DOI 10.1097/01.pgp.0000215298.38114.cc; Swisshelm K, 2005, ADV DRUG DELIVER REV, V57, P919, DOI 10.1016/j.addr.2005.01.006; TASSI RA, 2008, INT J GYNECOL CANC; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tzelepi VN, 2008, MODERN PATHOL, V21, P22, DOI 10.1038/modpathol.3800959; Usami Y, 2006, HUM PATHOL, V37, P569, DOI 10.1016/j.humpath.2005.12.018; Valle BL, 2010, CURR TOP MEMBR, V65, P293, DOI 10.1016/S1063-5823(10)65013-2; Van Itallie CM, 2005, J CELL SCI, V118, P1427, DOI 10.1242/jcs.01735; Vang R, 2009, ADV ANAT PATHOL, V16, P267, DOI 10.1097/PAP.0b013e3181b4fffa; Wang QW, 2009, UROLOGY, V73, P1119, DOI 10.1016/j.urology.2008.02.060; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zheng JY, 2003, J MEMBRANE BIOL, V194, P187, DOI 10.1007/s00232-003-2038-4; ZHONG Y, 1994, JPN J CANCER RES, V85, P351, DOI 10.1111/j.1349-7006.1994.tb02366.x	58	60	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22119	10.1371/journal.pone.0022119	http://dx.doi.org/10.1371/journal.pone.0022119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789222	gold, Green Published, Green Submitted			2022-12-25	WOS:000292811700025
J	Windholz, J; Kovacs, P; Tonjes, A; Dittrich, K; Bluher, S; Kiess, W; Stumvoll, M; Korner, A				Windholz, Jan; Kovacs, Peter; Toenjes, Anke; Dittrich, Kathrin; Blueher, Susann; Kiess, Wieland; Stumvoll, Michael; Koerner, Antje			Effects of Genetic Variants in ADCY5, GIPR, GCKR and VPS13C on Early Impairment of Glucose and Insulin Metabolism in Children	PLOS ONE			English	Article							FETAL-GROWTH; RISK	Objective: Recent genome-wide association studies identified novel candidate genes for fasting and 2 h blood glucose and levels in adults. We investigated the role of four of these loci (ADCY5, GIPR, GCKR and VPS13C) in early impairment of and insulin metabolism in children. Research Design and Methods: We genotyped four variants (rs2877716; rs1260326; rs10423928; rs17271305) in 638 children with detailed metabolic testing including an oGTT and assessed associations with measures of glucose insulin metabolism (including fasting blood glucose, insulin levels and insulin sensitivity/secretion indices) by linear analyses adjusted for age, sex, BMI-SDS and pubertal stage. Results: The major allele (C) of rs2877716 (ADCY5) was nominally associated with decreased fasting plasma insulin (P = 0.008), insulin (P = 0.009) and increased QUICKI (P = 0.016) and Matsuda insulin sensitivity index (P = 0.013). rs17271305 (VPS13C) was associated with 2 h blood glucose (P = 0.009), but not with any of the insulin or insulin sensitivity parameters. We found association of the GIPR and GCKR variants with parameters of glucose and insulin metabolism. None of the variants correlated anthropometric traits such as height, WHR or BMI-SDS, which excluded potential underlying associations with obesity. Conclusions: Our data on obese children indicate effects of genetic variation within ADCY5 in early impairment of insulin and VPS13C in early impairment of blood glucose homeostasis.	[Windholz, Jan; Dittrich, Kathrin; Blueher, Susann; Kiess, Wieland; Koerner, Antje] Univ Leipzig, Univ Hosp Children & Adolescents, Leipzig, Germany; [Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res, Leipzig, Germany; [Toenjes, Anke; Stumvoll, Michael] Univ Leipzig, Dept Med, Leipzig, Germany; [Toenjes, Anke; Blueher, Susann; Stumvoll, Michael; Koerner, Antje] Univ Leipzig, Med Ctr, IFB Adipos Dis, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Windholz, J (corresponding author), Univ Leipzig, Univ Hosp Children & Adolescents, Leipzig, Germany.	peter.kovacs@medizin.uni-leipzig.de	Körner, Antje/B-3988-2015; Stumvoll, Michael/ABE-1121-2021	Körner, Antje/0000-0001-6001-0356; Stumvoll, Michael/0000-0001-6225-8240; Kovacs, Peter/0000-0002-0290-5423	German Research Council (DFG) KFO 152 "Atherobesity'' [KO3512/1]; German Diabetes Association; Else Kroner-Fresenius Foundation; Integrated Research and Treatment Centre (IFB) [ADI K7-10, K7-36]	German Research Council (DFG) KFO 152 "Atherobesity''(German Research Foundation (DFG)); German Diabetes Association; Else Kroner-Fresenius Foundation; Integrated Research and Treatment Centre (IFB)	This work was supported by grants from the German Research Council (DFG) KFO 152 "Atherobesity'' KO3512/1 (to AK), the German Diabetes Association (to DF and AK), the Else Kroner-Fresenius Foundation (to AK) and the Integrated Research and Treatment Centre (IFB) Adiposity Diseases projects ADI K7-10 and K7-36. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2004, EUR J ENDOCRINOL, V150, P97, DOI 10.1530/eje.0.1500097; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; de Gortari P, 2010, BRAIN RES, V1310, P37, DOI 10.1016/j.brainres.2009.11.009; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Goran MI, 2001, DIABETES, V50, P2444, DOI 10.2337/diabetes.50.11.2444; Hu CL, 2009, AM J PHYSIOL-HEART C, V297, pH1776, DOI 10.1152/ajpheart.00050.2009; Ingelsson E, 2010, DIABETES, V59, P1266, DOI [10.2337/DB09-1568, 10.2337/db09-1568]; Korner A, 2007, J CLIN ENDOCR METAB, V92, P1956, DOI 10.1210/jc.2006-2514; Korner A, 2007, PEDIATR RES, V61, P640, DOI 10.1203/01.pdr.0000262638.48304.ef; KORNER A, 2010, INT J OBES LOND; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Ortiz-Capisano MC, 2007, HYPERTENSION, V49, P618, DOI 10.1161/01.HYP.0000255172.84842.d2; Povel CM, 2010, INT J OBESITY, V34, P840, DOI 10.1038/ijo.2009.302; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Velayos-Baeza A, 2004, GENOMICS, V84, P536, DOI 10.1016/j.ygeno.2004.04.012	17	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22101	10.1371/journal.pone.0022101	http://dx.doi.org/10.1371/journal.pone.0022101			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789219	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000292811700024
J	Lorrain, A; Arguelles, J; Alegre, A; Bertrand, A; Munaron, JM; Richard, P; Cherel, Y				Lorrain, Anne; Argueelles, Juan; Alegre, Ana; Bertrand, Arnaud; Munaron, Jean-Marie; Richard, Pierre; Cherel, Yves			Sequential Isotopic Signature Along Gladius Highlights Contrasted Individual Foraging Strategies of Jumbo Squid (Dosidicus gigas)	PLOS ONE			English	Article							STABLE-ISOTOPES; DIET; DELTA-N-15; CEPHALOPODA; INVESTIGATE; DELTA-C-13; PREDATORS; PATTERNS; NORTHERN; HISTORY	Background: Cephalopods play a major role in marine ecosystems, but knowledge of their feeding ecology is limited. In particular, intra- and inter-individual variations in their use of resources has not been adequatly explored, although there is growing evidence that individual organisms can vary considerably in the way they use their habitats and resources. Methodology/Principal Findings: Using delta C-13 and delta N-15 values of serially sampled gladius (an archival tissue), we examined high resolution variations in the trophic niche of five large (>60 cm mantle length) jumbo squids (Dosidicus gigas) that were collected off the coast of Peru. We report the first evidence of large inter-individual differences in jumbo squid foraging strategies with no systematic increase of trophic level with size. Overall, gladius delta C-13 values indicated one or several migrations through the squid's lifetime (similar to 8-9 months), during which delta N-15 values also fluctuated (range: 1 to 5 parts per thousand). One individual showed an unexpected terminal 4.6 parts per thousand delta N-15 decrease (more than one trophic level), thus indicating a shift from higher- to lower-trophic level prey at that time. The data illustrate the high diversity of prey types and foraging histories of this species at the individual level. Conclusions/Significance: The isotopic signature of gladii proved to be a powerful tool to depict high resolution and ontogenic variations in individual foraging strategies of squids, thus complementing traditional information offered by stomach content analysis and stable isotopes on metabolically active tissues. The observed differences in life history strategies highlight the high degree of plasticity of the jumbo squid and its high potential to adapt to environmental changes.	[Lorrain, Anne; Munaron, Jean-Marie] LEMAR UMR CNRS UBO IRD 6539, IRD, Plouzane, France; [Argueelles, Juan; Alegre, Ana; Bertrand, Arnaud] IMARPE, Lima, Peru; [Bertrand, Arnaud] UMR212 EME IFREMER IRD UM2, IRD, Sete, France; [Richard, Pierre] UMR 6250 CNRS Univ La Rochelle, La Rochelle, France; [Cherel, Yves] CNRS, UPR 1934, Ctr Etudes Biol Chize, Villers En Bois, France	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Instituto del Mar del Peru; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Lorrain, A (corresponding author), LEMAR UMR CNRS UBO IRD 6539, IRD, Plouzane, France.	anne.lorrain@ird.fr	Bertrand, Arnaud/E-4251-2010; Munaron, Jean-Marie/B-8282-2015; Lorrain, Anne/A-4152-2009; Richard, Pierre J/N-6482-2014	Bertrand, Arnaud/0000-0003-4723-179X; Lorrain, Anne/0000-0002-1289-2072; Richard, Pierre J/0000-0002-0393-9967; Arguelles, Juan/0000-0002-4227-0952				Arguelles J, 2008, PROG OCEANOGR, V79, P308, DOI 10.1016/j.pocean.2008.10.003; ARKHIPKIN AI, 1991, NTR ITPP SPEC PUBL, V1, P11; Bazzino G, 2010, PROG OCEANOGR, V86, P59, DOI 10.1016/j.pocean.2010.04.017; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Bertrand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010330; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Chavez FP, 2008, PROG OCEANOGR, V79, P95, DOI 10.1016/j.pocean.2008.10.012; Cherel Y, 2009, BIOL LETTERS, V5, P830, DOI 10.1098/rsbl.2009.0552; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Cherel Y, 2009, MAR BIOL, V156, P699, DOI 10.1007/s00227-008-1121-x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Fuenzalida R, 2009, DEEP-SEA RES PT II, V56, P1027, DOI 10.1016/j.dsr2.2008.11.001; Goodwin DH, 2003, PALAIOS, V18, P110, DOI 10.1669/0883-1351(2003)18<110:RAFOOI>2.0.CO;2; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Guerra A, 2010, ICES J MAR SCI, V67, P1425, DOI 10.1093/icesjms/fsq091; Ibanez CM, 2008, HELGOLAND MAR RES, V62, P331, DOI 10.1007/s10152-008-0120-0; Jaeger A, 2010, RAPID COMMUN MASS SP, V24, P3456, DOI 10.1002/rcm.4792; Kojadinovic J, 2008, WATERBIRDS, V31, P169, DOI 10.1675/1524-4695(2008)31[169:EOLEOC]2.0.CO;2; Markaida U, 2003, J MAR BIOL ASSOC UK, V83, P507, DOI 10.1017/S0025315403007434h; Naqvi SWA, 2000, NATURE, V408, P346, DOI 10.1038/35042551; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; Nigmatullin CM, 2001, FISH RES, V54, P9, DOI 10.1016/S0165-7836(01)00371-X; Paulmier A, 2009, PROG OCEANOGR, V80, P113, DOI 10.1016/j.pocean.2008.08.001; Perez JAA, 1996, CAN J FISH AQUAT SCI, V53, P2837, DOI 10.1139/cjfas-53-12-2837; RAU GH, 1982, DEEP-SEA RES, V29, P1035, DOI 10.1016/0198-0149(82)90026-7; Rodhouse PG, 1996, PHILOS T ROY SOC B, V351, P1003, DOI 10.1098/rstb.1996.0090; Ruiz-Cooley RI, 2010, MAR ECOL PROG SER, V399, P187, DOI 10.3354/meps08383; Ruiz-Cooley RI, 2006, J MAR BIOL ASSOC UK, V86, P437, DOI 10.1017/S0025315406013324; Sigman DM, 1999, GLOBAL BIOGEOCHEM CY, V13, P1149, DOI 10.1029/1999GB900038; Vander Zanden HB, 2010, BIOL LETTERS, V6, P711, DOI 10.1098/rsbl.2010.0124; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Voss M, 2001, DEEP-SEA RES PT I, V48, P1905, DOI 10.1016/S0967-0637(00)00110-2; Webb SC, 1998, J EXP BIOL, V201, P2903; ZEIDBERG LD, 2008, N PACIFIC P NATL ACA, V104, P12948	35	46	57	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22194	10.1371/journal.pone.0022194	http://dx.doi.org/10.1371/journal.pone.0022194			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779391	Green Published, gold			2022-12-25	WOS:000292811300045
J	Reinhardt, K; Naylor, R; Siva-Jothy, MT				Reinhardt, Klaus; Naylor, Richard; Siva-Jothy, Michael T.			Male Mating Rate Is Constrained by Seminal Fluid Availability in Bedbugs, Cimex lectularius	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; STALK-EYED FLY; SPERM COMPETITION; TRAUMATIC INSEMINATION; EXPERIMENTAL MANIPULATION; DROSOPHILA-MELANOGASTER; INBREEDING AVOIDANCE; ACCESSORY-GLAND; BED BUG; EJACULATE	Sexual selection, differences in reproductive success between individuals, continues beyond acquiring a mating partner and affects ejaculate size and composition (sperm competition). Sperm and seminal fluid have very different roles in sperm competition but both components encompass production costs for the male. Theoretical models predict that males should spend ejaculate components prudently and differently for sperm and seminal fluid but empirical evidence for independent variation of sperm number and seminal fluid volume is scarce. It is also largely unknown how sperm and seminal fluid variation affect future mating rate. In bedbugs we developed a protocol to examine the role of seminal fluids in ejaculate allocation and its effect on future male mating rate. Using age-related changes in sperm and seminal fluid volume we estimated the lowest capacity at which mating activity started. We then showed that sexually active males allocate 12% of their sperm and 19% of their seminal fluid volume per mating and predicted that males would be depleted of seminal fluid but not of sperm. We tested (and confirmed) this prediction empirically. Finally, the slightly faster replenishment of seminal fluid compared to sperm did not outweigh the faster decrease during mating. Our results suggest that male mating rate can be constrained by the availability of seminal fluids. Our protocol might be applicable to a range of other organisms. We discuss the idea that economic considerations in sexual conflict research might benefit from distinguishing between costs and benefits that are ejaculate dose-dependent and those that are frequency-dependent on the mating rate per se.	[Reinhardt, Klaus; Naylor, Richard; Siva-Jothy, Michael T.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Reinhardt, Klaus] Univ Tubingen, Inst Evolut & Ecol, Tubingen, Germany	University of Sheffield; Eberhard Karls University of Tubingen	Reinhardt, K (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	klaus.reinhardt@biologie.uni-tuebingen.de			Leverhulme Trust; VolkswagenStiftung; Natural Environment Research Council [NE/D009634/1] Funding Source: researchfish; NERC [NE/D009634/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); VolkswagenStiftung(Volkswagen); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by The Leverhulme Trust (to MSJ) and supported by a fellowship from the VolkswagenStiftung (to KR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-Honkola O, 2010, BEHAV ECOL SOCIOBIOL, V64, P1403, DOI 10.1007/s00265-010-0955-7; Alonzo SH, 2010, AM NAT, V175, P174, DOI 10.1086/649596; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist Goran, 2005, pUnpaginated; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Baer B, 2006, NATURE, V441, P872, DOI 10.1038/nature04698; Baker RH, 2003, BEHAV ECOL, V14, P607, DOI 10.1093/beheco/arg053; Bangham J, 2002, ANIM BEHAV, V64, P915, DOI 10.1006/anbe.2002.1976; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Cameron E, 2007, AM NAT, V169, pE158, DOI 10.1086/516718; CHAPMAN T, 1993, P ROY SOC B-BIOL SCI, V253, P211, DOI 10.1098/rspb.1993.0105; Crudgington HS, 2009, EVOLUTION, V63, P926, DOI 10.1111/j.1558-5646.2008.00601.x; Crudgington HS, 2000, NATURE, V407, P855, DOI 10.1038/35038154; Damiens D, 2005, PHYSIOL ENTOMOL, V30, P241, DOI 10.1111/j.1365-3032.2005.00453.x; DeBoer PACM, 1997, J EXP BIOL, V200, P941; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Fedorka KM, 2011, EVOLUTION, V65, P584, DOI 10.1111/j.1558-5646.2010.01141.x; Fricke C, 2008, EVOLUTION, V62, P3170, DOI 10.1111/j.1558-5646.2008.00515.x; GAGE MJG, 1995, P ROY SOC B-BIOL SCI, V261, P25, DOI 10.1098/rspb.1995.0112; Hoffer JNA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-393; Holman L, 2008, CURR BIOL, V18, P292, DOI 10.1016/j.cub.2008.01.048; Kamimura Y, 2007, BIOL LETTERS, V3, P401, DOI 10.1098/rsbl.2007.0192; Knell RJ, 2004, BIOL REV, V79, P557, DOI 10.1017/S1464793103006365; LEFEVRE G, 1962, GENETICS, V42, P1719; Linklater JR, 2007, EVOLUTION, V61, P2027, DOI 10.1111/j.1558-5646.2007.00157.x; Lockhart AB, 1996, BIOL REV, V71, P415, DOI 10.1111/j.1469-185X.1996.tb01281.x; Morrow EH, 2003, P ROY SOC B-BIOL SCI, V270, P2377, DOI 10.1098/rspb.2003.2514; Otti O, 2009, AM NAT, V174, P292, DOI 10.1086/600099; Parker GA, 2006, PHILOS T R SOC B, V361, P235, DOI 10.1098/rstb.2005.1785; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; PITNICK S, 1994, AM NAT, V143, P785, DOI 10.1086/285633; Pizzari T, 2008, TRENDS ECOL EVOL, V23, P131, DOI 10.1016/j.tree.2007.12.003; Poiani A, 2006, BEHAV ECOL SOCIOBIOL, V60, P289, DOI 10.1007/s00265-006-0178-0; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Rankin DJ, 2011, J EVOLUTION BIOL, V24, P71, DOI 10.1111/j.1420-9101.2010.02143.x; RAO HV, 1972, INDIAN J EXP BIOL, V10, P295; Reinhardt K, 2005, ECOL ENTOMOL, V30, P607, DOI 10.1111/j.0307-6946.2005.00730.x; Reinhardt K, 2003, P ROY SOC B-BIOL SCI, V270, P2371, DOI 10.1098/rspb.2003.2515; Reinhardt K, 2010, MED VET ENTOMOL, V24, P46, DOI 10.1111/j.1365-2915.2009.00847.x; Reinhardt K, 2009, PARASITOLOGY, V136, P283, DOI 10.1017/S0031182008005362; Reinhardt K, 2009, EVOLUTION, V63, P29, DOI 10.1111/j.1558-5646.2008.00502.x; Reinhardt K, 2007, EUR J ENTOMOL, V104, P725, DOI 10.14411/eje.2007.092; Reinhardt K, 2007, Q REV BIOL, V82, P375, DOI 10.1086/522811; Reinhardt K, 2007, AM NAT, V170, P931, DOI 10.1086/522844; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Reinhardt K, 2009, P NATL ACAD SCI USA, V106, P21743, DOI 10.1073/pnas.0905347106; Reinhold K, 2002, J EVOLUTION BIOL, V15, P201, DOI 10.1046/j.1420-9101.2002.00390.x; Rogers DW, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-37; Roth S, 2003, P ROY SOC B-BIOL SCI, V270, pS54, DOI 10.1098/rsbl.2003.0008; Ryne C, 2009, ANIM BEHAV, V78, P1471, DOI 10.1016/j.anbehav.2009.09.033; Savalli UM, 1999, FUNCT ECOL, V13, P169, DOI 10.1046/j.1365-2435.1999.00287.x; Sirot LK, 2009, BEHAV ECOL SOCIOBIOL, V63, P1505, DOI 10.1007/s00265-009-0806-6; Siva-Jothy MT, 2003, P ROY SOC B-BIOL SCI, V270, P649, DOI 10.1098/rspb.2002.2260; Stutt AD, 2001, P NATL ACAD SCI USA, V98, P5683, DOI 10.1073/pnas.101440698; Usinger RL, 1966, MONOGRAPH CIMICIDAE; VANVOORHIES WA, 1992, NATURE, V360, P456, DOI 10.1038/360456a0; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Welke K, 2009, BEHAV ECOL, V20, P1056, DOI 10.1093/beheco/arp097; Wigby S, 2009, CURR BIOL, V19, P751, DOI 10.1016/j.cub.2009.03.036	59	47	47	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e22082	10.1371/journal.pone.0022082	http://dx.doi.org/10.1371/journal.pone.0022082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779378	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000292680900029
J	Tognon, CE; Martin, MJ; Moradian, A; Trigo, G; Rotblat, B; Cheng, SWG; Pollard, M; Uy, E; Chow, C; Carboni, JM; Gottardis, MM; Pollak, M; Morin, GB; Sorensen, PHB				Tognon, C. E.; Martin, M. J.; Moradian, A.; Trigo, G.; Rotblat, B.; Cheng, S-W G.; Pollard, M.; Uy, E.; Chow, C.; Carboni, J. M.; Gottardis, M. M.; Pollak, M.; Morin, G. B.; Sorensen, P. H. B.			A tripartite complex composed of ETV6-NTRK3, IRS1 and IGF1R is required for ETV6-NTRK3-mediated membrane localization and transformation	ONCOGENE			English	Article						ETV6-NTRK3; insulin-like growth factor 1 receptor (IGF1R); insulin receptor substrate 1 (IRS1); BMS-536924; chimeric tyrosine kinase	FACTOR-I RECEPTOR; PROTEIN-TYROSINE KINASE; GENE FUSION; CONGENITAL FIBROSARCOMA; MESOBLASTIC NEPHROMA; INSULIN; CELLS; SUBSTRATE-1; CARCINOMA; DOMAINS	ETV6-NTRK3 (EN), a chimeric tyrosine kinase generated by t(12; 15) translocations, is a dominantly acting oncoprotein in diverse tumor types. We previously showed that insulin-like growth factor 1 receptor (IGF1R) is essential for EN-mediated oncogenesis and that insulin receptor substrate 1 (IRS1) is constitutively tyrosine phosphorylated and bound by EN in transformed cells. Given that IRS1 is also an adapter for IGF1R, we hypothesized that IRS1 might localize EN to IGF1R at the membrane to activate phosphatidylinositol 3-kinase (PI3K)-Akt, which is critical for EN oncogenesis. In this study, we examined EN/IRS1/IGF1R complexes in detail. We find that both IRS1 and kinase active IGF1R are required for EN transformation, that tyrosine phosphorylated IRS1 is present in high molecular weight complexes with EN and IGF1R, and that EN colocalizes with IGF1R at the plasma membrane. Both IGF1R kinase activity and an intact cytoplasmic Y950 residue, the IRS1-docking site of IGF1R, are required, confirming the importance of the IGF1R/IRS1 interaction for EN oncogenesis. The dual specificity IGF1R and insulin receptor (INSR) inhibitor, BMS-536924, blocks EN transformation activity, cell survival and its interaction with IRS proteins, and induces a striking shift of EN proteins to smaller sized molecular complexes. We conclude that a tripartite complex of EN, IRS1 and IGF1R localizes EN to the membrane and that this is essential for EN-mediated transformation. These findings provide an explanation for the observed IGF1R dependency of EN transformation. Blocking IGF1R kinase activity may, therefore, provide a tractable therapeutic strategy for the many tumor types driven by the EN oncoprotein. Oncogene (2012) 31, 1334-1340; doi: 10.1038/onc.2011.323; published online 1 August 2011	[Tognon, C. E.; Martin, M. J.; Trigo, G.; Rotblat, B.; Pollard, M.; Uy, E.; Chow, C.; Sorensen, P. H. B.] BC Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Moradian, A.; Cheng, S-W G.; Morin, G. B.] BC Canc Res Ctr, Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Carboni, J. M.; Gottardis, M. M.] Bristol Myers Squibb Co, Oncol Drug Discovery, Princeton, NJ USA; [Pollak, M.] McGill Univ, Jewish Gen Hosp, SMBD, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Morin, G. B.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	British Columbia Cancer Agency; British Columbia Cancer Agency; Bristol-Myers Squibb; Lady Davis Institute; McGill University; University of British Columbia	Sorensen, PHB (corresponding author), BC Canc Res Ctr, Dept Mol Oncol, 675 W10th Ave, Vancouver, BC V5Z 1L3, Canada.	psor@interchange.ubc.ca	Morin, Gregg B/E-9123-2012; Pollak, Michael/G-9094-2011; Rotblat, Barak/H-5970-2019	Morin, Gregg B/0000-0001-8949-4374; Pollak, Michael/0000-0003-3047-0604; Rotblat, Barak/0000-0003-2985-7115; , Matthew/0000-0002-8948-961X	ReThink Breast Cancer Career Development Award; Canadian Institutes of Health Research (CIHR); British Columbia Cancer Foundation	ReThink Breast Cancer Career Development Award; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); British Columbia Cancer Foundation	This work was supported by the following grants: a ReThink Breast Cancer Career Development Award to CET, a Canadian Institutes of Health Research (CIHR) Graduate Studentship to MJM, a CIHR grant to PHBS, and funds from the British Columbia Cancer Foundation through donations to PHBS from Team Finn and other generous riders in the Ride to Conquer Cancer. We thank Adrian Wan and Darren Saunders for assistance with the BiFC cloning.	Argani P, 2000, MODERN PATHOL, V13, P29, DOI 10.1038/modpathol.3880006; Baserga R, 2005, EXPERT OPIN THER TAR, V9, P753, DOI 10.1517/14728222.9.4.753; CRAPARO A, 1995, J BIOL CHEM, V270, P15639, DOI 10.1074/jbc.270.26.15639; Eguchi M, 1999, BLOOD, V93, P1355, DOI 10.1182/blood.V93.4.1355; Forghieri F, 2011, EUR J HAEMATOL, V86, P352, DOI 10.1111/j.1600-0609.2011.01576.x; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Kazakov DV, 2010, AM J SURG PATHOL, V34, P1226, DOI 10.1097/PAS.0b013e3181e4f49d; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Knezevich SR, 1998, CANCER RES, V58, P5046; Lannon CL, 2005, SEMIN CANCER BIOL, V15, P215, DOI 10.1016/j.semcancer.2005.01.003; Lannon CL, 2004, J BIOL CHEM, V279, P6225, DOI 10.1074/jbc.M307388200; Martin MJ, 2006, MOL CELL BIOL, V26, P1754, DOI 10.1128/MCB.26.5.1754-1769.2006; Morrison KB, 2002, ONCOGENE, V21, P5684, DOI 10.1038/sj.onc.1205669; MYERS MG, 1993, ENDOCRINOLOGY, V132, P1421, DOI 10.1210/en.132.4.1421; Skalova A, 2010, AM J SURG PATHOL, V34, P599, DOI 10.1097/PAS.0b013e3181d9efcc; Sun HZ, 2004, ENDOCRINOLOGY, V145, P5332, DOI 10.1210/en.2004-0668; Tognon C, 2001, CANCER RES, V61, P8909; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Tognon CE, 2004, MOL CELL BIOL, V24, P4636, DOI 10.1128/MCB.24.11.4636-4650.2004; Tognon CE, 2011, CANCER RES, V71, P1060, DOI 10.1158/0008-5472.CAN-10-3096; Wai DH, 2000, ONCOGENE, V19, P906, DOI 10.1038/sj.onc.1203396; Wittman M, 2005, J MED CHEM, V48, P5639, DOI 10.1021/jm050392q	23	15	16	3	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	10					1334	1340		10.1038/onc.2011.323	http://dx.doi.org/10.1038/onc.2011.323			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	906KS	21804605				2022-12-25	WOS:000301344600012
J	Dhamija, S; Kuehne, N; Winzen, R; Doerrie, A; Dittrich-Breiholz, O; Thakur, BK; Kracht, M; Holtmann, H				Dhamija, Sonam; Kuehne, Nancy; Winzen, Reinhard; Doerrie, Anneke; Dittrich-Breiholz, Oliver; Thakur, Basant Kumar; Kracht, Michael; Holtmann, Helmut			Interleukin-1 Activates Synthesis of Interleukin-6 by Interfering with a KH-type Splicing Regulatory Protein (KSRP)-dependent Translational Silencing Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEIN; TUMOR-NECROSIS-FACTOR; AU-RICH ELEMENTS; MESSENGER-RNA; POSTTRANSCRIPTIONAL CONTROL; KINASE 2; KSRP; EXPRESSION; IDENTIFICATION; STABILIZATION	Post-transcriptional mechanisms play an important role in the control of inflammatory gene expression. The heterogeneous nuclear ribonucleoprotein K homology (KH)-type splicing regulatory protein (KSRP) triggers rapid degradation of mRNAs for various cytokines, chemokines, and other inflammation-related proteins by interacting with AU-rich elements (AREs) in the 3'-untranslated mRNA regions. In addition to destabilizing mRNAs, AU-rich elements can restrict their translation. Evidence that KSRP also participates in translational silencing was obtained in a screen comparing the polysome profiles of cells with siRNA-mediated depletion of KSRP with that of control cells. Among the group of mRNAs showing increased polysome association upon KSRP depletion are those of interleukin (IL)-6 and IL-1 alpha as well as other ARE-containing transcripts. Redistribution of IL-6 mRNA to polysomes was associated with increased IL-6 protein secretion by the KSRP-depleted cells. Silencing of IL-6 and IL-1 alpha mRNAs depended on their 3'-untranslated regions. The sequence essential for translational control of IL-6 mRNA and its interaction with KSRP was located to an ARE. KSRP-dependent silencing was reversed by IL-1, a strong inducer of IL-6 mRNA and protein expression. The results identify KSRP as a protein involved in ARE-mediated translational silencing. They suggest that KSRP restricts inflammatory gene expression not only by enhancing degradation of mRNAs but also by inhibiting translation, both functions that are counteracted by the proinflammatory cytokine IL-1.	[Dhamija, Sonam; Kuehne, Nancy; Winzen, Reinhard; Doerrie, Anneke; Dittrich-Breiholz, Oliver; Thakur, Basant Kumar; Holtmann, Helmut] Hannover Med Sch, Inst Biochem, D-30623 Hannover, Germany; [Kracht, Michael] Univ Giessen, Rudolf Buchheim Inst Pharmakol, D-35392 Giessen, Germany	Hannover Medical School; Justus Liebig University Giessen	Holtmann, H (corresponding author), Hannover Med Sch, Inst Biochem, D-30623 Hannover, Germany.	holtmann.helmut@mh-hannover.de	Dhamija, Sonam/AAJ-2093-2020	Dhamija, Sonam/0000-0002-9569-2729; Kracht, Michael/0000-0002-8501-043X; Kuhne, Nancy/0000-0002-9418-7296; Thakur, Barun Kumar/0000-0002-1713-9186	Deutsche Forschungsgemeinschaft [SFB 566/A10, SFB 566/Z2, Ho 1116/5]; Niedersachsen Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Niedersachsen Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 566/A10, SFB 566/Z2, and Ho 1116/5 and by a grant from the Niedersachsen Foundation.	Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Briata P, 2005, MOL CELL, V20, P891, DOI 10.1016/j.molcel.2005.10.021; Briata P, 2011, FRONT BIOSCI-LANDMRK, V16, P1787, DOI 10.2741/3821; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; CONTENT J, 1985, EUR J BIOCHEM, V152, P253, DOI 10.1111/j.1432-1033.1985.tb09191.x; Danckwardt S, 2011, MOL CELL, V41, P298, DOI 10.1016/j.molcel.2010.12.032; DavisSmyth T, 1996, J BIOL CHEM, V271, P31679, DOI 10.1074/jbc.271.49.31679; Dhamija S, 2010, J BIOL CHEM, V285, P29165, DOI 10.1074/jbc.M110.146365; Gau BH, 2011, NUCLEIC ACIDS RES, V39, P3582, DOI 10.1093/nar/gkq1295; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Gherzi R, 2007, PLOS BIOL, V5, P82, DOI 10.1371/journal.pbio.0050005; HAEGEMAN G, 1986, EUR J BIOCHEM, V159, P625, DOI 10.1111/j.1432-1033.1986.tb09931.x; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; KOHASE M, 1986, CELL, V45, P659, DOI 10.1016/0092-8674(86)90780-4; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; KRUYS V, 1989, SCIENCE, V245, P852, DOI 10.1126/science.2672333; Lin JY, 2009, NUCLEIC ACIDS RES, V37, P47, DOI 10.1093/nar/gkn901; Lin WJ, 2011, MOL CELL BIOL, V31, P3196, DOI 10.1128/MCB.05073-11; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Olanich ME, 2011, ONCOGENE, V30, P77, DOI 10.1038/onc.2010.404; Paschoud S, 2006, MOL CELL BIOL, V26, P8228, DOI 10.1128/MCB.01155-06; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; PRICHETT W, 1995, J INFLAMM, V45, P97; Rothe F, 2006, BIOCHEM BIOPH RES CO, V343, P57, DOI 10.1016/j.bbrc.2006.02.112; Ruggiero T, 2009, FASEB J, V23, P2898, DOI 10.1096/fj.09-131342; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Stoecklin G, 2006, ADV IMMUNOL, V89, P1, DOI 10.1016/S0065-2776(05)89001-7; Suswam EA, 2005, INT J CANCER, V113, P911, DOI 10.1002/ijc.20675; Tebo J, 2003, J BIOL CHEM, V278, P12085, DOI 10.1074/jbc.M212992200; TONOUCHI N, 1992, J BIOTECHNOL, V22, P283, DOI 10.1016/0168-1656(92)90146-Z; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Winzen R, 2004, MOL CELL BIOL, V24, P4835, DOI 10.1128/MCB.24.11.4835-4847.2004; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Zhang XN, 2011, MOL CELL, V41, P371, DOI 10.1016/j.molcel.2011.01.020; ZILBERSTEIN A, 1986, EMBO J, V5, P2529, DOI 10.1002/j.1460-2075.1986.tb04531.x	43	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33279	33288		10.1074/jbc.M111.264754	http://dx.doi.org/10.1074/jbc.M111.264754			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795706	Green Published, hybrid			2022-12-25	WOS:000294968800047
J	Wang, K; Otu, HH; Chen, Y; Lee, Y; Latham, K; Cibelli, JB				Wang, Kai; Otu, Hasan H.; Chen, Ying; Lee, Young; Latham, Keith; Cibelli, Jose B.			Reprogrammed Transcriptome in Rhesus-Bovine Interspecies Somatic Cell Nuclear Transfer Embryos	PLOS ONE			English	Article							MATERNAL MESSENGER-RNAS; ZYGOTIC GENE ACTIVATION; STEM-CELLS; PREIMPLANTATION DEVELOPMENT; MOUSE; OOCYTES; OLIGONUCLEOTIDE; DEGRADATION; MICROARRAYS; ZEBRAFISH	Background: Global activation of the embryonic genome (EGA), one of the most critical steps in early mammalian embryo development, is recognized as the time when interspecies somatic cell nuclear transfer (iSCNT) embryos fail to thrive. Methodology/Principal Findings: In this study, we analyzed the EGA-related transcriptome of rhesus-bovine iSCNT 8-to 16-cell embryos and dissected the reprogramming process in terms of embryonic gene activation, somatic gene silencing, and maternal RNA degradation. Compared with fibroblast donor cells, two thousand and seven genes were activated in iSCNT embryos, one quarter of them reaching expression levels comparable to those found in in vitro fertilized (IVF) rhesus embryos. This suggested that EGA in iSCNT embryos had partially recapitulated rhesus embryonic development. Eight hundred and sixty somatic genes were not silenced properly and continued to be expressed in iSCNT embryos, which indicated incomplete nuclear reprogramming. We compared maternal RNA degradation in bovine oocytes between bovine-bovine SCNT and iSCNT embryos. While maternal RNA degradation occurred in both SCNT and iSCNT embryos, we saw more limited overall degradation of maternal RNA in iSCNT embryos than in SCNT embryos. Several important maternal RNAs, like GPF9, were not properly processed in SCNT embryos. Conclusions/Significance: Our data suggested that iSCNT embryos are capable of triggering EGA, while a portion of somatic cell-associated genes maintain their expression. Maternal RNA degradation seems to be impaired in iSCNT embryos. Further understanding of the biological roles of these genes, networks, and pathways revealed by iSCNT may expand our knowledge about cell reprogramming, pluripotency, and differentiation.	[Wang, Kai; Chen, Ying; Cibelli, Jose B.] Michigan State Univ, E Lansing, MI 48824 USA; [Otu, Hasan H.] Harvard Univ, Sch Med, BIDMC Genom Ctr, Boston, MA USA; [Otu, Hasan H.] Istanbul Bilgi Univ, Dept Bioengn, Istanbul, Turkey; [Lee, Young; Latham, Keith] Temple Univ, Philadelphia, PA 19122 USA; [Cibelli, Jose B.] Programa Andaluz Terapia Celular, Andalucia, Spain	Michigan State University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Istanbul Bilgi University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Wang, K (corresponding author), Michigan State Univ, E Lansing, MI 48824 USA.	Cibelli@anr.msu.edu	wang, kai/G-4932-2011; chen, ying/G-4926-2011	Otu, Hasan/0000-0002-9253-8152; Lee, Young/0000-0002-1692-4959	Michigan State University (MSU) Foundation; Michigan Agricultural Experiment Station (MAES); Naylor Family Foundation; Dubai Harvard Foundation for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR015253] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD012221] Funding Source: NIH RePORTER	Michigan State University (MSU) Foundation; Michigan Agricultural Experiment Station (MAES); Naylor Family Foundation; Dubai Harvard Foundation for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Michigan State University (MSU) Foundation, MSU's Vice President of Research, and the Michigan Agricultural Experiment Station (MAES), as well as the Naylor Family Foundation. HHO is partially supported by a grant from the Dubai Harvard Foundation for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberio R, 2006, REPRODUCTION, V132, P709, DOI 10.1530/rep.1.01077; Alizadeh Z, 2005, MOL REPROD DEV, V72, P281, DOI 10.1002/mrd.20340; Barash Y, 2004, BIOINFORMATICS, V20, P839, DOI 10.1093/bioinformatics/btg487; Beyhan Z, 2007, CELL STEM CELL, V1, P502, DOI 10.1016/j.stem.2007.10.009; Beyhan Z, 2007, DEV BIOL, V305, P637, DOI 10.1016/j.ydbio.2007.01.041; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Byrne JA, 2006, BIOL REPROD, V75, P908, DOI 10.1095/biolreprod.106.053868; Chen Y, 2003, CELL RES, V13, P251, DOI 10.1038/sj.cr.7290170; Chung Y, 2009, CLONING STEM CELLS, V11, P213, DOI 10.1089/clo.2009.0004; Cibelli J, 2007, SCIENCE, V318, P1879, DOI 10.1126/science.1153229; Dominko T, 1999, BIOL REPROD, V60, P1496, DOI 10.1095/biolreprod60.6.1496; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kikyo N, 2000, J CELL SCI, V113, P11; Kocabas AM, 2006, P NATL ACAD SCI USA, V103, P14027, DOI 10.1073/pnas.0603227103; Kues WA, 2008, P NATL ACAD SCI USA, V105, P19768, DOI 10.1073/pnas.0805616105; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Memili E, 1998, MOL REPROD DEV, V51, P381, DOI 10.1002/(SICI)1098-2795(199812)51:4&lt;381::AID-MRD4&gt;3.0.CO;2-G; Misirlioglu M, 2006, P NATL ACAD SCI USA, V103, P18905, DOI 10.1073/pnas.0608247103; PAYNTON BV, 1988, DEV BIOL, V129, P304, DOI 10.1016/0012-1606(88)90377-6; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Shedden K, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-26; SOUMARE S, 1973, ANN INST PASTEUR MIC, VB124, P81; Tecirlioglu RT, 2006, STEM CELL REV, V2, P277, DOI 10.1007/BF02698054; VandeVoort CA, 2009, BIOL REPROD, V81, P1139, DOI 10.1095/biolreprod.109.077198; Vassena R, 2007, DEV BIOL, V304, P75, DOI 10.1016/j.ydbio.2006.12.015; WANG K, 2009, CLONING STEM CELLS; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038	33	19	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22197	10.1371/journal.pone.0022197	http://dx.doi.org/10.1371/journal.pone.0022197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799794	Green Published, gold, Green Submitted			2022-12-25	WOS:000293172900016
J	Cui, B; Zhu, XL; Xu, M; Guo, T; Zhu, DL; Chen, G; Li, XJ; Xu, LY; Bi, YF; Chen, YH; Xu, Y; Li, XY; Wang, WQ; Wang, HF; Huang, W; Ning, G				Cui, Bin; Zhu, Xiaolin; Xu, Min; Guo, Ting; Zhu, Dalong; Chen, Gang; Li, Xuejun; Xu, Lingyan; Bi, Yufang; Chen, Yuhong; Xu, Yu; Li, Xiaoying; Wang, Weiqing; Wang, Haifeng; Huang, Wei; Ning, Guang			A Genome-Wide Association Study Confirms Previously Reported Loci for Type 2 Diabetes in Han Chinese	PLOS ONE			English	Article							LARGE-SCALE ASSOCIATION; SUSCEPTIBILITY LOCI; RISK LOCI; VARIANTS; REPLICATION; POPULATIONS; DISEASE; GLUCOSE; GENES; KCNQ1	Background: Genome-wide association study (GWAS) has identified more than 30 loci associated with type 2 diabetes (T2D) in Caucasians. However, genomic understanding of T2D in Asians, especially Han Chinese, is still limited. Methods and Principal Findings: A two-stage GWAS was performed in Han Chinese from Mainland China. The discovery stage included 793 T2D cases and 806 healthy controls genotyped using Illumina Human 660- and 610-Quad BeadChips; and the replication stage included two independent case-control populations (a total of 4445 T2D cases and 4458 controls) genotyped using TaqMan assay. We validated the associations of KCNQ1 (rs163182, p = 2.085 x 10(-17), OR 1.28) and C2CD4A/B (rs1370176, p = 3.677 x 10(-4), OR 1.124; rs1436953, p = 7.753 x 10(-6), OR 1.141; rs7172432, p = 4.001 x 10(-5), OR 1.134) in Han Chinese. Conclusions and Significance: Our study represents the first GWAS of T2D with both discovery and replication sample sets recruited from Han Chinese men and women residing in Mainland China. We confirmed the associations of KCNQ1 and C2CD4A/B with T2D, with the latter for the first time being examined in Han Chinese. Arguably, eight more independent loci were replicated in our GWAS.	[Cui, Bin; Zhu, Xiaolin; Xu, Min; Li, Xiaoying; Ning, Guang] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Key Lab Endocrine & Metab Dis,Minist Hlth, Shanghai 200030, Peoples R China; [Cui, Bin; Zhu, Xiaolin; Xu, Min; Guo, Ting; Xu, Lingyan; Bi, Yufang; Chen, Yuhong; Xu, Yu; Li, Xiaoying; Wang, Weiqing; Ning, Guang] Shanghai Jiao Tong Univ, Ruijin Hosp,Shanghai Inst Endocrine & Metab Dis, Sch Med,Shanghai Clin Ctr Endocrine & Metab Dis, Dept Endocrine & Metab Dis, Shanghai 200030, Peoples R China; [Zhu, Dalong] Nanjing Univ, Dept Endocrine Dis, Nanjing Drum Tower Hosp, Sch Med,Affiliated Hosp, Nanjing 210008, Peoples R China; [Chen, Gang] Fujian Prov Hosp, Dept Endocrine Dis, Fuzhou, Peoples R China; [Li, Xuejun] Xiamen Univ, Affiliated Hosp 1, Dept Endocrine Dis, Xiamen, Peoples R China; [Wang, Haifeng; Huang, Wei] Chinese Natl Human Genome Ctr, Dept Genet, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Nanjing University; Fujian Provincial Hospital; Xiamen University	Cui, B (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Key Lab Endocrine & Metab Dis,Minist Hlth, Shanghai 200030, Peoples R China.	huangwei@chgc.sh.cn; gning@sibs.ac.cn	Zhu, Xiaolin/GLV-1533-2022	Zhu, Xiaolin/0000-0002-3221-595X; Li, Xiaoying/0000-0002-9383-5757; Wang, Haifeng/0000-0001-5022-0720	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Chinese Health [1994DP131044]; State Key Laboratory of Medical Genomics, China; National Key New Drug Creation and Manufacturing Program [2008ZX09312/019]; Ministry of Health [201002002]	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Chinese Health; State Key Laboratory of Medical Genomics, China; National Key New Drug Creation and Manufacturing Program; Ministry of Health	This study was supported by the grants from Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Chinese Health (No. 1994DP131044), State Key Laboratory of Medical Genomics, China, National Key New Drug Creation and Manufacturing Program (2008ZX09312/019) and the Sector Funds of Ministry of Health (201002002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; MANTEL N, 1959, J NATL CANCER I, V22, P719; McCarthy MI, 2008, NAT GENET, V40, P1039, DOI 10.1038/ng0908-1039; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shu XO, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001127; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Xiang J, 2008, J CLIN ENDOCR METAB, V93, P4107, DOI 10.1210/jc.2008-0161; Xu M, 2009, DIABETOLOGIA, V52, P1511, DOI 10.1007/s00125-009-1386-8; Xu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014022; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	33	50	55	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22353	10.1371/journal.pone.0022353	http://dx.doi.org/10.1371/journal.pone.0022353			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799836	Green Published, gold, Green Submitted			2022-12-25	WOS:000293097300039
J	Salonen, MK; Kajantie, E; Osmond, C; Forsen, T; Yliharsila, H; Paile-Hyvarinen, M; Barker, DJP; Eriksson, JG				Salonen, Minna K.; Kajantie, Eero; Osmond, Clive; Forsen, Tom; Yliharsila, Hilkka; Paile-Hyvarinen, Maria; Barker, D. J. P.; Eriksson, Johan G.			Developmental Origins of Physical Fitness: The Helsinki Birth Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; ADULT BODY-COMPOSITION; MAXIMAL AEROBIC POWER; 2-KM WALK TEST; CARDIORESPIRATORY FITNESS; LATER LIFE; METABOLIC SYNDROME; CARDIOVASCULAR FITNESS; EARLY-CHILDHOOD	Background: Cardiorespiratory fitness (CRF) is a major factor influencing health and disease outcomes including all-cause mortality and cardiovascular disease. Importantly CRF is also modifiable and could therefore have a major public health impact. Early life exposures play a major role in chronic disease development. Our aim was to explore the potential prenatal and childhood origins of CRF in later life. Methods/Principal Findings: This sub-study of the HBCS (Helsinki Birth Cohort Study) includes 606 men and women who underwent a thorough clinical examination and participated in the UKK 2-km walk test, which has been validated against a maximal exercise stress test as a measure of CRF in population studies. Data on body size at birth and growth during infancy and childhood were obtained from hospital, child welfare and school health records. Body size at birth was not associated with adult CRF. A 1 cm increase in height at 2 and 7 years was associated with 0.21 ml/kg/min (95% CI 0.02 to 0.40) and 0.16 ml/kg/min (95% CI 0.03 to 0.28) higher VO2max, respectively. Adjustment for adult lean body mass strengthened these findings. Weight at 2 and 7 years and height at 11 years became positively associated with CRF after adult lean body mass adjustment. However, a 1 kg/m(2) higher BMI at 11 years was associated with -0.57 ml/kg/min (95% CI -0.91 to -0.24) lower adult VO2max, and remained so after adjustment for adult lean body mass. Conclusion/Significance: We did not observe any significant associations between body size at birth and CRF in later life. However, childhood growth was associated with CRF in adulthood. These findings suggest, importantly from a public point of view, that early growth may play a role in predicting adult CRF.	[Salonen, Minna K.; Kajantie, Eero; Forsen, Tom; Yliharsila, Hilkka; Paile-Hyvarinen, Maria; Eriksson, Johan G.] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Salonen, Minna K.] Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; [Osmond, Clive] Epidemiol Resource Ctr, Southampton, Hants, England; [Forsen, Tom] Vaasa Hlth Care Ctr, Diabet Unit, Vaasa, Finland; [Forsen, Tom] Univ Southampton, Dev Origins Hlth & Dis Div, Southampton, Hants, England; [Barker, D. J. P.; Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, FIN-00014 Helsinki, Finland; [Eriksson, Johan G.] Vaasa Cent Hosp, Vaasa, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Southampton; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Vaasa Central Hospital; Folkhalsan Research Center	Salonen, MK (corresponding author), Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland.	minna.salonen@thl.fi		Osmond, Clive/0000-0002-9054-4655; Eriksson, Johan/0000-0002-2516-2060	British Heart Foundation; Academy of Finland; Paivikki and Sakari Sohlberg Foundation; Finnish Cardiovascular Research Foundation; Juho Vainio Foundation; Jalmari and Rauha Ahokas Foundation; Yrjo Jahnsson Foundation; Signe and Arne Gyllenberg Foundation; Finska Lakaresallskapet; Samfundet Folkhalsan; Medical Research Council [U1475000004] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Academy of Finland(Academy of Finland); Paivikki and Sakari Sohlberg Foundation; Finnish Cardiovascular Research Foundation; Juho Vainio Foundation; Jalmari and Rauha Ahokas Foundation; Yrjo Jahnsson Foundation; Signe and Arne Gyllenberg Foundation; Finska Lakaresallskapet; Samfundet Folkhalsan; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The present study was supported by the British Heart Foundation (http://www.bhf.org.uk/),The Academy of Finland (http://www.aka.fi/en-gb/A/),the Paivikki and Sakari Sohlberg Foundation (http://www.pss-saatio.fi/english.htm), Finska Lakaresallskapet (http://www.fls.fi/sallskapet/),the Finnish Cardiovascular Research Foundation (http://www.sydantutkimussaatio.fi/site/?lan = 3&page_id = 31), the Juho Vainio Foundation (http://www.juhovainionsaatio.fi/pages/in-english/grants/grants-application.php), the Jalmari and Rauha Ahokas Foundation (http://www.ahokkaansaatio.org/english.htm), the Yrjo Jahnsson Foundation (http://www.yjs.fi/index_eng.cfm), Samfundet Folkhalsan (http://www.folkhalsan.fi/fi/startsida/Tietoa-Folkhalsanista/Organisaatiomme/Samfundet-Folkhalsan/) and the Signe and Arne Gyllenberg Foundation (http://www.gyllenberg-foundation.fi/english/foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008192; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; BARKER DJP, 1998, MOTHERS BABIES HLTH, P13; Bedogni G, 2002, EUR J CLIN NUTR, V56, P1143, DOI 10.1038/sj.ejcn.1601466; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; De Stavola BL, 2006, AM J EPIDEMIOL, V163, P84, DOI 10.1093/aje/kwj003; EATON CB, 1995, MED SCI SPORT EXER, V27, P340; Ekelund U, 2006, AM J CLIN NUTR, V83, P324; Ekelund U, 2007, J CLIN ENDOCR METAB, V92, P98, DOI 10.1210/jc.2006-1071; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; Eriksson JG, 2004, PREV MED, V39, P164, DOI 10.1016/j.ypmed.2004.01.035; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Eriksson JG, 2007, HYPERTENSION, V49, P1415, DOI 10.1161/HYPERTENSIONAHA.106.085597; Farrell SW, 2010, MED SCI SPORT EXER, V42, P2006, DOI 10.1249/MSS.0b013e3181df12bf; Gale CR, 2006, PEDIATRICS, V118, P1486, DOI 10.1542/peds.2005-2629; Huxley R, 2007, AM J CLIN NUTR, V85, P1244, DOI 10.1093/ajcn/85.5.1244; Kajantie E, 2008, INT J EPIDEMIOL, V37, P280, DOI 10.1093/ije/dyn012; Kajantie E, 2010, J PEDIATR-US, V157, P610, DOI 10.1016/j.jpeds.2010.04.002; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Kohrt WM, 2004, MED SCI SPORT EXER, V36, P1985, DOI 10.1249/01.MSS.0000142662.21767.58; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Laaksonen DE, 2003, DIABETES CARE, V26, P2156, DOI 10.2337/diacare.26.7.2156; Laaksonen DE, 2002, DIABETES CARE, V25, P1612, DOI 10.2337/diacare.25.9.1612; LAKKA TA, 1994, NEW ENGL J MED, V330, P1549, DOI 10.1056/NEJM199406023302201; LAUKKANEN R, 1992, INT J OBESITY, V16, P263; Laukkanen RMT, 2000, INT J SPORTS MED, V21, P113; LAUKKANEN RMT, 1992, SCAND J SOC MED, V20, P119, DOI 10.1177/140349489202000210; Lawlor DA, 2008, EUR J EPIDEMIOL, V23, P411, DOI 10.1007/s10654-008-9259-x; Lee CD, 2009, ARCH INTERN MED, V169, P2096, DOI 10.1001/archinternmed.2009.414; Lee DC, 2011, BRIT J SPORT MED, V45, P504, DOI 10.1136/bjsm.2009.066209; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Orozco LJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003054.pub3; Ortega FB, 2009, J PEDIATR, V154, P61, DOI 10.1016/j.jpeds.2008.07.041; Pescatello LS, 2004, MED SCI SPORT EXER, V36, P533, DOI 10.1249/01.MSS.0000115224.88514.3A; Rance M, 2005, INT J SPORTS MED, V26, P453, DOI 10.1055/s-2004-821157; Ridgway CL, 2009, MED SCI SPORT EXER, V41, P1212, DOI 10.1249/MSS.0b013e31819794ab; Salonen MK, 2009, DIABETES METAB, V35, P143, DOI 10.1016/j.diabet.2008.10.004; Salonen MK, 2009, DIABETES METAB, V35, P94, DOI 10.1016/j.diabet.2008.08.008; Salonen MK, 2011, EUR J PUBLIC HEALTH, V21, P719, DOI 10.1093/eurpub/ckq176; Sillanpaa E, 2009, SCAND J MED SCI SPOR, V19, P885, DOI 10.1111/j.1600-0838.2008.00849.x; Skidmore PML, 2007, J EPIDEMIOL COMMUN H, V61, P215, DOI 10.1136/jech.2006.047571; Tager IB, 1998, AM J EPIDEMIOL, V147, P921, DOI 10.1093/oxfordjournals.aje.a009382; Tzoulaki I, 2010, AM J EPIDEMIOL, V171, P989, DOI 10.1093/aje/kwq027; Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Yliharsila H, 2007, INT J OBESITY, V31, P1392, DOI 10.1038/sj.ijo.0803612; Yliharsila H, 2008, AM J CLIN NUTR, V87, P1769, DOI 10.1093/ajcn/87.6.1769	52	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22302	10.1371/journal.pone.0022302	http://dx.doi.org/10.1371/journal.pone.0022302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799817	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000293097300029
J	Szczesniak, MM; Williams, RB; Cook, IJ				Szczesniak, Michal Marcin; Williams, Rohan Benjamin; Cook, Ian James			Mechanisms of Esophago-Pharyngeal Acid Regurgitation in Human Subjects	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX; SPHINCTER PRESSURE; LARYNGITIS; RELAXATION; MANIFESTATIONS; DYSPHAGIA; DISEASE; GERD	Esophago-pharyngeal regurgitation is implicated in various otolaryngologic and respiratory disorders. The pathophysiological mechanisms causing regurgitation are still largely unknown. Aim: To determine the principal mechanisms behind esophago-pharyngeal regurgitation. Methods: We studied 11 patients with extra-esophageal GORD symptoms in whom esophago-pharyngeal acid regurgitation had previously been demonstrated using ambulatory, dual (pharyngo-esophageal) pH metry (>2 episodes/day using previously validated pH-metric criteria). Patients underwent continuous, 24 hr, stationary monitoring of pharyngo-esophageal manometry and dual (pharyngeal and esophageal) pH recordings. They were intubated with a 14-channel manometric assembly incorporating 2 sleeve sensors monitoring the upper and lower esophageal sphincters simultaneously. A dual pH catheter recorded pH signals 2 cm above the UES midpoint and 7 cm above the LES midpoint. Results: A total of 32 episodes of spontaneous esophago-pharyngeal acid regurgitation were recorded. All episodes occurred in the upright posture and 91% occurred within 3 hrs post-prandium. All regurgitation events were associated with a relaxation of the UES, which were classified as transient non-swallow related relaxations in 29 (91%) and swallow-related in the remaining 3 (9%). Straining was an additional associated factor in 41% of regurgitation events, but strain alone was not sufficient to cause esophago-pharyngeal regurgitation. Conclusion: Some form of active UES relaxation is necessary for regurgitation to occur. The dominant mechanism underlying esophago-pharyngeal acid regurgitation is the non-swallow related, transient UES relaxation.	[Szczesniak, Michal Marcin] Univ New S Wales, Dept Gastroenterol, Sydney, NSW, Australia; St George Hosp, Sydney, NSW, Australia	University of New South Wales Sydney; St George Hospital	Szczesniak, MM (corresponding author), Univ New S Wales, Dept Gastroenterol, Sydney, NSW, Australia.	m.szczesniak@unsw.edu.au	Szczesniak, Michal/AAL-9584-2021	Szczesniak, Michal/0000-0002-9812-8373	NHMRC Australia [ID 222880]	NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia)	The project was supported by NHMRC Australia (ID 222880). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali GN, 1996, GASTROENTEROLOGY, V110, P383, DOI 10.1053/gast.1996.v110.pm8566584; DENT J, 1976, GASTROENTEROLOGY, V71, P263; JACOB P, 1991, GASTROENTEROLOGY, V100, P305, DOI 10.1016/0016-5085(91)90196-R; KAHRILAS PJ, 1987, GASTROENTEROLOGY, V92, P466, DOI 10.1016/0016-5085(87)90143-0; KAHRILAS PJ, 1986, GASTROENTEROLOGY, V91, P133, DOI 10.1016/0016-5085(86)90449-X; KATZ PO, 1990, AM J GASTROENTEROL, V85, P38; KOUFMAN JA, 1991, LARYNGOSCOPE, V101, P1; Lang IM, 2001, AM J PHYSIOL-GASTR L, V281, pG1246, DOI 10.1152/ajpgi.2001.281.5.G1246; Pandolfino JE, 2004, AM J GASTROENTEROL, V99, P1430, DOI 10.1111/j.1572-0241.2004.30515.x; Richter JE, 2000, AM J MED S4A, V108, p153S; Sermon F, 2004, DIGEST LIVER DIS, V36, P105, DOI 10.1016/j.dld.2003.07.008; SHAKER R, 1995, GASTROENTEROLOGY, V109, P1575, DOI 10.1016/0016-5085(95)90646-0; Szczesniak MM, 2010, NEUROGASTROENT MOTIL, V22, P381, DOI 10.1111/j.1365-2982.2009.01452.x; Szczesniak MM, 2008, AM J PHYSIOL-GASTR L, V294, pG982, DOI 10.1152/ajpgi.00496.2007; Torrico S, 2000, AM J PHYSIOL-GASTR L, V279, pG262, DOI 10.1152/ajpgi.2000.279.2.G262; Williams RBH, 1999, AM J GASTROENTEROL, V94, P3448, DOI 10.1111/j.1572-0241.1999.01507.x; Williams RBH, 2004, AM J GASTROENTEROL, V99, P777, DOI 10.1111/j.1572-0241.2004.04151.x; Williams RBH, 2002, AM J PHYSIOL-GASTR L, V283, pG16, DOI 10.1152/ajpgi.00189.2001; Williams RBH, 1999, GASTROENTEROLOGY, V117, P1051, DOI 10.1016/S0016-5085(99)70389-6; WILLING J, 1993, GUT, V34, P904, DOI 10.1136/gut.34.7.904; WILSON JA, 1989, ANN OTO RHINOL LARYN, V98, P405; Ylitalo R, 2002, ANN OTO RHINOL LARYN, V111, P178, DOI 10.1177/000348940211100213	22	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22630	10.1371/journal.pone.0022630	http://dx.doi.org/10.1371/journal.pone.0022630			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799921	gold, Green Published, Green Submitted			2022-12-25	WOS:000293097300075
J	Schelder, S; Zaade, D; Litsanov, B; Bott, M; Brocker, M				Schelder, Stephanie; Zaade, Daniela; Litsanov, Boris; Bott, Michael; Brocker, Melanie			The Two-Component Signal Transduction System CopRS of Corynebacterium glutamicum Is Required for Adaptation to Copper-Excess Stress	PLOS ONE			English	Article							COMPARATIVE GENOMIC ANALYSES; ESCHERICHIA-COLI; GENE-EXPRESSION; MYCOBACTERIUM-TUBERCULOSIS; TRANSCRIPTIONAL REGULATORS; MOLECULAR ANALYSIS; RESPIRATORY-CHAIN; HOMEOSTASIS; GROWTH; IRON	Copper is an essential cofactor for many enzymes but at high concentrations it is toxic for the cell. Copper ion concentrations >= 50 mu M inhibited growth of Corynebacterium glutamicum. The transcriptional response to 20 mu M Cu2+ was studied using DNA microarrays and revealed 20 genes that showed a >= 3-fold increased mRNA level, including cg3281-cg3289. Several genes in this genomic region code for proteins presumably involved in the adaption to copper-induced stress, e. g. a multicopper oxidase (CopO) and a copper-transport ATPase (CopB). In addition, this region includes the copRS genes (previously named cgtRS9) which encode a two-component signal transduction system composed of the histidine kinase CopS and the response regulator CopR. Deletion of the copRS genes increased the sensitivity of C. glutamicum towards copper ions, but not to other heavy metal ions. Using comparative transcriptome analysis of the Delta copRS mutant and the wild type in combination with electrophoretic mobility shift assays and reporter gene studies the CopR regulon and the DNA-binding motif of CopR were identified. Evidence was obtained that CopR binds only to the intergenic region between cg3285 (copR) and cg3286 in the genome of C. glutamicum and activates expression of the divergently oriented gene clusters cg3285-cg3281 and cg3286-cg3289. Altogether, our data suggest that CopRS is the key regulatory system in C. glutamicum for the extracytoplasmic sensing of elevated copper ion concentrations and for induction of a set of genes capable of diminishing copper stress.	[Schelder, Stephanie; Zaade, Daniela; Litsanov, Boris; Bott, Michael; Brocker, Melanie] Forschungszentrum Julich, Inst Bio & Geowissensch, IBG Biotechnol 1, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Schelder, S (corresponding author), Forschungszentrum Julich, Inst Bio & Geowissensch, IBG Biotechnol 1, D-52425 Julich, Germany.	m.brocker@fz-juelich.de	Bott, Michael/E-8004-2011	Bott, Michael/0000-0002-4701-8254				ABE S, 1967, J GEN APPL MICROBIOL, V13, P279, DOI 10.2323/jgam.13.279; Bott M, 2003, J BIOTECHNOL, V104, P129, DOI 10.1016/S0168-1656(03)00144-5; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brocker M, 2009, J BACTERIOL, V191, P3869, DOI 10.1128/JB.00113-09; Eggeling L., 2005, HDB CORYNEBACTERIUM, DOI 10.1201/9781420039696; EIKMANNS BJ, 1991, GENE, V102, P93, DOI 10.1016/0378-1119(91)90545-M; Engels S, 2005, MOL MICROBIOL, V57, P576, DOI 10.1111/j.1365-2958.2005.04710.x; Engels S, 2004, MOL MICROBIOL, V52, P285, DOI 10.1111/j.1365-2958.2003.03979.x; Engels V, 2007, J BACTERIOL, V189, P2955, DOI 10.1128/JB.01596-06; Fan B, 2001, BIOCHEM BIOPH RES CO, V286, P414, DOI 10.1006/bbrc.2001.5367; Frangipani E, 2008, J BACTERIOL, V190, P6706, DOI 10.1128/JB.00450-08; Frunzke J, 2008, MOL MICROBIOL, V67, P305, DOI 10.1111/j.1365-2958.2007.06020.x; Frunzke Julia, 2008, P241; Gerstmeir R, 2003, J BIOTECHNOL, V104, P99, DOI 10.1016/S0168-1656(03)00167-6; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Hanssler Eva, 2008, P183; Janausch IG, 2004, MICROBIOL-SGM, V150, P877, DOI 10.1099/mic.0.26900-0; KEILHAUER C, 1993, J BACTERIOL, V175, P5595, DOI 10.1128/JB.175.17.5595-5603.1993; Kershaw CJ, 2005, MICROBIOL-SGM, V151, P1187, DOI 10.1099/mic.0.27650-0; Kim EH, 2010, NAT PROD REP, V27, P711, DOI 10.1039/b906681k; Kocan M, 2006, J BACTERIOL, V188, P724, DOI 10.1128/JB.188.2.724-732.2006; KRONEMEYER W, 1995, J BACTERIOL, V177, P1152, DOI 10.1128/jb.177.5.1152-1158.1995; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Munson GP, 2000, J BACTERIOL, V182, P5864, DOI 10.1128/JB.182.20.5864-5871.2000; Netzer R, 2004, ARCH MICROBIOL, V182, P354, DOI 10.1007/s00203-004-0710-4; Niebisch A, 2001, ARCH MICROBIOL, V175, P282, DOI 10.1007/s002030100262; Ordonez E, 2008, J BIOL CHEM, V283, P25706, DOI 10.1074/jbc.M803209200; Osman D, 2008, ADV APPL MICROBIOL, V65, P217, DOI 10.1016/S0065-2164(08)00608-4; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Polen T, 2004, APPL BIOCHEM BIOTECH, V118, P215, DOI 10.1385/ABAB:118:1-3:215; Quaranta D, 2009, J BACTERIOL, V191, P5304, DOI 10.1128/JB.00551-09; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Ridge PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001378; Sambrook J, 2001, MOL CLONING LAB MANU; Solioz M, 2003, FEMS MICROBIOL REV, V27, P183, DOI 10.1016/S0168-6445(03)00053-6; Solioz M, 2010, J BIOL INORG CHEM, V15, P3, DOI 10.1007/s00775-009-0588-3; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stoyanov JV, 2003, FEBS LETT, V546, P391, DOI 10.1016/S0014-5793(03)00640-9; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Teitzel GM, 2006, J BACTERIOL, V188, P7242, DOI 10.1128/JB.00837-06; van Bakel H, 2005, PHYSIOL GENOMICS, V22, P356, DOI 10.1152/physiolgenomics.00055.2005; Vasicova P, 1998, BIOTECHNOL TECH, V12, P743, DOI 10.1023/A:1008827609914; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; Ward SK, 2010, MOL MICROBIOL, V77, P1096, DOI 10.1111/j.1365-2958.2010.07273.x; Wennerhold J, 2006, J BACTERIOL, V188, P2907, DOI 10.1128/JB.188.8.2907-2918.2006; Wennerhold J, 2005, J BIOL CHEM, V280, P40500, DOI 10.1074/jbc.M508693200; Williams LE, 2006, APPL ENVIRON MICROB, V72, P4899, DOI 10.1128/AEM.00354-06; Winzerling JJ, 1997, ANNU REV NUTR, V17, P501, DOI 10.1146/annurev.nutr.17.1.501; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Zhang Y, 2010, J BIOL CHEM, V285, P3393, DOI 10.1074/jbc.M109.071746	52	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22143	10.1371/journal.pone.0022143	http://dx.doi.org/10.1371/journal.pone.0022143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799779	Green Published, gold			2022-12-25	WOS:000292931200027
J	Qiu, HY; KuoLee, R; Harris, G; Zhou, HY; Miller, H; Patel, GB; Chen, WX				Qiu, Hongyu; KuoLee, Rhonda; Harris, Greg; Zhou, Hongyan; Miller, Harvey; Patel, Girishchandra B.; Chen, Wangxue			Acinetobacter baumannii Infection Inhibits Airway Eosinophilia and Lung Pathology in a Mouse Model of Allergic Asthma	PLOS ONE			English	Article							REGULATORY T-CELLS; MURINE MODEL; CPG OLIGODEOXYNUCLEOTIDES; STREPTOCOCCUS-PNEUMONIAE; FRANCISELLA-TULARENSIS; HOST-RESISTANCE; INFLAMMATION; MICE; EXPRESSION; EOTAXIN	Allergic asthma is a dysregulation of the immune system which leads to the development of Th2 responses to innocuous antigens (allergens). Some infections and microbial components can re-direct the immune response toward the Th1 response, or induce regulatory T cells to suppress the Th2 response, thereby inhibiting the development of allergic asthma. Since Acinetobacter baumannii infection can modulate lung cellular and cytokine responses, we studied the effect of A. baumannii in modulating airway eosinophilia in a mouse model of allergic asthma. Ovalbumin (OVA)-sensitized mice were treated with live A. baumannii or phosphate buffered saline (PBS), then intranasally challenged with OVA. Compared to PBS, A. baumannii treatment significantly reduced pulmonary Th2 cytokine and chemokine responses to OVA challenge. More importantly, the airway inflammation in A. baumannii-treated mice was strongly suppressed, as seen by the significant reduction of the proportion and the total number of eosinophils in the bronchoalveolar lavage fluid. In addition, A. baumannii-treated mice diminished lung mucus overproduction and pathology. However, A. baumannii treatment did not significantly alter systemic immune responses to OVA. Serum OVA-specific IgE, IgG1 and IgG2a levels were comparable between A. baumannii- and PBS-treated mice, and tracheobronchial lymph node cells from both treatment groups produced similar levels of Th1 and Th2 cytokines in response to in vitro OVA stimulation. Moreover, it appears that TLR-4 and IFN-gamma were not directly involved in the A. baumannii-induced suppression of airway eosinophilia. Our results suggest that A. baumannii inhibits allergic airway inflammation by direct suppression of local pulmonary Th2 cytokine responses to the allergen.	[Qiu, Hongyu; KuoLee, Rhonda; Harris, Greg; Zhou, Hongyan; Miller, Harvey; Patel, Girishchandra B.; Chen, Wangxue] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Chen, Wangxue] Brock Univ, Dept Biol, St Catharines, ON L2S 3A1, Canada	National Research Council Canada; Brock University	Qiu, HY (corresponding author), Cangene Corp, Winnipeg, MB, Canada.	wangxue.chen@nrc.gc.ca			National Research Council Canada	National Research Council Canada	This work was supported by the intramural research funding program (A-base) of the National Research Council Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Careau E, 2004, AM J RESP CELL MOL, V31, P22, DOI 10.1165/rcmb.2003-0229OC; CHEN WX, 1992, J EXP MED, V176, P713, DOI 10.1084/jem.176.3.713; Debarry J, 2007, J ALLERGY CLIN IMMUN, V119, P1514, DOI 10.1016/j.jaci.2007.03.023; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Ennis DP, 2005, IMMUNOL LETT, V97, P91, DOI 10.1016/j.imlet.2004.10.011; Erb KJ, 1998, J EXP MED, V187, P561, DOI 10.1084/jem.187.4.561; Finn Patricia W, 2009, Proc Am Thorac Soc, V6, P260, DOI 10.1513/pats.200807-064RM; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; GAVETT SH, 1995, J EXP MED, V182, P1527, DOI 10.1084/jem.182.5.1527; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Gonzalo JA, 1996, J CLIN INVEST, V98, P2332, DOI 10.1172/JCI119045; Han XB, 2004, EUR J IMMUNOL, V34, P981, DOI 10.1002/eji.200324387; Hansen G, 2000, J IMMUNOL, V164, P223, DOI 10.4049/jimmunol.164.1.223; Hollingsworth JW, 2006, J IMMUNOL, V176, P5856, DOI 10.4049/jimmunol.176.10.5856; Jain VV, 2003, AM J PHYSIOL-LUNG C, V285, pL1137, DOI 10.1152/ajplung.00073.2003; Joly-Guillou ML, 2005, CLIN MICROBIOL INFEC, V11, P868, DOI 10.1111/j.1469-0691.2005.01227.x; Kline JN, 2002, AM J PHYSIOL-LUNG C, V283, pL170, DOI 10.1152/ajplung.00402.2001; Knapp S, 2006, AM J RESP CRIT CARE, V173, P122, DOI 10.1164/rccm.200505-730OC; KuoLee R, 2008, CLIN EXP ALLERGY, V38, P1003, DOI 10.1111/j.1365-2222.2008.02956.x; KuoLee R, 2007, INFECT IMMUN, V75, P1651, DOI 10.1128/IAI.01834-06; Lazaar AL, 2004, DRUG DISCOV TODAY DI, V1, P111; Lukacs NW, 2001, NAT REV IMMUNOL, V1, P108, DOI 10.1038/35100503; MacLean LL, 2009, CARBOHYD RES, V344, P474, DOI 10.1016/j.carres.2008.12.026; Matricardi PM, 2003, ALLERGY, V58, P461, DOI 10.1034/j.1398-9995.2003.00175.x; Michel O, 2003, J ENDOTOXIN RES, V9, P293, DOI 10.1179/096805103225002539; Mould AW, 2000, J IMMUNOL, V164, P2142, DOI 10.4049/jimmunol.164.4.2142; Nakagome K, 2009, J IMMUNOL, V183, P209, DOI 10.4049/jimmunol.0802712; Nauta AJ, 2008, EUR J PHARMACOL, V585, P354, DOI 10.1016/j.ejphar.2008.02.094; Pease James E., 2001, Current Opinion in Pharmacology, V1, P248, DOI 10.1016/S1471-4892(01)00044-3; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Ponath PD, 1996, J CLIN INVEST, V97, P604, DOI 10.1172/JCI118456; Pope SM, 2005, J IMMUNOL, V175, P5341, DOI 10.4049/jimmunol.175.8.5341; Pope SM, 2005, J BIOL CHEM, V280, P13952, DOI 10.1074/jbc.M406037200; Preston JA, 2011, EUR RESPIR J, V37, P53, DOI 10.1183/09031936.00049510; Preston JA, 2007, VACCINE, V25, P8154, DOI 10.1016/j.vaccine.2007.09.034; Rodriguez D, 2003, J IMMUNOL, V171, P1001, DOI 10.4049/jimmunol.171.2.1001; Rozen S, 2000, Methods Mol Biol, V132, P365; Sayers I, 2004, J ALLERGY CLIN IMMUN, V114, P302, DOI 10.1016/j.jaci.2004.03.057; Smani Y, 2011, MICROB PATHOGENESIS, V50, P224, DOI 10.1016/j.micpath.2011.01.008; Smit JJ, 2003, EUR J PHARMACOL, V470, P193, DOI 10.1016/S0014-2999(03)01794-1; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Van Faassen H, 2007, INFECT IMMUN, V75, P5597, DOI 10.1128/IAI.00762-07; von Mutius E, 2000, CLIN EXP ALLERGY, V30, P1230; Wang YF, 2006, J ALLERGY CLIN IMMUN, V118, P143, DOI 10.1016/j.jaci.2006.03.020; Wohlleben G, 2003, J IMMUNOL, V170, P4601, DOI 10.4049/jimmunol.170.9.4601; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Yoshida M, 2002, AM J RESP CRIT CARE, V166, P451, DOI 10.1164/rccm.200202-095OC; YOUNGSUKKIM, 2004, IMMUNOLOGY, V112, P624; Zuany-Amorim C, 2002, NAT MED, V8, P625, DOI 10.1038/nm0602-625	52	16	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22004	10.1371/journal.pone.0022004	http://dx.doi.org/10.1371/journal.pone.0022004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789200	Green Published, gold, Green Submitted			2022-12-25	WOS:000292812400023
J	Caillard, O				Caillard, Olivier			Pre & Postsynaptic Tuning of Action Potential Timing by Spontaneous GABAergic Activity	PLOS ONE			English	Article							NEURONS IN-VIVO; NEOCORTICAL PYRAMIDAL NEURONS; NEONATAL-RAT HIPPOCAMPUS; TEMPORAL-LOBE EPILEPSY; INHIBITORY SYNAPTIC-TRANSMISSION; CEREBELLAR PURKINJE-CELLS; REDUCED INHIBITION; GABA(A) RESPONSES; CORTICAL-NEURONS; NETWORK ACTIVITY	Frequency and timing of action potential discharge are key elements for coding and transfer of information between neurons. The nature and location of the synaptic contacts, the biophysical parameters of the receptor-operated channels and their kinetics of activation are major determinants of the firing behaviour of each individual neuron. Ultimately the intrinsic excitability of each neuron determines the input-output function. Here we evaluate the influence of spontaneous GABAergic synaptic activity on the timing of action potentials in Layer 2/3 pyramidal neurones in acute brain slices from the somatosensory cortex of young rats. Somatic dynamic current injection to mimic synaptic input events was employed, together with a simple computational model that reproduce subthreshold membrane properties. Besides the well-documented control of neuronal excitability, spontaneous background GABAergic activity has a major detrimental effect on spike timing. In fact, GABA(A) receptors tune the relationship between the excitability and fidelity of pyramidal neurons via a postsynaptic (the reversal potential for GABA(A) activity) and a presynaptic (the frequency of spontaneous activity) mechanism. GABAergic activity can decrease or increase the excitability of pyramidal neurones, depending on the difference between the reversal potential for GABA(A) receptors and the threshold for action potential. In contrast, spike time jitter can only be increased proportionally to the difference between these two membrane potentials. Changes in excitability by background GABAergic activity can therefore only be associated with deterioration of the reliability of spike timing.	[Caillard, Olivier] INSERM, IFR Jean Roche, UMR641, F-13258 Marseille, France; [Caillard, Olivier] Univ Mediterranee, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Caillard, O (corresponding author), INSERM, IFR Jean Roche, UMR641, F-13258 Marseille, France.	olivier.caillard@univmed.fr			Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National pour la Recherche Scientifique (CNRS); Fondation pour la Recherche sur l'Epilepsie (FFRE); European Community [LSHM-CT-2004-511995]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche sur l'Epilepsie (FFRE); European Community(European Commission)	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Centre National pour la Recherche Scientifique (CNRS), and by a grant from the Fondation pour la Recherche sur l'Epilepsie (FFRE). Part of the equipment used in this study was funded by a European Community grant attributed to D. Debanne (LSHM-CT-2004-511995). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AB, 2010, EUR J NEUROSCI, V31, P1196, DOI 10.1111/j.1460-9568.2010.07165.x; Aradi I, 2004, J NEUROPHYSIOL, V91, P2849, DOI 10.1152/jn.00916.2003; Aradi I, 2002, NEUROPHARMACOLOGY, V43, P511, DOI 10.1016/S0028-3908(02)00167-3; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Axmacher N, 2004, J PHYSIOL-LONDON, V555, P713, DOI 10.1113/jphysiol.2003.052225; Azouz R, 1999, J NEUROSCI, V19, P2209; Bacci A, 2006, NEURON, V49, P119, DOI 10.1016/j.neuron.2005.12.014; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Brun ICL, 2004, J PHYSIOL-LONDON, V559, P129, DOI 10.1113/jphysiol.2004.065060; Caillard O, 1999, J NEUROSCI, V19, P7568, DOI 10.1523/JNEUROSCI.19-17-07568.1999; Caillard O, 1999, J PHYSIOL-LONDON, V518, P109, DOI 10.1111/j.1469-7793.1999.0109r.x; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Cope DW, 2009, NAT MED, V15, P1392, DOI 10.1038/nm.2058; Daw MI, 2009, J NEUROSCI, V29, P11112, DOI 10.1523/JNEUROSCI.5760-08.2009; Debanne D, 2008, NAT PROTOC, V3, P1559, DOI 10.1038/nprot.2008.147; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; El-Hassar L, 2007, J PHYSIOL-LONDON, V578, P193, DOI 10.1113/jphysiol.2006.119297; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Galante M, 2000, J PHYSIOL-LONDON, V523, P639, DOI 10.1111/j.1469-7793.2000.t01-1-00639.x; Glickfeld LL, 2009, NAT NEUROSCI, V12, P21, DOI 10.1038/nn.2230; Gulledge AT, 2003, J NEUROSCI, V23, P11363; Hashimoto T, 1996, J PHYSIOL-LONDON, V497, P611, DOI 10.1113/jphysiol.1996.sp021794; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hirsch JC, 1999, NAT NEUROSCI, V2, P499, DOI 10.1038/9142; Holden AV., 1976, MODELS STOCHASTIC AC; Jacobson GA, 2005, J PHYSIOL-LONDON, V564, P145, DOI 10.1113/jphysiol.2004.080903; JEDLICKA P, 2010, HIPPOCAMPUS; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kobayashi M, 2003, J NEUROSCI, V23, P8471; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Kreiter AK, 1996, J NEUROSCI, V16, P2381; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Manwani A, 2002, NEURAL COMPUT, V14, P347, DOI 10.1162/08997660252741158; Marty A, 2005, TRENDS NEUROSCI, V28, P284, DOI 10.1016/j.tins.2005.04.003; McLean HA, 1996, J NEUROPHYSIOL, V76, P1036, DOI 10.1152/jn.1996.76.2.1036; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Ouardouz M, 2000, J NEUROPHYSIOL, V84, P1414, DOI 10.1152/jn.2000.84.3.1414; Pare D, 1998, NEUROSCIENCE, V84, P377, DOI 10.1016/S0306-4522(97)00530-7; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; PITLER TA, 1992, J NEUROSCI, V12, P4122; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Rheims S, 2008, J NEUROPHYSIOL, V100, P609, DOI 10.1152/jn.90402.2008; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Sceniak MP, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-8; Schneidman E, 1998, NEURAL COMPUT, V10, P1679, DOI 10.1162/089976698300017089; Stiefel KM, 2005, J COMPUT NEUROSCI, V19, P71, DOI 10.1007/s10827-005-0188-3; Tiesinga P, 2008, NAT REV NEUROSCI, V9, P97, DOI 10.1038/nrn2315; Tiesinga PHE, 2005, J COMPUT NEUROSCI, V18, P275, DOI 10.1007/s10827-005-0330-2; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Wolfart J, 2005, NAT NEUROSCI, V8, P1760, DOI 10.1038/nn1591	61	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22322	10.1371/journal.pone.0022322	http://dx.doi.org/10.1371/journal.pone.0022322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789249	Green Published, gold			2022-12-25	WOS:000292811700040
J	Seredenina, T; Gokce, O; Luthi-Carter, R				Seredenina, Tamara; Gokce, Ozgun; Luthi-Carter, Ruth			Decreased Striatal RGS2 Expression Is Neuroprotective in Huntington's Disease (HD) and Exemplifies a Compensatory Aspect of HD-Induced Gene Regulation	PLOS ONE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; CRE-MEDIATED TRANSCRIPTION; TYROSINE-PHOSPHATASE STEP; TRANSGENIC MICE; MOUSE MODEL; PROTEIN; BRAIN; DYSREGULATION; ACTIVATION; RHES	Background: The molecular phenotype of Huntington's disease (HD) is known to comprise highly reproducible changes in gene expression involving striatal signaling genes. Here we test whether individual changes in striatal gene expression are capable of mitigating HD-related neurotoxicity. Methodology/Principal Findings: We used protein-encoding and shRNA-expressing lentiviral vectors to evaluate the effects of RGS2, RASD2, STEP and NNAT downregulation in HD. Of these four genes, only RGS2 and RASD2 modified mutant htt fragment toxicity in cultured rat primary striatal neurons. In both cases, disease modulation was in the opposite of the predicted direction: whereas decreased expression of RGS2 and RASD2 was associated with the HD condition, restoring expression enhanced degeneration of striatal cells. Conversely, silencing of RGS2 or RASD2 enhanced disease-related changes in gene expression and resulted in significant neuroprotection. These results indicate that RGS2 and RASD2 downregulation comprises a compensatory response that allows neurons to better tolerate huntingtin toxicity. Assessment of the possible mechanism of RGS2-mediated neuroprotection showed that RGS2 downregulation enhanced ERK activation. These results establish a novel link between the inhibition of RGS2 and neuroprotective modulation of ERK activity. Conclusions: Our findings both identify RGS2 downregulation as a novel compensatory response in HD neurons and suggest that RGS2 inhibition might be considered as an innovative target for neuroprotective drug development.	[Seredenina, Tamara; Gokce, Ozgun; Luthi-Carter, Ruth] Ecole Polytech Fed Lausanne, Lab Funct Neurogenom, Lausanne, Switzerland	Ecole Polytechnique Federale de Lausanne	Seredenina, T (corresponding author), Ecole Polytech Fed Lausanne, Lab Funct Neurogenom, Lausanne, Switzerland.	ruth.luthi-carter@epfl.ch		gokce, ozgun/0000-0001-6319-404X	European Framework Programme 6 Early Stage Researcher training network in "Nervous System Repair"; Telethon Action Suisse; Swiss National Science Foundation; EPFL Ecole Polytechnique Federal de Lausanne	European Framework Programme 6 Early Stage Researcher training network in "Nervous System Repair"; Telethon Action Suisse; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EPFL Ecole Polytechnique Federal de Lausanne	These studies were funded by the European Framework Programme 6 Early Stage Researcher training network in "Nervous System Repair", the Telethon Action Suisse, the Swiss National Science Foundation and the EPFL Ecole Polytechnique Federal de Lausanne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anger T, 2007, J BIOCHEM MOL BIOL, V40, P899; Apostol BL, 2006, HUM MOL GENET, V15, P273, DOI 10.1093/hmg/ddi443; Ariano MA, 2002, J NEUROSCI RES, V68, P716, DOI 10.1002/jnr.10272; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Bibb JA, 2000, P NATL ACAD SCI USA, V97, P6809, DOI 10.1073/pnas.120166397; Chu CT, 2004, EUR J BIOCHEM, V271, P2060, DOI 10.1111/j.1432-1033.2004.04132.x; Crittenden JR, 2010, HUM MOL GENET, V19, P1756, DOI 10.1093/hmg/ddq055; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Desplats PA, 2006, J NEUROCHEM, V96, P743, DOI 10.1111/j.1471-4159.2005.03588.x; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Errico F, 2008, MOL CELL NEUROSCI, V37, P335, DOI 10.1016/j.mcn.2007.10.007; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; Han J, 2006, NEURON, V51, P575, DOI 10.1016/j.neuron.2006.07.012; Hetman M, 2004, EUR J BIOCHEM, V271, P2050, DOI 10.1111/j.1432-1033.2004.04133.x; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Heximer SP, 2003, J CLIN INVEST, V111, P1259, DOI 10.1172/JCI200318099C; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Ingi T, 1998, J NEUROSCI, V18, P7178; Inoue-Mochita M, 2009, MOL VIS, V15, P495; JOSEPH R, 1994, BIOCHEM BIOPH RES CO, V201, P1227, DOI 10.1006/bbrc.1994.1836; KOTTER R, 1994, PROG NEUROBIOL, V44, P163, DOI 10.1016/0301-0082(94)90037-X; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Lievens JC, 2002, MOL CELL NEUROSCI, V20, P638, DOI 10.1006/mcne.2002.1152; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1911, DOI 10.1093/hmg/11.17.1911; Luthi-Carter R, 2003, CLIN NEUROSCI RES, V3, P165, DOI 10.1016/S1566-2772(03)00059-8; LUTHICARTER R, 2007, DRUG DISCOV TODAY, P111; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maher P, 2011, HUM MOL GENET, V20, P261, DOI 10.1093/hmg/ddq460; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Obrietan K, 2004, J NEUROSCI, V24, P791, DOI 10.1523/JNEUROSCI.3493-03.2004; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Paul S, 2000, J NEUROSCI, V20, P5630, DOI 10.1523/JNEUROSCI.20-15-05630.2000; Roze E, 2008, FASEB J, V22, P1083, DOI 10.1096/fj.07-9814; RUDINSKIY N, 2009, DIMINISHED HIPPOCALC; Runne H, 2008, J NEUROSCI, V28, P9723, DOI 10.1523/JNEUROSCI.3044-08.2008; Salim S, 2003, J BIOL CHEM, V278, P15842, DOI 10.1074/jbc.M210663200; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Song Y, 2010, NATURE, V468, P933, DOI 10.1038/nature09564; Spano D, 2004, MOL CELL BIOL, V24, P5788, DOI 10.1128/MCB.24.13.5788-5796.2004; Spektor BS, 2002, MOL BRAIN RES, V102, P118, DOI 10.1016/S0169-328X(02)00216-4; Stack EC, 2007, HUM MOL GENET, V16, P1164, DOI 10.1093/hmg/ddm064; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Sugars KL, 2004, J BIOL CHEM, V279, P4988, DOI 10.1074/jbc.M310226200; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; Truant R, 2007, PROG NEUROBIOL, V83, P211, DOI 10.1016/j.pneurobio.2006.11.004; Vargiu P, 2001, MOL BRAIN RES, V94, P1, DOI 10.1016/S0169-328X(01)00140-1; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Zheng S, 2002, DEV BRAIN RES, V136, P101, DOI 10.1016/S0165-3806(02)00348-6; Zucker B, 2005, HUM MOL GENET, V14, P179, DOI 10.1093/hmg/ddi014	54	44	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22231	10.1371/journal.pone.0022231	http://dx.doi.org/10.1371/journal.pone.0022231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779398	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811300051
J	Lu, J; Esposito, G; Scuderi, C; Steardo, L; Delli-Bovi, LC; Hecht, JL; Dickinson, BC; Chang, CJ; Mori, T; Sheen, V				Lu, Jie; Esposito, Giuseppe; Scuderi, Caterina; Steardo, Luca; Delli-Bovi, Laurent C.; Hecht, Jonathan L.; Dickinson, Bryan C.; Chang, Christopher J.; Mori, Takashi; Sheen, Volney			S100B and APP Promote a Gliocentric Shift and Impaired Neurogenesis in Down Syndrome Neural Progenitors	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; MITOCHONDRIAL DYSFUNCTION; PRECURSOR PROTEIN; CELL-DEATH; APOPTOSIS; HYPERPHOSPHORYLATION; PROLIFERATION; ACTIVATION; S100-BETA; INHIBIT	Down syndrome (DS) is a developmental disorder associated with mental retardation (MR) and early onset Alzheimer's disease (AD). These CNS phenotypes are attributed to ongoing neuronal degeneration due to constitutive overexpression of chromosome 21 (HSA21) genes. We have previously shown that HSA21 associated S100B contributes to oxidative stress and apoptosis in DS human neural progenitors (HNPs). Here we show that DS HNPs isolated from fetal frontal cortex demonstrate not only disturbances in redox states within the mitochondria and increased levels of progenitor cell death but also transition to more gliocentric progenitor phenotypes with a consequent reduction in neuronogenesis. HSA21 associated S100B and amyloid precursor protein (APP) levels are simultaneously increased within DS HNPs, their secretions are synergistically enhanced in a paracrine fashion, and overexpressions of these proteins disrupt mitochondrial membrane potentials and redox states. HNPs show greater susceptibility to these proteins as compared to neurons, leading to cell death. Ongoing inflammation through APP and S100B overexpression further promotes a gliocentric HNPs phenotype. Thus, the loss in neuronal numbers seen in DS is not merely due to increased HNPs cell death and neurodegeneration, but also a fundamental gliocentric shift in the progenitor pool that impairs neuronal production.	[Lu, Jie; Sheen, Volney] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA; [Esposito, Giuseppe; Scuderi, Caterina; Steardo, Luca] Univ Roma La Sapienza, Dept Human Physiol & Pharmacol V Erspamer, Fac Pharm, Rome, Italy; [Delli-Bovi, Laurent C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Obstet & Gynecol, Boston, MA 02115 USA; [Hecht, Jonathan L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Dickinson, Bryan C.; Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA; [Mori, Takashi] Saitama Med Ctr, Dept Biomed Sci, Kawagoe, Saitama, Japan; [Mori, Takashi] Saitama Med Ctr, Dept Pathol, Kawagoe, Saitama, Japan; [Mori, Takashi] Saitama Med Univ, Kawagoe, Saitama, Japan	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Sapienza University Rome; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Saitama Medical University; Saitama Medical University; Saitama Medical University	Lu, J (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA.	vsheen@bidmc.harvard.edu	Esposito, Giuseppe/AAA-7949-2019; Scuderi, Caterina/J-4189-2012	Esposito, Giuseppe/0000-0001-8080-8218; Scuderi, Caterina/0000-0002-7314-1539; Lu, Jie/0000-0001-6843-9720; Steardo, Luca/0000-0003-3570-2195	NINDS [1R01NS063997]; NICHD [1R21HD054347]; Harvard Neurodiscovery Center; Doris Duke Clinical Scientist Development Award; NIH [GM 79465]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD054347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063997] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Harvard Neurodiscovery Center; Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants to V.L.S. from NINDS 1R01NS063997, NICHD 1R21HD054347, and the Harvard Neurodiscovery Center. V.L.S. is a Doris Duke Clinical Scientist Development Award recipient and Alzheimer's Association New Investigator. C.J.C. is an Investigator at the Howard Hughes Medical Institute and thanks the NIH (GM 79465) for research support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; Arancio O, 2004, EMBO J, V23, P4096, DOI 10.1038/sj.emboj.7600415; Awasthi A, 2005, EXP NEUROL, V196, P282, DOI 10.1016/j.expneurol.2005.08.001; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bhattacharyya A, 2009, DEV NEUROSCI-BASEL, V31, P497, DOI 10.1159/000236899; BROOKSBANK BWL, 1984, DEV BRAIN RES, V16, P37, DOI 10.1016/0165-3806(84)90060-9; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; Chen Y, 2008, J NEUROSCI, V28, P10983, DOI 10.1523/JNEUROSCI.3545-08.2008; Contestabile A, 2007, HIPPOCAMPUS, V17, P665, DOI 10.1002/hipo.20308; Conti E, 2010, ALZ DIS ASSOC DIS, V24, P96, DOI 10.1097/WAD.0b013e3181aba63a; de Haan JB, 2003, J NEURAL TRANSM-SUPP, P67; Devi L, 2010, BBA-MOL BASIS DIS, V1802, P11, DOI 10.1016/j.bbadis.2009.07.007; Dickinson BC, 2008, J AM CHEM SOC, V130, P9638, DOI 10.1021/ja802355u; DIROSA M, 1990, BIOCHEM BIOPH RES CO, V172, P1246, DOI 10.1016/0006-291X(90)91583-E; Esposito G, 2008, J CELL MOL MED, V12, P914, DOI 10.1111/j.1582-4934.2008.00159.x; Esposito G, 2008, HUM MOL GENET, V17, P440, DOI 10.1093/hmg/ddm322; GOLDEN JA, 1994, J NEUROPATH EXP NEUR, V53, P513, DOI 10.1097/00005072-199409000-00011; Griffin WST, 1998, NEUROBIOL AGING, V19, P401, DOI 10.1016/S0197-4580(98)00074-8; Guidi S, 2008, BRAIN PATHOL, V18, P180, DOI 10.1111/j.1750-3639.2007.00113.x; Gulesserian T, 2001, J NEURAL TRANSM-SUPP, P71; Helguera P, 2005, J NEUROSCI, V25, P2295, DOI 10.1523/JNEUROSCI.5107-04.2005; Hu JR, 1997, J NEUROCHEM, V69, P2294; IWATSUBO T, 1995, ANN NEUROL, V37, P294, DOI 10.1002/ana.410370305; Kienlen-Campard P, 2002, J BIOL CHEM, V277, P15666, DOI 10.1074/jbc.M200887200; Lam AGM, 2001, NEUROBIOL AGING, V22, P765, DOI 10.1016/S0197-4580(01)00233-0; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Leclerc E, 2010, CARDIOVAS PSYCH NEUR, V2010, DOI DOI 10.1155/2010/539581; Lorenzi HA, 2006, BRAIN RES, V1104, P153, DOI 10.1016/j.brainres.2006.05.022; Lu J, 2011, JOVE-J VIS EXP, DOI 10.3791/2681; Mazur-Kolecka B, 2006, NEUROBIOL AGING, V27, P1181, DOI 10.1016/j.neurobiolaging.2005.07.006; Mo ZC, 2008, CEREB CORTEX, V18, P1455, DOI 10.1093/cercor/bhm181; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; Mrak RE, 2005, J ALZHEIMERS DIS, V8, P369; Porta S, 2007, HUM MOL GENET, V16, P1039, DOI 10.1093/hmg/ddm049; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Roper RJ, 2006, GENETICS, V172, P437, DOI 10.1534/genetics.105.050898; ROSS MH, 1984, NEUROLOGY, V34, P909, DOI 10.1212/WNL.34.7.909; Sawa A, 2001, J NEURAL TRANSM-SUPP, P361; Seidl R, 2001, J CHILD NEUROL, V16, P438, DOI 10.1177/088307380101600610; SELINFREUND RH, 1991, P NATL ACAD SCI USA, V88, P3554, DOI 10.1073/pnas.88.9.3554; Shukkur EA, 2006, HUM MOL GENET, V15, P2752, DOI 10.1093/hmg/ddl211; Srikanth V, 2011, NEUROBIOL AGING, V32, P763, DOI 10.1016/j.neurobiolaging.2009.04.016; Takuma K, 2009, P NATL ACAD SCI USA, V106, P20021, DOI 10.1073/pnas.0905686106; Tatsumi K, 2008, J NEUROSCI RES, V86, P3494, DOI 10.1002/jnr.21862; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P59; Wiseman FK, 2009, HUM MOL GENET, V18, pR75, DOI 10.1093/hmg/ddp010; WISNIEWSKI T, 1995, ANN NEUROL, V37, P136, DOI 10.1002/ana.410370128; Yamamoto Y, 2001, J CLIN INVEST, V108, P261, DOI 10.1172/JCI11771; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200; Yin YI, 2007, J BIOL CHEM, V282, P23639, DOI 10.1074/jbc.M704601200	57	58	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e22126	10.1371/journal.pone.0022126	http://dx.doi.org/10.1371/journal.pone.0022126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779383	Green Published, gold, Green Submitted			2022-12-25	WOS:000292680900031
J	Azarov, I; Liu, C; Reynolds, H; Tsekouras, Z; Lee, JS; Gladwin, MT; Kim-Shapiro, DB				Azarov, Ivan; Liu, Chen; Reynolds, Hannah; Tsekouras, Zaharo; Lee, Janet S.; Gladwin, Mark T.; Kim-Shapiro, Daniel B.			Mechanisms of Slower Nitric Oxide Uptake by Red Blood Cells and Other Hemoglobin-containing Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKED HEMOGLOBIN; PULMONARY-HYPERTENSION; OXYGEN-UPTAKE; ERYTHROCYTE CONSUMPTION; PLASMA HEMOGLOBIN; RELAXING FACTOR; STORAGE LESION; DISEASE; DIFFUSION; NO	Nitric oxide (NO) acts as a smooth muscle relaxation factor and plays a crucial role in maintaining vascular homeostasis. NO is scavenged rapidly by hemoglobin (Hb). However, under normal physiological conditions, the encapsulation of Hb inside red blood cells (RBCs) significantly retards NO scavenging, permitting NO to reach the smooth muscle. The rate-limiting factors (diffusion of NO to the RBC surface, through the RBC membrane or inside of the RBC) responsible for this retardation have been the subject of much debate. Knowing the relative contribution of each of these factors is important for several reasons including optimization of the development of blood substitutes where Hb is contained within phospholipid vesicles. We have thus performed experiments of NO uptake by erythrocytes and microparticles derived from erythrocytes and conducted simulations of these data as well as that of others. We have included extracellular diffusion (that is, diffusion of the NO to the membrane) and membrane permeability, in addition to intracellular diffusion of NO, in our computational models. We find that all these mechanisms may modulate NO uptake by membrane-encapsulated Hb and that extracellular diffusion is the main rate-limiting factor for phospholipid vesicles and erythrocytes. In the case of red cell microparticles, we find a major role for membrane permeability. These results are consistent with prior studies indicating that extracellular diffusion of several gas ligands is also rate-limiting for erythrocytes, with some contribution of a low membrane permeability.	[Azarov, Ivan; Liu, Chen; Reynolds, Hannah; Tsekouras, Zaharo; Kim-Shapiro, Daniel B.] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA; [Azarov, Ivan] Wake Forest Univ, Dept Comp Sci, Winston Salem, NC 27109 USA; [Azarov, Ivan; Lee, Janet S.; Gladwin, Mark T.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15213 USA; [Lee, Janet S.; Gladwin, Mark T.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Sch Med, Pittsburgh, PA 15213 USA	Wake Forest University; Wake Forest University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kim-Shapiro, DB (corresponding author), Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA.	shapiro@wfu.edu	Kim-Shapiro, Daniel/HGA-2682-2022	Lee, Janet/0000-0002-6812-6043; Azarov, Ivan/0000-0002-9886-3298	National Institutes of Health [HL058091, HL098032]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058091, R37HL058091, R01HL098032, R29HL058091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL058091 and HL098032.	Abassi Z, 1997, J LAB CLIN MED, V129, P603, DOI 10.1016/S0022-2143(97)90194-3; Alayash AI, 1999, NAT BIOTECHNOL, V17, P545, DOI 10.1038/9849; Azarov I, 2005, J BIOL CHEM, V280, P39024, DOI 10.1074/jbc.M509045200; Azarov I, 2008, NITRIC OXIDE-BIOL CH, V18, P296, DOI 10.1016/j.niox.2008.02.006; Butler AR, 1998, BBA-GEN SUBJECTS, V1425, P168, DOI 10.1016/S0304-4165(98)00065-8; Chang TMS, 2006, ARTIF CELL BLOOD SUB, V34, P551, DOI 10.1080/10731190600973808; COIN JT, 1979, J BIOL CHEM, V254, P1178; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; Donadee C, 2011, CIRCULATION, V124, P465, DOI 10.1161/CIRCULATIONAHA.110.008698; Dou Y, 2002, BIOPHYS CHEM, V98, P127, DOI 10.1016/S0301-4622(02)00090-X; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; El-Farra NH, 2003, ANN BIOMED ENG, V31, P294, DOI 10.1114/1.1553454; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gladwin MT, 2009, CURR OPIN HEMATOL, V16, P515, DOI 10.1097/MOH.0b013e32833157f4; Gladwin MT, 2005, BLOOD, V106, P2925, DOI 10.1182/blood-2005-08-3285; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Gulati A, 1999, J LAB CLIN MED, V133, P112, DOI 10.1016/S0022-2143(99)90003-3; Han TH, 2005, BBA-GEN SUBJECTS, V1723, P135, DOI 10.1016/j.bbagen.2005.01.013; Han TH, 2003, P NATL ACAD SCI USA, V100, P12504, DOI 10.1073/pnas.2133409100; HESS JR, 1993, J APPL PHYSIOL, V74, P1769, DOI 10.1152/jappl.1993.74.4.1769; Huang KT, 2007, NITRIC OXIDE-BIOL CH, V16, P209, DOI 10.1016/j.niox.2006.11.002; Huang KT, 2001, P NATL ACAD SCI USA, V98, P11771, DOI 10.1073/pnas.201276698; Huang Z, 2001, BBA-GEN SUBJECTS, V1568, P252, DOI 10.1016/S0304-4165(01)00227-6; HUXLEY VH, 1981, J PHYSIOL-LONDON, V316, P75, DOI 10.1113/jphysiol.1981.sp013773; IGNARRO LJ, 1987, CIRC RES, V61, P866, DOI 10.1161/01.RES.61.6.866; Ignarro LJ, 2000, NITRIC OXIDE BIOL PA; Jeffers A, 2006, FREE RADICAL BIO MED, V41, P1557, DOI 10.1016/j.freeradbiomed.2006.08.017; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; KATSUKI S, 1977, J CYCLIC NUCL PROT, V3, P23; Kim HW, 2004, ARTIF ORGANS, V28, P813, DOI 10.1111/j.1525-1594.2004.07345.x; Kim-Shapiro DB, 2004, FREE RADICAL BIO MED, V36, P402, DOI 10.1016/j.freeradbiomed.2003.10.030; Kriebardis AG, 2008, TRANSFUSION, V48, P1943, DOI 10.1111/j.1537-2995.2008.01794.x; LANCASTER JR, 1994, P NATL ACAD SCI USA, V91, P8137, DOI 10.1073/pnas.91.17.8137; LEE R, 1995, J APPL PHYSIOL, V79, P236, DOI 10.1152/jappl.1995.79.1.236; Liao JC, 1999, P NATL ACAD SCI USA, V96, P8757, DOI 10.1073/pnas.96.15.8757; Liu XP, 1998, J BIOL CHEM, V273, P18709, DOI 10.1074/jbc.273.30.18709; Liu XP, 1998, P NATL ACAD SCI USA, V95, P2175, DOI 10.1073/pnas.95.5.2175; Liu XP, 2002, J BIOL CHEM, V277, P26194, DOI 10.1074/jbc.M201939200; Minneci PC, 2005, J CLIN INVEST, V115, P3409, DOI 10.1172/JCI25040; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; MURRAY JA, 1995, GASTROENTEROLOGY, V109, P1241, DOI 10.1016/0016-5085(95)90584-7; Nolan VG, 2005, BLOOD, V106, P3264, DOI 10.1182/blood-2005-04-1594; Olson JS, 2004, FREE RADICAL BIO MED, V36, P685, DOI 10.1016/j.freeradbiomed.2003.11.030; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Patel RP, 2000, FREE RADICAL BIO MED, V28, P1518, DOI 10.1016/S0891-5849(00)00259-8; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Reiter CD, 2003, CURR OPIN HEMATOL, V10, P99, DOI 10.1097/00062752-200303000-00001; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Rudolph AS, 1997, J APPL PHYSIOL, V82, P1826, DOI 10.1152/jappl.1997.82.6.1826; Sakai H, 2008, J BIOL CHEM, V283, P1508, DOI 10.1074/jbc.M707660200; Sampei K, 2005, AM J PHYSIOL-HEART C, V289, pH1191, DOI 10.1152/ajpheart.00251.2005; SHARMA AC, 1995, AM J PHYSIOL-HEART C, V269, pH1379, DOI 10.1152/ajpheart.1995.269.4.H1379; Sloan EP, 1999, JAMA-J AM MED ASSOC, V282, P1857, DOI 10.1001/jama.282.19.1857; Sou K, 2005, J PHARMACOL EXP THER, V312, P702, DOI 10.1124/jpet.104.074534; THOMPSON A, 1994, J APPL PHYSIOL, V77, P2348, DOI 10.1152/jappl.1994.77.5.2348; Ulatowski JA, 1996, CRIT CARE MED, V24, P558, DOI 10.1097/00003246-199604000-00003; VANDEGRIFF KD, 1984, BIOPHYS J, V45, P825, DOI 10.1016/S0006-3495(84)84226-5; VANDEGRIFF KD, 1984, J BIOL CHEM, V259, P2609; Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH1705, DOI 10.1152/ajpheart.1998.274.5.H1705; Vaughn MW, 2000, J BIOL CHEM, V275, P2342, DOI 10.1074/jbc.275.4.2342; Vaughn MW, 2001, NITRIC OXIDE-BIOL CH, V5, P18, DOI 10.1006/niox.2000.0328; VOGEL WM, 1986, AM J PHYSIOL, V251, pH413, DOI 10.1152/ajpheart.1986.251.2.H413; Xiong ZY, 2011, TRANSFUSION, V51, P610, DOI 10.1111/j.1537-2995.2010.02861.x	63	45	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33567	33579		10.1074/jbc.M111.228650	http://dx.doi.org/10.1074/jbc.M111.228650			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21808057	Green Published, hybrid			2022-12-25	WOS:000294968800073
J	Bossuyt, J; Chang, CW; Helmstadter, K; Kunkel, MT; Newton, AC; Campbell, KS; Martin, JL; Bossuyt, S; Robia, SL; Bers, DM				Bossuyt, Julie; Chang, Chia-Wei; Helmstadter, Kathryn; Kunkel, Maya T.; Newton, Alexandra C.; Campbell, Kenneth S.; Martin, Jody L.; Bossuyt, Sven; Robia, Seth L.; Bers, Donald M.			Spatiotemporally Distinct Protein Kinase D Activation in Adult Cardiomyocytes in Response to Phenylephrine and Endothelin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; CARDIAC-HYPERTROPHY; HISTONE DEACETYLASE-5; HEART-FAILURE; PRESSURE-OVERLOAD; MOLECULAR-CLONING; LOOP SER(744); LIVING CELLS; IN-VIVO; PKC-MU	Protein kinase D (PKD) is a nodal point in cardiac hypertrophic signaling. It triggers nuclear export of class II histone deacetylase (HDAC) and regulates transcription. Although this pathway is thought to be critical in cardiac hypertrophy and heart failure, little is known about spatiotemporal aspects of PKD activation at the myocyte level. Here, we demonstrate that in adult cardiomyocytes two important neurohumoral stimuli that induce hypertrophy, endothelin-1 (ET1) and phenylephrine (PE), trigger comparable global PKD activation and HDAC5 nuclear export, but via divergent spatiotemporal PKD signals. PE-induced HDAC5 export is entirely PKD-dependent, involving fleeting sarcolemmal PKD translocation (for activation) and very rapid subsequent nuclear import. In contrast, ET1 recruits and activates PKD that remains predominantly sarcolemmal. This explains why PE-induced nuclear HDAC5 export in myocytes is totally PKD-dependent, whereas ET1-induced HDAC5 export depends more prominently on InsP(3) and CaMKII signaling. Thus alpha-adrenergic and ET-1 receptor signaling via PKD in adult myocytes feature dramatic differences in cellular localization and translocation in mediating hypertrophic signaling. This raises new opportunities for targeted therapeutic intervention into distinct limbs of this hypertrophic signaling pathway.	[Bossuyt, Julie; Chang, Chia-Wei; Helmstadter, Kathryn; Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Chang, Chia-Wei; Martin, Jody L.; Robia, Seth L.] Loyola Univ Chicago, Dept Physiol, Maywood, IL 60153 USA; [Kunkel, Maya T.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Campbell, Kenneth S.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Bossuyt, Sven] Aalto Univ, Dept Engn Design & Prod, Sch Sci & Technol, FI-02015 Helsinki, Finland	University of California System; University of California Davis; Loyola University Chicago; University of California System; University of California San Diego; University of Kentucky; Aalto University	Bossuyt, J (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	jbossuyt@ucdavis.edu; dmbers@ucdavis.edu	Bossuyt, Sven/H-5660-2012; Bers, Donald M/C-4507-2012; Campbell, Kenneth/C-3285-2008	Bossuyt, Sven/0000-0002-9223-735X; Bossuyt, Julie/0000-0001-8874-4765; Campbell, Kenneth/0000-0001-5615-5958; Bers, Donald/0000-0002-2237-9483	National Institutes of Health Grants [R01HL103933, P01-HL80101, P01-DK5441, T32HL86350]; American Heart Association [SDG 0835312N]; predoctoral fellowship; FWO-Vlaanderen and Academy of Finland; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092321, R01HL103933, T32HL086350, P01HL080101] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); predoctoral fellowship; FWO-Vlaanderen and Academy of Finland; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL103933 (to J. B.), P01-HL80101 (to D. M. B.), P01-DK5441 (to A. C. N.), and T32HL86350 (to K. H.), American Heart Association Grant SDG 0835312N (to J. B.) and a predoctoral fellowship (to C. W. C.), and a grant from the FWO-Vlaanderen and Academy of Finland (to S. B.).	Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; Backs J, 2008, MOL CELL BIOL, V28, P3437, DOI 10.1128/MCB.01611-07; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; Beumer JH, 2010, CURR CLIN PHARMACOL, V5, P196, DOI 10.2174/157488410791498770; Bossuyt J, 2008, CIRC RES, V102, P695, DOI 10.1161/CIRCRESAHA.107.169755; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Cho YK, 2010, CIRC J, V74, P760, DOI 10.1253/circj.CJ-09-0580; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Ghanekar Y, 2005, TRENDS CELL BIOL, V15, P511, DOI 10.1016/j.tcb.2005.08.001; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Haworth RS, 2000, J MOL CELL CARDIOL, V32, P1013, DOI 10.1006/jmcc.2000.1143; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Jaggi M, 2007, FRONT BIOSCI-LANDMRK, V12, P3757, DOI 10.2741/2349; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; Kunkel MT, 2007, J BIOL CHEM, V282, P6733, DOI 10.1074/jbc.M608086200; LaValle CR, 2010, BBA-REV CANCER, V1806, P183, DOI 10.1016/j.bbcan.2010.05.003; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Liu F, 2008, J MOL CELL CARDIOL, V45, P715, DOI 10.1016/j.yjmcc.2008.08.015; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; McKinsey TA, 2007, CARDIOVASC RES, V73, P667, DOI 10.1016/j.cardiores.2006.11.036; Meredith EL, 2010, J MED CHEM, V53, P5400, DOI 10.1021/jm100075z; Meredith EL, 2010, J MED CHEM, V53, P5422, DOI 10.1021/jm100076w; Monovich L, 2010, FEBS LETT, V584, P631, DOI 10.1016/j.febslet.2009.12.014; Newton AC, 1998, BBA-REV BIOMEMBRANES, V1376, P155, DOI 10.1016/S0304-4157(98)00003-3; Remus TP, 2006, J BIOL CHEM, V281, P608, DOI 10.1074/jbc.M509645200; Rey O, 2004, J BIOL CHEM, V279, P34361, DOI 10.1074/jbc.M403265200; Rey O, 2001, J BIOL CHEM, V276, P49228, DOI 10.1074/jbc.M109395200; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rykx A, 2003, FEBS LETT, V546, P81, DOI 10.1016/S0014-5793(03)00487-3; Stimson L, 2009, ANN ONCOL, V20, P1293, DOI 10.1093/annonc/mdn792; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Trauzold A, 2003, ONCOGENE, V22, P8939, DOI 10.1038/sj.onc.1207001; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Wright CD, 2008, CIRC RES, V103, P992, DOI 10.1161/CIRCRESAHA.108.176024; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200	49	38	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33390	33400		10.1074/jbc.M111.246447	http://dx.doi.org/10.1074/jbc.M111.246447			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795686	hybrid, Green Published			2022-12-25	WOS:000294968800057
J	Gangopahyay, A; Oran, M; Bauer, EM; Wertz, JW; Comhair, SA; Erzurum, SC; Bauer, PM				Gangopahyay, Archana; Oran, Max; Bauer, Eileen M.; Wertz, Jeffrey W.; Comhair, Suzy A.; Erzurum, Serpil C.; Bauer, Philip M.			Bone Morphogenetic Protein Receptor II Is a Novel Mediator of Endothelial Nitric-oxide Synthase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY PULMONARY-HYPERTENSION; GERMLINE MUTATIONS; BMPR2; GENE; PHOSPHORYLATION; CAVEOLIN-1; SURVIVAL; EXPRESSION; HSP90; AXIS	Activation of bone morphogenetic protein (BMP) receptor II (BMPRII) promotes pulmonary artery endothelial cell (PAEC) survival, proliferation, and migration. Mutations to BMPRII are associated with the development of pulmonary arterial hypertension (PAH). Endothelial dysfunction, including decreased endothelial nitric-oxide synthase (eNOS) activity and loss of bioactive nitric oxide (NO), plays a prominent role in the development of PAH. We hypothesized that stimulation of BMPRII promotes normal PAEC function by activating eNOS. We report that BMPRII ligands, BMP2 and BMP4, (i) stimulate eNOS phosphorylation at a critical regulatory site, (ii) increase eNOS activity, and (iii) result in canonical changes in eNOS protein-protein interactions. The stimulation of eNOS activity by BMPRII ligands was largely dependent on protein kinase A (PKA) activation, as demonstrated using the PKA inhibitors H89 and myristoylated PKI(6-22) amide. PAEC migration stimulated by BMP2 and BMP4 was inhibited by the NOS inhibitor L-nitroarginine methyl ester, providing functional evidence of eNOS activation. Furthermore, BMP2 and BMP4 failed to stimulate eNOS phosphorylation when BMPRII was knocked down by siRNA. Most important to the pathophysiology of the disease, BMP2 and BMP4 failed to stimulate eNOS phosphorylation in PAECs isolated from patients with mutations in the BMPR2 gene. These data demonstrate a new action of BMPs/BMPRII in the pulmonary endothelium and provide novel mechanistic insight into the pathogenesis of PAH.	[Gangopahyay, Archana; Oran, Max; Bauer, Eileen M.; Wertz, Jeffrey W.; Bauer, Philip M.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15261 USA; [Bauer, Philip M.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Bauer, Philip M.] Univ Pittsburgh, Sch Med, Vasc Med Inst, Pittsburgh, PA 15261 USA; [Comhair, Suzy A.; Erzurum, Serpil C.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Comhair, Suzy A.; Erzurum, Serpil C.] Cleveland Clin, Resp Inst, Cleveland, OH 44195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Bauer, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, 200 Lothrop St,Starzl Biomed Sci Tower W1147, Pittsburgh, PA 15261 USA.	bauerpm@upmc.edu			National Institutes of Health [HL085134, HL60917]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL060917, R01HL060917, P01HL103453, R01HL085134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL085134 (to P. M. B.) and HL60917 (to S. C. E.).	Aldred MA, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9398; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Cogan JD, 2005, GENET MED, V7, P169, DOI 10.1097/01.GIM.0000156525.09595.E9; Cogan JD, 2006, AM J RESP CRIT CARE, V174, P590, DOI 10.1164/rccm.200602-165OC; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; GarciaCardena G, 1996, J BIOL CHEM, V271, P27237, DOI 10.1074/jbc.271.44.27237; Gratton JP, 2000, J BIOL CHEM, V275, P22268, DOI 10.1074/jbc.M001644200; Hansmann G, 2008, J CLIN INVEST, V118, P1846, DOI 10.1172/JCI32503; HIRSCH EZ, 1983, ATHEROSCLEROSIS, V46, P287, DOI 10.1016/0021-9150(83)90179-X; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Lee YS, 1997, J CELL PHYSIOL, V170, P153, DOI 10.1002/(SICI)1097-4652(199702)170:2<153::AID-JCP7>3.0.CO;2-N; Masri FA, 2007, AM J PHYSIOL-LUNG C, V293, pL548, DOI 10.1152/ajplung.00428.2006; Nohe A, 2005, J CELL SCI, V118, P643, DOI 10.1242/jcs.01402; Perez VADJ, 2009, J CELL BIOL, V184, P83, DOI 10.1083/jcb.200806049; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; Ramos M, 2006, VASC PHARMACOL, V44, P50, DOI 10.1016/j.vph.2005.09.007; SANDOVAL J, 1994, CIRCULATION, V89, P1733, DOI 10.1161/01.CIR.89.4.1733; Santos A, 2010, BIOCHEM BIOPH RES CO, V391, P364, DOI 10.1016/j.bbrc.2009.11.064; Schleicher M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000343; Takahashi S, 2003, J BIOL CHEM, V278, P30821, DOI 10.1074/jbc.M304471200; Teichert-Kuliszewska K, 2006, CIRC RES, V98, P209, DOI 10.1161/01.RES.0000200180.01710.e6; Thibeault S, 2010, MOL CELL, V39, P468, DOI 10.1016/j.molcel.2010.07.013; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; Wertz JW, 2008, BIOCHEM BIOPH RES CO, V375, P557, DOI 10.1016/j.bbrc.2008.08.066; Xu WL, 2007, P NATL ACAD SCI USA, V104, P1342, DOI 10.1073/pnas.0605080104; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68	31	65	69	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33134	33140		10.1074/jbc.M111.274100	http://dx.doi.org/10.1074/jbc.M111.274100			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21808054	Green Published, hybrid			2022-12-25	WOS:000294968800032
J	Fye, JM; Orebaugh, CD; Coffin, SR; Hollis, T; Perrino, FW				Fye, Jason M.; Orebaugh, Clinton D.; Coffin, Stephanie R.; Hollis, Thomas; Perrino, Fred W.			Dominant Mutations of the TREX1 Exonuclease Gene in Lupus and Aicardi-Goutieres Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL CHILBLAIN LUPUS; MEDIATED CELL-DEATH; AUTOIMMUNE-DISEASE; DNA FRAGMENTATION; PROTEIN; ERYTHEMATOSUS; APOPTOSIS; EXPRESSION; NM23-H1; FORM	TREX1 is a potent 3'-->35' exonuclease that degrades single- and double-stranded DNA (ssDNA and dsDNA). TREX1 mutations at amino acid positions Asp-18 and Asp-200 in familial chilblain lupus and Aicardi-Goutieres syndrome elicit dominant immune dysfunction phenotypes. Failure to appropriately disassemble genomic DNA during normal cell death processes could lead to persistent DNA signals that trigger the innate immune response and autoimmunity. We tested this concept using dsDNA plasmid and chromatin and show that the TREX1 exonuclease locates 3' termini generated by endonucleases and degrades the nicked DNA polynucleotide. A competition assay was designed using TREX1 dominant mutants and variants to demonstrate that an intact DNA binding process, coupled with dysfunctional chemistry in the active sites, explains the dominant phenotypes in TREX1 D18N, D200N, and D200H alleles. The TREX1 residues Arg-174 and Lys-175 positioned adjacent to the active sites act with the Arg-128 residues positioned in the catalytic cores to facilitate melting of dsDNA and generate ssDNA for entry into the active sites. Metal-dependent ssDNA binding in the active sites of the catalytically inactive dominant TREX1 mutants contributes to DNA retention and precludes access to DNA 3' termini by active TREX1 enzyme. Thus, the dominant disease genetics exhibited by the TREX1 D18N, D200N, and D200H alleles parallel precisely the biochemical properties of these TREX1 dimers during dsDNA degradation of plasmid and chromatin DNA in vitro. These results support the concept that failure to degrade genomic dsDNA is a principal pathway of immune activation in TREX1-mediated autoimmune disease.	[Fye, Jason M.; Orebaugh, Clinton D.; Coffin, Stephanie R.; Hollis, Thomas; Perrino, Fred W.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Wake Forest University	Perrino, FW (corresponding author), Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA.	fperrino@wfubmc.edu			National Institutes of Health [GM069962]; Alliance for Lupus Research [179222]; American Heart Association [10GRNT3650033];  [F32GM095290]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069962, F32GM095290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; American Heart Association(American Heart Association); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069962 (to F.W.P.). This work was also supported by Alliance for Lupus Research Grant 179222 (to F.W.P.), American Heart Association Grant 10GRNT3650033 (to T.H.), and postdoctoral fellowship award F32GM095290 (to S.R.C.).	Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Haaxma CA, 2010, AM J MED GENET A, V152A, P2612, DOI 10.1002/ajmg.a.33620; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Kavanagh D, 2008, CELL CYCLE, V7, P1718, DOI 10.4161/cc.7.12.6162; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Lee-Kirsch MA, 2006, AM J HUM GENET, V79, P731, DOI 10.1086/507848; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P14718, DOI 10.1074/jbc.M010051200; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Namjou B, 2011, GENES IMMUN, V12, P270, DOI 10.1038/gene.2010.73; Perrino FW, 2008, J BIOL CHEM, V283, P21441, DOI 10.1074/jbc.M803629200; Perrino FW, 2005, J BIOL CHEM, V280, P15212, DOI 10.1074/jbc.M500108200; Ramantani G, 2010, ARTHRITIS RHEUM-US, V62, P1469, DOI 10.1002/art.27367; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Richards A, 2007, NAT GENET, V39, P1068, DOI 10.1038/ng2082; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Yoshida A, 2003, J BIOL CHEM, V278, P37768, DOI 10.1074/jbc.M304914200	29	51	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32373	32382		10.1074/jbc.M111.276287	http://dx.doi.org/10.1074/jbc.M111.276287			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21808053	Green Published, hybrid			2022-12-25	WOS:000294726800047
J	Mittal, Y; Pavlova, Y; Garcia-Marcos, M; Ghosh, P				Mittal, Yash; Pavlova, Yelena; Garcia-Marcos, Mikel; Ghosh, Pradipta			Src Homology Domain 2-containing Protein-tyrosine Phosphatase-1 (SHP-1) Binds and Dephosphorylates G alpha-interacting, Vesicle-associated Protein (GIV)/Girdin and Attenuates the GIV-Phosphatidylinositol 3-Kinase (PI3K)-Akt Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; MOTH-EATEN MICE; CELL-MIGRATION; LEUKOCYTE PROTEIN; PROSTATE-CANCER; LIPID RAFTS; B-CELLS; ACTIVATION; AKT; PHOSPHORYLATION	GIV (G alpha-interacting vesicle-associated protein, also known as Girdin) is a bona fide enhancer of PI3K-Akt signals during a diverse set of biological processes, e. g. wound healing, macrophage chemotaxis, tumor angiogenesis, and cancer invasion/metastasis. We recently demonstrated that tyrosine phosphorylation of GIV by receptor and non-receptor-tyrosine kinases is a key step that is required for GIV to directly bind and enhance PI3K activity. Here we report the discovery that Src homology 2-containing phosphatase-1 (SHP-1) is the major protein-tyrosine phosphatase that targets two critical phosphotyrosines within GIV and antagonizes phospho-GIV-dependent PI3K enhancement in mammalian cells. Using phosphorylation-dephosphorylation assays, we demonstrate that SHP-1 is the major and specific protein-tyrosine phosphatase that catalyzes the dephosphorylation of tyrosine-phosphorylated GIV in vitro and inhibits ligand-dependent tyrosine phosphorylation of GIV downstream of both growth factor receptors and GPCRs in cells. In vitro binding and co-immunoprecipitation assays demonstrate that SHP-1 and GIV interact directly and constitutively and that this interaction occurs between the SH2 domain of SHP-1 and the C terminus of GIV. Overexpression of SHP-1 inhibits tyrosine phosphorylation of GIV and formation of phospho-GIV-PI3K complexes, and specifically suppresses GIV-dependent activation of Akt. Consistently, depletion of SHP-1 enhances peak tyrosine phosphorylation of GIV, which coincides with an increase in peak Akt activity. We conclude that SHP-1 antagonizes the action of receptor and non-receptor-tyrosine kinases on GIV and down-regulates the phospho-GIV-PI3K-Akt axis of signaling.	[Ghosh, Pradipta] Univ Calif San Diego, Dept Med, George Palade Labs Cellular & Mol Med, La Jolla, CA 92093 USA; [Garcia-Marcos, Mikel; Ghosh, Pradipta] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Ghosh, P (corresponding author), Univ Calif San Diego, Dept Med, George Palade Labs Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	prghosh@ucsd.edu		Garcia-Marcos, Mikel/0000-0001-9513-4826	Burroughs Wellcome Fund; American Gastroenterology Association; Doris Duke Charitable Foundation; University of California, San Diego; Susan G. Komen Postdoctoral Fellowship [KG080079]	Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Gastroenterology Association; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); University of California, San Diego(University of California System); Susan G. Komen Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation)	This work was funded by the Burroughs Wellcome Fund, Research Scholar Award (American Gastroenterology Association), and a Clinical Scientist Development Award (Doris Duke Charitable Foundation) (to P.G.).; Supported by the Sarah Rogers Fellowship (University of California, San Diego).; Supported by Susan G. Komen Postdoctoral Fellowship KG080079.	Anai M, 2005, J BIOL CHEM, V280, P18525, DOI 10.1074/jbc.M500586200; Bairstow SF, 2005, J BIOL CHEM, V280, P23884, DOI 10.1074/jbc.M500576200; BANVILLE D, 1995, GENOMICS, V27, P165, DOI 10.1006/geno.1995.1020; Bard-Chapeau EA, 2006, MOL CELL BIOL, V26, P4664, DOI 10.1128/MCB.02253-05; Benali N, 2000, P NATL ACAD SCI USA, V97, P9180, DOI 10.1073/pnas.130196697; Berg KL, 1999, J BIOL CHEM, V274, P35855, DOI 10.1074/jbc.274.50.35855; Blanchetot C, 2005, METHODS, V35, P44, DOI 10.1016/j.ymeth.2004.07.007; Bradshaw N. J., 2011, NEUROPHARMA IN PRESS; Burks J, 2006, ONCOGENE, V25, P7166, DOI 10.1038/sj.onc.1209728; Burshtyn DN, 1999, J IMMUNOL, V162, P897; Christophi GP, 2009, VIRAL IMMUNOL, V22, P371, DOI 10.1089/vim.2009.0052; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; Cote JF, 1998, BIOCHEMISTRY-US, V37, P13128, DOI 10.1021/bi981259l; Cuevas B, 1999, J BIOL CHEM, V274, P27583, DOI 10.1074/jbc.274.39.27583; Cui TX, 2002, MOL ENDOCRINOL, V16, P2113, DOI 10.1210/me.2001-0284; Dubois MJ, 2006, NAT MED, V12, P549, DOI 10.1038/nm1397; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Enomoto A, 2006, ANN NY ACAD SCI, V1086, P169, DOI 10.1196/annals.1377.016; Enomoto A, 2009, NEURON, V63, P774, DOI 10.1016/j.neuron.2009.08.015; Fawcett VCJ, 2005, J IMMUNOL, V174, P2849, DOI 10.4049/jimmunol.174.5.2849; Feng YH, 2002, P NATL ACAD SCI USA, V99, P12049, DOI 10.1073/pnas.192404199; Fortin CF, 2006, J LEUKOCYTE BIOL, V79, P1061, DOI 10.1189/jlb.0805481; Frank C, 2004, J BIOL CHEM, V279, P11375, DOI 10.1074/jbc.M309096200; Garcia-Marcos M, 2011, MOL BIOL CELL, V22, P673, DOI 10.1091/mbc.E10-08-0738; Garcia-Marcos M, 2011, FASEB J, V25, P590, DOI 10.1096/fj.10-167304; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Ghosh P, 2011, CELL ADHES MIGR, V5, P237, DOI 10.4161/cam.5.3.15909; Ghosh P, 2010, MOL BIOL CELL, V21, P2338, DOI 10.1091/mbc.E10-01-0028; Hakak Y, 2000, ONCOGENE, V19, P3164, DOI 10.1038/sj.onc.1203655; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Jiao HY, 1996, MOL CELL BIOL, V16, P6985; Jones ML, 2004, J BIOL CHEM, V279, P40475, DOI 10.1074/jbc.M402970200; KAMPS MP, 1986, MOL CELL BIOL, V6, P751, DOI 10.1128/MCB.6.3.751; Keilhack H, 1998, J BIOL CHEM, V273, P24839, DOI 10.1074/jbc.273.38.24839; Kharbanda S, 1996, P NATL ACAD SCI USA, V93, P6898, DOI 10.1073/pnas.93.14.6898; Kim CH, 1999, J EXP MED, V190, P681, DOI 10.1084/jem.190.5.681; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Koyama M, 2003, LAB INVEST, V83, P1849, DOI 10.1097/01.LAB.0000106503.65258.2B; Krotz F, 2005, J AM COLL CARDIOL, V45, P1700, DOI 10.1016/j.jacc.2005.02.039; Kruger J, 2000, J IMMUNOL, V165, P5847, DOI 10.4049/jimmunol.165.10.5847; Laramee M, 2007, J BIOL CHEM, V282, P7758, DOI 10.1074/jbc.M611327200; Larsen M, 2003, NAT REV MOL CELL BIO, V4, P700, DOI 10.1038/nrm1199; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Lin C., 2011, SCI STKE IN PRESS; Lu YL, 2003, J BIOL CHEM, V278, P40057, DOI 10.1074/jbc.M303621200; Miyake H, 2011, CIRC RES, V108, P1170, DOI 10.1161/CIRCRESAHA.110.236174; Mizuno K, 1996, J EXP MED, V184, P457, DOI 10.1084/jem.184.2.457; Mizuno K, 2000, J IMMUNOL, V165, P1344, DOI 10.4049/jimmunol.165.3.1344; Ngai J, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-27; Pei DH, 1996, P NATL ACAD SCI USA, V93, P1141, DOI 10.1073/pnas.93.3.1141; PEI DH, 1994, BIOCHEMISTRY-US, V33, P15483, DOI 10.1021/bi00255a030; Porteous D, 2009, NEURON, V63, P711, DOI 10.1016/j.neuron.2009.09.017; Seo DW, 2006, J BIOL CHEM, V281, P3711, DOI 10.1074/jbc.M509932200; Sugano M, 2005, FASEB J, V19, P2054, DOI 10.1096/fj.05-4020fje; Tassidis H, 2010, PROSTATE, V70, P1491, DOI 10.1002/pros.21184; Tassidis H, 2010, INT J CANCER, V126, P2296, DOI 10.1002/ijc.24917; Tenev T, 1997, J BIOL CHEM, V272, P5966, DOI 10.1074/jbc.272.9.5966; Wadley GD, 2007, J APPL PHYSIOL, V102, P1624, DOI 10.1152/japplphysiol.00821.2006; Witkiewicz A, 2007, HUM PATHOL, V38, P462, DOI 10.1016/j.humpath.2006.09.012; Yaffe MB, 2002, NAT REV MOL CELL BIO, V3, P177, DOI 10.1038/nrm759; Yoshida K, 1999, J BIOL CHEM, V274, P34663, DOI 10.1074/jbc.274.49.34663; Yu ZB, 1998, J BIOL CHEM, V273, P3687, DOI 10.1074/jbc.273.6.3687; Zito CI, 2004, J CELL PHYSIOL, V199, P227, DOI 10.1002/jcp.10446	65	29	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32404	32415		10.1074/jbc.M111.275685	http://dx.doi.org/10.1074/jbc.M111.275685			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21799016	Green Published, hybrid			2022-12-25	WOS:000294726800050
J	Singhal, E; Kumar, P; Sen, P				Singhal, Eshu; Kumar, Prakash; Sen, Pradip			A Novel Role for Bruton's Tyrosine Kinase in Hepatocyte Growth Factor-mediated Immunoregulation of Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; X-LINKED AGAMMAGLOBULINEMIA; SCATTER FACTOR-RECEPTOR; MULTIPLE-MYELOMA; ANTIGEN RECEPTOR; BINDING-PROTEIN; DOCKING SITE; T-CELLS; C-MET; BTK	The limited success of dendritic cell (DC)-based immunotherapy in multiple myeloma is partly due to hepatocyte growth factor (HGF)-induced DC dysfunction. From a therapeutic standpoint, it is important to understand the molecular events involved in inhibition of DC activation/maturation by HGF. Because Bruton's tyrosine kinase (Btk) negatively regulates maturation and immunostimulatory function of DCs, a role for Btk in HGF-induced inhibition of both murine and human DCs was investigated. We demonstrate that Btk is a novel proximal component of HGF-induced c-MET (HGF receptor) signaling. Following HGF treatment, Btk binds to c-MET and becomes activated. Btk activation in turn blocks the NF-kappa B pathway and subsequent DC activation via the c-Src-PI3K-AKT-mammalian target of rapamycin (mTOR) pathway. Notably, Btk activation is necessary for HGF-induced association of c-Src and PI3K with c-MET. Furthermore, we provide the first evidence that HGF inhibits DC activation by inducing autocrine interleukin (IL)-10 secretion, which requires activation of Btk. Blocking activation of Btk and its downstream the c-Src-PI3K-AKT-mTOR pathway prevents HGF-induced IL-10 secretion by DCs. In addition, neutralization of IL-10 secretion from DCs impaired the inhibitory effect of HGF on DCs. Thus, our study identifies a novel role for Btk in HGF-induced DC inhibition.	[Singhal, Eshu; Sen, Pradip] CSIR, Inst Microbial Technol, Div Cell Biol & Immunol, Chandigarh 160036, India; [Kumar, Prakash] CSIR, Inst Microbial Technol, Div Prot Sci & Engn, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Sen, P (corresponding author), CSIR, Inst Microbial Technol, Div Cell Biol & Immunol, Sect 39A, Chandigarh 160036, India.	psen@imtech.res.in	Sinha, Prakash Kumar/K-6048-2013; Sen, Pradip/AAA-8832-2022; Sinha, Eshu Singhal/D-9051-2013	Sinha, Prakash Kumar/0000-0002-2067-5676; Sinha, Eshu Singhal/0000-0001-6048-050X	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by a grant from the Department of Biotechnology, Government of India and an intramural grant from the Council of Scientific and Industrial Research, Government of India (to P. S.).	ADAMS DH, 1994, P NATL ACAD SCI USA, V91, P7144, DOI 10.1073/pnas.91.15.7144; Afar DEH, 1996, MOL CELL BIOL, V16, P3465; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Beilmann M, 2000, BLOOD, V95, P3964; Benkhoucha M, 2010, P NATL ACAD SCI USA, V107, P6424, DOI 10.1073/pnas.0912437107; BHARGAVA M, 1992, CELL GROWTH DIFFER, V3, P11; Bhattacharyya S, 2004, BLOOD, V104, P1100, DOI 10.1182/blood-2003-12-4302; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Chauhan D, 2002, ONCOGENE, V21, P1346, DOI 10.1038/sj.onc.1205205; Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312; Futamatsu H, 2005, CIRC RES, V96, P823, DOI 10.1161/01.RES.0000163016.52653.2e; Gagliardi MC, 2003, CLIN EXP IMMUNOL, V133, P115, DOI 10.1046/j.1365-2249.2003.t01-1-02178.x; Galimi F, 2001, J IMMUNOL, V166, P1241, DOI 10.4049/jimmunol.166.2.1241; Glassford J, 2003, ONCOGENE, V22, P2248, DOI 10.1038/sj.onc.1206425; Haldar AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000907; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; Hashimoto S, 1996, BLOOD, V88, P561, DOI 10.1182/blood.V88.2.561.bloodjournal882561; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Hilkens CMU, 1997, BLOOD, V90, P1920, DOI 10.1182/blood.V90.5.1920; Ikeda H, 2010, BLOOD, V116, P1460, DOI 10.1182/blood-2009-06-222943; Iwama A, 2002, J EXP MED, V195, P547, DOI 10.1084/jem.20011465; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Kawakami Y, 2006, P NATL ACAD SCI USA, V103, P153, DOI 10.1073/pnas.0509784103; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Kurosaki T, 1997, J BIOL CHEM, V272, P15595, DOI 10.1074/jbc.272.25.15595; Kurz SM, 2002, EUR J IMMUNOL, V32, P1832, DOI 10.1002/1521-4141(200207)32:7<1832::AID-IMMU1832>3.0.CO;2-2; Mine S, 1998, LAB INVEST, V78, P1395; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; Niemann C, 1998, J CELL BIOL, V143, P533, DOI 10.1083/jcb.143.2.533; Okunishi K, 2005, J IMMUNOL, V175, P4745, DOI 10.4049/jimmunol.175.7.4745; Poligone B, 2002, J IMMUNOL, V168, P188, DOI 10.4049/jimmunol.168.1.188; PONZETTO C, 1993, MOL CELL BIOL, V13, P4600, DOI 10.1128/MCB.13.8.4600; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Rawlings DJ, 1996, SCIENCE, V271, P822, DOI 10.1126/science.271.5250.822; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Rutella S, 2006, BLOOD, V108, P218, DOI 10.1182/blood-2005-08-3141; Shinners NP, 2007, J IMMUNOL, V179, P3872, DOI 10.4049/jimmunol.179.6.3872; Singhal E, 2011, INT J BIOCHEM CELL B, V43, P1134, DOI 10.1016/j.biocel.2011.04.006; Thompson J, 2004, MOL CELL NEUROSCI, V27, P441, DOI 10.1016/j.mcn.2004.07.007; Tomlinson MG, 1999, J BIOL CHEM, V274, P13577, DOI 10.1074/jbc.274.19.13577; Tulasne D, 1999, MOL BIOL CELL, V10, P551, DOI 10.1091/mbc.10.3.551; Tzeng SR, 2000, PROTEIN SCI, V9, P2377, DOI 10.1110/ps.9.12.2377; Ueki T, 1999, NAT MED, V5, P226, DOI 10.1038/5593; van der Voort R, 2000, J EXP MED, V192, P1115, DOI 10.1084/jem.192.8.1115; Weaver DJ, 2001, J IMMUNOL, V167, P1461, DOI 10.4049/jimmunol.167.3.1461; Yamaura K, 2004, CIRCULATION, V110, P1650, DOI 10.1161/01.CIR.0000143052.45956.71; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177	47	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32054	32063		10.1074/jbc.M111.271247	http://dx.doi.org/10.1074/jbc.M111.271247			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784852	Green Published, hybrid			2022-12-25	WOS:000294726800015
J	Tagoug, I; De Chalon, AS; Dumontet, C				Tagoug, Ines; De Chalon, Amelie Sauty; Dumontet, Charles			Inhibition of IGF-1 Signalling Enhances the Apoptotic Effect of AS602868, an IKK2 Inhibitor, in Multiple Myeloma Cell Lines	PLOS ONE			English	Article							GROWTH-FACTOR-I; FACTOR-KAPPA-B; RECEPTOR KINASE INHIBITOR; CONSTITUTIVE ACTIVATION; TUMOR-GROWTH; MONOCLONAL-ANTIBODY; PATHWAY INHIBITION; LUNG-CANCER; PROLIFERATION; INTERLEUKIN-6	Multiple myeloma (MM) is a B cell neoplasm characterized by bone marrow infiltration with malignant plasma cells. IGF-1 signalling has been explored as a therapeutic target in this disease. We analyzed the effect of the IKK2 inhibitor AS602868, in combination with a monoclonal antibody targeting IGF-1 receptor (anti-IGF-1R) in human MM cell lines. We found that anti-IGF-1R potentiated the apoptotic effect of AS602868 in LP1 and RPMI8226 MM cell lines which express high levels of IGF-1R. Anti-IGF-1R enhanced the inhibitory effect of AS602868 on NF-kappa B pathway signalling and potentiated the disruption of mitochondrial membrane potential caused by AS602868. These results support the role of IGF-1 signalling in MM and suggest that inhibition of this pathway could sensitize MM cells to NF-kappa B inhibitors.	[Tagoug, Ines; De Chalon, Amelie Sauty; Dumontet, Charles] Univ Lyon, Lyon, France; [Tagoug, Ines; De Chalon, Amelie Sauty; Dumontet, Charles] Ctr Rech Cancerol Lyon, INSERM, U1052, Lyon, France; [Tagoug, Ines; De Chalon, Amelie Sauty; Dumontet, Charles] Ctr Rech Cancerol Lyon, CNRS, UMR 5286, Lyon, France; [Tagoug, Ines; De Chalon, Amelie Sauty; Dumontet, Charles] HCL, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Leon Berard; CHU Lyon	Tagoug, I (corresponding author), Univ Lyon, Lyon, France.	charles.dumontet@chu-lyon.fr		Dumontet, Charles/0000-0003-1875-134X	Ligue contre le Cancer du Rhone; Association pour la Recherche contre le Cancer; Ministry of Higher Education and Scientific Research of Tunisia	Ligue contre le Cancer du Rhone; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ministry of Higher Education and Scientific Research of Tunisia	This work was supported in part by the Ligue contre le Cancer du Rhone and the Association pour la Recherche contre le Cancer and the Ministry of Higher Education and Scientific Research of Tunisia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berenson JR, 2001, SEMIN ONCOL, V28, P626, DOI 10.1053/sonc.2001.29542; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Birmann BM, 2009, CANCER EPIDEM BIOMAR, V18, P282, DOI 10.1158/1055-9965.EPI-08-0778; Blum G, 2003, J BIOL CHEM, V278, P40442, DOI 10.1074/jbc.M305490200; Bohula EA, 2003, ANTI-CANCER DRUG, V14, P669, DOI 10.1097/01.cad.0000092782.37568.04; Burtrum D, 2003, CANCER RES, V63, P8912; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chauhan D, 2005, MOL CANCER THER, V4, P686, DOI 10.1158/1535-7163.MCT-04-0338; Cohen BD, 2005, CLIN CANCER RES, V11, P2063, DOI 10.1158/1078-0432.CCR-04-1070; Denz U, 2006, EUR J CANCER, V42, P1591, DOI 10.1016/j.ejca.2005.11.040; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Franchimont N, 1997, ENDOCRINOLOGY, V138, P5248, DOI 10.1210/en.138.12.5248; Frassanito MA, 2001, BLOOD, V97, P483, DOI 10.1182/blood.V97.2.483; GeorgiiHemming P, 1996, BLOOD, V88, P2250, DOI 10.1182/blood.V88.6.2250.bloodjournal8862250; Giuliani N, 2004, LEUKEMIA, V18, P628, DOI 10.1038/sj.leu.2403269; Griessinger E, 2008, LEUKEMIA, V22, P1466, DOI 10.1038/sj.leu.2405102; Guo Yi-qun, 2006, Zhonghua Xue Ye Xue Za Zhi, V27, P231; Heron-Milhavet L, 2002, J BIOL CHEM, V277, P15600, DOI 10.1074/jbc.M111142200; Hideshima T, 2001, CANCER RES, V61, P3071; Hideshima T, 2005, BEST PRACT RES CL HA, V18, P509, DOI 10.1016/j.beha.2005.01.003; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Hsu JH, 2001, BLOOD, V98, P2853, DOI 10.1182/blood.V98.9.2853; Jelinek DF, 1997, J IMMUNOL, V159, P487; Jelinek DF, 1999, HEMATOL ONCOL CLIN N, V13, P1145, DOI 10.1016/S0889-8588(05)70117-9; Jordheim LP, 2011, CANCER CHEMOTH PHARM, V68, P97, DOI 10.1007/s00280-010-1458-y; Jordheim LP, 2004, CLIN CANCER RES, V10, P5614, DOI 10.1158/1078-0432.CCR-04-0506; Jourdan M, 2000, CELL DEATH DIFFER, V7, P1244, DOI 10.1038/sj.cdd.4400758; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Lounnas N, 2009, INT J CANCER, V125, P308, DOI 10.1002/ijc.24294; Maloney EK, 2003, CANCER RES, V63, P5073; Martins AS, 2006, CLIN CANCER RES, V12, P3532, DOI 10.1158/1078-0432.CCR-05-1778; Menu E, 2006, BLOOD, V107, P655, DOI 10.1182/blood-2005-01-0293; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Mitsiades CS, 2002, ONCOGENE, V21, P5673, DOI 10.1038/sj.onc.1205664; Ni H, 2001, BRIT J HAEMATOL, V115, P279, DOI 10.1046/j.1365-2141.2001.03102.x; Ogata A, 1997, J IMMUNOL, V159, P2212; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pene F, 2002, ONCOGENE, V21, P6587, DOI 10.1038/sj.onc.1205923; Qiang YW, 2002, BLOOD, V99, P4138, DOI 10.1182/blood.V99.11.4138; Raje N, 2004, BLOOD, V104, P4188, DOI 10.1182/blood-2004-06-2281; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Romagnoli M, 2007, CLIN CANCER RES, V13, P6010, DOI 10.1158/1078-0432.CCR-07-0140; Sahara N, 2006, EXP HEMATOL, V34, P736, DOI 10.1016/j.exphem.2006.02.012; Sors A, 2008, CLIN CANCER RES, V14, P901, DOI 10.1158/1078-0432.CCR-07-1419; Sprynski AC, 2009, BLOOD, V113, P4614, DOI 10.1182/blood-2008-07-170464; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Warshamana-Greene GS, 2005, CLIN CANCER RES, V11, P1563, DOI 10.1158/1078-0432.CCR-04-1544; Warshamana-Greene GS, 2004, MOL CANCER THER, V3, P527	50	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22641	10.1371/journal.pone.0022641	http://dx.doi.org/10.1371/journal.pone.0022641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799925	Green Published, gold, Green Submitted			2022-12-25	WOS:000293172900061
J	Wang, R; Li, Z; Wang, Y; Gui, JF				Wang, Rui; Li, Zhi; Wang, Yang; Gui, Jian-Fang			An Apo-14 Promoter-Driven Transgenic Zebrafish That Marks Liver Organogenesis	PLOS ONE			English	Article							DIGESTIVE-SYSTEM; EXPRESSION PATTERN; SPOTTED GROUPER; APOLIPOPROTEIN; MORPHOGENESIS; FISH; ENDODERM; DOMAINS; GENES; LOCI	Several transgenic zebrafish lines for liver development studies had been obtained in the first decade of this century, but not any transgenic GFP zebrafish lines that mark the through liver development and organogenesis were reported. In this study, we analyzed expression pattern of endogenous Apo-14 in zebrafish embryogenesis by whole-mount in situ hybridization, and revealed its expression in liver primordium and in the following liver development. Subsequently, we isolated zebrafish Apo-14 promoter of 1763 bp 5'-flanking sequence, and developed an Apo-14 promoter-driven transgenic zebrafish Tg(Apo14: GFP). And, maternal expression and post-fertilization translocation of Apo-14 promoter-driven GFP were observed in the transgenic zebrafish line. Moreover, we traced onset expression of Apo-14 promoter-driven GFP and developmental behavior of the expressed cells in early heterozygous embryos by out-crossing the Tg(Apo14: GFP) male to the wild type female. Significantly, the Apo-14 promoter-driven GFP is initially expressed around YSL beneath the embryo body at 10 hpf when the embryos develop to tail bud prominence. In about 14-somite embryos at 16-17 hpf, a typical "salt-and-pepper" expression pattern is clearly observed in YSL around the yolk sac. Then, a green fluorescence dot begins to appear between the notochord and the yolk sac adjacent to otic vesicle at about 20 hpf, which is later demonstrated to be liver primordium that gives rise to liver. Furthermore, we investigated dynamic progression of liver organogenesis in the Tg(Apo14: GFP) zebrafish, because the Apo-14 promoter-driven GFP is sustainably expressed from hepatoblasts and liver progenitor cells in liver primordium to hepatocytes in the larval and adult liver. Additionally, we observed similar morphology between the liver progenitor cells and the GFP-positive nuclei on the YSL, suggesting that they might originate from the same progenitor cells in early embryos. Overall, the current study provides a transgenic zebrafish line that marks the through liver organogenesis.	[Wang, Rui; Li, Zhi; Wang, Yang; Gui, Jian-Fang] Chinese Acad Sci, State Key Lab Freshwater Ecol & Biotechnol, Inst Hydrobiol, Wuhan, Peoples R China; [Wang, Rui; Li, Zhi; Wang, Yang; Gui, Jian-Fang] Wuhan Ctr Dev Biol, Wuhan, Peoples R China; [Wang, Rui] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, R (corresponding author), Chinese Acad Sci, State Key Lab Freshwater Ecol & Biotechnol, Inst Hydrobiol, Wuhan, Peoples R China.	jfgui@ihb.ac.cn			National Key Basic Research Program [2010CB126301]; State Key Laboratory of Freshwater Ecology and Biotechnology [2008FBZ15, 2008FBZ18, 085B181F01]; Institute of Hydrobiology, Chinese Academy of Sciences [075A011301, 085A011301]	National Key Basic Research Program(National Basic Research Program of China); State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences); Institute of Hydrobiology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by National Key Basic Research Program (2010CB126301), Open Project of State Key Laboratory of Freshwater Ecology and Biotechnology (2008FBZ15, 2008FBZ18, 085B181F01), and Innovation Project of Institute of Hydrobiology, Chinese Academy of Sciences (075A011301, 085A011301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choudhury M, 2009, ACTA BIOCH BIOPH SIN, V41, P370, DOI 10.1093/abbs/gmp015; Chung WS, 2010, P NATL ACAD SCI USA, V107, P1142, DOI 10.1073/pnas.0910205107; D'Amico LA, 2001, DEV DYNAM, V222, P611, DOI 10.1002/dvdy.1216; Dong PDS, 2007, NAT GENET, V39, P397, DOI 10.1038/ng1961; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Field HA, 2003, DEV BIOL, V261, P197, DOI 10.1016/S0012-1606(03)00308-7; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Gui JF, 2010, SCI CHINA LIFE SCI, V53, P409, DOI 10.1007/s11427-010-0092-6; Her GM, 2004, GENESIS, V38, P26, DOI 10.1002/gene.10248; Huang W, 2009, MOL CELL ENDOCRINOL, V307, P224, DOI 10.1016/j.mce.2009.04.003; Jin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012883; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kim KY, 2009, COMP BIOCHEM PHYS B, V152, P38, DOI 10.1016/j.cbpb.2008.09.084; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kondo H, 2001, BBA-MOL CELL BIOL L, V1531, P132, DOI 10.1016/S1388-1981(01)00099-3; Korzh S, 2001, MECH DEVELOP, V103, P137, DOI 10.1016/S0925-4773(01)00330-6; Korzh S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-84; Liu S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007261; Lusis AJ, 2008, NAT GENET, V40, P129, DOI 10.1038/ng0208-129; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Peng JX, 2009, J EXP ZOOL PART B, V312B, P855, DOI 10.1002/jez.b.21301; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Sun M, 2010, J EXP ZOOL PART A, V313A, P461, DOI 10.1002/jez.618; Warga RM, 1999, DEVELOPMENT, V126, P827; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Xia JH, 2008, INT J DEV BIOL, V52, P1089, DOI 10.1387/ijdb.072519jx; Xie J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-76; Zhou L, 2005, COMP BIOCHEM PHYS B, V142, P432, DOI 10.1016/j.cbpb.2005.09.007; Zhou L, 2010, FISH PHYSIOL BIOCHEM, V36, P181, DOI 10.1007/s10695-008-9219-0; Zhu R, 2008, J VIROL, V82, P6889, DOI 10.1128/JVI.02385-07; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	34	12	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22555	10.1371/journal.pone.0022555	http://dx.doi.org/10.1371/journal.pone.0022555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799896	Green Published, gold, Green Submitted			2022-12-25	WOS:000293097300065
J	Al-Khalaf, HH; Colak, D; Al-Saif, M; Al-Bakheet, A; Hendrayani, SF; Al-Yousef, N; Kaya, N; Khabar, KS; Aboussekhra, A				Al-Khalaf, Huda H.; Colak, Dilek; Al-Saif, Maher; Al-Bakheet, Albandary; Hendrayani, Siti-Faujiah; Al-Yousef, Nujoud; Kaya, Namik; Khabar, Khalid S.; Aboussekhra, Abdelilah			p16(INK4A) Positively Regulates Cyclin D1 and E2F1 through Negative Control of AUF1	PLOS ONE			English	Article							RNA-BINDING PROTEIN; TARGET MESSENGER-RNAS; CELL-CYCLE; TUMOR-SUPPRESSOR; REPLICATIVE SENESCENCE; ULTRAVIOLET-LIGHT; GENE-EXPRESSION; KINASE-ACTIVITY; RICH ELEMENTS; HUR	Background: The cyclin-D/CDK4,6/p16(INK4a)/pRB/E2F pathway, a key regulator of the critical G1 to S phase transition of the cell cycle, is universally disrupted in human cancer. However, the precise function of the different members of this pathway and their functional interplay are still not well defined. Methodology/Principal Findings: We have shown here that the tumor suppressor p16(INK4a) protein positively controls the expression of cyclin D1 and E2F1 in both human and mouse cells. p16(INK4a) stabilizes the mRNAs of the corresponding genes through negative regulation of the mRNA decay-promoting AUF1 protein. Immunoprecipitation of AUF1-associated RNAs followed by RT-PCR indicated that endogenous AUF1 binds to the cyclin D1 and E2F1 mRNAs. Furthermore, AUF1 down-regulation increased the expression levels of these genes, while concurrent silencing of AUF1 and p16(INK4a), using specific siRNAs, restored normal expression of both cyclinD1 and E2F1. Besides, we have shown the presence of functional AU-rich elements in the E2F1 3'UTR, which contributed to p16/AUF1-mediated regulation of E2F1 post-transcriptional events in vivo. Importantly, genome-wide gene expression microarray analysis revealed the presence of a large number of genes differentially expressed in a p16(INK4a) -dependent manner, and several of these genes are also members of the AUF1 and E2F1 regulons. We also present evidence that E2F1 mediates p16-dependent regulation of several pro-and anti-apoptotic proteins, and the consequent induction of spontaneous as well as doxorubicin-induced apoptosis. Conclusion/Significance: These findings show that the cyclin-dependent kinase inhibitor p16(INK4a) is also a modulator of transcription and apoptosis through controlling the expression of two major transcription regulators, AUF1 and E2F1.	[Al-Khalaf, Huda H.; Hendrayani, Siti-Faujiah; Al-Yousef, Nujoud; Aboussekhra, Abdelilah] King Faisal Specialist Hosp & Res Ctr, Dept Biol & Med Res, Riyadh 11211, Saudi Arabia; [Colak, Dilek] King Faisal Specialist Hosp & Res Ctr, Dept Biostat Epidemiol & Sci Comp, Riyadh 11211, Saudi Arabia; [Al-Saif, Maher; Khabar, Khalid S.] King Faisal Specialist Hosp & Res Ctr, Program Biomol Res, Riyadh 11211, Saudi Arabia; [Al-Bakheet, Albandary; Kaya, Namik] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center	Al-Khalaf, HH (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Biol & Med Res, Riyadh 11211, Saudi Arabia.	aboussekhra@kfshrc.edu.sa	Alkhalaf, Huda/Z-5701-2019; Khabar, Khalid/AAG-3487-2019; Khabar, Khalid/A-4772-2011	Khabar, Khalid/0000-0003-1003-9788; Khabar, Khalid/0000-0003-1003-9788; Colak, Dilek/0000-0001-6485-8768				Al-Ahmadi W, 2009, ONCOGENE, V28, P1782, DOI 10.1038/onc.2009.16; Al-Ahmadi W, 2009, NUCLEIC ACIDS RES, V37, P3612, DOI 10.1093/nar/gkp223; Al-Mohanna MA, 2004, ONCOGENE, V23, P201, DOI 10.1038/sj.onc.1206927; Al-Mohanna MA, 2007, NUCLEIC ACIDS RES, V35, P223, DOI 10.1093/nar/gkl1075; Al-Zoghaibi F, 2007, GENE, V391, P130, DOI 10.1016/j.gene.2006.12.013; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Carlson BA, 1996, CANCER RES, V56, P2973; Chang N, 2010, MOL CELL BIOL, V30, P3875, DOI 10.1128/MCB.00169-10; Crosby ME, 2004, CANCER BIOL THER, V3, P1208, DOI 10.4161/cbt.3.12.1494; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Hiyama H, 1997, ONCOGENE, V14, P2533, DOI 10.1038/sj.onc.1201080; Holst CR, 2003, CANCER RES, V63, P1596; JOHNSON DG, 1995, ONCOGENE, V11, P1685; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Kaye FJ, 2002, ONCOGENE, V21, P6908, DOI 10.1038/sj.onc.1205834; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Li C., 2001, GENOME BIOL, V2, DOI [10.1186/gb-2001-2-8-research0032, DOI 10.1186/GB-2001-2-8-RESEARCH0032]; Matsumura I, 2003, CELL CYCLE, V2, P333, DOI 10.4161/cc.2.4.428; Mazan-Mamczarz K, 2009, NUCLEIC ACIDS RES, V37, P204, DOI 10.1093/nar/gkn929; McConnell BB, 1999, MOL CELL BIOL, V19, P1981; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Pei XH, 2005, ONCOGENE, V24, P2787, DOI 10.1038/sj.onc.1208611; Putzer BM, 2007, J CELL MOL MED, V11, P239, DOI 10.1111/j.1582-4934.2007.00030.x; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Sedlacek HH, 2001, CRIT REV ONCOL HEMAT, V38, P139, DOI 10.1016/S1040-8428(00)00124-4; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sharpless NE, 2003, ONCOGENE, V22, P3092, DOI 10.1038/sj.onc.1206461; Singh P, 2007, CANCER LETT, V252, P19, DOI 10.1016/j.canlet.2006.11.012; Stanelle J, 2002, NUCLEIC ACIDS RES, V30, P1859, DOI 10.1093/nar/30.8.1859; Tashiro E, 2003, CANCER RES, V63, P424; Vernell R, 2003, J BIOL CHEM, V278, P46124, DOI 10.1074/jbc.M304930200; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wagoner J, 2007, J VIROL, V81, P309, DOI 10.1128/JVI.01411-06; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Wang WG, 2005, EMBO REP, V6, P158, DOI 10.1038/sj.embor.7400346; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Wang WG, 2001, MOL CELL BIOL, V21, P5889, DOI 10.1128/MCB.21.17.5889-5898.2001; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652	47	40	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e21111	10.1371/journal.pone.0021111	http://dx.doi.org/10.1371/journal.pone.0021111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799732	Green Published, Green Submitted, gold			2022-12-25	WOS:000292931200005
J	Irino, T; Uemura, M; Yamane, H; Umemura, S; Utsumi, T; Kakazu, N; Shirakawa, T; Ito, M; Suzuki, T; Kinoshita, K				Irino, Tamotsu; Uemura, Munehiro; Yamane, Humitsugu; Umemura, Shigeto; Utsumi, Takahiko; Kakazu, Naoki; Shirakawa, Taku; Ito, Mitsuhiro; Suzuki, Takayo; Kinoshita, Kazuo			JAK2 V617F-Dependent Upregulation of PU.1 Expression in the Peripheral Blood of Myeloproliferative Neoplasm Patients	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; BCR-ABL; DISORDERS; DIFFERENTIATION; MUTATION; CELLS; PROLIFERATION; HEMATOPOIESIS; LEUKEMIA; FAMILY	Myeloproliferative neoplasms (MPN) are multiple disease entities characterized by clonal expansion of one or more of the myeloid lineages (i.e. granulocytic, erythroid, megakaryocytic and mast cell). JAK2 mutations, such as the common V617F substitution and the less common exon 12 mutations, are frequently detected in such tumor cells and have been incorporated into the diagnostic criteria published by the World Health Organization since 2008. However, the mechanism by which these mutations contribute to MPN development is poorly understood. We examined gene expression profiles of MPN patients focusing on genes in the JAK-STAT signaling pathway using low-density real-time PCR arrays. We identified the following 2 upregulated genes in MPN patients: a known target of the JAK-STAT axis, SOCS3, and a potentially novel target, SPI1, encoding PU.1. Induction of PU. 1 expression by JAK2 V617F in JAK2-wildtype K562 cells and its downregulation by JAK2 siRNA transfection in JAK2 V617F-positive HEL cells supported this possibility. We also found that the ABL1 kinase inhibitor imatinib was very effective in suppressing PU. 1 expression in BCR-ABL1-positive K562 cells but not in HEL cells. This suggests that PU. 1 expression is regulated by both JAK2 and ABL1. The contribution of the two kinases in driving PU. 1 expression was dominant for JAK2 and ABL1 in HEL and K562 cells, respectively. Therefore, PU. 1 may be a common transcription factor upregulated in MPN. PU. 1 is a transcription factor required for myeloid differentiation and is implicated in erythroid leukemia. Therefore, expression of PU. 1 downstream of activated JAK2 may explain why JAK2 mutations are frequently observed in MPN patients.	[Irino, Tamotsu; Umemura, Shigeto; Utsumi, Takahiko; Suzuki, Takayo] Shiga Med Ctr Adults, Moriyama, Japan; [Irino, Tamotsu; Shirakawa, Taku; Ito, Mitsuhiro] Kobe Univ, Grad Sch Hlth Sci, Div Med Biophys, Kobe, Hyogo 657, Japan; [Uemura, Munehiro; Kinoshita, Kazuo] Shiga Med Ctr Res Inst, Moriyama, Japan; [Yamane, Humitsugu; Kakazu, Naoki] Shimane Univ, Sch Med, Dept Environm & Prevent Med, Izumo, Shimane, Japan	Kobe University; Shimane University	Irino, T (corresponding author), Shiga Med Ctr Adults, Moriyama, Japan.	kkinoshi.shigamed@mac.com			Grants-in-Aid for Scientific Research [23591388] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aittomaki S, 2000, J IMMUNOL, V164, P5689, DOI 10.4049/jimmunol.164.11.5689; Albajar M, 2008, CANCER LETT, V270, P328, DOI 10.1016/j.canlet.2008.05.024; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Berclaz PY, 2007, AM J RESP CELL MOL, V36, P114, DOI 10.1165/rcmb.2006-0174OC; Coppo P, 2006, BRIT J HAEMATOL, V134, P171, DOI 10.1111/j.1365-2141.2006.06161.x; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Elliott J, 2009, HAEMATOL-HEMATOL J, V94, P576, DOI 10.3324/haematol.2008.002352; Fisher RC, 2004, LEUKEMIA RES, V28, P83, DOI 10.1016/S0145-2126(03)00178-4; Gupta P, 2009, J CELL MOL MED, V13, P4349, DOI 10.1111/j.1582-4934.2009.00757.x; Hookham MB, 2007, BLOOD, V109, P4924, DOI 10.1182/blood-2006-08-039735; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; Isomaki P, 2007, RHEUMATOLOGY, V46, P1538, DOI 10.1093/rheumatology/kem198; Janknecht R, 2005, GENE, V363, P1, DOI 10.1016/j.gene.2005.08.007; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li WX, 2008, TRENDS CELL BIOL, V18, P545, DOI 10.1016/j.tcb.2008.08.008; Ma ACH, 2007, BLOOD, V110, P1824, DOI 10.1182/blood-2007-03-078287; Matushansky I, 2003, ONCOGENE, V22, P4143, DOI 10.1038/sj.onc.1206484; Morceau F, 2008, BIOFACTORS, V34, P313, DOI [10.1002/biof.5520340407, 10.3233/BIO-2009-1085]; MoreauGachelin F, 1996, MOL CELL BIOL, V16, P2453; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schroeder T, 2003, J IMMUNOL, V170, P5538, DOI 10.4049/jimmunol.170.11.5538; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955	29	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22148	10.1371/journal.pone.0022148	http://dx.doi.org/10.1371/journal.pone.0022148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789226	gold, Green Published, Green Submitted			2022-12-25	WOS:000292812400033
J	Adanja, I; Megalizzi, V; Debeir, O; Decaestecker, C				Adanja, Ivan; Megalizzi, Veronique; Debeir, Olivier; Decaestecker, Christine			A New Method to Address Unmet Needs for Extracting Individual Cell Migration Features from a Large Number of Cells Embedded in 3D Volumes	PLOS ONE			English	Article							MEAN-SHIFT; TRACKING; MICROSCOPY; LOCOMOTION; MOTILITY	Background: In vitro cell observation has been widely used by biologists and pharmacologists for screening molecule-induced effects on cancer cells. Computer-assisted time-lapse microscopy enables automated live cell imaging in vitro, enabling cell behavior characterization through image analysis, in particular regarding cell migration. In this context, 3D cell assays in transparent matrix gels have been developed to provide more realistic in vitro 3D environments for monitoring cell migration (fundamentally different from cell motility behavior observed in 2D), which is related to the spread of cancer and metastases. Methodology/Principal Findings: In this paper we propose an improved automated tracking method that is designed to robustly and individually follow a large number of unlabeled cells observed under phase-contrast microscopy in 3D gels. The method automatically detects and tracks individual cells across a sequence of acquired volumes, using a template matching filtering method that in turn allows for robust detection and mean-shift tracking. The robustness of the method results from detecting and managing the cases where two cell (mean-shift) trackers converge to the same point. The resulting trajectories quantify cell migration through statistical analysis of 3D trajectory descriptors. We manually validated the method and observed efficient cell detection and a low tracking error rate (6%). We also applied the method in a real biological experiment where the pro-migratory effects of hyaluronic acid (HA) were analyzed on brain cancer cells. Using collagen gels with increased HA proportions, we were able to evidence a dose-response effect on cell migration abilities. Conclusions/Significance: The developed method enables biomedical researchers to automatically and robustly quantify the pro-or anti-migratory effects of different experimental conditions on unlabeled cell cultures in a 3D environment.	[Adanja, Ivan; Debeir, Olivier; Decaestecker, Christine] Univ Libre Bruxelles, Fac Sci Appl, Lab Image Synth & Anal, Brussels, Belgium; [Megalizzi, Veronique; Decaestecker, Christine] Univ Libre Bruxelles, Fac Pharm, Toxicol Lab, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles	Adanja, I (corresponding author), Univ Libre Bruxelles, Fac Sci Appl, Lab Image Synth & Anal, Brussels, Belgium.	cdecaes@ulb.ac.be		Decaestecker, Christine/0000-0002-5495-1931	Belgian National Fund for Scientific Research (FNRS, Brussels, Belgium); Fonds de la Recherche Scientifique Medicale (FRSM, Belgium)	Belgian National Fund for Scientific Research (FNRS, Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS); Fonds de la Recherche Scientifique Medicale (FRSM, Belgium)(Fonds de la Recherche Scientifique - FNRS)	IA benefits from a Televie grant from the Belgian National Fund for Scientific Research (FNRS, Brussels, Belgium; http://www1.frs-fnrs.be) and CD is a senior research associate with the FNRS. This work is also supported by a grant awarded by the Fonds de la Recherche Scientifique Medicale (FRSM, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adanja I, 2010, EXP CELL RES, V316, P181, DOI 10.1016/j.yexcr.2009.10.004; Chen Y, 2009, J IMMUNOL METHODS, V340, P65, DOI 10.1016/j.jim.2008.09.024; CHENG YZ, 1995, IEEE T PATTERN ANAL, V17, P790, DOI 10.1109/34.400568; De Mey JR, 2008, METHOD CELL BIOL, V85, P83, DOI 10.1016/S0091-679X(08)85005-4; Debeir O, 2005, IEEE T MED IMAGING, V24, P697, DOI 10.1109/TMI.2005.846851; Debeir O., 2008, MOTILE ACTIN SYSTEM, P123; Decaestecker C, 2007, MED RES REV, V27, P149, DOI 10.1002/med.20078; Demou ZN, 2002, CANCER RES, V62, P5301; Dubois F, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2357174; Dufour A, 2005, IEEE T IMAGE PROCESS, V14, P1396, DOI 10.1109/TIP.2005.852790; Dzyubachyk O, 2010, IEEE T MED IMAGING, V29, P852, DOI 10.1109/TMI.2009.2038693; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Friedl Peter, 2004, Methods Mol Biol, V239, P77; Grinnell F, 2006, EXP CELL RES, V312, P86, DOI 10.1016/j.yexcr.2005.010.001; Jaensch S, 2010, BIOINFORMATICS, V26, pi13, DOI 10.1093/bioinformatics/btq190; Kim MS, 2005, CANCER RES, V65, P686; Lalande C, 2011, EUR CELLS MATER, V21, P341, DOI 10.22203/eCM.v021a25; Langehanenberg P, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3080133; Lew MD, 2010, PROC SPIE, V7571, DOI 10.1117/12.842608; Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; Meijering E, 2008, MICROSCOPE IMAGE PROCESSING, P401, DOI 10.1016/B978-0-12-372578-3.00015-5; MIURA K, 2008, ADV BIOCHEM ENG BIOT, V95, P267; Niggemann B, 2004, EXP CELL RES, V298, P178, DOI 10.1016/j.yexcr.2004.04.001; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Rey SM, 2009, J BIOPHOTONICS, V2, P370, DOI 10.1002/jbio.200910027; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Soll David R., 2007, P365, DOI 10.1007/978-3-540-71331-9_13; Supatto W, 2009, NAT PROTOC, V4, P1397, DOI 10.1038/nprot.2009.130; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; UCHUGONOVA A, 2011, CELL CYCLE, V10; Walsh MJ, 2003, FASEB J, V17, pA1007; Zimmer C, 2006, IEEE SIGNAL PROC MAG, V23, P54, DOI 10.1109/MSP.2006.1628878	34	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22263	10.1371/journal.pone.0022263	http://dx.doi.org/10.1371/journal.pone.0022263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789244	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811700038
J	Dave, KR; Bhattacharya, SK; Saul, I; DeFazio, RA; Dezfulian, C; Lin, HW; Raval, AP; Perez-Pinzon, MA				Dave, Kunjan R.; Bhattacharya, Sanjoy K.; Saul, Isabel; DeFazio, R. Anthony; Dezfulian, Cameron; Lin, Hung Wen; Raval, Ami P.; Perez-Pinzon, Miguel A.			Activation of Protein Kinase C Delta following Cerebral Ischemia Leads to Release of Cytochrome C from the Mitochondria via Bad Pathway	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; PHOSPHATASE 2A; PHOSPHOLIPID SCRAMBLASE-3; CARDIAC-ARREST; PROAPOPTOTIC FUNCTION; OXIDATIVE STRESS; NEURONAL DEATH; BRAIN; TRANSLOCATION; CARDIOLIPIN	Background: The release of cytochrome c from the mitochondria following cerebral ischemia is a key event leading to cell death. The goal of the present study was to determine the mechanisms involved in post-ischemic activation of protein kinase c delta (delta PKC) that lead to cytochrome c release. Methods/Findings: We used a rat model of cardiac arrest as an in vivo model, and an in vitro analog, oxygen glucose deprivation (OGD) in rat hippocampal synaptosomes. Cardiac arrest triggered translocation of delta PKC to the mitochondrial fraction at 1 h reperfusion. In synaptosomes, the peptide inhibitor of delta PKC blocked OGD-induced translocation to the mitochondria. We tested two potential pathways by which delta PKC activation could lead to cytochrome c release: phosphorylation of phospholipid scramblase-3 (PLSCR3) and/or protein phosphatase 2A (PP2A). Cardiac arrest increased levels of phosphorlyated PLSCR3; however, inhibition of delta PKC translocation failed to affect the OGD-induced increase in PLSCR3 in synaptosomal mitochondria suggesting the post-ischemic phosphorylation of PLSCR3 is not mediated by delta PKC. Inhibition of either delta PKC or PP2A decreased cytochrome c release from synaptosomal mitochondria. Cardiac arrest results in the dephosphorylation of Bad and Bax, both downstream targets of PP2A promoting apoptosis. Inhibition of delta PKC or PP2A prevented OGD-induced Bad, but not Bax, dephosphorylation. To complement these studies, we used proteomics to identify novel mitochondrial substrates of delta PKC. Conclusions: We conclude that delta PKC initiates cytochrome c release via phosphorylation of PP2A and subsequent dephosphorylation of Bad and identified delta PKC, PP2A and additional mitochondrial proteins as potential therapeutic targets for ischemic neuroprotection.	[Dave, Kunjan R.; Saul, Isabel; DeFazio, R. Anthony; Dezfulian, Cameron; Lin, Hung Wen; Raval, Ami P.; Perez-Pinzon, Miguel A.] Univ Miami, Leonard M Miller Sch Med, Dept Neurol, Cerebral Vasc Dis Res Ctr, Miami, FL 33152 USA; [Perez-Pinzon, Miguel A.] Univ Miami, Leonard M Miller Sch Med, Neurosci Program, Miami, FL USA; [Bhattacharya, Sanjoy K.] Univ Miami, Leonard M Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL USA; [Dezfulian, Cameron] Univ Miami, Leonard M Miller Sch Med, Dept Med, Miami, FL USA	University of Miami; University of Miami; Bascom Palmer Eye Institute; University of Miami; University of Miami	Dave, KR (corresponding author), Univ Miami, Leonard M Miller Sch Med, Dept Neurol, Cerebral Vasc Dis Res Ctr, Miami, FL 33152 USA.	MPerez18@med.miami.edu	DeFazio, Richard/AFO-0041-2022	DeFazio, Richard/0000-0001-7302-7528; Dezfulian, Cameron/0000-0002-4486-0446	National Institutes of Health [NS34773, NS045676, NS054147]; AHA [0735106N]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034773, R55NS034773, R29NS034773, R01NS045676, R01NS054147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health grants NS34773, NS045676 and NS054147 (MAPP), and AHA grant 0735106N (KRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2004, BRAIN RES, V1009, P159, DOI 10.1016/j.brainres.2004.03.003; ALLEN KL, 1995, J NEUROCHEM, V64, P2222; Aponte AM, 2009, J PROTEOME RES, V8, P2679, DOI 10.1021/pr800913j; BOGAERT YE, 1994, FREE RADICAL BIO MED, V16, P811, DOI 10.1016/0891-5849(94)90197-X; Bouwman RA, 2004, ANESTHESIOLOGY, V100, P506, DOI 10.1097/00000542-200403000-00008; Bright R, 2004, J NEUROSCI, V24, P6880, DOI 10.1523/JNEUROSCI.4474-03.2004; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Brown MR, 2004, J NEUROSCI METH, V137, P299, DOI 10.1016/j.jneumeth.2004.02.028; Cao GD, 2001, J CEREBR BLOOD F MET, V21, P321, DOI 10.1097/00004647-200104000-00001; Chan PH, 2004, NEUROCHEM RES, V29, P1943, DOI 10.1007/s11064-004-6869-x; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Chiang CW, 2001, BLOOD, V97, P1289, DOI 10.1182/blood.V97.5.1289; Churchill EN, 2005, ARCH BIOCHEM BIOPHYS, V439, P194, DOI 10.1016/j.abb.2005.05.007; Churchill EN, 2005, CIRC RES, V97, P78, DOI 10.1161/01.RES.0000173896.32522.6e; Clarkson AN, 2004, FASEB J, V18, P1114, DOI 10.1096/fj.03-1203fje; Dave KR, 2004, BRAIN RES, V1024, P89, DOI 10.1016/j.brainres.2004.07.050; Dave KR, 2008, J NEUROSCI, V28, P4172, DOI 10.1523/JNEUROSCI.5471-07.2008; David G, 2003, J PHYSIOL-LONDON, V548, P425, DOI 10.1113/jphysiol.2002.035196; Deng N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000117; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; DUNKLEY PR, 1988, BRAIN RES, V441, P59, DOI 10.1016/0006-8993(88)91383-2; Endo H, 2006, J NEUROSCI, V26, P7974, DOI 10.1523/JNEUROSCI.0897-06.2006; Fiskum G, 1999, J CEREBR BLOOD F MET, V19, P351, DOI 10.1097/00004647-199904000-00001; Fujimura M, 1998, J CEREBR BLOOD F MET, V18, P1239, DOI 10.1097/00004647-199811000-00010; Gardai SJ, 2004, J BIOL CHEM, V279, P44695, DOI 10.1074/jbc.M405313200; Ghibelli L, 2010, MITOCHONDRION, V10, P604, DOI 10.1016/j.mito.2010.08.003; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P614, DOI 10.1038/sj.cdd.4401571; Harada N, 2004, J CARDIOVASC PHARM, V44, P35, DOI 10.1097/00005344-200407000-00005; He Y, 2007, J CELL BIOCHEM, V101, P1210, DOI 10.1002/jcb.21243; Hetz C, 2005, J BIOL CHEM, V280, P42960, DOI 10.1074/jbc.M505843200; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Iijima T, 2003, NEUROCHEM INT, V43, P263, DOI 10.1016/S0197-0186(02)00228-0; Iverson SL, 2004, ARCH BIOCHEM BIOPHYS, V423, P37, DOI 10.1016/j.abb.2003.12.002; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; LAI JCK, 1988, NEUROCHEM RES, V13, P1043, DOI 10.1007/BF00973148; Leitges M, 2001, J CLIN INVEST, V108, P1505; Liedtke CM, 2005, J BIOL CHEM, V280, P25491, DOI 10.1074/jbc.M504473200; Liu D, 2002, J CEREBR BLOOD F MET, V22, P431, DOI 10.1097/00004647-200204000-00007; Liu JH, 2003, MOL CANCER RES, V1, P892; Liu JH, 2003, CANCER RES, V63, P1153; Lothstein L, 2006, ANTI-CANCER DRUG, V17, P495, DOI 10.1097/00001813-200606000-00002; Majumder PK, 2001, CELL GROWTH DIFFER, V12, P465; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; McMillin JB, 2002, BBA-MOL CELL BIOL L, V1585, P97, DOI 10.1016/S1388-1981(02)00329-3; Miyawaki T, 2008, P NATL ACAD SCI USA, V105, P4892, DOI 10.1073/pnas.0800628105; Nicholls DG, 2003, NEUROCHEM RES, V28, P1433, DOI 10.1023/A:1025653805029; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655; Ott M, 2007, CELL DEATH DIFFER, V14, P1243, DOI 10.1038/sj.cdd.4402135; Perez-Pinzon MA, 1999, J CEREBR BLOOD F MET, V19, P39, DOI 10.1097/00004647-199901000-00004; Perez-Pinzon MA, 2005, ANTIOXID REDOX SIGN, V7, P1150, DOI 10.1089/ars.2005.7.1150; Perez-Pinzon MA, 2002, MITOCHONDRION, V2, P181, DOI 10.1016/S1567-7249(02)00070-3; Raval AP, 2005, J CEREBR BLOOD F MET, V25, P730, DOI 10.1038/sj.jcbfm.9600071; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Seyedi N, 2002, J PHARMACOL EXP THER, V302, P539, DOI 10.1124/jpet.302.2.539; SHENOLIKAR S, 1994, ANNU REV CELL BIOL, V10, P55, DOI 10.1146/annurev.cellbio.10.1.55; Sloley S, 2007, J PROTEOME RES, V6, P2341, DOI 10.1021/pr070126w; Strack S, 1998, J COMP NEUROL, V392, P515; STRUB GM, 2011, FASEB J; Truttmann AC, 2004, NEUROSCIENCE, V127, P355, DOI 10.1016/j.neuroscience.2004.05.033; Van QY, 2007, BIOCHEM J, V401, P103, DOI 10.1042/BJ20060373; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; Zablocka B, 2001, BRAIN RES, V889, P105, DOI 10.1016/S0006-8993(00)03122-X; ZAIDAN E, 1993, J CEREBR BLOOD F MET, V13, P98, DOI 10.1038/jcbfm.1993.12; Zhang DH, 2007, J NEUROSCI, V27, P5349, DOI 10.1523/JNEUROSCI.4107-06.2007; Zhang TT, 2008, METAB BRAIN DIS, V23, P95, DOI 10.1007/s11011-007-9074-1	66	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22057	10.1371/journal.pone.0022057	http://dx.doi.org/10.1371/journal.pone.0022057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789211	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811700018
J	Lee, TY; Chen, YJ; Lu, TC; Huang, HD; Chen, YJ				Lee, Tzong-Yi; Chen, Yi-Ju; Lu, Tsung-Cheng; Huang, Hsien-Da; Chen, Yu-Ju			SNOSite: Exploiting Maximal Dependence Decomposition to Identify Cysteine S-Nitrosylation with Substrate Site Specificity	PLOS ONE			English	Article							ACID SIDE-CHAINS; PROTEOMIC ANALYSIS; STRUCTURE DETERMINANT; LOCAL INTERACTIONS; NITRIC-OXIDE; PROTEIN; IDENTIFICATION; PREDICTION; TOOL; REPRESENTATION	S-nitrosylation, the covalent attachment of a nitric oxide to (NO) the sulfur atom of cysteine, is a selective and reversible protein post-translational modification (PTM) that regulates protein activity, localization, and stability. Despite its implication in the regulation of protein functions and cell signaling, the substrate specificity of cysteine S-nitrosylation remains unknown. Based on a total of 586 experimentally identified S-nitrosylation sites from SNAP/L-cysteine-stimulated mouse endothelial cells, this work presents an informatics investigation on S-nitrosylation sites including structural factors such as the flanking amino acids composition, the accessible surface area (ASA) and physicochemical properties, i.e. positive charge and side chain interaction parameter. Due to the difficulty to obtain the conserved motifs by conventional motif analysis, maximal dependence decomposition (MDD) has been applied to obtain statistically significant conserved motifs. Support vector machine (SVM) is applied to generate predictive model for each MDD-clustered motif. According to five-fold cross-validation, the MDD-clustered SVMs could achieve an accuracy of 0.902, and provides a promising performance in an independent test set. The effectiveness of the model was demonstrated on the correct identification of previously reported S-nitrosylation sites of Bos taurus dimethylarginine dimethylaminohydrolase 1 (DDAH1) and human hemoglobin subunit beta (HBB). Finally, the MDD-clustered model was adopted to construct an effective web-based tool, named SNOSite (http://csb.cse.yzu.edu.tw/SNOSite/), for identifying S-nitrosylation sites on the uncharacterized protein sequences.	[Lee, Tzong-Yi; Lu, Tsung-Cheng] Yuan Ze Univ, Dept Comp Sci & Engn, Chungli, Taiwan; [Chen, Yi-Ju; Chen, Yu-Ju] Acad Sinica, Inst Chem, Taipei, Taiwan; [Huang, Hsien-Da] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Huang, Hsien-Da] Dept Biol Sci & Technol, Hsinchu, Taiwan	Yuan Ze University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University	Lee, TY (corresponding author), Yuan Ze Univ, Dept Comp Sci & Engn, Chungli, Taiwan.	francis@saturn.yzu.edu.tw; yjchen@chem.sinica.edu.tw	Chen, Yi-Ju/AAP-9052-2021; Chen, Yu-Ju/E-9481-2015; Chen, Yi-Ju/AFU-9499-2022; Huang, Hsien-Da/AAA-7376-2019	Chen, Yi-Ju/0000-0002-7203-9188; Chen, Yu-Ju/0000-0002-3178-6697; 	Taiwan National Science Council [NSC-99-2911-I-009-101]; National Science Council of the Republic of China [NSC 99-2320-B-155-001, NSC-100-2922-I-016-002, NSC 98-2311-B-009-004-MY3, NSC 99-2627-B-009-003]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported in part by the UST-UCSD International Center of Excellence in Advanced Bio-engineering sponsored by the Taiwan National Science Council I-RiCE Program under grant number: NSC-99-2911-I-009-101. The authors would like to thank the National Science Council of the Republic of China for financially supporting this research under Contract No. NSC 99-2320-B-155-001 to TYL, NSC-100-2922-I-016-002 YJC, NSC 98-2311-B-009-004-MY3 and NSC 99-2627-B-009-003 to HDH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2003, BIOINFORMATICS, V19, P1849, DOI 10.1093/bioinformatics/btg249; Ahmad S, 2003, PROTEINS, V50, P629, DOI 10.1002/prot.10328; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chang WC, 2009, J COMPUT CHEM, V30, P2526, DOI 10.1002/jcc.21258; CHEN YJ, 2010, J PROTEOME RES; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Derakhshan B, 2007, CARDIOVASC RES, V75, P210, DOI 10.1016/j.cardiores.2007.04.023; FASMAN GD, 1989, TRENDS BIOCHEM SCI, V14, P295, DOI 10.1016/0968-0004(89)90068-6; FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269; FINKELSTEIN AV, 1991, PROTEINS, V10, P287, DOI 10.1002/prot.340100403; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Gaston B, 2006, AM J RESP CRIT CARE, V173, P1186, DOI 10.1164/rccm.200510-1584PP; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; GUY HR, 1985, BIOPHYS J, V47, P61, DOI 10.1016/S0006-3495(85)83877-7; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; JANIN J, 1978, J MOL BIOL, V125, P357, DOI 10.1016/0022-2836(78)90408-4; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; Karpuzoglu E, 2006, NITRIC OXIDE-BIOL CH, V15, P177, DOI 10.1016/j.niox.2006.03.009; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kidera Y, 1985, Nihon Sanka Fujinka Gakkai Zasshi, V37, P1820; Knipp M, 2003, J BIOL CHEM, V278, P3410, DOI 10.1074/jbc.M209088200; KRIGBAUM WR, 1979, BIOCHIM BIOPHYS ACTA, V576, P204, DOI 10.1016/0005-2795(79)90498-7; KRIGBAUM WR, 1971, BIOCHIM BIOPHYS ACTA, V229, P368, DOI 10.1016/0005-2795(71)90196-6; Kuncewicz T, 2003, MOL CELL PROTEOMICS, V2, P156, DOI 10.1074/mcp.M300003-MCP200; Kuncewicz T, 2004, CONTRIB NEPHROL, V141, P221; Lam YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009075; LANE P, 2001, SCI STKE, pRE1; LEE TY, 2011, BIOINFORMATICS; LEVITT M, 1976, J MOL BIOL, V104, P59, DOI 10.1016/0022-2836(76)90004-8; Lin C-J, 2003, NIPS 2003 FEATURE SE, P1; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Marino SM, 2010, J MOL BIOL, V395, P844, DOI 10.1016/j.jmb.2009.10.042; MEIROVITCH H, 1980, MACROMOLECULES, V13, P1398, DOI 10.1021/ma60078a013; Nakamura T, 2009, APOPTOSIS, V14, P455, DOI 10.1007/s10495-008-0301-y; OOBATAKE M, 1977, J THEOR BIOL, V67, P567, DOI 10.1016/0022-5193(77)90058-3; Pang CNI, 2007, J PROTEOME RES, V6, P1833, DOI 10.1021/pr060674u; Punta M, 2003, PROTEINS, V50, P114, DOI 10.1002/prot.10247; RACKOVSKY S, 1982, MACROMOLECULES, V15, P1340, DOI 10.1021/ma00233a025; Romero-Puertas MC, 2008, PROTEOMICS, V8, P1459, DOI 10.1002/pmic.200700536; ROSEMAN MA, 1988, J MOL BIOL, V200, P513, DOI 10.1016/0022-2836(88)90540-2; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; SETH D, CURR OPINIO IN PRESS; Shien DM, 2009, J COMPUT CHEM, V30, P1532, DOI 10.1002/jcc.21232; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; TAKANO M, 1985, J BIOCHEM-TOKYO, V98, P1333, DOI 10.1093/oxfordjournals.jbchem.a135400; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Tung CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-310; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; WEBER AL, 1978, J MOL EVOL, V11, P199, DOI 10.1007/BF01734481; Xue Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011290; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101	63	73	74	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e21849	10.1371/journal.pone.0021849	http://dx.doi.org/10.1371/journal.pone.0021849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789187	gold, Green Published, Green Submitted			2022-12-25	WOS:000292811700006
J	Durand, D; Carniglia, L; Caruso, C; Lasaga, M				Durand, Daniela; Carniglia, Lila; Caruso, Carla; Lasaga, Mercedes			Reduced cAMP, Akt Activation and p65-c-Rel Dimerization: Mechanisms Involved in the Protective Effects of mGluR3 Agonists in Cultured Astrocytes	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; NITRIC-OXIDE SYNTHASE; C-REL; INFLAMMATORY RESPONSE; MESSENGER-RNAS; RAT ASTROCYTES; PROTEIN-KINASE; MAP-KINASE; NEUROPROTECTION; EXPRESSION	In recent decades, astrocytes have emerged as key pieces in the maintenance of normal functioning of the central nervous system. Any impairment in astroglial function can ultimately lead to generalized disturbance in the brain, thus pharmacological targets associated with prevention of astrocyte death are actually promising. Subtype 3 of metabotropic glutamate receptors (mGluR3) is present in astrocytes, its activation exerting neuroprotective roles. In fact, we have previously demonstrated that mGluR3 selective agonists prevent nitric oxide (NO)-induced astrocyte death. However, mechanisms responsible for that cytoprotective property are still subject to study. Although inhibition of adenylyl cyclase by mGluR3 activation was extensively reported, the involvement of reduced cAMP levels in the effects of mGluR3 agonists and the association between cAMP decrease and the downstream pathways activated by mGluR3 remain neglected. Thus, we studied intracellular signaling mediating anti-apoptotic actions of mGluR3 in cultured rat astrocytes exposed to NO. In the present work, we showed that the cytoprotective effect of mGluR3 agonists (LY379268 and LY404039) requires both the reduction of intracellular cAMP levels and activation of Akt, as assessed by MTT and TUNEL techniques. Moreover, dibutyryl-cAMP impairs Akt phosphorylation induced by LY404039, indicating a relationship between mGluR3-reduced cAMP levels and PI3K/Akt pathway activation. We also demonstrated, by co-immunoprecipitation followed by western-blot, that the mGluR3 agonists not only induce per se survival-linked interaction between members of the NF-kappa B family p65 and c-Rel, but also impede reduction of levels of p65-c-Rel dimers caused by NO, suggesting a possible anti-apoptotic role for p65-c-Rel. All together, these data suggest that mGluR3 agonists may regulate cAMP/Akt/p65-c-Rel pathway, which would contribute to the protective effect of mGluR3 against NO challenge in astrocytes. Our results widen the knowledge about mechanisms of action of mGluR3, potential targets for the treatment of neurodegenerative disorders where a pathophysiological role for NO has been established.	[Durand, Daniela; Carniglia, Lila; Caruso, Carla; Lasaga, Mercedes] Univ Buenos Aires, Sch Med, Inst Res Reprod, Buenos Aires, DF, Argentina	University of Buenos Aires	Durand, D (corresponding author), Univ Buenos Aires, Sch Med, Inst Res Reprod, Buenos Aires, DF, Argentina.	mlasaga@fmed.uba.ar	Caruso, Carla/AAR-5914-2020	Caruso, Carla/0000-0002-0889-0293; Carniglia, Lila/0000-0002-9354-8037; Lasaga, Mercedes/0000-0001-9916-3712	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Universidad de Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) (www.agencia.mincyt.gov.ar), Universidad de Buenos Aires (www.uba.ar) and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (www.conicet.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benarroch EE, 2005, MAYO CLIN PROC, V80, P1326, DOI 10.4065/80.10.1326; Bhattacharyya J, 2004, CURR MED CHEM, V11, P359, DOI 10.2174/0929867043456098; Bruno V, 1998, J NEUROSCI, V18, P9594; Caruso C, 2004, NEUROENDOCRINOLOGY, V79, P278, DOI 10.1159/000079321; Caruso C, 2007, ENDOCRINOLOGY, V148, P4918, DOI 10.1210/en.2007-0366; Chen SH, 2008, TOXICOL SCI, V102, P138, DOI 10.1093/toxsci/kfm292; Ciccarelli R, 1997, GLIA, V21, P390, DOI 10.1002/(SICI)1098-1136(199712)21:4<390::AID-GLIA6>3.0.CO;2-7; Ciccarelli R, 2007, MOL PHARMACOL, V71, P1369, DOI 10.1124/mol.106.031617; Condorelli DF, 1997, NEUROCHEM RES, V22, P1127, DOI 10.1023/A:1027317319166; D'Onofrio M, 2001, J NEUROCHEM, V78, P435, DOI 10.1046/j.1471-4159.2001.00435.x; Di Iorio P, 2004, GLIA, V46, P356, DOI 10.1002/glia.20002; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Durand D, 2010, J NEUROCHEM, V112, P420, DOI 10.1111/j.1471-4159.2009.06469.x; Faden AI, 1997, J NEUROTRAUM, V14, P885, DOI 10.1089/neu.1997.14.885; Fernandes A, 2007, EUR J NEUROSCI, V25, P1058, DOI 10.1111/j.1460-9568.2007.05340.x; Ferraguti F, 2001, EXP BRAIN RES, V137, P1, DOI 10.1007/s002210000633; Giri S, 2004, J IMMUNOL, V173, P5196, DOI 10.4049/jimmunol.173.8.5196; Janssens N, 2001, J NEUROCHEM, V77, P1457, DOI 10.1046/j.1471-4159.2001.00369.x; Kim S, 2001, J BIOL CHEM, V276, P12864, DOI 10.1074/jbc.M001492200; Kingston AE, 1999, EUR J PHARMACOL, V377, P155, DOI 10.1016/S0014-2999(99)00397-0; Kogel D, 2004, NEUROSCIENCE, V127, P913, DOI 10.1016/j.neuroscience.2004.06.013; Kozuka N, 2007, NEUROSCIENCE, V144, P911, DOI 10.1016/j.neuroscience.2006.10.040; Monn JA, 1999, J MED CHEM, V42, P1027, DOI 10.1021/jm980616n; Mudo G, 2007, BRAIN RES, V1149, P1, DOI 10.1016/j.brainres.2007.02.041; MURPHY S, 1995, GLIA, V15, P77, DOI 10.1002/glia.440150109; Nasuhara Y, 1999, J BIOL CHEM, V274, P19965, DOI 10.1074/jbc.274.28.19965; OHISHI H, 1993, J COMP NEUROL, V335, P252, DOI 10.1002/cne.903350209; OHISHI H, 1993, NEUROSCIENCE, V53, P1009, DOI 10.1016/0306-4522(93)90485-X; Peng XQ, 2010, ACTA PHARMACOL SIN, V31, P175, DOI 10.1038/aps.2009.190; Perez V, 2005, EUR J NEUROSCI, V21, P26, DOI 10.1111/j.1460-9568.2004.03845.x; Pizzi M, 2002, J BIOL CHEM, V277, P20717, DOI 10.1074/jbc.M201014200; Pizzi M, 2005, CELL DEATH DIFFER, V12, P761, DOI 10.1038/sj.cdd.4401598; Rorick-Kehn LM, 2007, J PHARMACOL EXP THER, V321, P308, DOI 10.1124/jpet.106.110809; Salminen A, 2010, CELL SIGNAL, V22, P573, DOI 10.1016/j.cellsig.2009.10.006; Sarnico I, 2008, J NEURAL TRANSM, V115, P669, DOI 10.1007/s00702-007-0007-2; Sarnico I, 2009, J NEUROCHEM, V108, P475, DOI 10.1111/j.1471-4159.2008.05783.x; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; Schools GP, 1999, J NEUROSCI RES, V58, P533, DOI 10.1002/(SICI)1097-4547(19991115)58:4<533::AID-JNR6>3.0.CO;2-G; Srivastava RK, 1998, MOL CELL BIOL, V18, P3509, DOI 10.1128/MCB.18.6.3509; Sumbayev VV, 2005, ARCH BIOCHEM BIOPHYS, V436, P406, DOI 10.1016/j.abb.2005.02.021; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Valerio A, 2009, STROKE, V40, P610, DOI 10.1161/STROKEAHA.108.528588; WANG Y, 2010, AM J PHYSIOL-HEART C, V299; Weil R, 1997, IMMUNOBIOLOGY, V198, P14, DOI 10.1016/S0171-2985(97)80023-X; Wroblewska B, 1998, GLIA, V24, P172, DOI 10.1002/(SICI)1098-1136(199810)24:2<172::AID-GLIA2>3.0.CO;2-6; Wroblewska B, 2006, J NEUROCHEM, V96, P1071, DOI 10.1111/j.1471-4159.2005.03569.x; Yoo YK, 2005, ARCH PHARM RES, V28, P942; Zhao ZJ, 2005, BIOORG MED CHEM LETT, V15, P905, DOI 10.1016/j.bmcl.2004.12.062	49	23	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22235	10.1371/journal.pone.0022235	http://dx.doi.org/10.1371/journal.pone.0022235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779400	gold, Green Submitted, Green Published			2022-12-25	WOS:000292811300054
J	Griffiths, HH; Whitehouse, IJ; Baybutt, H; Brown, D; Kellett, KAB; Jackson, CD; Turner, AJ; Piccardo, P; Manson, JC; Hooper, NM				Griffiths, Heledd H.; Whitehouse, Isobel J.; Baybutt, Herbert; Brown, Debbie; Kellett, Katherine A. B.; Jackson, Carolyn D.; Turner, Anthony J.; Piccardo, Pedro; Manson, Jean C.; Hooper, Nigel M.			Prion Protein Interacts with BACE1 Protein and Differentially Regulates Its Activity toward Wild Type and Swedish Mutant Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SECRETASE CLEAVAGE; ALZHEIMERS-DISEASE; PLAQUE-FORMATION; CLEAVING ENZYME; MUTATION; APP; PATHOGENESIS; OLIGOMERS; BRAIN; MICE	In Alzheimer disease amyloid-beta (A beta) peptides derived from the amyloid precursor protein (APP) accumulate in the brain. Cleavage of APP by the beta-secretase BACE1 is the rate-limiting step in the production of A beta. We have reported previously that the cellular prion protein (PrPC) inhibited the action of BACE1 toward human wild type APP (APP(WT)) in cellular models and that the levels of endogenous murine A beta were significantly increased in PrPC-null mouse brain. Here we investigated the molecular and cellular mechanisms underlying this observation. PrPC interacted directly with the prodomain of the immature Golgi-localized form of BACE1. This interaction decreased BACE1 at the cell surface and in endosomes where it preferentially cleaves APP(WT) but increased it in the Golgi where it preferentially cleaves APP with the Swedish mutation (APP(Swe)). In transgenic mice expressing human APP with the Swedish and Indiana familial mutations (APP(Swe,Ind)), PrPC deletion had no influence on APP proteolytic processing, A beta plaque deposition, or levels of soluble A beta or A beta oligomers. In cells, although PrPC inhibited the action of BACE1 on APP(WT), it did not inhibit BACE1 activity toward APP(Swe). The differential subcellular location of the BACE1 cleavage of APP(Swe) relative to APP(WT) provides an explanation for the failure of PrPC deletion to affect A beta accumulation in APP(Swe,Ind) mice. Thus, although PrPC exerts no control on cleavage of APP(Swe) by BACE1, it has a profound influence on the cleavage of APP(WT), suggesting that PrPC may be a key protective player against sporadic Alzheimer disease.	[Griffiths, Heledd H.; Whitehouse, Isobel J.; Kellett, Katherine A. B.; Jackson, Carolyn D.; Turner, Anthony J.; Hooper, Nigel M.] Univ Leeds, Inst Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Baybutt, Herbert; Brown, Debbie; Piccardo, Pedro; Manson, Jean C.] Univ Edinburgh, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; [Baybutt, Herbert; Brown, Debbie; Piccardo, Pedro; Manson, Jean C.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9PS, Midlothian, Scotland; [Piccardo, Pedro] US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20852 USA	University of Leeds; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; US Food & Drug Administration (FDA)	Hooper, NM (corresponding author), Univ Leeds, Inst Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.	n.m.hooper@leeds.ac.uk		Kellett, Katherine/0000-0002-2802-0615; Jarosz-Griffiths, Heledd/0000-0001-5154-4815; manson, jean/0000-0002-0175-9890; Hooper, Nigel/0000-0002-5811-3484	NIAID [Y1-AI-4893-02]; Medical Research Council of Great Britain [G9824728, G0802189]; Alzheimer's Research Trust of Great Britain [PG2008/2]; Food and Drug Administration Agreement [224-05-1307]; MRC [G9824728, G0802189] Funding Source: UKRI; Alzheimers Research UK [ART-PG2010-2, ART-PG2008-2] Funding Source: researchfish; Medical Research Council [G9824728, G0802189] Funding Source: researchfish	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research Trust of Great Britain; Food and Drug Administration Agreement; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Agreement Y1-AI-4893-02 from the NIAID. This work was also supported by Medical Research Council of Great Britain Grants G9824728 and G0802189, Alzheimer's Research Trust of Great Britain Grant PG2008/2, and Food and Drug Administration Agreement 224-05-1307.	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Bennett BD, 2000, J BIOL CHEM, V275, P20647, DOI 10.1074/jbc.M002688200; Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Haugabook SJ, 2001, J NEUROSCI METH, V108, P171, DOI 10.1016/S0165-0270(01)00388-0; Hooper NM, 2008, TRENDS BIOCHEM SCI, V33, P151, DOI 10.1016/j.tibs.2008.01.004; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Morrissette DA, 2009, J BIOL CHEM, V284, P6033, DOI 10.1074/jbc.R800030200; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Piccardo P, 2007, P NATL ACAD SCI USA, V104, P4712, DOI 10.1073/pnas.0609241104; Schwarze-Eicker KA, 2005, NEUROBIOL AGING, V26, P1177, DOI 10.1016/j.neurobiolaging.2004.10.004; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Sun XL, 2006, FASEB J, V20, P1369, DOI 10.1096/FJ.05-5632COM; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Vardy ERLC, 2005, TRENDS MOL MED, V11, P464, DOI 10.1016/j.molmed.2005.08.004; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Walmsley AR, 2001, EMBO J, V20, P703, DOI 10.1093/emboj/20.4.703; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Whitehouse IJ, 2010, J ALZHEIMERS DIS, V22, P1023, DOI 10.3233/JAD-2010-101071; Yamakawa H, 2010, J BIOL CHEM, V285, P1634, DOI 10.1074/jbc.M109.066753; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	40	50	51	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33489	33500		10.1074/jbc.M111.278556	http://dx.doi.org/10.1074/jbc.M111.278556			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795680	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000294968800066
J	Maric, D; McGwire, BS; Buchanan, KT; Olson, CL; Emmer, BT; Epting, CL; Engman, DM				Maric, Danijela; McGwire, Bradford S.; Buchanan, Kathryn T.; Olson, Cheryl L.; Emmer, Brian T.; Epting, Conrad L.; Engman, David M.			Molecular Determinants of Ciliary Membrane Localization of Trypanosoma cruzi Flagellar Calcium-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYRISTOYL-ELECTROSTATIC SWITCH; ACIDIC PHOSPHOLIPIDS; LIPID MODIFICATIONS; TARGETING PROTEINS; PLASMA-MEMBRANE; GENE-EXPRESSION; BLOOD-STREAM; BRUCEI; LEISHMANIA; FAMILY	The flagellar calcium-binding protein (FCaBP) of Trypanosoma cruzi is localized to the flagellar membrane in all life cycle stages of the parasite. Myristoylation and palmitoylation of the N terminus of FCaBP are necessary for flagellar membrane targeting. Not all dually acylated proteins in T. cruzi are flagellar, however. Other determinants of FCaBP therefore likely contribute to flagellar specificity. We generated T. cruzi transfectants expressing the N-terminal 24 or 12 amino acids of FCaBP fused to GFP. Analysis of these mutants revealed that although amino acids 1-12 are sufficient for dual acylation and membrane binding, amino acids 13-24 are required for flagellar specificity and lipid raft association. Mutagenesis of several conserved lysine residues in the latter peptide demonstrated that these residues are essential for flagellar targeting and lipid raft association. Finally, FCaBP was expressed in the protozoan Leishmania amazonensis, which lacks FCaBP. The flagellar localization and membrane association of FCaBP in L. amazonensis suggest that the mechanisms for flagellar targeting, including a specific palmitoyl acyltransferase, are conserved in this organism.	[Maric, Danijela; McGwire, Bradford S.; Buchanan, Kathryn T.; Olson, Cheryl L.; Emmer, Brian T.; Epting, Conrad L.; Engman, David M.] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; [Maric, Danijela; McGwire, Bradford S.; Buchanan, Kathryn T.; Olson, Cheryl L.; Emmer, Brian T.; Engman, David M.] Northwestern Univ, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Epting, Conrad L.] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University	Engman, DM (corresponding author), Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA.	d-engman@northwestern.edu	Engman, David/T-6747-2018	Engman, David/0000-0001-5869-9844; Emmer, Brian T./0000-0001-7365-1021	National Institutes of Health [R01 AI46781, K12 HD047349]; American Heart Association [0910101G, 0020652Z, 0010187Z]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD047349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 AI46781. This work was also supported by American Heart Association Fellowships 0910101G, 0020652Z, and 0010187Z (to D. M., B. S. M., and K. T. B.), respectively.; Supported by National Institutes of Health Pediatric Critical Care Scientist Development Award K12 HD047349.	ALLAND L, 1994, J BIOL CHEM, V269, P16701; BANGS JD, 1993, J CELL SCI, V105, P1101; BARNES DA, 1990, MOL BIOCHEM PARASIT, V41, P101, DOI 10.1016/0166-6851(90)90101-Q; BLOODGOOD RA, 1995, PROTOPLASMA, V185, P123, DOI 10.1007/BF01272852; CHAILLEY B, 1985, J HISTOCHEM CYTOCHEM, V33, P1, DOI 10.1177/33.1.3965567; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; COPPENS I, 1988, P NATL ACAD SCI USA, V85, P6753, DOI 10.1073/pnas.85.18.6753; Denny PW, 2000, J BIOL CHEM, V275, P11017, DOI 10.1074/jbc.275.15.11017; Emmer BT, 2010, J CELL SCI, V123, P529, DOI 10.1242/jcs.062968; Emmer BT, 2009, J CELL SCI, V122, P867, DOI 10.1242/jcs.041764; Furuya T, 2000, J BIOL CHEM, V275, P6428, DOI 10.1074/jbc.275.9.6428; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Godsel L. M, 1997, IMMUNOLOGY MICROBIAL, P180; Godsel LM, 1999, EMBO J, V18, P2057, DOI 10.1093/emboj/18.8.2057; GODSEL LM, 1995, J EUKARYOT MICROBIOL, V42, P320, DOI 10.1111/j.1550-7408.1995.tb01587.x; Gull K, 2003, CURR OPIN MICROBIOL, V6, P365, DOI 10.1016/S1369-5274(03)00092-4; HALLAK H, 1994, J BIOL CHEM, V269, P4571; Hertz-Fowler C, 2001, MOL BIOCHEM PARASIT, V116, P25, DOI 10.1016/S0166-6851(01)00296-1; Kaneshiro E.S., 1990, P241; KANESHIRO ES, 1984, J LIPID RES, V25, P369; KAWULA TH, 1994, J BACTERIOL, V176, P610, DOI 10.1128/jb.176.3.610-619.1994; KAYA K, 1984, J BIOL CHEM, V259, P3548; KIRCHHOFF LV, 1985, JAMA-J AM MED ASSOC, V254, P3058, DOI 10.1001/jama.254.21.3058; Kulkarni MM, 2009, INFECT IMMUN, V77, P2193, DOI 10.1128/IAI.01542-08; Landfear SM, 2001, MOL BIOCHEM PARASIT, V115, P1, DOI 10.1016/S0166-6851(01)00262-6; LIU X, 1992, P NATL ACAD SCI USA, V89, P4991, DOI 10.1073/pnas.89.11.4991; Maldonado RA, 1997, EXP PARASITOL, V86, P200, DOI 10.1006/expr.1997.4159; Maric D, 2010, CURR OPIN MICROBIOL, V13, P466, DOI 10.1016/j.mib.2010.06.001; Maurer-Stroh S, 2002, J MOL BIOL, V317, P523, DOI 10.1006/jmbi.2002.5425; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Mills E, 2007, MOL BIOCHEM PARASIT, V152, P22, DOI 10.1016/j.molbiopara.2006.11.008; MUMBY SM, 1994, P NATL ACAD SCI USA, V91, P2800, DOI 10.1073/pnas.91.7.2800; Okura M, 2005, J BIOL CHEM, V280, P16235, DOI 10.1074/jbc.M414535200; OLSON CL, 1994, J BIOL CHEM, V269, P3868; PAINDAVOINE P, 1992, MOL CELL BIOL, V12, P1218, DOI 10.1128/MCB.12.3.1218; Pazour GJ, 2008, CURR TOP DEV BIOL, V85, P115, DOI 10.1016/S0070-2153(08)00805-3; Porcel BM, 1996, EXP PARASITOL, V84, P387, DOI 10.1006/expr.1996.0127; RESH MD, 1993, BIOCHIM BIOPHYS ACTA, V1155, P307, DOI 10.1016/0304-419X(93)90012-2; ROBBINS SM, 1995, MOL CELL BIOL, V15, P3507; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Seykora JT, 1996, J BIOL CHEM, V271, P18797, DOI 10.1074/jbc.271.31.18797; SHENOYSCARIA AM, 1993, MOL CELL BIOL, V13, P6385, DOI 10.1128/MCB.13.10.6385; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; SIGAL CT, 1994, P NATL ACAD SCI USA, V91, P12253, DOI 10.1073/pnas.91.25.12253; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Snapp EL, 1997, J CELL BIOL, V139, P1775, DOI 10.1083/jcb.139.7.1775; Stegmayer C, 2005, J CELL SCI, V118, P517, DOI 10.1242/jcs.01645; TETLEY L, 1986, ACTA TROP, V43, P307; TIBBETS RS, 1994, INFECT IMMUN, V62, P2499, DOI 10.1128/IAI.62.6.2499-2507.1994; Tobin JL, 2009, GENET MED, V11, P386, DOI 10.1097/GIM.0b013e3181a02882; Tull D, 2004, MOL BIOL CELL, V15, P4775, DOI 10.1091/mbc.E04-06-0457; Tyler KM, 2009, J CELL SCI, V122, P859, DOI 10.1242/jcs.037721; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503; Wingard Jennifer N, 2008, J Biol Chem, V283, P23388, DOI 10.1074/jbc.M803178200; WU YM, 1992, BIOCHEM J, V287, P187, DOI 10.1042/bj2870187; ZHOU WJ, 1994, J VIROL, V68, P2556, DOI 10.1128/JVI.68.4.2556-2569.1994	58	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33109	33117		10.1074/jbc.M111.240895	http://dx.doi.org/10.1074/jbc.M111.240895			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21784841	hybrid, Green Published			2022-12-25	WOS:000294968800029
J	Bulat, N; Jaccard, E; Peltzer, N; Khalil, H; Yang, JY; Dubuis, G; Widmann, C				Bulat, Natasa; Jaccard, Evrim; Peltzer, Nieves; Khalil, Hadi; Yang, Jiang-Yan; Dubuis, Gilles; Widmann, Christian			RasGAP-Derived Fragment N Increases the Resistance of Beta Cells towards Apoptosis in NOD Mice and Delays the Progression from Mild to Overt Diabetes	PLOS ONE			English	Article							KAPPA-B ACTIVATION; ISLET TRANSPLANTATION; EXPRESSION; MOUSE; DEATH; AKT; PROTECTS; CLEAVAGE; REQUIRES; KINASE	The caspase-3-generated RasGAP N-terminal fragment (fragment N) inhibits apoptosis in a Ras-PI3K-Akt-dependent manner. Fragment N protects various cell types, including insulin-secreting cells, against different types of stresses. Whether fragment N exerts a protective role during the development of type 1 diabetes is however not known. Non-obese diabetic (NOD) mice represent a well-known model for spontaneous development of type 1 diabetes that shares similarities with the diseases encountered in humans. To assess the role of fragment N in type 1 diabetes development, a transgene encoding fragment N under the control of the rat insulin promoter (RIP) was back-crossed into the NOD background creating the NOD-RIPN strain. Despite a mosaic expression of fragment N in the beta cell population of NOD-RIPN mice, islets isolated from these mice were more resistant to apoptosis than control NOD islets. Islet lymphocytic infiltration and occurrence of a mild increase in glycemia developed with the same kinetics in both strains. However, the period of time separating the mild increase in glycemia and overt diabetes was significantly longer in NOD-RIPN mice compared to the control NOD mice. There was also a significant decrease in the number of apoptotic beta cells in situ at 16 weeks of age in the NOD-RIPN mice. Fragment N exerts therefore a protective effect on beta cells within the pro-diabetogenic NOD background and this prevents a fast progression from mild to overt diabetes.	[Bulat, Natasa; Jaccard, Evrim; Peltzer, Nieves; Khalil, Hadi; Yang, Jiang-Yan; Dubuis, Gilles; Widmann, Christian] Univ Lausanne, Dept Physiol, Biol & Med Fac, Lausanne, Switzerland	University of Lausanne	Bulat, N (corresponding author), Univ Lausanne, Dept Physiol, Biol & Med Fac, Lausanne, Switzerland.	Christian.Widmann@unil.ch	Peltzer, Nieves/AAI-2831-2020; Widmann, Christian/N-9851-2013	Peltzer, Nieves/0000-0002-4134-5852; Widmann, Christian/0000-0002-6881-0363; Dubuis, Gilles/0000-0003-1036-8514; Khalil, Hadi/0000-0003-3860-5331; Jaccard, MD PhD, Evrim/0000-0002-2179-1257	Chuard-Schmid Foundation in Lausanne, Switzerland; Juvenile Diabetes Research Foundation [1-2006-98]; Swiss National Science Foundation [31003A_119876]	Chuard-Schmid Foundation in Lausanne, Switzerland; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants to C.W. from the Chuard-Schmid Foundation in Lausanne, Switzerland; the Juvenile Diabetes Research Foundation (1-2006-98) and the Swiss National Science Foundation (31003A_119876). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliouachene S, 2008, J CLIN INVEST, V118, P3629, DOI 10.1172/JCI35237; Allison J, 2000, INT IMMUNOL, V12, P9, DOI 10.1093/intimm/12.1.9; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Andre I, 1996, P NATL ACAD SCI USA, V93, P2260, DOI 10.1073/pnas.93.6.2260; Bonvin C, 2002, CELL SIGNAL, V14, P123, DOI 10.1016/S0898-6568(01)00219-4; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Eldor R, 2006, P NATL ACAD SCI USA, V103, P5072, DOI 10.1073/pnas.0508166103; Emamaullee JA, 2007, CELL TRANSPLANT, V16, P1, DOI 10.3727/000000007783464461; Emamaullee JA, 2006, DIABETES, V55, P1907, DOI 10.2337/db05-1254; Giannoukakis N, 2000, J BIOL CHEM, V275, P36509, DOI 10.1074/jbc.M005943200; Kane LP, 2002, MOL CELL BIOL, V22, P5962, DOI 10.1128/MCB.22.16.5962-5974.2002; Liadis N, 2005, MOL CELL BIOL, V25, P3620, DOI 10.1128/MCB.25.9.3620-3629.2005; Makino S, 1980, Jikken Dobutsu, V29, P1; Mandrup-Poulsen T, 2003, BIOCHEM PHARMACOL, V66, P1433, DOI 10.1016/S0006-2952(03)00494-5; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Meier JJ, 2005, DIABETOLOGIA, V48, P2221, DOI 10.1007/s00125-005-1949-2; Michod D, 2007, MOL CANCER RES, V5, P497, DOI 10.1158/1541-7786.MCR-06-0257; Millet I, 2006, J AUTOIMMUN, V26, P7, DOI 10.1016/j.jaut.2005.10.005; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; OBrien BA, 1997, DIABETES, V46, P750, DOI 10.2337/diabetes.46.5.750; Ozes ON, 1999, NATURE, V401, P82; Paraskevas S, 2000, PANCREAS, V20, P270, DOI 10.1097/00006676-200004000-00008; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Turner S, 1999, IMMUNOL CELL BIOL, V77, P236, DOI 10.1046/j.1440-1711.1999.00820.x; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; WICKER LS, 1986, DIABETES, V35, P855, DOI 10.2337/diabetes.35.8.855; Yang JY, 2009, DIABETES, V58, P2596, DOI 10.2337/db09-0104; Yang JY, 2005, J BIOL CHEM, V280, P32835, DOI 10.1074/jbc.M504058200; Yang JY, 2005, MOL BIOL CELL, V16, P3511, DOI 10.1091/mbc.E05-01-0080; Yang JY, 2004, MOL CELL BIOL, V24, P10425, DOI 10.1128/MCB.24.23.10425-10436.2004; Yang JY, 2002, J BIOL CHEM, V277, P14641, DOI 10.1074/jbc.M111540200; Yang JY, 2001, MOL CELL BIOL, V21, P5346, DOI 10.1128/MCB.21.16.5346-5358.2001; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	39	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22609	10.1371/journal.pone.0022609	http://dx.doi.org/10.1371/journal.pone.0022609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799917	Green Submitted, Green Published, gold			2022-12-25	WOS:000293172900058
J	Mbaye, PS; Sarr, A; Sire, JM; Evra, ML; Ba, A; Daveiga, J; Diallo, A; Fall, F; Chartier, L; Simon, F; Vray, M				Mbaye, Papa Saliou; Sarr, Anna; Sire, Jean-Marie; Evra, Marie-Louise; Ba, Adama; Daveiga, Jean; Diallo, Aboubakry; Fall, Fatou; Chartier, Loic; Simon, Francois; Vray, Muriel			Liver Stiffness Measurement and Biochemical Markers in Senegalese Chronic Hepatitis B Patients with Normal ALT and High Viral Load	PLOS ONE			English	Article							BLOOD-TESTS; NONINVASIVE ASSESSMENT; PREDICTIVE MODEL; FIBROSIS; BIOPSY; DIAGNOSIS; ELASTOGRAPHY; PERFORMANCE; ACCURACY; SCORES	Background and Aims: Despite the high prevalence of chronic hepatitis B (CHB) in Africa, few studies have been performed among African patients. We sought to evaluate liver stiffness measurement by FibroScan (R) (LSM) and two biochemical scores (FibroTest (R), Fibrometer (R)) to diagnose liver fibrosis in Senegalese CHB patients with HBV plasma DNA load >= 3.2 log(10) IU/mL and normal alanine aminotransferase (ALT) values. Methods: LSM and liver fibrosis biochemical markers were performed on 225 consecutive HBV infected Senegalese patients with high viral load. Patients with an LSM range between 7 and 13 kPa underwent liver biopsy (LB). Two experienced liver pathologists performed histological grading using Metavir and Ishak scoring. Results: 225 patients were evaluated (84% male) and LB was performed in 69 patients, showing F2 and F3 fibrosis in 17% and 10% respectively. In these patients with a 7-13 kPa range of LSM, accuracy for diagnosis of significant fibrosis according to LB was unsatisfactory for all non-invasive markers with AUROCs below 0.70. For patients with LSM values below 7 kPa, FibroTest (R) (FT), and Fibrometer (R) (FM) using the cut-offs recommended by the test promoters suggested a fibrosis in 18% of cases for FT (8% severe fibrosis) and 8% for FM. For patients with LSM values greater than 13 kPa, FT, FM suggested a possible fibrosis in 73% and 70%, respectively. Conclusion: In highly replicative HBV-infected African patients with normal ALT and LSM value below 13 kPa, FibroScan (R), FibroTest (R) or Fibrometer (R) were unsuitable to predict the histological liver status of fibrosis.	[Mbaye, Papa Saliou; Ba, Adama; Fall, Fatou] Principal Hosp, Dept Gastroenterol & Hepatol, Dakar, Senegal; [Sarr, Anna; Evra, Marie-Louise] Abass Ndao Hosp, Dept Gastroenterol & Hepatol, Dakar, Senegal; [Sire, Jean-Marie; Simon, Francois] Univ Med Paris Diderot, St Louis Hosp, INSERM, U941, Paris, France; [Sire, Jean-Marie] Inst Pasteur, Med Lab, Dakar, Senegal; [Daveiga, Jean] St Jean Dieu Hosp, Dept Gastroenterol & Hepatol, Thies, Senegal; [Diallo, Aboubakry] Grand Yoff Hosp, Dept Gastroenterol & Hepatol, Dakar, Senegal; [Chartier, Loic; Vray, Muriel] Inst Pasteur, INSERM, Epidemiol Unit Infect Dis, F-75724 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Mbaye, PS (corresponding author), Principal Hosp, Dept Gastroenterol & Hepatol, Dakar, Senegal.	vray@pasteur.fr	Vray, Muriel/M-7947-2018		ANRS (National Institute of Research on AIDS and Viral Hepatitis)	ANRS (National Institute of Research on AIDS and Viral Hepatitis)(ANRS)	The ANRS (National Institute of Research on AIDS and Viral Hepatitis) funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, CLIN CHEM, V51, P1867, DOI 10.1373/clinchem.2005.048389; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Bonnard P, 2010, AM J TROP MED HYG, V82, P454, DOI 10.4269/ajtmh.2010.09-0088; Boursier J, 2009, LIVER INT, V29, P1507, DOI 10.1111/j.1478-3231.2009.02101.x; Boursier J, 2009, EUR J GASTROEN HEPAT, V21, P28, DOI 10.1097/MEG.0b013e32830cebd7; Cadranel JF, 2000, HEPATOLOGY, V32, P477, DOI 10.1053/jhep.2000.16602; Cales P, 2005, HEPATOLOGY, V42, P1373, DOI 10.1002/hep.20935; Cales P, 2008, LIVER INT, V28, P1352, DOI 10.1111/j.1478-3231.2008.01789.x; Castera L, 1999, HEPATOLOGY, V30, P1529, DOI 10.1002/hep.510300624; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Castera L, 2009, J VIRAL HEPATITIS, V16, P300, DOI 10.1111/j.1365-2893.2009.01087.x; de Ledinghen V, 2008, GASTROEN CLIN BIOL, V32, pS90, DOI 10.1016/S0399-8320(08)73271-8; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Diallo Sall, 2004, DAKAR MED, V49, P136; Fung J, 2008, LIVER INT, V28, P1408, DOI 10.1111/j.1478-3231.2008.01784.x; Ganne-Carrie N, 2006, J MED VIROL, V78, P335, DOI 10.1002/jmv.20545; Halfon P, 2007, J HEPATOL, V46, P395, DOI 10.1016/j.jhep.2006.09.020; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Lai CL, 2007, J VIRAL HEPATITIS, V14, P6, DOI 10.1111/j.1365-2893.2007.00909.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Leroy V, 2007, J HEPATOL, V46, P775, DOI 10.1016/j.jhep.2006.12.013; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; McMahon Brian J, 2008, Medscape J Med, V10, P91; Nousbaum JB, 2002, GASTROEN CLIN BIOL, V26, P848; Oliveri F, 2008, WORLD J GASTROENTERO, V14, P6154, DOI 10.3748/wjg.14.6154; Poynard T, 2004, CLIN CHEM, V50, P1344, DOI 10.1373/clinchem.2004.032227; Poynard T, 2008, ADV CLIN CHEM, V46, P131, DOI 10.1016/S0065-2423(08)00404-6; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Sebastian G, 2008, J VIRAL HEPATITIS, V15, P212, DOI 10.1111/j.1365-2893.2007.00932.x; Sebastiani G, 2007, WORLD J GASTROENTERO, V13, P525, DOI 10.3748/wjg.v13.i4.525; Vray M, 2006, J MED VIROL, V78, P329, DOI 10.1002/jmv.20544; Wu SD, 2010, WORLD J GASTROENTERO, V16, P501, DOI 10.3748/wjg.v16.i4.501; Zeng MD, 2005, HEPATOLOGY, V42, P1437, DOI 10.1002/hep.20960; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506; 2009, HEPATOLOGY, V50, P1	38	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22291	10.1371/journal.pone.0022291	http://dx.doi.org/10.1371/journal.pone.0022291			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799814	gold, Green Published, Green Submitted			2022-12-25	WOS:000293172900020
J	Poe, JC; Smith, SH; Haas, KM; Yanaba, K; Tsubata, T; Matsushita, T; Tedder, TF				Poe, Jonathan C.; Smith, Susan H.; Haas, Karen M.; Yanaba, Koichi; Tsubata, Takeshi; Matsushita, Takashi; Tedder, Thomas F.			Amplified B Lymphocyte CD40 Signaling Drives Regulatory B10 Cell Expansion in Mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; INDEPENDENT IMMUNE-RESPONSES; HYPER-IGM SYNDROME; T-CELLS; IN-VIVO; INFLAMMATORY RESPONSES; CD22-DEFICIENT MICE; CD40-DEFICIENT MICE; SUPPRESSIVE ROLE; LIGAND	Background: Aberrant CD40 ligand (CD154) expression occurs on both T cells and B cells in human lupus patients, which is suggested to enhance B cell CD40 signaling and play a role in disease pathogenesis. Transgenic mice expressing CD154 by their B cells (CD154(TG)) have an expanded spleen B cell pool and produce autoantibodies (autoAbs). CD22 deficient (CD22(-/-)) mice also produce autoAbs, and importantly, their B cells are hyper-proliferative following CD40 stimulation ex vivo. Combining these 2 genetic alterations in CD154(TG)CD22(-/-) mice was thereby predicted to intensify CD40 signaling and autoimmune disease due to autoreactive B cell expansion and/or activation. Methodology/Principal Findings: CD154(TG)CD22(-/-) mice were assessed for their humoral immune responses and for changes in their endogenous lymphocyte subsets. Remarkably, CD154(TG)CD22(-/-) mice were not autoimmune, but instead generated minimal IgG responses against both self and foreign antigens. This paucity in IgG isotype switching occurred despite an expanded spleen B cell pool, higher serum IgM levels, and augmented ex vivo B cell proliferation. Impaired IgG responses in CD154(TG)CD22(-/-) mice were explained by a 16-fold expansion of functional, mature IL-10-competent regulatory spleen B cells (B10 cells: 26.7x10(6)+/- 6 in CD154(TG)CD22(-/-) mice; 1.7x10(6)+/- 0.4 in wild type mice, p < 0.01), and an 11-fold expansion of B10 cells combined with their ex vivo-matured progenitors (B10+B10pro cells: 66610 663 in CD154(TG)CD22(-/-) mice; 6.1x10(6)+/- 2 in wild type mice, p < 0.01) that represented 39% of all spleen B cells. Conclusions/Significance: These results demonstrate for the first time that the IL-10-producing B10 B cell subset has the capacity to suppress IgG humoral immune responses against both foreign and self antigens. Thereby, therapeutic agents that drive regulatory B10 cell expansion in vivo may inhibit pathogenic IgG autoAb production in humans.	[Poe, Jonathan C.; Smith, Susan H.; Haas, Karen M.; Yanaba, Koichi; Matsushita, Takashi; Tedder, Thomas F.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27706 USA; [Tsubata, Takeshi] Tokyo Med & Dent Univ, Immunol Lab, Grad Sch Biomed Sci, Tokyo, Japan	Duke University; Tokyo Medical & Dental University (TMDU)	Poe, JC (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27706 USA.	thomas.tedder@duke.edu	Tsubata, Takeshi/AAI-7489-2021; Matsushita, Takashi/C-4750-2015	Tsubata, Takeshi/0000-0003-0760-1258; Matsushita, Takashi/0000-0002-1617-086X; Poe, Jonathan/0000-0002-7789-1564	National Institutes of Health [CA96547, AI56363]; NATIONAL CANCER INSTITUTE [R01CA096547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056363] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants CA96547 and AI56363 (to TFT). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; ARUFFO A, 1993, CELL, V72, P291, DOI 10.1016/0092-8674(93)90668-G; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Blossom S, 1997, J IMMUNOL, V159, P4580; Bolduc A, 2010, J IMMUNOL, V185, P220, DOI 10.4049/jimmunol.0901689; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; CASTIGLI E, 1994, P NATL ACAD SCI USA, V91, P12135, DOI 10.1073/pnas.91.25.12135; DesaiMehta A, 1996, J CLIN INVEST, V97, P2063, DOI 10.1172/JCI118643; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; Dullforce P, 1998, NAT MED, V4, P88, DOI 10.1038/nm0198-088; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Erickson LD, 2000, EUR J IMMUNOL, V30, P3121, DOI 10.1002/1521-4141(200011)30:11<3121::AID-IMMU3121>3.0.CO;2-M; Erickson LD, 2002, J CLIN INVEST, V109, P613, DOI 10.1172/JCI200214110; Fang W, 1996, IMMUNITY, V4, P291, DOI 10.1016/S1074-7613(00)80437-9; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Fillatreau S, 2008, NAT REV IMMUNOL, V8, P391, DOI 10.1038/nri2315; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; Grammer AC, 2003, J CLIN INVEST, V112, P1506, DOI 10.1172/JCI200319301; Haas KM, 2006, J IMMUNOL, V177, P3063, DOI 10.4049/jimmunol.177.5.3063; Haas KM, 2010, J IMMUNOL, V184, P4789, DOI 10.4049/jimmunol.0902391; Higuchi T, 2002, J IMMUNOL, V168, P9, DOI 10.4049/jimmunol.168.1.9; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kawamura T, 2004, J IMMUNOL, V172, P6388, DOI 10.4049/jimmunol.172.10.6388; Kishi Y, 2010, J IMMUNOL, V185, P211, DOI 10.4049/jimmunol.0901694; Lund FE, 2008, CURR OPIN IMMUNOL, V20, P332, DOI 10.1016/j.coi.2008.03.003; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Matsushita T, 2010, J IMMUNOL, V185, P2240, DOI 10.4049/jimmunol.1001307; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2008, TRENDS IMMUNOL, V29, P34, DOI 10.1016/j.it.2007.10.004; Mizoguchi A, 1997, J EXP MED, V186, P1749, DOI 10.1084/jem.186.10.1749; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; O'Keefe TL, 1999, J EXP MED, V189, P1307, DOI 10.1084/jem.189.8.1307; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Poe JC, 2000, J BIOL CHEM, V275, P17420, DOI 10.1074/jbc.M001892200; Poe JC, 2004, NAT IMMUNOL, V5, P1078, DOI 10.1038/ni1121; Poe JC, 2004, J IMMUNOL, V172, P2100, DOI 10.4049/jimmunol.172.4.2100; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Serra P, 2006, TRENDS IMMUNOL, V27, P7, DOI 10.1016/j.it.2005.11.003; Smith SH, 2010, INT IMMUNOL, V22, P681, DOI 10.1093/intimm/dxq055; Stout RD, 1996, IMMUNOL TODAY, V17, P487, DOI 10.1016/0167-5699(96)10060-I; TSUBATA T, 1993, NATURE, V364, P645, DOI 10.1038/364645a0; Wagner DH, 2009, DIABETOLOGIA, V52, P997, DOI 10.1007/s00125-009-1357-0; Watanabe R, 2010, J IMMUNOL, V184, P4801, DOI 10.4049/jimmunol.0902385; Wolf SD, 1996, J EXP MED, V184, P2271, DOI 10.1084/jem.184.6.2271; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270	54	57	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22464	10.1371/journal.pone.0022464	http://dx.doi.org/10.1371/journal.pone.0022464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799861	Green Submitted, Green Published, gold			2022-12-25	WOS:000293172900033
J	Svard, M; Biterova, EI; Bourhis, JM; Guy, JE				Svard, Maria; Biterova, Ekaterina I.; Bourhis, Jean-Marie; Guy, Jodie E.			The Crystal Structure of the Human Co-Chaperone P58(IPK)	PLOS ONE			English	Article							INDUCED PROTEIN-KINASE; J-DOMAIN; MOLECULAR CHAPERONE; CELLULAR INHIBITOR; ATPASE ACTIVITY; HSP70; PKR; STIMULATION; BINDING; HSP40	P58(IPK) is one of the endoplasmic reticulum-(ER-) localised DnaJ (ERdj) proteins which interact with the chaperone BiP, the mammalian ER ortholog of Hsp70, and are thought to contribute to the specificity and regulation of its diverse functions. P58(IPK), expression of which is upregulated in response to ER stress, has been suggested to act as a co-chaperone, binding un- or misfolded proteins and delivering them to BiP. In order to give further insights into the functions of P58IPK, and the regulation of BiP by ERdj proteins, we have determined the crystal structure of human P58(IPK) to 3.0 angstrom resolution using a combination of molecular replacement and single wavelength anomalous diffraction. The structure shows the human P58(IPK) monomer to have a very elongated overall shape. In addition to the conserved J domain, P58(IPK) contains nine N-terminal tetratricopeptide repeat motifs, divided into three subdomains of three motifs each. The J domain is attached to the C-terminal end via a flexible linker, and the structure shows the conserved Hsp70-binding histidine-proline-aspartate (HPD) motif to be situated on the very edge of the elongated protein, 100 angstrom from the putative binding site for unfolded protein substrates. The residues that comprise the surface surrounding the HPD motif are highly conserved in P58(IPK) from other organisms but more varied between the human ERdj proteins, supporting the view that their regulation of different BiP functions is facilitated by differences in BiP-binding.	[Svard, Maria; Biterova, Ekaterina I.; Bourhis, Jean-Marie; Guy, Jodie E.] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden	Karolinska Institutet	Svard, M (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	Jodie.Guy@ki.se		Guy, Jodie/0000-0003-0331-0699	Swedish Research Council, Vetenskapsradet; Jeanssons Stiftelser; Stiftelsen Lars Hiertas Minne; Ake Wibergs Stiftelse; Novo Nordisk Foundation; Wenner-Gren Foundations	Swedish Research Council, Vetenskapsradet(Swedish Research Council); Jeanssons Stiftelser; Stiftelsen Lars Hiertas Minne; Ake Wibergs Stiftelse; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Wenner-Gren Foundations	Funding for this study was obtained from the Swedish Research Council, Vetenskapsradet (www.vr.se), Jeanssons Stiftelser (www.jeanssonsstiftelser.se), Stiftelsen Lars Hiertas Minne (www.larshiertasminne.se), Ake Wibergs Stiftelse (www.ake-wiberg.com) and the Novo Nordisk Foundation (www.novonordiskfonden.dk). EIB is supported by a postdoctoral fellowship from the Wenner-Gren Foundations (www.swgc.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Awad W, 2008, P NATL ACAD SCI USA, V105, P1164, DOI 10.1073/pnas.0702132105; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; Gale M, 1998, MOL CELL BIOL, V18, P859, DOI 10.1128/MCB.18.2.859; Gale M, 2002, BIOCHEMISTRY-US, V41, P11878, DOI 10.1021/bi020397e; Gale M, 1996, MOL CELL BIOL, V16, P4172; Genevaux P, 2002, GENETICS, V162, P1045; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Jiang JW, 2003, BIOCHEMISTRY-US, V42, P5748, DOI 10.1021/bi034270g; Jin Y, 2008, EMBO J, V27, P2873, DOI 10.1038/emboj.2008.207; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ladiges WC, 2005, DIABETES, V54, P1074, DOI 10.2337/diabetes.54.4.1074; LEE TG, 1990, P NATL ACAD SCI USA, V87, P6208, DOI 10.1073/pnas.87.16.6208; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Li JZ, 2009, PROTEIN PEPTIDE LETT, V16, P606, DOI 10.2174/092986609788490159; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2007, MOL BIOL CELL, V18, P3681, DOI 10.1091/mbc.e07-03-0272; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Tan SL, 1998, MOL CELL BIOL, V18, P2431, DOI 10.1128/MCB.18.5.2431; Tang NM, 1996, J BIOL CHEM, V271, P28660, DOI 10.1074/jbc.271.45.28660; Tao JH, 2008, ACTA CRYSTALLOGR F, V64, P108, DOI 10.1107/S1744309108000833; Tao JH, 2010, J MOL BIOL, V397, P1307, DOI 10.1016/j.jmb.2010.02.028; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wiseman RL, 2010, CELL, V140, P590, DOI 10.1016/j.cell.2010.02.006; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Yan W, 2002, BIOCHEMISTRY-US, V41, P4938, DOI 10.1021/bi0121499; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec	49	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22337	10.1371/journal.pone.0022337	http://dx.doi.org/10.1371/journal.pone.0022337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799829	Green Published, Green Submitted, gold			2022-12-25	WOS:000293172900023
J	Abrahamyan, A; Clifford, CWG; Ruzzoli, M; Phillips, D; Arabzadeh, E; Harris, JA				Abrahamyan, Arman; Clifford, Colin W. G.; Ruzzoli, Manuela; Phillips, Dan; Arabzadeh, Ehsan; Harris, Justin A.			Accurate and Rapid Estimation of Phosphene Thresholds (REPT)	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN VISUAL-CORTEX; MOTOR THRESHOLD; CORTICAL EXCITABILITY; PSYCHOMETRIC FUNCTION; BRAIN; CONTRAST; DISSOCIATION; DISTANCE; AREA	To calibrate the intensity of transcranial magnetic stimulation (TMS) at the occipital pole, the phosphene threshold is used as a measure of cortical excitability. The phosphene threshold (PT) refers to the intensity of magnetic stimulation that induces illusory flashes of light (phosphenes) on a proportion of trials. The existing PT estimation procedures lack the accuracy and mathematical rigour of modern threshold estimation methods. We present an improved and automatic procedure for estimating the PT which is based on the well-established Psi Bayesian adaptive staircase approach. To validate the new procedure, we compared it with another commonly used procedure for estimating the PT. We found that our procedure is more accurate, reliable, and rapid when compared with an existing PT measurement procedure. The new procedure is implemented in Matlab and works automatically with the Magstim Rapid(2) stimulator using a convenient graphical user interface. The Matlab program is freely available for download.	[Abrahamyan, Arman; Clifford, Colin W. G.; Harris, Justin A.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Ruzzoli, Manuela] IRCCS San Giovanni Dio Fatebenefratelli, Cognit Neurosci Sect, Brescia, Italy; [Phillips, Dan] Magstim Co Ltd, Whitland, Wales; [Arabzadeh, Ehsan] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	University of Sydney; IRCCS Fatebenefratelli; University of New South Wales Sydney	Abrahamyan, A (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	arman.abrahamyan@sydney.edu.au	Abrahamyan, Arman/E-6616-2012; Ruzzoli, Manuela/B-6909-2012	Ruzzoli, Manuela/0000-0002-1719-7140; Phillips, Dan/0000-0003-3252-4602; Arabzadeh, Ehsan/0000-0001-9632-0735; Harris, Justin/0000-0003-3865-8097	Australian Research Council [DP0986137]	Australian Research Council(Australian Research Council)	This research was funded by the Australian Research Council grant DP0986137. Dan Phillips was employed by The Magstim Company Ltd. His contribution to the project was to provide the necessary information about the "computer-to-stimulator" interface for the Magstim Rapid<SUP>2</SUP> stimulator. He also provided guidance in troubleshooting the Rapid<SUP>2</SUP> toolbox. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamyan A, 2011, J NEUROSCI, V31, P3290, DOI 10.1523/JNEUROSCI.6256-10.2011; Anderson AJ, 2006, VISION RES, V46, P2403, DOI 10.1016/j.visres.2006.01.018; Awiszus F, 2003, SUPPL CLIN NEUROPHYS, V56, P13; Awiszus F, 1999, EXP BRAIN RES, V129, P317, DOI 10.1007/s002210050901; Awiszus F, 2011, BRAIN STIMUL, V4, P58, DOI 10.1016/j.brs.2010.09.004; BARKER AT, 1985, LANCET, V1, P1106; BARKER AT, 1985, J PHYSIOL-LONDON, V369, pP3; Bestmann S, 2007, CURR BIOL, V17, P134, DOI 10.1016/j.cub.2006.11.063; Borckardt JJ, 2010, BRAIN STIMU IN PRESS; Boroojerdi B, 2000, CEREB CORTEX, V10, P529, DOI 10.1093/cercor/10.5.529; Boroojerdi B, 2002, CLIN NEUROPHYSIOL, V113, P1501, DOI 10.1016/S1388-2457(02)00198-0; CHAUDHRY V, 1991, ANN NEUROL, V30, P841, DOI 10.1002/ana.410300614; Deblieck C, 2008, HUM BRAIN MAPP, V29, P662, DOI 10.1002/hbm.20427; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Fernandez E, 2002, BRAIN RES PROTOC, V10, P115, DOI 10.1016/S1385-299X(02)00189-7; Fuggetta G, 2005, NEUROIMAGE, V27, P896, DOI 10.1016/j.neuroimage.2005.05.013; Gerwig M, 2003, J NEUROL SCI, V215, P75, DOI 10.1016/S0022-510X(03)00228-4; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Harris JA, 2008, J COGNITIVE NEUROSCI, V20, P734, DOI 10.1162/jocn.2008.20048; Kaelin-Lang A, 2000, J NEUROSCI METH, V102, P81, DOI 10.1016/S0165-0270(00)00284-3; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P2015, DOI 10.1016/S1388-2457(01)00673-3; Kammer T, 2002, EXP BRAIN RES, V145, P407, DOI 10.1007/s00221-002-1160-3; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P250, DOI 10.1016/S1388-2457(00)00513-7; Kingdom F, 2009, PALAMEDES MATLAB ROU; Kontsevich LL, 1999, VISION RES, V39, P2729, DOI 10.1016/S0042-6989(98)00285-5; MARG E, 1994, OPTOMETRY VISION SCI, V71, P301, DOI 10.1097/00006324-199405000-00001; MEYER BU, 1991, ELECTROEN CLIN NEURO, P121; NACHMIAS J, 1981, VISION RES, V21, P215, DOI 10.1016/0042-6989(81)90115-2; O'Shea J, 2004, J COGNITIVE NEUROSCI, V16, P1060, DOI 10.1162/0898929041502634; O'Shea J, 2007, CURR BIOL, V17, pR196, DOI 10.1016/j.cub.2007.01.030; Pitcher D, 2009, CURR BIOL, V19, P319, DOI 10.1016/j.cub.2009.01.007; Qi F, 2011, BRAIN STIMUL, V4, P50, DOI 10.1016/j.brs.2010.06.002; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; Rauschecker AM, 2004, EXP BRAIN RES, V157, P124, DOI 10.1007/s00221-004-1910-5; Remus JJ, 2007, PERCEPT PSYCHOPHYS, V69, P311, DOI 10.3758/BF03193752; Robertson EM, 2003, J COGNITIVE NEUROSCI, V15, P948, DOI 10.1162/089892903770007344; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rothwell J C, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P97; Ruzzoli M, 2011, J NEUROPHYS IN PRESS; Sandrini M, 2011, NEUROSCI BIOBEHAV R, V35, P516, DOI 10.1016/j.neubiorev.2010.06.005; Silvanto J, 2005, CEREB CORTEX, V15, P1736, DOI 10.1093/cercor/bhi050; Silvanto J, 2008, J NEUROPHYSIOL, V99, P2725, DOI 10.1152/jn.01392.2007; Sinclair C, 2006, J NEUROSCI METH, V158, P133, DOI 10.1016/j.jneumeth.2006.05.021; Stewart LM, 2001, NEUROPSYCHOLOGIA, V39, P415, DOI 10.1016/S0028-3932(00)00130-5; Stokes MG, 2007, CLIN NEUROPHYSIOL, V118, P1617, DOI 10.1016/j.clinph.2007.04.004; Stokes MG, 2005, J NEUROPHYSIOL, V94, P4520, DOI 10.1152/jn.00067.2005; Tranulis C, 2006, NEUROPHYSIOL CLIN, V36, P1, DOI 10.1016/j.neucli.2006.01.005; Treutwein B, 1995, VISION RES; TYRRELL RA, 1988, BEHAV RES METH INSTR, V20, P137, DOI 10.3758/BF03203817; UENO S, 1988, J APPL PHYS, V64, P5862, DOI 10.1063/1.342181; Wagner T, 2009, CORTEX, V45, P1025, DOI 10.1016/j.cortex.2008.10.002; Walsh V, 1998, P ROY SOC B-BIOL SCI, V265, P537, DOI 10.1098/rspb.1998.0328; Wassermann E., 2008, OXFORD HDB TRANSCRAN; Wassermann EM, 2002, CLIN NEUROPHYSIOL, V113, P1165, DOI 10.1016/S1388-2457(02)00144-X; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544	59	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22342	10.1371/journal.pone.0022342	http://dx.doi.org/10.1371/journal.pone.0022342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799833	gold, Green Accepted, Green Published			2022-12-25	WOS:000293097300037
J	Yong, MH; Fook-Chong, S; Pavanni, R; Lim, LL; Tan, EK				Yong, Ming-Hui; Fook-Chong, Stephanie; Pavanni, Ratnagopal; Lim, Li-Ling; Tan, Eng-King			Case Control Polysomnographic Studies of Sleep Disorders in Parkinson's Disease	PLOS ONE			English	Article							EXCESSIVE DAYTIME SLEEPINESS; RESTLESS LEGS SYNDROME; PRACTICE PARAMETERS; NONMOTOR SYMPTOMS; APNEA; DISTURBANCES; MANAGEMENT; LEVODOPA; GENETICS; RISK	Background: The relationship between a number of primary sleep disorders and Parkinson's disease (PD) is still debated. There are limited case control polysomnographic studies in PD and most of these study sample sizes are small. Methodology/Findings: We conducted one of the largest case-control studies involving overnight polysomnographic evaluation, with prospective recruitment of unselected Parkinson's disease patients and healthy controls from an Asian population. The cases were recruited from the specialized movement disorder outpatient clinics in a tertiary referral center, and controls from the same geographical locations. All subjects underwent an overnight polysomnographic study and a multiple sleep latency test. A total of 124 subjects including 56 patients and 68 controls frequency-matched for age and sex were included. Multivariate analysis revealed that patients had significantly shorter total sleep time than controls (p = 0.01), lower sleep efficiency (p = 0.001) and increased REM latency (p = 0.007). In patients, multivariate analysis showed that reduced total sleep time was significantly associated with increased age (p = 0.001) and increased levodopa dose (p = 0.032). The mean Insomnia Severity Index was higher in PD patients (9.0 +/- 7.1) compared to controls (3.3 +/- 3.9, p<0.001). The mean Epworth Sleepiness Scale score was higher in PD patients (9.3 +/- 5.9 vs. 5.7 +/- 4.8, p<0.001). Nocturnal arousals, obstructive sleep apnea, periodic leg movements and objective abnormal sleepiness were not increased in our patients. Conclusions/Significance: Our case-control polysomnographic study, the first-ever performed in an Asian population, revealed altered sleep architecture and reduced sleep in PD patients compared to controls. Reduced total sleep time was associated with increased age and levodopa dose. However, nocturnal arousals, primary sleep disorders and abnormal sleepiness were not increased in our PD patients suggesting that ethnic/genetic differences may be a factor in the pathophysiology of these conditions.	[Yong, Ming-Hui; Pavanni, Ratnagopal; Lim, Li-Ling; Tan, Eng-King] Natl Inst Neurosci, Dept Neurol, Singapore, Singapore; [Fook-Chong, Stephanie] Singapore Gen Hosp, Dept Clin Res, Singapore 0316, Singapore; [Yong, Ming-Hui; Pavanni, Ratnagopal; Tan, Eng-King] Duke NUS Grad Med Sch, Singapore, Singapore	National Neuroscience Institute (NNI); Singapore General Hospital; National University of Singapore	Yong, MH (corresponding author), Natl Inst Neurosci, Dept Neurol, Singapore, Singapore.	gnrtek@sgh.com.sg			National Medical Research Council; Duke-NUS Graduate Medical School; Singapore General Hospital; National Neuroscience Institute	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Duke-NUS Graduate Medical School(National University of Singapore); Singapore General Hospital; National Neuroscience Institute	The study was supported by a National Medical Research Council Grant, Duke-NUS Graduate Medical School, Singapore General Hospital, National Neuroscience Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; ARMITAGE R, 2005, PRINCIPLES PRACTICE, P1266; Arnulf I, 2002, NEUROLOGY, V58, P1019, DOI 10.1212/WNL.58.7.1019; Arnulf I, 2009, PARKINSONISM RELAT D, V15, pS101, DOI 10.1016/S1353-8020(09)70792-8; Barone P, 2004, NEUROLOGY, V63, pS35, DOI 10.1212/WNL.63.8_suppl_3.S35; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; COMELLA CL, 1993, ANN NEUROL, V34, P710, DOI 10.1002/ana.410340514; De Cock VC, 2010, SLEEP MED, V11, P247, DOI 10.1016/j.sleep.2009.05.008; Dhawan V, 2006, AGE AGEING, V35, P220, DOI 10.1093/ageing/afj087; Diederich NJ, 2009, ACTA NEUROL SCAND, V120, P308, DOI 10.1111/j.1600-0404.2009.01167.x; Diederich NJ, 2005, SLEEP MED, V6, P313, DOI 10.1016/j.sleep.2005.03.011; Diederich NJ, 2005, MOVEMENT DISORD, V20, P1413, DOI 10.1002/mds.20624; Eisensehr I, 2001, J NEUROL SCI, V186, P7, DOI 10.1016/S0022-510X(01)00480-4; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Happe S, 2005, J NEUROL, V252, P936, DOI 10.1007/s00415-005-0785-0; Kent BD, 2010, CURR OPIN PULM MED, V16, P536, DOI 10.1097/MCP.0b013e32833ef7fe; Korczyn AD, 2006, J NEUROL SCI, V248, P163, DOI 10.1016/j.jns.2006.05.041; Kushida CA, 2005, SLEEP, V28, P499, DOI 10.1093/sleep/28.4.499; Littner M, 2003, SLEEP, V26, P754, DOI 10.1093/sleep/26.6.754; Littner MR, 2005, SLEEP, V28, P113, DOI 10.1093/sleep/28.1.113; Maria B, 2003, RESP MED, V97, P1151, DOI 10.1016/S0954-6111(03)00188-4; Menza M, 2010, MOVEMENT DISORD, V25, pS117, DOI 10.1002/mds.22788; Mitra T, 2009, PARKINSONISM RELAT D, V15, pS93, DOI 10.1016/S1353-8020(09)70790-4; Poryazova R, 2010, EUR NEUROL, V63, P129, DOI 10.1159/000276402; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Rye DB, 2000, J SLEEP RES, V9, P63, DOI 10.1046/j.1365-2869.2000.00201.x; Shpirer I, 2006, MOVEMENT DISORD, V21, P1432, DOI 10.1002/mds.21002; Stefansson H, 2007, NEW ENGL J MED, V357, P639, DOI 10.1056/NEJMoa072743; Stocchi F, 1998, J NEUROL, V245, pS15, DOI 10.1007/PL00007731; Taheri S, 2002, LANCET NEUROL, V1, P242, DOI 10.1016/S1474-4422(02)00103-5; Tan EK, 2001, MOVEMENT DISORD, V16, P577, DOI 10.1002/mds.1102; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Trotti LM, 2010, MOVEMENT DISORD, V25, P2246, DOI 10.1002/mds.23231; Wailke S, 2011, EUR J NEUROL, V18, P590, DOI 10.1111/j.1468-1331.2010.03213.x; Wetter TC, 2001, WIEN KLIN WOCHENSCHR, V113, P249; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099; Zoccolella S, 2011, SLEEP MED REV, V15, P41, DOI 10.1016/j.smrv.2010.02.004	38	82	90	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22511	10.1371/journal.pone.0022511	http://dx.doi.org/10.1371/journal.pone.0022511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799880	Green Published, gold, Green Submitted			2022-12-25	WOS:000293097300057
J	Supek, F; Bosnjak, M; Skunca, N; Smuc, T				Supek, Fran; Bosnjak, Matko; Skunca, Nives; Smuc, Tomislav			REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms	PLOS ONE			English	Article							EXPRESSION DATA; TOOL; OVERREPRESENTATION; INTEGRATION; ANNOTATION; ENRICHMENT	Outcomes of high-throughput biological experiments are typically interpreted by statistical testing for enriched gene functional categories defined by the Gene Ontology (GO). The resulting lists of GO terms may be large and highly redundant, and thus difficult to interpret. REVIGO is a Web server that summarizes long, unintelligible lists of GO terms by finding a representative subset of the terms using a simple clustering algorithm that relies on semantic similarity measures. Furthermore, REVIGO visualizes this non-redundant GO term set in multiple ways to assist in interpretation: multidimensional scaling and graph-based visualizations accurately render the subdivisions and the semantic relationships in the data, while treemaps and tag clouds are also offered as alternative views. REVIGO is freely available at http://revigo.irb.hr/.	[Supek, Fran; Bosnjak, Matko; Skunca, Nives; Smuc, Tomislav] Rudjer Boskovic Inst, Div Elect, Zagreb, Croatia; [Supek, Fran] CRG, Bioinformat & Genom Programme, Barcelona, Spain; [Supek, Fran] UPF, Barcelona, Spain	Rudjer Boskovic Institute; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University	Supek, F (corresponding author), Rudjer Boskovic Inst, Div Elect, Zagreb, Croatia.	fran.supek@irb.hr	Supek, Fran/B-2359-2012	Supek, Fran/0000-0002-7811-6711; Smuc, Tomislav/0000-0002-9185-9384	Ministry of Science, Education, and Sport of Croatia [2008-057]; Marie Curie Actions;  [098-0000000-3168]	Ministry of Science, Education, and Sport of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Marie Curie Actions(European Commission); 	This work was supported by grant 098-0000000-3168 and by iProject 2008-057 of the Ministry of Science, Education, and Sport of Croatia. FS was co-funded by Marie Curie Actions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Bauer S, 2010, NUCLEIC ACIDS RES, V38, P3523, DOI 10.1093/nar/gkq045; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Ester K, 2012, INVEST NEW DRUG, V30, P450, DOI 10.1007/s10637-010-9571-7; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; Herrmann C, 2009, BIOINFORMATICS, V25, P3197, DOI 10.1093/bioinformatics/btp553; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Newman JC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r81; Nowick K, 2010, MOL BIOL EVOL, V27, P2606, DOI 10.1093/molbev/msq157; Pehkonen P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-162; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Pich C, 2009, MDSJ JAVA LIB MULTID; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schlicker A, 2008, NUCLEIC ACIDS RES, V36, pD434, DOI 10.1093/nar/gkm806; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Supek F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001004; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Zeeberg BR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-52; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168	26	3315	3339	1	147	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e21800	10.1371/journal.pone.0021800	http://dx.doi.org/10.1371/journal.pone.0021800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789182	gold, Green Published			2022-12-25	WOS:000292812400016
J	Fernandez-Mazuecos, M; Vargas, P				Fernandez-Mazuecos, Mario; Vargas, Pablo			Historical Isolation versus Recent Long-Distance Connections between Europe and Africa in Bifid Toadflaxes (Linaria sect. Versicolores)	PLOS ONE			English	Article							DISPERSAL-VICARIANCE ANALYSIS; DNA-SEQUENCES; CHLOROPLAST DNA; PHYLOGEOGRAPHICAL VARIATION; COLONIZATION HISTORY; BAYESIAN-APPROACH; GEOGRAPHIC RANGE; PLASTID DNA; BIOGEOGRAPHY; EVOLUTION	Background: Due to its complex, dynamic and well-known paleogeography, the Mediterranean region provides an ideal framework to study the colonization history of plant lineages. The genus Linaria has its diversity centre in the Mediterranean region, both in Europe and Africa. The last land connection between both continental plates occurred during the Messinian Salinity Crisis, in the late Miocene (5.96 to 5.33 Ma). Methodology/Principal Findings: We analyzed the colonization history of Linaria sect. Versicolores (bifid toadflaxes), which includes c. 22 species distributed across the Mediterranean, including Europe and Africa. Two cpDNA regions (rpl32-trnL(UAG) and trnK-matK) were sequenced from 66 samples of Linaria. We conducted phylogenetic, dating, biogeographic and phylogeographic analyses to reconstruct colonization patterns in space and time. Four major clades were found: two of them exclusively contain Iberian samples, while the other two include northern African samples together with some European samples. The bifid toadflaxes have been split in African and European clades since the late Miocene, and most lineage and speciation differentiation occurred during the Pliocene and Quaternary. We have strongly inferred four events of post-Messinian colonization following long-distance dispersal from northern Africa to the Iberian Peninsula, Sicily and Greece. Conclusions/Significance: The current distribution of Linaria sect. Versicolores lineages is explained by both ancient isolation between African and European populations and recent events of long-distance dispersal over sea barriers. This result provides new evidence for the biogeographic complexity of the Mediterranean region.	[Fernandez-Mazuecos, Mario; Vargas, Pablo] CSIC, Real Jardin Bot, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Fernandez-Mazuecos, M (corresponding author), CSIC, Real Jardin Bot, Madrid, Spain.	mfmazuecos@rjb.csic.es	Fernández-Mazuecos, Mario/F-9699-2011	Fernández-Mazuecos, Mario/0000-0003-4027-6477	Spanish Ministerio de Ciencia e Innovacion [CGL2009-10031]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This research has no specific funding for result publication. However, the research has been supported by the Spanish Ministerio de Ciencia e Innovacion (www.micinn.es) through project CGL2009-10031 and a PhD scholarship to MFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arafeh R, 2006, J BIOGEOGR, V33, P1461, DOI 10.1111/j.1365-2699.2006.01512.x; Besnard G, 2009, ANN BOT-LONDON, V104, P143, DOI 10.1093/aob/mcp105; BOCQUET G, 1978, Candollea, V33, P269; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Buerki S, 2011, J BIOGEOGR, V38, P531, DOI 10.1111/j.1365-2699.2010.02432.x; Burban C, 2003, MOL ECOL, V12, P1487, DOI 10.1046/j.1365-294X.2003.01817.x; CALL VB, 1992, REV PALAEOBOT PALYNO, V74, P249, DOI 10.1016/0034-6667(92)90010-E; Cano-Maqueda J, 2008, TAXON, V57, P1252, DOI 10.1002/tax.574016; Caujape-Castells J, 2003, MOL ECOL, V12, P1515, DOI 10.1046/j.1365-294X.2003.01839.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Comes Hans Peter, 2004, New Phytol, V164, P11, DOI 10.1111/j.1469-8137.2004.01194.x; CONTANDRIOPOULOS J, 1975, Candollea, V30, P293; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Drummond A.J, 2010, GENEIOUS, V5, P3; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Escudero M, 2010, MOL ECOL, V19, P352, DOI 10.1111/j.1365-294X.2009.04449.x; Escudero M, 2008, AM J BOT, V95, P745, DOI 10.3732/ajb.2007342; Fernandez-Mazuecos M, 2010, MOL ECOL, V19, P1381, DOI 10.1111/j.1365-294X.2010.04549.x; Font M, 2009, ANN BOT-LONDON, V103, P985, DOI 10.1093/aob/mcp022; Garrick RC, 2009, MOL ECOL, V18, P1916, DOI 10.1111/j.1365-294X.2009.04148.x; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Goloboff P.A., 2003, TREE ANAL USING NEW; Gomiz Garcia Francisco, 2004, Anales del Jardin Botanico de Madrid, V61, P205; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GULLON ES, 2006, LAGASCALIA, V26, P187; Guzman B, 2009, J BIOGEOGR, V36, P954, DOI 10.1111/j.1365-2699.2008.02040.x; Harris AJ, 2009, J SYST EVOL, V47, P349, DOI 10.1111/j.1759-6831.2009.00044.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaramillo-Correa JP, 2010, MOL ECOL, V19, P5452, DOI 10.1111/j.1365-294X.2010.04912.x; JOHNSON LA, 1994, SYST BOT, V19, P143, DOI 10.2307/2419718; Jolivet L, 2006, SEDIMENT GEOL, V188, P9, DOI 10.1016/j.sedgeo.2006.02.004; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kodandaramaiah U, 2010, J BIOGEOGR, V37, P3, DOI 10.1111/j.1365-2699.2009.02221.x; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Lamm KS, 2009, J SYST EVOL, V47, P369, DOI 10.1111/j.1759-6831.2009.00042.x; LANCUCKA-SRODONIOWA M, 1977, Acta Palaeobotanica, V18, P37; Lo Presti RM, 2009, J BIOGEOGR, V36, P1313, DOI 10.1111/j.1365-2699.2009.02121.x; LOPRESTI RM, 2011, J BIOGEOGR, DOI DOI 10.1111/J.1365-2699.2010.02464.X; Lumaret R, 2005, ANN BOT-LONDON, V96, P853, DOI 10.1093/aob/mci237; Lumaret R, 2002, MOL ECOL, V11, P2327, DOI 10.1046/j.1365-294X.2002.01611.x; Mansion G, 2008, SYST BIOL, V57, P269, DOI 10.1080/10635150802044029; Mansion G, 2009, J BIOGEOGR, V36, P1282, DOI 10.1111/j.1365-2699.2009.02082.x; Martinez-Millan M, 2010, BOT REV, V76, P83, DOI 10.1007/s12229-010-9040-1; NAGY ESTHER, 1963, ACTA BOT ACAD SCI HUNG, V9, P387; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Oberprieler C, 2005, TAXON, V54, P951, DOI 10.2307/25065480; Petit RJ, 2005, TAXON, V54, P877, DOI 10.2307/25065474; Pineiro R, 2007, MOL ECOL, V16, P2155, DOI 10.1111/j.1365-294X.2007.03280.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Mijarra JMP, 2009, J BIOGEOGR, V36, P2025, DOI 10.1111/j.1365-2699.2009.02142.x; QUEIROZ A, 2005, TRENDS ECOL EVOL, V20, P68, DOI DOI 10.1016/J.TREE.2004.11.006; Rambaut A., 2007, TRACER VER 1 4; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ree RH, 2009, J BIOGEOGR, V36, P1211, DOI 10.1111/j.1365-2699.2008.02068.x; Reid E. M., 1926, CATALOGUE CAINOZOIC, V1; Rodriguez-Sanchez F, 2008, QUATERNARY SCI REV, V27, P2100, DOI 10.1016/j.quascirev.2008.08.006; Rodriguez-Sanchez F, 2009, J BIOGEOGR, V36, P1270, DOI 10.1111/j.1365-2699.2009.02091.x; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Roquet C, 2009, MOL PHYLOGENET EVOL, V52, P575, DOI 10.1016/j.ympev.2009.05.014; Saez L, 2009, FLORA IBERICA, V13, P232; Salvo G, 2010, SYST BIOL, V59, P705, DOI 10.1093/sysbio/syq046; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Schaal BA, 1998, MOL ECOL, V7, P465, DOI 10.1046/j.1365-294x.1998.00318.x; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Stock M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-56; SUC JP, 1984, NATURE, V307, P429, DOI 10.1038/307429a0; Sutton D. A., 1988, REVISION TRIBE ANTIR; Tan K., 2001, ENDEMIC PLANTS GREEC; TEMPLETON AR, 1992, GENETICS, V132, P619; Terrab A, 2007, TAXON, V56, P409, DOI 10.1002/tax.562012; THIEDE J, 1978, NATURE, V276, P680, DOI 10.1038/276680a0; Thiv M, 2010, MOL PHYLOGENET EVOL, V54, P607, DOI 10.1016/j.ympev.2009.10.009; Thompson JD, 1999, HEREDITY, V82, P229, DOI 10.1038/sj.hdy.6885040; VALDES B, 1986, Lagascalia, V14, P157; Valdes B, 2002, CHECKLIST VASCULAR P; Valente LM, 2011, GLOBAL ECOL BIOGEOGR, V20, P881, DOI 10.1111/j.1466-8238.2010.00644.x; Vargas P, 2004, PLANT SYST EVOL, V249, P151, DOI 10.1007/s00606-004-0216-1; Vargas P, 1999, AM J BOT, V86, P724, DOI 10.2307/2656582; VIANO J, 1978, Candollea, V33, P209; Viano J, 1978, CANDOLLEA, V33, P33; VIANO J, 1969, WILLD NATURALIA MO B, V20, P219; Vicioso, 1946, ANAL JAR BOT MADRID, V6, P5; Yesson C, 2009, J BIOGEOGR, V36, P1234, DOI 10.1111/j.1365-2699.2008.01971.x; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011	88	50	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22234	10.1371/journal.pone.0022234	http://dx.doi.org/10.1371/journal.pone.0022234			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779399	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811300053
J	Nies, AT; Hofmann, U; Resch, C; Schaeffeler, E; Rius, M; Schwab, M				Nies, Anne T.; Hofmann, Ute; Resch, Claudia; Schaeffeler, Elke; Rius, Maria; Schwab, Matthias			Proton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs)	PLOS ONE			English	Article							CISPLATIN-INDUCED NEPHROTOXICITY; GENETIC-VARIATION; DIABETES-MELLITUS; PHARMACOKINETICS; BINDING; OMEPRAZOLE; EXPRESSION; HOCT1; PHARMACOPHORES; LANSOPRAZOLE	Metformin, an oral insulin-sensitizing drug, is actively transported into cells by organic cation transporters (OCT) 1, 2, and 3 (encoded by SLC22A1, SLC22A2, or SLC22A3), which are tissue specifically expressed at significant levels in various organs such as liver, muscle, and kidney. Because metformin does not undergo hepatic metabolism, drug-drug interaction by inhibition of OCT transporters may be important. So far, comprehensive data on the interaction of proton pump inhibitors (PPIs) with OCTs are missing although PPIs are frequently used in metformin-treated patients. Using in silico modeling and computational analyses, we derived pharmacophore models indicating that PPIs (i.e. omeprazole, pantoprazole, lansoprazole, rabeprazole, and tenatoprazole) are potent OCT inhibitors. We then established stably transfected cell lines expressing the human uptake transporters OCT1, OCT2, or OCT3 and tested whether these PPIs inhibit OCT-mediated metformin uptake in vitro. All tested PPIs significantly inhibited metformin uptake by OCT1, OCT2, and OCT3 in a concentration-dependent manner. Half-maximal inhibitory concentration values (IC50) were in the low micromolar range (3-36 mu M) and thereby in the range of IC50 values of other potent OCT drug inhibitors. Finally, we tested whether the PPIs are also transported by OCTs, but did not identify PPIs as OCT substrates. In conclusion, PPIs are potent inhibitors of the OCT-mediated metformin transport in vitro. Further studies are needed to elucidate the clinical relevance of this drug-drug interaction with potential consequences on metformin disposition and/or efficacy.	[Nies, Anne T.; Hofmann, Ute; Resch, Claudia; Schaeffeler, Elke; Schwab, Matthias] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany; [Nies, Anne T.; Hofmann, Ute; Resch, Claudia; Schaeffeler, Elke] Univ Tubingen, Tubingen, Germany; [Rius, Maria] German Canc Res Ctr, Div Epigenet, D-6900 Heidelberg, Germany; [Schwab, Matthias] Univ Hosp, Inst Expt & Clin Pharmacol & Toxicol, Dept Clin Pharmacol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Nies, AT (corresponding author), Dr Margarete Fischer Bosch Inst Clin Pharmacol, Auerbachstr 112, D-7000 Stuttgart, Germany.	anne.nies@ikp-stuttgart.de	Schwab, Matthias/ABH-7449-2020; Nies, Anne T./D-7923-2016	Nies, Anne T./0000-0001-6862-0730; Hofmann, Ute/0000-0003-0823-9027	Robert Bosch Foundation (Stuttgart, Germany); Federal Ministry for Education and Research (BMBF, Berlin, Germany) [03IS2061C, 0315755]; EU [PITN-GA-2009-238132]	Robert Bosch Foundation (Stuttgart, Germany); Federal Ministry for Education and Research (BMBF, Berlin, Germany)(Federal Ministry of Education & Research (BMBF)); EU(European Commission)	This work was supported by the Robert Bosch Foundation (Stuttgart, Germany) and from grants by the Federal Ministry for Education and Research (BMBF, Berlin, Germany; 03IS2061C and 0315755) and the 7FP EU Initial Training Network program "FightingDrugFailure" (PITN-GA-2009-238132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlin G, 2011, PHARMACOGENOMICS J, V11, P400, DOI 10.1038/tpj.2010.54; Ahlin G, 2008, J MED CHEM, V51, P5932, DOI 10.1021/jm8003152; Bachmakov I, 2009, DIABETES OBES METAB, V11, P1080, DOI 10.1111/j.1463-1326.2009.01076.x; Bachmakov L, 2008, DIABETES, V57, P1463, DOI 10.2337/db07-1515; Becker ML, 2009, PHARMACOGENOMICS J, V9, P242, DOI 10.1038/tpj.2009.15; Bednarczyk D, 2003, MOL PHARMACOL, V63, P489, DOI 10.1124/mol.63.3.489; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; Charlton J, 2008, DIABETES CARE, V31, P1761, DOI 10.2337/dc08-0137; Chen LG, 2010, PHARMACOGENET GENOM, V20, P687, DOI 10.1097/FPC.0b013e32833fe789; Ciarimboli G, 2005, AM J PATHOL, V167, P1477, DOI 10.1016/S0002-9440(10)61234-5; Ciarimboli G, 2010, AM J PATHOL, V176, P1169, DOI 10.2353/ajpath.2010.090610; Ertl P, 2000, J MED CHEM, V43, P3714, DOI 10.1021/jm000942e; Ferguson DD, 2007, EXPERT OPIN PHARMACO, V8, P39, DOI 10.1517/14656566.8.1.39; Filion KB, 2009, PHARMACOEPIDEM DR S, V18, P973, DOI 10.1002/pds.1802; Freston JW, 2003, ALIMENT PHARM THER, V17, P361, DOI 10.1046/j.1365-2036.2003.01455.x; Fujiwara Y, 2009, J GASTROENTEROL, V44, P518, DOI 10.1007/s00535-009-0047-5; Gorboulev V, 1997, DNA CELL BIOL, V16, P871, DOI 10.1089/dna.1997.16.871; HERMANN LS, 1994, DIABETES CARE, V17, P1100, DOI 10.2337/diacare.17.10.1100; Hofmann U, 2006, J CHROMATOGR B, V831, P85, DOI 10.1016/j.jchromb.2005.11.036; Ito K, 2002, AAPS PHARMSCI, V4, DOI 10.1208/ps040425; Katsuda H, 2010, BIOL PHARM BULL, V33, P1867, DOI 10.1248/bpb.33.1867; Kerb R, 2010, ENZYME- AND TRANSPORTER-BASED DRUG-DRUG INTERACTIONS: PROGRESS AND FUTURE CHALLENGES, P51, DOI 10.1007/978-1-4419-0840-7_3; Kimura N, 2005, PHARM RES-DORDR, V22, P255, DOI 10.1007/s11095-004-1193-3; Kimura Naoko, 2005, Drug Metab Pharmacokinet, V20, P379, DOI 10.2133/dmpk.20.379; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Lub R, 2006, BRIT J CLIN PHARMACO, V62, P660, DOI 10.1111/j.1365-2125.2006.02711.x; Moreno-Navarrete JM, 2011, DIABETES, V60, P168, DOI 10.2337/db10-0805; Minuesa G, 2009, J PHARMACOL EXP THER, V329, P252, DOI 10.1124/jpet.108.146225; Moaddel R, 2007, BRIT J PHARMACOL, V151, P1305, DOI 10.1038/sj.bjp.0707341; Moaddel R, 2005, CHIRALITY, V17, P501, DOI 10.1002/chir.20195; Motohashi H, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134866; Nies AT, 2008, N-S ARCH PHARMACOL, V376, P449, DOI 10.1007/s00210-007-0219-x; Nies AT, 2011, HANDB EXP PHARMACOL, V201, P105, DOI 10.1007/978-3-642-14541-4_3; Nies AT, 2009, HEPATOLOGY, V50, P1227, DOI 10.1002/hep.23103; Pauli-Magnus C, 2001, N-S ARCH PHARMACOL, V364, P551, DOI 10.1007/s00210-001-0489-7; PENTIKAINEN PJ, 1979, EUR J CLIN PHARMACOL, V16, P195, DOI 10.1007/BF00562061; PUE MA, 1993, EUR J CLIN PHARMACOL, V44, P575, DOI 10.1007/BF02440862; REGARDH CG, 1990, THER DRUG MONIT, V12, P163, DOI 10.1097/00007691-199003000-00010; Royc KS, 2007, ADV THER, V24, P803, DOI 10.1007/BF02849973; Schwabedissen HEMZ, 2010, AM J PHYSIOL-RENAL, V298, pF997, DOI 10.1152/ajprenal.00431.2009; Sellin JH, 2008, NAT CLIN PRACT GASTR, V5, P162, DOI 10.1038/ncpgasthep1054; Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; SIRTORI CR, 1978, CLIN PHARMACOL THER, V24, P683; SLEIJFER DT, 1987, CANCER, V60, P2823; Suhre WM, 2005, MOL PHARMACOL, V67, P1067, DOI 10.1124/mol.104.004713; Thomson ABR, 2006, ALIMENT PHARM THER, V23, P1179, DOI 10.1111/j.1365-2036.2006.02781.x; Urakami Y, 1998, J PHARMACOL EXP THER, V287, P800; Wang DS, 2002, J PHARMACOL EXP THER, V302, P510, DOI 10.1124/jpet.102.034140; Wang RX, 1997, J CHEM INF COMP SCI, V37, P615, DOI 10.1021/ci960169p; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Wolber G, 2006, J COMPUT AID MOL DES, V20, P773, DOI 10.1007/s10822-006-9078-7; YASUDA S, 1994, INT J CLIN PHARM TH, V32, P466; Yonezawa A, 2006, J PHARMACOL EXP THER, V319, P879, DOI 10.1124/jpet.106.110346; Zolk O., 2008, N-S ARCH PHARMACOL, V379, P337	55	124	128	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22163	10.1371/journal.pone.0022163	http://dx.doi.org/10.1371/journal.pone.0022163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779389	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811300043
J	Hupkes, M; Jonsson, MKB; Scheenen, WJ; van Rotterdam, W; Sotoca, AM; van Someren, EP; van der Heyden, MAG; van Veen, TA; van Ravestein-van Os, RI; Bauerschmidt, S; Piek, E; Ypey, DL; van Zoelen, EJ; Dechering, KJ				Hupkes, Marlinda; Jonsson, Malin K. B.; Scheenen, Wim J.; van Rotterdam, Walter; Sotoca, Ana M.; van Someren, Eugene P.; van der Heyden, Marcel A. G.; van Veen, Toon A.; van Ravestein-van Os, Roselinde I.; Bauerschmidt, Susanne; Piek, Ester; Ypey, Dirk L.; van Zoelen, Everardus J.; Dechering, Koen J.			Epigenetics: DNA demethylation promotes skeletal myotube maturation	FASEB JOURNAL			English	Article						5-azacytidine; C2C12 myogenesis; sarcomere development; spontaneous myotube contractions	C2C12 MOUSE MYOTUBES; EMBRYONIC STEM-CELLS; MYOBLAST DIFFERENTIATION; MUSCLE DIFFERENTIATION; CALCIUM TRANSIENTS; ELECTRICAL-STIMULATION; DENERVATED MUSCLE; CANCER-THERAPY; IN-VITRO; METHYLATION	Mesenchymal progenitor cells can be differentiated in vitro into myotubes that exhibit many characteristic features of primary mammalian skeletal muscle fibers. However, in general, they do not show the functional excitation-contraction coupling or the striated sarcomere arrangement typical of mature myofibers. Epigenetic modifications have been shown to play a key role in regulating the progressional changes in transcription necessary for muscle differentiation. In this study, we demonstrate that treatment of murine C2C12 mesenchymal progenitor cells with 10 mu M of the DNA methylation inhibitor 5-azacytidine (5AC) promotes myogenesis, resulting in myotubes with enhanced maturity as compared to untreated myotubes. Specifically, 5AC treatment resulted in the up-regulation of muscle genes at the myoblast stage, while at later stages nearly 50% of the 5AC-treated myotubes displayed a mature, well-defined sarcomere organization, as well as spontaneous contractions that coincided with action potentials and intracellular calcium transients. Both the percentage of striated myotubes and their contractile activity could be inhibited by 20 nM TTX, 10 mu M ryanodine, and 100 mu M nifedipine, suggesting that action potential-induced calcium transients are responsible for these characteristics. Our data suggest that genomic demethylation induced by 5AC overcomes an epigenetic barrier that prevents untreated C2C12 myotubes from reaching full maturity.-Hupkes, M., Jonsson, M. K. B., Scheenen, W. J., van Rotterdam, W., Sotoca, A. M., van Someren, E. P., van der Heyden, M. A. G., van Veen, T. A., van Ravestein-van Os, R. I., Bauerschmidt, S., Piek, E., Ypey, D. L., van Zoelen, E. J., Dechering, K. J. Epigenetics: DNA demethylation promotes skeletal myotube maturation. FASEB J. 25, 3861-3872 (2011). www.fasebj.org	[Hupkes, Marlinda; van Rotterdam, Walter; Sotoca, Ana M.; van Someren, Eugene P.; Piek, Ester; van Zoelen, Everardus J.; Dechering, Koen J.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Cell & Appl Biol, Fac Sci, NL-6525 AJ Nijmegen, Netherlands; [Scheenen, Wim J.] Radboud Univ Nijmegen, Dept Cellular Anim Physiol, Donders Ctr Neurosci, Fac Sci, NL-6525 AJ Nijmegen, Netherlands; [Jonsson, Malin K. B.; van der Heyden, Marcel A. G.; van Veen, Toon A.] Univ Med Ctr Utrecht, Dept Med Physiol, Div Heart & Lungs, Utrecht, Netherlands; [van Someren, Eugene P.] TNO, Dept Microbiol & Syst Biol, NL-3700 AJ Zeist, Netherlands; [van Ravestein-van Os, Roselinde I.; Bauerschmidt, Susanne; Dechering, Koen J.] Merck Res Labs, Oss, Netherlands; [Ypey, Dirk L.] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Netherlands Organization Applied Science Research; Merck & Company; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hupkes, M (corresponding author), Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Cell & Appl Biol, Fac Sci, Heyendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands.	m.hupkes@science.ru.nl	Scheenen, Wim/E-3674-2012; van Zoelen, Everardus J./D-9192-2012	van der Heyden, Marcel/0000-0002-4225-7942; Jonsson, Malin/0000-0003-2986-2889	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) [018.002.035]; Merck Sharp & Dohme (Oss, the Netherlands)	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); Merck Sharp & Dohme (Oss, the Netherlands)(Netherlands GovernmentMerck & Company)	The authors thank Elisabeth Pierson (Department of General Instruments, Radboud University Nijmegen) for her expert assistance with the confocal and the DIC microscopes. This work was supported by a Casimir grant from the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO; project 018.002.035) and by Merck Sharp & Dohme (Oss, the Netherlands).	Aguirre-Arteta AM, 2000, CELL GROWTH DIFFER, V11, P551; Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Almirza WHM, 2010, CELL CALCIUM, V47, P544, DOI 10.1016/j.ceca.2010.05.004; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berendse M, 2003, EXP CELL RES, V291, P435, DOI 10.1016/j.yexcr.2003.07.004; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Brunk BP, 1996, DEV BIOL, V177, P490, DOI 10.1006/dbio.1996.0180; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Capetanaki Y, 1997, CELL STRUCT FUNCT, V22, P103, DOI 10.1247/csf.22.103; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Collas P, 2009, BBA-GEN SUBJECTS, V1790, P900, DOI 10.1016/j.bbagen.2008.10.006; Cooper ST, 2004, CELL MOTIL CYTOSKEL, V58, P200, DOI 10.1002/cm.20010; Cornelisse LN, 2002, J NEUROENDOCRINOL, V14, P778, DOI 10.1046/j.1365-2826.2002.00838.x; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; De Deyne PG, 2000, AM J PHYSIOL-CELL PH, V279, pC1801, DOI 10.1152/ajpcell.2000.279.6.C1801; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Ferrari MB, 1998, J CELL BIOL, V141, P1349, DOI 10.1083/jcb.141.6.1349; Ferrari MB, 2006, CELL BIOCHEM BIOPHYS, V45, P317, DOI 10.1385/CBB:45:3:317; Fujita H, 2007, EXP CELL RES, V313, P1853, DOI 10.1016/j.yexcr.2007.03.002; Fuso A, 2010, CELL CYCLE, V9, P3965, DOI 10.4161/cc.9.19.13193; GIOVANELLI A, 1991, P NATL ACAD SCI USA, V88, P10069, DOI 10.1073/pnas.88.22.10069; GIOVANNELLI A, 1995, CELL CALCIUM, V18, P41, DOI 10.1016/0143-4160(95)90044-6; GOLDHAMER DJ, 1995, DEVELOPMENT, V121, P637; Gowher H, 2004, CANCER BIOL THER, V3, P1062, DOI 10.4161/cbt.3.11.1308; GRASSI F, 1993, PFLUG ARCH EUR J PHY, V422, P591, DOI 10.1007/BF00374007; GROUSELLE M, 1991, PFLUG ARCH EUR J PHY, V418, P40, DOI 10.1007/BF00370450; Guasconi V, 2009, TRENDS CELL BIOL, V19, P286, DOI 10.1016/j.tcb.2009.03.002; Harris BN, 2005, CELL MOTIL CYTOSKEL, V60, P129, DOI 10.1002/cm.20054; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hupkes M, 2011, BBA-MOL CELL RES, V1813, P839, DOI 10.1016/j.bbamcr.2011.01.022; Jost JP, 2001, NUCLEIC ACIDS RES, V29, P4452, DOI 10.1093/nar/29.21.4452; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kablar B, 1999, DEV BIOL, V206, P219, DOI 10.1006/dbio.1998.9126; Kislinger T, 2005, MOL CELL PROTEOMICS, V4, P887, DOI 10.1074/mcp.M400182-MCP200; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Komashko Vitalina M, 2010, Epigenetics, V5, P229; Kontrogianni-Konstantopoulos A, 2006, AM J PHYSIOL-CELL PH, V290, pC626, DOI 10.1152/ajpcell.00442.2005; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Lamb GD, 2000, CLIN EXP PHARMACOL P, V27, P216, DOI 10.1046/j.1440-1681.2000.03224.x; Lee KH, 1999, EXP CELL RES, V252, P401, DOI 10.1006/excr.1999.4648; Lee S, 2006, SEPAR SCI TECHNOL, V41, P1, DOI 10.1080/01496390500446426; Li HY, 2004, DEV DYNAM, V229, P231, DOI 10.1002/dvdy.10428; Liu YL, 1996, NUCLEIC ACIDS RES, V24, P2718, DOI 10.1093/nar/24.14.2718; Lorenzon P, 2000, J PHYSIOL-LONDON, V525, P499, DOI 10.1111/j.1469-7793.2000.00499.x; Lorenzon P, 1997, EUR J NEUROSCI, V9, P800, DOI 10.1111/j.1460-9568.1997.tb01429.x; Lucarelli M, 2001, J BIOL CHEM, V276, P7500, DOI 10.1074/jbc.M008234200; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; MCMAHON DK, 1994, AM J PHYSIOL, V266, pC1795, DOI 10.1152/ajpcell.1994.266.6.C1795; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Palacios D, 2006, J CELL PHYSIOL, V207, P1, DOI 10.1002/jcp.20489; Palacios D, 2010, MOL CELL BIOL, V30, P3805, DOI 10.1128/MCB.00050-10; PAPPONE PA, 1980, J PHYSIOL-LONDON, V306, P377, DOI 10.1113/jphysiol.1980.sp013403; Park H, 2008, J TISSUE ENG REGEN M, V2, P279, DOI 10.1002/term.93; Perdiguero E, 2009, EPIGENETICS-US, V4, P541, DOI 10.4161/epi.4.8.10258; Porter GA, 2002, J BIOL CHEM, V277, P28942, DOI 10.1074/jbc.M203961200; PURVES D, 1974, J PHYSIOL-LONDON, V239, P125, DOI 10.1113/jphysiol.1974.sp010559; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; SZENTGYORGYI AG, 1975, BIOPHYS J, V15, P707, DOI 10.1016/S0006-3495(75)85849-8; SZYF M, 1992, J BIOL CHEM, V267, P12831; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; TESSERAUX I, 1987, N-S ARCH PHARMACOL, V336, P232, DOI 10.1007/BF00165810; Thelen MHM, 1997, BIOCHEM J, V321, P845, DOI 10.1042/bj3210845; THESLEFF S, 1975, J PHYSIOL-LONDON, V244, P313, DOI 10.1113/jphysiol.1975.sp010800; van Veen TAB, 2000, CARDIOVASC RES, V46, P496, DOI 10.1016/S0008-6363(00)00047-X; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zebedin E, 2007, AM J PHYSIOL-HEART C, V292, pH439, DOI 10.1152/ajpheart.00119.2006	75	55	58	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2011	25	11					3861	3872		10.1096/fj.11-186122	http://dx.doi.org/10.1096/fj.11-186122			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21795504				2022-12-25	WOS:000296723100011
J	Chew, KCM; Ang, ET; Tai, YK; Tsang, F; Lo, SQ; Ong, E; Ong, WY; Shen, HM; Lim, KL; Dawson, VL; Dawson, TM; Soong, TW				Chew, Katherine C. M.; Ang, Eng-Tat; Tai, Yee Kit; Tsang, Fai; Lo, Shun Qiang; Ong, Elijah; Ong, Wei-Yi; Shen, Han-Ming; Lim, Kah-Leong; Dawson, Valina L.; Dawson, Ted M.; Soong, Tuck Wah			Enhanced Autophagy from Chronic Toxicity of Iron and Mutant A53T alpha-Synuclein IMPLICATIONS FOR NEURONAL CELL DEATH IN PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; DOUBLE-EDGED-SWORD; LEWY BODY; SUBSTANTIA-NIGRA; OXIDATIVE DAMAGE; NEURODEGENERATION; MUTATION; BRAIN; TRANSPORTER; PROTEIN	Parkinson disease (PD), a prevalent neurodegenerative motor disorder, is characterized by the rather selective loss of dopaminergic neurons and the presence of alpha-synuclein-enriched Lewy body inclusions in the substantia nigra of the midbrain. Although the etiology of PD remains incompletely understood, emerging evidence suggests that dysregulated iron homeostasis may be involved. Notably, nigral dopaminergic neurons are enriched in iron, the uptake of which is facilitated by the divalent metal ion transporter DMT1. To clarify the role of iron in PD, we generated SH-SY5Y cells stably expressing DMT1 either singly or in combination with wild type or mutant alpha-synuclein. We found that DMT1 overexpression dramatically enhances Fe2+ uptake, which concomitantly promotes cell death. This Fe2+-mediated toxicity is aggravated by the presence of mutant alpha-synuclein expression, resulting in increased oxidative stress and DNA damage. Curiously, Fe2+-mediated cell death does not appear to involve apoptosis. Instead, the phenomenon seems to occur as a result of excessive autophagic activity. Accordingly, pharmacological inhibition of autophagy reverses cell death mediated by Fe2+ overloading. Taken together, our results suggest a role for iron in PD pathogenesis and provide a mechanism underlying Fe2+-mediated cell death.	[Soong, Tuck Wah] Natl Univ Singapore, Ion Channel & Transporter Lab, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Ang, Eng-Tat; Ong, Wei-Yi] Natl Univ Singapore, Dept Anat, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Shen, Han-Ming] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Lim, Kah-Leong; Soong, Tuck Wah] Natl Inst Neurosci, Singapore 308443, Singapore; [Lim, Kah-Leong] Duke Natl Univ Singapore Neurosci Res Partnership, Agcy Sci Technol & Res A STAR, Singapore 169857, Singapore; [Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Inst Cell Engn, Sch Med, Baltimore, MD 21205 USA	National University of Singapore; National University of Singapore; National University of Singapore; National Neuroscience Institute (NNI); Agency for Science Technology & Research (A*STAR); Johns Hopkins University	Soong, TW (corresponding author), Natl Univ Singapore, Ion Channel & Transporter Lab, Dept Physiol, Yong Loo Lin Sch Med, Block MD9,2 Med Dr, Singapore 117597, Singapore.	phsstw@nus.edu.sg	Lim, Kah/L-5426-2019; Ang, Eng-Tat/AAV-2294-2020; Tai, Yee Kit/AHB-6200-2022; Tai, Yee Kit/HCH-5864-2022; SHEN, Han-Ming/B-5942-2011; Lim, Kah-Leong/AAY-3308-2020; Dawson, Valina/Y-9757-2019; Tai, Yee Kit/AAC-9347-2020	SHEN, Han-Ming/0000-0001-7369-5227; Tai, Yee Kit/0000-0003-0798-3575; Dawson, Valina/0000-0002-2915-3970; Lim, Kah-Leong/0000-0002-5440-2588; Ang, Eng-Tat/0000-0003-1770-2482	Biomedical Research Council (BMRC) [R-185-000-093-305]; BMRC [0813319580]; National Medical Research Council Exploratory/Developmental Singapore [10nov065]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038377] Funding Source: NIH RePORTER	Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); BMRC(Agency for Science Technology & Research (A*STAR)); National Medical Research Council Exploratory/Developmental Singapore(National Medical Research Council, Singapore); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Biomedical Research Council (BMRC) Grant R-185-000-093-305 (to T. W. S.), BMRC Grant 0813319580, and National Medical Research Council Exploratory/Developmental Grant 10nov065 (to K.-L. L.), Singapore.	Alam ZI, 1997, J NEUROCHEM, V69, P1326; Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x; Arawaka S, 1998, NEUROLOGY, V51, P887, DOI 10.1212/WNL.51.3.887; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Cecarini V, 2007, BBA-MOL CELL RES, V1773, P93, DOI 10.1016/j.bbamcr.2006.08.039; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Cherra SJ, 2008, FUTUR NEUROL, V3, P309, DOI 10.2217/14796708.3.3.309; CRUZORIVE LM, 1987, J MICROSC-OXFORD, V145, P121; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; DEXTER DT, 1994, MOVEMENT DISORD, V9, P92, DOI 10.1002/mds.870090115; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Ling DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004201; Low GKM, 2008, INT J BIOCHEM CELL B, V40, P2583, DOI 10.1016/j.biocel.2008.05.009; Martinet W, 2009, CLIN SCI, V116, P697, DOI 10.1042/CS20080508; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Matsuzaki M, 2004, BRAIN RES, V1004, P83, DOI 10.1016/j.brainres.2004.01.017; Mitchell RM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-6; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; RIEDERER P, 1989, J NEUROCHEM, V52, P515, DOI 10.1111/j.1471-4159.1989.tb09150.x; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; Sherer TB, 2005, ANTIOXID REDOX SIGN, V7, P627, DOI 10.1089/ars.2005.7.627; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shimizu S, 2010, ONCOGENE, V29, P2070, DOI 10.1038/onc.2009.487; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Singleton A, 2004, BRAIN, V127, P768, DOI 10.1093/brain/awh081; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Tan JMM, 2009, ANTIOXID REDOX SIGN, V11, P2119, DOI 10.1089/ARS.2009.2490; Tsang F, 2003, IUBMB LIFE, V55, P323, DOI 10.1080/1521654031000153058; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Ye FQ, 1996, MOVEMENT DISORD, V11, P243, DOI 10.1002/mds.870110305; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang L, 2000, BIOCHEM J, V349, P289, DOI 10.1042/0264-6021:3490289	45	67	67	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33380	33389		10.1074/jbc.M111.268409	http://dx.doi.org/10.1074/jbc.M111.268409			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795716	hybrid, Green Published			2022-12-25	WOS:000294968800056
J	Poll, F; Doll, C; Schulz, S				Poell, Florian; Doll, Christian; Schulz, Stefan			Rapid Dephosphorylation of G Protein-coupled Receptors by Protein Phosphatase 1 beta Is Required for Termination of beta-Arrestin-dependent Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOMATOSTATIN; PHOSPHORYLATION; OCTREOTIDE; DESENSITIZATION; SUBTYPES; SST(2A); HETERODIMERIZATION; INTERNALIZATION; RESENSITIZATION; TRAFFICKING	Termination of signaling of activated G protein-coupled receptors (GPCRs) is essential for maintenance of cellular homeostasis. It is well established that beta-arrestin redistributes to phosphorylated GPCRs and thereby facilitates desensitization of classical G protein-dependent signaling. beta-Arrestin in turn serves as a scaffold to initiate a second wave of signaling. Here, we report a molecular mechanism that regulates the termination of unconventional beta-arrestin-dependent GPCR signaling. We identify protein phosphatase 1 beta (PP1 beta) as a phosphatase for the cluster of phosphorylated threonines ((353)TTETQRT(359)) within the sst(2A) somatostatin receptor carboxyl terminus that mediates beta-arrestin binding using siRNA knock-down screening. We show that PP1 beta-mediated sst(2A) dephosphorylation is initiated directly after receptor activation at or near the plasma membrane. As a functional consequence of diminished PP1 beta activity, we find that somatostatin-and substance P-induced but not epidermal growth factor-induced ERK activation was aberrantly enhanced and prolonged. Thus, we demonstrate a novel mechanism for fine tuning unconventional beta-arrestin-dependent GPCR signaling in that recruitment of PP1 beta to activated GPCRs facilitates GPCR dephosphorylation and, hence, leads to disruption of the beta-arrestin-GPCR complex.	[Poell, Florian; Doll, Christian; Schulz, Stefan] Univ Jena, Inst Pharmacol & Toxicol, Univ Hosp, D-07747 Jena, Germany	Friedrich Schiller University of Jena	Schulz, S (corresponding author), Univ Jena, Inst Pharmacol & Toxicol, Univ Hosp, Drackendorfer Str 1, D-07747 Jena, Germany.	Stefan.Schulz@mti.uni-jena.de	Schulz, Stefan/A-6928-2017	Schulz, Stefan/0000-0002-5997-8885	Deutsche Forschungsgemeinschaft [SCHU924/10-3]; Deutsche Krebshilfe [108036]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHU924/10-3 and Deutsche Krebshilfe Grant 108036.	BYK T, 1993, P NATL ACAD SCI USA, V90, P1907, DOI 10.1073/pnas.90.5.1907; Chauvin S, 2002, MOL ENDOCRINOL, V16, P2720, DOI 10.1210/me.2002-0049; Cohen PTW, 2005, FEBS LETT, V579, P3278, DOI 10.1016/j.febslet.2005.04.070; DeFea KA, 2011, CELL SIGNAL, V23, P621, DOI 10.1016/j.cellsig.2010.10.004; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Fischer T, 2008, J CLIN ENDOCR METAB, V93, P4519, DOI 10.1210/jc.2008-1063; Gardner B, 2001, MOL PHARMACOL, V59, P310, DOI 10.1124/mol.59.2.310; Ghosh M, 2011, J BIOL CHEM, V286, P13561, DOI 10.1074/jbc.M110.215723; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Innamorati G, 1998, J BIOL CHEM, V273, P7155, DOI 10.1074/jbc.273.12.7155; Krueger KM, 1997, J BIOL CHEM, V272, P5; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lesche S, 2009, J CLIN ENDOCR METAB, V94, P654, DOI 10.1210/jc.2008-1919; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Mundschenk J, 2003, J CLIN ENDOCR METAB, V88, P5150, DOI 10.1210/jc.2003-030262; Nagel F, 2011, MOL ENDOCRINOL, V25, P859, DOI 10.1210/me.2010-0407; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Pfeiffer M, 2001, J BIOL CHEM, V276, P14027, DOI 10.1074/jbc.M006084200; Pfeiffer M, 2002, J BIOL CHEM, V277, P19762, DOI 10.1074/jbc.M110373200; PITCHER JA, 1995, P NATL ACAD SCI USA, V92, P8343, DOI 10.1073/pnas.92.18.8343; Plockinger U, 2008, J CLIN ENDOCR METAB, V93, P1203, DOI 10.1210/jc.2007-1986; Poll F, 2010, MOL ENDOCRINOL, V24, P436, DOI 10.1210/me.2009-0315; Schulz S, 2000, CLIN CANCER RES, V6, P1865; Spurney RF, 2001, J PHARMACOL EXP THER, V296, P592; STEELE FR, 1992, CELL, V69, P669, DOI 10.1016/0092-8674(92)90230-A; Tran TM, 2007, MOL PHARMACOL, V71, P47, DOI 10.1124/mol.106.028456; Tulipano G, 2004, J BIOL CHEM, V279, P21374, DOI 10.1074/jbc.M313522200; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015	32	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32931	32936		10.1074/jbc.M111.224899	http://dx.doi.org/10.1074/jbc.M111.224899			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795688	Green Published, hybrid			2022-12-25	WOS:000294968800011
J	Kirschner, R; Hubmacher, D; Iyengar, G; Kaur, J; Fagotto-Kaufmann, C; Bromme, D; Bartels, R; Reinhardt, DP				Kirschner, Ryan; Hubmacher, Dirk; Iyengar, Garud; Kaur, Jasvir; Fagotto-Kaufmann, Christine; Broemme, Dieter; Bartels, Rainer; Reinhardt, Dieter P.			Classical and Neonatal Marfan Syndrome Mutations in Fibrillin-1 Cause Differential Protease Susceptibilities and Protein Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR MODULES; CBEGF DOMAIN PAIR; CALCIUM-BINDING; CATHEPSIN-K; MATRIX METALLOPROTEINASES; SECONDARY STRUCTURE; BACKBONE DYNAMICS; FBN1 MUTATIONS; EXPRESSION; MICROFIBRILS	Mutations in fibrillin-1 give rise to Marfan syndrome (MFS) characterized by vascular, skeletal, and ocular abnormalities. Fibrillins form the backbone of extracellular matrix microfibrils in tissues including blood vessels, bone, and skin. They are crucial for regulating elastic fiber biogenesis and growth factor bioavailability. To compare the molecular consequences of mutations causing the severe neonatal MFS with mutations causing the milder classical MFS, we introduced representative point mutations from each group in a recombinant human fibrillin-1 fragment. Structural effects were analyzed by circular dichroism spectroscopy and analytical gel filtration chromatography. Proteolytic susceptibility was probed with non-physiological and physiological proteases, including plasmin, thrombin, matrix metalloproteinases, and cathepsins. All mutant proteins showed a similar gross secondary structure and no differences in heat stability as compared with the wild-type protein. Proteins harboring neonatal mutations were typically more susceptible to proteolytic cleavage compared with those with classical mutations and the wild-type protein. Proteolytic neo-cleavage sites were found both in close proximity and distant to the mutations, indicating small but significant structural changes exposing cryptic cleavage sites. We also report for the first time that cathepsin K and V cleave non-mutated fibrillin-1 at several domain boundaries. Compared with the classical mutations and the wild type, the group of neonatal mutations more severely affected the ability of fibrillin-1 to interact with heparin/heparan sulfate, which plays a role in microfibril assembly. These results suggest differential molecular pathogenetic concepts for neonatal and classical MFS including enhanced proteolytic susceptibility for physiologically relevant enzymes and loss of function for heparin binding.	[Hubmacher, Dirk; Iyengar, Garud; Kaur, Jasvir; Fagotto-Kaufmann, Christine; Reinhardt, Dieter P.] McGill Univ, Dept Anat & Cell Biol, Fac Med, Montreal, PQ H3A 2B2, Canada; [Kirschner, Ryan; Reinhardt, Dieter P.] McGill Univ, Fac Dent, Div Biomed Sci, Montreal, PQ H3A 2B2, Canada; [Broemme, Dieter] Univ British Columbia, Vancouver, BC V6T 1Z3, Canada; [Bartels, Rainer] Res Ctr Borstel, D-23845 Borstel, Germany	McGill University; McGill University; University of British Columbia; Forschungszentrum Borstel	Reinhardt, DP (corresponding author), McGill Univ, Dept Anat & Cell Biol, Fac Med, 3640 Univ St, Montreal, PQ H3A 2B2, Canada.	dieter.reinhardt@mcgill.ca	Hubmacher, Dirk/AAE-1875-2020; Reinhardt, Dieter P/A-3102-2008	Reinhardt, Dieter P/0000-0001-6535-9872; Hubmacher, Dirk/0000-0003-1569-9451	Canadian Institutes of Health Research [IMH-102821, MOP-106494]; Canadian Marfan Association; Canada Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Marfan Association; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by the Canadian Institutes of Health Research Grants IMH-102821 and MOP-106494, the Canadian Marfan Association, and the Canada Foundation for Innovation.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AOYAMA T, 1993, HUM MOL GENET, V2, P2135, DOI 10.1093/hmg/2.12.2135; Ashworth JL, 1999, BIOCHEM J, V340, P171, DOI 10.1042/0264-6021:3400171; Booms P, 2005, HUM GENET, V116, P51, DOI 10.1007/s00439-004-1194-7; Bromme D, 1999, BIOCHEMISTRY-US, V38, P2377, DOI 10.1021/bi982175f; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; BRUNE DC, 1992, ANAL BIOCHEM, V207, P285, DOI 10.1016/0003-2697(92)90013-W; Buhling F, 2000, ADV EXP MED BIOL, V477, P281; Cain SA, 2005, J BIOL CHEM, V280, P30526, DOI 10.1074/jbc.M501390200; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Chung AWY, 2007, CIRC RES, V101, P512, DOI 10.1161/CIRCRESAHA.107.157776; Collod-Beroud G, 2003, HUM MUTAT, V22, P199, DOI 10.1002/humu.10249; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; Faivre L, 2009, EUR J HUM GENET, V17, P491, DOI 10.1038/ejhg.2008.207; Fleischer KJ, 1997, ANN THORAC SURG, V63, P1012, DOI 10.1016/S0003-4975(97)00061-1; HALME T, 1985, EXP MOL PATHOL, V43, P1, DOI 10.1016/0014-4800(85)90050-4; HANDFORD P, 1995, J BIOL CHEM, V270, P6751, DOI 10.1074/jbc.270.12.6751; HAYWARD C, 1994, HUM MOL GENET, V3, P373, DOI 10.1093/hmg/3.2.373; Hindson VJ, 1999, FEBS LETT, V452, P195, DOI 10.1016/S0014-5793(99)00623-7; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P152, DOI 10.1056/NEJM199007193230303; Hubmacher D, 2008, P NATL ACAD SCI USA, V105, P6548, DOI 10.1073/pnas.0706335105; Hubmacher D, 2006, CURR TOP DEV BIOL, V75, P93, DOI 10.1016/S0070-2153(06)75004-9; Ikonomidis JS, 2006, CIRCULATION, V114, pI365, DOI 10.1161/CIRCULATIONAHA.105.000810; Jensen SA, 2001, J BIOL CHEM, V276, P39661, DOI 10.1074/jbc.M104533200; Kettle S, 1999, J MOL BIOL, V285, P1277, DOI 10.1006/jmbi.1998.2368; Kielty CM, 2005, ADV PROTEIN CHEM, V70, P405, DOI 10.1016/S0065-3233(04)70012-1; KIELTY CM, 1994, MATRIX BIOL, V14, P191, DOI 10.1016/0945-053X(94)90008-6; Lin GQ, 2002, J BIOL CHEM, V277, P50795, DOI 10.1074/jbc.M210611200; Linnevers CJ, 1997, PROTEIN SCI, V6, P919; Loeys BL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000488; Lutgens E, 2006, CIRCULATION, V113, P98, DOI 10.1161/CIRCULATIONAHA.105.561449; McGettrick AJ, 2000, HUM MOL GENET, V9, P1987, DOI 10.1093/hmg/9.13.1987; Mellody KT, 2006, J BIOL CHEM, V281, P31854, DOI 10.1074/jbc.M602743200; MILEWICZ DM, 1992, J CLIN INVEST, V89, P79, DOI 10.1172/JCI115589; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Ng DK, 1999, J PAEDIATR CHILD H, V35, P321, DOI 10.1046/j.1440-1754.1999.00355.x; NIJBROEK G, 1995, AM J HUM GENET, V57, P8; Perez A B, 1999, Hum Mutat, V13, P84, DOI 10.1002/(SICI)1098-1004(1999)13:1<84::AID-HUMU15>3.0.CO;2-U; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Pyeritz RE, 2000, ANNU REV MED, V51, P481, DOI 10.1146/annurev.med.51.1.481; RAGHUNATH M, 1994, BIOCHEM J, V302, P889, DOI 10.1042/bj3020889; RAGHUNATH M, 1993, HUM GENET, V90, P511; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; Reinhardt DP, 2000, J BIOL CHEM, V275, P12339, DOI 10.1074/jbc.275.16.12339; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Reinhardt DP, 1997, J BIOL CHEM, V272, P1231, DOI 10.1074/jbc.272.2.1231; Ritty TM, 2003, BIOCHEM J, V375, P425, DOI 10.1042/BJ20030649; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Samokhin AO, 2008, ATHEROSCLEROSIS, V200, P58, DOI 10.1016/j.atherosclerosis.2007.12.047; Segura AM, 1998, CIRCULATION, V98, pII331; Shang J, 2005, METHODS, V35, P390, DOI 10.1016/j.ymeth.2004.10.012; Smallridge RS, 2003, J BIOL CHEM, V278, P12199, DOI 10.1074/jbc.M208266200; Smallridge RS, 1999, J MOL BIOL, V286, P661, DOI 10.1006/jmbi.1998.2536; Suk JY, 2004, J BIOL CHEM, V279, P51258, DOI 10.1074/jbc.M408156200; Tiedemann K, 2005, J BIOL CHEM, V280, P11404, DOI 10.1074/jbc.M409882200; Tiedemann K, 2001, J BIOL CHEM, V276, P36035, DOI 10.1074/jbc.M104985200; TSUJI T, 1986, J CUTAN PATHOL, V13, P144, DOI 10.1111/j.1600-0560.1986.tb01515.x; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Vollbrandt T, 2004, J BIOL CHEM, V279, P32924, DOI 10.1074/jbc.M405239200; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Werner JM, 2000, J MOL BIOL, V296, P1065, DOI 10.1006/jmbi.1999.3513; Whiteman P, 2001, J BIOL CHEM, V276, P17156, DOI 10.1074/jbc.M006547200; Wilson SR, 2009, J BIOL CHEM, V284, P2584, DOI 10.1074/jbc.M805280200; Yasuda Y, 2004, J BIOL CHEM, V279, P36761, DOI 10.1074/jbc.M403986200; Yuan XM, 2002, J MOL BIOL, V316, P113, DOI 10.1006/jmbi.2001.5329; Yuan XM, 1997, EMBO J, V16, P6659, DOI 10.1093/emboj/16.22.6659	67	38	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32810	32823		10.1074/jbc.M111.221804	http://dx.doi.org/10.1074/jbc.M111.221804			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784848	Green Published, hybrid			2022-12-25	WOS:000294726800088
J	Li, ZC; Zhang, ZB; Xie, JX; Li, X; Tian, J; Cai, T; Cui, HJ; Ding, HF; Shapiro, JI; Xie, ZJ				Li, Zhichuan; Zhang, Zhongbing; Xie, Joe X.; Li, Xin; Tian, Jiang; Cai, Ting; Cui, Hongjuan; Ding, Hanfei; Shapiro, Joseph I.; Xie, Zijian			Na/K-ATPase Mimetic pNaKtide Peptide Inhibits the Growth of Human Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; ANDROGEN RECEPTOR; K-ATPASE; EPITHELIAL-CELLS; BETA-SUBUNIT; C-SRC; NA,K-ATPASE; KINASE; ACTIVATION; EXPRESSION	Cells contain a large pool of nonpumping Na/K-ATPase that participates in signal transduction. Here, we show that the expression of alpha 1 Na/K-ATPase is significantly reduced in human prostate carcinoma as well as in several human cancer cell lines. This down-regulation impairs the ability of Na/K-ATPase to regulate Src-related signaling processes. A supplement of pNaKtide, a peptide derived from alpha 1 Na/K-ATPase, reduces the activities of Src and Src effectors. Consequently, these treatments stimulate apoptosis and inhibit growth in cultures of human cancer cells. Moreover, administration of pNaKtide inhibits angiogenesis and growth of tumor xenograft. Thus, the new findings demonstrate the in vivo effectiveness of pNaKtide and suggest that the defect in Na/K-ATPase-mediated signal transduction may be targeted for developing new anticancer therapeutics.	[Li, Zhichuan; Zhang, Zhongbing; Xie, Joe X.; Tian, Jiang; Cai, Ting; Xie, Zijian] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Li, Xin] Univ Toledo, Coll Med, Dept Pathol, Toledo, OH 43614 USA; [Cui, Hongjuan; Ding, Hanfei] Univ Toledo, Coll Med, Dept Biochem & Canc Biol, Toledo, OH 43614 USA; [Li, Zhichuan; Tian, Jiang; Shapiro, Joseph I.; Xie, Zijian] Univ Toledo, Coll Med, Dept Med, Toledo, OH 43614 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Xie, ZJ (corresponding author), Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Mail Stop 1008,3000 Arlington Ave, Toledo, OH 43614 USA.	Zi-Jian.Xie@utoledo.edu	Li, Zhichuan/Q-7379-2017	Ding, Han-Fei/0000-0001-5702-3439	National Institutes of Health from the NHLBI [HL-36573]; National Institutes of Health from the NIGMS [GM-78565]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078565] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-36573 from the NHLBI and GM-78565 from the NIGMS.	Aalinkeel R, 2004, CANCER RES, V64, P5311, DOI 10.1158/0008-5472.CAN-2506-2; Barwe SP, 2005, MOL BIOL CELL, V16, P1082, DOI 10.1091/mbc.E04-05-0427; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; Chang YM, 2008, ONCOGENE, V27, P6365, DOI 10.1038/onc.2008.250; Chen YL, 2009, J BIOL CHEM, V284, P14881, DOI 10.1074/jbc.M109.003574; Contreras RG, 1999, J CELL SCI, V112, P4223; Desai SJ, 2006, CANCER RES, V66, P10449, DOI 10.1158/0008-5472.CAN-06-2582; Espineda C, 2003, CANCER-AM CANCER SOC, V97, P1859, DOI 10.1002/cncr.11267; Ferrandi M, 2004, J BIOL CHEM, V279, P33306, DOI 10.1074/jbc.M402187200; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Gilbert CA, 2010, CANCER RES, V70, P6870, DOI 10.1158/0008-5472.CAN-10-1378; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; Inge LJ, 2008, HISTOL HISTOPATHOL, V23, P459, DOI 10.14670/HH-23.459; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; KAPLAN KB, 1992, J CELL BIOL, V118, P321, DOI 10.1083/jcb.118.2.321; KAPLAN KB, 1994, EMBO J, V13, P4745, DOI 10.1002/j.1460-2075.1994.tb06800.x; Lara PN, 2009, ANTI-CANCER DRUG, V20, P179, DOI 10.1097/CAD.0b013e328325a867; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Li ZC, 2009, J BIOL CHEM, V284, P21066, DOI 10.1074/jbc.M109.013821; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Rabbani SA, 2010, MOL CANCER THER, V9, P1147, DOI 10.1158/1535-7163.MCT-09-0962; Rajasekaran AK, 2003, AM J PHYSIOL-RENAL, V285, pF388, DOI 10.1152/ajprenal.00439.2002; Rajasekaran SA, 1999, J UROLOGY, V162, P574, DOI 10.1016/S0022-5347(05)68629-6; Rajasekaran SA, 2003, AM J PHYSIOL-CELL PH, V284, pC1497, DOI 10.1152/ajpcell.00355.2002; Rajasekaran SA, 2007, AM J PHYSIOL-GASTR L, V292, pG124, DOI 10.1152/ajpgi.00297.2006; Sakai H, 2004, FEBS LETT, V563, P151, DOI 10.1016/S0014-5793(04)00292-3; Sandilands E, 2007, J CELL SCI, V120, P2555, DOI 10.1242/jcs.003657; Seligson DB, 2008, J UROLOGY, V179, P338, DOI 10.1016/j.juro.2007.08.094; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Tatarov O, 2009, CLIN CANCER RES, V15, P3540, DOI 10.1158/1078-0432.CCR-08-1857; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Tian J, 2008, PHYSIOLOGY, V23, P205, DOI 10.1152/physiol.00008.2008; Wang GM, 2007, PROSTATE, V67, P968, DOI 10.1002/pros.20582; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Yamanaka Y, 1989, Nihon Ika Daigaku Zasshi, V56, P579; Ye QQ, 2011, J BIOL CHEM, V286, P6225, DOI 10.1074/jbc.M110.202051; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	47	70	77	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32394	32403		10.1074/jbc.M110.207597	http://dx.doi.org/10.1074/jbc.M110.207597			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784855	Green Published, hybrid			2022-12-25	WOS:000294726800049
J	Rath, P; Demange, P; Saurel, O; Tropis, M; Daffe, M; Dotsch, V; Ghazi, A; Bernhard, F; Milon, A				Rath, Parthasarathi; Demange, Pascal; Saurel, Olivier; Tropis, Marielle; Daffe, Mamadou; Doetsch, Volker; Ghazi, Alexandre; Bernhard, Frank; Milon, Alain			Functional Expression of the PorAH Channel from Corynebacterium glutamicum in Cell-free Expression Systems IMPLICATIONS FOR THE ROLE OF THE NATURALLY OCCURRING MYCOLIC ACID MODIFICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRAL MEMBRANE-PROTEINS; OUTER-MEMBRANE; FORMING PROTEIN; WALL; IDENTIFICATION; DETERGENTS; PORINS; MYCOBACTERIA; EXISTENCE; REVEAL	PorA and PorH are two small membrane proteins from the outer membrane of Corynebacterium glutamicum, which have been shown to form heteromeric ion channels and to be post-translationally modified by mycolic acids. Any structural details of the channel could not be analyzed so far due to tremendous difficulties in the production of sufficient amounts of protein samples. Cell-free (CF) expression is a new and remarkably successful strategy for the production of membrane proteins for which toxicity, membrane targeting, and degradation are key issues. In addition, reaction conditions can easily be modified to modulate the quality of synthesized protein samples. We developed an efficient CF expression strategy to produce the channel subunits devoid of post-translational modifications. N-15-labeled PorA and PorH samples were furthermore characterized by NMR and gave well resolved spectra, opening the way for structural studies. The comparison of ion channel activities of CF-expressed proteins with channels isolated from C. glutamicum gave clear insights on the influence of the mycolic acid modification of the two subunits on their functional properties.	[Rath, Parthasarathi; Demange, Pascal; Saurel, Olivier; Tropis, Marielle; Daffe, Mamadou; Milon, Alain] Inst Pharmacol & Biol Struct, CNRS, UMR 5089, F-31077 Toulouse 04, France; [Rath, Parthasarathi; Demange, Pascal; Saurel, Olivier; Tropis, Marielle; Daffe, Mamadou; Milon, Alain] Univ Toulouse UPS, IPBS, F-31062 Toulouse, France; [Ghazi, Alexandre] Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulair, UMR8619, F-91405 Orsay, France; [Doetsch, Volker; Bernhard, Frank] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Inst Biophys Chem, D-60438 Mainz, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Goethe University Frankfurt	Demange, P (corresponding author), Inst Pharmacol & Biol Struct, CNRS, UMR 5089, 205 Rte Narbonne, F-31077 Toulouse 04, France.	pascal.demange@ipbs.fr; alain.milon@ipbs.fr	Olivier, Saurel/AAQ-7007-2020; demange, pascal JP/U-3561-2018; MILON, Alain/B-3767-2010	demange, pascal JP/0000-0002-9572-9990; MILON, Alain/0000-0001-5692-8201; Dotsch, Volker/0000-0001-5720-212X; Bernhard, Frank/0000-0002-4860-1783; Saurel, Olivier/0000-0003-1439-4103	European Community [FP7/2007-2013, 211800]; European Drug Initiative on Channels and Transporters [HEALTH-F4-2007-201924];  [SFB 807]	European Community(European Commission); European Drug Initiative on Channels and Transporters; 	This work was supported by the European Community's Seventh Framework Programme FP7/2007-2013 (Grant 211800) and from the European Drug Initiative on Channels and Transporters (Grant HEALTH-F4-2007-201924) and by the SFB 807 "Transport across membranes."	Abdine A, 2010, J MAGN RESON, V204, P155, DOI 10.1016/j.jmr.2010.02.003; Barth E, 2010, J BACTERIOL, V192, P786, DOI 10.1128/JB.01142-09; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; Berrier C, 2004, BIOCHEMISTRY-US, V43, P12585, DOI 10.1021/bi049049y; Berrier C, 1997, J MEMBRANE BIOL, V156, P105, DOI 10.1007/s002329900193; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Costa-Riu N, 2003, MOL MICROBIOL, V50, P1295, DOI 10.1046/j.1365-2958.2003.03754.x; Daffe M., 2005, HDB CORYNEBACTERIUM, P121; Genisyuerek S, 2011, MOL MICROBIOL, V79, P1643, DOI 10.1111/j.1365-2958.2011.07549.x; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Huc E, 2010, J BIOL CHEM, V285, P21908, DOI 10.1074/jbc.C110.133033; Hunten P, 2005, BBA-BIOMEMBRANES, V1715, P25, DOI 10.1016/j.bbamem.2005.07.011; Kai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012972; Klackta C, 2011, BBA-BIOMEMBRANES, V1808, P1601, DOI 10.1016/j.bbamem.2010.11.011; Klammt C, 2005, FEBS J, V272, P6024, DOI 10.1111/j.1742-4658.2005.05002.x; Klammt C, 2004, EUR J BIOCHEM, V271, P568, DOI 10.1111/j.1432-1033.2003.03959.x; Klammt C, 2006, FEBS J, V273, P4141, DOI 10.1111/j.1742-4658.2006.05432.x; Koglin A, 2006, MAGN RESON CHEM, V44, pS17, DOI 10.1002/mrc.1833; Lichtinger T, 1998, BIOCHEMISTRY-US, V37, P15024, DOI 10.1021/bi980961e; Maslennikov I, 2010, P NATL ACAD SCI USA, V107, P10902, DOI 10.1073/pnas.1001656107; Massari P, 2003, TRENDS MICROBIOL, V11, P87, DOI 10.1016/S0966-842X(02)00037-9; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; Reckel S, 2008, P NATL ACAD SCI USA, V105, P8262, DOI 10.1073/pnas.0710843105; Reckel S, 2010, METHODS MOL BIOL, V607, P187, DOI 10.1007/978-1-60327-331-2_16; Renault M, 2009, J MOL BIOL, V385, P117, DOI 10.1016/j.jmb.2008.10.021; SAMBROOK J, 2000, MOL CLONING LAB MANU; Savage DF, 2007, PROTEIN SCI, V16, P966, DOI 10.1110/ps.062696307; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schiffler B, 2007, J BACTERIOL, V189, P7709, DOI 10.1128/JB.00864-07; Schneider B, 2010, METHODS MOL BIOL, V601, P165, DOI 10.1007/978-1-60761-344-2_11; Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426; Shirokov Vladimir A., 2007, V375, P19; Svetlikova Z, 2009, ANTIMICROB AGENTS CH, V53, P4015, DOI 10.1128/AAC.00590-09; Thein M, 2008, J BACTERIOL, V190, P7035, DOI 10.1128/JB.00818-08; Wuu JJ, 2008, BBA-BIOMEMBRANES, V1778, P1237, DOI 10.1016/j.bbamem.2008.01.023; Yeung YG, 2008, ANAL BIOCHEM, V382, P135, DOI 10.1016/j.ab.2008.07.034; Ziegler K, 2008, J MOL BIOL, V379, P482, DOI 10.1016/j.jmb.2008.04.017; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	39	20	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32525	32532		10.1074/jbc.M111.276956	http://dx.doi.org/10.1074/jbc.M111.276956			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21799011	Green Published, hybrid			2022-12-25	WOS:000294726800062
J	Yi, JX; Ma, CL; Li, Y; Weisleder, N; Rios, E; Ma, JJ; Zhou, JS				Yi, Jianxun; Ma, Changling; Li, Yan; Weisleder, Noah; Rios, Eduardo; Ma, Jianjie; Zhou, Jingsong			Mitochondrial Calcium Uptake Regulates Rapid Calcium Transients in Skeletal Muscle during Excitation-Contraction (E-C) Coupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; CA2+ SIGNALS; MEMBRANE DEPOLARIZATION; FLUORESCENT INDICATORS; ENDOPLASMIC-RETICULUM; VENTRICULAR MYOCYTES; INTRACELLULAR CA2+; CARDIAC MYOCYTES; RELEASE; FIBERS	Defective coupling between sarcoplasmic reticulum and mitochondria during control of intracellular Ca2+ signaling has been implicated in the progression of neuromuscular diseases. Our previous study showed that skeletal muscles derived from an amyotrophic lateral sclerosis (ALS) mouse model displayed segmental loss of mitochondrial function that was coupled with elevated and uncontrolled sarcoplasmic reticulum Ca2+ release activity. The localized mitochondrial defect in the ALS muscle allows for examination of the mitochondrial contribution to Ca2+ removal during excitation-contraction coupling by comparing Ca2+ transients in regions with normal and defective mitochondria in the same muscle fiber. Here we show that Ca2+ transients elicited by membrane depolarization in fiber segments with defective mitochondria display an similar to 10% increased amplitude. These regional differences in Ca2+ transients were abolished by the application of 1,2-bis(O-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid, a fast Ca2+ chelator that reduces mitochondrial Ca2+ uptake. Using a mitochondria-targeted Ca2+ biosensor (mt11-YC3.6) expressed in ALS muscle fibers, we monitored the dynamic change of mitochondrial Ca2+ levels during voltage-induced Ca2+ release and detected a reduced Ca2+ uptake by mitochondria in the fiber segment with defective mitochondria, which mirrored the elevated Ca2+ transients in the cytosol. Our study constitutes a direct demonstration of the importance of mitochondria in shaping the cytosolic Ca2+ signaling in skeletal muscle during excitation-contraction coupling and establishes that malfunction of this mechanism may contribute to neuromuscular degeneration in ALS.	[Yi, Jianxun; Ma, Changling; Li, Yan; Rios, Eduardo; Zhou, Jingsong] Rush Univ Sch Med, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA; [Weisleder, Noah; Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA	Rush University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Zhou, JS (corresponding author), 1750 W Harrison St, Chicago, IL 60612 USA.	jingsong_zhou@rush.edu	Weisleder, Noah L/A-7098-2013	Weisleder, Noah L/0000-0002-2619-8022; Weisleder, Noah/0000-0003-2710-3088	Muscular Dystrophy Association [MDA-4351]; NIAMS/National Institutes of Health [AR057404, AR032808, AR049184, AG28614, AR054793]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032808, K99AR054793, R37AR032808, R00AR054793, R01AR057404, R01AR049184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028614] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); NIAMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was fully supported by Muscular Dystrophy Association Grant MDA-4351 and NIAMS/National Institutes of Health Grant AR057404 (to J. Z.) and partially supported by NIAMS/National Institutes of Health Grants AR032808 and AR049184 (to E. R.) AG28614 (to J. M.), and AR054793 (to N. W.).	Andrienko TN, 2009, J MOL CELL CARDIOL, V46, P1027, DOI 10.1016/j.yjmcc.2009.03.015; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Bers D.M., 2001, EXCITATION CONTRACTI, V2nd ed.; Bianchi K, 2004, BBA-MOL CELL RES, V1742, P119, DOI 10.1016/j.bbamcr.2004.09.015; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Bruton J, 2003, J PHYSIOL-LONDON, V551, P179, DOI 10.1113/jphysiol.2003.043927; Csernoch L, 2004, J PHYSIOL-LONDON, V557, P43, DOI 10.1113/jphysiol.2003.059154; Csordas G, 2001, CELL CALCIUM, V29, P249, DOI 10.1054/ceca.2000.0191; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; DiFranco M, 2008, P NATL ACAD SCI USA, V105, P14698, DOI 10.1073/pnas.0802217105; Dirksen RT, 2009, APPL PHYSIOL NUTR ME, V34, P389, DOI 10.1139/H09-044; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Eisenberg B.R, 1983, QUANTITATIVE ULTRAST; GONZALEZ A, 1993, J GEN PHYSIOL, V102, P373, DOI 10.1085/jgp.102.3.373; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; ISENBERG G, 1993, CARDIOVASC RES, V27, P1800, DOI 10.1093/cvr/27.10.1800; Kavanagh NI, 2000, BBA-BIOENERGETICS, V1457, P57, DOI 10.1016/S0005-2728(00)00054-2; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Lannergren J, 2001, J MUSCLE RES CELL M, V22, P265, DOI 10.1023/A:1012227009544; Maack C, 2006, CIRC RES, V99, P172, DOI 10.1161/01.RES.0000232546.92777.05; Martins AS, 2008, J PHYSIOL-LONDON, V586, P197, DOI 10.1113/jphysiol.2007.146571; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; MELZER W, 1984, BIOPHYS J, V45, P637, DOI 10.1016/S0006-3495(84)84203-4; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; O'Rourke B, 2009, J MOL CELL CARDIOL, V46, P767, DOI 10.1016/j.yjmcc.2008.12.011; Pacher P, 2000, J PHYSIOL-LONDON, V529, P553, DOI 10.1111/j.1469-7793.2000.00553.x; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Pouvreau S, 2007, P NATL ACAD SCI USA, V104, P5235, DOI 10.1073/pnas.0700748104; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Royer L, 2008, J PHYSIOL-LONDON, V586, P4609, DOI 10.1113/jphysiol.2008.157990; Rudolf R, 2006, J CELL BIOL, V173, P187, DOI 10.1083/jcb.200601160; Rudolf R, 2004, J CELL BIOL, V166, P527, DOI 10.1083/jcb.200403102; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Schuhmeier RP, 2004, J GEN PHYSIOL, V123, P33, DOI 10.1085/jgp.200308908; Sedova M, 2006, AM J PHYSIOL-CELL PH, V291, pC840, DOI 10.1152/ajpcell.00619.2005; Shirokova N, 1996, J GEN PHYSIOL, V107, P1, DOI 10.1085/jgp.107.1.1; Shkryl VM, 2006, J BIOL CHEM, V281, P1547, DOI 10.1074/jbc.M505024200; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Weisleder N, 2006, J CELL BIOL, V174, P639, DOI 10.1083/jcb.200604166; ZAIDI NF, 1989, J BIOL CHEM, V264, P21725; Zhou JS, 2010, J BIOL CHEM, V285, P705, DOI 10.1074/jbc.M109.041319; Zhou Z, 1998, J PHYSIOL-LONDON, V507, P379, DOI 10.1111/j.1469-7793.1998.379bt.x	46	63	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32436	32443		10.1074/jbc.M110.217711	http://dx.doi.org/10.1074/jbc.M110.217711			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795684	Green Published, hybrid			2022-12-25	WOS:000294726800053
J	Lossner, C; Meier, J; Warnken, U; Rogers, MA; Lichter, P; Pscherer, A; Schnolzer, M				Loessner, Christopher; Meier, Jan; Warnken, Uwe; Rogers, Michael A.; Lichter, Peter; Pscherer, Armin; Schnoelzer, Martina			Quantitative Proteomics Identify Novel miR-155 Target Proteins	PLOS ONE			English	Article							MICRORNA-BINDING-SITES; MESSENGER-RNAS; POSTTRANSCRIPTIONAL REGULATION; AMINO-ACIDS; IDENTIFICATION; INITIATION; TRANSLATION; EXPRESSION; BIOGENESIS; INHIBITION	Background: MicroRNAs are 22 nucleotides long non-coding RNAs and exert their function either by transcriptional or translational inhibition. Although many microRNA profiles in different tissues and disease states have already been discovered, only little is known about their target proteins. The microRNA miR-155 is deregulated in many diseases, including cancer, where it might function as an oncoMir. Methodology/Principal Findings: We employed a proteomics technique called "stable isotope labelling by amino acids in cell culture" (SILAC) allowing relative quantification to reliably identify target proteins of miR-155. Using SILAC, we identified 46 putative miR-155 target proteins, some of which were previously reported. With luciferase reporter assays, CKAP5 was confirmed as a new target of miR-155. Functional annotation of miR-155 target proteins pointed to a role in cell cycle regulation. Conclusions/Significance: To the best of our knowledge we have investigated for the first time miR-155 target proteins in the HEK293T cell line in large scale. In addition, by comparing our results to previously identified miR-155 target proteins in other cell lines, we provided further evidence for the cell line specificity of microRNAs.	[Meier, Jan; Rogers, Michael A.; Lichter, Peter; Pscherer, Armin] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Lossner, C (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 10 Kent Ridge Crescent, Singapore 117548, Singapore.	m.schnoelzer@dkfz.de	Rogers, Michael A./J-9803-2012	Rogers, Michael A./0000-0002-3728-2107; Lossner, Christopher/0000-0003-1261-0335	Baden-Wurttemberg Stiftung [P-LS-Prot/54]; Deutsche Krebshilfe [107581]	Baden-Wurttemberg Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by Baden-Wurttemberg Stiftung (Forschungsprogramm "Proteinbiochemie/Proteomics'' P-LS-Prot/54; www.bwstiftung.de) and Deutsche Krebshilfe 107581. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellare P, 2007, NAT STRUCT MOL BIOL, V14, P684, DOI 10.1038/nsmb0807-684; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; De Luca M, 2008, ONCOGENE, V27, P6539, DOI 10.1038/onc.2008.252; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grosshans H, 2008, CELL, V134, P560, DOI 10.1016/j.cell.2008.08.008; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inomata M, 2009, BLOOD, V113, P396, DOI 10.1182/blood-2008-07-163907; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Koller E, 2006, CANCER RES, V66, P2059, DOI 10.1158/0008-5472.CAN-05-1531; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lossner C, 2011, ANAL BIOCHEM, V412, P123, DOI 10.1016/j.ab.2011.01.011; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Ngoka LCM, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-30; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shah AR, 2007, BIOINFORMATICS, V23, P906, DOI 10.1093/bioinformatics/btm031; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Townsley FM, 1997, P NATL ACAD SCI USA, V94, P2362, DOI 10.1073/pnas.94.6.2362; Vinther J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl590; Wang V, 2009, BIODRUGS, V23, P15, DOI 10.2165/00063030-200923010-00002; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yang Y, 2010, MOL BIOSYST, V6, P1873, DOI 10.1039/c004401f; Yang Y, 2009, PROTEOMICS, V9, P1374, DOI 10.1002/pmic.200800551	56	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22146	10.1371/journal.pone.0022146	http://dx.doi.org/10.1371/journal.pone.0022146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799781	Green Published, Green Submitted, gold			2022-12-25	WOS:000293172900012
J	Apabhai, S; Gorman, GS; Sutton, L; Elson, JL; Plotz, T; Turnbull, DM; Trenell, MI				Apabhai, Shehnaz; Gorman, Grainne S.; Sutton, Laura; Elson, Joanna L.; Ploetz, Thomas; Turnbull, Douglass M.; Trenell, Michael I.			Habitual Physical Activity in Mitochondrial Disease	PLOS ONE			English	Article							ENERGY-EXPENDITURE; RESPIRATORY-CHAIN; EXERCISE; DNA; MYOPATHIES; METABOLISM; OBESITY; ADULTS; SCALE; MERRF	Purpose: Mitochondrial disease is the most common neuromuscular disease and has a profound impact upon daily life, disease and longevity. Exercise therapy has been shown to improve mitochondrial function in patients with mitochondrial disease. However, no information exists about the level of habitual physical activity of people with mitochondrial disease and its relationship with clinical phenotype. Methods: Habitual physical activity, genotype and clinical presentations were assessed in 100 patients with mitochondrial disease. Comparisons were made with a control group individually matched by age, gender and BMI. Results: Patients with mitochondrial disease had significantly lower levels of physical activity in comparison to matched people without mitochondrial disease (steps/day; 6883 +/- 3944 vs. 9924 +/- 4088, p = 0.001). 78% of the mitochondrial disease cohort did not achieve 10,000 steps per day and 48%were classified as overweight or obese. Mitochondrial disease was associated with less breaks in sedentary activity (Sedentary to Active Transitions, % per day; 13 +/- 0.03 vs. 14 +/- 0.03, p = 0.001) and an increase in sedentary bout duration (bout lengths / fraction of total sedentary time; 0.206 +/- 0.044 vs. 0.187 +/- 0.026, p = 0.001). After adjusting for covariates, higher physical activity was moderately associated with lower clinical disease burden (steps / day; r(s) = -0.49; 95% CI -0.33, -0.63, P<0.01). There were no systematic differences in physical activity between different genotypes mitochondrial disease. Conclusions: These results demonstrate for the first time that low levels of physical activity are prominent in mitochondrial disease. Combined with a high prevalence of obesity, physical activity may constitute a significant and potentially modifiable risk factor in mitochondrial disease.	[Apabhai, Shehnaz; Gorman, Grainne S.; Elson, Joanna L.; Turnbull, Douglass M.; Trenell, Michael I.] Newcastle Univ, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Gorman, Grainne S.; Turnbull, Douglass M.; Trenell, Michael I.] Newcastle Univ, NIHR Biomed Res Ctr Ageing & Age Related Dis, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Gorman, Grainne S.; Sutton, Laura; Turnbull, Douglass M.; Trenell, Michael I.] Newcastle Univ, Newcastle Ctr Brain Ageing & Vital, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ploetz, Thomas] Newcastle Univ, Sch Comp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Apabhai, S (corresponding author), Newcastle Univ, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	michael.trenell@ncl.ac.uk		Trenell, Michael/0000-0001-8253-5620; /0000-0002-3551-5624; Gorman, Grainne/0000-0002-7585-3409; Turnbull, Doug/0000-0002-8878-9901	UK NIHR Biomedical Research Centre for Ageing and Age-related Disease; Research Council UK; Medical Research Council, Muscular Dystrophy Campaign, Newcastle University Centre for Brain Ageing and Vitality; Wellcome Trust; Diabetes UK; MRC [G0601943, G0900686, G90/63] Funding Source: UKRI; Medical Research Council [G0601943, G0900686, G0700718B, G90/63] Funding Source: researchfish; National Institute for Health Research [SRF-2011-04-017] Funding Source: researchfish	UK NIHR Biomedical Research Centre for Ageing and Age-related Disease(National Institute for Health Research (NIHR)); Research Council UK(UK Research & Innovation (UKRI)); Medical Research Council, Muscular Dystrophy Campaign, Newcastle University Centre for Brain Ageing and Vitality(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Muscular Dystrophy Association); Wellcome Trust(Wellcome TrustEuropean Commission); Diabetes UK(Diabetes UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Dr. Gorman is funded by the UK NIHR Biomedical Research Centre for Ageing and Age-related Disease. Dr. Elson is supported by a Research Council UK Academic fellowship. Professor Turnbull acknowledges funding from the UK NIHR Biomedical Research Centre for Ageing and Age-related Disease, the Medical Research Council, Muscular Dystrophy Campaign, Newcastle University Centre for Brain Ageing and Vitality and the Wellcome Trust. Dr. Trenell acknowledges the Medical Research Council and is supported by a fellowship from Diabetes UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JS, 2004, BIOESSAYS, V26, P894, DOI 10.1002/bies.20071; BYRNE E, 1991, ACTA NEUROPATHOL, V81, P318, DOI 10.1007/BF00305874; Chastin SFM, 2010, GAIT POSTURE, V31, P82, DOI 10.1016/j.gaitpost.2009.09.002; Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.0.CO;2-P; Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; DiMauro S, 1997, MOL GENETIC BASIS NE, P201; Gill TM, 1997, J GEN INTERN MED, V12, P757, DOI 10.1046/j.1525-1497.1997.07161.x; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149; Jonker JT, 2006, DIABETES CARE, V29, P38; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; MORRIS JN, 1953, LANCET, V265, P1111; Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252; Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41; Schaefer Andrew M., 2001, Current Opinion in Pharmacology, V1, P288; St-Onge M, 2007, AM J CLIN NUTR, V85, P742, DOI 10.1093/ajcn/85.3.742; Taivassalo T, 2005, MED SCI SPORT EXER, V37, P2094, DOI 10.1249/01.mss.0000177446.97671.2a; Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028; Trenell MI, 2006, MUSCLE NERVE, V33, P524, DOI 10.1002/mus.20484; Weller I, 1998, EPIDEMIOLOGY, V9, P632, DOI 10.1097/00001648-199811000-00012; World Health Organization, 1995, PHYS STAT US INT ANT	26	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22294	10.1371/journal.pone.0022294	http://dx.doi.org/10.1371/journal.pone.0022294			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799815	Green Submitted, Green Published, gold			2022-12-25	WOS:000293097300027
J	Gerling, M; Glauben, R; Habermann, JK; Kuhl, AA; Loddenkemper, C; Lehr, HA; Zeitz, M; Siegmund, B				Gerling, Marco; Glauben, Rainer; Habermann, Jens K.; Kuehl, Anja A.; Loddenkemper, Christoph; Lehr, Hans-Anton; Zeitz, Martin; Siegmund, Britta			Characterization of Chromosomal Instability in Murine Colitis-Associated Colorectal Cancer	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CHRONIC ULCERATIVE-COLITIS; COLON-CANCER; PROGRESSION; MICE; EXPRESSION; MUTATIONS; DYSPLASIA; SULFATE; ANEUPLOIDY	Background: Patients suffering from ulcerative colitis (UC) bear an increased risk for colorectal cancer. Due to the sparsity of colitis-associated cancer (CAC) and the long duration between UC initiation and overt carcinoma, elucidating mechanisms of inflammation-associated carcinogenesis in the gut is particularly challenging. Adequate murine models are thus highly desirable. For human CACs a high frequency of chromosomal instability (CIN) reflected by aneuploidy could be shown, exceeding that of sporadic carcinomas. The aim of this study was to analyze mouse models of CAC with regard to CIN. Additionally, protein expression of p53, beta-catenin and Ki67 was measured to further characterize murine tumor development in comparison to UC-associated carcinogenesis in men. Methods: The AOM/DSS model (n = 23) and IL-10(-/-) mice (n = 8) were applied to monitor malignancy development via endoscopy and to analyze premalignant and malignant stages of CACs. CIN was assessed using DNA-image cytometry. Protein expression of p53, beta-catenin and Ki67 was evaluated by immunohistochemistry. The degree of inflammation was analyzed by histology and paralleled to local interferon-gamma release. Results: CIN was detected in 81.25% of all murine CACs induced by AOM/DSS, while all carcinomas that arose in IL-10(-/-) mice were chromosomally stable. Beta-catenin expression was strongly membranous in IL-10(-/-) mice, while 87.50% of AOM/DSS-induced tumors showed cytoplasmatic and/or nuclear translocation of beta-catenin. p53 expression was high in both models and Ki67 staining revealed higher proliferation of IL-10(-/-)-induced CACs. Conclusions: AOM/DSS-colitis, but not IL-10(-/-) mice, could provide a powerful murine model to mechanistically investigate CIN in colitis-associated carcinogenesis.	[Gerling, Marco; Glauben, Rainer; Zeitz, Martin; Siegmund, Britta] Charite Univ Med Berlin, Med Clin 1, Berlin, Germany; [Habermann, Jens K.] Med Univ Lubeck, Dept Surg, Surg Res Lab, D-23538 Lubeck, Germany; [Kuehl, Anja A.; Loddenkemper, Christoph] Charite Univ Med Berlin, RCIS, Inst Pathol, Berlin, Germany; [Lehr, Hans-Anton] CHU Vaudois, Inst Univ Pathol, CH-1011 Lausanne, Switzerland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lubeck; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Gerling, M (corresponding author), Charite Univ Med Berlin, Med Clin 1, Campus Benjamin Franklin, Berlin, Germany.	marco.gerling@charite.de	Siegmund, Britta/E-6929-2018; Habermann, Jens/AAA-5149-2020	Siegmund, Britta/0000-0002-0055-958X; Gerling, Marco/0000-0002-1810-0662; Kuhl, Anja/0000-0003-2293-5387	Werner and Clara Kreitz Foundation; German Cancer Aid (DKH) [108446]; German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG Si-749/5-3, SFB633]	Werner and Clara Kreitz Foundation; German Cancer Aid (DKH)(Deutsche Krebshilfe); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The authors wish to express their gratitude to Katja Grollich for performing immunohistochemistry and Gisela Grosser-Pape for excellent assistance in preparation of slides for DNA-cytometry. Grants from the Werner and Clara Kreitz Foundation and the German Cancer Aid (DKH # 108446: the North German Tumorbank of Colorectal Cancer) are gratefully acknowledged.; Studies were in part founded by the German Research Foundation (Deutsche Forschungsgemeinschaft) under No. DFG Si-749/5-3 and SFB633, www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Araujo SEA, 2007, DIS COLON RECTUM, V50, P1800, DOI 10.1007/s10350-007-9013-6; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; AUER GU, 1980, ANAL QUANT CYTOL, V2, P280; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Beatty PL, 2007, J IMMUNOL, V179, P735, DOI 10.4049/jimmunol.179.2.735; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; BEFRITS R, 1994, DIS COLON RECTUM, V37, P313, DOI 10.1007/BF02053590; Benson AB, 2007, J MANAGE CARE PHARM, V13, pS5; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z; BRENTNALL TA, 1994, GASTROENTEROLOGY, V107, P369, DOI 10.1016/0016-5085(94)90161-9; Castro-Santos P, 2006, AM J GASTROENTEROL, V101, P1039, DOI 10.1111/j.1572-0241.2006.00501.x; CHAUBERT P, 1994, AM J PATHOL, V144, P767; Chichlowski M, 2008, COMPARATIVE MED, V58, P534; Claessen MMH, 2010, CELL ONCOL, V32, P303, DOI 10.3233/CLO-2009-0503; Clapper ML, 2007, ACTA PHARMACOL SIN, V28, P1450, DOI 10.1111/j.1745-7254.2007.00695.x; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Gerling M, 2010, ANN SURG, V252, P74, DOI 10.1097/SLA.0b013e3181deb664; Glauben R, 2009, CANCER LETT, V280, P154, DOI 10.1016/j.canlet.2008.11.019; Goldberg-Bittman L, 2008, CANCER GENET CYTOGEN, V180, P20, DOI 10.1016/j.cancergencyto.2007.09.009; Guda K, 2004, ONCOGENE, V23, P3813, DOI 10.1038/sj.onc.1207489; Habermann J, 2001, SCAND J GASTROENTERO, V36, P751, DOI 10.1080/003655201300192021; HARPAZ N, 1994, HUM PATHOL, V25, P1069, DOI 10.1016/0046-8177(94)90067-1; Hegazi RAF, 2003, INFLAMM BOWEL DIS, V9, P230, DOI 10.1097/00054725-200307000-00003; ISHIOKA T, 1987, CRIT REV TOXICOL, V17, P215, DOI 10.3109/10408448709071209; Kanai Y, 2010, CANCER SCI, V101, P36, DOI 10.1111/j.1349-7006.2009.01383.x; Kurze A, 2011, EMBO J, V30, P364, DOI 10.1038/emboj.2010.315; O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Paulson TG, 2009, CLIN CANCER RES, V15, P3305, DOI 10.1158/1078-0432.CCR-08-2494; Pohl C, 2000, HEPATO-GASTROENTEROL, V47, P57; Risques RA, 2008, GASTROENTEROLOGY, V135, P410, DOI 10.1053/j.gastro.2008.04.008; Rosenberg DW, 2009, CARCINOGENESIS, V30, P183, DOI 10.1093/carcin/bgn267; Siegmund B, 2002, GASTROENTEROLOGY, V122, P2011, DOI 10.1053/gast.2002.33631; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Suzuki R, 2005, HISTOL HISTOPATHOL, V20, P483, DOI 10.14670/HH-20.483; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Tomlinson I, 1998, J PATHOL, V184, P148, DOI 10.1002/(SICI)1096-9896(199802)184:2<148::AID-PATH986>3.0.CO;2-M; Wright WE, 2000, NAT MED, V6, P849, DOI 10.1038/78592; YAMADA M, 1992, GUT, V33, P1521, DOI 10.1136/gut.33.11.1521; Yan B, 2009, METHODS MOL BIOL, V512, P15, DOI 10.1007/978-1-60327-530-9_2; YIN J, 1993, GASTROENTEROLOGY, V104, P1633, DOI 10.1016/0016-5085(93)90639-T	43	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22114	10.1371/journal.pone.0022114	http://dx.doi.org/10.1371/journal.pone.0022114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799775	Green Published, gold, Green Submitted			2022-12-25	WOS:000293097300015
J	Hauquier, F; Ingels, J; Gutt, J; Raes, M; Vanreusel, A				Hauquier, Freija; Ingels, Jeroen; Gutt, Julian; Raes, Maarten; Vanreusel, Ann			Characterisation of the Nematode Community of a Low-Activity Cold Seep in the Recently Ice-Shelf Free Larsen B Area, Eastern Antarctic Peninsula	PLOS ONE			English	Article							FREE-LIVING NEMATODES; MOSBY-MUD-VOLCANO; MEIOFAUNA COMMUNITIES; ORGANIC-MATTER; METAZOAN MEIOFAUNA; WEDDELL SEA; DIVERSITY; MEIOBENTHOS; VENT; BIODIVERSITY	Background: Recent climate-induced ice-shelf disintegration in the Larsen A (1995) and B (2002) areas along the Eastern Antarctic Peninsula formed a unique opportunity to assess sub-ice-shelf benthic community structure and led to the discovery of unexplored habitats, including a low-activity methane seep beneath the former Larsen B ice shelf. Since both limited particle sedimentation under previously permanent ice coverage and reduced cold-seep activity are likely to influence benthic meiofauna communities, we characterised the nematode assemblage of this low-activity cold seep and compared it with other, now seasonally ice-free, Larsen A and B stations and other Antarctic shelf areas (Weddell Sea and Drake Passage), as well as cold-seep ecosystems world-wide. Principal Findings: The nematode community at the Larsen B seep site differed significantly from other Antarctic sites in terms of dominant genera, diversity and abundance. Densities in the seep samples were high (>2000 individuals per 10 cm(2)) and showed below-surface maxima at a sediment depth of 2-3 cm in three out of four replicates. All samples were dominated by one species of the family Monhysteridae, which was identified as a Halomonhystera species that comprised between 80 and 86% of the total community. The combination of high densities, deeper density maxima and dominance of one species is shared by many cold-seep ecosystems world-wide and suggested a possible dependence upon a chemosynthetic food source. Yet stable C-13 isotopic signals (ranging between -21.97+/-0.86% and -24.85+/-1.89%) were indicative of a phytoplankton-derived food source. Conclusion: The recent ice-shelf collapse and enhanced food input from surface phytoplankton blooms were responsible for the shift from oligotrophic pre-collapse conditions to a phytodetritus-based community with high densities and low diversity. The parthenogenetic reproduction of the highly dominant Halomonhystera species is rather unusual for marine nematodes and may be responsible for the successful colonisation by this single species.	[Hauquier, Freija; Ingels, Jeroen; Raes, Maarten; Vanreusel, Ann] Univ Ghent, Marine Biol Sect, B-9000 Ghent, Belgium; [Gutt, Julian] Alfred Wegener Inst Polar & Marine Res, D-2850 Bremerhaven, Germany	Ghent University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Hauquier, F (corresponding author), Univ Ghent, Marine Biol Sect, B-9000 Ghent, Belgium.	freija.hauquier@ugent.be	Ingels, Jeroen/A-1691-2008	Ingels, Jeroen/0000-0001-8342-2222; Gutt, Julian/0000-0003-3773-9370; Hauquier, Freija/0000-0002-6606-2162	Belgian Science Policy (Scientific Research Program on Antarctica); FWO [G034607]	Belgian Science Policy (Scientific Research Program on Antarctica)(Belgian Federal Science Policy Office); FWO(FWO)	This study was supported by the BIANZO II project, financed by the Belgian Science Policy (Scientific Research Program on Antarctica) and the FWO project "Cold Seeps" nr.G034607. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austen MC, 1998, MAR ECOL PROG SER, V174, P233, DOI 10.3354/meps174233; BARNETT PRO, 1984, OCEANOL ACTA, V7, P399; Beier S, 2003, NEMATOLOGY, V5, P113, DOI 10.1163/156854102765216740; Bergquist DC, 2007, MAR ECOL PROG SER, V330, P49, DOI 10.3354/meps330049; Boeckner MJ, 2009, HYDROBIOLOGIA, V624, P91, DOI 10.1007/s10750-008-9669-5; Braeckman U, 2010, MAR ECOL PROG SER, V399, P173, DOI 10.3354/meps08336; Bright M, 2010, DEEP-SEA RES PT II, V57, P1982, DOI 10.1016/j.dsr2.2010.05.003; Clarke A, 2007, PHILOS T R SOC B, V362, P149, DOI 10.1098/rstb.2006.1958; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Copley JTP, 2007, J MAR BIOL ASSOC UK, V87, P1141, DOI 10.1017/S0025315407055956; CURRIN CA, 1995, MAR ECOL PROG SER, V121, P99, DOI 10.3354/meps121099; DANDO PR, 1991, MAR ECOL PROG SER, V70, P49, DOI 10.3354/meps070049; Danovaro R, 1995, PROG OCEANOGR, V36, P329, DOI 10.1016/0079-6611(96)00002-X; Deprez T, 2005, NEMYS WORLD WIDE WEB; Domack E., 2005, EOS, V86, P269, DOI DOI 10.1029/2005EO290001; Domack E, 2005, EOS, V86, P271; Drazen JC, 1998, DEEP-SEA RES PT II, V45, P893, DOI 10.1016/S0967-0645(98)00007-1; Edwards MS, 2002, COPEIA, P1106; Fabiano M, 1999, POLAR BIOL, V22, P115, DOI 10.1007/s003000050398; Flint HC, 2006, CAH BIOL MAR, V47, P365; Fonseca G, 2010, PROG OCEANOGR, V84, P174, DOI 10.1016/j.pocean.2009.11.001; Fonseca G, 2008, J MAR BIOL ASSOC UK, V88, P1371, DOI 10.1017/S0025315408001719; Giere, 2009, MEIOBENTHOLOGY THE M; GUTT J, 2008, BER POLARFORSCH MEER, V569; Gutt J, 2011, DEEP-SEA RES PT II, V58, P74, DOI 10.1016/j.dsr2.2010.05.024; Gutzmann E, 2004, DEEP-SEA RES PT II, V51, P1617, DOI 10.1016/j.dsr2.2004.06.026; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Heip C., 1982, Helminthologia (Bratislava), V51, P1; HERMAN RL, 1992, POLAR BIOL, V12, P313; Higgins R. P., 1988, INTRO STUDY MEIOFAUN; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Ingels J, 2006, POLAR BIOL, V29, P936, DOI 10.1007/s00300-006-0135-4; Lee HJ, 2001, POLAR BIOL, V24, P918, DOI 10.1007/s003000100300; Levin L, 1997, J MAR RES, V55, P595, DOI 10.1357/0022240973224337; Levin LA, 2005, OCEANOGR MAR BIOL, V43, P1, DOI 10.1201/9781420037449.ch1; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; Mincks SL, 2008, DEEP-SEA RES PT II, V55, P2502, DOI 10.1016/j.dsr2.2008.06.009; Moens T, 2002, MAR ECOL PROG SER, V234, P127, DOI 10.3354/meps234127; Moens T, 2007, POLAR BIOL, V31, P1, DOI 10.1007/s00300-007-0323-x; Niemann H, 2009, BIOGEOSCIENCES, V6, P2383, DOI 10.5194/bg-6-2383-2009; Olu K, 1997, DEEP-SEA RES PT I, V44, P811, DOI 10.1016/S0967-0637(96)00123-9; Olu K, 1996, MAR ECOL PROG SER, V132, P109, DOI 10.3354/meps132109; Peters L, 2005, NEMATOLOGY, V7, P901, DOI 10.1163/156854105776186352; Peters L, 2005, NEMATOLOGY, V7, P267, DOI 10.1163/1568541054879520; Pires-DaSilva A, 2007, SEMIN CELL DEV BIOL, V18, P362, DOI 10.1016/j.semcdb.2006.11.014; Portnova D, 2011, MAR ECOL-EVOL PERSP, V32, P24, DOI 10.1111/j.1439-0485.2010.00403.x; Rack W, 2004, ANN GLACIOL-SER, V39, P505, DOI 10.3189/172756404781814005; Raes M, 2010, GLOBAL CHANGE BIOL, V16, P1618, DOI 10.1111/j.1365-2486.2009.02137.x; RAES M, 2007, ANTXXIII820062007; Sane E, 2011, J SEA RES, V65, P94, DOI 10.1016/j.seares.2010.07.005; Scambos TA, 2000, J GLACIOL, V46, P516, DOI 10.3189/172756500781833043; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; Smale DA, 2008, ECOGRAPHY, V31, P289, DOI 10.1111/j.0906-7590.2008.05456.x; Soltwedel T, 2005, J MARINE SYST, V55, P271, DOI 10.1016/j.jmarsys.2004.09.001; Soltwedel T, 2003, VIE MILIEU, V53, P1; Soltwedel T, 2000, PROG OCEANOGR, V46, P59, DOI 10.1016/S0079-6611(00)00030-6; Van Dover CL, 2003, DEEP-SEA RES PT I, V50, P281, DOI 10.1016/S0967-0637(02)00162-0; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; Van Gaever S, 2006, MAR ECOL PROG SER, V321, P143, DOI 10.3354/meps321143; Van Gaever S, 2010, MAR ECOL-EVOL PERSP, V31, P66, DOI 10.1111/j.1439-0485.2009.00314.x; Van Gaever S, 2009, DEEP-SEA RES PT II, V56, P2259, DOI 10.1016/j.dsr2.2009.04.008; Van Gaever S, 2009, DEEP-SEA RES PT I, V56, P772, DOI 10.1016/j.dsr.2008.12.015; Van Gaever S, 2009, MAR BIOL, V156, P1289, DOI 10.1007/s00227-009-1170-9; Vanhove S, 2004, DEEP-SEA RES PT II, V51, P1665, DOI 10.1016/j.dsr2.2004.06.029; Vanhove S, 1998, J MAR BIOL ASSOC UK, V78, P411, DOI 10.1017/S0025315400041539; VANHOVE S, 1995, MAR ECOL PROG SER, V127, P65, DOI 10.3354/meps127065; VANHOVE S, 1997, BELGIAN RES PROGRAMM, V3, P1; Vanreusel A, 1997, MAR ECOL PROG SER, V157, P207, DOI 10.3354/meps157207; Vanreusel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012449; Vanreusel A, 2009, OCEANOGRAPHY, V22, P110, DOI 10.5670/oceanog.2009.12; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Vincx Magda, 1996, P187; Warwick R, 1998, SYNOPSES BRIT FAUNA, V53, P1; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; Widdicombe S, 1999, MAR ECOL PROG SER, V189, P181, DOI 10.3354/meps189181; Zekely J, 2006, DEEP-SEA RES PT I, V53, P1363, DOI 10.1016/j.dsr.2006.05.010	76	23	23	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22240	10.1371/journal.pone.0022240	http://dx.doi.org/10.1371/journal.pone.0022240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799799	Green Submitted, Green Published, gold			2022-12-25	WOS:000292931200036
J	Packer, C; Swanson, A; Ikanda, D; Kushnir, H				Packer, Craig; Swanson, Alexandra; Ikanda, Dennis; Kushnir, Hadas			Fear of Darkness, the Full Moon and the Nocturnal Ecology of African Lions	PLOS ONE			English	Article							NATIONAL-PARK; MOONLIGHT AVOIDANCE; HUNTING SUCCESS; PREDATION RISK; CARNIVORES; BEHAVIOR	Nocturnal carnivores are widely believed to have played an important role in human evolution, driving the need for night-time shelter, the control of fire and our innate fear of darkness. However, no empirical data are available on the effects of darkness on the risks of predation in humans. We performed an extensive analysis of predatory behavior across the lunar cycle on the largest dataset of lion attacks ever assembled and found that African lions are as sensitive to moonlight when hunting humans as when hunting herbivores and that lions are most dangerous to humans when the moon is faint or below the horizon. At night, people are most active between dusk and 10: 00 pm, thus most lion attacks occur in the first weeks following the full moon (when the moon rises at least an hour after sunset). Consequently, the full moon is a reliable indicator of impending danger, perhaps helping to explain why the full moon has been the subject of so many myths and misconceptions.	[Packer, Craig; Swanson, Alexandra; Kushnir, Hadas] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Ikanda, Dennis] Tanzanian Wildlife Res Inst, Arusha, Tanzania	University of Minnesota System; University of Minnesota Twin Cities	Packer, C (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	packer@umn.edu	Callahan, Charles D/L-1641-2013		NSF [DEB-0343960, 0918142]; Biocomplexity grant [BE-0308486]; Wildlife Conservation Society; Tanzanian Wildlife Protection Fund; Panthera; Direct For Biological Sciences [1020479] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Biocomplexity grant; Wildlife Conservation Society; Tanzanian Wildlife Protection Fund; Panthera; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Research in the Serengeti and Ngorongoro was funded by NSF LTREB grants DEB-0343960 and 0918142 and Biocomplexity grant BE-0308486. Funding for the surveys in southeastern Tanzania came from Wildlife Conservation Society, Tanzanian Wildlife Protection Fund and Panthera. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000251; BERTRAM B C R, 1975, East African Wildlife Journal, V13, P141; CLOTTES J, 2001, GROTTE CHAUVET ART O, P177; DALY M, 1992, ANIM BEHAV, V44, P1, DOI 10.1016/S0003-3472(05)80748-1; Darwin G., 1871, P423; de Heinzelin J, 1999, SCIENCE, V284, P625; Di Bitetti MS, 2006, J ZOOL, V270, P153, DOI 10.1111/j.1469-7998.2006.00102.x; Foster RG, 2008, CURR BIOL, V18, pR784, DOI 10.1016/j.cub.2008.07.003; Funston PJ, 2001, J ZOOL, V253, P419, DOI 10.1017/S0952836901000395; Gilbert WH, 2008, MID AWASH SER, V1, P1; Gurung B, 2008, BIOL CONSERV, V141, P3069, DOI 10.1016/j.biocon.2008.09.013; Hayward MW, 2009, S AFR J WILDL RES, V39, P109, DOI 10.3957/056.039.0207; Kissui BM, 2004, P ROY SOC B-BIOL SCI, V271, P1867, DOI 10.1098/rspb.2004.2797; Klein R., 2009, HUMAN CAREER; Kushnir H., 2010, Human Dimensions of Wildlife, V15, P315, DOI 10.1080/10871200903510999; Lang AB, 2006, OECOLOGIA, V146, P659, DOI 10.1007/s00442-005-0131-3; Lewis ME, 2007, VERTEBR PALEOBIOL PA, P77, DOI 10.1007/978-1-4020-3098-7_4; Loe J, 2004, AMBIO, V33, P283, DOI 10.1639/0044-7447(2004)033[0283:LCAHSA]2.0.CO;2; McPherron SP, 2010, NATURE, V466, P857, DOI 10.1038/nature09248; Mougeot F, 2000, J AVIAN BIOL, V31, P376, DOI 10.1034/j.1600-048X.2000.310314.x; OWENS M, 1998, GER J PSYCHIAT, V9, P123; Packer C, 2005, NATURE, V436, P927, DOI 10.1038/436927a; Packer C, 2005, SCIENCE, V307, P390, DOI 10.1126/science.1105122; PETERHANS JCK, 2001, J E AFRICAN NATURAL, V90, P1, DOI DOI 10.2982/0012-8317(2001)90[1:TSOMAL]2.0.CO;2; R Development Core Team, 2009, R FDN STAT COMP; VANORSDOL KG, 1984, AFR J ECOL, V22, P79; Voracek M, 2008, WIEN KLIN WOCHENSCHR, V120, P343, DOI 10.1007/s00508-008-0985-6; Worthman C.M., 2002, ADOLESCENT SLEEP PAT, P69, DOI DOI 10.1017/CBO9780511499999.009	28	75	76	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22285	10.1371/journal.pone.0022285	http://dx.doi.org/10.1371/journal.pone.0022285			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799812	Green Submitted, gold, Green Published			2022-12-25	WOS:000292931200044
J	Walter, E; Dassonville, P				Walter, Elizabeth; Dassonville, Paul			Activation in a Frontoparietal Cortical Network Underlies Individual Differences in the Performance of an Embedded Figures Task	PLOS ONE			English	Article							EVENT-RELATED FMRI; AUTISM; CHILDREN; CORTEX; SUSCEPTIBILITY; PERCEPTION; SEARCH; BRAIN; SPACE	The Embedded Figures Test (EFT) requires observers to search for a simple geometric shape hidden inside a more complex figure. Surprisingly, performance in the EFT is negatively correlated with susceptibility to illusions of spatial orientation, such as the Roelofs effect. Using fMRI, we previously demonstrated that regions in parietal cortex are involved in the contextual processing associated with the Roelofs task. In the present study, we found that similar parietal regions (superior parietal cortex and precuneus) were more active during the EFT than during a simple matching task. Importantly, these parietal activations overlapped with regions found to be involved during contextual processing in the Roelofs illusion. Additional parietal and frontal areas, in the right hemisphere, showed strong correlations between brain activity and behavioral performance during the search task. We propose that the posterior parietal regions are necessary for processing contextual information across many different, but related visuospatial tasks, with additional parietal and frontal regions serving to coordinate this processing in participants proficient in the task.	[Walter, Elizabeth] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon; University of Oregon	Walter, E (corresponding author), Univ Oregon, Dept Psychol, Eugene, OR 97403 USA.	prd@uoregon.edu			NIH [5-T32-GM07257]; Telemedicine and Advanced Technology Research Center [DAMD17-01-1-0750]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007257] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telemedicine and Advanced Technology Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	External funding for this study was provided by an NIH Systems Physiology Training Grant (5-T32-GM07257) to EW and an award from the Telemedicine and Advanced Technology Research Center (DAMD17-01-1-0750) to PD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Bridgeman B, 1997, PERCEPT PSYCHOPHYS, V59, P456, DOI 10.3758/BF03211912; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Dassonville P, 2004, PLOS BIOL, V2, P1936, DOI 10.1371/journal.pbio.0020364; Dassonville P, 2004, VISION RES, V44, P603, DOI 10.1016/j.visres.2003.10.017; de Jonge MV, 2006, J AUTISM DEV DISORD, V36, P677, DOI 10.1007/s10803-006-0113-2; Ekstrom R.B., 1976, MANUAL KIT FACTOR RE; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Jolliffe T, 1997, J CHILD PSYCHOL PSYC, V38, P527, DOI 10.1111/j.1469-7610.1997.tb01539.x; Lee PS, 2007, NEUROIMAGE, V38, P184, DOI 10.1016/j.neuroimage.2007.07.013; Manjaly ZM, 2007, NEUROIMAGE, V35, P283, DOI 10.1016/j.neuroimage.2006.11.036; Manjaly ZM, 2003, NEUROIMAGE, V19, P674, DOI 10.1016/S1053-8119(03)00095-8; Ring HA, 1999, BRAIN, V122, P1305, DOI 10.1093/brain/122.7.1305; Ropar D, 2001, J CHILD PSYCHOL PSYC, V42, P539, DOI 10.1017/S002196300100717X; Serences JT, 2005, PSYCHOL SCI, V16, P114, DOI 10.1111/j.0956-7976.2005.00791.x; SHAH A, 1983, J CHILD PSYCHOL PSYC, V24, P613, DOI 10.1111/j.1469-7610.1983.tb00137.x; Shannon CE, 1949, MATH THEORY COMMUNIC, p[v, vii, 117]; Talairach J., 1988, COPLANAR STEREOTAXIC; Walter E, 2008, NEUROIMAGE, V42, P1686, DOI 10.1016/j.neuroimage.2008.06.016; Walter E, 2009, J AUTISM DEV DISORD, V39, P339, DOI 10.1007/s10803-008-0630-2; Witkin H A, 1981, Psychol Issues, P1; Witkin H. A., 1954, PERSONALITY PERCEPTI; WITKIN HA, 1948, J EXP PSYCHOL, V38, P762, DOI 10.1037/h0053671; WITKIN HA, 1950, J PERS, V19, P1, DOI 10.1111/j.1467-6494.1950.tb01084.x	27	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e20742	10.1371/journal.pone.0020742	http://dx.doi.org/10.1371/journal.pone.0020742			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799729	Green Published, gold, Green Submitted			2022-12-25	WOS:000292931200003
J	Amoedo, ND; Rodrigues, MF; Pezzuto, P; Galina, A; da Costa, RM; de Almeida, FCL; El-Bacha, T; Rumjanek, FD				Amoedo, Nivea Dias; Rodrigues, Mariana Figueiredo; Pezzuto, Paula; Galina, Antonio; da Costa, Rodrigo Madeiro; Lacerda de Almeida, Fabio Ceneviva; El-Bacha, Tatiana; Rumjanek, Franklin David			Energy Metabolism in H460 Lung Cancer Cells: Effects of Histone Deacetylase Inhibitors	PLOS ONE			English	Article							OXYGEN SPECIES GENERATION; GLUCOSE-METABOLISM; TUMOR-CELLS; EXPRESSION; VALPROATE; GROWTH; MITOCHONDRIA; RESPIRATION; PATHWAYS	Background: Tumor cells are characterized by accelerated growth usually accompanied by up-regulated pathways that ultimately increase the rate of ATP production. These cells can suffer metabolic reprogramming, resulting in distinct bioenergetic phenotypes, generally enhancing glycolysis channeled to lactate production. In the present work we showed metabolic reprogramming by means of inhibitors of histone deacetylase (HDACis), sodium butyrate and trichostatin. This treatment was able to shift energy metabolism by activating mitochondrial systems such as the respiratory chain and oxidative phosphorylation that were largely repressed in the untreated controls. Methodology/Principal Findings: Various cellular and biochemical parameters were evaluated in lung cancer H460 cells treated with the histone deacetylase inhibitors (HDACis), sodium butyrate (NaB) and trichostatin A (TSA). NaB and TSA reduced glycolytic flux, assayed by lactate release by H460 cells in a concentration dependent manner. NaB inhibited the expression of glucose transporter type 1 (GLUT 1), but substantially increased mitochondria bound hexokinase (HK) activity. NaB induced increase in HK activity was associated to isoform HK I and was accompanied by 1.5 fold increase in HK I mRNA expression and cognate protein biosynthesis. Lactate dehydrogenase (LDH) and pyruvate kinase (PYK) activities were unchanged by HDACis suggesting that the increase in the HK activity was not coupled to glycolytic flux. High resolution respirometry of H460 cells revealed NaB-dependent increased rates of oxygen consumption coupled to ATP synthesis. Metabolomic analysis showed that NaB altered the glycolytic metabolite profile of intact H460 cells. Concomitantly we detected an activation of the pentose phosphate pathway (PPP). The high O-2 consumption in NaB-treated cells was shown to be unrelated to mitochondrial biogenesis since citrate synthase (CS) activity and the amount of mitochondrial DNA remained unchanged. Conclusion: NaB and TSA induced an increase in mitochondrial function and oxidative metabolism in H460 lung tumor cells concomitant with a less proliferative cellular phenotype.	[Amoedo, Nivea Dias; Rodrigues, Mariana Figueiredo; Pezzuto, Paula; Galina, Antonio; da Costa, Rodrigo Madeiro; Lacerda de Almeida, Fabio Ceneviva; El-Bacha, Tatiana; Rumjanek, Franklin David] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Amoedo, ND (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Cidade Univ, Rio De Janeiro, Brazil.	franklin@bioqmed.ufrj.br	El-Bacha, Tatiana/ABH-1287-2020; Galina, Antonio/A-9292-2008	El-Bacha, Tatiana/0000-0003-0809-0218; Rumjanek, Franklin/0000-0002-6618-7096	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao do Cancer; Brazilian Institute of Neuroscience - IBNnet FINEP; INCT - Excitotoxicity and Neuroprotection [01.06.0842]; INCT - Cancer	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao do Cancer; Brazilian Institute of Neuroscience - IBNnet FINEP; INCT - Excitotoxicity and Neuroprotection; INCT - Cancer	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundacao do Cancer, Brazilian Institute of Neuroscience - IBNnet FINEP, INCT - Excitotoxicity and Neuroprotection #01.06.0842 and INCT - Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Alcarraz-Vizan G, 2010, METABOLOMICS, V6, P229, DOI 10.1007/s11306-009-0192-0; Annibaldi A, 2010, CURR OPIN CLIN NUTR, V13, P466, DOI 10.1097/MCO.0b013e32833a5577; Boren J, 2003, J BIOL CHEM, V278, P28395, DOI 10.1074/jbc.M302932200; Boren J, 2002, MOL BIOL REP, V29, P7, DOI 10.1023/A:1020333730485; Cervera AM, 2008, CANCER RES, V68, P4058, DOI 10.1158/0008-5472.CAN-07-5580; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; da-Silva WS, 2004, J BIOL CHEM, V279, P39846, DOI 10.1074/jbc.M403835200; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; GUAN KL, 2010, TRENDS BIOCH SCI; HAMILTON SD, 1984, CLIN CHEM, V30, P226; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lamprecht W, 1974, METHOD ENZYMAT AN, P2101; Lecona E, 2008, BIOCHEM J, V409, P311, DOI 10.1042/BJ20070374; Lee MN, 2010, J NATL CANCER I, V102, P426, DOI 10.1093/jnci/djq026; Leschelle X, 2000, EUR J BIOCHEM, V267, P6435, DOI 10.1046/j.1432-1327.2000.01731.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marin-Hernandez A, 2011, BBA-BIOENERGETICS, V1807, P755, DOI 10.1016/j.bbabio.2010.11.006; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Merkwirth C, 2008, CELL, V135, P1165, DOI 10.1016/j.cell.2008.12.005; Meyer LE, 2006, J BIOL CHEM, V281, P37361, DOI 10.1074/jbc.M604123200; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; da Silva APP, 2009, BIOCHEM J, V417, P717, DOI 10.1042/BJ20080805; PONCHAUT S, 1992, BIOCHEM PHARMACOL, V43, P644, DOI 10.1016/0006-2952(92)90590-F; Sanderson L, 2004, DRUG METAB DISPOS, V32, P1132, DOI 10.1124/dmd.104.000638; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Silva MFB, 2001, CHEM-BIOL INTERACT, V137, P203, DOI 10.1016/S0009-2797(01)00234-4; TURNBULL DM, 1983, BIOCHEM PHARMACOL, V32, P1887, DOI 10.1016/0006-2952(83)90054-0; WARBURG O, 1956, SCIENCE, V124, P269; Wardell SE, 2009, MOL ENDOCRINOL, V23, P388, DOI 10.1210/me.2008-0179; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599	40	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22264	10.1371/journal.pone.0022264	http://dx.doi.org/10.1371/journal.pone.0022264			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789245	Green Published, Green Submitted, gold			2022-12-25	WOS:000292812400043
J	Kolb, AF; Huber, RC; Lillico, SG; Carlisle, A; Robinson, CJ; Neil, C; Petrie, L; Sorensen, DB; Olsson, IAS; Whitelaw, CBA				Kolb, Andreas F.; Huber, Reinhard C.; Lillico, Simon G.; Carlisle, Ailsa; Robinson, Claire J.; Neil, Claire; Petrie, Linda; Sorensen, Dorte B.; Olsson, I. Anna S.; Whitelaw, C. Bruce A.			Milk Lacking alpha-Casein Leads to Permanent Reduction in Body Size in Mice	PLOS ONE			English	Article							MAMMARY-GLAND DEVELOPMENT; EQUILIBRIUM THERMODYNAMIC MODEL; LATER OBESITY RISK; ENDOPLASMIC-RETICULUM; CALCIUM-PHOSPHATE; EPITHELIAL-CELLS; KAPPA-CASEIN; BETA-CASEIN; PROTEIN SECRETION; TRANSGENIC MICE	The major physiological function of milk is the transport of amino acids, carbohydrates, lipids and minerals to mammalian offspring. Caseins, the major milk proteins, are secreted in the form of a micelle consisting of protein and calcium-phosphate. We have analysed the role of the milk protein alpha-casein by inactivating the corresponding gene in mice. Absence of alpha-casein protein significantly curtails secretion of other milk proteins and calcium-phosphate, suggesting a role for alpha-casein in the establishment of casein micelles. In contrast, secretion of albumin, which is not synthesized in the mammary epithelium, into milk is not reduced. The absence of alpha-casein also significantly inhibits transcription of the other casein genes. alpha-Casein deficiency severely delays pup growth during lactation and results in a life-long body size reduction compared to control animals, but has only transient effects on physical and behavioural development of the pups. The data support a critical role for alpha-casein in casein micelle assembly. The results also confirm lactation as a critical window of metabolic programming and suggest milk protein concentration as a decisive factor in determining adult body weight.	[Kolb, Andreas F.; Robinson, Claire J.] Hannah Res Inst, Mol Recognit Grp, Ayr KA6 5HL, Scotland; [Kolb, Andreas F.; Petrie, Linda] Univ Aberdeen, Nutr & Epigenet Grp, Vasc Hlth Div, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Huber, Reinhard C.; Olsson, I. Anna S.] Univ Porto, Lab Anim Sci Grp, Inst Biol Mol & Celular, P-4100 Oporto, Portugal; [Huber, Reinhard C.; Lillico, Simon G.; Carlisle, Ailsa; Neil, Claire; Whitelaw, C. Bruce A.] Univ Edinburgh, Div Dev Biol, Roslin Inst, Edinburgh, Midlothian, Scotland; [Huber, Reinhard C.; Lillico, Simon G.; Carlisle, Ailsa; Neil, Claire; Whitelaw, C. Bruce A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland; [Sorensen, Dorte B.] Univ Copenhagen, Dept Large Anim Sci, Copenhagen, Denmark; [Huber, Reinhard C.; Olsson, I. Anna S.] Univ Copenhagen, Fac Life Sci, Danish Ctr Bioeth & Risk Assessment, Copenhagen, Denmark	University of Aberdeen; Universidade do Porto; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Copenhagen; University of Copenhagen	Kolb, AF (corresponding author), Hannah Res Inst, Mol Recognit Grp, Ayr KA6 5HL, Scotland.	a.kolb@abdn.ac.uk	Olsson, Anna/C-1792-2008; Lillico, Simon/X-6233-2019	Olsson, Anna/0000-0002-4369-8723; Lillico, Simon/0000-0002-5101-2277; Whitelaw, Bruce/0000-0002-2918-1605; Kolb, Andreas/0000-0001-9056-5504; Sorensen, Dorte Bratbo/0000-0002-6144-1710	Scottish Executive Environment and Rural Affairs Department [ROAME 31190]; BBSRC through ISPG; Gene Technologies [12599]; Hannah Development Fund; Genomia Seed Fund; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/36682/2007]; European Commission [NEST029025]; Biotechnology and Biological Sciences Research Council [BBS/E/D/05251442, BBS/E/D/05251444, BBS/E/D/05251445, BBS/E/D/05251443] Funding Source: researchfish; BBSRC [BBS/E/D/05251443, BBS/E/D/05251445, BBS/E/D/05251442, BBS/E/D/05251444] Funding Source: UKRI	Scottish Executive Environment and Rural Affairs Department; BBSRC through ISPG(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gene Technologies; Hannah Development Fund; Genomia Seed Fund; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Scottish Executive Environment and Rural Affairs Department (ROAME 31190), the BBSRC through ISPG support and Gene Technologies underpinning Health Care project grant #12599, the Hannah Development Fund and the Genomia Seed Fund, the Fundacao para a Ciencia e a Tecnologia (PhD grant to RH SFRH/BD/36682/2007), and the European Commission NEST029025 project INTEGRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beierle EA, 2004, PEDIATR RES, V56, P250, DOI 10.1203/01.PDR.0000132753.81333.39; Bellinger L, 2004, BRIT J NUTR, V92, P513, DOI 10.1079/BJN20041224; Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005; Boisgard R, 2000, BBA-MOL CELL RES, V1495, P281, DOI 10.1016/S0167-4889(99)00167-6; Brawley L, 2003, PEDIATR RES, V54, P83, DOI 10.1203/01.PDR.0000065731.00639.02; Cao YX, 2003, J MAMMARY GLAND BIOL, V8, P215, DOI 10.1023/A:1025905008934; Chanat E, 1999, J CELL SCI, V112, P3399; Chatterjee D, 2007, BRAIN RES, V1158, P11, DOI 10.1016/j.brainres.2007.04.069; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Cripps RL, 2009, CLIN SCI, V117, P85, DOI 10.1042/CS20080393; de Roos B, 2008, PROTEOMICS, V8, P1965, DOI 10.1002/pmic.200700457; Flint DJ, 2006, J MOL ENDOCRINOL, V36, P435, DOI 10.1677/jme.1.01873; Ginger MR, 1999, COMP BIOCHEM PHYS B, V124, P133, DOI 10.1016/S0305-0491(99)00110-8; Hales CN, 2003, J PHYSIOL-LONDON, V547, P5, DOI 10.1113/jphysiol.2002.024406; HOLT C, 1988, PROTEIN ENG, V2, P251, DOI 10.1093/protein/2.4.251; Holt C, 2004, EUR BIOPHYS J BIOPHY, V33, P421, DOI 10.1007/s00249-003-0377-9; HOLT C, 1982, BIOCHIM BIOPHYS ACTA, V719, P299, DOI 10.1016/0304-4165(82)90102-7; HOLT C, 1992, ADV PROTEIN CHEM, V43, P63, DOI 10.1016/S0065-3233(08)60554-9; Holt C, 2009, FEBS J, V276, P2308, DOI 10.1111/j.1742-4658.2009.06958.x; JENNESS R, 1987, EXPERIENTIA, V43, P1015, DOI 10.1007/BF01952224; Kantor L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003783; Kappeler L, 2009, ENDOCRINOLOGY, V150, P314, DOI 10.1210/en.2008-0981; Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; Kolb AF, 1999, GENE, V227, P21, DOI 10.1016/S0378-1119(98)00607-6; Kolb AF, 1996, J GEN VIROL, V77, P2515, DOI 10.1099/0022-1317-77-10-2515; Koletzko B, 2006, NESTLE NUTR WORKS SE, V58, P1, DOI 10.1159/000094838; Koletzko B, 2009, AM J CLIN NUTR, V89, P1836, DOI 10.3945/ajcn.2008.27091; Koletzko B, 2009, AM J CLIN NUTR, V89, pS1502, DOI 10.3945/ajcn.2009.27113D; KOZUTSUMI Y, 1989, J CELL SCI, P115; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; KRUKOWSKI M, 1987, BONE, V8, P251, DOI 10.1016/8756-3282(87)90173-6; KUMAR S, 1994, P NATL ACAD SCI USA, V91, P6138, DOI 10.1073/pnas.91.13.6138; Levin BE, 2006, PHILOS T R SOC B, V361, P1107, DOI 10.1098/rstb.2006.1851; Little EM, 2004, EUR BIOPHYS J BIOPHY, V33, P435, DOI 10.1007/s00249-003-0376-x; Matsukura S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng077; McMahon DJ, 2008, J DAIRY SCI, V91, P1709, DOI 10.3168/jds.2007-0819; McManaman JL, 2004, ADV EXP MED BIOL, V554, P263; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; MELNICK J, 1992, J BIOL CHEM, V267, P21303; NEVILLE MC, 1979, J PHYSIOL-LONDON, V290, P59, DOI 10.1113/jphysiol.1979.sp012759; Ozanne SE, 2004, CLIN SCI, V106, P141, DOI 10.1042/CS20030278; Palmer CA, 2003, TRANSGENIC RES, V12, P283, DOI 10.1023/A:1023398926763; Pauloin A, 1997, EUR J CELL BIOL, V72, P324; RIJNKELS M, 1995, BIOCHEM J, V311, P929, DOI 10.1042/bj3110929; Rijnkels M, 2002, J MAMMARY GLAND BIOL, V7, P327, DOI 10.1023/A:1022808918013; Robinson C, 2009, EXP CELL RES, V315, P508, DOI 10.1016/j.yexcr.2008.10.029; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SAWYER L, 1993, J DAIRY SCI, V76, P3062, DOI 10.3168/jds.S0022-0302(93)77646-8; Shekar PC, 2006, P NATL ACAD SCI USA, V103, P8000, DOI 10.1073/pnas.0601611103; Sorrell DA, 2005, J DAIRY RES, V72, P433, DOI 10.1017/S0022029905001202; Stevenson EM, 1994, INT DAIRY J, V4, P205, DOI 10.1016/0958-6946(94)90013-2; Szymanowska M, 2009, J CELL BIOCHEM, V106, P52, DOI 10.1002/jcb.21975; TZIBOULACLARKE A, 2002, ENCY DAIRY SCI; Velkoska E, 2008, J NUTR, V138, P1622, DOI 10.1093/jn/138.9.1622; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079; Ziegler EE, 2006, NESTLE NUTR WORKS SE, V58, P51, DOI 10.1159/000095010	58	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e21775	10.1371/journal.pone.0021775	http://dx.doi.org/10.1371/journal.pone.0021775			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789179	gold, Green Published, Green Submitted			2022-12-25	WOS:000292812400014
J	Patnaik, SK; Kannisto, E; Mallick, R; Yendamuri, S				Patnaik, Santosh Kumar; Kannisto, Eric; Mallick, Reema; Yendamuri, Sai			Overexpression of the Lung Cancer-Prognostic miR-146b MicroRNAs Has a Minimal and Negative Effect on the Malignant Phenotype of A549 Lung Cancer Cells	PLOS ONE			English	Article							EXPRESSION PROFILES; STRAND SELECTION; INHIBITION; MIGRATION; INVASION; TARGET	Introduction: Expression levels of miR-146b-5p and -3p microRNAs in human non-small cell lung cancer (NSCLC) are associated with recurrence of the disease after surgery. To understand this, the effect of miR-146b overexpression was studied in A549 human lung cancer cells. Methods: A549 cells, engineered with lentiviruses to overexpress the human pre-miR-146b precursor microRNA, were examined for proliferation, colony formation on plastic surface and in soft agar, migration and invasiveness in cell culture and in vivo in mice, chemosensitivity to cisplatin and doxorubicin, and global gene expression. miR-146b expressions were assessed in microdissected stroma and epithelia of human NSCLC tumors. Association of miR-146b-5p and -3p expression in early stage NSCLC with recurrence was analyzed. Principal Findings: A549 pre-miR-146b-overexpressors had 3-8-fold higher levels of both miR-146b microRNAs than control cells. Overexpression did not alter cellular proliferation, chemosensitivity, migration, or invasiveness; affected only 0.3% of the mRNA transcriptome; and, reduced the ability to form colonies in vitro by 25%. In human NSCLC tumors, expression of both miR-146b microRNAs was 7-10-fold higher in stroma than in cancerous epithelia, and higher miR-146b-5p but lower 3p levels were predictive of recurrence. Conclusions: Only a minimal effect of pre-miR-146b overexpression on the malignant phenotype was seen in A549 cells. This could be because of opposing effects of miR-146b-5p and -3p overexpression as suggested by the conflicting recurrence-predictive values of the two microRNAs, or because miR-146b expression changes in non-cancerous stroma and not cancerous epithelia of tumors are responsible for the prognostic value of miR-146b.	[Patnaik, Santosh Kumar; Kannisto, Eric; Yendamuri, Sai] Roswell Pk Canc Inst, Dept Thorac Surg, Buffalo, NY 14263 USA; [Mallick, Reema] Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Rootstown, OH 44272 USA; [Yendamuri, Sai] SUNY Buffalo, Dept Surg, Buffalo, NY 14260 USA	Roswell Park Cancer Institute; Northeast Ohio Medical University (NEOMED); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Patnaik, SK (corresponding author), Roswell Pk Canc Inst, Dept Thorac Surg, Buffalo, NY 14263 USA.	sai.yendamuri@roswellpark.org		Yendamuri, Sai/0000-0001-6654-3487	American Association of Thoracic Surgery; Buswell Foundation; Cancer and Leukemia Group B; Thoracic Surgery Foundation for Research and Education; NATIONAL CANCER INSTITUTE [K23CA149076, P30CA016056] Funding Source: NIH RePORTER	American Association of Thoracic Surgery; Buswell Foundation; Cancer and Leukemia Group B; Thoracic Surgery Foundation for Research and Education; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Summer Internship award from the American Association of Thoracic Surgery to RM, and awards from the Buswell Foundation, Cancer and Leukemia Group B, and the Thoracic Surgery Foundation for Research and Education to SY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarini A, 2011, CURR BIOL, V21, P369, DOI 10.1016/j.cub.2011.01.067; Backhus LM, 2006, J THORAC CARDIOV SUR, V132, P297, DOI 10.1016/j.jtcvs.2005.10.060; Bannister SC, 2009, BIOL REPROD, V81, P165, DOI 10.1095/biolreprod.108.074005; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Chatterjee S, 2011, DEV CELL, V20, P388, DOI 10.1016/j.devcel.2011.02.008; Chen PY, 2008, RNA, V14, P263, DOI 10.1261/rna.789808; Chou CK, 2010, THYROID, V20, P489, DOI 10.1089/thy.2009.0027; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; DWEEP H, 2011, J BIOMED INFORM; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Esau CC, 2008, METHODS, V44, P55, DOI 10.1016/j.ymeth.2007.11.001; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Hsu YC, 2009, CLIN CANCER RES, V15, P7309, DOI 10.1158/1078-0432.CCR-09-1572; Hu HY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-413; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Katakowski M, 2010, CANCER INVEST, V28, P1024, DOI 10.3109/07357907.2010.512596; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee HC, 2011, BIOCHEM BIOPH RES CO, V404, P1065, DOI 10.1016/j.bbrc.2010.12.114; Li K, 2010, CANCER INVEST, V28, P479, DOI 10.3109/07357900903476745; Merkerova M, 2010, STEM CELLS DEV, V19, P17, DOI 10.1089/scd.2009.0071; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Ogata A, 2010, BIOORG MED CHEM LETT, V20, P7299, DOI 10.1016/j.bmcl.2010.10.077; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Patnaik SK, 2010, CANCER RES, V70, P36, DOI 10.1158/0008-5472.CAN-09-3153; Petriv OI, 2010, P NATL ACAD SCI USA, V107, P15443, DOI 10.1073/pnas.1009320107; Qi B, 2009, CURR PHARM DESIGN, V15, P2336, DOI 10.2174/138161209788682352; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Sempere LF, 2010, CLIN CANCER RES, V16, P4246, DOI 10.1158/1078-0432.CCR-10-1152; Wang Y, 2008, CLIN GENET, V74, P307, DOI 10.1111/j.1399-0004.2008.01075.x; Winter J, 2011, METHODS MOL BIOL, V676, P3, DOI 10.1007/978-1-60761-863-8_1; Xia HP, 2009, BRAIN RES, V1269, P158, DOI 10.1016/j.brainres.2009.02.037; Yang JH, 2010, NUCLEIC ACIDS RES, V38, pD123, DOI 10.1093/nar/gkp943; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	34	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22379	10.1371/journal.pone.0022379	http://dx.doi.org/10.1371/journal.pone.0022379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789255	Green Published, Green Submitted, gold			2022-12-25	WOS:000292812400048
J	Hamanaka, S; Yamaguchi, T; Kobayashi, T; Kato-Itoh, M; Yamazaki, S; Sato, H; Umino, A; Wakiyama, Y; Arai, M; Sanbo, M; Hirabayashi, M; Nakauchi, H				Hamanaka, Sanae; Yamaguchi, Tomoyuki; Kobayashi, Toshihiro; Kato-Itoh, Megumi; Yamazaki, Satoshi; Sato, Hideyuki; Umino, Ayumi; Wakiyama, Yukiko; Arai, Mami; Sanbo, Makoto; Hirabayashi, Masumi; Nakauchi, Hiromitsu			Generation of Germline-Competent Rat Induced Pluripotent Stem Cells	PLOS ONE			English	Article							HUMAN FIBROBLASTS; DEFINED FACTORS; MOUSE; LINES; ESTABLISHMENT; BLASTOCYSTS; MODELS; NANOG; PIG	Background: Recent progress in rat pluripotent stem cell technology has been remarkable. Particularly salient is the demonstration that embryonic stem cells (ESCs) in the rat (rESCs) can contribute to germline transmission, permitting generation of gene-modified rats as is now done using mouse ESCs (mESCs) or mouse induced pluripotent stem cells (iPSCs; miPSCs). However, determinations of whether rat iPSCs (riPSCs) can contribute to germ cells are not published. Here we report the germline competency of riPSCs. Methodology/Principal Findings: We generated riPSCs by transducing three mouse reprogramming factors (Oct3/4, Klf4, and Sox2) into rat somatic cells, followed by culture in the presence of exogenous rat leukemia inhibitory factor (rLIF) and small molecules that specifically inhibit GSK3, MEK, and FGF receptor tyrosine kinases. We found that, like rESCs, our riPSCs can contribute to germline transmission. Furthermore we found, by immunostaining of testis from mouse-rat interspecific chimeras with antibody against mouse vasa homolog, that riPSCs can contribute to embryonic development with chimera formation in mice (rat-mouse interspecific chimeras) and to interspecific germlines. Conclusions/Significance: Our data clearly demonstrate that using only three reprogramming factors (Oct3/4, Klf4, and Sox2) rat somatic cells can be reprogrammed into a ground state. Our generated riPSCs exhibited germline transmission in either rat-rat intraspecific or mouse-rat interspecific chimeras.	[Hamanaka, Sanae; Yamaguchi, Tomoyuki; Kobayashi, Toshihiro; Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO, Nakauchi Stem Cell & Organ Regenerat Project, Tokyo, Japan; [Hamanaka, Sanae; Yamaguchi, Tomoyuki; Kobayashi, Toshihiro; Kato-Itoh, Megumi; Yamazaki, Satoshi; Sato, Hideyuki; Umino, Ayumi; Wakiyama, Yukiko; Arai, Mami; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy, Tokyo, Japan; [Sanbo, Makoto; Hirabayashi, Masumi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Okazaki, Aichi 444, Japan; [Hirabayashi, Masumi] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi, Japan	Japan Science & Technology Agency (JST); University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan	Hamanaka, S (corresponding author), Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO, Nakauchi Stem Cell & Organ Regenerat Project, Tokyo, Japan.	tomoyama@ims.u-tokyo.ac.jp; nakauchi@ims.u-tokyo.ac.jp	Hirabayashi, Masumi/C-8935-2019	Hirabayashi, Masumi/0000-0002-1059-5883; Kobayashi, Toshihiro/0000-0001-8019-0008	Japan Science and Technology Agency; Ministry of Education, Culture, Sport, Science, and Technology, Japan; National Institute for Physiological Sciences, Japan	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sport, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute for Physiological Sciences, Japan	This work was supported by grants from the Japan Science and Technology Agency, the Ministry of Education, Culture, Sport, Science, and Technology, Japan, and in part by the Cooperative Study Program of National Institute for Physiological Sciences, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chang MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009838; Demers SP, 2007, CLONING STEM CELLS, V9, P512, DOI 10.1089/clo.2007.0029; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Hirabayashi M, 2010, MOL REPROD DEV, V77, P94, DOI 10.1002/mrd.21123; Honda A, 2010, J BIOL CHEM, V285, P31362, DOI 10.1074/jbc.M110.150540; Honda A, 2008, REPROD BIOMED ONLINE, V17, P706, DOI 10.1016/S1472-6483(10)60320-3; Kawamata M, 2010, P NATL ACAD SCI USA, V107, P14223, DOI 10.1073/pnas.1009582107; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nagy A., 2003, MANIPULATING MOUSE E; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takayama N, 2010, J EXP MED, V207, P2817, DOI 10.1084/jem.20100844; Tomioka I, 2010, GENES CELLS, V15, P959, DOI 10.1111/j.1365-2443.2010.01437.x; Ueda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002800; Vassilieva S, 2000, EXP CELL RES, V258, P361, DOI 10.1006/excr.2000.4940; Wu YH, 2010, STEM CELL RES, V4, P180, DOI 10.1016/j.scr.2010.02.003; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	31	55	59	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22008	10.1371/journal.pone.0022008	http://dx.doi.org/10.1371/journal.pone.0022008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789202	gold, Green Published, Green Submitted			2022-12-25	WOS:000292811700013
J	Lalevee, S; Anno, YN; Chatagnon, A; Samarut, E; Poch, O; Laudet, V; Benoit, G; Lecompte, O; Rochette-Egly, C				Lalevee, Sebastien; Anno, Yannick N.; Chatagnon, Amandine; Samarut, Eric; Poch, Olivier; Laudet, Vincent; Benoit, Gerard; Lecompte, Odile; Rochette-Egly, Cecile			Genome-wide in Silico Identification of New Conserved and Functional Retinoic Acid Receptor Response Elements (Direct Repeats Separated by 5 bp)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR; GENE-EXPRESSION; RAR-GAMMA; INDUCED DIFFERENTIATION; BINDING-SITE; VINEXIN-BETA; F9 CELLS; ALPHA; PHOSPHORYLATION; TRANSCRIPTION	The nuclear retinoic acid receptors interact with specific retinoic acid (RA) response elements (RAREs) located in the promoters of target genes to orchestrate transcriptional networks involved in cell growth and differentiation. Here we describe a genome-wide in silico analysis of consensus DR5 RAREs based on the recurrent RGKTSA motifs. More than 15,000 DR5 RAREs were identified and analyzed for their localization and conservation in vertebrates. We selected 138 elements located +/- 10 kb from transcription start sites and gene ends and conserved across more than 6 species. We also validated the functionality of these RAREs by analyzing their ability to bind retinoic acid receptors (ChIP sequencing experiments) as well as the RA regulation of the corresponding genes (RNA sequencing and quantitative real time PCR experiments). Such a strategy provided a global set of high confidence RAREs expanding the known experimentally validated RAREs repertoire associated to a series of new genes involved in cell signaling, development, and tumor suppression. Finally, the present work provides a valuable knowledge base for the analysis of a wider range of RA-target genes in different species.	[Lalevee, Sebastien; Samarut, Eric; Rochette-Egly, Cecile] Univ Strasbourg, Dept Funct Genom & Canc, Inst Genet & Biol Mol & Cellulaire, INSERM,U596, F-67404 Illkirch Graffenstaden, France; [Anno, Yannick N.; Poch, Olivier; Lecompte, Odile] Univ Strasbourg, Dept Integrated Struct Biol, Inst Genet & Biol Mol & Cellulaire, INSERM,U596, F-67404 Illkirch Graffenstaden, France; [Anno, Yannick N.; Poch, Olivier; Lecompte, Odile] Univ Strasbourg, CNRS, UMR7104, F-67404 Illkirch Graffenstaden, France; [Lalevee, Sebastien; Chatagnon, Amandine; Benoit, Gerard] CNRS, UMR5534, F-69622 Villeurbanne, France; [Chatagnon, Amandine; Benoit, Gerard] Univ Lyon 1, UMR5534, F-69622 Villeurbanne, France; [Laudet, Vincent] Univ Lyon, Inst Genom Fonct Lyon, UMR 5242, Inst Natl Rech Agron,Ecole Normale Super Lyon, F-69364 Lyon 07, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON)	Rochette-Egly, C (corresponding author), 1 Rue Laurent Fries,BP 10142, F-67404 Illkirch Graffenstaden, France.	cegly@igbmc.fr	Lecompte, Odile/N-7992-2019; Lecompte, Odile/F-4741-2011	Lecompte, Odile/0000-0002-2005-460X; Lecompte, Odile/0000-0002-2005-460X; SAMARUT, ERIC/0000-0001-7818-2009; BENOIT, Gerard/0000-0001-9462-6570	CNRS; INSERM; Association pour la Recherche sur le Cancer (ARC) [3169]; Agence Nationale pour la Recherche [ANR-05-BLAN-0390-02, ANR-09-BLAN-0127-01]; Fondation pour la Recherche Medicale [DEQ20090515423]; Institut National du Cancer [INCa-PLO7-96099, PL09-194]; Association pour la Recherche sur le Cancer (ARC); Ministere de l'Enseignement Superieur et de la Recherche	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut National du Cancer(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This work was supported by funds from CNRS, INSERM, the Association pour la Recherche sur le Cancer (ARC 3169), the Agence Nationale pour la Recherche (ANR-05-BLAN-0390-02 and ANR-09-BLAN-0127-01), the Fondation pour la Recherche Medicale (DEQ20090515423), and the Institut National du Cancer (INCa-PLO7-96099 and PL09-194).; Supported by the Association pour la Recherche sur le Cancer (ARC).; Supported by the Ministere de l'Enseignement Superieur et de la Recherche.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anno YN, 2011, NUCLEIC ACIDS RES, V39, P3116, DOI 10.1093/nar/gkq1301; Balmer JE, 2005, J STEROID BIOCHEM, V96, P347, DOI 10.1016/j.jsbmb.2005.05.005; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bollig F, 2009, DEVELOPMENT, V136, P2883, DOI 10.1242/dev.031773; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; BOUILLET P, 1995, DEV DYNAM, V204, P372, DOI 10.1002/aja.1002040404; Bour G, 2005, J BIOL CHEM, V280, P17027, DOI 10.1074/jbc.M501344200; Bour G, 2006, AD DEV BIOL, V16, P211, DOI 10.1016/S1574-3349(06)16007-X; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Bruck N, 2009, EMBO J, V28, P34, DOI 10.1038/emboj.2008.256; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Cotnoir-White D, 2011, MOL CELL ENDOCRINOL, V334, P76, DOI 10.1016/j.mce.2010.10.021; Coulombe Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010600; Delacroix L, 2010, MOL CELL BIOL, V30, P231, DOI 10.1128/MCB.00756-09; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Doerksen LF, 1996, NUCLEIC ACIDS RES, V24, P2849, DOI 10.1093/nar/24.14.2849; Duong V, 2011, BBA-MOL BASIS DIS, V1812, P1023, DOI 10.1016/j.bbadis.2010.10.007; Eifert C, 2006, MOL REPROD DEV, V73, P796, DOI 10.1002/mrd.20444; Faralli H, 2011, J BIOL CHEM, V286, P23498, DOI 10.1074/jbc.M110.206003; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Garitaonandia I, 2009, J RECEPT SIG TRANSD, V29, P67, DOI 10.1080/10799890902729456; Gillespie RF, 2007, J BIOL CHEM, V282, P33421, DOI 10.1074/jbc.M704845200; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Harris Thomas M, 2002, Funct Integr Genomics, V2, P105, DOI 10.1007/s10142-002-0062-6; Hoffman BG, 2009, J ENDOCRINOL, V201, P1, DOI 10.1677/JOE-08-0526; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Huang D, 1998, DEVELOPMENT, V125, P3235; Jing Y, 2011, CELL MOL NEUROBIOL, V31, P715, DOI 10.1007/s10571-011-9669-2; Lalevee S, 2010, FASEB J, V24, P4523, DOI 10.1096/fj.10-160572; LANGSTON AW, 1992, MECH DEVELOP, V38, P217, DOI 10.1016/0925-4773(92)90055-O; LEHMANN JM, 1992, MOL CELL BIOL, V12, P2976, DOI 10.1128/MCB.12.7.2976; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; LEROY P, 1991, P NATL ACAD SCI USA, V88, P10138, DOI 10.1073/pnas.88.22.10138; Lickert H, 2002, DEV DYNAM, V225, P216, DOI 10.1002/dvdy.10149; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Mead AN, 2003, J NEUROSCI, V23, P9500; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Mercader N, 2000, DEVELOPMENT, V127, P3961; Milinkovitch MC, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r16; OuladAbdelghani M, 1996, J CELL BIOL, V135, P469, DOI 10.1083/jcb.135.2.469; OuladAbdelghani M, 1997, DEV DYNAM, V210, P173, DOI 10.1002/(SICI)1097-0177(199710)210:2<173::AID-AJA9>3.0.CO;2-D; OuladAbdelghani M, 1996, EXP CELL RES, V225, P338, DOI 10.1006/excr.1996.0184; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; ROCHETTEEGLY C, 1992, MOL ENDOCRINOL, V6, P2197, DOI 10.1210/me.6.12.2197; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Samarut E., 2011, MOL CELL EN IN PRESS; Samarut E, 2011, MOL BIOL EVOL, V28, P2125, DOI 10.1093/molbev/msr035; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Su D, 2008, BIOCHEM PHARMACOL, V75, P1129, DOI 10.1016/j.bcp.2007.11.006; Tabaries S, 2005, MOL CELL BIOL, V25, P1389, DOI 10.1128/MCB.25.4.1389-1401.2005; Taneja R, 1997, EMBO J, V16, P6452, DOI 10.1093/emboj/16.21.6452; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Xing Y, 2009, MOL CELL ENDOCRINOL, V300, P43, DOI 10.1016/j.mce.2008.10.036	62	62	63	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33322	33334		10.1074/jbc.M111.263681	http://dx.doi.org/10.1074/jbc.M111.263681			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21803772	Green Published, hybrid			2022-12-25	WOS:000294968800051
J	Thangasamy, A; Rogge, J; Krishnegowda, NK; Freeman, JW; Ammanamanchi, S				Thangasamy, Amalraj; Rogge, Jessica; Krishnegowda, Naveen K.; Freeman, James W.; Ammanamanchi, Sudhakar			Novel Function of Transcription Factor Nrf2 as an Inhibitor of RON Tyrosine Kinase Receptor-mediated Cancer Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; OXIDATIVE STRESS; ACTIVATION; SENSITIVITY; PREVENTION; MUTATIONS; MICE	Recepteur d' origine nantais (RON), a tyrosine kinase receptor, is aberrantly expressed in human tumors and promotes cancer cell invasion. RON receptor activation is also associated with resistance to tamoxifen treatment in breast cancer cells. Nrf2 is a positive regulator of cytoprotective genes. Using chromatin immunoprecipitation (ChIP) and site-directed mutagenesis studies of the RON promoter, we identified Nrf2 as a negative regulator of RON gene expression. High Nrf2 and low RON expression was observed in normal mammary tissue whereas high RON and low or undetectable expression of Nrf2 was observed in breast tumors. The Nrf2 inducer sulforaphane (SFN) as well as ectopic Nrf2 expression or knock-down of the Nrf2 negative regulator keap1, which stabilizes Nrf2, inhibited RON expression and invasion of carcinoma cells. Consequently, our studies identified a novel functional role for Nrf2 as a "repressor" and RON kinase as a molecular target of SFN, which mediates the anti-tumor effects of SFN. These results are not limited to breast cancer cells since the Nrf2 inducer SFN stabilized Nrf2 and inhibited RON expression in carcinoma cells from various tumor types.	[Thangasamy, Amalraj; Rogge, Jessica; Krishnegowda, Naveen K.; Freeman, James W.; Ammanamanchi, Sudhakar] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Hematol Med Oncol, San Antonio, TX 78229 USA; [Freeman, James W.] Audie L Murphy Mem Vet Adm Med Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Ammanamanchi, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Hematol Med Oncol, San Antonio, TX 78229 USA.	sammanamanchi@hotmail.com			Veterans Administration; NATIONAL CANCER INSTITUTE [R01CA069122] Funding Source: NIH RePORTER	Veterans Administration(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Veterans Administration Merit Award (to J. W. F.).	Aoki Y, 2007, CANCER RES, V67, P5643, DOI 10.1158/0008-5472.CAN-06-3355; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Keller UAD, 2006, MOL CELL BIOL, V26, P3773, DOI 10.1128/MCB.26.10.3773-3784.2006; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Lee WY, 2005, CLIN CANCER RES, V11, P2222, DOI 10.1158/1078-0432.CCR-04-1761; Leonis Mike A, 2007, Future Oncol, V3, P441, DOI 10.2217/14796694.3.4.441; Loignon M, 2009, MOL CANCER THER, V8, P2432, DOI 10.1158/1535-7163.MCT-08-1186; McClaine RJ, 2010, NEOPLASIA, V12, P650, DOI 10.1593/neo.10476; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Thangasamy A, 2008, J BIOL CHEM, V283, P5335, DOI 10.1074/jbc.M706957200; Thangasamy A, 2009, J BIOL CHEM, V284, P14001, DOI 10.1074/jbc.M809320200; Wang MH, 2007, J PATHOL, V213, P402, DOI 10.1002/path.2245; Xu CJ, 2006, CANCER RES, V66, P8293, DOI 10.1158/0008-5472.CAN-06-0300; Zinser GM, 2006, CANCER RES, V66, P11967, DOI 10.1158/0008-5472.CAN-06-2473	20	28	29	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32115	32122		10.1074/jbc.M111.245746	http://dx.doi.org/10.1074/jbc.M111.245746			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21799005	Green Published, hybrid			2022-12-25	WOS:000294726800021
J	Campayo, M; Navarro, A; Vinolas, N; Tejero, R; Munoz, C; Diaz, T; Marrades, R; Cabanas, ML; Gimferrer, JM; Gascon, P; Ramirez, J; Monzo, M				Campayo, Marc; Navarro, Alfons; Vinolas, Nuria; Tejero, Rut; Munoz, Carmen; Diaz, Tania; Marrades, Ramon; Cabanas, Maria L.; Gimferrer, Josep M.; Gascon, Pere; Ramirez, Jose; Monzo, Mariano			A Dual Role for KRT81: A miR-SNP Associated with Recurrence in Non-Small-Cell Lung Cancer and a Novel Marker of Squamous Cell Lung Carcinoma	PLOS ONE			English	Article							MICRORNA-RELATED GENES; VINORELBINE PLUS CISPLATIN; BINDING-SITE POLYMORPHISM; FUNCTIONAL POLYMORPHISM; EXPRESSION; RISK; SURVIVAL; PROGNOSIS; VARIANTS; PROFILES	MicroRNAs (miRNAs) play an important role in carcinogenesis through the regulation of their target genes. miRNA-related single nucleotide polymorphisms (miR-SNPs) can affect miRNA biogenesis and target sites and can alter microRNA expression and functions. We examined 11 miR-SNPs, including 5 in microRNA genes, 3 in microRNA binding sites and 3 in microRNA-processing machinery components, and evaluated time to recurrence (TTR) according to miR-SNP genotypes in 175 surgically resected non-small-cell lung cancer (NSCLC) patients. Significant differences in TTR were found according to KRT81 rs3660 (median TTR: 20.3 months for the CC genotype versus 86.8 months for the CG or GG genotype; P = 0.003) and XPO5 rs11077 (median TTR: 24.7 months for the AA genotype versus 73.1 months for the AC or CC genotypes; P = 0.029). Moreover, when patients were divided according to stage, these differences were maintained for stage I patients (P = 0.002 for KRT81 rs3660; P < 0.001 for XPO5 rs11077). When patients were divided into sub-groups according to histology, the effect of the KRT81 rs3660 genotype on TTR was significant in patients with squamous cell carcinoma (P = 0.004) but not in those with adenocarcinoma. In the multivariate analyses, the KRT81 rs3660 CC genotype (OR = 1.8; P = 0.023) and the XPO5 rs11077 AA genotype (OR = 1.77; P = 0.026) emerged as independent variables influencing TTR. Immunohistochemical analyses in 80 lung specimens showed that 95% of squamous cell carcinomas were positive for KRT81, compared to only 19% of adenocarcinomas (P < 0.0001). In conclusion, miR-SNPs are a novel class of SNPs that can add useful prognostic information on the clinical outcome of resected NSCLC patients and may be a potential key tool for selecting high-risk stage I patients. Moreover, KRT81 has emerged as a promising immunohistochemical marker for the identification of squamous cell lung carcinoma.	[Campayo, Marc; Vinolas, Nuria; Gascon, Pere] Univ Barcelona, Hosp Clin Barcelona, Dept Med Oncol, ICMHO,IDIBAPS, Barcelona, Spain; [Navarro, Alfons; Tejero, Rut; Munoz, Carmen; Diaz, Tania; Monzo, Mariano] Univ Barcelona, Human Anat & Embryol Unit, Lab Mol Oncol & Embryol, Sch Med,IDIBAPS, Barcelona, Spain; [Marrades, Ramon] Univ Barcelona, Hosp Clin Barcelona, Dept Pneumol, ICT,IDIBAPS,CIBERES, Barcelona, Spain; [Cabanas, Maria L.; Ramirez, Jose] Univ Barcelona, Hosp Clin Barcelona, Dept Pathol, IDIBAPS,CIBERES,CDB, Barcelona, Spain; [Gimferrer, Josep M.] Univ Barcelona, Hosp Clin Barcelona, Dept Thorac Surg, ICT, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona	Campayo, M (corresponding author), Univ Barcelona, Hosp Clin Barcelona, Dept Med Oncol, ICMHO,IDIBAPS, Barcelona, Spain.	mmonzo@ub.edu	MArrades, Ramón M/AFU-6757-2022; Navarro, Alfons/C-2453-2015; Gascon, Pere/F-7905-2015	Navarro, Alfons/0000-0001-6071-0926; MONZO, MARIANO/0000-0003-2322-4851; Campayo, Marc/0000-0002-9874-4707; Ramirez, Jose/0000-0002-7833-1374; Tejero-Villalba, Rut/0000-0001-5134-4813	Hospital Clinic de Barcelona (Premi Fi de Residencia Emili Letang); Fondo de Investigaciones Sanitarias de la Seguridad Social [FIS-PI09/00547]; AGAUR, Generalitat de Catalunya; Fondo Social Europeo	Hospital Clinic de Barcelona (Premi Fi de Residencia Emili Letang); Fondo de Investigaciones Sanitarias de la Seguridad Social(Instituto de Salud Carlos III); AGAUR, Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Fondo Social Europeo(European Social Fund (ESF)European Commission)	This work was supported by grants from Hospital Clinic de Barcelona (Premi Fi de Residencia Emili Letang) and Fondo de Investigaciones Sanitarias de la Seguridad Social FIS-PI09/00547. Tania Diaz is an FI fellow supported by AGAUR, Generalitat de Catalunya and Fondo Social Europeo. Rut Tejero is an APIF fellow of the University of Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brundage MD, 2002, CHEST, V122, P1037, DOI 10.1378/chest.122.3.1037; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Christensen BC, 2010, CLIN CANCER RES, V16, P3713, DOI 10.1158/1078-0432.CCR-10-0657; Christensen BC, 2009, CARCINOGENESIS, V30, P1003, DOI 10.1093/carcin/bgp099; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Duncavage E, 2010, J THORAC ONCOL, V5, P1755, DOI 10.1097/JTO.0b013e3181f3909d; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gallardo E, 2009, CARCINOGENESIS, V30, P1903, DOI 10.1093/carcin/bgp219; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hu ZB, 2011, AM J RESP CRIT CARE, V183, P641, DOI 10.1164/rccm.201005-0717OC; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Karantza V, 2011, ONCOGENE, V30, P127, DOI 10.1038/onc.2010.456; Kargi A, 2007, APPL IMMUNOHISTO M M, V15, P415, DOI 10.1097/PAI.0b013e31802fab75; Kato H, 2004, NEW ENGL J MED, V350, P1713, DOI 10.1056/NEJMoa032792; Kim JS, 2010, MOL CARCINOGEN, V49, P913, DOI 10.1002/mc.20672; Kim MJ, 2010, LUNG CANCER, V69, P127, DOI 10.1016/j.lungcan.2010.04.015; Landi MT, 2010, CLIN CANCER RES, V16, P430, DOI 10.1158/1078-0432.CCR-09-1736; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Lin J, 2010, CARCINOGENESIS, V31, P1805, DOI 10.1093/carcin/bgq168; Mishra PJ, 2008, CELL CYCLE, V7, P853, DOI 10.4161/cc.7.7.5666; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Mishra PJ, 2009, PHARMACOGENOMICS, V10, P399, DOI 10.2217/14622416.10.3.399; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Patnaik SK, 2010, CANCER RES, V70, P36, DOI 10.1158/0008-5472.CAN-09-3153; Peng S, 2010, DIGEST DIS SCI, V55, P2288, DOI 10.1007/s10620-009-1007-x; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Regnier CH, 1998, BRIT J CANCER, V78, P1640, DOI 10.1038/bjc.1998.736; Ring BZ, 2009, MODERN PATHOL, V22, P1032, DOI 10.1038/modpathol.2009.60; Rotunno M, 2010, BRIT J CANCER, V103, P1870, DOI 10.1038/sj.bjc.6605976; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tian T, 2009, CANCER EPIDEM BIOMAR, V18, P1183, DOI 10.1158/1055-9965.EPI-08-0814; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Wu MQ, 2008, CARCINOGENESIS, V29, P1710, DOI 10.1093/carcin/bgn073; Xu B, 2010, PROSTATE, V70, P467, DOI 10.1002/pros.21080; Xu T, 2008, CARCINOGENESIS, V29, P2126, DOI 10.1093/carcin/bgn195; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Ye YQ, 2008, CANCER PREV RES, V1, P460, DOI 10.1158/1940-6207.CAPR-08-0135; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480	51	47	54	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22509	10.1371/journal.pone.0022509	http://dx.doi.org/10.1371/journal.pone.0022509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799879	Green Published, gold, Green Submitted			2022-12-25	WOS:000293172900041
J	Johansson, MA; Arana-Vizcarrondo, N; Biggerstaff, BJ; Staples, JE; Gallagher, N; Marano, N				Johansson, Michael A.; Arana-Vizcarrondo, Neysari; Biggerstaff, Brad J.; Staples, J. Erin; Gallagher, Nancy; Marano, Nina			On the Treatment of Airline Travelers in Mathematical Models	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; UNITED-STATES; AIR-TRAVEL; SPREAD; SURVEILLANCE; INFLUENZA; DENGUE; IMPACT; INFECTIONS; DISEASE	The global spread of infectious diseases is facilitated by the ability of infected humans to travel thousands of miles in short time spans, rapidly transporting pathogens to distant locations. Mathematical models of the actual and potential spread of specific pathogens can assist public health planning in the case of such an event. Models should generally be parsimonious, but must consider all potentially important components of the system to the greatest extent possible. We demonstrate and discuss important assumptions relative to the parameterization and structural treatment of airline travel in mathematical models. Among other findings, we show that the most common structural treatment of travelers leads to underestimation of the speed of spread and that connecting travel is critical to a realistic spread pattern. Models involving travelers can be improved significantly by relatively simple structural changes but also may require further attention to details of parameterization.	[Johansson, Michael A.; Arana-Vizcarrondo, Neysari] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR USA; [Biggerstaff, Brad J.; Staples, J. Erin] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA; [Gallagher, Nancy; Marano, Nina] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Johansson, MA (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR USA.	mjohansson@cdc.gov		Johansson, Michael/0000-0002-5090-7722				Ackers ML, 2000, JAMA-J AM MED ASSOC, V283, P2668, DOI 10.1001/jama.283.20.2668; Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Colizza V, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-34; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; Failloux AB, 2002, J MOL EVOL, V55, P653, DOI 10.1007/s00239-002-2360-y; Fenner L, 2007, EMERG INFECT DIS, V13, P217, DOI 10.3201/eid1302.060847; Flahault A, 2006, VACCINE, V24, P6751, DOI 10.1016/j.vaccine.2006.05.079; FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Grais R F, 2004, Health Care Manag Sci, V7, P127, DOI 10.1023/B:HCMS.0000020652.38181.da; Grais RF, 2003, EUR J EPIDEMIOL, V18, P1065, DOI 10.1023/A:1026140019146; Hollingsworth TD, 2007, EMERG INFECT DIS, V13, P1288, DOI 10.3201/eid1309.070081; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Keeling MJ, 2002, ECOL LETT, V5, P20, DOI 10.1046/j.1461-0248.2002.00268.x; Leder K, 2006, CLIN INFECT DIS, V43, P1185, DOI 10.1086/507893; Lessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004403; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nishiura H, 2007, J INFECT DIS, V195, P1007, DOI 10.1086/511825; R Development Core Team, 2010, R LANG ENV STAT COMP; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Skarbinski Jacek, 2006, Morbidity and Mortality Weekly Report, V55, P23; Soumahoro MK, 2010, EMERG INFECT DIS, V16, P162, DOI 10.3201/eid1601.080776; Steinberg EB, 2004, CLIN INFECT DIS, V39, P186, DOI 10.1086/421945; United States Department of Homeland Security, 2009, YB IMM STAT 2008; *US INT TRAD ADM, 2009, PROF US RES TRAV VIS; Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002	33	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22151	10.1371/journal.pone.0022151	http://dx.doi.org/10.1371/journal.pone.0022151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799782	gold, Green Published			2022-12-25	WOS:000293172900013
J	Viala, JPM; Meresse, S; Pocachard, B; Guilhon, AA; Aussel, L; Barras, F				Viala, Julie P. M.; Meresse, Stephane; Pocachard, Berengere; Guilhon, Aude-Agnes; Aussel, Laurent; Barras, Frederic			Sensing and Adaptation to Low pH Mediated by Inducible Amino Acid Decarboxylases in Salmonella	PLOS ONE			English	Article							III SECRETION SYSTEM; ESCHERICHIA-COLI; GENE-EXPRESSION; ORNITHINE-DECARBOXYLASE; LYSINE DECARBOXYLASE; TOLERANCE RESPONSE; TRANSPORT PROTEIN; INTERNAL PH; ASR GENE; TYPHIMURIUM	During the course of infection, Salmonella enterica serovar Typhimurium must successively survive the harsh acid stress of the stomach and multiply into a mild acidic compartment within macrophages. Inducible amino acid decarboxylases are known to promote adaptation to acidic environments. Three low pH inducible amino acid decarboxylases were annotated in the genome of S. Typhimurium, AdiA, CadA and SpeF, which are specific for arginine, lysine and ornithine, respectively. In this study, we characterized and compared the contributions of those enzymes in response to acidic challenges. Individual mutants as well as a strain deleted for the three genes were tested for their ability (i) to survive an extreme acid shock, (ii) to grow at mild acidic pH and (iii) to infect the mouse animal model. We showed that the lysine decarboxylase CadA had the broadest range of activity since it both had the capacity to promote survival at pH 2.3 and growth at pH 4.5. The arginine decarboxylase AdiA was the most performant in protecting S. Typhimurium from a shock at pH 2.3 and the ornithine decarboxylase SpeF conferred the best growth advantage under anaerobiosis conditions at pH 4.5. We developed a GFP-based gene reporter to monitor the pH of the environment as perceived by S. Typhimurium. Results showed that activities of the lysine and ornithine decarboxylases at mild acidic pH did modify the local surrounding of S. Typhimurium both in culture medium and in macrophages. Finally, we tested the contribution of decarboxylases to virulence and found that these enzymes were dispensable for S. Typhimurium virulence during systemic infection. In the light of this result, we examined the genomes of Salmonella spp. normally responsible of systemic infection and observed that the genes encoding these enzymes were not well conserved, supporting the idea that these enzymes may be not required during systemic infection.	[Viala, Julie P. M.; Pocachard, Berengere; Aussel, Laurent; Barras, Frederic] CNRS, Chim Bacterienne Lab, Inst Microbiol Mediterranee, UPR 9043, F-13277 Marseille, France; [Meresse, Stephane; Guilhon, Aude-Agnes] Univ Aix Marseille 2, INSERM, CNRS, Ctr Immunol Marseille Luminy,U631,UMR 6102, Marseille, France; [Viala, Julie P. M.; Meresse, Stephane; Pocachard, Berengere; Guilhon, Aude-Agnes; Aussel, Laurent; Barras, Frederic] Aix Marseille Univ, Fac Sci, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Viala, JPM (corresponding author), CNRS, Inst Microbiol Mediterranee, Lab Ingn Syst Macromol, UPR 9027, Marseille, France.	jviala@ifr88.cnrs-mrs.fr	Meresse, Stephane/E-2192-2012	Meresse, Stephane/0000-0001-6578-5177; Barras, Frederic/0000-0003-3458-2574; Aussel, Laurent/0000-0001-5239-4556	ANR; CNRS; Aix-Marseille Universite; Fondation pour la Recherche Medicale (FRM)	ANR(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was funded by the ANR (Programme M.I.E. "Salmo-sensor"), the CNRS and the Aix-Marseille Universite. JV was supported by the Fondation pour la Recherche Medicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Ordonez A, 2010, INT J FOOD MICROBIOL, V136, P278, DOI 10.1016/j.ijfoodmicro.2009.09.024; ARANDA CMA, 1992, P NATL ACAD SCI USA, V89, P10079, DOI 10.1073/pnas.89.21.10079; Audia JP, 2001, INT J MED MICROBIOL, V291, P97, DOI 10.1078/1438-4221-00106; Bearson BL, 1998, J BACTERIOL, V180, P2409, DOI 10.1128/JB.180.9.2409-2417.1998; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; BOEKER EA, 1971, J BIOL CHEM, V246, P6776; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Chakravortty D, 2005, EMBO J, V24, P2043, DOI 10.1038/sj.emboj.7600676; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Drecktrah D, 2006, TRAFFIC, V7, P39, DOI 10.1111/j.1600-0854.2005.00360.x; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; GARCIADELPORTILLO F, 1992, MOL MICROBIOL, V6, P3289, DOI 10.1111/j.1365-2958.1992.tb02197.x; Heithoff DM, 1997, P NATL ACAD SCI USA, V94, P934, DOI 10.1073/pnas.94.3.934; KASHIWAGI K, 1994, BIOCHEM BIOPH RES CO, V200, P591, DOI 10.1006/bbrc.1994.1489; KASHIWAGI K, 1991, J BIOL CHEM, V266, P20922; Kieboom J, 2006, J BACTERIOL, V188, P5650, DOI 10.1128/JB.00323-06; Merrell DS, 1999, MOL MICROBIOL, V34, P836, DOI 10.1046/j.1365-2958.1999.01650.x; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Park YK, 1996, MOL MICROBIOL, V20, P605, DOI 10.1046/j.1365-2958.1996.5441070.x; Prosseda G, 2007, RES MICROBIOL, V158, P487, DOI 10.1016/j.resmic.2007.05.001; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; Rathman M, 1996, INFECT IMMUN, V64, P2765, DOI 10.1128/IAI.64.7.2765-2773.1996; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; Richard HT, 2003, ADV APPL MICROBIOL, V52, P167, DOI 10.1016/S0065-2164(03)01007-4; SABO DL, 1974, BIOCHEMISTRY-US, V13, P662, DOI 10.1021/bi00701a005; Seputiene V, 2004, RES MICROBIOL, V155, P535, DOI 10.1016/j.resmic.2004.03.010; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; Suziedeliene E, 1999, J BACTERIOL, V181, P2084; Torres AG, 2009, ANAEROBE, V15, P1, DOI 10.1016/j.anaerobe.2008.05.002; Tucker DL, 2002, J BACTERIOL, V184, P6551, DOI 10.1128/JB.184.23.6551-6558.2002; Valdivia RH, 1996, MOL MICROBIOL, V22, P367, DOI 10.1046/j.1365-2958.1996.00120.x; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	36	46	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22397	10.1371/journal.pone.0022397	http://dx.doi.org/10.1371/journal.pone.0022397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799843	Green Submitted, Green Published, gold			2022-12-25	WOS:000293172900026
J	Giros, A; Grgur, K; Gossler, A; Costell, M				Giros, Amparo; Grgur, Katja; Gossler, Achim; Costell, Mercedes			alpha 5 beta 1 Integrin-Mediated Adhesion to Fibronectin Is Required for Axis Elongation and Somitogenesis in Mice	PLOS ONE			English	Article							SOMITE SEGMENTATION CLOCK; CELL-MATRIX ADHESIONS; PRESOMITIC MESODERM; BOUNDARY FORMATION; TRANSCRIPTION FACTOR; NOTCH ACTIVITY; PROXIMAL RIBS; MOUSE EMBRYO; EXPRESSION; BINDING	The arginine-glycine-aspartate (RGD) motif in fibronectin (FN) represents the major binding site for alpha 5 beta 1 and alpha v beta 3 integrins. Mice lacking a functional RGD motif in FN (FNRGE/RGE) or alpha 5 integrin develop identical phenotypes characterized by embryonic lethality and a severely shortened posterior trunk with kinked neural tubes. Here we show that the FNRGE/RGE embryos arrest both segmentation and axis elongation. The arrest is evident at about E9.0, corresponding to a stage when gastrulation ceases and the tail bud-derived presomitic mesoderm (PSM) induces alpha 5 integrin expression and assumes axis elongation. At this stage cells of the posterior part of the PSM in wild type embryos are tightly coordinated, express somitic oscillator and cyclic genes required for segmentation, and form a tapered tail bud that extends caudally. In contrast, the posterior PSM cells in FNRGE/RGE embryos lost their tight associations, formed a blunt tail bud unable to extend the body axis, failed to induce the synchronised expression of Notch1 and cyclic genes and cease the formation of new somites. Mechanistically, the interaction of PSM cells with the RGD motif of FN is required for dynamic formation of lamellipodia allowing motility and cell-cell contact formation, as these processes fail when wild type PSM cells are seeded into a FN matrix derived from FNRGE/RGE fibroblasts. Thus, alpha 5 beta 1-mediated adhesion to FN in the PSM regulates the dynamics of membrane protrusions and cell-to-cell communication essential for elongation and segmentation of the body axis.	[Giros, Amparo; Costell, Mercedes] Univ Valencia, Dept Bioquim & Biol Mol, E-46100 Burjassot, Spain; [Giros, Amparo; Grgur, Katja] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Gossler, Achim] Hannover Med Sch, Inst Mol Biol, D-30623 Hannover, Germany	University of Valencia; Max Planck Society; Hannover Medical School	Giros, A (corresponding author), Univ Valencia, Dept Bioquim & Biol Mol, E-46100 Burjassot, Spain.	mercedes.costell@uv.es	Costell, Mercedes/H-7850-2015	Costell, Mercedes/0000-0001-6146-996X	Boehringer Ingelheim Fonds; Universitat de Valencia; Deutsche Forschungsgemeinschaft	Boehringer Ingelheim Fonds(Boehringer Ingelheim); Universitat de Valencia; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	K.G. gratefully acknowledges the Ph.D. fellowship from the Boehringer Ingelheim Fonds. This work was supported by the Universitat de Valencia (to M.C. and A. Giros) and the Deutsche Forschungsgemeinschaft for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy; to A. Gossler). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aulehla A, 2004, GENE DEV, V18, P2060, DOI 10.1101/gad.1217404; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Barrantes ID, 1999, CURR BIOL, V9, P470, DOI 10.1016/S0960-9822(99)80212-7; BEDDINGTON RSP, 1992, DEVELOPMENT, P157; Benazeraf B, 2010, NATURE, V466, P248, DOI 10.1038/nature09151; Cairns DM, 2008, DEV BIOL, V323, P152, DOI 10.1016/j.ydbio.2008.08.024; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Dunty WC, 2008, DEVELOPMENT, V135, P85, DOI 10.1242/dev.009266; Durbin L, 1998, GENE DEV, V12, P3096, DOI 10.1101/gad.12.19.3096; Eloy-Trinquet S, 2002, DEVELOPMENT, V129, P3609; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; Feller J, 2008, GENE DEV, V22, P2166, DOI 10.1101/gad.480408; Ferjentsik Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000662; FOGERTY FJ, 1990, J CELL BIOL, V111, P699, DOI 10.1083/jcb.111.2.699; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gloushankova NA, 1998, P NATL ACAD SCI USA, V95, P4362, DOI 10.1073/pnas.95.8.4362; Goh KL, 1997, DEVELOPMENT, V124, P4309; Gridley T, 2006, DEV DYNAM, V235, P2330, DOI 10.1002/dvdy.20850; Huveneers S, 2008, J CELL SCI, V121, P2452, DOI 10.1242/jcs.033001; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; JOHNSON RL, 1994, CELL, V79, P1165, DOI 10.1016/0092-8674(94)90008-6; Jouve C, 2000, DEVELOPMENT, V127, P1421; Julich D, 2009, DEVELOPMENT, V136, P2913, DOI 10.1242/dev.038935; Julich D, 2005, DEV CELL, V8, P575, DOI 10.1016/j.devcel.2005.01.016; Kinsey R, 2008, J CELL SCI, V121, P2696, DOI 10.1242/jcs.029819; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; Kragtorp KA, 2007, DEV DYNAM, V236, P2713, DOI 10.1002/dvdy.21280; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; Leitges M, 2000, DEVELOPMENT, V127, P2259; Mansouri A, 2000, DEVELOPMENT, V127, P2251; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; MCDONALD JA, 1987, J BIOL CHEM, V262, P2957; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Niwa Y, 2007, DEV CELL, V13, P298, DOI 10.1016/j.devcel.2007.07.013; ORDAHL CP, 1992, DEVELOPMENT, V114, P339; Ozbudak EM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040015; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; PAULSON JR, 1982, J BIOL CHEM, V257, P6064; PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Pulina MV, 2011, DEV BIOL, V354, P208, DOI 10.1016/j.ydbio.2011.03.026; Rifes P, 2007, DEVELOPMENT, V134, P3155, DOI 10.1242/dev.003665; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; SELLECK MAJ, 1991, DEVELOPMENT, V112, P615; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Wang HV, 2004, DEV DYNAM, V231, P128, DOI 10.1002/dvdy.20119; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; Yang JT, 1999, DEV BIOL, V215, P264, DOI 10.1006/dbio.1999.9451; YANG JT, 1993, DEVELOPMENT, V119, P1093; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607	57	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22002	10.1371/journal.pone.0022002	http://dx.doi.org/10.1371/journal.pone.0022002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799763	gold, Green Published, Green Submitted			2022-12-25	WOS:000293097300011
J	Minami, M; Ichikawa, M; Hata, N; Hasegawa, T				Minami, Masaaki; Ichikawa, Mariko; Hata, Nanako; Hasegawa, Tadao			Protective Effect of Hainosankyuto, a Traditional Japanese Medicine, on Streptococcus pyogenes Infection in Murine Model	PLOS ONE			English	Article							SKIN INFECTION; MICE; INTERLEUKIN-12; INHIBITION; ACID	Background: Streptococcus pyogenes (S. pyogenes) causes various serious diseases including necrotizing fasciitis and streptococcal toxic shock syndrome. One serious problem observed recently with S. pyogenes therapy is attenuation of the antibiotic effect, especially penicillin treatment failure and macrolide resistance. Hainosankyuto, a traditional Japanese medicine based on ancient Chinese medicine, has been used for treatment of infectious purulent diseases in Japan. In this study, we investigated the protective and therapeutic efficacy of Hainosankyuto against S. pyogenes-skin infection. Methodology/Principal Findings: A broth microdilution method revealed that Hainosankyuto did not show a direct antibacterial effect against S. pyogenes. Force-feeding Hainosankyuto to infected mice for 4 consecutive days increased the survival rate and reduced the size of local skin lesions compared with mice fed PBS. Although we did not find the significant recovery of survival rate in Hainosankyuto administration only after S. pyogenes infection, the sizes of ulcer lesion were significant smaller after Hainosankyuto administration compared with mice fed PBS. No difference was observed in the antibacterial effect of Hainosankyuto between macrolide-susceptible and -resistant strains. Blood bactericidal assay showed that the survival rate of S. pyogenes using the blood from Hainosankyuto -treated mice was lower than that using the blood from untreated mice. We also found increased levels of IL-12, IFN-gamma and a decreased level of TNF-alpha in the serum of S. pyogenes-infected mice treated with Hainosankyuto. Mouse peritoneal macrophage from Hainosankyuto-treated mice had significant phagocytic activity and increased mRNA levels of IL-12, IFN-gamma and decreased mRNA level of TNF-alpha compared with control macrophage. Conclusions/Significance: Hainosankyuto increased survival rate after S. pyogenes infection and up-regulated both blood bactericidal activity and macrophage phagocytic activity through modulation of inflammatory cytokines. Our data also suggest Hainosankyuto may be useful for the treatment of S. pyogenes infection more prophylactically than therapeutically.	[Minami, Masaaki; Ichikawa, Mariko; Hasegawa, Tadao] Nagoya City Univ, Grad Sch Med Sci, Dept Bacteriol, Nagoya, Aichi, Japan; [Hata, Nanako] Nagoya City Univ Hosp, Dept Microbiol, Nagoya, Aichi, Japan	Nagoya City University; Nagoya City University	Minami, M (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Bacteriol, Nagoya, Aichi, Japan.	minami@med.nagoya-cu.ac.jp			Nagoya City University; Toyo Igaku Kenkyu Association	Nagoya City University; Toyo Igaku Kenkyu Association	This study was supported by a Grant-in-Aid for Research from Nagoya City University and the research fund of the Toyo Igaku Kenkyu Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltina LA, 2003, CURR MED CHEM, V10, P155, DOI 10.2174/0929867033368538; Brook I, 2001, J OTOLARYNGOL, V30, P324, DOI 10.2310/7070.2001.19359; Chung JW, 2008, BIOL PHARM BULL, V31, P2114, DOI 10.1248/bpb.31.2114; *CLSI NCCLS, 2003, M7A6 CLSI NCCLS; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dai Y, 2002, BIOL PHARM BULL, V25, P1175, DOI 10.1248/bpb.25.1175; Diao H, 2005, INFECT IMMUN, V73, P3745, DOI 10.1128/IAI.73.6.3745-3748.2005; Hasegawa T, 2010, MICROBIOL-SGM, V156, P184, DOI 10.1099/mic.0.031955-0; Ishih A, 2007, J NAT MED-TOKYO, V61, P280, DOI 10.1007/s11418-007-0146-7; Kroes BH, 1997, IMMUNOLOGY, V90, P115, DOI 10.1046/j.1365-2567.1997.00131.x; Kuo CF, 2005, J MED MICROBIOL, V54, P795, DOI 10.1099/jmm.0.45704-0; METZGER DW, 1995, J INFECT DIS, V171, P1643, DOI 10.1093/infdis/171.6.1643; Minami M, 2010, ANTIMICROB AGENTS CH, V54, P98, DOI 10.1128/AAC.00804-09; OZAKI Y, 1995, BIOL PHARM BULL, V18, P559, DOI 10.1248/bpb.18.559; Peng XH, 2000, J LEUKOCYTE BIOL, V68, P723; Raeder RH, 2000, J INFECT DIS, V181, P639, DOI 10.1086/315281; Richter SS, 2005, CLIN INFECT DIS, V41, P599, DOI 10.1086/432473; SHIMIZU H, 1990, J TRAD MED, V7, P54; SHIMIZU S, 1997, JPN TOYO IGAKU ZASSH, V48, P369; Tanaka M, 2005, ANTIMICROB AGENTS CH, V49, P88, DOI 10.1128/AAC.49.1.88-96.2005	20	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22188	10.1371/journal.pone.0022188	http://dx.doi.org/10.1371/journal.pone.0022188			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799792	gold, Green Submitted, Green Published			2022-12-25	WOS:000293097300020
J	Xu, QP; Rawlings, ND; Chiu, HJ; Jaroszewski, L; Klock, HE; Knuth, MW; Miller, MD; Elsliger, MA; Deacon, AM; Godzik, A; Lesley, SA; Wilson, IA				Xu, Qingping; Rawlings, Neil D.; Chiu, Hsiu-Ju; Jaroszewski, Lukasz; Klock, Heath E.; Knuth, Mark W.; Miller, Mitchell D.; Elsliger, Marc-Andre; Deacon, Ashley M.; Godzik, Adam; Lesley, Scott A.; Wilson, Ian A.			Structural Analysis of Papain-Like NlpC/P60 Superfamily Enzymes with a Circularly Permuted Topology Reveals Potential Lipid Binding Sites	PLOS ONE			English	Article							LECITHIN-RETINOL ACYLTRANSFERASE; MAXIMUM-LIKELIHOOD; ESCHERICHIA-COLI; DOWN-REGULATION; SPECIFICITY; REFINEMENT; CATALYSIS; H-REV107; GENOMICS; INSIGHTS	NlpC/P60 superfamily papain-like enzymes play important roles in all kingdoms of life. Two members of this superfamily, LRAT-like and YaeF/YiiX-like families, were predicted to contain a catalytic domain that is circularly permuted such that the catalytic cysteine is located near the C-terminus, instead of at the N-terminus. These permuted enzymes are widespread in virus, pathogenic bacteria, and eukaryotes. We determined the crystal structure of a member of the YaeF/YiiX-like family from Bacillus cereus in complex with lysine. The structure, which adopts a ligand-induced, "closed" conformation, confirms the circular permutation of catalytic residues. A comparative analysis of other related protein structures within the NlpC/P60 superfamily is presented. Permutated NlpC/P60 enzymes contain a similar conserved core and arrangement of catalytic residues, including a Cys/His-containing triad and an additional conserved tyrosine. More surprisingly, permuted enzymes have a hydrophobic S1 binding pocket that is distinct from previously characterized enzymes in the family, indicative of novel substrate specificity. Further analysis of a structural homolog, YiiX (PDB 2if6) identified a fatty acid in the conserved hydrophobic pocket, thus providing additional insights into possible function of these novel enzymes.	[Xu, Qingping; Chiu, Hsiu-Ju; Jaroszewski, Lukasz; Klock, Heath E.; Knuth, Mark W.; Miller, Mitchell D.; Elsliger, Marc-Andre; Deacon, Ashley M.; Godzik, Adam; Lesley, Scott A.; Wilson, Ian A.] Joint Ctr Struct Genom, La Jolla, CA USA; [Xu, Qingping; Chiu, Hsiu-Ju; Miller, Mitchell D.; Deacon, Ashley M.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA; [Rawlings, Neil D.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Jaroszewski, Lukasz; Godzik, Adam] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Jaroszewski, Lukasz; Godzik, Adam] Sanford Burnham Med Res Inst, Program Bioinformat & Syst Biol, Jolla, CA USA; [Klock, Heath E.; Knuth, Mark W.; Lesley, Scott A.] Novartis Res Fdn, Genom Inst, Prot Sci Dept, San Diego, CA USA; [Elsliger, Marc-Andre; Lesley, Scott A.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Wellcome Trust Sanger Institute; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; Novartis; Scripps Research Institute	Xu, QP (corresponding author), Joint Ctr Struct Genom, La Jolla, CA USA.	wilson@scripps.edu	Godzik, Adam/AAW-1467-2020; Rawlings, Neil D./I-4867-2012; Godzik, Adam/A-7279-2009; Rawlings, Neil/M-5566-2013	Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; Rawlings, Neil/0000-0001-5557-7665; Elsliger, Marc Andre/0000-0002-1989-7626; Miller, Mitchell/0000-0003-1626-4943	NIH, National Institute of General Medical Sciences, Protein Structure Initiative [U54 GM094586, U54 GM074898]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-ENG-38]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources [P41RR001209]; National Institute of General Medical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074898, U54GM094586] Funding Source: NIH RePORTER	NIH, National Institute of General Medical Sciences, Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH, National Institute of General Medical Sciences, Protein Structure Initiative grants U54 GM094586 and U54 GM074898 (http://www.nigms.nih.gov/Initiatives/PSI/). The Advanced Photon Source is supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science Contract W-31-109-ENG-38. GM/CA CAT is supported by National Cancer Institute Grant Y1-CO-1020 and National Institute of General Medical Science Grant Y1-GM-1104. The role of the Advanced Photon Source in this study was data collection. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Heath E. Klock, Mark W. Knuth and Scott A. Lesley are employees of the Novartis Research Foundation and were involved with the design of the experiments.; We thank the members of the JCSG high-throughput structural biology pipeline for their contribution to this work. We thank the staff for assistance during data collection at The General Medicine and Cancer Institutes Collaborative Access Team (GM/CA-CAT). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL). The SSRL is a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program (P41RR001209), and the National Institute of General Medical Sciences. Genomic DNA from Bacillus cereus NRS248 (ATCC #10987D) was obtained from the American Type Culture Collection (ATCC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Aramini JM, 2008, BIOCHEMISTRY-US, V47, P9715, DOI 10.1021/bi8010779; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Elsliger MA, 2010, ACTA CRYSTALLOGR F, V66, P1137, DOI 10.1107/S1744309110038212; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estes KA, 2007, DEV BIOL, V308, P196, DOI 10.1016/j.ydbio.2007.05.020; Grosenbach Douglas W., 1998, Frontiers in Bioscience, V3, pD354; Ha BH, 2008, J BIOL CHEM, V283, P14893, DOI 10.1074/jbc.M708756200; Hanna-Rose W, 2002, DEV BIOL, V241, P247, DOI 10.1006/dbio.2001.0514; Husmann K, 1998, ONCOGENE, V17, P1305, DOI 10.1038/sj.onc.1202060; Iyer LM, 2004, CELL CYCLE, V3, P1440, DOI 10.4161/cc.3.11.1206; Jahng WJ, 2003, BIOCHEMISTRY-US, V42, P12805, DOI 10.1021/bi035370p; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Kumar A, 2010, ACTA CRYSTALLOGR F, V66, P1309, DOI 10.1107/S1744309110008092; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Mondal MS, 2000, BIOCHEMISTRY-US, V39, P5215, DOI 10.1021/bi9929554; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pai CH, 2006, EMBO J, V25, P5970, DOI 10.1038/sj.emboj.7601440; Pei JM, 2009, PROTEINS, V77, P413, DOI 10.1002/prot.22447; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Santarsiero BD, 2002, J APPL CRYSTALLOGR, V35, P278, DOI 10.1107/S0021889802001474; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Senkevich TG, 2008, VIROLOGY, V374, P506, DOI 10.1016/j.virol.2008.01.009; Sers C, 1997, J CELL BIOL, V136, P935, DOI 10.1083/jcb.136.4.935; Speers AE, 2010, ACTA CRYSTALLOGR F, V66, P1306, DOI 10.1107/S1744309110035748; Sugawara K, 2005, J BIOL CHEM, V280, P40058, DOI 10.1074/jbc.M509158200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Uyama T, 2009, J LIPID RES, V50, P685, DOI 10.1194/jlr.M800453-JLR200; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1354, DOI 10.1107/S1744309110021214; Xu QP, 2009, STRUCTURE, V17, P303, DOI 10.1016/j.str.2008.12.008; Xue LL, 2004, BIOCHEMISTRY-US, V43, P6120, DOI 10.1021/bi049556f	40	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22013	10.1371/journal.pone.0022013	http://dx.doi.org/10.1371/journal.pone.0022013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799766	gold, Green Published, Green Submitted			2022-12-25	WOS:000293097300013
J	Zhavoronkov, A; Cantor, CR				Zhavoronkov, Alex; Cantor, Charles R.			Methods for Structuring Scientific Knowledge from Many Areas Related to Aging Research	PLOS ONE			English	Article							BOOLEAN FACTOR-ANALYSIS; NEURAL-NETWORK; DEMOGRAPHICS; PERSPECTIVES; POPULATION; STRATEGIES; MEDICINE; AMERICA; DISEASE; POLICY	Aging and age-related disease represents a substantial quantity of current natural, social and behavioral science research efforts. Presently, no centralized system exists for tracking aging research projects across numerous research disciplines. The multidisciplinary nature of this research complicates the understanding of underlying project categories, the establishment of project relations, and the development of a unified project classification scheme. We have developed a highly visual database, the International Aging Research Portfolio (IARP), available at AgingPortfolio.org to address this issue. The database integrates information on research grants, peer-reviewed publications, and issued patent applications from multiple sources. Additionally, the database uses flexible project classification mechanisms and tools for analyzing project associations and trends. This system enables scientists to search the centralized project database, to classify and categorize aging projects, and to analyze the funding aspects across multiple research disciplines. The IARP is designed to provide improved allocation and prioritization of scarce research funding, to reduce project overlap and improve scientific collaboration thereby accelerating scientific and medical progress in a rapidly growing area of research. Grant applications often precede publications and some grants do not result in publications, thus, this system provides utility to investigate an earlier and broader view on research activity in many research disciplines. This project is a first attempt to provide a centralized database system for research grants and to categorize aging research projects into multiple subcategories utilizing both advanced machine algorithms and a hierarchical environment for scientific collaboration.	[Zhavoronkov, Alex] Russian State Med Univ, Moscow 117437, Russia; [Zhavoronkov, Alex] Biogerontol Res Fdn, Reading, Berks, England; [Cantor, Charles R.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Cantor, Charles R.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA	Pirogov Russian National Research Medical University; Boston University; University of California System; University of California Irvine	Zhavoronkov, A (corresponding author), Russian State Med Univ, Moscow 117437, Russia.	alex@biogerontology.org	Zhavoronkov, Alex/X-6241-2019; Zhavoronkov, Alex/HCI-9762-2022	Zhavoronkov, Alex/0000-0001-7067-8966; Zhavoronkov, Alexander/0000-0001-5009-3848				Alonso Allende R, 2009, NAT METHODS ADVERTIS, V6; Calvanese V, 2009, AGEING RES REV, V8, P268, DOI 10.1016/j.arr.2009.03.004; Camici GG, 2011, GERONTOLOGY, V57, P101, DOI 10.1159/000314227; Cevenini E, 2010, CURR PHARM DESIGN, V16, P802, DOI 10.2174/138161210790883660; Coppede Fabio, 2010, Curr Aging Sci, V3, P3; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Crews Douglas E., 2007, Journal of Physiological Anthropology, V26, P365, DOI 10.2114/jpa2.26.365; Crews J E, 1994, J Am Optom Assoc, V65, P63; Doms A, 2005, NUCLEIC ACIDS RES, V33, pW783, DOI 10.1093/nar/gki470; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Dressel P, 1997, INT J HEALTH SERV, V27, P579, DOI 10.2190/7XAY-PYBN-AA5L-3DRC; Farage MA, 2009, AM J CLIN DERMATOL, V10, P73, DOI 10.2165/00128071-200910020-00001; Foley CL, 2002, HOSP MED, V63, P460, DOI 10.12968/hosp.2002.63.8.1965; Frolov AA, 2006, P COMP STAT ROM IT A, P1035; Frolov AA, 2007, IEEE T NEURAL NETWOR, V18, P698, DOI 10.1109/TNN.2007.891664; Frolov AA, 2009, IEEE T NEURAL NETWOR, V20, P1073, DOI 10.1109/TNN.2009.2016090; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kaeberlein M, 2004, SCI AGING KNOWLEDGE, V42, P39; Kinsella K, 2002, AGING CLIN EXP RES, V14, P159; Kligman AM, 1997, DERMATOL CLIN, V15, P549, DOI 10.1016/S0733-8635(05)70464-2; Kuhn H. W., 1951, P 2 BERK S MATH STAT, P481, DOI DOI 10.1007/BF01582292; Lin CJ, 2008, J MACH LEARN RES, V9, P627; MANTON KG, 1991, MILBANK Q, V69, P309, DOI 10.2307/3350207; Olshansky SJ, 2009, MILBANK Q, V87, P842, DOI 10.1111/j.1468-0009.2009.00581.x; Pincus Z, 2010, DEV DYNAM, V239, P1306, DOI 10.1002/dvdy.22224; REUBEN DB, 1988, J AM GERIATR SOC, V36, P1135, DOI 10.1111/j.1532-5415.1988.tb04403.x; SALTON G, 1988, INFORM PROCESS MANAG, V24, P513, DOI 10.1016/0306-4573(88)90021-0; Seeman TE, 2001, ANN NY ACAD SCI, V954, P88; Sikora E, 2010, Immun Ageing, V7, P1, DOI 10.1186/1742-4933-7-1; Smith J, 2003, NEUROBIOL AGING S1, V24, pS81; Smith J, 2003, NEUROBIOL AGING S1, V24, pS7780; Thompson HJ, 2009, RES GERONTOL NURS, V2, P137, DOI 10.3928/19404921-20090401-09; Tse T, 2009, CHEST, V136, P295, DOI 10.1378/chest.08-3022; Tykhonov AN, 1977, SOLUTIONS ILL POSED, P80; Vapnik N. V., 1995, NATURE STAT LEARNING, P138, DOI DOI 10.2307/1271368; Worsowicz GM, 2004, ARCH PHYS MED REHAB, V85, pS3, DOI 10.1016/j.apmr.2004.03.005; Yancik R, 2000, HEMATOL ONCOL CLIN N, V14, P17, DOI 10.1016/S0889-8588(05)70275-6; Yellowitz Janet A, 2005, Dent Clin North Am, V49, P389, DOI 10.1016/j.cden.2004.10.010	38	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22597	10.1371/journal.pone.0022597	http://dx.doi.org/10.1371/journal.pone.0022597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	797BJ	21799912	Green Published, gold			2022-12-25	WOS:000293097300071
J	Chaves-Campos, J; Johnson, SG; Hulsey, CD				Chaves-Campos, Johel; Johnson, Steven G.; Hulsey, C. Darrin			Spatial Geographic Mosaic in an Aquatic Predator-Prey Network	PLOS ONE			English	Article							MORPHOLOGICAL TRADE-OFFS; CUATRO-CIENEGAS; PUMPKINSEED SUNFISH; NATURAL-SELECTION; GENETIC-VARIATION; INDUCED DEFENSES; GASTROPOD SHELL; EVOLUTION; SNAIL; PHYLOGEOGRAPHY	The geographic mosaic theory of coevolution predicts 1) spatial variation in predatory structures as well as prey defensive traits, and 2) trait matching in some areas and trait mismatching in others mediated by gene flow. We examined gene flow and documented spatial variation in crushing resistance in the freshwater snails Mexipyrgus churinceanus, Mexithauma quadripaludium, Nymphophilus minckleyi, and its relationship to the relative frequency of the crushing morphotype in the trophically polymorphic fish Herichthys minckleyi. Crushing resistance and the frequency of the crushing morphotype did show spatial variation among 11 naturally replicated communities in the Cuatro Cienegas valley in Mexico where these species are all endemic. The variation in crushing resistance among populations was not explained by geographic proximity or by genetic similarity in any species. We detected clear phylogeographic patterns and limited gene flow for the snails but not for the fish. Gene flow among snail populations in Cuatro Cienegas could explain the mosaic of local divergence in shell strength and be preventing the fixation of the crushing morphotype in Herichthys minckleyi. Finally, consistent with trait matching across the mosaic, the frequency of the fish morphotype was negatively correlated with shell crushing resistance likely reflecting the relative disadvantage of the crushing morphotype in communities where the snails exhibit relatively high crushing resistance.	[Chaves-Campos, Johel; Johnson, Steven G.] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA; [Hulsey, C. Darrin] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA	University of Louisiana System; University of New Orleans; University of Tennessee System; University of Tennessee Knoxville	Chaves-Campos, J (corresponding author), Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA.	sgjohnso@uno.edu	Chaves-Campos, Johel/AAF-9147-2020	Chaves-Campos, Johel/0000-0001-8026-7626; Hulsey, C. Darrin/0000-0002-9653-6728	National Geographic Society; National Science Foundation [IOS-0919459]; University of New Orleans	National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); University of New Orleans	C. D. Hulsey was supported by the National Geographic Society and by the National Science Foundation (IOS-0919459). The University of New Orleans provided support to S. G. Johnson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Arias JL, 2008, CHEM REV, V108, P4475, DOI 10.1021/cr078269p; Benkman CW, 2001, EVOLUTION, V55, P282, DOI 10.1111/j.0014-3820.2001.tb01293.x; Bourdeau PE, 2010, P ROY SOC B-BIOL SCI, V277, P455, DOI 10.1098/rspb.2009.1295; Brodersen J, 2003, HYDROBIOLOGIA, V490, P181, DOI 10.1023/A:1023495326473; Brodie ED, 2002, EVOLUTION, V56, P2067; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Carson EW, 2006, MOL ECOL, V15, P667, DOI 10.1111/j.1365-294X.2005.02763.x; Chaves-Campos J, 2011, CONSERV GENET, V12, P557, DOI 10.1007/s10592-010-0163-z; CLARK CW, 1992, AM NAT, V139, P521, DOI 10.1086/285342; Cohen Adam E., 2005, Hidrobiológica, V15, P169; Dinger E, 2001, AQUATIC INVERTEBRATE; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgell TC, 2007, EVOL ECOL RES, V9, P579; Edgell TC, 2009, J EXP MAR BIOL ECOL, V382, P1, DOI 10.1016/j.jembe.2009.10.004; Elser JJ, 2005, FRESHWATER BIOL, V50, P1808, DOI 10.1111/j.1365-2427.2005.01451.x; Evans S.B., 2005, USING CHEM DATA DEFI; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; Gandon S, 2009, AM NAT, V173, P212, DOI 10.1086/593706; Gomulkiewicz R, 2007, HEREDITY, V98, P249, DOI 10.1038/sj.hdy.6800949; Gomulkiewicz R, 2000, AM NAT, V156, P156, DOI 10.1086/303382; Hanifin CT, 2008, PLOS BIOL, V6, P471, DOI 10.1371/journal.pbio.0060060; HENDRICKSON DA, 2008, ARIDLAND SPRINGS N A; HERSHLER R, 1985, MALACOLOGIA, V26, P31; Hershler R, 1984, Journal of the Arizona-Nevada Academy of Science, V19, P61; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hulsey CD, 2006, EVOLUTION, V60, P2096, DOI 10.1111/j.0014-3820.2006.tb01847.x; Hulsey CD, 2008, EVOLUTION, V62, P1587, DOI 10.1111/j.1558-5646.2008.00384.x; Hulsey CD, 2006, J FISH BIOL, V68, P1399, DOI 10.1111/j.0022-1112.2006.01021.x; Hulsey CD, 2005, EVOL ECOL RES, V7, P303; Hulsey CD, 2004, MOL PHYLOGENET EVOL, V31, P754, DOI 10.1016/j.ympev.2003.08.024; Johnson SG, 2005, MOL ECOL, V14, P2299, DOI 10.1111/j.1365-294X.2005.02580.x; Johnson SG, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-50; Kim SH, 2007, GENETICA, V131, P151, DOI 10.1007/s10709-006-9125-2; Kishida O, 2007, ECOLOGY, V88, P1948, DOI 10.1890/07-0132.1; KLOEPPEL H, 2002, MOLLUSCIVORE HERICHT; KORNFIELD I, 1982, EVOLUTION, V36, P658, DOI 10.1111/j.1558-5646.1982.tb05433.x; KORNFIELD IL, 1975, EVOLUTION, V29, P427, DOI 10.1111/j.1558-5646.1975.tb00832.x; Liu HP, 2001, MOL PHYLOGENET EVOL, V21, P17, DOI 10.1006/mpev.2001.0988; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Marxen JC, 2003, BBA-PROTEINS PROTEOM, V1650, P92, DOI 10.1016/S1570-9639(03)00203-6; Mccoy MW, 2006, OECOLOGIA, V148, P547, DOI 10.1007/s00442-006-0403-6; MINCKLEY WL, 1969, U TEXAS EL PASO SCI, V2, P1; MITTELBACH GG, 1992, OECOLOGIA, V90, P8, DOI 10.1007/BF00317802; Mougi A, 2010, P ROY SOC B-BIOL SCI, V277, P3163, DOI 10.1098/rspb.2010.0691; Moya-Larano Jordi, 2008, Web Ecology, V8, P35; Near TJ, 2003, EVOLUTION, V57, P1610; NORTON SF, 1988, SCIENCE, V241, P92, DOI 10.1126/science.241.4861.92; Nuismer SL, 2006, EVOLUTION, V60, P2207; Nuismer SL, 2000, EVOLUTION, V54, P1102; OSENBERG CW, 1989, ECOL MONOGR, V59, P405, DOI 10.2307/1943074; Pakes D, 2010, J EVOLUTION BIOL, V23, P1613, DOI 10.1111/j.1420-9101.2010.02026.x; PALMER AR, 1992, P NATL ACAD SCI USA, V89, P1379, DOI 10.1073/pnas.89.4.1379; PALMER AR, 1979, EVOLUTION, V33, P697, DOI 10.1111/j.1558-5646.1979.tb04722.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2022, R LANG ENV STAT COMP; Rosenberg MS, 2001, PASSAGE PATTERN ANAL; Rundle SD, 2004, P ROY SOC B-BIOL SCI, V271, pS67, DOI 10.1098/rsbl.2003.0106; SAGE RD, 1975, P NATL ACAD SCI USA, V72, P4669, DOI 10.1073/pnas.72.11.4669; Simmons RB, 2001, MOL PHYLOGENET EVOL, V20, P196, DOI 10.1006/mpev.2001.0958; Soler JJ, 2003, BIOL J LINN SOC, V79, P551, DOI 10.1046/j.1095-8312.2003.00209.x; Thompson J. N., 2005, INTERSPEC INTERACT; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson JN, 1999, AM NAT, V153, pS1, DOI 10.1086/303208; Toju H, 2006, AM NAT, V167, P105, DOI 10.1086/498277; Toju H, 2006, MOL ECOL, V15, P4161, DOI 10.1111/j.1365-294X.2006.03088.x; Toju H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-273; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Trapani J, 2003, J FISH BIOL, V62, P276, DOI 10.1046/j.1095-8649.2003.00006.x; Trussell GC, 2000, EVOLUTION, V54, P151, DOI 10.1111/j.0014-3820.2000.tb00016.x; Trussell GC, 2000, EVOL ECOL RES, V2, P803; Trussell GC, 2000, P NATL ACAD SCI USA, V97, P2123, DOI 10.1073/pnas.040423397; Vermeij G.J., 1993, NATURAL HIST SHELLS; Vermeij G.J., 1993, EVOLUTION ESCALATION; VERMEIJ GJ, 1994, ANNU REV ECOL SYST, V25, P219, DOI 10.1146/annurev.es.25.110194.001251; VERMEIJ GJ, 1978, AM NAT, V112, P833, DOI 10.1086/283326; Wainwright PC, 1996, ECOLOGY, V77, P1336, DOI 10.2307/2265531; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wilke T, 2003, ZOOL J LINN SOC-LOND, V137, P319, DOI 10.1046/j.1096-3642.2003.00049.x; Zhang C, 2006, MAR BIOTECHNOL, V8, P572, DOI 10.1007/s10126-005-6029-6; Zhang WB, 2004, J SHELLFISH RES, V23, P1065	85	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22472	10.1371/journal.pone.0022472	http://dx.doi.org/10.1371/journal.pone.0022472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799865	Green Published, gold			2022-12-25	WOS:000292931200056
J	Jorge, PE; Sowter, D; Marques, PAM				Jorge, Paulo E.; Sowter, David; Marques, Paulo A. M.			Differential Annual Movement Patterns in a Migratory Species: Effects of Experience and Sexual Maturation	PLOS ONE			English	Article							BLACK-BACKED GULL; BIRD MIGRATION; LARUS-FUSCUS; BEHAVIOR; SOUTH; SATELLITE; ECOLOGY; SEABIRD; AUTUMN	Some animals migrate long distances to exploit important seasonal food resources in the northern regions of the northern hemisphere, whilst avoiding winter starvation. Changes in the individual's age and navigational skills are likely to affect migration, which in turn influences the geographic distribution of individuals. Processes such as sexual maturation and navigational abilities are affected by age, and age is thus a key factor in understanding migration patterns and differences in distribution ranges. In the present study, we investigated the effects of age on the geographic distribution of a population of Lesser Black-backed Gulls Larus fuscus throughout its annual cycle, by analyzing a dataset of 19,096 records from 10,000 color-ringed gulls. In contrast to previous assumptions, the results showed that gulls were geographically segregated by age throughout the entire annual cycle, rather than showing a geographic age-related cline only in the wintering areas. This asymmetric distribution results from a reduction in the annual range of sexually mature gulls, and the differential distribution of mature and immature individuals (mature birds remained in more northern areas, compared to immature birds, throughout the annual cycle). Furthermore, although immature gulls travelled longer distances than adults, they initiated their fall migration with short movements, in contrast to adults that migrated using longer movements. The effects identified in this study explain the non-homogenous distribution of populations throughout the annual cycle, with wide implications for the development of effective human health policies and/or wildlife management strategies.	[Jorge, Paulo E.; Marques, Paulo A. M.] ISPA Inst Univ, Unidade Invest Ecoetol, Lisbon, Portugal; [Jorge, Paulo E.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Sowter, David] NW Gull Project, Preston, Lancs, England; [Marques, Paulo A. M.] Univ Lisbon, Museo Nacl Hist Nat, P-1699 Lisbon, Portugal	Instituto Superior Psicologia Aplicada (ISPA); Virginia Polytechnic Institute & State University; Universidade de Lisboa	Jorge, PE (corresponding author), ISPA Inst Univ, Unidade Invest Ecoetol, Lisbon, Portugal.	pajorge@ispa.pt	Marques, Paulo A. M./A-1934-2009; Jorge, Paulo/I-7049-2013	Marques, Paulo A. M./0000-0003-1285-2051; Jorge, Paulo/0000-0001-9348-6510	Portuguese Science Foundation (FCT) [SFRH/BPD/34846/2007, SFRH/BPD/22669/2005]; Synthesys [DK-TAF 808]	Portuguese Science Foundation (FCT)(Portuguese Foundation for Science and Technology); Synthesys	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PAMM was supported by grant SFRH/BPD/34846/2007 and PEJ by grant SFRH/BPD/22669/2005 both from the Portuguese Science Foundation (FCT). This project was financed by Synthesys under DK-TAF 808 visit to SNM/DK.	Akesson S, 1996, BEHAV ECOL SOCIOBIOL, V38, P293, DOI 10.1007/s002650050245; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Anker-Nilssen T, 2009, POLAR BIOL, V32, P1657, DOI 10.1007/s00300-009-0665-7; BAKER RR, 1980, BIRD STUDY, V27, P41, DOI 10.1080/00063658009476655; Bartumeus F, 2008, P NATL ACAD SCI USA, V105, P19072, DOI 10.1073/pnas.0801926105; Batschelet E, 1981, CIRCULAR STAT BIOL; Bauer S, 2010, ECOLOGY, V91, P1822, DOI 10.1890/09-1281.1; Bonnedahl J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005958; Boyle WA, 2008, J ANIM ECOL, V77, P1122, DOI 10.1111/j.1365-2656.2008.01451.x; Buehler DM, 2008, PHILOS T R SOC B, V363, P247, DOI 10.1098/rstb.2007.2138; Cristol Daniel A., 1999, Current Ornithology, V15, P33; Descamps S, 2010, OIKOS, V119, P1526, DOI 10.1111/j.1600-0706.2010.18508.x; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Fritz H, 2003, P ROY SOC B-BIOL SCI, V270, P1143, DOI 10.1098/rspb.2003.2350; Fryxell JM, 2008, P NATL ACAD SCI USA, V105, P19114, DOI 10.1073/pnas.0801737105; Greenberg R., 2005, BIRDS 2 WORLDS ECOLO; Hake M, 2003, OIKOS, V103, P385, DOI 10.1034/j.1600-0706.2003.12145.x; Hall-Karlsson S., 2008, SWEDISH BIRD RINGING, V2; Helberg M, 2009, ARDEA, V97, P281, DOI 10.5253/078.097.0303; Holden C, 2006, SCIENCE, V313, P779, DOI 10.1126/science.313.5788.779; Jenouvrier S, 2008, OIKOS, V117, P620, DOI 10.1111/j.0030-1299.2008.16394.x; Mansfield KL, 2009, MAR BIOL, V156, P2555, DOI 10.1007/s00227-009-1279-x; Markovets ML, 2008, NATURWISSENSCHAFTEN, V95, P655, DOI 10.1007/s00114-008-0371-2; Marques PAM, 2010, OIKOS, V119, P946, DOI 10.1111/j.1600-0706.2009.18192.x; Marshak, 2015, EARTH PORTRAIT PLANE; Mathot KJ, 2007, ECOLOGY, V88, P781, DOI 10.1890/06-1225; McNamara JM, 2008, PHILOS T R SOC B, V363, P301, DOI 10.1098/rstb.2007.2141; Moreau RE., PALEARCTIC AFRICAN B; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Newlands NK, 2004, POPUL ECOL, V46, P39, DOI 10.1007/s10144-004-0169-9; Newton I., 2010, BIRD MIGRATION; NOSSAL R, 1972, EXP CELL RES, V75, P138, DOI 10.1016/0014-4827(72)90529-0; Puetz K., 2008, Ringing & Migration, V24, P7; Rock Peter, 2005, British Birds, V98, P338; Rock R, 2002, MIGRATION ATLAS MOVE, P365; Rodriguez A, 2009, DIVERS DISTRIB, V15, P1010, DOI 10.1111/j.1472-4642.2009.00600.x; Rolshausen G, 2009, CURR BIOL, V19, P2097, DOI 10.1016/j.cub.2009.10.061; Varty N, 2009, BACKGROUND DOCUMENT; Votier SC, 2011, MAR BIOL, V158, P355, DOI 10.1007/s00227-010-1563-9; Weimerskirch H, 2006, J AVIAN BIOL, V37, P23, DOI 10.1111/j.2006.0908-8857.03675.x; Wille M, 2011, ARCH VIROL, V156, P107, DOI 10.1007/s00705-010-0839-1; Wingfield JC, 2008, PHILOS T R SOC B, V363, P425, DOI 10.1098/rstb.2007.2149; Zehnder S, 2001, J AVIAN BIOL, V32, P239, DOI 10.1111/j.0908-8857.2001.320306.x	43	10	10	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22433	10.1371/journal.pone.0022433	http://dx.doi.org/10.1371/journal.pone.0022433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799853	gold, Green Published, Green Submitted			2022-12-25	WOS:000292931200054
J	Liu, WY; Morito, D; Takashima, S; Mineharu, Y; Kobayashi, H; Hitomi, T; Hashikata, H; Matsuura, N; Yamazaki, S; Toyoda, A; Kikuta, K; Takagi, Y; Harada, KH; Fujiyama, A; Herzig, R; Krischek, B; Zou, LP; Kim, JE; Kitakaze, M; Miyamoto, S; Nagata, K; Hashimoto, N; Koizumi, A				Liu, Wanyang; Morito, Daisuke; Takashima, Seiji; Mineharu, Yohei; Kobayashi, Hatasu; Hitomi, Toshiaki; Hashikata, Hirokuni; Matsuura, Norio; Yamazaki, Satoru; Toyoda, Atsushi; Kikuta, Ken-ichiro; Takagi, Yasushi; Harada, Kouji H.; Fujiyama, Asao; Herzig, Roman; Krischek, Boris; Zou, Liping; Kim, Jeong Eun; Kitakaze, Masafumi; Miyamoto, Susumu; Nagata, Kazuhiro; Hashimoto, Nobuo; Koizumi, Akio			Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; MIDDLE CEREBRAL-ARTERY; CEREBROSPINAL-FLUID; SPONTANEOUS OCCLUSION; LINKAGE ANALYSIS; VIRUS-INFECTION; ZEBRAFISH; WILLIS; CIRCLE; EXPRESSION	Background: Moyamoya disease is an idiopathic vascular disorder of intracranial arteries. Its susceptibility locus has been mapped to 17q25.3 in Japanese families, but the susceptibility gene is unknown. Methodology/Principal Findings: Genome-wide linkage analysis in eight three-generation families with moyamoya disease revealed linkage to 17q25.3 (P < 10(-4)). Fine mapping demonstrated a 1.5-Mb disease locus bounded by D17S1806 and rs2280147. We conducted exome analysis of the eight index cases in these families, with results filtered through Ng criteria. There was a variant of p.N321S in PCMTD1 and p.R4810K in RNF213 in the 1.5-Mb locus of the eight index cases. The p.N321S variant in PCMTD1 could not be confirmed by the Sanger method. Sequencing RNF213 in 42 index cases confirmed p.R4810K and revealed it to be the only unregistered variant. Genotyping 39 SNPs around RNF213 revealed a founder haplotype transmitted in 42 families. Sequencing the 260-kb region covering the founder haplotype in one index case did not show any coding variants except p.R4810K. A case-control study demonstrated strong association of p.R4810K with moyamoya disease in East Asian populations (251 cases and 707 controls) with an odds ratio of 111.8 (P=10(-119)). Sequencing of RNF213 in East Asian cases revealed additional novel variants: p.D4863N, p.E4950D, p.A5021V, p.D5160E, and p.E5176G. Among Caucasian cases, variants p.N3962D, p.D4013N, p.R4062Q and p.P4608S were identified. RNF213 encodes a 591-kDa cytosolic protein that possesses two functional domains: a Walker motif and a RING finger domain. These exhibit ATPase and ubiquitin ligase activities. Although the mutant alleles (p.R4810K or p.D4013N in the RING domain) did not affect transcription levels or ubiquitination activity, knockdown of RNF213 in zebrafish caused irregular wall formation in trunk arteries and abnormal sprouting vessels. Conclusions/Significance: We provide evidence suggesting, for the first time, the involvement of RNF213 in genetic susceptibility to moyamoya disease.	[Liu, Wanyang; Kobayashi, Hatasu; Hitomi, Toshiaki; Hashikata, Hirokuni; Matsuura, Norio; Harada, Kouji H.; Koizumi, Akio] Kyoto Univ, Dept Hlth & Environm Sci, Kyoto, Japan; [Morito, Daisuke; Nagata, Kazuhiro] Kyoto Sangyo Univ, Fac Life Sci, Kyoto 603, Japan; [Takashima, Seiji] Osaka Univ, Dept Mol Cardiol, Osaka, Japan; [Mineharu, Yohei; Hashikata, Hirokuni; Kikuta, Ken-ichiro; Takagi, Yasushi; Miyamoto, Susumu; Hashimoto, Nobuo] Kyoto Univ, Dept Neurosurg, Kyoto, Japan; [Yamazaki, Satoru; Kitakaze, Masafumi; Hashimoto, Nobuo] Natl Cerebral & Cardiovasc Ctr, Osaka, Japan; [Toyoda, Atsushi; Fujiyama, Asao] Natl Inst Genet, Comparat Genom Lab, Shizuoka, Japan; [Fujiyama, Asao] Natl Inst Informat, Principles Informat Res Div, Tokyo, Japan; [Herzig, Roman] Palacky Univ Hosp, Olomouc, Czech Republic; [Krischek, Boris] Univ Tubingen, Dept Neurosurg, Tubingen, Germany; [Zou, Liping] Chinese Peoples Liberat Army Gen Hosp, Dept Pediat, Beijing, Peoples R China; [Kim, Jeong Eun] Seoul Natl Univ, Coll Med, Seoul, South Korea	Kyoto University; Kyoto Sangyo University; Osaka University; Kyoto University; National Cerebral & Cardiovascular Center - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Palacky University Olomouc; University Hospital Olomouc; Eberhard Karls University of Tubingen; Chinese People's Liberation Army General Hospital; Seoul National University (SNU)	Liu, WY (corresponding author), Kyoto Univ, Dept Hlth & Environm Sci, Kyoto, Japan.	hashimot@hsp.ncvc.go.jp; koizumi.akio.5v@kyoto-u.ac.jp	Kim, Jeong Eun/J-5434-2012; Kobayashi, Hatasu/R-8012-2019; Herzig, Roman/O-8901-2017	Kobayashi, Hatasu/0000-0002-5664-6869; Herzig, Roman/0000-0001-7238-7724; Mineharu, Yohei/0000-0002-6346-3999; Morito, Daisuke/0000-0003-2263-8200	Ministry of Education, Science, Sports and Culture of Japan [14207016, 22249020, 17109007, 15012231, 16012232, 17019034, 18018022];  [22710193];  [20590598];  [19G50314];  [225192]; Grants-in-Aid for Scientific Research [23590741, 23659329, 23122520, 19GS0314, 10J05192] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was mainly supported by grants from the Ministry of Education, Science, Sports and Culture of Japan (Kiban Kenkyu A: 14207016 and 22249020, S: 17109007, Tokutei Kenkyu: 15012231, 16012232, 17019034 and 18018022) and partially by grants (Wakate Kenkyu B: 22710193, Kiban Kenkyu C: 20590598, Creative Scientific Research: 19G50314, Tokubetukenkyuin Syoureihi: 225192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-114; Amlie-Lefond C, 2009, CIRCULATION, V119, P1417, DOI 10.1161/CIRCULATIONAHA.108.806307; Bauersachs S, 2006, REPRODUCTION, V132, P319, DOI 10.1530/rep.1.00996; BITZER M, 1995, STROKE, V26, P131, DOI 10.1161/01.STR.26.1.131; Coe BP, 2007, GENOMICS, V89, P647, DOI 10.1016/j.ygeno.2006.12.012; Czartoski T, 2005, J NEUROL NEUROSUR PS, V76, P256, DOI 10.1136/jnnp.2004.041046; El Ramahi KM, 2000, LUPUS, V9, P632, DOI 10.1191/096120300678828686; Fukui M, 2000, NEUROPATHOLOGY, V20, pS61, DOI 10.1046/j.1440-1789.2000.00300.x; Fukui M, 1997, CLIN NEUROL NEUROSUR, V99, pS238; Goto Yasunobu, 1992, Neurologia Medico-Chirurgica, V32, P883, DOI 10.2176/nmc.32.883; Hojo M, 1998, J NEUROSURG, V89, P623, DOI 10.3171/jns.1998.89.4.0623; Ikeda H, 1999, AM J HUM GENET, V64, P533, DOI 10.1086/302243; Inoue TK, 2000, J CHILD NEUROL, V15, P179, DOI 10.1177/088307380001500307; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Kim SK, 2003, STROKE, V34, P2835, DOI 10.1161/01.STR.0000100159.43123.D7; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Liu Wanyang, 2010, Environmental Health and Preventive Medicine, V15, P94, DOI 10.1007/s12199-009-0116-7; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Malek AM, 1997, PEDIATR NEUROSURG, V27, P182, DOI 10.1159/000121249; Miao W, 2010, CLIN NEUROL NEUROSUR, V112, P199, DOI 10.1016/j.clineuro.2009.11.009; Mineharu Y, 2008, NEUROLOGY, V70, P2357, DOI 10.1212/01.wnl.0000291012.49986.f9; Mineharu Y, 2006, J NEUROL NEUROSUR PS, V77, P1025, DOI 10.1136/jnnp.2006.096040; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Nanba R, 2004, STROKE, V35, P2837, DOI 10.1161/01.STR.0000148237.13659.e6; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Ogawa K, 2003, STROKE, V34, pE244, DOI 10.1161/01.STR.0000100479.63243.48; Phillips JA, 2008, GENET MED, V10, P359, DOI 10.1097/GIM.0b013e318172dcdf; Sakurai K, 2004, J HUM GENET, V49, P278, DOI 10.1007/s10038-004-0143-6; Seguchi O, 2007, J CLIN INVEST, V117, P2812, DOI 10.1172/JCI30804; Sharfstein Sophia R, 2007, J Stroke Cerebrovasc Dis, V16, P268, DOI 10.1016/j.jstrokecerebrovasdis.2007.07.001; Somarajan A, 2005, J Assoc Physicians India, V53, P49; Soriano SG, 2002, NEUROSURGERY, V50, P544, DOI 10.1097/00006123-200203000-00022; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012; Takagi Y, 2007, NEUROSURGERY, V60, P338, DOI 10.1227/01.NEU.0000249275.87310.FF; Takagi Y, 2006, NEUROSURGERY, V59, P894, DOI 10.1227/01.NEU.0000232771.80339.15; TAKAHASHI A, 1993, NEUROSCI LETT, V160, P214, DOI 10.1016/0304-3940(93)90416-I; TAKEBAYASHI S, 1984, STROKE, V15, P728, DOI 10.1161/01.STR.15.4.728; Takeuchi K., 1957, BRAIN NERVE, V9, P37; Tanigawara T, 1997, CLIN NEUROL NEUROSUR, V99, pS225; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Ueno M, 2002, BRAIN DEV-JPN, V24, P106, DOI 10.1016/S0387-7604(02)00005-0; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Yamada S, 2003, STROKE, V34, P892, DOI 10.1161/01.STR.0000062887.71400.B4; Yamauchi T, 2000, STROKE, V31, P930, DOI 10.1161/01.STR.31.4.930; Yoshimoto T, 1996, STROKE, V27, P2160, DOI 10.1161/01.STR.27.12.2160; Zhang SY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000648	49	396	416	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22542	10.1371/journal.pone.0022542	http://dx.doi.org/10.1371/journal.pone.0022542			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799892	Green Published, Green Submitted, gold			2022-12-25	WOS:000292931200062
J	Schleicher, SM; Thotala, DK; Linkous, AG; Hu, R; Leahy, KM; Yazlovitskaya, EM; Hallahan, DE				Schleicher, Stephen M.; Thotala, Dinesh K.; Linkous, Amanda G.; Hu, Rong; Leahy, Kathleen M.; Yazlovitskaya, Eugenia M.; Hallahan, Dennis E.			Autotaxin and LPA Receptors Represent Potential Molecular Targets for the Radiosensitization of Murine Glioma through Effects on Tumor Vasculature	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID RECEPTORS; CANCER METASTASIS; CELL MOTILITY; AKT; PATHWAY; IDENTIFICATION; ANGIOGENESIS; MECHANISMS; INVASION; ANALOGS	Despite wide margins and high dose irradiation, unresectable malignant glioma (MG) is less responsive to radiation and is uniformly fatal. We previously found that cytosolic phospholipase A2 (cPLA(2)) is a molecular target for radiosensitizing cancer through the vascular endothelium. Autotaxin (ATX) and lysophosphatidic acid (LPA) receptors are downstream from cPLA(2) and highly expressed in MG. Using the ATX and LPA receptor inhibitor, alpha-bromomethylene phosphonate LPA (BrP-LPA), we studied ATX and LPA receptors as potential molecular targets for the radiosensitization of tumor vasculature in MG. Treatment of Human Umbilical Endothelial cells (HUVEC) and mouse brain microvascular cells bEND. 3 with 5 mu mol/L BrP-LPA and 3 Gy irradiation showed decreased clonogenic survival, tubule formation, and migration. Exogenous addition of LPA showed radioprotection that was abrogated in the presence of BrP-LPA. In co-culture experiments using bEND. 3 and mouse GL-261 glioma cells, treatment with BrP-LPA reduced Akt phosphorylation in both irradiated cell lines and decreased survival and migration of irradiated GL-261 cells. Using siRNA to knock down LPA receptors LPA1, LPA2 or LPA3 in HUVEC, we demonstrated that knockdown of LPA2 but neither LPA1 nor LPA3 led to increased viability and proliferation. However, knockdown of LPA1 and LPA3 but not LPA2 resulted in complete abrogation of tubule formation implying that LPA1 and LPA3 on endothelial cells are likely targets of BrP-LPA radiosensitizing effect. Using heterotopic tumor models of GL-261, mice treated with BrP-LPA and irradiation showed a tumor growth delay of 6.8 days compared to mice treated with irradiation alone indicating that inhibition of ATX and LPA receptors may significantly improve malignant glioma response to radiation therapy. These findings identify ATX and LPA receptors as molecular targets for the development of radiosensitizers for MG.	[Schleicher, Stephen M.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Yazlovitskaya, Eugenia M.] Vanderbilt Univ, Dept Med, Div Nephrol, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Linkous, Amanda G.] NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USA; [Thotala, Dinesh K.; Hu, Rong; Leahy, Kathleen M.; Hallahan, Dennis E.] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO USA; [Hallahan, Dennis E.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA; [Hallahan, Dennis E.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO USA	Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL)	Schleicher, SM (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.	dhallahan@radonc.wustl.edu		Linkous, Amanda/0000-0003-1663-6364	U.S. National Cancer Institute [1R01CA140220-02, 5R01CA125757-06, 7R01CA112385-0]; Siteman Cancer Research Award; Elizabeth and James McDonnell III Endowment; Howard Hughes Medical Institute-Ivy Foundation; Department of Radiation Oncology Startup Funds; NATIONAL CANCER INSTITUTE [R01CA125757, R01CA112385, R01CA140220] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Siteman Cancer Research Award; Elizabeth and James McDonnell III Endowment; Howard Hughes Medical Institute-Ivy Foundation; Department of Radiation Oncology Startup Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by U.S. National Cancer Institute grants 1R01CA140220-02, 5R01CA125757-06, 7R01CA112385-0, Siteman Cancer Research Award, Elizabeth and James McDonnell III Endowment (D. Hallahan), Howard Hughes Medical Institute-Ivy Foundation Research Training Fellowship (www.hhmi.org) (S. Schleicher), and Department of Radiation Oncology Startup Funds (D. Thotala). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DL, 2001, ANAL BIOCHEM, V292, P287, DOI 10.1006/abio.2001.5063; Berens M E, 1990, Neurosurg Clin N Am, V1, P1; Cechin SR, 2005, NEUROCHEM RES, V30, P603, DOI 10.1007/s11064-005-2747-4; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Chautard E, 2010, NEURO-ONCOLOGY, V12, P434, DOI 10.1093/neuonc/nop059; Contos JJA, 2000, MOL PHARMACOL, V58, P1188, DOI 10.1124/mol.58.6.1188; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; Deng W, 2007, GASTROENTEROLOGY, V132, P1834, DOI 10.1053/j.gastro.2007.03.038; FIDLER IJ, 1990, CANCER RES, V50, P6130; Gong F, 1999, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V16, P216; Griffioen AW, 2000, PHARMACOL REV, V52, P237; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Hoelzinger DB, 2008, J NEURO-ONCOL, V86, P297, DOI 10.1007/s11060-007-9480-6; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; Jiang GW, 2007, CHEMMEDCHEM, V2, P679, DOI 10.1002/cmdc.200600280; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kishi Y, 2006, J BIOL CHEM, V281, P17492, DOI 10.1074/jbc.M601803200; Linkous A, 2009, CLIN CANCER RES, V15, P1635, DOI 10.1158/1078-0432.CCR-08-1905; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; LoPiccolo J, 2007, ANTI-CANCER DRUG, V18, P861; Manning TJ, 2000, CELL MOTIL CYTOSKEL, V45, P185, DOI 10.1002/(SICI)1097-0169(200003)45:3<185::AID-CM2>3.0.CO;2-G; Nam SW, 2001, CANCER RES, V61, P6938; Prestwich GD, 2008, BBA-MOL CELL BIOL L, V1781, P588, DOI 10.1016/j.bbalip.2008.03.008; Ptaszynska MM, 2010, MOL CANCER RES, V8, P309, DOI 10.1158/1541-7786.MCR-09-0288; Roy HK, 2002, CARCINOGENESIS, V23, P201, DOI 10.1093/carcin/23.1.201; Stassar MJJG, 2001, BRIT J CANCER, V85, P1372, DOI 10.1054/bjoc.2001.2074; Stefan C, 1999, BBA-MOL CELL RES, V1450, P45, DOI 10.1016/S0167-4889(99)00031-2; Stracke ML, 1997, ADV ENZYME REGUL, V37, P135, DOI 10.1016/S0065-2571(96)00017-9; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Tanno S, 2004, CANCER RES, V64, P3486, DOI 10.1158/0008-5472.CAN-03-1788; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wachsberger P, 2003, CLIN CANCER RES, V9, P1957; Wen Patrick Y, 2004, Curr Neurol Neurosci Rep, V4, P218, DOI 10.1007/s11910-004-0042-4; Xia HHX, 2009, CANCER-AM CANCER SOC, V115, P5441, DOI 10.1002/cncr.24609; Xue JX, 2010, ONCOL REP, V24, P1515, DOI 10.3892/or_00001013; Yazlovitskaya EM, 2008, CELL DEATH DIFFER, V15, P1641, DOI 10.1038/cdd.2008.93; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378	39	51	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22182	10.1371/journal.pone.0022182	http://dx.doi.org/10.1371/journal.pone.0022182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799791	Green Published, gold, Green Submitted			2022-12-25	WOS:000292931200033
J	Slone, SR; Lesort, M; Yacoubian, TA				Slone, Sunny R.; Lesort, Mathieu; Yacoubian, Talene A.			14-3-3theta Protects against Neurotoxicity in a Cellular Parkinson's Disease Model through Inhibition of the Apoptotic Factor Bax	PLOS ONE			English	Article							ENCODING ALPHA-SYNUCLEIN; LEWY BODIES; CYTOPLASMIC LOCALIZATION; NEURONAL APOPTOSIS; PESTICIDE EXPOSURE; OXIDATIVE DAMAGE; PROTEINS; MUTATION; PHOSPHORYLATION; TRANSLOCATION	Disruption of 14-3-3 function by alpha-synuclein has been implicated in Parkinson's disease. As 14-3-3s are important regulators of cell death pathways, disruption of 14-3-3s could result in the release of pro-apoptotic factors, such as Bax. We have previously shown that overexpression of 14-3-3 theta reduces cell loss in response to rotenone and MPP+ in dopaminergic cell culture and reduces cell loss in transgenic C. elegans that overexpress alpha-synuclein. In this study, we investigate the mechanism for 14-3-3 theta's neuroprotection against rotenone toxicity. While 14-3-3s can inhibit many pro-apoptotic factors, we demonstrate that inhibition of one factor in particular, Bax, is important to 14-3-3s' protection against rotenone toxicity in dopaminergic cells. We found that 14-3-3 theta overexpression reduced Bax activation and downstream signaling events, including cytochrome C release and caspase 3 activation. Pharmacological inhibition or shRNA knockdown of Bax provided protection against rotenone, comparable to 14-3-3 theta's neuroprotective effects. A 14-3-3 theta mutant incapable of binding Bax failed to protect against rotenone. These data suggest that 14-3-3 theta's neuroprotective effects against rotenone are at least partially mediated by Bax inhibition and point to a potential therapeutic role of 14-3-3s in Parkinson's disease.	[Slone, Sunny R.; Yacoubian, Talene A.] Univ Alabama, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA; [Lesort, Mathieu] Univ Alabama, Dept Psychiat, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Slone, SR (corresponding author), Univ Alabama, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, UAB Stn, Birmingham, AL 35294 USA.	tyacoub@uab.edu			National Institutes of Health National Institute of Neurological Disorders and Stroke (NINDS) [K08 (NS060948)]; American Parkinson Disease Association; Parkinson's Association of Alabama; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS060948] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Parkinson Disease Association; Parkinson's Association of Alabama; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a National Institutes of Health National Institute of Neurological Disorders and Stroke (NINDS) K08 (NS060948), by the American Parkinson Disease Association George C. Cotzias Memorial Fellowship, and by the Parkinson's Association of Alabama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Ascherio A, 2006, ANN NEUROL, V60, P197, DOI 10.1002/ana.20904; Athanassiadou A, 1999, AM J HUM GENET, V65, P555, DOI 10.1086/302486; Berg D, 2003, ANN NEUROL, V54, P135, DOI 10.1002/ana.10621; Betarbet R, 2006, NEUROBIOL DIS, V22, P404, DOI 10.1016/j.nbd.2005.12.003; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Firestone JA, 2005, ARCH NEUROL-CHICAGO, V62, P91, DOI 10.1001/archneur.62.1.91; Gill MB, 2009, J NEUROSCI RES, V87, P2047, DOI 10.1002/jnr.22019; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Kawamoto Y, 2002, J NEUROPATH EXP NEUR, V61, P245, DOI 10.1093/jnen/61.3.245; King TD, 2005, NEUROREPORT, V16, P597, DOI 10.1097/00001756-200504250-00016; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Lee DY, 2008, EUR J CELL BIOL, V87, P389, DOI 10.1016/j.ejcb.2008.03.003; Li XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017153; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Nomura M, 2003, J BIOL CHEM, V278, P2058, DOI 10.1074/jbc.M207880200; Perier C, 2005, P NATL ACAD SCI USA, V102, P19126, DOI 10.1073/pnas.0508215102; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Priyadarshi A, 2000, NEUROTOXICOLOGY, V21, P435; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Samuel T, 2001, J BIOL CHEM, V276, P45201, DOI 10.1074/jbc.M106427200; Sato S, 2006, EMBO J, V25, P211, DOI 10.1038/sj.emboj.7600774; Sherer TB, 2002, J NEUROSCI, V22, P7006; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smaili SS, 2001, CELL DEATH DIFFER, V8, P909, DOI 10.1038/sj.cdd.4400889; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tatton NA, 2000, EXP NEUROL, V166, P29, DOI 10.1006/exnr.2000.7489; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Vila M, 2001, P NATL ACAD SCI USA, V98, P2837, DOI 10.1073/pnas.051633998; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Yacoubian TA, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.4; Yacoubian TA, 2008, NEUROBIOL DIS, V29, P515, DOI 10.1016/j.nbd.2007.11.008; Yacoubian TA, 2009, BBA-MOL BASIS DIS, V1792, P676, DOI 10.1016/j.bbadis.2008.09.009; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	45	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e21720	10.1371/journal.pone.0021720	http://dx.doi.org/10.1371/journal.pone.0021720			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799745	Green Published, gold, Green Submitted			2022-12-25	WOS:000292931200011
J	Yang, B; Guo, HF; Zhang, YL; Chen, L; Ying, DJ; Dong, SW				Yang, Bo; Guo, Hongfeng; Zhang, Yulan; Chen, Lei; Ying, Dajun; Dong, Shiwu			MicroRNA-145 Regulates Chondrogenic Differentiation of Mesenchymal Stem Cells by Targeting Sox9	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; NUCLEAR EXPORT; SMAD3; DICER; TRANSCRIPTION; ACTIVATION; PHENOTYPE; MECHANISM; SIGNALS; PROTEIN	Chondrogenic differentiation of mesenchymal stem cells (MSCs) is accurately regulated by essential transcription factors and signaling cascades. However, the precise mechanisms involved in this process still remain to be defined. MicroRNAs (miRNAs) regulate various biological processes by binding target mRNA to attenuate protein synthesis. To investigate the mechanisms for miRNAs-mediated regulation of chondrogenic differentiation, we identified that miR-145 was decreased during transforming growth factor beta 3 (TGF-beta 3)-induced chondrogenic differentiation of murine MSCs. Subsequently, dual-luciferase reporter gene assay data demonstrated that miR-145 targets a putative binding site in the 3'-UTR of SRY-related high mobility group-Box gene 9 (Sox9) gene, the key transcription factor for chondrogenesis. In addition, overexpression of miR-145 decreased expression of Sox9 only at protein levels and miR-145 inhibition significantly elevated Sox9 protein levels. Furthermore, over-expression of miR-145 decreased mRNA levels for three chondrogenic marker genes, type II collagen (Col2a1), aggrecan (Agc1), cartilage oligomeric matrix protein (COMP), type IX collagen (Col9a2) and type XI collagen (Col11a1) in C3H10T1/2 cells induced by TGF-beta 3, whereas anti-miR-145 inhibitor increased the expression of these chondrogenic marker genes. Thus, our studies demonstrated that miR-145 is a key negative regulator of chondrogenic differentiation by directly targeting Sox9 at early stage of chondrogenic differentiation.	[Yang, Bo; Guo, Hongfeng; Zhang, Yulan; Ying, Dajun; Dong, Shiwu] Third Mil Med Univ, Dept Anat, Biomech Lab, Chongqing, Peoples R China; [Zhang, Yulan] Chengdu Mil Gen Hosp, Dept Anesthesiol, Chengdu, Peoples R China; [Chen, Lei] Southwest Hosp, Dept Orthopaed, Chongqing, Peoples R China	Army Medical University; Army Medical University	Yang, B (corresponding author), Third Mil Med Univ, Dept Anat, Biomech Lab, Chongqing, Peoples R China.	ydj96@yahoo.com.cn; shiwudong@gmail.com			National High Technology Research and Development Program of China [2006AA02A125]; National Basic Research Program of China [2011CB964701]; National Natural Science Foundation of China [30872636, 31070864]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National High Technology Research and Development Program of China (2006AA02A125), the National Basic Research Program of China (2011CB964701), and the National Natural Science Foundation of China (30872636, 31070864). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2007, MATRIX BIOL, V26, P224, DOI 10.1016/j.matbio.2006.12.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Csaki C, 2008, ANN ANAT, V190, P395, DOI 10.1016/j.aanat.2008.07.007; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Fan HB, 2008, BIOMACROMOLECULES, V9, P927, DOI 10.1021/bm7013203; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Furumatsu T, 2005, J BIOL CHEM, V280, P8343, DOI 10.1074/jbc.M413913200; Furumatsu T, 2009, INT J BIOCHEM CELL B, V41, P1198, DOI 10.1016/j.biocel.2008.10.032; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Karlsen TA, 2010, TISSUE ENG C; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Ko MH, 2008, FEBS J, V275, P2605, DOI 10.1111/j.1742-4658.2008.06408.x; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Kong YW, 2008, P NATL ACAD SCI USA, V105, P8866, DOI 10.1073/pnas.0800650105; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lakshmipathy U, 2008, STEM CELLS, V26, P356, DOI 10.1634/stemcells.2007-0625; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin EA, 2009, J BIOL CHEM, V284, P11326, DOI 10.1074/jbc.M807709200; Liu CJ, 2007, FRONT BIOSCI, V12, P3899, DOI 10.2741/2359; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mehlhorn AT, 2006, TISSUE ENG, V12, P1393, DOI 10.1089/ten.2006.12.1393; Michael MZ, 2003, MOL CANCER RES, V1, P882; Pais H, 2010, RNA, V16, P489, DOI 10.1261/rna.1701210; Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Wang YH, 2009, CELL METAB, V9, P287, DOI 10.1016/j.cmet.2009.01.013; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yang B, 2011, BMB REP, V44, P28, DOI 10.5483/BMBRep.2011.44.1.28; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zeng L, 2002, GENE DEV, V16, P1990, DOI 10.1101/gad.1008002; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	53	180	194	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e21679	10.1371/journal.pone.0021679	http://dx.doi.org/10.1371/journal.pone.0021679			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799743	Green Submitted, Green Published, gold			2022-12-25	WOS:000292931200009
J	Auburn, S; Campino, S; Clark, TG; Djimde, AA; Zongo, I; Pinches, R; Manske, M; Mangano, V; Alcock, D; Anastasi, E; Maslen, G; MacInnis, B; Rockett, K; Modiano, D; Newbold, CI; Doumbo, OK; Ouedraogo, JB; Kwiatkowski, DP				Auburn, Sarah; Campino, Susana; Clark, Taane G.; Djimde, Abdoulaye A.; Zongo, Issaka; Pinches, Robert; Manske, Magnus; Mangano, Valentina; Alcock, Daniel; Anastasi, Elisa; Maslen, Gareth; MacInnis, Bronwyn; Rockett, Kirk; Modiano, David; Newbold, Christopher I.; Doumbo, Ogobara K.; Ouedraogo, Jean Bosco; Kwiatkowski, Dominic P.			An Effective Method to Purify Plasmodium falciparum DNA Directly from Clinical Blood Samples for Whole Genome High-Throughput Sequencing	PLOS ONE			English	Article							VIVAX-INFECTED ERYTHROCYTES; PERCOLL GRADIENTS; REMOVAL; SEPARATION; LEUKOCYTES; CELLS	Highly parallel sequencing technologies permit cost-effective whole genome sequencing of hundreds of Plasmodium parasites. The ability to sequence clinical Plasmodium samples, extracted directly from patient blood without a culture step, presents a unique opportunity to sample the diversity of "natural'' parasite populations in high resolution clinical and epidemiological studies. A major challenge to sequencing clinical Plasmodium samples is the abundance of human DNA, which may substantially reduce the yield of Plasmodium sequence. We tested a range of human white blood cell (WBC) depletion methods on P. falciparum-infected patient samples in search of a method displaying an optimal balance of WBC-removal efficacy, cost, simplicity, and applicability to low resource settings. In the first of a two-part study, combinations of three different WBC depletion methods were tested on 43 patient blood samples in Mali. A two-step combination of Lymphoprep plus Plasmodipur best fitted our requirements, although moderate variability was observed in human DNA quantity. This approach was further assessed in a larger sample of 76 patients from Burkina Faso. WBC-removal efficacy remained high (<30% human DNA in >70% samples) and lower variation was observed in human DNA quantities. In order to assess the Plasmodium sequence yield at different human DNA proportions, 59 samples with up to 60% human DNA contamination were sequenced on the Illumina Genome Analyzer platform. An average similar to 40-fold coverage of the genome was observed per lane for samples with <= 30% human DNA. Even in low resource settings, using a simple two-step combination of Lymphoprep plus Plasmodipur, over 70% of clinical sample preparations should exhibit sufficiently low human DNA quantities to enable similar to 40-fold sequence coverage of the P. falciparum genome using a single lane on the Illumina Genome Analyzer platform. This approach should greatly facilitate large-scale clinical and epidemiologic studies of P. falciparum.	[Auburn, Sarah; Campino, Susana; Clark, Taane G.; Manske, Magnus; Alcock, Daniel; Anastasi, Elisa; Maslen, Gareth; MacInnis, Bronwyn; Rockett, Kirk; Newbold, Christopher I.; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Hinxton, England; [Auburn, Sarah] Charles Darwin Univ, Menzies Sch Hlth Res, Global Hlth Div, Darwin, NT 0909, Australia; [Clark, Taane G.] London Sch Hyg & Trop Med, London WC1, England; [Djimde, Abdoulaye A.; Doumbo, Ogobara K.] Univ Bamako, Fac Med, Malaria Res & Training Ctr, Bamako, Mali; [Zongo, Issaka; Ouedraogo, Jean Bosco] Direct Reg Ouest, Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso; [Pinches, Robert; Newbold, Christopher I.] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Mangano, Valentina; Modiano, David] Univ Roma La Sapienza, Dept Publ Hlth Sci, Sect Parasitol, Rome, Italy; [Rockett, Kirk; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	Wellcome Trust Sanger Institute; Charles Darwin University; Menzies School of Health Research; University of London; London School of Hygiene & Tropical Medicine; University of Bamako; University of Oxford; Sapienza University Rome; University of Oxford; Wellcome Centre for Human Genetics	Auburn, S (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England.	sa3@sanger.ac.uk	Mead, Daniel/AAE-6629-2019; mangano, valentina/I-2456-2012; Clark, Taane G./AAM-2570-2020; Campino, Susana/AAM-2577-2020; Auburn, Sarah/N-2266-2013	Mead, Daniel/0000-0001-7717-4330; Clark, Taane G./0000-0001-8985-9265; Campino, Susana/0000-0003-1403-6138; Ouedraogo, Jean Bosco/0000-0003-0412-8733; Kwiatkowski, Dominic/0000-0002-5023-0176; Maslen, Gareth/0000-0001-7318-3678; Manske, Magnus/0000-0001-5916-0947; Mangano, Valentina D/0000-0002-2021-6162; Newbold, Chris/0000-0002-9274-3789; Auburn, Sarah/0000-0002-4638-536X	Wellcome Trust; Bill and Melinda Gates Foundation; Medical Research Council; European and Developing Countries Clinical Trial Partnership Senior Fellowship [2004.2.C.f1]; Howard Hughes Medical Institution [55005502]; Medical Research Council [G0600718, G19/9] Funding Source: researchfish; MRC [G19/9, G0600718] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European and Developing Countries Clinical Trial Partnership Senior Fellowship; Howard Hughes Medical Institution(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The genetic component of this research was funded by the Wellcome Trust, the Bill and Melinda Gates Foundation, and the Medical Research Council. SA, SC, TGC, MM, DA, GM, BM, KK and DPK were funded by the Wellcome Trust, the Bill and Melinda Gates Foundation, and the Medical Research Council. AAD is supported by a European and Developing Countries Clinical Trial Partnership Senior Fellowship (grant 2004.2.C.f1) and a Howard Hughes Medical Institution International Scholarship (grant 55005502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRYSIAK PM, 1986, AM J TROP MED HYG, V35, P251, DOI 10.4269/ajtmh.1986.35.251; BROWN GV, 1980, AM J TROP MED HYG, V29, P1147, DOI 10.4269/ajtmh.1980.29.1147; Dharia NV, 2010, P NATL ACAD SCI USA, V107, P20045, DOI 10.1073/pnas.1003776107; ELING W, 1977, B WORLD HEALTH ORGAN, V55, P105; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; FULTON JD, 1956, BIOCHEM J, V63, P274, DOI 10.1042/bj0630274; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; JANSE CJ, 1994, ANN TROP MED PARASIT, V88, P213, DOI 10.1080/00034983.1994.11812860; JANSE CJ, 1995, PARASITOL TODAY, V11, P138, DOI 10.1016/0169-4758(95)80133-2; KRAMER KJ, 1982, J PARASITOL, V68, P336, DOI 10.2307/3281203; Manske HM, 2009, BIOINFORMATICS, V25, P2434, DOI 10.1093/bioinformatics/btp403; MONS B, 1988, ANN TROP MED PARASIT, V82, P621, DOI 10.1080/00034983.1988.11812298; RIVADENEIRA EM, 1983, J PROTOZOOL, V30, P367, DOI 10.1111/j.1550-7408.1983.tb02932.x; Rogers YH, 2005, NATURE, V437, P326, DOI 10.1038/437326a; Sriprawat K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-115; Trang DTX, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-7; WAKI S, 1986, ANN TROP MED PARASIT, V80, P125, DOI 10.1080/00034983.1986.11811991	17	47	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22213	10.1371/journal.pone.0022213	http://dx.doi.org/10.1371/journal.pone.0022213			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789235	Green Published, gold, Green Submitted			2022-12-25	WOS:000292812400038
J	Niebert, M; Vogelgesang, S; Koch, UR; Bischoff, AM; Kron, M; Bock, N; Manzke, T				Niebert, Marcus; Vogelgesang, Steffen; Koch, Uwe R.; Bischoff, Anna-Maria; Kron, Miriam; Bock, Nathalie; Manzke, Till			Expression and Function of Serotonin 2A and 2B Receptors in the Mammalian Respiratory Network	PLOS ONE			English	Article							PRE-BOTZINGER COMPLEX; LONG-TERM FACILITATION; CENTRAL-NERVOUS-SYSTEM; PHRENIC MOTONEURONS; 5-HT2A RECEPTOR; IN-VITRO; RHYTHM GENERATION; RAPHE OBSCURUS; SPINAL-CORD; RAT	Neurons of the respiratory network in the lower brainstem express a variety of serotonin receptors (5-HTRs) that act primarily through adenylyl cyclase. However, there is one receptor family including 5-HT2A, 5-HT2B, and 5-HT2C receptors that are directed towards protein kinase C (PKC). In contrast to 5-HT(2A)Rs, expression and function of 5-HT(2B)Rs within the respiratory network are still unclear. 5-HT2BR utilizes a Gq-mediated signaling cascade involving calcium and leading to activation of phospholipase C and IP3/DAG pathways. Based on previous studies, this signal pathway appears to mediate excitatory actions on respiration. In the present study, we analyzed receptor expression in pontine and medullary regions of the respiratory network both at the transcriptional and translational level using quantitative RT-PCR and self-made as well as commercially available antibodies, respectively. In addition we measured effects of selective agonists and antagonists for 5-HT(2A)Rs and 5-HT(2B)Rs given intra-arterially on phrenic nerve discharges in juvenile rats using the perfused brainstem preparation. The drugs caused significant changes in discharge activity. Co-administration of both agonists revealed a dominance of the 5-HT2BR. Given the nature of the signaling pathways, we investigated whether intracellular calcium may explain effects observed in the respiratory network. Taken together, the results of this study suggest a significant role of both receptors in respiratory network modulation.	[Niebert, Marcus; Vogelgesang, Steffen; Koch, Uwe R.; Bischoff, Anna-Maria; Manzke, Till] Univ Gottingen, Dept Neuro & Sensory Physiol, Gottingen, Germany; [Niebert, Marcus; Vogelgesang, Steffen; Kron, Miriam; Manzke, Till] German Res Council, Res Ctr Mol Physiol Brain, Gottingen, Germany; [Bock, Nathalie] Univ Gottingen, Dept Child & Adolescent Psychiat, Gottingen, Germany	University of Gottingen; University of Gottingen	Niebert, M (corresponding author), Univ Gottingen, Dept Neuro & Sensory Physiol, Gottingen, Germany.	tmanzke@gwdg.de			DFG Research Center Molecular Physiology of the Brain (CMPB) [FZT 103]	DFG Research Center Molecular Physiology of the Brain (CMPB)(German Research Foundation (DFG))	This work was supported by the DFG Research Center Molecular Physiology of the Brain (CMPB; FZT 103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alheid GF, 2008, RESP PHYSIOL NEUROBI, V164, P3, DOI 10.1016/j.resp.2008.07.014; Audia JE, 1996, J MED CHEM, V39, P2773, DOI 10.1021/jm960062t; Baker-Herman TL, 2002, J NEUROSCI, V22, P6239; BEDLACK RS, 1994, NEURON, V13, P1187, DOI 10.1016/0896-6273(94)90056-6; Callebert J, 2006, J PHARMACOL EXP THER, V317, P724, DOI 10.1124/jpet.105.098269; CONNELLY CA, 1992, BRAIN RES, V590, P337, DOI 10.1016/0006-8993(92)91118-X; Cornea-Hebert V, 1999, J COMP NEUROL, V409, P187, DOI 10.1002/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO;2-P; DICK TE, 1985, J NEUROPHYSIOL, V53, P1590, DOI 10.1152/jn.1985.53.6.1590; Duxon MS, 1997, NEUROSCIENCE, V76, P323, DOI 10.1016/S0306-4522(96)00480-0; El-Khatib Mohamad F, 2003, Respir Care, V48, P956; Ezure K, 2006, NEUROSCIENCE, V141, P1011, DOI 10.1016/j.neuroscience.2006.04.020; Fay R, 2000, J COMP NEUROL, V418, P323; Feldman JL, 2006, J APPL PHYSIOL, V100, P2096, DOI 10.1152/japplphysiol.00119.2006; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; Fox MA, 2010, PSYCHOPHARMACOLOGY, V212, P13, DOI 10.1007/s00213-009-1694-1; GARRATT JC, 1991, EUR J PHARMACOL, V199, P349, DOI 10.1016/0014-2999(91)90499-G; Gunther S, 2006, J NEUROBIOL, V66, P949, DOI 10.1002/neu.20253; Guenther U, 2009, ANESTH ANALG, V108, P1169, DOI 10.1213/ane.0b013e318198f828; Haji A, 1996, J PHYSIOL-LONDON, V494, P297, DOI 10.1113/jphysiol.1996.sp021492; HOLTMAN JR, 1986, J NEUROSCI, V6, P1185; HOLTMAN JR, 1990, NEUROSCIENCE, V37, P541, DOI 10.1016/0306-4522(90)90422-Z; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; HOYER D, 1994, PHARMACOL REV, V46, P157; JIANG C, 1990, EXP BRAIN RES, V81, P639, DOI 10.1007/BF02423514; Kennett GA, 1996, BRIT J PHARMACOL, V117, P427, DOI 10.1111/j.1476-5381.1996.tb15208.x; Kinkead R, 2001, COMP BIOCHEM PHYS A, V130, P207, DOI 10.1016/S1095-6433(01)00393-2; Kubin L, 2008, RESP PHYSIOL NEUROBI, V164, P64, DOI 10.1016/j.resp.2008.04.012; Ladewig T, 2000, PFLUG ARCH EUR J PHY, V440, P322, DOI 10.1007/s004240000277; Lalley PM, 1997, BRAIN RES, V747, P156, DOI 10.1016/S0006-8993(96)01233-4; LALLEY PM, 1994, NEUROSCI LETT, V172, P59, DOI 10.1016/0304-3940(94)90662-9; LALLEY PM, 1995, J PHYSIOL-LONDON, V487, P653, DOI 10.1113/jphysiol.1995.sp020907; LALLEY PM, 1986, J PHYSIOL-LONDON, V380, P373, DOI 10.1113/jphysiol.1986.sp016291; Lips MB, 1999, J NEUROPHYSIOL, V82, P2936, DOI 10.1152/jn.1999.82.6.2936; Lovett-Barr MR, 2006, NEUROSCIENCE, V142, P885, DOI 10.1016/j.neuroscience.2006.06.036; Mahamed S, 2008, J PHYSIOL-LONDON, V586, P2171, DOI 10.1113/jphysiol.2007.149047; Manzke T, 2003, SCIENCE, V301, P226, DOI 10.1126/science.1084674; Manzke T, 2009, PHILOS T R SOC B, V364, P2589, DOI 10.1098/rstb.2009.0068; McLean TH, 2006, J MED CHEM, V49, P5794, DOI 10.1021/jm060656o; MILLHORN DE, 1989, EXP BRAIN RES, V75, P536; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P9508, DOI 10.1073/pnas.97.17.9508; Onimaru H, 1998, PFLUG ARCH EUR J PHY, V435, P485, DOI 10.1007/s004240050543; PALACIOS JM, 1990, ANN NY ACAD SCI, V600, P36; Paton JFR, 1996, J NEUROSCI METH, V65, P63, DOI 10.1016/0165-0270(95)00147-6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierrefiche O, 1998, J PHYSIOL-LONDON, V509, P245, DOI 10.1111/j.1469-7793.1998.245bo.x; Richter DW, 1997, RESP PHYSIOL, V110, P113, DOI 10.1016/S0034-5687(97)00077-7; SCHWARZACHER SW, 1995, J NEUROPHYSIOL, V73, P1452, DOI 10.1152/jn.1995.73.4.1452; SIETNIEKS A, 1985, J NEURAL TRANSM, V61, P65, DOI 10.1007/BF01253052; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Song G, 2006, J NEUROSCI, V26, P300, DOI 10.1523/JNEUROSCI.3029-05.2006; Stettner GM, 2008, RESP PHYSIOL NEUROBI, V161, P10, DOI 10.1016/j.resp.2007.11.001; Tian GF, 1998, EXP BRAIN RES, V122, P149, DOI 10.1007/s002210050502; Verge D, 2000, J CHEM NEUROANAT, V18, P41, DOI 10.1016/S0891-0618(99)00050-2; Wilken B, 1997, J PEDIATR-US, V130, P89, DOI 10.1016/S0022-3476(97)70315-9; WRIGHT IK, 1990, BRIT J PHARMACOL, V99, P221, DOI 10.1111/j.1476-5381.1990.tb14683.x; Xu C, 2003, BIOPHYS J, V84, P4144, DOI 10.1016/S0006-3495(03)75139-X; Yamauchi M, 2008, RESP PHYSIOL NEUROBI, V162, P117, DOI 10.1016/j.resp.2008.05.003; Yamauchi M, 2008, J APPL PHYSIOL, V105, P518, DOI 10.1152/japplphysiol.00069.2008	58	29	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e21395	10.1371/journal.pone.0021395	http://dx.doi.org/10.1371/journal.pone.0021395			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789169	Green Published, Green Submitted, gold			2022-12-25	WOS:000292812400007
J	Shen, L; Ji, HF				Shen, Liang; Ji, Hong-Fang			Small Cofactors May Assist Protein Emergence from RNA World: Clues from RNA-Protein Complexes	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; GENETIC-CODE; AMINO-ACIDS; FOLD ARCHITECTURE; NUCLEIC-ACIDS; ORIGIN; LIFE; HOMOCHIRALITY; EVOLUTION; BIOMOLECULES	It is now widely accepted that at an early stage in the evolution of life an RNA world arose, in which RNAs both served as the genetic material and catalyzed diverse biochemical reactions. Then, proteins have gradually replaced RNAs because of their superior catalytic properties in catalysis over time. Therefore, it is important to investigate how primitive functional proteins emerged from RNA world, which can shed light on the evolutionary pathway of life from RNA world to the modern world. In this work, we proposed that the emergence of most primitive functional proteins are assisted by the early primitive nucleotide cofactors, while only a minority are induced directly by RNAs based on the analysis of RNA-protein complexes. Furthermore, the present findings have significant implication for exploring the composition of primitive RNA, i.e., adenine base as principal building blocks.	[Shen, Liang; Ji, Hong-Fang] Shandong Univ Technol, Shandong Prov Res Ctr Bioinformat Engn & Tech, Zibo, Peoples R China	Shandong University of Technology	Shen, L (corresponding author), Shandong Univ Technol, Shandong Prov Res Ctr Bioinformat Engn & Tech, Zibo, Peoples R China.	jhf@sdut.edu.cn			National Natural Science Foundation of China [30700113, 30800184]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (30700113 and 30800184). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeevski A., 2004, BIOFIZIKA S1, V48, P146; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Bairoch A, 1999, NUCLEIC ACIDS RES, V27, P49, DOI 10.1093/nar/27.1.49; Blackmond DG, 2004, P NATL ACAD SCI USA, V101, P5732, DOI 10.1073/pnas.0308363101; Bolik S, 2007, RNA, V13, P1877, DOI 10.1261/rna.564507; Caetano-Anolles G, 2005, J MOL EVOL, V60, P484, DOI 10.1007/s00239-004-0221-6; Caetano-Anolles G, 2003, GENOME RES, V13, P1563, DOI 10.1101/gr.1161903; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Di Giulio M, 1997, J MOL EVOL, V45, P571, DOI 10.1007/PL00006261; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Faglioni F, 2005, ORIGINS LIFE EVOL B, V35, P461, DOI 10.1007/s11084-005-3511-0; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Fujii N, 2004, CHEM REC, V4, P267, DOI 10.1002/tcr.20020; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Grandori R, 2000, EUR J BIOCHEM, V267, P1168, DOI 10.1046/j.1432-1327.2000.01114.x; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; HALL DO, 1971, NATURE, V233, P136, DOI 10.1038/233136a0; Hazen RM, 2001, P NATL ACAD SCI USA, V98, P5487, DOI 10.1073/pnas.101085998; Ji HF, 2005, J MOL STRUC-THEOCHEM, V756, P109, DOI 10.1016/j.theochem.2005.09.001; Ji HF, 2008, BIOESSAYS, V30, P766, DOI 10.1002/bies.20788; Ji HF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r176; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Karyagina Anna, 2006, Journal of Bioinformatics and Computational Biology, V4, P357, DOI 10.1142/S0219720006001837; Keszthelyi L, 1995, Q REV BIOPHYS, V28, P473, DOI 10.1017/S0033583500003309; Klabunovskii EI, 2001, ASTROBIOLOGY, V1, P127, DOI 10.1089/153110701753198891; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Ma BG, 2008, BIOCHEM BIOPH RES CO, V366, P607, DOI 10.1016/j.bbrc.2007.12.014; MARX PA, 1975, J GEN VIROL, V27, P247, DOI 10.1099/0022-1317-27-2-247; McGinness KE, 2003, CHEM BIOL, V10, P5, DOI 10.1016/S1074-5521(03)00003-6; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; ORGEL LE, 1968, J MOL BIOL, V38, P381, DOI 10.1016/0022-2836(68)90393-8; ORGEL LE, 1986, J THEOR BIOL, V123, P127, DOI 10.1016/S0022-5193(86)80149-7; Podlech J, 2001, CELL MOL LIFE SCI, V58, P44, DOI 10.1007/PL00000777; REANNEY DC, 1977, J THEOR BIOL, V65, P555, DOI 10.1016/0022-5193(77)90214-4; Rodin AS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-14; Rodin AS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-4; ROSE GD, 1979, J MOL BIOL, V134, P447, DOI 10.1016/0022-2836(79)90363-2; RUCKER RB, 1988, FASEB J, V2, P2252, DOI 10.1096/fasebj.2.7.3127264; Smith CA, 2000, MOL CELL, V6, P1067, DOI 10.1016/S1097-2765(00)00105-2; Spirin S, 2007, BIOINFORMATICS, V23, P3247, DOI 10.1093/bioinformatics/btm519; STOKS PG, 1981, GEOCHIM COSMOCHIM AC, V45, P563, DOI 10.1016/0016-7037(81)90189-7; STOKS PG, 1979, NATURE, V282, P709, DOI 10.1038/282709a0; SZATHMARY E, 1993, P NATL ACAD SCI USA, V90, P9916, DOI 10.1073/pnas.90.21.9916; Szathmary E, 1999, TRENDS GENET, V15, P223, DOI 10.1016/S0168-9525(99)01730-8; Taylor WR, 2005, COMPUT BIOL CHEM, V29, P259, DOI 10.1016/j.compbiolchem.2005.04.009; WACHTERSHAUSER G, 1992, PROG BIOPHYS MOL BIO, V58, P85, DOI 10.1016/0079-6107(92)90022-X; Wang ML, 2006, COMPLEXITY, V12, P27, DOI 10.1002/cplx.20141; WONG JTF, 1991, ORIGINS LIFE EVOL B, V21, P165, DOI 10.1007/BF01809445; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; YAMAGATA Y, 1966, J THEOR BIOL, V11, P495, DOI 10.1016/0022-5193(66)90110-X	53	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22494	10.1371/journal.pone.0022494	http://dx.doi.org/10.1371/journal.pone.0022494			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789260	gold, Green Submitted, Green Published			2022-12-25	WOS:000292812400052
J	Tamulonis, C; Postma, M; Kaandorp, J				Tamulonis, Carlos; Postma, Marten; Kaandorp, Jaap			Modeling Filamentous Cyanobacteria Reveals the Advantages of Long and Fast Trichomes for Optimizing Light Exposure	PLOS ONE			English	Article							BLUE-GREEN-ALGA; AUF DIE BEWEGUNG; GLIDING MOTILITY; PHOTOMOVEMENT; CYANOPHYCEEN; RADIATION; RESPONSES; BREAKAGE; SIGNAL; DEATH	Cyanobacteria form a very large and diverse phylum of prokaryotes that perform oxygenic photosynthesis. Many species of cyanobacteria live colonially in long trichomes of hundreds to thousands of cells. Of the filamentous species, many are also motile, gliding along their long axis, and display photomovement, by which a trichome modulates its gliding according to the incident light. The latter has been found to play an important role in guiding the trichomes to optimal lighting conditions, which can either inhibit the cells if the incident light is too weak, or damage the cells if too strong. We have developed a computational model for gliding filamentous photophobic cyanobacteria that allows us to perform simulations on the scale of a Petri dish using over 10(5) individual trichomes. Using the model, we quantify the effectiveness of one commonly observed photomovement strategy-photophobic responses-in distributing large populations of trichomes optimally over a light field. The model predicts that the typical observed length and gliding speeds of filamentous cyanobacteria are optimal for the photophobic strategy. Therefore, our results suggest that not just photomovement but also the trichome shape itself improves the ability of the cyanobacteria to optimize their light exposure.	[Tamulonis, Carlos; Kaandorp, Jaap] Univ Amsterdam, Inst Informat, Amsterdam, Netherlands; [Postma, Marten] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Tamulonis, C (corresponding author), Univ Amsterdam, Inst Informat, Amsterdam, Netherlands.	ctamulon@gmail.com						Adamec F, 2005, J PHYCOL, V41, P835, DOI 10.1111/j.1529-8817.2005.00104.x; Adams DG, 1999, NEW PHYTOL, V144, P3, DOI 10.1046/j.1469-8137.1999.00505.x; Bhaya D, 1999, P NATL ACAD SCI USA, V96, P3188, DOI 10.1073/pnas.96.6.3188; BURKART U, 1980, J MATH BIOL, V10, P257, DOI 10.1007/BF00276985; CHECCUCCI G, 2004, CRC HDB ORGANIC PHOT; DONKOR V, 1991, FEMS MICROBIOL ECOL, V86, P159; DONKOR VA, 1993, FEMS MICROBIOL ECOL, V12, P143; Feynman R, 1970, FEYNMAN LECT PHYS, VII; Fourcans A, 2006, FEMS MICROBIOL ECOL, V57, P367, DOI 10.1111/j.1574-6941.2006.00124.x; GABAI VL, 1985, FEMS MICROBIOL LETT, V30, P125; GARCIAPICHEL F, 1994, APPL ENVIRON MICROB, V60, P1500, DOI 10.1128/AEM.60.5.1500-1511.1994; GLAGOLEVA TN, 1980, FEBS LETT, V117, P49, DOI 10.1016/0014-5793(80)80911-2; HADER D, 1987, PHOTOMOVEMENT COLLEC, P325; HADER DP, 1978, J MATH BIOL, V5, P293, DOI 10.1007/BF00276124; HADER DP, 1978, ARCH MICROBIOL, V118, P115, DOI 10.1007/BF00406083; HADER DP, 1977, ARCH MICROBIOL, V114, P83, DOI 10.1007/BF00429635; HADER DP, 1988, BIOPHYS CHEM, V29, P155, DOI 10.1016/0301-4622(88)87035-2; HADER DP, 1982, PLANT CELL PHYSIOL, V23, P1391; Hader DP., 1987, FAY P, P325; HALFEN LN, 1971, J PHYCOL, V7, P133, DOI 10.1111/j.0022-3646.1971.00133.x; Hangarter RP, 2004, PHOTOSYNTH RES, V80, P421, DOI 10.1023/B:PRES.0000030426.98007.6a; Harvey CW, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/2/026016; Hoiczyk E, 1998, CURR BIOL, V8, P1161, DOI 10.1016/S0960-9822(07)00487-3; HOICZYK E, 1995, J BACTERIOL, V177, P2387, DOI 10.1128/jb.177.9.2387-2395.1995; Hoiczyk E, 2000, ARCH MICROBIOL, V174, P11, DOI 10.1007/s002030000187; Janulevicius A, 2010, BIOPHYS J, V99, P3129, DOI 10.1016/j.bpj.2010.08.075; JORGENSEN B, 1977, MARINE BIOL; Kamp A, 2008, MICROB ECOL, V56, P484, DOI 10.1007/s00248-008-9367-x; LAMONT HC, 1969, ARCH MIKROBIOL, V69, P237, DOI 10.1007/BF00408976; McBride MJ, 2001, ANNU REV MICROBIOL, V55, P49, DOI 10.1146/annurev.micro.55.1.49; MURVANIDZE GV, 1982, J BACTERIOL, V150, P239, DOI 10.1128/JB.150.1.239-244.1982; NELSON DC, 1982, ARCH MICROBIOL, V131, P146, DOI 10.1007/BF01053997; NULTSCH W, 1988, PHOTOCHEM PHOTOBIOL, V47, P837, DOI 10.1111/j.1751-1097.1988.tb01668.x; NULTSCH W, 1979, ARCH MICROBIOL, V122, P85, DOI 10.1007/BF00408050; NULTSCH W, 1962, PLANTA, V58, P647, DOI 10.1007/BF01914754; NULTSCH W, 1962, PLANTA, V57, P613, DOI 10.1007/BF01930343; Peruani F, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.030904; RAMSING NB, 1994, NATO ASI SERIES G, V35, P183; REICHENBACH H, 1981, ANNU REV MICROBIOL, V35, P339, DOI 10.1146/annurev.mi.35.100181.002011; RICHARDSON LL, 1987, APPL ENVIRON MICROB, V53, P2142, DOI 10.1128/AEM.53.9.2142-2150.1987; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; SEVERINA II, 1988, J CELL BIOL, V107, P497, DOI 10.1083/jcb.107.2.497; Stal L.J., 2000, ECOLOGY CYANOBACTERI, P61; Whitton BA, 2002, ECOLOGY CYANOBACTERI, P1, DOI DOI 10.1007/0-306-46855-7_1; Wolk CP, 2004, ADV PHOTOSYNTHESIS R, P769; Wu YL, 2009, P NATL ACAD SCI USA, V106, P1222, DOI 10.1073/pnas.0811662106; Wu YL, 2007, PLOS COMPUT BIOL, V3, P2546, DOI 10.1371/journal.pcbi.0030253	47	14	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22084	10.1371/journal.pone.0022084	http://dx.doi.org/10.1371/journal.pone.0022084			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789215	gold, Green Submitted, Green Published			2022-12-25	WOS:000292812400030
J	Warman, GR; Pawley, MDM; Bolton, C; Cheeseman, JF; Fernando, AT; Arendt, J; Wirz-Justice, A				Warman, Guy R.; Pawley, Matthew D. M.; Bolton, Catherine; Cheeseman, James F.; Fernando, Antonio T., III; Arendt, Josephine; Wirz-Justice, Anna			Circadian-Related Sleep Disorders and Sleep Medication Use in the New Zealand Blind Population: An Observational Prevalence Survey	PLOS ONE			English	Article							MELATONIN RHYTHMS; ENTRAINMENT; PEOPLE; PACEMAKER; INSOMNIA; PERIOD; PHASE; LIGHT; TEMPERATURE; SUPPRESSION	Study Objectives: To determine the prevalence of self-reported circadian-related sleep disorders, sleep medication and melatonin use in the New Zealand blind population. Design: A telephone survey incorporating 62 questions on sleep habits and medication together with validated questionnaires on sleep quality, chronotype and seasonality. Participants: Participants were grouped into: (i) 157 with reduced conscious perception of light (RLP); (ii) 156 visually impaired with no reduction in light perception (LP) matched for age, sex and socioeconomic status, and (iii) 156 matched fully-sighted controls (FS). Sleep Habits and Disturbances: The incidence of sleep disorders, daytime somnolence, insomnia and sleep timing problems was significantly higher in RLP and LP compared to the FS controls (p<0.001). The RLP group had the highest incidence (55%) of sleep timing problems, and 26% showed drifting sleep patterns (vs. 4% FS). Odds ratios for unconventional sleep timing were 2.41 (RLP) and 1.63 (LP) compared to FS controls. For drifting sleep patterns, they were 7.3 (RLP) and 6.0 (LP). Medication Use: Zopiclone was the most frequently prescribed sleep medication. Melatonin was used by only 4% in the RLP group and 2% in the LP group. Conclusions: Extrapolations from the current study suggest that 3,000 blind and visually impaired New Zealanders may suffer from circadian-related sleep problems, and that of these, fewer than 15% have been prescribed melatonin. This may represent a therapeutic gap in the treatment of circadian-related sleep disorders in New Zealand, findings that may generalize to other countries.	[Warman, Guy R.; Pawley, Matthew D. M.; Bolton, Catherine; Cheeseman, James F.] Univ Auckland, Fac Med & Hlth Sci, Dept Anaesthesiol, Auckland 1, New Zealand; [Warman, Guy R.; Cheeseman, James F.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Pawley, Matthew D. M.] Massey Univ, Inst Informat & Math Sci, Auckland, New Zealand; [Fernando, Antonio T., III] Univ Auckland, Fac Med & Hlth Sci, Dept Psychol Med, Auckland 1, New Zealand; [Arendt, Josephine] Univ Surrey, Fac Med & Hlth Sci, Ctr Chronobiol, Guildford GU2 5XH, Surrey, England; [Wirz-Justice, Anna] Univ Basel, Hosp Psychiat, Ctr Chronobiol, Basel, Switzerland	University of Auckland; University of Auckland; Massey University; University of Auckland; University of Surrey; University of Basel	Warman, GR (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Anaesthesiol, Auckland 1, New Zealand.	G.warman@auckland.ac.nz		Cheeseman, James/0000-0001-5590-1808; Warman, Guy/0000-0001-9064-3090	Health Research Council of New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand)	This study was funded by the Health Research Council of New Zealand. Prof. Wirz-Justice was a visiting University of Auckland Hood Fellow in 2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Sleep Medicine, 2001, INT CLASS SLEEP DIS; Andersen IM, 2008, J CHILD NEUROL, V23, P482, DOI 10.1177/0883073807309783; Arendt J, 1997, J BIOL RHYTHM, V12, P673, DOI 10.1177/074873049701200624; ARENDT J, 1988, LANCET, V1, P772; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Crampton P SC, 1997, SOC POLICY J N Z, V9, P186; CZEISLER CA, 1995, NEW ENGL J MED, V332, P6, DOI 10.1056/NEJM199501053320102; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; Duffy JF, 2005, J BIOL RHYTHM, V20, P326, DOI 10.1177/0748730405277983; FOLKARD S, 1990, NEUROSCI LETT, V113, P193, DOI 10.1016/0304-3940(90)90302-P; Hack LM, 2003, J BIOL RHYTHM, V18, P420, DOI 10.1177/0748730403256796; Herxheimer A, 2003, BRIT MED J, V326, P296, DOI 10.1136/bmj.326.7384.296; Herxheimer A, 2002, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD001520, DOI 10.1002/14651858.CD001520]; Horne JA, 1976, INT J CHRONOBIOL, V4, P97; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Leger D, 1999, CLIN SCI, V97, P193, DOI 10.1042/CS19990004; Lewy AJ, 2005, CHRONOBIOL INT, V22, P1093, DOI 10.1080/07420520500398064; Lewy AJ, 2004, J BIOL RHYTHM, V19, P68, DOI 10.1177/0748730403259670; Lewy AJ, 2002, CHRONOBIOL INT, V19, P649, DOI 10.1081/CBI-120004546; Lewy AJ, 2001, BRAIN RES, V918, P96, DOI 10.1016/S0006-8993(01)02964-X; LEWY AJ, 1983, J CLIN ENDOCR METAB, V56, P1103, DOI 10.1210/jcem-56-6-1103; LOCKLEY S, 1995, LANCET, V346, P1491, DOI 10.1016/S0140-6736(95)92508-2; Lockley Steven W, 2007, Dialogues Clin Neurosci, V9, P301; Lockley SW, 2000, J ENDOCRINOL, V164, pR1, DOI 10.1677/joe.0.164R001; Lockley SW, 1997, J CLIN ENDOCR METAB, V82, P3763, DOI 10.1210/jc.82.11.3763; Lockley SW, 1999, SLEEP, V22, P616, DOI 10.1093/sleep/22.5.616; Magnusson A, 1996, J AFFECT DISORDERS, V40, P121, DOI 10.1016/0165-0327(96)00036-5; MILES LEM, 1977, SCIENCE, V198, P421, DOI 10.1126/science.910139; Moseley MJ, 1996, LANCET, V348, P1514, DOI 10.1016/S0140-6736(05)65928-4; OKAWA M, 1987, SLEEP, V10, P101, DOI 10.1093/sleep/10.2.101; ORTH DN, 1979, CLIN ENDOCRINOL, V10, P603, DOI 10.1111/j.1365-2265.1979.tb02120.x; Paine SJ, 2005, AUST NZ J PUBL HEAL, V29, P22, DOI 10.1111/j.1467-842X.2005.tb00743.x; Paine SJ, 2004, SLEEP, V27, P1163, DOI 10.1093/sleep/27.6.1163; Parslow RA, 2004, J AFFECT DISORDERS, V80, P181, DOI 10.1016/S0165-0327(03)00113-7; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; SACK RL, 1992, J CLIN ENDOCR METAB, V75, P127, DOI 10.1210/jc.75.1.127; Sack RL, 1997, J BIOL RHYTHM, V12, P595, DOI 10.1177/074873049701200615; SARRAFZADEH A, 1990, SLEEP 90, P51; SEWITCH DE, 1986, BIOL PSYCHIAT, V21, P201, DOI 10.1016/0006-3223(86)90147-2; Tabandeh H, 1998, AM J OPHTHALMOL, V126, P707, DOI 10.1016/S0002-9394(98)00133-0; TERMAN M, 2008, PREDICTORS WINTER DE, P56; Wirz-Justice A, 2003, ACTA PSYCHIAT SCAND, V108, P92, DOI 10.1034/j.1600-0447.108.s418.18.x; WIRZJUSTICE A, 2009, SLEEP MED C IN PRESS; Wright HR, 2001, CHRONOBIOL INT, V18, P801, DOI 10.1081/CBI-100107515; Wright KP, 2001, P NATL ACAD SCI USA, V98, P14027, DOI 10.1073/pnas.201530198; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152	46	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22073	10.1371/journal.pone.0022073	http://dx.doi.org/10.1371/journal.pone.0022073			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	793HY	21789214	gold, Green Submitted, Green Published			2022-12-25	WOS:000292812400029
J	Park, CH; Uh, KJ; Mulligan, BP; Jeung, EB; Hyun, SH; Shin, T; Ka, H; Lee, CK				Park, Chi-Hun; Uh, Kyung-Jun; Mulligan, Brendan P.; Jeung, Eui-Bae; Hyun, Sang-Hwan; Shin, Taeyoung; Ka, Hakhyun; Lee, Chang-Kyu			Analysis of Imprinted Gene Expression in Normal Fertilized and Uniparental Preimplantation Porcine Embryos	PLOS ONE			English	Article							EARLY MAMMALIAN DEVELOPMENT; IN-VITRO FERTILIZATION; MOUSE EMBRYOS; METHYLATION; CULTURE; H19; OOCYTES; IGF2R; IDENTIFICATION; INACTIVATION	In the present study quantitative real-time PCR was used to determine the expression status of eight imprinted genes (GRB10, H19, IGF2R, XIST, IGF2, NNAT, PEG1 and PEG10) during preimplantation development, in normal fertilized and uniparental porcine embryos. The results demonstrated that, in all observed embryo samples, a non imprinted gene expression pattern up to the 16-cell stage of development was common for most genes. This was true for all classes of embryo, regardless of parental-origins and the direction of imprint. However, several differentially expressed genes (H19, IGF2, XIST and PEG10) were detected amongst the classes at the blastocyst stage of development. Most interestingly and despite the fact that maternally and paternally expressed genes should not be expressed in androgenones and parthenogenones, respectively, both uniparental embryos expressed these genes when tested for in this study. In order to account for this phenomenon, we compared the expression patterns of eight imprinted genes along with the methylation status of the IGF2/H19 DMR3 in haploid and diploid parthenogenetic embryos. Our findings revealed that IGF2, NNAT and PEG10 were silenced in haploid but not diploid parthenogenetic blastocysts and differential methylation of the IGF2/H19 DMR3 was consistently observed between haploid and diploid parthenogenetic blastocysts. These results appear to suggest that there exists a process to adjust the expression status of imprinted genes in diploid parthenogenetic embryos and that this phenomenon may be associated with altered methylation at an imprinting control region. In addition we believe that imprinted expression occurs in at least four genes, namely H19, IGF2, XIST and PEG10 in porcine blastocyst stage embryos.	[Park, Chi-Hun; Uh, Kyung-Jun; Shin, Taeyoung] Sooam Biotech Res Fdn, Seoul, South Korea; [Park, Chi-Hun] RDA, Natl Inst Anim Sci, Suwon, South Korea; [Jeung, Eui-Bae; Hyun, Sang-Hwan] Chungbuk Natl Univ, Coll Vet Med, Cheongju, Chungbuk, South Korea; [Ka, Hakhyun] Yonsei Univ, Inst Biomat, Wonju, South Korea; [Ka, Hakhyun] Yonsei Univ, Div Biol Sci & Technol, Wonju, South Korea; [Lee, Chang-Kyu] Seoul Natl Univ, Dept Agr Biotechnol, Res Inst Agr & Life Sci, Seoul, South Korea	National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Chungbuk National University; Yonsei University; Yonsei University; Seoul National University (SNU)	Park, CH (corresponding author), Sooam Biotech Res Fdn, Seoul, South Korea.	leeck@snu.ac.kr	Park, Chi-Hun/J-1258-2019	Park, Chi-Hun/0000-0002-7618-9028	Rural Development Administration, Republic of Korea [20070401034031]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the BioGreen 21 Program (#20070401034031), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; Arnaud P, 2003, HUM MOL GENET, V12, P1005, DOI 10.1093/hmg/ddg110; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; Cheng HC, 2007, GENET SEL EVOL, V39, P599, DOI 10.1051/gse:2007024; Daniels R, 1997, AM J HUM GENET, V61, P33, DOI 10.1086/513892; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; Ferguson-Smith A, 2003, SEMIN CELL DEV BIOL, V14, P43, DOI 10.1016/S1084-9521(02)00171-4; Hendrich BD, 1997, NUCLEIC ACIDS RES, V25, P2661, DOI 10.1093/nar/25.13.2661; Imamura T, 2005, J BIOL CHEM, V280, P20171, DOI 10.1074/jbc.M501749200; JIN DI, 1991, THERIOGENOLOGY, V35, P521, DOI 10.1016/0093-691X(91)90448-M; JINNO Y, 1995, NAT GENET, V10, P318, DOI 10.1038/ng0795-318; Kagitani F, 1997, NUCLEIC ACIDS RES, V25, P3428, DOI 10.1093/nar/25.17.3428; Kelsey G, 1998, METHODS, V14, P211, DOI 10.1006/meth.1997.0579; Khosla S, 2001, HUM REPROD UPDATE, V7, P419, DOI 10.1093/humupd/7.4.419; KONO T, 1993, MOL REPROD DEV, V34, P43, DOI 10.1002/mrd.1080340107; Lagutina I, 2004, BIOL REPROD, V70, P400, DOI 10.1095/biolreprod.103.021972; LATHAM KE, 1994, GENE DEV, V8, P290, DOI 10.1101/gad.8.3.290; Latham KE, 2005, TRENDS GENET, V21, P120, DOI 10.1016/j.tig.2004.12.003; Lee JW, 2004, MOL REPROD DEV, V68, P51, DOI 10.1002/mrd.20043; Lighten AD, 1997, NAT GENET, V15, P122, DOI 10.1038/ng0297-122; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucifero D, 2004, HUM REPROD UPDATE, V10, P3, DOI 10.1093/humupd/dmh002; Mann MRW, 2004, DEVELOPMENT, V131, P3727, DOI 10.1242/dev.01241; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Park CH, 2009, ANIM REPROD SCI, V115, P169, DOI 10.1016/j.anireprosci.2008.12.004; Park CH, 2009, GENOMICS, V93, P179, DOI 10.1016/j.ygeno.2008.10.002; Petkov SG, 2009, MOL REPROD DEV, V76, P22, DOI 10.1002/mrd.20926; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Ruddock NT, 2004, BIOL REPROD, V70, P1131, DOI 10.1095/biolreprod.103.022236; Sasaki H, 1995, DEVELOPMENT, V121, P4195; Shemer R, 1996, P NATL ACAD SCI USA, V93, P6371, DOI 10.1073/pnas.93.13.6371; Sotomaru Y, 2002, J BIOL CHEM, V277, P12474, DOI 10.1074/jbc.M109212200; Sun BW, 2006, HUM MOL GENET, V15, P65, DOI 10.1093/hmg/ddi427; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Thurston A, 2008, REPRODUCTION, V135, P29, DOI 10.1530/REP-07-0211; Whitworth KM, 2005, BIOL REPROD, V72, P1437, DOI 10.1095/biolreprod.104.037952; Xu CC, 2007, ACTA BIOCH BIOPH SIN, V39, P633, DOI 10.1111/j.1745-7270.2007.00315.x; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769	41	42	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22216	10.1371/journal.pone.0022216	http://dx.doi.org/10.1371/journal.pone.0022216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21804912	gold, Green Published, Green Submitted			2022-12-25	WOS:000292811700033
J	Zhou, YJ; Chen, HQ; Li, X; Wang, YJ; Chen, KP; Zhang, SF; Meng, X; Lee, EYC; Lee, MYWT				Zhou, Yajing; Chen, Huiqing; Li, Xiao; Wang, Yujue; Chen, Keping; Zhang, Sufang; Meng, Xiao; Lee, Ernest Y. C.; Lee, Marietta Y. W. T.			Production of Recombinant Human DNA Polymerase Delta in a Bombyx mori Bioreactor	PLOS ONE			English	Article							BASE-EXCISION-REPAIR; CELL NUCLEAR ANTIGEN; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; REPLICATION FORK; P12 SUBUNIT; EXPRESSION; SILKWORM; DAMAGE; SYSTEM	Eukaryotic DNA polymerase delta (pol delta) plays a crucial role in chromosomal DNA replication and various DNA repair processes. It is thought to consist of p125, p66 (p68), p50 and p12 subunits. However, rigorous isolation of mammalian pol delta from natural sources has usually yielded two-subunit preparations containing only p125 and p50 polypeptides. While recombinant pol delta isolated from infected insect cells have some problems of consistency in the quality of the preparations, and the yields are much lower. To address these deficiencies, we have constructed recombinant BmNPV baculoviruses using MultiBac system. This method makes the generation of recombinant forms of pol delta containing mutations in any one of the subunits or combinations thereof extremely facile. From about 350 infected larvae, we obtained as much as 4 mg of pol delta four-subunit complex. Highly purified enzyme behaved like the one of native form by rigorous characterization and comparison of its activities on poly(dA)/oligo(dT) template-primer and singly primed M13 DNA, and its homogeneity on FPLC gel filtration. In vitro base excision repair (BER) assays showed that pol delta plays a significant role in uracil-intiated BER and is more likely to mediate LP BER, while the trimer lacking p12 is more likely to mediate SN BER. It seems likely that loss of p12 modulates the rate of SN BER and LP BER during the repair process. Thus, this work provides a simple, fast, reliable and economic way for the large-scale production of human DNA polymerase delta with a high activity and purity, setting up a new platform for our further research on the biochemical properties of pol delta, its regulation and the integration of its functions, and how alterations in pol delta function could contribute to the etiology of human cancer or other diseases that can result from loss of genomic stability.	[Zhou, Yajing; Chen, Huiqing; Li, Xiao; Wang, Yujue; Chen, Keping] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China; [Zhang, Sufang; Meng, Xiao; Lee, Ernest Y. C.; Lee, Marietta Y. W. T.] New York Med Coll, Dept Biochem & Mol Biol, Valhalla, NY 10595 USA	Jiangsu University; New York Medical College	Zhou, YJ (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China.	yajingzhou@ujs.edu.cn	Wang, Yujue/HHN-4296-2022	Zhang, Sufang/0000-0003-3883-023X	National Natural Science Foundation of China [30970612]; Jiangsu University for Advanced Professionals [09JDG002]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031973] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu University for Advanced Professionals; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Natural Science Foundation of China (30970612) and Startup Scientific Research Fund from Jiangsu University for Advanced Professionals (09JDG002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bermudez VP, 2002, J BIOL CHEM, V277, P36853, DOI 10.1074/jbc.M202897200; Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; Braithwaite EK, 2005, J BIOL CHEM, V280, P18469, DOI 10.1074/jbc.M411864200; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; BYRNES JJ, 1976, BIOCHEMISTRY-US, V15, P2817, DOI 10.1021/bi00658a018; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Gerik KJ, 1998, J BIOL CHEM, V273, P19747, DOI 10.1074/jbc.273.31.19747; Hou EW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm639; Huang Jin-shan, 2007, Virologica Sinica, V22, P218, DOI 10.1007/s12250-007-0025-0; Hughes P, 1999, NUCLEIC ACIDS RES, V27, P2108, DOI 10.1093/nar/27.10.2108; JIANG YQ, 1995, ARCH BIOCHEM BIOPHYS, V320, P297, DOI 10.1016/0003-9861(95)90013-6; Johansson E, 2001, J BIOL CHEM, V276, P43824, DOI 10.1074/jbc.M108842200; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; KADONOOKUDA K, 1995, BIOCHEM BIOPH RES CO, V213, P389, DOI 10.1006/bbrc.1995.2144; Kato T, 2010, APPL MICROBIOL BIOT, V85, P459, DOI 10.1007/s00253-009-2267-2; LEE MYWT, 1991, J BIOL CHEM, V266, P2423; LEE MYWT, 1984, BIOCHEMISTRY-US, V23, P1906, DOI 10.1021/bi00304a003; Li H, 2006, J BIOL CHEM, V281, P14748, DOI 10.1074/jbc.M600322200; Liu L, 2000, J BIOL CHEM, V275, P18739, DOI 10.1074/jbc.M001217200; MAEDA S, 1985, NATURE, V315, P592, DOI 10.1038/315592a0; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Meng X, 2009, NUCLEIC ACIDS RES, V37, P647, DOI 10.1093/nar/gkn1000; Mo JY, 2000, BIOCHEMISTRY-US, V39, P7245, DOI 10.1021/bi0000871; Motohashi T, 2005, BIOCHEM BIOPH RES CO, V326, P564, DOI 10.1016/j.bbrc.2004.11.060; Podust VN, 2002, J BIOL CHEM, V277, P3894, DOI 10.1074/jbc.M109684200; QIU P, 1994, BIOL CHEM H-S, V375, P413, DOI 10.1515/bchm3.1994.375.6.413; Reynolds N, 1998, CURR GENET, V34, P250, DOI 10.1007/s002940050394; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Takeda DY, 2005, ONCOGENE, V24, P2827, DOI 10.1038/sj.onc.1208616; Wei WL, 2000, BIOCHEM PHARMACOL, V60, P121, DOI 10.1016/S0006-2952(00)00238-0; Xie B, 2005, J BIOL CHEM, V280, P22375, DOI 10.1074/jbc.M414597200; Xie B, 2002, BIOCHEMISTRY-US, V41, P13133, DOI 10.1021/bi0262707; Yoshimura M, 2006, MOL CELL, V24, P115, DOI 10.1016/j.molcel.2006.07.032; ZHANG P, 1995, BIOCHEMISTRY-US, V34, P10703, DOI 10.1021/bi00034a002; Zhang SF, 2007, J BIOL CHEM, V282, P15330, DOI 10.1074/jbc.M610356200; Zuo SJ, 2000, J BIOL CHEM, V275, P5153, DOI 10.1074/jbc.275.7.5153	40	23	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22224	10.1371/journal.pone.0022224	http://dx.doi.org/10.1371/journal.pone.0022224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789240	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811700036
J	Bloomfield, GS; Hogan, JW; Keter, A; Sang, E; Carter, EJ; Velazquez, EJ; Kimaiyo, S				Bloomfield, Gerald S.; Hogan, Joseph W.; Keter, Alfred; Sang, Edwin; Carter, E. Jane; Velazquez, Eric J.; Kimaiyo, Sylvester			Hypertension and Obesity as Cardiovascular Risk Factors among HIV Seropositive Patients in Western Kenya	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; ANTIRETROVIRAL THERAPY; MYOCARDIAL-INFARCTION; PROTEASE INHIBITORS; INFECTED PATIENTS; BLOOD-PRESSURE; PREVALENCE; POPULATION; MORTALITY	Background: There is increased risk of cardiovascular disease among HIV seropositive individuals. The prevalence of HIV is highest in sub-Saharan Africa; however, HIV-related cardiovascular risk research is largely derived from developed country settings. Herein, we describe the prevalence of hypertension and obesity in a large HIV treatment program in Kenya. Methods: We performed a retrospective analysis of the electronic medical records of a large HIV treatment program in Western Kenya between 2006 and 2009. We calculated the prevalence of hypertension and obesity among HIV+ adults as well as utilized multiple logistic regression analyses to examine the relationship between clinical characteristics, HIV-related characteristics, and hypertension. Results: Our final sample size was 12,194. The median systolic/diastolic blood pressures were similar for both sexes (male: 110/70 mmHg, female: 110/70 mmHg). The prevalence of hypertension among men and women were 11.2% and 7.4%, respectively. Eleven percent of men and 22.6% of women were overweight/obese (body mass index >= 25 kg/m(2)). Ordinal logistic regression analyses showed that overweight/obesity was more strongly associated with hypertension among HIV+ men (OR 2.41, 95% CI 1.88-3.09) than a higher successive age category (OR 1.62, 95% CI 1.40-1.87 comparing 16-35, 36-45 and >45 years categories). Among women, higher age category and overweight/obesity were most strongly associated with hypertension (age category: OR 2.21, 95% CI 1.95-2.50, overweight/obesity: OR 1.80, 95% CI 1.50-2.16). Length of time on protease inhibitors was not found to be related to hypertension for men (OR 1.62, 95% CI 0.42-6.20) or women (OR 1.17, 95% CI 0.37-2.65) after adjustment for CD4 count, age and BMI. Conclusion: In Western Kenya, there is a high prevalence of hypertension and overweight/obesity among HIV+ patients with differences observed between men and women. The care of HIV+ patients in sub-Saharan Africa should also include both identification and management of associated cardiovascular risk factors.	[Bloomfield, Gerald S.; Velazquez, Eric J.] Duke Univ, Div Cardiol, Durham, NC 27706 USA; [Bloomfield, Gerald S.; Velazquez, Eric J.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Hogan, Joseph W.] Brown Univ, Dept Biostat, Providence, RI 02912 USA; [Keter, Alfred; Sang, Edwin; Kimaiyo, Sylvester] Moi Univ, Sch Med, Dept Med, Eldoret, Kenya; [Carter, E. Jane] Brown Univ, Alpert Sch Med, Div Infect Dis, Providence, RI 02912 USA; [Carter, E. Jane] Brown Univ, Alpert Sch Med, Div Pulm Med, Providence, RI 02912 USA	Duke University; Duke University; Brown University; Moi University; Brown University; Brown University	Bloomfield, GS (corresponding author), Duke Univ, Div Cardiol, Durham, NC 27706 USA.	gerald.bloomfield@duke.edu	Hogan, Joseph/J-4579-2014	Hogan, Joseph/0000-0001-7959-7361; Bloomfield, Gerald/0000-0002-7176-1611	United States Agency for International Development; National Heart Lung and Blood Institute Global Health Initiative's AMPATH Cardiovascular and Pulmonary Disease Center of Excellence [HV-09-12]; NIH [R24TW007988]; Duke University; FOGARTY INTERNATIONAL CENTER [R24TW007988, K01TW008407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER	United States Agency for International Development(United States Agency for International Development (USAID)); National Heart Lung and Blood Institute Global Health Initiative's AMPATH Cardiovascular and Pulmonary Disease Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant to the USAID-Academic Model Providing Access to Healthcare (AMPATH) Partnership from the United States Agency for International Development as part of the President's Emergency Plan for AIDS Relief (PEPFAR), the National Heart Lung and Blood Institute Global Health Initiative's AMPATH Cardiovascular and Pulmonary Disease Center of Excellence (HV-09-12), the NIH Fogarty International Clinical Research Fellowship Program (R24TW007988) and the Dr. Joseph C. Greenfield Scholar Award in Cardiovascular Medicine at Duke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2022, WORLD HLTH STAT; Baekken M, 2008, J HYPERTENS, V26, P2126, DOI 10.1097/HJH.0b013e32830ef5fb; Barbaro G, 2006, CURR HIV RES, V4, P79, DOI 10.2174/157016206775197664; Bergersen BM, 2003, EUR J CLIN MICROBIOL, V22, P731, DOI 10.1007/s10096-003-1034-z; Bloomfield GS, 2011, AM HEART J, V161, P842, DOI 10.1016/j.ahj.2010.12.020; Crane HM, 2006, AIDS, V20, P1019, DOI 10.1097/01.aids.0000222074.45372.00; Crum-Cianflone N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010106; de Arruda ER, 2010, BRAZ J INFECT DIS, V14, P281, DOI 10.1590/S1413-86702010000300014; Einterz RM, 2007, ACAD MED, V82, P812, DOI 10.1097/ACM.0b013e3180cc29f1; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; FUSTER V, PROMOTING CARDIOVASC; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; Guaraldi G, 2010, ATHEROSCLEROSIS, V208, P222, DOI 10.1016/j.atherosclerosis.2009.06.011; Guaraldi G, 2009, CLIN INFECT DIS, V49, P1756, DOI 10.1086/648080; Holmberg SD, 2002, LANCET, V360, P1747, DOI 10.1016/S0140-6736(02)11672-2; Jerico C, 2005, AM J HYPERTENS, V18, P1396, DOI 10.1016/j.amjhyper.2005.05.016; Jones CY, 2003, CLIN INFECT DIS, V37, pS69, DOI 10.1086/375889; Joubert J, 2006, CHRONIC DIS LIFESTYL; Kannel WB, 2004, AM J CARDIOL, V94, P901, DOI 10.1016/j.amjcard.2004.06.025; Kaplan RC, 2007, CLIN INFECT DIS, V45, P1074, DOI 10.1086/521935; Kenya National Bureau of Statistics; Ministry of Health; National AIDS Control Council; The DHS Program ICF International KDHS, 2003, KEN DEM HLTH SURV 20; Klein D, 2002, J ACQ IMMUN DEF SYND, V30, P471, DOI 10.1097/00126334-200208150-00002; Lazar JM, 2009, AIDS RES HUM RETROV, V25, P877, DOI 10.1089/aid.2008.0269; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lichtenstein KA, 2010, CLIN INFECT DIS, V51, P435, DOI 10.1086/655144; Mamlin Burke W, 2005, AMIA Annu Symp Proc, P490; Mary-Krause M, 2003, AIDS, V17, P2479, DOI 10.1097/00002030-200311210-00010; McDonald CL, 2009, J AM COLL CARDIOL, V54, P1185, DOI 10.1016/j.jacc.2009.05.055; Mutimura E, 2007, JAIDS-J ACQ IMM DEF, V46, P451, DOI 10.1097/QAI.0b013e318158c0a6; Mutimura Eugene, 2008, J Cardiometab Syndr, V3, P106, DOI 10.1111/j.1559-4572.2008.07584.x; Ntsekhe M, 2005, CIRCULATION, V112, P3602, DOI 10.1161/CIRCULATIONAHA.105.549220; Randell P, 2009, AM J THER, V16, P579, DOI 10.1097/MJT.0b013e318192116f; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Sklar P, 2003, NEW ENGL J MED, V349, P2065, DOI 10.1056/NEJMe038158; Sridhar D, 2008, LANCET, V372, P1185, DOI 10.1016/S0140-6736(08)61485-3; Stevens J, 1998, OBES RES, V6, P268, DOI 10.1002/j.1550-8528.1998.tb00349.x; Steyn K, 2005, CIRCULATION, V112, P3554, DOI 10.1161/CIRCULATIONAHA.105.563452; Taylor HA, 2010, OBESITY, V18, P1638, DOI 10.1038/oby.2009.407; Thiebaut R, 2005, ANTIVIR THER, V10, P811; *UNAIDS, 2008, REP GLOB HIV AIDS EP; Westaway MS, 2010, ARCH GERONTOL GERIAT, V50, P213, DOI 10.1016/j.archger.2009.03.012; Wilson SL, 2009, HIV MED, V10, P388, DOI 10.1111/j.1468-1293.2009.00699.x; World Health Organization, WHO GLOB INF; World Health Organization Expert Committee on Physical Status, 1995, US INT ANTHR; Yiannoutsos CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003843	46	81	86	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22288	10.1371/journal.pone.0022288	http://dx.doi.org/10.1371/journal.pone.0022288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779407	Green Submitted, Green Published, gold			2022-12-25	WOS:000292811300060
J	Persson, J; Beyer, I; Yumul, R; Li, ZY; Kiem, HP; Roffler, S; Lieber, A				Persson, Jonas; Beyer, Ines; Yumul, Roma; Li, ZongYi; Kiem, Hans-Peter; Roffler, Steve; Lieber, Andre			Immuno-Therapy with Anti-CTLA4 Antibodies in Tolerized and Non-Tolerized Mouse Tumor Models	PLOS ONE			English	Article							REGULATORY T-CELLS; COMBINATION IMMUNOTHERAPY; NKT CELLS; GENE-EXPRESSION; CTLA4 BLOCKADE; INSULATOR; VECTORS; BETA; REJECTION; EFFECTOR	Monoclonal antibodies specific for cytotoxic T lymphocyte-associated antigen 4 (anti-CTLA4) are a novel form of cancer immunotherapy. While preclinical studies in mouse tumor models have shown anti-tumor efficacy of anti-CTLA4 injection or expression, anti-CTLA4 treatment in patients with advanced cancers had disappointing therapeutic benefit. These discrepancies have to be addressed in more adequate pre-clinical models. We employed two tumor models. The first model is based on C57BI/6 mice and syngeneic TC-1 tumors expressing HPV16 E6/E7. In this model, the HPV antigens are neo-antigens, against which no central tolerance exists. The second model involves mice transgenic for the proto-oncogen neu and syngeneic mouse mammary carcinoma (MMC) cells. In this model tolerance to Neu involves both central and peripheral mechanisms. Anti-CTLA4 delivery as a protein or expression from gene-modified tumor cells were therapeutically efficacious in the non-tolerized TC-1 tumor model, but had no effect in the MMC-model. We also used the two tumor models to test an immuno-gene therapy approach for anti-CTLA4. Recently, we used an approach based on hematopoietic stem cells (HSC) to deliver the relaxin gene to tumors and showed that this approach facilitates pre-existing anti-tumor T-cells to control tumor growth in the MMC tumor model. However, unexpectedly, when used for anti-CTLA4 gene delivery in this study, the HSC-based approach was therapeutically detrimental in both the TC-1 and MMC models. Anti-CTLA4 expression in these models resulted in an increase in the number of intratumoral CD1d+ NKT cells and in the expression of TGF-beta 1. At the same time, levels of pro-inflammatory cytokines and chemokines, which potentially can support anti-tumor T-cell responses, were lower in tumors of mice that received anti-CTLA4-HSC therapy. The differences in outcomes between the tolerized and non-tolerized models also provide a potential explanation for the low efficacy of CTLA4 blockage approaches in cancer immunotherapy trials.	[Persson, Jonas; Beyer, Ines; Yumul, Roma; Li, ZongYi; Lieber, Andre] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Kiem, Hans-Peter] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Roffler, Steve] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Lieber, Andre] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Academia Sinica - Taiwan; University of Washington; University of Washington Seattle	Persson, J (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	lieber00@u.washington.edu	Roffler, Steve R/N-7791-2018; Beyer, Ines/Q-3236-2017	Roffler, Steve R/0000-0003-2543-7295; Beyer, Ines/0000-0001-7468-4466; Lieber, Andre/0000-0001-6742-6266	NIH [R01CA080192]; National Science Council [NSC96-2628-B001-003-MY3]; Deutsche Krebshilfe; Swedish Research Council [524-2009-539]; NATIONAL CANCER INSTITUTE [P01CA018029, R01CA080192] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council(Ministry of Science and Technology, Taiwan); Deutsche Krebshilfe(Deutsche Krebshilfe); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The work was supported by NIH grant R01CA080192 (to A.L.); National Science Council Grant NSC96-2628-B001-003-MY3 (to S. R.); Deutsche Krebshilfe Postdoctoral Training Grant (to I.B.); and Swedish Research Council Postdoctoral Grant 524-2009-539 (to J.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala SS, 2010, J IMMUNOTHER, V33, P557, DOI 10.1097/CJI.0b013e3181dcd260; Aker M, 2007, HUM GENE THER, V18, P333, DOI 10.1089/hum.2007.021; Attia P, 2005, J CLIN ONCOL, V23, P6043, DOI 10.1200/JCO.2005.06.205; BEYER I, 2010, MOL THER; Beyer I, 2011, MOL THER, V19, P479, DOI 10.1038/mt.2010.256; Camacho LH, 2009, J CLIN ONCOL, V27, P1075, DOI 10.1200/JCO.2008.19.2435; De Palma M, 2009, BBA-REV CANCER, V1796, P5, DOI 10.1016/j.bbcan.2009.04.001; Diao J, 2010, J IMMUNOL, V184, P1261, DOI 10.4049/jimmunol.0903050; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; Emery DW, 2000, P NATL ACAD SCI USA, V97, P9150, DOI 10.1073/pnas.160159597; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Griffin MD, 2001, J IMMUNOL METHODS, V248, P77, DOI 10.1016/S0022-1759(00)00344-6; Hegde S, 2010, IMMUNOLOGY, V130, P471, DOI 10.1111/j.1365-2567.2010.03293.x; Hurwitz AA, 2000, CANCER RES, V60, P2444; Kavanagh B, 2008, BLOOD, V112, P1175, DOI 10.1182/blood-2007-11-125435; Khan S, 2011, CLIN IMMUNOL, V138, P85, DOI 10.1016/j.clim.2010.09.011; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Knutson KL, 2006, J IMMUNOL, V177, P1526, DOI 10.4049/jimmunol.177.3.1526; Knutson KL, 2006, J IMMUNOL, V177, P84, DOI 10.4049/jimmunol.177.1.84; Knutson KL, 2004, CANCER RES, V64, P1146, DOI 10.1158/0008-5472.CAN-03-0173; Ko K, 2005, J EXP MED, V202, P885, DOI 10.1084/jem.20050940; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Li CL, 2008, GENE THER, V15, P49, DOI 10.1038/sj.gt.3303009; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li Z, 2009, BLOOD, V113, P5423, DOI 10.1182/blood-2008-10-187237; Lu HL, 2006, CANCER RES, V66, P9754, DOI 10.1158/0008-5472.CAN-06-1083; Malik P, 2005, ANN NY ACAD SCI, V1054, P238, DOI 10.1196/annals.1345.030; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Read S, 2006, J IMMUNOL, V177, P4376, DOI 10.4049/jimmunol.177.7.4376; Shieh SJ, 2009, J IMMUNOL, V183, P2277, DOI 10.4049/jimmunol.0900679; Shimizu J, 1999, J IMMUNOL, V163, P5211; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Stearman RS, 2008, CANCER RES, V68, P34, DOI 10.1158/0008-5472.CAN-07-0988; Stone D, 2008, J VIROL, V82, P7711, DOI 10.1128/JVI.00542-08; Strauss R, 2009, CURR OPIN MOL THER, V11, P513; Strauss R, 2009, CANCER RES, V69, P5115, DOI 10.1158/0008-5472.CAN-09-0645; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Teige A, 2010, J IMMUNOL, V185, P345, DOI 10.4049/jimmunol.0901693; Terabe M, 2008, ADV CANCER RES, V101, P277, DOI 10.1016/S0065-230X(08)00408-9; Tuve S, 2007, CANCER RES, V67, P5929, DOI 10.1158/0008-5472.CAN-06-4296; Tuve S, 2009, VACCINE, V27, P4225, DOI 10.1016/j.vaccine.2009.03.074; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Yamaguchi T, 2006, SEMIN CANCER BIOL, V16, P115, DOI 10.1016/j.semcancer.2005.11.005	43	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22303	10.1371/journal.pone.0022303	http://dx.doi.org/10.1371/journal.pone.0022303			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779410	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811300063
J	Huertas, D; Soler, M; Moreto, J; Villanueva, A; Martinez, A; Vidal, A; Charlton, M; Moffat, D; Patel, S; McDermott, J; Owen, J; Brotherton, D; Krige, D; Cuthill, S; Esteller, M				Huertas, D.; Soler, M.; Moreto, J.; Villanueva, A.; Martinez, A.; Vidal, A.; Charlton, M.; Moffat, D.; Patel, S.; McDermott, J.; Owen, J.; Brotherton, D.; Krige, D.; Cuthill, S.; Esteller, M.			Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin	ONCOGENE			English	Article						epigenetics; histone; inhibitor	SPINDLE-ASSEMBLY CHECKPOINT; MYELOID-LEUKEMIA CELLS; AURORA-B; MYELODYSPLASTIC SYNDROMES; DEACETYLASE INHIBITORS; THR-3 PHOSPHORYLATION; CANCER THERAPEUTICS; CHROMOSOME COHESION; TUMOR-GROWTH; DRUG TARGET	The approval of histone deacetylase inhibitors for treatment of lymphoma subtypes has positioned histone modifications as potential targets for the development of new classes of anticancer drugs. Histones also undergo phosphorylation events, and Haspin is a protein kinase the only known target of which is phosphorylation of histone H3 at Thr3 residue (H3T3ph), which is necessary for mitosis progression. Mitotic kinases can be blocked by small drugs and several clinical trials are underway with these agents. As occurs with Aurora kinase inhibitors, Haspin might be an optimal candidate for the pharmacological development of these compounds. A high-throughput screening for Haspin inhibitors identified the CHR-6494 compound as being one promising such agent. We demonstrate that CHR-6494 reduces H3T3ph levels in a dose-dependent manner and causes a mitotic catastrophe characterized by metaphase misalignment, spindle abnormalities and centrosome amplification. From the cellular standpoint, the identified small-molecule Haspin inhibitor causes arrest in G2/M and subsequently apoptosis. Importantly, ex vivo assays also demonstrate its anti-angiogenetic features; in vivo, it shows antitumor potential in xenografted nude mice without any observed toxicity. Thus, CHR-6494 is a first-in-class Haspin inhibitor with a wide spectrum of anticancer effects that merits further preclinical research as a new member of the family of mitotic kinase inhibitors. Oncogene (2012) 31, 1408-1418; doi:10.1038/onc.2011.335; published online 1 August 2011	[Huertas, D.; Soler, M.; Moreto, J.; Esteller, M.] Hosp Duran & Reynals, Canc Epigenet & Biol Program PEBC, Bellvitge Biomed Res Inst IDIBELL, Barcelona 08908, Catalonia, Spain; [Villanueva, A.] Bellvitge Biomed Res Inst IDIBELL, Translat Res Lab, Inst Catala Oncol, Barcelona, Catalonia, Spain; [Martinez, A.] Ctr Biomed Res La Rioja CIBIR, Oncol Area, Logrono, Spain; [Vidal, A.] Hosp Univ Bellvitge IDIBELL, Dept Pathol, Barcelona 08908, Catalonia, Spain; [Charlton, M.; Moffat, D.; Patel, S.; McDermott, J.; Owen, J.; Brotherton, D.; Krige, D.; Cuthill, S.] Chroma Therapeut, Abingdon, Oxon, England; [Esteller, M.] Univ Barcelona, Dept Physiol Sci 2, Sch Med, Barcelona, Catalonia, Spain; [Esteller, M.] ICREA, Barcelona, Catalonia, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; ICREA	Esteller, M (corresponding author), Hosp Duran & Reynals, Canc Epigenet & Biol Program PEBC, Bellvitge Biomed Res Inst IDIBELL, 3rd Floor,Avda Gran Via LHospitalet 199-203, Barcelona 08908, Catalonia, Spain.	mesteller@idibell.cat	Soler, Marta/AEW-9527-2022; Vidal, August/N-4662-2016; Esteller, Manel/L-5956-2014; Soler, Marta/AAF-1232-2021; Martinez, Alfredo/GQH-5998-2022	Vidal, August/0000-0001-5727-2099; Esteller, Manel/0000-0003-4490-6093; Soler, Marta/0000-0002-6656-957X; Martinez, Alfredo/0000-0003-4882-4044	European Community [LSHG-CT-2006-037415, SAF2007-00027-65134, CSD2006-49]; Steiner Cancer Research Foundation; ICREA Funding Source: Custom	European Community(European Commission); Steiner Cancer Research Foundation; ICREA(ICREA)	The research leading to these results has received funding from the European Community's Sixth Framework Programme (FP6/2000-2006) under grant agreement no. LSHG-CT-2006-037415-SMARTER project, grant numbers SAF2007-00027-65134, Consolider CSD2006-49 and Dr. Josef Steiner Cancer Research Foundation. ME is an ICREA Research Professor.	Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Bryan J, 2010, DRUGS, V70, P1381, DOI 10.2165/11537920-000000000-00000; Carpinelli P, 2008, ADV EXP MED BIOL, V610, P54, DOI 10.1007/978-0-387-73898-7_5; Cheng AY, 1998, CANCER RES, V58, P3611; Chopra P, 2010, EXPERT OPIN INV DRUG, V19, P27, DOI 10.1517/13543780903483191; Cuny GD, 2010, BIOORG MED CHEM LETT, V20, P3491, DOI 10.1016/j.bmcl.2010.04.150; D'Alise AM, 2008, MOL CANCER THER, V7, P1140, DOI 10.1158/1535-7163.MCT-07-2051; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Dai J, 2009, J CELL SCI, V122, P4168, DOI 10.1242/jcs.054122; Dar AA, 2010, MOL CANCER THER, V9, P268, DOI 10.1158/1535-7163.MCT-09-0765; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Eswaran J, 2009, P NATL ACAD SCI USA, V106, P20198, DOI 10.1073/pnas.0901989106; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Gleixner KV, 2010, CANCER RES, V70, P1513, DOI 10.1158/0008-5472.CAN-09-2181; Gotze K, 2010, ANN HEMATOL, V89, P841, DOI 10.1007/s00277-010-1015-0; Graham JS, 2009, EUR J CANCER, V45, P1129, DOI 10.1016/j.ejca.2009.01.003; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Higgins JMG, 2001, PROTEIN SCI, V10, P1677, DOI 10.1110/ps.49901; Johnson EF, 2007, BIOCHEMISTRY-US, V46, P9551, DOI 10.1021/bi7008745; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kim MS, 2001, NAT MED, V7, P437, DOI 10.1038/86507; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Ma XJ, 2009, DRUGS, V69, P1911, DOI 10.2165/11315680-000000000-00000; Macurek L, 2009, CANCER RES, V69, P4555, DOI 10.1158/0008-5472.CAN-09-0142; Malumbres M, 2008, TRENDS PHARMACOL SCI, V29, P16, DOI 10.1016/j.tips.2007.10.012; Marks PA, 2010, BBA-GENE REGUL MECH, V1799, P717, DOI 10.1016/j.bbagrm.2010.05.008; Martinez A, 2004, CANCER RES, V64, P6489, DOI 10.1158/0008-5472.CAN-04-0103; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nakai R, 2009, CANCER RES, V69, P3901, DOI 10.1158/0008-5472.CAN-08-4373; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Oke A, 2009, CANCER RES, V69, P4150, DOI 10.1158/0008-5472.CAN-08-3203; Patnaik D, 2008, J BIOMOL SCREEN, V13, P1025, DOI 10.1177/1087057108326081; Rebacz B, 2007, CANCER RES, V67, P6342, DOI 10.1158/0008-5472.CAN-07-0663; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Stemmann O, 2006, CELL CYCLE, V5, P11, DOI 10.4161/cc.5.1.2296; Takeuchi T, 2009, BIOORGAN MED CHEM, V17, P8113, DOI 10.1016/j.bmc.2009.09.050; Tao YG, 2009, CELL CYCLE, V8, P3172, DOI 10.4161/cc.8.19.9729; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Villa F, 2009, P NATL ACAD SCI USA, V106, P20204, DOI 10.1073/pnas.0908485106; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Zubia A, 2009, ONCOGENE, V28, P1477, DOI 10.1038/onc.2008.501	48	79	82	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	11					1408	1418		10.1038/onc.2011.335	http://dx.doi.org/10.1038/onc.2011.335			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	912FL	21804608	hybrid, Green Published			2022-12-25	WOS:000301780000008
J	Ratushny, V; Pathak, HB; Beeharry, N; Tikhmyanova, N; Xiao, F; Li, T; Litwin, S; Connolly, DC; Yen, TJ; Weiner, LM; Godwin, AK; Golemis, EA				Ratushny, V.; Pathak, H. B.; Beeharry, N.; Tikhmyanova, N.; Xiao, F.; Li, T.; Litwin, S.; Connolly, D. C.; Yen, T. J.; Weiner, L. M.; Godwin, A. K.; Golemis, E. A.			Dual inhibition of SRC and Aurora kinases induces postmitotic attachment defects and cell death	ONCOGENE			English	Article						SRC; NEDD9; Aurora; drug; mitosis; attachment	CANCER-CELLS; TARGETED THERAPIES; COLORECTAL-CANCER; CHRONIC-PHASE; PROTEIN HEF1; A KINASE; ACTIVATION; CYTOKINESIS; DASATINIB; ADHESION	Increased activity of SRC family kinases promotes tumor invasion and metastasis, and overexpression of the mitotic regulator Aurora kinase A (AURKA) drives tumor aneuploidy and chromosomal instability. These functions nominate SRC and AURKA as valuable therapeutic targets for cancer, and inhibitors for SRC and Aurora kinases are now being used in the clinic. In this study, we demonstrate potent synergy between multiple inhibitors of Aurora and SRC kinases in ovarian and colorectal cancer cell lines, but not in normal ovarian epithelial cell lines. Combination of Aurora and SRC inhibitors selectively killed cells that have undergone a preceding aberrant mitosis, and was associated with a postmitotic reattachment defect, and selective removal of aneuploid cell populations. Combined inhibition of Aurora kinase and SRC potentiated dasatinib-dependent loss of activated (Y416-phosphorylated) SRC. SRC and AURKA share a common interaction partner, NEDD9, which serves as a scaffolding protein with activities in cell attachment and mitotic control, suggesting SRC and AURKA might interact directly. In vitro, we observed physical interaction and mutual cross-phosphorylation between SRC and AURKA that enhanced SRC kinase activity. Together, these findings suggest that combination of SRC and Aurora-targeting inhibitors in the clinic may be a productive strategy. Oncogene (2012) 31, 1217-1227; doi:10.1038/onc.2011.314; published online 25 July 2011	[Ratushny, V.; Pathak, H. B.; Beeharry, N.; Tikhmyanova, N.; Xiao, F.; Li, T.; Litwin, S.; Connolly, D. C.; Yen, T. J.; Godwin, A. K.; Golemis, E. A.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Ratushny, V.] Drexel Univ, Coll Med, Program Mol & Cell Biol & Genet, Philadelphia, PA USA; [Weiner, L. M.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA	Fox Chase Cancer Center; Drexel University; Georgetown University	Golemis, EA (corresponding author), Fox Chase Canc Ctr, 333 Cottman Ave,W406, Philadelphia, PA 19111 USA.	EA_Golemis@fccc.edu		Yen, Tim/0000-0003-2159-0997; Golemis, Erica/0000-0003-3618-3673	Army Materiel Command [DOD W81XWH-07-1-0676]; State of Pennsylvania; Ovarian Cancer Research Fund; Ovarian SPORE [P50 CA083638]; Commonwealth of Pennsylvania; Greenberg Fund; NCI [CA06927]; Pew Charitable Fund; Fox Chase Cancer Center;  [R01-CA63366];  [R01-CA113342];  [R01-CA140323];  [R01-GM86877];  [R01-CA136596];  [R01-CA151374];  [R01-CA50633]; NATIONAL CANCER INSTITUTE [R01CA113342, R01CA136596, R01CA140323, P50CA083638, R01CA151374, P30CA006927, R01CA063366, R01CA050633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086877] Funding Source: NIH RePORTER	Army Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); State of Pennsylvania; Ovarian Cancer Research Fund; Ovarian SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Commonwealth of Pennsylvania; Greenberg Fund; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pew Charitable Fund; Fox Chase Cancer Center; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Lisa Vanderveer for assistance with maintaining EOC cell lines; Carolyn Slater for isolating and producing the primary HOSE cultures; Christine Klimowicz for assistance with the drug synergy assays; and Ilya Serebriiskii for assistance with editing the figures. This work was supported by R01-CA63366 and R01-CA113342; DOD W81XWH-07-1-0676 from the Army Materiel Command; and Tobacco Settlement funding from the State of Pennsylvania (to EAG); R01-CA140323 and the Ovarian Cancer Research Fund (to AKG); Ovarian SPORE P50 CA083638 (Project 4, to EAG, AKG, and DCC); R01-GM86877, an appropriation from the Commonwealth of Pennsylvania, and the Greenberg Fund (to TJY); R01-CA136596 and R01-CA151374 (to DCC); R01-CA50633 (to LMW); and by NCI CA06927 and support from the Pew Charitable Fund (to Fox Chase Cancer Center). Additional funds were provided by Fox Chase Cancer Center via institutional support of the Head and Neck Cancer Keystone Program.	Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Astsaturov I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001083; Bagnyukova T, 2010, CANCER BIOL THER, V10, P843, DOI 10.4161/cbt.10.9.13738; Bellacosa A, 2010, CANCER PREV RES, V3, P48, DOI 10.1158/1940-6207.CAPR-09-0078; BENZEEV A, 1981, CELL, V26, P107, DOI 10.1016/0092-8674(81)90038-6; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Boss DS, 2009, ONCOLOGIST, V14, P780, DOI 10.1634/theoncologist.2009-0019; Brandsma D, 2007, CURR OPIN ONCOL, V19, P598, DOI 10.1097/CCO.0b013e3282f0313b; Cao YH, 2007, ADV CANCER RES, V97, P203, DOI 10.1016/S0065-230X(06)97009-2; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Dadke D, 2006, MOL BIOL CELL, V17, P1204, DOI 10.1091/mbc.E05-03-0237; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dutertre S, 2002, ONCOGENE, V21, P6175, DOI 10.1038/sj.onc.1205775; Dyck HG, 1996, INT J CANCER, V69, P429, DOI 10.1002/(SICI)1097-0215(19961220)69:6<429::AID-IJC1>3.0.CO;2-6; Fei F, 2010, MOL CANCER THER, V9, P1318, DOI 10.1158/1535-7163.MCT-10-0069; Fernandez-Miranda G, 2011, DEVELOPMENT, V138, P2661, DOI 10.1242/dev.066381; Friedman A, 2007, CELL, V128, P225, DOI 10.1016/j.cell.2007.01.007; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; Giet R, 2005, TRENDS CELL BIOL, V15, P241, DOI 10.1016/j.tcb.2005.03.004; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Guan Z, 2007, CANCER RES, V67, P10436, DOI 10.1158/0008-5472.CAN-07-1379; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Hochhaus A, 2008, LEUKEMIA, V22, P1200, DOI 10.1038/leu.2008.84; Huang X, 2005, CELL CYCLE, V4, P801, DOI 10.4161/cc.4.6.1695; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Jones RJ, 2002, BRIT J CANCER, V87, P1128, DOI 10.1038/sj.bjc.6600594; Kaestner P, 2009, MOL CANCER THER, V8, P2046, DOI 10.1158/1535-7163.MCT-09-0323; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Kasahara K, 2007, J BIOL CHEM, V282, P5327, DOI 10.1074/jbc.M608396200; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Kopetz S, 2007, CLIN CANCER RES, V13, P7232, DOI 10.1158/1078-0432.CCR-07-1902; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Minegishi M, 1996, J EXP MED, V184, P1365, DOI 10.1084/jem.184.4.1365; MUSTELIN T, 2002, SCI STKE, pPE3; Ng MM, 2005, DEV CELL, V9, P781, DOI 10.1016/j.devcel.2005.11.002; O'Neill GM, 2001, MOL CELL BIOL, V21, P5094, DOI 10.1128/MCB.21.15.5094-5108.2001; Obara Y, 2004, J CELL SCI, V117, P6085, DOI 10.1242/jcs.01527; ORLY J, 1979, CELL, V17, P295, DOI 10.1016/0092-8674(79)90155-7; Pfeiffer P, 2007, ONCOGENE, V26, P3661, DOI 10.1038/sj.onc.1210377; Plotnikova OV, 2011, J CELL BIOL, V193, P1021, DOI 10.1083/jcb.201012061; Plotnikova OV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1061; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Shor AC, 2007, CANCER RES, V67, P2800, DOI 10.1158/0008-5472.CAN-06-3469; Soncini C, 2006, CLIN CANCER RES, V12, P4080, DOI 10.1158/1078-0432.CCR-05-1964; Wong ST, 2009, PHARMACOTHERAPY, V29, P954, DOI 10.1592/phco.29.8.954; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	50	24	25	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	10					1217	1227		10.1038/onc.2011.314	http://dx.doi.org/10.1038/onc.2011.314			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	906KS	21785464	Green Accepted			2022-12-25	WOS:000301344600002
J	Wang, Q; Levay, K; Chanturiya, T; Dvoriantchikova, G; Anderson, KL; Bianco, SDC; Ueta, CB; Molano, RD; Pileggi, A; Gurevich, EV; Gavrilova, O; Slepak, VZ				Wang, Qiang; Levay, Konstantin; Chanturiya, Tatyana; Dvoriantchikova, Galina; Anderson, Karen L.; Bianco, Suzy D. C.; Ueta, Cintia B.; Molano, R. Damaris; Pileggi, Antonello; Gurevich, Eugenia V.; Gavrilova, Oksana; Slepak, Vladlen Z.			Targeted deletion of one or two copies of the G protein beta subunit G beta 5 gene has distinct effects on body weight and behavior in mice	FASEB JOURNAL			English	Article						RGS protein; obesity; insulin; pancreas; RGS7	RGS PROTEINS; REGULATORS; RECEPTOR; FAMILY; COMPLEX; DOMAIN; SELECTIVITY; ACTIVATION; MODULATOR; SURVIVAL	We investigated the physiological role of G beta 5, a unique G protein beta subunit that dimerizes with regulators of G protein signaling (RGS) proteins of the R7 family instead of G gamma. G beta 5 is essential for stability of these complexes, so that its knockout (KO) causes degradation of the entire G beta 5-R7 family. We report that the G beta 5-KO mice remain leaner than the wild type (WT) throughout their lifetime and are resistant to a high-fat diet. They have a 5-fold increase in locomotor activity, increased thermogenesis, and lower serum insulin, all of which correlate with a higher level of secreted epinephrine. Heterozygous (HET) mice are 2-fold more active than WT mice. Surprisingly, with respect to body weight, the HET mice display a phenotype opposite to that of the KO mice: by the age of 6 mo, they are >= 15% heavier than the WT and have increased adiposity, insulin resistance, and liver steatosis. These changes occur in HET mice fed a normal diet and without apparent hyperphagia, mimicking basic characteristics of human metabolic syndrome. We conclude that even a partial reduction in G beta 5-R7 level can perturb normal animal metabolism and behavior. Our data on G beta 5 haploinsufficient mice may explain earlier observations of genetic linkage between R7 family mutations and obesity in humans.-Wang, Q., Levay, K., Chanturiya, T., Dvoriantchikova, G., Anderson, K. L., Bianco, S. D. C., Ueta, C. B., Molano, R. D., Pileggi, A., Gurevich, E. V., Gavrilova, O., and Slepak, V. Z. Targeted deletion of one or two copies of the G protein beta subunit G beta 5 gene has distinct effects on body weight and behavior in mice. FASEB J. 25, 3949-3957 (2011). www.fasebj.org	[Wang, Qiang; Levay, Konstantin; Bianco, Suzy D. C.; Slepak, Vladlen Z.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Dvoriantchikova, Galina] Univ Miami, Miller Sch Med, Dept Ophthalmol, Miami, FL 33136 USA; [Anderson, Karen L.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Bianco, Suzy D. C.; Ueta, Cintia B.] Univ Miami, Miller Sch Med, Div Endocrinol Diabet & Metab, Miami, FL 33136 USA; [Molano, R. Damaris; Pileggi, Antonello] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33136 USA; [Pileggi, Antonello] Univ Miami, Miller Sch Med, Dept Surg, Div Cellular Transplantat, Miami, FL 33136 USA; [Chanturiya, Tatyana; Gavrilova, Oksana] NIDDK, Mouse Metab Core Lab, NIH, Bethesda, MD USA; [Gurevich, Eugenia V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami; University of Miami; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University	Slepak, VZ (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, 1600 NW 10th Ave, Miami, FL 33136 USA.	v.slepak@miami.edu	Molano, Ruth Damaris/B-8633-2015; Pileggi, Antonello/A-2394-2008; Ueta, Cintia/D-6832-2013; Bianco, Suzy D.C./E-8892-2010	Molano, Ruth Damaris/0000-0002-6132-8750; Pileggi, Antonello/0000-0001-7819-2813; Bianco, Suzy D.C./0000-0003-3794-9853	U.S. National Institutes of Health (NIH) [GM 060019, 1R01 EB008009, NS065868]; Juvenile Diabetes Research Foundation; NIH [DK70460, NIHU42 RR016603]; City of Hope (Duarte, CA, USA); NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR016603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK070002, U01DK070460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065868] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); City of Hope (Duarte, CA, USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. Ching-Kang Chen (Virginia Commonwealth University, Richmond, VA, USA) for G beta 5-KO mice and Drs. Yossef Itzhak, Ronald Goldberg, Alessia Fornoni, and Valery Shestopalov for providing necessary equipment and invaluable critical discussions. The authors are also grateful to Darla Karpinsky, Elsie Zahr-Akrawi, Maite Lopez, Yelena Gadea, and Susana Villate for technical assistance. This study was supported by U.S. National Institutes of Health (NIH) grants GM 060019 (V.Z.S), 1R01 EB008009, and NS065868 (E.V.G) and by the Juvenile Diabetes Research Foundation (A.P.). Pancreatic islets were obtained through the support of NIH grants DK70460 and NIHU42 RR016603 and the City of Hope (Duarte, CA, USA).	Aissani B, 2006, OBESITY, V14, P1605, DOI 10.1038/oby.2006.185; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Berney T, 2003, TRANSPLANTATION, V76, P1669, DOI 10.1097/01.TP.0000092525.17025.D0; Bernstein LS, 2004, J BIOL CHEM, V279, P21248, DOI 10.1074/jbc.M312407200; Cao Y, 2009, J NEUROSCI, V29, P9301, DOI 10.1523/JNEUROSCI.1367-09.2009; Chase DL, 2001, CURR BIOL, V11, P222, DOI 10.1016/S0960-9822(01)00071-9; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Chidiac P, 2003, RECEPTOR CHANNEL, V9, P135, DOI 10.3109/10606820308244; Cone RD, 2000, J CLIN INVEST, V106, P185, DOI 10.1172/JCI10628; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Gautam D., ENDOCRINOLOGY, V151, P5185; Gautam D, 2006, CELL METAB, V4, P363, DOI 10.1016/j.cmet.2006.09.008; Gavrilova O, 2000, DIABETES, V49, P1910, DOI 10.2337/diabetes.49.11.1910; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; Hepler JR, 1999, TRENDS PHARMACOL SCI, V20, P376, DOI 10.1016/S0165-6147(99)01369-3; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Itoh M, 2006, J NEUROCHEM, V99, P1505, DOI 10.1111/j.1471-4159.2006.04220.x; Jayaraman M, 2009, TRENDS PHARMACOL SCI, V30, P17, DOI 10.1016/j.tips.2008.10.002; Jones MB, 2004, MOL INTERV, V4, P200, DOI 10.1124/mi.4.4.4; Kong K. C., P NATL ACAD SCI US, V107, P21181; Kovoor A, 2000, J BIOL CHEM, V275, P3397, DOI 10.1074/jbc.275.5.3397; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Molano RD, 2003, DIABETES, V52, P957, DOI 10.2337/diabetes.52.4.957; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Oswal A, 2007, OBES REV, V8, P293, DOI 10.1111/j.1467-789X.2007.00378.x; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Posner BA, 1999, J BIOL CHEM, V274, P31087, DOI 10.1074/jbc.274.43.31087; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Psifogeorgou K, 2007, J NEUROCHEM, V103, P617, DOI 10.1111/j.1471-4159.2007.04812.x; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Roy AA, 2003, MOL PHARMACOL, V64, P587, DOI 10.1124/mol.64.3.587; Sandiford SL, 2009, BIOCHEMISTRY-US, V48, P2282, DOI 10.1021/bi801989c; Sibbel SP, 2011, OBESITY, V19, P1433, DOI 10.1038/oby.2010.333; Slepak V. Z., 2009, STRUCTURE FUNCTION L, V86; Sondek J, 2001, BIOCHEM PHARMACOL, V61, P1329, DOI 10.1016/S0006-2952(01)00633-5; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Witherow DS, 2003, RECEPTOR CHANNEL, V9, P205, DOI 10.1080/10606820390203848; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zahr E, 2007, TRANSPLANTATION, V84, P1576, DOI 10.1097/01.tp.0000296035.48728.28	42	24	24	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	NOV	2011	25	11					3949	3957		10.1096/fj.11-190157	http://dx.doi.org/10.1096/fj.11-190157			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21804131	Green Published			2022-12-25	WOS:000296723100019
J	Roze, LV; Chanda, A; Wee, J; Awad, D; Linz, JE				Roze, Ludmila V.; Chanda, Anindya; Wee, Josephine; Awad, Deena; Linz, John E.			Stress-related Transcription Factor AtfB Integrates Secondary Metabolism with Oxidative Stress Response in Aspergilli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFLATOXIN BIOSYNTHESIS; ACTIVATION; EXPRESSION; NRF2; PARASITICUS; ELEMENT; SPORULATION; PATHWAYS; REVEALS; PROTEIN	In filamentous fungi, several lines of experimental evidence indicate that secondary metabolism is triggered by oxidative stress; however, the functional and molecular mechanisms that mediate this association are unclear. The basic leucine zipper (bZIP) transcription factor AtfB, a member of the bZIP/CREB family, helps regulate conidial tolerance to oxidative stress. In this work, we investigated the role of AtfB in the connection between oxidative stress response and secondary metabolism in the filamentous fungus Aspergillus parasiticus. This well characterized model organism synthesizes the secondary metabolite and carcinogen aflatoxin. Chromatin immunoprecipitation with specific anti-AtfB demonstrated AtfB binding at promoters of seven genes in the aflatoxin gene cluster that carry CREs. Promoters lacking CREs did not show AtfB binding. The binding of AtfB to the promoters occurred under aflatoxin-inducing but not under aflatoxin-noninducing conditions and correlated with activation of transcription of the aflatoxin genes. Deletion of veA, a global regulator of secondary metabolism and development, nearly eliminated this binding. Electrophoretic mobility shift analysis demonstrated that AtfB binds to the nor-1 (an early aflatoxin gene) promoter at a composite regulatory element that consists of highly similar, adjacent CRE1 and AP-1-like binding sites. The five nucleotides immediately upstream from CRE1, AGCC(G/C), are highly conserved in five aflatoxin promoters that demonstrate AtfB binding. We propose that AtfB is a key player in the regulatory circuit that integrates secondary metabolism and cellular response to oxidative stress.	[Roze, Ludmila V.; Chanda, Anindya; Wee, Josephine; Awad, Deena; Linz, John E.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Linz, John E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Linz, John E.] Michigan State Univ, Food Safety & Toxicol Ctr, E Lansing, MI 48824 USA; [Linz, John E.] Michigan State Univ, Ctr Integrat Toxicol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	Linz, JE (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, 234B GM Trout Bldg, E Lansing, MI 48824 USA.	jlinz@msu.edu	Chanda, A/G-1436-2015; Linz, John/AAF-1682-2020; Chanda, Anindya/I-1014-2014	Chanda, A/0000-0003-4184-1909; 	National Institutes of Health from NCI [RO1 52003-19]; Michigan Agricultural Experiment Station; NATIONAL CANCER INSTITUTE [R01CA052003] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Michigan Agricultural Experiment Station; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 52003-19 from NCI. This work was also supported by the Michigan Agricultural Experiment Station.	ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; Balazs A, 2010, MOL GENET GENOMICS, V283, P289, DOI 10.1007/s00438-010-0513-z; Calvo AM, 2004, APPL ENVIRON MICROB, V70, P4733, DOI 10.1128/AEM.70.8.4733-4739.2004; Chanda A, 2010, EUKARYOT CELL, V9, P1724, DOI 10.1128/EC.00118-10; Chanda A, 2009, P NATL ACAD SCI USA, V106, P19533, DOI 10.1073/pnas.0907416106; Chang PK, 2011, TOXINS, V3, P82, DOI 10.3390/toxins3010082; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Coisne C, 2011, ANTIOXID REDOX SIGN, V15, P1285, DOI 10.1089/ars.2011.3929; Degols G, 1997, MOL CELL BIOL, V17, P3356, DOI 10.1128/MCB.17.6.3356; Desikan R, 2001, PLANT PHYSIOL, V127, P159, DOI 10.1104/pp.127.1.159; DeWeese TL, 1998, P NATL ACAD SCI USA, V95, P11915, DOI 10.1073/pnas.95.20.11915; Gessler NN, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1091, DOI 10.1134/S0006297907100070; GuzmandePena D, 1997, FUNGAL GENET BIOL, V21, P198, DOI 10.1006/fgbi.1996.0945; Hagiwara D, 2008, BIOSCI BIOTECH BIOCH, V72, P2756, DOI 10.1271/bbb.80001; Hicks JK, 1997, EMBO J, V16, P4916, DOI 10.1093/emboj/16.16.4916; Hu DY, 2007, NEUROBIOL LEARN MEM, V87, P372, DOI 10.1016/j.nlm.2006.10.003; Huang JQ, 2009, INT J FOOD MICROBIOL, V130, P17, DOI 10.1016/j.ijfoodmicro.2008.12.027; Hur W, 2011, CURR OPIN CHEM BIOL, V15, P162, DOI 10.1016/j.cbpa.2010.12.009; Jayashree T, 2000, FREE RADICAL BIO MED, V29, P981, DOI 10.1016/S0891-5849(00)00398-1; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kim JH, 2008, INT J FOOD MICROBIOL, V122, P49, DOI 10.1016/j.ijfoodmicro.2007.11.058; Lara-Rojas F, 2011, MOL MICROBIOL, V80, P436, DOI 10.1111/j.1365-2958.2011.07581.x; Lee JS, 2005, CANCER LETT, V224, P171, DOI 10.1016/j.canlet.2004.09.042; Lee LW, 2002, APPL ENVIRON MICROB, V68, P5718, DOI 10.1128/AEM.68.11.5718-5727.2002; Leiser SF, 2010, MOL CELL BIOL, V30, P871, DOI 10.1128/MCB.01145-09; Meyer TE, 1998, INT J CANCER, V77, P55, DOI 10.1002/(SICI)1097-0215(19980703)77:1<55::AID-IJC10>3.0.CO;2-8; Miskei M, 2009, FUNGAL GENET BIOL, V46, pS105, DOI 10.1016/j.fgb.2008.07.013; Narasaiah KV, 2006, MYCOPATHOLOGIA, V162, P179, DOI 10.1007/s11046-006-0052-7; Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Proft M, 2005, EUKARYOT CELL, V4, P1343, DOI 10.1128/EC.4.8.1343-1352.2005; Radunovic A, 1997, NEUROSCI LETT, V239, P105, DOI 10.1016/S0304-3940(97)00905-1; Reverberi M, 2007, FOOD ADDIT CONTAM A, V24, P1070, DOI 10.1080/02652030701553244; Reverberi M, 2008, EUKARYOT CELL, V7, P988, DOI 10.1128/EC.00228-07; Roze LV, 2007, MOL MICROBIOL, V66, P713, DOI 10.1111/j.1365-2958.2007.05952.x; Roze LV, 2011, FUNGAL GENET BIOL, V48, P35, DOI 10.1016/j.fgb.2010.05.006; Roze LV, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-33; Roze LV, 2004, J BIOL CHEM, V279, P27428, DOI 10.1074/jbc.M400075200; Sakamoto K, 2008, FUNGAL GENET BIOL, V45, P922, DOI 10.1016/j.fgb.2008.03.009; Sakamoto K, 2009, FUNGAL GENET BIOL, V46, P887, DOI 10.1016/j.fgb.2009.09.004; Scandalios JG, 2005, BRAZ J MED BIOL RES, V38, P995, DOI 10.1590/S0100-879X2005000700003; Scott B, 2008, CURR OPIN MICROBIOL, V11, P488, DOI 10.1016/j.mib.2008.10.008; Shen GX, 2010, CAN J PHYSIOL PHARM, V88, P241, DOI 10.1139/Y10-018; SKORY CD, 1993, APPL ENVIRON MICROB, V59, P1642, DOI 10.1128/AEM.59.5.1642-1646.1993; Spooner R, 2011, INT J MOL SCI, V12, P334, DOI 10.3390/ijms12010334; Weseler AR, 2010, CURR HYPERTENS REP, V12, P154, DOI 10.1007/s11906-010-0103-9; Wingler K., 2011, BR J PHARM IN PRESS	51	80	86	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					35137	35148		10.1074/jbc.M111.253468	http://dx.doi.org/10.1074/jbc.M111.253468			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21808056	Green Published, hybrid			2022-12-25	WOS:000295406300067
J	Remen, KMR; Henning, P; Lerner, UH; Gustafsson, JA; Andersson, G				Remen, Kirsten M. Robertson; Henning, Petra; Lerner, Ulf H.; Gustafsson, Jan-Ake; Andersson, Goran			Activation of Liver X Receptor (LXR) Inhibits Receptor Activator of Nuclear Factor kappa B Ligand (RANKL)-induced Osteoclast Differentiation in an LXR beta-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROPHTHALMIA TRANSCRIPTION FACTOR; RESISTANT ACID-PHOSPHATASE; COLLAGEN-INDUCED ARTHRITIS; T-CELLS C1; GENE-EXPRESSION; BONE-RESORPTION; CATHEPSIN-K; DC-STAMP; TERMINAL DIFFERENTIATION; DEFICIENT MICE	Bone destruction is the major pathological process in many bone metabolic diseases and is a result of increased osteoclast formation and bone resorption. The liver X receptors (alpha, beta), important regulators of cholesterol metabolism and inflammatory signaling, have recently been observed to play a role in both physiological and pathological bone turnover. However, the relationship between liver X receptors (LXR) and osteoclast differentiation/formation remains unknown. Here, we report that the LXR ligand GW3965 is able to clearly and potently inhibit the formation of mature osteoclasts from receptor activator of nuclear factor kappa B ligand (RANKL)-stimulated human and murine osteoclast precursors. This results in a significant inhibition of bone resorption. We observed that GW3965 significantly inhibited expression of the osteoclast markers tartrate-resistant acid phosphatase, cathepsin K, osteoclast-associated receptor (OSCAR), and calcitonin receptor, appearing to act in an NFATc1/p38/microphthalmia-associated transcription factor (MITF)-dependent mechanism, independently of receptor activator of nuclear factor kappa B or c-Fos and not directly involving the NF kappa B pathways. GW3965 was less effective in RAW264.7 monocyte/macrophage cells, which are more committed into the osteoclast lineage. Also, GW3965 seemed to act differently depending on the source of the progenitor cells as it had no effect on calvarial osteoclasts, compared with marrow or blood-derived monocytes. As these effects were abolished in osteoclast precursors derived from LXR beta(-/-) mice, we suggest that GW3965 acts via an LXR beta-dependent mechanism. Taken together, our results suggest that the LXR can act as an important inhibitor of RANKL-mediated osteoclast differentiation.	[Remen, Kirsten M. Robertson; Gustafsson, Jan-Ake] Karolinska Inst, Novum, Dept Biosci & Nutr, S-14157 Huddinge, Sweden; [Henning, Petra; Lerner, Ulf H.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, S-41345 Gothenburg, Sweden; [Lerner, Ulf H.] Umea Univ, S-90187 Umea, Sweden; [Gustafsson, Jan-Ake] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77204 USA; [Andersson, Goran] Karolinska Univ Hosp, Karolinska Inst, Div Pathol, Dept Lab Med, S-14186 Huddinge, Sweden	Karolinska Institutet; University of Gothenburg; Umea University; University of Houston System; University of Houston; Karolinska Institutet; Karolinska University Hospital	Remen, KMR (corresponding author), Karolinska Inst, Novum, Dept Biosci & Nutr, S-14157 Huddinge, Sweden.	kirsten.remen@ki.se		Lerner, Ulf/0000-0002-3579-1960	Swedish Research Council [K209-52X-10363-17-3, 2006-17820-42007-12]; Robert A. Welch Foundation; Karolinska Institute Foundation for Geriatric Diseases; Karolinska Institute Research Foundation; Apotekare Hedbergs Fund for Medical Research; Swedish Rheumatism Association; Royal 80 Year Fund of King Gustav V	Swedish Research Council(Swedish Research CouncilEuropean Commission); Robert A. Welch Foundation(The Welch Foundation); Karolinska Institute Foundation for Geriatric Diseases; Karolinska Institute Research Foundation(Karolinska Institutet); Apotekare Hedbergs Fund for Medical Research; Swedish Rheumatism Association; Royal 80 Year Fund of King Gustav V	This work was supported by the Swedish Research Council Grants K209-52X-10363-17-3 and 2006-17820-42007-12, the Robert A. Welch Foundation, the Karolinska Institute Foundation for Geriatric Diseases, the Karolinska Institute Research Foundation, the Apotekare Hedbergs Fund for Medical Research, the Swedish Rheumatism Association, and the Royal 80 Year Fund of King Gustav V.	Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bandyopadhyay S, 2006, BIOCHEM PHARMACOL, V72, P184, DOI 10.1016/j.bcp.2006.04.018; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chintalacharuvu SR, 2007, ARTHRITIS RHEUM, V56, P1365, DOI 10.1002/art.22528; Conaway H. H., 2011, J BIOL CHEM     0629, DOI [10.1074/jbc.M111247734, DOI 10.1074/JBC.M111247734]; Conaway HH, 2009, FASEB J, V23, P3526, DOI 10.1096/fj.09-132548; EkRylander B, 1997, BIOCHEM J, V321, P305, DOI 10.1042/bj3210305; Everts V, 2009, BBA-MOL BASIS DIS, V1792, P757, DOI 10.1016/j.bbadis.2009.05.004; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Gohda J, 2005, EMBO J, V24, P790, DOI 10.1038/sj.emboj.7600564; Granholm S, 2007, J ENDOCRINOL, V195, P415, DOI 10.1677/JOE-07-0338; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Kawase Y, 2003, J BONE MINER RES, V18, P975, DOI 10.1359/jbmr.2003.18.6.975; Kim JH, 2008, J MOL BIOL, V383, P502, DOI 10.1016/j.jmb.2008.08.036; Kim K, 2005, J BIOL CHEM, V280, P35209, DOI 10.1074/jbc.M505815200; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Kim Y, 2005, J BIOL CHEM, V280, P32905, DOI 10.1074/jbc.M505820200; Kinser S, 2005, J NUTR BIOCHEM, V16, P88, DOI 10.1016/j.jnutbio.2004.10.003; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lerner UH, 1997, ACTA PHYSIOL SCAND, V161, P81, DOI 10.1046/j.1365-201X.1997.d01-1933.x; LERNER UH, 1987, J BONE MINER RES, V2, P375; Levin N, 2005, ARTERIOSCL THROM VAS, V25, P135, DOI 10.1161/01.ATV.0000150044.84012.68; Liu Y, 2003, J BIOL CHEM, V278, P20603, DOI 10.1074/jbc.M212093200; LJUNGGREN O, 1991, J BONE MINER RES, V6, P543; Lu SY, 2010, MOL BIOL CELL, V21, P1763, DOI 10.1091/mbc.E09-07-0584; Luchin A, 2001, J BIOL CHEM, V276, P36703, DOI 10.1074/jbc.M106418200; Luchin A, 2000, J BONE MINER RES, V15, P451, DOI 10.1359/jbmr.2000.15.3.451; Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200; Mansky KC, 2002, J LEUKOCYTE BIOL, V71, P304; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Meadows NA, 2007, J BIOL CHEM, V282, P1891, DOI 10.1074/jbc.M608572200; Motyckova G, 2001, P NATL ACAD SCI USA, V98, P5798, DOI 10.1073/pnas.091479298; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Park MC, 2010, RHEUMATOLOGY, V49, P882, DOI 10.1093/rheumatology/keq007; Pettit AR, 2008, BONE, V43, P976, DOI 10.1016/j.bone.2008.08.128; Prawitt J, 2011, BONE, V48, P339, DOI 10.1016/j.bone.2010.08.018; Robertson KM, 2006, J BONE MINER RES, V21, P1276, DOI 10.1359/JBMR.060503; Schilcher J, 2011, NEW ENGL J MED, V364, P1728, DOI 10.1056/NEJMoa1010650; Schuster GU, 2002, CIRCULATION, V106, P1147, DOI 10.1161/01.CIR.0000026802.79202.96; Shinohara Masahiro, 2007, Curr Osteoporos Rep, V5, P67; So H, 2003, J BIOL CHEM, V278, P24209, DOI 10.1074/jbc.M302940200; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Treuter E, 2007, MOL CELL, V25, P178, DOI 10.1016/j.molcel.2007.01.009; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yamaza T, 1998, BONE, V23, P499, DOI 10.1016/S8756-3282(98)00138-0; Zenger S, 2010, BIOCHEM BIOPH RES CO, V394, P743, DOI 10.1016/j.bbrc.2010.03.063	59	36	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33084	33094		10.1074/jbc.M111.235937	http://dx.doi.org/10.1074/jbc.M111.235937			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21784849	hybrid, Green Published			2022-12-25	WOS:000294968800027
J	Aletrari, MO; McKibbin, C; Williams, H; Pawar, V; Pietroni, P; Lord, JM; Flitsch, SL; Whitehead, R; Swanton, E; High, S; Spooner, RA				Aletrari, Mina-Olga; McKibbin, Craig; Williams, Helen; Pawar, Vidya; Pietroni, Paola; Lord, J. Michael; Flitsch, Sabine L.; Whitehead, Roger; Swanton, Eileithyia; High, Stephen; Spooner, Robert A.			Eeyarestatin 1 Interferes with Both Retrograde and Anterograde Intracellular Trafficking Pathways	PLOS ONE			English	Article							RICIN-A-CHAIN; PROTEIN DISULFIDE-ISOMERASE; N-GLYCOSIDASE ACTIVITY; I HEAVY-CHAINS; ENDOPLASMIC-RETICULUM; SHIGA TOXIN; BREFELDIN-A; QUALITY-CONTROL; MEMBRANE GLYCOPROTEIN; GOLGI-APPARATUS	Background: The small molecule Eeyarestatin I (ESI) inhibits the endoplasmic reticulum (ER)-cytosol dislocation and subsequent degradation of ERAD (ER associated protein degradation) substrates. Toxins such as ricin and Shiga/Shiga-like toxins (SLTx) are endocytosed and trafficked to the ER. Their catalytic subunits are thought to utilise ERAD-like mechanisms to dislocate from the ER into the cytosol, where a proportion uncouples from the ERAD process, recovers a catalytic conformation and destroys their cellular targets. We therefore investigated ESI as a potential inhibitor of toxin dislocation. Methodology and Principal Findings: Using cytotoxicity measurements, we found no role for ESI as an inhibitor of toxin dislocation from the ER, but instead found that for SLTx, ESI treatment of cells was protective by reducing the rate of toxin delivery to the ER. Microscopy of the trafficking of labelled SLTx and its B chain (lacking the toxic A chain) showed a delay in its accumulation at a peri-nuclear location, confirmed to be the Golgi by examination of SLTx B chain metabolically labelled in the trans-Golgi cisternae. The drug also reduced the rate of endosomal trafficking of diphtheria toxin, which enters the cytosol from acidified endosomes, and delayed the Golgi-specific glycan modifications and eventual plasma membrane appearance of tsO45 VSV-G protein, a classical marker for anterograde trafficking. Conclusions and Significance: ESI acts on one or more components that function during vesicular transport, whilst at least one retrograde trafficking pathway, that of ricin, remains unperturbed.	[Aletrari, Mina-Olga; Pawar, Vidya; Pietroni, Paola; Lord, J. Michael; Spooner, Robert A.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [McKibbin, Craig; Swanton, Eileithyia; High, Stephen] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Williams, Helen; Flitsch, Sabine L.; Whitehead, Roger] Univ Manchester, Sch Chem, Manchester, Lancs, England; [Flitsch, Sabine L.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England	University of Warwick; University of Manchester; University of Manchester; University of Manchester	Aletrari, MO (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	stephen.high@manchester.ac.uk; R.A.Spooner@warwick.ac.uk	Spooner, Robert/A-9870-2010; Flitsch, Sabine/AAJ-6812-2020; Whitehead, Roger/AAE-9077-2020	Spooner, Robert/0000-0001-9593-0195; Flitsch, Sabine/0000-0003-3974-646X; Whitehead, Roger/0000-0003-2910-4033; High, Stephen/0000-0002-4532-8152; Swanton, Eileithyia/0000-0002-3299-4228	Biotechnology and Biological Sciences Research Council [BB/D005752/1]; National Institutes of Health [5U01AI65869-02]; Wellcome Trust [080566/Z/06/Z]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI065869] Funding Source: NIH RePORTER; BBSRC [BB/D005752/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the Biotechnology and Biological Sciences Research Council (Grant number BB/D005752/1) http://www.bbsrc.ac.uk/, the National Institutes of Health (Grant number 5U01AI65869-02) http://www.nih.gov/and the Wellcome Trust (Program Grant number 080566/Z/06/Z) http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghi M, 1998, J NATL CANCER I, V90, P370, DOI 10.1093/jnci/90.5.370; Amessou M, 2007, J CELL SCI, V120, P1457, DOI 10.1242/jcs.03436; Baker BM, 2007, J BIOL CHEM, V282, P26845, DOI 10.1074/jbc.M704315200; Bellisola G, 2004, BIOCHEM PHARMACOL, V67, P1721, DOI 10.1016/j.bcp.2004.01.013; BLEWITT MG, 1985, BIOCHEMISTRY-US, V24, P5458, DOI 10.1021/bi00341a027; Bujny MV, 2007, J CELL SCI, V120, P2010, DOI 10.1242/jcs.003111; Burr ML, 2011, P NATL ACAD SCI USA, V108, P2034, DOI 10.1073/pnas.1016229108; Chadfield MS, 2004, J APPL MICROBIOL, V96, P1002, DOI 10.1111/j.1365-2672.2004.02225.x; Chen A, 2003, J CELL SCI, V116, P3503, DOI 10.1242/jcs.00641; CHEN SSL, 1986, J VIROL, V59, P210, DOI 10.1128/JVI.59.2.210-215.1986; Chiu CF, 2008, EMBO J, V27, P934, DOI 10.1038/emboj.2008.40; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; Cresswell P, 2000, TRAFFIC, V1, P301, DOI 10.1034/j.1600-0854.2000.010402.x; Cross BCS, 2009, J CELL SCI, V122, P4393, DOI 10.1242/jcs.054494; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Dolan BP, 2011, J IMMUNOL, V186, P2065, DOI 10.4049/jimmunol.1003096; DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; Dyve AB, 2009, BIOCHEM BIOPH RES CO, V390, P109, DOI 10.1016/j.bbrc.2009.09.076; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Falguieres T, 2006, BIOL CELL, V98, P125, DOI 10.1042/BC20050001; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Fu LW, 2003, J CELL BIOL, V160, P157, DOI 10.1083/jcb.200210086; GALLIONE CJ, 1985, J VIROL, V54, P374, DOI 10.1128/JVI.54.2.374-382.1985; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; Hosokawa N, 2007, BIOCHEM BIOPH RES CO, V362, P626, DOI 10.1016/j.bbrc.2007.08.057; HUDSON TH, 1987, J BIOL CHEM, V262, P16484; Kar R, 2009, ONCOGENE, V28, P2556, DOI 10.1038/onc.2009.118; Lakkaraju AKK, 2007, EXP CELL RES, V313, P834, DOI 10.1016/j.yexcr.2006.12.003; Letelier ME, 2004, J APPL TOXICOL, V24, P519, DOI 10.1002/jat.999; Li SY, 2010, MOL BIOL CELL, V21, P2543, DOI 10.1091/mbc.E09-08-0743; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Maya JD, 2003, BIOCHEM PHARMACOL, V65, P999, DOI 10.1016/S0006-2952(02)01663-5; Mayerhofer PU, 2009, J BIOL CHEM, V284, P10232, DOI 10.1074/jbc.M808387200; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Monier S, 2002, TRAFFIC, V3, P289, DOI 10.1034/j.1600-0854.2002.030406.x; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; NEVILLE DM, 1982, IMMUNOL REV, V62, P75, DOI 10.1111/j.1600-065X.1982.tb00390.x; ORCI L, 1991, CELL, V64, P1183; Polycarpou-Schwarz M, 2007, CANCER RES, V67, P4451, DOI 10.1158/0008-5472.CAN-07-0393; Popoff V, 2009, TRAFFIC, V10, P1868, DOI 10.1111/j.1600-0854.2009.00993.x; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Redmann V, 2011, J BIOL CHEM, V286, P21231, DOI 10.1074/jbc.M111.234708; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; SANDVIG K, 1994, J CELL BIOL, V126, P53, DOI 10.1083/jcb.126.1.53; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Scheel J, 1997, J CELL BIOL, V137, P319, DOI 10.1083/jcb.137.2.319; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Skanland SS, 2007, TRAFFIC, V8, P297, DOI 10.1111/j.1600-0854.2006.00527.x; Slominska-Wojewodzka M, 2006, MOL BIOL CELL, V17, P1664, DOI 10.1091/mbc.E05-10-0961; Smith DC, 2006, TRAFFIC, V7, P379, DOI 10.1111/j.1600-0854.2006.00391.x; Spooner RA, 2004, BIOCHEM J, V383, P285, DOI 10.1042/BJ20040742; Spooner RA, 2008, P NATL ACAD SCI USA, V105, P17408, DOI 10.1073/pnas.0809013105; Spooner RA, 2008, BIOCHEM J, V414, P471, DOI 10.1042/BJ20080149; Spooner RA, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-26; Stirling CJ, 2006, CURR BIOL, V16, pR1035, DOI 10.1016/j.cub.2006.11.013; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Tam PJ, 2007, MICROBIOL-SGM, V153, P2700, DOI 10.1099/mic.0.2007/006858-0; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; Wakana Y, 2008, MOL BIOL CELL, V19, P1825, DOI 10.1091/mbc.E07-08-0781; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Wesche J, 1999, J BIOL CHEM, V274, P34443, DOI 10.1074/jbc.274.48.34443; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Willer M, 2008, J BIOL CHEM, V283, P33883, DOI 10.1074/jbc.M803054200; WILLIAMS DB, 1995, CURR OPIN IMMUNOL, V7, P77, DOI 10.1016/0952-7915(95)80032-8; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164	81	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22713	10.1371/journal.pone.0022713	http://dx.doi.org/10.1371/journal.pone.0022713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799938	Green Submitted, gold, Green Published			2022-12-25	WOS:000293172900070
J	Guo, Q; Subramanian, H; Gupta, K; Ali, H				Guo, Qiang; Subramanian, Hariharan; Gupta, Kshitij; Ali, Hydar			Regulation of C3a Receptor Signaling in Human Mast Cells by G Protein Coupled Receptor Kinases	PLOS ONE			English	Article							CHEMOKINE PRODUCTION; PHOSPHOLIPASE D1; CUTTING EDGE; ACTIVATION; PHOSPHORYLATION; DEGRANULATION; ANAPHYLATOXIN; C3A-RECEPTOR; ARRESTINS; NFAT	Background: The complement component C3a activates human mast cells via its cell surface G protein coupled receptor (GPCR) C3aR. For most GPCRs, agonist-induced receptor phosphorylation leads to receptor desensitization, internalization as well as activation of downstream signaling pathways such as ERK1/2 phosphorylation. Previous studies in transfected COS cells overexpressing G protein coupled receptor kinases (GRKs) demonstrated that GRK2, GRK3, GRK5 and GRK6 participate in agonist-induced C3aR phosphorylation. However, the roles of these GRKs on the regulation of C3aR signaling and mediator release in human mast cells remain unknown. Methodology/Principal Findings: We utilized lentivirus short hairpin (sh)RNA to stably knockdown the expression of GRK2, GRK3, GRK5 and GRK6 in human mast cell lines, HMC-1 and LAD2, that endogenously express C3aR. Silencing GRK2 or GRK3 expression caused a more sustained Ca2+ mobilization, attenuated C3aR desensitization, and enhanced degranulation as well as ERK1/2 phosphorylation when compared to shRNA control cells. By contrast, GRK5 or GRK6 knockdown had no effect on C3aR desensitization, but caused a significant decrease in C3a-induced mast cell degranulation. Interestingly, GRK5 or GRK6 knockdown rendered mast cells more responsive to C3a for ERK1/2 phosphorylation. Conclusion/Significance: This study demonstrates that GRK2 and GRK3 are involved in C3aR desensitization. Furthermore, it reveals the novel finding that GRK5 and GRK6 promote C3a-induced mast cell degranulation but inhibit ERK1/2 phosphorylation via C3aR desensitization-independent mechanisms. These findings thus reveal a new level of complexity for C3aR regulation by GRKs in human mast cells.	[Guo, Qiang; Subramanian, Hariharan; Gupta, Kshitij; Ali, Hydar] Univ Penn, Dept Pathol, Sch Dent Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Guo, Q (corresponding author), Univ Penn, Dept Pathol, Sch Dent Med, Philadelphia, PA 19104 USA.	alih@upenn.edu	Subramanian, Hariharan/AHC-5755-2022		National Institutes of Health [R01-AI080852, RO1-HL085774]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI080852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants R01-AI080852 and RO1-HL085774 from the National Institutes of Health to HA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed J, 2004, J IMMUNOL, V172, P6961, DOI 10.4049/jimmunol.172.11.6961; Ahamed J, 2001, J IMMUNOL, V167, P3559, DOI 10.4049/jimmunol.167.7.3559; Ali H, 2000, J IMMUNOL, V165, P7215, DOI 10.4049/jimmunol.165.12.7215; ALI H, 1994, J BIOL CHEM, V269, P24557; Barthet G, 2009, EMBO J, V28, P2706, DOI 10.1038/emboj.2009.215; Bautsch W, 2000, J IMMUNOL, V165, P5401, DOI 10.4049/jimmunol.165.10.5401; Bhattacharya M, 2002, NAT CELL BIOL, V4, P547, DOI 10.1038/ncb821; Brown FD, 1998, CURR BIOL, V8, P835, DOI 10.1016/S0960-9822(98)70326-4; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; BUTTERFIELD JH, 1989, INT ARCH ALLER A IMM, V89, P297, DOI 10.1159/000234963; Choi WS, 2002, J IMMUNOL, V168, P5682, DOI 10.4049/jimmunol.168.11.5682; Corrotte M, 2010, J IMMUNOL, V185, P2942, DOI 10.4049/jimmunol.0903138; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Drouin SM, 2002, J IMMUNOL, V169, P5926, DOI 10.4049/jimmunol.169.10.5926; Fukuoka Y, 2008, J IMMUNOL, V180, P6307, DOI 10.4049/jimmunol.180.9.6307; Hitomi T, 2004, BLOOD, V104, P4122, DOI 10.1182/blood-2004-06-2091; Kashem SW, 2011, EUR J PHARMACOL, V668, P299, DOI 10.1016/j.ejphar.2011.06.027; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Kim JH, 1998, FEBS LETT, V430, P231, DOI 10.1016/S0014-5793(98)00661-9; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Langkabel P, 1999, EUR J IMMUNOL, V29, P3035, DOI 10.1002/(SICI)1521-4141(199909)29:09<3035::AID-IMMU3035>3.0.CO;2-Z; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McNeil HP, 2007, J BIOL CHEM, V282, P20785, DOI 10.1074/jbc.R700017200; Peng Z, 2005, J IMMUNOL, V174, P5201, DOI 10.4049/jimmunol.174.9.5201; Penn RB, 2000, TRENDS CARDIOVAS MED, V10, P81, DOI 10.1016/S1050-1738(00)00053-0; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Settmacher B, 2003, EUR J IMMUNOL, V33, P920, DOI 10.1002/eji.200323293; Subramanian H, 2011, MOL PHARMACOL, V79, P1005, DOI 10.1124/mol.111.071472; Tatemoto K, 2006, BIOCHEM BIOPH RES CO, V349, P1322, DOI 10.1016/j.bbrc.2006.08.177; Tipping M, 2010, EMBO J, V29, P3222, DOI 10.1038/emboj.2010.202; TOMHAVE ED, 1994, J IMMUNOL, V153, P3267; Venkatesha RT, 2005, MOL IMMUNOL, V42, P581, DOI 10.1016/j.molimm.2004.09.009; Vibhuti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019585	35	34	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22559	10.1371/journal.pone.0022559	http://dx.doi.org/10.1371/journal.pone.0022559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799898	Green Published, gold, Green Submitted			2022-12-25	WOS:000293172900046
J	Maserati, M; Walentuk, M; Dai, XP; Holston, O; Adams, D; Mager, J				Maserati, Marc; Walentuk, Melanie; Dai, Xiangpeng; Holston, Olivia; Adams, Danielle; Mager, Jesse			Wdr74 Is Required for Blastocyst Formation in the Mouse	PLOS ONE			English	Article							WD-REPEAT PROTEINS; PREIMPLANTATION DEVELOPMENT; MAMMALIAN DEVELOPMENT; GENE-EXPRESSION; E-CADHERIN; IN-VITRO; RNA; TROPHECTODERM; EMBRYO; DIFFERENTIATION	Preimplantation is a dynamic developmental period during which a combination of maternal and zygotic factors program the early embryo resulting in lineage specification and implantation. A reverse genetic RNAi screen in mouse embryos identified the WD Repeat Domain 74 gene (Wdr74) as being required for these critical first steps of mammalian development. Knockdown of Wdr74 results in embryos that develop normally until the morula stage but fail to form blastocysts or properly specify the inner cell mass and trophectoderm. In Wdr74-deficient embryos, we find activated Trp53-dependent apoptosis as well as a global reduction of RNA polymerase I, II and III transcripts. In Wdr74-deficient embryos blocking Trp53 function rescues blastocyst formation and lineage differentiation. These results indicate that Wdr74 is required for RNA transcription, processing and/or stability during preimplantation development and is an essential gene in the mouse.	[Maserati, Marc; Walentuk, Melanie; Dai, Xiangpeng; Holston, Olivia; Adams, Danielle; Mager, Jesse] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Maserati, M (corresponding author), Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA.	jmager@vasci.umass.edu			Massachusetts Life Science Center; Massachusetts Life Science Center, a "quasi-public agency of the Commonwealth of Massachusetts"	Massachusetts Life Science Center; Massachusetts Life Science Center, a "quasi-public agency of the Commonwealth of Massachusetts"	This work was funded in part by the Massachusetts Life Science Center (http://www.masslifesciences.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; This work was supported in part by the Massachusetts Life Science Center, a "quasi-public agency of the Commonwealth of Massachusetts". This did not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; BI Y, 2010, BIOL REPROD; BIGGERS JD, 1988, AM J PHYSIOL, V255, pC419, DOI 10.1152/ajpcell.1988.255.4.C419; Chen H, 2008, BIOCHEM BIOPH RES CO, V365, P636, DOI 10.1016/j.bbrc.2007.11.019; Cloutier P, 2010, BIOCHEM CELL BIOL, V88, P211, DOI [10.1139/O09-173, 10.1139/o09-173]; Cockburn K, 2010, J CLIN INVEST, V120, P995, DOI 10.1172/JCI41229; DAS G, 1988, EMBO J, V7, P503, DOI 10.1002/j.1460-2075.1988.tb02838.x; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; Fleming TP, 2001, FRONT BIOSCI-LANDMRK, V6, pD1000, DOI 10.2741/Fleming; Gallenberger M, 2011, HUM MOL GENET, V20, P422, DOI 10.1093/hmg/ddq478; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hisbergues M, 2001, PROTEIN SCI, V10, P293, DOI 10.1110/ps.22701; Janda L, 1996, J BACTERIOL, V178, P1487, DOI 10.1128/jb.178.5.1487-1489.1996; Jumaa H, 1999, CURR BIOL, V9, P899, DOI 10.1016/S0960-9822(99)80394-7; Kan NG, 2007, DEVELOPMENT, V134, P31, DOI 10.1242/dev.02722; Kickhoefer VA, 2003, GENE, V309, P65, DOI 10.1016/S0378-1119(03)00507-9; Kidder GM, 2001, FRONT BIOSCI, V6, pD731, DOI 10.2741/Kidder; LATHAM KE, 1991, MOL REPROD DEV, V30, P182, DOI 10.1002/mrd.1080300303; Lee JH, 2008, MOL CELL BIOL, V28, P609, DOI 10.1128/MCB.01356-07; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Mager J, 2006, MAMM GENOME, V17, P941, DOI 10.1007/s00335-006-0034-6; MAJUMDER S, 1994, J CELL BIOCHEM, V55, P59, DOI 10.1002/jcb.240550107; MIYASHITA T, 1994, ONCOGENE, V9, P1799; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; NICHOLS J, 1984, J EMBRYOL EXP MORPH, V80, P225; NISWANDER L, 1992, DEVELOPMENT, V114, P755; NOTHIAS JY, 1995, J BIOL CHEM, V270, P22077, DOI 10.1074/jbc.270.38.22077; Penel S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S3; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Ralston A, 2008, DEV BIOL, V313, P614, DOI 10.1016/j.ydbio.2007.10.054; RIETHMACHER D, 1995, P NATL ACAD SCI USA, V92, P855, DOI 10.1073/pnas.92.3.855; SCHULTZ GA, 1993, MOL REPROD DEV, V35, P414, DOI 10.1002/mrd.1080350416; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Shen Hongmei, 2008, V430, P77, DOI 10.1007/978-1-59745-182-6_5; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stein P, 2005, DEV BIOL, V286, P464, DOI 10.1016/j.ydbio.2005.08.015; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; WATSON AJ, 1990, DEV BIOL, V141, P104, DOI 10.1016/0012-1606(90)90105-R; Williams JW, 2002, MOL REPROD DEV, V61, P281, DOI 10.1002/mrd.10100; Yang YH, 2008, DEV DYNAM, V237, P2315, DOI 10.1002/dvdy.21666; Yonemasu R, 2005, DNA REPAIR, V4, P479, DOI 10.1016/j.dnarep.2004.12.004; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018	44	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22516	10.1371/journal.pone.0022516	http://dx.doi.org/10.1371/journal.pone.0022516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799883	Green Published, Green Submitted, gold			2022-12-25	WOS:000293172900042
J	Bee, A; Brewer, D; Beesley, C; Dodson, A; Forootan, S; Dickinson, T; Gerard, P; Lane, B; Yao, S; Cooper, CS; Djamgoz, MBA; Gosden, CM; Ke, YQ; Foster, CS				Bee, Alix; Brewer, Daniel; Beesley, Carol; Dodson, Andrew; Forootan, Shiva; Dickinson, Timothy; Gerard, Patricia; Lane, Brian; Yao, Sheng; Cooper, Colin S.; Djamgoz, Mustafa B. A.; Gosden, Christine M.; Ke, Youqiang; Foster, Christopher S.			siRNA Knockdown of Ribosomal Protein Gene RPL19 Abrogates the Aggressive Phenotype of Human Prostate Cancer	PLOS ONE			English	Article							EPITHELIAL-STROMAL INTERACTIONS; HIGH-LEVEL EXPRESSION; CELL-SURFACE; SIALIC-ACID; DIFFERENTIAL EXPRESSION; MESSENGER-RNA; POOR SURVIVAL; BREAST; GROWTH; L19	We provide novel functional data that posttranscriptional silencing of gene RPL19 using RNAi not only abrogates the malignant phenotype of PC-3M prostate cancer cells but is selective with respect to transcription and translation of other genes. Reducing RPL19 transcription modulates a subset of genes, evidenced by gene expression array analysis and Western blotting, but does not compromise cell proliferation or apoptosis in-vitro. However, growth of xenografted tumors containing the knocked-down RPL19 in-vivo is significantly reduced. Analysis of the modulated genes reveals induction of the non-malignant phenotype principally to involve perturbation of networks of transcription factors and cellular adhesion genes. The data provide evidence that extra-ribosomal regulatory functions of RPL19, beyond protein synthesis, are critical regulators of cellular phenotype. Targeting key members of affected networks identified by gene expression analysis raises the possibility of therapeutically stabilizing a benign phenotype generated by modulating the expression of an individual gene and thereafter constraining a malignant phenotype while leaving non-malignant tissues unaffected.	[Bee, Alix; Beesley, Carol; Dodson, Andrew; Forootan, Shiva; Dickinson, Timothy; Gerard, Patricia; Yao, Sheng; Gosden, Christine M.; Ke, Youqiang; Foster, Christopher S.] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Canc Med, Sect Cellular Pathol & Mol Genet, Liverpool L69 3BX, Merseyside, England; [Brewer, Daniel; Cooper, Colin S.] Inst Canc Res, Mol Carcinogenesis Grp, Sutton, Surrey, England; [Lane, Brian] Univ Liverpool, Ctr Genom Res, Liverpool Microarray Facil, Liverpool L69 3BX, Merseyside, England; [Djamgoz, Mustafa B. A.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London, England	University of Liverpool; University of London; Institute of Cancer Research - UK; University of Liverpool; Imperial College London	Bee, A (corresponding author), Univ Liverpool, Inst Translat Med, Dept Mol & Clin Canc Med, Sect Cellular Pathol & Mol Genet, Liverpool L69 3BX, Merseyside, England.	csfoster@liv.ac.uk	Brewer, Daniel S/D-6201-2018	Brewer, Daniel S/0000-0003-4753-9794	North West Cancer Research Fund (UK); Cancer Research-UK; National Cancer Research Institute (MRC-UK); US National Cancer Institute (USA); Grand Charity of Freemasons; Rosetrees Trust; Bob Champion Cancer Trust; Orchid Appeal and David Koch Foundation	North West Cancer Research Fund (UK); Cancer Research-UK(Cancer Research UK); National Cancer Research Institute (MRC-UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Cancer Institute (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grand Charity of Freemasons; Rosetrees Trust(Rosetrees Trust); Bob Champion Cancer Trust; Orchid Appeal and David Koch Foundation	This work was funded by the North West Cancer Research Fund (UK), Cancer Research-UK, the National Cancer Research Institute (MRC-UK), a Specialized Program of Research Excellence (SPORE) grant from the US National Cancer Institute (USA), Grand Charity of Freemasons, Rosetrees Trust, The Bob Champion Cancer Trust, The Orchid Appeal and David Koch Foundation. Funding bodies had no involvement in the design and conduct of the study, in collection management, analysis and interpretation of the data, or in preparation, review and approval of the paper.	Adamson J, 2003, ONCOGENE, V22, P2739, DOI 10.1038/sj.onc.1206341; Avondo F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-442; Barkic M, 2009, MOL CELL BIOL, V29, P2489, DOI 10.1128/MCB.01588-08; BASHIR I, 1990, BIOCHEM SOC T, V18, P968, DOI 10.1042/bst0180968; Bee A, 2006, CLIN CANCER RES, V12, P2061, DOI 10.1158/1078-0432.CCR-05-2445; Beerenwinkel N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-60; Belin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007147; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brachvogel B, 2003, MOL CELL BIOL, V23, P2907, DOI 10.1128/MCB.23.8.2907-2913.2003; Campagnoli MF, 2008, HUM MUTAT, V29, P911, DOI 10.1002/humu.20752; CARLSSON G, 1983, J CANCER RES CLIN, V105, P20, DOI 10.1007/BF00391826; CHAN YL, 1987, J BIOL CHEM, V262, P1111; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chari R, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-32; Chaudhuri S, 2007, RNA, V13, P2224, DOI 10.1261/rna.694007; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Cheung P, 2007, GLYCOBIOLOGY, V17, P767, DOI 10.1093/glycob/cwm037; Cooper CS, 2009, BRIT J CANCER, V100, P240, DOI 10.1038/sj.bjc.6604771; Cornford P, 1999, AM J PATHOL, V154, P137, DOI 10.1016/S0002-9440(10)65260-1; Cornford PA, 2000, CANCER RES, V60, P7099; CUSSENOT O, 1991, J UROLOGY, V146, P881, DOI 10.1016/S0022-5347(17)37953-3; Custodio N, 2001, J CELL MOL MED, V5, P267, DOI 10.1111/j.1582-4934.2001.tb00160.x; Cuzick J, 2011, LANCET ONCOL, V12, P245, DOI 10.1016/S1470-2045(10)70295-3; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; DELAUNAY J, 1974, FEBS LETT, V40, P97, DOI 10.1016/0014-5793(74)80902-6; DENNIS JW, 1989, CANCER CELL-MON REV, V1, P87; Diss JKJ, 2005, PROSTATE CANCER P D, V8, P266, DOI 10.1038/sj.pcan.4500796; Dressman MA, 2003, CANCER RES, V63, P2194; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Edwards S, 2005, BRIT J CANCER, V92, P376, DOI 10.1038/sj.bjc.6602261; Ellis SR, 2011, SEMIN HEMATOL, V48, P89, DOI 10.1053/j.seminhematol.2011.02.005; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Forootan SS, 2007, HUM PATHOL, V38, P1321, DOI 10.1016/j.humpath.2007.02.011; Forootan SS, 2010, INT J ONCOL, V36, P69, DOI 10.3892/ijo_00000476; Foster CS, 2009, BRIT J CANCER, V101, P1137, DOI 10.1038/sj.bjc.6605227; FOSTER CS, 1990, BRIT J CANCER, V62, P57; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilbert WV, 2011, TRENDS BIOCHEM SCI, V36, P127, DOI 10.1016/j.tibs.2010.12.002; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; HATAKEYAMA T, 1989, EUR J BIOCHEM, V185, P685, DOI 10.1111/j.1432-1033.1989.tb15166.x; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; HENRY JL, 1993, CANCER RES, V53, P1403; Hormozdiari F, 2009, J COMPUT BIOL, V16, P159, DOI 10.1089/cmb.2008.03TT; Huang CJ, 2008, J CELL MOL MED, V12, P1936, DOI 10.1111/j.1582-4934.2008.00253.x; Ito T, 1997, J VIROL, V71, P3357, DOI 10.1128/JVI.71.4.3357-3362.1997; Jonkers J, 1999, MECH DEVELOP, V88, P183, DOI 10.1016/S0925-4773(99)00187-2; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kauraniemi P, 2006, ENDOCR-RELAT CANCER, V13, P39, DOI 10.1677/erc.1.01147; Ke SD, 2008, GENOME RES, V18, P533, DOI 10.1101/gr.070268.107; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Komarova Natalia L, 2004, Cell Cycle, V3, P1081; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Kuroda K, 2010, CANCER SCI, V101, P46, DOI 10.1111/j.1349-7006.2009.01351.x; Lai K, 2009, DEV DYNAM, V238, P76, DOI 10.1002/dvdy.21815; Lai MD, 2007, CURR GENOMICS, V8, P43; Laniado ME, 2001, PROSTATE, V46, P262, DOI 10.1002/1097-0045(20010301)46:4<262::AID-PROS1032>3.0.CO;2-F; LaTulippe E, 2002, CANCER RES, V62, P4499; Leong WF, 2009, MOL CANCER RES, V7, P354, DOI 10.1158/1541-7786.MCR-08-0373; Lindstrom MS, 2007, CELL CYCLE, V6, P434, DOI 10.4161/cc.6.4.3861; Luft F, 2010, J MOL MED-JMM, V88, P1, DOI 10.1007/s00109-009-0570-0; MacInnes AW, 2008, P NATL ACAD SCI USA, V105, P10408, DOI 10.1073/pnas.0805036105; Mano MS, 2007, CANCER TREAT REV, V33, P64, DOI 10.1016/j.ctrv.2006.10.001; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; Matsuoka MP, 2008, MAR BIOTECHNOL, V10, P676, DOI 10.1007/s10126-008-9104-y; Mayer C, 2005, CELL CYCLE, V4, P1036, DOI 10.4161/cc.4.8.1925; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; Minner S, 2010, CLIN CANCER RES, V16, P1553, DOI 10.1158/1078-0432.CCR-09-2546; Mitra A, 2009, HISTOPATHOLOGY, V55, P696, DOI 10.1111/j.1365-2559.2009.03448.x; Mori S, 2009, ONCOGENE, V28, P2796, DOI 10.1038/onc.2009.139; Nakajima T, 2009, BRIT J PHARMACOL, V156, P420, DOI 10.1111/j.1476-5381.2008.00059.x; Nalbandian A, 2005, DIFFERENTIATION, V73, P385, DOI 10.1111/j.1432-0436.2005.00040.x; Narita S, 2008, CLIN CANCER RES, V14, P5769, DOI 10.1158/1078-0432.CCR-07-4282; Nickels BE, 2009, METHODS, V47, P53, DOI 10.1016/j.ymeth.2008.10.011; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Paddison PJ, 2008, CURR TOP MICROBIOL, V320, P1; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Ramieri MT, 2010, ANTICANCER RES, V30, P1287; Redondo PDG, 2004, J HISTOCHEM CYTOCHEM, V52, P629, DOI 10.1177/002215540405200507; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rose A, 2005, CANCER LETT, V227, P213, DOI 10.1016/j.canlet.2005.01.037; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sato T, 2003, J BIOL CHEM, V278, P3063, DOI 10.1074/jbc.M208886200; Shaaban AM, 2003, AM J SURG PATHOL, V27, P1502, DOI 10.1097/00000478-200312000-00002; SHARPE JC, 1994, BRIT J UROL, V74, P609, DOI 10.1111/j.1464-410X.1994.tb09193.x; SHEVRIN DH, 1989, PROSTATE, V15, P187, DOI 10.1002/pros.2990150212; Smith P, 1998, UROLOGY, V51, P663, DOI 10.1016/S0090-4295(97)00695-X; Smith P, 1998, FEBS LETT, V423, P19, DOI 10.1016/S0014-5793(98)00050-7; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Solier S, 2010, CANCER RES, V70, P8055, DOI 10.1158/0008-5472.CAN-10-2491; Sorensen KD, 2010, EXPERT REV MOL DIAGN, V10, P49, DOI 10.1586/ERM.09.74; STECK PA, 1984, TRANSPLANT P, V16, P355; Svaren J, 2000, J BIOL CHEM, V275, P38524, DOI 10.1074/jbc.M005220200; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; Teng SL, 2009, BIOPHYS J, V96, P2178, DOI 10.1016/j.bpj.2008.12.3904; TENNISWOOD M, 1986, PROSTATE, V9, P375, DOI 10.1002/pros.2990090407; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Uechi T, 2001, GENOMICS, V72, P223, DOI 10.1006/geno.2000.6470; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; Vaarala MH, 1998, INT J CANCER, V78, P27, DOI 10.1002/(SICI)1097-0215(19980925)78:1<27::AID-IJC6>3.3.CO;2-A; vanDiest PJ, 1997, J CLIN PATHOL, V50, P801, DOI 10.1136/jcp.50.10.801; Wang FL, 2009, CANCER DETECT PREV, V32, P437, DOI 10.1016/j.cdp.2009.01.001; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Weisberg RA, 2008, MOL CELL, V32, P747, DOI 10.1016/j.molcel.2008.12.010; Wittmann H G, 1980, Mol Biol Biochem Biophys, V32, P376; Wong YC, 2000, INT REV CYTOL, V199, P65, DOI 10.1016/S0074-7696(00)99002-8; Wool IG, 1995, BIOCHEM CELL BIOL, V73, P933, DOI 10.1139/o95-101; Yang DC, 1999, MOL PHYLOGENET EVOL, V12, P177, DOI 10.1006/mpev.1998.0607; Yang SH, 2010, HEPATO-GASTROENTEROL, V57, P710; Yang XL, 2010, INT J MOL MED, V26, P17, DOI 10.3892/ijmm_00000429; Yao Sheng, 2010, Genes Cancer, V1, P444, DOI 10.1177/1947601910376079; Zhang Xiaohua Douglas, 2008, BMC Res Notes, V1, P33, DOI 10.1186/1756-0500-1-33; Zhang Y, 2007, PROSTATE CANCER P D, V10, P293, DOI 10.1038/sj.pcan.4500960; Zhou C, 2011, HUMAN MUTATION   MAR, P15; Zhou LH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-75	119	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22672	10.1371/journal.pone.0022672	http://dx.doi.org/10.1371/journal.pone.0022672			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799931	Green Published, gold, Green Submitted			2022-12-25	WOS:000293097300079
J	Higham, JP; Girard-Buttoz, C; Engelhardt, A; Heistermann, M				Higham, James P.; Girard-Buttoz, Cedric; Engelhardt, Antje; Heistermann, Michael			Urinary C-Peptide of Insulin as a Non-Invasive Marker of Nutritional Status: Some Practicalities	PLOS ONE			English	Article							REPRODUCTIVE HORMONES; FECAL STEROIDS; ENERGY-BALANCE; STORAGE; FIELD	Nutritional status is a critical element of many aspects of animal ecology, but has proven difficult to measure non-invasively in studies of free-ranging animals. Urinary C-peptide of insulin (UCP), a small polypeptide cleaved in an equimolar ratio from proinsulin when the body converts it to insulin, offers great promise in this regard, and recent studies of several non-human primate species have utilized it with encouraging results. Despite this, there are a number of unresolved issues related to the collection, processing, storage and transport of samples. These include: contamination of samples on collection (most commonly by dirt or faeces), short-term storage before returning to a field station, differences in processing and long-term storage methods (blotting onto filter paper, freezing, lyophilizing), and for frozen samples, transportation while keeping samples frozen. Such issues have been investigated for urine samples in particular with respect to their effects on steroid hormone metabolites, but there has been little investigation of their effects on UCP measurement. We collected samples from captive macaques, and undertook a series of experiments where we systematically manipulated samples and tested the effects on subsequent UCP measurements. We show that contamination of urine samples by faeces led to a decrease in UCP levels by >90%, but that contamination with dirt did not have substantial effects. Short-term storage (up to 12 hours) of samples on ice did not affect UCP levels significantly, but medium-term storage (up to 78 hours) did. Freezing and lyophilization for long-term storage did not affect UCP levels, but blotting onto filter paper did. A transportation simulation showed that transporting frozen samples packed in ice and insulated should be acceptable, but only if it can be completed within a period of a few days and if freeze-thaw can be avoided. We use our data to make practical recommendations for fieldworkers.	[Higham, James P.; Girard-Buttoz, Cedric; Engelhardt, Antje] German Primate Ctr, Reprod Biol Unit, Jr Res Grp Primate Sexual Select, Gottingen, Lower Saxony, Germany; [Higham, James P.] Univ Chicago, Inst Mind & Biol, Chicago, IL 60637 USA; [Girard-Buttoz, Cedric; Engelhardt, Antje] Univ Gottingen, Courant Res Ctr Evolut Social Behav, Gottingen, Lower Saxony, Germany	Deutsches Primatenzentrum (DPZ); University of Chicago; University of Gottingen	Higham, JP (corresponding author), German Primate Ctr, Reprod Biol Unit, Jr Res Grp Primate Sexual Select, Gottingen, Lower Saxony, Germany.	jhigham@dpz.eu	Girard-Buttoz, Cedric/J-6285-2019; Engelhardt, Antje/A-2660-2013	Engelhardt, Antje/0000-0003-2704-7493	German Research Council [DFG EN 719/2]; Volkswagen Foundation	German Research Council(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen)	Research was supported by the German Research Council (DFG EN 719/2) and the Volkswagen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anestis SF, 2009, AM J PRIMATOL, V71, P130, DOI 10.1002/ajp.20631; Bahr NI, 2000, GEN COMP ENDOCR, V117, P427, DOI 10.1006/gcen.1999.7431; Deschner T, 2008, HORM BEHAV, V54, P620, DOI 10.1016/j.yhbeh.2008.06.005; Girard-Buttoz C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018042; Harris TR, 2010, BEHAV ECOL, V21, P46, DOI 10.1093/beheco/arp150; Higham JP, 2011, ANIM BEHAV, V81, P1001, DOI 10.1016/j.anbehav.2011.02.001; Hodges JK, 2011, FIELD LAB METHODS PR, P282; KESNER JS, 1995, REPROD TOXICOL, V9, P239, DOI 10.1016/0890-6238(95)00005-U; Knott CD, 2005, AM J PRIMATOL, V67, P121, DOI 10.1002/ajp.20173; KRUSZYNSKA YT, 1987, DIABETOLOGIA, V30, P16, DOI 10.1007/BF01788901; MEISTAS MT, 1982, METABOLISM, V31, P1224, DOI 10.1016/0026-0495(82)90008-7; Palme R, 2005, ANN NY ACAD SCI, V1046, P75, DOI 10.1196/annals.1343.007; RUBENSTEIN D, 1969, NATURE, V224, P697; Santymire RM, 2010, ZOO BIOL, V29, P289, DOI 10.1002/zoo.20248; Sherry DS, 2007, AM J PHYS ANTHROPOL, V133, P771, DOI 10.1002/ajpa.20562; Terio KA, 2002, ZOO BIOL, V21, P215, DOI 10.1002/zoo.10036; Thompson ME, 2008, HORM BEHAV, V53, P526, DOI 10.1016/j.yhbeh.2007.12.005; Thompson ME, 2009, HORM BEHAV, V55, P299, DOI 10.1016/j.yhbeh.2008.11.005; Valeggia CR, 2007, POPUL DEV REV, V33, P525, DOI 10.1111/j.1728-4457.2007.00183.x; WASSER SK, 1988, BIOL REPROD, V39, P862, DOI 10.1095/biolreprod39.4.862; Ziegler TE, 2005, AM J PRIMATOL, V67, P159, DOI 10.1002/ajp.20175	21	29	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22398	10.1371/journal.pone.0022398	http://dx.doi.org/10.1371/journal.pone.0022398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799844	Green Published, Green Accepted, gold			2022-12-25	WOS:000293097300043
J	Kostal, L; Lansky, P; Pokora, O				Kostal, Lubomir; Lansky, Petr; Pokora, Ondrej			Variability Measures of Positive Random Variables	PLOS ONE			English	Article							FISHER INFORMATION; DISTRIBUTIONS; ENTROPY; NEURONS; INTERVALS	During the stationary part of neuronal spiking response, the stimulus can be encoded in the firing rate, but also in the statistical structure of the interspike intervals. We propose and discuss two information-based measures of statistical dispersion of the interspike interval distribution, the entropy-based dispersion and Fisher information-based dispersion. The measures are compared with the frequently used concept of standard deviation. It is shown, that standard deviation is not well suited to quantify some aspects of dispersion that are often expected intuitively, such as the degree of randomness. The proposed dispersion measures are not entirely independent, although each describes the interspike intervals from a different point of view. The new methods are applied to common models of neuronal firing and to both simulated and experimental data.	[Kostal, Lubomir; Lansky, Petr; Pokora, Ondrej] Acad Sci Czech Republ, Inst Physiol, Dept Computat Neurosci, Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Kostal, L (corresponding author), Acad Sci Czech Republ, Inst Physiol, Dept Computat Neurosci, Prague, Czech Republic.	kostal@biomed.cas.cz	Pokora, Ondřej/B-7469-2012; Lansky, Petr/C-2971-2012; Kostal, Lubomir/B-7468-2012	Pokora, Ondřej/0000-0001-5327-5882; Lansky, Petr/0000-0003-2725-1160; Kostal, Lubomir/0000-0002-2708-6268	Centre for Neuroscience [LC554]; Grant Agency of the Czech Republic [P103/11/0282];  [AV0Z50110509]	Centre for Neuroscience; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); 	This work was supported by AV0Z50110509, Centre for Neuroscience LC554, and the Grant Agency of the Czech Republic project P103/11/0282. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1965, HDB MATH FUNCTIONS F; Ash R.B., 1965, INFORM THEORY; Bercher JF, 2009, INFORM SCIENCES, V179, P3832, DOI 10.1016/j.ins.2009.07.013; Berger AL, 1996, COMPUT LINGUIST, V22, P39; BERGER D, 1990, EXP BRAIN RES, V80, P129; Bershadskii A, 2001, EUR PHYS J B, V24, P409, DOI 10.1007/s10051-001-8691-4; Buracas GT, 1999, TRENDS NEUROSCI, V22, P303, DOI 10.1016/S0166-2236(98)01376-9; BURNS BD, 1964, J PHYSIOL-LONDON, V175, P445, DOI 10.1113/jphysiol.1964.sp007526; Chakravarty S., 1990, ETHICAL SOCIAL INDEX; Cover TM, 1991, ELEMENTS INFORM THEO; DellaPietra S, 1997, IEEE T PATTERN ANAL, V19, P380, DOI 10.1109/34.588021; Di Crescenzo A, 2002, J APPL PROBAB, V39, P434, DOI 10.1239/jap/1025131441; DITLEVSEN S, 2011, NEURAL COMP IN PRESS; Duchamp-Viret P, 2005, J NEUROBIOL, V65, P97, DOI 10.1002/neu.20177; FRIEDEN BR, 1990, PHYS REV A, V41, P4265, DOI 10.1103/PhysRevA.41.4265; GOOD IJ, 1971, BIOMETRIKA, V58, P255, DOI 10.2307/2334515; HUBER PJ, 1974, ANN STAT, V2, P1029, DOI 10.1214/aos/1176342822; Johnson DH, 2004, NEUROCOMPUTING, V58, P13, DOI 10.1016/j.neucom.2004.01.016; Kass RE, 2005, J NEUROPHYSIOL, V94, P8, DOI 10.1152/jn.00648.2004; KENDALL MG, 1977, ADV THEORY STAT, V1; Kostal L, 2007, EUR J NEUROSCI, V26, P2693, DOI 10.1111/j.1460-9568.2007.05880.x; Kostal L, 2007, NETWORK-COMP NEURAL, V18, P63, DOI 10.1080/09548980701243134; Kostal L, 2010, CHINESE J PHYSIOL, V53, P454, DOI 10.4077/CJP.2010.AMM031; KULLBACK S, 1968, INFORM THEORY STAT; Lansky P, 1999, J PERIPHER NERV SYST, V4, P27; Lansky P, 2004, NEURAL COMPUT, V16, P477, DOI 10.1162/089976604772744875; LEVINE MW, 1991, BIOL CYBERN, V65, P459, DOI 10.1007/BF00204659; MOORE GP, 1966, ANNU REV PHYSIOL, V28, P493, DOI 10.1146/annurev.ph.28.030166.002425; Nemenman I, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000025; Olypher AV, 2002, NEUROSCIENCE, V111, P553, DOI 10.1016/S0306-4522(01)00586-3; Perkel DH, 1969, NEUROSCI RES PROG SU, P405; Pouzat C, 2009, J NEUROSCI METH, V181, P119, DOI 10.1016/j.jneumeth.2009.01.037; R Development Core Team, 2009, R FDN STAT COMP; RATLIFF F, 1968, P NATL ACAD SCI USA, V60, P464, DOI 10.1073/pnas.60.2.464; Reeke GN, 2004, NEURAL COMPUT, V16, P941, DOI 10.1162/089976604773135050; Shinomoto S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000433; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; Telesca L, 2005, PHYSICA A, V351, P637, DOI 10.1016/j.physa.2004.12.041; THEUNISSEN F, 1995, J COMPUT NEUROSCI, V2, P149, DOI 10.1007/BF00961885; Tuckwell H. C., 1988, INTRO THEORETICAL NE, V2; VASICEK O, 1976, J R STAT SOC B, V38, P54; Victor JD, 1997, NETWORK-COMP NEURAL, V8, P127, DOI 10.1088/0954-898X/8/2/003; Vignat C, 2003, PHYS LETT A, V312, P27, DOI 10.1016/S0375-9601(03)00570-X; ZIVOJNOVIC V, 1993, IEEE INT C AC SPEECH, V4, P516	46	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e21998	10.1371/journal.pone.0021998	http://dx.doi.org/10.1371/journal.pone.0021998			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799762	Green Submitted, Green Published, gold			2022-12-25	WOS:000293097300010
J	Burba, I; Colombo, GI; Staszewsky, LI; De Simone, M; Devanna, P; Nanni, S; Avitabile, D; Molla, F; Cosentino, S; Russo, I; De Angelis, N; Soldo, A; Biondi, A; Gambini, E; Gaetano, C; Farsetti, A; Pompilio, G; Latini, R; Capogrossi, MC; Pesce, M				Burba, Ilaria; Colombo, Gualtiero I.; Staszewsky, Lidia Irene; De Simone, Marco; Devanna, Paolo; Nanni, Simona; Avitabile, Daniele; Molla, Fabiola; Cosentino, Simona; Russo, Ilaria; De Angelis, Noeleen; Soldo, Annarita; Biondi, Antonella; Gambini, Elisa; Gaetano, Carlo; Farsetti, Antonella; Pompilio, Giulio; Latini, Roberto; Capogrossi, Maurizio C.; Pesce, Maurizio			Histone Deacetylase Inhibition Enhances Self Renewal and Cardioprotection by Human Cord Blood-Derived CD34(+) Cells	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; HEMATOPOIETIC STEM-CELLS; CHROMATIN-MODIFYING AGENTS; VALPROIC ACID; PROSTATE-CANCER; CLONAL ANALYSIS; DIFFERENTIATION; ANGIOGENESIS; PLURIPOTENT; EXPRESSION	Background: Use of peripheral blood-or bone marrow-derived progenitors for ischemic heart repair is a feasible option to induce neo-vascularization in ischemic tissues. These cells, named Endothelial Progenitors Cells (EPCs), have been extensively characterized phenotypically and functionally. The clinical efficacy of cardiac repair by EPCs cells remains, however, limited, due to cell autonomous defects as a consequence of risk factors. The devise of "enhancement'' strategies has been therefore sought to improve repair ability of these cells and increase the clinical benefit. Principal Findings: Pharmacologic inhibition of histone deacetylases (HDACs) is known to enhance hematopoietic stem cells engraftment by improvement of self renewal and inhibition of differentiation in the presence of mitogenic stimuli in vitro. In the present study cord blood-derived CD34(+) were pre-conditioned with the HDAC inhibitor Valproic Acid. This treatment affected stem cell growth and gene expression, and improved ischemic myocardium protection in an immunodeficient mouse model of myocardial infarction. Conclusions: Our results show that HDAC blockade leads to phenotype changes in CD34+ cells with enhanced self renewal and cardioprotection.	[Burba, Ilaria; De Simone, Marco; Devanna, Paolo; Avitabile, Daniele; Gambini, Elisa; Pompilio, Giulio; Pesce, Maurizio] IRCCS, Ctr Cardiol Monzino, Lab Biol Vasc & Med Rigenerat, Milan, Italy; [Colombo, Gualtiero I.] IRCCS, Ctr Cardiol Monzino, Lab Genom Funz & Immunol, Milan, Italy; [Staszewsky, Lidia Irene; Molla, Fabiola; Russo, Ilaria; De Angelis, Noeleen; Soldo, Annarita; Biondi, Antonella; Latini, Roberto] Ist Ric Farmacol Mario Negri, Dipartimento Sci Cardiovasc, Milan, Italy; [Nanni, Simona] Univ Cattolica Sacro Cuore, Ist Patol Med, Rome, Italy; [Cosentino, Simona] IRCCS, Ctr Cardiol Monzino, Lab Aterotrombosi, Milan, Italy; [Gaetano, Carlo; Capogrossi, Maurizio C.] IRCCS, IDI, Lab Patol Vasc, Rome, Italy; [Farsetti, Antonella] Ist Regina Elena, Dipartimento Oncol Sperimentale, I-00161 Rome, Italy	IRCCS Centro Cardiologico Monzino; IRCCS Centro Cardiologico Monzino; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Centro Cardiologico Monzino; IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Burba, I (corresponding author), IRCCS, Ctr Cardiol Monzino, Lab Biol Vasc & Med Rigenerat, Milan, Italy.	maurizio.pesce@ccfm.it	Colombo, Gualtiero I./B-4737-2010; Latini, Roberto/AAB-1410-2020; Pesce, Maurizio/B-4260-2010; Pesce, Maurizio/AAA-4207-2019; Gaetano, Carlo/P-9997-2019; Avitabile, Daniele/H-3760-2019; Russo, Ilaria/K-4039-2019; Farsetti, Antonella/I-8710-2018; Pompilio, Giulio/J-6701-2014; Gambini, Elisa/B-3744-2011	Colombo, Gualtiero I./0000-0002-7348-1939; Latini, Roberto/0000-0002-3729-4650; Pesce, Maurizio/0000-0002-3097-8961; Pesce, Maurizio/0000-0002-3097-8961; Gaetano, Carlo/0000-0002-5238-1832; Avitabile, Daniele/0000-0002-1360-2700; Russo, Ilaria/0000-0001-6432-3798; Farsetti, Antonella/0000-0002-8603-7925; Pompilio, Giulio/0000-0003-2581-5735; Gambini, Elisa/0000-0002-8859-8259; Devanna, Paolo/0000-0003-3966-1837; Staszewsky, Lidia/0000-0002-3702-1038	EU [LSHB-CT-2005-018817]; Italian Ministry of Health; Fondazione Monzino; Associazione Italiana Ricerca sul Cancro (AIRC)	EU(European Commission); Italian Ministry of Health(Ministry of Health, Italy); Fondazione Monzino; Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	The present work was funded by Thercord EU-P6 funded grant (contract no LSHB-CT-2005-018817), by Ricerca Finalizzata (ex art 56) from the Italian Ministry of Health, and by Fondazione Monzino. This work was also in part supported by Associazione Italiana Ricerca sul Cancro (AIRC) to Antonella Farsetti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki H, 2006, EXP HEMATOL, V34, P140, DOI 10.1016/j.exphem.2005.10.002; Araki H, 2007, BLOOD, V109, P3570, DOI 10.1182/blood-2006-07-035287; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Bryant JE, 2009, J MOL CELL CARDIOL, V46, P186, DOI 10.1016/j.yjmcc.2008.10.022; Burba Ilaria, 2010, Recent Pat Cardiovasc Drug Discov, V5, P1; CARLSON S, 2011, CARDIOVASC RES; Chaurasia P, 2011, BLOOD, V117, P4632, DOI 10.1182/blood-2010-10-314567; Chen JM, 2010, AM J PATHOL, V176, P2520, DOI 10.2353/ajpath.2010.091061; Cieslik KA, 2011, J MOL CELL CARDIOL, V50, P248, DOI 10.1016/j.yjmcc.2010.10.019; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; De Felice LD, 2005, CANCER RES, V65, P1505, DOI 10.1158/0008-5472.CAN-04-3063; Delorme B, 2005, THROMB HAEMOSTASIS, V94, P1270, DOI 10.1160/TH05-07-0499; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Duenas-Gonzalez A, 2008, CANCER TREAT REV, V34, P206, DOI 10.1016/j.ctrv.2007.11.003; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Eyal S, 2005, BIOCHEM PHARMACOL, V69, P1501, DOI 10.1016/j.bcp.2005.02.012; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Gerstner T, 2008, EXPERT OPIN PHARMACO, V9, P285, DOI 10.1517/14656566.9.2.285 ; Gianella A, 2010, CARDIOVASC RES, V85, P503, DOI 10.1093/cvr/cvp325; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Haudek SB, 2006, P NATL ACAD SCI USA, V103, P18284, DOI 10.1073/pnas.0608799103; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kwon SM, 2009, TRENDS CARDIOVAS MED, V19, P170, DOI 10.1016/j.tcm.2009.10.002; Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061; Masson S, 1998, J MOL CELL CARDIOL, V30, P1505, DOI 10.1006/jmcc.1998.0714; Meng F, 2008, ONCOGENE, V27, P378, DOI 10.1038/sj.onc.1210648; Michaelis M, 2004, MOL PHARMACOL, V65, P520, DOI 10.1124/mol.65.3.520; Michaelis M, 2007, CURR PHARM DESIGN, V13, P3378, DOI 10.2174/138161207782360519; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Milhem M, 2004, BLOOD, V103, P4102, DOI 10.1182/blood-2003-07-2431; Milutinovic S, 2007, CARCINOGENESIS, V28, P560, DOI 10.1093/carcin/bgl167; Mottet D, 2007, CIRC RES, V101, P1237, DOI 10.1161/CIRCRESAHA.107.149377; Nanni S, 2009, J CLIN INVEST, V119, P1093, DOI 10.1172/JCI35079; Orlandi A, 2009, DIFFERENTIATION, V77, P360, DOI 10.1016/j.diff.2008.12.002; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Pesce M, 2003, CIRC RES, V93, pE51, DOI 10.1161/01.RES.0000090624.04507.45; Pesce M, 2011, PHARMACOL THERAPEUT, V129, P50, DOI 10.1016/j.pharmthera.2010.10.003; Popovic R, 2009, BLOOD, V113, P3314, DOI 10.1182/blood-2008-04-154310; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Povsic TJ, 2007, J AM COLL CARDIOL, V50, P2243, DOI 10.1016/j.jacc.2007.08.033; Ramos AL, 2010, CIRC RES, V107, P1460, DOI 10.1161/CIRCRESAHA.110.223669; Rauhala HE, 2010, INT J CANCER, V127, P1363, DOI 10.1002/ijc.25162; Rossig L, 2004, ARTERIOSCL THROM VAS, V24, P1977, DOI 10.1161/01.ATV.0000146815.54702.75; Rossig L, 2005, J EXP MED, V201, P1825, DOI 10.1084/jem.20042097; Scarola M, 2010, CANCER RES, V70, P6925, DOI 10.1158/0008-5472.CAN-10-0141; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; SCHELLER M, 2006, NAT IMMUNOL; Seeger Florian H, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS110, DOI 10.1038/ncpcardio0734; Seet LF, 2009, EUR J HAEMATOL, V82, P124, DOI 10.1111/j.1600-0609.2008.01169.x; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Spallotta F, 2010, STEM CELLS, V28, P431, DOI 10.1002/stem.300; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wagner W, 2004, BLOOD, V104, P675, DOI 10.1182/blood-2003-10-3423; WHITTAKER P, 1991, CIRCULATION, V84, P2123, DOI 10.1161/01.CIR.84.5.2123; Wu JJ, 2010, CELL CYCLE, V9, P1809, DOI 10.4161/cc.9.9.11535; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471	65	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22158	10.1371/journal.pone.0022158	http://dx.doi.org/10.1371/journal.pone.0022158			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789227	Green Submitted, Green Published, gold			2022-12-25	WOS:000292812400034
J	Helft, L; Reddy, V; Chen, XY; Koller, T; Federici, L; Fernandez-Recio, J; Gupta, R; Bent, A				Helft, Laura; Reddy, Vignyan; Chen, Xiyang; Koller, Teresa; Federici, Luca; Fernandez-Recio, Juan; Gupta, Rishabh; Bent, Andrew			LRR Conservation Mapping to Predict Functional Sites within Protein Leucine-Rich Repeat Domains	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; POLYGALACTURONASE-INHIBITING PROTEINS; PAMP-TRIGGERED IMMUNITY; ELONGATION-FACTOR TU; RIBONUCLEASE INHIBITOR; DISEASE RESISTANCE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; INNATE IMMUNITY; ANKYRIN REPEAT	Computational prediction of protein functional sites can be a critical first step for analysis of large or complex proteins. Contemporary methods often require several homologous sequences and/or a known protein structure, but these resources are not available for many proteins. Leucine-rich repeats (LRRs) are ligand interaction domains found in numerous proteins across all taxonomic kingdoms, including immune system receptors in plants and animals. We devised Repeat Conservation Mapping (RCM), a computational method that predicts functional sites of LRR domains. RCM utilizes two or more homologous sequences and a generic representation of the LRR structure to identify conserved or diversified patches of amino acids on the predicted surface of the LRR. RCM was validated using solved LRR+ligand structures from multiple taxa, identifying ligand interaction sites. RCM was then used for de novo dissection of two plant microbe-associated molecular pattern (MAMP) receptors, EF-TU RECEPTOR (EFR) and FLAGELLIN-SENSING 2 (FLS2). In vivo testing of Arabidopsis thaliana EFR and FLS2 receptors mutagenized at sites identified by RCM demonstrated previously unknown functional sites. The RCM predictions for EFR, FLS2 and a third plant LRR protein, PGIP, compared favorably to predictions from ODA (optimal docking area), Consurf, and PAML (positive selection) analyses, but RCM also made valid functional site predictions not available from these other bioinformatic approaches. RCM analyses can be conducted with any LRR-containing proteins at www.plantpath.wisc.edu/RCM, and the approach should be modifiable for use with other types of repeat protein domains.	[Helft, Laura; Bent, Andrew] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA; [Reddy, Vignyan; Gupta, Rishabh] Univ Wisconsin, Dept Elect & Comp Engn, Madison, WI 53706 USA; [Chen, Xiyang; Koller, Teresa; Bent, Andrew] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Federici, Luca] Univ G DAnnunzio, Dipartimento Sci Biomed, Chieti, Italy; [Fernandez-Recio, Juan] Barcelona Supercomp Ctr, Dept Life Sci, Barcelona, Spain	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; G d'Annunzio University of Chieti-Pescara; Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS)	Helft, L (corresponding author), Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI 53706 USA.	afbent@wisc.edu	Bent, Andrew/E-5391-2016	Bent, Andrew/0000-0001-6610-9525; Fernandez-Recio, Juan/0000-0002-3986-7686	U.S. Department of Energy Basic Energy Sciences [DE-FG02-02ER15342]; National Science Foundation; MIUR of Italy [PRIN2007K7KY8Y]	U.S. Department of Energy Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); MIUR of Italy(Ministry of Education, Universities and Research (MIUR))	This work was supported by U.S. Department of Energy Basic Energy Sciences Grant DE-FG02-02ER15342 to AB, and by an National Science Foundation Predoctoral Fellowship to LH. Support from MIUR of Italy (PRIN2007K7KY8Y) to LF is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Phillips L, 2010, PLANT PHYSIOL, V152, P267, DOI 10.1104/pp.109.148049; Albert M, 2010, J BIOL CHEM, V285, P19035, DOI 10.1074/jbc.M110.124800; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Casasoli M, 2009, P NATL ACAD SCI USA, V106, P7666, DOI 10.1073/pnas.0812625106; Celikel R, 2003, SCIENCE, V301, P218, DOI 10.1126/science.1084183; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chinchilla D, 2007, ADV EXP MED BIOL, V598, P358; Clark LB, 2004, J BIOL CHEM, V279, P13616, DOI 10.1074/jbc.M313202200; Couvreur TLP, 2010, MOL BIOL EVOL, V27, P55, DOI 10.1093/molbev/msp202; D'Ovidio R, 2004, PLANT PHYSIOL, V135, P2424, DOI 10.1104/pp.104.044644; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Di Matteo A, 2003, P NATL ACAD SCI USA, V100, P10124, DOI 10.1073/pnas.1733690100; Dickson KA, 2005, PROG NUCLEIC ACID RE, V80, P349, DOI 10.1016/S0079-6603(05)80009-1; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; Dunning FM, 2007, PLANT CELL, V19, P3297, DOI 10.1105/tpc.106.048801; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Federici L, 2006, TRENDS PLANT SCI, V11, P65, DOI 10.1016/j.tplants.2005.12.005; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fernandez-Recio J, 2005, PROTEINS, V58, P134, DOI 10.1002/prot.20285; Forsyth A, 2010, MOL PLANT MICROBE IN, V23, P1545, DOI 10.1094/MPMI-02-10-0047; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Herrin BR, 2010, J IMMUNOL, V185, P1367, DOI 10.4049/jimmunol.0903128; Innis CA, 2004, J MOL BIOL, V337, P1053, DOI 10.1016/j.jmb.2004.01.053; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kajander Tommi, 2006, V340, P151; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kishimoto K, 2010, PLANT J, V64, P343, DOI 10.1111/j.1365-313X.2010.04328.x; Kobe B, 1996, J MOL BIOL, V264, P1028, DOI 10.1006/jmbi.1996.0694; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Krasileva KV, 2010, PLANT CELL, V22, P2444, DOI 10.1105/tpc.110.075358; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Lacombe S, 2010, NAT BIOTECHNOL, V28, P365, DOI 10.1038/nbt.1613; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Leckie F, 1999, EMBO J, V18, P2352, DOI 10.1093/emboj/18.9.2352; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Mercer AA, 2005, VIRUS GENES, V31, P127, DOI 10.1007/s11262-005-1784-z; Morillo SA, 2006, CURR OPIN PLANT BIOL, V9, P460, DOI 10.1016/j.pbi.2006.07.009; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Napier R, 2004, ANN BOT-LONDON, V93, P227, DOI 10.1093/aob/mch041; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; Padmanabhan M, 2009, CELL MICROBIOL, V11, P191, DOI 10.1111/j.1462-5822.2008.01260.x; Papageorgiou AC, 1997, EMBO J, V16, P5162, DOI 10.1093/emboj/16.17.5162; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Parniske M, 1997, CELL, V91, P821, DOI 10.1016/S0092-8674(00)80470-5; Proell M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002119; Rafiqi M, 2009, SEMIN CELL DEV BIOL, V20, P1017, DOI 10.1016/j.semcdb.2009.04.010; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Schwessinger B, 2008, CURR OPIN PLANT BIOL, V11, P389, DOI 10.1016/j.pbi.2008.06.001; Shanmugam V, 2005, MICROBIOL RES, V160, P83, DOI 10.1016/j.micres.2004.09.014; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Sicilia F, 2005, PLANT PHYSIOL, V139, P1380, DOI 10.1104/pp.105.067546; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Suzuki Y, 2004, MOL BIOL EVOL, V21, P2352, DOI 10.1093/molbev/msh249; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tasumi S, 2009, P NATL ACAD SCI USA, V106, P12891, DOI 10.1073/pnas.0904443106; Torii KU, 2004, INT REV CYTOL, V234, P1, DOI 10.1016/S0074-7696(04)34001-5; van der Hoorn RAL, 2005, PLANT CELL, V17, P1000, DOI 10.1105/tpc.104.028118; Van Loy T, 2008, GEN COMP ENDOCR, V155, P14, DOI 10.1016/j.ygcen.2007.06.022; Velikovsky CA, 2009, NAT STRUCT MOL BIOL, V16, P725, DOI 10.1038/nsmb.1619; Walsh TA, 2006, PLANT PHYSIOL, V142, P542, DOI 10.1104/pp.106.085969; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; WILBUR WJ, 1983, P NATL ACAD SCI-BIOL, V80, P726, DOI 10.1073/pnas.80.3.726; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Ye ZM, 2008, CURR OPIN IMMUNOL, V20, P3, DOI 10.1016/j.coi.2008.01.003; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zhou L, 2009, PLANT CELL ENVIRON, V32, P1804, DOI 10.1111/j.1365-3040.2009.02039.x; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	90	37	38	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e21614	10.1371/journal.pone.0021614	http://dx.doi.org/10.1371/journal.pone.0021614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789174	gold, Green Published, Green Submitted			2022-12-25	WOS:000292812400010
J	Stallings, CL; Chu, LD; Li, LX; Glickman, MS				Stallings, Christina L.; Chu, Linda; Li, Lucy X.; Glickman, Michael S.			Catalytic and Non-Catalytic Roles for the Mono-ADP-Ribosyltransferase Arr in the Mycobacterial DNA Damage Response	PLOS ONE			English	Article							STREPTOMYCES-COELICOLOR A3(2); BACILLUS-SUBTILIS SPORULATION; MEDIATED RIFAMPIN RESISTANCE; RIBOSOMAL-PROTEIN L11; COLI RNA-POLYMERASE; ESCHERICHIA-COLI; STRINGENT RESPONSE; EARLY TRANSCRIPTION; MUTATION ANALYSIS; STATIONARY-PHASE	Recent evidence indicates that the mycobacterial response to DNA double strand breaks (DSBs) differs substantially from previously characterized bacteria. These differences include the use of three DSB repair pathways (HR, NHEJ, SSA), and the CarD pathway, which integrates DNA damage with transcription. Here we identify a role for the mono-ADP-ribosyltransferase Arr in the mycobacterial DNA damage response. Arr is transcriptionally induced following DNA damage and cellular stress. Although Arr is not required for induction of a core set of DNA repair genes, Arr is necessary for suppression of a set of ribosomal protein genes and rRNA during DNA damage, placing Arr in a similar pathway as CarD. Surprisingly, the catalytic activity of Arr is not required for this function, as catalytically inactive Arr was still able to suppress ribosomal protein and rRNA expression during DNA damage. In contrast, Arr substrate binding and catalytic activities were required for regulation of a small subset of other DNA damage responsive genes, indicating that Arr has both catalytic and noncatalytic roles in the DNA damage response. Our findings establish an endogenous cellular function for a mono-ADP-ribosyltransferase apart from its role in mediating Rifampin resistance.	[Stallings, Christina L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Li, Lucy X.] Gerstner Sloan Kettering Grad Sch Biomed Sci, Summer Undergrad Res Program, New York, NY USA; [Glickman, Michael S.] Mem Sloan Kettering Canc Ctr, Div Infect Dis, New York, NY 10021 USA; [Chu, Linda; Glickman, Michael S.] Sloan Kettering Inst, Program Immunol, New York, NY USA	Washington University (WUSTL); Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Stallings, CL (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	glickmam@mskcc.org		Glickman, Michael S/0000-0001-7918-5164; Glickman, Michael/0000-0002-1222-8104; Li, Lucy X./0000-0002-5857-6227	National Institutes of Health [AI064693, AI075805]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064693, F32AI075805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI064693 to MSG and AI075805 to CLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlet G, 2001, ANTIMICROB AGENTS CH, V45, P2971, DOI 10.1128/AAC.45.10.2971-2972.2001; Avarbock D, 2000, BIOCHEMISTRY-US, V39, P11640, DOI 10.1021/bi001256k; Baysarowich J, 2008, P NATL ACAD SCI USA, V105, P4886, DOI 10.1073/pnas.0711939105; BLOCK R, 1975, J BIOL CHEM, V250, P1212; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; BUCHMEIER NA, 1995, J CLIN INVEST, V95, P1047, DOI 10.1172/JCI117750; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Chatterji D, 2001, CURR OPIN MICROBIOL, V4, P160, DOI 10.1016/S1369-5274(00)00182-X; DABBS ER, 1995, ANTIMICROB AGENTS CH, V39, P1007, DOI 10.1128/AAC.39.4.1007; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Dahl JL, 2005, J BACTERIOL, V187, P2439, DOI 10.1128/JB.187.7.2439-2447.2005; Darwin KH, 2005, INFECT IMMUN, V73, P4581, DOI 10.1128/IAI.73.8.4581-4587.2005; Depping R, 2005, BIOCHEM BIOPH RES CO, V335, P1217, DOI 10.1016/j.bbrc.2005.08.023; EASTMAN D, 1994, MICROBIOL-UK, V140, P3167, DOI 10.1099/13500872-140-11-3167; FaraoneMennella MR, 1996, FEBS LETT, V378, P199; FRIESEN JD, 1974, P NATL ACAD SCI USA, V71, P3465, DOI 10.1073/pnas.71.9.3465; Glickman MS, 2003, J BIOL CHEM, V278, P7844, DOI 10.1074/jbc.M212458200; GOLDFARB A, 1981, NUCLEIC ACIDS RES, V9, P4863, DOI 10.1093/nar/9.19.4863; Gong CL, 2005, NAT STRUCT MOL BIOL, V12, P304, DOI 10.1038/nsmb915; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Houang ETS, 2003, ANTIMICROB AGENTS CH, V47, P1382, DOI 10.1128/AAC.47.4.1382-1390.2003; Huh JW, 1996, J BACTERIOL, V178, P4935, DOI 10.1128/jb.178.16.4935-4941.1996; Jenvert RM, 2007, J MOL BIOL, V365, P764, DOI 10.1016/j.jmb.2006.10.065; Kasai K, 2006, J BACTERIOL, V188, P7111, DOI 10.1128/JB.00574-06; Kawamoto S, 1997, MOL GEN GENET, V255, P549, DOI 10.1007/s004380050528; KOCH T, 1994, VIROLOGY, V203, P294, DOI 10.1006/viro.1994.1487; Koch Thomas, 1995, Gene Expression, V4, P253; Krasny L, 2008, MOL MICROBIOL, V69, P42, DOI 10.1111/j.1365-2958.2008.06256.x; KRUEGER KM, 1995, CLIN MICROBIOL REV, V8, P34, DOI 10.1128/CMR.8.1.34; LAUTIER D, 1993, MOL CELL BIOCHEM, V122, P171, DOI 10.1007/BF01076101; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Naas T, 2001, J BACTERIOL, V183, P235, DOI 10.1128/JB.183.1.235-249.2001; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; OCHI K, 1992, J GEN MICROBIOL, V138, P1745, DOI 10.1099/00221287-138-8-1745; OCHI K, 1981, J BIOL CHEM, V256, P6866; OCHI K, 1990, J GEN MICROBIOL, V136, P2405, DOI 10.1099/00221287-136-12-2405; OCHI K, 1990, J BACTERIOL, V172, P4008, DOI 10.1128/jb.172.7.4008-4016.1990; OCHI K, 1982, J BACTERIOL, V151, P1062, DOI 10.1128/JB.151.2.1062-1065.1982; Ojha AK, 2000, INFECT IMMUN, V68, P4084, DOI 10.1128/IAI.68.7.4084-4091.2000; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P302, DOI 10.1016/S0966-842X(01)02074-1; PARKER J, 1976, MOL GEN GENET, V144, P111, DOI 10.1007/BF00277313; Pitcher RS, 2007, DNA REPAIR, V6, P1271, DOI 10.1016/j.dnarep.2007.02.009; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Quan S, 1999, ANTIMICROB AGENTS CH, V43, P181, DOI 10.1128/AAC.43.1.181; Quan SW, 1997, ANTIMICROB AGENTS CH, V41, P2456, DOI 10.1128/AAC.41.11.2456; Rand L, 2003, MOL MICROBIOL, V50, P1031, DOI 10.1046/j.1365-2958.2003.03765.x; Sander P, 2001, INFECT IMMUN, V69, P3562, DOI 10.1128/IAI.69.6.3562-3568.2001; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Serres MH, 1996, J BACTERIOL, V178, P6074, DOI 10.1128/jb.178.20.6074-6077.1996; Shima J, 1996, J BACTERIOL, V178, P3785, DOI 10.1128/jb.178.13.3785-3790.1996; Sinha KM, 2007, J BIOL CHEM, V282, P15114, DOI 10.1074/jbc.M701167200; Sinha KM, 2009, GENE DEV, V23, P1423, DOI 10.1101/gad.1805709; SMITH I, 1978, P NATL ACAD SCI USA, V75, P5993, DOI 10.1073/pnas.75.12.5993; Sommer N, 2000, MICROBIOL-SGM, V146, P2643, DOI 10.1099/00221287-146-10-2643; Stallings CL, 2009, CELL, V138, P146, DOI 10.1016/j.cell.2009.04.041; STENT GS, 1961, P NATL ACAD SCI USA, V47, P2005, DOI 10.1073/pnas.47.12.2005; Stephanou NC, 2007, J BACTERIOL, V189, P5237, DOI 10.1128/JB.00332-07; Tiemann B, 2004, J BACTERIOL, V186, P7262, DOI 10.1128/JB.186.21.7262-7272.2004; Tribuddharat C, 1999, ANTIMICROB AGENTS CH, V43, P960, DOI 10.1128/AAC.43.4.960; Wang JD, 2007, CELL, V128, P865, DOI 10.1016/j.cell.2006.12.043; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1; Wilkens K, 1997, ADV EXP MED BIOL, V419, P71; Yang XM, 2001, J BACTERIOL, V183, P6532, DOI 10.1128/JB.183.22.6532-6537.2001; Yates SP, 2006, TRENDS BIOCHEM SCI, V31, P123, DOI 10.1016/j.tibs.2005.12.007	67	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e21807	10.1371/journal.pone.0021807	http://dx.doi.org/10.1371/journal.pone.0021807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789183	Green Published, gold, Green Submitted			2022-12-25	WOS:000292812400017
J	Zimmer, C; Boos, M; Poulin, N; Gosler, A; Petit, O; Robin, JP				Zimmer, Cedric; Boos, Mathieu; Poulin, Nicolas; Gosler, Andrew; Petit, Odile; Robin, Jean-Patrice			Evidence of the Trade-Off between Starvation and Predation Risks in Ducks	PLOS ONE			English	Article							MASS-DEPENDENT PREDATION; BLACKBIRDS TURDUS-MERULA; GREEN-WINGED TEAL; BODY-MASS; FLIGHT PERFORMANCE; FAT RESERVES; GREAT TIT; DIURNAL-VARIATION; ESCAPE FLIGHTS; DIVING DUCKS	The theory of trade-off between starvation and predation risks predicts a decrease in body mass in order to improve flight performance when facing high predation risk. To date, this trade-off has mainly been validated in passerines, birds that store limited body reserves for short-term use. In the largest avian species in which the trade-off has been investigated (the mallard, Anas platyrhynchos), the slope of the relationship between mass and flight performance was steeper in proportion to lean body mass than in passerines. In order to verify whether the same case can be applied to other birds with large body reserves, we analyzed the response to this trade-off in two other duck species, the common teal (Anas crecca) and the tufted duck (Aythya fuligula). Predation risk was simulated by disturbing birds. Ducks within disturbed groups were compared to non-disturbed control birds. In disturbed groups, both species showed a much greater decrease in food intake and body mass during the period of simulated high risk than those observed in the control group. This loss of body mass allows reaching a more favourable wing loading and increases power for flight, hence enhancing flight performances and reducing predation risk. Moreover, body mass loss and power margin gain in both species were higher than in passerines, as observed in mallards. Our results suggest that the starvation-predation risk trade-off is one of the major life history traits underlying body mass adjustments, and these findings can be generalized to all birds facing predation. Additionally, the response magnitude seems to be influenced by the strategy of body reserve management.	[Zimmer, Cedric; Poulin, Nicolas; Petit, Odile; Robin, Jean-Patrice] Univ Strasbourg, IPHC, Strasbourg, France; [Zimmer, Cedric; Poulin, Nicolas; Petit, Odile; Robin, Jean-Patrice] CNRS, UMR 7178, Strasbourg, France; [Boos, Mathieu] Naturaconst, Res Agcy Appl Ecol, Wilshausen, France; [Gosler, Andrew] Univ Oxford, Edward Grey Inst Field Ornithol, Oxford, England	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Oxford	Zimmer, C (corresponding author), Univ Strasbourg, IPHC, Strasbourg, France.	cedric.zimmer@c-strasbourg.fr	Zimmer, Cédric/C-5654-2011; Gosler, Andrew/HCH-4278-2022	Zimmer, Cedric/0000-0001-8160-2836; Poulin, Nicolas/0000-0003-2740-7559	Region Alsace; National Fund for Biological Research on Game and Wildlife Species; CNRS	Region Alsace(Region Grand-Est); National Fund for Biological Research on Game and Wildlife Species; CNRS(Centre National de la Recherche Scientifique (CNRS))	This study was supported by grants from "Region Alsace'', National Fund for Biological Research on Game and Wildlife Species and CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDASSARRE GA, 1986, SOUTHWEST NAT, V31, P361, DOI 10.2307/3671840; BEDNEKOFF PA, 1994, OIKOS, V71, P408, DOI 10.2307/3545828; Blem C.R., 1990, Current Ornithology, V7, P59; BLEM CR, 1976, AM ZOOL, V16, P671; Boos M, 2007, BIRD STUDY, V54, P154, DOI 10.1080/00063650709461470; Brodin A, 2001, ANIM BEHAV, V62, P993, DOI 10.1006/anbe.2001.1844; Burns JG, 2002, BEHAV ECOL SOCIOBIOL, V52, P128, DOI 10.1007/s00265-002-0494-y; Carrascal LM, 1999, ANIM BEHAV, V58, P281, DOI 10.1006/anbe.1999.1142; Cresswell W, 1998, J ANIM ECOL, V67, P78, DOI 10.1046/j.1365-2656.1998.00174.x; Cresswell W, 2008, IBIS, V150, P209, DOI 10.1111/j.1474-919X.2008.00784.x; del Hoyo J, 2013, HDB BIRDS WORLD; FOX AD, 1992, BIRD STUDY, V39, P53, DOI 10.1080/00063659209477099; Gentle LK, 2001, P ROY SOC B-BIOL SCI, V268, P487, DOI 10.1098/rspb.2000.1405; GOSLER AG, 1995, NATURE, V377, P621, DOI 10.1038/377621a0; Gosler AG, 2001, ARDEA, V89, P75; Grissom N, 2009, NEUROBIOL LEARN MEM, V92, P215, DOI 10.1016/j.nlm.2008.07.001; HAFTORN S, 1989, WILSON BULL, V101, P217; HEDENSTROM A, 1992, J THEOR BIOL, V158, P535, DOI 10.1016/S0022-5193(05)80714-3; HEDENSTROM A, 1992, J EXP BIOL, V164, P19; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; Kullberg C, 1998, P ROY SOC B-BIOL SCI, V265, P1659, DOI 10.1098/rspb.1998.0485; Kullberg C, 2000, AUK, V117, P1034, DOI 10.1642/0004-8038(2000)117[1034:HMFLIP]2.0.CO;2; Kullberg C, 2005, FUNCT ECOL, V19, P98, DOI 10.1111/j.0269-8463.2005.00932.x; Kullberg C, 1998, ANIM BEHAV, V56, P227, DOI 10.1006/anbe.1998.0765; Kullberg C, 1996, P ROY SOC B-BIOL SCI, V263, P1671, DOI 10.1098/rspb.1996.0244; Lilliendahl K, 1998, ANIM BEHAV, V55, P1335, DOI 10.1006/anbe.1997.0706; Lilliendahl K, 1997, ANIM BEHAV, V53, P75, DOI 10.1006/anbe.1996.0279; LIMA SL, 1986, ECOLOGY, V67, P377, DOI 10.2307/1938580; Lind J, 1999, BEHAV ECOL SOCIOBIOL, V46, P65, DOI 10.1007/s002650050593; LOESCH CR, 1992, J WILDLIFE MANAGE, V56, P735, DOI 10.2307/3809467; MacLeod R, 2007, P ROY SOC B-BIOL SCI, V274, P2587, DOI 10.1098/rspb.2007.0786; MacLeod R, 2006, ANIM BEHAV, V71, P523, DOI 10.1016/j.anbehav.2005.04.020; Macleod R, 2005, J ANIM ECOL, V74, P956, DOI 10.1111/j.1365-2656.2005.00993.x; Macleod R, 2005, J ANIM ECOL, V74, P292, DOI 10.1111/j.1365-2656.2005.00923.x; MacLeod R, 2006, ANIM BEHAV, V71, P1081, DOI 10.1016/j.anbehav.2005.07.022; Marsden SJ, 2000, ENVIRON MANAGE, V26, P207, DOI 10.1007/s002670010082; MCNAMARA JM, 1994, J AVIAN BIOL, V25, P287, DOI 10.2307/3677276; MCNAMARA JM, 1990, ACTA BIOTHEOR, V38, P37, DOI 10.1007/BF00047272; METCALFE NB, 1995, P ROY SOC B-BIOL SCI, V261, P395, DOI 10.1098/rspb.1995.0165; Nebel S, 2005, BEHAV ECOL SOCIOBIOL, V59, P44, DOI 10.1007/s00265-005-0007-x; NILSSON L, 1970, OIKOS, V21, P145, DOI 10.2307/3543670; Norberg Ulla M., 1996, P199; Nudds RL, 2000, J EXP BIOL, V203, P1561; PATTENDEN RK, 1989, CAN J ZOOL, V67, P495, DOI 10.1139/z89-072; Pedroli J.-C., 1982, Wildfowl, V33, P105; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Piersma T, 1997, TRENDS ECOL EVOL, V12, P134, DOI 10.1016/S0169-5347(97)01003-3; Rands SA, 2001, P ROY SOC B-BIOL SCI, V268, P1783, DOI 10.1098/rspb.2001.1653; RAVE DP, 1991, J WILDLIFE MANAGE, V55, P457, DOI 10.2307/3808974; RYAN RR, 1972, J WILDLIFE MANAGE, V36, P759, DOI 10.2307/3799428; Schmidt-Nielsen K., 1990, ANIMAL PHYSL ADAPTAT; Stearns S.C., 1992, pi; SUTER W, 1992, ARDEA, V80, P229; TAMISIER A, 1972, ALAUDA, V10, P107; TAMISIER A, 1972, ALAUDA, V10, P235; van den Hout PJ, 2006, J AVIAN BIOL, V37, P425; van den Hout PJ, 2010, BEHAV ECOL, V21, P16, DOI 10.1093/beheco/arp146; van der Veen IT, 2000, FUNCT ECOL, V14, P638; Van der Veen IT, 2000, ANIM BEHAV, V59, P593, DOI 10.1006/anbe.1999.1331; Veasey JS, 1998, ANIM BEHAV, V56, P883, DOI 10.1006/anbe.1998.0880; Verhulst S, 1996, J AVIAN BIOL, V27, P203, DOI 10.2307/3677223; Videler JJ., 2005, AVIAN FLIGHT; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050; WITTER MS, 1994, ANIM BEHAV, V48, P201, DOI 10.1006/anbe.1994.1227; Zimmer C, 2010, J AVIAN BIOL, V41, P637, DOI 10.1111/j.1600-048X.2010.05110.x	66	21	24	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22352	10.1371/journal.pone.0022352	http://dx.doi.org/10.1371/journal.pone.0022352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789252	Green Published, gold			2022-12-25	WOS:000292812400046
J	Kelsey, TW; Wright, P; Nelson, SM; Anderson, RA; Wallace, WHB				Kelsey, Thomas W.; Wright, Phoebe; Nelson, Scott M.; Anderson, Richard A.; Wallace, W. Hamish B.			A Validated Model of Serum Anti-Mullerian Hormone from Conception to Menopause	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; SPONTANEOUS MENSTRUAL-CYCLE; INHIBIN B LEVELS; FOLLICULAR DEVELOPMENT; POSTNATAL-DEVELOPMENT; REPRODUCTIVE AGE; GONADAL-FUNCTION; INFANT GIRLS; NORMAL WOMEN; MOUSE OVARY	Background: Anti-Mullerian hormone (AMH) is a product of growing ovarian follicles. The concentration of AMH in blood may also reflect the non-growing follicle (NGF) population, i.e. the ovarian reserve, and be of value in predicting reproductive lifespan. A full description of AMH production up to the menopause has not been previously reported. Methodology/Principal Findings: By searching the published literature for AMH concentrations in healthy pre-menopausal females, and using our own data (combined n=3,260) we have generated and robustly validated the first model of AMH concentration from conception to menopause. This model shows that 34% of the variation in AMH is due to age alone. We have shown that AMH peaks at age 24.5 years, followed by a decline to the menopause. We have also shown that there is a neonatal peak and a potential pre-pubertal peak. Our model allows us to generate normative data at all ages. Conclusions/Significance: These data highlight key inflection points in ovarian follicle dynamics. This first validated model of circulating AMH in healthy females describes a transition period in early adulthood, after which AMH reflects the progressive loss of the NGF pool. The existence of a neonatal increase in gonadal activity is confirmed for females. An improved understanding of the relationship between circulating AMH and age will lead to more accurate assessment of ovarian reserve for the individual woman.	[Kelsey, Thomas W.] Univ St Andrews, Sch Comp Sci, St Andrews, Fife, Scotland; [Anderson, Richard A.] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Nelson, Scott M.] Univ Glasgow, Ctr Populat & Hlth Sci, Glasgow, Lanark, Scotland; [Wallace, W. Hamish B.] Univ Edinburgh, Div Reprod & Dev Sci, Edinburgh, Midlothian, Scotland	University of St Andrews; University of Edinburgh; University of Glasgow; University of Edinburgh	Kelsey, TW (corresponding author), Univ St Andrews, Sch Comp Sci, St Andrews, Fife, Scotland.	hamish.wallace@nhs.net	Kelsey, Thomas W/H-3727-2019	Kelsey, Thomas W/0000-0002-8091-1458; wallace, william, hamish/0000-0001-8080-5674; Nelson, Scott/0000-0002-9099-3047	United Kingdom Engineering and Physical Sciences Research Council (EPSRC); Engineering and Physical Sciences Research Council [EP/H004092/1] Funding Source: researchfish; Medical Research Council [G1002033, G1100357] Funding Source: researchfish; EPSRC [EP/H004092/1] Funding Source: UKRI; MRC [G1002033, G1100357] Funding Source: UKRI	United Kingdom Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the United Kingdom Engineering and Physical Sciences Research Council (EPSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SF, 2010, CLIN ENDOCRINOL, V72, P814, DOI 10.1111/j.1365-2265.2009.03724.x; ALMOG B, 2011, FERTILITY STERILITY; Andersson AM, 1998, J CLIN ENDOCR METAB, V83, P675, DOI 10.1210/jc.83.2.675; BAARENDS WM, 1995, ENDOCRINOLOGY, V136, P4951, DOI 10.1210/en.136.11.4951; BEZARD J, 1987, J REPROD FERTIL, V80, P509, DOI 10.1530/jrf.0.0800509; Broekmans FJ, 2009, ENDOCR REV, V30, P465, DOI 10.1210/er.2009-0006; Chellakooty M, 2003, J CLIN ENDOCR METAB, V88, P3515, DOI 10.1210/jc.2002-021468; Cook CL, 2000, FERTIL STERIL, V73, P859, DOI 10.1016/S0015-0282(99)00639-1; de Vet A, 2002, FERTIL STERIL, V77, P357, DOI 10.1016/S0015-0282(01)02993-4; Dorgan JF, 2009, JNCI-J NATL CANCER I, V101, P1501, DOI 10.1093/jnci/djp331; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601; Durlinger ALL, 2001, ENDOCRINOLOGY, V142, P4891, DOI 10.1210/en.142.11.4891; Faddy MJ, 1996, HUM REPROD, V11, P1484; FADDY MJ, 1992, HUM REPROD, V7, P1342, DOI 10.1093/oxfordjournals.humrep.a137570; Faddy MJ, 2000, MOL CELL ENDOCRINOL, V163, P43, DOI 10.1016/S0303-7207(99)00238-5; Fanchin R, 2005, HUM REPROD, V20, P923, DOI 10.1093/humrep/deh688; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gigli I, 2005, MOL REPROD DEV, V71, P480, DOI 10.1002/mrd.20338; Gougeon A, 1996, ENDOCR REV, V17, P121, DOI 10.1210/er.17.2.121; Guibourdenche J, 2003, MOL CELL ENDOCRINOL, V211, P55, DOI 10.1016/j.mce.2003.09.011; Hagen CP, 2010, J CLIN ENDOCR METAB, V95, P5003, DOI 10.1210/jc.2010-0930; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; Hansen KR, 2011, FERTIL STERIL, V95, P170, DOI 10.1016/j.fertnstert.2010.04.006; Hehenkamp WJK, 2006, J CLIN ENDOCR METAB, V91, P4057, DOI 10.1210/jc.2006-0331; Hudecova M, 2009, HUM REPROD, V24, P1176, DOI 10.1093/humrep/den482; Huwaldt J, 2005, PLOT DIGITIZER; Kevenaar ME, 2006, ENDOCRINOLOGY, V147, P3228, DOI 10.1210/en.2005-1588; Knauff EAH, 2009, J CLIN ENDOCR METAB, V94, P786, DOI 10.1210/jc.2008-1818; La Marca A, 2005, J SOC GYNECOL INVEST, V12, P545, DOI 10.1016/j.jsgi.2005.06.001; La Marca A, 2004, HUM REPROD, V19, P2738, DOI 10.1093/humrep/deh508; La Marca A, 2010, HUM REPROD UPDATE, V16, P113, DOI 10.1093/humupd/dmp036; Laven JSE, 2004, J CLIN ENDOCR METAB, V89, P318, DOI 10.1210/jc.2003-030932; Lee MM, 2003, J CLIN ENDOCR METAB, V88, P3513, DOI 10.1210/jc.2003-031038; Lee MM, 1996, J CLIN ENDOCR METAB, V81, P571, DOI 10.1210/jc.81.2.571; LINTERNMOORE S, 1974, J REPROD FERTIL, V39, P53; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; Mulders AGMGJ, 2004, HUM REPROD, V19, P2036, DOI 10.1093/humrep/deh373; Nelson SM, 2011, FERTIL STERIL, V95, P736, DOI 10.1016/j.fertnstert.2010.08.022; NELSON SM, 2011, REPROD BIOMEDICINE; Pastor CL, 2005, FERTIL STERIL, V84, P1462, DOI 10.1016/j.fertnstert.2005.05.024; Piltonen T, 2005, HUM REPROD, V20, P1820, DOI 10.1093/humrep/deh850; Sanders RD, 2009, FERTIL STERIL, V92, P344, DOI 10.1016/j.fertnstert.2008.04.060; Seifer DB, 2011, FERTIL STERIL, V95, P747, DOI 10.1016/j.fertnstert.2010.10.011; Soto N, 2009, HUM REPROD, V24, P2838, DOI 10.1093/humrep/dep276; Sowers MF, 2010, FERTIL STERIL, V94, P1482, DOI 10.1016/j.fertnstert.2009.07.1674; Tehrani FR, 2010, HUM REPROD, V25, P1775, DOI 10.1093/humrep/deq088; TRELOAR AE, 1981, MATURITAS, V3, P249, DOI 10.1016/0378-5122(81)90032-3; van Beek RD, 2007, J CLIN ENDOCR METAB, V92, P3869, DOI 10.1210/jc.2006-2374; van Disseldorp J, 2008, J CLIN ENDOCR METAB, V93, P2129, DOI 10.1210/jc.2007-2093; van Rooij IAJ, 2005, FERTIL STERIL, V83, P979, DOI 10.1016/j.fertnstert.2004.11.029; Wallace WHB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008772; Weenen C, 2004, MOL HUM REPROD, V10, P77, DOI 10.1093/molehr/gah015	53	305	316	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22024	10.1371/journal.pone.0022024	http://dx.doi.org/10.1371/journal.pone.0022024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789206	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000292811700015
J	Fu, K; Ren, H; Wang, Y; Fei, E; Wang, H; Wang, G				Fu, K.; Ren, H.; Wang, Y.; Fei, E.; Wang, H.; Wang, G.			DJ-1 inhibits TRAIL-induced apoptosis by blocking pro-caspase-8 recruitment to FADD	ONCOGENE			English	Article						DJ-1; TRAIL; FADD; caspase-8; DISC; apoptosis	P53 TRANSCRIPTIONAL ACTIVITY; FAMILIAL PARKINSONS-DISEASE; CANCER-CELLS; ANDROGEN RECEPTOR; DEATH RECEPTORS; TNF-FAMILY; PROTEIN; IDENTIFICATION; EXPRESSION; REGULATOR	DJ-1 was initially identified as an oncogene product involved in human tumorigenesis in cooperation with Ras. Increased DJ-1 expression is associated with tumorigenesis in many cancers, whereas the loss of DJ-1 function is linked to an autosomal recessive form of Parkinson's disease (PD). It has been reported that DJ-1 protects cells from TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis. However, the mechanism by which DJ-1 is involved is still largely unknown. Here we show that DJ-1 inhibits TRAIL-induced apoptosis by blocking Fas-associated protein death domain (FADD)-mediated pro-caspase-8 activation. Wild-type DJ-1, but not the PD-associated mutant L166P, binds to FADD to inhibit the formation of the death-inducing signaling complex (DISC). DJ-1 competes with pro-caspase-8 to bind to FADD at the death effector domain, thereby repressing the recruitment and activation of pro-caspase-8 to the active form of caspase-8. Thus, our study suggests that DJ-1 protects against TRAIL-induced apoptosis through the regulation of DISC formation. Oncogene (2012) 31, 1311-1322; doi:10.1038/onc.2011.315; published online 25 July 2011	Univ Sci & Technol China, Chinese Acad Sci, Lab Mol Neuropathol, Dept Neurobiol,Key Lab Brain Funct & Dis, Hefei, Anhui, Peoples R China; Univ Sci & Technol China, Chinese Acad Sci, Sch Life Sci, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wang, G (corresponding author), Univ Sci & Technol China, Chinese Acad Sci, Lab Mol Neuropathol, Dept Neurobiol,Key Lab Brain Funct & Dis, 443 Huangshan Rd, Hefei 230027, Anhui, Peoples R China.	wghui@ustc.edu.cn	FEI, Erkang/AAI-9825-2021; Ren, Haigang/U-6034-2017; Wang, Guanghui/U-3979-2017	Ren, Haigang/0000-0001-8844-4754; Wang, Guanghui/0000-0001-8551-6468; FEI, Erkang/0000-0002-3581-9521	National Natural Sciences Foundation of China [30970921]; National High-tech Research and Development program of China 973 [2011CB5004102]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech Research and Development program of China 973	We grateful to Dr Juha Klefstrom (University of Helsinki, Finland) and Dr Xiaolu Yang (University of Pennsylvania) for the kind gifts of pC4M-Fv2E-caspase-8 and the pC4M-Fv2E-caspase-8 C-A mutant and Mian Wu (University of Science and Technology of China, China) for the pGBKT7- FADD plasmid. The ARGENT Regulated Homodimerization Kit was kindly provided by ARIAD Pharmaceuticals (www.ariad.com/regulationkits). This work was supported in part by the National Natural Sciences Foundation of China (No. 30970921) and the National High-tech Research and Development program of China 973-projects (2011CB5004102).	Agata N, 2008, CANCER RES, V68, P6136, DOI 10.1158/0008-5472.CAN-08-0464; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Condorelli G, 1999, ONCOGENE, V18, P4409, DOI 10.1038/sj.onc.1202831; Davidson B, 2008, HUM PATHOL, V39, P87, DOI 10.1016/j.humpath.2007.05.014; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Fan J, 2008, FEBS LETT, V582, P1151, DOI 10.1016/j.febslet.2008.03.003; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Foti R, 2010, J BIOL CHEM, V285, P18565, DOI 10.1074/jbc.M109.088294; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Giaime E, 2010, CELL DEATH DIFFER, V17, P158, DOI 10.1038/cdd.2009.116; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hod Y, 2004, J CELL BIOCHEM, V92, P1221, DOI 10.1002/jcb.20159; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Le Naour F, 2001, CLIN CANCER RES, V7, P3328; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Macedo MG, 2003, HUM MOL GENET, V12, P2807, DOI 10.1093/hmg/ddg304; MacKeigan JP, 2003, CANCER RES, V63, P6928; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Miller DW, 2003, J BIOL CHEM, V278, P36588, DOI 10.1074/jbc.M304272200; Mo JS, 2008, CELL DEATH DIFFER, V15, P1030, DOI 10.1038/cdd.2008.26; Moore DJ, 2003, J NEUROCHEM, V87, P1558, DOI 10.1111/j.1471-4159.2003.02265.x; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nieminen AI, 2007, EMBO J, V26, P1055, DOI 10.1038/sj.emboj.7601551; Niki T, 2003, MOL CANCER RES, V1, P247; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Pardo M, 2006, INT J CANCER, V119, P1014, DOI 10.1002/ijc.21942; Ren HG, 2010, CANCER LETT, V297, P101, DOI 10.1016/j.canlet.2010.05.001; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Scaffidi C, 1999, CURR OPIN IMMUNOL, V11, P277, DOI 10.1016/S0952-7915(99)80045-4; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Sitaram RT, 2009, INT J CANCER, V125, P783, DOI 10.1002/ijc.24335; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tillman JE, 2007, CANCER RES, V67, P4630, DOI 10.1158/0008-5472.CAN-06-4556; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Zhang HY, 2008, ENDOCR-RELAT CANCER, V15, P535, DOI 10.1677/ERC-07-0195	52	26	29	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	10					1311	1322		10.1038/onc.2011.315	http://dx.doi.org/10.1038/onc.2011.315			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	906KS	21785459	Bronze			2022-12-25	WOS:000301344600010
J	Lee, J; Li, L; Gretz, N; Gebert, J; Dihlmann, S				Lee, J.; Li, L.; Gretz, N.; Gebert, J.; Dihlmann, S.			Absent in Melanoma 2 (AIM2) is an important mediator of interferon-dependent and -independent HLA-DRA and HLA-DRB gene expression in colorectal cancers	ONCOGENE			English	Article						IFN-gamma; AIM2; HLA class II; tumor immunity; interferon-stimulated genes; ISG	CLASS-II TRANSACTIVATOR; GAMMA IN-SITU; MICROSATELLITE INSTABILITY; ANTIGEN-EXPRESSION; CYTOPLASMIC DNA; FRANCISELLA-TULARENSIS; POSITIVE FEEDBACK; INNATE IMMUNITY; GOOD PROGNOSIS; COMMON TARGET	Absent in Melanoma 2 (AIM2) is a member of the HIN-200 family of hematopoietic, IFN-inducible, nuclear proteins, associated with both, infection defense and tumor pathology. Recently, AIM2 was found to act as a DNA sensor in innate immunity. In addition, we and others have previously demonstrated a high frequency of AIM2-alterations in microsatellite unstable (MSI-H) tumors. To further elucidate AIM2 function in colorectal tumors, we here addressed AIM2-responsive target genes by microarray based gene expression profiling of 22 244 human genes. A total of 111 transcripts were significantly upregulated, whereas 80 transcripts turned out to be significantly downregulated in HCT116 cells, constitutively expressing AIM2, compared with AIM2-negative cells. Among the upregulated genes that were validated by quantitative PCR and western blotting we recognized several interferon-stimulated genes (ISGs: IFIT1, IFIT2, IFIT3, IFI6, IRF7, ISG15, HLA-DRA, HLA-DRB, TLR3 and CIITA), as well as genes involved in intercellular adhesion and matrix remodeling. Expression of ISGs correlated with expression of AIM2 in 10 different IFN-gamma treated colorectal cancer cell lines. Moreover, small interfering RNA-mediated knock-down of AIM2 resulted in reduced expression of HLA-DRA, HLA-DRB and CIITA in IFN-gamma-treated cells. IFN-gamma independent induction of HLA-DR genes and their encoded proteins was also demonstrated upon doxy-cyclin-regulated transient induction of AIM2. Luciferase reporter assays revealed induction of the HLA-DR promoter upon AIM2 transfection in different cell lines. STAT-signaling was not involved in IFN-gamma independent induction of ISGs, arguing against participation of cytokines released in an autostimulating manner. Our data indicate that AIM2 mediates both IFN-gamma dependent and independent induction of several ISGs, including genes encoding the major histocompatibility complex (MHC) class II antigens HLA-DR-alpha and -beta. This suggests a novel role of the IFN/AIM2/ISG cascade likewise in cancer cells. Oncogene (2012) 31, 1242-1253; doi:10.1038/onc.2011.320; published online 1 August 2011	[Lee, J.; Gebert, J.] Univ Heidelberg, Inst Pathol, Dept Appl Tumor Biol, D-6900 Heidelberg, Germany; [Li, L.; Gretz, N.] Univ Heidelberg, Fac Clin Med, Ctr Med Res ZMF, D-6800 Mannheim, Germany; [Dihlmann, S.] Univ Heidelberg, Inst Pathol, Dept Gen Pathol, D-6900 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Dihlmann, S (corresponding author), Univ Heidelberg Hosp, Dept Vasc Surg, Neuenheimer Feld 110, D-69120 Heidelberg, Germany.	susanne.dihlmann@med.uni-heidelberg.de		Dihlmann, Susanne/0000-0002-3737-7755	Deutsche Forschungsgmeinschaft, DFG [Di-933 4/1]	Deutsche Forschungsgmeinschaft, DFG(German Research Foundation (DFG))	The work was funded by a grant of the Deutsche Forschungsgmeinschaft, DFG to Dr S Dihlmann (Di-933 4/1).	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; ANDERSEN SN, 1993, BRIT J CANCER, V68, P80, DOI 10.1038/bjc.1993.290; Brennan K, 2010, CURR OPIN MICROBIOL, V13, P503, DOI 10.1016/j.mib.2010.05.007; Buckowitz A, 2005, BRIT J CANCER, V92, P1746, DOI 10.1038/sj.bjc.6602534; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Chen IF, 2006, MOL CANCER THER, V5, P1, DOI 10.1158/1535-7163.MCT-05-0310; Cheriyath V, 2007, J CLIN INVEST, V117, P3107, DOI 10.1172/JCI31122; DCunha J, 1996, P NATL ACAD SCI USA, V93, P211, DOI 10.1073/pnas.93.1.211; DCunha J, 1996, J IMMUNOL, V157, P4100; DeYoung KL, 1997, ONCOGENE, V15, P453, DOI 10.1038/sj.onc.1201206; Diederichsen ACP, 2003, CANCER IMMUNOL IMMUN, V52, P423, DOI 10.1007/s00262-003-0388-5; Dihlmann S, 1999, CANCER RES, V59, P1857; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Garrity-Park MM, 2009, GUT, V58, P1226, DOI 10.1136/gut.2008.166686; Harton JA, 2000, MOL CELL BIOL, V20, P6185, DOI 10.1128/MCB.20.17.6185-6194.2000; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Krawczyk M, 2006, TISSUE ANTIGENS, V67, P183, DOI 10.1111/j.1399-0039.2006.00557.x; Lee JH, 2010, GUT, V59, P907, DOI 10.1136/gut.2009.194068; Lovig T, 2002, BRIT J CANCER, V87, P756, DOI 10.1038/sj.bjc.6600507; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Matsushita K, 2006, CANCER SCI, V97, P57, DOI 10.1111/j.1349-7006.2006.00137.x; Matsushita K, 1996, BRIT J CANCER, V73, P644, DOI 10.1038/bjc.1996.112; Michel S, 2010, INT J CANCER, V127, P889, DOI 10.1002/ijc.25106; Michel S, 2010, MOL CARCINOGEN, V49, P175, DOI 10.1002/mc.20587; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Osborne A, 2001, MOL CELL BIOL, V21, P6495, DOI 10.1128/MCB.21.19.6495-6506.2001; Oshita F, 2006, ONCOL REP, V16, P817; Patsos G, 2010, INT J CANCER, V126, P1838, DOI 10.1002/ijc.24905; PFIZENMAIER K, 1985, CANCER RES, V45, P3503; Pitha-Rowe IF, 2007, CYTOKINE GROWTH F R, V18, P409, DOI 10.1016/j.cytogfr.2007.06.017; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Satoh A, 2004, ONCOGENE, V23, P8876, DOI 10.1038/sj.onc.1208144; Sauer JD, 2010, CELL HOST MICROBE, V7, P412, DOI 10.1016/j.chom.2010.04.004; Schroder K, 2009, CURR BIOL, V19, pR262, DOI 10.1016/j.cub.2009.02.011; Tahara E, 2005, CANCER IMMUNOL IMMUN, V54, P729, DOI 10.1007/s00262-004-0645-2; TEMPONI M, 1993, J IMMUNOL METHODS, V161, P239, DOI 10.1016/0022-1759(93)90300-V; Tsuchiya K, 2010, J IMMUNOL, V185, P1186, DOI 10.4049/jimmunol.1001058; Walsh MD, 2009, INT J CANCER, V125, P1231, DOI 10.1002/ijc.24484; Welman A, 2005, J CELL BIOCHEM, V94, P1148, DOI 10.1002/jcb.20342; Woerner SM, 2005, ONCOGENE, V24, P2525, DOI 10.1038/sj.onc.1208456; Woerner SM, 2003, ONCOGENE, V22, P2226, DOI 10.1038/sj.onc.1206421; Woerner SM, 2001, INT J CANCER, V93, P12, DOI 10.1002/ijc.1299; Woerner SM, 2007, GENE CHROMOSOME CANC, V46, P1080, DOI 10.1002/gcc.20493; Zhang LW, 2002, J INTERF CYTOK RES, V22, P95, DOI 10.1089/107999002753452700	51	35	37	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	10					1242	1253		10.1038/onc.2011.320	http://dx.doi.org/10.1038/onc.2011.320			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	906KS	21804607	hybrid, Green Published			2022-12-25	WOS:000301344600004
J	Visser-Grieve, S; Hao, Y; Yang, X				Visser-Grieve, S.; Hao, Y.; Yang, X.			Human homolog of Drosophila expanded, hEx, functions as a putative tumor suppressor in human cancer cell lines independently of the Hippo pathway	ONCOGENE			English	Article						expanded; FRMD6; Willin; Hippo; LATS1; tumor suppressor	REGULATE GROWTH; PROLIFERATION; MERLIN; PROTEIN; LATS1; TUMORIGENESIS; INHIBITION; TRANSITION; APOPTOSIS; DOMAIN	The Hippo signaling network is proving to be an essential regulator within the cell, participating in multiple cellular phenotypes including cell proliferation, apoptosis, cell migration and organ size control. Much of this pathway is conserved from flies to mammals; however, how the upstream components, namely Expanded, affect downstream processes in mammalian systems has remained elusive. Only recently has human Expanded (hEx), also known as FRMD6 or Willin, been identified. However, its functional significance with respect to its putative tumor suppressor function and activation of the Hippo pathway has not been studied. In this study, we show for the first time that hEx possesses several tumor suppressor properties. First, hEx dramatically inhibits cell proliferation in two human cancer cell lines, MDA-MB-231 and MDA-MB-436 cells, and sensitizes these cells to the chemotherapeutic drug Taxol. Furthermore, downregulation of hEx in the immortalized MCF10A breast cell line leads to enhanced proliferation and resistance to Taxol treatment. As evidence for its tumor suppressor function, overexpression of hEx inhibits colony formation, soft agar colony growth in vitro and in vivo tumor growth in nude mice. Although Drosophila expanded (ex) can activate the Hippo pathway, surprisingly no significant alterations were discovered in the phosphorylation status of any of the Hippo pathway components, including downstream tumor suppressor LATS1, upon overexpression of hEx. In addition, knockdown of both LATS1 and LATS2 in hEx-overexpressing cells was unable to rescue the hEx phenotype, suggesting that hEx functions independently of the Hippo pathway in this cell line. Alternatively, we propose a mechanism through which hEx inhibits progression through the S phase of the cell cycle by upregulating p21(Cip1) and downregulating Cyclin A. This is the first study to functionally characterize hEx and show that hEx acts in a distinct manner compared with Drosophila expanded. Oncogene (2012) 31, 1189-1195; doi:10.1038/onc.2011.318; published online 25 July 2011	[Yang, X.] Queens Univ, Dept Pathol & Mol Med, Richardson Labs 201, Kingston, ON K7L 3N6, Canada	McMaster University; Queens University - Canada	Yang, X (corresponding author), Queens Univ, Dept Pathol & Mol Med, Richardson Labs 201, 88 Stuart St, Kingston, ON K7L 3N6, Canada.	yang@cliff.path.queensu.ca		Grieve, Stacy/0000-0003-3090-5583	Canadian Institute of Health Research; Ontario Ministry of Research and Innovation, Canada; Ontario Graduate Scholarship	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research and Innovation, Canada(Ministry of Research and Innovation, Ontario); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by a grant from the Canadian Institute of Health Research, a New Investigator Award from the Canadian Institute of Health Research and an Early Researcher Award from the Ontario Ministry of Research and Innovation, Canada, to Xiaolong Yang; and an Ontario Graduate Scholarship to Stacy Visser-Grieve. We would like to thank Matt Gordon at the Queen's Cancer Research Institute for performing the FACS analysis and Dr Frank Gunn-Moore for providing the hEx-GFP plasmid.	Badouel C, 2009, DEV CELL, V16, P411, DOI 10.1016/j.devcel.2009.01.010; Blaumueller CM, 2000, MECH DEVELOP, V92, P251, DOI 10.1016/S0925-4773(00)00246-X; BOEDIGHEIMER M, 1993, DEVELOPMENT, V118, P1291; Boedigheimer MJ, 1997, DEV GENET, V20, P103, DOI 10.1002/(SICI)1520-6408(1997)20:2<103::AID-DVG3>3.0.CO;2-B; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Feng YQ, 2007, P NATL ACAD SCI USA, V104, P20362, DOI 10.1073/pnas.0706722105; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Gunn-Moore FJ, 2005, FEBS LETT, V579, P5089, DOI 10.1016/j.febslet.2005.07.097; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lau YKI, 2008, CANCER RES, V68, P5733, DOI 10.1158/0008-5472.CAN-08-0190; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li WQ, 2011, CANCER RES, V71, P2162, DOI 10.1158/0008-5472.CAN-10-3268; Li YF, 2003, ONCOGENE, V22, P4398, DOI 10.1038/sj.onc.1206603; McCartney BM, 2000, DEVELOPMENT, V127, P1315; McGrogan BT, 2008, BBA-REV CANCER, V1785, P96, DOI 10.1016/j.bbcan.2007.10.004; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pellock BJ, 2007, DEV BIOL, V304, P102, DOI 10.1016/j.ydbio.2006.12.021; Polesello C, 2006, CURR BIOL, V16, P2459, DOI 10.1016/j.cub.2006.10.060; Radu M, 2009, CURR BIOL, V19, pR421, DOI 10.1016/j.cub.2009.04.022; Stern C, 1926, GENETICS, V11, P503; Visser S, 2010, CELL CYCLE, V9, P3892, DOI 10.4161/cc.9.19.13386; Visser S, 2010, GENE, V449, P22, DOI 10.1016/j.gene.2009.09.008; Xia H, 2002, ONCOGENE, V21, P1233, DOI 10.1038/sj.onc.1205174; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; Yang XL, 2001, ONCOGENE, V20, P6516, DOI 10.1038/sj.onc.1204817; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	37	35	35	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	9					1189	1195		10.1038/onc.2011.318	http://dx.doi.org/10.1038/onc.2011.318			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	901EW	21785462				2022-12-25	WOS:000300945900012
J	Berlin, S; Tsemakhovich, VA; Castel, R; Ivanina, T; Dessauer, CW; Keren-Raifman, T; Dascal, N				Berlin, Shai; Tsemakhovich, Vladimir A.; Castel, Ruth; Ivanina, Tatiana; Dessauer, Carmen W.; Keren-Raifman, Tal; Dascal, Nathan			Two Distinct Aspects of Coupling between G alpha(i) Protein and G Protein-activated K+ Channel (GIRK) Revealed by Fluorescently Labeled G alpha(i3) Protein Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-BETA-GAMMA; HETEROTRIMERIC G-PROTEINS; RECTIFYING POTASSIUM CHANNELS; C-TERMINAL DOMAIN; PERTUSSIS-TOXIN; ALPHA-SUBUNITS; XENOPUS OOCYTES; LIVING CELLS; KIR3 CHANNELS; RECEPTOR	G protein-activated K+ channels (Kir3 or GIRK) are activated by direct interaction with G beta gamma. G alpha is essential for specific signaling and regulates basal activity of GIRK (I-basal) and kinetics of the response elicited by activation by G protein-coupled receptors (I-evoked). These regulations are believed to occur within a GIRK-G alpha-G beta gamma signaling complex. Fluorescent energy resonance transfer (FRET) studies showed strong GIRK-G beta gamma interactions but yielded controversial results regarding the GIRK-G alpha(i/o) interaction. We investigated the mechanisms of regulation of GIRK by G alpha(i/o) using wild-type G alpha(i3) (G alpha i3WT) and G alpha(i3) labeled at three different positions with fluorescent proteins, CFP or YFP (xFP). G alpha(i3)xFP proteins bound the cytosolic domain of GIRK1 and interacted with G beta gamma in a guanine nucleotide-dependent manner. However, only an N-terminally labeled, myristoylated G alpha(i3)xFP (G alpha i3NT) closely mimicked all aspects of G alpha i3WT regulation except for a weaker regulation of I-basal. G alpha(i3) labeled with YFP within the G alpha helical domain preserved regulation of I-basal but failed to restore fast I-evoked. Titrated expression of G alpha i3NT and G alpha(i3) WT confirmed that regulation of I-basal and of the kinetics of I-evoked of GIRK1/2 are independent functions of G alpha(i). FRET and direct biochemical measurements indicated much stronger interaction between GIRK1 and G beta gamma than between GIRK1 and G alpha(i3). Thus, G alpha(i/o)beta gamma heterotrimer may be attached to GIRK primarily via G beta gamma within the signaling complex. Our findings support the notion that G alpha(i/o) actively regulates GIRK. Although regulation of I-basal is a function of G alpha(GDP)(i), our new findings indicate that regulation of kinetics of I-evoked is mediated by G alpha(GTP)(i).	[Berlin, Shai; Tsemakhovich, Vladimir A.; Castel, Ruth; Ivanina, Tatiana; Keren-Raifman, Tal; Dascal, Nathan] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Dessauer, Carmen W.] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	Tel Aviv University; Sackler Faculty of Medicine; University of Texas System; University of Texas Health Science Center Houston	Dascal, N (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	dascaln@post.tau.ac.il	Dascal, Nathan/O-3915-2015; Dessauer, Carmen/N-6933-2018	Dascal, Nathan/0000-0002-5397-4146; Dessauer, Carmen/0000-0003-1210-4280; Berlin, shai/0000-0002-5153-4876	National Institutes of Health [GM60419]; United States Israel Binational Science Foundation [2009255]; Israel Science Foundation [1396/05, 49/08, 386/09]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60419 (to C. W. D.). This work was also supported by United States Israel Binational Science Foundation Grant 2009255 (to N. D. and C. W. D.) and Israel Science Foundation Grants 1396/05 and 49/08 (to N. D.) and 386/09 (to T. I.).	Berlin S, 2010, J BIOL CHEM, V285, P6179, DOI 10.1074/jbc.M109.085944; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Bykova EA, 2006, NAT STRUCT MOL BIOL, V13, P1115, DOI 10.1038/nsmb1176; Chan KW, 1997, J BIOL CHEM, V272, P6548, DOI 10.1074/jbc.272.10.6548; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Corey S, 2001, J BIOL CHEM, V276, P11409, DOI 10.1074/jbc.M100058200; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; Dascal N, 2001, TRENDS ENDOCRIN MET, V12, P391, DOI 10.1016/S1043-2760(01)00475-1; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P99, DOI 10.1085/jgp.200910345; Finley M, 2004, J PHYSIOL-LONDON, V555, P643, DOI 10.1113/jphysiol.2003.056101; Fowler CE, 2007, J PHYSIOL-LONDON, V580, P51, DOI 10.1113/jphysiol.2006.123216; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Hakak Y, 2003, FEBS LETT, V550, P11, DOI 10.1016/S0014-5793(03)00762-2; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; Hebert TE, 2006, CELL BIOCHEM BIOPHYS, V45, P85, DOI 10.1385/CBB:45:1:85; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Ivanina T, 2004, J BIOL CHEM, V279, P17260, DOI 10.1074/jbc.M313425200; Ivanina T, 2003, J BIOL CHEM, V278, P29174, DOI 10.1074/jbc.M304518200; Ivanina T, 2000, FEBS LETT, V466, P327, DOI 10.1016/S0014-5793(99)01738-X; IvanovaNikolova TT, 1997, J GEN PHYSIOL, V109, P245, DOI 10.1085/jgp.109.2.245; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P29059, DOI 10.1074/jbc.270.49.29059; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Leal-Pinto E, 2010, J BIOL CHEM, V285, P39790, DOI 10.1074/jbc.M110.151373; Leaney JL, 2002, J BIOL CHEM, V277, P28803, DOI 10.1074/jbc.M204683200; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Mirshahi T, 2004, J BIOL CHEM, V279, P11890, DOI 10.1074/jbc.M313322200; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; Rebois RV, 2006, J CELL SCI, V119, P2807, DOI 10.1242/jcs.03021; Rishal I, 2005, J BIOL CHEM, V280, P16685, DOI 10.1074/jbc.M412196200; Rishal I, 2003, J BIOL CHEM, V278, P3840, DOI 10.1074/jbc.C200605200; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Rubinstein M, 2007, J PHYSIOL-LONDON, V581, P17, DOI 10.1113/jphysiol.2006.125864; Rubinstein M, 2009, J PHYSIOL-LONDON, V587, P3473, DOI 10.1113/jphysiol.2009.173229; Rusinova R, 2007, J BIOL CHEM, V282, P34019, DOI 10.1074/jbc.M704928200; Sadja R, 2002, P NATL ACAD SCI USA, V99, P10783, DOI 10.1073/pnas.162346199; Schreibmayer W, 1996, NATURE, V380, P624, DOI 10.1038/380624a0; Sharon D, 1997, J GEN PHYSIOL, V109, P477, DOI 10.1085/jgp.109.4.477; Singer-Lahat D, 2000, PFLUG ARCH EUR J PHY, V440, P627, DOI 10.1007/s004240000341; SUNYER T, 1989, MOL ENDOCRINOL, V3, P1115, DOI 10.1210/mend-3-7-1115; VOGEL SS, 2006, SCI STKE, pRE2, DOI DOI 10.1126/STKE.3312006RE2; Vorobiov D, 2000, J BIOL CHEM, V275, P4166, DOI 10.1074/jbc.275.6.4166; Waldhoer M, 1999, J BIOL CHEM, V274, P30571, DOI 10.1074/jbc.274.43.30571; Wang JT, 2009, J BIOL CHEM, V284, P16906, DOI 10.1074/jbc.M109.006585; WEST RE, 1985, J BIOL CHEM, V260, P4428; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; YAMADA M, 1993, J BIOL CHEM, V268, P24551; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yevenes GE, 2010, J BIOL CHEM, V285, P30203, DOI 10.1074/jbc.M110.134676; Zheng J, 2003, J NEUROSCI, V23, P8167; ZHENG J, 2003, SCI STKE, pPL7; Zylbergold P, 2010, CHANNELS, V4, P411, DOI 10.4161/chan.4.5.13327	62	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33223	33235		10.1074/jbc.M111.271056	http://dx.doi.org/10.1074/jbc.M111.271056			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795707	Green Published, hybrid			2022-12-25	WOS:000294968800041
J	Samal, AB; Ghanam, RH; Fernandez, TF; Monroe, EB; Saad, JS				Samal, Alexandra B.; Ghanam, Ruba H.; Fernandez, Timothy F.; Monroe, Eric B.; Saad, Jamil S.			NMR, Biophysical, and Biochemical Studies Reveal the Minimal Calmodulin Binding Domain of the HIV-1 Matrix Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 MATRIX; PLASMA-MEMBRANE; TARGET RECOGNITION; GAG PROTEIN; INTRACELLULAR TRAFFICKING; MYRISTATE EXPOSURE; STRUCTURAL BIOLOGY; ENV INCORPORATION; IN-VITRO; PEPTIDE	Subcellular distribution of Calmodulin (CaM) in human immunodeficiency virus type-1 (HIV-1)-infected cells is distinct from that observed in uninfected cells. CaM has been shown to interact and co-localize with the HIV-1 Gag protein in infected cells. However, the precise molecular mechanism of this interaction is not known. Binding of Gag to CaM is dependent on calcium and is mediated by the N-terminal-myristoylated matrix (myr(+) MA) domain. We have recently shown that CaM binding induces a conformational change in the MA protein, triggering exposure of the myristate group. To unravel the molecular mechanism of CaM-MA interaction and to identify the minimal CaM binding domain of MA, we devised multiple approaches utilizing NMR, biochemical, and biophysical methods. Short peptides derived from the MA protein have been examined. Our data revealed that whereas peptides spanning residues 11-28 (MA-(11-28)) and 31-46 (MA-(31-46)) appear to bind preferentially to the C-terminal lobe of CaM, a peptide comprising residues 11-46 (MA-(11-46)) appears to engage both domains of CaM. Limited proteolysis data conducted on the MA-CaM complex yielded a MA peptide (residues 8-43) that is protected by CaM and resistant to proteolysis. MA-(8-43) binds to CaM with a very high affinity (dissociation constant = 25 nM) and in a manner that is similar to that observed for the full-length MA protein. The present findings provide new insights on how MA interacts with CaM that may ultimately help in identification of the functional role of CaM-Gag interactions in the HIV replication cycle.	[Samal, Alexandra B.; Ghanam, Ruba H.; Fernandez, Timothy F.; Monroe, Eric B.; Saad, Jamil S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Saad, JS (corresponding author), 845 19th St S, Birmingham, AL 35294 USA.	saad@uab.edu		Monroe, Eric/0000-0002-6404-5801; Saad, Jamil/0000-0001-9503-6484	National Institutes of Health [1R01AI087101, CA13148-35, P30CA13148, 1S10RR026478]; NCI; University of Alabama at Birmingham Comprehensive Cancer Center; Center for AIDS Research at the University of Alabama at Birmingham; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Alabama at Birmingham Comprehensive Cancer Center; Center for AIDS Research at the University of Alabama at Birmingham; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01AI087101 (to J. S. S.), CA13148-35 (NCI; University of Alabama at Birmingham Comprehensive Cancer Center Junior Faculty Development Grant Program, to J. S. S.), and by intramural funding from the Center for AIDS Research at the University of Alabama at Birmingham.; We thank to Madeline Shea (University of Iowa) for providing the CaM molecular clone, Jin-Biao Ma for providing SUMO and SUMO protease plasmids, and Peter Prevelige (University of Alabama at Birmingham) and David King (Howard Hughes Medical Institute, University of California Berkeley) for helping with the mass spectrometry data. We thank the University of Alabama at Birmingham Comprehensive Cancer Center x-ray core facility, funded by NCI, National Institutes of Health Grant P30CA13148, which houses the Auto-ITC<INF>200</INF>, acquired through NIH Grant 1S10RR026478.	Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; BRYANT M, 1990, P NATL ACAD SCI USA, V87, P523, DOI 10.1073/pnas.87.2.523; Campbell S, 1999, J VIROL, V73, P2270, DOI 10.1128/JVI.73.3.2270-2279.1999; Campbell S, 2001, P NATL ACAD SCI USA, V98, P10875, DOI 10.1073/pnas.191224698; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chow JYH, 2010, J MOL BIOL, V400, P702, DOI 10.1016/j.jmb.2010.05.022; Chu H, 2009, CURR TOP MICROBIOL, V339, P67, DOI 10.1007/978-3-642-02175-6_4; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Chukkapalli V, 2010, P NATL ACAD SCI USA, V107, P1600, DOI 10.1073/pnas.0908661107; Davis MR, 2006, J VIROL, V80, P2405, DOI 10.1128/JVI.80.5.2405-2417.2006; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; DORFMAN T, 1994, J VIROL, V68, P1689, DOI 10.1128/JVI.68.3.1689-1696.1994; DORFMAN T, 1994, J VIROL, V68, P8180, DOI 10.1128/JVI.68.12.8180-8187.1994; Fallon JL, 2003, STRUCTURE, V11, P1303, DOI 10.1016/j.str.2003.09.004; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Fledderman EL, 2010, BIOCHEMISTRY-US, V49, P9551, DOI 10.1021/bi101245j; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ghanam RH, 2010, J BIOL CHEM, V285, P41911, DOI 10.1074/jbc.M110.179093; GIETZEN K, 1982, BIOCHEM J, V207, P541, DOI 10.1042/bj2070541; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Han Z, 2007, VIRUS GENES, V35, P511, DOI 10.1007/s11262-007-0125-9; Hayashi N, 2002, PROTEIN SCI, V11, P529, DOI 10.1110/ps.23702; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; Izumi Y, 2008, BIOCHEMISTRY-US, V47, P7158, DOI 10.1021/bi702416b; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Joshi A, 2009, J VIROL, V83, P5375, DOI 10.1128/JVI.00109-09; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; Li H, 2007, J VIROL, V81, P12899, DOI 10.1128/JVI.01280-07; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; Matsubara M, 2005, PROTEIN SCI, V14, P494, DOI 10.1110/ps.04969605; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; Matsubara M, 2003, J BIOL CHEM, V278, P48898, DOI 10.1074/jbc.M305488200; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; MILLER MA, 1993, AIDS RES HUM RETROV, V9, P1057, DOI 10.1089/aid.1993.9.1057; Nishi M, 2009, FEBS LETT, V583, P1243, DOI 10.1016/j.febslet.2009.03.041; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Ono A, 1997, J VIROL, V71, P4409, DOI 10.1128/JVI.71.6.4409-4418.1997; Ono A, 2010, VACCINE, V28, pB55, DOI 10.1016/j.vaccine.2009.10.021; Ono A, 2010, BIOL CELL, V102, P335, DOI 10.1042/BC20090165; Ono A, 2009, FUTURE VIROL, V4, P241, DOI 10.2217/FVL.09.4; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Osawa M, 1998, J MOL BIOL, V276, P165, DOI 10.1006/jmbi.1997.1524; Paillart JC, 1999, J VIROL, V73, P2604, DOI 10.1128/JVI.73.4.2604-2612.1999; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; Radding W, 2000, AIDS RES HUM RETROV, V16, P1519, DOI 10.1089/088922200750006047; Radding W, 1996, BIOCHEM BIOPH RES CO, V218, P192, DOI 10.1006/bbrc.1996.0034; Reil H, 1998, EMBO J, V17, P2699, DOI 10.1093/emboj/17.9.2699; Ryo A, 2008, P NATL ACAD SCI USA, V105, P294, DOI 10.1073/pnas.0704831105; Saad JS, 2007, J MOL BIOL, V366, P574, DOI 10.1016/j.jmb.2006.11.068; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; SIIVARI K, 1995, FEBS LETT, V366, P104, DOI 10.1016/0014-5793(95)00504-3; Sorensen BR, 1998, BIOCHEMISTRY-US, V37, P4244, DOI 10.1021/bi9718200; SRINIVAS SK, 1993, J BIOL CHEM, V268, P22895; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; TOWLER DA, 1988, J BIOL CHEM, V263, P1784; Turner BG, 1999, J MOL BIOL, V285, P1, DOI 10.1006/jmbi.1998.2354; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; VOGEL HJ, 1994, BIOCHEM CELL BIOL, V72, P357, DOI 10.1139/o94-049; Waheed AA, 2009, VIRUS RES, V143, P162, DOI 10.1016/j.virusres.2009.04.007; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yuan T, 1999, J BIOL CHEM, V274, P8411, DOI 10.1074/jbc.274.13.8411; ZHOU WJ, 1994, J VIROL, V68, P2556, DOI 10.1128/JVI.68.4.2556-2569.1994	81	19	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33533	33543		10.1074/jbc.M111.273623	http://dx.doi.org/10.1074/jbc.M111.273623			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21799007	Green Published, hybrid			2022-12-25	WOS:000294968800070
J	Zhu, CF; Luong, R; Zhuo, M; Johnson, DT; McKenney, JK; Cunha, GR; Sun, ZJ				Zhu, Chunfang; Luong, Richard; Zhuo, Ming; Johnson, Daniel T.; McKenney, Jesse K.; Cunha, Gerald R.; Sun, Zijie			Conditional Expression of the Androgen Receptor Induces Oncogenic Transformation of the Mouse Prostate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIAS-LIKE PROTEIN; CANCER PROGRESSION; THERAPY FAILURE; GENE; MICE; MUTATION; MODELS; CASTRATION; GENERATION; TRANSGENE	The androgen signaling pathway, mediated through the androgen receptor (AR), is critical in prostate tumorigenesis. However, the precise role of AR in prostate cancer development and progression still remains largely unknown. Specifically, it is unclear whether overexpression of AR is sufficient to induce prostate tumor formation in vivo. Here, we inserted the human AR transgene with a LoxP-stop-loxP (LSL) cassette into the mouse ROSA26 locus, permitting "conditionally" activated AR transgene expression through Cre recombinase-mediated removal of the LSL cassette. By crossing this AR floxed strain with Osr1-Cre (odd skipped related) mice, in which the Osr1 promoter activates at embryonic day 11.5 in urogenital sinus epithelium, we generated a conditional transgenic line, R26hAR(loxP):Osr1-Cre+. Expression of transgenic AR was detected in both prostatic luminal and basal epithelial cells and is resistant to castration. Approximately one-half of the transgenic mice displayed mouse prostatic intraepithelial neoplasia (mPIN) lesions. Intriguingly, four mice (10%) developed prostatic adenocarcinomas, with two demonstrating invasive diseases. Positive immunostaining of transgenic AR protein was observed in the majority of atypical and tumor cells in the mPIN and prostatic adenocarcinomas, providing a link between transgenic AR expression and oncogenic transformation. An increase in Ki67-positive cells appeared in all mPIN and prostatic adenocarcinoma lesions of the mice. Thus, we demonstrated for the first time that conditional activation of transgenic AR expression by Osr1 promoter induces prostate tumor formation in mice. This new AR transgenic mouse line mimics the human disease and can be used for study of prostate tumorigenesis and drug development.	[Zhu, Chunfang; Zhuo, Ming; Johnson, Daniel T.; Sun, Zijie] Stanford Univ, Dept Urol & Genet, Sch Med, Stanford, CA 94305 USA; [Luong, Richard] Stanford Univ, Dept Comparat Med, Sch Med, Stanford, CA 94305 USA; [McKenney, Jesse K.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Cunha, Gerald R.] Univ Calif San Francisco, Dept Urol, Sch Med, San Francisco, CA 94143 USA	Stanford University; Stanford University; Stanford University; University of California System; University of California San Francisco	Sun, ZJ (corresponding author), Stanford Univ, Dept Urol, Sch Med, S287 Grant Bldg, Stanford, CA 94305 USA.	zsun@stanford.edu		Johnson, Daniel/0000-0003-4669-037X	National Cancer Institute [CA-070297]; NATIONAL CANCER INSTITUTE [R01CA070297, R29CA070297] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Service Grant CA-070297 from the National Cancer Institute.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Abate-Shen C, 2006, CLIN CANCER RES, V12, P5274, DOI 10.1158/1078-0432.CCR-06-0500; Bruchovsky N, 1975, Vitam Horm, V33, P61; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Culig Z, 2000, UROL RES, V28, P211, DOI 10.1007/s002400000111; Culig ZR, 2003, J UROLOGY, V170, P1363, DOI 10.1097/01.ju.0000075099.20662.7f; DEWINTER JAR, 1994, AM J PATHOL, V144, P735; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; GADDIPATI JP, 1994, CANCER RES, V54, P2861; Gann PH, 1996, J NATL CANCER I, V88, P1118, DOI 10.1093/jnci/88.16.1118; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; Gao H, 2006, CANCER RES, V66, P7929, DOI 10.1158/0008-5472.CAN-06-1637; Garabedian EM, 1998, P NATL ACAD SCI USA, V95, P15382, DOI 10.1073/pnas.95.26.15382; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Gingrich JR, 1997, CANCER RES, V57, P4687; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Grieshammer U, 2008, GENESIS, V46, P69, DOI 10.1002/dvg.20366; Huang CY, 2005, MOL ENDOCRINOL, V19, P2915, DOI 10.1210/me.2005-0097; Huggins C, 2002, J UROLOGY, V168, P9, DOI 10.1016/S0022-5347(05)64820-3; Jenster G, 1999, SEMIN ONCOL, V26, P407; Kasper S, 2008, STEM CELL REV, V4, P193, DOI 10.1007/s12015-008-9033-1; Kerkhofs S, 2009, J MOL ENDOCRINOL, V42, P11, DOI 10.1677/JME-08-0122; Koivisto P, 1997, CANCER RES, V57, P314; Koivisto P, 1998, AM J PATHOL, V152, P1; KYPRIANOU N, 1988, ENDOCRINOLOGY, V122, P552, DOI 10.1210/endo-122-2-552; Li XM, 2006, J BIOL CHEM, V281, P23748, DOI 10.1074/jbc.M508365200; Matusik RJ, 2008, DIFFERENTIATION, V76, P682, DOI 10.1111/j.1432-0436.2008.00276.x; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Palazzolo I, 2008, J STEROID BIOCHEM, V108, P245, DOI 10.1016/j.jsbmb.2007.09.016; Pienta KJ, 2008, PROSTATE, V68, P629, DOI 10.1002/pros.20726; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Salinas CA, 2005, PROSTATE, V65, P58, DOI 10.1002/pros.20230; Shaneyfelt T, 2000, J CLIN ONCOL, V18, P847, DOI 10.1200/JCO.2000.18.4.847; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stanbrough M, 2001, P NATL ACAD SCI USA, V98, P10823, DOI 10.1073/pnas.191235898; Stanford JL, 1997, CANCER RES, V57, P1194; SUGIMURA Y, 1986, BIOL REPROD, V34, P973, DOI 10.1095/biolreprod34.5.973; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Weinstein MH, 2002, MODERN PATHOL, V15, P1302, DOI 10.1097/01.MP.0000038460.95912.6E; Winter SF, 2003, PROSTATE CANCER P D, V6, P204, DOI 10.1038/sj.pcan.4500655; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yanagawa Y, 1999, TRANSGENIC RES, V8, P215, DOI 10.1023/A:1008914020843	48	34	36	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33478	33488		10.1074/jbc.M111.269894	http://dx.doi.org/10.1074/jbc.M111.269894			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795710	Green Published, hybrid			2022-12-25	WOS:000294968800065
J	Pingali, SV; O'Neill, HM; McGaughey, J; Urban, VS; Rempe, CS; Petridis, L; Smith, JC; Evans, BR; Heller, WT				Pingali, Sai Venkatesh; O'Neill, Hugh M.; McGaughey, Joseph; Urban, Volker S.; Rempe, Caroline S.; Petridis, Loukas; Smith, Jeremy C.; Evans, Barbara R.; Heller, William T.			Small Angle Neutron Scattering Reveals pH-dependent Conformational Changes in Trichoderma reesei Cellobiohydrolase I IMPLICATIONS FOR ENZYMATIC ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; FACTORS INFLUENCING GLYCOSYLATION; STRUCTURAL-CHARACTERIZATION; PROTEIN DENATURATION; N-GLYCOSYLATION; CORE PROTEIN; CELLULASE; CEL7A; MUTANT; MACROMOLECULES	Cellobiohydrolase I (Cel7A) of the fungus Trichoderma reesei (now classified as an anamorph of Hypocrea jecorina) hydrolyzes crystalline cellulose to soluble sugars, making it of key interest for producing fermentable sugars from biomass for biofuel production. The activity of the enzyme is pH-dependent, with its highest activity occurring at pH 4-5. To probe the response of the solution structure of Cel7A to changes in pH, we measured small angle neutron scattering of it in a series of solutions having pH values of 7.0, 6.0, 5.3, and 4.2. As the pH decreases from 7.0 to 5.3, the enzyme structure remains well defined, possessing a spatial differentiation between the cellulose binding domain and the catalytic core that only changes subtly. At pH 4.2, the solution conformation of the enzyme changes to a structure that is intermediate between a properly folded enzyme and a denatured, unfolded state, yet the secondary structure of the enzyme is essentially unaltered. The results indicate that at the pH of optimal activity, the catalytic core of the enzyme adopts a structure in which the compact packing typical of a fully folded polypeptide chain is disrupted and suggest that the increased range of structures afforded by this disordered state plays an important role in the increased activity of Cel7A through conformational selection.	[Pingali, Sai Venkatesh; O'Neill, Hugh M.; McGaughey, Joseph; Urban, Volker S.; Rempe, Caroline S.; Evans, Barbara R.; Heller, William T.] Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37831 USA; [Pingali, Sai Venkatesh; O'Neill, Hugh M.; Urban, Volker S.; Heller, William T.] Oak Ridge Natl Lab, Ctr Struct Mol Biol, Oak Ridge, TN 37831 USA; [O'Neill, Hugh M.; Urban, Volker S.; Heller, William T.] Oak Ridge Natl Lab, Neutron Scattering Sci Div, Oak Ridge, TN 37831 USA; [Petridis, Loukas; Smith, Jeremy C.] Univ Tennessee, Oak Ridge Natl Lab, Ctr Biophys Mol, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville	Evans, BR (corresponding author), Oak Ridge Natl Lab, Div Chem Sci, POB 2008,MS-6194, Oak Ridge, TN 37831 USA.	evansb@ornl.gov; hellerwt@ornl.gov	Petridis, Loukas/B-3457-2009; smith, jeremy c/B-7287-2012; Heller, William/ABE-1104-2020; Urban, Volker S/N-5361-2015	Petridis, Loukas/0000-0001-8569-060X; smith, jeremy c/0000-0002-2978-3227; Heller, William/0000-0001-6456-2975; Urban, Volker S/0000-0002-7962-3408; Pingali, Sai Venkatesh/0000-0001-7961-4176; O'Neill, Hugh/0000-0003-2966-5527; Rempe, Caroline/0000-0002-8326-6423	Office of Biological and Environmental Research, U.S. Department of Energy [FWP ERKP752]; Office of Biological and Environmental Research [FWP ERKP291]; U.S. Department of Energy [DE-AC05-00OR22725]; Department of Energy Science Undergraduate Laboratory	Office of Biological and Environmental Research, U.S. Department of Energy(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.S. Department of Energy(United States Department of Energy (DOE)); Department of Energy Science Undergraduate Laboratory	This work was supported by the Genomic Science Program, Office of Biological and Environmental Research, U.S. Department of Energy, under Contract FWP ERKP752. The research at Oak Ridge National Laboratory Center for Structural Molecular Biology (CSMB) was supported by the Office of Biological and Environmental Research under Contract FWP ERKP291, using facilities supported by the U.S. Department of Energy. Oak Ridge National Laboratory is managed by UT-Battelle, LLC for the U.S. Department of Energy under Contract DE-AC05-00OR22725.; Supported by a Department of Energy Science Undergraduate Laboratory internship and Higher Education Research Experience internship managed by Oak Ridge Institute of Science and Education.	ABUJA PM, 1988, EUR BIOPHYS J BIOPHY, V15, P339, DOI 10.1007/BF00254721; Baker GA, 2009, CHEM ENG J, V147, P6, DOI 10.1016/j.cej.2008.11.033; Becker D, 2001, BIOCHEM J, V356, P19, DOI 10.1042/0264-6021:3560019; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernado P, 2010, EUR BIOPHYS J BIOPHY, V39, P769, DOI 10.1007/s00249-009-0549-3; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Boer H, 2003, EUR J BIOCHEM, V270, P841, DOI 10.1046/j.1432-1033.2003.03431.x; Boer H, 2000, BIOTECHNOL BIOENG, V69, P486, DOI 10.1002/1097-0290(20000905)69:5<486::AID-BIT3>3.0.CO;2-N; CALMETTES P, 1994, BIOPHYS CHEM, V53, P105, DOI 10.1016/0301-4622(94)00081-6; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Das A, 2004, PRAMANA-J PHYS, V63, P363, DOI 10.1007/BF02704999; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Doniach S, 2001, CHEM REV, V101, P1763, DOI 10.1021/cr990071k; EVANS BR, 1994, ARCH BIOCHEM BIOPHYS, V312, P459, DOI 10.1006/abbi.1994.1332; FAGERSTAM LG, 1984, FEBS LETT, V167, P309, DOI 10.1016/0014-5793(84)80148-9; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guinier A., 1955, SMALL ANGLE SCATTERI; Harrison MJ, 1998, EUR J BIOCHEM, V256, P119, DOI 10.1046/j.1432-1327.1998.2560119.x; Heller WT, 2005, ACTA CRYSTALLOGR D, V61, P33, DOI 10.1107/S0907444904025855; Heller WT, 2003, BIOCHEMISTRY-US, V42, P10579, DOI 10.1021/bi0348664; HENRISSAT B, 1985, BIO-TECHNOL, V3, P722, DOI 10.1038/nbt0885-722; Hui JPM, 2001, J CHROMATOGR B, V752, P349, DOI 10.1016/S0378-4347(00)00373-X; Kirste R.G., 1982, SMALL ANGLE XRAY SCA, P387; Klarskov K, 1997, CARBOHYD RES, V304, P143, DOI 10.1016/S0008-6215(97)00215-2; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Lee HJ, 1997, J BIOTECHNOL, V57, P127, DOI 10.1016/S0168-1656(97)00111-9; Lee I, 2000, ULTRAMICROSCOPY, V82, P213, DOI 10.1016/S0304-3991(99)00158-8; Lynn GW, 2006, PHYSICA B, V385-86, P880, DOI 10.1016/j.physb.2006.05.133; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Myers J, 2006, PROTEINS, V63, P928, DOI 10.1002/prot.20922; Porod V. G., 1951, KOLLOID Z, V124, P83; Receveur V, 2002, J BIOL CHEM, V277, P40887, DOI 10.1074/jbc.M205404200; SCHMUCK M, 1986, BIOTECHNOL LETT, V8, P397, DOI 10.1007/BF01026739; Segel DJ, 1998, BIOCHEMISTRY-US, V37, P12443, DOI 10.1021/bi980535t; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; SHOEMAKER S, 1983, BIO-TECHNOL, V1, P691, DOI 10.1038/nbt1083-691; Stals I, 2004, GLYCOBIOLOGY, V14, P713, DOI 10.1093/glycob/cwh080; Stals I, 2004, GLYCOBIOLOGY, V14, P725, DOI 10.1093/glycob/cwh081; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WOODWARD J, 1994, BIOTECHNOL APPL BIOC, V19, P141; Zhong L, 2008, CELLULOSE, V15, P261, DOI 10.1007/s10570-007-9186-0; Zhong LH, 2009, CARBOHYD RES, V344, P1984, DOI 10.1016/j.carres.2009.07.005	45	25	25	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32801	32809		10.1074/jbc.M111.263004	http://dx.doi.org/10.1074/jbc.M111.263004			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784865	hybrid, Green Published			2022-12-25	WOS:000294726800087
J	Hu, YZ; Mivechi, NF				Hu, Yanzhong; Mivechi, Nahid F.			Promotion of Heat Shock Factor Hsf1 Degradation via Adaptor Protein Filamin A-interacting Protein 1-Like (FILIP-1L)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVITY; MOLECULAR CHAPERONES; TARGETED DISRUPTION; SUMO MODIFICATION; LENS DEVELOPMENT; FACTOR-II; STRESS; PHOSPHORYLATION; BINDING; DIFFERENTIATION	Heat shock factor Hsf1 is involved in the regulation of a variety of cellular processes including heat shock response, development and differentiation, aging, and tumorigenesis. Hsf1 transcriptional activity is tightly controlled through phosphorylation, sumoylation, and acetylation, and through association with a number of regulatory proteins. However, regulation of Hsf1 protein stability or turnover remains unknown. We have identified a novel Hsf1-interacting protein, FILIP-1L, that was found to bind to Hsf1 through yeast two-hybrid screening. FILIP-1L encodes multiple isoforms spanning from 711 to 1135 amino acid residues. FILIP-1L contains four coiled-coil and two N-terminal leucine zipper domains. Ectopic expression of FILIP-1L reduces the expression of the Hsf1 protein because FILIP-1L promotes Hsf1 ubiquitination and degradation through the ubiquitin-proteasome system, leading to a reduction in Hsf1-mediated transcription. FILIP-1L, Hsf1, and the ubiquitin-binding domain of HhR23A, a receptor that transports polyubiquitinated proteins to the 19 S proteasome subunit targeting them for degradation, are found in a complex. This indicates that FILIP-1L is a potential adaptor that is involved in the Hsf1 degradation pathway. Taken together, our results indicate that FILIP-1L interacts with Hsf1, controlling its stability and thus modulating the heat shock response. These data indicate a novel function for FILIP-1L and a pathway for Hsf1 degradation through the ubiquitin-proteasome system.	[Hu, Yanzhong; Mivechi, Nahid F.] Georgia Hlth Sci Univ, Ctr Mol Chaperone Radiobiol & Canc Virol, Augusta, GA 30912 USA; [Mivechi, Nahid F.] Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA 30912 USA; [Mivechi, Nahid F.] Charlie Norwood Vet Affairs Med Ctr, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Mivechi, NF (corresponding author), 1410 Laney Walker Blvd,CN-3141, Augusta, GA 30912 USA.	nmivechi@georgiahealth.edu			National Institutes of Health [CA062130, CA132640]; Veterans Affairs Award [1I01BX000161]; NATIONAL CANCER INSTITUTE [R01CA132640, R01CA062130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA062130 and CA132640 (to N. F. M.).; Recipient of Veterans Affairs Award 1I01BX000161. To whom correspondence should be addressed: 1410 Laney Walker Blvd., CN-3141, Augusta, GA 30912. Tel.: 706-721-8759; E-mail: nmivechi@georgiahealth.edu.	Ahlskog JK, 2010, MOL CELL BIOL, V30, P5608, DOI 10.1128/MCB.01506-09; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Boellmann F, 2004, P NATL ACAD SCI USA, V101, P4100, DOI 10.1073/pnas.0304768101; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Dai RJ, 2000, J BIOL CHEM, V275, P18210, DOI 10.1074/jbc.M000958200; Dantuma NP, 2009, DNA REPAIR, V8, P449, DOI 10.1016/j.dnarep.2009.01.005; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hilgarth RS, 2004, J BIOL CHEM, V279, P53899, DOI 10.1074/jbc.R400021200; Homma S, 2007, J NEUROSCI, V27, P7974, DOI 10.1523/JNEUROSCI.0006-07.2007; Hu YZ, 2003, J BIOL CHEM, V278, P17299, DOI 10.1074/jbc.M300788200; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kallio M, 2002, EMBO J, V21, P2591, DOI 10.1093/emboj/21.11.2591; Khaleque M, 2008, ONCOGENE, V27, P1886, DOI 10.1038/sj.onc.1210834; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; KROEGER PE, 1993, MOL CELL BIOL, V13, P3370, DOI 10.1128/MCB.13.6.3370; Kwon M, 2008, CANCER RES, V68, P7332, DOI 10.1158/0008-5472.CAN-08-1087; Lee YJ, 2008, CANCER RES, V68, P7550, DOI 10.1158/0008-5472.CAN-08-0129; Leon S, 2009, EXP CELL RES, V315, P1574, DOI 10.1016/j.yexcr.2008.11.014; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; Min JN, 2004, GENESIS, V40, P205, DOI 10.1002/gene.20087; MOK SC, 1994, GYNECOL ONCOL, V52, P247, DOI 10.1006/gyno.1994.1040; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Nakai A, 1997, MOL CELL BIOL, V17, P469, DOI 10.1128/MCB.17.1.469; Satyal SH, 1998, GENE DEV, V12, P1962, DOI 10.1101/gad.12.13.1962; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; SISTONEN L, 1992, MOL CELL BIOL, V12, P4104, DOI 10.1128/MCB.12.9.4104; Tandle AT, 2005, CYTOKINE, V30, P347, DOI 10.1016/j.cyto.2005.01.020; Wang GH, 2004, GENESIS, V38, P66, DOI 10.1002/gene.20005; Wang GH, 2003, GENESIS, V36, P48, DOI 10.1002/gene.10200; Wang XZ, 2006, J BIOL CHEM, V281, P782, DOI 10.1074/jbc.M505822200; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	36	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31397	31408		10.1074/jbc.M111.255851	http://dx.doi.org/10.1074/jbc.M111.255851			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21784850	hybrid, Green Published			2022-12-25	WOS:000294487500034
J	Roy, L; Buronfosse, T				Roy, Lise; Buronfosse, Thierry			Using Mitochondrial and Nuclear Sequence Data for Disentangling Population Structure in Complex Pest Species: A Case Study with Dermanyssus gallinae	PLOS ONE			English	Article							HYBRIDIZATION; DIVERSITY; PATTERNS; BIOLOGY; LEVEL	Among global changes induced by human activities, association of breakdown of geographical barriers and impoverishered biodiversity of agroecosystems may have a strong evolutionary impact on pest species. As a consequence of trade networks' expansion, secondary contacts between incipient species, if hybrid incompatibility is not yet reached, may result in hybrid swarms, even more when empty niches are available as usual in crop fields and farms. By providing important sources of genetic novelty for organisms to adapt in changing environments, hybridization may be strongly involved in the emergence of invasive populations. Because national and international trade networks offered multiple hybridization opportunities during the previous and current centuries, population structure of many pest species is expected to be the most intricate and its inference often blurred when using fast-evolving markers. Here we show that mito-nuclear sequence datasets may be the most helpful in disentangling successive layers of admixture in the composition of pest populations. As a model we used D. gallinae s. l., a mesostigmatid mite complex of two species primarily parasitizing birds, namely D. gallinae L1 and D. gallinae s. str. The latter is a pest species, considered invading layer farms in Brazil. The structure of the pest as represented by isolates from both wild and domestic birds, from European (with a focus on France), Australian and Brazilian farms, revealed past hybridization events and very recent contact between deeply divergent lineages. The role of wild birds in the dissemination of mites appears to be null in European and Australian farms, but not in Brazilian ones. In French farms, some recent secondary contact is obviously consecutive to trade flows. Scenarios of populations' history were established, showing five different combinations of more or less dramatic bottlenecks and founder events, nearly interspecific hybridizations and recent population mixing within D. gallinae s. str.	[Roy, Lise] Anses Lyon, Unite Resistance Produits Phytosanitaires, Lyon, France; [Buronfosse, Thierry] VetAgro Sup, Marcy Letoile, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); VetAgro Sup	Roy, L (corresponding author), Anses Lyon, Unite Resistance Produits Phytosanitaires, Lyon, France.	lise.roy@anses.fr	, Roy/G-5648-2017	, Roy/0000-0001-8833-1717	PEP (Pole d'Experimentation et de Progres) Avicole of the Region Rhone-Alpes (France)	PEP (Pole d'Experimentation et de Progres) Avicole of the Region Rhone-Alpes (France)(Region Auvergne-Rhone-Alpes)	This work was supported by the PEP (Pole d'Experimentation et de Progres) Avicole of the Region Rhone-Alpes (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F., 2007, CONSERVATION GENETIC; ARASHIRO O, 1989, HIST AVICULTURA BRAS; Arkle S, 2010, RES VET SCI, V88, P279, DOI 10.1016/j.rvsc.2009.08.002; Brisson JA, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-22; DALLACOSTA AJ, 1997, THESIS U SORBONNE NO; Fay JC, 1999, MOL BIOL EVOL, V16, P1003, DOI 10.1093/oxfordjournals.molbev.a026175; Hoban SM, 2009, BIOL LETTERS, V5, P324, DOI 10.1098/rsbl.2009.0031; HUBER DM, 2002, INVASIVE PEST SPECIE; HUTCHESON HJ, 1988, J MED ENTOMOL, V25, P321, DOI 10.1093/jmedent/25.5.321; Kaeuffer R, 2007, HEREDITY, V99, P374, DOI 10.1038/sj.hdy.6801010; Kneitel JM, 2006, COMMUNITY ECOL, V7, P245, DOI 10.1556/ComEc.7.2006.2.11; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MEEUS T, 2007, MEEGID, V7, P308; OLIVER JAMES H., 1966, J MED ENTOMOL, V3, P29; Orr HA, 2005, GENETICS, V169, P671, DOI 10.1534/genetics.104.033274; Palumbi SR, 2001, EVOLUTION, V55, P859, DOI 10.1554/0014-3820(2001)055[0859:PNGCFM]2.0.CO;2; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Rollins LA, 2009, MOL ECOL, V18, P1560, DOI 10.1111/j.1365-294X.2009.04132.x; Roy L, 2009, EXP APPL ACAROL, V48, P115, DOI 10.1007/s10493-008-9231-1; Roy L, 2009, MOL PHYLOGENET EVOL, V50, P446, DOI 10.1016/j.ympev.2008.11.012; ROY L, 2011, BIOSYSTEMA IN PRESS, V28; ROY L, 2009, THESIS AGRO PARIS TE; Roy Lise, 2010, Acarologia (Paris), V50, P207, DOI 10.1051/acarologia/20101958; Roy L, 2010, INT J MOL SCI, V11, P1704, DOI 10.3390/ijms11041704; Samadi S, 2006, BIOL J LINN SOC, V89, P509, DOI 10.1111/j.1095-8312.2006.00689.x; Samadi S, 2009, BIOL J LINN SOC, V97, P217, DOI 10.1111/j.1095-8312.2009.01191.x; SCOTT P, 2005, STRUCTURE DYNAMICS A; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Sousa-Santos C, 2005, DNA SEQUENCE, V16, P462, DOI 10.1080/10425170500356065; Sparagano O, 2009, EXP APPL ACAROL, V48, P3, DOI 10.1007/s10493-008-9233-z; Tranah G, 2004, J HERED, V95, P474, DOI 10.1093/jhered/esh077; Tucci EC, 2008, VET PARASITOL, V155, P127, DOI 10.1016/j.vetpar.2008.04.005; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211	35	29	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22305	10.1371/journal.pone.0022305	http://dx.doi.org/10.1371/journal.pone.0022305			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799818	Green Published, gold, Green Submitted			2022-12-25	WOS:000293172900021
J	Yang, P; Li, XL; Wu, M; Kwoh, CK; Ng, SK				Yang, Peng; Li, Xiaoli; Wu, Min; Kwoh, Chee-Keong; Ng, See-Kiong			Inferring Gene-Phenotype Associations via Global Protein Complex Network Propagation	PLOS ONE			English	Article							DISEASE GENES; BREAST; EXPRESSION; PRIORITIZATION; INTERACTOME; MUTATION; PHENOME; RISK	Background: Phenotypically similar diseases have been found to be caused by functionally related genes, suggesting a modular organization of the genetic landscape of human diseases that mirrors the modularity observed in biological interaction networks. Protein complexes, as molecular machines that integrate multiple gene products to perform biological functions, express the underlying modular organization of protein-protein interaction networks. As such, protein complexes can be useful for interrogating the networks of phenome and interactome to elucidate gene-phenotype associations of diseases. Methodology/Principal Findings: We proposed a technique called RWPCN (Random Walker on Protein Complex Network) for predicting and prioritizing disease genes. The basis of RWPCN is a protein complex network constructed using existing human protein complexes and protein interaction network. To prioritize candidate disease genes for the query disease phenotypes, we compute the associations between the protein complexes and the query phenotypes in their respective protein complex and phenotype networks. We tested RWPCN on predicting gene-phenotype associations using leave-oneout cross-validation; our method was observed to outperform existing approaches. We also applied RWPCN to predict novel disease genes for two representative diseases, namely, Breast Cancer and Diabetes. Conclusions/Significance: Guilt-by-association prediction and prioritization of disease genes can be enhanced by fully exploiting the underlying modular organizations of both the disease phenome and the protein interactome. Our RWPCN uses a novel protein complex network as a basis for interrogating the human phenome-interactome network. As the protein complex network can capture the underlying modularity in the biological interaction networks better than simple protein interaction networks, RWPCN was found to be able to detect and prioritize disease genes better than traditional approaches that used only protein-phenotype associations.	[Yang, Peng; Wu, Min; Kwoh, Chee-Keong] Nanyang Technol Univ, Sch Comp Engn, Bioinformat Res Ctr, Singapore, Singapore; [Li, Xiaoli; Ng, See-Kiong] Agcy Sci Technol & Res, Inst Infocomm Res, Dept Data Min, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R)	Yang, P (corresponding author), Nanyang Technol Univ, Sch Comp Engn, Bioinformat Res Ctr, Singapore, Singapore.	xlli@i2r.a-star.edu.sg	Li, Xiaoli/C-9739-2012; Wu, Min/AAB-2446-2022; Li, Xiaoli/GYQ-7384-2022	Li, Xiaoli/0000-0002-0762-6562; Wu, Min/0000-0003-0977-3600; 	Singapore MOE AcRF [MOE2008-T2-1-074]	Singapore MOE AcRF(Ministry of Education, Singapore)	This research was supported by Singapore MOE AcRF Grant No: MOE2008-T2-1-074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Brunner HG, 2004, NAT REV GENET, V5, P545, DOI 10.1038/nrg1383; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; COLEMAN TF, 1983, SIAM J NUMER ANAL, V20, P187, DOI 10.1137/0720013; Desjardins S, 2008, INT J CANCER, V122, P108, DOI 10.1002/ijc.23058; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Frijters R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000943; Giallourakis C, 2005, ANNU REV GENOM HUM G, V6, P381, DOI 10.1146/annurev.genom.6.080604.162234; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Huang HY, 2010, P NATL ACAD SCI USA, V107, P6823, DOI 10.1073/pnas.0912043107; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Kaur H, 2006, DIABETES, V55, P3104, DOI 10.2337/db06-0519; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; LI X, 2010, BMC GENOMICS S1S3, V11; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Lovasz L, 1993, COMBINATORICS P ERDO, V2, P353; Madsen BE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002492; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Montanez-Wiscovich ME, 2009, ONCOGENE, V28, P3608, DOI 10.1038/onc.2009.221; ORON V, 2008, P GERM C BIOINF GERM, P54; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Parts L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001276; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Qiu YQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-26; Rebhan M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/bioinformatics/14.8.656; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Suzuki J, 2009, CLIN CANCER RES, V15, P3163, DOI 10.1158/1078-0432.CCR-08-2319; Tarasov AI, 2008, DIABETES, V57, P1595, DOI 10.2337/db07-1547; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Tsou HC, 1997, AM J HUM GENET, V61, P1036, DOI 10.1086/301607; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Wakayama Y, 2008, HISTOL HISTOPATHOL, V23, P1425, DOI 10.14670/HH-23.1425; Wu M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-169; Wu MH, 2007, MOL CANCER RES, V5, P1285, DOI 10.1158/1541-7786.MCR-07-0126; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Wu XB, 2009, BIOINFORMATICS, V25, P98, DOI 10.1093/bioinformatics/btn593; XIE Z, 2011, 19 ANN INT IN PRESS	45	68	72	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e21502	10.1371/journal.pone.0021502	http://dx.doi.org/10.1371/journal.pone.0021502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799737	Green Published, gold			2022-12-25	WOS:000293172900003
J	Zhang, WJ; Wu, J; Qiao, B; Xu, W; Xiong, SD				Zhang, Weijuan; Wu, Jin; Qiao, Bin; Xu, Wei; Xiong, Sidong			Amelioration of Lupus Nephritis by Serum Amyloid P Component Gene Therapy with Distinct Mechanisms Varied from Different Stage of the Disease	PLOS ONE			English	Article							MURINE LUPUS; APOPTOTIC CELLS; INNATE IMMUNITY; ERYTHEMATOSUS; MICE; MACROPHAGES; AUTOIMMUNITY; PROTEIN; DNA; PHAGOCYTOSIS	Background: Our previous study revealed that administration of syngeneic female BALB/c mice with excessive self activated lymphocyte-derived DNA (ALD-DNA) could induce systemic lupus erythematosus (SLE) disease, indicating that overload of self-DNA might exceed normal clearance ability and comprise the major source of autoantigens in lupus mice. Serum amyloid P component (SAP), an acute-phase serum protein with binding reactivity to DNA in mice, was proved to promote the clearance of free DNA and prevent mice against self-antigen induced autoimmune response. It is reasonable to hypothesize that SAP treatment might contribute to alleviation of SLE disease, whereas its role in ALD-DNA-induced lupus nephritis is not fully understood. Methodology/Principal Findings: The ratios of SAP to DNA significantly decreased and were negatively correlated with the titers of anti-dsDNA antibodies in ALD-DNA-induced lupus mice, indicating SAP was relatively insufficient in lupus mice. Herein a pcDNA3-SAP plasmid (pSAP) was genetically constructed and intramuscularly injected into BALB/c mice. It was found that SAP protein purified from the serum of pSAP-treated mice bound efficiently to ALD-DNA and inhibited ALD-DNA-mediated innate immune response in vitro. Treatment of ALD-DNA-induced lupus mice with pSAP in the early stage of SLE disease with the onset of proteinuria reversed lupus nephritis via decreasing anti-dsDNA autoantibody production and immune complex (IC) deposition. Further administration of pSAP in the late stage of SLE disease that had established lupus nephritis alleviated proteinuria and ameliorated lupus nephritis. This therapeutic effect of SAP was not only attributable to the decreased levels of anti-dsDNA autoantibodies, but also associated with the decreased infiltration of lymphocytes and the reduced production of inflammatory markers. Conclusion/Significance: These results suggest that SAP administration could effectively alleviated lupus nephritis via modulating anti-dsDNA antibody production and the inflammation followed IC deposition, and SAP-based intervening strategy may provide new approaches for treating SLE disease.	[Zhang, Weijuan; Wu, Jin; Qiao, Bin; Xu, Wei; Xiong, Sidong] Fudan Univ, Inst Immunobiol, Shanghai 200433, Peoples R China; [Zhang, Weijuan; Wu, Jin; Qiao, Bin; Xu, Wei; Xiong, Sidong] Fudan Univ, Dept Immunol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Xiong, Sidong] Soochow Univ, Inst Biol, Suzhou, Peoples R China; [Xiong, Sidong] Soochow Univ, Inst Med Sci, Suzhou, Peoples R China	Fudan University; Fudan University; Soochow University - China; Soochow University - China	Zhang, WJ (corresponding author), Fudan Univ, Inst Immunobiol, Shanghai 200433, Peoples R China.	sdxiongfd@126.com	Zhang, Weijuan/Q-1645-2019	Zhang, Weijuan/0000-0003-3494-3114	National Natural Science Foundation of China [30890141, 30671952]; Major State Basic Research Development Program of China [2007CB512401]; Shanghai STC grant [10JC1401400, 07JC14004]; Program for Outstanding Medical Academic Leader of Shanghai [LJ06011]; Shanghai Medical College, Fudan University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); Shanghai STC grant; Program for Outstanding Medical Academic Leader of Shanghai; Shanghai Medical College, Fudan University	This work was supported by grants of National Natural Science Foundation of China (30890141, 30671952), Major State Basic Research Development Program of China (2007CB512401), Shanghai STC grant (10JC1401400, 07JC14004), Program for Outstanding Medical Academic Leader of Shanghai (LJ06011), Research Fellow Fund and Startup Fund for Young Backbone Scholars of Shanghai Medical College, Fudan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Bharadwaj D, 2001, J IMMUNOL, V166, P6735, DOI 10.4049/jimmunol.166.11.6735; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; BREATHNACH SM, 1989, J EXP MED, V170, P1433, DOI 10.1084/jem.170.4.1433; Bygrave AE, 2004, PLOS BIOL, V2, P1081, DOI 10.1371/journal.pbio.0020243; Chintalacharuvu SR, 2005, IMMUNOL LETT, V100, P202, DOI 10.1016/j.imlet.2005.03.012; Chung EY, 2007, IMMUNITY, V27, P952, DOI 10.1016/j.immuni.2007.11.014; Dupont KM, 2010, P NATL ACAD SCI USA, V107, P3305, DOI 10.1073/pnas.0905444107; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Estabrook MM, 2004, J IMMUNOL, V172, P3784, DOI 10.4049/jimmunol.172.6.3784; Fenton K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008474; Gao B, 2009, HEPATOLOGY, V50, P424, DOI 10.1002/hep.23011; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Gillmore JD, 2004, IMMUNOLOGY, V112, P255, DOI 10.1111/j.1365-2567.2004.01860.x; Hale MB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006756; Hoffmann MH, 2010, J AUTOIMMUN, V34, pJ178, DOI 10.1016/j.jaut.2009.11.013; Ito T, 2009, J CLIN INVEST, V119, P33, DOI 10.1172/JCI35647; Kotzin BL, 1996, CELL, V85, P303, DOI 10.1016/S0092-8674(00)81108-3; Kuroiwa T, 1998, LUPUS, V7, P597, DOI 10.1191/096120398678920712; LAKE FR, 1994, J CLIN INVEST, V93, P1661, DOI 10.1172/JCI117148; Lu JH, 2008, NATURE, V456, P989, DOI 10.1038/nature07468; Mold C, 2001, J IMMUNOL, V166, P1200, DOI 10.4049/jimmunol.166.2.1200; MUEHRCKE RC, 1957, MEDICINE, V36, P1; Murray LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009683; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; PEPYS MB, 1987, BIOCHEM BIOPH RES CO, V148, P308, DOI 10.1016/0006-291X(87)91111-9; Qiao B, 2005, RHEUMATOLOGY, V44, P1108, DOI 10.1093/rheumatology/keh656; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schiffer L, 2008, J IMMUNOL, V180, P1938, DOI 10.4049/jimmunol.180.3.1938; Sheerin NS, 2006, J AM SOC NEPHROL, V17, P686, DOI 10.1681/ASN.2004070515; Sorensen IJ, 2000, J CLIN IMMUNOL, V20, P408, DOI 10.1023/A:1026478914129; Tamaoki T, 2005, NAT MED, V11, P11, DOI 10.1038/nm0105-11; Triantafyllopoulou A, 2010, P NATL ACAD SCI USA, V107, P3012, DOI 10.1073/pnas.0914902107; Walport MJ, 2000, NAT GENET, V25, P135, DOI 10.1038/75963; Wen ZK, 2007, RHEUMATOLOGY, V46, P1796, DOI 10.1093/rheumatology/kem275; Xu JJ, 2010, HEPATOLOGY, V52, P142, DOI 10.1002/hep.23613; Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016; Zykova SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012096	40	23	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22659	10.1371/journal.pone.0022659	http://dx.doi.org/10.1371/journal.pone.0022659			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799927	Green Submitted, Green Published, gold			2022-12-25	WOS:000293172900063
J	Zhang, YQ; Ho, SMY				Zhang, Yuqing; Ho, Samuel M. Y.			Risk Factors of Posttraumatic Stress Disorder among Survivors after the 512 Wenchuan Earthquake in China	PLOS ONE			English	Article							ADULT SURVIVORS; EVENT SCALE; SYMPTOMS; PTSD; PERSONALITY; VICTIMS; IMPACT	This study investigated the psychological reactions of survivors of the 512 Wenchuan earthquake in China and the risk factors associated with those reactions. The Impact of Event Scale-Revised (IES-R), Type D Scale-14 (DS14), a self-developed trauma experience questionniare, and a demographic questionnaire were administered to 956 earthquake survivors (389 males and 567 females) in Mianzhu, one of the cities most affected by the earthquake. The results showed that postraumatic stress disorder (PTSD) symptoms affected 84.8% of survivors one to two months after the earthquake. Significant risk factors associated with PTSD symptoms included: (1) being female; (2) older age; (3) higher exposure to traumatic events during the earthquake; and (4) negative affect in Type-D personality.	[Zhang, Yuqing] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Ho, Samuel M. Y.] City Univ Hong Kong, Dept Appl Social Studies, Hong Kong, Hong Kong, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; City University of Hong Kong	Zhang, YQ (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	munyinho@cityu.edu.hk	Ho, Samuel M.Y. M.Y./D-2454-2014	Ho, Samuel M.Y. M.Y./0000-0001-7803-1657	Institute of Psychology, CAS [O9KF014001]; National Foundation of Natural Science [71073156]; National Hi-Tech Research and Development Program of China [2008AA021204]	Institute of Psychology, CAS(Chinese Academy of Sciences); National Foundation of Natural Science(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This study was supported by the Development Fund of the Institute of Psychology, CAS (O9KF014001), the National Foundation of Natural Science (No. 71073156), and the National Hi-Tech Research and Development Program of China (2008AA021204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Armenian HK, 2000, ACTA PSYCHIAT SCAND, V102, P58, DOI 10.1034/j.1600-0447.2000.102001058.x; ASSHRAF H, 2005, B WORLD HEALTH ORGAN, V83, P405; BAI JY, 2006, CHINESE MENTAL HLTH, V21, P329; Bhushan B, 2007, J LOSS TRAUMA, V12, P245, DOI 10.1080/15325020600945996; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; Denollet J, 1998, ANN BEHAV MED, V20, P209, DOI 10.1007/BF02884962; Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49; Denollet J, 2000, J PSYCHOSOM RES, V49, P255, DOI 10.1016/S0022-3999(00)00177-X; Fan F, 2011, J TRAUMA STRESS, V24, P44, DOI 10.1002/jts.20599; GARRISON CZ, 1995, J AM ACAD CHILD PSY, V34, P1193, DOI 10.1097/00004583-199509000-00017; Giannopoulou L, 2006, PERS INDIV DIFFER, V40, P1027, DOI 10.1016/j.paid.2005.11.002; GREEN BL, 1985, J CONSULT CLIN PSYCH, V53, P672; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Hsu CC, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200207000-00022; [黄国平 HUANG GuoPing], 2006, [中国心理卫生杂志, Chinese Mental Health Journal], V20, P28; Kun P, 2009, PUBLIC HEALTH, V123, P703, DOI 10.1016/j.puhe.2009.09.017; Kun P, 2009, DEPRESS ANXIETY, V26, P1134, DOI 10.1002/da.20612; Kuo HW, 2007, J PSYCHOSOM RES, V62, P495, DOI 10.1016/j.jpsychores.2004.11.012; Liu ZY, 2012, ASIA-PAC J PUBLIC HE, V24, P21, DOI 10.1177/1010539510373945; Ma XH, 2011, PSYCHIAT RES, V189, P385, DOI [10.1016/j.psychres.2010.12.016, 10.1016/j.psychres.2011.02.016]; McMillen JC, 2000, J TRAUMA STRESS, V13, P57, DOI 10.1023/A:1007768830246; Oginska-Bulik Nina, 2006, International Journal of Occupational Medicine and Environmental Health, V19, P113, DOI 10.2478/v10001-006-0016-7; TSAI M, 1979, J ABNORM PSYCHOL, V88, P407, DOI 10.1037/0021-843X.88.4.407; Wang B, 2011, PSYCHIAT RES, V187, P392, DOI 10.1016/j.psychres.2009.07.001; Wang L, 2009, PSYCHOL REP, V105, P879, DOI 10.2466/PR0.105.3.879-885; Wang L, 2009, J TRAUMA STRESS, V22, P444, DOI 10.1002/jts.20439; Wang XD, 2000, AM J PSYCHIAT, V157, P1260, DOI 10.1176/appi.ajp.157.8.1260; Weiss Daniel S., 1997, P399; Yule W., 2002, TRAUMATOLOGY, V8, P160, DOI DOI 10.1177/153476560200800304; Zhang Z, 2011, PUBLIC HEALTH, V125, P293, DOI 10.1016/j.puhe.2010.12.008	31	74	81	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22371	10.1371/journal.pone.0022371	http://dx.doi.org/10.1371/journal.pone.0022371			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	798AP	21799838	Green Published, gold			2022-12-25	WOS:000293172900025
J	Baggott, S; Palermo, R; Williams, MA				Baggott, Samantha; Palermo, Romina; Williams, Mark A.			Involuntary Facial Expression Processing: Extracting Information from Two Simultaneously Presented Faces	PLOS ONE			English	Article							AMYGDALA RESPONSES; BINOCULAR-RIVALRY; ATTENTION; INTERFERENCE; WORDS; TASK; STIMULI; FEARFUL; HAPPY	Facial expressions play an important role in successful social interactions, with previous research suggesting that facial expressions may be processed involuntarily. In the current study, we investigate whether involuntary processing of facial expressions would also occur when facial expression distractors are simultaneously presented in the same spatial location as facial expression targets. Targets and distractors from another stimulus class (lions) were also used. Results indicated that angry facial expression distractors interfered more than neutral face distractors with the ability to respond to both face and lion targets. These findings suggest that information from angry facial expressions can be extracted rapidly from a very brief presentation (50 ms), providing compelling evidence that angry facial expressions are processed involuntarily.	[Baggott, Samantha; Williams, Mark A.] Macquarie Univ, ARC Ctr Cognit & its Disorders, Sydney, NSW 2109, Australia; [Baggott, Samantha; Williams, Mark A.] Macquarie Univ, MACCS, Sydney, NSW 2109, Australia; [Palermo, Romina] Australian Natl Univ, Dept Psychol, ARC Ctr Cognit & its Disorders, Canberra, ACT, Australia	Macquarie University; Macquarie University; Australian National University	Baggott, S (corresponding author), Macquarie Univ, ARC Ctr Cognit & its Disorders, Sydney, NSW 2109, Australia.	samantha.baggott@mq.edu.au	Palermo, Romina/G-2533-2014	Palermo, Romina/0000-0002-8678-4592; Williams, Mark/0000-0002-3897-5167	Australian Postgraduate Award; Australian Research Council [DP0984919]; John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development	Australian Postgraduate Award(Australian Government); Australian Research Council(Australian Research Council); John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development	SB is supported by an Australian Postgraduate Award. MAW is a Queen Elizabeth II Fellow supported by the Australian Research Council (http://www.arc.gov.au/), Fellowship Schemes: DP0984919. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; For details regarding the NimStim facial expressions see http://macbrain.org/resources.htm. Development of the MacBrain Face Stimulus Set was overseen by Nim Tottenham and supported by the John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development. Please contact Nim Tottenham at: tott0006@tc.umn.edu for more information concerning the stimulus set. We thank Anina Rich, Tracey Shaw, Megan Willis and two anonymous reviewers for their comments on earlier versions of this manuscript, and Tess Veuthey for her involvement in the creation of the stimuli.	Anderson AK, 2003, J NEUROSCI, V23, P5627; Baggott S, 2011, COGNITION EMOTION, V25, P369, DOI 10.1080/02699931.2010.488945; Beall P, 2008, COGNITION EMOTION, V22, P1613, DOI 10.1080/02699930801940370; Bindemann M, 2005, COGNITION, V98, P177, DOI 10.1016/j.cognition.2004.11.004; Boutet I, 2001, PERCEPTION, V30, P743, DOI 10.1068/p3183; Carlson TA, 2004, NEURON, V43, P907, DOI 10.1016/j.neuron.2004.08.039; Chen XC, 2004, CURR BIOL, V14, P1013, DOI 10.1016/j.cub.2004.05.042; FARAH MJ, 1991, COGNITIVE NEUROPSYCH, V8, P1, DOI 10.1080/02643299108253364; GLASER WR, 1989, J EXP PSYCHOL GEN, V118, P13, DOI 10.1037/0096-3445.118.1.13; HANSEN CH, 1988, J PERS SOC PSYCHOL, V54, P917, DOI 10.1037/0022-3514.54.6.917; He CH, 2010, PSYCHOL RES-PSYCH FO, V74, P268, DOI 10.1007/s00426-009-0252-0; Horstmann G, 2006, EMOTION, V6, P193, DOI 10.1037/1528-3542.6.2.193; Jenkins R, 2003, PERCEPT PSYCHOPHYS, V65, P298, DOI 10.3758/BF03194801; Lavie N, 2003, PSYCHOL SCI, V14, P510, DOI 10.1111/1467-9280.03453; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Megreya AM, 2006, APPL COGNITIVE PSYCH, V20, P957, DOI 10.1002/acp.1243; Palermo R, 2002, COGNITION, V82, P225, DOI 10.1016/S0010-0277(01)00160-3; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Preston SD, 2008, COGN AFFECT BEHAV NE, V8, P54, DOI 10.3758/CABN.8.1.54; Stenberg G, 1998, COGNITION EMOTION, V12, P755, DOI 10.1080/026999398379420; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Williams MA, 2004, J NEUROSCI, V24, P2898, DOI 10.1523/JNEUROSCI.4977-03.2004; Williams MA, 2005, NEUROIMAGE, V24, P417, DOI 10.1016/j.neuroimage.2004.08.017; Wolfe Jeremy M., 2005, P101, DOI 10.1016/B978-012375731-9/50021-5; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; YOUNG AW, 1986, J EXP PSYCHOL HUMAN, V12, P466, DOI 10.1037/0096-1523.12.4.466	27	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22287	10.1371/journal.pone.0022287	http://dx.doi.org/10.1371/journal.pone.0022287			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	797BJ	21799813	Green Published, Green Submitted, gold			2022-12-25	WOS:000293097300026
J	Cassado, AD; de Albuquerque, JAT; Sardinha, LR; Buzzo, CD; Faustino, L; Nascimento, R; Ghosn, EEB; Lima, MRD; Alvarez, JMM; Bortoluci, KR				Cassado, Alexandra dos Anjos; Tavares de Albuquerque, Jose Antonio; Sardinha, Luiz Roberto; Buzzo, Carina de Lima; Faustino, Lucas; Nascimento, Rogerio; Ghosn, Eliver Eid Bou; D'Imperio Lima, Maria Regina; Mosig Alvarez, Jose Maria; Bortoluci, Karina Ramalho			Cellular Renewal and Improvement of Local Cell Effector Activity in Peritoneal Cavity in Response to Infectious Stimuli	PLOS ONE			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; PATTERN-RECOGNITION RECEPTORS; FLOW-CYTOMETRY; IFN-GAMMA; ANTIGEN PRESENTATION; DENDRITIC CELLS; IN-VIVO; HETEROGENEITY; POPULATIONS; MECHANISMS	The peritoneal cavity (PerC) is a singular compartment where many cell populations reside and interact. Despite the widely adopted experimental approach of intraperitoneal (i.p.) inoculation, little is known about the behavior of the different cell populations within the PerC. To evaluate the dynamics of peritoneal macrophage (Mempty set) subsets, namely small peritoneal Mempty set (SPM) and large peritoneal Mempty set (LPM), in response to infectious stimuli, C57BL/6 mice were injected i.p. with zymosan or Trypanosoma cruzi. These conditions resulted in the marked modification of the PerC myelo-monocytic compartment characterized by the disappearance of LPM and the accumulation of SPM and monocytes. In parallel, adherent cells isolated from stimulated PerC displayed reduced staining for beta-galactosidase, a biomarker for senescence. Further, the adherent cells showed increased nitric oxide (NO) and higher frequency of IL-12-producing cells in response to subsequent LPS and IFN-gamma stimulation. Among myelo-monocytic cells, SPM rather than LPM or monocytes, appear to be the central effectors of the activated PerC; they display higher phagocytic activity and are the main source of IL-12. Thus, our data provide a first demonstration of the consequences of the dynamics between peritoneal Mempty set subpopulations by showing that substitution of LPM by a robust SPM and monocytes in response to infectious stimuli greatly improves PerC effector activity.	[Cassado, Alexandra dos Anjos; Buzzo, Carina de Lima; Bortoluci, Karina Ramalho] Univ Fed Sao Paulo, Dept Ciencias Biol, Sao Paulo, Brazil; [Cassado, Alexandra dos Anjos; Tavares de Albuquerque, Jose Antonio; Buzzo, Carina de Lima; Faustino, Lucas; Nascimento, Rogerio; D'Imperio Lima, Maria Regina; Mosig Alvarez, Jose Maria] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508 Sao Paulo, Brazil; [Sardinha, Luiz Roberto] Inst Israelita Ensino & Pesquisa Albert Einstein, Sao Paulo, Brazil; [Ghosn, Eliver Eid Bou] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Cassado, Alexandra dos Anjos; Buzzo, Carina de Lima; Bortoluci, Karina Ramalho] Univ Fed Sao Paulo, Ctr Terapia Celular & Mol CTC Mol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Hospital Israelita Albert Einstein; Stanford University; Universidade Federal de Sao Paulo (UNIFESP)	Cassado, AD (corresponding author), Univ Fed Sao Paulo, Dept Ciencias Biol, Campus Diadema, Sao Paulo, Brazil.	kbortoluci@gmail.com	Alvarez, Jose M/I-6181-2012; Ghosn, Eliver/AAO-5788-2020; Cassado, Alexandra/J-1680-2015; D'Império Lima, Maria Regina/I-4747-2012; Sardinha, Luiz Roberto/C-2367-2012; Bortoluci, Karina/P-9296-2019; Bortoluci, Karina/C-6018-2012; Faustino, Lucas D./G-7642-2014	Alvarez, Jose M/0000-0002-9711-4914; Ghosn, Eliver/0000-0001-7258-906X; D'Império Lima, Maria Regina/0000-0002-4683-7709; Bortoluci, Karina/0000-0001-6780-5397; Bortoluci, Karina/0000-0001-6780-5397; Faustino, Lucas D./0000-0002-9535-3735	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Brazil) [08/50958-8]; Brazilian Research Council (CNPq-Brazil); CAPES	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Research Council (CNPq-Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Brazil) (grant 08/50958-8 to KRB), Brazilian Research Council (CNPq-Brazil) and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Aliberti J, 2005, NAT REV IMMUNOL, V5, P162, DOI 10.1038/nri1547; Bastos KRB, 2007, J INTERF CYTOK RES, V27, P399, DOI 10.1089/jir.2007.0128; Bastos KRB, 2004, MICROBES INFECT, V6, P630, DOI 10.1016/j.micinf.2004.02.012; Bastos KRB, 2002, J LEUKOCYTE BIOL, V71, P271; Bogdan C, 2006, TRENDS IMMUNOL, V27, P282, DOI 10.1016/j.it.2006.04.004; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; CECILIO CA, 2011, BRAZ J MED BIOL RES; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dioszeghy V, 2008, J IMMUNOL, V181, P6514, DOI 10.4049/jimmunol.181.9.6514; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Herrero C, 2002, EXP GERONTOL, V37, P389, DOI 10.1016/S0531-5565(01)00205-4; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; JUNG T, 1993, J IMMUNOL METHODS, V159, P197, DOI 10.1016/0022-1759(93)90158-4; Kovacs EJ, 2009, TRENDS IMMUNOL, V30, P319, DOI 10.1016/j.it.2009.03.012; Lloberas J, 2002, EXP GERONTOL, V37, P1325, DOI 10.1016/S0531-5565(02)00125-0; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez-Pomares L, 2007, CELL, V131, P641, DOI 10.1016/j.cell.2007.10.046; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Noel W, 2004, TRENDS PARASITOL, V20, P126, DOI 10.1016/j.pt.2004.01.004; Plackett TP, 2004, J LEUKOCYTE BIOL, V76, P291, DOI 10.1189/jlb.1103592; Plowden J, 2004, AGING CELL, V3, P161, DOI 10.1111/j.1474-9728.2004.00102.x; Rodriguez-Sosa M, 2002, INFECT IMMUN, V70, P3656, DOI 10.1128/IAI.70.7.3656-3664.2002; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; Rosas M, 2010, J LEUKOCYTE BIOL, V88, P169, DOI 10.1189/jlb.0809548; Schleicher U, 2005, BLOOD, V105, P1319, DOI 10.1182/blood-2004-05-1749; Schleicher Ulrike, 2009, V531, P203, DOI 10.1007/978-1-59745-396-7_14; Taylor PR, 2003, EUR J IMMUNOL, V33, P2090, DOI 10.1002/eji.200324003; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; VILLACRESERIKSSON M, 1995, CLIN EXP IMMUNOL, V102, P46	36	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22141	10.1371/journal.pone.0022141	http://dx.doi.org/10.1371/journal.pone.0022141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799778	Green Submitted, Green Published, gold			2022-12-25	WOS:000293097300017
J	Nunes, FLD; Norris, RD; Knowlton, N				Nunes, Flavia L. D.; Norris, Richard D.; Knowlton, Nancy			Long Distance Dispersal and Connectivity in Amphi-Atlantic Corals at Regional and Basin Scales	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENE FLOW; SIDERASTREA-STELLATA; LARVAL METAMORPHOSIS; GENOTYPIC DIVERSITY; SPECIES BOUNDARIES; MITOCHONDRIAL-DNA; CARIBBEAN CORALS; SPAWNING CORALS; PLANULA LARVAE	Among Atlantic scleractinian corals, species diversity is highest in the Caribbean, but low diversity and high endemism are observed in various peripheral populations in central and eastern Atlantic islands and along the coasts of Brazil and West Africa. The degree of connectivity between these distantly separated populations is of interest because it provides insight into processes at both evolutionary and ecological time scales, such as speciation, recruitment dynamics and the persistence of coral populations. To assess connectivity in broadly distributed coral species of the Atlantic, DNA sequence data from two nuclear markers were obtained for six coral species spanning their distributional ranges. At basin-wide scales, significant differentiation was generally observed among populations in the Caribbean, Brazil and West Africa. Concordance of patterns in connectivity among co-distributed taxa indicates that extrinsic barriers, such as the Amazon freshwater plume or long stretches of open ocean, restrict dispersal of coral larvae from region to region. Within regions, dispersal ability appears to be influenced by aspects of reproduction and life history. Two broadcasting species, Siderastrea siderea and Montastraea cavernosa, were able to maintain gene flow among populations separated by as much as 1,200 km along the coast of Brazil. In contrast, brooding species, such as Favia gravida and Siderastrea radians, had more restricted gene flow along the Brazilian coast.	[Nunes, Flavia L. D.] Univ Geneva, Lab Artificial & Nat Evolut, Geneva, Switzerland; [Nunes, Flavia L. D.; Norris, Richard D.; Knowlton, Nancy] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Knowlton, Nancy] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA	University of Geneva; University of California System; University of California San Diego; Scripps Institution of Oceanography; Smithsonian Institution; Smithsonian National Museum of Natural History	Nunes, FLD (corresponding author), Univ Geneva, Lab Artificial & Nat Evolut, Geneva, Switzerland.	nunesf@gmail.com	Nunes, Flavia/B-5041-2011; Nunes, Flavia/AAK-1390-2020	Nunes, Flavia/0000-0002-3947-6634; Nunes, Flavia/0000-0002-3947-6634	John Dove Isaacs Chair in Natural Philosophy; Center of Marine Biodiversity and Conservation	John Dove Isaacs Chair in Natural Philosophy; Center of Marine Biodiversity and Conservation	This work was supported by the John Dove Isaacs Chair in Natural Philosophy to NK, by an anonymous private donation to the SIO Graduate Department to FN, and by a Graduate Fellowship from the Center of Marine Biodiversity and Conservation to FN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATODA K, 1947, SCI REP TOHOKU U, V18, P48; Atoda K, 1951, BIOLOGY, V19, P33; ATODA KENJI, 1947, SCI REPTS TOHOKU IMP UNIV SER 4, V18, P24; Ayre DJ, 2004, ECOL LETT, V7, P273, DOI 10.1111/j.1461-0248.2004.00585.x; Ayre DJ, 2000, EVOLUTION, V54, P1590; BAIRD A, 1998, AUST CORAL REEF SOC, V27, P6; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Bowen BW, 2006, MAR BIOL, V149, P899, DOI 10.1007/s00227-006-0252-1; Brazeau DA, 2005, MAR BIOL, V147, P1141, DOI 10.1007/s00227-005-0022-5; Brazeau DA, 1998, J EXP MAR BIOL ECOL, V231, P225, DOI 10.1016/S0022-0981(98)00097-5; Calderon EN, 2000, ZOOLOGIA, V429, P1; Chen IP, 2009, MAR BIOTECHNOL, V11, P141, DOI 10.1007/s10126-008-9129-2; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Concepcion GT, 2010, MAR ECOL PROG SER, V401, P113, DOI 10.3354/meps08364; Coyne JA, 2004, SPECIATION, V37; Edmunds PJ, 2001, MAR BIOL, V139, P981; EXCOFFIER L, 2005, EVOLUTIONARY BIOINFO; Fadlallah Y.H., 1983, Coral Reefs, V2, P129, DOI 10.1007/BF00336720; FAHRIG L, 1985, ECOLOGY, V66, P1762, DOI 10.2307/2937372; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Gavrilets S, 2003, EVOLUTION, V57, P2197; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; HOORN C, 1995, GEOLOGY, V23, P237, DOI 10.1130/0091-7613(1995)023<0237:ATAACF>2.3.CO;2; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; LABOREL J, 1969, ANN I OCEANOGR PARIS, V47, P171; Laborel J., 1974, P 2 INT COR REEF S, V1, P425; Laborel J, 1969, ANN U ABIDJAN E; LENTZ SJ, 1995, J GEOPHYS RES-OCEANS, V100, P2391, DOI 10.1029/94JC01847; Lessios HA, 2001, EVOLUTION, V55, P955, DOI 10.1554/0014-3820(2001)055[0955:PSASIT]2.0.CO;2; Lessios HA, 1999, EVOLUTION, V53, P806, DOI 10.1111/j.1558-5646.1999.tb05374.x; Lessios HA, 2003, EVOLUTION, V57, P2026, DOI 10.1554/02-681; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McCartney MA, 2000, MOL ECOL, V9, P1391, DOI 10.1046/j.1365-294x.2000.01022.x; Miller K, 2003, CORAL REEFS, V22, P99, DOI 10.1007/s00338-003-0290-9; Miller KJ, 2008, J ANIM ECOL, V77, P713, DOI 10.1111/j.1365-2656.2008.01387.x; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; MULLERKARGER FE, 1988, NATURE, V333, P56, DOI 10.1038/333056a0; Muss A, 2001, EVOLUTION, V55, P561, DOI 10.1111/j.0014-3820.2001.tb00789.x; Neves EG, 2003, HYDROBIOLOGIA, V501, P139, DOI 10.1023/A:1026235832253; Neves E, 2006, ZOOTAXA, P45, DOI 10.11646/zootaxa.1366.1.2; Neves Elizabeth G., 2010, Check List, V6, P505; Neves EG, 2008, GENETICA, V132, P243, DOI 10.1007/s10709-007-9168-z; Nikiema O, 2007, CONT SHELF RES, V27, P873, DOI 10.1016/j.csr.2006.12.004; Nunes F, 2008, CORAL REEFS, V27, P423, DOI 10.1007/s00338-007-0349-0; Nunes F, 2009, MOL ECOL, V18, P4283, DOI 10.1111/j.1365-294X.2009.04347.x; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; PAWLIK JR, 1992, OCEANOGR MAR BIOL, V30, P273; Richards CM, 2000, AM NAT, V155, P383, DOI 10.1086/303324; RICHMOND RH, 1987, MAR BIOL, V93, P527, DOI 10.1007/BF00392790; Rocha LA, 2004, COPEIA, P770, DOI 10.1643/CG-04-106; Rocha LA, 2002, MOL ECOL, V11, P243, DOI 10.1046/j.0962-1083.2001.01431.x; Severance EG, 2006, MAR BIOL, V150, P57, DOI 10.1007/s00227-006-0332-2; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; SOONG K, 1991, B MAR SCI, V49, P832; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; SZMANT AM, 1986, CORAL REEFS, V5, P43, DOI 10.1007/BF00302170; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Thiel M, 2005, OCEANOGR MAR BIOL, V43, P279; Van Oppen MJH, 2000, MOL ECOL, V9, P1363, DOI 10.1046/j.1365-294x.2000.01010.x; Vermeij MJA, 2006, MAR ECOL PROG SER, V310, P119, DOI 10.3354/meps310119; Veron J.E.N., 2000, CORALS WORLD, V1-3; Vollmer SV, 2007, J HERED, V98, P40, DOI 10.1093/jhered/esl057; Wright S, 1931, GENETICS, V16, P0097	70	71	72	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22298	10.1371/journal.pone.0022298	http://dx.doi.org/10.1371/journal.pone.0022298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799816	Green Submitted, Green Published, gold			2022-12-25	WOS:000293097300028
J	Dutton, AJ; Hepburn, C; Macdonald, DW				Dutton, Adam J.; Hepburn, Cameron; Macdonald, David W.			A Stated Preference Investigation into the Chinese Demand for Farmed vs. Wild Bear Bile	PLOS ONE			English	Article							URSODEOXYCHOLIC ACID; HEALTH	Farming of animals and plants has recently been considered not merely as a more efficient and plentiful supply of their products but also as a means of protecting wild populations from that trade. Amongst these nascent farming products might be listed bear bile. Bear bile has been exploited by traditional Chinese medicinalists for millennia. Since the 1980s consumers have had the options of: illegal wild gall bladders, bile extracted from caged live bears or the acid synthesised chemically. Despite these alternatives bears continue to be harvested from the wild. In this paper we use stated preference techniques using a random sample of the Chinese population to estimate demand functions for wild bear bile with and without competition from farmed bear bile. We find a willingness to pay considerably more for wild bear bile than farmed. Wild bear bile has low own price elasticity and cross price elasticity with farmed bear bile. The ability of farmed bear bile to reduce demand for wild bear bile is at best limited and, at prevailing prices, may be close to zero or have the opposite effect. The demand functions estimated suggest that the own price elasticity of wild bear bile is lower when competing with farmed bear bile than when it is the only option available. This means that the incumbent product may actually sell more items at a higher price when competing than when alone in the market. This finding may be of broader interest to behavioural economists as we argue that one explanation may be that as product choice increases price has less impact on decision making. For the wildlife farming debate this indicates that at some prices the introduction of farmed competition might increase the demand for the wild product.	[Dutton, Adam J.; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Oxford OX1 3PS, England; [Hepburn, Cameron] Univ Oxford, Smith Sch Enterprise & Environm, Said Business Sch, Oxford, England; [Hepburn, Cameron] Univ Oxford, James Martin Inst, Said Business Sch, Oxford, England	University of Oxford; University of Oxford; University of Oxford	Dutton, AJ (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, S Parks Rd, Oxford OX1 3PS, England.	adam.dutton@zoo.ox.ac.uk		Hepburn, Cameron/0000-0003-0467-7441	World Society for the Protection of Animals (WSPA)	World Society for the Protection of Animals (WSPA)	The funding for this work came from the World Society for the Protection of Animals (WSPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PRESS CS CHIN STAT Y; [Anonymous], AHAN BEAR BIL FARM V; [Anonymous], 2005, FINDING HERBAL ALTER; Barclay L, 2003, ANN SURG, V238, P697; BATEMAN I., 2002, EC VALUATION STATED; Bekoff M, 2009, BEAR TAPPING BILE BU; Bensky D., 2004, MAT MED CHINESE HERB, Vthird; Blamey RK, 2000, ECOL ECON, V32, P269, DOI 10.1016/S0921-8009(99)00101-9; de Bekker-Grob EW, 2010, VALUE HEALTH, V13, P315, DOI 10.1111/j.1524-4733.2009.00670.x; Dutton A, KEY TOPICS IN PRESS; eTranslate, 2006, SHOP SURV CHIN; GARSHELIS DL, 2007, URSUS THIBETANUS ASI; Gratwicke B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002544; Group ICS, 2006, CSG STEER COMM M MON; HAGEY LR, 1993, J LIPID RES, V34, P1911; Howitt P., 1987, MONEY ILLUSION NEW P, VIII, P518; Huang J, 1994, ASIAN PERSPECTIVES T; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; Hutton J, 2003, TRADE IN WILDLIFE: REGULATION FOR CONSERVATION, P108; Ikegami T, 1998, CANCER LETT, V134, P129, DOI 10.1016/S0304-3835(98)00248-1; IUCN, IUCN RED LIST THREAT; Kanazawa T, 1954, P JPN ACAD, V30, P391, DOI 10.2183/pjab1945.30.391; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Loeffler IK, 2009, ANIM WELFARE, V18, P225; Mainka SA, 1995, J ZOO WILDLIFE MED, V26, P193; Mills J, 1994, ASIAN TRADE BEARS BE, P161; MISHAN EJ, 1971, J POLIT ECON, V79, P687, DOI 10.1086/259784; Nowell K., 2000, FAR CURE TIGER TRADE; Peppin L, 2008, J FORENSIC SCI, V53, P1358, DOI 10.1111/j.1556-4029.2008.00857.x; Peyton B., 1999, BEARS STATUS SURVEY; Phillips T, 2002, BEAR BILE BUSINESS; Raloff J, 2005, SCI NEWS, V168, P250; Roda E, 2002, DIGEST LIVER DIS, V34, P523, DOI 10.1016/S1590-8658(02)80112-8; Servheen C., 1994, P INT S TRAD BEAR PA; Shoda M, 1927, J BIOCH, V7, P505; Tanaka MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005192; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; WSPA, 2010, INS BEAR FARMS; Wyler LS, 2009, INT ILLEGAL WILDLIFE	39	65	67	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e21243	10.1371/journal.pone.0021243	http://dx.doi.org/10.1371/journal.pone.0021243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799733	Green Published, gold, Green Submitted			2022-12-25	WOS:000292931200006
J	Akbar, H; Shang, X; Perveen, R; Berryman, M; Funk, K; Johnson, JF; Tandon, NN; Zheng, Y				Akbar, Huzoor; Shang, Xun; Perveen, Rehana; Berryman, Mark; Funk, Kevin; Johnson, James F.; Tandon, Narendra N.; Zheng, Yi			Gene Targeting Implicates Cdc42 GTPase in GPVI and Non-GPVI Mediated Platelet Filopodia Formation, Secretion and Aggregation	PLOS ONE			English	Article							MOUSE EMBRYONIC FIBROBLASTS; RHO-GTPASES; AKT PHOSPHORYLATION; ACTIN CYTOSKELETON; SIGNALING PATHWAYS; INSULIN-SECRETION; BINDING-PROTEIN; MAST-CELLS; ACTIVATION; RECEPTOR	Background: Cdc42 and Rac1, members of the Rho family of small GTPases, play critical roles in actin cytoskeleton regulation. We have shown previously that Rac1 is involved in regulation of platelet secretion and aggregation. However, the role of Cdc42 in platelet activation remains controversial. This study was undertaken to better understand the role of Cdc42 in platelet activation. Methodology/Principal Findings: We utilized the Mx-cre; Cdc42(lox/lox) inducible mice with transient Cdc42 deletion to investigate the involvement of Cdc42 in platelet function. The Cdc42-deficient mice exhibited a significantly reduced platelet count than the matching Cdc42(+/+) mice. Platelets isolated from Cdc42(-/-), as compared to Cdc42(+/+), mice exhibited (a) diminished phosphorylation of PAK1/2, an effector molecule of Cdc42, (b) inhibition of filopodia formation on immobilized CRP or fibrinogen, (c) inhibition of CRP- or thrombin-induced secretion of ATP and release of P-selectin, (d) inhibition of CRP, collagen or thrombin induced platelet aggregation, and (e) minimal phosphorylation of Akt upon stimulation with CRP or thrombin. The bleeding times were significantly prolonged in Cdc42(-/-) mice compared with Cdc42(+/+) mice. Conclusion/Significance: Our data demonstrate that Cdc42 is required for platelet filopodia formation, secretion and aggregation and therefore plays a critical role in platelet mediated hemostasis and thrombosis.	[Akbar, Huzoor; Perveen, Rehana; Berryman, Mark; Funk, Kevin] Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA; [Shang, Xun; Johnson, James F.; Zheng, Yi] Univ Cincinnati, Childrens Hosp, Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH USA; [Tandon, Narendra N.] Otsuka Maryland Med Labs, Rockville, MD USA	University System of Ohio; Ohio University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Akbar, H (corresponding author), Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA.	akbar@ohio.edu	Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074	National Institutes of Health [R01 HL085362, R01 CA125658 S1]; American Heart Association Ohio Valley Affiliate; RSAC at OUCOM; Higher Education Commission of Pakistan; NATIONAL CANCER INSTITUTE [R01CA125658] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Ohio Valley Affiliate(American Heart Association); RSAC at OUCOM; Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants R01 HL085362 and R01 CA125658 S1 (to YZ) and grants from the American Heart Association Ohio Valley Affiliate and the RSAC at OUCOM (to HA). Rehana Perveen was supported by a post-doctoral fellowship from the Higher Education Commission of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar H, 2007, J THROMB HAEMOST, V5, P1747, DOI 10.1111/j.1538-7836.2007.02646.x; Azim AC, 2000, BLOOD, V95, P959, DOI 10.1182/blood.V95.3.959.003k22_959_964; Cambien B, 2003, J CLIN INVEST, V112, P1589, DOI 10.1172/JCI200319284; Chang JC, 2005, J BIOMED SCI, V12, P881, DOI 10.1007/s11373-005-9021-2; Cho MJ, 2002, BLOOD, V99, P2442, DOI 10.1182/blood.V99.7.2442; DASH D, 1995, J BIOL CHEM, V270, P17321, DOI 10.1074/jbc.270.29.17321; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FOX JEB, 1993, ADV EXP MED BIOL, V344, P175; Guo FK, 2010, P NATL ACAD SCI USA, V107, P18505, DOI 10.1073/pnas.1010249107; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hong-Geller E, 2001, P NATL ACAD SCI USA, V98, P1154, DOI 10.1073/pnas.98.3.1154; Hong-Geller E, 2000, J CELL BIOL, V148, P481, DOI 10.1083/jcb.148.3.481; HUZOOR A, 1993, P NATL ACAD SCI USA, V90, P868; HUZOOR A, 1991, J BIOL CHEM, V266, P4387; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Jirouskova M, 2007, BLOOD, V109, P5260, DOI 10.1182/blood-2006-10-054015; Jones NP, 2007, MOL CELL BIOL, V27, P5790, DOI 10.1128/MCB.00778-07; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Kim S, 2009, J BIOL CHEM, V284, P33763, DOI 10.1074/jbc.M109.048553; Kroner C, 2000, J BIOL CHEM, V275, P27790, DOI 10.1074/jbc.M000540200; Li JS, 2004, AM J PHYSIOL-ENDOC M, V286, pE818, DOI 10.1152/ajpendo.00307.2003; Li ZY, 2003, J BIOL CHEM, V278, P30725, DOI 10.1074/jbc.M301838200; Lockyer S, 2006, THROMB RES, V118, P371, DOI 10.1016/j.thromres.2005.08.001; Momboisse F, 2009, J CELL SCI, V122, P798, DOI 10.1242/jcs.038109; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Pleines I, 2010, BLOOD, V115, P3364, DOI 10.1182/blood-2009-09-242271; POLAKIS PG, 1989, BIOCHEM BIOPH RES CO, V160, P25, DOI 10.1016/0006-291X(89)91615-X; Pula G, 2008, PLATELETS, V19, P199, DOI 10.1080/09537100701777303; Quinton TM, 2004, J THROMB HAEMOST, V2, P978, DOI 10.1111/j.1538-7836.2004.00741.x; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Shcherbina A, 2010, BRIT J HAEMATOL, V148, P416, DOI 10.1111/j.1365-2141.2009.07959.x; Smith SD, 2008, J CELL SCI, V121, P3729, DOI 10.1242/jcs.027680; Szczur K, 2009, BLOOD, V114, P4527, DOI 10.1182/blood-2008-12-195164; TEO M, 1995, J BIOL CHEM, V270, P26690, DOI 10.1074/jbc.270.44.26690; Thurmond DC, 2009, ENDOCRINOLOGY, V150, P5202, DOI 10.1210/en.2009-1178; Vidal C, 2002, BLOOD, V100, P4462, DOI 10.1182/blood.V100.13.4462; Vidali L, 2006, MOL BIOL CELL, V17, P2377, DOI 10.1091/mbc.e05-10-0955; Wang ZX, 2007, J BIOL CHEM, V282, P9536, DOI 10.1074/jbc.M610553200; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Weng Z, 2010, BLOOD, V116, P2579, DOI 10.1182/blood-2010-03-277236; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; Xiang B, 2010, J THROMB HAEMOST, V8, P2032, DOI 10.1111/j.1538-7836.2010.03969.x; Yang FC, 2001, P NATL ACAD SCI USA, V98, P5614, DOI 10.1073/pnas.101546898; Yang L, 2007, BLOOD, V110, P3853, DOI 10.1182/blood-2007-03-079582; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466	48	43	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22117	10.1371/journal.pone.0022117	http://dx.doi.org/10.1371/journal.pone.0022117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789221	Green Published, gold, Green Submitted			2022-12-25	WOS:000292812400032
J	Harbitz, E; Andersson, KK				Harbitz, Espen; Andersson, K. Kristoffer			Cytochrome c-554 from Methylosinus trichosporium OB3b; a Protein That Belongs to the Cytochrome c2 Family and Exhibits a HALS-Type EPR Signal	PLOS ONE			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; SOLUBLE METHANE MONOOXYGENASE; AMINO-ACID-SEQUENCE; NITROSOMONAS-EUROPAEA; METHYLOCOCCUS-CAPSULATUS; RHODOBACTER-SPHAEROIDES; CRYSTAL-STRUCTURE; GENOME SEQUENCE; HEME-PROTEINS; BIS-HISTIDINE	A small soluble cytochrome c-554 purified from Methylosinus trichosporium OB3b has been purified and analyzed by amino acid sequencing, mass spectrometry, visible, CD and EPR spectroscopies. It is found to be a mono heme protein with a characteristic cytochrome c fold, thus fitting into the class of cytochrome c(2), which is the bacterial homologue of mitochondrial cytochrome c. The heme iron has a Histidine/Methionine axial ligation and exhibits a highly anisotropic/axial low spin (HALS) EPR signal, with a g(max) at 3.40, and ligand field parameters V/xi = 0.99, Delta/xi = 4.57. This gives the rhombicity V/Delta = 0.22. The structural basis for this HALS EPR signal in Histidine/Methionine ligated hemes is not resolved. The ligand field parameters observed for cytochrome c-554 fits the observed pattern for other cytochromes with similar ligation and EPR behaviour.	[Harbitz, Espen; Andersson, K. Kristoffer] Univ Oslo, Dept Mol Biosci, Oslo, Norway	University of Oslo	Harbitz, E (corresponding author), Univ Oslo, Dept Mol Biosci, Oslo, Norway.	k.k.andersson@imbv.uio.no			Norwegian Research Council [157855, 177661/V30]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This research was funded by the Norwegian Research Council (grant number 157855 [to EH] and grant number 177661/V30 [to KKA]). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMBLER RP, 1986, BIOCHEM J, V233, P333, DOI 10.1042/bj2330333; ANDERSSON KK, 1986, J BIOL CHEM, V261, P1126; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; ARCIERO DM, 1994, FEBS LETT, V342, P217, DOI 10.1016/0014-5793(94)80504-0; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; AXELROD HL, 1994, ACTA CRYSTALLOGR D, V50, P596, DOI 10.1107/S0907444994001319; Balasubramanian R, 2007, ACCOUNTS CHEM RES, V40, P573, DOI 10.1021/ar700004s; Banci L, 1999, J BIOL INORG CHEM, V4, P824, DOI 10.1007/s007750050356; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benini S, 2000, BIOCHEMISTRY-US, V39, P13115, DOI 10.1021/bi000402j; Berry EA, 2008, J BIOL INORG CHEM, V13, P481, DOI 10.1007/s00775-008-0372-9; Bertini I, 2006, CHEM REV, V106, P90, DOI 10.1021/cr050241v; Bothe H, 2002, APPL MICROBIOL BIOT, V59, P33, DOI 10.1007/s00253-002-0964-1; Bowman SEJ, 2008, NAT PROD REP, V25, P1118, DOI 10.1039/b717196j; BRUDVIG GW, 1995, METHOD ENZYMOL, V246, P536; BUSHNELL GW, 1990, J MOL BIOL, V214, P585, DOI 10.1016/0022-2836(90)90200-6; Carrell CJ, 1999, BIOCHEMISTRY-US, V38, P9590, DOI 10.1021/bi9903190; CORNISH A, 1984, J GEN MICROBIOL, V130, P2565; DALES SL, 1995, BIOCHEM J, V312, P261, DOI 10.1042/bj3120261; DEVRIES S, 1979, BIOCHIM BIOPHYS ACTA, V546, P334; Drepper F, 1997, BIOCHEMISTRY-US, V36, P1428, DOI 10.1021/bi961351m; EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283; FALK JE, 1964, PORPHYRINS METALLOPO, P181; FINZEL BC, 1985, J MOL BIOL, V186, P627, DOI 10.1016/0022-2836(85)90135-4; FONTANA A, 1973, FEBS LETT, V32, P135, DOI 10.1016/0014-5793(73)80756-2; FOX BG, 1990, BIOCHEMISTRY-US, V29, P6419, DOI 10.1021/bi00479a013; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GROSS E, 1961, J AM CHEM SOC, V83, P1510, DOI 10.1021/ja01467a052; Hakemian AS, 2007, ANNU REV BIOCHEM, V76, P223, DOI 10.1146/annurev.biochem.76.061505.175355; HEDERSTEDT L, 1986, J BACTERIOL, V167, P735, DOI 10.1128/jb.167.2.735-739.1986; HOOPER AB, 1985, MICROBIOL REV, V49, P140, DOI 10.1128/MMBR.49.2.140-157.1985; Kjaeraas S, 2006, AMYLOID, V13, P260, DOI 10.1080/13506120600960767; Lancaster CRD, 1996, PHOTOSYNTH RES, V48, P65, DOI 10.1007/BF00040997; LIPSCOMB JD, 1994, ANNU REV MICROBIOL, V48, P371, DOI 10.1146/annurev.mi.48.100194.002103; MAGNUSSON KE, 1976, BIOTECHNOL BIOENG, V18, P975, DOI 10.1002/bit.260180710; Robinson, 1982, CYCLOTRONS CYTOCHROM, P263, DOI 10.1016/B978-0-12-397580-5.50026-0; SALEMME FR, 1973, J BIOL CHEM, V248, P3910; SALERNO JC, 1984, J BIOL CHEM, V259, P2331; SALMEEN I, 1968, J CHEM PHYS, V48, P2049, DOI 10.1063/1.1669014; Semrau JD, 2010, FEMS MICROBIOL REV, V34, P496, DOI 10.1111/j.1574-6976.2010.00212.x; SOGABE S, 1995, J MOL BIOL, V252, P235, DOI 10.1006/jmbi.1995.0491; Stein LY, 2010, J BACTERIOL, V192, P6497, DOI 10.1128/JB.01144-10; STELLWAGEN E, 1974, BIOCHEM BIOPH RES CO, V60, P371, DOI 10.1016/0006-291X(74)90214-9; Sullivan JP, 1998, CRIT REV MICROBIOL, V24, P335, DOI 10.1080/10408419891294217; TAYLOR CPS, 1977, BIOCHIM BIOPHYS ACTA, V491, P137, DOI 10.1016/0005-2795(77)90049-6; Timkovich R, 1998, BIOPHYS J, V75, P1964, DOI 10.1016/S0006-3495(98)77637-4; TONGE GM, 1977, BIOCHEM J, V161, P333, DOI 10.1042/bj1610333; Walker FA, 1999, COORDIN CHEM REV, V185-6, P471, DOI 10.1016/S0010-8545(99)00029-6; WHITTENB.R, 1970, J GEN MICROBIOL, V61, P205, DOI 10.1099/00221287-61-2-205; WOOD PM, 1983, FEBS LETT, V164, P223, DOI 10.1016/0014-5793(83)80289-0; YAMANAKA T, 1974, J BIOCHEM-TOKYO, V75, P1265, DOI 10.1093/oxfordjournals.jbchem.a130510; Yatsunyk LA, 2003, J AM CHEM SOC, V125, P15986, DOI 10.1021/ja036398r; Zoppellaro G, 2006, CHEMPHYSCHEM, V7, P1258, DOI 10.1002/cphc.200500693; Zoppellaro G, 2009, BIOPOLYMERS, V91, P1064, DOI 10.1002/bip.21267; Zoppellaro G, 2008, J AM CHEM SOC, V130, P15348, DOI 10.1021/ja8033312	56	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22014	10.1371/journal.pone.0022014	http://dx.doi.org/10.1371/journal.pone.0022014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789203	Green Submitted, Green Published, gold			2022-12-25	WOS:000292812400025
J	Yan, DS; He, DD; He, SM; Chen, XY; Fan, Z; Chen, RS				Yan, Dongsheng; He, Dandan; He, Shunmin; Chen, Xiaoyan; Fan, Zhen; Chen, Runsheng			Identification and Analysis of Intermediate Size Noncoding RNAs in the Human Fetal Brain	PLOS ONE			English	Article							DENDRITIC BC1 RNA; ALZHEIMERS-DISEASE; CODING RNA; GENE; EXPRESSION; PROTEIN; GENOME; DIFFERENTIATION; PROLIFERATION; TRANSLATION	The involvement of noncoding RNAs (ncRNAs) in the development of the human brain remains largely unknown. Applying a cloning strategy for detection of intermediate size (50-500 nt) ncRNAs (is-ncRNAs) we have identified 82 novel transcripts in human fetal brain tissue. Most of the novel is-ncRNAs are not well conserved in vertebrates, and several transcripts were only found in primates. Northern blot and microarray analysis indicated considerable variation in expression across human fetal brain development stages and fetal tissues for both novel and known is-ncRNAs. Expression of several of the novel is-ncRNAs was conspicuously absent in one or two brain cancer cell lines, and transient overexpression of some transcripts in cancer cells significantly inhibited cell proliferation. Overall, our results suggest that is-ncRNAs play important roles in the development and tumorigenesis of human brain.	[Yan, Dongsheng; He, Dandan; He, Shunmin; Fan, Zhen; Chen, Runsheng] Chinese Acad Sci, Inst Biophys, Bioinformat Lab, Beijing 100080, Peoples R China; [Yan, Dongsheng; He, Dandan; He, Shunmin; Fan, Zhen; Chen, Runsheng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Yan, Dongsheng; Chen, Xiaoyan] Wenzhou Med Coll, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [He, Dandan; Fan, Zhen] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [He, Shunmin] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Wenzhou Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS	Yan, DS (corresponding author), Chinese Acad Sci, Inst Biophys, Bioinformat Lab, Beijing 100080, Peoples R China.	crs@sun5.ibp.ac.cn	Chen, Runsheng/S-9834-2017; Yan, Dongsheng/B-1861-2018; He, Shunmin/B-8037-2011	Chen, Runsheng/0000-0001-6049-8347; Yan, Dongsheng/0000-0003-0551-2219; He, Shunmin/0000-0002-7294-0865	Natural Science Foundation of China [30630040]; Ministry of Science and Technology of China [2007CB946901, 2007CB935703]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	work was supported by a Natural Science Foundation of China grant (30630040), 973 (2007CB946901 and 2007CB935703) Projects from the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Berteaux N, 2005, J BIOL CHEM, V280, P29625, DOI 10.1074/jbc.M504033200; Cannarozzi G, 2007, PLOS COMPUT BIOL, V3, P9, DOI 10.1371/journal.pcbi.0030002; CAO X, 2006, ANN REV NEUROSCI; Cavaille J, 2001, J BIOL CHEM, V276, P26374, DOI 10.1074/jbc.M103544200; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Cuellar TL, 2008, P NATL ACAD SCI USA, V105, P5614, DOI 10.1073/pnas.0801689105; Deng W, 2006, GENOME RES, V16, P20, DOI 10.1101/gr.4139206; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gallagher RC, 2002, AM J HUM GENET, V71, P669, DOI 10.1086/342408; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hertel J, 2008, BIOINFORMATICS, V24, P158, DOI 10.1093/bioinformatics/btm464; Iacoangeli A, 2004, CARCINOGENESIS, V25, P2125, DOI 10.1093/carcin/bgh228; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; KISHORE S, 2005, SCIENCE; Laurent GS, 2007, TRENDS NEUROSCI, V30, P612, DOI 10.1016/j.tins.2007.10.002; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Manji SSM, 2006, J NEUROSCI RES, V83, P181, DOI 10.1002/jnr.20721; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Mehler MF, 2006, J PHYSIOL-LONDON, V575, P333, DOI 10.1113/jphysiol.2006.113191; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Muddashetty RS, 2002, J MOL BIOL, V321, P433, DOI 10.1016/S0022-2836(02)00655-1; Mukherjee S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp318; MUS E, 2007, PNAS; Muslimov IA, 1998, J CELL BIOL, V141, P1601, DOI 10.1083/jcb.141.7.1601; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Presutti C, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S5; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Saha S, 2006, J GEN VIROL, V87, P1991, DOI 10.1099/vir.0.81768-0; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schmieder S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-330; Seemann SE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-316; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Skryabin BV, 2003, MOL CELL BIOL, V23, P6435, DOI 10.1128/MCB.23.18.6435-6441.2003; TIEDGE H, 1991, P NATL ACAD SCI USA, V88, P2093, DOI 10.1073/pnas.88.6.2093; TIEDGE H, 1993, J NEUROSCI, V13, P2382, DOI 10.1523/JNEUROSCI.13-06-02382.1993; TIEDGE H, 1993, J NEUROSCI, V13, P4214; Wang HD, 2002, J NEUROSCI, V22, P10232; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; Young TL, 2005, CURR BIOL, V15, P501, DOI 10.1016/j.cub.2005.02.027; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893	57	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e21652	10.1371/journal.pone.0021652	http://dx.doi.org/10.1371/journal.pone.0021652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789175	Green Published, gold, Green Submitted			2022-12-25	WOS:000292812400011
J	Bremmer, RH; de Bruin, DM; de Joode, M; Buma, WJ; van Leeuwen, TG; Aalders, MCG				Bremmer, Rolf H.; de Bruin, Daniel M.; de Joode, Maarten; Buma, Wybren Jan; van Leeuwen, Ton G.; Aalders, Maurice C. G.			Biphasic Oxidation of Oxy-Hemoglobin in Bloodstains	PLOS ONE			English	Article							MOLECULAR-MECHANISM; AGE; OXYHEMOGLOBIN; AUTOXIDATION; SPECTROSCOPY	Background: In forensic science, age determination of bloodstains can be crucial in reconstructing crimes. Upon exiting the body, bloodstains transit from bright red to dark brown, which is attributed to oxidation of oxy-hemoglobin (HbO(2)) to methemoglobin (met-Hb) and hemichrome (HC). The fractions of HbO(2), met-Hb and HC in a bloodstain can be used for age determination of bloodstains. In this study, we further analyze the conversion of HbO(2) to met-Hb and HC, and determine the effect of temperature and humidity on the conversion rates. Methodology: The fractions of HbO(2), met-Hb and HC in a bloodstain, as determined by quantitative analysis of optical reflectance spectra (450-800 nm), were measured as function of age, temperature and humidity. Additionally, Optical Coherence Tomography around 1300 nm was used to confirm quantitative spectral analysis approach. Conclusions: The oxidation rate of HbO(2) in bloodstains is biphasic. At first, the oxidation of HbO(2) is rapid, but slows down after a few hours. These oxidation rates are strongly temperature dependent. However, the oxidation of HbO(2) seems to be independent of humidity, whereas the transition of met-Hb into HC strongly depends on humidity. Knowledge of these decay rates is indispensable for translating laboratory results into forensic practice, and to enable bloodstain age determination on the crime scene.	[Bremmer, Rolf H.; de Bruin, Daniel M.; de Joode, Maarten; van Leeuwen, Ton G.; Aalders, Maurice C. G.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Buma, Wybren Jan] Univ Amsterdam, Van t Hoff Inst Mol Sci, Amsterdam, Netherlands; [van Leeuwen, Ton G.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; University of Twente	Bremmer, RH (corresponding author), Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.h.bremmer@amc.uva.nl	Aalders, Maurice/H-8474-2014; Buma, Wybren Jan/F-6691-2011; van Leeuwen, Ton G/C-9135-2010	Buma, Wybren Jan/0000-0002-1265-8016; van Leeuwen, Ton G/0000-0002-5642-1133; Aalders, Maurice/0000-0001-8083-9209; de Bruin, Daniel Martijn/0000-0003-3047-3637	Netherlands Organization of Scientific Research (NWO) [AGT07547]; Technology Foundation STW	Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Technology Foundation STW(Technologiestichting STW)	MCGA is funded by a personal grant (AGT07547) in the Vernieuwingsimpuls program by the Netherlands Organization of Scientific Research (NWO) and the Technology Foundation STW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalders MCG, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2337302; ANDERSON SE, 2010, J FORENSIC SCI; Bremmer RH, 2011, FORENSIC SCI INT, V206, P166, DOI 10.1016/j.forsciint.2010.07.034; Bremmer RH, 2011, BIOMED OPT EXPRESS, V2, P396, DOI 10.1364/BOE.2.000396; de Bruin DM, 2008, INVEST OPHTH VIS SCI, V49, P4545, DOI 10.1167/iovs.07-1553; de Bruin DM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3369003; Faber DJ, 2004, OPT EXPRESS, V12, P4353, DOI 10.1364/OPEX.12.004353; Fujita Y, 2005, FORENSIC SCI INT, V152, P39, DOI 10.1016/j.forsciint.2005.02.029; Hanson EK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012830; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Kanick SC, 2009, OPT EXPRESS, V17, P860, DOI 10.1364/OE.17.000860; Kellum JA, 2000, CRIT CARE, V4, P6, DOI 10.1186/cc644; Marrone A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005110; MATSUOKA T, 1995, BIOL PHARM BULL, V18, P1031; Nagababu E, 1998, BIOCHEM BIOPH RES CO, V247, P592, DOI 10.1006/bbrc.1998.8846; Randeberg LL, 2010, J BIOPHOTONICS, V3, P53, DOI 10.1002/jbio.200910059; Shikama K, 1998, CHEM REV, V98, P1357, DOI 10.1021/cr970042e; Smith A., 2004, BASIC MED BIOCH; Strasser S, 2007, FORENSIC SCI INT, V170, P8, DOI 10.1016/j.forsciint.2006.08.023; Sugawara Y, 2003, ACTA PHYSIOL SCAND, V179, P49, DOI 10.1046/j.1365-201X.2003.01142.x; Tsuruga M, 1998, J BIOL CHEM, V273, P8607, DOI 10.1074/jbc.273.15.8607; Venkatesh B, 1999, SPECTROCHIM ACTA A, V55, P1691, DOI 10.1016/S1386-1425(99)00008-6; Verkruysse W, 1997, PHYS MED BIOL, V42, P51, DOI 10.1088/0031-9155/42/1/003; WEVER R, 1973, BIOCHIM BIOPHYS ACTA, V302, P475, DOI 10.1016/0005-2744(73)90180-0; ZIJLSTRA WG, 1991, CLIN CHEM, V37, P1633	26	45	47	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e21845	10.1371/journal.pone.0021845	http://dx.doi.org/10.1371/journal.pone.0021845			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789186	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811700005
J	Glesner, J; Wunschmann, S; Li, M; Gustchina, A; Wlodawer, A; Himly, M; Chapman, MD; Pomes, A				Glesner, Jill; Wuenschmann, Sabina; Li, Mi; Gustchina, Alla; Wlodawer, Alexander; Himly, Martin; Chapman, Martin D.; Pomes, Anna			Mechanisms of Allergen-Antibody Interaction of Cockroach Allergen Bla g 2 with Monoclonal Antibodies That Inhibit IgE Antibody Binding	PLOS ONE			English	Article							MAGNETIC-RESONANCE STRUCTURE; FLUORESCENT MULTIPLEX ARRAY; SITE-DIRECTED MUTAGENESIS; DUST-MITE ALLERGEN; MAJOR ALLERGEN; CARBOHYDRATE DETERMINANTS; MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; GRASS-POLLEN; AMINO-ACID	Background: Cockroach allergy is strongly associated with asthma, and involves the production of IgE antibodies against inhaled allergens. Reports of conformational epitopes on inhaled allergens are limited. The conformational epitopes for two specific monoclonal antibodies (mAb) that interfere with IgE antibody binding were identified by X-ray crystallography on opposite sites of the quasi-symmetrical cockroach allergen Bla g 2. Methodology/Principal Findings: Mutational analysis of selected residues in both epitopes was performed based on the Xray crystal structures of the allergen with mAb Fab/Fab9 fragments, to investigate the structural basis of allergen-antibody interactions. The epitopes of Bla g 2 for the mAb 7C11 or 4C3 were mutated, and the mutants were analyzed by SDS-PAGE, circular dichroism, and/or mass spectrometry. Mutants were tested for mAb and IgE antibody binding by ELISA and fluorescent multiplex array. Single or multiple mutations of five residues from both epitopes resulted in almost complete loss of mAb binding, without affecting the overall folding of the allergen. Preventing glycosylation by mutation N268Q reduced IgE binding, indicating a role of carbohydrates in the interaction. Cation-p interactions, as well as electrostatic and hydrophobic interactions, were important for mAb and IgE antibody binding. Quantitative differences in the effects of mutations on IgE antibody binding were observed, suggesting heterogeneity in epitope recognition among cockroach allergic patients. Conclusions/Significance: Analysis by site-directed mutagenesis of epitopes identified by X-ray crystallography revealed an overlap between monoclonal and IgE antibody binding sites and provided insight into the B cell repertoire to Bla g 2 and the mechanisms of allergen-antibody recognition, including involvement of carbohydrates.	[Glesner, Jill; Wuenschmann, Sabina; Chapman, Martin D.; Pomes, Anna] INDOOR Biotechnol Inc, Charlottesville, VA USA; [Li, Mi] SAIC Frederick, Basic Res Program, Frederick, MD USA; [Li, Mi; Gustchina, Alla; Wlodawer, Alexander] NCI, Macromol Crystallog Lab, Frederick, MD 21701 USA; [Himly, Martin] Salzburg Univ, Div Allergy & Immunol, Dept Mol Biol, A-5020 Salzburg, Austria	INDOOR Biotechnologies; Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Salzburg University	Glesner, J (corresponding author), INDOOR Biotechnol Inc, Charlottesville, VA USA.	apomes@inbio.com	Pomés, Anna/H-7010-2019; Himly, Martin/D-1568-2015	Pomés, Anna/0000-0002-8729-1829; Chapman, Martin/0000-0002-0845-3632; Himly, Martin/0000-0001-5416-085X	National Institute of Allergy and Infectious Diseases [RO1AI077653]; NIH, National Cancer Institute, Center for Cancer Research; National Cancer Institute, NIH [HHSN261200800001E]; NIAID/NIH; NATIONAL CANCER INSTITUTE [ZIABC010348] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported in part by Award Number RO1AI077653 from the National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov), in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, and in part with Federal funds from the National Cancer Institute, NIH, under Contract No. HHSN261200800001E. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors JG, SW, MDC and AP are employed by Indoor Biotechnologies, Inc. MDC is the president and owner of the company. AP is the contact PI of the RO1 from the NIAID/NIH that finances this study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; ARRUDA LK, 1995, J BIOL CHEM, V270, P19563, DOI 10.1074/jbc.270.33.19563; Arruda LK, 2001, J ALLERGY CLIN IMMUN, V107, P419, DOI 10.1067/mai.2001.112854; Beezhold DH, 2001, J ALLERGY CLIN IMMUN, V107, P1069, DOI 10.1067/mai.2001.115482; Burks AW, 1997, EUR J BIOCHEM, V245, P334, DOI 10.1111/j.1432-1033.1997.t01-1-00334.x; Chan SL, 2008, J IMMUNOL, V181, P2586, DOI 10.4049/jimmunol.181.4.2586; Chan SL, 2006, J IMMUNOL, V176, P4852, DOI 10.4049/jimmunol.176.8.4852; Christensen LH, 2008, J ALLERGY CLIN IMMUN, V122, P298, DOI 10.1016/j.jaci.2008.05.026; Commins SP, 2011, J ALLERGY CLIN IMMUN, V127, P1286, DOI 10.1016/j.jaci.2011.02.019; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Earle CD, 2007, J ALLERGY CLIN IMMUN, V119, P428, DOI 10.1016/j.jaci.2006.11.004; Foetisch K, 2003, J ALLERGY CLIN IMMUN, V111, P889, DOI 10.1067/mai.2003.173; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gehlhar K, 2006, INT ARCH ALLERGY IMM, V140, P285, DOI 10.1159/000093706; GELBER LE, 1993, AM REV RESPIR DIS, V147, P573, DOI 10.1164/ajrccm/147.3.573; Gruchalla RS, 2005, J ALLERGY CLIN IMMUN, V115, P478, DOI 10.1016/j.jaci.2004.12.006; Gustchina A, 2005, J MOL BIOL, V348, P433, DOI 10.1016/j.jmb.2005.02.062; King EM, 2007, J ALLERGY CLIN IMMUN, V120, P1126, DOI 10.1016/j.jaci.2007.06.043; Li M, 2008, J BIOL CHEM, V283, P22806, DOI 10.1074/jbc.M800937200; Li M, 2011, J IMMUNOL, V186, P333, DOI 10.4049/jimmunol.1002318; Lin J, 2009, CURR OPIN ALLERGY CL, V9, P357, DOI 10.1097/ACI.0b013e32832d05ba; Livesay DR, 2004, PROTEIN ENG DES SEL, V17, P463, DOI 10.1093/protein/gzh058; LOMBARDERO M, 1990, J IMMUNOL, V144, P1353; Morea V, 1998, J MOL BIOL, V275, P269, DOI 10.1006/jmbi.1997.1442; NSCHMANN S, 2005, J ALLERGY CLIN IMMUN, V116, P140; Oezguen N, 2008, MOL IMMUNOL, V45, P3740, DOI 10.1016/j.molimm.2008.05.026; POLLART SM, 1989, J ALLERGY CLIN IMMUN, V83, P875, DOI 10.1016/0091-6749(89)90100-0; POLLART SM, 1991, J ALLERGY CLIN IMMUN, V87, P505, DOI 10.1016/0091-6749(91)90009-D; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Satinover SM, 2005, J ALLERGY CLIN IMMUN, V115, P803, DOI 10.1016/j.jaci.2005.01.018; Schramm G, 1999, J IMMUNOL, V162, P2406; Schramm G, 2001, CLIN EXP ALLERGY, V31, P331, DOI 10.1046/j.1365-2222.2001.01049.x; Smith AM, 1996, MOL IMMUNOL, V33, P399, DOI 10.1016/0161-5890(95)00150-6; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; Sporik R, 1999, THORAX, V54, P675, DOI 10.1136/thx.54.8.675; TANG J, 1978, NATURE, V271, P618, DOI 10.1038/271618a0; vanderVeen MJ, 1997, J ALLERGY CLIN IMMUN, V100, P327, DOI 10.1016/S0091-6749(97)70245-8; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6	38	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22223	10.1371/journal.pone.0022223	http://dx.doi.org/10.1371/journal.pone.0022223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789239	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811700035
J	Huang, L; Zhao, SP; Frasor, JM; Dai, Y				Huang, Lei; Zhao, Shuangping; Frasor, Jonna M.; Dai, Yang			An Integrated Bioinformatics Approach Identifies Elevated Cyclin E2 Expression and E2F Activity as Distinct Features of Tamoxifen Resistant Breast Tumors	PLOS ONE			English	Article							CONNECTIVITY MAP; CANCER CELLS; ESTROGEN; GENE; CARCINOMAS; ANTIESTROGENS; INDUCTION; SIGNATURE; APOPTOSIS; MOLECULE	Approximately half of estrogen receptor (ER) positive breast tumors will fail to respond to endocrine therapy. Here we used an integrative bioinformatics approach to analyze three gene expression profiling data sets from breast tumors in an attempt to uncover underlying mechanisms contributing to the development of resistance and potential therapeutic strategies to counteract these mechanisms. Genes that are differentially expressed in tamoxifen resistant vs. sensitive breast tumors were identified from three different publically available microarray datasets. These differentially expressed (DE) genes were analyzed using gene function and gene set enrichment and examined in intrinsic subtypes of breast tumors. The Connectivity Map analysis was utilized to link gene expression profiles of tamoxifen resistant tumors to small molecules and validation studies were carried out in a tamoxifen resistant cell line. Despite little overlap in genes that are differentially expressed in tamoxifen resistant vs. sensitive tumors, a high degree of functional similarity was observed among the three datasets. Tamoxifen resistant tumors displayed enriched expression of genes related to cell cycle and proliferation, as well as elevated activity of E2F transcription factors, and were highly correlated with a Luminal intrinsic subtype. A number of small molecules, including phenothiazines, were found that induced a gene signature in breast cancer cell lines opposite to that found in tamoxifen resistant vs. sensitive tumors and the ability of phenothiazines to down-regulate cyclin E2 and inhibit proliferation of tamoxifen resistant breast cancer cells was validated. Our findings demonstrate that an integrated bioinformatics approach to analyze gene expression profiles from multiple breast tumor datasets can identify important biological pathways and potentially novel therapeutic options for tamoxifen-resistant breast cancers.	[Huang, Lei; Dai, Yang] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA; [Zhao, Shuangping; Frasor, Jonna M.] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Huang, L (corresponding author), Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.	jfrasor@uic.edu; yangdai@uic.edu	zhao, shuangling/HCI-6255-2022		Chicago Biomedical Consortium [C-019]; Chicago Community Trust	Chicago Biomedical Consortium; Chicago Community Trust	This work was funded in part by the Chicago Biomedical Consortium(#C-019) with support from The Searle Funds at The Chicago Community Trust (http://www.chicagobiomedicalconsortium.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], MSIGDB; Arpino G, 2007, JNCI-J NATL CANCER I, V99, P694, DOI 10.1093/jnci/djk151; Arpino G, 2009, ONCOLOGY-BASEL, V77, P23, DOI 10.1159/000258493; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chanrion M, 2008, CLIN CANCER RES, V14, P1744, DOI 10.1158/1078-0432.CCR-07-1833; Clarke M, 1998, LANCET, V351, P1451; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Desmedt C, 2006, INT J CANCER, V119, P2539, DOI 10.1002/ijc.22149; Felice DL, 2009, J FUNCT FOODS, V1, P109, DOI 10.1016/j.jff.2008.09.014; FRANKFURT OS, 1995, CANCER LETT, V97, P149, DOI 10.1016/0304-3835(95)03970-8; Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GULINO A, 1986, CANCER RES, V46, P6274; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jansen MPHM, 2005, J CLIN ONCOL, V23, P732, DOI 10.1200/JCO.2005.05.145; JORDAN VC, 1990, ENDOCR REV, V11, P578, DOI 10.1210/edrv-11-4-578; KATZENELLENBOGEN BS, 1985, BREAST CANCER RES TR, V5, P231, DOI 10.1007/BF01806018; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li ZG, 2001, J BIOL CHEM, V276, P17354, DOI 10.1074/jbc.M010238200; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Loi S, 2007, CRIT REV ONCOL HEMAT, V61, P187, DOI 10.1016/j.critrevonc.2006.09.005; Loi S, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-37; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Murren JR, 1996, CANCER CHEMOTH PHARM, V38, P65, DOI 10.1007/s002800050449; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Musgrove EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002987; Payton M, 2002, ONCOGENE, V21, P8529, DOI 10.1038/sj.onc.1206035; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stanculescu Adina, 2010, Hormones & Cancer, V1, P127, DOI 10.1007/s12672-010-0018-6; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tafani M, 2008, AUTOPHAGY, V4, P1042, DOI 10.4161/auto.7070; Tari AM, 2005, LAB INVEST, V85, P1357, DOI 10.1038/labinvest.3700339; VANSLOOTEN HJ, 1995, BRIT J CANCER, V72, P22, DOI 10.1038/bjc.1995.271; Vendrell JA, 2007, ONCOGENE, V26, P4656, DOI 10.1038/sj.onc.1210269; WU CL, 1995, MOL CELL BIOL, V15, P2536; Yde CW, 2009, ANTI-CANCER DRUG, V20, P723, DOI 10.1097/CAD.0b013e32832ec041; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; TRANSFAC; CONNECTIVITY MAP	43	33	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22274	10.1371/journal.pone.0022274	http://dx.doi.org/10.1371/journal.pone.0022274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789246	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811700039
J	Zhang, J; Jin, Z; Sun, GQ; Zhou, T; Ruan, SG				Zhang, Juan; Jin, Zhen; Sun, Gui-Quan; Zhou, Tao; Ruan, Shigui			Analysis of Rabies in China: Transmission Dynamics and Control	PLOS ONE			English	Article							HETEROGENEOUS LANDSCAPES; DOG RABIES; MODELS; POPULATION; ECONOMICS; RACCOONS; SPREAD; STATES	Human rabies is one of the major public-health problems in China. The number of human rabies cases has increased dramatically in the last 15 years, partially due to the poor understanding of the transmission dynamics of rabies and the lack of effective control measures of the disease. In this article, in order to explore effective control and prevention measures we propose a deterministic model to study the transmission dynamics of rabies in China. The model consists of susceptible, exposed, infectious, and recovered subpopulations of both dogs and humans and describes the spread of rabies among dogs and from infectious dogs to humans. The model simulations agree with the human rabies data reported by the Chinese Ministry of Health. We estimate that the basic reproduction number R-0 = 2 for the rabies transmission in China and predict that the number of the human rabies is decreasing but may reach another peak around 2030. We also perform some sensitivity analysis of R0 in terms of the model parameters and compare the effects of culling and immunization of dogs. Our study demonstrates that (i) reducing dog birth rate and increasing dog immunization coverage rate are the most effective methods for controlling rabies in China; and (ii) large scale culling of susceptible dogs can be replaced by immunization of them.	[Zhang, Juan; Jin, Zhen; Sun, Gui-Quan] N Univ China, Dept Math, Taiyuan, Shanxi, Peoples R China; [Zhou, Tao] Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610054, Sichuan, Peoples R China; [Zhou, Tao] Univ Sci & Technol China, Dept Modern Phys, Hefei, Anhui, Peoples R China; [Ruan, Shigui] Univ Miami, Dept Math, Coral Gables, FL 33124 USA	North University of China; University of Electronic Science & Technology of China; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Miami	Zhang, J (corresponding author), N Univ China, Dept Math, Taiyuan, Shanxi, Peoples R China.	ruan@math.miami.edu	Zhou, Tao/D-5849-2012; Sun, Gui-Quan/AAE-7769-2019; Sun, Gui-Quan/Y-3606-2019; jin, zhen/B-6563-2015; zhou, tao/GQA-3572-2022; Ruan, Shigui/AAF-9165-2020	Sun, Gui-Quan/0000-0002-1831-1603; jin, zhen/0000-0002-9763-707X; Ruan, Shigui/0000-0002-6348-8205	National Natural Science Foundation of China; Program for New Century Excellent Talents in Universities; Program for Basic Research; Beiren Project; International and Technical Cooperation Project of Shan'xi Province; National Science Foundation; Division Of Mathematical Sciences [1022728] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Program for Basic Research; Beiren Project; International and Technical Cooperation Project of Shan'xi Province; National Science Foundation(National Science Foundation (NSF)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was partially supported by the National Natural Science Foundation of China, Program for New Century Excellent Talents in Universities, Program for Basic Research, Beiren Project and International and Technical Cooperation Project of Shan'xi Province, and the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allen LJS, 2002, APPL MATH COMPUT, V132, P271, DOI 10.1016/S0096-3003(01)00192-8; ANDERSON RM, 1981, NATURE, V289, P765, DOI 10.1038/289765a0; [Anonymous], 2010, B MIN HLTH PEOPL REP; Artois M, 1997, ECOL MODEL, V97, P23, DOI 10.1016/S0304-3800(96)00059-2; BaiduBaike, 2011, RAB; Beyer HB, 2010, THESIS U GLASGOW; Carroll MJ, 2010, WILDLIFE RES, V37, P676, DOI 10.1071/WR10027; CDC, 2010, RAB; Childs JE, 2000, P NATL ACAD SCI USA, V97, P13666, DOI 10.1073/pnas.240326697; Clayton Tim, 2010, Journal of Biological Dynamics, V4, P43, DOI 10.1080/17513750902935216; Coleman PG, 1996, VACCINE, V14, P185, DOI 10.1016/0264-410X(95)00197-9; COYNE MJ, 1989, AM J VET RES, V50, P2148; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Dimitrov DT, 2007, J THEOR BIOL, V245, P498, DOI 10.1016/j.jtbi.2006.11.001; Fxxue, 2011, CHIN STAT ANN BIRTH; Hampson K, 2007, P NATL ACAD SCI USA, V104, P7717, DOI 10.1073/pnas.0609122104; Hampson K, 2009, PLOS BIOL, V7, P462, DOI 10.1371/journal.pbio.1000053; Hu RL, 2009, VECTOR-BORNE ZOONOT, V9, P1, DOI 10.1089/vbz.2008.0046; KALLEN A, 1985, J THEOR BIOL, V116, P377, DOI 10.1016/S0022-5193(85)80276-9; KUREISHI A, 1992, B WORLD HEALTH ORGAN, V70, P443; Macdonald DW., 1980, RABIES WILDLIFE BIOL; Ministry of Health of the People's Republic of China (MOHC), 2009, STAT PREV CONTR RAB STAT PREV CONTR RAB; National Bureau of Statistics of China, 2009, CHIN DEM YB 2009; ROBERTS MG, 1995, VET PARASITOL, V56, P67, DOI 10.1016/0304-4017(94)00655-V; Russell CA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000027; Si H, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-113; Smith DL, 2002, P NATL ACAD SCI USA, V99, P3668, DOI [10.1073/pnas.042400799, 10.1073/pnas.132272199]; Smith G. C., 1989, Mammals as pests., P209; Smith GC, 2002, ECOL MODEL, V150, P45, DOI 10.1016/S0304-3800(01)00471-9; Song M, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-210; Sterner RT, 2006, BIOL CONSERV, V131, P163, DOI 10.1016/j.biocon.2006.05.004; Tang XC, 2005, EMERG INFECT DIS, V11, P1970, DOI 10.3201/eid1112.050271; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Wang XW, 2008, J BIOL SYST, V16, P519, DOI 10.1142/S0218339008002666; Wang XJ, 2001, RABIES RABIES VACCIN, P127; WHO, 2010, RAB; World Health Organization, 2004, 1 WHO; Wu XF, 2009, EMERG INFECT DIS, V15, P1159, DOI 10.3201/eid1508.081426; Yang W., 2009, B U M I, P591; Zhang YZ, 2005, EMERG INFECT DIS, V11, P1983; Zinsstag J, 2009, P NATL ACAD SCI USA, V106, P14996, DOI 10.1073/pnas.0904740106	41	34	38	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e20891	10.1371/journal.pone.0020891	http://dx.doi.org/10.1371/journal.pone.0020891			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21789166	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811300004
J	Haapa-Paananen, S; Kiviluoto, S; Waltari, M; Puputti, M; Mpindi, JP; Kohonen, P; Tynninen, O; Haapasalo, H; Joensuu, H; Perala, M; Kallioniemi, O				Haapa-Paananen, S.; Kiviluoto, S.; Waltari, M.; Puputti, M.; Mpindi, J. P.; Kohonen, P.; Tynninen, O.; Haapasalo, H.; Joensuu, H.; Perala, M.; Kallioniemi, O.			HES6 gene is selectively overexpressed in glioma and represents an important transcriptional regulator of glioma proliferation	ONCOGENE			English	Article						HES6; glioma; astrocytoma; glioblastoma; TMA; RNAi	BINDING PROTEIN; NEURONAL DIFFERENTIATION; GLIOBLASTOMA-MULTIFORME; CELL-PROLIFERATION; PROMOTES; RECEPTOR; GROWTH; EXPRESSION; PATHWAYS; KIT	Malignant glioma is the most common brain tumor with 16 000 new cases diagnosed annually in the United States. We performed a systematic large-scale transcriptomics data mining study of 9783 tissue samples from the GeneSapiens database to systematically identify genes that are most glioma-specific. We searched for genes that were highly expressed in 322 glioblastoma multiforme tissue samples and 66 anaplastic astrocytomas as compared with 425 samples from histologically normal central nervous system. Transcription cofactor HES6 (hairy and enhancer of split 6) emerged as the most glioma-specific gene. Immunostaining of a tissue micro-array showed HES6 expression in 335 (98.8%) out of the 339 glioma samples. HES6 was expressed in endothelial cells of the normal brain and glioma tissue. Recurrent grade 2 astrocytomas and grade 2 or 3 oligodendrogliomas showed higher levels of HES6 immunoreactivity than the corresponding primary tumors. High HES6 mRNA expression correlated with the proneural subtype that generally has a favorable outcome but is prone to recur. Functional studies suggested an important role for HES6 in supporting survival of glioma cells, as evidenced by reduction of cancer cell proliferation and migration after HES6 silencing. The biological role and consequences of HES6 silencing and overexpression was explored with genome-wide analyses, which implicated a role for HES6 in p53, c-myc and nuclear factor-kappa B transcriptional networks. We conclude that HES6 is important for glioma cell proliferation and migration, and may have a role in angiogenesis. Oncogene (2012) 31, 1299-1310; doi:10.1038/onc.2011.316; published online 25 July 2011	[Haapa-Paananen, S.; Kiviluoto, S.; Mpindi, J. P.; Kohonen, P.; Perala, M.; Kallioniemi, O.] Univ Turku, Dept Med Biotechnol, VTT Tech Res Ctr Finland, FI-20521 Turku, Finland; [Haapa-Paananen, S.; Kiviluoto, S.; Mpindi, J. P.; Kohonen, P.; Perala, M.; Kallioniemi, O.] Univ Turku, Ctr Biotechnol, FI-20521 Turku, Finland; [Waltari, M.; Puputti, M.; Joensuu, H.] Univ Helsinki, Dept Oncol, Helsinki, Finland; [Tynninen, O.] Helsinki Univ Cent Hosp, Dept Pathol, Helsinki, Finland; [Mpindi, J. P.; Kallioniemi, O.] Univ Helsinki, FIMM Inst Mol Med Finland, Helsinki, Finland; [Tynninen, O.] Univ Helsinki, Haartman Inst, Helsinki, Finland; [Haapasalo, H.] Tampere Univ Hosp, Dept Pathol, Tampere, Finland	University of Turku; VTT Technical Research Center Finland; University of Turku; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Tampere University; Tampere University Hospital	Haapa-Paananen, S (corresponding author), Univ Turku, Dept Med Biotechnol, VTT Tech Res Ctr Finland, Itainen Pitkakatu 4C,POB 106, FI-20521 Turku, Finland.	saija.haapa-paananen@vtt.fi	Kohonen, Pekka/F-9596-2011; Kallioniemi, Olli P/H-5111-2011; Kiviluoto, Santeri/M-2743-2014; Haapa-Paananen, Saija/D-3075-2012	Kohonen, Pekka/0000-0002-7845-3611; Kallioniemi, Olli P/0000-0002-3231-0332; Kiviluoto, Santeri/0000-0001-5010-5327; Joensuu, Heikki/0000-0003-0281-2507	Academy of Finland Translational Genome-Scale Biology Center of Excellence; Sigrid Juselius foundation; EU [LSHB-CT-2004-005276]; Cancer Foundation Finland sr [120084, 110071] Funding Source: researchfish	Academy of Finland Translational Genome-Scale Biology Center of Excellence(Academy of Finland); Sigrid Juselius foundation(Sigrid Juselius Foundation); EU(European Commission); Cancer Foundation Finland sr	This work was supported by the Academy of Finland Translational Genome-Scale Biology Center of Excellence, the Sigrid Juselius foundation and EU-FP6 project RIGHT (LSHB-CT-2004-005276). We acknowledge Dr Bokkee Eun for the generous gift of the HES6 overexpression plasmid pEYFP-C1-Hes6 (Eun et al., 2008). We also acknowledge the Finnish DNA Microarray Centre for their excellent technical assistance.	Bae SK, 2000, DEVELOPMENT, V127, P2933; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cooper LAD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012548; Cossins J, 2002, DEVELOPMENT, V129, P2195; Eun B, 2008, J BIOL CHEM, V283, P5939, DOI 10.1074/jbc.M707683200; Eun B, 2010, BRAIN RES, V1313, P1, DOI 10.1016/j.brainres.2009.11.078; Gratton MO, 2003, MOL CELL BIOL, V23, P6922, DOI 10.1128/MCB.23.19.6922-6935.2003; Haapasalo JA, 2006, CLIN CANCER RES, V12, P473, DOI 10.1158/1078-0432.CCR-05-0848; Hartman J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2446; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Illi B, 2000, CIRC RES, V86, pE110; Jennings BH, 1999, MOL CELL BIOL, V19, P4600; Jhas S, 2006, J NEUROSCI, V26, P11061, DOI 10.1523/JNEUROSCI.1358-06.2006; Joensuu H, 2005, J PATHOL, V207, P224, DOI 10.1002/path.1823; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Koyano-Nakagawa N, 2000, DEVELOPMENT, V127, P4203; Kumar Hari R, 2008, Expert Rev Neurother, V8, P1497, DOI 10.1586/14737175.8.10.1497; Lassman AB, 2004, NEURON GLIA BIOL, V1, P157, DOI 10.1017/S1740925X04000249; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Margolin AA, 2009, P NATL ACAD SCI USA, V106, P244, DOI 10.1073/pnas.0806445106; Mpindi JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017259; Naumann U, 2008, INT J ONCOL, V33, P759, DOI 10.3892/ijo_00000062; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Ovaska K, 2010, GENOME MED, V2, DOI 10.1186/gm186; Panicker SP, 2010, ONCOTARGET, V1, P289; Puputti M, 2006, MOL CANCER RES, V4, P927, DOI 10.1158/1541-7786.MCR-06-0085; Schiffer D, 2010, ANTICANCER RES, V30, P1977; Sihto H, 2009, HISTOPATHOLOGY, V55, P544, DOI 10.1111/j.1365-2559.2009.03418.x; Somasundaram K, 2005, ONCOGENE, V24, P7073, DOI 10.1038/sj.onc.1208865; Strojnik T, 2007, SURG NEUROL, V68, P133, DOI 10.1016/j.surneu.2006.10.050; Swearingen ML, 2003, CANCER LETT, V198, P229, DOI 10.1016/S0304-3835(03)00313-6; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vias M, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-17; Wang GK, 2006, J BIOL CHEM, V281, P14085, DOI 10.1074/jbc.M513686200; Watson PA, 2002, ENDOCRINOLOGY, V143, P2922, DOI 10.1210/en.143.8.2922; Wesolowska A, 2008, ONCOGENE, V27, P918, DOI 10.1038/sj.onc.1210683; Wu JM, 2009, NAT METHODS, V6, P75, DOI [10.1038/nmeth.1282, 10.1038/NMETH.1282]	39	23	23	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	10					1299	1310		10.1038/onc.2011.316	http://dx.doi.org/10.1038/onc.2011.316			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	906KS	21785461				2022-12-25	WOS:000301344600009
J	Joha, S; Nugues, AL; Hetuin, D; Berthon, C; Dezitter, X; Dauphin, V; Mahon, FX; Roche-Lestienne, C; Preudhomme, C; Quesnel, B; Idziorek, T				Joha, S.; Nugues, A-L; Hetuin, D.; Berthon, C.; Dezitter, X.; Dauphin, V.; Mahon, F-X; Roche-Lestienne, C.; Preudhomme, C.; Quesnel, B.; Idziorek, T.			GILZ inhibits the mTORC2/AKT pathway in BCR-ABL(+) cells	ONCOGENE			English	Article						GILZ; imatinib; dasatinib; BCR-ABL; mTORC2; AKT	PROTECTS T-LYMPHOCYTES; LEUCINE-ZIPPER GILZ; DORMANT TUMOR-CELLS; BCR-ABL; GLUCOCORTICOID-RECEPTOR; MAMMALIAN TARGET; INDUCE APOPTOSIS; LEUKEMIC-CELLS; TOR COMPLEX-2; RAPAMYCIN	The malignant phenotype of chronic myeloid leukemia (CML) is due to the abnormal tyrosine kinase activity of the BCR-ABL oncoprotein, which signals several downstream cell survival pathways, including phosphoinositide 3-kinase/AKT, signal transducer and activator of transcription 5 and extracellular signal-regulated kinase 1/2. In patients with CML, tyrosine kinase inhibitors (TKIs) are used to suppress the BCR-ABL tyrosine kinase, resulting in impressive response rates. However, resistance can occur, especially in acute-phase CML, through various mechanisms. Here, we show that the glucocorticoid-induced leucine zipper protein (GILZ) modulates imatinib and dasatinib resistance and suppresses tumor growth by inactivating the mammalian target of rapamycin complex-2 (mTORC2)/AKT signaling pathway. In mouse and human models, GILZ binds to mTORC2, but not to mTORC1, inhibiting phosphorylation of AKT (at Ser473) and activating FoxO3a-mediated transcription of the pro-apoptotic protein Bim; these results demonstrate that GILZ is a key inhibitor of the mTORC2 pathway. Furthermore, CD34(+) stem cells isolated from relapsing CML patients underwent apoptosis and showed inhibition of mTORC2 after incubation with glucocorticoids and imatinib. Our findings provide new mechanistic insights into the role of mTORC2 in BCR-ABL(+) cells and indicate that regulation by GILZ may influence TKI sensitivity. Oncogene (2012) 31, 1419-1430; doi:10.1038/onc.2011.328; published online 1 August 2011	[Quesnel, B.] CHU Lille, Serv Malad Sang, F-59037 Lille, France; [Joha, S.; Nugues, A-L; Hetuin, D.; Berthon, C.; Dezitter, X.; Dauphin, V.; Roche-Lestienne, C.; Preudhomme, C.; Quesnel, B.; Idziorek, T.] Univ Lille Nord de France, INSERM, U837, Inst Rech Canc Lille, Lille, France; [Mahon, F-X] Univ Victor Segalen, INSERM, U876, Bordeaux, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Quesnel, B (corresponding author), CHU Lille, Serv Malad Sang, Rue Polonovski, F-59037 Lille, France.	brunoquesnel@hotmail.com	Quesnel, Bruno/D-5533-2018; Preudhomme, Claude/T-8553-2018; Dezitter, Xavier/H-6923-2018	Quesnel, Bruno/0000-0002-6563-2709; Preudhomme, Claude/0000-0002-1267-9546; Dezitter, Xavier/0000-0001-6932-6947; Roche-Lestienne, Catherine/0000-0002-7998-3817	Ligue Nationale Contre le Cancer (Equipe labellisee); Fondation de France; Institut National du Cancer; Ministere des Relations Exterieures; Institut de Recherche sur le Cancer de Lille; Region Nord Pas de Calais	Ligue Nationale Contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); Fondation de France(Fondation de France); Institut National du Cancer(Institut National du Cancer (INCA) France); Ministere des Relations Exterieures; Institut de Recherche sur le Cancer de Lille; Region Nord Pas de Calais(Region Hauts-de-France)	We are grateful to Professor Carlo Riccardi (University of Perugia, Perugia, Italy) for providing the mouse GILZ antibodies and plasmids and to Professor Michael Hall (Biozentrum, University of Basel, Basel, Switzerland) for providing the mouse Rictor plasmid. This work was supported by the Ligue Nationale Contre le Cancer (Equipe labellisee), the Fondation de France, Region Nord Pas de Calais and the Institut National du Cancer (project IMMUDORM). SJ was supported by the Ministere des Relations Exterieures and Institut de Recherche sur le Cancer de Lille.	Aichberger KJ, 2005, BLOOD, V105, P3303, DOI 10.1182/blood-2004-02-0749; Asselin-Labat ML, 2004, BLOOD, V104, P215, DOI 10.1182/blood-2003-12-4295; Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; Carayol N, 2010, P NATL ACAD SCI USA, V107, P12469, DOI 10.1073/pnas.1005114107; Cohen N, 2006, BLOOD, V107, P2037, DOI 10.1182/blood-2005-07-2760; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Dayyani F, 2003, J LEUKOCYTE BIOL, V74, P33, DOI 10.1189/jlb.1202612; deJong R, 1997, ONCOGENE, V14, P507, DOI 10.1038/sj.onc.1200885; Delfino DV, 2011, CELL DEATH DIFFER, V18, P183, DOI 10.1038/cdd.2010.86; Delfino DV, 2004, BLOOD, V104, P4134, DOI 10.1182/blood-2004-03-0920; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Grugan KD, 2008, J STEROID BIOCHEM, V110, P244, DOI 10.1016/j.jsbmb.2007.11.003; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hicsonmez G, 2006, LEUKEMIA RES, V30, P60, DOI 10.1016/j.leukres.2005.05.015; Hietakangas V, 2007, GENE DEV, V21, P632, DOI 10.1101/gad.416307; IHLE JN, 1985, CONTEMP TOP MOLEC IM, V10, P93; Ikenoue T, 2009, METHOD ENZYMOL, V452, P165, DOI 10.1016/S0076-6879(08)03611-2; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kawauchi K, 2003, BLOOD CELL MOL DIS, V31, P11, DOI 10.1016/S1079-9796(03)00070-6; Kharas MG, 2008, J CLIN INVEST, V118, P3038, DOI 10.1172/JCI33337; Kolbus A, 2003, BLOOD, V102, P3136, DOI 10.1182/blood-2003-03-0923; Liu J, 2008, LEUKEMIA, V22, P791, DOI 10.1038/leu.2008.3; Ly C, 2003, CANCER RES, V63, P5716; Mancini M, 2010, J CELL BIOCHEM, V109, P320, DOI 10.1002/jcb.22380; Martin J, 2008, BIOCHEM BIOPH RES CO, V372, P578, DOI 10.1016/j.bbrc.2008.05.086; Mills JR, 2008, P NATL ACAD SCI USA, V105, P10853, DOI 10.1073/pnas.0804821105; Miyoshi H, 1997, LEUKEMIA RES, V21, P45, DOI 10.1016/S0145-2126(96)00089-6; Mohi MG, 2004, P NATL ACAD SCI USA, V101, P3130, DOI 10.1073/pnas.0400063101; Perez SA, 2005, BLOOD, V106, P158, DOI 10.1182/blood-2004-08-3232; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Pocaly M, 2008, PROTEOMICS, V8, P2394, DOI 10.1002/pmic.200701035; Polak P, 2006, DEV CELL, V11, P433, DOI 10.1016/j.devcel.2006.09.005; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Saudemont A, 2005, BLOOD, V105, P2428, DOI 10.1182/blood-2004-09-3458; Saudemont A, 2004, BLOOD, V104, P2124, DOI 10.1182/blood-2004-01-0064; Saudemont A, 2007, CANCER RES, V67, P4491, DOI 10.1158/0008-5472.CAN-06-1627; Schmidt M, 2001, J IMMUNOL, V166, P1344, DOI 10.4049/jimmunol.166.2.1344; Sharma SV, 2006, CANCER CELL, V10, P425, DOI 10.1016/j.ccr.2006.09.014; Steelman LS, 2008, LEUKEMIA, V22, P686, DOI 10.1038/leu.2008.26; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; Vakana E, 2010, AUTOPHAGY, V6, P966, DOI 10.1073/pnas.1005114107; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wang SW, 2005, APOPTOSIS, V10, P341, DOI 10.1007/s10495-005-0808-4; Yu CR, 2002, CANCER RES, V62, P188; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833	54	36	36	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	11					1419	1430		10.1038/onc.2011.328	http://dx.doi.org/10.1038/onc.2011.328			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	912FL	21804606	Green Published, hybrid			2022-12-25	WOS:000301780000009
J	Lamberto, GR; Torres-Monserrat, V; Bertoncini, CW; Salvatella, X; Zweckstetter, M; Griesinger, C; Fernandez, CO				Lamberto, Gonzalo R.; Torres-Monserrat, Valentina; Bertoncini, Carlos W.; Salvatella, Xavier; Zweckstetter, Markus; Griesinger, Christian; Fernandez, Claudio O.			Toward the Discovery of Effective Polycyclic Inhibitors of alpha-Synuclein Amyloid Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; PARKINSONS-DISEASE; FIBRIL FORMATION; PHOTODYNAMIC THERAPY; ALZHEIMERS-DISEASE; LEWY BODIES; IN-VITRO; AGGREGATION; PHTHALOCYANINE; MECHANISM	The fibrillation of amyloidogenic proteins is a critical step in the etiology of neurodegenerative disorders such as Alzheimer and Parkinson diseases. There is major interest in the therapeutic intervention on such aberrant aggregation phenomena, and the utilization of polyaromatic scaffolds has lately received considerable attention. In this regard, the molecular and structural basis of the anti-amyloidogenicity of polyaromatic compounds, required to evolve this molecular scaffold toward therapeutic drugs, is not known in detail. We present here biophysical and biochemical studies that have enabled us to characterize the interaction of metal-substituted, tetrasulfonated phthalocyanines (PcTS) with alpha-synuclein (AS), the major protein component of amyloid-like deposits in Parkinson disease. The inhibitory activity of the assayed compounds on AS amyloid fibril formation decreases in the order PcTS[Ni(II)] similar to PcTS > PcTS[Zn(II)] >> PcTS[Al(III)] approximate to 0. Using NMR and electronic absorption spectroscopies we demonstrated conclusively that the differences in binding capacity and anti-amyloid activity of phthalocyanines on AS are attributed to their relative ability to self-stack through pi-pi interactions, modulated by the nature of the metal ion bound at the molecule. Low order stacked aggregates of phthalocyanines were identified as the active amyloid inhibitory species, whose effects are mediated by residue specific interactions. Such sequence-specific anti-amyloid behavior of self-stacked phthalocyanines contrasts strongly with promiscuous amyloid inhibitors with self-association capabilities that act via nonspecific sequestration of AS molecules. The new findings reported here constitute an important contribution for future drug discovery efforts targeting amyloid formation.	[Lamberto, Gonzalo R.; Torres-Monserrat, Valentina; Fernandez, Claudio O.] Univ Nacl Rosario, Consejo Nacl Invest Cient & Tecn, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina; [Bertoncini, Carlos W.; Salvatella, Xavier] Inst Res Biomed, Barcelona 08029, Spain; [Fernandez, Claudio O.] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Partner Grp, D-37077 Gottingen, Germany; [Zweckstetter, Markus] Deutsch Forsch Gemeinschaft Ctr Mol Physiol Brain, D-37077 Gottingen, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Max Planck Society	Fernandez, CO (corresponding author), Univ Nacl Rosario, Consejo Nacl Invest Cient & Tecn, Inst Biol Mol & Celular Rosario, Suipacha 531,S2002LRK, RA-2000 Rosario, Santa Fe, Argentina.	cfernan@gwdg.de	Salvatella, Xavier/C-7337-2008	Salvatella, Xavier/0000-0002-8371-4185; Fernandez, Claudio Oscar/0000-0003-0454-7735; Zweckstetter, Markus/0000-0002-2536-6581; Bertoncini, Carlos/0000-0001-7695-2882	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina; Fundacion Antorchas; Max Planck Society; Alexander von Humboldt Foundation; Fundacion Josefina Prats; Government of Santa Fe; ANPCyT [PME2003-2006]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (CONICET); CONICET in Argentina; Framework Programme 7 Marie Curie Intra-European Fellowship; Institucio Catalana de Recerca i Estudis Avancats; Institute for Research in Biomedicine, Barcelona, Spain; Ministerio de Ciencia e Innovacion de Espana [CTQ2009-08850-BQU]; Max Planck Society, Federal Ministry of Education and Research, Germany [NGFN-Plus 01GS08190]; Deutsche Forschungsgemeinschaft [ZW 71/2-2, 3-2]	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); Fundacion Antorchas; Max Planck Society(Max Planck SocietyFoundation CELLEX); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Fundacion Josefina Prats; Government of Santa Fe; ANPCyT(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET in Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Framework Programme 7 Marie Curie Intra-European Fellowship; Institucio Catalana de Recerca i Estudis Avancats(ICREA); Institute for Research in Biomedicine, Barcelona, Spain; Ministerio de Ciencia e Innovacion de Espana(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Max Planck Society, Federal Ministry of Education and Research, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina, Fundacion Antorchas, Max Planck Society, Alexander von Humboldt Foundation, Fundacion Josefina Prats, and the Government of Santa Fe. The Bruker Avance II 600 MHz NMR spectrometer used in this work was purchased with funds from ANPCyT (PME2003-2006) and Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (CONICET).; Recipient of a fellowship from CONICET in Argentina and Fundacion Josefina Prats.; Recipient of a Framework Programme 7 Marie Curie Intra-European Fellowship grant.; Supported by Institucio Catalana de Recerca i Estudis Avancats, Institute for Research in Biomedicine, Barcelona, Spain, and Ministerio de Ciencia e Innovacion de Espana Grant CTQ2009-08850-BQU.; Supported by the Max Planck Society, Federal Ministry of Education and Research, Germany, Grant NGFN-Plus 01GS08190, and Deutsche Forschungsgemeinschaft Heisenberg Scholarships ZW 71/2-2 and 3-2.	Abedini A, 2007, J AM CHEM SOC, V129, P11300, DOI 10.1021/ja072157y; Bertini I, 1996, COORDIN CHEM REV, V150, pR7; Bertoncini CW, 2007, J MOL BIOL, V372, P708, DOI 10.1016/j.jmb.2007.07.009; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Blanchard BJ, 2004, P NATL ACAD SCI USA, V101, P14326, DOI 10.1073/pnas.0405941101; Boyle RW, 1996, PHOTOCHEM PHOTOBIOL, V64, P469, DOI 10.1111/j.1751-1097.1996.tb03093.x; Braga CA, 2011, J MOL BIOL, V405, P254, DOI 10.1016/j.jmb.2010.10.027; Bulic B, 2009, ANGEW CHEM INT EDIT, V48, P1741, DOI 10.1002/anie.200802621; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Caughey WS, 2007, ANTIMICROB AGENTS CH, V51, P3887, DOI 10.1128/AAC.01599-06; Caughey WS, 1998, P NATL ACAD SCI USA, V95, P12117, DOI 10.1073/pnas.95.21.12117; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chopra V, 2007, P NATL ACAD SCI USA, V104, P16685, DOI 10.1073/pnas.0707842104; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Hill JS, 1995, P NATL ACAD SCI USA, V92, P12126, DOI 10.1073/pnas.92.26.12126; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Hoyer WG, 2004, J MOL BIOL, V340, P127, DOI 10.1016/j.jmb.2004.04.051; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Laia CAT, 2008, J PHYS CHEM B, V112, P4276, DOI 10.1021/jp076100+; Lamberto GR, 2009, P NATL ACAD SCI USA, V106, P21057, DOI 10.1073/pnas.0902603106; Lee EN, 2004, BIOCHEMISTRY-US, V43, P3704, DOI 10.1021/bi0356707; Lee JC, 2005, J AM CHEM SOC, V127, P16388, DOI 10.1021/ja0561901; Lee JC, 2007, J PHYS CHEM B, V111, P2107, DOI 10.1021/jp068604y; Lendel C, 2009, BIOCHEMISTRY-US, V48, P8322, DOI 10.1021/bi901285x; Luheshi LM, 2008, CURR OPIN CHEM BIOL, V12, P25, DOI 10.1016/j.cbpa.2008.02.011; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Priola SA, 2000, SCIENCE, V287, P1503, DOI 10.1126/science.287.5457.1503; Rao JN, 2008, BIOCHEMISTRY-US, V47, P4651, DOI 10.1021/bi8002378; SIPE JD, 1992, ANNU REV BIOCHEM, V61, P947, DOI 10.1146/annurev.bi.61.070192.004503; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; STYLLI SS, 1995, J CLIN NEUROSCI, V2, P64, DOI 10.1016/0967-5868(95)90033-0; STYLLI SS, 1995, J CLIN NEUROSCI, V2, P146, DOI 10.1016/0967-5868(95)90008-X; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Yan LM, 2006, P NATL ACAD SCI USA, V103, P2046, DOI 10.1073/pnas.0507471103; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200	49	38	40	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32036	32044		10.1074/jbc.M111.242958	http://dx.doi.org/10.1074/jbc.M111.242958			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795682	Green Published, hybrid			2022-12-25	WOS:000294726800013
J	Absoud, M; Cummins, C; Lim, MJ; Wassmer, E; Shaw, N				Absoud, Michael; Cummins, Carole; Lim, Ming J.; Wassmer, Evangeline; Shaw, Nick			Prevalence and Predictors of Vitamin D Insufficiency in Children: A Great Britain Population Based Study	PLOS ONE			English	Article							D DEFICIENCY; INTERNATIONAL SURVEY; ASSOCIATION; ADOLESCENTS; MANAGEMENT	Objectives: To evaluate the prevalence and predictors of vitamin D insufficiency (VDI) in children In Great Britain. Design: A nationally representative cross-sectional study survey of children (1102) aged 4-18 years (999 white, 570 male) living in private households (January 1997-1998). Interventions provided information about dietary habits, physical activity, socio-demographics, and blood sample. Outcome measures were vitamin D insufficiency (<50 nmol/L). Results: Vitamin D levels (mean = 62.1 nmol/L, 95% CI 60.4-63.7) were insufficient in 35%, and decreased with age in both sexes (p<0.001). Young People living between 53-59 degrees latitude had lower levels (compared with 50-53 degrees, p = 0.045). Dietary intake and gender had no effect on vitamin D status. A logistic regression model showed increased risk of VDI in the following: adolescents (14-18 years old), odds ratio (OR) = 3.6 (95% CI 1.8-7.2) compared with younger children (4-8 years); non white children (OR = 37 [95% CI 15-90]); blood levels taken December-May (OR = 6.5 [95% CI 4.3-10.1]); on income support (OR = 2.2 [95% CI 1.3-3.9]); not taking vitamin D supplementation (OR = 3.7 [95% CI 1.4-9.8]); being overweight (OR 1.6 [95% CI 1.0-2.5]); <1/2 hour outdoor exercise/day/week (OR = 1.5 [95% CI 1.0-2.3]); watched >2.5 hours of TV/day/week (OR = 1.6[95% CI 1.0-2.4]). Conclusion: We confirm a previously under-recognised risk of VDI in adolescents. The marked higher risk for VDI in non-white children suggests they should be targeted in any preventative strategies. The association of higher risk of VDI among children who exercised less outdoors, watched more TV and were overweight highlights potentially modifiable risk factors. Clearer guidelines and an increased awareness especially in adolescents are needed, as there are no recommendations for vitamin D supplementation in older children.	[Absoud, Michael; Cummins, Carole] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England; [Lim, Ming J.] Guys & St Thomas NHS Fdn Trust, Evelina Childrens Hosp, Dept Paediat Neurol, London, England; [Wassmer, Evangeline] Birmingham Childrens Hosp NHS Fdn Trust, Dept Paediat Neurol, Birmingham, W Midlands, England; [Shaw, Nick] Birmingham Childrens Hosp NHS Fdn Trust, Dept Paediat Endocrinol, Birmingham, W Midlands, England	University of Birmingham; Guy's & St Thomas' NHS Foundation Trust; University of Birmingham; University of Birmingham	Absoud, M (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England.	michaelabsoud@childdemyelination.org.uk	Absoud, Michael/AAT-4832-2020; Wassmer, Evangeline/K-5467-2019	Absoud, Michael/0000-0002-0577-1897; Lim, Ming/0000-0001-7738-8910; Cummins, Carole/0000-0001-5464-1944	Medical Research Council Funding Source: Medline; Department of Health Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health		AHMED SF, 2010, ARCH DIS CHILD; Ashraf S, 2002, ARCH DIS CHILD, V87, P263, DOI 10.1136/adc.87.3.263-a; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Das G, 2006, ARCH DIS CHILD, V91, P569, DOI 10.1136/adc.2005.077974; Davies JH, 2010, ARCH DIS CHILD; *DEP HLTH, 2010, VIT D ESS NUTR ALL R; Grant WB, 2009, PROG BIOPHYS MOL BIO, V99, P104, DOI 10.1016/j.pbiomolbio.2009.02.003; Greer FR, 2009, PEDIATRICS, V124, P1471, DOI 10.1542/peds.2009-2307; GREGORY J, 2000, NATL DIET NUTR SURVE, V1; HANWELL HE, 2010, BIOCH BIOPHYS ACTA; HOLLIS BW, 1993, CLIN CHEM, V39, P529; Houghton LA, 2010, AM J CLIN NUTR, V92, P69, DOI 10.3945/ajcn.2009.29055; Kumar J, 2009, PEDIATRICS, V124, pE362, DOI 10.1542/peds.2009-0051; Lanham-New S A, 2011, Br J Nutr, V105, P144, DOI 10.1017/S0007114510002576; Mansbach JM, 2009, PEDIATRICS, V124, P1404, DOI 10.1542/peds.2008-2041; Misra M, 2008, PEDIATRICS, V122, P398, DOI 10.1542/peds.2007-1894; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Papandreou D, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/472173; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; Ramagopalan SV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000369; REIS JP, 2009, PEDIATRICS; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; *SCI ADV COMM NUTR, 2007, POS STAT SCI ADV COM; Shaw NJ, 2002, ARCH DIS CHILD, V86, P147, DOI 10.1136/adc.86.3.147; Taylor BV, 2010, MULT SCLER J, V16, P398, DOI 10.1177/1352458509359724; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Weng FL, 2007, AM J CLIN NUTR, V86, P150, DOI 10.1093/ajcn/86.1.150	28	131	133	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22179	10.1371/journal.pone.0022179	http://dx.doi.org/10.1371/journal.pone.0022179			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799790	gold, Green Submitted, Green Published			2022-12-25	WOS:000293097300019
J	Jankovics, F; Henn, L; Bujna, A; Vilmos, P; Kiss, N; Erdelyi, M				Jankovics, Ferenc; Henn, Laszlo; Bujna, Agnes; Vilmos, Peter; Kiss, Nora; Erdelyi, Miklos			A Functional Genomic Screen Combined with Time-Lapse Microscopy Uncovers a Novel Set of Genes Involved in Dorsal Closure of Drosophila Embryos	PLOS ONE			English	Article							CELL-SHAPE CHANGES; NERVOUS-SYSTEM DEVELOPMENT; RNA INTERFERENCE; DYNAMIC-ANALYSIS; EPITHELIAL MORPHOGENESIS; ACTIN CYTOSKELETON; ADHERENS JUNCTIONS; TRANSGENIC RNAI; EXCHANGE FACTOR; LARVAL CUTICLE	Morphogenesis, the establishment of the animal body, requires the coordinated rearrangement of cells and tissues regulated by a very strictly-determined genetic program. Dorsal closure of the epithelium in the Drosophila melanogaster embryo is one of the best models for such a complex morphogenetic event. To explore the genetic regulation of dorsal closure, we carried out a large-scale RNA interference-based screen in combination with in vivo time-lapse microscopy and identified several genes essential for the closure or affecting its dynamics. One of the novel dorsal closure genes, the small GTPase activator pebble (pbl), was selected for detailed analysis. We show that pbl regulates actin accumulation and protrusion dynamics in the leading edge of the migrating epithelial cells. In addition, pbl affects dorsal closure dynamics by regulating head involution, a morphogenetic process mechanically coupled with dorsal closure. Finally, we provide evidence that pbl is involved in closure of the adult thorax, suggesting its general requirement in epithelial closure processes.	[Jankovics, Ferenc; Henn, Laszlo; Bujna, Agnes; Vilmos, Peter; Kiss, Nora; Erdelyi, Miklos] Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary	Hungarian Academy of Sciences; Hungarian Biological Research Center	Jankovics, F (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary.	jankovic@brc.hu		Jankovics, Ferenc/0000-0001-9697-4472; Henn, Laszlo/0000-0002-4071-5719	Hungarian National Science Foundation [OTKA-H07-B-74357]; Howard Hughes Medical Institutes (HHMI) [55005606]	Hungarian National Science Foundation; Howard Hughes Medical Institutes (HHMI)(Howard Hughes Medical Institute)	This work was supported by the Hungarian National Science Foundation (OTKA-H07-B-74357 to F.J.) (http://www.otka.hu) and the Howard Hughes Medical Institutes (HHMI, 55005606 to M.E.) (http://www.hhmi.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boettner B, 2003, GENETICS, V165, P159; Boettner B, 2007, MOL CELL BIOL, V27, P7966, DOI 10.1128/MCB.01275-07; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dyer N, 2007, DEVELOPMENT, V134, P4437, DOI 10.1242/dev.010983; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Folk P, 2004, CELL MOL LIFE SCI, V61, P629, DOI 10.1007/s00018-003-3215-4; Garcia-Fernandez B, 2009, INT J DEV BIOL, V53, P1549, DOI 10.1387/ijdb.072308bg; Gettings M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000390; Gorfinkiel N, 2007, J CELL SCI, V120, P3289, DOI 10.1242/jcs.010850; Harden N, 2002, DIFFERENTIATION, V70, P181, DOI 10.1046/j.1432-0436.2002.700408.x; Harden N, 2002, J CELL SCI, V115, P2119; Harden N, 1999, J CELL SCI, V112, P273; HIME G, 1992, DEVELOPMENT, V114, P165; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Jacinto A, 2002, CURR BIOL, V12, P1245, DOI 10.1016/S0960-9822(02)00955-7; Jacinto A, 2002, DEV CELL, V3, P9, DOI 10.1016/S1534-5807(02)00208-3; Jankovics F, 2006, DEV CELL, V11, P375, DOI 10.1016/j.devcel.2006.07.014; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; Kaltschmidt JA, 2002, NAT CELL BIOL, V4, P937, DOI 10.1038/ncb882; Kim YO, 2004, P NATL ACAD SCI USA, V101, P159, DOI 10.1073/pnas.0307205101; Li JL, 2007, P NATL ACAD SCI USA, V104, P2626, DOI 10.1073/pnas.0610945104; Luschnig S, 2004, GENETICS, V167, P325, DOI 10.1534/genetics.167.1.325; Magie CR, 1999, DEVELOPMENT, V126, P5353; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Millard TH, 2008, DEVELOPMENT, V135, P621, DOI 10.1242/dev.014001; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Negeri D, 2002, MECH DEVELOP, V117, P151, DOI 10.1016/S0925-4773(02)00193-4; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Osmani N, 2010, J CELL BIOL, V191, P1261, DOI 10.1083/jcb.201003091; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Peralta XG, 2007, BIOPHYS J, V92, P2583, DOI 10.1529/biophysj.106.094110; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Pilot F, 2006, DEVELOPMENT, V133, P711, DOI 10.1242/dev.02251; Prokopenko SN, 1999, GENE DEV, V13, P2301, DOI 10.1101/gad.13.17.2301; Raymond K, 2001, J BIOL CHEM, V276, P35909, DOI 10.1074/jbc.M105779200; Roeth JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007634; Sawamoto K, 1999, J CELL BIOL, V146, P361, DOI 10.1083/jcb.146.2.361; Sawyer JK, 2009, J CELL BIOL, V186, P57, DOI 10.1083/jcb.200904001; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schumacher S, 2004, DEVELOPMENT, V131, P2631, DOI 10.1242/dev.01149; Smallhorn M, 2004, DEVELOPMENT, V131, P2641, DOI 10.1242/dev.01150; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; Song J, 1998, J CELL SCI, V111, P2257; SPENCER M, 2004, P NATL ACAD SCI USA, V101, P16216; Stark KA, 1997, DEVELOPMENT, V124, P4583; Takahashi K, 1998, MECH DEVELOP, V78, P97, DOI 10.1016/S0925-4773(98)00151-8; Thomas C, 2009, DEV BIOL, V331, P250, DOI 10.1016/j.ydbio.2009.05.001; Van Aelst L, 2002, GENE DEV, V16, P1032, DOI 10.1101/gad.978802; van Impel A, 2009, DEVELOPMENT, V136, P813, DOI 10.1242/dev.026203; VanHook A, 2008, DEV DYNAM, V237, P28, DOI 10.1002/dvdy.21405; Woolner S, 2005, DEV BIOL, V282, P163, DOI 10.1016/j.ydbio.2005.03.005; Zecchini V, 1999, CURR BIOL, V9, P460, DOI 10.1016/S0960-9822(99)80211-5; Zeitlinger J, 1999, DEVELOPMENT, V126, P3947	59	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22229	10.1371/journal.pone.0022229	http://dx.doi.org/10.1371/journal.pone.0022229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799798	gold, Green Submitted, Green Published			2022-12-25	WOS:000292931200035
J	Alyousefi, NA; Mahdy, MAK; Mahmud, R; Lim, YAL				Alyousefi, Naelah A.; Mahdy, Mohammed A. K.; Mahmud, Rohela; Lim, Yvonne A. L.			Factors Associated with High Prevalence of Intestinal Protozoan Infections among Patients in Sana'a City, Yemen	PLOS ONE			English	Article							RISK-FACTORS; DRINKING-WATER; TYPHOID-FEVER; PARASITES; DIARRHEA; HYGIENE; GIARDIA; LOCALITIES; DIAGNOSIS; CHILDREN	Background: Intestinal protozoan diseases in Yemen are a significant health problem with prevalence ranging from 18% to 27%. The present study is a cross-sectional study aimed at determining the factors associated with the high prevalence of intestinal protozoan infections among patients seeking health care in Sana'a City, the capital of Yemen. Methodology/Principal Findings: Stool samples were collected from 503 patients aged between 1 and 80 years old; 219 were males and 284 females. Biodata were collected via pretested standard questionnaire. Faecal samples were processed and examined for (oo)cysts or ova using a wet mount preparation after formal-ether concentration technique. Cryptosporidium oocysts were detected using the Ziehl-Neelsen staining technique. The overall prevalence of intestinal protozoan infections was 30.9%. Infection rates of Giardia duodenalis, Entamoeba histolytica/dispar and Cryptosporidium were 17.7%, 17.1% and 1%, respectively. Other parasites detected included Ascaris lumbricoides (2.4%), Schistosoma mansoni (0.3%), Hymenolepis nana (1.4%) and Enterobius vermicularis (0.4%). Multivariate analysis using forward stepwise logistic regression based on intestinal protozoan infections showed that contact with animals (OR = 1.748, 95% CI = 1.168-2.617) and taking bath less than twice a week (OR = 1.820, 95% CI = 1.192-2.779) were significant risk factors of protozoan infections. Conclusions/Significance: This present study indicated that intestinal protozoan infections are still a public health problem in Yemen, with Giardia and Entamoeba infections being most common. Statistical analysis indicated that low personal hygiene and contact with animals were important predictors for intestinal protozoan infections. As highlighted in this study, in order to effectively reduce these infections, a multi-sectoral effort is needed. Preventive measures should include good hygienic practices, good animal husbandry practices, heightened provision of educational health programs, health services in all governorates including rural areas. Furthermore, it is also essential to find radical solutions to the recent water crises in Yemen.	[Alyousefi, Naelah A.; Mahdy, Mohammed A. K.; Mahmud, Rohela; Lim, Yvonne A. L.] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Mahdy, Mohammed A. K.] Sanaa Univ, Fac Med, Dept Parasitol, Sanaa, Yemen	Universiti Malaya	Alyousefi, NA (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	naelaalyousfi@yahoo.com; limailian@um.edu.my	MAHMUD, ROHELA/B-9593-2010; LIM, YVONNE AL/B-5276-2010; Alyousefi, Naelah/D-2006-2010; Mahdy, Mohammed A.K./C-1187-2010	LIM, YVONNE AL/0000-0003-4050-6332; Alyousefi, Naelah/0000-0001-8871-1824; Mahdy, Mohammed A.K./0000-0002-8340-5219; kamal, amera/0000-0002-9154-9415	University of Malaya [PS204/2010A, RG181/10HTM, RG221/10HTM]	University of Malaya(Universiti Malaya)	This work was supported by research grants from the University of Malaya (Grant no. PS204/2010A, RG181/10HTM and RG221/10HTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKHTER J, 1994, J INT MED RES, V22, P47, DOI 10.1177/030006059402200106; Al-Haddad A M, 2010, J Egypt Soc Parasitol, V40, P479; Al-Shammari S, 2001, TROP MED INT HEALTH, V6, P184, DOI 10.1046/j.1365-3156.2001.00698.x; Al-Shibani Latifa A., 2009, Journal of the Egyptian Society of Parasitology, V39, P263; Azazy A A, 2003, East Mediterr Health J, V9, P1048; BAKER DG, 1987, J AM VET MED ASSOC, V190, P53; Curtis V, 2000, TROP MED INT HEALTH, V5, P22, DOI 10.1046/j.1365-3156.2000.00512.x; Ebrahim A, 1997, AM J TROP MED HYG, V57, P706, DOI 10.4269/ajtmh.1997.57.706; ESREY SA, 1985, B WORLD HEALTH ORGAN, V63, P757; ESREY SA, 1989, INT J EPIDEMIOL, V18, P248, DOI 10.1093/ije/18.1.248; FARAG HF, 1985, TROP GEOGR MED, V37, P29; Gasem MH, 2001, TROP MED INT HEALTH, V6, P484, DOI 10.1046/j.1365-3156.2001.00734.x; Gillespie TR, 2005, J PARASITOL, V91, P569, DOI 10.1645/GE-434R; Gorter AC, 1998, INT J EPIDEMIOL, V27, P1090, DOI 10.1093/ije/27.6.1090; GYAWALI N, 2010, OFFICIAL J DIGESTIVE, V30, P145; HAN AM, 1989, T ROY SOC TROP MED H, V83, P128, DOI 10.1016/0035-9203(89)90737-2; HAZZA YA, 1983, AM J TROP MED HYG, V32, P1023, DOI 10.4269/ajtmh.1983.32.1023; Hoque BA, 1999, PUBLIC HEALTH, V113, P57, DOI 10.1016/S0033-3506(99)00119-5; KHAN MU, 1982, T ROY SOC TROP MED H, V76, P164, DOI 10.1016/0035-9203(82)90266-8; Kinfu A, 2008, T ROY SOC TROP MED H, V102, P1143, DOI 10.1016/j.trstmh.2008.05.009; KNIGHT SM, 1992, INT J EPIDEMIOL, V21, P812, DOI 10.1093/ije/21.4.812; Kopecky K, 1992, J Hyg Epidemiol Microbiol Immunol, V36, P253; KUNTZ RE, 1953, AM J TROP MED HYG, V2, P13, DOI 10.4269/ajtmh.1953.2.13; Legesse M, 2004, ACTA TROP, V90, P231, DOI 10.1016/j.actatropica.2003.12.003; Mahdy AKM, 2008, T ROY SOC TROP MED H, V102, P465, DOI 10.1016/j.trstmh.2008.02.004; Mehraj V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003680; Mintz E, 2001, AM J PUBLIC HEALTH, V91, P1565, DOI 10.2105/AJPH.91.10.1565; OMAR MS, 1995, J COMMUN HEALTH, V20, P433, DOI 10.1007/BF02260439; Prakash KP, 2008, IRAN J PUBLIC HEALTH, V37, P60; Raja'a YA, 2000, SAUDI MED J, V21, P635; Raswaid SH, 2008, IRAN J PARASITOL, V3, P37; Rivera WL, 2010, PRIMATES, V51, P69, DOI 10.1007/s10329-009-0174-x; Saab BR, 2004, SAUDI MED J, V25, P34; Sayyari A. A., 2005, Eastern Mediterranean Health Journal, V11, P377; Schmidt M, 2008, ENVIRON PROT EUR UNI, V3, P133; SHAID N, 1996, DIARRHOEAL DIS RES, V4, P85; THOMPSON R, 2009, PARASITOLOGY, V112, P7; Velema JP, 1997, TROP MED INT HEALTH, V2, P1088, DOI 10.1046/j.1365-3156.1997.d01-179.x; VINAYAK VK, 1976, INDIAN J MED RES, V64, P1347; *WHO, 2009, YEM CONV PRIM HLTH C; World Bank, 2009, WORLD BANK GROUP GUARANTEE INSTRUMENTS, 1990-2007: AN INDEPENDENT EVALUATION, P1, DOI 10.1596/978-0-8213-7679-9; World Bank, 2008, WORLD BANK COUNTRY, P1, DOI 10.1596/978-0-8213-7462-7; *WORLD BANK, 2004, YEM REP GLANC; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x; Xiao LH, 2008, INT J PARASITOL, V38, P1239, DOI 10.1016/j.ijpara.2008.03.006	45	40	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22044	10.1371/journal.pone.0022044	http://dx.doi.org/10.1371/journal.pone.0022044			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789210	Green Published, Green Accepted, gold			2022-12-25	WOS:000292812400028
J	Glorieux, S; Bachert, C; Favoreel, HW; Vandekerckhove, AP; Steukers, L; Rekecki, A; van den Broeck, W; Goossens, J; Croubels, S; Clayton, RF; Nauwynck, HJ				Glorieux, Sarah; Bachert, Claus; Favoreel, Herman W.; Vandekerckhove, Annelies P.; Steukers, Lennert; Rekecki, Anamaria; van den Broeck, Wim; Goossens, Joline; Croubels, Siska; Clayton, Reginald F.; Nauwynck, Hans J.			Herpes Simplex Virus Type 1 Penetrates the Basement Membrane in Human Nasal Respiratory Mucosa	PLOS ONE			English	Article							US3 PROTEIN-KINASE; ORGAN-CULTURE; IN-VIVO; APOPTOSIS; CELLS; INFECTION; ACYCLOVIR; TRANSPORT; EXPLANTS; SUBUNIT	Background: Herpes simplex virus infections are highly prevalent in humans. However, the current therapeutics suffer important drawbacks such as limited results in neonates, increasing occurrence of resistance and impeded treatment of stromal infections. Remarkably, interactions of herpesviruses with human mucosa, the locus of infection, remain poorly understood and the underlying mechanisms in stromal infection remain controversial. Methodology/Principal Findings: A human model consisting of nasal respiratory mucosa explants was characterised. Viability and integrity were examined during 96 h of cultivation. HSV1-mucosa interactions were analysed. In particular, we investigated whether HSV1 is able to reach the stroma. Explant viability and integrity remained preserved. HSV1 induced rounding up and loosening of epithelial cells with very few apoptotic and necrotic cells observed. Following 16-24 h of infection, HSV1 penetrated the basement membrane and replicated in the underlying lamina propria. Conclusions/Significance: This human explant model can be used to study virus-mucosa interactions and viral mucosal invasion mechanisms. Using this model, our results provide a novel insight into the HSV1 stromal invasion mechanism and for the first time directly demonstrate that HSV1 can penetrate the basement membrane.	[Glorieux, Sarah; Favoreel, Herman W.; Vandekerckhove, Annelies P.; Steukers, Lennert; Nauwynck, Hans J.] Univ Ghent, Fac Vet Med, Virol Lab, Merelbeke, Belgium; [Bachert, Claus] Ghent Univ Hosp, Dept Otorhinolaryngol, B-9000 Ghent, Belgium; [Favoreel, Herman W.] Univ Ghent, Fac Vet Med, Immunol Lab, Merelbeke, Belgium; [Rekecki, Anamaria; van den Broeck, Wim] Univ Ghent, Fac Vet Med, Dept Morphol, Merelbeke, Belgium; [Goossens, Joline; Croubels, Siska] Univ Ghent, Fac Vet Med, Dept Pharmacol Toxicol & Biochem, Merelbeke, Belgium; [Clayton, Reginald F.] Tibotec BVBA, Beerse, Belgium	Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University; Ghent University; Johnson & Johnson	Glorieux, S (corresponding author), Univ Ghent, Fac Vet Med, Virol Lab, Merelbeke, Belgium.	Sarah.Glorieux@UGent.be	Favoreel, Herman W/H-8712-2013; Rekecki, Anamaria/AAE-4181-2022; Bachert, Claus/J-8825-2012	Favoreel, Herman W/0000-0003-4993-6857; Nauwynck, Hans/0000-0001-5470-0713; Croubels, Siska/0000-0001-6357-3517	Agency for Innovation by Science and Technology in Flanders (IWT) [IWT/OZM/090644]	Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	Sarah Glorieux was supported by a post-doctoral research grant of the Agency for Innovation by Science and Technology in Flanders (IWT) [IWT/OZM/090644]. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Reginald Clayton is employed by a commercial company, Tibotec BVBA, and as a native English speaker, was involved in proofreading and critical analysis of the data of the manuscript.	Ali M, 1996, AM J PHYSIOL-LUNG C, V270, pL595, DOI 10.1152/ajplung.1996.270.4.L595; Asano S, 1999, J GEN VIROL, V80, P51, DOI 10.1099/0022-1317-80-1-51; Aubert M, 1999, J VIROL, V73, P2803, DOI 10.1128/JVI.73.4.2803-2813.1999; Avlasevich SL, 2006, ENVIRON MOL MUTAGEN, V47, P56, DOI 10.1002/em.20170; Bernstein JM, 1997, J ALLERGY CLIN IMMUN, V99, P165, DOI 10.1016/S0091-6749(97)70091-5; Berrington WR, 2009, CLIN INFECT DIS, V49, P1295, DOI 10.1086/606053; Betz UAK, 2002, ANTIMICROB AGENTS CH, V46, P1766, DOI 10.1128/AAC.46.6.1766-1772.2002; Bradbury P., 1977, THEORY PRACTICE HIST; BRADBURY P, 1977, THEORY PRACTICE HIST, P109; Chen TS, 2006, MODERN PATHOL, V19, P726, DOI 10.1038/modpathol.3800584; COTTON CU, 1987, J CLIN INVEST, V79, P80, DOI 10.1172/JCI112812; DINGWELL KS, 1994, J VIROL, V68, P834, DOI 10.1128/JVI.68.2.834-845.1994; Duan R, 2008, J INFECT DIS, V198, P659, DOI 10.1086/590668; Esaki S, 2010, ARCH VIROL, V155, P1235, DOI 10.1007/s00705-010-0712-2; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Galvan V, 1998, P NATL ACAD SCI USA, V95, P3931, DOI 10.1073/pnas.95.7.3931; GARTNER LP, 2006, CELL BIOL HISTOLOGY, P83; GIZURARSON S, 1991, VACCINE, V9, P825, DOI 10.1016/0264-410X(91)90220-Z; Glorieux S, 2007, J VIROL METHODS, V142, P105, DOI 10.1016/j.jviromet.2007.01.018; Glorieux S, 2009, VET MICROBIOL, V136, P341, DOI 10.1016/j.vetmic.2008.11.005; Greco A., 2007, Infectious Disorders - Drug Targets, V7, P11, DOI 10.2174/187152607780090766; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; HAM AW, 1979, HISTOLOGY, P222; Hata S, 1999, MICROBES INFECT, V1, P601, DOI 10.1016/S1286-4579(99)80059-8; Ingber DE, 2002, DIFFERENTIATION, V70, P547, DOI 10.1046/j.1432-0436.2002.700908.x; Jackson AD, 1996, AM J RESP CRIT CARE, V153, P1130, DOI 10.1164/ajrccm.153.3.8630556; Jang YJ, 2005, J VIROL METHODS, V125, P41, DOI 10.1016/j.jviromet.2004.12.004; Javouhey E, 2008, VIROLOGY, V376, P31, DOI 10.1016/j.virol.2008.02.031; Jerome KR, 1999, J VIROL, V73, P8950, DOI 10.1128/JVI.73.11.8950-8957.1999; Johnston C, 2008, J INFECT DIS, V198, P31, DOI 10.1086/588676; Kierszenbaum A.L., 2007, HISTOLOGY CELL BIOL; King MA, 2000, J IMMUNOL METHODS, V243, P155, DOI 10.1016/S0022-1759(00)00232-5; Kissel T, 1998, J CONTROL RELEASE, V53, P195, DOI 10.1016/S0168-3659(97)00253-8; Koelle DM, 2003, CLIN MICROBIOL REV, V16, P96, DOI 10.1128/CMR.16.1.96-113.2003; LANDON DN, 1971, J ANAT, V108, P419; Langelier Y, 2002, J GEN VIROL, V83, P2779, DOI 10.1099/0022-1317-83-11-2779; Marshall DS, 2001, MODERN PATHOL, V14, P152, DOI 10.1038/modpathol.3880273; Matter K, 2003, METHODS, V30, P228, DOI 10.1016/S1046-2023(03)00029-X; MCGILL J, 1987, BRIT J OPHTHALMOL, V71, P118, DOI 10.1136/bjo.71.2.118; Miles DH, 2004, CURR EYE RES, V29, P79, DOI 10.1080/02713680490504669; Mitchell BM, 2003, J NEUROVIROL, V9, P194, DOI 10.1080/13550280390194000; Nguyen ML, 2007, ADV VIRUS RES, V69, P67, DOI 10.1016/S0065-3527(06)69002-7; Patel Asha R, 2007, Adv Skin Wound Care, V20, P408, DOI 10.1097/01.ASW.0000280199.58260.62; Patel AR, 2009, INT J DERMATOL, V48, P36, DOI 10.1111/j.1365-4632.2009.03788.x; Pebody RG, 2004, SEX TRANSM INFECT, V80, P185, DOI 10.1136/sti.2003.005850; Pena KC, 2010, J CLIN MICROBIOL, V48, P150, DOI 10.1128/JCM.01336-09; Perng GC, 2000, SCIENCE, V287, P1500, DOI 10.1126/science.287.5457.1500; Polcicova K, 2005, P NATL ACAD SCI USA, V102, P11462, DOI 10.1073/pnas.0503230102; Quondamatteo F, 2002, HISTOCHEM J, V34, P369, DOI 10.1023/A:1023675619251; SCHIERHORN K, 1995, IN VITRO CELL DEV-AN, V31, P215; Stanberry LR, 2000, CLIN INFECT DIS, V30, P549, DOI 10.1086/313687; STEUKERS L, ILAR E J IN PRESS; Vandekerckhove AP, 2010, J GEN VIROL, V91, P2019, DOI 10.1099/vir.0.019257-0; Wang K, 2007, J VIROL, V81, P6817, DOI 10.1128/JVI.00166-07; Weeks BS, 2000, ARCH VIROL, V145, P385, DOI 10.1007/s007050050030; WHITLEY R, 1991, NEW ENGL J MED, V324, P444, DOI 10.1056/NEJM199102143240703; Whitley RJ, FIELDS VIROLOGY FIEL, V2, P297; Yamauchi Y, 2003, MICROBIOL IMMUNOL, V47, P685, DOI 10.1111/j.1348-0421.2003.tb03432.x	58	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22160	10.1371/journal.pone.0022160	http://dx.doi.org/10.1371/journal.pone.0022160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789229	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811700030
J	Lan, X; Adams, C; Landers, M; Dudas, M; Krissinger, D; Marnellos, G; Bonneville, R; Xu, MX; Wang, JB; Huang, THM; Meredith, G; Jin, VX				Lan, Xun; Adams, Christopher; Landers, Mark; Dudas, Miroslav; Krissinger, Daniel; Marnellos, George; Bonneville, Russell; Xu, Maoxiong; Wang, Junbai; Huang, Tim H. -M.; Meredith, Gavin; Jin, Victor X.			High Resolution Detection and Analysis of CpG Dinucleotides Methylation Using MBD-Seq Technology	PLOS ONE			English	Article							FACTOR-BINDING SITES; CHIP-SEQ; DNA-METHYLATION; MAXIMUM-LIKELIHOOD; CHROMATIN IMMUNOPRECIPITATION; GENOME BROWSER; GENES; IDENTIFICATION; METHYLOME; SOFTWARE	Methyl-CpG binding domain protein sequencing (MBD-seq) is widely used to survey DNA methylation patterns. However, the optimal experimental parameters for MBD-seq remain unclear and the data analysis remains challenging. In this study, we generated high depth MBD-seq data in MCF-7 cell and developed a bi-asymmetric-Laplace model (BALM) to perform data analysis. We found that optimal efficiency of MBD-seq experiments was achieved by sequencing similar to 100 million unique mapped tags from a combination of 500 mM and 1000 mM salt concentration elution in MCF-7 cells. Clonal bisulfite sequencing results showed that the methylation status of each CpG dinucleotides in the tested regions was accurately detected with high resolution using the proposed model. These results demonstrated the combination of MBD-seq and BALM could serve as a useful tool to investigate DNA methylome due to its low cost, high specificity, efficiency and resolution.	[Lan, Xun; Bonneville, Russell; Xu, Maoxiong; Jin, Victor X.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Adams, Christopher; Landers, Mark; Dudas, Miroslav; Krissinger, Daniel; Marnellos, George; Meredith, Gavin] Life Technol, Carlsbad, CA USA; [Wang, Junbai] Univ Oslo, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Huang, Tim H. -M.] Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Thermo Fisher Scientific; University of Oslo; University System of Ohio; Ohio State University	Lan, X (corresponding author), Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA.	victor.jin@osumc.edu	wang, junbai/AFQ-5325-2022; wang, junbai/B-2093-2008	wang, junbai/0000-0001-5505-5613; Lan, Xun/0000-0002-6523-046X	Biomedical Informatics Start-up funds; Howard Hughes Medical Institute	Biomedical Informatics Start-up funds; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The study is funded by Biomedical Informatics Start-up funds. XL is awarded a Howard Hughes Medical Institute Med Into Grad Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Brinkman AB, 2010, METHODS, V52, P232, DOI 10.1016/j.ymeth.2010.06.012; Bruzzone L, 2000, IEEE T GEOSCI REMOTE, V38, P1171, DOI 10.1109/36.843009; Choi JK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r89; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dai XF, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-165; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Fragiadakis K, 2008, AIP CONF PROC, V1060, P121, DOI 10.1063/1.3037034; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jacinto FV, 2008, BIOTECHNIQUES, V44, P35, DOI 10.2144/000112708; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; JORDAN MI, 1994, NEURAL COMPUT, V6, P181, DOI 10.1162/neco.1994.6.2.181; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kotz S, 2002, ANN I STAT MATH, V54, P816, DOI 10.1023/A:1022467519537; KOTZ S, 2001, LAPLACE DISTRIBUTION, P349; Lan X, 2011, BIOINFORMATICS, V27, P428, DOI 10.1093/bioinformatics/btq669; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Patra SK, 2007, ONCOL REP, V17, P1279; Pomraning KR, 2009, METHODS, V47, P142, DOI 10.1016/j.ymeth.2008.09.022; Rauch T, 2006, CANCER RES, V66, P7939, DOI 10.1158/0008-5472.CAN-06-1888; Rauch TA, 2010, METHODS, V52, P213, DOI 10.1016/j.ymeth.2010.03.004; REDNER RA, 1984, SIAM REV, V26, P195, DOI 10.1137/1026034; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992; Vaid M, 2009, ONCOL REP, V21, P3, DOI 10.3892/or_00000182; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Volik S, 2003, P NATL ACAD SCI USA, V100, P7696, DOI 10.1073/pnas.1232418100; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Wilbanks EG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011471; Xuan GR, 2001, IEEE IMAGE PROC, P145, DOI 10.1109/ICIP.2001.958974; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; ZHANG X, 2010, BIOMETRICS; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZD, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000158	53	57	59	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e22226	10.1371/journal.pone.0022226	http://dx.doi.org/10.1371/journal.pone.0022226			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779396	gold, Green Published, Green Submitted			2022-12-25	WOS:000292680900034
J	Khromova, N; Kopnin, P; Rybko, V; Kopnin, BP				Khromova, N.; Kopnin, P.; Rybko, V.; Kopnin, B. P.			Downregulation of VEGF-C expression in lung and colon cancer cells decelerates tumor growth and inhibits metastasis via multiple mechanisms	ONCOGENE			English	Article						metastasis; epithelial-mesenchymal transition (EMT); cancer stem cells (CSCs); cell migration; tumor vascularization; VEGF-C	EPITHELIAL-MESENCHYMAL TRANSITIONS; STEM-CELLS; CLINICAL-SIGNIFICANCE; FACTOR RECEPTOR-3; NUDE-MICE; LYMPHANGIOGENESIS; AUTOCRINE; PROMOTES; CARCINOMA; AXIS	Experimental and clinical studies positively correlate expression of vascular endothelial growth factor (VEGF)-C in cancer cells with accelerated tumor progression and/or unfavorable clinical outcome. However, many aspects of tumor-promoting activity of VEGF-C and consequences of its downregulation for tumor progression remain poorly understood. To clarify these points, we created a set of VEGF receptor 3-positive lung carcinoma A549 and colon carcinoma HCT116 cell sublines with stable repression of VEGF-C synthesis. Analysis of the behavior of these cells revealed multiple effects of VEGF-C downregulation, which, in addition to deceleration of cell proliferation and invasion in vitro and inhibition of lymphangiogenesis in tumor and surrounding tissues observed earlier, included previously undescribed effects, in particular, partial restoration of epithelial phenotype, reduction in the percentage of tumor-initiating cells (cancer stem cells) in the cell population and inhibition of metastasis of orthotopic lung cancer xenografts to other lung lobes. These results are consistent with the idea of high potentiality of VEGF-C as a cancer drug target. Oncogene (2012) 31, 1389-1397; doi:10.1038/onc.2011.330; published online 1 August 2011	[Khromova, N.; Kopnin, P.; Rybko, V.; Kopnin, B. P.] Blokhin Russian Canc Res Ctr, Inst Carcinogenesis, Moscow 115478, Russia	N.N. Blokhin Russian Cancer Research Center	Kopnin, BP (corresponding author), Blokhin Russian Canc Res Ctr, Inst Carcinogenesis, Kashirskoye Shosse 24, Moscow 115478, Russia.	bkopnin@mail.ru	Kopnin, Pavel/R-8213-2019; Kopnin, Boris/R-8240-2019	Kopnin, Pavel/0000-0002-2078-4274; Kopnin, Boris/0000-0003-3100-2212	Russian Fund for Basic Research [08-04-00252]; PROTEK-CRC; Russian Federal Program 'Scientific and pedagogical personnel of innovative Russia' [02.740.11.0085]	Russian Fund for Basic Research(Russian Foundation for Basic Research (RFBR)); PROTEK-CRC; Russian Federal Program 'Scientific and pedagogical personnel of innovative Russia'	The work was supported by grants from Russian Fund for Basic Research (BK, # 08-04-00252), PROTEK-CRC Program for Basic Research in Oncology and Russian Federal Program 'Scientific and pedagogical personnel of innovative Russia' (BK, # 02.740.11.0085).	Arinaga M, 2003, CANCER-AM CANCER SOC, V97, P457, DOI 10.1002/cncr.11073; Bahram Fuad, 2010, Pathophysiology, V17, P253, DOI 10.1016/j.pathophys.2009.10.004; Chen YL, 2010, MOL CELL BIOCHEM, V345, P77, DOI 10.1007/s11010-010-0562-y; Gu Y, 2008, CLIN EXP METASTAS, V25, P717, DOI 10.1007/s10585-008-9180-4; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Hoshida T, 2006, CANCER RES, V66, P8065, DOI 10.1158/0008-5472.CAN-06-1392; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jackson MW, 2002, CANCER RES, V62, P854; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Joukov V, 1996, EMBO J, V15, P290; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Karpanen T, 2006, FASEB J, V20, P1462, DOI 10.1096/fj.05-5646com; Khromova NV, 2009, CANCER LETT, V276, P143, DOI 10.1016/j.canlet.2008.10.049; Kodama M, 2008, CLIN CANCER RES, V14, P7205, DOI 10.1158/1078-0432.CCR-08-0818; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Miyazaki T, 2008, JPN J CLIN ONCOL, V38, P839, DOI 10.1093/jjco/hyn106; Orlandini M, 2006, J BIOL CHEM, V281, P17961, DOI 10.1074/jbc.M600413200; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Skobe M, 1999, J INVEST DERMATOL, V113, P1047, DOI 10.1046/j.1523-1747.1999.00798.x; Strizzi L, 2001, J PATHOL, V193, P468, DOI 10.1002/path.824; Su JL, 2008, CANCER CELL, V13, P557, DOI 10.1016/j.ccr.2008.04.021; Su JL, 2006, CANCER CELL, V9, P209, DOI 10.1016/j.ccr.2006.02.018; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Timoshenko AV, 2007, BRIT J CANCER, V97, P1090, DOI 10.1038/sj.bjc.6603993; WANG XE, 1992, ANTICANCER RES, V12, P1399; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Xu YL, 2010, J CELL BIOL, V188, P115, DOI 10.1083/jcb.200903137; Yamashita T, 2010, LUNG CANCER, V70, P320, DOI 10.1016/j.lungcan.2010.02.013; Yamaura T, 2000, NEOPLASIA, V2, P315, DOI 10.1038/sj.neo.7900098; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	36	56	66	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	11					1389	1397		10.1038/onc.2011.330	http://dx.doi.org/10.1038/onc.2011.330			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	912FL	21804602				2022-12-25	WOS:000301780000006
J	Rogel, MR; Soni, PN; Troken, JR; Sitikov, A; Trejo, HE; Ridge, KM				Rogel, Micah R.; Soni, Pritin N.; Troken, James R.; Sitikov, Albert; Trejo, Humberto E.; Ridge, Karen M.			Vimentin is sufficient and required for wound repair and remodeling in alveolar epithelial cells	FASEB JOURNAL			English	Article						TGF-beta 1; migration; scratch wound assay; intermediate filaments; lung injury	GROWTH-FACTOR-BETA; KERATIN INTERMEDIATE-FILAMENTS; TGF-BETA; IN-VITRO; P21-ACTIVATED KINASE; PULMONARY-FIBROSIS; ASSEMBLY DYNAMICS; GENE-EXPRESSION; PHOSPHORYLATION; MIGRATION	The physiological and pathophysiological implications of the expression of vimentin, a type III intermediate filament protein, in alveolar epithelial cells (AECs) are unknown. We provide data demonstrating that vimentin is regulated by TGF beta 1, a major cytokine released in response to acute lung injury and that vimentin is required for wound repair and remodeling of the alveolar epithelium. Quantitative real-time PCR shows a 16-fold induction of vimentin mRNA in TGF beta 1-treated transformed AECs. Luciferase assays identify a Smad-binding element in the 5' promoter of vimentin responsible for TGF beta 1-induced transcription. Notably, TGF beta 1 induces vimentin protein expression in AECs, which is associated with a 2.5-fold increase in cell motility, resulting in increased rates of migration and wound closure. These effects are independent of cell proliferation. TGF beta 1-mediated vimentin protein expression, cell migration, and wound closure are prevented by a pharmacological inhibitor of the Smad pathway and by expression of Ad-shRNA against vimentin. Conversely, overexpression of mEmerald-vimentin is sufficient for increased cell-migration and wound-closure rates. These results demonstrate that vimentin is required and sufficient for increased wound repair in an in vitro model of lung injury.-Rogel, M. R., Soni, P. N., Troken, J. R., Sitikov, A., Trejo, H. E., Ridge, K. M. Vimentin is sufficient and required for wound repair and remodeling in alveolar epithelial cells. FASEB J. 25, 3873-3883 (2011). www.fasebj.org	[Ridge, Karen M.] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Rogel, Micah R.] Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA; [Ridge, Karen M.] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Ridge, Karen M.] Dept Vet Affairs, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University	Ridge, KM (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, 240 E Huron St,McGaw M328, Chicago, IL 60611 USA.	kridge@northwestern.edu		Trejo BIttar, Humberto/0000-0003-2701-6531	U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NIH-NHLBI) [PO1 HL71643, T32-076139-02]; Department of Veterans Affairs; American Heart Association (AHA) [10PRE4210064]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079190, P01HL071643] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NIH-NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association (AHA)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Robert D. Goldman (Northwestern University, Evanston, IL, USA) for the mEmerald-vimentin vector construct, Dr. Robert B. Hamanaka for technical help and suggestions, and Mr. Luke Skertich for assistance with wound closure data analysis. This work was supported by grants from the U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (PO1 HL71643 NIH-NHLBI), the Department of Veterans Affairs (MERIT Award), the Training Program in Lung Science (T32-076139-02 NIH-NHLBI; to M.R.R.), and the American Heart Association (AHA 10PRE4210064; to M.R.R.).	ADAMSON IYR, 1990, AM J PATHOL, V137, P385; Barberis L, 2009, EUR J IMMUNOL, V39, P1136, DOI 10.1002/eji.200838884; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bargagna-Mohan P, 2010, J BIOL CHEM, V285, P7657, DOI 10.1074/jbc.M109.093765; Bergeron A, 2003, EUR RESPIR J, V22, P69, DOI 10.1183/09031936.03.00014703; Berthiaume Y, 1999, THORAX, V54, P150, DOI 10.1136/thx.54.2.150; Bhattacharya R, 2009, J CELL SCI, V122, P1390, DOI 10.1242/jcs.043042; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; Boyer B, 2000, BIOCHEM PHARMACOL, V60, P1091, DOI 10.1016/S0006-2952(00)00427-5; Brown MJ, 2001, J IMMUNOL, V166, P6640, DOI 10.4049/jimmunol.166.11.6640; Buisson AC, 1996, LAB INVEST, V74, P658; Dennler S, 2002, J LEUKOCYTE BIOL, V71, P731; Dhainaut JF, 2003, CRIT CARE MED, V31, pS258, DOI 10.1097/01.CCM.0000057901.92381.75; Draper BK, 2003, J CELL BIOCHEM, V89, P1126, DOI 10.1002/jcb.10584; Dumon N, 2003, J BIOL CHEM, V278, P3275, DOI 10.1074/jbc.M204623200; Eckes B, 1998, J CELL SCI, V111, P1897; Eckes B, 2000, J CELL SCI, V113, P2455; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Geiser T, 2000, AM J PHYSIOL-LUNG C, V279, pL1184, DOI 10.1152/ajplung.2000.279.6.L1184; Gilles C, 1999, J CELL SCI, V112, P4615; Godsel LM, 2005, J CELL BIOL, V171, P1045, DOI 10.1083/jcb.200510038; Goto H, 2002, GENES CELLS, V7, P91, DOI 10.1046/j.1356-9597.2001.00504.x; Khalil N, 1996, AM J RESP CELL MOL, V14, P131, DOI 10.1165/ajrcmb.14.2.8630262; Khalil N, 1996, AM J RESP CELL MOL, V15, P252, DOI 10.1165/ajrcmb.15.2.8703482; KHERADMAND F, 1994, AM J PHYSIOL-LUNG C, V267, pL728, DOI 10.1152/ajplung.1994.267.6.L728; Lesur O, 1996, AM J PHYSIOL-LUNG C, V270, pL311, DOI 10.1152/ajplung.1996.270.3.L311; Li QF, 2006, J BIOL CHEM, V281, P34716, DOI 10.1074/jbc.M607715200; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; Ridge KM, 2005, J BIOL CHEM, V280, P30400, DOI 10.1074/jbc.M504239200; Savla U, 2004, J APPL PHYSIOL, V96, P566, DOI 10.1152/japplphysiol.00510.2003; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P889, DOI 10.1073/pnas.0710728105; Sivaramakrishnan S, 2009, MOL BIOL CELL, V20, P2755, DOI 10.1091/mbc.E08-10-1028; SUNDARRAJ N, 1992, CELL TISSUE RES, V267, P347, DOI 10.1007/BF00302973; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Tian F, 2004, CANCER RES, V64, P4523, DOI 10.1158/0008-5472.CAN-04-0030; Uhal BD, 1997, AM J PHYSIOL-LUNG C, V272, pL1031, DOI 10.1152/ajplung.1997.272.6.L1031; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Wu YZ, 2007, BBA-MOL CELL RES, V1773, P427, DOI 10.1016/j.bbamcr.2006.11.017; Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147; ZAHM JM, 1991, AM J RESP CELL MOL, V5, P242, DOI 10.1165/ajrcmb/5.3.242	52	82	84	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2011	25	11					3873	3883		10.1096/fj.10-170795	http://dx.doi.org/10.1096/fj.10-170795			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21803859	Green Published			2022-12-25	WOS:000296723100012
J	Zarrabi, K; Dufour, A; Li, J; Kuscu, C; Pulkoski-Gross, A; Zhi, JZ; Hu, YJ; Sampson, NS; Zucker, S; Cao, J				Zarrabi, Kevin; Dufour, Antoine; Li, Jian; Kuscu, Cem; Pulkoski-Gross, Ashleigh; Zhi, Jizu; Hu, Youjun; Sampson, Nicole S.; Zucker, Stanley; Cao, Jian			Inhibition of Matrix Metalloproteinase 14 (MMP-14)-mediated Cancer Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOPEXIN-LIKE DOMAIN; BREAST-CANCER; 1-MATRIX METALLOPROTEINASE; TRANSMEMBRANE DOMAIN; PROMMP-2 ACTIVATION; PROSTATE-CANCER; CD44 CLEAVAGE; TUMOR-GROWTH; MT1-MMP; INVASION	Matrix metalloproteinases (MMPs) have been shown to be key players in both extracellular matrix remodeling and cell migration during cancer metastasis. MMP-14, a membrane-anchored MMP, in particular, is closely associated with these processes. The hemopexin (PEX) domain of MMP-14 has been proposed as the modulating region involved in the molecular cross-talk that initiates cell migration through homodimerization of MMP-14 as well as heterodimerization with the cell surface adhesion molecule CD44. In this study, minimal regions required for function within the PEX domain were investigated through a series of substitution mutations. Blades I and IV were found to be involved in cell migration. We found that blade IV is necessary for MMP-14 homodimerization and that blade I is required for CD44 MMP-14 heterodimerization. Cross-talk between MMP-14 and CD44 results in phosphorylation of EGF receptor and downstream activation of the MAPK and PI3K signaling pathways involved in cell migration. Based on these mutagenesis analyses, peptides mimicking the essential outermost strand motifs within the PEX domain of MMP-14 were designed. These synthetic peptides inhibit MMP-14-enhanced cell migration in a dose-dependent manner but have no effect on the function of other MMPs. Furthermore, these peptides interfere with cancer metastasis without affecting primary tumor growth. Thus, targeting the MMP-14 hemopexin domain represents a novel approach to inhibit MMP-14-mediated cancer dissemination.	[Zarrabi, Kevin; Li, Jian; Kuscu, Cem; Pulkoski-Gross, Ashleigh; Cao, Jian] SUNY Stony Brook, Dept Med Canc Prevent, Stony Brook, NY 11794 USA; [Dufour, Antoine; Sampson, Nicole S.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Zhi, Jizu] SUNY Stony Brook, Bioinformat Facil, Stony Brook, NY 11794 USA; [Hu, Youjun; Cao, Jian] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Zucker, Stanley] SUNY Stony Brook, Dept Hematol & Oncol, Stony Brook, NY 11794 USA; [Zucker, Stanley] Vet Affairs Med Ctr, Dept Res, Northport, NY 11768 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Cao, J (corresponding author), Room 004,Life Sci Bldg, Stony Brook, NY 11794 USA.	jian.cao@sunysb.edu	Sampson, Nicole/C-4598-2014; Dufour, Antoine/AAB-7886-2019; Zarrabi, Kevin/AHH-3952-2022	Sampson, Nicole/0000-0002-2835-7760; KUSCU, CEM/0000-0001-7154-6762	National Institutes of Health [5R01CA113553]; Carol Baldwin Breast Cancer Foundation; New York State Foundation for Science, Technology, and Innovation [C040076]; Veterans Affairs Merit Review grant; NATIONAL CANCER INSTITUTE [R01CA113553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM092714, T32GM007518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carol Baldwin Breast Cancer Foundation; New York State Foundation for Science, Technology, and Innovation; Veterans Affairs Merit Review grant(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in whole or in part, by National Institutes of Health Grant 5R01CA113553 (to J. C. and N. S. S.). This work was also supported by a Carol Baldwin Breast Cancer Foundation grant (to J. C.), by New York State Foundation for Science, Technology, and Innovation Faculty Development Program Grant C040076 (to N. S.), by a Veterans Affairs Merit Review grant, and by a Carol Baldwin Breast Cancer Foundation grant (to S. Z.).	Anderegg U, 2009, J INVEST DERMATOL, V129, P1471, DOI 10.1038/jid.2008.323; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Bode W, 1999, CELL MOL LIFE SCI, V55, P639, DOI 10.1007/s000180050320; Cao J, 2005, THROMB HAEMOSTASIS, V93, P770, DOI 10.1160/TH04-08-0555; Cao J, 2004, J BIOL CHEM, V279, P14129, DOI 10.1074/jbc.M312120200; Cao J, 2008, J BIOL CHEM, V283, P6232, DOI 10.1074/jbc.M705759200; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; D'Alessio S, 2008, J BIOL CHEM, V283, P87, DOI 10.1074/jbc.M705492200; Deryugina EI, 2008, HISTOCHEM CELL BIOL, V130, P1119, DOI 10.1007/s00418-008-0536-2; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Dufour A, 2008, J CELL PHYSIOL, V217, P643, DOI 10.1002/jcp.21535; Dufour A, 2010, J BIOL CHEM, V285, P35944, DOI 10.1074/jbc.M109.091769; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eisenach PA, 2010, J CELL SCI, V123, P4182, DOI 10.1242/jcs.062711; Galvez BG, 2001, J BIOL CHEM, V276, P37491, DOI 10.1074/jbc.M104094200; Giubellino A, 2007, CANCER RES, V67, P6012, DOI 10.1158/0008-5472.CAN-07-0022; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Itoh Y, 2008, J BIOL CHEM, V283, P13053, DOI 10.1074/jbc.M709327200; Itoh Y, 2006, MOL BIOL CELL, V17, P5390, DOI 10.1091/mbc.e06-08-0740; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Khaldoyanidi SK, 2003, J BIOL CHEM, V278, P4127, DOI 10.1074/jbc.M209590200; Kirsch M, 2004, CANC TREAT, V117, P285; Lauer-Fields JL, 2009, J BIOL CHEM, V284, P24017, DOI 10.1074/jbc.M109.016873; Lehti K, 2005, GENE DEV, V19, P979, DOI 10.1101/gad.1294605; Li XY, 2008, MOL BIOL CELL, V19, P3221, DOI 10.1091/mbc.E08-01-0016; Lichte A, 1996, FEBS LETT, V397, P277, DOI 10.1016/S0014-5793(96)01206-9; Magenta G, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-47; Marrero-Diaz R, 2009, CELL MOTIL CYTOSKEL, V66, P48, DOI 10.1002/cm.20325; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Okamoto I, 1999, ONCOGENE, V18, P1435, DOI 10.1038/sj.onc.1202447; Pavlaki M, 2002, J BIOL CHEM, V277, P2740, DOI 10.1074/jbc.M108987200; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Price JE, 1996, BREAST CANCER RES TR, V39, P93, DOI 10.1007/BF01806081; Remacle AG, 2005, J CELL SCI, V118, P4975, DOI 10.1242/jcs.02610; Ribatti D, 2006, NAT PROTOC, V1, P85, DOI 10.1038/nprot.2006.13; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Rozanov DV, 2004, EXP CELL RES, V293, P81, DOI 10.1016/j.yexcr.2003.10.006; Sabeh F, 2009, J BIOL CHEM, V284, P23001, DOI 10.1074/jbc.M109.002808; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Seiki M, 2003, CANCER METAST REV, V22, P129, DOI 10.1023/A:1023087113214; Seraj MJ, 2000, CANCER RES, V60, P2764; Sounni NE, 2002, FASEB J, V16, P555, DOI 10.1096/fj.01-0790com; Sounnil NE, 2010, INT J CANCER, V126, P1067, DOI 10.1002/ijc.24690; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Suenaga N, 2005, ONCOGENE, V24, P859, DOI 10.1038/sj.onc.1208258; Tochowicz A, 2011, J BIOL CHEM, V286, P7587, DOI 10.1074/jbc.M110.178434; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Verma RP, 2007, BIOORGAN MED CHEM, V15, P2223, DOI 10.1016/j.bmc.2007.01.011; Wang P, 2004, J BIOL CHEM, V279, P51148, DOI 10.1074/jbc.M409074200; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Zucker S, 2003, CURR TOP DEV BIOL, V54, P1, DOI 10.1016/S0070-2153(03)54004-2	53	150	161	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33167	33177		10.1074/jbc.M111.256644	http://dx.doi.org/10.1074/jbc.M111.256644			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795678	Green Published, hybrid			2022-12-25	WOS:000294968800036
J	Ferreira-Gomes, MS; Gonzalez-Lebrero, RM; de la Fuente, MC; Strehler, EE; Rossi, RC; Rossi, JPFC				Ferreira-Gomes, Mariela S.; Gonzalez-Lebrero, Rodolfo M.; de la Fuente, Maria C.; Strehler, Emanuel E.; Rossi, Rolando C.; Rossi, Juan Pablo F. C.			Calcium Occlusion in Plasma Membrane Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-DEPENDENT ATPASE; NA+/K+-ATPASE; PUMP; INHIBITION; MECHANISM; TRANSPORT; CA2+; PHOSPHOENZYME; STOICHIOMETRY; ACTIVATION	In this work, we set out to identify and characterize the calcium occluded intermediate(s) of the plasma membrane Ca2+-ATPase (PMCA) to study the mechanism of calcium transport. To this end, we developed a procedure for measuring the occlusion of Ca2+ in microsomes containing PMCA. This involves a system for overexpression of the PMCA and the use of a rapid mixing device combined with a filtration chamber, allowing the isolation of the enzyme and quantification of retained calcium. Measurements of retained calcium as a function of the Ca2+ concentration in steady state showed a hyperbolic dependence with an apparent dissociation constant of 12 +/- 2.2 mu M, which agrees with the value found through measurements of PMCA activity in the absence of calmodulin. When enzyme phosphorylation and the retained calcium were studied as a function of time in the presence of La-III (inducing accumulation of phosphoenzyme in the E1P state), we obtained apparent rate constants not significantly different from each other. Quantification of EP and retained calcium in steady state yield a stoichiometry of one mole of occluded calcium per mole of phosphoenzyme. These results demonstrate for the first time that one calcium ion becomes occluded in the E1P-phosphorylated intermediate of the PMCA.	[Rossi, Rolando C.; Rossi, Juan Pablo F. C.] Univ Buenos Aires, Fac Farm & Bioquim, Consejo Nacl Invest Cient & Tecn, Inst Quim & Fis Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Strehler, Emanuel E.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Mayo Clinic	Rossi, RC (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Consejo Nacl Invest Cient & Tecn, Inst Quim & Fis Quim Biol, Junin 956, RA-1113 Buenos Aires, DF, Argentina.	rcr@qb.ffyb.uba.ar; jprossi@qb.ffyb.uba.ar		Rossi, Juan Pablo/0000-0001-7087-844X; Gonzalez Lebrero, Rodolfo M./0000-0002-3832-2270	National Institutes of Health, Fogarty International Center [R03TW006837]; Agencia Nacional de Promocion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Universidad de Buenos Aires, Ciencia y Tecnica from Argentina; FOGARTY INTERNATIONAL CENTER [R03TW006837] Funding Source: NIH RePORTER	National Institutes of Health, Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires, Ciencia y Tecnica from Argentina(University of Buenos Aires); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported, in whole or in part, by National Institutes of Health, Fogarty International Center Grant R03TW006837. This work was also supported by Agencia Nacional de Promocion Cientifica y Tecnologica, Consejo Nacional de Investigaciones Cientificas y Tecnicas, and Universidad de Buenos Aires, Ciencia y Tecnica from Argentina.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANDERSEN JP, 1985, P NATL ACAD SCI USA, V82, P4573, DOI 10.1073/pnas.82.14.4573; Caride AJ, 2001, J BIOL CHEM, V276, P39797, DOI 10.1074/jbc.M104380200; Caride AJ, 2001, CELL CALCIUM, V30, P49, DOI 10.1054/ceca.2001.0212; CLARK A, 1983, CELL CALCIUM, V4, P83, DOI 10.1016/0143-4160(83)90037-4; Echarte MM, 2001, ANAL BIOCHEM, V289, P267, DOI 10.1006/abio.2000.4950; GARRAHAN PJ, 1978, BIOCHIM BIOPHYS ACTA, V513, P59, DOI 10.1016/0005-2736(78)90111-6; GLYNN IM, 1990, ANNU REV BIOCHEM, V59, P171, DOI 10.1146/annurev.bi.59.070190.001131; GLYNN IM, 1982, J PHYSIOL-LONDON, V330, P17, DOI 10.1113/jphysiol.1982.sp014326; Herscher CJ, 1996, BIOCHEMISTRY-US, V35, P14917, DOI 10.1021/bi961879r; Kaufman SB, 1999, J BIOL CHEM, V274, P20779, DOI 10.1074/jbc.274.30.20779; KRATJE RB, 1983, BIOCHIM BIOPHYS ACTA, V731, P40, DOI 10.1016/0005-2736(83)90395-4; LARSEN FL, 1978, J MEMBRANE BIOL, V41, P361, DOI 10.1007/BF01872000; LUTERBACHER S, 1983, EXPERIENTIA, V39, P311, DOI 10.1007/BF01955322; Montes MR, 2011, BBA-BIOMEMBRANES, V1808, P316, DOI 10.1016/j.bbamem.2010.08.022; Moreira OC, 2005, BBA-BIOENERGETICS, V1708, P411, DOI 10.1016/j.bbabio.2005.05.010; Rega A. F., 1986, CA2 PUMP PLASMA MEMB; RITOV VB, 1993, BIOCHIM BIOPHYS ACTA, V1148, P257, DOI 10.1016/0005-2736(93)90137-O; Rossi RC, 1999, ANAL BIOCHEM, V270, P276, DOI 10.1006/abio.1999.4094; SAGARA Y, 1992, J BIOL CHEM, V267, P12606; SCHATZMANN HJ, 1973, J PHYSIOL-LONDON, V235, P551, DOI 10.1113/jphysiol.1973.sp010403; SCHWARZBAUM PJ, 1995, BBA-BIOMEMBRANES, V1233, P33, DOI 10.1016/0005-2736(94)00229-I; STREHLER EE, 1990, J BIOL CHEM, V265, P2835; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; SUMIDA M, 1974, J BIOCHEM-TOKYO, V75, P283, DOI 10.1093/oxfordjournals.jbchem.a130396; TAKISAWA H, 1983, J BIOL CHEM, V258, P2986; Verma AK, 1996, J BIOL CHEM, V271, P3714; WEBER T, 1995, J AM CHEM SOC, V117, P3084, DOI 10.1021/ja00116a013	28	11	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32018	32025		10.1074/jbc.M111.266650	http://dx.doi.org/10.1074/jbc.M111.266650			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795697	Green Published, hybrid			2022-12-25	WOS:000294726800011
J	Agbavwe, C; Somoza, MM				Agbavwe, Christy; Somoza, Mark M.			Sequence-Dependent Fluorescence of Cyanine Dyes on Microarrays	PLOS ONE			English	Article							PHOTOINDUCED ELECTRON-TRANSFER; SINGLE-STRANDED-DNA; LABELING REAGENTS; BIAS; CY5; REPRODUCIBILITY; PHOTOPHYSICS; ENHANCEMENT; NONCOVALENT; STABILITY	Cy3 and Cy5 are among the most commonly used oligonucleotide labeling molecules. Studies of nucleic acid structure and dynamics use these dyes, and they are ubiquitous in microarray experiments. They are sensitive to their environment and have higher quantum yield when bound to DNA. The fluorescent intensity of terminal cyanine dyes is also known to be significantly dependent on the base sequence of the oligonucleotide. We have developed a very precise and high-throughput method to evaluate the sequence dependence of oligonucleotide labeling dyes using microarrays and have applied the method to Cy3 and Cy5. We used light-directed in-situ synthesis of terminally-labeled microarrays to determine the fluorescence intensity of each dye on all 1024 possible 5'-labeled 5-mers. Their intensity is sensitive to all five bases. Their fluorescence is higher with 5' guanines, and adenines in subsequent positions. Cytosine suppresses fluorescence. Intensity falls by half over the range of all 5-mers for Cy3, and two-thirds for Cy5. Labeling with 5'-biotin-streptavidin-Cy3/Cy5 gives a completely different sequence dependence and greatly reduces fluorescence compared with direct terminal labeling.	[Agbavwe, Christy; Somoza, Mark M.] Univ Vienna, Inst Inorgan Chem, Vienna, Austria	University of Vienna	Agbavwe, C (corresponding author), Univ Vienna, Inst Inorgan Chem, Vienna, Austria.	mark.somoza@univie.ac.at		Somoza, Mark/0000-0002-8039-1341	University of Vienna; Faculty of Chemistry of the University of Vienna	University of Vienna; Faculty of Chemistry of the University of Vienna	This work was supported by the University of Vienna and the Faculty of Chemistry of the University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brauns EB, 1998, J AM CHEM SOC, V120, P2449, DOI 10.1021/ja973207+; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Chain B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-344; Chen S, 2009, LANGMUIR, V25, P6570, DOI 10.1021/la9000297; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Cox WG, 2004, ANAL BIOCHEM, V331, P243, DOI 10.1016/j.ab.2004.05.010; Crockett AO, 2001, ANAL BIOCHEM, V290, P89, DOI 10.1006/abio.2000.4957; DEMPSTER DN, 1972, J CHEM SOC FARAD T 2, V68, P1479, DOI 10.1039/f29726801479; Dobbin KK, 2005, BIOINFORMATICS, V21, P2430, DOI 10.1093/bioinformatics/bti378; DOKTYCZ MJ, 1990, BIOPOLYMERS, V30, P829, DOI 10.1002/bip.360300718; Dombkowski AA, 2004, FEBS LETT, V560, P120, DOI 10.1016/S0014-5793(04)00083-3; Fuller CW, 2009, NAT BIOTECHNOL, V27, P1013, DOI 10.1038/nbt.1585; Gruber HJ, 2000, BIOCONJUGATE CHEM, V11, P696, DOI 10.1021/bc000015m; Guckian KM, 2000, J AM CHEM SOC, V122, P2213, DOI 10.1021/ja9934854; Han JY, 2010, CHEM REV, V110, P2709, DOI 10.1021/cr900249z; Harvey BJ, 2009, J FLUORESC, V19, P443, DOI 10.1007/s10895-008-0431-1; Harvey BJ, 2009, PHOTOCH PHOTOBIO SCI, V8, P1105, DOI 10.1039/b905078g; Heinlein T, 2003, J PHYS CHEM B, V107, P7957, DOI 10.1021/jp0348068; Huang ZX, 2006, J PHYS CHEM A, V110, P45, DOI 10.1021/jp0562936; Iqbal A, 2008, BIOCHEMISTRY-US, V47, P7857, DOI 10.1021/bi800773f; Jeon Hosang, 2007, Genomics & Informatics, V5, P113; Lackey JG, 2009, CHIM OGGI, V27, P30; Lackey JG, 2009, J AM CHEM SOC, V131, P8496, DOI 10.1021/ja9002074; LUBYPHELPS K, 1993, BIOPHYS J, V65, P236, DOI 10.1016/S0006-3495(93)81075-0; Martin-Magniette ML, 2005, BIOINFORMATICS, V21, P1995, DOI 10.1093/bioinformatics/bti302; McGall GH, 1997, J AM CHEM SOC, V119, P5081, DOI 10.1021/ja964427a; Mikelsons L, 2005, PHOTOCH PHOTOBIO SCI, V4, P798, DOI 10.1039/b508720a; MUJUMDAR RB, 1993, BIOCONJUGATE CHEM, V4, P105, DOI 10.1021/bc00020a001; Mujumdar SR, 1996, BIOCONJUGATE CHEM, V7, P356, DOI 10.1021/bc960021b; Murphy MC, 2004, BIOPHYS J, V86, P2530, DOI 10.1016/S0006-3495(04)74308-8; Norman DG, 2000, BIOCHEMISTRY-US, V39, P6317, DOI 10.1021/bi992944a; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; PETERSHEIM M, 1983, BIOCHEMISTRY-US, V22, P256, DOI 10.1021/bi00271a004; Sain A, 2006, PHYSICA A, V369, P679, DOI 10.1016/j.physa.2006.01.084; Sanborn ME, 2007, J PHYS CHEM B, V111, P11064, DOI 10.1021/jp072912u; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Seidel CAM, 1996, J PHYS CHEM-US, V100, P5541, DOI 10.1021/jp951507c; SHAFIROVICH VY, 1995, J AM CHEM SOC, V117, P4920, DOI 10.1021/ja00122a024; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; SOLIE TN, 1968, J MOL BIOL, V33, P61, DOI 10.1016/0022-2836(68)90281-7; Somoza MM, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2768352; Somoza MM, 2004, NUCLEIC ACIDS RES, V32, P2494, DOI 10.1093/nar/gkh577; Torimura M, 2001, ANAL SCI, V17, P155, DOI 10.2116/analsci.17.155; TURNER DH, 1988, ANNU REV BIOPHYS BIO, V17, P167; Widengren J, 2000, J PHYS CHEM A, V104, P6416, DOI 10.1021/jp000059s; Widengren J, 1997, CHEM PHYS, V216, P417, DOI 10.1016/S0301-0104(97)00014-1	49	33	33	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22177	10.1371/journal.pone.0022177	http://dx.doi.org/10.1371/journal.pone.0022177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799789	Green Submitted, gold, Green Published			2022-12-25	WOS:000293172900015
J	Callow, MG; Tran, H; Phu, L; Lau, T; Lee, J; Sandoval, WN; Liu, PS; Bheddah, S; Tao, J; Lill, JR; Hongo, JA; Davis, D; Kirkpatrick, DS; Polakis, P; Costa, M				Callow, Marinella G.; Tran, Hoanh; Phu, Lilian; Lau, Ted; Lee, James; Sandoval, Wendy N.; Liu, Peter S.; Bheddah, Sheila; Tao, Janet; Lill, Jennie R.; Hongo, Jo-Anne; Davis, David; Kirkpatrick, Donald S.; Polakis, Paul; Costa, Mike			Ubiquitin Ligase RNF146 Regulates Tankyrase and Axin to Promote Wnt Signaling	PLOS ONE			English	Article							NEGATIVE REGULATOR; PATHWAY; STABILITY; DISEASE; CATENIN; CANCER; MUTATIONS; RECEPTOR; DOMAIN; CELLS	Canonical Wnt signaling is controlled intracellularly by the level of beta-catenin protein, which is dependent on Axin scaffolding of a complex that phosphorylates beta-catenin to target it for ubiquitylation and proteasomal degradation. This function of Axin is counteracted through relocalization of Axin protein to the Wnt receptor complex to allow for ligand-activated Wnt signaling. AXIN1 and AXIN2 protein levels are regulated by tankyrase-mediated poly(ADP-ribosyl)ation (PARsylation), which destabilizes Axin and promotes signaling. Mechanistically, how tankyrase limits Axin protein accumulation, and how tankyrase levels and activity are regulated for this function, are currently under investigation. By RNAi screening, we identified the RNF146 RING-type ubiquitin E3 ligase as a positive regulator of Wnt signaling that operates with tankyrase to maintain low steady-state levels of Axin proteins. RNF146 also destabilizes tankyrases TNKS1 and TNKS2 proteins and, in a reciprocal relationship, tankyrase activity reduces RNF146 protein levels. We show that RNF146, tankyrase, and Axin form a protein complex, and that RNF146 mediates ubiquitylation of all three proteins to target them for proteasomal degradation. RNF146 is a cytoplasmic protein that also prevents tankyrase protein aggregation at a centrosomal location. Tankyrase auto-PARsylation and PARsylation of Axin is known to lead to proteasome-mediated degradation of these proteins, and we demonstrate that, through ubiquitylation, RNF146 mediates this process to regulate Wnt signaling.	[Callow, Marinella G.; Tran, Hoanh; Lau, Ted; Polakis, Paul; Costa, Mike] Genentech Res & Early Dev, Dept Canc Targets, San Francisco, CA USA; [Phu, Lilian; Sandoval, Wendy N.; Liu, Peter S.; Lill, Jennie R.; Kirkpatrick, Donald S.] Genentech Res & Early Dev, Dept Prot Chem, San Francisco, CA USA; [Lee, James; Davis, David] Genentech Res & Early Dev, Dept Discovery Oncol, San Francisco, CA USA; [Bheddah, Sheila; Tao, Janet] Genentech Res & Early Dev, Dept Pathol Res, San Francisco, CA USA; [Hongo, Jo-Anne] Genentech Res & Early Dev, Dept Antibody Engn, San Francisco, CA USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Callow, MG (corresponding author), Genentech Res & Early Dev, Dept Canc Targets, San Francisco, CA USA.	mcosta@gene.com		Kirkpatrick, Donald/0000-0003-3091-2804	Genentech Research and Early Development	Genentech Research and Early Development	This work was supported by Genentech Research and Early Development. The funder did have roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P273, DOI 10.1016/S0968-0004(01)01787-X; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; De Rycker M, 2004, MOL CELL BIOL, V24, P9802, DOI 10.1128/MCB.24.22.9802-9812.2004; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gong Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012682; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kim S, 2010, J BIOL CHEM, V285, P36420, DOI 10.1074/jbc.M110.137471; Kirchhoff T, 2009, CANCER EPIDEM BIOMAR, V18, P2468, DOI 10.1158/1055-9965.EPI-09-0151; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Menachem TD, 2009, FAM CANCER, V8, P399, DOI 10.1007/s10689-009-9255-7; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; Phu LL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003756; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Sbodio JI, 2002, BIOCHEM J, V361, P451, DOI 10.1042/0264-6021:3610451; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 1999, J CELL SCI, V112, P3649; von Rotz RC, 2005, EUR J NEUROSCI, V21, P1289, DOI 10.1111/j.1460-9568.2005.03977.x; Wigley WC, 1999, J CELL BIOL, V145, P481; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yeh TYJ, 2006, BIOCHEM J, V399, P415, DOI 10.1042/BJ20060713; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222	35	147	158	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22595	10.1371/journal.pone.0022595	http://dx.doi.org/10.1371/journal.pone.0022595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799911	gold, Green Submitted, Green Published			2022-12-25	WOS:000293172900054
J	Hartholt, KA; Oudshoorn, C; Zielinski, SM; Burgers, PTPW; Panneman, MJM; van Beeck, EF; Patka, P; van der Cammen, TJM				Hartholt, Klaas A.; Oudshoorn, Christian; Zielinski, Stephanie M.; Burgers, Paul T. P. W.; Panneman, Martien J. M.; van Beeck, Ed F.; Patka, Peter; van der Cammen, Tischa J. M.			The Epidemic of Hip Fractures: Are We on the Right Track?	PLOS ONE			English	Article							OSTEOPOROSIS; RISK; MORTALITY; FALLS; CONSEQUENCES; METAANALYSIS; MANAGEMENT; TRENDS; CARE	Background: Hip fractures are a public health problem, leading to hospitalization, long-term rehabilitation, reduced quality of life, large healthcare expenses, and a high 1-year mortality. Especially older adults are at greater risk of fractures than the general population, due to the combination of an increased fall risk and osteoporosis. The aim of this study was to determine time trends in numbers and incidence rates of hip fracture-related hospitalizations and admission duration in the older Dutch population. Methods and Findings: Secular trend analysis of all hospitalizations in the older Dutch population (>= 65 years) from 1981 throughout 2008, using the National Hospital Discharge Registry. Numbers, age-specific and age-adjusted incidence rates (per 10,000 persons) of hospital admissions and hospital days due to a hip fracture were used as outcome measures in each year of the study. Between 1981 and 2008, the absolute number of hip fractures doubled in the older Dutch population. Incidence rates of hip fracture-related hospital admissions increased with age, and were higher in women than in men. The age-adjusted incidence rate increased from 52.0 to 67.6 per 10,000 older persons. However, since 1994 the incidence rate decreased (percentage annual change -0.5%, 95% Cl: -0.7; -0.3), compared with the period 1981-1993 (percentage annual change 2.3%, 95% Cl: 2.0; 2.7). The total number of hospital days was reduced by a fifth, due to a reduced admission duration in all age groups. A possible limitation was that data were obtained from a linked administrative database, which did not include information on medication use or co-morbidities. Conclusions: A trend break in the incidence rates of hip fracture-related hospitalizations was observed in the Netherlands around 1994, possibly as a first result of efforts to prevent falls and fractures. However, the true cause of the observation is unknown.	[Hartholt, Klaas A.; Oudshoorn, Christian; van der Cammen, Tischa J. M.] Univ Med Ctr Rotterdam, Erasmus MC, Geriatr Med Sect, Dept Internal Med, Rotterdam, Netherlands; [Hartholt, Klaas A.; Zielinski, Stephanie M.; Burgers, Paul T. P. W.; Patka, Peter] Univ Med Ctr Rotterdam, Erasmus MC, Dept Surg Traumatol, Rotterdam, Netherlands; [Panneman, Martien J. M.] Consumer & Safety Inst, Amsterdam, Netherlands; [van Beeck, Ed F.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Hartholt, KA (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Geriatr Med Sect, Dept Internal Med, Rotterdam, Netherlands.	t.vandercammen@erasmusmc.nl	Golmohamad, Ramez/E-4848-2014; Hartholt, Klaas A/Q-1782-2016	Golmohamad, Ramez/0000-0002-9958-7037; Hartholt, Klaas A/0000-0001-5019-9239	Netherlands Organization for Health Research and Development [170.885.607, 170.882.503]; NutsOhra [T-0602-43]	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); NutsOhra	Grants from The Netherlands Organization for Health Research and Development (ZonMw, project number 170.885.607 and 170.882.503) and a grant from NutsOhra (project number T-0602-43) were received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A grant from NutsOhra (project number T-0602-43) was received. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Boonen S, 2008, CURR MED RES OPIN, V24, P1781, DOI 10.1185/03007990802115796; Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; BRUGGINK J, 2010, HLTH LIFE EXPECTANCY; CHRISCHILLES EA, 1991, ARCH INTERN MED, V151, P2026, DOI 10.1001/archinte.151.10.2026; Curran D, 2010, JOINT BONE SPINE, V77, P546, DOI 10.1016/j.jbspin.2010.02.006; Curtis JR, 2009, J GEN INTERN MED, V24, P956, DOI 10.1007/s11606-009-1031-8; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; Dijcks BPJ, 2005, NED TIJDSCHR GENEES, V149, P1043; DRAPER H, 2008, NUMBER SMOKERS IS ST; *DUTCH I HEALTHC I, 2004, GUID PREV FALL INC E; *DUTCH I HEALTHC I, 2002, OST 2 REV GUID; Gibson Richard E, 2008, N S W Public Health Bull, V19, P166, DOI 10.1071/NB07049; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Haentjens P, 2005, DISABIL REHABIL, V27, P1129, DOI 10.1080/09638280500055529; Haentjens P, 2010, ANN INTERN MED, V152, P380, DOI 10.7326/0003-4819-152-6-201003160-00008; HARTHOLT KA, 2010, J TRAUMA, DOI DOI 10.1097/TA.0B013E3181F6F5E5; HARTHOLT KA, 2011, AM J PUBLIC IN PRESS; Hartholt KA, 2011, J TRAUMA, V71, P255, DOI 10.1097/TA.0b013e31821c36e7; Hartholt KA, 2010, ARCH INTERN MED, V170, P905, DOI 10.1001/archinternmed.2010.106; Hoidrup S, 2003, SCAND J PUBLIC HEALT, V31, P24, DOI 10.1080/14034940210134185; Hollingworth SA, 2010, DRUG AGING, V27, P255, DOI 10.2165/11318400-000000000-00000; Icks A, 2008, OSTEOPOROSIS INT, V19, P1139, DOI 10.1007/s00198-007-0534-6; Johnell O, 1997, AM J MED, V103, p20S, DOI DOI 10.1016/S0002-9343(97)90023-1; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P229, DOI 10.1007/s00198-004-1811-2; Kannus P, 2009, OSTEOPOROSIS INT, V20, P43, DOI 10.1007/s00198-008-0625-z; Kannus P, 1999, JAMA-J AM MED ASSOC, V281, P1895, DOI 10.1001/jama.281.20.1895; Kannus P, 2006, J BONE MINER RES, V21, P1836, DOI 10.1359/JBMR.060815; Kern LM, 2005, ANN INTERN MED, V142, P173, DOI 10.7326/0003-4819-142-3-200502010-00007; Khosla S, 2008, ENDOCR REV, V29, P441, DOI 10.1210/er.2008-0002; Law MR, 1997, BMJ-BRIT MED J, V315, P841, DOI 10.1136/bmj.315.7112.841; Leslie WD, 2009, JAMA-J AM MED ASSOC, V302, P883, DOI 10.1001/jama.2009.1231; Meerding WJ, 2006, EUR J PUBLIC HEALTH, V16, P271, DOI 10.1093/eurpub/ckl006; National Highway Traffic Safety Administration, 2010, TOB US TARG NAT LEAD, P1; Patja K, 2009, SCAND J PUBLIC HEALT, V37, P153, DOI 10.1177/1403494808100277; PECK WA, 1993, AM J MED, V94, P646; Polinder S, 2008, ACCIDENT ANAL PREV, V40, P182, DOI 10.1016/j.aap.2007.05.001; Saltzherr T P, 2006, Ned Tijdschr Geneeskd, V150, P2599; Sennerby U, 2009, JAMA-J AM MED ASSOC, V302, P1666, DOI 10.1001/jama.2009.1463; Stalenhoef PA, 1997, EUR J PUBLIC HEALTH, V7, P328, DOI 10.1093/eurpub/7.3.328; *STAT NETH CBS, 2010, HLTH LIF STYL HEALTH; *STAT NETH CBS, 2009, HLTH CAR US HOSP ADM; Statistics Netherlands (CBS), 2009, POP PROGN; United Nations, 2007, WORLD POP PROSP 2006; Van der Stegen R, 2009, DISCRIPTION METHODS; VANVUGHT AB, 2007, GUIDELINE TREATMENT; Weller I, 2005, J BONE JOINT SURG BR, V87B, P361, DOI 10.1302/0301-620X.87B3.15300	48	50	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22227	10.1371/journal.pone.0022227	http://dx.doi.org/10.1371/journal.pone.0022227			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799797	Green Published, gold			2022-12-25	WOS:000293172900017
J	Prasad, A; Pospisil, P				Prasad, Ankush; Pospisil, Pavel			Linoleic Acid-Induced Ultra-Weak Photon Emission from Chlamydomonas reinhardtii as a Tool for Monitoring of Lipid Peroxidation in the Cell Membranes	PLOS ONE			English	Article							BIOPHOTON EMISSION; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; SINGLET-OXYGEN; PHOTOSYSTEM-II; THERMOLUMINESCENCE; CHEMILUMINESCENCE; CHLOROPHYLL; LEAVES; SIGNAL	Reactive oxygen species formed as a response to various abiotic and biotic stresses cause an oxidative damage of cellular component such are lipids, proteins and nucleic acids. Lipid peroxidation is considered as one of the major processes responsible for the oxidative damage of the polyunsaturated fatty acid in the cell membranes. Various methods such as a loss of polyunsaturated fatty acids, amount of the primary and the secondary products are used to monitor the level of lipid peroxidation. To investigate the use of ultra-weak photon emission as a non-invasive tool for monitoring of lipid peroxidation, the involvement of lipid peroxidation in ultra-weak photon emission was studied in the unicellular green alga Chlamydomonas reinhardtii. Lipid peroxidation initiated by addition of exogenous linoleic acid to the cells was monitored by ultra-weak photon emission measured with the employment of highly sensitive charged couple device camera and photomultiplier tube. It was found that the addition of linoleic acid to the cells significantly increased the ultra-weak photon emission that correlates with the accumulation of lipid peroxidation product as measured using thiobarbituric acid assay. Scavenging of hydroxyl radical by mannitol, inhibition of intrinsic lipoxygenase by catechol and removal of molecular oxygen considerably suppressed ultra-weak photon emission measured after the addition of linoleic acid. The photon emission dominated at the red region of the spectrum with emission maximum at 680 nm. These observations reveal that the oxidation of linoleic acid by hydroxyl radical and intrinsic lipoxygenase results in the ultra-weak photon emission. Electronically excited species such as excited triplet carbonyls are the likely candidates for the primary excited species formed during the lipid peroxidation, whereas chlorophylls are the final emitters of photons. We propose here that the ultra-weak photon emission can be used as a non-invasive tool for the detection of lipid peroxidation in the cell membranes.	[Prasad, Ankush; Pospisil, Pavel] Palacky Univ, Fac Sci, Dept Biophys, Ctr Reg Hana Biotechnol & Agr Res, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc	Prasad, A (corresponding author), Palacky Univ, Fac Sci, Dept Biophys, Ctr Reg Hana Biotechnol & Agr Res, CR-77147 Olomouc, Czech Republic.	pospip@prfnw.upol.cz	POSPÍŠIL, Pavel/AAH-4451-2019; Prasad, Ankush/G-6690-2011	POSPÍŠIL, Pavel/0000-0001-9126-2011; Prasad, Ankush/0000-0002-2009-8987	Centre of the Region Hana for Biotechnological and Agricultural Research [CZ.1.05/2.1.00/01.0007]; Ministry of Education, Youth and Sports of Czech Republic [MSM6198959215]; Palacky University [PrF_2010_050]	Centre of the Region Hana for Biotechnological and Agricultural Research; Ministry of Education, Youth and Sports of Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Palacky University	This work was supported by the grants of the Centre of the Region Hana for Biotechnological and Agricultural Research CZ.1.05/2.1.00/01.0007, the Ministry of Education, Youth and Sports of Czech Republic MSM6198959215 and the student project PrF_2010_050 of the Palacky University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES FB, 1986, ANNU REV PLANT PHYS, V37, P49, DOI 10.1146/annurev.pp.37.060186.000405; Adam W, 2005, CHEM REV, V105, P3371, DOI 10.1021/cr0300035; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; AUGUSTO O, 1979, PHOTOCHEM PHOTOBIOL, V30, P191, DOI 10.1111/j.1751-1097.1979.tb07135.x; Bennett M, 2005, MOL PLANT MICROBE IN, V18, P95, DOI 10.1094/MPMI-18-0095; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; BOHNE C, 1986, ANAL BIOCHEM, V155, P1, DOI 10.1016/0003-2697(86)90215-0; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; CAMPA A, 1984, PHOTOCHEM PHOTOBIOL, V40, P127, DOI 10.1111/j.1751-1097.1984.tb04563.x; Ducruet JM, 2003, J EXP BOT, V54, P2419, DOI 10.1093/jxb/erg268; Fedorova GF, 2007, ARKIVOC, P163, DOI 10.3998/ark.5550190.0008.815; Flor-Henry Michel, 2004, BMC Plant Biology, V4, P19, DOI 10.1186/1471-2229-4-19; Foyer C.H., 2002, OXIDATIVE STRESS PLA, P33; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; FRANKEL E N, 1980, Progress in Lipid Research, V19, P1, DOI 10.1016/0163-7827(80)90006-5; Fridovich I, 1998, J EXP BIOL, V201, P1203; Girotti AW, 1998, J LIPID RES, V39, P1529; HALLIWELL B, 1993, AM J CLIN NUTR, V57, P715; Halliwell B., 2007, FREE RADICALS BIOL M; Havaux M, 2003, TRENDS PLANT SCI, V8, P409, DOI 10.1016/S1360-1385(03)00185-7; Havaux M, 2006, TRENDS PLANT SCI, V11, P480, DOI 10.1016/j.tplants.2006.08.001; HIDEG E, 1990, FEBS LETT, V275, P121, DOI 10.1016/0014-5793(90)81454-V; HIDEG E, 1993, PHOTOCHEM PHOTOBIOL, V58, P280, DOI 10.1111/j.1751-1097.1993.tb09562.x; Kobayashi M, 1997, PHOTOCHEM PHOTOBIOL, V65, P535, DOI 10.1111/j.1751-1097.1997.tb08600.x; Kobayashi M, 2007, J EXP BOT, V58, P465, DOI 10.1093/jxb/erl215; KRICKA LJ, 1991, CLIN CHEM, V37, P1472; LAVOREL J, 1980, BIOCHIM BIOPHYS ACTA, V590, P385, DOI 10.1016/0005-2728(80)90209-1; Ledford HK, 2005, PLANT CELL ENVIRON, V28, P1037, DOI 10.1111/j.1365-3040.2005.01374.x; Maccarrone M, 2001, CELL DEATH DIFFER, V8, P776, DOI 10.1038/sj.cdd.4400908; Makino T, 2005, Biophotonics: Optical Science and Engineering for the 21st Century, P205, DOI 10.1007/0-387-24996-6_16; Mansfield JW, 2005, TRENDS PLANT SCI, V10, P307, DOI 10.1016/j.tplants.2005.05.007; Marder JB, 1998, PHYSIOL PLANTARUM, V104, P713, DOI 10.1034/j.1399-3054.1998.1040428.x; McGinley CM, 2003, CHEM COMMUN, P2843, DOI 10.1039/b311008g; Meagher EA, 2000, FREE RADICAL BIO MED, V28, P1745, DOI 10.1016/S0891-5849(00)00232-X; NELSON MJ, 1988, BIOCHEMISTRY-US, V27, P4273, DOI 10.1021/bi00412a011; Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Pospisil P, 2009, BBA-BIOENERGETICS, V1787, P1151, DOI 10.1016/j.bbabio.2009.05.005; PRYOR WA, 1984, METHOD ENZYMOL, V105, P293; Rastogi A, 2010, PLANT PHYSIOL BIOCH, V48, P117, DOI 10.1016/j.plaphy.2009.12.011; Skotnica J, 1999, PHOTOCHEM PHOTOBIOL, V69, P211, DOI 10.1111/j.1751-1097.1999.tb03275.x; SLATER TF, 1984, METHOD ENZYMOL, V105, P283; STALLAERT VM, 1995, BBA-BIOENERGETICS, V1229, P290, DOI 10.1016/0005-2728(95)00017-D; Triantaphylides C, 2009, TRENDS PLANT SCI, V14, P219, DOI 10.1016/j.tplants.2009.01.008; VANWIJK R, 1988, EXPERIENTIA, V44, P586; VAVILLIN DV, 1998, PHOTOCHEM PHOTOBIO B, V42, P233; VLADIMIROV YA, 1995, FREE RADICAL BIO MED, V18, P739, DOI 10.1016/0891-5849(94)00199-T; Yamamoto Y, 2008, PHOTOSYNTH RES, V98, P589, DOI 10.1007/s11120-008-9372-4; Yan Y, 2005, Biophotonics: Optical Science and Engineering for the 21st Century, P195, DOI 10.1007/0-387-24996-6_15; Yan Y, 2003, SEED SCI TECHNOL, V31, P249, DOI 10.15258/sst.2003.31.2.03	52	45	45	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22345	10.1371/journal.pone.0022345	http://dx.doi.org/10.1371/journal.pone.0022345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799835	Green Submitted, Green Published, gold			2022-12-25	WOS:000293172900024
J	Hadidjojo, J; Cheong, SA				Hadidjojo, Jeremy; Cheong, Siew Ann			Equal Graph Partitioning on Estimated Infection Network as an Effective Epidemic Mitigation Measure	PLOS ONE			English	Article							SOCIAL NETWORKS; INFLUENZA SEASONALITY; OUTBREAKS; DISEASE; STRATEGIES; SPREAD; SARS	Controlling severe outbreaks remains the most important problem in infectious disease area. With time, this problem will only become more severe as population density in urban centers grows. Social interactions play a very important role in determining how infectious diseases spread, and organization of people along social lines gives rise to non-spatial networks in which the infections spread. Infection networks are different for diseases with different transmission modes, but are likely to be identical or highly similar for diseases that spread the same way. Hence, infection networks estimated from common infections can be useful to contain epidemics of a more severe disease with the same transmission mode. Here we present a proof-of-concept study demonstrating the effectiveness of epidemic mitigation based on such estimated infection networks. We first generate artificial social networks of different sizes and average degrees, but with roughly the same clustering characteristic. We then start SIR epidemics on these networks, censor the simulated incidences, and use them to reconstruct the infection network. We then efficiently fragment the estimated network by removing the smallest number of nodes identified by a graph partitioning algorithm. Finally, we demonstrate the effectiveness of this targeted strategy, by comparing it against traditional untargeted strategies, in slowing down and reducing the size of advancing epidemics.	[Hadidjojo, Jeremy; Cheong, Siew Ann] Nanyang Technol Univ, Sch Phys & Math Sci, Div Phys & Appl Phys, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Hadidjojo, J (corresponding author), Nanyang Technol Univ, Sch Phys & Math Sci, Div Phys & Appl Phys, Singapore, Singapore.	cheongsa@ntu.edu.sg	Cheong, Siew Ann/B-6991-2011	Cheong, Siew Ann/0000-0002-8589-6699	Nanyang Technological University [SUG 19/07]; Undergraduate Research Experience on Campus (URECA) programme	Nanyang Technological University(Nanyang Technological University); Undergraduate Research Experience on Campus (URECA) programme	This research is supported by Nanyang Technological University start-up grant SUG 19/07 and the Undergraduate Research Experience on Campus (URECA) programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BOCCARA N, 1993, J PHYS A-MATH GEN, V26, P3707, DOI 10.1088/0305-4470/26/15/020; Boguna M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.056122; Chao DL, 2010, J INFECT DIS, V202, P877, DOI 10.1086/655810; Chen YP, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.058701; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Chowell G, 2003, J THEOR BIOL, V224, P1, DOI 10.1016/S0022-5193(03)00228-5; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Dezso Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055103; Dowell SF, 2004, LANCET INFECT DIS, V4, P704, DOI 10.1016/S1473-3099(04)01177-6; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Flahault A, 2006, VACCINE, V24, P6751, DOI 10.1016/j.vaccine.2006.05.079; Grais R F, 2004, Health Care Manag Sci, V7, P127, DOI 10.1023/B:HCMS.0000020652.38181.da; Holme P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.026107; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Jin EM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046132; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; KLOVDAHL AS, 1994, SOC SCI MED, V38, P79, DOI 10.1016/0277-9536(94)90302-6; KLOVDAHL AS, 1985, SOC SCI MED, V21, P1203, DOI 10.1016/0277-9536(85)90269-2; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Lipsitch M, 2009, P NATL ACAD SCI USA, V106, P3645, DOI 10.1073/pnas.0900933106; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; May RM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066112; May RM, 2006, TRENDS ECOL EVOL, V21, P394, DOI 10.1016/j.tree.2006.03.013; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.036122; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Newman MEJ, 2002, P NATL ACAD SCI USA, V99, P2566, DOI 10.1073/pnas.012582999; Olinky R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.030902; Ong JBS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010036; Rothenberg RB, 1998, SEX TRANSM DIS, V25, P154, DOI 10.1097/00007435-199803000-00009; Schank T., 2005, J GRAPH ALGORITHMS A, V9, P265, DOI DOI 10.7155/JGAA.00108	35	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22124	10.1371/journal.pone.0022124	http://dx.doi.org/10.1371/journal.pone.0022124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799777	Green Published, gold, Green Submitted			2022-12-25	WOS:000293097300016
J	Yin, Y; Wu, CC; Song, JJ; Wang, JZ; Zhang, EJ; Liu, HY; Yang, DL; Chen, XW; Lu, MJ; Xu, Y				Yin, Ying; Wu, Chunchen; Song, Jingjiao; Wang, Junzhong; Zhang, Ejuan; Liu, Hongyan; Yang, Dongliang; Chen, Xinwen; Lu, Mengji; Xu, Yang			DNA Immunization with Fusion of CTLA-4 to Hepatitis B Virus (HBV) Core Protein Enhanced Th2 Type Responses and Cleared HBV with an Accelerated Kinetic	PLOS ONE			English	Article							HIV GAG PROTEIN; CD8(+) T-CELLS; ANTITUMOR IMMUNITY; DENDRITIC CELLS; IMMUNODEFICIENCY-VIRUS; TARGETED DELIVERY; DEC-205 RECEPTOR; GAMMA-INTERFERON; SURFACE-ANTIGEN; TUMOR-ANTIGENS	Background: Typically, DNA immunization via the intramuscular route induces specific, Th1-dominant immune responses. However, plasmids expressing viral proteins fused to cytotoxic T lymphocyte antigen 4 (CTLA-4) primed Th2-biased responses and were able to induced effective protection against viral challenge in the woodchuck model. Thus, we addressed the question in the mouse model how the Th1/Th2 bias of primed immune responses by a DNA vaccine influences hepatitis B virus (HBV) clearance. Principal Findings: Plasmids expressing HBV core protein (HBcAg) or HBV e antigen and HBcAg fused to the extracellular domain of CTLA-4 (pCTLA-4-HBc), CD27, and full length CD40L were constructed. Immunizations of these DNA plasmids induced HBcAg-specific antibody and cytotoxic T-cell responses in mice, but with different characteristics regarding the titers and subtypes of specific antibodies and intensity of T-cell responses. The plasmid pHBc expressing HBcAg induced an IgG2a-dominant response while immunizations of pCTLA-4-HBc induced a balanced IgG1/IgG2a response. To assess the protective values of the immune responses of different characteristics, mice were pre-immunized with pCTLA-4-HBc and pHBc, and challenged by hydrodynamic injection (HI) of pAAV/HBV1.2. HBV surface antigen (HBsAg) and DNA in peripheral blood and HBcAg in liver tissue were cleared with significantly accelerated kinetics in both groups. The clearance of HBsAg was completed within 16 days in immunized mice while more than 50% of the control mice are still positive for HBsAg on day 22. Stronger HBcAg-specific T-cell responses were primed by pHBc correlating with a more rapid decline of HBcAg expression in liver tissue, while anti-HBs antibody response developed rapidly in the mice immunized with pCTLA-4-HBc, indicating that the Th1/Th2 bias of vaccine-primed immune responses influences the mode of viral clearance. Conclusion: Viral clearance could be efficiently achieved by Th1/Th2-balanced immune response, with a small but significant shift in T-cell and B-cell immune responses.	[Yin, Ying; Zhang, Ejuan; Lu, Mengji; Xu, Yang] Huazhong Univ Sci & Technol, Dept Microbiol, Tongji Med Coll, Wuhan 430074, Peoples R China; [Wu, Chunchen; Chen, Xinwen] Chinese Acad Sci, Wuhan Inst Virol, Wuhan, Peoples R China; [Song, Jingjiao; Wang, Junzhong; Yang, Dongliang] Huazhong Univ Sci & Technol, Div Clin Immunol, Tongji Hosp, Wuhan 430074, Peoples R China; [Liu, Hongyan; Lu, Mengji] Univ Hosp Essen, Inst Virol, Essen, Germany	Huazhong University of Science & Technology; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Huazhong University of Science & Technology; University of Duisburg Essen	Yin, Y (corresponding author), Huazhong Univ Sci & Technol, Dept Microbiol, Tongji Med Coll, Wuhan 430074, Peoples R China.	orangexuyang@hotmail.com	Lu, Mengji/ABF-9410-2020; Wang, Junzhong/AAS-9767-2021		Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [2009-1341]; National Basic Research Priorities Program of China [2005CB522901, 2006CB933100]; Transregio [TRR60]	Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); National Basic Research Priorities Program of China(National Basic Research Program of China); Transregio	This work is supported by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry 2009-1341 (to YX), the National Basic Research Priorities Program of China (2005CB522901 and 2006CB933100), and Transregio TRR60 (to ML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertoletti A, 2006, J GEN VIROL, V87, P1439, DOI 10.1099/vir.0.81920-0; Boyle JS, 1998, NATURE, V392, P408, DOI 10.1038/32932; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; Bozzacco L, 2010, EUR J IMMUNOL, V40, P36, DOI 10.1002/eji.200939748; CHEONG C, 2010, BLOOD; COTE PJ, 1992, J INFECT DIS, V166, P628, DOI 10.1093/infdis/166.3.628; Davis HL, 1998, CURR TOP MICROBIOL, V226, P57; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; IWARSON S, 1985, GASTROENTEROLOGY, V88, P763, DOI 10.1016/0016-5085(85)90148-9; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kuhober A, 1996, J IMMUNOL, V156, P3687; Lu M, 2005, J VIROL, V79, P6368, DOI 10.1128/JVI.79.10.6368-6376.2005; Lu MJ, 1999, J VIROL, V73, P281, DOI 10.1128/JVI.73.1.281-289.1999; Maini MK, 2010, J HEPATOL, V52, P616, DOI 10.1016/j.jhep.2009.12.017; Mancini-Bourgine M, 2006, VACCINE, V24, P4482, DOI 10.1016/j.vaccine.2005.08.013; Menne S, 1997, J VIROL, V71, P65, DOI 10.1128/JVI.71.1.65-74.1997; Michel ML, 2005, J CLIN VIROL, V34, pS108, DOI 10.1016/S1386-6532(05)80019-8; MICHEL ML, 1995, P NATL ACAD SCI USA, V92, P5307, DOI 10.1073/pnas.92.12.5307; MILICH DR, 1987, NATURE, V329, P547, DOI 10.1038/329547a0; Nayak BP, 2003, J VIROL, V77, P10850, DOI 10.1128/JVI.77.20.10850-10861.2003; Nchinda G, 2008, J CLIN INVEST, V118, P1427, DOI 10.1172/JCI34224; Nchinda G, 2010, P NATL ACAD SCI USA, V107, P4281, DOI 10.1073/pnas.1000621107; Neighbors M, 2008, J IMMUNOTHER, V31, P644, DOI 10.1097/CJI.0b013e3181826d89; Pancholi P, 2001, HEPATOLOGY, V33, P448, DOI 10.1053/jhep.2001.21594; Rajcani J, 2005, REV MED VIROL, V15, P303, DOI 10.1002/rmv.467; Riedl P, 2009, J IMMUNOL, V183, P370, DOI 10.4049/jimmunol.0900505; Rohrbach F, 2005, J IMMUNOL, V174, P5481, DOI 10.4049/jimmunol.174.9.5481; SCHODEL F, 1993, VACCINE, V11, P624, DOI 10.1016/0264-410X(93)90307-J; Siegel F, 2001, J VIROL, V75, P5036, DOI 10.1128/JVI.75.11.5036-5042.2001; Sloots A, 2008, CLIN CANCER RES, V14, P6933, DOI 10.1158/1078-0432.CCR-08-1257; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; Wang JG, 2007, J VIROL, V81, P903, DOI 10.1128/JVI.01537-06; Wei HF, 2009, CLIN CANCER RES, V15, P4612, DOI 10.1158/1078-0432.CCR-08-3321; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635; Xu DZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002565; Zolla-Pazner S, 2009, VIROLOGY, V392, P82, DOI 10.1016/j.virol.2009.05.039	38	47	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22524	10.1371/journal.pone.0022524	http://dx.doi.org/10.1371/journal.pone.0022524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799884	Green Published, Green Submitted, gold			2022-12-25	WOS:000293097300060
J	Repeke, CE; Ferreira, SB; Vieira, AE; Silveira, EM; Avila-Campos, MJ; da Silva, JS; Santos, CF; Campanelli, AP; Trombone, APF; Garlet, GP				Repeke, Carlos Eduardo; Ferreira, Samuel Barros, Jr.; Vieira, Andreia Espindola; Silveira, Elcia Maria; Avila-Campos, Mario Julio; da Silva, Joao Santana; Santos, Carlos Ferreira; Campanelli, Ana Paula; Favaro Trombone, Ana Paula; Garlet, Gustavo Pompermaier			Dose-Response Met-RANTES Treatment of Experimental Periodontitis: A Narrow Edge between the Disease Severity Attenuation and Infection Control	PLOS ONE			English	Article							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; RHEUMATOID-ARTHRITIS; CHEMOKINE RECEPTORS; TISSUE DESTRUCTION; BONE LOSS; CYTOKINES; CELLS; MICE; INFLAMMATION; MIGRATION	Chemokines and chemokine receptors have been implicated in the selective migration of leukocyte subsets to periodontal tissues, which consequently influences the disease outcome. Among these chemoattractants, the chemokines CCL3, CCL4 and CCL5 and its receptors, CCR1 and CCR5, have been associated with increased disease severity in mice and humans. Therefore, in this study we investigated the modulation of experimental periodontitis outcome by the treatment with a specific antagonist of CCR1 and 5 receptors, called met-RANTES. C57Bl/6 mice was orally infected with Aggregatibacter actinomycetemcomitans and treated with 0.05, 0.1, 0.5, 1.5 and 5 mg doses of met-RANTES on alternate days, and evaluated by morphometric, cellular, enzymatic and molecular methods. At 0.5 mg up to 5 mg doses, a strong reduction in the alveolar bone loss and inflammatory cell migration were observed. Interestingly, 5 mg dose treatment resulted in the maximum inhibition of inflammatory cell migration, but resulted in a similar inhibition of bone loss when compared with the lower doses, and also resulted in increased bacterial load and CRP response. When 0.5 and 5 mg therapy regimens were compared it was observed that both therapeutic protocols were able to downregulate the levels of pro-inflammatory, Th1-type and osteoclastogenic cytokines, and CD3+ and F4/80+ cells migration to periodontal tissues, but the high dose modulates host response in a more pronounced and unspecific and excessive way, interfering also with the production of antimicrobial mediators such as MPO, iNOS and IgG, and with GR1+ and CD19+ cells migration. Our results demonstrate a thin line between beneficial immunoregulation and impaired host defense during experimental periodontitis, and the determination of the exact equilibrium point is mandatory for the improvement of immune-targeted therapy of periodontitis.	[Repeke, Carlos Eduardo; Ferreira, Samuel Barros, Jr.; Vieira, Andreia Espindola; Silveira, Elcia Maria; Santos, Carlos Ferreira; Campanelli, Ana Paula; Garlet, Gustavo Pompermaier] Sao Paulo Univ FOB USP, Sch Dent Bauru, Dept Biol Sci, Sao Paulo, Brazil; [Avila-Campos, Mario Julio] Sao Paulo Univ ICB USP, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil; [da Silva, Joao Santana] Sao Paulo Univ FMRP USP, Sch Med Ribeirao Preto, Dept Biochem & Immunol, Sao Paulo, Brazil; [Favaro Trombone, Ana Paula] Inst Lauro Souza Lima, Dept Pathol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Repeke, CE (corresponding author), Sao Paulo Univ FOB USP, Sch Dent Bauru, Dept Biol Sci, Sao Paulo, Brazil.	garletgp@usp.br	Silveira, Elcia/F-5891-2012; Garlet, Ana Paula Trombone/N-9346-2013; Silva, Joao/A-4484-2008; Repeke, Carlos Eduardo/AAQ-2968-2020; Campanelli, Ana Paula/B-9144-2012; Vieira, Andreia/HGC-4528-2022; Santos, Carlos F/B-7676-2012; Repeke, Carlos/E-5590-2012; Avila-Campos, Mario/D-7727-2012; Vieira, Andreia Espindola/F-5892-2012; Garlet, Gustavo Pompermaier/E-6762-2012	Garlet, Ana Paula Trombone/0000-0002-8102-6098; Silva, Joao/0000-0002-3410-3927; Santos, Carlos F/0000-0002-0405-3500; Avila-Campos, Mario/0000-0002-2378-7251; Vieira, Andreia Espindola/0000-0002-1344-1185; Garlet, Gustavo Pompermaier/0000-0002-5071-8382; Campanelli, Ana Paula/0000-0002-0536-5469; Repeke, Carlos Eduardo/0000-0001-7933-0114	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [06/00534-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (06/00534-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 2001, J IMMUNOL, V166, P552, DOI 10.4049/jimmunol.166.1.552; Alayan J, 2006, ORAL MICROBIOL IMMUN, V21, P360, DOI 10.1111/j.1399-302X.2006.00304.x; Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Bachmann MF, 2006, NAT REV IMMUNOL, V6, P159, DOI 10.1038/nri1776; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Barcelos LS, 2009, MICROVASC RES, V78, P148, DOI 10.1016/j.mvr.2009.04.009; Bartold PM, 2005, J PERIODONTOL, V76, P2066, DOI 10.1902/jop.2005.76.11-S.2066; Bertolini A, 2001, PHARMACOL RES, V44, P437, DOI 10.1006/phrs.2001.0872; Brandner B, 2009, PROTEIN ENG DES SEL, V22, P367, DOI 10.1093/protein/gzp013; Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233; D'Aiuto F, 2004, J DENT RES, V83, P156, DOI 10.1177/154405910408300214; Doodes PD, 2009, ARTHRITIS RHEUM-US, V60, P2945, DOI 10.1002/art.24842; Eming SA, 2009, SEMIN CELL DEV BIOL, V20, P517, DOI 10.1016/j.semcdb.2009.04.009; Ernst CWO, 2007, CLIN EXP IMMUNOL, V148, P271, DOI 10.1111/j.1365-2249.2006.03318.x; Ferreira Jr. SB, J DENT RES; Ferreira Jr. SB, J DENT RES IN PRESS; Gamonal J, 2000, J CLIN PERIODONTOL, V27, P675, DOI 10.1034/j.1600-051x.2000.027009675.x; Gamonal J, 2001, J PERIODONTAL RES, V36, P194, DOI 10.1034/j.1600-0765.2001.360309.x; Garlet GP, 2007, CLIN EXP IMMUNOL, V147, P128, DOI 10.1111/j.1365-2249.2006.03260.x; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Garlet GP, 2006, ORAL MICROBIOL IMMUN, V21, P12, DOI 10.1111/j.1399-302X.2005.00245.x; Garlet GP, 2005, MICROBES INFECT, V7, P738, DOI 10.1016/j.micinf.2005.01.012; Garlet GP, 2003, J PERIODONTAL RES, V38, P210, DOI 10.1034/j.1600-0765.2003.02012.x; Garlet GP, 2008, MICROBES INFECT, V10, P489, DOI 10.1016/j.micinf.2008.01.010; Garred P, 1998, J RHEUMATOL, V25, P1462; Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183; Kabashima H, 2002, CYTOKINE, V20, P70, DOI 10.1006/cyto.2002.1985; Kim Chang H., 2009, Inflammation & Allergy Drug Targets, V8, P221; Kucuk C, 2006, AM J SURG, V191, P77, DOI 10.1016/j.amjsurg.2005.10.005; Oba Y, 2005, EXP HEMATOL, V33, P272, DOI 10.1016/j.exphem.2004.11.015; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Proudfoot AEI, 1996, J BIOL CHEM, V271, P2599, DOI 10.1074/jbc.271.5.2599; Proudfoot AEI, 2003, SEMIN IMMUNOL, V15, P57, DOI 10.1016/S1044-5323(02)00128-8; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Repeke CE, 2010, BONE, V46, P1122, DOI 10.1016/j.bone.2009.12.030; Satoh J, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-18; Shahrara S, 2005, ARTHRITIS RHEUM, V52, P1907, DOI 10.1002/art.21033; Silva TA, 2007, J DENT RES, V86, P306, DOI 10.1177/154405910708600403; Song EW, 2002, KIDNEY INT, V61, P676, DOI 10.1046/j.1523-1755.2002.00148.x; Stojanovic T, 2002, J VASC RES, V39, P51, DOI 10.1159/000048993; Szekanecz Z, 2003, SEMIN IMMUNOL, V15, P15, DOI 10.1016/S1044-5323(02)00124-0; Takayanagi H, 2005, J PERIODONTAL RES, V40, P287, DOI 10.1111/j.1600-0765.2005.00814.x; Trombone APF, 2009, J PERIODONTAL RES, V44, P443, DOI 10.1111/j.1600-0765.2008.01133.x; Trombone AP, GENES IMMUN, V11, P479; Yu XF, 2004, J BONE MINER RES, V19, P2065, DOI 10.1359/JBMR.040910	45	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22526	10.1371/journal.pone.0022526	http://dx.doi.org/10.1371/journal.pone.0022526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799885	Green Published, gold			2022-12-25	WOS:000292931200059
J	Coma, R; Serrano, E; Linares, C; Ribes, M; Diaz, D; Ballesteros, E				Coma, Rafel; Serrano, Eduard; Linares, Cristina; Ribes, Marta; Diaz, David; Ballesteros, Enric			Sea Urchins Predation Facilitates Coral Invasion in a Marine Reserve	PLOS ONE			English	Article							CLADOCORA-CAESPITOSA ANTHOZOA; LONG-TERM DECLINE; PARACENTROTUS-LIVIDUS; OCULINA-PATAGONICA; MASS MORTALITY; COMMUNITY STRUCTURE; ALGAL COMMUNITIES; TROPHIC CASCADES; CYSTOSEIRA SPP.; PROTECTED AREAS	Macroalgae is the dominant trophic group on Mediterranean infralittoral rocky bottoms, whereas zooxanthellate corals are extremely rare. However, in recent years, the invasive coral Oculina patagonica appears to be increasing its abundance through unknown means. Here we examine the pattern of variation of this species at a marine reserve between 2002 and 2010 and contribute to the understanding of the mechanisms that allow its current increase. Because indirect interactions between species can play a relevant role in the establishment of species, a parallel assessment of the sea urchin Paracentrotus lividus, the main herbivorous invertebrate in this habitat and thus a key species, was conducted. O. patagonica has shown a 3-fold increase in abundance over the last 8 years and has become the most abundant invertebrate in the shallow waters of the marine reserve, matching some dominant erect macroalgae in abundance. High recruitment played an important role in this increasing coral abundance. The results from this study provide compelling evidence that the increase in sea urchin abundance may be one of the main drivers of the observed increase in coral abundance. Sea urchins overgraze macroalgae and create barren patches in the space-limited macroalgal community that subsequently facilitate coral recruitment. This study indicates that trophic interactions contributed to the success of an invasive coral in the Mediterranean because sea urchins grazing activity indirectly facilitated expansion of the coral. Current coral abundance at the marine reserve has ended the monopolization of algae in rocky infralittoral assemblages, an event that could greatly modify both the underwater seascape and the sources of primary production in the ecosystem.	[Coma, Rafel; Serrano, Eduard; Ballesteros, Enric] CSIC, Ctr Estudis Avancats Blanes, Blanes, Spain; [Serrano, Eduard; Ribes, Marta] CSIC, Inst Ciencies Mar, Barcelona, Spain; [Linares, Cristina] Univ Barcelona, Fac Biol, Dept Ecol, Barcelona, Spain; [Diaz, David] Inst Espanol Oceanog, Ctr Oceanog Balears, Palma De Mallorca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Barcelona; Spanish Institute of Oceanography	Coma, R (corresponding author), CSIC, Ctr Estudis Avancats Blanes, Blanes, Spain.	coma@ceab.csic.es	DIAZ, DAVID/AAS-8722-2021; Coma, Rafel/J-8987-2012; Ballesteros, Enric/K-6497-2012; Coma, Rafel/ABF-2082-2021; Ribes, Marta/B-2495-2013; Linares, Cristina/A-5244-2018; Serrano, Eduard/B-5269-2019	DIAZ, DAVID/0000-0003-0611-2516; Coma, Rafel/0000-0001-6107-225X; Coma, Rafel/0000-0001-6107-225X; Ribes, Marta/0000-0001-9747-295X; Linares, Cristina/0000-0003-3855-2743; Serrano, Eduard/0000-0001-9082-473X	Spanish Ministry of Science and Innovation [CTM2006-01463, CGL2007-66757-C02-01/BOS, C5D2007-00067]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Financial support for this work was provided by projects CTM2006-01463, CGL2007-66757-C02-01/BOS and C5D2007-00067 from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardy T., 1997, MARINE PROTECTED ARE; Arevalo R, 2007, MAR POLLUT BULL, V55, P104, DOI 10.1016/j.marpolbul.2006.08.023; Ballesteros, 1989, SCI MAR, V53, P3; BALLESTEROS E, 1989, Scientia Marina, V53, P357; BALLESTEROS E, 2008, INFORM PROGRAMA ESTU; BALLESTEROS E, 1991, OECOL AQUAT, V10, P223; BELLAN-SANTINI D, 1968, Revue Internationale d'Oceanographie Medicale, V10, P27; BENEDETTICECCHI L, 1995, MAR ECOL PROG SER, V126, P203, DOI 10.3354/meps126203; Boudouresque, 1987, C INT PAR LIV OURS C, P5; Boudouresque C, 1990, MAP TECHNICAL REPORT, V43; Boudouresque CF, 2002, MAR POLLUT BULL, V44, P32, DOI 10.1016/S0025-326X(01)00150-3; Boudouresque CF, 2007, DEV AQUAC FISH SCI, V37, P243; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Bulleri F, 1999, J EXP MAR BIOL ECOL, V241, P81, DOI 10.1016/S0022-0981(99)00073-8; CALVIN JC, 2004, ESTUDIO ESTADO CONSE, V6; Cardona L, 2007, ESTUAR COAST SHELF S, V72, P273, DOI 10.1016/j.ecss.2006.10.023; Carpenter RC, 2006, ECOL LETT, V9, P268, DOI 10.1111/j.1461-0248.2005.00866.x; Cebrian E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020211; COLL M, 2010, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0011842; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; DIGERONIMO I, 1984, 7 JOURN ET POLL LUC, P791; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; Eklof JS, 2008, ESTUAR COAST SHELF S, V79, P569, DOI 10.1016/j.ecss.2008.05.005; Elmhirst T, 2009, CORAL REEFS, V28, P949, DOI 10.1007/s00338-009-0530-8; Eviner VT, 2003, SCOPE SER, V61, P151; Fine M, 2002, MAR ECOL PROG SER, V234, P119, DOI 10.3354/meps234119; Fine M, 2001, MAR BIOL, V138, P1195; Garcia-Raso J.E., 1992, FAUNA FLORA MARINAS; GARCIACHARTON JA, 2008, ESTUDIO SEGUIMIENTO; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Hereu B, 2004, THESIS U BARCELONA B; Hereu B, 2006, MAR ECOL PROG SER, V313, P95, DOI 10.3354/meps313095; Hereu B, 2008, ECOLOGY, V89, P3423, DOI 10.1890/07-0613.1; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 1996, ECOLOGY, V77, P2256, DOI 10.2307/2265718; HUGHES TP, 1989, ECOLOGY, V70, P275, DOI 10.2307/1938434; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; IVANOV ED, 2009, NATURBANIZATION NEW; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Khoury C., 1987, THESIS U AIX MARSEIL; Knowlton N, 2001, MARINE COMMUNITY ECOLOGY, P395; Kruzic P, 2003, CORAL REEFS, V22, P536, DOI 10.1007/s00338-003-0345-y; Kruzic P, 2008, MAR ECOL-EVOL PERSP, V29, P125, DOI 10.1111/j.1439-0485.2008.00220.x; LAWTON JH, 1992, NATURE, V355, P19, DOI 10.1038/355019a0; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Maldonado M, 2010, MAR BIOL, V157, P1577, DOI 10.1007/s00227-010-1431-7; Marti R, 2005, ESTUAR COAST SHELF S, V64, P613, DOI 10.1016/j.ecss.2005.04.009; Micheli F, 2005, ECOL MONOGR, V75, P81, DOI 10.1890/03-4058; Montoya JM, 2010, PHILOS T R SOC B, V365, P2013, DOI 10.1098/rstb.2010.0114; Nugues MM, 2003, MAR POLLUT BULL, V46, P314, DOI 10.1016/S0025-326X(02)00402-2; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Palacin C, 1998, J SEA RES, V39, P281, DOI 10.1016/S1385-1101(97)00061-0; Perez T, 2000, CR ACAD SCI III-VIE, V323, P853, DOI 10.1016/S0764-4469(00)01237-3; Petraitis PS, 2004, J EXP MAR BIOL ECOL, V300, P343, DOI 10.1016/j.jembe.2003.12.026; Pinedo S, 2007, MAR POLLUT BULL, V55, P126, DOI 10.1016/j.marpolbul.2006.08.044; Pinnegar JK, 2000, ENVIRON CONSERV, V27, P179, DOI 10.1017/S0376892900000205; Piraino S, 2002, MAR BIOL, V140, P1067, DOI 10.1007/s00227-001-0769-2; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; QUIGNARD JP, 1966, RECHERCHES LABRIDAE; Ramos-Espla A.A., 1985, RESERVA MARINA ISLA; Rodolfo-Metalpa R, 2005, ITAL J ZOOL, V72, P271, DOI 10.1080/11250000509356685; Rodolfo-Metalpa R, 2008, MAR ECOL PROG SER, V369, P103, DOI 10.3354/meps07608; RODOLFOMETALPA R, 2007, THESIS U AIX MARSEIL; Sala E, 1998, MAR ECOL PROG SER, V168, P135, DOI 10.3354/meps168135; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Sala E, 1997, MAR BIOL, V129, P531, DOI 10.1007/s002270050194; Sala E, 2004, ECOSYSTEMS, V7, P333, DOI 10.1007/s10021-003-0241-x; Sala E., 1996, THESIS U AIX MARSEIL; Sala E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017356; SAMMARCO PW, 1980, J EXP MAR BIOL ECOL, V45, P245, DOI 10.1016/0022-0981(80)90061-1; Sartoretto S., 2008, Aquatic Invasions, V3, P173, DOI 10.3391/ai.2008.3.2.7; SERRANO E, 2008, THESIS U BARCELONA B; SIMO R, 2010, SEGON INFORM CANVI C, V1, P469; Sokal R.R., 1995, BIOMETRY; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Thibaut T, 2005, MAR POLLUT BULL, V50, P1472, DOI 10.1016/j.marpolbul.2005.06.014; Underwood A.J, 1997, EXPT ECOLOGY THEIR L; Vargas-Yanez M, 2010, J MARINE SYST, V82, P171, DOI 10.1016/j.jmarsys.2010.04.013; Verges A, 2009, MAR ECOL PROG SER, V375, P1, DOI 10.3354/meps07778; VERLAQUE M, 1983, Vie et Milieu, V33, P191; VERLAQUE M, 1984, BOT MAR, V27, P401, DOI 10.1515/botm.1984.27.9.401; Verlaque M., 1987, THESIS U AIX MARSEIL; WITMAN JD, 1987, ECOL MONOGR, V57, P167, DOI 10.2307/1942623; Witman JD, 2001, MARINE COMMUNITY ECOLOGY, P339; Zibrowius H., 1983, Rapports et Proces-Verbaux des Reunions Commission Internationale pour l'Exploration Scientifique de la Mer Mediterranee Monaco, V28, P297; ZIBROWIUS H, 1974, HELGOLAND WISS MEER, V26, P153, DOI 10.1007/BF01611381	92	46	48	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22017	10.1371/journal.pone.0022017	http://dx.doi.org/10.1371/journal.pone.0022017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789204	Green Published, gold			2022-12-25	WOS:000292812400026
J	Ellong, EN; Soni, KG; Bui, QT; Sougrat, R; Golinelli-Cohen, MP; Jackson, CL				Ellong, Emy Njoh; Soni, Krishnakant G.; Quynh-Trang Bui; Sougrat, Rachid; Golinelli-Cohen, Marie-Pierre; Jackson, Catherine L.			Interaction between the Triglyceride Lipase ATGL and the Arf1 Activator GBF1	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTORS; TRANS-GOLGI NETWORK; LIPID DROPLETS; PROTEIN; PATATIN; CGI-58; FAMILY; DEGRADATION; MAINTENANCE; HYDROLASE	The Arf1 exchange factor GBF1 (Golgi Brefeldin A resistance factor 1) and its effector COPI are required for delivery of ATGL (adipose triglyceride lipase) to lipid droplets (LDs). Using yeast two hybrid, co-immunoprecipitation in mammalian cells and direct protein binding approaches, we report here that GBF1 and ATGL interact directly and in cells, through multiple contact sites on each protein. The C-terminal region of ATGL interacts with N-terminal domains of GBF1, including the catalytic Sec7 domain, but not with full-length GBF1 or its entire N-terminus. The N-terminal lipase domain of ATGL (called the patatin domain) interacts with two C-terminal domains of GBF1, HDS (Homology downstream of Sec7) 1 and HDS2. These two domains of GBF1 localize to lipid droplets when expressed alone in cells, but not to the Golgi, unlike the full-length GBF1 protein, which localizes to both. We suggest that interaction of GBF1 with ATGL may be involved in the membrane trafficking pathway mediated by GBF1, Arf1 and COPI that contributes to the localization of ATGL to lipid droplets.	[Ellong, Emy Njoh; Quynh-Trang Bui; Golinelli-Cohen, Marie-Pierre; Jackson, Catherine L.] CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France; [Soni, Krishnakant G.; Sougrat, Rachid] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ellong, EN (corresponding author), CNRS, Lab Enzymol & Biochim Struct, Bat 34, Gif Sur Yvette, France.	jackson@ijm.univ-paris-diderot.fr	Jackson, Catherine/A-3421-2013; Jackson, Catherine/T-5688-2019; Golinelli, Marie-Pierre/K-4287-2013	Jackson, Catherine/0000-0002-0843-145X; Golinelli, Marie-Pierre/0000-0002-6738-8631; Sougrat, Rachid/0000-0001-6476-1886	ANR; CNRS; Fondation pour la Recherche Medicale (FRM); NICHD; Ministere de l'Enseignement Superieur et de la Recherche	ANR(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This work was funded by a grant from the ANR (Chaire d'Excellence), the CNRS, the Fondation pour la Recherche Medicale (FRM), and the Intramural Program of NICHD. ENE was supported by a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altan-Bonnet N, 2004, CURR OPIN CELL BIOL, V16, P364, DOI 10.1016/j.ceb.2004.06.011; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2010, CELL METAB, V11, P173, DOI 10.1016/j.cmet.2010.02.008; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Bui QT, 2009, MOL GENET GENOMICS, V282, P329, DOI 10.1007/s00438-009-0473-3; Chantalat S, 2004, J CELL SCI, V117, P711, DOI 10.1242/jcs.00896; Deng Y, 2009, EMBO REP, V10, P58, DOI 10.1038/embor.2008.221; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Garcia-Mata R, 2003, EMBO REP, V4, P320, DOI 10.1038/sj.embor.embor762; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gloor Y, 2010, EUR J CELL BIOL, V89, P575, DOI 10.1016/j.ejcb.2010.02.004; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hommel A, 2010, MOL CELL BIOL, V30, P1231, DOI 10.1128/MCB.01269-09; Hughes H, 2008, HISTOCHEM CELL BIOL, V129, P129, DOI 10.1007/s00418-007-0363-x; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; Liu PS, 2007, BBA-MOL CELL RES, V1773, P784, DOI 10.1016/j.bbamcr.2007.02.004; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Lu X, 2010, CELL CYCLE, V9, P2719, DOI 10.4161/cc.9.14.12181; Manolea F, 2008, MOL BIOL CELL, V19, P523, DOI 10.1091/mbc.E07-04-0394; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Murphy S, 2009, BBA-MOL CELL BIOL L, V1791, P441, DOI 10.1016/j.bbalip.2008.07.004; Natarajan P, 2009, NAT CELL BIOL, V11, P1421, DOI 10.1038/ncb1989; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Ramaen O, 2007, J BIOL CHEM, V282, P28834, DOI 10.1074/jbc.M705525200; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Saraste J, 2007, MOL BIOL CELL, V18, P1430, DOI 10.1091/mbc.E06-10-0933; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; Togawa A, 1999, J BIOL CHEM, V274, P12308, DOI 10.1074/jbc.274.18.12308; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zehmer JK, 2009, J CELL SCI, V122, P3694, DOI 10.1242/jcs.054700; Zehmer JK, 2009, PROTEOMICS, V9, P914, DOI 10.1002/pmic.200800584; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zimmermann R, 2009, BBA-MOL CELL BIOL L, V1791, P494, DOI 10.1016/j.bbalip.2008.10.005	54	39	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e21889	10.1371/journal.pone.0021889	http://dx.doi.org/10.1371/journal.pone.0021889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789191	Green Submitted, Green Published, gold			2022-12-25	WOS:000292812400019
J	Holland, DP; Sanders, GD; Hamilton, CD; Stout, JE				Holland, David P.; Sanders, Gillian D.; Hamilton, Carol D.; Stout, Jason E.			Potential Economic Viability of Two Proposed Rifapentine-Based Regimens for Treatment of Latent Tuberculosis Infection	PLOS ONE			English	Article							COST-EFFECTIVENESS ANALYSIS; DIRECTLY OBSERVED THERAPY; ISONIAZID PROPHYLAXIS; TREATMENT COMPLETION; LOW-RISK; HEALTH; RIFAMPIN; EPIDEMIOLOGY; PYRAZINAMIDE	Rationale: Rifapentine-based regimens for treating latent tuberculosis infection (LTBI) are being considered for future clinical trials, but even if they prove effective, high drug costs may limit their economic viability. Objectives: To inform clinical trial design by estimating the potential costs and effectiveness of rifapentine-based regimens for treatment of latent tuberculosis infection (LTBI). Methods: We used a Markov model to estimate cost and societal benefits for three regimens for treating LTBI: Isoniazid/rifapentine daily for one month, isoniazid/rifapentine weekly for three months (self-administered and directly-observed), and isoniazid daily for nine months; a strategy of "no treatment'' used for comparison. Costs, quality-adjusted life-years gained, and instances of active tuberculosis averted were calculated for all arms. Results: Both daily isoniazid/rifapentine for one month and weekly isoniazid/rifapentine for three months were less expensive and more effective than other strategies under a wide variety of clinically plausibly parameter estimates. Daily isoniazid/rifapentine for one month was the least expensive and most effective regimen. Conclusions: Daily isoniazid/rifapentine for one month and weekly isoniazid/rifapentine for three months should be studied in a large-scale clinical trial for efficacy. Because both regimens performed well even if their efficacy is somewhat reduced, study designers should consider relaxing non-inferiority boundaries.	[Holland, David P.; Sanders, Gillian D.; Hamilton, Carol D.; Stout, Jason E.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Holland, David P.; Hamilton, Carol D.; Stout, Jason E.] Duke Univ, Med Ctr, Div Infect Dis, Durham, NC 27710 USA; [Hamilton, Carol D.] Family Hlth Int, Res Triangle Pk, NC 27709 USA	Duke University; Duke University	Holland, DP (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	david.p.holland@duke.edu	Trajman, Anete/C-7679-2016	Trajman, Anete/0000-0002-4000-4984; Stout, Jason/0000-0002-6698-8176	National Institutes of Health [5K01AI083782-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI083782] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by National Institutes of Health grant 5K01AI083782-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], REP TUB US; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; BROWN RE, 1995, ARCH INTERN MED, V155, P1595, DOI 10.1001/archinte.155.15.1595; Burman WJ, 1997, CHEST, V112, P63, DOI 10.1378/chest.112.1.63; BUSH OB, 1965, AM REV RESPIR DIS, V92, P732; COMSTOCK GW, 1975, AM J EPIDEMIOL, V101, P363, DOI 10.1093/oxfordjournals.aje.a112105; COMSTOCK GW, 1962, AM REV RESPIR DIS, V86, P810; EGSMOSE T, 1965, B WORLD HEALTH ORGAN, V33, P419; Gordin F, 2000, JAMA-J AM MED ASSOC, V283, P1445, DOI 10.1001/jama.283.11.1445; Guo N, 2008, VALUE HEALTH, V11, P1154, DOI 10.1111/j.1524-4733.2008.00355.x; Holland DP, 2009, AM J RESP CRIT CARE, V179, P1055, DOI 10.1164/rccm.200901-0153OC; Horsburgh CR, 2010, AM J RESP CRIT CARE, V182, P420, DOI 10.1164/rccm.200909-1355OC; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Jasmer RM, 2004, CLIN INFECT DIS, V38, P363, DOI 10.1086/380966; Lardizabal A, 2006, CHEST, V130, P1712, DOI 10.1378/chest.130.6.1712; LoBue PA, 2003, AM J RESP CRIT CARE, V168, P443, DOI 10.1164/rccm.200303-390OC; Menzies D, 2004, AM J RESP CRIT CARE, V170, P445, DOI 10.1164/rccm.200404-478OC; Moss AR, 2000, AM J RESP CRIT CARE, V162, P460, DOI 10.1164/ajrccm.162.2.9910055; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Nuermberger E, 2005, AM J RESP CRIT CARE, V172, P1452, DOI 10.1164/rccm.200507-1047OC; PERRY D, 2011, N CAROLINA TUBERCULO; Salpeter EE, 1998, AM J EPIDEMIOL, V147, P398; Salpeter SR, 1997, ANN INTERN MED, V127, P1051, DOI 10.7326/0003-4819-127-12-199712150-00001; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Schechter M, 2006, AM J RESP CRIT CARE, V173, P922, DOI 10.1164/rccm.200512-1953OC; Snyder DC, 1999, AM J RESP CRIT CARE, V160, P582, DOI 10.1164/ajrccm.160.2.9901049; Sterling TR, 2010, PREVENT TB STUDY TB; Taylor Z, 2000, INT J TUBERC LUNG D, V4, P931; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Zhang TY, 2009, AM J RESP CRIT CARE, V180, P1151, DOI 10.1164/rccm.200905-0795OC	32	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22276	10.1371/journal.pone.0022276	http://dx.doi.org/10.1371/journal.pone.0022276			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789248	Green Published, gold, Green Submitted			2022-12-25	WOS:000292812400045
J	Zygmunt, BM; Groebe, L; Guzman, CA				Zygmunt, Beata M.; Groebe, Lothar; Guzman, Carlos A.			Peritoneal Cavity Is Dominated by IFN gamma-Secreting CXCR3(+) Th1 Cells	PLOS ONE			English	Article							CD8(+) T-CELLS; CUTTING EDGE; RECEPTOR; MICROENVIRONMENT; INDUCTION; CD4(+); LUNG; INFLAMMATION; RECRUITMENT; RESPONSES	chemokine receptor CXCR3, which was shown to take part in many inflammatory processes, is considered as a Th1 specific marker. Here, we show in a mouse model that CXCR3 expressing CD4(+) cells preferentially migrate to the peritoneal cavity under steady-state conditions. The peritoneal cavity milieu leads to an up-regulated expression of CXCR3. However, blocking of known ligands of this chemokine receptor did not alter the preferential migration. The peritoneal cavity environment also results in an increased percentage of memory cells producing cytokines. Up-regulation of IFN gamma production occurs mostly in CXCR3(+) cells considered as Th1, whereas the up-regulation of IL-4 affects mostly in CXCR3(-) cells which are considered as Th2. We conclude that the peritoneal cavity does not change the Th-lineage of the cells, but that domination of this anatomic niche by Th1 cells rather results from preferential migration to this compartment.	[Zygmunt, Beata M.; Guzman, Carlos A.] Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Groebe, Lothar] Helmholtz Ctr Infect Res, Dept Expt Immunol, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research	Zygmunt, BM (corresponding author), Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany.	beata.zygmunt@bbsrc.ac.uk			European Community [MEST-2004-504990]; German Research Foundation [EXC 62/1]	European Community(European Commission); German Research Foundation(German Research Foundation (DFG))	This study was in part supported by the Marie Curie Early Stage Training of the European Community's Sixth Framework Programme under contract number MEST-2004-504990 and the Excellence Cluster "From Regenerative Biology to Reconstructive Therapy'' by the German Research Foundation (EXC 62/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Barbi J, 2007, BLOOD, V110, P2215, DOI 10.1182/blood-2007-03-081307; Berberich S, 2007, BLOOD, V109, P4627, DOI 10.1182/blood-2006-12-064345; Debes GF, 2006, J IMMUNOL, V176, P557, DOI 10.4049/jimmunol.176.1.557; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hildebrandt GC, 2004, J IMMUNOL, V173, P2050, DOI 10.4049/jimmunol.173.3.2050; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI200113543; Kohlmeier JE, 2007, J IMMUNOL, V178, P4721, DOI 10.4049/jimmunol.178.8.4721; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Masopust D, 2006, J IMMUNOL, V176, P2079, DOI 10.4049/jimmunol.176.4.2079; Mohan K, 2005, EUR J IMMUNOL, V35, P1702, DOI 10.1002/eji.200425885; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakajima C, 2002, EUR J IMMUNOL, V32, P1792, DOI 10.1002/1521-4141(200206)32:6<1792::AID-IMMU1792>3.0.CO;2-0; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Stoermann B, 2007, EUR J IMMUNOL, V37, P1613, DOI 10.1002/eji.200636640; Takenaka S, 2009, CLIN VACCINE IMMUNOL, V16, P1615, DOI 10.1128/CVI.00216-09; Widney DP, 2005, INFECT IMMUN, V73, P485, DOI 10.1128/IAI.73.1.485-493.2005; Xie JH, 2003, J LEUKOCYTE BIOL, V73, P771, DOI 10.1189/jlb.1102573; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007	23	6	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e18032	10.1371/journal.pone.0018032	http://dx.doi.org/10.1371/journal.pone.0018032			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789162	Green Published, Green Submitted, gold			2022-12-25	WOS:000292812400001
J	Arthofer, W; Riegler, M; Schuler, H; Schneider, D; Moder, K; Miller, WJ; Stauffer, C				Arthofer, Wolfgang; Riegler, Markus; Schuler, Hannes; Schneider, Daniela; Moder, Karl; Miller, Wolfgang J.; Stauffer, Christian			Allele Intersection Analysis: A Novel Tool for Multi Locus Sequence Assignment in Multiply Infected Hosts	PLOS ONE			English	Article							RHAGOLETIS-CERASI DIPTERA; CHERRY FRUIT-FLY; WOLBACHIA-PIPIENTIS; CYTOPLASMIC INCOMPATIBILITY; DROSOPHILA-SIMULANS; RECOMBINATION; WSP; AMPLIFICATION; POPULATIONS; PHYLOGENY	Wolbachia are wide-spread, endogenous alpha-Proteobacteria of arthropods and filarial nematodes. 15-75% of all insect species are infected with these endosymbionts that alter their host's reproduction to facilitate their spread. In recent years, many insect species infected with multiple Wolbachia strains have been identified. As the endosymbionts are not cultivable outside living cells, strain typing relies on molecular methods. A Multi Locus Sequence Typing (MLST) system was established for standardizing Wolbachia strain identification. However, MLST requires hosts to harbour individual and not multiple strains of supergroups without recombination. This study revisits the applicability of the current MLST protocols and introduces Allele Intersection Analysis (AIA) as a novel approach. AIA utilizes natural variations in infection patterns and allows correct strain assignment of MLST alleles in multiply infected host species without the need of artificial strain segregation. AIA identifies pairs of multiply infected individuals that share Wolbachia and differ in only one strain. In such pairs, the shared MLST sequences can be used to assign alleles to distinct strains. Furthermore, AIA is a powerful tool to detect recombination events. The underlying principle of AIA may easily be adopted for MLST approaches in other uncultivable bacterial genera that occur as multiple strain infections and the concept may find application in metagenomic high-throughput parallel sequencing projects.	[Arthofer, Wolfgang] Univ Innsbruck, Inst Ecol, Mol Ecol Grp, A-6020 Innsbruck, Austria; [Riegler, Markus] Univ Western Australia, Hawkesbury Inst Environm, Richmond, WA, Australia; [Schuler, Hannes; Stauffer, Christian] Univ Nat Resources & Life Sci, Inst Forest Entomol Forest Pathol & Forest Protec, Dept Forest & Soil Sci, Vienna, Austria; [Moder, Karl] Univ Nat Resources & Life Sci, Inst Appl Stat & Comp, Dept Landscape Spatial & Infrastruct Sci, Vienna, Austria; [Schneider, Daniela; Miller, Wolfgang J.] Med Univ Vienna, Ctr Anat & Cell Biol, Vienna, Austria	University of Innsbruck; University of Western Australia; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; Medical University of Vienna	Arthofer, W (corresponding author), Univ Innsbruck, Inst Ecol, Mol Ecol Grp, A-6020 Innsbruck, Austria.	wolfgang.arthofer@uibk.ac.at	Miller, Wolfgang J/E-5716-2015; Schuler, Hannes/Q-4825-2016; Schuler, Hannes/AAZ-6914-2020	Miller, Wolfgang J/0000-0002-5044-6276; Riegler, Markus/0000-0001-7363-431X; Schuler, Hannes/0000-0001-8307-9831; Schneider, Daniela/0000-0002-7740-8827	Austrian Science Fund [FWF P19206-B17]; COST Action [FA0701]; Austrian Science Fund (FWF) [P 22634] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); COST Action(European Cooperation in Science and Technology (COST)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The work presented here was supported by the Austrian Science Fund Project FWF P19206-B17 (http://www.fwf.ac.at/) and the COST Action FA0701 (http://www.cost.esf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthofer W, 2009, MOL ECOL, V18, P3816, DOI 10.1111/j.1365-294X.2009.04321.x; Baldo L, 2006, MOL BIOL EVOL, V23, P437, DOI 10.1093/molbev/msj049; Baldo L, 2005, J BACTERIOL, V187, P5406, DOI 10.1128/JB.187.15.5406-5418.2005; Baldo L, 2007, CURR MICROBIOL, V55, P81, DOI 10.1007/s00284-007-0055-8; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; Becker S, 2000, APPL ENVIRON MICROB, V66, P4945, DOI 10.1128/AEM.66.11.4945-4953.2000; Behura SK, 2001, INSECT MOL BIOL, V10, P163, DOI 10.1046/j.1365-2583.2001.00251.x; BORM S, 2003, MOL PHYLOGENET EVOL, V26, P102; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Dedeine F, 2005, MOL ECOL, V14, P1543, DOI 10.1111/j.1365-294X.2005.02499.x; Dedeine F, 2001, P NATL ACAD SCI USA, V98, P6247, DOI 10.1073/pnas.101304298; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Jamnongluk W, 2002, CURR MICROBIOL, V45, P255, DOI 10.1007/s00284-002-3746-1; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kobayashi N, 1999, BIOCHEM GENET, V37, P317, DOI 10.1023/A:1018759210666; Koukou K, 2006, EVOLUTION, V60, P87, DOI 10.1111/j.0014-3820.2006.tb01084.x; Lemee L, 2004, J CLIN MICROBIOL, V42, P2609, DOI 10.1128/JCM.42.6.2609-2617.2004; Lo N, 2002, MOL BIOL EVOL, V19, P341, DOI 10.1093/oxfordjournals.molbev.a004087; Malloch G, 2005, MOL ECOL, V14, P627, DOI 10.1111/j.1365-294X.2005.02432.x; McGraw EA, 2004, CURR OPIN MICROBIOL, V7, P67, DOI 10.1016/j.mib.2003.12.003; Mercot H, 1998, ENTOMOL EXP APPL, V86, P97, DOI 10.1023/A:1003170928067; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; ONeill SL, 1997, INSECT MOL BIOL, V6, P33, DOI 10.1046/j.1365-2583.1997.00157.x; Pignatelli M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019984; Raychoudhury R, 2009, EVOLUTION, V63, P165, DOI 10.1111/j.1558-5646.2008.00533.x; Reuter M, 2003, MOL BIOL EVOL, V20, P748, DOI 10.1093/molbev/msg082; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; Riegler M, 2004, APPL ENVIRON MICROB, V70, P273, DOI 10.1128/AEM.70.1.273-279.2004; Riegler M, 2002, MOL ECOL, V11, P2425, DOI 10.1046/j.1365-294X.2002.01614.x; Rodriguez-Valera F, 2004, FEMS MICROBIOL LETT, V231, P153, DOI 10.1016/S0378-1097(04)00006-0; Salzberg SL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r23; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schnell S, 1997, J THEOR BIOL, V188, P313, DOI 10.1006/jtbi.1997.0473; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vernez I, 2005, FEMS IMMUNOL MED MIC, V43, P29, DOI 10.1016/j.femsim.2004.06.024; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren JH, 2001, CURR BIOL, V11, P431, DOI 10.1016/S0960-9822(01)00101-4; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V262, P197, DOI 10.1098/rspb.1995.0196; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	49	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22198	10.1371/journal.pone.0022198	http://dx.doi.org/10.1371/journal.pone.0022198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789233	Green Submitted, gold, Green Published			2022-12-25	WOS:000292811700032
J	Thorley, AJ; Grandolfo, D; Lim, E; Goldstraw, P; Young, A; Tetley, TD				Thorley, Andrew J.; Grandolfo, Davide; Lim, Eric; Goldstraw, Peter; Young, Alan; Tetley, Teresa D.			Innate Immune Responses to Bacterial Ligands in the Peripheral Human Lung - Role of Alveolar Epithelial TLR Expression and Signalling	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTOR-4; CYTOKINE RELEASE; CELLS; ACTIVATION; TOLL-LIKE-RECEPTOR-2; MACROPHAGES; RECOGNITION; COMPLEX	It is widely believed that the alveolar epithelium is unresponsive to LPS, in the absence of serum, due to low expression of TLR4 and CD14. Furthermore, the responsiveness of the epithelium to TLR-2 ligands is also poorly understood. We hypothesised that human alveolar type I (ATI) and type II (ATII) epithelial cells were responsive to TLR2 and TLR4 ligands (MALP-2 and LPS respectively), expressed the necessary TLRs and co-receptors (CD14 and MD2) and released distinct profiles of cytokines via differential activation of MAP kinases. Primary ATII cells and alveolar macrophages and an immortalised ATI cell line (TT1) elicited CD14 and MD2-dependent responses to LPS which did not require the addition of exogenous soluble CD14. TT1 and primary ATII cells expressed CD14 whereas A549 cells did not, as confirmed by flow cytometry. Following LPS and MALP-2 exposure, macrophages and ATII cells released significant amounts of TNF alpha, IL-8 and MCP-1 whereas TT1 cells only released IL-8 and MCP-1. P38, ERK and JNK were involved in MALP-2 and LPS-induced cytokine release from all three cell types. However, ERK and JNK were significantly more important than p38 in cytokine release from macrophages whereas all three were similarly involved in LPS-induced mediator release from TT1 cells. In ATII cells, JNK was significantly more important than p38 and ERK in LPS-induced MCP-1 release. MALP-2 and LPS exposure stimulated TLR4 protein expression in all three cell types; significantly more so in ATII cells than macrophages and TT1 cells. In conclusion, this is the first study describing the expression of CD14 on, and TLR2 and 4 signalling in, primary human ATII cells and ATI cells; suggesting that differential activation of MAP kinases, cytokine secretion and TLR4 expression by the alveolar epithelium and macrophages is important in orchestrating a co-ordinated response to inhaled pathogens.	[Thorley, Andrew J.; Grandolfo, Davide; Tetley, Teresa D.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Sect Pharmacol & Toxicol, London, England; [Lim, Eric; Goldstraw, Peter] Royal Brompton & Harefield NHS Trust, Dept Thorac Surg, London, England; [Young, Alan] AstraZeneca R&D, Loughborough, Leics, England	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; AstraZeneca	Thorley, AJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Sect Pharmacol & Toxicol, London, England.	t.tetley@imperial.ac.uk	Tetley, Teresa D/B-3288-2016; Thorley, Andrew/B-3883-2016	Thorley, Andrew/0000-0001-7854-7012; Lim, Eric/0000-0002-9078-3226	AstraZeneca; MRC [G0700926] Funding Source: UKRI; Medical Research Council [G0700926] Funding Source: researchfish	AstraZeneca(AstraZeneca); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by funding from AstraZeneca. Dr. Alan Young was involved in the design of the studies carried out. However, he was not involved in data collection and analysis, decision to publish or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Albiger B, 2007, J INTERN MED, V261, P511, DOI 10.1111/j.1365-2796.2007.01821.x; Armstrong L, 2004, AM J RESP CELL MOL, V31, P241, DOI 10.1165/rcmb.2004-0078OC; BAZIL V, 1986, EUR J IMMUNOL, V16, P1583, DOI 10.1002/eji.1830161218; Droemann D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-68; Fehrenbach H, 2003, EUR RESPIR J, V21, P421, DOI 10.1183/09031936.03.00083002; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Hasebe A, 2007, INFECT IMMUN, V75, P1820, DOI 10.1128/IAI.00516-06; HAZIOT A, 1988, J IMMUNOL, V141, P547; Hedlund M, 2001, MOL MICROBIOL, V39, P542, DOI 10.1046/j.1365-2958.2001.02205.x; HELLWEG CE, 2008, ANN NY ACAD SCI, V1091, P191; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kanj RS, 2006, J TOXICOL ENV HEAL A, V69, P1097, DOI 10.1080/14736480500360504; Kato A, 2004, J IMMUNOL, V172, P6185, DOI 10.4049/jimmunol.172.10.6185; Kemp SJ, 2008, AM J RESP CELL MOL, V39, P591, DOI 10.1165/rcmb.2007-0334OC; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; KNAPP S, 2005, AM J RESP CRIT CARE; Lenoir C, 2008, LIFE SCI, V82, P519, DOI 10.1016/j.lfs.2007.12.007; MacRedmond R, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-116; Medvedev AE, 2002, J IMMUNOL, V169, P5209, DOI 10.4049/jimmunol.169.9.5209; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Morello S, 2006, J IMMUNOL, V177, P7173, DOI 10.4049/jimmunol.177.10.7173; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Nakata T, 2006, CELL MICROBIOL, V8, P1899, DOI 10.1111/j.1462-5822.2006.00756.x; O'Hare MJ, 2001, P NATL ACAD SCI USA, V98, P646, DOI 10.1073/pnas.98.2.646; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Payne JP, 2004, J OCCUP ENVIRON MED, V46, P420, DOI 10.1097/01.jom.0000126021.25149.64; PIGUET PF, 1993, AM J PATHOL, V143, P651; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Revets H, 2005, J IMMUNOL, V174, P1097, DOI 10.4049/jimmunol.174.2.1097; Saito T, 2005, CELL TISSUE RES, V321, P75, DOI 10.1007/s00441-005-1113-9; Schroder NWJ, 2004, J IMMUNOL, V173, P2683, DOI 10.4049/jimmunol.173.4.2683; Schulz C, 2002, SCAND J IMMUNOL, V56, P294, DOI 10.1046/j.1365-3083.2002.01137.x; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Taylor AE, 2010, EUR RESPIR J, V35, P1039, DOI 10.1183/09031936.00036709; Thorley AJ, 2005, AM J RESP CELL MOL, V32, P262, DOI 10.1165/rcmb.2004-0196OC; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Tudhope SJ, 2008, J PHARMACOL EXP THER, V324, P306, DOI 10.1124/jpet.107.127670; Wang SJ, 2002, TOXICOLOGY, V173, P211, DOI 10.1016/S0300-483X(02)00037-9; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; WILLIAMS DL, 2003, CRITICAL CARE MED, V31; Witherden IR, 2004, AM J RESP CELL MOL, V30, P500, DOI 10.1165/rcmb.4890; Witherden IR, 2001, METH MOLEC MED, V56, P137, DOI 10.1385/1-59259-151-5:137; Wyllie DH, 2000, J IMMUNOL, V165, P7125, DOI 10.4049/jimmunol.165.12.7125	48	63	65	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e21827	10.1371/journal.pone.0021827	http://dx.doi.org/10.1371/journal.pone.0021827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789185	gold, Green Published, Green Submitted			2022-12-25	WOS:000292811700004
J	Chiang, MK; Lu, MC; Liu, LC; Lin, CT; Lai, YC				Chiang, Ming-Ko; Lu, Min-Chi; Liu, Li-Cheng; Lin, Ching-Ting; Lai, Yi-Chyi			Impact of Hfq on Global Gene Expression and Virulence in Klebsiella pneumoniae	PLOS ONE			English	Article							RNA CHAPERONE HFQ; ENVELOPE STRESS-RESPONSE; BINDING PROTEIN HFQ; HOST FACTOR-I; ESCHERICHIA-COLI; OUTER-MEMBRANE; STATIONARY-PHASE; REGULATORY RNAS; LIVER-ABSCESS; RPOS	Klebsiella pneumoniae is responsible for a wide range of clinical symptoms. How this bacterium adapts itself to ever-changing host milieu is still a mystery. Recently, small non-coding RNAs (sRNAs) have received considerable attention for their functions in fine-tuning gene expression at a post-transcriptional level to promote bacterial adaptation. Here we demonstrate that Hfq, an RNA-binding protein, which facilitates interactions between sRNAs and their mRNA targets, is critical for K. pneumoniae virulence. A K. pneumoniae mutant lacking hfq (Delta hfq) failed to disseminate into extra-intestinal organs and was attenuated on induction of a systemic infection in a mouse model. The absence of Hfq was associated with alteration in composition of envelope proteins, increased production of capsular polysaccharides, and decreased resistance to H2O2, heat shock, and UV irradiation. Microarray-based transcriptome analyses revealed that 897 genes involved in numerous cellular processes were deregulated in the Delta hfq strain. Interestingly, Hfq appeared to govern expression of many genes indirectly by affecting sigma factor RpoS and RpoE, since 19.5% (175/897) and 17.3% (155/897) of Hfq-dependent genes belong to the RpoE- and RpoS-regulon, respectively. These results indicate that Hfq regulates global gene expression at multiple levels to modulate the physiological fitness and virulence potential of K. pneumoniae.	[Chiang, Ming-Ko] Natl Chung Cheng Univ, Dept Life Sci, Chiayi, Taiwan; [Lu, Min-Chi; Lai, Yi-Chyi] Chung Shan Med Univ Hosp, Dept Internal Med, Div Infect Dis, Taichung, Taiwan; [Lu, Min-Chi; Lai, Yi-Chyi] Chung Shan Med Univ, Dept Microbiol & Immunol, Taichung, Taiwan; [Liu, Li-Cheng] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Lin, Ching-Ting] China Med Univ, Sch Chinese Med, Taichung, Taiwan	National Chung Cheng University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; China Medical University Taiwan	Chiang, MK (corresponding author), Natl Chung Cheng Univ, Dept Life Sci, Chiayi, Taiwan.	yclai@csmu.edu.tw		LAI, YICHYI/0000-0003-2396-1827	Chung-Shan Medical University of Taiwan R.O.C. [NSC 98-2311-B-194-001-MY3, NSC98-2320-B-040-013, CSMU-TSMH-099-005]; National Science Council; Ministry of Education; Chung Shan Medical University	Chung-Shan Medical University of Taiwan R.O.C.; National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education; Chung Shan Medical University	This work was supported by the National Science Council and Chung-Shan Medical University of Taiwan R.O.C. (NSC 98-2311-B-194-001-MY3 to Ming-Ko Chiang, NSC98-2320-B-040-013 and CSMU-TSMH-099-005 to Yi-Chyi Lai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank Ting-Quan Yan for advice and assistance with microarray work, and Jia-Zhen Weng and Pei-Shan Wu for help with Northern and Western blotting experiments. Freeze ultracentrifuge was performed in the Instrument Center of Chung Shan Medical University, which is supported by National Science Council, Ministry of Education and Chung Shan Medical University.	Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Arluison V, 2002, J MOL BIOL, V320, P705, DOI 10.1016/S0022-2836(02)00548-X; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Barra-Bily L, 2010, J BACTERIOL, V192, P1719, DOI 10.1128/JB.01429-09; Berghoff BA, 2011, MOL MICROBIOL, V80, P1479, DOI 10.1111/j.1365-2958.2011.07658.x; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Brown L, 1996, J BACTERIOL, V178, P3763, DOI 10.1128/jb.178.13.3763-3770.1996; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Chang HY, 1996, MICROB PATHOGENESIS, V20, P255, DOI 10.1006/mpat.1996.0024; Cheng HY, 2010, J BACTERIOL, V192, P3144, DOI 10.1128/JB.00031-10; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Dierksen KP, 1996, J BACTERIOL, V178, P5053, DOI 10.1128/jb.178.16.5053-5056.1996; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; DOMENICO P, 1989, INFECT IMMUN, V57, P3778, DOI 10.1128/IAI.57.12.3778-3782.1989; Figueroa-Bossi N, 2006, MOL MICROBIOL, V62, P838, DOI 10.1111/j.1365-2958.2006.05413.x; Folichon M, 2005, FEBS J, V272, P454, DOI 10.1111/j.1742-4658.2004.04485.x; Fouts DE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000141; FRANZE MT, 1968, NATURE, V219, P588, DOI 10.1038/219588a0; Geng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006213; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Guillier M, 2006, GENE DEV, V20, P2338, DOI 10.1101/gad.1457506; Guisbert E, 2007, J BACTERIOL, V189, P1963, DOI 10.1128/JB.01243-06; Hajnsdorf E, 2000, P NATL ACAD SCI USA, V97, P1501, DOI 10.1073/pnas.040549897; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Kulesus RR, 2008, INFECT IMMUN, V76, P3019, DOI 10.1128/IAI.00022-08; Lai YC, 2003, FEMS MICROBIOL LETT, V218, P121, DOI 10.1016/S0378-1097(02)01120-5; Lai YC, 2003, J BACTERIOL, V185, P788, DOI 10.1128/JB.185.3.788-800.2003; Le Derout J, 2003, NUCLEIC ACIDS RES, V31, P4017, DOI 10.1093/nar/gkg456; Le Derout J, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-17; Lee T, 2008, RNA, V14, P514, DOI 10.1261/rna.531408; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Lin CT, 2006, J BIOCHEM, V140, P639, DOI 10.1093/jb/mvj196; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; McNealy TL, 2005, J BACTERIOL, V187, P1527, DOI 10.1128/JB.187.4.1527-1532.2005; Meibom KL, 2009, INFECT IMMUN, V77, P1866, DOI 10.1128/IAI.01496-08; Mohanty BK, 2004, MOL MICROBIOL, V54, P905, DOI 10.1111/j.1365-2958.2004.04337.x; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Morita T, 2011, GENE DEV, V25, P294, DOI 10.1101/gad.2030311; Muffler A, 1996, GENE DEV, V10, P1143, DOI 10.1101/gad.10.9.1143; Nelson EC, 2003, J ANTIMICROB CHEMOTH, V52, P899, DOI 10.1093/jac/dkg486; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Repoila F, 2003, MOL MICROBIOL, V48, P855, DOI 10.1046/j.1365-2958.2003.03454.x; Robertson GT, 1999, MOL MICROBIOL, V34, P690, DOI 10.1046/j.1365-2958.1999.01629.x; Roop RM, 2003, ANNU REV MICROBIOL, V57, P57, DOI 10.1146/annurev.micro.57.030502.090803; Schiano CA, 2010, INFECT IMMUN, V78, P2034, DOI 10.1128/IAI.01046-09; SENEAR AW, 1976, J BIOL CHEM, V251, P1902; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Sukhodolets MV, 2003, BIOCHEMISTRY-US, V42, P8022, DOI 10.1021/bi020638i; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Tu YC, 2009, INFECT IMMUN, V77, P2657, DOI 10.1128/IAI.01523-08; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Vanderpool CK, 2007, CURR OPIN MICROBIOL, V10, P146, DOI 10.1016/j.mib.2007.03.011; Vecerek B, 2005, RNA, V11, P976, DOI 10.1261/rna.2360205; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wu KM, 2009, J BACTERIOL, V191, P4492, DOI 10.1128/JB.00315-09; Zhang Y, 2006, BIOCHEM BIOPH RES CO, V343, P950, DOI 10.1016/j.bbrc.2006.02.196	58	31	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22248	10.1371/journal.pone.0022248	http://dx.doi.org/10.1371/journal.pone.0022248			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779404	Green Submitted, Green Published, gold			2022-12-25	WOS:000292811300057
J	Jabeen, R; Chang, HC; Goswami, R; Nutt, SL; Kaplan, MH				Jabeen, Rukhsana; Chang, Hua-Chen; Goswami, Ritobrata; Nutt, Stephen L.; Kaplan, Mark H.			The Transcription Factor PU.1 Regulates gamma delta T Cell Homeostasis	PLOS ONE			English	Article							ALPHA-BETA; HEMATOPOIETIC PROGENITORS; INTERFERON-GAMMA; MYELOID CELLS; STEM-CELLS; DIFFERENTIATION; EXPRESSION; LINEAGE; TCR; COMMITMENT	Background: T cell development results in the generation of both mature alpha beta and gamma delta T cells. While alpha beta T cells predominate in secondary lymphoid organs, gamma delta T cells are more abundant in mucosal tissues. PU.1, an Ets family transcription factor, also identified as the spleen focus forming virus proviral integration site-1 (Sfpi1) is essential for early stages of T cell development, but is down regulated during the DN T-cell stage. Methodology/Principal Findings: In this study, we show that in mice specifically lacking PU.1 in T cells using an lck-Cre transgene with a conditional Sfpi1 allele (Sfpi1(lck-/-)) there are increased numbers of gamma delta T cells in spleen, thymus and in the intestine when compared to wild-type mice. The increase in gamma delta T cell numbers in PU.1-deficient mice is consistent in gamma delta T cell subsets identified by TCR variable regions. PU.1-deficient gamma delta T cells demonstrate greater proliferation in vivo and in vitro. Conclusions/Significance: The increase of gamma delta T cell numbers in Lck-Cre deleter strains, where deletion occurs after PU.1 expression is diminished, as well as the observation that PU.1-deficient gamma delta T cells have greater proliferative responses than wild type cells, suggests that PU.1 effects are not developmental but rather at the level of homeostasis. Thus, our data shows that PU.1 has a negative influence on gamma delta T cell expansion.	[Jabeen, Rukhsana; Chang, Hua-Chen; Kaplan, Mark H.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN USA; [Goswami, Ritobrata; Kaplan, Mark H.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN USA; [Nutt, Stephen L.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Walter & Eliza Hall Institute	Jabeen, R (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN USA.	mkaplan2@iupui.edu	Goswami, Ritobrata/W-9057-2019; Nutt, Stephen L/C-9256-2013	Goswami, Ritobrata/0000-0002-4388-7962; Nutt, Stephen L/0000-0002-0020-6637; Kaplan, Mark/0000-0002-2923-8245	United States Public Health Service [RO1 AI057459]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057459] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by United States Public Health Service Grant RO1 AI057459 to MHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Anderson MK, 2002, IMMUNITY, V16, P285, DOI 10.1016/S1074-7613(02)00277-7; Anderson MK, 1999, DEVELOPMENT, V126, P3131; Born WK, 2010, J IMMUNOL, V184, P4055, DOI 10.4049/jimmunol.0903679; Burtrum DB, 1996, J IMMUNOL, V157, P4293; Chang HC, 2005, IMMUNITY, V22, P693, DOI 10.1016/j.immuni.2005.03.016; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Chang HC, 2009, J IMMUNOL, V183, P4887, DOI 10.4049/jimmunol.0900363; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; FERRICK DA, 1995, NATURE, V373, P255, DOI 10.1038/373255a0; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kang J, 2001, J EXP MED, V193, P689, DOI 10.1084/jem.193.6.689; Lloberas J, 1999, IMMUNOL TODAY, V20, P184, DOI 10.1016/S0167-5699(99)01442-5; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Montufar-Solis D, 2006, J IMMUNOL METHODS, V308, P251, DOI 10.1016/j.jim.2005.10.008; Nagamura-Inoue T, 2001, Int Rev Immunol, V20, P83, DOI 10.3109/08830180109056724; Narayan K, 2007, CURR OPIN IMMUNOL, V19, P169, DOI 10.1016/j.coi.2007.01.002; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Riera-Sans L, 2007, J IMMUNOL, V178, P5690, DOI 10.4049/jimmunol.178.9.5690; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Schmidt M, 2004, BLOOD, V103, P4142, DOI 10.1182/blood-2003-01-0285; Silva-Santos B, 2005, SCIENCE, V307, P925, DOI 10.1126/science.1103978; Somervaille TCP, 2006, CANCER CELL, V10, P456, DOI 10.1016/j.ccr.2006.11.009; Steidl U, 2006, NAT GENET, V38, P1269, DOI 10.1038/ng1898; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Tschan MP, 2008, ONCOGENE, V27, P3489, DOI 10.1038/sj.onc.1211004; Ueno S, 2009, ONCOGENE, V28, P4116, DOI 10.1038/onc.2009.263; Van de Walle I, 2009, BLOOD, V113, P2988, DOI 10.1182/blood-2008-06-164871	31	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22189	10.1371/journal.pone.0022189	http://dx.doi.org/10.1371/journal.pone.0022189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779390	gold, Green Published			2022-12-25	WOS:000292811300044
J	Kwok, KO; Leung, GM; Riley, S				Kwok, Kin On; Leung, Gabriel M.; Riley, Steven			Modelling the Proportion of Influenza Infections within Households during Pandemic and Non-Pandemic Years	PLOS ONE			English	Article							A H1N1; TRANSMISSION; OUTBREAK; DISEASE	Background: The key epidemiological difference between pandemic and seasonal influenza is that the population is largely susceptible during a pandemic, whereas, during non-pandemic seasons a level of immunity exists. The population-level efficacy of household-based mitigation strategies depends on the proportion of infections that occur within households. In general, mitigation measures such as isolation and quarantine are more effective at the population level if the proportion of household transmission is low. Methods/Results: We calculated the proportion of infections within households during pandemic years compared with non-pandemic years using a deterministic model of household transmission in which all combinations of household size and individual infection states were enumerated explicitly. We found that the proportion of infections that occur within households was only partially influenced by the hazard h of infection within household relative to the hazard of infection outside the household, especially for small basic reproductive numbers. During pandemics, the number of within-household infections was lower than one might expect for a given h because many of the susceptible individuals were infected from the community and the number of susceptible individuals within household was thus depleted rapidly. In addition, we found that for the value of h at which 30% of infections occur within households during non-pandemic years, a similar 31% of infections occur within households during pandemic years. Interpretation: We suggest that a trade off between the community force of infection and the number of susceptible individuals in a household explains an apparent invariance in the proportion of infections that occur in households in our model. During a pandemic, although there are more susceptible individuals in a household, the community force of infection is very high. However, during non-pandemic years, the force of infection is much lower but there are fewer susceptible individuals within the household.	[Kwok, Kin On; Leung, Gabriel M.; Riley, Steven] Univ Hong Kong, Dept Community Med, Pokfulam, Hong Kong, Peoples R China; [Kwok, Kin On; Leung, Gabriel M.; Riley, Steven] Univ Hong Kong, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China; [Riley, Steven] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England	University of Hong Kong; University of Hong Kong; Imperial College London	Kwok, KO (corresponding author), Univ Hong Kong, Dept Community Med, Pokfulam, Hong Kong, Peoples R China.	kkokwok@gmail.com	Kwok, Kin On/A-5074-2018	Kwok, Kin On/0000-0002-2804-5433; Riley, Steven/0000-0001-7904-4804; Leung, Gabriel/0000-0002-2503-6283	University of Hong Kong; MRC [G0600719] Funding Source: UKRI; Medical Research Council [G0600719B, G0600719] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10252] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [R01TW008246] Funding Source: NIH RePORTER	University of Hong Kong(University of Hong Kong); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research is part of the PhD studies of Kin On Kwok, whose studentship was financed by the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Bailey N. T. J., MATH THEORY INFECT D; Ball F, 2002, MATH BIOSCI, V180, P73, DOI 10.1016/S0025-5564(02)00125-6; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Chowell G, 2007, J R SOC INTERFACE, V4, P155, DOI 10.1098/rsif.2006.0161; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferrari MJ, 2008, NATURE, V451, P679, DOI 10.1038/nature06509; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; FRASER C, 2009, SCIENCE; Fraser C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000758; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; House T, 2008, MATH BIOSCI, V213, P29, DOI 10.1016/j.mbs.2008.01.011; Ironmonger, 1999, J POPULATION RES, V16, P65, DOI DOI 10.1007/BF03029455; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Lipsitch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006895; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Olson DR, 2005, P NATL ACAD SCI USA, V102, P11059, DOI 10.1073/pnas.0408290102; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Press WH., 2002, NUMERICAL RECIPES C, V2; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001; TRUSCOTT J, 2009, PLOS CURR INFLUENZA; Viboud C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000259; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; WHITE LF, 2009, INFLUENZA OTHER RESP, P1; Wu JT, 2006, PLOS MED, V3, P1532, DOI 10.1371/journal.pmed.0030361	30	8	8	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22089	10.1371/journal.pone.0022089	http://dx.doi.org/10.1371/journal.pone.0022089			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779380	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811300039
J	Farzan, SF; Palermo, LM; Yokoyama, CC; Orefice, G; Fornabaio, M; Sarkar, A; Kellogg, GE; Greengard, O; Porotto, M; Moscona, A				Farzan, Shohreh F.; Palermo, Laura M.; Yokoyama, Christine C.; Orefice, Gianmarco; Fornabaio, Micaela; Sarkar, Aurijit; Kellogg, Glen E.; Greengard, Olga; Porotto, Matteo; Moscona, Anne			Premature Activation of the Paramyxovirus Fusion Protein before Target Cell Attachment with Corruption of the Viral Fusion Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PARAINFLUENZA VIRUS; HEMAGGLUTININ-NEURAMINIDASE PROTEIN; HN-RECEPTOR INTERACTION; MEMBRANE-FUSION; BINDING-SITE; INFLUENZA HEMAGGLUTININ; CONFORMATIONAL-CHANGE; 4-GU-DANA ZANAMIVIR; RESPIRATORY-DISEASE; AIRWAY EPITHELIUM	Paramyxoviruses, including the childhood pathogen human parainfluenza virus type 3, enter host cells by fusion of the viral and target cell membranes. This fusion results from the concerted action of its two envelope glycoproteins, the hemagglutinin-neuraminidase (HN) and the fusion protein (F). The receptor-bound HN triggers F to undergo conformational changes that render it competent to mediate fusion of the viral and cellular membranes. We proposed that, if the fusion process could be activated prematurely before the virion reaches the target host cell, infection could be prevented. We identified a small molecule that inhibits paramyxovirus entry into target cells and prevents infection. We show here that this compound works by an interaction with HN that results in F-activation prior to receptor binding. The fusion process is thereby prematurely activated, preventing fusion of the viral membrane with target cells and precluding viral entry. This first evidence that activation of a paramyxovirus F can be specifically induced before the virus contacts its target cell suggests a new strategy with broad implications for the design of antiviral agents.	[Farzan, Shohreh F.; Palermo, Laura M.; Yokoyama, Christine C.; Orefice, Gianmarco; Greengard, Olga; Porotto, Matteo; Moscona, Anne] Cornell Univ, Dept Pediat, Weill Med Coll, New York, NY 10021 USA; [Farzan, Shohreh F.; Palermo, Laura M.; Yokoyama, Christine C.; Orefice, Gianmarco; Greengard, Olga; Porotto, Matteo; Moscona, Anne] Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA; [Fornabaio, Micaela; Sarkar, Aurijit; Kellogg, Glen E.] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23298 USA; [Fornabaio, Micaela; Sarkar, Aurijit; Kellogg, Glen E.] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23298 USA; [Greengard, Olga] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA	Cornell University; Cornell University; Virginia Commonwealth University; Virginia Commonwealth University; Icahn School of Medicine at Mount Sinai	Moscona, A (corresponding author), Cornell Univ, Dept Pediat, Weill Med Coll, 515 E 71st St,Box 309, New York, NY 10021 USA.	anm2047@med.cornell.edu	Sarkar, Aurijit/AAW-3417-2020; Sarkar, Aurijit/I-5175-2012	Sarkar, Aurijit/0000-0003-3735-6345; Kellogg, Glen/0000-0002-6282-6794; POROTTO, Matteo/0000-0003-3866-9220	National Institutes of Health [U54AI057158, R01AI31971, 3R01AI031971-19S1, R21EBO11707, R01GM017894]; Parker B. Francis Fellowship in Pulmonary Research; Bill and Melinda Gates Grand Challenges Exploration grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R01AI031971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB011707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Fellowship in Pulmonary Research; Bill and Melinda Gates Grand Challenges Exploration grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants U54AI057158 (to M. P. and A. M., from the Northeast Center of Excellence for Bio-defense and Emerging Infectious Disease Research R01AI31971 (to A. M.), 3R01AI031971-19S1 (Research Supplement to Promote Diversity in Health-related Research Program, to A. M.), R21EBO11707 (to M. P.), and R01GM017894 (to G. E. K.). This work was also supported by a Parker B. Francis Fellowship in Pulmonary Research (to L. M. P.) and by a Bill and Melinda Gates Grand Challenges Exploration grant (to A. M.).	Calvo C., 2011, PEDIAT INFECT DIS J; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Collins P. L., 1996, FIELDS VIROLOGY, P1205; Connolly SA, 2009, J VIROL, V83, P10857, DOI 10.1128/JVI.01191-09; Cozzini P, 2002, J MED CHEM, V45, P2469, DOI 10.1021/jm0200299; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; Cunha BA, 2011, HEART LUNG, V40, P76, DOI 10.1016/j.hrtlng.2010.05.060; Damico R, 2000, J VIROL, V74, P6469, DOI 10.1128/JVI.74.14.6469-6475.2000; Damico R, 1999, J VIROL, V73, P3087, DOI 10.1128/JVI.73.4.3087-3094.1999; Deng R, 1997, ARCH VIROL, P115; DENG RT, 1995, VIROLOGY, V209, P457, DOI 10.1006/viro.1995.1278; Greengard O, 2000, J VIROL, V74, P11108, DOI 10.1128/JVI.74.23.11108-11114.2000; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Hodson A., 2011, BONE MARROW TRANSPLA; Hoffman LR, 1997, J VIROL, V71, P8808, DOI 10.1128/JVI.71.11.8808-8820.1997; HOMMA M, 1973, J VIROL, V12, P1457, DOI 10.1128/JVI.12.6.1457-1465.1973; HURST T, 1994, J CHEM INF COMP SCI, V34, P190, DOI 10.1021/ci00017a025; Irwin JJ, 2005, BIOCHEMISTRY-US, V44, P12316, DOI 10.1021/bi050801k; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kellogg GE, 2000, EUR J MED CHEM, V35, P651, DOI 10.1016/S0223-5234(00)00167-7; LAMB RA, 1993, VIROLOGY, V197, P1, DOI 10.1006/viro.1993.1561; Lawrence MC, 2004, J MOL BIOL, V335, P1343, DOI 10.1016/j.jmb.2003.11.032; Lee A. V., 2011, TRANSPL INFECT DIS; Madhi SA, 2006, VACCINE, V24, P2432, DOI 10.1016/j.vaccine.2005.12.002; Marcolini JA, 2003, EUR J CLIN MICROBIOL, V22, P79, DOI 10.1007/s10096-002-0864-4; Mirza AM, 2011, J BIOL CHEM, V286, P17851, DOI 10.1074/jbc.M111.233965; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P1171, DOI 10.1093/nar/24.6.1171; Moscona A, 2005, J CLIN INVEST, V115, P1688, DOI 10.1172/JCI25669; MOSCONA A, 1992, J VIROL, V66, P6280, DOI 10.1128/JVI.66.11.6280-6287.1992; Moscona A, 2010, J INFECT DIS, V202, P234, DOI 10.1086/653621; Murrell M, 2003, J VIROL, V77, P309, DOI 10.1128/JVI.77.1.309-317.2003; Neurath AR, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-6; OBRIG TG, 1971, J BIOL CHEM, V246, P174; Palermo LM, 2007, J VIROL, V81, P9152, DOI 10.1128/JVI.00888-07; Palermo LM, 2009, J VIROL, V83, P6900, DOI 10.1128/JVI.00475-09; Perlman SL, 1999, VIROLOGY, V265, P57, DOI 10.1006/viro.1999.0024; Plemper RK, 2003, BIOCHEMISTRY-US, V42, P6645, DOI 10.1021/bi034385k; Porotto M, 2007, J VIROL, V81, P10567, DOI 10.1128/JVI.01181-07; Porotto M, 2006, J VIROL, V80, P9837, DOI 10.1128/JVI.00736-06; Porotto M, 2006, J VIROL, V80, P1204, DOI 10.1128/JVI.80.3.1204-1213.2006; Porotto M, 2005, J VIROL, V79, P2383, DOI 10.1128/JVI.79.4.2383-2392.2005; Porotto M, 2004, J VIROL, V78, P13911, DOI 10.1128/JVI.78.24.13911-13919.2004; Porotto M, 2003, J VIROL, V77, P3647, DOI 10.1128/JVI.77.6.3647-3654.2003; Porotto M, 2001, J VIROL, V75, P7481, DOI 10.1128/JVI.75.16.7481-7488.2001; Porotto M, 2007, J VIROL, V81, P3216, DOI 10.1128/JVI.02617-06; Porotto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016874; Porotto M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001168; Porotto M, 2010, J VIROL, V84, P6760, DOI 10.1128/JVI.00135-10; Porotto M, 2009, J VIROL, V83, P6947, DOI 10.1128/JVI.00416-09; Romero-Gomez MP, 2011, J CLIN MICROBIOL, V49, P2072, DOI 10.1128/JCM.02638-10; Russell CJ, 2003, J CELL BIOL, V163, P363, DOI 10.1083/jcb.200305130; Russell CJ, 2001, EMBO J, V20, P4024, DOI 10.1093/emboj/20.15.4024; Sarkar A, 2010, CURR TOP MED CHEM, V10, P67, DOI 10.2174/156802610790232233; SCHEID A, 1974, VIROLOGY, V57, P475, DOI 10.1016/0042-6822(74)90187-1; Srinivasan A., 2011, BIOL BLOOD MARROW TR; Toupin M., 2011, BONE MARROW TRANSPLA; Wharton SA, 2000, VIROLOGY, V271, P71, DOI 10.1006/viro.2000.0280; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Yang HT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-58; Yuan P, 2005, STRUCTURE, V13, P803, DOI 10.1016/j.str.2005.02.019; Zaitsev V, 2004, J VIROL, V78, P3733, DOI 10.1128/JVI.78.7.3733-3741.2004; Zhang LQ, 2005, J VIROL, V79, P1113, DOI 10.1128/JVI.79.2.1113-1124.2005; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	65	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					37945	37954		10.1074/jbc.M111.256248	http://dx.doi.org/10.1074/jbc.M111.256248			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21799008	hybrid, Green Published			2022-12-25	WOS:000296594200007
J	Kuzhikandathil, EV; Clark, L; Li, Y				Kuzhikandathil, Eldo V.; Clark, Leslie; Li, Ying			The Extracellular cAMP-Adenosine Pathway Regulates Expression of Renal D1 Dopamine Receptors in Diabetic Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOMERULAR-FILTRATION RATE; CENTRAL-NERVOUS-SYSTEM; OBESE ZUCKER RATS; CYCLIC-AMP; GLUCAGON; RELEASE; PLASMA; CELLS; HYPERTENSION; 3',5'-MONOPHOSPHATE	Activation of D1 dopamine receptors expressed in the kidneys promotes the excretion of sodium and regulates sodium levels during increases in dietary sodium intake. A decrease in the expression or function of D1 receptors results in increased sodium retention which can potentially lead to the development of hypertension. Studies have shown that in the absence of functional D1 receptors, in null mice, the systolic, diastolic, and mean arterial pressures are higher. Previous studies have shown that the expression and function of D1 receptors in the kidneys are decreased in animal models of diabetes. The mechanisms that down-regulate the expression of renal D1 receptor gene in diabetes are not well understood. Using primary renal cells and acutely isolated kidneys from the streptozotocin-induced rat diabetic model, we demonstrate that the renal D1 receptor expression is down-regulated by the extracellular cAMP-adenosine pathway in vitro and in vivo. In cultures of primary renal cells, a 3 mM, 60-h cAMP treatment down-regulated the expression of D1 receptors. In vivo, we determined that the plasma and urine cAMP levels as well as the expression of 5'-ectonucleotidase, tissue-nonspecific alkaline phosphatase, and adenosine A2a receptors are significantly increased in diabetic rats. Inhibitors of 5'-ectonucleotidase and tissue-nonspecific alkaline phosphatase, alpha,beta-methyleneadenosine 5'-diphosphate, and levamisole, respectively, blocked the down-regulation of D1 receptors in the primary renal cells and in the kidney of diabetic animals. The results suggest that inhibitors of the extracellular cAMP-adenosine pathway reverse the down-regulation of renal D1 receptor in diabetes.	[Kuzhikandathil, Eldo V.; Clark, Leslie; Li, Ying] Univ Med & Dent New Jersey, Dept Physiol & Pharmacol, New Jersey Med Sch, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Kuzhikandathil, EV (corresponding author), MSB, 185 S Orange Ave,I-647, Newark, NJ 07103 USA.	kuzhikev@umdnj.edu			American Heart Association Heritage Affiliate [0755940T]	American Heart Association Heritage Affiliate(American Heart Association)	The work was supported by Grant-in-aid 0755940T from the American Heart Association Heritage Affiliate (to E. V. K.).	Albrecht FE, 1996, J CLIN INVEST, V97, P2283, DOI 10.1172/JCI118670; Angielski S, 1989, Contrib Nephrol, V73, P52; Aperia AC, 2000, ANNU REV PHYSIOL, V62, P621, DOI 10.1146/annurev.physiol.62.1.621; Banday AA, 2004, AM J PHYSIOL-RENAL, V287, pF109, DOI 10.1152/ajprenal.00396.2003; BROADUS AE, 1970, J CLIN INVEST, V49, P2237, DOI 10.1172/JCI106442; Cometti B, 2003, BIOL REPROD, V69, P868, DOI 10.1095/biolreprod.103.017962; DAVOREN PR, 1963, J BIOL CHEM, V238, P3009; Do T, 2007, J NEUROCHEM, V101, P619, DOI 10.1111/j.1471-4159.2006.04388.x; Dubey RK, 2000, HYPERTENSION, V36, P337, DOI 10.1161/01.HYP.36.3.337; EXTON JH, 1971, J BIOL CHEM, V246, P6166; HENDY GN, 1977, EUR J CLIN INVEST, V7, P155, DOI 10.1111/j.1365-2362.1977.tb01591.x; Hoshi K, 1997, HISTOCHEM CELL BIOL, V107, P183, DOI 10.1007/s004180050103; Hussain T, 1999, HYPERTENSION, V34, P1091, DOI 10.1161/01.HYP.34.5.1091; Hussain T, 2003, EXP BIOL MED, V228, P134, DOI 10.1177/153537020322800202; Iannello S, 1998, MOL GENET METAB, V63, P214, DOI 10.1006/mgme.1997.2670; Jackson EK, 2006, J PHARMACOL EXP THER, V317, P1219, DOI 10.1124/jpet.106.101360; Jackson EK, 2001, AM J PHYSIOL-RENAL, V281, pF597, DOI 10.1152/ajprenal.2001.281.4.F597; Jackson EK, 2003, J PHARMACOL EXP THER, V307, P888, DOI 10.1124/jpet.103.057166; Jackson EK, 2004, ANNU REV PHYSIOL, V66, P571, DOI 10.1146/annurev.physiol.66.032102.111604; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; JAMAL Z, 1987, BIOCHEM J, V245, P881, DOI 10.1042/bj2450881; KUSTER J, 1973, FEBS LETT, V32, P73, DOI 10.1016/0014-5793(73)80740-9; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; LEVY M, 1972, KIDNEY INT, V2, P76, DOI 10.1038/ki.1972.74; Lunkes GI, 2003, THROMB RES, V109, P189, DOI 10.1016/S0049-3848(03)00178-6; Lunkes GIL, 2004, DIABETES RES CLIN PR, V65, P1, DOI 10.1016/j.diabres.2003.11.016; Marwaha A, 2004, AM J PHYSIOL-RENAL, V286, pF451, DOI 10.1152/ajprenal.00227.2003; Matsuoka I, 2004, J PHARMACOL SCI, V94, P95, DOI 10.1254/jphs.94.95; MCCOY DE, 1993, SEMIN NEPHROL, V13, P31; MCDONALD RH, 1964, J CLIN INVEST, V43, P1116, DOI 10.1172/JCI104996; Mishra SK, 2006, DEVELOPMENT, V133, P675, DOI 10.1242/dev.02233; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Muruganandan S, 2005, TOXICOLOGY, V215, P57, DOI 10.1016/j.tox.2005.06.008; NOUWEN EJ, 1994, KIDNEY INT, pS43; Ohkubo S, 2000, JPN J PHARMACOL, V84, P325, DOI 10.1254/jjp.84.325; Pasuit JB, 2004, J NEUROCHEM, V89, P1508, DOI 10.1111/j.1471-4159.2004.02450.x; Pawelczyk T, 2005, AM J PATHOL, V167, P315, DOI 10.1016/S0002-9440(10)62977-X; Pawelczyk T, 2000, ARCH BIOCHEM BIOPHYS, V375, P1, DOI 10.1006/abbi.1999.1548; SABRA R, 1991, ANTIMICROB AGENTS CH, V35, P2509, DOI 10.1128/AAC.35.12.2509; Song ZL, 2005, BRAIN RES, V1047, P105, DOI 10.1016/j.brainres.2005.04.025; STONE EA, 1990, J NEUROCHEM, V55, P1942, DOI 10.1111/j.1471-4159.1990.tb05780.x; Vekaria RM, 2006, AM J PHYSIOL-RENAL, V290, pF550, DOI 10.1152/ajprenal.00151.2005; Velliquette RA, 2002, EXP BIOL MED, V227, P164, DOI 10.1177/153537020222700303; Yaar R, 2005, J CELL PHYSIOL, V202, P9, DOI 10.1002/jcp.20138; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	45	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32454	32463		10.1074/jbc.M111.268136	http://dx.doi.org/10.1074/jbc.M111.268136			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21803776	hybrid, Green Published			2022-12-25	WOS:000294726800055
J	de Keijzer, S; Meddens, MBM; Kilic, D; Joosten, B; Reinieren-Beeren, I; Lidke, DS; Cambi, A				de Keijzer, Sandra; Meddens, Marjolein B. M.; Kilic, Dilek; Joosten, Ben; Reinieren-Beeren, Inge; Lidke, Diane S.; Cambi, Alessandra			Interleukin-4 Alters Early Phagosome Phenotype by Modulating Class I PI3K Dependent Lipid Remodeling and Protein Recruitment	PLOS ONE			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; PLECKSTRIN HOMOLOGY DOMAIN; PHOSPHATIDYLINOSITOL 3-KINASE; ALTERNATIVE ACTIVATION; MYCOBACTERIUM-TUBERCULOSIS; SIGNALING MECHANISMS; ENDOSOME FUSION; CELL-SURFACE; BETA-GLUCAN; PH DOMAIN	Phagocytosis is a complex process that involves membranelipid remodeling and the attraction and retention of key effector proteins. Phagosome phenotype depends on the type of receptor engaged and can be influenced by extracellular signals. Interleukin 4 (IL-4) is a cytokine that induces the alternative activation of macrophages (M Phi s) upon prolonged exposure, triggering a different cell phenotype that has an altered phagocytic capacity. In contrast, the direct effects of IL-4 during phagocytosis remain unknown. Here, we investigate the impact of short-termIL-4 exposure (1 hour) during phagocytosis of IgG-opsonized yeast particles by M Phi s. By time-lapse confocal microscopy of GFP-tagged lipid-sensing probes, we show that IL-4 increases the negative charge of the phagosomal membrane by prolonging the presence of the negatively charged second messenger PI(3,4,5) P3. Biochemical assays reveal an enhanced PI3K/Akt activity upon phagocytosis in the presence of IL-4. Blocking the specific class I PI3K after the onset of phagocytosis completely abrogates the IL-4-induced changes in lipid remodeling and concomitant membrane charge. Finally, we show that IL-4 direct signaling leads to a significantly prolonged retention profile of the signaling molecules Rac1 and Rab5 to the phagosomal membrane in a PI3K-dependent manner. This protracted early phagosome phenotype suggests an altered maturation, which is supported by the delayed phagosome acidification measured in the presence of IL-4. Our findings reveal that molecular differences in IL-4 levels, in the extracellular microenvironment, influence the coordination of lipid remodeling and protein recruitment, which determine phagosome phenotype and, eventually, fate. Endosomal and phagosomal membranes provide topological constraints to signaling molecules. Therefore, changes in the phagosome phenotype modulated by extracellular factors may represent an additional mechanism that regulates the outcome of phagocytosis and could have significant impact on the net biochemical output of a cell.	[de Keijzer, Sandra; Meddens, Marjolein B. M.; Kilic, Dilek; Joosten, Ben; Reinieren-Beeren, Inge; Cambi, Alessandra] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands; [Lidke, Diane S.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Lidke, Diane S.] Univ New Mexico, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA	Radboud University Nijmegen; University of New Mexico; University of New Mexico	de Keijzer, S (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands.	a.cambi@ncmls.ru.nl	Joosten, Ben HGM/Q-5527-2016; Cambi, Alessandra/L-4242-2015	Cambi, Alessandra/0000-0003-1597-1582	International Human Frontier Science Program Organization [RGY 0072/2008]; Netherlands Organization for Scientific Research (NWO) [836.09.002]; NWO Incentive Fund Open Access [036.001.453]	International Human Frontier Science Program Organization(Human Frontier Science Program); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO Incentive Fund Open Access	This work was financed by a Young investigator grant, awarded to Dr. Cambi and Dr. Lidke, from the International Human Frontier Science Program Organization (RGY 0072/2008). Dr. Cambi is the recipient of a Meervoud grant (836.09.002) from the Netherlands Organization for Scientific Research (NWO). Dr. Cambis' publication costs were in part defrayed by a subsidy of the NWO Incentive Fund Open Access (036.001.453). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohdanowicz M, 2010, J CELL BIOL, V191, P999, DOI 10.1083/jcb.201004005; Botelho RJ, 2000, J BIOL CHEM, V275, P15717, DOI 10.1074/jbc.M910068199; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Campos MRM, 2009, MOL IMMUNOL, V46, P1204, DOI 10.1016/j.molimm.2008.11.024; Chatila TA, 2004, TRENDS MOL MED, V10, P493, DOI 10.1016/j.molmed.2004.08.004; Colombo MI, 1997, J BIOL CHEM, V272, P7707, DOI 10.1074/jbc.272.12.7707; Coppolino MG, 2002, J BIOL CHEM, V277, P43849, DOI 10.1074/jbc.M209046200; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; Downward J, 1998, SCIENCE, V279, P673, DOI 10.1126/science.279.5351.673; Ganesan LP, 2004, J BIOL CHEM, V279, P54416, DOI 10.1074/jbc.M408188200; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P1092; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P107; GIBSON TJ, 1994, TRENDS BIOCHEM SCI, V19, P349, DOI 10.1016/0968-0004(94)90108-2; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Gratchev A, 2005, SCAND J IMMUNOL, V61, P10, DOI 10.1111/j.0300-9475.2005.01524.x; Gu HH, 2003, J CELL BIOL, V161, P1151, DOI 10.1083/jcb.200212158; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Halstead JR, 2010, J CELL SCI, V123, P3535, DOI 10.1242/jcs.062679; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Johannes L, 2002, TRAFFIC, V3, P443, DOI 10.1034/j.1600-0854.2002.30701.x; Kelley VA, 2003, MOL BIOL CELL, V14, P3366, DOI 10.1091/mbc.E02-12-0780; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Lemmon MA, 1997, TRENDS CELL BIOL, V7, P237, DOI 10.1016/S0962-8924(97)01065-9; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; Ma AD, 1998, MOL CELL BIOL, V18, P4744, DOI 10.1128/MCB.18.8.4744; Mancuso P, 2001, INFECT IMMUN, V69, P2011, DOI 10.1128/IAI.69.4.2011-2016.2001; Marshall AJ, 2002, MOL CELL BIOL, V22, P5479, DOI 10.1128/MCB.22.15.5479-5491.2002; Marshall JG, 2001, J CELL BIOL, V153, P1369, DOI 10.1083/jcb.153.7.1369; Mason D, 2007, J GEN PHYSIOL, V129, P267, DOI 10.1085/jgp.200609656; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; MUKHOPADHYAY S, 2010, BLOOD; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Nelms K, 1998, ADV EXP MED BIOL, V452, P37; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Shah VB, 2009, MOL IMMUNOL, V46, P1845, DOI 10.1016/j.molimm.2009.01.014; Shaw G, 1996, BIOESSAYS, V18, P35, DOI 10.1002/bies.950180109; Steinberg BE, 2008, J CLIN INVEST, V118, P2002, DOI 10.1172/JCI35433; Strzelecka A, 1997, FEBS LETT, V400, P11, DOI 10.1016/S0014-5793(96)01359-2; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Taylor PR, 2004, J IMMUNOL, V172, P1157, DOI 10.4049/jimmunol.172.2.1157; Tjelle TE, 2000, BIOESSAYS, V22, P255, DOI 10.1002/(SICI)1521-1878(200003)22:3<255::AID-BIES7>3.0.CO;2-R; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Voelz K, 2009, INFECT IMMUN, V77, P3450, DOI 10.1128/IAI.00297-09; Wainszelbaum MJ, 2006, EXP CELL RES, V312, P2238, DOI 10.1016/j.yexcr.2006.03.025; WIRTH JJ, 1989, IMMUNOLOGY, V66, P296; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yeung T, 2006, CURR OPIN CELL BIOL, V18, P429, DOI 10.1016/j.ceb.2006.06.006; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551	64	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22328	10.1371/journal.pone.0022328	http://dx.doi.org/10.1371/journal.pone.0022328			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799824	Green Submitted, Green Published, gold			2022-12-25	WOS:000293172900022
J	Melkani, GC; Bodmer, R; Ocorr, K; Bernstein, SI				Melkani, Girish C.; Bodmer, Rolf; Ocorr, Karen; Bernstein, Sanford I.			The UNC-45 Chaperone Is Critical for Establishing Myosin-Based Myofibrillar Organization and Cardiac Contractility in the Drosophila Heart Model	PLOS ONE			English	Article							GENE-EXPRESSION; HEAVY-CHAIN; ADULT HEART; PROTEIN; MUTATIONS; MUSCLE; SKELETAL; DOMAIN; CARDIOMYOPATHY; IDENTIFICATION	UNC-45 is a UCS (UNC-45/CRO1/She4P) class chaperone necessary for myosin folding and/or accumulation, but its requirement for maintaining cardiac contractility has not been explored. Given the prevalence of myosin mutations in eliciting cardiomyopathy, chaperones like UNC-45 are likely to be equally critical in provoking or modulating myosin-associated cardiomyopathy. Here, we used the Drosophila heart model to examine its role in cardiac physiology, in conjunction with RNAi-mediated gene silencing specifically in the heart in vivo. Analysis of cardiac physiology was carried out using high-speed video recording in conjunction with movement analysis algorithms. unc-45 knockdown resulted in severely compromised cardiac function in adults as evidenced by prolonged diastolic and systolic intervals, and increased incidence of arrhythmias and extreme dilation; the latter was accompanied by a significant reduction in muscle contractility. Structural analysis showed reduced myofibrils, myofibrillar disarray, and greatly decreased cardiac myosin accumulation. Cardiac unc-45 silencing also dramatically reduced life-span. In contrast, third instar larval and young pupal hearts showed mild cardiac abnormalities, as severe cardiac defects only developed during metamorphosis. Furthermore, cardiac unc-45 silencing in the adult heart (after metamorphosis) led to less severe phenotypes. This suggests that UNC-45 is mostly required for myosin accumulation/folding during remodeling of the forming adult heart. The cardiac defects, myosin deficit and decreased life-span in flies upon heart-specific unc-45 knockdown were significantly rescued by UNC-45 overexpression. Our results are the first to demonstrate a cardiac-specific requirement of a chaperone in Drosophila, suggestive of a critical role of UNC-45 in cardiomyopathies, including those associated with unfolded proteins in the failing human heart. The dilated cardiomyopathy phenotype associated with UNC-45 deficiency is mimicked by myosin knockdown suggesting that UNC-45 plays a crucial role in stabilizing myosin and possibly preventing human cardiomyopathies associated with functional deficiencies of myosin.	[Melkani, Girish C.; Bernstein, Sanford I.] San Diego State Univ, Inst Mol Biol, Dept Biol, San Diego, CA 92182 USA; [Melkani, Girish C.; Bernstein, Sanford I.] San Diego State Univ, Inst Heart, San Diego, CA 92182 USA; [Melkani, Girish C.; Bodmer, Rolf; Ocorr, Karen] Sanford Burnham Inst Med Res, Dev & Aging Program, La Jolla, CA USA	California State University System; San Diego State University; California State University System; San Diego State University; Sanford Burnham Prebys Medical Discovery Institute	Melkani, GC (corresponding author), San Diego State Univ, Inst Mol Biol, Dept Biol, San Diego, CA 92182 USA.	kocorr@sanfordburnham.org; sbernst@sciences.sdsu.edu		Bernstein, Sanford/0000-0001-7094-5390; Melkani, Girish/0000-0003-0353-4633	Muscular Dystrophy Association [3682]; National Institutes of Health (NIH) [R01AR055958]; American Heart Association [AHA0835243N]; Western States Affiliate postdoctoral fellowship; NIH (NHLBI); Ellison Medical Foundation; NIH (NIA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055958] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Western States Affiliate postdoctoral fellowship; NIH (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ellison Medical Foundation(Lawrence Ellison Foundation); NIH (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Muscular Dystrophy Association research grant 3682 and National Institutes of Health (NIH) R01AR055958 to S.I.B. and an American Heart Association grant AHA0835243N to K.O., as well as a Western States Affiliate postdoctoral fellowship to G.C.M. Support for R.B. is provided by NIH (NHLBI and NIA) and the Ellison Medical Foundation.	Alayari NN, 2009, JOVE-J VIS EXP, pe1423, DOI DOI 10.3791/1423; Amorim MJ, 2009, EMBO REP, V10, P186, DOI 10.1038/embor.2008.228; Anderson MJ, 2008, DEV BIOL, V318, P258, DOI 10.1016/j.ydbio.2008.03.022; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Bernick EP, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-70; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cammarato A, 2008, MOL BIOL CELL, V19, P553, DOI 10.1091/mbc.E07-09-0890; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Curtis NJ, 1999, J MORPHOL, V240, P225, DOI 10.1002/(SICI)1097-4687(199906)240:3<225::AID-JMOR2>3.3.CO;2-M; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; EPSTEIN HF, 1974, NATURE, V250, P579, DOI 10.1038/250579a0; EPSTEIN HF, 1992, DEV BIOL, V154, P231, DOI 10.1016/0012-1606(92)90064-N; Etard C, 2007, DEV BIOL, V308, P133, DOI 10.1016/j.ydbio.2007.05.014; Fink M, 2009, BIOTECHNIQUES, V46, P101, DOI 10.2144/000113078; Geach TJ, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-75; Han Z, 2005, DEVELOPMENT, V132, P3525, DOI 10.1242/dev.01899; Hayashi M, 2006, NAT MED, V12, P128, DOI 10.1038/nm1327; Inagaki N, 2006, BIOCHEM BIOPH RES CO, V342, P379, DOI 10.1016/j.bbrc.2006.01.154; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Kachur TM, 2008, INT J MOL SCI, V9, P1863, DOI 10.3390/ijms9091863; Kachur TM, 2008, DEV BIOL, V314, P287, DOI 10.1016/j.ydbio.2007.11.028; Knowlton AA, 1998, J MOL CELL CARDIOL, V30, P811, DOI 10.1006/jmcc.1998.0646; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landsverk ML, 2007, J CELL BIOL, V177, P205, DOI 10.1083/jcb.200607084; Lee CF, 2011, STRUCTURE, V19, P397, DOI 10.1016/j.str.2011.01.002; Lee CF, 2011, J CELL SCI, V124, P699, DOI 10.1242/jcs.078964; Lo PCH, 2001, MECH DEVELOP, V104, P49, DOI 10.1016/S0925-4773(01)00361-6; Lord M, 2004, J CELL BIOL, V167, P315, DOI 10.1083/jcb.200404045; Lowes BD, 1997, J CLIN INVEST, V100, P2315, DOI 10.1172/JCI119770; MCGUIRE SE, 2004, SCI STKE, P16; Melkani GC, 2010, BIOCHEM BIOPH RES CO, V396, P317, DOI 10.1016/j.bbrc.2010.04.090; MOGAMI K, 1986, P NATL ACAD SCI USA, V83, P1393, DOI 10.1073/pnas.83.5.1393; Molina MR, 2001, MECH DEVELOP, V109, P51, DOI 10.1016/S0925-4773(01)00509-3; Monier B, 2005, DEVELOPMENT, V132, P5283, DOI 10.1242/dev.02091; Morita H, 2010, J CARDIOVASC TRANSL, V3, P297, DOI 10.1007/s12265-010-9188-4; Neely GG, 2010, CELL, V141, P142, DOI 10.1016/j.cell.2010.02.023; OCORR K, 2009, J VIS EXP, V10; Ocorr K, 2007, TRENDS CARDIOVAS MED, V17, P177, DOI 10.1016/j.tcm.2007.04.001; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Oldfors A, 2007, NEUROMUSCULAR DISORD, V17, P355, DOI 10.1016/j.nmd.2007.02.008; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Shi H, 2010, P NATL ACAD SCI USA, V107, P21382, DOI 10.1073/pnas.1013038107; Srikakulam R, 1999, J BIOL CHEM, V274, P27265, DOI 10.1074/jbc.274.38.27265; Srikakulam R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002137; STANLEY BA, 2005, CIRC RES, V97, P10; Tsoutsman T, 2008, CLIN EXP PHARMACOL P, V35, P1349, DOI 10.1111/j.1440-1681.2008.05037.x; WIEGAND V, 1989, CLIN CARDIOL, V12, P656, DOI 10.1002/clc.4960121108; Willis MS, 2010, CIRCULATION, V122, P1740, DOI 10.1161/CIRCULATIONAHA.110.942250; Willis MS, 2009, CARDIOVASC RES, V81, P439, DOI 10.1093/cvr/cvn289; Wohlgemuth SL, 2007, DEV BIOL, V303, P483, DOI 10.1016/j.ydbio.2006.11.027; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103; Wong KCY, 2000, J CELL SCI, V113, P2421; Yu Q, 2003, CURR BIOL, V13, pR525, DOI 10.1016/S0960-9822(03)00447-0; Zeitouni B, 2007, PLOS GENET, V3, P1907, DOI 10.1371/journal.pgen.0030174	57	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22579	10.1371/journal.pone.0022579	http://dx.doi.org/10.1371/journal.pone.0022579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799905	gold, Green Published, Green Submitted			2022-12-25	WOS:000293172900051
J	Narayanan, NN; Ihemere, U; Ellery, C; Sayre, RT				Narayanan, Narayanan N.; Ihemere, Uzoma; Ellery, Claire; Sayre, Richard T.			Overexpression of Hydroxynitrile Lyase in Cassava Roots Elevates Protein and Free Amino Acids while Reducing Residual Cyanogen Levels	PLOS ONE			English	Article							GENE-EXPRESSION; LINAMARASE; CYANIDE; BIOSYNTHESIS; LOCALIZATION; PURIFICATION; GLUCOSIDES; TRANSPORT; SYNTHASE; TUBERS	Cassava is the major source of calories for more than 250 million Sub-Saharan Africans, however, it has the lowest protein-to-energy ratio of any major staple food crop in the world. A cassava-based diet provides less than 30% of the minimum daily requirement for protein. Moreover, both leaves and roots contain potentially toxic levels of cyanogenic glucosides. The major cyanogen in cassava is linamarin which is stored in the vacuole. Upon tissue disruption linamarin is deglycosylated by the apolplastic enzyme, linamarase, producing acetone cyanohydrin. Acetone cyanohydrin can spontaneously decompose at pHs > 5.0 or temperatures > 35 degrees C, or is enzymatically broken down by hydroxynitrile lyase (HNL) to produce acetone and free cyanide which is then volatilized. Unlike leaves, cassava roots have little HNL activity. The lack of HNL activity in roots is associated with the accumulation of potentially toxic levels of acetone cyanohydrin in poorly processed roots. We hypothesized that the over-expression of HNL in cassava roots under the control of a root-specific, patatin promoter would not only accelerate cyanogenesis during food processing, resulting in a safer food product, but lead to increased root protein levels since HNL is sequestered in the cell wall. Transgenic lines expressing a patatin-driven HNL gene construct exhibited a 2-20 fold increase in relative HNL mRNA levels in roots when compared with wild type resulting in a threefold increase in total root protein in 7 month old plants. After food processing, HNL overexpressing lines had substantially reduced acetone cyanohydrin and cyanide levels in roots relative to wild-type roots. Furthermore, steady state linamarin levels in intact tissues were reduced by 80% in transgenic cassava roots. These results suggest that enhanced linamarin metabolism contributed to the elevated root protein levels.	[Narayanan, Narayanan N.; Ihemere, Uzoma; Ellery, Claire; Sayre, Richard T.] Donald Danforth Plant Sci Ctr, St Louis, MO USA	Donald Danforth Plant Science Center	Narayanan, NN (corresponding author), Donald Danforth Plant Sci Ctr, St Louis, MO USA.	rsayre@danforthcenter.org		Sayre, Richard/0000-0002-3153-7084; Narayanan, Narayanan/0000-0002-9503-2288	Bill and Melinda Gates Foundation; Rockefeller Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Rockefeller Foundation	Funding for this work was provided by the Bill and Melinda Gates Foundation and Rockefeller Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhary M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016256; BLUMENTHAL S G, 1968, Journal of Biological Chemistry, V243, P5302; Cock JH, 1985, CASSAVA NEW POTENTIA, P191; Conn E. E., 1994, Acta Horticulturae, P31; Conn E. E., 1979, Herbivores: their interaction with secondary plant metabolites, P387; Diretto G, 2010, PLANT PHYSIOL, V154, P899, DOI 10.1104/pp.110.159368; Elias M, 1997, PHYTOCHEMISTRY, V46, P469, DOI 10.1016/S0031-9422(97)00305-1; Elias M, 1997, PLANT SCI, V126, P155, DOI 10.1016/S0168-9452(97)00100-3; Hacham Y, 2002, PLANT PHYSIOL, V128, P454, DOI 10.1104/pp.010819; Hickel A, 1996, PHYSIOL PLANTARUM, V98, P891, DOI 10.1111/j.1399-3054.1996.tb06700.x; Jenrich R, 2007, P NATL ACAD SCI USA, V104, P18848, DOI 10.1073/pnas.0709315104; Jorgensen K, 2005, PLANT PHYSIOL, V139, P363, DOI 10.1104/pp.105.065904; KAKES P, 1985, PLANTA, V166, P156, DOI 10.1007/BF00397342; LEA PJ, 1992, PR PHYT SOC, V33, P153; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCMAHON JM, 1995, J EXP BOT, V46, P731, DOI 10.1093/jxb/46.7.731; MKPONG OE, 1990, PLANT PHYSIOL, V93, P176, DOI 10.1104/pp.93.1.176; Morandini P, 2010, NEW BIOTECHNOL, V27, P482, DOI 10.1016/j.nbt.2010.06.011; NAHRSTEDT A, 1985, PLANT SYST EVOL, V150, P35, DOI 10.1007/BF00985566; NARTEY F, 1969, PHYSIOL PLANTARUM, V22, P1085, DOI 10.1111/j.1399-3054.1969.tb07470.x; Nweke F. I., 1994, 12 COSCA INT I TROP; Osuntokun B O, 1981, World Rev Nutr Diet, V36, P141; PANCORO A, 1992, PLANT J, V2, P821, DOI 10.1111/j.1365-313X.1992.tb00152.x; Santana MA, 2002, PLANT PHYSIOL, V129, P1686, DOI 10.1104/pp.000927; Sayre R, 2011, ANNU REV PLANT BIOL, V62, P251, DOI 10.1146/annurev-arplant-042110-103751; SELMAR D, 1988, PLANT PHYSIOL, V86, P711, DOI 10.1104/pp.86.3.711; Selmar D., 1994, Acta Horticulturae, P61; Siritunga D, 2004, PLANT MOL BIOL, V56, P661, DOI 10.1007/s11103-004-3415-9; Siritunga D, 2004, PLANT BIOTECHNOL J, V2, P37, DOI 10.1046/j.1467-7652.2003.00047.x; Siritunga D, 2003, PLANTA, V217, P367, DOI 10.1007/s00425-003-1005-8; Siritunga D, 2007, J AOAC INT, V90, P1450; Stone GD, 2002, CURR ANTHROPOL, V43, P611, DOI 10.1086/341532; Stupak M, 2006, TRENDS FOOD SCI TECH, V17, P634, DOI 10.1016/j.tifs.2006.06.004; Taylor N, 2004, PLANT MOL BIOL, V56, P671, DOI 10.1007/s11103-004-4872-x; TYLLESKAR T, 1992, LANCET, V339, P208, DOI 10.1016/0140-6736(92)90006-O; WAJANT H, 1994, PLANT MOL BIOL, V26, P735, DOI 10.1007/BF00013758; Wajant H, 1996, BIOL CHEM, V377, P611; White W.L.B., 1994, INT WORKSH CASS SAF, V375, P69; White WLB, 1998, PLANT PHYSIOL, V116, P1219, DOI 10.1104/pp.116.4.1219; Yakunin AF, 1998, ANAL BIOCHEM, V258, P146, DOI 10.1006/abio.1998.2571	41	26	29	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e21996	10.1371/journal.pone.0021996	http://dx.doi.org/10.1371/journal.pone.0021996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799761	Green Submitted, Green Published, gold			2022-12-25	WOS:000293172900009
J	Wetzler, DE; Comin, MJ; Krajewski, K; Gallo, M				Wetzler, Diana E.; Comin, Maria J.; Krajewski, Krzysztof; Gallo, Mariana			New Human Papilloma Virus E2 Transcription Factor Mimics: A Tripyrrole-Peptide Conjugate with Tight and Specific DNA-Recognition	PLOS ONE			English	Article							BINDING MODES; MINOR-GROOVE; CERVICAL-CANCER; SEQUENCE; DISCRIMINATION; DISTAMYCIN; PROTEINS; HELIX; SIDE	Background: Human papillomavirus (HPV) is the main causative agent of cervical cancer, particularly high risk strains such us HPV-16, -18 and -31. The viral encoded E2 protein acts as a transcriptional modulator and exerts a key role in viral DNA replication. Thus, E2 constitutes an attractive target for developing antiviral agents. E2 is a homodimeric protein that interacts with the DNA target through an alpha-helix of each monomer. However, a peptide corresponding to the DNA recognition helix of HPV-16 E2 binds DNA with lower affinity than its full-length DNA binding domain. Therefore, in an attempt to promote the DNA binding of the isolated peptide, we have designed a conjugate compound of the E2 alpha-helix peptide and a derivative of the antibiotic distamycin, which involves simultaneous minor- and major-groove interactions. Methodology/Principal Findings: An E2 alpha-helix peptide-distamycin conjugate was designed and synthesized. It was characterized by NMR and CD spectroscopy, and its DNA binding properties were investigated by CD, DNA melting and gel shift experiments. The coupling of E2 peptide with distamycin does not affect its structural properties. The conjugate improves significantly the affinity of the peptide for specific DNA. In addition, stoichiometric amounts of specific DNA increase meaningfully the helical population of the peptide. The conjugate enhances the DNA binding constant 50-fold, maintaining its specificity. Conclusions/Significance: These results demonstrate that peptide-distamycin conjugates are a promising tool to obtain compounds that bind the E2 target DNA-sequences with remarkable affinity and suggest that a bipartite major/minor groove binding scaffold can be a useful approach for therapeutic treatment of HPV infection.	[Wetzler, Diana E.] Univ Buenos Aires, FCEN, Dept Biol Chem, Buenos Aires, DF, Argentina; [Comin, Maria J.] INTI, Ctr Res & Dev Chem, Buenos Aires, DF, Argentina; [Krajewski, Krzysztof] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Gallo, Mariana] Fdn Inst Leloir, Buenos Aires, DF, Argentina	University of Buenos Aires; Instituto Nacional de Tecnologia Industrial (INTI); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Leloir Institute	Wetzler, DE (corresponding author), Univ Buenos Aires, FCEN, Dept Biol Chem, Buenos Aires, DF, Argentina.	mgallo@leloir.org.ar		Gallo, Mariana/0000-0002-0022-4499; Wetzler, Diana Elena/0000-0003-2231-6690; Krajewski, Krzysztof/0000-0001-7159-617X	Consejo Nacional de Investigaciones Cientifico y Tecnicas (CONICET); University of Buenos Aires (UBA); Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT)	Consejo Nacional de Investigaciones Cientifico y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires (UBA)(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT)(ANPCyT)	This work was supported by Consejo Nacional de Investigaciones Cientifico y Tecnicas (CONICET), the University of Buenos Aires (UBA), and Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco JB, 2005, CHEMBIOCHEM, V6, P2173, DOI 10.1002/cbic.200500294; Blanco JB, 2005, CHEM-EUR J, V11, P4171, DOI 10.1002/chem.200500010; Chen FM, 1998, BIOCHEMISTRY-US, V37, P11143, DOI 10.1021/bi980950l; Cicero DO, 2006, BIOCHEMISTRY-US, V45, P6551, DOI 10.1021/bi060123h; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dell C, 2001, CELL MOL LIFE SCI, V58, P1923, DOI 10.1007/PL00000827; Dellarole M, 2007, BIOCHEMISTRY-US, V46, P12441, DOI 10.1021/bi701104q; Faber-Barata J, 2006, FEBS LETT, V580, P1919, DOI 10.1016/j.febslet.2006.02.047; Ferreiro DU, 2005, J BIOL CHEM, V280, P32480, DOI 10.1074/jbc.M505706200; Ferreiro DU, 2000, BIOCHEMISTRY-US, V39, P14692, DOI 10.1021/bi001694r; Hegde RS, 2002, ANNU REV BIOPH BIOM, V31, P343, DOI 10.1146/annurev.biophys.31.100901.142129; Hill JJ, 1997, METHOD ENZYMOL, V278, P390; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kim SS, 2000, J BIOL CHEM, V275, P31245, DOI 10.1074/jbc.M004541200; Koh JT, 2007, ACS CHEM BIOL, V2, P599, DOI 10.1021/cb700183s; LYU PC, 1991, P NATL ACAD SCI USA, V88, P5317, DOI 10.1073/pnas.88.12.5317; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Su JH, 2010, BIODRUGS, V24, P109, DOI 10.2165/11532810-000000000-00000; Thierry F, 2009, VIROLOGY, V384, P375, DOI 10.1016/j.virol.2008.11.014; Uytterhoeven K, 2002, EUR J BIOCHEM, V269, P2868, DOI 10.1046/j.1432-1033.2002.02952.x; Vazquez ME, 2003, CHEM SOC REV, V32, P338, DOI 10.1039/b206274g; Vazquez ME, 2001, ANGEW CHEM INT EDIT, V40, P4723, DOI 10.1002/1521-3773(20011217)40:24<4723::AID-ANIE4723>3.0.CO;2-L; Vazquez O, 2007, ANGEW CHEM INT EDIT, V46, P6886, DOI 10.1002/anie.200702345; Vazquez O, 2008, CHEMBIOCHEM, V9, P2822, DOI 10.1002/cbic.200800345; Wetzler DE, 2009, BIOPOLYMERS, V91, P432, DOI 10.1002/bip.21146	26	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22409	10.1371/journal.pone.0022409	http://dx.doi.org/10.1371/journal.pone.0022409			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799846	Green Published, Green Submitted, gold			2022-12-25	WOS:000293172900027
J	Balakirev, ES; Anisimova, M; Ayala, FJ				Balakirev, Evgeniy S.; Anisimova, Maria; Ayala, Francisco J.			Complex Interplay of Evolutionary Forces in the ladybird Homeobox Genes of Drosophila melanogaster	PLOS ONE			English	Article							RNA SECONDARY STRUCTURE; SYNONYMOUS CODON USAGE; POSITIVE SELECTION; MOLECULAR EVOLUTION; STATISTICAL TESTS; NUCLEOTIDE VARIATION; COALESCENT PROCESS; NATURAL-SELECTION; DNA VARIABILITY; EST-6 GENE	Tandemly arranged paralogous genes lbe and lbl are members of the Drosophila NK homeobox family. We analyzed population samples of Drosophila melanogaster from Africa, Europe, North and South America, and single strains of D. sechellia, D. simulans, and D. yakuba within two linked regions encompassing partial sequences of lbe and lbl. The evolution of lbe and lbl is highly constrained due to their important regulatory functions. Despite this, a variety of forces have shaped the patterns of variation in lb genes: recombination, intragenic gene conversion and natural selection strongly influence background variation created by linkage disequilibrium and dimorphic haplotype structure. The two genes exhibited similar levels of nucleotide diversity and positive selection was detected in the noncoding regions of both genes. However, synonymous variability was significantly higher for lbe: no nonsynonymous changes were observed in this gene. We argue that balancing selection impacts some synonymous sites of the lbe gene. Stability of mRNA secondary structure was significantly different between the lbe (but not lbl) haplotype groups and may represent a driving force of balancing selection in epistatically interacting synonymous sites. Balancing selection on synonymous sites may be the first, or one of a few such observations, in Drosophila. In contrast, recurrent positive selection on lbl at the protein level influenced evolution at three codon sites. Transcription factor binding-site profiles were different for lbe and lbl, suggesting that their developmental functions are not redundant. Combined with our previous results on nucleotide variation in esterase and other homeobox genes, these results suggest that interplay of balancing and directional selection may be a general feature of molecular evolution in Drosophila and other eukaryote genomes.	[Balakirev, Evgeniy S.; Ayala, Francisco J.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Balakirev, Evgeniy S.] Russian Acad Sci, AV Zhirmunsky Inst Marine Biol, Far Easter Branch, Vladivostok 690022, Russia; [Anisimova, Maria] Swiss Fed Inst Technol, Dept Comp Sci, Swiss Fed Inst Technol, Zurich, Switzerland; [Anisimova, Maria] Swiss Inst Bioinformat, Lausanne, Switzerland	University of California System; University of California Irvine; Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics	Balakirev, ES (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	balakire@uci.edu	Balakirev, Evgeniy Stanislavovich/O-1462-2017	Anisimova, Maria/0000-0001-8145-7966	University of California, Irvine; Swiss Federal Institute of Technology Zurich	University of California, Irvine(University of California System); Swiss Federal Institute of Technology Zurich(ETH Zurich)	This study was supported by Bren Professor Funds at the University of California, Irvine to F. J. Ayala and E. S. Balakirev and Swiss Federal Institute of Technology Zurich to Maria Anisimova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguade M, 1999, GENETICS, V152, P543; AKASHI H, 1994, GENETICS, V136, P927; AKASHI H, 1995, GENETICS, V139, P1067; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Anisimova M, 2009, MOL BIOL EVOL, V26, P255, DOI 10.1093/molbev/msn232; Balakirev ES, 2006, J MOL EVOL, V62, P496, DOI 10.1007/s00239-005-0140-1; Balakirev ES, 2004, GENETICA, V121, P165, DOI 10.1023/B:GENE.0000040391.27307.51; Balakirev ES, 2004, GENETICS, V166, P1845, DOI 10.1534/genetics.166.4.1845; Balakirev ES, 2003, GENETICS, V165, P1901; Balakirev ES, 2002, GENE, V288, P167, DOI 10.1016/S0378-1119(02)00477-8; Balakirev ES, 1999, GENETICS, V153, P1357; Basak S, 2010, BIOINFORMATION, V4, P352, DOI 10.6026/97320630004352; Cagliani R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-123; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Charlesworth B, 1997, GENET RES, V70, P155, DOI 10.1017/S0016672397002954; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; De Graeve F, 2004, DEV BIOL, V270, P122, DOI 10.1016/j.ydbio.2004.02.014; Dietrich S, 1998, DEVELOPMENT, V125, P2235; Down TA, 2007, PLOS COMPUT BIOL, V3, P95, DOI 10.1371/journal.pcbi.0030007; DuMont VLB, 2009, GENOME BIOL EVOL, V1, P67, DOI 10.1093/gbe/evp008; DuMont VB, 2004, GENETICS, V167, P171, DOI 10.1534/genetics.167.1.171; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Filatov DA, 2002, MOL ECOL NOTES, V2, P621, DOI 10.1046/j.1471-8286.2002.00313.x; Floris M, 2009, INT J MOL SCI, V10, P3168, DOI 10.3390/ijms10073168; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717; Haddrill PR, 2005, GENOME RES, V15, P790, DOI 10.1101/gr.3541005; Haerty W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-399; HANFSTINGL U, 1994, GENETICS, V138, P811; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Holloway AK, 2008, GENOME RES, V18, P1592, DOI 10.1101/gr.077131.108; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; HUDSON RR, 1994, GENETICS, V136, P1329; HUDSON RR, 1988, GENETICS, V120, P831; HUDSON RR, 1987, GENETICS, V116, P153; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; HUDSON RR, 1985, GENETICS, V111, P147; Huff CD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-8; JAGLA K, 1994, NUCLEIC ACIDS RES, V22, P1202, DOI 10.1093/nar/22.7.1202; Jagla K, 1997, DEVELOPMENT, V124, P91; JAGLA K, 1995, MECH DEVELOP, V53, P345, DOI 10.1016/0925-4773(95)00450-5; Jagla K, 2001, BIOESSAYS, V23, P125, DOI 10.1002/1521-1878(200102)23:2<125::AID-BIES1019>3.3.CO;2-3; Jensen JD, 2008, MOL BIOL EVOL, V25, P438, DOI 10.1093/molbev/msm273; Jovelin R, 2009, GENETICS, V181, P1385, DOI 10.1534/genetics.107.082651; Kanamoto T, 2006, GENE EXPR PATTERNS, V6, P241, DOI 10.1016/j.modgep.2005.08.004; KAPLAN NL, 1988, GENETICS, V120, P819; Kelly JK, 1997, GENETICS, V146, P1197; KIM YS, 1989, P NATL ACAD SCI USA, V86, P7716, DOI 10.1073/pnas.86.20.7716; Kimura M., 1985, J GENET, V64, P7, DOI [10.1007/BF02923549, DOI 10.1007/BF02923549]; KIRBY DA, 1995, P NATL ACAD SCI USA, V92, P9047, DOI 10.1073/pnas.92.20.9047; Klaff P, 1996, PLANT MOL BIOL, V32, P89, DOI 10.1007/BF00039379; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lachaise D, 2004, GENETICA, V120, P17, DOI 10.1023/B:GENE.0000017627.27537.ef; Lee SE, 2003, J MOL EVOL, V56, P509, DOI 10.1007/s00239-002-2421-2; LIEBHABER SA, 1984, J BIOL CHEM, V259, P5597; Ling SHM, 2009, BIOSCIENCE REP, V29, P339, DOI 10.1042/BSR20090034; Lynch VJ, 2008, EVOLUTION, V62, P2131, DOI 10.1111/j.1558-5646.2008.00440.x; Manuel M, 2000, MOL PHYLOGENET EVOL, V17, P97, DOI 10.1006/mpev.2000.0822; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McVean G, 2002, GENETICS, V160, P1231; Meireles ACA, 2009, CURR OPIN GENET DEV, V19, P565, DOI 10.1016/j.gde.2009.10.006; Moriyama EN, 1996, MOL BIOL EVOL, V13, P261, DOI 10.1093/oxfordjournals.molbev.a025563; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Neafsey DE, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-119; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2001, HEREDITY, V86, P641, DOI 10.1046/j.1365-2540.2001.00895.x; Nielsen R, 2007, MOL BIOL EVOL, V24, P228, DOI 10.1093/molbev/msl146; Olsen KM, 2002, GENETICS, V160, P1641; Papatsenko D, 2007, BIOINFORMATICS, V23, P1032, DOI 10.1093/bioinformatics/btm047; Parmley JL, 2006, MOL BIOL EVOL, V23, P301, DOI 10.1093/molbev/msj035; Parmley JL, 2007, BIOESSAYS, V29, P515, DOI 10.1002/bies.20592; Pavlidis P, 2010, GENETICS, V185, P907, DOI 10.1534/genetics.110.116459; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Pogson GH, 2001, GENETICS, V157, P317; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Purugganan MD, 2000, MOL ECOL, V9, P1451, DOI 10.1046/j.1365-294x.2000.01016.x; Resch AM, 2007, MOL BIOL EVOL, V24, P1821, DOI 10.1093/molbev/msm100; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; SEAGER RD, 1982, GENETICS, V102, P467; Singh ND, 2007, MOL BIOL EVOL, V24, P2687, DOI 10.1093/molbev/msm196; Stephan W, 2007, HEREDITY, V98, P65, DOI 10.1038/sj.hdy.6800901; STROBECK C, 1983, GENETICS, V103, P545; TAJIMA F, 1989, GENETICS, V123, P585; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vassilakos D, 2009, MOL BIOL EVOL, V26, P681, DOI 10.1093/molbev/msn296; Wall JD, 1999, GENET RES, V74, P65, DOI 10.1017/S0016672399003870; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wayne ML, 1998, TRENDS ECOL EVOL, V13, P236, DOI 10.1016/S0169-5347(98)01360-3; Wong WSW, 2004, GENETICS, V167, P949, DOI 10.1534/genetics.102.010959; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Xing Y, 2005, P NATL ACAD SCI USA, V102, P13526, DOI 10.1073/pnas.0501213102; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2008, MOL BIOL EVOL, V25, P568, DOI 10.1093/molbev/msm284; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhong M, 2010, EUR J HUM GENET, V18, P1148, DOI 10.1038/ejhg.2010.60	105	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22613	10.1371/journal.pone.0022613	http://dx.doi.org/10.1371/journal.pone.0022613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799919	Green Published, gold, Green Submitted			2022-12-25	WOS:000293097300074
J	Rajasingh, J; Thangavel, J; Siddiqui, MR; Gomes, I; Gao, XP; Kishore, R; Malik, AB				Rajasingh, Johnson; Thangavel, Jayakumar; Siddiqui, Mohammad R.; Gomes, Ignatius; Gao, Xiao-pei; Kishore, Raj; Malik, Asrar B.			Improvement of Cardiac Function in Mouse Myocardial Infarction after Transplantation of Epigenetically-Modified Bone Marrow Progenitor Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; DNA METHYLATION; HUMAN FIBROBLASTS; CARDIOMYOCYTES; NEOVASCULARIZATION; VASCULOGENESIS; ANGIOGENESIS; ACTIVATION; DERIVATION; INDUCTION	Objective: To study usefulness of bone marrow progenitor cells (BPCs) epigenetically altered by chromatin modifying agents in mediating heart repair after myocardial infarction in mice. Methods and Results: We tested the therapeutic efficacy of bone marrow progenitor cells treated with the clinically-used chromatin modifying agents Trichostatin A (TSA, histone deacetylase inhibitor) and 5Aza-2-deoxycytidine (Aza, DNA methylation inhibitor) in a mouse model of acute myocardial infarction (AMI). Treatment of BPCs with Aza and TSA induced expression of pluripotent genes Oct4, Nanog, Sox2, and thereafter culturing these cells in defined cardiac myocyte-conditioned medium resulted in their differentiation into cardiomyocyte progenitors and subsequently into cardiac myocytes. Their transition was deduced by expression of repertoire of markers: Nkx2.5, GATA4, cardiotroponin T, cardiotroponin I, alpha-sarcomeric actinin, Mef2c and MHC-alpha. We observed that the modified BPCs had greater AceH3K9 expression and reduced histone deacetylase1 (HDAC1) and lysine-specific demethylase1 (LSD1) expression compared to untreated BPCs, characteristic of epigenetic changes. Intra-myocardial injection of modified BPCs after AMI in mice significantly improved left ventricular function. These changes were ascribed to differentiation of the injected cells into cardiomyocytes and endothelial cells. Conclusion: Treatment of BPCs with Aza and TSA converts BPCs into multipotent cells, which can then be differentiated into myocyte progenitors. Transplantation of these modified progenitor cells into infarcted mouse hearts improved left ventricular function secondary to differentiation of cells in the niche into myocytes and endothelial cells.	[Rajasingh, Johnson; Thangavel, Jayakumar; Siddiqui, Mohammad R.; Gomes, Ignatius; Gao, Xiao-pei; Malik, Asrar B.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL USA; [Rajasingh, Johnson; Thangavel, Jayakumar; Siddiqui, Mohammad R.; Gomes, Ignatius; Gao, Xiao-pei; Malik, Asrar B.] Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL USA; [Kishore, Raj] Northwestern Univ, Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University	Rajasingh, J (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, Cardiovasc Res Inst, Kansas City, KS 66103 USA.	rjohnson9@kumc.edu	Rajasingh, Johnson/AAT-1985-2021	Rajasingh, Johnson/0000-0002-6172-4083; Malik, Asrar/0000-0002-8205-7128	American Heart Association - Jon Holden DeHaan Foundation [10SDG2630181]; National Institutes of Health (NIH) [R21HL97349, RO1HL90152]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090152, R21HL097349] Funding Source: NIH RePORTER	American Heart Association - Jon Holden DeHaan Foundation(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by American Heart Association Grant - Jon Holden DeHaan Foundation 10SDG2630181 and National Institutes of Health (NIH) grant R21HL97349 (to JR) and RO1HL90152 (to ABM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki H, 2007, BLOOD, V109, P3570, DOI 10.1182/blood-2006-07-035287; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beitnes JO, 2009, HEART, V95, P1983, DOI 10.1136/hrt.2009.178913; Bird A, 1999, SCIENCE, V286, P2287, DOI 10.1126/science.286.5448.2287; Bui HT, 2010, BIOL REPROD, V83, P454, DOI 10.1095/biolreprod.109.083337; Cheng XD, 2010, BIOCHEMISTRY-US, V49, P2999, DOI 10.1021/bi100213t; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Gupta R, 2010, J NUCL MED, V51, p122S, DOI 10.2967/jnumed.109.068304; Han JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012297; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Ishimaru N, 2010, BIOCHEM BIOPH RES CO, V394, P173, DOI 10.1016/j.bbrc.2010.02.139; Iwakura A, 2006, CIRCULATION, V113, P1605, DOI 10.1161/CIRCULATIONAHA.105.553925; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jujo K, 2008, J MOL CELL CARDIOL, V45, P530, DOI 10.1016/j.yjmcc.2008.08.003; Kishore R, 2005, J CLIN INVEST, V115, P1785, DOI 10.1172/JCI22849; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05; Lyko F, 2001, TRENDS GENET, V17, P169, DOI 10.1016/S0168-9525(01)02234-X; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ng HH, 2000, MOL CELL BIOL, V20, P1394, DOI 10.1128/MCB.20.4.1394-1406.2000; Perin EC, 2011, CARDIOVASC THER, V29, P211, DOI 10.1111/j.1755-5922.2010.00214.x; Rajasingh J, 2008, CIRC RES, V102, pE107, DOI 10.1161/CIRCRESAHA.108.176115; Rajasingh J, 2007, CIRC RES, V101, P910, DOI 10.1161/CIRCRESAHA.107.156786; Ruau D, 2008, STEM CELLS, V26, P920, DOI 10.1634/stemcells.2007-0649; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shoemaker R, 2010, WILEY INTERDISCIP RE, V3, P281; Si J, 2010, CANCER RES, V70, P6968, DOI 10.1158/0008-5472.CAN-09-4474; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; Urbich C, 2005, KIDNEY INT, V67, P1672, DOI 10.1111/j.1523-1755.2005.00261.x; Wu X, 2010, ZYGOTE, V8, P1; Yamashita T, 2010, CELL TRANSPLANT 1105	45	36	39	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22550	10.1371/journal.pone.0022550	http://dx.doi.org/10.1371/journal.pone.0022550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799893	gold, Green Submitted, Green Published			2022-12-25	WOS:000293097300064
J	Liang, YC; Zhang, F; Wang, JX; Joshi, T; Wang, Y; Xu, D				Liang, Yanchun; Zhang, Fan; Wang, Juexin; Joshi, Trupti; Wang, Yan; Xu, Dong			Prediction of Drought-Resistant Genes in Arabidopsis thaliana Using SVM-RFE	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; ABIOTIC-STRESS; EXPRESSION DATA; TOLERANCE; CLASSIFICATION; SELECTION; NORMALIZATION	Background: Identifying genes with essential roles in resisting environmental stress rates high in agronomic importance. Although massive DNA microarray gene expression data have been generated for plants, current computational approaches underutilize these data for studying genotype-trait relationships. Some advanced gene identification methods have been explored for human diseases, but typically these methods have not been converted into publicly available software tools and cannot be applied to plants for identifying genes with agronomic traits. Methodology: In this study, we used 22 sets of Arabidopsis thaliana gene expression data from GEO to predict the key genes involved in water tolerance. We applied an SVM-RFE (Support Vector Machine-Recursive Feature Elimination) feature selection method for the prediction. To address small sample sizes, we developed a modified approach for SVM-RFE by using bootstrapping and leave-one-out cross-validation. We also expanded our study to predict genes involved in water susceptibility. Conclusions: We analyzed the top 10 genes predicted to be involved in water tolerance. Seven of them are connected to known biological processes in drought resistance. We also analyzed the top 100 genes in terms of their biological functions. Our study shows that the SVM-RFE method is a highly promising method in analyzing plant microarray data for studying genotype-phenotype relationships. The software is freely available with source code at http://ccst.jlu.edu.cn/JCSB/RFET/.	[Liang, Yanchun; Zhang, Fan; Wang, Juexin; Wang, Yan; Xu, Dong] Jilin Univ, Coll Comp Sci & Technol, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun 130023, Peoples R China; [Joshi, Trupti; Xu, Dong] Univ Missouri, Dept Comp Sci, Digital Biol Lab, Columbia, MO USA; [Joshi, Trupti; Xu, Dong] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO USA	Jilin University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Wang, Y (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun 130023, Peoples R China.	wy6868@hotmail.com; xudong@missouri.edu	Zhang, Fan/ABD-7525-2021; Wang, Juexin/HHN-5377-2022	Zhang, Fan/0000-0002-6102-2970; Joshi, Trupti/0000-0001-8944-4924	National High-Tech R&D Program of China [2009AA02Z307]; National Natural Science Foundation of China [61073075, 60903097, 10872077]; U.S. Department of Energy [DE-FOA-0000223]; U.S. National Science Foundation [1025752]; Division Of Integrative Organismal Systems [1025752] Funding Source: National Science Foundation	National High-Tech R&D Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. Department of Energy(United States Department of Energy (DOE)); U.S. National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National High-Tech R&D Program of China (2009AA02Z307), National Natural Science Foundation of China (61073075, 60903097, and 10872077), U.S. Department of Energy (DE-FOA-0000223) and the U.S. National Science Foundation (1025752). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Ding YY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S12; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johannes M, 2010, BIOINFORMATICS, V26, P2136, DOI 10.1093/bioinformatics/btq345; Kankainen M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl694; Kathiresan A, 2006, FIELD CROP RES, V97, P101, DOI 10.1016/j.fcr.2005.08.021; Kwon YR, 2008, BIOTECHNOL LETT, V30, P1281, DOI 10.1007/s10529-008-9678-5; LeCun Y, 1990, ADV NEURAL INFORM PR, P598, DOI DOI 10.5555/109230.109298; [李建更 LI Jian-geng], 2009, [生物物理学报, Acta Biophysica Sinica], V25, P51; Lionneton E, 2004, THEOR APPL GENET, V109, P792, DOI 10.1007/s00122-004-1682-0; Liu XL, 2008, BIOTECHNOL LETT, V30, P1275, DOI 10.1007/s10529-008-9672-y; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Lu YM, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-13; Matsui A, 2010, METHODS MOL BIOL, V639, P141, DOI 10.1007/978-1-60761-702-0_8; Narusaka Y, 2004, PLANT MOL BIOL, V55, P327, DOI 10.1007/s11103-004-0685-1; Perera IY, 2008, PLANT CELL, V20, P2876, DOI 10.1105/tpc.108.061374; Ramanjulu S, 2002, PLANT CELL ENVIRON, V25, P141, DOI 10.1046/j.0016-8025.2001.00764.x; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Swindell WR, 2007, HEREDITY, V99, P143, DOI 10.1038/sj.hdy.6800975; Tsang IW, 2005, J MACH LEARN RES, V6, P363; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; Villadsen D, 2005, FUNCT PLANT BIOL, V32, P1033, DOI 10.1071/FP05102; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Wang JX, 2011, IEEE INT C BIOINFORM, P37, DOI 10.1109/BIBM.2011.45; Yousef M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-337; Zhang WX, 2005, BIOINFORMATICS, V21, P3074, DOI 10.1093/bioinformatics/bti490; Zhou X, 2007, BIOINFORMATICS, V23, P1106, DOI 10.1093/bioinformatics/btm036	31	32	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e21750	10.1371/journal.pone.0021750	http://dx.doi.org/10.1371/journal.pone.0021750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789178	gold, Green Published, Green Submitted			2022-12-25	WOS:000292811700002
J	Ghaffar, MBAB; Pritchard, J; Ford-Lloyd, B				Ghaffar, Mohamad Bahagia A. B.; Pritchard, Jeremy; Ford-Lloyd, Brian			Brown Planthopper (N. lugens Stal) Feeding Behaviour on Rice Germplasm as an Indicator of Resistance	PLOS ONE			English	Article							NILAPARVATA-LUGENS; CULTIVATED RICE; PROBING BEHAVIOR; ORYZA; DELPHACIDAE; GENES; PLANT; PENETRATION; HOMOPTERA; PHLOEM	Background: The brown planthopper (BPH) Nilaparvata lugens (Stal) is a serious pest of rice in Asia. Development of novel control strategies can be facilitated by comparison of BPH feeding behaviour on varieties exhibiting natural genetic variation, and then elucidation of the underlying mechanisms of resistance. Methodology/Principal Findings: BPH feeding behaviour was compared on 12 rice varieties over a 12 h period using the electrical penetration graph (EPG) and honeydew clocks. Seven feeding behaviours (waveforms) were identified and could be classified into two phases. The first phase involved patterns of sieve element location including non penetration (NP), pathway (N1+N2+N3), xylem (N5) [21] and two new feeding waveforms, derailed stylet mechanics (N6) and cell penetration (N7). The second feeding phase consisted of salivation into the sieve element (N4-a) and sieve element sap ingestion (N4-b). Production of honeydew drops correlated with N4-b waveform patterns providing independent confirmation of this feeding behaviour. Conclusions/Significance: Overall variation in feeding behaviour was highly correlated with previously published field resistance or susceptibility of the different rice varieties: BPH produced lower numbers of honeydew drops and had a shorter period of phloem feeding on resistant rice varieties, but there was no significant difference in the time to the first salivation (N4-b). These qualitative differences in behaviour suggest that resistance is caused by differences in sustained phloem ingestion, not by phloem location. Cluster analysis of the feeding and honeydew data split the 12 rice varieties into three groups: susceptible, moderately resistant and highly resistant. The screening methods that we have described uncover novel aspects of the resistance mechanism (or mechanisms) of rice to BPH and will in combination with molecular approaches allow identification and development of new control strategies.	[Ghaffar, Mohamad Bahagia A. B.; Pritchard, Jeremy; Ford-Lloyd, Brian] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham	Ghaffar, MBAB (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	mba738@bham.ac.uk			University of Birmingham; Malaysia Agriculture Research and Development Institute (MARDI)	University of Birmingham; Malaysia Agriculture Research and Development Institute (MARDI)	This project was funded by University of Birmingham and Malaysia Agriculture Research and Development Institute (MARDI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIAS I, 2001, PEMBENTUKAN DAN PRES, P283; ATHWAL DS, 1971, CROP SCI, V11, P747, DOI 10.2135/cropsci1971.0011183X001100050043x; Barrion Alberto T., 1994, P13; BRAR DS, 2010, BREEDING RESISTANCE, P401; CHEN YH, 2009, PLANTHOPPERS NEW THR, P315; Cohen MB, 1997, ENTOMOL EXP APPL, V85, P221, DOI 10.1023/A:1003177914842; Daniels M, 2009, J INSECT PHYSIOL, V55, P758, DOI 10.1016/j.jinsphys.2009.03.002; Elliott AC, 2011, COMPUT METH PROG BIO, V102, P75, DOI 10.1016/j.cmpb.2010.11.002; FISK J, 1980, ENTOMOL EXP APPL, V27, P211, DOI 10.1007/BF00333831; GRAYER RJ, 1994, ACTA HORTIC, V381, P391, DOI DOI 10.17660/ACTAHORTIC.1994.381.100; Hao PY, 2008, PLANT PHYSIOL, V146, P1810, DOI 10.1104/pp.107.111484; Hattori M, 2002, J INSECT BEHAV, V15, P283, DOI 10.1023/A:1015445202906; Hattori M, 2001, APPL ENTOMOL ZOOL, V36, P83, DOI 10.1303/aez.2001.83; Henry DB, 2005, J FAM PSYCHOL, V19, P121, DOI 10.1037/0893-3200.19.1.121; Hirabayashi H., 1999, BREED RES, V1, P48; Huang J., 2000, FARM PESTICIDE RICE; ISHII T, 1994, GENOME, V37, P217, DOI 10.1139/g94-030; Jairin Jirapong, 2007, ScienceAsia, V33, P347, DOI 10.2306/scienceasia1513-1874.2007.33.347; Jena KK, 2006, THEOR APPL GENET, V112, P288, DOI 10.1007/s00122-005-0127-8; Jena KK, 2003, EUPHYTICA, V129, P81, DOI 10.1023/A:1021590025240; Jena KK, 2010, BREEDING SCI, V60, P518, DOI 10.1270/jsbbs.60.518; KHAN ZR, 1988, J ECON ENTOMOL, V81, P1338, DOI 10.1093/jee/81.5.1338; Khush G. S., 1991, ADV AGRON, V45, P223, DOI 10.1016/S0065-2113(08)60042-5; Khush GS., 1985, J GENET, V64, P121, DOI [10.1007/bf02931140, DOI 10.1007/BF02931140, 10.1007/BF02931140]; KIMMINS FM, 1989, ENTOMOL EXP APPL, V50, P69, DOI 10.1007/BF00190132; LAKSHMINARAYANA A, 1977, CROP SCI, V17, P96, DOI 10.2135/cropsci1977.0011183X001700010028x; LOSEL PM, 1993, PHYSIOL ENTOMOL, V18, P67, DOI 10.1111/j.1365-3032.1993.tb00450.x; MCLEAN DL, 1964, NATURE, V202, P1358, DOI 10.1038/2021358a0; NEMOTO H, 1989, JPN J BREED, V39, P23; PARK CG, 1983, KOREAN J PLANT PROTE, V4, P262; Ren X, 2004, CEREAL RES COMMUN, V32, P31; Renganayaki K, 2002, CROP SCI, V42, P2112, DOI 10.2135/cropsci2002.2112; Rola A. C., 1993, PESTICIDES RICE PROD; Seo Bo Yoon, 2009, Journal of Asia-Pacific Entomology, V12, P89, DOI 10.1016/j.aspen.2009.02.002; Sharma N, 2003, EUPHYTICA, V129, P109; Sheth P. R., 2008, CURRENT SCI, V95, P441; SHIGEMATSU Y, 1982, AGR BIOL CHEM TOKYO, V46, P2877, DOI 10.1080/00021369.1982.10865529; SOGAWA K, 1982, ANNU REV ENTOMOL, V27, P49, DOI 10.1146/annurev.en.27.010182.000405; SPILLER NJ, 1990, ENTOMOL EXP APPL, V54, P191, DOI 10.1007/BF00343529; Stevenson PC, 1996, ENTOMOL EXP APPL, V80, P246, DOI 10.1007/BF00194767; Thompson GA, 2006, J EXP BOT, V57, P755, DOI 10.1093/jxb/erj135; Tjallingii W.F., 1988, P95; TJALLINGII WF, 1978, ENTOMOL EXP APPL, V24, P721, DOI 10.1007/BF02385128; Tjallingii WF, 2006, J EXP BOT, V57, P739, DOI 10.1093/jxb/erj088; TJALLINGII WF, 1985, ENTOMOL EXP APPL, V38, P177, DOI 10.1007/BF00361930; TJALLINGII WF, 1990, CONTINUOUS RECORDING, P89; VELUSAMY R, 1986, ENVIRON ENTOMOL, V15, P678, DOI 10.1093/ee/15.3.678; Wang HY, 2008, CROP PROT, V27, P514, DOI 10.1016/j.cropro.2007.08.004; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WILKINSON TL, 1995, J INSECT PHYSIOL, V41, P635, DOI 10.1016/0022-1910(95)00036-T; Yang HY, 2004, THEOR APPL GENET, V110, P182, DOI 10.1007/s00122-004-1844-0; YOSHIHARA T, 1979, ENTOMOL EXP APPL, V26, P314, DOI 10.1111/j.1570-7458.1979.tb02932.x; YOSHIHARA T, 1980, ENTOMOL EXP APPL, V27, P149, DOI 10.1007/BF00573889; Yoshihara T., 1979, International Rice Research Newsletter, V4, P10	54	64	70	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22137	10.1371/journal.pone.0022137	http://dx.doi.org/10.1371/journal.pone.0022137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779386	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811300042
J	Li, CX; Tao, J; Mao, DQ; He, CZ				Li, Chunxia; Tao, Jun; Mao, Daqing; He, Chaozu			A Novel Manganese Efflux System, YebN, Is Required for Virulence by Xanthomonas oryzae pv. oryzae	PLOS ONE			English	Article							ESCHERICHIA-COLI; SUPEROXIDE-DISMUTASE; HYDROGEN-PEROXIDE; GENE ENCODES; TRANSPORTER; STRESS; PATHOGENESIS; HOMEOSTASIS; EXPRESSION; PROTEINS	Manganese ions (Mn2+) play a crucial role in virulence and protection against oxidative stress in bacterial pathogens. Such pathogens appear to have evolved complex mechanisms for regulating Mn2+ uptake and efflux. Despite numerous studies on Mn2+ uptake, however, only one efflux system has been identified to date. Here, we report on a novel Mn2+ export system, YebN, in Xanthomonas oryzae pv. oryzae (Xoo), the causative agent of bacterial leaf blight. Compared with wild-type PXO99, the yebN mutant was highly sensitive to Mn2+ and accumulated high concentrations of intracellular manganese. In addition, we found that expression of yebN was positively regulated by Mn2+ and the Mn2+-dependent transcription regulator, MntR. Interestingly, the yebN mutant was more tolerant to methyl viologen and H2O2 in low Mn2+ medium than PXO99, but more sensitive in high Mn2+ medium, implying that YebN plays an important role in Mn2+ homoeostasis and detoxification of reactive oxygen species (ROS). Notably, deletion of yebN rendered Xoo sensitive to hypo-osmotic shock, suggesting that YebN may protect against such stress. That mutation of yebN substantially reduced the Xoo growth rate and lesion formation in rice implies that YebN could be involved in Xoo fitness in host. Although YebN has two DUF204 domains, it lacks homology to any known metal transporter. Hence, this is the first report of a novel metal export system that plays essential roles in hypo-osmotic and oxidative stress, and virulence. Our results lay the foundations for elucidating the complex and fascinating relationship between metal homeostasis and host-pathogen interactions.	[Li, Chunxia; Tao, Jun; He, Chaozu] Chinese Acad Sci, Inst Microbiol, State Key Lab Plant Genom, Beijing, Peoples R China; [Li, Chunxia] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Tao, Jun] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Mao, Daqing] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [He, Chaozu] Hainan Univ, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Haikou, Hainan, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Tsinghua University; Hainan University	Li, CX (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Plant Genom, Beijing, Peoples R China.	hecz@im.ac.cn		tao, jun/0000-0002-9046-0283	Ministry of Science and Technology of China [2006AA02Z180]; Chinese Academy of Sciences [KSCX2-SW-314]; Hainan University	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Hainan University	This work was supported by The High-Tech Program of the Ministry of Science and Technology of China (Grant No. 2006AA02Z180) and the Chinese Academy of Sciences (Grant KSCX2-SW-314). CH was supported by Startup Funding of Hainan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ES, 2009, INFECT IMMUN, V77, P3466, DOI 10.1128/IAI.00444-09; Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; Aparna G, 2009, PLANT CELL, V21, P1860, DOI 10.1105/tpc.109.066886; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bayer AS, 1999, INFECT IMMUN, V67, P740, DOI 10.1128/IAI.67.2.740-744.1999; BERNARDINI ML, 1990, J BACTERIOL, V172, P6274, DOI 10.1128/jb.172.11.6274-6281.1990; Cartee RT, 2000, J BIOL CHEM, V275, P3907, DOI 10.1074/jbc.275.6.3907; Deng W, 2010, CARDIOVASC RES, V88, P93, DOI 10.1093/cvr/cvq125; Dillon DA, 1996, J BIOL CHEM, V271, P30548, DOI 10.1074/jbc.271.48.30548; Ferluga S, 2007, MOL PLANT PATHOL, V8, P529, DOI [10.1111/j.1364-3703.2007.00415.x, 10.1111/J.1364-3703.2007.00415.X]; Hao ZQ, 1999, APPL ENVIRON MICROB, V65, P4746; Haskew-Layton RE, 2005, J BIOL CHEM, V280, P3548, DOI 10.1074/jbc.M409803200; Hohle TH, 2009, MOL MICROBIOL, V72, P399, DOI 10.1111/j.1365-2958.2009.06650.x; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; Jakubovics NS, 2009, MOL MICROBIOL, V72, P1, DOI 10.1111/j.1365-2958.2009.06637.x; Jakubovics NS, 2002, MICROBIOL-SGM, V148, P3255, DOI 10.1099/00221287-148-10-3255; Janulczyk R, 2003, INFECT IMMUN, V71, P2656, DOI 10.1128/IAI.71.5.2656-2664.2003; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kehres DG, 2000, MOL MICROBIOL, V36, P1085, DOI 10.1046/j.1365-2958.2000.01922.x; Kehres DG, 2003, FEMS MICROBIOL REV, V27, P263, DOI 10.1016/S0168-6445(03)00052-4; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; Kolenbrander PE, 1998, J BACTERIOL, V180, P290, DOI 10.1128/JB.180.2.290-295.1998; Kuo MMC, 2007, J BIOL CHEM, V282, P24294, DOI 10.1074/jbc.M703618200; Kuo MMC, 2003, EMBO J, V22, P4049, DOI 10.1093/emboj/cdg409; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Matsumoto TK, 2002, J BIOL CHEM, V277, P33075, DOI 10.1074/jbc.M205037200; Miller KJ, 1996, ANNU REV MICROBIOL, V50, P101, DOI 10.1146/annurev.micro.50.1.101; Mongkolsuk S, 1996, J BACTERIOL, V178, P3578, DOI 10.1128/jb.178.12.3578-3584.1996; Moore Richard A, 2008, BMC Res Notes, V1, P11, DOI 10.1186/1756-0500-1-11; Nelson N, 1999, EMBO J, V18, P4361, DOI 10.1093/emboj/18.16.4361; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; Niven DF, 1999, CAN J MICROBIOL, V45, P1027, DOI 10.1139/cjm-45-12-1027; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Ouyang ZM, 2009, P NATL ACAD SCI USA, V106, P3449, DOI 10.1073/pnas.0812999106; Pandey A, 2010, J BACTERIOL, V192, P3187, DOI 10.1128/JB.01558-09; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Park SY, 2010, CELL, V142, P737, DOI 10.1016/j.cell.2010.07.046; Qi HY, 1999, J BIOL CHEM, V274, P8993, DOI 10.1074/jbc.274.13.8993; Rosch JW, 2009, MOL MICROBIOL, V72, P12, DOI 10.1111/j.1365-2958.2009.06638.x; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schumann U, 2010, P NATL ACAD SCI USA, V107, P12664, DOI 10.1073/pnas.1001405107; Shen YW, 2002, MOL MICROBIOL, V44, P37, DOI 10.1046/j.1365-2958.2002.02862.x; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; Subramoni S, 2005, MOL PLANT MICROBE IN, V18, P644, DOI 10.1094/MPMI-18-0644; Sueyoshi N, 2002, J BACTERIOL, V184, P540, DOI 10.1128/JB.184.2.540-546.2002; Sun QH, 2003, FEMS MICROBIOL LETT, V226, P145, DOI 10.1016/S0378-1097(03)00583-4; Trischitta F, 2005, COMP BIOCHEM PHYS B, V140, P359, DOI 10.1016/j.cbpc.2004.10.011; Tseng HJ, 2001, MOL MICROBIOL, V40, P1175, DOI 10.1046/j.1365-2958.2001.02460.x; Van Dort HM, 2001, J BIOL CHEM, V276, P46968, DOI 10.1074/jbc.M107855200; Wang LF, 2008, MOL PLANT MICROBE IN, V21, P555, DOI 10.1094/MPMI-21-5-0555; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Wu HJ, 2010, J PROTEOMICS, V73, P899, DOI 10.1016/j.jprot.2009.12.001; Yang WF, 2007, CURR MICROBIOL, V54, P307, DOI 10.1007/s00284-006-0485-8	54	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e21983	10.1371/journal.pone.0021983	http://dx.doi.org/10.1371/journal.pone.0021983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21789199	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811300032
J	Vilasi, S; Sarcina, R; Maritato, R; De Simone, A; Irace, G; Sirangelo, I				Vilasi, Silvia; Sarcina, Rosalba; Maritato, Rosa; De Simone, Antonella; Irace, Gaetano; Sirangelo, Ivana			Heparin Induces Harmless Fibril Formation in Amyloidogenic W7FW14F Apomyoglobin and Amyloid Aggregation in Wild-Type Protein In Vitro	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; PRION PROTEIN; MISFOLDING DISEASES; NEURODEGENERATIVE DISEASE; SULFATE PROTEOGLYCANS; AFFINITY BINDING; COMMON MECHANISM; THIOFLAVINE-T; BETA; GLYCOSAMINOGLYCANS	Glycosaminoglycans (GAGs) are frequently associated with amyloid deposits in most amyloid diseases, and there is evidence to support their active role in amyloid fibril formation. The purpose of this study was to obtain structural insight into GAG-protein interactions and to better elucidate the molecular mechanism underlying the effect of GAGs on the amyloid aggregation process and on the related cytotoxicity. To this aim, using Fourier transform infrared and circular diochroism spectroscopy, electron microscopy and thioflavin fluorescence dye we examined the effect of heparin and other GAGs on the fibrillogenesis and cytotoxicity of aggregates formed by the amyloidogenic W7FW14 apomyoglobin mutant. Although this protein is unrelated to human disease, it is a suitable model for in vitro studies because it forms amyloid-like fibrils under physiological conditions of pH and temperature. Heparin strongly stimulated aggregation into amyloid fibrils, thereby abolishing the lag-phase normally detected following the kinetics of the process, and increasing the yield of fibrils. Moreover, the protein aggregates were harmless when assayed for cytotoxicity in vitro. Neutral or positive compounds did not affect the aggregation rate, and the early aggregates were highly cytotoxic. The surprising result that heparin induced amyloid fibril formation in wild-type apomyoglobin and in the partially folded intermediate state of the mutant, i.e., proteins that normally do not show any tendency to aggregate, suggested that the interaction of heparin with apomyoglobin is highly specific because of the presence, in protein turn regions, of consensus sequences consisting of alternating basic and non-basic residues that are capable of binding heparin molecules. Our data suggest that GAGs play a dual role in amyloidosis, namely, they promote beneficial fibril formation, but they also function as pathological chaperones by inducing amyloid aggregation.	[Vilasi, Silvia; Sarcina, Rosalba; Maritato, Rosa; Irace, Gaetano; Sirangelo, Ivana] Univ Naples 2, Dipartimento Biochim & Biofis, Naples, Italy; [Vilasi, Silvia; Sarcina, Rosalba; Maritato, Rosa; Irace, Gaetano; Sirangelo, Ivana] Ist Nazl Biostrutture & Biosistemi, Rome, Italy; [De Simone, Antonella] Univ Naples 2, Dipartimento Med Pubbl Clin & Prevent, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Vilasi, S (corresponding author), Univ Naples 2, Dipartimento Biochim & Biofis, Naples, Italy.	ivana.sirangelo@unina2.it		VILASI, SILVIA/0000-0002-9926-7199; Sirangelo, Ivana/0000-0002-6408-4990	Regione Campania [DGR 2270]	Regione Campania(Regione Campania)	This work was supported by grants from Regione Campania (DGR 2270, Dec 30, 2006). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrescu AT, 2005, PROTEIN SCI, V14, P1; Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bellotti V, 2008, CURR OPIN STRUC BIOL, V18, P771, DOI 10.1016/j.sbi.2008.10.001; BISMUTO E, 1983, BIOCHEMISTRY-US, V22, P4165, DOI 10.1021/bi00287a001; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Bodner RA, 2006, CELL CYCLE, V5, P1477, DOI 10.4161/cc.5.14.2929; Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437; Bourgault S, 2011, BIOCHEMISTRY-US, V50, P1001, DOI 10.1021/bi101822y; BRUNDEN KR, 1993, J NEUROCHEM, V61, P2147, DOI 10.1111/j.1471-4159.1993.tb07453.x; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CARDIN AD, 1998, ADV EXP MED BIOL, V243, P157; Castillo GM, 1999, J NEUROCHEM, V72, P1681, DOI 10.1046/j.1471-4159.1999.721681.x; Castillo GM, 1997, J NEUROCHEM, V69, P2452; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Cortijo-Arellano M, 2008, BIOCHEM BIOPH RES CO, V368, P238, DOI 10.1016/j.bbrc.2008.01.049; Diaz-Nido J, 2002, PEPTIDES, V23, P1323, DOI 10.1016/S0196-9781(02)00068-2; Dzwolak W, 2003, BIOCHEMISTRY-US, V42, P11347, DOI 10.1021/bi034879h; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Elimova E, 2004, FASEB J, V18, P1749, DOI 10.1096/fj.03-1436fje; Elimova E, 2009, FASEB J, V23, P3436, DOI 10.1096/fj.09-134981; Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Heegaard NHH, 2002, J BIOL CHEM, V277, P11184, DOI 10.1074/jbc.M108837200; Iannuzzi C, 2007, PROTEIN SCI, V16, P507, DOI 10.1110/ps.062471107; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kisilevsky R, 2004, AM J PATHOL, V164, P2127, DOI 10.1016/S0002-9440(10)63771-6; Kvam E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005727; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; Madine J, 2010, EUR BIOPHYS J BIOPHY, V39, P1281, DOI 10.1007/s00249-010-0581-3; Makin OS, 2002, BIOCHEM SOC T, V30, P521, DOI 10.1042/bst0300521; Malmo C, 2006, FASEB J, V20, P346, DOI 10.1096/fj.05-4652fje; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; Mok SS, 1997, FEBS LETT, V415, P303, DOI 10.1016/S0014-5793(97)01146-0; Motamedi-Shad N, 2009, J BIOCHEM, V146, P805, DOI 10.1093/jb/mvp128; Motamedi-Shad N, 2009, J BIOL CHEM, V284, P29921, DOI 10.1074/jbc.M109.018747; MULTHAUP G, 1994, BIOCHIMIE, V76, P304, DOI 10.1016/0300-9084(94)90163-5; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; NARINDRASORASAK S, 1991, J BIOL CHEM, V266, P12878; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Ohashi K, 2002, NEPHRON, V90, P158, DOI 10.1159/000049037; Park K, 2001, J BIOL CHEM, V276, P16611, DOI 10.1074/jbc.M008423200; PUETT D, 1973, J BIOL CHEM, V248, P4623; Relini A, 2008, J BIOL CHEM, V283, P4912, DOI 10.1074/jbc.M702712200; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Sirangelo I, 2004, J BIOL CHEM, V279, P13183, DOI 10.1074/jbc.M308207200; Sirangelo I, 2002, J BIOL CHEM, V277, P45887, DOI 10.1074/jbc.M207659200; SNOW AD, 1985, LAB INVEST, V53, P37; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stefani M, 2008, INT J MOL SCI, V9, P2515, DOI 10.3390/ijms9122515; Suk JY, 2006, BIOCHEMISTRY-US, V45, P2234, DOI 10.1021/bi0519295; van Horssen J, 2003, LANCET NEUROL, V2, P482, DOI 10.1016/S1474-4422(03)00484-8; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zhu M, 2002, J BIOL CHEM, V277, P50914, DOI 10.1074/jbc.M207225200	67	48	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22076	10.1371/journal.pone.0022076	http://dx.doi.org/10.1371/journal.pone.0022076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21779376	Green Published, gold, Green Submitted			2022-12-25	WOS:000292781500028
J	Karolczak-Bayatti, M; Sweeney, M; Cheng, JAN; Edey, L; Robson, SC; Ulrich, SM; Treumann, A; Taggart, MJ; Europe-Finner, GN				Karolczak-Bayatti, Magdalena; Sweeney, Michele; Cheng, Joanna; Edey, Lydia; Robson, Stephen C.; Ulrich, Scott M.; Treumann, Achim; Taggart, Michael J.; Europe-Finner, G. Nicholas			Acetylation of Heat Shock Protein 20 (Hsp20) Regulates Human Myometrial Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I HISTONE DEACETYLASE; SMOOTH-MUSCLE; KINASE-A; ACTIN DYNAMICS; EXPRESSION; COFILIN; PARTURITION; RELAXATION; PREGNANCY; SUBSTRATE	Phosphorylation of heat shock protein 20 (Hsp20) by protein kinase A (PKA) is now recognized as an important regulatory mechanism modulating contractile activity in the human myometrium. Thus agonists that stimulate cyclic AMP production may cause relaxation with resultant beneficial effects on pathologies that affect this tissue such as the onset of premature contractions prior to term. Here we describe for the first time that acetylation of Hsp20 is also a potent post-translational modification that can affect human myometrial activity. We show that histone deacetylase 8 (HDAC8) is a non-nuclear lysine deacetylase (KDAC) that can interact with Hsp20 to affect its acetylation. Importantly, use of a selective linkerless hydroxamic acid HDAC8 inhibitor increases Hsp20 acetylation with no elevation of nuclear-resident histone acetylation nor marked global gene expression changes. These effects are associated with significant inhibition of spontaneous and oxytocin-augmented contractions of ex vivo human myometrial tissue strips. A potential molecular mechanism by which Hsp20 acetylation can affect myometrial activity by liberating cofilin is described and further high-lights the use of specific effectors of KDACs as therapeutic agents in regulating contractility in this smooth muscle.	[Karolczak-Bayatti, Magdalena; Sweeney, Michele; Cheng, Joanna; Edey, Lydia; Robson, Stephen C.; Taggart, Michael J.; Europe-Finner, G. Nicholas] Newcastle Univ, Inst Cellular Med, Fac Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Ulrich, Scott M.] Ithaca Coll, Dept Chem, Ithaca, NY 14850 USA; [Treumann, Achim] NEPAF, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Karolczak-Bayatti, M (corresponding author), Newcastle Univ, Inst Cellular Med, Fac Med Sci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	magda.karolczak@ncl.ac.uk; g.n.europe-finner@ncl.ac.uk	europe-finner, Nicholas/F-2569-2010; Treumann, Achim/H-1295-2013	Taggart, Michael/0000-0002-9981-2783; Treumann, Achim/0000-0002-9417-3505	Medical Research Council, UK [G00800202]; MRC [G0800202] Funding Source: UKRI; Medical Research Council [G0800202] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Grant G00800202 from the Medical Research Council, UK.	Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; Birkenfeld J, 2003, BIOCHEM J, V369, P45, DOI 10.1042/BJ20021152; Brophy CM, 1999, J BIOL CHEM, V274, P6324, DOI 10.1074/jbc.274.10.6324; Bugg GJ, 2006, EUR J CLIN INVEST, V36, P133, DOI 10.1111/j.1365-2362.2006.01600.x; Buggy JJ, 2000, BIOCHEM J, V350, P199, DOI 10.1042/0264-6021:3500199; Chapman NR, 2004, J CLIN ENDOCR METAB, V89, P5683, DOI 10.1210/jc.2004-0873; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; Chernik IS, 2007, MOL CELL BIOCHEM, V295, P9, DOI 10.1007/s11010-006-9266-8; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dreiza CM, 2004, FASEB J, V18, P261, DOI 10.1096/fj.04-2911fje; Estiu G, 2010, BIOORGAN MED CHEM, V18, P4103, DOI 10.1016/j.bmc.2010.03.080; EUROPEFINNER GN, 1993, ENDOCRINOLOGY, V132, P2484, DOI 10.1210/en.132.6.2484; EUROPEFINNER GN, 1994, J CLIN ENDOCR METAB, V79, P1835, DOI 10.1210/jc.79.6.1835; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gupta MP, 2008, J BIOL CHEM, V283, P10135, DOI 10.1074/jbc.M710277200; Hu E, 2000, J BIOL CHEM, V275, P15254, DOI 10.1074/jbc.M908988199; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Karolczak-Bayatti M., 2009, J CELL MOL MED, V15, P94; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Komalavilas P, 2008, AM J PHYSIOL-LUNG C, V294, pL69, DOI 10.1152/ajplung.00235.2007; KrennHrubec K, 2007, BIOORG MED CHEM LETT, V17, P2874, DOI 10.1016/j.bmcl.2007.02.064; Lee H, 2004, MOL CELL BIOL, V24, P765, DOI 10.1128/MCB.24.2.765-773.2004; MacDougall MWJ, 2003, J CLIN ENDOCR METAB, V88, P2194, DOI 10.1210/jc.2002-021862; MacIntyre DA, 2008, ENDOCRINOLOGY, V149, P245, DOI 10.1210/en.2007-0662; Moynihan AT, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.01.002; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; PHANEUF S, 1993, J ENDOCRINOL, V136, P497, DOI 10.1677/joe.0.1360497; Salinthone S, 2008, PHARMACOL THERAPEUT, V119, P44, DOI 10.1016/j.pharmthera.2008.04.005; San Martin A, 2008, CIRC RES, V102, P432, DOI 10.1161/CIRCRESAHA.107.158923; Thangapandian S, 2010, EUR J MED CHEM, V45, P4409, DOI 10.1016/j.ejmech.2010.06.024; Tyson EK, 2008, ENDOCRINOLOGY, V149, P6157, DOI 10.1210/en.2008-0593; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Waltregny D, 2004, AM J PATHOL, V165, P553, DOI 10.1016/S0002-9440(10)63320-2; Yoshino Y, 2005, JPN J PHYSIOL, V55, P373, DOI 10.2170/jjphysiol.RP002605	36	47	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34346	34355		10.1074/jbc.M111.278549	http://dx.doi.org/10.1074/jbc.M111.278549			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21803775	Green Published, hybrid			2022-12-25	WOS:000295159200063
J	Fronz, K; Guttinger, S; Burkert, K; Kuhn, U; Stohr, N; Schierhorn, A; Wahle, E				Fronz, Katharina; Guettinger, Stefan; Burkert, Kerstin; Kuehn, Uwe; Stoehr, Nadine; Schierhorn, Angelika; Wahle, Elmar			Arginine Methylation of the Nuclear Poly(A) Binding Protein Weakens the Interaction with Its Nuclear Import Receptor, Transportin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; POLY(A)-BINDING PROTEIN; N-METHYLTRANSFERASE; IN-VIVO; SACCHAROMYCES-CEREVISIAE; SUBSTRATE-SPECIFICITY; EXPORT; LOCALIZATION; PRMT1; SIGNAL	The nuclear poly(A) binding protein, PABPN1, promotes mRNA polyadenylation in the cell nucleus by increasing the processivity of poly(A) polymerase and contributing to poly(A) tail length control. In its C-terminal domain, the protein carries 13 arginine residues that are all asymmetrically dimethylated. The function of this modification in PABPN1 has been unknown. Part of the methylated domain serves as nuclear localization signal, binding the import receptor transportin. Here we report that arginine methylation weakens the affinity of PABPN1 for transportin. Recombinant, unmethylated PABPN1 binds more strongly to transportin than its methylated counterpart from mammalian tissue, and in vitro methylation reduces the affinity. Transportin and RNA compete for binding to PABPN1. Methylation favors RNA binding. Transportin also inhibits in vitro methylation of the protein. Finally, a peptide corresponding to the nuclear localization signal of PABPN1 competes with transportin-dependent nuclear import of the protein in a permeabilized cell assay and does so less efficiently when it is methylated. We hypothesize that transportin binding might delay methylation of PABPN1 until after nuclear import. In the nucleus, arginine methylation may favor the transition of PABPN1 to the competing ligand RNA and serve to reduce the risk of the protein being reexported to the cytoplasm by transportin.	[Fronz, Katharina; Burkert, Kerstin; Kuehn, Uwe; Schierhorn, Angelika; Wahle, Elmar] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06099 Halle, Germany; [Guettinger, Stefan] Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland; [Stoehr, Nadine] Univ Halle Wittenberg, Sect Mol Cell Biol, Dept Med, D-06097 Halle, Germany	Martin Luther University Halle Wittenberg; Swiss Federal Institutes of Technology Domain; ETH Zurich; Martin Luther University Halle Wittenberg	Wahle, E (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06099 Halle, Germany.	ewahle@biochemtech.uni-halle.de		Guttinger, Stephan/0000-0001-9448-973X; Wahle, Elmar/0000-0003-2504-0677	Deutsche Forschungsgemeinschaft [SFB 610]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 610 (to E. W.).	Aoki K, 2002, NUCLEIC ACIDS RES, V30, P5182, DOI 10.1093/nar/gkf638; Araya N, 2005, BIOCHEM BIOPH RES CO, V329, P653, DOI 10.1016/j.bbrc.2005.02.018; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Becskei A, 2003, P NATL ACAD SCI USA, V100, P1717, DOI 10.1073/pnas.252766999; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Belyanskaya LL, 2001, J BIOL CHEM, V276, P18681, DOI 10.1074/jbc.M011446200; Benoit B, 2005, DEV CELL, V9, P511, DOI 10.1016/j.devcel.2005.09.002; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Calado A, 2000, RNA, V6, P245, DOI 10.1017/S1355838200991908; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Cote J, 2003, MOL BIOL CELL, V14, P274, DOI 10.1091/mbc.E02-08-0484; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Fronz K, 2008, J BIOL CHEM, V283, P20408, DOI 10.1074/jbc.M802329200; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Goulet I, 2007, J BIOL CHEM, V282, P33009, DOI 10.1074/jbc.M704349200; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; Guttinger S, 2004, P NATL ACAD SCI USA, V101, P2918, DOI 10.1073/pnas.0400342101; Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Iijima M, 2006, FEBS LETT, V580, P1365, DOI 10.1016/j.febslet.2006.01.058; Imasaki T, 2007, MOL CELL, V28, P57, DOI 10.1016/j.molcel.2007.08.006; Ishidate T, 1997, FEBS LETT, V409, P237, DOI 10.1016/S0014-5793(97)00455-9; Jobert L, 2009, EXP CELL RES, V315, P1273, DOI 10.1016/j.yexcr.2008.12.008; Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347; Kolbel K, 2009, J BIOL CHEM, V284, P8274, DOI 10.1074/jbc.M809547200; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kuhn U, 2009, J BIOL CHEM, V284, P22803, DOI 10.1074/jbc.M109.018226; Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lacovides DC, 2007, J VIROL, V81, P13209, DOI 10.1128/JVI.01415-06; Lakowski TM, 2009, BIOCHEM J, V421, P253, DOI 10.1042/BJ20090268; Lange A, 2008, J BIOL CHEM, V283, P12926, DOI 10.1074/jbc.M800898200; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Li HW, 2002, J BIOL CHEM, V277, P44623, DOI 10.1074/jbc.M206187200; McBride AE, 2005, J BIOL CHEM, V280, P30888, DOI 10.1074/jbc.M505831200; McBride AE, 2007, EUKARYOT CELL, V6, P1119, DOI 10.1128/EC.00074-07; Muhlhausser P, 2001, EMBO REP, V2, P690, DOI 10.1093/embo-reports/kve168; NEMETH A, 1995, NUCLEIC ACIDS RES, V23, P4034, DOI 10.1093/nar/23.20.4034; Nichols RC, 2000, EXP CELL RES, V256, P522, DOI 10.1006/excr.2000.4827; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Ostareck-Lederer A, 2006, J BIOL CHEM, V281, P11115, DOI 10.1074/jbc.M513053200; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Passos DO, 2006, BIOCHEM BIOPH RES CO, V346, P517, DOI 10.1016/j.bbrc.2006.05.152; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Perreault A, 2007, J BIOL CHEM, V282, P7552, DOI 10.1074/jbc.M610512200; Pintucci G, 1996, MOL BIOL CELL, V7, P1249, DOI 10.1091/mbc.7.8.1249; Rappsilber J, 2003, ANAL CHEM, V75, P3107, DOI 10.1021/ac026283q; Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304; Shen EC, 1998, GENE DEV, V12, P679, DOI 10.1101/gad.12.5.679; Smith JJ, 1999, J BIOL CHEM, V274, P13229, DOI 10.1074/jbc.274.19.13229; Smith WA, 2004, J BIOL CHEM, V279, P22795, DOI 10.1074/jbc.C300512200; Souki SK, 2009, J VIROL, V83, P5309, DOI 10.1128/JVI.00238-09; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Suzuki M, 2005, FEBS J, V272, P3975, DOI 10.1111/j.1742-4658.2005.04820.x; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tavanez JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006418; Temme C, 2009, J BIOL CHEM, V284, P8337, DOI 10.1074/jbc.M808319200; Verheesen P, 2006, HUM MOL GENET, V15, P105, DOI 10.1093/hmg/ddi432; Verheesen P, 2006, BBA-PROTEINS PROTEOM, V1764, P1307, DOI 10.1016/j.bbapap.2006.05.011; WAHLE E, 1993, J BIOL CHEM, V268, P2937; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; Xu C, 2004, MOL CELL BIOL, V24, P10742, DOI 10.1128/MCB.24.24.10742-10756.2004; Yun CY, 2000, J CELL BIOL, V150, P707, DOI 10.1083/jcb.150.4.707; Zakaryan RP, 2006, J MOL BIOL, V363, P27, DOI 10.1016/j.jmb.2006.08.018	74	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32986	32994		10.1074/jbc.M111.273912	http://dx.doi.org/10.1074/jbc.M111.273912			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21808065	Green Published, hybrid			2022-12-25	WOS:000294968800016
J	Mandal, MNA; Moiseyev, GP; Elliott, MH; Kasus-Jacobi, A; Li, XM; Chen, H; Zheng, LX; Nikolaeva, O; Floyd, RA; Ma, JX; Anderson, RE				Mandal, Md Nawajes A.; Moiseyev, Gennadiy P.; Elliott, Michael H.; Kasus-Jacobi, Anne; Li, Xiaoman; Chen, Hui; Zheng, Lixin; Nikolaeva, Olga; Floyd, Robert A.; Ma, Jian-Xing; Anderson, Robert E.			alpha-Phenyl-N-tert-butylnitrone (PBN) Prevents Light-induced Degeneration of the Retina by Inhibiting RPE65 Protein Isomerohydrolase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC CELL-DEATH; SPIN-TRAPPING AGENT; VISUAL CYCLE; MACULAR DEGENERATION; RAT RETINA; IN-VIVO; CONGENITAL AMAUROSIS; LIPID-PEROXIDATION; BUTYL NITRONE; VITAMIN-A	alpha-Phenyl-N-tert-butylnitrone (PBN), a free radical spin trap, has been shown previously to protect retinas against light-induced neurodegeneration, but the mechanism of protection is not known. Here we report that PBN-mediated retinal protection probably occurs by slowing down the rate of rhodopsin regeneration by inhibiting RPE65 activity. PBN (50 mg/kg) protected albino Sprague-Dawley rat retinas when injected 0.5-12 h before exposure to damaging light at 2,700 lux intensity for 6 h but had no effect when administered after the exposure. PBN injection significantly inhibited in vivo recovery of rod photoresponses and the rate of recovery of functional rhodopsin photopigment. Assays for visual cycle enzyme activities indicated that PBN inhibited one of the key enzymes of the visual cycle, RPE65, with an IC50 = 0.1 mM. The inhibition type for RPE65 was found to be uncompetitive with K-i = 53 mu M. PBN had no effect on the activity of other visual cycle enzymes, lecithin retinol acyltransferase and retinol dehydrogenases. Interestingly, a more soluble form of PBN, N-tert-butyl-alpha-(2-sulfophenyl) nitrone, which has similar free radical trapping activity, did not protect the retina or inhibit RPE65 activity, providing some insight into the mechanism of PBN specificity and action. Slowing down the visual cycle is considered a treatment strategy for retinal diseases, such as Stargardt disease and dry age-related macular degeneration, in which toxic byproducts of the visual cycle accumulate in retinal cells. Thus, PBN inhibition of RPE65 catalytic action may provide therapeutic benefit for such retinal diseases.	[Mandal, Md Nawajes A.] Univ Oklahoma Hlth Sci Ctr, Dept Ophthalmol, Dean A McGee Eye Inst, Oklahoma City, OK 73104 USA; [Mandal, Md Nawajes A.; Moiseyev, Gennadiy P.; Elliott, Michael H.; Kasus-Jacobi, Anne; Nikolaeva, Olga; Ma, Jian-Xing] Univ Oklahoma Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA; [Floyd, Robert A.] Univ Oklahoma Hlth Sci Ctr, Dept Biochem, Oklahoma City, OK 73104 USA; [Anderson, Robert E.] Univ Oklahoma Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Moiseyev, Gennadiy P.; Nikolaeva, Olga; Ma, Jian-Xing] Univ Oklahoma Hlth Sci Ctr, Harold Hamm Oklahoma Diabet Ctr, Oklahoma City, OK 73104 USA; [Floyd, Robert A.] Oklahoma Med Res Fdn, Expt Therapeut Res Lab, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation	Mandal, MNA (corresponding author), Univ Oklahoma Hlth Sci Ctr, Dept Ophthalmol, Dean A McGee Eye Inst, 608 SL Young Blvd, Oklahoma City, OK 73104 USA.	mmandal@ouhsc.edu	KASUS-JACOBI, Anne/V-7799-2019; du, zhao jiang/F-6229-2011	KASUS-JACOBI, Anne/0000-0003-3844-0450; hui, chen/0000-0001-5276-2515	National Institutes of Health (NIH), NEI [EY 012190, EY 04149, EY 019494, EY 012231, EY 00871]; NIH, NCRR [RR 17703]; Foundation Fighting Blindness, USA; Research to Prevent Blindness, Inc., USA; University of Oklahoma College of Medicine Alumni Association	National Institutes of Health (NIH), NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Foundation Fighting Blindness, USA; Research to Prevent Blindness, Inc., USA(Research to Prevent Blindness (RPB)); University of Oklahoma College of Medicine Alumni Association	This work was supported, in whole or in part, by National Institutes of Health (NIH), NEI Grants EY 012190, EY 04149, EY 019494, EY 012231, and EY 00871 and NIH, NCRR, Grant RR 17703. This work was also supported by the Foundation Fighting Blindness, USA, Research to Prevent Blindness, Inc., USA, and the University of Oklahoma College of Medicine Alumni Association.	CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633; DELAPAZ MA, 1992, INVEST OPHTH VIS SCI, V33, P2091; Fan J, 2003, P NATL ACAD SCI USA, V100, P13662, DOI 10.1073/pnas.2234461100; Fersht A, 1985, ENZYME STRUCTURE MEC, P108; Gollapalli DR, 2004, P NATL ACAD SCI USA, V101, P10030, DOI 10.1073/pnas.0401936101; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Grimm C, 2001, INVEST OPHTH VIS SCI, V42, P497; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hafezi F, 1997, NAT MED, V3, P346, DOI 10.1038/nm0397-346; HAMBURGER SA, 1989, CIRC SHOCK, V29, P329; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kasus-Jacobi A, 2005, J BIOL CHEM, V280, P20413, DOI 10.1074/jbc.M413789200; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; Konovalova TA, 2000, FREE RADICAL BIO MED, V28, P1030, DOI 10.1016/S0891-5849(00)00192-1; Kotake Y, 1998, BBA-MOL CELL RES, V1448, P77, DOI 10.1016/S0167-4889(98)00126-8; Kubota R., 2011, RETINA IN PRESS; Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Maiti P, 2006, BIOCHEMISTRY-US, V45, P852, DOI 10.1021/bi0518545; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Mata NL, 2010, CURR OPIN OPHTHALMOL, V21, P190, DOI 10.1097/ICU.0b013e32833866c8; MIYAJIMA T, 1995, BIOCHEM BIOPH RES CO, V215, P114, DOI 10.1006/bbrc.1995.2440; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Moiseyev G, 2003, BIOCHEMISTRY-US, V42, P2229, DOI 10.1021/bi026911y; Moiseyev G, 2008, J BIOL CHEM, V283, P8110, DOI 10.1074/jbc.M703654200; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Nikolaeva O, 2009, FEBS J, V276, P3020, DOI 10.1111/j.1742-4658.2009.07021.x; Noell W K, 1966, Invest Ophthalmol, V5, P450; NOELL WK, 1971, SCIENCE, V172, P76, DOI 10.1126/science.172.3978.76; NOELL WK, 1971, SCIENCE, V172, P72, DOI 10.1126/science.172.3978.72; Novelli G P, 1986, Free Radic Res Commun, V1, P321, DOI 10.3109/10715768609080971; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; ORGANISCIAK DT, 1992, INVEST OPHTH VIS SCI, V33, P1599; ORGANISCIAK DT, 1985, INVEST OPHTH VIS SCI, V26, P1580; PHILLIS JW, 1990, NEUROSCI LETT, V116, P315, DOI 10.1016/0304-3940(90)90093-O; Poliakov E, 2011, BIOCHEMISTRY-US, V50, P6739, DOI 10.1021/bi200532m; Radu RA, 2003, P NATL ACAD SCI USA, V100, P4742, DOI 10.1073/pnas.0737855100; Ranchon I, 2003, J NEUROSCI, V23, P6050, DOI 10.1523/JNEUROSCI.23-14-06050.2003; Ranchon I, 2001, INVEST OPHTH VIS SCI, V42, P1375; Redmond TM, 2010, J BIOL CHEM, V285, P1919, DOI 10.1074/jbc.M109.027458; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Sack CA, 1996, NEUROSCI LETT, V205, P181, DOI 10.1016/0304-3940(96)12417-4; Saito K, 1998, BIOSCI BIOTECH BIOCH, V62, P792, DOI 10.1271/bbb.62.792; Sang H, 1999, ARCH BIOCHEM BIOPHYS, V363, P341, DOI 10.1006/abbi.1998.1086; SHICHI H, 1969, J BIOL CHEM, V244, P529; Sieving PA, 2001, P NATL ACAD SCI USA, V98, P1835, DOI 10.1073/pnas.041606498; Sugawara T, 1998, INVEST OPHTH VIS SCI, V39, P2458; Tabatabaie T, 1997, FEBS LETT, V407, P148, DOI 10.1016/S0014-5793(97)00327-X; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P3859, DOI 10.1167/iovs.05-0672; Tanito M, 2007, INVEST OPHTH VIS SCI, V48, P1864, DOI 10.1167/iovs.06-1065; Tanito M, 2009, J LIPID RES, V50, P807, DOI 10.1194/jlr.M800170-JLR200; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Tomita H, 2005, INVEST OPHTH VIS SCI, V46, P427, DOI 10.1167/iovs.04-0946; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wenzel A, 2001, INVEST OPHTH VIS SCI, V42, P1653; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; WIEGAND RD, 1983, INVEST OPHTH VIS SCI, V24, P1433; Williams HE, 2007, FREE RADICAL RES, V41, P1047, DOI 10.1080/10715760701557161; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Znoiko SL, 2002, INVEST OPHTH VIS SCI, V43, P1604	65	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32491	32501		10.1074/jbc.M111.255877	http://dx.doi.org/10.1074/jbc.M111.255877			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21785167	Green Published, hybrid			2022-12-25	WOS:000294726800059
J	Okunishi, K; Sisson, TH; Huang, SK; Hogaboam, CM; Simon, RH; Peters-Golden, M				Okunishi, Katsuhide; Sisson, Thomas H.; Huang, Steven K.; Hogaboam, Cory M.; Simon, Richard H.; Peters-Golden, Marc			Plasmin Overcomes Resistance to Prostaglandin E-2 in Fibrotic Lung Fibroblasts by Reorganizing Protein Kinase A Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-MEDIATED INDUCTION; SCAFFOLDING PROTEIN; PULMONARY-FIBROSIS; ACTIVATION; INHIBITION; RECEPTOR; PROLIFERATION; MACROPHAGES; MECHANISMS; EXPRESSION	Collagen deposition by fibroblasts contributes to scarring in fibrotic diseases. Activation of protein kinase A (PKA) by cAMP represents a pivotal brake on fibroblast activation, and the lipid mediator prostaglandin E-2 (PGE(2)) exerts its well known anti-fibrotic actions through cAMP signaling. However, fibrotic fibroblasts from the lungs of patients with idiopathic pulmonary fibrosis, or of mice with bleomycin-induced fibrosis, are resistant to the normal collagen-inhibiting action of PGE(2). In this study, we demonstrate that plasminogen activation to plasmin restores PGE(2) sensitivity in fibrotic lung fibroblasts from human and mouse. This involves amplified PKA signaling resulting from the promotion of new interactions between AKAP9 and PKA regulatory subunit II in the perinuclear region as well as from the inhibition of protein phosphatase 2A. This is the first report to show that an extracellular mediator can dramatically reorganize and amplify the intracellular PKA-A-kinase anchoring protein signaling network and suggests a new strategy to control collagen deposition by fibrotic fibroblasts.	[Okunishi, Katsuhide; Sisson, Thomas H.; Huang, Steven K.; Simon, Richard H.; Peters-Golden, Marc] Univ Michigan Hlth Syst, Div Pulm & Crit Care Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Hogaboam, Cory M.] Univ Michigan Hlth Syst, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Peters-Golden, M (corresponding author), 6301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	petersm@umich.edu	Hogaboam, Cory M./AAI-1433-2021; hogaboam, cory/M-3578-2014	Hogaboam, Cory M./0000-0003-3366-4850; 	National Institutes of Health [HL094311, HL078871, HL094657]; American Lung Association; Uehara Memorial Foundation; Parker B. Francis fellowship; American Thoracic Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078871, K08HL094657, R01HL094311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; Uehara Memorial Foundation(Uehara Memorial Foundation); Parker B. Francis fellowship; American Thoracic Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL094311 (to M.P.-G.), HL078871 (to T.H.S.), and HL094657 (to S.K.H.). This work was also supported by an American Lung Association senior research training fellowship (to K.O.), a Uehara Memorial Foundation research fellowship (to K.O.), a Parker B. Francis fellowship (to S.K.H.), and an American Thoracic Society career development award (to S.K.H.).	*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; Aronoff DM, 2005, J IMMUNOL, V174, P595, DOI 10.4049/jimmunol.174.2.595; Bauman KA, 2010, J CLIN INVEST, V120, P1950, DOI 10.1172/JCI38369; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BOROK Z, 1991, AM REV RESPIR DIS, V144, P1080, DOI 10.1164/ajrccm/144.5.1080; Brassart B, 2001, J BIOL CHEM, V276, P5222, DOI 10.1074/jbc.M003642200; CARMELIET P, 1993, J CLIN INVEST, V92, P2746, DOI 10.1172/JCI116892; Chambers RC, 1998, BIOCHEM J, V333, P121, DOI 10.1042/bj3330121; CHAPMAN HA, 1986, AM REV RESPIR DIS, V133, P437; Chaturvedi D, 2009, J BIOL CHEM, V284, P23670, DOI 10.1074/jbc.M109.032813; Christensen JG, 2003, CANCER RES, V63, P7345; Day JRS, 2004, CIRCULATION, V110, P2597, DOI 10.1161/01.CIR.0000138027.80056.31; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; El Homasany BSED, 2005, J IMMUNOL, V175, P7811, DOI 10.4049/jimmunol.175.12.7811; ESTREICHER A, 1989, J BIOL CHEM, V264, P1180; Farber HW, 2004, NEW ENGL J MED, V351, P1655, DOI 10.1056/NEJMra035488; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Gil-Bernabe AM, 2006, MOL CELL BIOL, V26, P4017, DOI 10.1128/MCB.01904-05; Hattori N, 2004, AM J PATHOL, V164, P1091, DOI 10.1016/S0002-9440(10)63196-3; Hetzel M, 2005, LUNG, V183, P225, DOI 10.1007/s00408-004-2534-z; Huang S, 2007, AM J PHYSIOL-LUNG C, V292, pL405, DOI 10.1152/ajplung.00232.2006; Huang SK, 2008, AM J RESP CELL MOL, V39, P482, DOI 10.1165/rcmb.2008-0080OC; Huang SK, 2008, AM J RESP CRIT CARE, V177, P66, DOI 10.1164/rccm.200706-963OC; Huang SK, 2010, AM J PATHOL, V177, P2245, DOI 10.2353/ajpath.2010.100446; Johnson M, 1998, AM J RESP CRIT CARE, V158, pS146, DOI 10.1164/ajrccm.158.supplement_2.13tac110; KOTANI I, 1995, THROMB RES, V77, P493, DOI 10.1016/0049-3848(95)00025-9; Liu XQ, 2005, J PHARMACOL EXP THER, V315, P678, DOI 10.1124/jpet.105.090324; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; Moore BB, 2005, J IMMUNOL, V174, P5644, DOI 10.4049/jimmunol.174.9.5644; OGREID D, 1989, EUR J BIOCHEM, V181, P19; Quesnel C, 2010, EUR RESPIR J, V35, P1312, DOI 10.1183/09031936.00074709; Rhim JH, 2006, AGING CELL, V5, P451, DOI 10.1111/j.1474-9726.2006.00239.x; SCOTT JD, 1991, PHARMACOL THERAPEUT, V50, P123, DOI 10.1016/0163-7258(91)90075-W; Serezani CH, 2009, BLOOD, V114, P3316, DOI 10.1182/blood-2009-01-199919; Serezani CHC, 2005, BLOOD, V106, P1067, DOI 10.1182/blood-2004-08-3323; Singh T, 2010, ARCH OTOLARYNGOL, V136, P163, DOI 10.1001/archoto.2009.175; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; Takahashi M, 1999, J BIOL CHEM, V274, P17267, DOI 10.1074/jbc.274.24.17267; TASKEN KA, 1991, MOL ENDOCRINOL, V5, P21, DOI 10.1210/mend-5-1-21; Ugland H, 2008, MOL BIOL CELL, V19, P5082, DOI 10.1091/mbc.E08-01-0094; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	46	26	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32231	32243		10.1074/jbc.M111.235606	http://dx.doi.org/10.1074/jbc.M111.235606			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795691	hybrid, Green Published			2022-12-25	WOS:000294726800033
J	Xu, XQ; Oliveira, F; Chang, BW; Collin, N; Gomes, R; Teixeira, C; Reynoso, D; Pham, VM; Elnaiem, DE; Kamhawi, S; Ribeiro, JMC; Valenzuela, JG; Andersen, JF				Xu, Xueqing; Oliveira, Fabiano; Chang, Bianca W.; Collin, Nicolas; Gomes, Regis; Teixeira, Clarissa; Reynoso, David; Pham, Van My; Elnaiem, Dia-Eldin; Kamhawi, Shaden; Ribeiro, Jose M. C.; Valenzuela, Jesus G.; Andersen, John F.			Structure and Function of a "Yellow" Protein from Saliva of the Sand Fly Lutzomyia longipalpis That Confers Protective Immunity against Leishmania major Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; BINDING; EVOLUTION; VECTOR; MODEL; HYPERSENSITIVITY; IDENTIFICATION; TRANSCRIPTOME; PHAGOCYTOSIS; MECHANISM	LJM11, an abundant salivary protein from the sand fly Lutzomyia longipalpis, belongs to the insect "yellow" family of proteins. In this study, we immunized mice with 17 plasmids encoding L. longiplapis salivary proteins and demonstrated that LJM11 confers protective immunity against Leishmania major infection. This protection correlates with a strong induction of a delayed type hypersensitivity (DTH) response following exposure to L. longipalpis saliva. Additionally, splenocytes of exposed mice produce IFN-gamma upon stimulation with LJM11, demonstrating the systemic induction of Th1 immunity by this protein. In contrast to LJM11, LJM111, another yellow protein from L. longipalpis saliva, does not produce a DTH response in these mice, suggesting that structural or functional features specific to LJM11 are important for the induction of a robust DTH response. To examine these features, we used calorimetric analysis to probe a possible ligand binding function for the salivary yellow proteins. LJM11, LJM111, and LJM17 all acted as high affinity binders of prohemostatic and proinflammatory biogenic amines, particularly serotonin, catecholamines, and histamine. We also determined the crystal structure of LJM11, revealing a six-bladed beta-propeller fold with a single ligand binding pocket located in the central part of the propeller structure on one face of the molecule. A hypothetical model of LJM11 suggests a positive electrostatic potential on the face containing entry to the ligand binding pocket, whereas LJM111 is negative to neutral over its entire surface. This may be the reason for differences in antigenicity between the two proteins.	[Xu, Xueqing; Oliveira, Fabiano; Chang, Bianca W.; Collin, Nicolas; Gomes, Regis; Teixeira, Clarissa; Reynoso, David; Pham, Van My; Elnaiem, Dia-Eldin; Kamhawi, Shaden; Ribeiro, Jose M. C.; Valenzuela, Jesus G.; Andersen, John F.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Collin, Nicolas] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Elnaiem, Dia-Eldin] Univ Maryland Eastern Shore, Dept Nat Sci, Princess Anne, MD 21853 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Lausanne; University System of Maryland; University of Maryland Eastern Shore	Andersen, JF (corresponding author), 12735 Twinbrook Pkwy, Rockville, MD 20852 USA.	jandersen@niaid.nih.gov	Gomes, Regis Bernardo Brandim Regis/AAJ-1471-2021; Reynoso, David/AAM-4476-2021; Oliveira, Fabiano/AAG-5388-2019	Gomes, Regis Bernardo Brandim Regis/0000-0001-7603-5101; Reynoso, David/0000-0002-2639-4197; Oliveira, Fabiano/0000-0002-7924-8038; Ribeiro, Jose/0000-0002-9107-0818	National Institutes of Health, NIAID; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000932, ZIAAI000810, ZIAAI001012] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health, NIAID, Intramural Research Program. Use of the Advanced Photon Source beamlines was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	Andersen JF, 2003, J BIOL CHEM, V278, P4611, DOI 10.1074/jbc.M211438200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Belkaid Y, 2000, P NATL ACAD SCI USA, V97, P6704, DOI 10.1073/pnas.97.12.6704; Bethony JM, 2011, IMMUNOL REV, V239, P237, DOI 10.1111/j.1600-065X.2010.00976.x; Blum MM, 2006, J AM CHEM SOC, V128, P12750, DOI 10.1021/ja061887n; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Calvo E, 2009, P NATL ACAD SCI USA, V106, P3728, DOI 10.1073/pnas.0813190106; Collin N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000441; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dai JY, 2004, CELL, V116, P649, DOI 10.1016/S0092-8674(04)00172-2; de Moura TR, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000084; Drapeau MD, 2006, GENOME RES, V16, P1385, DOI 10.1101/gr.5012006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang JM, 2002, BIOCHEM BIOPH RES CO, V290, P287, DOI 10.1006/bbrc.2001.6200; Ferguson LC, 2011, MOL BIOL EVOL, V28, P257, DOI 10.1093/molbev/msq192; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Gomes R, 2008, P NATL ACAD SCI USA, V105, P7845, DOI 10.1073/pnas.0712153105; Gudderra NP, 2005, J BIOL CHEM, V280, P25022, DOI 10.1074/jbc.M504386200; Han D, 2002, BIOCHEM J, V368, P333; Kamhawi S, 2000, SCIENCE, V290, P1351, DOI 10.1126/science.290.5495.1351; Kamhawi S, 2000, MICROBES INFECT, V2, P1765, DOI 10.1016/S1286-4579(00)01331-9; Lima HC, 1997, PARASITOL TODAY, V13, P80, DOI 10.1016/S0169-4758(96)40010-2; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P862, DOI 10.1016/j.ibmb.2008.06.002; Mans BJ, 2008, J BIOL CHEM, V283, P18721, DOI 10.1074/jbc.M800188200; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morris RV, 2001, J IMMUNOL, V167, P5226, DOI 10.4049/jimmunol.167.9.5226; Oliveira F, 2006, VACCINE, V24, P374, DOI 10.1016/j.vaccine.2005.07.085; Oliveira F, 2009, PARASITOL INT, V58, P1, DOI 10.1016/j.parint.2008.07.004; Oliveira F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000226; Oliveira MCG, 2007, NEUROSCIENCE, V145, P708, DOI 10.1016/j.neuroscience.2006.12.021; RIBEIRO JMC, 1994, J EXP MED, V180, P2251, DOI 10.1084/jem.180.6.2251; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Roser M, 1998, EUR J PHARM BIOPHARM, V46, P255, DOI 10.1016/S0939-6411(98)00038-1; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Teixeira C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000638; Thiakaki M, 2005, MICROBES INFECT, V7, P760, DOI 10.1016/j.micinf.2005.01.013; Thiele L, 2001, J CONTROL RELEASE, V76, P59, DOI 10.1016/S0168-3659(01)00412-6; Valenzuela JG, 2004, J EXP BIOL, V207, P3717, DOI 10.1242/jeb.01185; Valenzuela JG, 2001, J EXP MED, V194, P331, DOI 10.1084/jem.194.3.331; Xanthos DN, 2008, PAIN, V137, P640, DOI 10.1016/j.pain.2007.10.031	44	87	89	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32383	32393		10.1074/jbc.M111.268904	http://dx.doi.org/10.1074/jbc.M111.268904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795673	hybrid, Green Published			2022-12-25	WOS:000294726800048
J	Lee, YL; Chiao, CH; Hsu, MT				Lee, Yu-Ling; Chiao, Chun-Hui; Hsu, Ming-Ta			Transcription of Muscle Actin Genes by a Nuclear Form of Mitochondrial RNA Polymerase	PLOS ONE			English	Article							EXPRESSION	Actins are the major constituent of the cytoskeleton. In this report we present several lines of evidence that muscle actin genes are transcribed by nuclear isoform of mitochondrial RNA polymerase (spRNAP-IV) whereas the non-muscle actin genes are transcribed by the conventional RNA polymerase II (PolII). We show that mRNA level of muscle actin genes are resistant to PolII inhibitors alpha-amanitin and triptolide as well as insensitive to knockdown of PolII but not to knockdown of spRNAP-IV, in contrast to non-muscle actin genes in several cell lines. Similar results are obtained from nuclear run-on experiments. Reporter assay using muscle actin or PolII gene promoters also demonstrate the differential sensitivity to PolII inhibitors. Finally, chromatin-immunoprecipitation experiment was used to demonstrate that spRNAP-IV is associated with promoter of muscle actin genes but not with that of non-muscle gene and knockdown of spRNAP-IV depleted this polymerase from muscle actin genes. In summary, these experiments indicate that the two types of actin genes are transcribed by different transcription machinery. We also found that POLRMT gene is transcribed by spRNAP-IV, and actin genes are sensitive to oligomycin, suggesting a transcription coupling between mitochondria and nucleus.	[Lee, Yu-Ling; Chiao, Chun-Hui; Hsu, Ming-Ta] Natl Yang Ming Univ, Sch Life Sci, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Hsu, Ming-Ta] Natl Yang Ming Univ, VGH Yang Ming Genome Res Ctr, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lee, YL (corresponding author), Natl Yang Ming Univ, Sch Life Sci, Inst Biochem & Mol Biol, Taipei 112, Taiwan.	mth@ym.edu.tw		Lee, Yu-Ling/0000-0003-1897-9918	Ministry of Education; High-throughput Genome Analysis Core Facility [NSC 99-3112-B-010-020]	Ministry of Education; High-throughput Genome Analysis Core Facility	This work is supported by a grant from the Ministry of Education, Aim for the Top University Plan, and by a grant from High-throughput Genome Analysis Core Facility (NSC 99-3112-B-010-020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Irrcher I, 2004, J APPL PHYSIOL, V97, P2207, DOI 10.1152/japplphysiol.00388.2004; KEDINGER C, 1970, BIOCHEM BIOPH RES CO, V38, P165, DOI 10.1016/0006-291X(70)91099-5; Kravchenko JE, 2005, NATURE, V436, P735, DOI 10.1038/nature03848; Liu T, 2000, J MOL EVOL, V50, P22, DOI 10.1007/s002399910003; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; MOUNIER N, 1992, J MOL EVOL, V34, P406, DOI 10.1007/BF00162997; Patrone G, 2000, BIOTECHNIQUES, V29, P1012, DOI 10.2144/00295st02; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; SHUEY DJ, 1985, J BIOL CHEM, V260, P1952; Vispe S, 2009, MOL CANCER THER, V8, P2780, DOI 10.1158/1535-7163.MCT-09-0549; Yang JH, 2008, J GENET GENOMICS, V35, P65, DOI 10.1016/S1673-8527(08)60010-7	12	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22583	10.1371/journal.pone.0022583	http://dx.doi.org/10.1371/journal.pone.0022583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799907	Green Submitted, Green Published, gold			2022-12-25	WOS:000293172900053
J	Ng, EKO; Leung, CPH; Shin, VY; Wong, CLP; Ma, ESK; Jin, HC; Chu, KM; Kwong, A				Ng, Enders K. O.; Leung, Candy P. H.; Shin, Vivian Y.; Wong, Chris L. P.; Ma, Edmond S. K.; Jin, Hong Chuan; Chu, Kent-Man; Kwong, Ava			Quantitative Analysis and Diagnostic Significance of Methylated SLC19A3 DNA in the Plasma of Breast and Gastric Cancer Patients	PLOS ONE			English	Article							THIAMINE TRANSPORTER THTR2; PROMOTER HYPERMETHYLATION; GENE-EXPRESSION; CIRCULATING DNA; DOWN-REGULATION; SERUM; THERAPY; MARKER; FAMILY; TUMORS	Background: Previously, we have examined the methylation status of SLC19A3 (solute carrier family 19, member 3) promoter and found that SLC19A3 was epigenetically down-regulated in gastric cancer. Here, we aim to develop a new biomarker for cancer diagnosis using methylated SLC19A3 DNA in plasma. Methodology/Principal Findings: SLC19A3 gene expression was examined by RT-qPCR. Methylation status of SLC19A3 promoter was evaluated by methylation-specific qPCR. SLC19A3 expression was significantly down-regulated in 80% (12/15) of breast tumors (P<0.005). Breast tumors had significant increase in methylation percentage when compared to adjacent non-tumor tissues (P<0.005). A robust and simple methylation-sensitive restriction enzyme digestion and real-time quantitative PCR (MSRED-qPCR) was developed to quantify SLC19A3 DNA methylation in plasma. We validated this biomarker in an independent validation cohort of 165 case-control plasma including 60 breast cancer, 45 gastric cancer patients and 60 healthy subjects. Plasma SLC19A3 methylated DNA level was effective in differentiating both breast and gastric cancer from healthy subjects. We further validated this biomarker in another independent blinded cohort of 78 plasma including 38 breast cancer, 20 gastric cancer patients and 20 healthy subjects. The positive predictive values for breast and gastric cancer were 90% and 85%, respectively. The negative predictive value of this biomarker was 85%. Elevated level in plasma has been detected not only in advanced stages but also early stages of tumors. The positive predictive value for ductal carcinoma in situ (DCIS) cases was 100%. Conclusions: These results suggested that aberrant SLC19A3 promoter hypermethylation in plasma may be a novel biomarker for breast and gastric cancer diagnosis.	[Ng, Enders K. O.; Leung, Candy P. H.; Shin, Vivian Y.; Chu, Kent-Man] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Ng, Enders K. O.; Wong, Chris L. P.; Ma, Edmond S. K.; Kwong, Ava] Hong Kong Sanat & Hosp, Dept Mol Pathol, Hong Kong, Hong Kong, Peoples R China; [Ng, Enders K. O.; Wong, Chris L. P.; Ma, Edmond S. K.; Kwong, Ava] Hong Kong Sanat & Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Jin, Hong Chuan] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Biomed Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Wong, Chris L. P.; Ma, Edmond S. K.; Kwong, Ava] Hong Kong Hereditary Breast Canc Family Registry, Hong Kong, Hong Kong, Peoples R China; [Kwong, Ava] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA	University of Hong Kong; Zhejiang University; Stanford University	Ng, EKO (corresponding author), Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	akwong@asiabreastregistry.com	wong, chris/GSN-0962-2022; Ma, Shiu Kwan Edmond/AAZ-7637-2021; Ng, Enders K.O./F-2787-2010; Ng, Enders/T-3881-2019; Kwong, Ava/D-8005-2013; Jin, Hongchuan/C-3686-2009	Ma, Shiu Kwan Edmond/0000-0002-1259-2205; Ng, Enders K.O./0000-0002-6955-0030; Ng, Enders/0000-0002-6955-0030; Kwong, Ava/0000-0002-6968-9489; Jin, Hongchuan/0000-0002-6697-3097; Shin, Vivian Yvonne/0000-0003-1282-7593; Wang, Xian/0000-0003-0041-7589; Ng, Enders Kai-on/0000-0002-5293-3529	University of Hong Kong [10400959]; Dr. Ellen Li Charitable Foundation	University of Hong Kong(University of Hong Kong); Dr. Ellen Li Charitable Foundation	The University of Hong Kong Seed Fund for Basic Research 2009 (Ref #: 10400959). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely thank The Dr. Ellen Li Charitable Foundation for their support. We would also like to thank Dr. Dacita Suen, Dr. Catherine Choi and Ms. Wong Ling for helping in patient recruitment.	Chiu RWK, 2005, CLIN CHEM, V51, P2209, DOI 10.1373/clinchem.2005.056366; Chiu RWK, 2003, CLIN CHEM, V49, P719, DOI 10.1373/49.5.719; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Eudy JD, 2000, MOL GENET METAB, V71, P581, DOI 10.1006/mgme.2000.3112; Fiegl H, 2005, CANCER RES, V65, P1141, DOI 10.1158/0008-5472.CAN-04-2438; Gal S, 2004, BRIT J CANCER, V90, P1211, DOI 10.1038/sj.bjc.6601609; Ganapathy V, 2004, PFLUG ARCH EUR J PHY, V447, P641, DOI 10.1007/s00424-003-1068-1; Lee BY, 2005, ONCOL REP, V14, P1589; Liu SQ, 2004, MOL CANCER RES, V2, P477; Liu SQ, 2003, MOL CANCER RES, V1, P665; Liu X, 2009, TUMOR BIOL, V30, P242, DOI 10.1159/000243767; Muller HM, 2003, CANCER RES, V63, P7641; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Rajgopal A, 2001, BBA-MOL BASIS DIS, V1537, P175, DOI 10.1016/S0925-4439(01)00073-4; Rashid A, 2004, GASTROENTEROLOGY, V127, P1578, DOI 10.1053/j.gastro.2004.09.007; Reidling JC, 2010, GASTROENTEROLOGY, V138, P1802, DOI 10.1053/j.gastro.2009.10.042; Wang YC, 2008, WORLD J GASTROENTERO, V14, P3074, DOI 10.3748/wjg.14.3074; Widschwendter A, 2004, CLIN CANCER RES, V10, P565, DOI 10.1158/1078-0432.CCR-0825-03; Widschwendter M, 2002, ONCOGENE, V21, P5462, DOI 10.1038/sj.onc.1205606; Widschwendter M, 2006, CLIN CANCER RES, V12, P7205, DOI 10.1158/1078-0432.CCR-06-2531	21	57	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22233	10.1371/journal.pone.0022233	http://dx.doi.org/10.1371/journal.pone.0022233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789241	Green Published, gold, Green Submitted			2022-12-25	WOS:000292812400041
J	Risher, WC; Lee, MR; Fomitcheva, IV; Hess, DC; Kirov, SA				Risher, W. Christopher; Lee, Mark R.; Fomitcheva, Ioulia V.; Hess, David C.; Kirov, Sergei A.			Dibucaine Mitigates Spreading Depolarization in Human Neocortical Slices and Prevents Acute Dendritic Injury in the Ischemic Rodent Neocortex	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; INTRINSIC OPTICAL SIGNALS; IN-VIVO; ANOXIC DEPOLARIZATION; PERIINFARCT DEPOLARIZATIONS; HIPPOCAMPAL SLICES; BRAIN-SLICES; GLUCOSE DEPRIVATION; LOCAL-ANESTHETICS; NA+ CHANNELS	Background: Spreading depolarizations that occur in patients with malignant stroke, subarachnoid/intracranial hemorrhage, and traumatic brain injury are known to facilitate neuronal damage in metabolically compromised brain tissue. The dramatic failure of brain ion homeostasis caused by propagating spreading depolarizations results in neuronal and astroglial swelling. In essence, swelling is the initial response and a sign of the acute neuronal injury that follows if energy deprivation is maintained. Choosing spreading depolarizations as a target for therapeutic intervention, we have used human brain slices and in vivo real-time two-photon laser scanning microscopy in the mouse neocortex to study potentially useful therapeutics against spreading depolarization-induced injury. Methodology/Principal Findings: We have shown that anoxic or terminal depolarization, a spreading depolarization wave ignited in the ischemic core where neurons cannot repolarize, can be evoked in human slices from pediatric brains during simulated ischemia induced by oxygen/glucose deprivation or by exposure to ouabain. Changes in light transmittance (LT) tracked terminal depolarization in time and space. Though spreading depolarizations are notoriously difficult to block, terminal depolarization onset was delayed by dibucaine, a local amide anesthetic and sodium channel blocker. Remarkably, the occurrence of ouabain-induced terminal depolarization was delayed at a concentration of 1 mu M that preserves synaptic function. Moreover, in vivo two-photon imaging in the penumbra revealed that, though spreading depolarizations did still occur, spreading depolarization-induced dendritic injury was inhibited by dibucaine administered intravenously at 2.5 mg/kg in a mouse stroke model. Conclusions/Significance: Dibucaine mitigated the effects of spreading depolarization at a concentration that could be well-tolerated therapeutically. Hence, dibucaine is a promising candidate to protect the brain from ischemic injury with an approach that does not rely on the complete abolishment of spreading depolarizations.	[Risher, W. Christopher] Georgia Hlth Sci Univ, Grad Program Neurosci, Augusta, GA USA; [Lee, Mark R.; Fomitcheva, Ioulia V.; Kirov, Sergei A.] Georgia Hlth Sci Univ, Dept Neurosurg, Augusta, GA USA; [Hess, David C.] Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA USA; [Risher, W. Christopher; Hess, David C.; Kirov, Sergei A.] Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Risher, WC (corresponding author), Duke Univ, Med Ctr, Durham, NC 27708 USA.	skirov@georgiahealth.edu	Risher, W Christopher/AAZ-3982-2020	Risher, W Christopher/0000-0002-2230-2865	National Institutes of Health [NS064753, NS057113, NS062154]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS062154, R01NS057113, F31NS064753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS064753 (W.C.R.), NS057113 (S.A.K.), and NS062154 (S.A.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken PG, 1998, J NEUROPHYSIOL, V80, P1514, DOI 10.1152/jn.1998.80.3.1514; ALEXANDER JT, 1975, J APPL PHYSIOL, V39, P1041, DOI 10.1152/jappl.1975.39.6.1041; Anderson TR, 2005, J NEUROPHYSIOL, V93, P963, DOI 10.1152/jn.00654.2004; Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; Basarsky TA, 1998, J NEUROSCI, V18, P7189; Busch E, 1996, J CEREBR BLOOD F MET, V16, P1090, DOI 10.1097/00004647-199611000-00002; Davies ML, 2007, J NEUROSCI METH, V166, P203, DOI 10.1016/j.jneumeth.2007.07.012; Dayan PS, 1996, ANN EMERG MED, V28, P442, DOI 10.1016/S0196-0644(96)70013-6; Dietz RM, 2009, J NEUROCHEM, V109, P145, DOI 10.1111/j.1471-4159.2009.05853.x; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Donnan GA, 2008, STROKE, V39, P242, DOI 10.1161/STROKEAHA.107.493296; Douglas HA, 2011, J NEUROPHYSIOL, V105, P1482, DOI 10.1152/jn.00817.2010; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Enright LE, 2007, J CEREBR BLOOD F MET, V27, P1185, DOI 10.1038/sj.jcbfm.9600428; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Farkas E, 2010, NEUROIMAGE, V51, P734, DOI 10.1016/j.neuroimage.2010.02.055; Fung ML, 1999, NEUROSCI LETT, V275, P41, DOI 10.1016/S0304-3940(99)00728-4; Hartings JA, 2003, J NEUROSCI, V23, P11602; HORI N, 1994, EXP NEUROL, V129, P279, DOI 10.1006/exnr.1994.1170; Jarvis CR, 1999, NEUROIMAGE, V10, P357, DOI 10.1006/nimg.1999.0473; Jarvis CR, 2001, CEREB CORTEX, V11, P249, DOI 10.1093/cercor/11.3.249; JIANG C, 1992, J NEUROPHYSIOL, V68, P2165, DOI 10.1152/jn.1992.68.6.2165; Kirov SA, 2004, NEUROSCIENCE, V127, P69, DOI 10.1016/j.neuroscience.2004.04.053; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; MACVICAR BA, 1991, J NEUROSCI, V11, P1458; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; Momota Y, 2000, ANESTH ANALG, V91, P362, DOI 10.1097/00000539-200008000-00024; Muller M, 1998, BRAIN RES, V812, P1, DOI 10.1016/S0006-8993(98)00812-9; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Nakamura H, 2010, BRAIN, V133, P1994, DOI 10.1093/brain/awq117; NEDERGAARD M, 1993, J CEREBR BLOOD F MET, V13, P568, DOI 10.1038/jcbfm.1993.74; Obeidat AS, 1998, EUR J NEUROSCI, V10, P3451, DOI 10.1046/j.1460-9568.1998.00358.x; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Ohta K, 2001, STROKE, V32, P535, DOI 10.1161/01.STR.32.2.535; Oliveira-Ferreira AI, 2010, J CEREBR BLOOD F MET, V30, P1504, DOI 10.1038/jcbfm.2010.40; Palmini A, 2004, NEUROLOGY, V62, pS2, DOI 10.1212/01.WNL.0000114507.30388.7E; PARDRIDGE WM, 1983, J CLIN INVEST, V71, P900, DOI 10.1172/JCI110844; Petzold GC, 2005, STROKE, V36, P1270, DOI 10.1161/01.STR.0000166023.51307.e0; Risher WC, 2010, J NEUROSCI, V30, P9859, DOI 10.1523/JNEUROSCI.1917-10.2010; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; SHIBATA M, 1994, REGION ANESTH, V19, P255; Shin HK, 2006, J CEREBR BLOOD F MET, V26, P1018, DOI 10.1038/sj.jcbfm.9600252; Somjen G. G., 2004, IONS BRAIN NORMAL FU; Strong AJ, 2007, BRAIN, V130, P995, DOI 10.1093/brain/awl392; TAYLOR CP, 1995, TRENDS PHARMACOL SCI, V16, P309, DOI 10.1016/S0165-6147(00)89060-4; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, CHANNELS, V2, P81, DOI 10.4161/chan.2.2.6003; Urenjak J, 1996, PHARMACOL REV, V48, P21; WEBER ML, 1994, BRAIN RES, V664, P167, DOI 10.1016/0006-8993(94)91967-4; WESTER P, 1995, STROKE, V26, P444, DOI 10.1161/01.STR.26.3.444; Witcher MR, 2010, GLIA, V58, P572, DOI 10.1002/glia.20946; Yamada A, 2004, NEUROSCI RES, V50, P291, DOI 10.1016/j.neures.2004.07.008; Zhang SX, 2007, PLOS BIOL, V5, P1152, DOI 10.1371/journal.pbio.0050119; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005; Zhou N, 2010, CEREB CORTEX, V20, P2614, DOI 10.1093/cercor/bhq018	59	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22351	10.1371/journal.pone.0022351	http://dx.doi.org/10.1371/journal.pone.0022351			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789251	Green Submitted, Green Published, gold			2022-12-25	WOS:000292811700042
J	Samal, A; Martin, OC				Samal, Areejit; Martin, Olivier C.			Randomizing Genome-Scale Metabolic Networks	PLOS ONE			English	Article							SMALL-WORLD; ORGANIZATION; DISTRIBUTIONS; CELLS	Networks coming from protein-protein interactions, transcriptional regulation, signaling, or metabolism may appear to have "unusual" properties. To quantify this, it is appropriate to randomize the network and test the hypothesis that the network is not statistically different from expected in a motivated ensemble. However, when dealing with metabolic networks, the randomization of the network using edge exchange generates fictitious reactions that are biochemically meaningless. Here we provide several natural ensembles of randomized metabolic networks. A first constraint is to use valid biochemical reactions. Further constraints correspond to imposing appropriate functional constraints. We explain how to perform these randomizations with the help of Markov Chain Monte Carlo (MCMC) and show that they allow one to approach the properties of biological metabolic networks. The implication of the present work is that the observed global structural properties of real metabolic networks are likely to be the consequence of simple biochemical and functional constraints.	[Samal, Areejit; Martin, Olivier C.] CNRS, LPTMS, F-91405 Orsay, France; [Samal, Areejit; Martin, Olivier C.] Univ Paris 11, UMR8626, Orsay, France; [Samal, Areejit] Max Planck Inst Math Sci, Leipzig, Germany; [Martin, Olivier C.] Univ Paris Sud, INRA, Genet Vegetale UMR0320 UMR8120, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech	Samal, A (corresponding author), CNRS, LPTMS, F-91405 Orsay, France.	olivier.martin@u-psud.fr	Samal, Areejit/AAC-2485-2020; Martin, Olivier C/B-6656-2012; Samal, Areejit/E-5422-2011	Martin, Olivier C/0000-0002-5295-5963; Samal, Areejit/0000-0002-6796-9604	CNRS [GDRE513]; Agence Nationale de la Recherche [ANR-08-SYSC011]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	AS acknowledges support from CNRS GDRE513. OCM acknowledges support from the Agence Nationale de la Recherche, Metacoli grant ANR-08-SYSC011. The LPTMS is an Unite de Recherche de l'Universite Paris-Sud associee au CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Csardi ~ G, 2006, INTERJ COMP SYST, V1695; Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Harary F., 1969, GRAPH THEORY; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Ma HW, 2003, BIOINFORMATICS, V19, P270, DOI 10.1093/bioinformatics/19.2.270; Ma HW, 2003, BIOINFORMATICS, V19, P1423, DOI 10.1093/bioinformatics/btg177; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Papp B, 2009, HFSP J, V3, P24, DOI 10.2976/1.3020599; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; RODRIGUES JFM, 2009, PLOS COMPUT IN PRESS; Samal A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-30; SCHUSTER S, 1991, J MATH CHEM, V6, P17, DOI 10.1007/BF01192571; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Tanaka R, 2005, IEE P SYST BIOL, V152, P179, DOI 10.1049/ip-syb:20050042; Tanaka R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.168101; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Wagner A, 2008, EVOLUTIONARY GENOMICS AND PROTEOMICS, P255; Wasserman S., 1994, SOCIAL NETWORK ANAL; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	36	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22295	10.1371/journal.pone.0022295	http://dx.doi.org/10.1371/journal.pone.0022295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779409	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811300062
J	Nakatake, M; Monte-Mor, B; Debili, N; Casadevall, N; Ribrag, V; Solary, E; Vainchenker, W; Plo, I				Nakatake, M.; Monte-Mor, B.; Debili, N.; Casadevall, N.; Ribrag, V.; Solary, E.; Vainchenker, W.; Plo, I.			JAK2(V617F) negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms	ONCOGENE			English	Article						JAK2(V617F); p53; MDM2; La protein; myeloproliferative neoplasms	CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; HOMOLOGOUS RECOMBINATION; MYELOID METAPLASIA; ESSENTIAL THROMBOCYTHEMIA; PROGNOSTIC-SIGNIFICANCE; HEMATOPOIETIC-CELLS; CANCER-THERAPY; DISORDERS	JAK2(V617F) is a gain of function mutation that promotes cytokine-independent growth of myeloid cells and accounts for a majority of myeloproliferative neoplasms (MPN). Mutations in p53 are rarely found in these diseases before acute leukemia transformation, but this does not rule out a role for p53 deregulation in disease progression. Using Ba/F3-EPOR cells and ex vivo cultured CD34(+) cells from MPN patients, we demonstrate that expression of JAK2(V617F) affected the p53 response to DNA damage. We show that E3 ubiquitin ligase MDM2 accumulated in these cells, due to an increased translation of MDM2 mRNA. Accumulation of the La autoantigen, which interacts with MDM2 mRNA and promotes its translation, was responsible for the increase in MDM2 protein level and the subsequent degradation of p53 after DNA damage. Downregulation of La protein or cell treatment with nutlin-3, a MDM2 antagonist, restored the p53 response to DNA damage and the cytokine-dependence of Ba/F3-EPOR-JAK2(V617F) cells. Altogether, these data indicate that the JAK2(V617F) mutation affects p53 response to DNA damage through the upregulation of La antigen and accumulation of MDM2. They also suggest that p53 functional inactivation accounts for the cytokine hypersensitivity of JAK2(V617F) MPN and might have a role in disease progression. Oncogene ( 2012) 31, 1323-1333; doi:10.1038/onc.2011.313; published online 25 July 2011	[Nakatake, M.; Monte-Mor, B.; Debili, N.; Casadevall, N.; Ribrag, V.; Solary, E.; Vainchenker, W.; Plo, I.] INSERM, UMR 1009, Villejuif, France; [Nakatake, M.; Monte-Mor, B.; Debili, N.; Ribrag, V.; Solary, E.; Vainchenker, W.; Plo, I.] Univ Paris 11, Inst Gustave Roussy, UMR1009, Villejuif, France; [Plo, I.] Inst Gustave Roussy, INSERM, U1009, F-94805 Villejuif, France; [Casadevall, N.] Hop St Antoine, AP HP, Hematol Lab, F-75571 Paris, France; [Casadevall, N.] Univ Paris 06, F-75252 Paris 05, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Plo, I (corresponding author), Inst Gustave Roussy, INSERM, U1009, 114 Rue Edouard Vaillant, F-94805 Villejuif, France.	isabelle.plo@igr.fr	Da Costa Reis Monte Mor, Barbara DCR/A-9909-2015; Plo, Isabelle/C-9056-2017; Plo, Isabelle/AAT-6742-2021	Plo, Isabelle/0000-0002-5915-6910; Vainchenker, William/0000-0003-4705-202X; Solary, Eric/0000-0002-8629-1341	Ligue Nationale Contre le Cancer; INCa; INSERM; Fondation pour la Recherche Medicale	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); INCa(Institut National du Cancer (INCA) France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank all the patients and the controls who participated in the study, and AstraZeneca for the gift of the JAK2 inhibitor (AZD1480). We are grateful to Drs LT Vassilev and R Fahraeus for fruitful discussion. We also thank Dr F Wendling for critical reading of the manuscript. This work was supported by grants from the Ligue Nationale Contre le Cancer (equipe labellisee 2007-2010 et 2010-2012), INCa (projets libres 2007) and INSERM. IP was a recipient from INCA, MN from the Ligue Nationale Contre le Cancer, BMM from the Fondation pour la Recherche Medicale.	Akyuz N, 2002, MOL CELL BIOL, V22, P6306, DOI 10.1128/MCB.22.17.6306-6317.2002; Barosi G, 1999, BRIT J HAEMATOL, V104, P730, DOI 10.1046/j.1365-2141.1999.01262.x; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Berthebaud M, 2005, BLOOD, V106, P2962, DOI 10.1182/blood-2005-02-0526; Bertrand P, 2004, TRENDS GENET, V20, P235, DOI 10.1016/j.tig.2004.04.003; Candeias MM, 2008, NAT CELL BIOL, V10, P1098, DOI 10.1038/ncb1770; Capoulade C, 1998, ONCOGENE, V16, P1603, DOI 10.1038/sj.onc.1201702; Cummings WJ, 2007, PLOS BIOL, V5, P2145, DOI 10.1371/journal.pbio.0050246; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Faderl S, 2000, CANCER, V89, P1976, DOI 10.1002/1097-0142(20001101)89:9<1976::AID-CNCR14>3.3.CO;2-E; FEINSTEIN E, 1991, P NATL ACAD SCI USA, V88, P6293, DOI 10.1073/pnas.88.14.6293; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Gaidano G, 1997, GENE CHROMOSOME CANC, V19, P250; Gangat N, 2008, EUR J HAEMATOL, V80, P197, DOI 10.1111/j.1600-0609.2007.01003.x; Goetz AW, 2001, CANCER RES, V61, P7635; Hernandez-Boussard T, 1999, HUM MUTAT, V14, P1; Holcik M, 2000, MOL CELL BIOL, V20, P4648, DOI 10.1128/MCB.20.13.4648-4657.2000; Ishiguro K, 2005, MOL CANCER THER, V4, P1755, DOI 10.1158/1535-7163.MCT-05-0169; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jastrzebski K, 2007, GROWTH FACTORS, V25, P209, DOI 10.1080/08977190701779101; KANTARJIAN HM, 1987, AM J MED, V83, P445, DOI 10.1016/0002-9343(87)90754-6; Kawamata N, 2008, EXP HEMATOL, V36, P1471, DOI 10.1016/j.exphem.2008.06.006; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Le Scolan E, 2001, ONCOGENE, V20, P5484, DOI 10.1038/sj.onc.1204708; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Liu R, 2000, ONCOGENE, V19, P571, DOI 10.1038/sj.onc.1203364; Maetens M, 2007, BLOOD, V109, P2630, DOI 10.1182/blood-2006-03-013656; Mendrysa SM, 2001, GENE, V264, P139, DOI 10.1016/S0378-1119(00)00589-8; Michiels JJ, 2000, LEUKEMIA LYMPHOMA, V36, P239, DOI 10.3109/10428190009148845; Perrotti D, 2007, CLIN CANCER RES, V13, P1638, DOI 10.1158/1078-0432.CCR-06-2320; Plo I, 2008, BLOOD, V112, P1402, DOI 10.1182/blood-2008-01-134114; Reilly JT, 2005, SEMIN ONCOL, V32, P359, DOI 10.1053/j.seminoncol.2005.04.007; Seliger B, 1996, EUR J HAEMATOL, V57, P230; Sengupta S, 2003, EMBO J, V22, P1210, DOI 10.1093/emboj/cdg114; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Shide K, 2008, LEUKEMIA, V22, P87, DOI 10.1038/sj.leu.2405043; Sieff CA, 2010, BRIT J HAEMATOL, V148, P611, DOI 10.1111/j.1365-2141.2009.07993.x; Smith ML, 2002, MUTAGENESIS, V17, P149, DOI 10.1093/mutage/17.2.149; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tefferi A, 2009, LEUKEMIA RES, V33, P662, DOI 10.1016/j.leukres.2008.09.009; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; Tsurumi S, 2002, AM J HEMATOL, V71, P131, DOI 10.1002/ajh.10188; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Wong KS, 1999, ONCOGENE, V18, P5525, DOI 10.1038/sj.onc.1202938; Zhao R, 2008, NEW ENGL J MED, V359, P2778, DOI 10.1056/NEJMoa0804953; Zhou M, 2000, LEUKEMIA, V14, P61, DOI 10.1038/sj.leu.2401619	49	80	82	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	10					1323	1333		10.1038/onc.2011.313	http://dx.doi.org/10.1038/onc.2011.313			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	906KS	21785463				2022-12-25	WOS:000301344600011
J	Zhou, YF; Zhou, Y; Shingu, T; Feng, L; Chen, Z; Ogasawara, M; Keating, MJ; Kondo, S; Huang, P				Zhou, Yunfei; Zhou, Yan; Shingu, Takashi; Feng, Li; Chen, Zhao; Ogasawara, Marcia; Keating, Michael J.; Kondo, Seiji; Huang, Peng			Metabolic Alterations in Highly Tumorigenic Glioblastoma Cells PREFERENCE FOR HYPOXIA AND HIGH DEPENDENCY ON GLYCOLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR STEM-CELLS; CANCER-CELLS; BRAIN-TUMORS; IN-VIVO; PHENOTYPE; DIFFERENTIATION; IDENTIFICATION; NICHE; EGF	Recent studies suggest that a small subpopulation of malignant cells with stem-like properties is resistant to chemotherapy and may be responsible for the existence of residual cancer after treatment. We have isolated highly tumorigenic cancer cells with 100-fold increase in tumor initiating capacity from the tumor xenografts of human glioblastoma U87 cells in mice. These cells exhibit stem-like properties and show unique energy metabolic characteristics including low mitochondrial respiration, increased glycolysis for ATP generation, and preference for hypoxia to maintain their stemness and tumor forming capacity. Mechanistically, mitochondrial depression in the highly tumorigenic cells occurs mainly at complex II of the electron transport chain with a down-regulation of the succinate dehydrogenase subunit B, leading to deregulation of hypoxia-inducible factors. Under hypoxia, the stem-like cancer cells are resistant to conventional anticancer agents but are sensitive to glycolytic inhibition. Furthermore, combination of glycolytic inhibition with standard therapeutic agents is effective in killing the tumor-initiating cells in vitro and inhibits tumor formation in vivo. Our study suggests that stem-like cancer cells prefer a low oxygen microenvironment and actively utilize the glycolytic pathway for ATP generation. Inhibition of glycolysis may be an effective strategy to eradicate residual cancer stem cells that are otherwise resistant to chemotherapeutic agents in their hypoxic niches.	[Huang, Peng] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Shingu, Takashi; Kondo, Seiji] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Keating, Michael J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Huang, P (corresponding author), Unit 951,1515 Holcombe Blvd, Houston, TX 77030 USA.	phuang@mdanderson.org	Shingu, Takashi/AAS-4820-2021		National Institutes of Health [CA085563, CA100428, CA109041, CA16672]; Houston Endowment; Odyssey Fellowship; NATIONAL CANCER INSTITUTE [R01CA100428, R01CA085563, R01CA109041, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Houston Endowment; Odyssey Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA085563, CA100428, CA109041, and CA16672. This work was also supported by an Odyssey Fellowship sponsored by the Houston Endowment.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Dahia PLM, 2005, PLOS GENET, V1, P72, DOI 10.1371/journal.pgen.0010008; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Geschwind JFH, 2002, CANCER RES, V62, P3909; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Guzman ML, 2002, P NATL ACAD SCI USA, V99, P16220, DOI 10.1073/pnas.252462599; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; HOLZER T, 1993, J COMPUT ASSIST TOMO, V17, P681; Jensen RL, 2009, J NEURO-ONCOL, V92, P317, DOI 10.1007/s11060-009-9827-2; Jiang H, 2007, J NATL CANCER I, V99, P1410, DOI 10.1093/jnci/djm102; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Moppett IK, 2007, ANESTH ANALG, V105, P1094, DOI 10.1213/01.ane.0000284620.37846.e5; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Parker GC, 2009, STEM CELLS DEV, V18, P803, DOI 10.1089/scd.2009.1806.edi; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Singh SK, 2003, CANCER RES, V63, P5821; SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xu RH, 2005, CANCER RES, V65, P613; Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	39	163	169	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32843	32853		10.1074/jbc.M111.260935	http://dx.doi.org/10.1074/jbc.M111.260935			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795717	Green Published, hybrid			2022-12-25	WOS:000294726800091
J	Carey, JB; Pearson, FE; Vrdoljak, A; McGrath, MG; Crean, AM; Walsh, PT; Doody, T; O'Mahony, C; Hill, AVS; Moore, AC				Carey, John B.; Pearson, Frances E.; Vrdoljak, Anto; McGrath, Marie G.; Crean, Abina M.; Walsh, Patrick T.; Doody, Timothy; O'Mahony, Conor; Hill, Adrian V. S.; Moore, Anne C.			Microneedle Array Design Determines the Induction of Protective Memory CD8(+) T Cell Responses Induced by a Recombinant Live Malaria Vaccine in Mice	PLOS ONE			English	Article							ADENOVIRAL VECTORS; IMMUNIZATION; DELIVERY; IMMUNOGENICITY; EFFICACY; EXPRESSION	Background: Vaccine delivery into the skin has received renewed interest due to ease of access to the immune system and microvasculature, however the stratum corneum (SC), must be breached for successful vaccination. This has been achieved by removing the SC by abrasion or scarification or by delivering the vaccine intradermally (ID) with traditional needle-and-syringes or with long microneedle devices. Microneedle patch-based transdermal vaccine studies have predominantly focused on antibody induction by inactivated or subunit vaccines. Here, our principal aim is to determine if the design of a microneedle patch affects the CD8(+) T cell responses to a malaria antigen induced by a live vaccine. Methodology and Findings: Recombinant modified vaccinia virus Ankara (MVA) expressing a malaria antigen was percutaneously administered to mice using a range of silicon microneedle patches, termed ImmuPatch, that differed in microneedle height, density, patch area and total pore volume. We demonstrate that microneedle arrays that have small total pore volumes induce a significantly greater proportion of central memory T cells that vigorously expand to secondary immunization. Microneedle-mediated vaccine priming induced significantly greater T cell immunity post-boost and equivalent protection against malaria challenge compared to ID vaccination. Notably, unlike ID administration, ImmuPatch-mediated vaccination did not induce inflammatory responses at the site of immunization or in draining lymph nodes. Conclusions/Significance: This study demonstrates that the design of microneedle patches significantly influences the magnitude and memory of vaccine-induced CD8(+) T cell responses and can be optimised for the induction of desired immune responses. Furthermore, ImmuPatch-mediated delivery may be of benefit to reducing unwanted vaccine reactogenicity. In addition to the advantages of low cost and lack of pain, the development of optimised microneedle array designs for the induction of T cell responses by live vaccines aids the development of solutions to current obstacles of immunization programmes.	[Carey, John B.; Vrdoljak, Anto; McGrath, Marie G.; Crean, Abina M.; Doody, Timothy; Moore, Anne C.] Univ Coll Cork, Sch Pharm, Cork, Ireland; [Pearson, Frances E.; Hill, Adrian V. S.] Univ Oxford, Jenner Inst, Oxford, England; [Walsh, Patrick T.] Our Ladys Childrens Hosp Crumlin, Natl Childrens Res Ctr, Dublin, Ireland; [O'Mahony, Conor] Univ Coll Cork, Tyndall Natl Inst, Cork, Ireland; [Moore, Anne C.] Univ Coll Cork, Dept Pharmacol, Cork, Ireland	University College Cork; University of Oxford; Jenner Institute; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; University College Cork; University College Cork	Carey, JB (corresponding author), Univ Coll Cork, Sch Pharm, Cork, Ireland.	anne.moore@ucc.ie	Walsh, Patrick/I-7909-2014; Pearson, Frances E/K-8928-2018; O'Mahony, Conor/E-7326-2011	Walsh, Patrick/0000-0002-0130-8766; Crean, Abina/0000-0001-6171-0303; Pearson, Frances/0000-0001-7274-9211; Moore, Anne/0000-0003-3656-4230; O'Mahony, Conor/0000-0003-4018-103X	Enterprise Ireland [CFTD 07/117]; Science Foundation Ireland [NAP156, NAP170]; Medical Research Council, United Kingdom [G0600311]	Enterprise Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by Enterprise Ireland (CFTD 07/117, http://www.enterprise-ireland.com), Science Foundation Ireland (NAP156, NAP170, www.sfi.ie) and the Medical Research Council, United Kingdom (G0600311, www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Belkaid Y, 1996, J IMMUNOL METHODS, V199, P5, DOI 10.1016/S0022-1759(96)00117-2; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dean CH, 2005, HUM VACCINES, V1, P106, DOI 10.4161/hv.1.3.1797; Draper SJ, 2008, NAT MED, V14, P819, DOI 10.1038/nm.1850; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Enfield J, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3463002; Finn JD, 2009, J VIROL, V83, P12027, DOI 10.1128/JVI.00593-09; Good MF, 1999, CURR OPIN IMMUNOL, V11, P412, DOI 10.1016/S0952-7915(99)80069-7; Gopee NV, 2007, TOXICOL SCI, V98, P249, DOI 10.1093/toxsci/kfm074; Haq MI, 2009, BIOMED MICRODEVICES, V11, P35, DOI 10.1007/s10544-008-9208-1; HARVEY AJ, 2010, PHARM RES; HIRAISHI Y, 2011, VACCINE; Jabbari A, 2006, J IMMUNOL METHODS, V313, P161, DOI 10.1016/j.jim.2006.04.005; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Koutsonanos DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004773; KUPPER TS, 1990, J INVEST DERMATOL, V94, pS146, DOI 10.1111/1523-1747.ep12876130; Laurent PE, 2010, VACCINE, V28, P5850, DOI 10.1016/j.vaccine.2010.06.062; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Milewski M, 2010, EXPERT OPIN DRUG DEL, V7, P617, DOI 10.1517/17425241003663228; Moore AC, 2005, J IMMUNOL, V175, P7264, DOI 10.4049/jimmunol.175.11.7264; Nicolas JF, 2008, EXPERT REV VACCINES, V7, P1201, DOI 10.1586/14760584.7.8.1201; ORMEROD LP, 1988, ARCH DIS CHILD, V63, P1491, DOI 10.1136/adc.63.12.1491; ORMEROD LP, 1993, ARCH DIS CHILD, V69, P155, DOI 10.1136/adc.69.1.155; Pham NLL, 2009, J IMMUNOL, V183, P2337, DOI 10.4049/jimmunol.0901203; Prausnitz MR, 2009, CURR TOP MICROBIOL, V333, P369, DOI 10.1007/978-3-540-92165-3_18; Puri N, 2000, VACCINE, V18, P2600, DOI 10.1016/S0264-410X(99)00440-5; Reyes-Sandoval A, 2008, EUR J IMMUNOL, V38, P732, DOI 10.1002/eji.200737672; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Sridhar S, 2008, J VIROL, V82, P3822, DOI 10.1128/JVI.02568-07; Tatsis N, 2007, BLOOD, V110, P1916, DOI 10.1182/blood-2007-02-062117; Vogt A, 2008, J IMMUNOL, V180, P1482, DOI 10.4049/jimmunol.180.3.1482; Widera G, 2006, VACCINE, V24, P1653, DOI 10.1016/j.vaccine.2005.09.049; Wilke N, 2005, MICROELECTRON J, V36, P650, DOI 10.1016/j.mejo.2005.04.044; Wolfson LJ, 2008, B WORLD HEALTH ORGAN, V86, P27, DOI 10.2471/BLT.07.045096	36	53	55	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22442	10.1371/journal.pone.0022442	http://dx.doi.org/10.1371/journal.pone.0022442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799855	gold, Green Published, Green Submitted			2022-12-25	WOS:000293172900030
J	Galetto, L; Bosco, D; Balestrini, R; Genre, A; Fletcher, J; Marzachi, C				Galetto, Luciana; Bosco, Domenico; Balestrini, Raffaella; Genre, Andrea; Fletcher, Jacqueline; Marzachi, Cristina			The Major Antigenic Membrane Protein of "Candidatus Phytoplasma asteris" Selectively Interacts with ATP Synthase and Actin of Leafhopper Vectors	PLOS ONE			English	Article							SPIROPLASMA-CITRI; BINDING-PROTEIN; REDUCTIVE EVOLUTION; INSECT VECTORS; SURFACE; PLANT; IDENTIFICATION; CELLS; RECEPTOR; ADHESION	Phytoplasmas, uncultivable phloem-limited phytopathogenic wall-less bacteria, represent a major threat to agriculture worldwide. They are transmitted in a persistent, propagative manner by phloem-sucking Hemipteran insects. Phytoplasma membrane proteins are in direct contact with hosts and are presumably involved in determining vector specificity. Such a role has been proposed for phytoplasma transmembrane proteins encoded by circular extrachromosomal elements, at least one of which is a plasmid. Little is known about the interactions between major phytoplasma antigenic membrane protein (Amp) and insect vector proteins. The aims of our work were to identify vector proteins interacting with Amp and to investigate their role in transmission specificity. In controlled transmission experiments, four Hemipteran species were identified as vectors of "Candidatus Phytoplasma asteris", the chrysanthemum yellows phytoplasmas (CYP) strain, and three others as non-vectors. Interactions between a labelled (recombinant) CYP Amp and insect proteins were analysed by far Western blots and affinity chromatography. Amp interacted specifically with a few proteins from vector species only. Among Amp-binding vector proteins, actin and both the alpha and beta subunits of ATP synthase were identified by mass spectrometry and Western blots. Immunofluorescence confocal microscopy and Western blots of plasma membrane and mitochondrial fractions confirmed the localisation of ATP synthase, generally known as a mitochondrial protein, in plasma membranes of midgut and salivary gland cells in the vector Euscelidius variegatus. The vector-specific interaction between phytoplasma Amp and insect ATP synthase is demonstrated for the first time, and this work also supports the hypothesis that host actin is involved in the internalization and intracellular motility of phytoplasmas within their vectors. Phytoplasma Amp is hypothesized to play a crucial role in insect transmission specificity.	[Galetto, Luciana; Marzachi, Cristina] CNR, Ist Virol Vegetale, I-10126 Turin, Italy; [Bosco, Domenico] Univ Turin, Dipartimento Valorizzaz & Protez Risorse Agroalim, Grugliasco, Italy; [Balestrini, Raffaella] CNR, Ist Protez Piante, I-10126 Turin, Italy; [Genre, Andrea] Univ Turin, Dipartimento Biol Vegetale, Turin, Italy; [Fletcher, Jacqueline] Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA	Consiglio Nazionale delle Ricerche (CNR); University of Turin; Consiglio Nazionale delle Ricerche (CNR); University of Turin; Oklahoma State University System; Oklahoma State University - Stillwater	Galetto, L (corresponding author), CNR, Ist Virol Vegetale, I-10126 Turin, Italy.	c.marzachi@ivv.cnr.it	Marzachi, Cristina/B-9967-2015; Galetto, Luciana/C-4368-2015; Balestrini, Raffaella/Q-1106-2015; Balestrini, Raffaella/D-1975-2010; Genre, Andrea/AAQ-1466-2020	Marzachi, Cristina/0000-0002-1084-6048; Galetto, Luciana/0000-0001-6637-0678; Balestrini, Raffaella/0000-0001-7958-7681; Balestrini, Raffaella/0000-0001-7958-7681; BOSCO, Domenico/0000-0003-3945-2752; Genre, Andrea/0000-0001-5029-6194	National Research Council; University of Torino; Piemonte Region	National Research Council; University of Torino; Piemonte Region(Regione Piemonte)	This research was funded by the National Research Council and University of Torino. LG was supported by a post doc fellowship from the Piemonte Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alma A., 2001, Journal of Plant Pathology, V83, P181; Arakaki N, 2003, MOL CANCER RES, V1, P931; Arakaki N, 2007, FEBS LETT, V581, P3405, DOI 10.1016/j.febslet.2007.06.041; Bae TJ, 2004, PROTEOMICS, V4, P3536, DOI 10.1002/pmic.200400952; Bai XD, 2006, J BACTERIOL, V188, P3682, DOI 10.1128/JB.188.10.3682-3696.2006; Bai XD, 2009, MOL PLANT MICROBE IN, V22, P18, DOI 10.1094/MPMI-22-1-0018; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Bosco D, 2007, J ECON ENTOMOL, V100, P1504, DOI 10.1603/0022-0493-100.5.1504; Bosco D, 2010, PHYTOPLASMAS: GENOMES, PLANT HOSTS AND VECTORS, P293; Boutareaud A, 2004, APPL ENVIRON MICROB, V70, P3960, DOI 10.1128/AEM.70.7.3960-3967.2004; BRETON M, 2010, APPL ENV MICROB, V76; Cainelli Christian, 2007, IOBC-WPRS Bulletin, V30, P261; Champagne E, 2006, CURR OPIN LIPIDOL, V17, P279, DOI 10.1097/01.mol.0000226120.27931.76; Chaudhry R, 2007, FRONT BIOSCI-LANDMRK, V12, P690, DOI 10.2741/2093; Chi SL, 2006, ANN MED, V38, P429, DOI 10.1080/07853890600928698; Foissac X, 2010, PHYTOPLASMAS: GENOMES, PLANT HOSTS AND VECTORS, P309, DOI 10.1079/9781845935306.0309; Galetto L, 2011, J ECON ENTOMOL, V104, P360, DOI 10.1603/EC10174; Galetto L, 2008, CAN J MICROBIOL, V54, P341, DOI [10.1139/W08-010, 10.1139/w08-010]; Galetto L, 2009, ENTOMOL EXP APPL, V131, P200, DOI 10.1111/j.1570-7458.2009.00845.x; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Gasparich GE, 2010, BIOLOGICALS, V38, P193, DOI 10.1016/j.biologicals.2009.11.007; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Gratz NG, 1999, ANNU REV ENTOMOL, V44, P51, DOI 10.1146/annurev.ento.44.1.51; Hayward RD, 2002, TRENDS CELL BIOL, V12, P15, DOI 10.1016/S0962-8924(01)02183-3; Hogenhout SA, 2008, MOL PLANT PATHOL, V9, P403, DOI 10.1111/J.1364-3703.2008.00472.X; Hoshi A, 2009, P NATL ACAD SCI USA, V106, P6416, DOI 10.1073/pnas.0813038106; Ishii Y, 2009, GENE, V446, P51, DOI 10.1016/j.gene.2009.07.010; Ishii Y, 2009, MICROBIOL-SGM, V155, P2058, DOI 10.1099/mic.0.027409-0; Ji XL, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-20; Kakizawa S, 2006, J BACTERIOL, V188, P3424, DOI 10.1128/JB.188.9.3424-3428.2006; Kakizawa S, 2006, TRENDS MICROBIOL, V14, P254, DOI 10.1016/j.tim.2006.04.008; Kakizawa S, 2009, FEMS MICROBIOL LETT, V293, P92, DOI 10.1111/j.1574-6968.2009.01509.x; Khanna MR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-302; Killiny N, 2006, MICROBIOL-SGM, V152, P1221, DOI 10.1099/mic.0.28602-0; Killiny N, 2005, PHYTOPATHOLOGY, V95, P541, DOI 10.1094/PHYTO-95-0541; Kim BW, 2004, EXP MOL MED, V36, P476, DOI 10.1038/emm.2004.60; Krause DC, 2004, MOL MICROBIOL, V51, P917, DOI 10.1046/j.1365-2958.2003.03899.x; Krishnamoorthy M, 2007, INSECT BIOCHEM MOLEC, V37, P189, DOI 10.1016/j.ibmb.2006.10.004; Kube M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-306; Labroussaa F, 2010, APPL ENVIRON MICROB, V76, P1879, DOI 10.1128/AEM.02384-09; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE IM, 1994, PHYTOPATHOLOGY, V84, P559, DOI 10.1094/Phyto-84-559; LEE IM, 1993, PHYTOPATHOLOGY, V83, P834, DOI 10.1094/Phyto-83-834; Liang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-144; Lin XH, 2009, EXP CELL RES, V315, P1171, DOI 10.1016/j.yexcr.2009.01.001; Lyly A, 2008, HUM MOL GENET, V17, P1406, DOI 10.1093/hmg/ddn028; Mangiullo R, 2008, BBA-BIOENERGETICS, V1777, P1326, DOI 10.1016/j.bbabio.2008.08.003; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; Marzachi C, 2005, MOL BIOTECHNOL, V30, P117, DOI 10.1385/MB:30:2:117; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811; Negri I, 2006, P ROY SOC B-BIOL SCI, V273, P2409, DOI 10.1098/rspb.2006.3592; Ohkawa T, 2010, J CELL BIOL, V190, P187, DOI 10.1083/jcb.201001162; Ohta T, 2009, BBA-BIOMEMBRANES, V1788, P1099, DOI 10.1016/j.bbamem.2009.03.005; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Ozeri V, 2001, MOL MICROBIOL, V41, P561, DOI 10.1046/j.1365-2958.2001.02535.x; Paingankar MS, 2010, ARCH VIROL, V155, P1453, DOI 10.1007/s00705-010-0728-7; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Suzuki S, 2006, P NATL ACAD SCI USA, V103, P4252, DOI 10.1073/pnas.0508668103; Toruno TY, 2010, MOL MICROBIOL, V77, P1406, DOI 10.1111/j.1365-2958.2010.07296.x; Tran-Nguyen LTT, 2008, J BACTERIOL, V190, P3979, DOI 10.1128/JB.01301-07; Tyrrell GJ, 2002, MICROBIOL-SGM, V148, P3921, DOI 10.1099/00221287-148-12-3921; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; WU J, 2007, NATURE PROTOCOLS, V2, P3278; Yu J, 2000, PHYTOPATHOLOGY, V90, P716, DOI 10.1094/PHYTO.2000.90.7.716; Zalewska M, 2009, BBA-BIOMEMBRANES, V1788, P1695, DOI 10.1016/j.bbamem.2009.04.022; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092	69	65	68	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22571	10.1371/journal.pone.0022571	http://dx.doi.org/10.1371/journal.pone.0022571			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799902	Green Published, Green Submitted, gold			2022-12-25	WOS:000293172900050
J	Puddu, P; Latorre, D; Carollo, M; Catizone, A; Ricci, G; Valenti, P; Gessani, S				Puddu, Patrizia; Latorre, Daniela; Carollo, Maria; Catizone, Angela; Ricci, Giulia; Valenti, Piera; Gessani, Sandra			Bovine Lactoferrin Counteracts Toll-Like Receptor Mediated Activation Signals in Antigen Presenting Cells	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; LPS-BINDING-PROTEIN; CD4(+) T-CELLS; IN-VIVO; IMMUNOLOGICAL-TOLERANCE; CYTOKINE PRODUCTION; HUMAN MONOCYTES; DIFFERENTIATION; LIPOPOLYSACCHARIDE; MACROPHAGES	Lactoferrin (LF), a key element in mammalian immune system, plays pivotal roles in host defence against infection and excessive inflammation. Its protective effects range from direct antimicrobial activities against a large panel of microbes, including bacteria, viruses, fungi and parasites, to antinflammatory and anticancer activities. In this study, we show that monocyte-derived dendritic cells (MD-DCs) generated in the presence of bovine LF (bLF) fail to undergo activation by up-modulating CD83, co-stimulatory and major histocompatibility complex molecules, and cytokine/chemokine secretion. Moreover, these cells are weak activators of T cell proliferation and retain antigen uptake activity. Consistent with an impaired maturation, bLF-MD-DC primed T lymphocytes exhibit a functional unresponsiveness characterized by reduced expression of CD154 and impaired expression of IFN-gamma and IL-2. The observed imunosuppressive effects correlate with an increased expression of molecules with negative regulatory functions (i.e. immunoglobulin-like transcript 3 and programmed death ligand 1), indoleamine 2,3-dioxygenase, and suppressor of cytokine signaling-3. Interestingly, bLF-MD-DCs produce IL-6 and exhibit constitutive signal transducer and activator of transcription 3 activation. Conversely, bLF exposure of already differentiated MD-DCs completely fails to induce IL-6, and partially inhibits Toll-like receptor (TLR) agonist-induced activation. Cell-specific differences in bLF internalization likely account for the distinct response elicited by bLF in monocytes versus immature DCs, providing a mechanistic base for its multiple effects. These results indicate that bLF exerts a potent anti-inflammatory activity by skewing monocyte differentiation into DCs with impaired capacity to undergo activation and to promote Th1 responses. Overall, these bLF-mediated effects may represent a strategy to block excessive DC activation upon TLR-induced inflammation, adding further evidence for a critical role of bLF in directing host immune function.	[Puddu, Patrizia; Latorre, Daniela; Carollo, Maria; Gessani, Sandra] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Catizone, Angela] Univ Rome, Dept Anat Histol Forens Med & Orthoped, Rome, Italy; [Ricci, Giulia] Univ Naples 2, Dept Expt Med, Naples, Italy; [Valenti, Piera] Univ Rome, Dept Publ Hlth Sci & Infect Dis, Rome, Italy	Istituto Superiore di Sanita (ISS); Sapienza University Rome; Universita della Campania Vanvitelli; Sapienza University Rome	Puddu, P (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	sandra.gessani@iss.it	Gessani, Sandra/K-5151-2016; Puddu, Patrizia/J-9763-2012; Latorre, Daniela/HHZ-9540-2022; Ricci, Giulia/AAO-1856-2020	Gessani, Sandra/0000-0002-8451-0758; Latorre, Daniela/0000-0003-1031-1534; Ricci, Giulia/0000-0002-2199-170X; VALENTI, Piera/0000-0002-4354-3190; catizone, angela/0000-0002-7836-9495	Sapienza University of Rome, Italy; Microbo srl Biotechnology Company, Rome, Italy; European Commission [LSHB-CT-2004-512074 DC-THERA]	Sapienza University of Rome, Italy; Microbo srl Biotechnology Company, Rome, Italy; European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by funds from Sapienza University of Rome, Italy to PV, Microbo srl Biotechnology Company, Rome, Italy, and European Commission FP6 "Network of Excellence" (LSHB-CT-2004-512074 DC-THERA) to SG. DL was the recipient of a fellowship provided by Microbo srl Biotechnology Company, Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AE, 2008, J LEUKOCYTE BIOL, V84, P124, DOI 10.1189/jlb.1107744; APPELMELK BJ, 1994, INFECT IMMUN, V62, P2628, DOI 10.1128/IAI.62.6.2628-2632.1994; Banchereau J, 2003, ANN NY ACAD SCI, V987, P180, DOI 10.1111/j.1749-6632.2003.tb06047.x; Bartz H, 2006, BLOOD, V108, P4102, DOI 10.1182/blood-2006-03-008946; BEVERLY B, 1992, INT IMMUNOL, V4, P661, DOI 10.1093/intimm/4.6.661; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Cella M, 1997, J EXP MED, V185, P1743, DOI 10.1084/jem.185.10.1743; Cernadas M, 2009, CLIN EXP IMMUNOL, V155, P523, DOI 10.1111/j.1365-2249.2008.03853.x; Chang CCJ, 2000, J IMMUNOL, V165, P3584, DOI 10.4049/jimmunol.165.7.3584; Cheng FD, 2003, IMMUNITY, V19, P425, DOI 10.1016/S1074-7613(03)00232-2; Conti L, 2008, EUR J IMMUNOL, V38, P750, DOI 10.1002/eji.200737395; De la Rosa G, 2008, J IMMUNOL, V180, P6868, DOI 10.4049/jimmunol.180.10.6868; Del Corno M, 2009, BLOOD, V114, P796, DOI 10.1182/blood-2009-01-199406; Dienz O, 2009, CLIN IMMUNOL, V130, P27, DOI 10.1016/j.clim.2008.08.018; Dunn-Siegrist I, 2007, J BIOL CHEM, V282, P34817, DOI 10.1074/jbc.M706440200; Elass-Rochard E, 1998, INFECT IMMUN, V66, P486, DOI 10.1128/IAI.66.2.486-491.1998; ElassRochard E, 1995, BIOCHEM J, V312, P839, DOI 10.1042/bj3120839; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Frick JS, 2010, INT J MED MICROBIOL, V300, P19, DOI 10.1016/j.ijmm.2009.08.010; Gauzzi MC, 2005, J IMMUNOL, V174, P270, DOI 10.4049/jimmunol.174.1.270; Gauzzi MC, 2002, J IMMUNOL, V169, P3038, DOI 10.4049/jimmunol.169.6.3038; GESSANI S, 1993, J IMMUNOL, V151, P3758; Gogolak P, 2007, BLOOD, V109, P643, DOI 10.1182/blood-2006-04-016840; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Gregori S, 2011, TISSUE ANTIGENS, V77, P89, DOI 10.1111/j.1399-0039.2010.01615.x; Groot F, 2005, J VIROL, V79, P3009, DOI 10.1128/JVI.79.5.3009-3015.2005; Hegde S, 2004, FASEB J, V18, P1439, DOI 10.1096/fj.03-0969fje; Kortylewski M, 2005, NAT MED, V11, P1314, DOI 10.1038/nm1325; Legrand D, 2005, CELL MOL LIFE SCI, V62, P2549, DOI 10.1007/s00018-005-5370-2; Legrand D, 2008, ADV EXP MED BIOL, V606, P163, DOI 10.1007/978-0-387-74087-4_6; Li YH, 2006, J IMMUNOL, V177, P1679, DOI 10.4049/jimmunol.177.3.1679; Lunz JG, 2007, HEPATOLOGY, V46, P1946, DOI 10.1002/hep.21906; Macagno A, 2007, TRENDS IMMUNOL, V28, P227, DOI 10.1016/j.it.2007.03.008; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Meng GX, 2004, J CLIN INVEST, V113, P1473, DOI 10.1172/JCI200420762; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Na YJ, 2004, INT IMMUNOPHARMACOL, V4, P1187, DOI 10.1016/j.intimp.2004.05.009; Nakata T, 2006, CELL MICROBIOL, V8, P1899, DOI 10.1111/j.1462-5822.2006.00756.x; Nefedova Y, 2004, J IMMUNOL, V172, P464, DOI 10.4049/jimmunol.172.1.464; Okazaki T, 2006, TRENDS IMMUNOL, V27, P195, DOI 10.1016/j.it.2006.02.001; Palucka KA, 1999, J LEUKOCYTE BIOL, V65, P232, DOI 10.1002/jlb.65.2.232; Park SJ, 2004, J IMMUNOL, V173, P3844, DOI 10.4049/jimmunol.173.6.3844; PENCO S, 1995, J BIOL CHEM, V270, P12263, DOI 10.1074/jbc.270.20.12263; Puddu P, 2007, J LEUKOCYTE BIOL, V82, P347, DOI 10.1189/jlb.1106688; Puddu P, 2010, BIOMETALS, V23, P387, DOI 10.1007/s10534-010-9307-3; Puddu P, 2009, BIOCHIMIE, V91, P11, DOI 10.1016/j.biochi.2008.05.005; Ratta M, 2002, BLOOD, V100, P230, DOI 10.1182/blood.V100.1.230; Rotta G, 2003, J EXP MED, V198, P1253, DOI 10.1084/jem.20030335; SPADARO M, 2008, FASEB J; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Steinman RM, 2003, APMIS, V111, P675, DOI 10.1034/j.1600-0463.2003.11107802.x; Valenti P, 2005, CELL MOL LIFE SCI, V62, P2576, DOI 10.1007/s00018-005-5372-0; Ward PP, 2005, CELL MOL LIFE SCI, V62, P2540, DOI 10.1007/s00018-005-5369-8; Wells AD, 2009, J IMMUNOL, V182, P7331, DOI 10.4049/jimmunol.0803917; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Xie J, 2003, J IMMUNOL, V171, P4792, DOI 10.4049/jimmunol.171.9.4792	57	66	70	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22504	10.1371/journal.pone.0022504	http://dx.doi.org/10.1371/journal.pone.0022504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799877	Green Published, gold, Green Submitted			2022-12-25	WOS:000293172900040
J	Eckhardt, M; Anders, M; Muranyi, W; Heilemann, M; Krijnse-Locker, J; Muller, B				Eckhardt, Manon; Anders, Maria; Muranyi, Walter; Heilemann, Mike; Krijnse-Locker, Jacomine; Mueller, Barbara			A SNAP-Tagged Derivative of HIV-1-A Versatile Tool to Study Virus-Cell Interactions	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FUSION PROTEINS; LIVE CELLS; FLUORESCENCE MICROSCOPY; STIMULATED-EMISSION; PLASMA-MEMBRANE; LIVING CELLS; REAL-TIME; TYPE-1; GAG	Fluorescently labeled human immunodeficiency virus (HIV) derivatives, combined with the use of advanced fluorescence microscopy techniques, allow the direct visualization of dynamic events and individual steps in the viral life cycle. HIV proteins tagged with fluorescent proteins (FPs) have been successfully used for live-cell imaging analyses of HIV-cell interactions. However, FPs display limitations with respect to their physicochemical properties, and their maturation kinetics. Furthermore, several independent FP-tagged constructs have to be cloned and characterized in order to obtain spectral variations suitable for multi-color imaging setups. In contrast, the so-called SNAP-tag represents a genetically encoded non-fluorescent tag which mediates specific covalent coupling to fluorescent substrate molecules in a self-labeling reaction. Fusion of the SNAP-tag to the protein of interest allows specific labeling of the fusion protein with a variety of synthetic dyes, thereby offering enhanced flexibility for fluorescence imaging approaches. Here we describe the construction and characterization of the HIV derivative HIV(SNAP), which carries the SNAP-tag as an additional domain within the viral structural polyprotein Gag. Introduction of the tag close to the C-terminus of the matrix domain of Gag did not interfere with particle assembly, release or proteolytic virus maturation. The modified virions were infectious and could be propagated in tissue culture, albeit with reduced replication capacity. Insertion of the SNAP domain within Gag allowed specific staining of the viral polyprotein in the context of virus producing cells using a SNAP reactive dye as well as the visualization of individual virions and viral budding sites by stochastic optical reconstruction microscopy. Thus, HIV(SNAP) represents a versatile tool which expands the possibilities for the analysis of HIV-cell interactions using live cell imaging and sub-diffraction fluorescence microscopy.	[Eckhardt, Manon; Anders, Maria; Muranyi, Walter; Krijnse-Locker, Jacomine; Mueller, Barbara] Univ Heidelberg Hosp, Dept Infect Dis, Heidelberg, Germany; [Heilemann, Mike] Univ Heidelberg, BIOQUANT Ctr, Heidelberg, Germany; [Heilemann, Mike] Univ Wurzburg, Wurzburg, Germany; [Krijnse-Locker, Jacomine] Univ Heidelberg, BIOQUANT, Elect Microscopy Core Facil, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Wurzburg; Ruprecht Karls University Heidelberg	Eckhardt, M (corresponding author), Univ Heidelberg Hosp, Dept Infect Dis, Heidelberg, Germany.	Barbara_Mueller@med.uni-heidelberg.de	Locker, Jacomine Krijnse/E-1009-2016; Muller, Barbara/AAC-4483-2020; Locker, Jacomine Krijnse/AAX-1185-2020	Heilemann, Mike/0000-0002-9821-3578; Eckhardt, Manon/0000-0001-8143-6129	European Commission within European Union [HEALTH-F3-2008-201095]; Deutsche Forschungsgemeinschaft [MU885/4-2]	European Commission within European Union; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work is part of the activities of the HIV-ACE research network (HEALTH-F3-2008-201095) supported by a grant of the European Commission within the Priority 1 "Health" work program of the 7th Framework Program of the European Union. The work has also been funded in part by a grant from the Deutsche Forschungsgemeinschaft (MU885/4-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Albanese A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002413; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Bohne J, 2004, FEBS LETT, V563, P113, DOI 10.1016/S0014-5793(04)00277-7; Brandenburg B, 2007, NAT REV MICROBIOL, V5, P197, DOI 10.1038/nrmicro1615; Briggs JAG, 2006, J MOL BIOL, V355, P157, DOI 10.1016/j.jmb.2005.10.025; Campbell EM, 2008, TRENDS MICROBIOL, V16, P580, DOI 10.1016/j.tim.2008.09.006; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Danielson CM, 2009, CURR TOP MICROBIOL, V339, P103, DOI 10.1007/978-3-642-02175-6_6; EHRLICH LS, 1990, AIDS RES HUM RETROV, V6, P1169, DOI 10.1089/aid.1990.6.1169; Farr GA, 2009, J CELL BIOL, V186, P269, DOI 10.1083/jcb.200901021; FOLKS T, 1985, P NATL ACAD SCI USA, V82, P4539, DOI 10.1073/pnas.82.13.4539; Fuller SD, 1997, CURR BIOL, V7, P729, DOI 10.1016/S0960-9822(06)00331-9; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Hearps AC, 2007, J FLUORESC, V17, P593, DOI 10.1007/s10895-007-0225-x; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hein B, 2010, BIOPHYS J, V98, P158, DOI 10.1016/j.bpj.2009.09.053; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Hubner W, 2007, J VIROL, V81, P12596, DOI 10.1128/JVI.01088-07; Ivanchenko S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000652; Jochmans D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-89; Jouvenet N, 2011, NAT CELL BIOL, V13, P394, DOI 10.1038/ncb2207; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Klein T, 2011, NAT METHODS, V8, P7, DOI 10.1038/nmeth0111-7b; Koch P, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-84; Lampe M, 2007, VIROLOGY, V360, P92, DOI 10.1016/j.virol.2006.10.005; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; MIYOSHI I, 1982, GANN, V73, P339; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; Munk C, 2002, P NATL ACAD SCI USA, V99, P13843, DOI 10.1073/pnas.212400099; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Ono A, 2009, FUTURE VIROL, V4, P241, DOI 10.2217/FVL.09.4; Pereira CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017016; Perlman M, 2006, TRAFFIC, V7, P731, DOI 10.1111/j.1398-9219.2006.00428.x; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Rudner L, 2005, J VIROL, V79, P4055, DOI 10.1128/JVI.79.7.4055-4065.2005; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; SALAHUDDIN SZ, 1983, VIROLOGY, V129, P51, DOI 10.1016/0042-6822(83)90395-1; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Sena-Esteves M, 1999, J VIROL, V73, P10426, DOI 10.1128/JVI.73.12.10426-10439.1999; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Stroffekova K, 2001, PFLUG ARCH EUR J PHY, V442, P859, DOI 10.1007/s004240100619; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Welsch S, 2006, TRAFFIC, V7, P1551, DOI 10.1111/j.1600-0854.2006.00489.x; Wolter S, 2010, J MICROSC-OXFORD, V237, P12, DOI 10.1111/j.1365-2818.2009.03287.x	56	39	41	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22007	10.1371/journal.pone.0022007	http://dx.doi.org/10.1371/journal.pone.0022007			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799764	Green Published, gold, Green Submitted			2022-12-25	WOS:000293097300012
J	Goffredo, S; Vergni, P; Reggi, M; Caroselli, E; Sparla, F; Levy, O; Dubinsky, Z; Falini, G				Goffredo, Stefano; Vergni, Patrizia; Reggi, Michela; Caroselli, Erik; Sparla, Francesca; Levy, Oren; Dubinsky, Zvy; Falini, Giuseppe			The Skeletal Organic Matrix from Mediterranean Coral Balanophyllia europaea Influences Calcium Carbonate Precipitation	PLOS ONE			English	Article							SCLERACTINIAN CORAL; SOLUBLE MATRICES; PRECURSOR PHASE; MAGNESIUM; ARAGONITE; GROWTH; CRYSTALLIZATION; PARAMETERS; PROTEIN	Scleractinian coral skeletons are made mainly of calcium carbonate in the form of aragonite. The mineral deposition occurs in a biological confined environment, but it is still a theme of discussion to what extent the calcification occurs under biological or environmental control. Hence, the shape, size and organization of skeletal crystals from the cellular level through the colony architecture, were attributed to factors as diverse as mineral supersaturation levels and organic mediation of crystal growth. The skeleton contains an intra-skeletal organic matrix ( OM) of which only the water soluble component was chemically and physically characterized. In this work that OM from the skeleton of the Balanophyllia europaea, a solitary scleractinian coral endemic to the Mediterranean Sea, is studied in vitro with the aim of understanding its role in the mineralization of calcium carbonate. Mineralization of calcium carbonate was conducted by overgrowth experiments on coral skeleton and in calcium chloride solutions containing different ratios of water soluble and/or insoluble OM and of magnesium ions. The precipitates were characterized by diffractometric, spectroscopic and microscopic techniques. The results showed that both soluble and insoluble OM components influence calcium carbonate precipitation and that the effect is enhanced by their co-presence. The role of magnesium ions is also affected by the presence of the OM components. Thus, in vitro, OM influences calcium carbonate crystal morphology, aggregation and polymorphism as a function of its composition and of the content of magnesium ions in the precipitation media. This research, although does not resolve the controversy between environmental or biological control on the deposition of calcium carbonate in corals, sheds a light on the role of OM, which appears mediated by the presence of magnesium ions.	[Goffredo, Stefano; Reggi, Michela; Caroselli, Erik] Univ Bologna, Marine Sci Grp, Bologna, Italy; [Vergni, Patrizia; Falini, Giuseppe] Univ Bologna, Dipartimento Chim G Ciamician, I-40126 Bologna, Italy; [Sparla, Francesca] Univ Bologna, Dipartimento Biol Evoluzionist Sperimentale, I-40126 Bologna, Italy; [Levy, Oren; Dubinsky, Zvy] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	University of Bologna; University of Bologna; University of Bologna; Bar Ilan University	Goffredo, S (corresponding author), Univ Bologna, Marine Sci Grp, Bologna, Italy.	giuseppe.falini@unibo.it	Caroselli, Erik/GXW-2445-2022	goffredo, stefano/0000-0002-5022-9503; Sparla, Francesca/0000-0002-2103-4870; CAROSELLI, ERIK/0000-0001-6434-5663	European Research Council under the European Union [249930]; Consorzio Interuniversitario di Ricerca della Chimica dei Metalli nei Sistemi Biologici (CIRC MSB); Mediterranean versus the Red Sea	European Research Council under the European Union(European Research Council (ERC)); Consorzio Interuniversitario di Ricerca della Chimica dei Metalli nei Sistemi Biologici (CIRC MSB); Mediterranean versus the Red Sea	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no [249930 - CoralWarm: Corals and global warming: the Mediterranean versus the Red Sea]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; GF and PV thank the Consorzio Interuniversitario di Ricerca della Chimica dei Metalli nei Sistemi Biologici (CIRC MSB) for the support. SG, EC and MR thank M. Cova, G. Gasparini and P. Bonzi for their underwater assistance in collecting the samples. The diving centre Sub Maldive supplied logistic assistance in the field. The experiments complied with current Italian law.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; ADDADI L, 1987, P NATL ACAD SCI USA, V84, P2732, DOI 10.1073/pnas.84.9.2732; AIZENBERG J, 1994, J CRYST GROWTH, V142, P156, DOI 10.1016/0022-0248(94)90283-6; Albeck S, 1996, CHEM-EUR J, V2, P278, DOI 10.1002/chem.19960020308; Arias JL, 2008, CHEM REV, V108, P4475, DOI 10.1021/cr078269p; BARNES DJ, 1970, SCIENCE, V170, P1305, DOI 10.1126/science.170.3964.1305; Baronnet A, 2008, MINERAL MAG, V72, P617, DOI 10.1180/minmag.2008.072.2.617; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; CHESSIN H, 1965, ACTA CRYSTALLOGR, V18, P689, DOI 10.1107/S0365110X65001585; Clode PL, 2011, CORAL REEFS, V30, P1, DOI 10.1007/s00338-010-0673-7; Cohen AL, 2003, REV MINERAL GEOCHEM, V54, P151, DOI 10.2113/0540151; CONSTANTZ B, 1988, J EXP ZOOL, V248, P253, DOI 10.1002/jez.1402480302; CONSTANTZ B R, 1986, Palaios, V1, P152, DOI 10.2307/3514508; Cuif Jean-Pierre, 1998, Palaeontologische Zeitschrift, V72, P257; Cuif JP, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000783; Cuif JP, 2005, J STRUCT BIOL, V150, P319, DOI 10.1016/j.jsb.2005.03.004; Cuif JP, 2003, GEOCHIM COSMOCHIM AC, V67, P75, DOI 10.1016/S0016-7037(02)01041-4; Cuif JP, 1999, COMP BIOCHEM PHYS A, V123, P269, DOI 10.1016/S1095-6433(99)00059-8; Dauphin Y, 2001, INT J BIOL MACROMOL, V28, P293, DOI 10.1016/S0141-8130(01)00124-6; Dauphin Y, 2008, COMP BIOCHEM PHYS B, V150, P10, DOI 10.1016/j.cbpb.2008.01.002; Estroff LA, 2004, CHEM REV, V104, P1201, DOI 10.1021/cr0302049; Estroff LA, 2008, CHEM REV, V108, P4329, DOI 10.1021/cr8004789; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Falini G, 2005, EUR J INORG CHEM, P162, DOI 10.1002/ejic.200400419; Falini G, 2009, CRYST GROWTH DES, V9, P2065, DOI 10.1021/cg8002959; Farre B, 2010, ZOOLOGY, V113, P250, DOI 10.1016/j.zool.2009.11.004; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Gayathri S, 2007, CHEM-EUR J, V13, P3262, DOI 10.1002/chem.200600825; Goffredo S, 2008, CORAL REEFS, V27, P623, DOI 10.1007/s00338-008-0362-y; Goffredo S, 2002, MAR ECOL PROG SER, V229, P83, DOI 10.3354/meps229083; Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Holcomb M, 2009, GEOCHIM COSMOCHIM AC, V73, P4166, DOI 10.1016/j.gca.2009.04.015; Kaczorowska B, 2003, ANAL BIOANAL CHEM, V377, P1032, DOI 10.1007/s00216-003-2153-1; Lipmann F, 1973, SEDIMENTARY CARBONAT; Lowenstam HA, 1989, BIOMINERALIZATION; MACINTYRE IG, 1976, SCIENCE, V193, P701, DOI 10.1126/science.193.4254.701; Meibom A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021313; MITTERER RM, 1978, B MAR SCI, V28, P173; Muscatine L, 2005, P NATL ACAD SCI USA, V102, P1525, DOI 10.1073/pnas.0408921102; Nakamura M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014521; Nassif N, 2005, P NATL ACAD SCI USA, V102, P12653, DOI 10.1073/pnas.0502577102; OGILVIE MM, 1896, PHIL T R SOC LOND, V0187, P00083; Pilati T, 1998, ACTA CRYSTALLOGR B, V54, P515, DOI 10.1107/S0108768197018181; Politi Y, 2008, P NATL ACAD SCI USA, V105, P17362, DOI 10.1073/pnas.0806604105; Pouget EM, 2009, SCIENCE, V323, P1455, DOI 10.1126/science.1169434; Puverel S, 2005, COMP BIOCHEM PHYS B, V141, P480, DOI 10.1016/j.cbpc.2005.05.013; Raz S, 2000, ADV MATER, V12, P38, DOI 10.1002/(SICI)1521-4095(200001)12:1<38::AID-ADMA38>3.0.CO;2-I; Ries JB, 2006, GEOLOGY, V34, P525, DOI 10.1130/G22600.1; Stephenson AE, 2008, SCIENCE, V322, P724, DOI 10.1126/science.1159417; Stolarski J, 2007, SCIENCE, V318, P92, DOI 10.1126/science.1149237; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Tambutte E, 2007, CORAL REEFS, V26, P517, DOI 10.1007/s00338-007-0263-5; Tao JH, 2009, P NATL ACAD SCI USA, V106, P22096, DOI 10.1073/pnas.0909040106; Tester CC, 2011, CRYSTENGCOMM, V13, P3975, DOI 10.1039/c1ce05153a; Wang DB, 2009, P NATL ACAD SCI USA, V106, P21511, DOI 10.1073/pnas.0906741106; Watanabe T, 2003, COMP BIOCHEM PHYS B, V136, P767, DOI 10.1016/S1096-4959(03)00177-5; WEBER JN, 1974, AM J SCI, V274, P84, DOI 10.2475/ajs.274.1.84; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Wells J. W., 1956, pf328; White W.B, 1974, INFRARED SPECTRA MIN	61	55	56	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22338	10.1371/journal.pone.0022338	http://dx.doi.org/10.1371/journal.pone.0022338			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799830	Green Submitted, Green Published, gold			2022-12-25	WOS:000293097300036
J	Haislip, NA; Gray, MJ; Hoverman, JT; Miller, DL				Haislip, Nathan A.; Gray, Matthew J.; Hoverman, Jason T.; Miller, Debra L.			Development and Disease: How Susceptibility to an Emerging Pathogen Changes through Anuran Development	PLOS ONE			English	Article							RANAVIRUS INFECTION; IMMUNE-SYSTEM; MORTALITY EVENTS; XENOPUS; METAMORPHOSIS; PLASTICITY; RESPONSES; CHYTRIDIOMYCOSIS; SALAMANDERS; IRIDOVIRUS	Ranaviruses have caused die-offs of amphibians across the globe. In North America, these pathogens cause more amphibian mortality events than any other pathogen. Field observations suggest that ranavirus epizootics in amphibian communities are common during metamorphosis, presumably due to changes in immune function. However, few controlled studies have compared the relative susceptibility of amphibians to ranaviruses across life stages. Our objectives were to measure differences in mortality and infection prevalence following exposure to ranavirus at four developmental stages and determine whether the differences were consistent among seven anuran species. Based on previous studies, we hypothesized that susceptibility to ranavirus would be greatest at metamorphosis. Our results did not support this hypothesis, as four of the species were most susceptible to ranavirus during the larval or hatchling stages. The embryo stage had the lowest susceptibility among species probably due to the protective membranous layers of the egg. Our results indicate that generalizations should be made cautiously about patterns of susceptibility to ranaviruses among amphibian developmental stages and species. Further, if early developmental stages of amphibians are susceptible to ranaviruses, the impact of ranavirus epizootic events may be greater than realized due to the greater difficulty of detecting morbid hatchlings and larvae compared to metamorphs.	[Haislip, Nathan A.; Gray, Matthew J.; Hoverman, Jason T.; Miller, Debra L.] Univ Tennessee, Ctr Wildlife Hlth, Dept Forestry Wildlife & Fisheries, Knoxville, TN 37996 USA; [Miller, Debra L.] Univ Georgia, Coll Vet Med, Vet Diagnost & Invest Lab, Tifton, GA USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University System of Georgia; University of Georgia	Haislip, NA (corresponding author), Univ Tennessee, Ctr Wildlife Hlth, Dept Forestry Wildlife & Fisheries, Knoxville, TN 37996 USA.	jason.hoverman@colorado.edu	Hoverman, Jason T/D-1756-2013; Hoverman, Jason/AGR-0056-2022	Hoverman, Jason T/0000-0002-4002-2728; Hoverman, Jason/0000-0002-4002-2728; Miller, Debra/0000-0002-8544-174X	University of Tennessee Institute of Agriculture; Tennessee Wildlife Resources Agency (TWRA)	University of Tennessee Institute of Agriculture; Tennessee Wildlife Resources Agency (TWRA)	The University of Tennessee Institute of Agriculture and Tennessee Wildlife Resources Agency (TWRA) provided funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L.J.S., 2006, INTRO MATH BIOL; Altig R., 1999, TADPOLES BIOL ANURAN, P170; Berrill M, 1998, ENVIRON TOXICOL CHEM, V17, P1738, DOI [10.1002/etc.5620170914, 10.1897/1551-5028(1998)017&lt;1738:TOETAS&gt;2.3.CO;2]; Bollinger TK, 1999, J WILDLIFE DIS, V35, P413, DOI 10.7589/0090-3558-35.3.413; Brunner JL, 2005, OECOLOGIA, V144, P399, DOI 10.1007/s00442-005-0093-5; Chinchar V. G., 2005, VIRUS TAXONOMY, P163; Chinchar VG, 2002, ARCH VIROL, V147, P447, DOI 10.1007/s007050200000; Converse Kathryn A., 2005, P72; Cotter JD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-493; Cullen BR, 2002, DIS AQUAT ORGAN, V49, P83, DOI 10.3354/dao049083; CULLEN BR, 1995, DIS AQUAT ORGAN, V23, P83, DOI 10.3354/dao023083; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Denver RJ, 1997, HORM BEHAV, V31, P169, DOI 10.1006/hbeh.1997.1383; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; DUPASQUIER L, 1989, ANNU REV IMMUNOL, V7, P251, DOI 10.1146/annurev.immunol.7.1.251; FLAJNIK MF, 1987, IMMUNOL TODAY, V8, P58, DOI 10.1016/0167-5699(87)90240-4; Gahl MK, 2010, CAN J ZOOL, V88, P108, DOI 10.1139/Z09-124; Gantress J, 2003, VIROLOGY, V311, P254, DOI 10.1016/S0042-6822(03)00151-X; Gosner K. L., 1960, Herpetologica, V16, P183; Grant P, 1998, DEV COMP IMMUNOL, V22, P449, DOI 10.1016/S0145-305X(97)00057-8; Gray MJ, 2009, DIS AQUAT ORGAN, V87, P243, DOI 10.3354/dao02138; Green D. Earl, 2005, P89; Green DE, 2002, ANN NY ACAD SCI, V969, P323, DOI 10.1111/j.1749-6632.2002.tb04400.x; Greer AL, 2005, DIS AQUAT ORGAN, V67, P9, DOI 10.3354/dao067009; HAIMOVICH J, 1973, P NATL ACAD SCI USA, V70, P1898, DOI 10.1073/pnas.70.6.1898; Han YP, 2008, COMP BIOCHEM PHYS B, V149, P58, DOI 10.1016/j.cbpb.2007.08.003; Harp EM, 2006, J WILDLIFE DIS, V42, P307, DOI 10.7589/0090-3558-42.2.307; Hoverman JT, 2010, DIS AQUAT ORGAN, V89, P97, DOI 10.3354/dao02200; HSU E, 1984, DIFFERENTIATION, V28, P116, DOI 10.1111/j.1432-0436.1984.tb00274.x; Johnson PTJ, 2009, J ANIM ECOL, V78, P191, DOI 10.1111/j.1365-2656.2008.01455.x; Johnson PJ, 2011, FUNCTIONAL IN PRESS; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Lang E, 2009, FROGS TOADS N AM; Maniero GD, 2006, DEV COMP IMMUNOL, V30, P649, DOI 10.1016/j.dci.2005.09.007; Miller DL, 2007, EMERG INFECT DIS, V13, P342, DOI 10.3201/eid1302.061073; Morales HD, 2010, J VIROL, V84, P4912, DOI 10.1128/JVI.02486-09; Muths E., 2006, 20065224 US GEOL SUR; NEWMAN RA, 1992, BIOSCIENCE, V42, P671, DOI 10.2307/1312173; Pallister Jackie A., 2011, PLoS ONE, V6, P1, DOI 10.1371/journal.pone.0014576; Pauli BD, 1999, ENVIRON TOXICOL CHEM, V18, P2538, DOI [10.1897/1551-5028(1999)018&lt;2538:SOAEAT&gt;2.3.CO;2, 10.1002/etc.5620181122]; Pearman PB, 2005, ECOL LETT, V8, P401, DOI 10.1111/j.1461-0248.2005.00735.x; Picco AM, 2007, J WILDLIFE DIS, V43, P286, DOI 10.7589/0090-3558-43.2.286; Pryor JL, 2000, ENVIRON HEALTH PERSP, V108, P491, DOI 10.2307/3454541; Relyea RA, 2002, ECOL MONOGR, V72, P523, DOI 10.1890/0012-9615(2002)072[0523:CIPITC]2.0.CO;2; Richmond JQ, 2009, BIOSCIENCE, V59, P311, DOI 10.1525/bio.2009.59.4.9; Robert J, 2007, J WILDLIFE DIS, V43, P645, DOI 10.7589/0090-3558-43.4.645; Rojas S, 2005, DIS AQUAT ORGAN, V63, P95, DOI 10.3354/dao063095; Rollins-Smith LA, 1998, IMMUNOL REV, V166, P221, DOI 10.1111/j.1600-065X.1998.tb01265.x; Rollins-Smith LA, 2001, IMMUNOL RES, V23, P273, DOI 10.1385/IR:23:2-3:273; ROLLINSSMITH LA, 1993, DIFFERENTIATION, V54, P155, DOI 10.1111/j.1432-0436.1993.tb01598.x; Schock DM, 2008, COPEIA, P133, DOI 10.1643/CP-06-134; Schock DM, 2010, DIS AQUAT ORGAN, V92, P231, DOI 10.3354/dao02134; Schotthoefer AM, 2003, J PARASITOL, V89, P475, DOI 10.1645/0022-3395(2003)089[0475:ROTSTL]2.0.CO;2; Stokes ME, 2000, CATEGORICAL DATA ANA; Tabin CJ, 1998, NATURE, V396, P322, DOI 10.1038/24516; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; TWEEDELL K, 1968, J NATL CANCER I, V40, P407; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Warne RW, 2011, FUNCT ECOL, V25, P139, DOI 10.1111/j.1365-2435.2010.01793.x; Webster WS, 1998, TERATOLOGY, V58, P13; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Wright KM., 2001, AMPHIBIAN MED CAPTIV; Zar JH, 1999, BIOSTATISTICAL ANAL; Zettergren LD, 2000, J EXP ZOOL, V286, P736, DOI 10.1002/(SICI)1097-010X(20000601)286:7<736::AID-JEZ8>3.0.CO;2-G	64	64	65	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22307	10.1371/journal.pone.0022307	http://dx.doi.org/10.1371/journal.pone.0022307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799820	Green Published, Green Submitted, gold			2022-12-25	WOS:000293097300030
J	Jiao, X; Rosenlund, M; Hooper, SD; Tellgren-Roth, C; He, LQ; Fu, YT; Mangion, J; Sjoblom, T				Jiao, Xiang; Rosenlund, Magnus; Hooper, Sean D.; Tellgren-Roth, Christian; He, Liqun; Fu, Yutao; Mangion, Jonathan; Sjoblom, Tobias			Structural Alterations from Multiple Displacement Amplification of a Human Genome Revealed by Mate-Pair Sequencing	PLOS ONE			English	Article							HUMAN BREAST; DNA; PCR	Comprehensive identification of the acquired mutations that cause common cancers will require genomic analyses of large sets of tumor samples. Typically, the tissue material available from tumor specimens is limited, which creates a demand for accurate template amplification. We therefore evaluated whether phi29-mediated whole genome amplification introduces false positive structural mutations by massive mate-pair sequencing of a normal human genome before and after such amplification. Multiple displacement amplification led to a decrease in clone coverage and an increase by two orders of magnitude in the prevalence of inversions, but did not increase the prevalence of translocations. While multiple strand displacement amplification may find uses in translocation analyses, it is likely that alternative amplification strategies need to be developed to meet the demands of cancer genomics.	[Jiao, Xiang; Rosenlund, Magnus; Hooper, Sean D.; Tellgren-Roth, Christian; Sjoblom, Tobias] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [He, Liqun] Appl Biosyst Inc, Life Technol, Stockholm, Sweden; [Fu, Yutao] Appl Biosyst Inc, Life Technol, Beverly, MA USA; [Mangion, Jonathan] Appl Biosyst Inc, Life Technol, Renfrew, Scotland	Uppsala University; Thermo Fisher Scientific; Applied Biosystems; Thermo Fisher Scientific; Applied Biosystems; Thermo Fisher Scientific; Applied Biosystems	Jiao, X (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden.	tobias.sjoblom@igp.uu.se		He, Liqun/0000-0003-2127-7597; Tellgren-Roth, Christian/0000-0003-0502-3693	Swedish Cancer Foundation; Swedish Foundation for Strategic Research	Swedish Cancer Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	The study was supported by a Young Investigator Award grant to TS from the Swedish Cancer Foundation, and a Future Research Leaders grant to TS from the Swedish Foundation for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Lasken Roger S, 2007, BMC Biotechnol, V7, P19, DOI 10.1186/1472-6750-7-19; Lovmar L, 2006, HUM MUTAT, V27, P603, DOI 10.1002/humu.20341; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Nelson JR, 2002, BIOTECHNIQUES, P44; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Tanabe C, 2003, GENE CHROMOSOME CANC, V38, P168, DOI 10.1002/gcc.10269; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Volik S, 2003, P NATL ACAD SCI USA, V100, P7696, DOI 10.1073/pnas.1232418100; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	14	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22250	10.1371/journal.pone.0022250	http://dx.doi.org/10.1371/journal.pone.0022250			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799804	gold, Green Published, Green Submitted			2022-12-25	WOS:000293097300023
J	Iannuzzi, C; Adinolfi, S; Howes, BD; Garcia-Serres, R; Clemancey, M; Latour, JM; Smulevich, G; Pastore, A				Iannuzzi, Clara; Adinolfi, Salvatore; Howes, Barry D.; Garcia-Serres, Ricardo; Clemancey, Martin; Latour, Jean-Marc; Smulevich, Giulietta; Pastore, Annalisa			The Role of CyaY in Iron Sulfur Cluster Assembly on the E. coli IscU Scaffold Protein	PLOS ONE			English	Article							4FE-4S CLUSTERS; BINDING PROPERTIES; 2FE-2S CLUSTER; HUMAN FRATAXIN; GENE-CLUSTER; BIOSYNTHESIS; BIOGENESIS; ISD11	Progress in understanding the mechanism underlying the enzymatic formation of iron-sulfur clusters is difficult since it involves a complex reaction and a multi-component system. By exploiting different spectroscopies, we characterize the effect on the enzymatic kinetics of cluster formation of CyaY, the bacterial ortholog of frataxin, on cluster formation on the scaffold protein IscU. Frataxin/CyaY is a highly conserved protein implicated in an incurable ataxia in humans. Previous studies had suggested a role of CyaY as an inhibitor of iron sulfur cluster formation. Similar studies on the eukaryotic proteins have however suggested for frataxin a role as an activator. Our studies independently confirm that CyaY slows down the reaction and shed new light onto the mechanism by which CyaY works. We observe that the presence of CyaY does not alter the relative ratio between [2Fe2S](2+) and [4Fe4S](2+) but directly affects enzymatic activity.	[Iannuzzi, Clara; Adinolfi, Salvatore; Pastore, Annalisa] Natl Inst Med Res, MRC, London NW7 1AA, England; [Howes, Barry D.; Smulevich, Giulietta] Univ Florence, Dipartimento Chim Ugo Schiff, Florence, Italy; [Garcia-Serres, Ricardo] iRTSV LCBM, Commissariat Energie Atom, Grenoble, France; [Clemancey, Martin] CNRS, UMR 5249, Grenoble, France; [Latour, Jean-Marc] Univ Grenoble 1, Grenoble, France	MRC National Institute for Medical Research; University of Florence; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Iannuzzi, C (corresponding author), Natl Inst Med Res, MRC, London NW7 1AA, England.	apastor@nimr.mrc.ac.uk	García-Serres, Ricardo/E-4344-2012; Iannuzzi, Clara/H-6764-2012	García-Serres, Ricardo/0000-0001-5203-0568; IANNUZZI, Clara/0000-0003-0092-5997; Smulevich, Giulietta/0000-0003-3021-8919; ADINOLFI, Salvatore/0000-0003-1319-5516	MRC [U117584256]; EU EFACTS consortium; Region Rhone-Alpes [CIBLE 07 016335]; MRC [MC_U117584256] Funding Source: UKRI; Medical Research Council [MC_U117584256] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU EFACTS consortium; Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	AP acknowledges the financial support of MRC (Grant ref. U117584256) and of the EU EFACTS consortium. JML acknowledges the support of the Region Rhone-Alpes through contract CIBLE 07 016335. GS acknowledges the support of a local Italian grant (ex 60%). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Adinolfi S, 2002, HUM MOL GENET, V11, P1865, DOI 10.1093/hmg/11.16.1865; Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Bedekovics T, 2007, FEMS YEAST RES, V7, P1276, DOI 10.1111/j.1567-1364.2007.00296.x; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; BONOMI F, 1985, EUR J BIOCHEM, V148, P67, DOI 10.1111/j.1432-1033.1985.tb08808.x; Brereton PS, 1999, BIOCHEMISTRY-US, V38, P10594, DOI 10.1021/bi990671d; Cavadini P, 2002, HUM MOL GENET, V11, P217, DOI 10.1093/hmg/11.3.217; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; CONOVER RC, 1990, J BIOL CHEM, V265, P8533; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; FU WG, 1991, FEBS LETT, V284, P165, DOI 10.1016/0014-5793(91)80676-T; Gakh O, 2010, J BIOL CHEM, V285, P38486, DOI 10.1074/jbc.M110.145144; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; HOLM RH, 1977, BIOL ASPECTS INORGAN, P71; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; JOHNSON MK, 2005, ENCY INORGANIC CHEM, V2, P2589; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Pandolfo M, 2009, J NEUROL, V256, P9, DOI 10.1007/s00415-009-1003-2; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Prischi F, 2010, PROTEIN EXPRES PURIF, V73, P161, DOI 10.1016/j.pep.2010.05.003; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; SPIRO TG, RESONANCE RAMAN SPEC, P523; Takahashi Y, 1999, J BIOCHEM, V126, P917, DOI 10.1093/oxfordjournals.jbchem.a022535; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	36	36	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e21992	10.1371/journal.pone.0021992	http://dx.doi.org/10.1371/journal.pone.0021992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799759	gold, Green Published			2022-12-25	WOS:000292931200018
J	Pilon, R; Leonard, L; Kim, J; Vallee, D; De Rubeis, E; Jolly, AM; Wylie, J; Pelude, L; Sandstrom, P				Pilon, Richard; Leonard, Lynne; Kim, John; Vallee, Dominic; De Rubeis, Emily; Jolly, Ann M.; Wylie, John; Pelude, Linda; Sandstrom, Paul			Transmission Patterns of HIV and Hepatitis C Virus among Networks of People Who Inject Drugs	PLOS ONE			English	Article							EPIDEMIOLOGY; INFECTIONS; USERS	Background: The risk-related behaviours and practices associated with injection drug use remain a driver of HIV and hepatitis C virus (HCV) transmission throughout the world. Here we evaluated HIV and HCV transmission patterns in the context of social networks of injection drug users (IDU) recruited from a higher incidence region in order to better understand factors that contribute to ongoing transmission among IDU. Methods: IDU recruited through a chain-referral method provided biological specimens for analysis. HIV and HCV positive specimens were sequenced and analyzed using phylogenetic methods (Neighbour-joining and Bayesian) and transmission patterns of HIV and HCV evaluated in the context of the recruitment networks. Results: Among the 407 recruited IDU, HCV and HIV prevalence were 60.6% and 10.1%, respectively; 98% of HIV positive individuals were co-infected with HCV. Thirty-six percent of HCV sequences were associated with clusters, compared to 67% of HIV sequences. Four (16.7%) of the 24 HCV clusters contained membership separated by 2 or fewer recruitment cycles, compared to 10 (41.6%) derived from more than one recruitment component. Two (28.6%) of the 7 HIV clusters contained membership separated by 2 or fewer recruitment cycles while 6 (85.7%) were composed of inter component membership. Conclusions: Few HIV and HCV transmissions coincided with the recruitment networks, suggesting that they occurred in a different social context or a context not captured by the recruitment network. However, among the complete cohort, a higher degree of HIV clustering indicates many are recent infections originating from within current social networks, whereas a larger proportion of HCV infections may have occurred earlier in injecting history and in the context of a different social environment.	[Pilon, Richard; Kim, John; Vallee, Dominic; Sandstrom, Paul] Publ Hlth Agcy Canada, Natl HIV & Retrovirol Labs, Ottawa, ON, Canada; [Leonard, Lynne; De Rubeis, Emily; Jolly, Ann M.] Univ Ottawa, Ottawa, ON, Canada; [Jolly, Ann M.; Pelude, Linda] Publ Hlth Agcy Canada, Ctr Communicable Dis & Infect Control, Ottawa, ON, Canada; [Wylie, John] Univ Manitoba, Winnipeg, MB, Canada; [Wylie, John] Manitoba Hlth, Cadham Prov Lab, Winnipeg, MB, Canada	Public Health Agency of Canada; University of Ottawa; Public Health Agency of Canada; University of Manitoba	Pilon, R (corresponding author), Publ Hlth Agcy Canada, Natl HIV & Retrovirol Labs, Ottawa, ON, Canada.	paul.sandstrom@phac-aspc.gc.ca		Pilon, Richard/0000-0003-0100-6917	Ontario HIV Treatment Network [ROGB171]; Public Health Agency of Canada	Ontario HIV Treatment Network; Public Health Agency of Canada	This study was funded by Ontario HIV Treatment Network (www.ohtn.on.ca, grant number ROGB171), as well as support from the Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CK, 2004, J INFECT DIS, V190, P1586, DOI 10.1086/424678; [Anonymous], 2010, WHO MANUAL HIV DRUG; Batagelj V, 2002, LECT NOTES COMPUT SC, V2265, P477; Bernard EJ, 2007, HIV MED, V8, P382, DOI 10.1111/j.1468-1293.2007.00486.x; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Brooks JT, 2006, AIDS, V20, P923, DOI 10.1097/01.aids.0000218558.82402.59; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SS, 2009, HONG KONG MED J, V15, P45; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; McMahon JM, 2007, J INFECT DIS, V195, P1572, DOI 10.1086/516785; Millson P, 2005, INJECTION DRUG USE H; Pham ST, 2010, HEPATOLOGY, V52, P1564, DOI 10.1002/hep.23885; Public Health Agency of Canada, 2007, MOD INC PREV HEP C I; Public Health Agency of Canada, 2007, HIV AIDS EP UPD; Smyth BP, 1998, ADDICTION, V93, P1649, DOI 10.1046/j.1360-0443.1998.931116493.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; *UNAIDS, 2008, REP GLOB HIV AIDS EP; Yirrell DI, 1997, BRIT MED J, V314, P1446, DOI 10.1136/bmj.314.7092.1446	20	52	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22245	10.1371/journal.pone.0022245	http://dx.doi.org/10.1371/journal.pone.0022245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799802	Green Published, Green Submitted, gold			2022-12-25	WOS:000292931200038
J	Sayadi, A; Briganti, L; Tramontano, A; Via, A				Sayadi, Ahmed; Briganti, Leonardo; Tramontano, Anna; Via, Allegra			Exploiting Publicly Available Biological and Biochemical Information for the Discovery of Novel Short Linear Motifs	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; ERYTHROPOIETIN RECEPTOR; INTERACTION NETWORKS; PROTEIN FAMILIES; LIGAND-BINDING; DOMAIN; LOCALIZATION; VIRULENCE; REVEALS; COMPLEX	The function of proteins is often mediated by short linear segments of their amino acid sequence, called Short Linear Motifs or SLiMs, the identification of which can provide important information about a protein function. However, the short length of the motifs and their variable degree of conservation makes their identification hard since it is difficult to correctly estimate the statistical significance of their occurrence. Consequently, only a small fraction of them have been discovered so far. We describe here an approach for the discovery of SLiMs based on their occurrence in evolutionarily unrelated proteins belonging to the same biological, signalling or metabolic pathway and give specific examples of its effectiveness in both rediscovering known motifs and in discovering novel ones. An automatic implementation of the procedure, available for download, allows significant motifs to be identified, automatically annotated with functional, evolutionary and structural information and organized in a database that can be inspected and queried. An instance of the database populated with pre-computed data on seven organisms is accessible through a publicly available server and we believe it constitutes by itself a useful resource for the life sciences (http://www.biocomputing.it/modipath).	[Sayadi, Ahmed; Tramontano, Anna; Via, Allegra] Sapienza Univ Rome, Dept Phys, Rome, Italy; [Briganti, Leonardo] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Tramontano, Anna] Sapienza Univ Rome, Ist Pasteur Fdn Cenci Bolognetti, Rome, Italy	Sapienza University Rome; University of Rome Tor Vergata; Fondazione Cenci Bolognetti; Sapienza University Rome	Sayadi, A (corresponding author), Sapienza Univ Rome, Dept Phys, Rome, Italy.	allegra.via@uniroma1.it	Tramontano, anna/D-5378-2009; Via, Allegra/AAY-7435-2020	Tramontano, anna/0000-0002-5610-3338; 	King Abdullah University of Science and Technology (KAUST) [KUK-I1-012-43]; Fondazione Roma; Italian Ministry of Health [onc_ord 25/07]	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); Fondazione Roma(Fondazione RomaEuropean Commission); Italian Ministry of Health(Ministry of Health, Italy)	This work was partially supported by Award No. KUK-I1-012-43 made by King Abdullah University of Science and Technology (KAUST: http://www.kaust.edu.sa/), by Fondazione Roma (http://www.fondazioneroma.it/it/index.html) and by the Italian Ministry of Health (http://www.salute.gov.it/), contract no. onc_ord 25/07, FIRB ITALBIONET and PROTEOMICA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Ceol A, 2007, NUCLEIC ACIDS RES, V35, pD557, DOI 10.1093/nar/gkl961; Cesareni G, 2002, FEBS LETT, V513, P38, DOI 10.1016/S0014-5793(01)03307-5; DAVEY NE, NUCL ACIDS RES S, V38, pW534; Davey NE, 2006, NUCLEIC ACIDS RES, V34, P3546, DOI 10.1093/nar/gkl486; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Edwards RJ, 2008, BIOINFORMATICS, V24, P1307, DOI 10.1093/bioinformatics/btn105; FUJIKI Y, 1992, No To Hattatsu, V24, P181; Furmanek A, 2000, ACTA BIOCHIM POL, V47, P781, DOI 10.18388/abp.2000_3996; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; GOULD SJ, 1988, J CELL BIOL, V107, P897, DOI 10.1083/jcb.107.3.897; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karp PD, 2000, NUCLEIC ACIDS RES, V28, P56, DOI 10.1093/nar/28.1.56; Klukas C, 2007, BIOINFORMATICS, V23, P344, DOI 10.1093/bioinformatics/btl611; Lesa GM, 2003, J CELL SCI, V116, P4965, DOI 10.1242/jcs.00918; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Marcatili P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S11; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Marza E, 2008, MOL BIOL CELL, V19, P833, DOI 10.1091/mbc.E07-07-0719; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; MIURA S, 1992, J BIOL CHEM, V267, P14405; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Passani LA, 2000, HUM MOL GENET, V9, P2175, DOI 10.1093/hmg/9.14.2175; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; Russo T, 1998, FEBS LETT, V434, P1, DOI 10.1016/S0014-5793(98)00941-7; SCHIMMENTI LA, 1995, EXP HEMATOL, V23, P1341; Shannon CE, 1997, M D COMPUT, V14, P306; Tamada T, 2006, P NATL ACAD SCI USA, V103, P3135, DOI 10.1073/pnas.0511264103; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; YOSHIMURA A, 1992, J BIOL CHEM, V267, P11619	50	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22270	10.1371/journal.pone.0022270	http://dx.doi.org/10.1371/journal.pone.0022270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799808	Green Published, gold, Green Submitted			2022-12-25	WOS:000292931200042
J	Zirbes, L; Mescher, M; Vrancken, V; Wathelet, JP; Verheggen, FJ; Thonart, P; Haubruge, E				Zirbes, Lara; Mescher, Mark; Vrancken, Veronique; Wathelet, Jean-Paul; Verheggen, Francois J.; Thonart, Philippe; Haubruge, Eric			Earthworms Use Odor Cues to Locate and Feed on Microorganisms in Soil	PLOS ONE			English	Article							GEOTRICHUM-CANDIDUM; VOLATILE COMPOUNDS; ORGANIC-MATTER; IDENTIFICATION; PREFERENCES; ATTRACTANT; NEMATODES; BEHAVIOR; FRUIT	Earthworms are key components of temperate soil ecosystems but key aspects of their ecology remain unexamined. Here we elucidate the role of olfactory cues in earthworm attraction to food sources and document specific chemical cues that attract Eisenia fetida to the soil fungi Geotrichum candidum. Fungi and other microorganisms are major sources of volatile emissions in soil ecosystems as well as primary food sources for earthworms, suggesting the likelihood that earthworms might profitably use olfactory cues to guide foraging behavior. Moreover, previous studies have documented earthworm movement toward microbial food sources. But, the specific olfactory cues responsible for earthworm attraction have not previously been identified. Using olfactometer assays combined with chemical analyses (GC-MS), we documented the attraction of E. fetida individuals to filtrate derived from G. candidum colonies and to two individual compounds tested in isolation: ethyl pentanoate and ethyl hexanoate. Attraction at a distance was observed when barriers prevented the worms from reaching the target stimuli, confirming the role of volatile cues. These findings enhance our understanding of the mechanisms underlying key trophic interactions in soil ecosystems and have potential implications for the extraction and collection of earthworms in vermiculture and other applied activities.	[Zirbes, Lara; Wathelet, Jean-Paul] Univ Liege, Lab Gen & Organ Chem, Gembloux, Belgium; [Mescher, Mark] Penn State Univ, Ctr Chem Ecol, Dept Entomol, State Coll, PA USA; [Thonart, Philippe] Univ Liege, Lab Bioind, Gembloux, Belgium	University of Liege; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Liege	Zirbes, L (corresponding author), Univ Liege, Lab Gen & Organ Chem, Gembloux, Belgium.	Lara.Zirbes@ulg.ac.be		Verheggen, Francois/0000-0002-5849-1661; Haubruge, Eric/0000-0002-8138-0476	Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture (FRIA), Belgium	Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture (FRIA), Belgium(Fonds de la Recherche Scientifique - FNRS)	LZ was financially supported by a PhD grant from the Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture (FRIA), Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Mukdsi MCA, 2009, FOOD CHEM, V117, P241, DOI 10.1016/j.foodchem.2009.03.105; [Anonymous], 2014, PHEROMONES ANIMAL BE; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Boff MIC, 2001, ENTOMOL EXP APPL, V98, P329, DOI 10.1023/A:1018907812376; Bonkowski M, 2000, PEDOBIOLOGIA, V44, P666, DOI 10.1078/S0031-4056(04)70080-3; Bonkowski M, 1997, SOIL BIOL BIOCHEM, V29, P499, DOI 10.1016/S0038-0717(96)00107-1; Boutrou R, 2005, INT J FOOD MICROBIOL, V102, P1, DOI 10.1016/j.ijfoodmicro.2004.12.028; BURGER BV, 1995, Z NATURFORSCH C, V50, P675; Chan KY, 2001, PEDOBIOLOGIA, V45, P272, DOI 10.1078/0031-4056-00084; Chaudhuri P. S., 1996, Indian Journal of Experimental Biology, V34, P277; Chen F, 2004, PLANT PHYSIOL, V135, P1956, DOI 10.1104/pp.104.044388; Coleman D.C., 2004, FUNDAMENTALS SOIL EC; COSSE AA, 1994, ENTOMOL EXP APPL, V72, P233, DOI 10.1007/BF02383810; Curry JP, 2007, PEDOBIOLOGIA, V50, P463, DOI 10.1016/j.pedobi.2006.09.001; DACKS AM, 2009, OLFACTION INVERTEBRA, P49; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Doube Bernard M., 1998, P179; Doube BM, 1997, SOIL BIOL BIOCHEM, V29, P569, DOI 10.1016/S0038-0717(96)00032-6; Edwards C.A., 1996, BIOL ECOLOGY EARTHWO, V3rd; EDWARDS CA, 1988, AGR ECOSYST ENVIRON, V24, P235, DOI 10.1016/0167-8809(88)90069-2; Fischer G, 1999, CHEMOSPHERE, V39, P795, DOI 10.1016/S0045-6535(99)00015-6; Grasse P.-P, 1965, TRAITE ZOOLOGIE ANAT; Gronstol Gaute Bo, 2000, Fauna  Norvegica, V20, P27; Hansson B.S., 1999, INSECT OLFACTION; HILDEBRAND JG, 1995, P NATL ACAD SCI USA, V92, P67, DOI 10.1073/pnas.92.1.67; Hogger C.H., 1993, B BODENKUNDL GES SCH, V17, P5; Hong RL, 2006, CURR BIOL, V16, P2359, DOI 10.1016/j.cub.2006.10.031; JOLLIVET N, 1994, J DAIRY RES, V61, P241, DOI 10.1017/S0022029900028259; LATRASSE A, 1987, SCI ALIMENT, V7, P637; LAVERACK MS, 1960, COMP BIOCHEM PHYSIOL, V1, P155, DOI 10.1016/0010-406X(60)90047-5; Lee K. E., 1985, Earthworms: their ecology and relationships with soils and land use.; Mendgen K, 2006, PLANTA, V224, P1353, DOI 10.1007/s00425-006-0320-2; Muramoto Joji, 2002, Edaphologia, V70, P7; Neilson R, 2003, PEDOBIOLOGIA, V47, P1, DOI 10.1078/S0031-4056(04)70173-0; Nuutinen V, 1997, J ZOOL, V242, P783, DOI 10.1111/j.1469-7998.1997.tb05826.x; Olive P.J.W., 1978, P271; Parthasarathi K, 2007, J ENVIRON BIOL, V28, P87; Randlkofer B, 2010, BASIC APPL ECOL, V11, P383, DOI 10.1016/j.baae.2010.03.003; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Runyon JB, 2006, SCIENCE, V313, P1964, DOI 10.1126/science.1131371; Satchell J. E., 1967, pUnpaginated; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Verheggen FJ, 2010, VITAM HORM, V83, P215, DOI 10.1016/S0083-6729(10)83009-2; Wenke K, 2010, PLANTA, V231, P499, DOI 10.1007/s00425-009-1076-2; Yamazoe A, 2010, NEUROSCI RES, V68, pE278, DOI 10.1016/j.neures.2010.07.1237; Zirbes L, 2010, ETHOLOGY, V116, P546, DOI 10.1111/j.1439-0310.2010.01768.x	51	25	26	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e21927	10.1371/journal.pone.0021927	http://dx.doi.org/10.1371/journal.pone.0021927			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799756	gold, Green Published			2022-12-25	WOS:000292931200017
J	Nogueira, J; Caputi, AA				Nogueira, Javier; Ariel Caputi, Angel			Timing Actions to Avoid Refractoriness: A Simple Solution for Streaming Sensory Signals	PLOS ONE			English	Article							WEAKLY ELECTRIC FISH; TIME-COMPARISON CIRCUIT; PULSATILE MOTOR OUTPUT; CENTRAL-NERVOUS-SYSTEM; JAMMING AVOIDANCE; TEMPORAL INFORMATION; POTASSIUM CURRENTS; DISCHARGE PATTERNS; GYMNOTUS-CARAPO; LATERAL-LINE	Segmenting self-from allo-generated signals is crucial for active sensory processing. We report a dynamic filter used by South American pulse electric fish to distinguish active electro-sensory signals carried by their own electric discharges from other concomitant electrical stimuli (i.e. communication signals). The filter has a sensory component, consisting of an onset type central electro-sensory neuron, and a motor component, consisting of a change in the fish's discharge rate when allo-generated electrical events occur in temporal proximity to the fish's own discharge. We investigated the sensory component of the filter by in vitro mimicking synaptic inputs occurring during behavioral responses to allo-generated interfering signals. We found that active control of the discharge enhances self-generated over allo-generated responses by forcing allo-generated signals into a central refractory period. This hypothesis was confirmed by field potential recordings in freely discharging fish. Similar sensory-motor mechanisms may also contribute to signal segmentation in other sensory systems.	[Nogueira, Javier; Ariel Caputi, Angel] Inst Invest Biol Clemente Estable, Dept Neurociencias Integrat & Computac, Montevideo, Uruguay; [Nogueira, Javier] Univ Republ Oriental Uruguay, Fac Med, Dept Histol & Embriol, Montevideo, Uruguay	Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Universidad de la Republica, Uruguay	Nogueira, J (corresponding author), Inst Invest Biol Clemente Estable, Dept Neurociencias Integrat & Computac, Montevideo, Uruguay.	angel@iibce.edu.uy			European Commission Information, Society and Media Future and Emergent Technologies (FET) [231845]	European Commission Information, Society and Media Future and Emergent Technologies (FET)	Partially funded by European Commission Information, Society and Media Future and Emergent Technologies (FET) Grant # 231845 and PEDECIBA (Uruguay). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER CL, 1980, J COMP PHYSIOL A, V136, P336; Bal R, 2001, J NEUROPHYSIOL, V86, P2299, DOI 10.1152/jn.2001.86.5.2299; Bell CC, 2005, SPR HDB AUD, V21, P68; BELL CC, 1993, P NATL ACAD SCI USA, V90, P4650, DOI 10.1073/pnas.90.10.4650; BELL CC, 1989, J NEUROSCI, V9, P1029; BELL CC, 1992, J NEUROPHYSIOL, V68, P859, DOI 10.1152/jn.1992.68.3.859; BELL CC, 1974, J COMP PHYSIOL, V92, P201, DOI 10.1007/BF00694506; BELL CC, 1981, SCIENCE, V214, P450, DOI 10.1126/science.7291985; BULLOCK TH, 1969, BRAIN BEHAV EVOLUT, V2, P85, DOI 10.1159/000125815; BULLOCK TH, 1961, SCIENCE, V134, P1426; Capurro A, 1998, BIOSYSTEMS, V48, P21, DOI 10.1016/S0303-2647(98)00046-X; Capurro A, 2001, BIOL CYBERN, V84, P309, DOI 10.1007/s004220000222; Caputi AA, 2003, J EXP BIOL, V206, P999, DOI 10.1242/jeb.00199; CARR CE, 1986, J NEUROSCI, V6, P1372; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; CARR CE, 1986, J NEUROSCI, V6, P107; Carr CE, 2001, CURR OPIN NEUROBIOL, V11, P727, DOI 10.1016/S0959-4388(01)00276-8; Castello ME, 1998, J COMP NEUROL, V401, P549; HEILIGENBERG W, 1982, J COMP PHYSIOL, V148, P287, DOI 10.1007/BF00679013; HEILIGENBERG W, 1978, J COMP PHYSIOL, V124, P211, DOI 10.1007/BF00657053; HEILIGENBERG W, 1991, NEURAL NETS IS ELECT; KAWASAKI M, 1993, J COMP PHYSIOL A, V173, P9; LISSMANN HW, 1958, J EXP BIOL, V35, P156; LLINAS RR, 1991, LIFE SCI R, V50, P223; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Lorenzo D, 2005, J COMP PHYSIOL A, V191, P85, DOI 10.1007/s00359-004-0575-7; MacLeod KM, 2006, J COMP NEUROL, V495, P185, DOI 10.1002/cne.20862; MALER L, 1979, J COMP NEUROL, V183, P323, DOI 10.1002/cne.901830208; MANIS PB, 1991, J NEUROSCI, V11, P2865; Nogueira J, 2006, J EXP BIOL, V209, P1122, DOI 10.1242/jeb.02080; Pereira AC, 2005, J EXP BIOL, V208, P961, DOI 10.1242/jeb.01481; Poulet JFA, 2006, SCIENCE, V311, P518, DOI 10.1126/science.1120847; Prescott SA, 2002, J PHYSIOL-LONDON, V539, P817, DOI 10.1113/jphysiol.2001.013437; RETHELYI M, 1973, EXP BRAIN RES, V18, P323, DOI 10.1007/BF00239103; Richer-de-Forges MM, 2009, COPEIA, P538, DOI 10.1643/CI-07-103; Rieke F., 1999, SPIKES EXPLORING NEU; SCHLEGEL PA, 1977, EXP BRAIN RES, V29, P201; Scott LL, 2005, J NEUROSCI, V25, P7887, DOI 10.1523/JNEUROSCI.1016-05.2005; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Svirskis G, 2004, J NEUROPHYSIOL, V91, P2465, DOI 10.1152/jn.00717.2003; SZABO T, 1975, BRAIN RES, V95, P459, DOI 10.1016/0006-8993(75)90121-3; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; WATSON D, 1979, J COMP PHYSIOL, V134, P191, DOI 10.1007/BF00610394; Wessberg J, 1996, J PHYSIOL-LONDON, V493, P895, DOI 10.1113/jphysiol.1996.sp021432; WESSBERG J, 1995, J PHYSIOL-LONDON, V485, P271, DOI 10.1113/jphysiol.1995.sp020729; WESTBY GWM, 1974, J COMP PHYSIOL, V92, P327; WESTBY GWM, 1981, TRENDS NEUROSCI, V4, P205; WESTBY GWM, 1979, BEHAV ECOL SOCIOBIOL, V4, P381	50	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22159	10.1371/journal.pone.0022159	http://dx.doi.org/10.1371/journal.pone.0022159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789228	gold, Green Published			2022-12-25	WOS:000292811700029
J	Schurks, M; Buring, JE; Ridker, PM; Chasman, DI; Kurth, T				Schuerks, Markus; Buring, Julie E.; Ridker, Paul M.; Chasman, Daniel I.; Kurth, Tobias			Genetic Determinants of Cardiovascular Events among Women with Migraine: A Genome-Wide Association Study	PLOS ONE			English	Article							PRIMARY PREVENTION; ISCHEMIC-STROKE; DISEASE; RISK; POLYMORPHISM; AGREEMENT; HEALTH; AURA	Background: Migraine is associated with an increased risk for cardiovascular disease (CVD). Both migraine and CVD are highly heritable. However, the genetic liability for CVD among migraineurs is unclear. Methods: We performed a genome-wide association study for incident CVD events during 12 years of follow-up among 5,122 migraineurs participating in the population-based Women's Genome Health Study. Migraine was self-reported and CVD events were confirmed after medical records review. We calculated odds ratios (OR) and 95% confidence intervals (CI) and considered a genome-wide p-value <5x10(-8) as significant. Results: Among the 5,122 women with migraine 164 incident CVD events occurred during follow-up. No SNP was associated with major CVD, ischemic stroke, myocardial infarction, or CVD death at the genome-wide level; however, five SNPs showed association with p<5x10(-6). Among migraineurs with aura rs7698623 in MEPE (OR = 6.37; 95% CI 3.15-12.90; p = 2.7x10(-7)) and rs4975709 in IRX4 (OR = 5.06; 95% CI 2.66-9.62; p = 7.7x10(-7)) appeared to be associated with ischemic stroke, rs2143678 located close to MDF1 with major CVD (OR = 3.05; 95% CI 1.98-4.69; p = 4.3x10(-7)), and the intergenic rs1406961 with CVD death (OR = 12.33; 95% CI 4.62-32.87; p = 5.2x10(-7)). Further, rs1047964 in BACE1 appeared to be associated with CVD death among women with any migraine (OR = 4.67; 95% CI 2.53-8.62; p = 8.0x10(-7)). Conclusion: Our results provide some suggestion for an association of five SNPs with CVD events among women with migraine; none of the results was genome-wide significant. Four associations appeared among migraineurs with aura, two of those with ischemic stroke. Although our population is among the largest with migraine and incident CVD information, these results must be treated with caution, given the limited number of CVD events among women with migraine and the low minor allele frequencies for three of the SNPs. Our results await independent replication and should be considered hypothesis generating for future research.	[Schuerks, Markus; Buring, Julie E.; Ridker, Paul M.; Chasman, Daniel I.; Kurth, Tobias] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Prevent Med, Boston, MA 02115 USA; [Schuerks, Markus] Univ Hosp Essen, Dept Neurol, Essen, Germany; [Kurth, Tobias] INSERM Unit 708 Neuroepidemiol, Paris, France; [Kurth, Tobias] UPMC Univ Paris 06, F-75005 Paris, France	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Duisburg Essen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Schurks, M (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Prevent Med, Boston, MA 02115 USA.	markus.schuerks@post.harvard.edu	Kurth, Tobias/A-9243-2012	Kurth, Tobias/0000-0001-7169-2620; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Migraine Research Foundation; National Institute of Neurological Disorders and Stroke [NS061836]; National Heart, Lung, and Blood Institute [HL-043851, HL-080467, HL-099355]; National Cancer Institute [CA-47988]; Donald W. Reynolds Foundation; Leducq Foundation; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851, RC1HL099355, R01HL080467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061836] Funding Source: NIH RePORTER	Migraine Research Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W. Reynolds Foundation; Leducq Foundation(Leducq Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from the Migraine Research Foundation and the National Institute of Neurological Disorders and Stroke (NS061836). The "Women's Health Study"' and "Women's Genome Health Study" are supported by grants from the National Heart, Lung, and Blood Institute (HL-043851, HL-080467, HL-099355), and the National Cancer Institute (CA-47988). Part of the research for this work was supported by grants from the Donald W. Reynolds Foundation and the Leducq Foundation. Genome-wide genotyping and collaborative scientific support was provided by Amgen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed B, 2006, AM J MED, V119, P670, DOI 10.1016/j.amjmed.2006.03.023; Atiya M, 2003, STROKE, V34, P565, DOI 10.1161/01.STR.0000054159.21017.7C; Bigal ME, 2010, NEUROLOGY, V74, P628, DOI 10.1212/WNL.0b013e3181d0cc8b; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Bruneau BG, 2000, DEV BIOL, V217, P266, DOI 10.1006/dbio.1999.9548; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Debette S, 2010, STROKE, V41, P210, DOI 10.1161/STROKEAHA.109.569194; Galwey NW, 2009, GENET EPIDEMIOL, V33, P559, DOI 10.1002/gepi.20408; Gudmundsson LS, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3966; Hall GC, 2004, NEUROLOGY, V62, P563, DOI 10.1212/01.WNL.0000110312.36809.7F; Haut SR, 2006, LANCET NEUROL, V5, P148, DOI 10.1016/S1474-4422(06)70348-9; HENRICH JB, 1989, J CLIN EPIDEMIOL, V42, P773, DOI 10.1016/0895-4356(89)90075-9; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; KERR JM, 1993, GENOMICS, V17, P408, DOI 10.1006/geno.1993.1340; Kraut N, 1998, EMBO J, V17, P6276, DOI 10.1093/emboj/17.21.6276; Kurth T, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a636; Kurth T, 2007, ARCH INTERN MED, V167, P795, DOI 10.1001/archinte.167.8.795; Kurth T, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3659; Kurth T, 2006, JAMA-J AM MED ASSOC, V296, P283, DOI 10.1001/jama.296.3.283; Lanktree MB, 2010, STROKE, V41, P825, DOI 10.1161/STROKEAHA.109.570523; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Lee ST, 2008, NEUROLOGY, V70, P1510, DOI 10.1212/01.wnl.0000294329.93565.94; Lipton RB, 2001, HEADACHE, V41, P638, DOI 10.1046/j.1526-4610.2001.041007638.x; MacClellan LR, 2007, STROKE, V38, P2438, DOI 10.1161/STROKEAHA.107.488395; Matarin M, 2010, J INTERN MED, V267, P139, DOI 10.1111/j.1365-2796.2009.02202.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rowe PSN, 2000, GENOMICS, V67, P54, DOI 10.1006/geno.2000.6235; Ruckert F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012243; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schurks M, 2009, CEPHALALGIA, V29, P1086, DOI 10.1111/j.1468-2982.2008.01835.x; Schurks M, 2009, NEUROLOGY, V72, P650, DOI 10.1212/01.wnl.0000342517.97178.f6; Schurks M, 2010, HEADACHE, V50, P588, DOI 10.1111/j.1526-4610.2009.01570.x; Schurks M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3914; Schurks M, 2008, NEUROLOGY, V71, P505, DOI 10.1212/01.wnl.0000316198.34558.e5; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Sternfeld B, 1995, NEUROLOGY, V45, P2135, DOI 10.1212/WNL.45.12.2135; Tietjen GE, 2007, NEUROLOGY, V68, P1555, DOI 10.1212/01.wnl.0000265415.18382.fb; Vanmolkot FH, 2007, NEUROLOGY, V68, P1563, DOI 10.1212/01.wnl.0000260964.28393.ed; Velentgas P, 2004, HEADACHE, V44, P642, DOI 10.1111/j.1526-4610.2004.04122.x	43	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22106	10.1371/journal.pone.0022106	http://dx.doi.org/10.1371/journal.pone.0022106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779381	gold, Green Submitted, Green Published			2022-12-25	WOS:000292811300040
J	de Andrea, CE; Reijnders, CMA; Kroon, HM; de Jong, D; Hogendoorn, PCW; Szuhai, K; Bovee, JVMG				de Andrea, C. E.; Reijnders, C. M. A.; Kroon, H. M.; de Jong, D.; Hogendoorn, P. C. W.; Szuhai, K.; Bovee, J. V. M. G.			Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT	ONCOGENE			English	Article						chondrosarcoma; osteochondroma; EXT1; array-CGH; FISH; bone tumors	HEREDITARY MULTIPLE EXOSTOSES; HEPARAN-SULFATE; MOUSE MODEL; HETEROZYGOSITY; BONE; EXPRESSION; TUMORS; CHROMOSOME-11; INACTIVATION; PROGRESSION	Secondary peripheral chondrosarcoma is the result of malignant transformation of a pre-existing osteochondroma, the most common benign bone tumor. Osteochondromas are caused by genetic abnormalities in EXT1 or EXT2: homozygous deletion of EXT1 characterizes sporadic osteochondromas (non-familial/solitary), and germline mutations in EXT1 or EXT2 combined with loss of heterozygosity define hereditary multiple osteochondromas. While cells with homozygous inactivation of EXT and wild-type cells shape osteochondromas, the cellular composition of secondary peripheral chondrosarcomas and the role of EXT in their formation have remained unclear. We report using a targeted-tiling-resolution oligo-array-CGH (array comparative genomic hybridization) that homozygous deletions of EXT1 or EXT2 are much less frequently detected (2/17, 12%) in sporadic secondary peripheral chondrosarcomas than expected based on the assumption that they originate in sporadic osteochondromas, in which homozygous inactivation of EXT1 is found in similar to 80% of our cases. FISH with an EXT1 probe confirmed that, unlike sporadic osteochondromas, cells from sporadic secondary peripheral chondrosarcomas predominantly retained one (hemizygous deleted loci) or both copies (wild-type) of the EXT1 locus. By immunohistochemistry, we confirm the presence of cells with dysfunctional EXT1 in sporadic osteochondromas and show cells with functional EXT1 in sporadic secondary peripheral chondrosarcomas. These immuno results were verified in osteochondromas and secondary peripheral chondrosarcomas in the setting of hereditary multiple osteochondromas. Our data therefore point to a model of oncogenesis in which the osteochondroma creates a niche in which wild-type cells with functional EXT are predisposed to acquire other mutations giving rise to secondary peripheral chondrosarcoma, indicating that EXT-independent mechanisms are involved in the pathogenesis of secondary peripheral chondrosarcoma. Oncogene (2012) 31, 1095-1104; doi:10.1038/onc.2011.311; published online 1 August 2011	[de Andrea, C. E.; Reijnders, C. M. A.; Hogendoorn, P. C. W.; Bovee, J. V. M. G.] Leiden Univ, Dept Pathol, Med Ctr, NL-2300 RC Leiden, Netherlands; [Kroon, H. M.] Leiden Univ, Dept Radiol, Med Ctr, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Bovee, JVMG (corresponding author), Leiden Univ, Dept Pathol, Med Ctr, POB 9600,L1-Q, NL-2300 RC Leiden, Netherlands.	j.v.m.g.bovee@lumc.nl	Szuhai, Karoly/A-1100-2008; Hogendoorn, Pancras/O-6494-2019; Hogendoorn, Pancras C.W./H-5859-2015	Szuhai, Karoly/0000-0002-1228-4245; Hogendoorn, Pancras/0000-0002-1513-8104; Hogendoorn, Pancras C.W./0000-0002-1513-8104; de Jong, Danielle/0000-0003-4003-5593; Bovee, Judith/0000-0003-1155-0481	Netherlands Organization for Scientific Research [917-76-315]; EuroBoNeT [LSHC-CT-2006-018814]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); EuroBoNeT(European CommissionEuropean Commission Joint Research Centre)	We acknowledge the expert technical work of Marja van der Burg, Inge Briaire-de Bruijn, Maayke van Ruler and Pauline M Wijers-Koster (Leiden University Medical Center, Leiden, The Netherlands). We also thank the Netherlands Committee on Bone Tumors. Professor E Bakker is acknowledged for EXT mutation analysis. This study was supported by Netherlands Organization for Scientific Research (917-76-315 to CMAR and JVMGB) and by EuroBoNeT (a European Commission-granted European Network of Excellence for studying the pathology and genetics of bone tumors; grant number: LSHC-CT-2006-018814 (to CEA, JVMGB, DJ, KS and PCWH).	Bernard SA, 2010, RADIOLOGY, V255, P857, DOI 10.1148/radiol.10082120; Bertoni F., 2002, WHO CLASSIFICATION T, P247; Bovee JVMG, 2010, NAT REV CANCER, V10, P481, DOI 10.1038/nrc2869; Bovee JVMG, 2000, AM J PATHOL, V157, P1587, DOI 10.1016/S0002-9440(10)64796-7; Bovee JVMG, 1999, GENE CHROMOSOME CANC, V26, P237; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Clement A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000136; de Andrea CE, 2011, J PATHOL, V224, P160, DOI 10.1002/path.2886; de Andrea CE, 2010, LAB INVEST, V90, P1091, DOI 10.1038/labinvest.2010.81; Dorfman HD, 2002, WHO CLASSIFICATION T, P226; EVANS HL, 1977, CANCER-AM CANCER SOC, V40, P818, DOI 10.1002/1097-0142(197708)40:2<818::AID-CNCR2820400234>3.0.CO;2-B; Hallor KH, 2009, CLIN CANCER RES, V15, P2685, DOI 10.1158/1078-0432.CCR-08-2330; Hameetman L, 2007, J PATHOL, V211, P399, DOI 10.1002/path.2127; Hameetman L, 2007, JNCI-J NATL CANCER I, V99, P396, DOI 10.1093/jnci/djk067; HECHT JT, 1995, AM J HUM GENET, V56, P1125; Jones KB, 2010, P NATL ACAD SCI USA, V107, P2054, DOI 10.1073/pnas.0910875107; Khurana J, 2002, WHO CLASSIFICATION T, P234; Matsumoto K, 2010, P NATL ACAD SCI USA, V107, P10932, DOI 10.1073/pnas.0914642107; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; Mohseny AB, 2010, GENE CHROMOSOME CANC, V49, P1095, DOI 10.1002/gcc.20817; Pansuriya TC, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-2; Raaijmakers MHGP, 2011, HAEMATOL-HEMATOL J, V96, P1041, DOI 10.3324/haematol.2010.028035; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; RASKIND WH, 1995, AM J HUM GENET, V56, P1132; Reijmers RM, 2010, BLOOD, V115, P601, DOI 10.1182/blood-2009-02-204396; Reijnders CMA, 2010, AM J PATHOL, V177, P1946, DOI 10.2353/ajpath.2010.100296; Szuhai K, 2011, HUM MUTAT, V32, pE2036, DOI 10.1002/humu.21423; Szuhai K, 2009, CLIN CANCER RES, V15, P2259, DOI 10.1158/1078-0432.CCR-08-2184; van den Berg H, 2008, J PEDIATR ORTHOPED, V28, P29, DOI 10.1097/BPO.0b013e3181558cb5; Ventura RA, 2006, J MOL DIAGN, V8, P141, DOI 10.2353/jmoldx.2006.050083; Zak BM, 2002, BBA-GEN SUBJECTS, V1573, P346, DOI 10.1016/S0304-4165(02)00402-6; Zuntini M, 2010, ONCOGENE, V29, P3827, DOI 10.1038/onc.2010.135	32	45	45	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	9					1095	1104		10.1038/onc.2011.311	http://dx.doi.org/10.1038/onc.2011.311			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	901EW	21804604	Green Published			2022-12-25	WOS:000300945900003
J	Petersen, PS; Jin, CY; Madsen, AN; Rasmussen, M; Kuhre, R; Egerod, KL; Nielsen, LB; Schwartz, TW; Holst, B				Petersen, Pia Steen; Jin, Chunyu; Madsen, Andreas Nygaard; Rasmussen, Maria; Kuhre, Rune; Egerod, Kristoffer L.; Nielsen, Lars Bo; Schwartz, Thue W.; Holst, Birgitte			Deficiency of the GPR39 receptor is associated with obesity and altered adipocyte metabolism	FASEB JOURNAL			English	Article						7TM receptor signaling; lipolysis; high-fat diet	DIET-INDUCED THERMOGENESIS; BETA-ADRENERGIC-RECEPTORS; ADIPOSE-TISSUE; ENERGY-METABOLISM; SURROGATE INDEXES; PROTEIN; LIPOLYSIS; MICE; EXPRESSION; WHITE	GPR39, a constitutively active 7TM receptor important for glucose-induced insulin secretion and maturation of pancreatic beta-cell function, is up-regulated in adipose tissue on abstinence from food and chemically induced diabetes. In the present study, we investigated the effect of GPR39 deficiency on body weight and adipocyte metabolism. GPR39-deficient mice were subjected to a high-fat diet and body composition, glucose tolerance, insulin secretion, food intake, and energy expenditure were evaluated. The cell biology of adipocyte metabolism was studied on both mRNA and protein levels. A significant increase in body weight corresponding to a 2-fold selective increase in fat mass was observed in GPR39-deficient mice fed a high-fat diet as compared with wild-type littermate controls fed the same diet. The GPR39-deficient animals had similar food intake but displayed almost eliminated diet-induced thermogenesis, measured by the oxygen consumption rate (Vo(2)) on change from normal to high-fat diet. Analysis of the adipose tissue for lipolytic enzymes demonstrated decreased level of phosphorylated hormone-sensitive lipase (HSL) and a decreased level of adipose triglyceride lipase (ATGL) by 35 and 60%, respectively, after food withdrawal in the GPR39-deficient mice. Extracellular signal-regulated kinases (ERK1/2), a signaling pathway known to be important for lipolysis, was decreased by 56% in the GPR39-deficient mice. GPR39 deficiency is associated with increased fat accumulation on a high-fat diet, conceivably due to decreased energy expenditure and adipocyte lipolytic activity.-Petersen, P. S., Jin, C., Madsen, A. N., Rasmussen, M., Kuhre, R., L. Egerod, K. L., Nielsen, L. B., Schwartz. T. W., Holst, B. Deficiency of the GPR39 receptor is associated with obesity and altered adipocyte metabolism. FASEB J. 25, 3803-3814 (2011). www.fasebj.org	[Petersen, Pia Steen; Jin, Chunyu; Madsen, Andreas Nygaard; Rasmussen, Maria; Kuhre, Rune; Egerod, Kristoffer L.; Schwartz, Thue W.; Holst, Birgitte] Univ Copenhagen, Fac Hlth Sci, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, DK-2200 Copenhagen, Denmark; [Nielsen, Lars Bo] Univ Copenhagen, Fac Hlth Sci, Dept Clin Biochem, DK-2200 Copenhagen, Denmark; [Schwartz, Thue W.; Holst, Birgitte] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Holst, B (corresponding author), Univ Copenhagen, Mol Pharmacol Lab, Dept Pharmacol, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	holst@sund.ku.dk	Egerod, Kristoffer L/D-9481-2012; Kuhre, Rune Ehrenreich/Q-9415-2016	Egerod, Kristoffer L/0000-0003-2781-1594; Holst, Birgitte/0000-0001-7432-097X; Schwartz, Thue W./0000-0002-0261-6904; Kuhre, Rune Ehrenreich/0000-0003-4787-340X	Danish Medical Research Council; Novo Nordisk Foundation; Lundbeck Foundation; Alfred Benzon Foundation; Danish Ministry of Science, Technology, and Innovation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Alfred Benzon Foundation; Danish Ministry of Science, Technology, and Innovation	The authors are grateful to Bente Friis and Line Olsen for expert technical assistance and to Dr. Helen Cox for critically reading the manuscript. The study was supported by research grant from the Danish Medical Research Council, the Novo Nordisk Foundation, the Lundbeck Foundation, and the Alfred Benzon Foundation and by a grant from the Novo Nordisk Foundation to the Novo Nordisk Foundation Center for Basic Metabolic Research. This work is carried out as a part of the research program of the UNIK: Food, Fitness & Pharma for Health and Disease. The UNIK project is supported by the Danish Ministry of Science, Technology, and Innovation.	Ahmadian M, 2009, DIABETES, V58, P855, DOI 10.2337/db08-1644; Ahmed K, 2010, CELL METAB, V11, P311, DOI 10.1016/j.cmet.2010.02.012; Ahmed K, 2009, TRENDS PHARMACOL SCI, V30, P557, DOI 10.1016/j.tips.2009.09.001; Armani A, 2010, J CELL BIOCHEM, V110, P564, DOI 10.1002/jcb.22598; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Cai TQ, 2008, BIOCHEM BIOPH RES CO, V377, P987, DOI 10.1016/j.bbrc.2008.10.088; Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193; Dittmer S, 2008, J BIOL CHEM, V283, P7074, DOI 10.1074/jbc.M704323200; Egerod KL, 2007, MOL ENDOCRINOL, V21, P1685, DOI 10.1210/me.2007-0055; Gaidhu MP, 2010, AM J PHYSIOL-CELL PH, V298, pC961, DOI 10.1152/ajpcell.00547.2009; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Harada K, 2003, AM J PHYSIOL-ENDOC M, V285, pE1182, DOI 10.1152/ajpendo.00259.2003; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; Holst B, 2007, ENDOCRINOLOGY, V148, P13, DOI 10.1210/en.2006-0933; Holst B, 2009, ENDOCRINOLOGY, V150, P2577, DOI 10.1210/en.2008-1250; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Jimenez M, 2002, FEBS LETT, V530, P37, DOI 10.1016/S0014-5793(02)03387-2; Lee S, 2008, AM J PHYSIOL-ENDOC M, V294, pE261, DOI 10.1152/ajpendo.00676.2007; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Lowell BB, 2003, J BIOL CHEM, V278, P29385, DOI 10.1074/jbc.R300011200; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Moechars D, 2006, GASTROENTEROLOGY, V131, P1131, DOI 10.1053/j.gastro.2006.07.009; Muniyappa R, 2009, AM J PHYSIOL-ENDOC M, V297, pE1023, DOI 10.1152/ajpendo.00397.2009; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Shklyaev S, 2003, P NATL ACAD SCI USA, V100, P14217, DOI 10.1073/pnas.2333912100; Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811; Tremblay F, 2009, ENDOCRINOLOGY, V150, P2586, DOI 10.1210/en.2008-1251; VAUGHAN M, 1964, J BIOL CHEM, V239, P401; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang YH, 2009, CELL METAB, V9, P287, DOI 10.1016/j.cmet.2009.01.013; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Wijers SLJ, 2009, OBES REV, V10, P218, DOI 10.1111/j.1467-789X.2008.00538.x; Woods SC, 2008, J CLIN ENDOCR METAB, V93, pS37, DOI 10.1210/jc.2008-1630; Woods SC, 2009, CELL METAB, V9, P489, DOI 10.1016/j.cmet.2009.04.007; Wortley KE, 2005, J CLIN INVEST, V115, P3573, DOI 10.1172/JCI26003; Zechner R, 2009, NATURE, V458, P1118, DOI 10.1038/4581118a; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zimmermann R, 2003, J LIPID RES, V44, P2089, DOI 10.1194/jlr.M300190-JLR200	47	34	35	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2011	25	11					3803	3814		10.1096/fj.11-184531	http://dx.doi.org/10.1096/fj.11-184531			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21784784				2022-12-25	WOS:000296723100006
J	Koinuma, D; Shinozaki, M; Nagano, Y; Ikushima, H; Horiguchi, K; Goto, K; Chano, T; Saitoh, M; Imamura, T; Miyazono, K; Miyazawa, K				Koinuma, Daizo; Shinozaki, Masahiko; Nagano, Yoshiko; Ikushima, Hiroaki; Horiguchi, Kana; Goto, Kouichiro; Chano, Tokuhiro; Saitoh, Masao; Imamura, Takeshi; Miyazono, Kohei; Miyazawa, Keiji			RB1CC1 Protein Positively Regulates Transforming Growth Factor-beta Signaling through the Modulation of Arkadia E3 Ubiquitin Ligase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; TGF-BETA; C-SKI; DEPENDENT DEGRADATION; MEDIATED DEGRADATION; NEGATIVE REGULATION; CELL-MEMBRANE; HECT DOMAIN; I RECEPTOR; SMAD7	Transforming growth factor-beta (TGF-beta) signaling is controlled by a variety of regulators, of which Smad7, c-Ski, and SnoN play a pivotal role in its negative regulation. Arkadia is a RING-type E3 ubiquitin ligase that targets these negative regulators for degradation to enhance TGF-beta signaling. In the present study we identified a candidate human tumor suppressor gene product RB1CC1/FIP200 as a novel positive regulator of TGF-beta signaling that functions as a substrate-selective cofactor of Arkadia. Overexpression of RB1CC1 enhanced TGF-beta signaling, and knockdown of endogenous RB1CC1 attenuated TGF-beta beta-induced expression of target genes as well as TGF-beta-induced cytostasis. RB1CC1 down-regulated the protein levels of c-Ski but not SnoN by enhancing the activity of Arkadia E3 ligase toward c-Ski. Substrate selectivity is primarily attributable to the physical interaction of RB1CC1 with substrates, suggesting its role as a scaffold protein. RB1CC1 thus appears to play a unique role as a modulator of TGF-beta signaling by restricting substrate specificity of Arkadia.	[Koinuma, Daizo; Shinozaki, Masahiko; Nagano, Yoshiko; Ikushima, Hiroaki; Horiguchi, Kana; Goto, Kouichiro; Saitoh, Masao; Miyazono, Kohei; Miyazawa, Keiji] Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Koinuma, Daizo; Imamura, Takeshi] Japanese Fdn Canc Res, Inst Canc, Div Biochem, Koto Ku, Tokyo 1358550, Japan; [Chano, Tokuhiro] Shiga Univ Med Sci, Dept Clin Lab Med, Shiga 5202192, Japan; [Saitoh, Masao; Miyazawa, Keiji] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biochem, Chuo Ku, Yamanashi 4093898, Japan; [Imamura, Takeshi] Ehime Univ, Dept Mol Med Pathogenesis, Grad Sch Med, Toon, Ehime 7910295, Japan	University of Tokyo; Japanese Foundation for Cancer Research; Shiga University of Medical Science; University of Yamanashi; Ehime University	Miyazono, K (corresponding author), Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan.	miyazono@m.u-tokyo.ac.jp	MIYAZAWA, KEIJI/I-9713-2014; Koinuma, Daizo/Y-8716-2018; Chano, Tokuhiro/F-5816-2018	Koinuma, Daizo/0000-0001-5611-2122; Chano, Tokuhiro/0000-0002-9959-1183	KAKENHI; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22112002, 22390052] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI (grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan).	Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; Chano T, 2002, GENE, V291, P29, DOI 10.1016/S0378-1119(02)00585-1; Chano T, 2002, NAT GENET, V31, P285, DOI 10.1038/ng911; Chano T, 2002, ONCOGENE, V21, P1295, DOI 10.1038/sj.onc.1205178; Chano T, 2006, INT J MOL MED, V18, P425; Chano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011404; Chong PA, 2006, J BIOL CHEM, V281, P17069, DOI 10.1074/jbc.M601493200; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Episkopou V, 2001, NATURE, V410, P825, DOI 10.1038/35071095; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fukuchi M, 2001, MOL BIOL CELL, V12, P1431, DOI 10.1091/mbc.12.5.1431; Gan B, 2008, CELL SIGNAL, V20, P787, DOI 10.1016/j.cellsig.2007.10.021; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Gan BY, 2005, J CELL BIOL, V170, P379, DOI 10.1083/jcb.200411106; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Ibarrola N, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-2; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Ikushima H, 2008, EMBO J, V27, P2955, DOI 10.1038/emboj.2008.218; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Itoh F, 2001, EMBO J, V20, P4132, DOI 10.1093/emboj/20.15.4132; Johnsen SA, 2002, ONCOGENE, V21, P5783, DOI 10.1038/sj.onc.1205681; Kamiya Y, 2010, J BIOL CHEM, V285, P30804, DOI 10.1074/jbc.M110.166140; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kim BC, 2004, MOL CELL BIOL, V24, P2251, DOI 10.1128/MCB.24.6.2251-2262.2004; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Le Scolan E, 2008, CANCER RES, V68, P3277, DOI 10.1158/0008-5472.CAN-07-6793; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Liu W, 2006, EMBO J, V25, P1646, DOI 10.1038/sj.emboj.7601057; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mavrakis KJ, 2007, PLOS BIOL, V5, P586, DOI 10.1371/journal.pbio.0050067; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Miyazono K, 2011, J BIOCHEM, V149, P1, DOI 10.1093/jb/mvq133; Mizutani A, 2010, J BIOCHEM, V148, P733, DOI 10.1093/jb/mvq127; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; Nagano Y, 2007, J BIOL CHEM, V282, P20492, DOI 10.1074/jbc.M701294200; Nagano Y, 2010, J BIOCHEM, V147, P545, DOI 10.1093/jb/mvp202; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Niederlander C, 2001, NATURE, V410, P830, DOI 10.1038/35071103; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Piek E, 2001, ADV CANCER RES, V83, P1, DOI 10.1016/S0065-230X(01)83001-3; Seo SR, 2004, EMBO J, V23, P3780, DOI 10.1038/sj.emboj.7600398; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Suzuki H, 2004, ONCOGENE, V23, P5068, DOI 10.1038/sj.onc.1207690; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Ueda H, 2000, J CELL BIOL, V149, P423, DOI 10.1083/jcb.149.2.423; Wei HJ, 2009, J BIOL CHEM, V284, P6004, DOI 10.1074/jbc.M806375200; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Xin H, 2005, J BIOL CHEM, V280, P20842, DOI 10.1074/jbc.M412275200; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Yuzawa H, 2009, BONE, V44, P53, DOI 10.1016/j.bone.2008.09.013; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974	66	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32502	32512		10.1074/jbc.M111.227561	http://dx.doi.org/10.1074/jbc.M111.227561			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795712	Green Published, hybrid			2022-12-25	WOS:000294726800060
J	Ma, HP				Ma, He-Ping			Hydrogen Peroxide Stimulates the Epithelial Sodium Channel through a Phosphatidylinositide 3-Kinase-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE; NITRIC-OXIDE; SUPEROXIDE-PRODUCTION; INDUCED HYPERTENSION; OXIDATIVE STRESS; APICAL MEMBRANE; NADPH OXIDASE; RENAL MEDULLA; H2O2; ENAC	Recent studies indicate that oxidative stress mediates salt-sensitive hypertension. To test the hypothesis that the renal epithelial sodium channel (ENaC) is a target of oxidative stress, patch clamp techniques were used to determine whether ENaC in A6 distal nephron cells is regulated by hydrogen peroxide (H2O2). In the cell-attached configuration, H2O2 significantly increased ENaC open probability (P-o) and single-channel current amplitude but not the unit conductance. High concentrations of exogenous H2O2 are required to elevate intracellular H2O2, probably because catalase, the enzyme that promotes the decomposition of H2O2 to H2O and O-2, is highly expressed in A6 cells. The effect of H2O2 on ENaC P-o was enhanced by 3-aminotriazole, a catalase inhibitor, and abolished by overexpression of catalase, indicating that intracellular H2O2 levels are critical to produce the effect. However, H2O2 did not directly activate ENaC in inside-out patches. The effects of H2O2 on ENaC P-o and amiloride-sensitive Na+ current were abolished by inhibition of phosphatidylinositide 3-kinase (PI3K). Confocal microscopy data showed that H2O2 elevated phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P-3) in the apical membrane by stimulating PI3K. Because ENaC is stimulated by PI(3,4,5) P-3, these data suggest that H2O2 stimulates ENaC via PI3K-mediated increases in apical PI(3,4,5) P-3.	Emory Univ Sch Med, Dept Physiol, Atlanta, GA 30322 USA	Emory University	Ma, HP (corresponding author), Emory Univ Sch Med, Dept Physiol, 615 Michael St,Suite 601, Atlanta, GA 30322 USA.	heping.ma@emory.edu			National Institutes of Health [5R01-DK067110]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067110] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01-DK067110 (to H.-P. M.).	Abe M, 2006, AM J PHYSIOL-RENAL, V291, pF350, DOI 10.1152/ajprenal.00407.2005; Avshalumov MV, 2003, P NATL ACAD SCI USA, V100, P11729, DOI 10.1073/pnas.1834314100; Bao HF, 2007, AM J PHYSIOL-RENAL, V293, pF1178, DOI 10.1152/ajprenal.00153.2007; Barlow RS, 2000, AM J PHYSIOL-HEART C, V279, pH475, DOI 10.1152/ajpheart.2000.279.2.H475; Bettowski J, 2006, PEPTIDES, V27, P3234, DOI 10.1016/j.peptides.2006.08.010; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Blazer-Yost BL, 2004, AM J PHYSIOL-CELL PH, V287, pC1569, DOI 10.1152/ajpcell.00226.2004; Chen YF, 2003, AM J PHYSIOL-REG I, V285, pR827, DOI 10.1152/ajpregu.00636.2002; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; Gamper N, 2006, EMBO J, V25, P4996, DOI 10.1038/sj.emboj.7601374; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Kitiyakara C, 2003, J AM SOC NEPHROL, V14, P2775, DOI 10.1097/01.ASN.0000092145.90389.65; Lin MJ, 2007, AM J PHYSIOL-LUNG C, V292, pL1598, DOI 10.1152/ajplung.00323.2006; Ma HP, 2007, PFLUG ARCH EUR J PHY, V455, P169, DOI 10.1007/s00424-007-0294-3; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; MARUNAKA Y, 1991, AM J PHYSIOL, V260, pC1071, DOI 10.1152/ajpcell.1991.260.5.C1071; Mori T, 2007, HYPERTENSION, V49, P1336, DOI 10.1161/HYPERTENSIONAHA.106.085811; Nistico R, 2008, BRIT J PHARMACOL, V153, P1022, DOI 10.1038/sj.bjp.0707587; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; Pech V, 2010, J AM SOC NEPHROL, V21, P1928, DOI 10.1681/ASN.2009121257; Pochynyuk O, 2006, AM J PHYSIOL-RENAL, V290, pF949, DOI 10.1152/ajprenal.00386.2005; Pochynyuk O, 2007, J PHYSIOL-LONDON, V580, P365, DOI 10.1113/jphysiol.2006.127449; Rhee SG, 2005, ANTIOXID REDOX SIGN, V7, P619, DOI 10.1089/ars.2005.7.619; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Taylor NE, 2006, HYPERTENSION, V47, P692, DOI 10.1161/01.HYP.0000203161.02046.8d; Taylor NE, 2005, AM J PHYSIOL-REG I, V289, pR1573, DOI 10.1152/ajpregu.00525.2005; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wang J, 2009, AM J PHYSIOL-RENAL, V296, pF284, DOI 10.1152/ajprenal.90647.2008; Warnock D G, 1999, Curr Hypertens Rep, V1, P158, DOI 10.1007/s11906-999-0013-x; Warnock DG, 2001, AM J MED SCI, V322, P302, DOI 10.1097/00000441-200112000-00002; Williams SS, 2007, CURR OPIN PEDIATR, V19, P192, DOI 10.1097/MOP.0b013e32801e217c; Yu L, 2008, AM J PHYSIOL-RENAL, V295, pF1519, DOI 10.1152/ajprenal.00605.2007; Yu L, 2007, AM J PHYSIOL-RENAL, V293, pF1666, DOI 10.1152/ajprenal.00444.2006; Zhang WY, 2007, AM J PHYSIOL-CELL PH, V292, pC1746, DOI 10.1152/ajpcell.00569.2006; Zhang Y, 2005, HYPERTENSION, V46, P732, DOI 10.1161/01.HYP.0000182660.74266.6d; Zhang ZR, 2010, PFLUG ARCH EUR J PHY, V459, P377, DOI 10.1007/s00424-009-0733-4	38	51	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32444	32453		10.1074/jbc.M111.254102	http://dx.doi.org/10.1074/jbc.M111.254102			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795700	Green Published, hybrid			2022-12-25	WOS:000294726800054
J	Kovanda, A; Kocjan, BJ; Luzar, B; Bravo, IG; Poljak, M				Kovanda, Anja; Kocjan, Bostjan J.; Luzar, Bostjan; Bravo, Ignacio G.; Poljak, Mario			Characterization of Novel Cutaneous Human Papillomavirus Genotypes HPV-150 and HPV-151	PLOS ONE			English	Article							NONMELANOMA SKIN-CANCER; EPIDERMODYSPLASIA-VERRUCIFORMIS; GENOMIC DIVERSITY; CELL CARCINOMAS; SQUAMOUS-CELL; HPV GENOTYPES; DNA; SEQUENCE; BENIGN; CLASSIFICATION	DNA from two novel HPV genotypes, HPV-150 and HPV-151, isolated from hair follicles of immuno-competent individuals, was fully cloned, sequenced and characterized. The complete genomes of HPV-150 and HPV-151 are 7,436-bp and 7,386-bp in length, respectively. Both contain genes for at least six proteins, namely E6, E7, E1, E2, L2, L1, as well as a non-coding upstream regulatory region located between the L1 and E6 genes: spanning 416-bp in HPV-150 (genomic positions 7,371 to 350) and 322-bp in HPV-151 (genomic positions 7,213 to 148). HPV-150 and HPV-151 are phylogenetically placed within the Betapapillomavirus genus and are most closely related to HPV-96 and HPV-22, respectively. As in other members of this genus, the intergenic E2-L2 region is very short and does not encode for an E5 gene. Both genotypes contain typical zinc binding domains in their E6 and E7 proteins, but HPV-151 lacks the regular pRb-binding core sequence within its E7 protein. In order to assess the tissue predilection and clinical significance of the novel genotypes, quantitative type-specific real-time PCR assays were developed. The 95% detection limits of the HPV-150 and HPV-151 assays were 7.3 copies/reaction (range 5.6 to 11.4) and 3.4 copies/reaction (range 2.5 to 6.0), respectively. Testing of a representative collection of HPV-associated mucosal and cutaneous benign and malignant neoplasms and hair follicles (total of 540 samples) revealed that HPV-150 and HPV-151 are relatively rare genotypes with a cutaneous tropism. Both genotypes were found in sporadic cases of common warts and SCC and BCC of the skin as single or multiple infections usually with low viral loads. HPV-150 can establish persistent infection of hair follicles in immuno-competent individuals. A partial L1 sequence of a putative novel HPV genotype, related to HPV-150, was identified in a squamous cell carcinoma of the skin obtained from a 64-year old immuno-compromised male patient.	[Kovanda, Anja; Kocjan, Bostjan J.; Poljak, Mario] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia; [Luzar, Bostjan] Univ Ljubljana, Fac Med, Inst Pathol, Ljubljana, Slovenia; [Bravo, Ignacio G.] Catalan Inst Oncol ICO, Unit Infect & Canc, Barcelona, Spain; [Bravo, Ignacio G.] CIBER Epidemiol & Publ Hlth CIBERESP, Barcelona, Spain; [Bravo, Ignacio G.] Genom & Hlth Ctr Publ Hlth Res CSISP, Valencia, Spain	University of Ljubljana; University of Ljubljana; Catalan Institute of Oncology; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Kovanda, A (corresponding author), Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia.	mario.poljak@mf.uni-lj.si	Luzar, Bostjan/ACR-4860-2022; Kovanda, Anja/AAX-1117-2020; luzar, bostjan/AGY-8991-2022; Kovanda, Anja/F-5828-2013; Bravo, Ignacio G./A-2483-2009	Kovanda, Anja/0000-0002-7468-878X; luzar, bostjan/0000-0003-2534-8671; Kovanda, Anja/0000-0002-7468-878X; Bravo, Ignacio G./0000-0003-3389-3389	Slovenian Research Agency; Ministry of Health; Spanish MICINN [CGL2010-16713];  [Z3-0220-0381-08]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Ministry of Health; Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); 	A.K. is funded by the Young Researcher Training Program of the Slovenian Research Agency and the Ministry of Health and B.J.K. is funded through grant Z3-0220-0381-08. I.G.B. is funded by the Spanish MICINN (Ramon y Cajal Program, and CGL2010-16713). No additional external funding was received for this study. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Antonsson A, 2003, J GEN VIROL, V84, P1881, DOI 10.1099/vir.0.18836-0; Antonsson A, 2003, J CLIN MICROBIOL, V41, P2509, DOI 10.1128/JCM.41.6.2509-2514.2003; Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; Berkhout RJM, 2000, J CLIN MICROBIOL, V38, P2087; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Boukamp P, 2005, CARCINOGENESIS, V26, P1657, DOI 10.1093/carcin/bgi123; Boxman ILA, 2000, INT J CANCER, V86, P118, DOI 10.1002/(SICI)1097-0215(20000401)86:1&lt;118::AID-IJC18&gt;3.0.CO;2-2; Boxman ILA, 1997, J INVEST DERMATOL, V108, P712, DOI 10.1111/1523-1747.ep12292090; Castellsague X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-74; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; de Villiers EM, 2009, J GEN VIROL, V90, P1999, DOI 10.1099/vir.0.011478-0; DEJONGTIEBEN LM, 1995, J INVEST DERMATOL, V105, P367, DOI 10.1111/1523-1747.ep12320803; deVilliers EM, 1997, INT J CANCER, V73, P356, DOI 10.1002/(SICI)1097-0215(19971104)73:3<356::AID-IJC9>3.3.CO;2-S; ENSSER A, 1990, NUCLEIC ACIDS RES, V18, P3919, DOI 10.1093/nar/18.13.3919; Forslund O, 2003, VIROLOGY, V312, P255, DOI 10.1016/S0042-6822(03)00391-X; Gottschling M., 2011, MOL BIOL EVOL; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hazard K, 2007, J INVEST DERMATOL, V127, P116, DOI 10.1038/sj.jid.5700570; Hazard K, 2006, INT J CANCER, V119, P1073, DOI 10.1002/ijc.21920; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Jablonska S, 1997, CLIN DERMATOL, V15, P309, DOI 10.1016/S0738-081X(96)00170-8; Jablonska S, 1994, Curr Top Microbiol Immunol, V186, P157; Jancar N, 2009, EUR J OBSTET GYN R B, V145, P184, DOI 10.1016/j.ejogrb.2009.04.030; Karagas MR, 2006, J NATL CANCER I, V98, P389, DOI 10.1093/jnci/djj092; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kocjan Bogtjan J., 2005, Infection Genetics and Evolution, V5, P255, DOI 10.1016/j.meegid.2004.05.009; Kocjan BJ, 2009, VIROLOGY, V391, P274, DOI 10.1016/j.virol.2009.06.030; Kocjan BJ, 2009, J MED VIROL, V81, P288, DOI 10.1002/jmv.21392; Kohler A, 2009, BRIT J DERMATOL, V161, P528, DOI 10.1111/j.1365-2133.2009.09297.x; KREMSDORF D, 1984, J VIROL, V52, P1013, DOI 10.1128/JVI.52.3.1013-1018.1984; KRUBKE J, 1987, J GEN VIROL, V68, P3091, DOI 10.1099/0022-1317-68-12-3091; Lazarczyk M, 2009, MICROBIOL MOL BIOL R, V73, P348, DOI 10.1128/MMBR.00033-08; Li LL, 2009, J GEN VIROL, V90, P2413, DOI 10.1099/vir.0.012344-0; Nindl I, 2007, DIS MARKERS, V23, P247, DOI 10.1155/2007/942650; Orth G, 2005, J INVEST DERMATOL, V125, pXII, DOI 10.1111/j.0022-202X.2005.23811.x; OTT M, 2007, SUPERCOMPUTING 2007, P1; Plasmeijer EI, 2010, J CLIN VIROL, V47, P216, DOI 10.1016/j.jcv.2009.12.004; Potocnik M, 2007, ACTA DERMATOVEN ALP, V16, P91; Potocnik M, 2006, J MED VIROL, V78, P1673, DOI 10.1002/jmv.20753; Purdie KJ, 2005, J INVEST DERMATOL, V125, P98, DOI 10.1111/j.0022-202X.2005.23635.x; Rector A, 2004, J VIROL, V78, P4993, DOI 10.1128/JVI.78.10.4993-4998.2004; SHAMANIN V, 1994, CANCER RES, V54, P4610; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Vasiljevic N, 2007, J GEN VIROL, V88, P1479, DOI 10.1099/vir.0.82679-0; Weissenborn SJ, 2005, J INVEST DERMATOL, V125, P93, DOI 10.1111/j.0022-202X.2005.23733.x; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0	50	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22529	10.1371/journal.pone.0022529	http://dx.doi.org/10.1371/journal.pone.0022529			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799888	gold, Green Submitted, Green Published			2022-12-25	WOS:000293172900044
J	Sable, SB; Cheruvu, M; Nandakumar, S; Sharma, S; Bandyopadhyay, K; Kellar, KL; Posey, JE; Plikaytis, BB; Amara, RR; Shinnick, TM				Sable, Suraj B.; Cheruvu, Mani; Nandakumar, Subhadra; Sharma, Sunita; Bandyopadhyay, Kakali; Kellar, Kathryn L.; Posey, James E.; Plikaytis, Bonnie B.; Amara, Rama Rao; Shinnick, Thomas M.			Cellular Immune Responses to Nine Mycobacterium tuberculosis Vaccine Candidates following Intranasal Vaccination	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; CD8(+) T-CELLS; 45/47-KILODALTON ANTIGEN COMPLEX; FIBRONECTIN ATTACHMENT PROTEIN; BOVIS BCG; PROTECTIVE EFFICACY; PULMONARY TUBERCULOSIS; MUCOSAL IMMUNIZATION; DENDRITIC CELLS; VIRUS ANKARA	Background: The identification of Mycobacterium tuberculosis vaccines that elicit a protective immune response in the lungs is important for the development of an effective vaccine against tuberculosis. Methods and Principal Findings: In this study, a comparison of intranasal (i.n.) and subcutaneous (s.c.) vaccination with the BCG vaccine demonstrated that a single moderate dose delivered intranasally induced a stronger and sustained M. tuberculosis-specific T-cell response in lung parenchyma and cervical lymph nodes of BALB/c mice than vaccine delivered subcutaneously. Both BCG and a multicomponent subunit vaccine composed of nine M. tuberculosis recombinant proteins induced strong antigen-specific T-cell responses in various local and peripheral immune compartments. Among the nine recombinant proteins evaluated, the alanine proline rich antigen (Apa, Rv1860) was highly antigenic following i.n. BCG and immunogenic after vaccination with a combination of the nine recombinant antigens. The Apa-induced responses included induction of both type 1 and type 2 cytokines in the lungs as evaluated by ELISPOT and a multiplexed microsphere-based cytokine immunoassay. Of importance, i.n. subunit vaccination with Apa imparted significant protection in the lungs and spleen of mice against M. tuberculosis challenge. Despite observed differences in the frequencies and location of specific cytokine secreting T cells both BCG vaccination routes afforded comparable levels of protection in our study. Conclusion and Significance: Overall, our findings support consideration and further evaluation of an intranasally targeted Apa-based vaccine to prevent tuberculosis.	[Sable, Suraj B.; Cheruvu, Mani; Nandakumar, Subhadra; Posey, James E.; Plikaytis, Bonnie B.; Shinnick, Thomas M.] Ctr Dis Control & Prevent, Div TB Eliminat, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Sharma, Sunita; Amara, Rama Rao] Emory Univ, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Sharma, Sunita; Amara, Rama Rao] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Bandyopadhyay, Kakali; Kellar, Kathryn L.] Ctr Dis Control & Prevent, Biotechnol Core Facil Branch, Div Sci Resources, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Emory University; Emory University; Centers for Disease Control & Prevention - USA	Sable, SB (corresponding author), Ctr Dis Control & Prevent, Div TB Eliminat, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	ssable@cdc.gov	Sable, Suraj/AAI-2439-2020; Amara, Rama/AAO-8136-2021; Nandakumar, Subhadra/F-5892-2011	Sable, Suraj/0000-0001-8440-1693; 	National Centers for Infectious Diseases, CDC, USA; ASM-NCID; ORISE	National Centers for Infectious Diseases, CDC, USA(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); ASM-NCID; ORISE(United States Department of Energy (DOE))	This work was carried out at the Laboratory Branch, Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, and is supported by intramural funds. Part of this work was performed during an American Society for Microbiology and National Centers for Infectious Diseases, CDC, USA, fellowship to SBS, for which TMS served as the preceptor. MC and SN acknowledge the postdoctoral financial assistance from ASM-NCID and ORISE fellowships, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005930; Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Abolhassani M, 2000, INFECT IMMUN, V68, P5657; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Asanuma H, 1997, J IMMUNOL METHODS, V202, P123, DOI 10.1016/S0022-1759(96)00243-8; Beatty WL, 2000, INFECT IMMUN, V68, P6997, DOI 10.1128/IAI.68.12.6997-7002.2000; Carpenter ZK, 2005, J CONTROL RELEASE, V104, P67, DOI 10.1016/j.jconrel.2005.01.014; Castanon-Arreola M, 2005, TUBERCULOSIS, V85, P115, DOI 10.1016/j.tube.2004.10.004; Chen LH, 2004, INFECT IMMUN, V72, P238, DOI 10.1128/IAI.72.1.238-246.2004; Ciabattini A, 2008, INFECT IMMUN, V76, P5817, DOI 10.1128/IAI.00793-08; D'Souza S, 2002, INFECT IMMUN, V70, P3681, DOI 10.1128/IAI.70.7.3681-3688.2002; Di Rosa F, 2005, TRENDS IMMUNOL, V26, P360, DOI 10.1016/j.it.2005.04.011; Dietrich J, 2006, J IMMUNOL, V177, P6353, DOI 10.4049/jimmunol.177.9.6353; Dobos KM, 1996, J BACTERIOL, V178, P2498, DOI 10.1128/jb.178.9.2498-2506.1996; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Falero-Diaz G, 2000, VACCINE, V18, P3223, DOI 10.1016/S0264-410X(00)00134-1; Fattorini L, 2002, J MED MICROBIOL, V51, P1071, DOI 10.1099/0022-1317-51-12-1071; Ferraz JC, 2004, INFECT IMMUN, V72, P6945, DOI 10.1128/IAI.72.12.6945-6950.2004; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Giri PK, 2005, FEMS IMMUNOL MED MIC, V45, P87, DOI 10.1016/j.femsim.2005.02.009; Giri PK, 2008, EXPERT REV VACCINES, V7, P1341, DOI 10.1586/14760584.7.9.1341; Giri PK, 2006, J INFECTION, V53, P350, DOI 10.1016/j.jinf.2005.12.017; Giri PK, 2006, FEMS IMMUNOL MED MIC, V47, P233, DOI 10.1111/j.1574-695X.2006.00087.x; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Griffiths G, 2010, NAT REV MICROBIOL, V8, P827, DOI 10.1038/nrmicro2437; Gruppo V, 2002, TUBERCULOSIS, V82, P267, DOI 10.1054/tube.2002.0340; Hamasur B, 2003, VACCINE, V21, P4081, DOI 10.1016/S0264-410X(03)00274-3; Hoft DF, 2008, J INFECT DIS, V198, P1491, DOI 10.1086/592450; Hokey DA, 2011, TUBERCULOSIS, V91, P82, DOI 10.1016/j.tube.2010.09.007; Horn C, 1999, J BIOL CHEM, V274, P32023, DOI 10.1074/jbc.274.45.32023; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Horwitz MA, 2006, VACCINE, V24, P443, DOI 10.1016/j.vaccine.2005.08.001; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jeyanathan M, 2010, TRENDS IMMUNOL, V31, P247, DOI 10.1016/j.it.2010.05.002; Kallenius G, 2007, TUBERCULOSIS, V87, P257, DOI 10.1016/j.tube.2006.12.006; Kamath AT, 1999, INFECT IMMUN, V67, P1702; Kaufmann SHE, 2006, NAT REV IMMUNOL, V6, P699, DOI 10.1038/nri1920; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Kohama H, 2008, VACCINE, V26, P924, DOI 10.1016/j.vaccine.2007.12.005; Kumar P, 2003, INFECT IMMUN, V71, P1929, DOI 10.1128/IAI.71.4.1929-1937.2003; KURODA K, 1993, J CLIN INVEST, V91, P69, DOI 10.1172/JCI116202; Lee JS, 2009, INFECT IMMUN, V77, P2979, DOI 10.1128/IAI.01411-08; Lefrancois L, 2002, CURR OPIN IMMUNOL, V14, P503, DOI 10.1016/S0952-7915(02)00360-6; Lorenzi JCC, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-77; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; MUSTAFA AS, 1993, INFECT IMMUN, V61, P5294, DOI 10.1128/IAI.61.12.5294-5301.1993; Okada M, 2009, VACCINE, V27, P3267, DOI 10.1016/j.vaccine.2009.01.064; Olsen AW, 2004, SCAND J IMMUNOL, V60, P273, DOI 10.1111/j.0300-9475.2004.01471.x; Palendira U, 2002, INFECT IMMUN, V70, P1410, DOI 10.1128/IAI.70.3.1410-1416.2002; Parida SK, 2005, ANN NY ACAD SCI, V1056, P366, DOI 10.1196/annals.1352.030; Ragas A, 2007, J BIOL CHEM, V282, P5133, DOI 10.1074/jbc.M610183200; ROMAIN F, 1993, INFECT IMMUN, V61, P742, DOI 10.1128/IAI.61.2.742-750.1993; Romain F, 1999, INFECT IMMUN, V67, P5567, DOI 10.1128/IAI.67.11.5567-5572.1999; Rook GAW, 2005, VACCINE, V23, P2115, DOI 10.1016/j.vaccine.2005.01.069; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Sable SB, 2007, EUR RESPIR J, V29, P337, DOI 10.1183/09031936.00111205; Sable SB, 2005, VACCINE, V23, P4175, DOI 10.1016/j.vaccine.2005.03.040; Sable SB, 2007, CLIN IMMUNOL, V122, P239, DOI 10.1016/j.clim.2006.10.010; Sali M, 2010, INFECT IMMUN, V78, P5202, DOI 10.1128/IAI.00267-10; Sullivan Vincent J, 2006, Expert Opin Drug Deliv, V3, P87, DOI 10.1517/17425247.3.1.87; Tree JA, 2004, CLIN EXP IMMUNOL, V138, P405, DOI 10.1111/j.1365-2249.2004.02648.x; VANSAVAGE J, 1990, J INFECT DIS, V161, P487, DOI 10.1093/infdis/161.3.487; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Wu Y, 2008, INFECT IMMUN, V76, P2249, DOI 10.1128/IAI.00024-08; Zhao WC, 2000, INT J CANCER, V86, P83, DOI 10.1002/(SICI)1097-0215(20000401)86:1<83::AID-IJC13>3.0.CO;2-R	66	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22718	10.1371/journal.pone.0022718	http://dx.doi.org/10.1371/journal.pone.0022718			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799939	gold, Green Published			2022-12-25	WOS:000293172900071
J	Burger, DE; Wang, LM; Ban, LQ; Okubo, Y; Kuhtreiber, WM; Leichliter, AK; Faustman, DL				Burger, Douglas E.; Wang, Limei; Ban, Liqin; Okubo, Yoshiaki; Kuehtreiber, Willem M.; Leichliter, Ashley K.; Faustman, Denise L.			Novel Automated Blood Separations Validate Whole Cell Biomarkers	PLOS ONE			English	Article							PERIPHERAL-BLOOD; T-CELLS; LYMPHOCYTES; INHIBITORS	Background: Progress in clinical trials in infectious disease, autoimmunity, and cancer is stymied by a dearth of successful whole cell biomarkers for peripheral blood lymphocytes (PBLs). Successful biomarkers could help to track drug effects at early time points in clinical trials to prevent costly trial failures late in development. One major obstacle is the inaccuracy of Ficoll density centrifugation, the decades-old method of separating PBLs from the abundant red blood cells (RBCs) of fresh blood samples. Methods and Findings: To replace the Ficoll method, we developed and studied a novel blood-based magnetic separation method. The magnetic method strikingly surpassed Ficoll in viability, purity and yield of PBLs. To reduce labor, we developed an automated platform and compared two magnet configurations for cell separations. These more accurate and labor-saving magnet configurations allowed the lymphocytes to be tested in bioassays for rare antigen-specific T cells. The automated method succeeded at identifying 79% of patients with the rare PBLs of interest as compared with Ficoll's uniform failure. We validated improved upfront blood processing and show accurate detection of rare antigen-specific lymphocytes. Conclusions: Improving, automating and standardizing lymphocyte detections from whole blood may facilitate development of new cell-based biomarkers for human diseases. Improved upfront blood processes may lead to broad improvements in monitoring early trial outcome measurements in human clinical trials.	[Burger, Douglas E.] Massachusetts Gen Hosp, Dept Med, Immunobiol Labs, Charlestown, MA USA; Harvard Univ, Sch Med, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University	Burger, DE (corresponding author), Massachusetts Gen Hosp, Dept Med, Immunobiol Labs, Charlestown, MA USA.	faustman@helix.mgh.harvard.edu		Kuhtreiber, Willem/0000-0002-5717-5915	Iacocca Foundation; James Pendleton Charitable Trust; Friends United; Partnerships for Cure; National Institutes of Health (NIH)	Iacocca Foundation; James Pendleton Charitable Trust; Friends United; Partnerships for Cure; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by The Iacocca Foundation, James Pendleton Charitable Trust, Friends United, Partnerships for Cure, and National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, EVALUATION BIOMARKER; Baker MK, 2003, CLIN CANCER RES, V9, P4865; Ban LQ, 2008, P NATL ACAD SCI USA, V105, P13644, DOI 10.1073/pnas.0803429105; FDA, 2006, CRIT PATH OPP REP; Gilliam BL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S9; HOKLAND P, 1980, SCAND J IMMUNOL, V11, P353, DOI 10.1111/j.1365-3083.1980.tb00245.x; HOOK GR, 1988, MAGNESIUM, V7, P1; Kuhtreiber WM, 2005, J IMMUNOL METHODS, V306, P137, DOI 10.1016/j.jim.2005.08.008; Lin SJ, 2002, CLIN LAB HAEMATOL, V24, P353, DOI 10.1046/j.1365-2257.2002.00462.x; Lissina A, 2009, J IMMUNOL METHODS, V340, P11, DOI 10.1016/j.jim.2008.09.014; NOBLE P. B., 1967, CAN VET J, V8, P110; Rosenberg R, 2002, CYTOMETRY, V49, P150, DOI 10.1002/cyto.10161; Trusheim MR, 2007, NAT REV DRUG DISCOV, V6, P287, DOI 10.1038/nrd2251; Williams SA, 2006, NAT REV DRUG DISCOV, V5, P897, DOI 10.1038/nrd2174; 2007, CANC BIOMARKERS PROM; 2010, NATURE REV DRUG DISC, V9, P415	16	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22430	10.1371/journal.pone.0022430	http://dx.doi.org/10.1371/journal.pone.0022430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799852	Green Published, Green Submitted, gold			2022-12-25	WOS:000293097300046
J	Frey, AG; Bird, AJ; Evans-Galea, MV; Blankman, E; Winge, DR; Eide, DJ				Frey, Avery G.; Bird, Amanda J.; Evans-Galea, Marguerite V.; Blankman, Elizabeth; Winge, Dennis R.; Eide, David J.			Zinc-Regulated DNA Binding of the Yeast Zap1 Zinc-Responsive Activator	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATOR; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; CELLULAR ZINC; PHOSPHORYLATION; HOMEOSTASIS; EXPRESSION; AFFINITY; FINGERS; SENSORS	The Zap1 transcription factor of Saccharomyces cerevisiae plays a central role in zinc homeostasis by controlling the expression of genes involved in zinc metabolism. Zap1 is active in zinc-limited cells and repressed in replete cells. At the transcriptional level, Zap1 controls its own expression via positive autoregulation. In addition, Zap1's two activation domains are regulated independently of each other by zinc binding directly to those regions and repressing activation function. In this report, we show that Zap1 DNA binding is also inhibited by zinc. DMS footprinting showed that Zap1 target gene promoter occupancy is regulated with or without transcriptional autoregulation. These results were confirmed using chromatin immunoprecipitation. Zinc regulation of DNA binding activity mapped to the DNA binding domain indicating other parts of Zap1 are unnecessary for this control. Overexpression of Zap1 overrode DNA binding regulation and resulted in constitutive promoter occupancy. Under these conditions of constitutive binding, both the zinc dose response of Zap1 activity and cellular zinc accumulation were altered suggesting the importance of DNA binding control to zinc homeostasis. Thus, our results indicated that zinc regulates Zap1 activity post-translationally via three independent mechanisms, all of which contribute to the overall zinc responsiveness of Zap1.	[Frey, Avery G.; Eide, David J.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Bird, Amanda J.; Evans-Galea, Marguerite V.; Blankman, Elizabeth; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT USA	University of Wisconsin System; University of Wisconsin Madison; Utah System of Higher Education; University of Utah	Frey, AG (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	deide@wisc.edu	Bird, Amanda Jane/ABD-2295-2021; Evans-Galea, Marguerite/A-4673-2013	Bird, Amanda Jane/0000-0002-1846-7050; Evans-Galea, Marguerite/0000-0003-1867-9667	National Institutes of Health [RO1-GM056285, RO1-GM083292, T32-DK007665]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083292, R01GM056285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants RO1-GM056285 (DJE), RO1-GM083292 (DRW), and the T32-DK007665 Molecular and Applied Nutrition Training Program grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSON JN, GUIDE YEAST GENETICS; AUSUBEL FM, 1995, CURRENT PROTOCOLS MO, P1600; Berg JM, 1997, ANNU REV BIOPH BIOM, V26, P357, DOI 10.1146/annurev.biophys.26.1.357; Bird A, 2000, J BIOL CHEM, V275, P16160, DOI 10.1074/jbc.M000664200; Bird AJ, 2004, EMBO J, V23, P1123, DOI 10.1038/sj.emboj.7600122; Bird AJ, 2000, EMBO J, V19, P3704, DOI 10.1093/emboj/19.14.3704; Bird AJ, 2003, EMBO J, V22, P5137, DOI 10.1093/emboj/cdg484; Bird AJ, 2006, EMBO J, V25, P5726, DOI 10.1038/sj.emboj.7601453; Brocklehurst KR, 1999, MOL MICROBIOL, V31, P893, DOI 10.1046/j.1365-2958.1999.01229.x; Calkhoven CF, 1996, BIOCHEM J, V317, P329, DOI 10.1042/bj3170329; Dittmer PJ, 2009, J BIOL CHEM, V284, P16289, DOI 10.1074/jbc.M900501200; DOHRMANN PR, 1992, GENE DEV, V6, P93, DOI 10.1101/gad.6.1.93; Dovat S, 2002, GENE DEV, V16, P2985, DOI 10.1101/gad.1040502; DUMITRU I, 1994, NUCLEIC ACIDS RES, V22, P1450; Evans-Galea MV, 2003, BIOCHEMISTRY-US, V42, P1053, DOI 10.1021/bi0263199; Frey AG, 2011, J BIOL CHEM, V286, P6844, DOI 10.1074/jbc.M110.203927; Gao CY, 2000, BIOTECHNIQUES, V29, P1226, DOI 10.2144/00296st02; Gitan RS, 1998, J BIOL CHEM, V273, P28617, DOI 10.1074/jbc.273.44.28617; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Harlow E., 1988, ANTIBODIES LAB MANUA; Herbig A, 2005, MOL MICROBIOL, V57, P834, DOI 10.1111/j.1365-2958.2005.04734.x; Jantz D, 2004, P NATL ACAD SCI USA, V101, P7589, DOI 10.1073/pnas.0402191101; Kacherovsky N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003213; Kanin EI, 2007, P NATL ACAD SCI USA, V104, P5812, DOI 10.1073/pnas.0611505104; Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; MANN K, 1980, FEBS LETT, V122, P95, DOI 10.1016/0014-5793(80)80410-8; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; PETER M, 1993, CELL, V73, P747, DOI 10.1016/0092-8674(93)90254-N; Sensi SL, 1997, J NEUROSCI, V17, P9554; Vinkenborg JL, 2009, NAT METHODS, V6, P737, DOI [10.1038/NMETH.1368, 10.1038/nmeth.1368]; Wu CY, 2009, J BIOL CHEM, V284, P27544, DOI 10.1074/jbc.M109.042036; Wu CY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-370; Zhao H, 1998, J BIOL CHEM, V273, P28713, DOI 10.1074/jbc.273.44.28713; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044; Zhao H, 1996, J BIOL CHEM, V271, P23203, DOI 10.1074/jbc.271.38.23203	37	27	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22535	10.1371/journal.pone.0022535	http://dx.doi.org/10.1371/journal.pone.0022535			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799889	gold, Green Published			2022-12-25	WOS:000293097300062
J	Zarrella, TM; Singh, A; Bitsaktsis, C; Rahman, T; Sahay, B; Feustel, PJ; Gosselin, EJ; Sellati, TJ; Hazlett, KRO				Zarrella, Tiffany M.; Singh, Anju; Bitsaktsis, Constantine; Rahman, Tabassum; Sahay, Bikash; Feustel, Paul J.; Gosselin, Edmund J.; Sellati, Timothy J.; Hazlett, Karsten R. O.			Host-Adaptation of Francisella tularensis Alters the Bacterium's Surface-Carbohydrates to Hinder Effectors of Innate and Adaptive Immunity	PLOS ONE			English	Article							LIVE VACCINE STRAIN; OUTER-MEMBRANE PROTEIN; MAJOR EXTRACELLULAR PROTEINS; VIRULENT TYPE-A; PROTECTIVE IMMUNITY; O-ANTIGEN; MYCOBACTERIUM-TUBERCULOSIS; TREPONEMA-PALLIDUM; GLUTAMINE-SYNTHETASE; MEDIATED ACTIVATION	Background: The gram-negative bacterium Francisella tularensis survives in arthropods, fresh water amoeba, and mammals with both intracellular and extracellular phases and could reasonably be expected to express distinct phenotypes in these environments. The presence of a capsule on this bacterium has been controversial with some groups finding such a structure while other groups report that no capsule could be identified. Previously we reported in vitro culture conditions for this bacterium which, in contrast to typical methods, yielded a bacterial phenotype that mimics that of the bacterium's mammalian, extracellular phase. Methods/Findings: SDS-PAGE and carbohydrate analysis of differentially-cultivated F. tularensis LVS revealed that bacteria displaying the host-adapted phenotype produce both longer polymers of LPS O-antigen (OAg) and additional HMW carbohydrates/glycoproteins that are reduced/absent in non-host-adapted bacteria. Analysis of wildtype and OAg-mutant bacteria indicated that the induced changes in surface carbohydrates involved both OAg and non-OAg species. To assess the impact of these HMW carbohydrates on the access of outer membrane constituents to antibody we used differentially-cultivated bacteria in vitro to immunoprecipitate antibodies directed against outer membrane moieties. We observed that the surface-carbohydrates induced during host-adaptation shield many outer membrane antigens from binding by antibody. Similar assays with normal mouse serum indicate that the induced HMW carbohydrates also impede complement deposition. Using an in vitro macrophage infection assay, we find that the bacterial HMW carbohydrate impedes TLR2-dependent, pro-inflammatory cytokine production by macrophages. Lastly we show that upon host-adaptation, the human-virulent strain, F. tularensis SchuS4 also induces capsule production with the effect of reducing macrophage-activation and accelerating tularemia pathogenesis in mice. Conclusion: F. tularensis undergoes host-adaptation which includes production of multiple capsular materials. These capsules impede recognition of bacterial outer membrane constituents by antibody, complement, and Toll-Like Receptor 2. These changes in the host-pathogen interface have profound implications for pathogenesis and vaccine development.	[Zarrella, Tiffany M.; Singh, Anju; Bitsaktsis, Constantine; Rahman, Tabassum; Sahay, Bikash; Gosselin, Edmund J.; Sellati, Timothy J.; Hazlett, Karsten R. O.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Feustel, Paul J.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA	Albany Medical College; Albany Medical College	Zarrella, TM (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.	Hazlett@mail.amc.edu	Sellati, Timothy/ABE-8023-2021; Feustel, Paul/AAW-5157-2021; Zarrella, Tiffany/AAX-9307-2021	Feustel, Paul/0000-0002-6963-4349; Zarrella, Tiffany/0000-0002-3053-4025; Sahay, Bikash/0000-0003-0905-733X	Public Health Service grants [PO1 AI056320, RO1 AI075193]; National Institute of Allergy and Infectious Diseases [RO1 AI07640801]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056320, R01AI076408, R01AI075193] Funding Source: NIH RePORTER	Public Health Service grants(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Public Health Service grants PO1 AI056320 (P.J.F., E.J.G., T.J.S., K.R.O.H.), RO1 AI075193 (T.J.S.), and RO1 AI07640801 (E.J.G.) from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd H, 2003, APPL ENVIRON MICROB, V69, P600, DOI 10.1128/AEM.69.1.600-606.2003; Apicella MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011060; Balagopal A, 2006, INFECT IMMUN, V74, P5114, DOI 10.1128/IAI.00795-06; Bandara AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019003; Bar-Haim E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000211; Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Baron GS, 1998, MOL MICROBIOL, V29, P247, DOI 10.1046/j.1365-2958.1998.00926.x; BARTHOLD SW, 1995, INFECT IMMUN, V63, P2255, DOI 10.1128/IAI.63.6.2255-2261.1995; Berry RE, 2009, INFECT IMMUN, V77, P2762, DOI 10.1128/IAI.00323-09; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Broms JE, 2009, J BACTERIOL, V191, P2431; Carlson PE, 2009, J BACTERIOL, V191, P6855, DOI 10.1128/JB.00995-09; Charity JC, 2007, PLOS PATHOG, V3, P770, DOI 10.1371/journal.ppat.0030084; Chase JC, 2010, INFECT IMMUN, V78, P154, DOI 10.1128/IAI.00750-09; Chase JC, 2009, INFECT IMMUN, V77, P180, DOI 10.1128/IAI.00879-08; CHERWONOGRODZKY JW, 1994, VACCINE, V12, P773, DOI 10.1016/0264-410X(94)90284-4; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Clay CD, 2008, J IMMUNOL, V181, P5568, DOI 10.4049/jimmunol.181.8.5568; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; Clinton SR, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-76; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Cole LE, 2009, P NATL ACAD SCI USA, V106, P4343, DOI 10.1073/pnas.0813411106; Comstock LE, 2006, CELL, V126, P847, DOI 10.1016/j.cell.2006.08.021; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P39, DOI 10.1016/S0882-4010(02)00194-8; Conlan JW, 2002, VACCINE, V20, P3465, DOI 10.1016/S0264-410X(02)00345-6; Crane DD, 2009, J IMMUNOL, V183, P4593, DOI 10.4049/jimmunol.0901655; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; DRABICK JJ, 1994, AM J MED SCI, V308, P83, DOI 10.1097/00000441-199408000-00003; Dreisbach VC, 2000, INFECT IMMUN, V68, P1988, DOI 10.1128/IAI.68.4.1988-1996.2000; Edwards JA, 2010, MICROBIOL-SGM, V156, P327, DOI 10.1099/mic.0.031716-0; Evrard B, 2010, INFECT IMMUN, V78, P210, DOI 10.1128/IAI.00864-09; Forestal CA, 2007, J INFECT DIS, V196, P134, DOI 10.1086/518611; Forestal CA, 2008, MICROB PATHOGENESIS, V44, P512, DOI 10.1016/j.micpath.2008.01.003; Forslund AL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-227; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Foshay L, 1940, MEDICINE, V19, P1, DOI 10.1097/00005792-194002000-00001; FULOP M, 1995, VACCINE, V13, P1220, DOI 10.1016/0264-410X(95)00062-6; Fulop M, 1996, FEMS IMMUNOL MED MIC, V13, P245, DOI 10.1111/j.1574-695X.1996.tb00245.x; FULOP MJ, 1991, J CLIN MICROBIOL, V29, P1407, DOI 10.1128/JCM.29.7.1407-1412.1991; Golovliov I, 1997, INFECT IMMUN, V65, P2183, DOI 10.1128/IAI.65.6.2183-2189.1997; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Hager AJ, 2006, MOL MICROBIOL, V62, P227, DOI 10.1111/j.1365-2958.2006.05365.x; HARTH G, 1994, P NATL ACAD SCI USA, V91, P9342, DOI 10.1073/pnas.91.20.9342; Hazlett KRO, 2008, INFECT IMMUN, V76, P4479, DOI 10.1128/IAI.00610-08; Hazlett KRO, 2005, J BACTERIOL, V187, P6499, DOI 10.1128/JB.187.18.6499-6508.2005; Hazlett KRO, 2001, J EXP MED, V193, P1015, DOI 10.1084/jem.193.9.1015; Holzer SU, 2009, INFECT IMMUN, V77, P5458, DOI 10.1128/IAI.00871-09; HOOD AM, 1977, J HYG-CAMBRIDGE, V79, P47, DOI 10.1017/S0022172400052840; HORWITZ MA, 1995, P NATL ACAD SCI USA, V92, P1530, DOI 10.1073/pnas.92.5.1530; Huntley JF, 2008, INFECT IMMUN, V76, P3664, DOI 10.1128/IAI.00374-08; Huntley JF, 2007, J BACTERIOL, V189, P561, DOI 10.1128/JB.01505-06; Ireland R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000921; Kadzhaev K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005463; Kim TH, 2010, J BIOL CHEM, V285, P27839, DOI 10.1074/jbc.M110.143859; Kirimanjeswara GS, 2007, J IMMUNOL, V179, P532, DOI 10.4049/jimmunol.179.1.532; Klimpel GR, 2008, VACCINE, V26, P6874, DOI 10.1016/j.vaccine.2008.09.077; Klimpel GR, 2008, J LEUKOC BIOL; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Konecna K, 2010, PROTEOMICS, V10, P4501, DOI 10.1002/pmic.201000248; Kovacs-Simon A, 2010, INFECT IMMUN; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Lavine CL, 2007, EUR J IMMUNOL, V37, P3007, DOI 10.1002/eji.200737620; Lee BY, 2006, INFECT IMMUN, V74, P4002, DOI 10.1128/IAI.00257-06; Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294; Li J, 2007, MICROBIOL-SGM, V153, P3141, DOI 10.1099/mic.0.2007/006460-0; Lindemann SR, 2010, INFECT IMMUN; Loegering DJ, 2006, MICROB PATHOGENESIS, V41, P218, DOI 10.1016/j.micpath.2006.07.007; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Mara-Koosham G., 2011, INFECT IMMUN; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Melillo A, 2006, FEMS MICROBIOL LETT, V263, P102, DOI 10.1111/j.1574-6968.2006.00413.x; Melillo AA, 2010, J BIOL CHEM, V285, P27553, DOI 10.1074/jbc.M110.144394; Moayeri M, 1997, INFECT IMMUN, V65, P2233, DOI 10.1128/IAI.65.6.2233-2239.1997; Mohapatra NP, 2007, INFECT IMMUN, V75, P3305, DOI 10.1128/IAI.00351-07; Molins CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010205; MOURINO M, 1994, MICROB PATHOGENESIS, V16, P249, DOI 10.1006/mpat.1994.1026; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; PAL PG, 1992, INFECT IMMUN, V60, P4781, DOI 10.1128/IAI.60.11.4781-4792.1992; Parra MC, 2010, MICROBIOL RES, V165, P531, DOI 10.1016/j.micres.2009.11.004; Petersen JM, 2009, VET RES, V40, DOI 10.1051/vetres:2008045; RADOLF JD, 1988, INFECT IMMUN, V56, P490, DOI 10.1128/IAI.56.2.490-498.1988; Raynaud C, 1998, MICROBIOL-SGM, V144, P577, DOI 10.1099/00221287-144-2-577; Raynaud C, 2007, INFECT IMMUN, V75, P536, DOI 10.1128/IAI.01429-06; RHINEHARTJONES TR, 1994, INFECT IMMUN, V62, P3129, DOI 10.1128/IAI.62.8.3129-3137.1994; Russo TA, 2009, VACCINE, V27, P388, DOI 10.1016/j.vaccine.2008.10.082; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Sammons-Jackson WL, 2008, DNA CELL BIOL, V27, P387, DOI 10.1089/dna.2007.0687; SANDSTROM G, 1988, INFECT IMMUN, V56, P1194; SANDSTROM G, 1987, J CLIN MICROBIOL, V25, P641; Savitt AG, 2009, CLIN VACCINE IMMUNOL; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; Schulert GS, 2006, J LEUKOCYTE BIOL, V80, P563, DOI 10.1189/jlb.0306219; Sebastian S, 2007, INFECT IMMUN, V75, P2591, DOI 10.1128/IAI.01789-06; SJOSTEDT A, 1991, INFECT IMMUN, V59, P3163; Soloaga A, 1999, MOL MICROBIOL, V31, P1013, DOI 10.1046/j.1365-2958.1999.01225.x; Stenmark S, 2003, MICROB PATHOGENESIS, V35, P73, DOI 10.1016/S0882-4010(03)00095-0; Stollerman GH, 2008, CLIN INFECT DIS, V46, P1038, DOI 10.1086/529194; STRUNK RC, 1988, J CLIN INVEST, V81, P1419, DOI 10.1172/JCI113472; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Telepnev M, 2005, MICROB PATHOGENESIS, V38, P239, DOI 10.1016/j.micpath.2005.02.003; Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x; Thakran S, 2008, J BIOL CHEM, V283, P3751, DOI 10.1074/jbc.M706854200; Thelaus J, 2009, FEMS MICROBIOL ECOL, V67, P69, DOI 10.1111/j.1574-6941.2008.00612.x; Thurlow LR, 2009, INFECT IMMUN, V77, P5551, DOI 10.1128/IAI.00576-09; Toapanta FR, 2006, IMMUNOL RES, V36, P197, DOI 10.1385/IR:36:1:197; Tullius MV, 2001, INFECT IMMUN, V69, P6348, DOI 10.1128/IAI.69.10.6348-6363.2001; Twine SM, 2006, BIOCHEM BIOPH RES CO, V345, P1621, DOI 10.1016/j.bbrc.2006.05.070; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x; Wiker HG, 2001, SCAND J IMMUNOL, V54, P82, DOI 10.1046/j.1365-3083.2001.00946.x; WILLIAMS MD, 1994, MOL MICROBIOL, V11, P1029, DOI 10.1111/j.1365-2958.1994.tb00381.x; Wu MF, 2009, INFECT IMMUN, V77, P615, DOI 10.1128/IAI.00931-08; Yu JJ, 2008, EUR J CLIN MICROBIOL, V27, P323, DOI 10.1007/s10096-007-0434-x; Zhang JM, 2005, J LEUKOCYTE BIOL, V78, P665, DOI 10.1189/jlb.1204699	114	49	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22335	10.1371/journal.pone.0022335	http://dx.doi.org/10.1371/journal.pone.0022335			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799828	Green Published, Green Submitted, gold			2022-12-25	WOS:000293097300035
J	Bonetto, A; Aydogdu, T; Kunzevitzky, N; Guttridge, DC; Khuri, S; Koniaris, LG; Zimmers, TA				Bonetto, Andrea; Aydogdu, Tufan; Kunzevitzky, Noelia; Guttridge, Denis C.; Khuri, Sawsan; Koniaris, Leonidas G.; Zimmers, Teresa A.			STAT3 Activation in Skeletal Muscle Links Muscle Wasting and the Acute Phase Response in Cancer Cachexia	PLOS ONE			English	Article							COLON-26 ADENOCARCINOMA; SIGNALING PATHWAYS; TARGET GENES; WEIGHT-LOSS; CONDITIONAL ACTIVATION; UBIQUITIN LIGASES; LIVER-INJURY; INTERLEUKIN-6; ATROPHY; GROWTH	Background: Cachexia, or weight loss despite adequate nutrition, significantly impairs quality of life and response to therapy in cancer patients. In cancer patients, skeletal muscle wasting, weight loss and mortality are all positively associated with increased serum cytokines, particularly Interleukin-6 (IL-6), and the presence of the acute phase response. Acute phase proteins, including fibrinogen and serum amyloid A (SAA) are synthesized by hepatocytes in response to IL-6 as part of the innate immune response. To gain insight into the relationships among these observations, we studied mice with moderate and severe Colon-26 (C26)-carcinoma cachexia. Methodology/Principal Findings: Moderate and severe C26 cachexia was associated with high serum IL-6 and IL-6 family cytokines and highly similar patterns of skeletal muscle gene expression. The top canonical pathways up-regulated in both were the complement/coagulation cascade, proteasome, MAPK signaling, and the IL-6 and STAT3 pathways. Cachexia was associated with increased muscle pY705-STAT3 and increased STAT3 localization in myonuclei. STAT3 target genes, including SOCS3 mRNA and acute phase response proteins, were highly induced in cachectic muscle. IL-6 treatment and STAT3 activation both also induced fibrinogen in cultured C2C12 myotubes. Quantitation of muscle versus liver fibrinogen and SAA protein levels indicates that muscle contributes a large fraction of serum acute phase proteins in cancer. Conclusions/Significance: These results suggest that the STAT3 transcriptome is a major mechanism for wasting in cancer. Through IL-6/STAT3 activation, skeletal muscle is induced to synthesize acute phase proteins, thus establishing a molecular link between the observations of high IL-6, increased acute phase response proteins and muscle wasting in cancer. These results suggest a mechanism by which STAT3 might causally influence muscle wasting by altering the profile of genes expressed and translated in muscle such that amino acids liberated by increased proteolysis in cachexia are synthesized into acute phase proteins and exported into the blood.	[Bonetto, Andrea; Koniaris, Leonidas G.; Zimmers, Teresa A.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Aydogdu, Tufan; Koniaris, Leonidas G.; Zimmers, Teresa A.] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA; [Kunzevitzky, Noelia; Khuri, Sawsan] Univ Miami, Miller Sch Med, Ctr Computat Sci, Miami, FL 33136 USA; [Guttridge, Denis C.] Ohio State Univ, Sch Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Koniaris, Leonidas G.; Zimmers, Teresa A.] Univ Miami, Miller Sch Med, DeWitt Daughtry Family Dept Surg, Div Surg Oncol, Miami, FL 33136 USA; [Zimmers, Teresa A.] Univ Miami, Miller Sch Med, DeWitt Daughtry Family Dept Surg, Div Burns, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University System of Ohio; Ohio State University; University of Miami; University of Miami	Bonetto, A (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA.	tzimmers@kimmelcancercenter.org	Zimmers, Teresa/AAD-5461-2019	Zimmers, Teresa/0000-0001-7872-0540; Bonetto, Andrea/0000-0002-3235-1871; Khuri, Sawsan/0000-0003-1372-1133; Kunzevitzky, Noelia/0000-0002-8993-6520; Guttridge, Denis/0000-0002-7276-6609	National Cancer Institute [R01 CA122596]; National Institute for General Medical Studies [R01 GM092758]; American Cancer Society [TBE-111831]; ACS; Papanicoulau Corps for Cancer Research; Women's Cancer Association of the University of Miami; Wendy Will Case Cancer Fund; Department of Defense [BC045536]; Amit family; NATIONAL CANCER INSTITUTE [R01CA122596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092758] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute for General Medical Studies; American Cancer Society(American Cancer Society); ACS(American Cancer Society); Papanicoulau Corps for Cancer Research; Women's Cancer Association of the University of Miami; Wendy Will Case Cancer Fund; Department of Defense(United States Department of Defense); Amit family; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants to T.A.Z. from the National Cancer Institute R01 CA122596 (www.nci.nih.gov), from the National Institute for General Medical Studies R01 GM092758 (www.nigms..nih.gov), from the American Cancer Society Research Scholar Grant TBE-111831 (www.acs.org), by individual allocation from an ACS Institutional Grant to the University of Miami, by the Papanicoulau Corps for Cancer Research (www.papcorps.org), by the Women's Cancer Association of the University of Miami (www.wcaofum.org), by the Wendy Will Case Cancer Fund (www.wwccf.org), by the Department of Defense Breast Cancer Research Program (BCRP) BC045536 (cdmrp.army.mil), and by the Amit family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe JI, 2001, ANN NY ACAD SCI, V947, P341; Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Acharyya S, 2007, CLIN CANCER RES, V13, P1356, DOI 10.1158/1078-0432.CCR-06-2307; Allen DL, 2010, AM J PHYSL REGUL INT; Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Argiles JM, 2003, CURR OPIN CLIN NUTR, V6, P401, DOI 10.1097/01.mco.0000078983.18774.cc; Barber MD, 1999, NUTR CANCER, V35, P106, DOI 10.1207/S15327914NC352_2; BLACK K, 1991, ENDOCRINOLOGY, V128, P2657, DOI 10.1210/endo-128-5-2657; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Crepaldi T, 2007, J BIOL CHEM, V282, P6812, DOI 10.1074/jbc.M610916200; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Davis C, 2001, PLAST RECONSTR SURG, V107, P1918, DOI 10.1097/00006534-200106000-00060; Desiderio S, 2003, ANN NY ACAD SCI, V987, P280, DOI 10.1111/j.1749-6632.2003.tb06062.x; Diffee GM, 2002, AM J PHYSIOL-CELL PH, V283, pC1376, DOI 10.1152/ajpcell.00154.2002; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; FALCONER JS, 1995, CANCER, V75, P2077, DOI 10.1002/1097-0142(19950415)75:8<2077::AID-CNCR2820750808>3.0.CO;2-9; FEARON KCH, 1991, ANN SURG, V213, P26, DOI 10.1097/00000658-199101000-00005; FUJIMOTOOUCHI K, 1995, INT J CANCER, V61, P522, DOI 10.1002/ijc.2910610416; Glass DJ, 2007, J CLIN INVEST, V117, P2388, DOI 10.1172/JCI33379; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Glass DJ, 2005, CANCER CELL, V8, P351, DOI 10.1016/j.ccr.2005.10.016; Glass DJ, 1997, P NATL ACAD SCI USA, V94, P8848, DOI 10.1073/pnas.94.16.8848; Glass DJ, 2003, TRENDS MOL MED, V9, P344, DOI 10.1016/S1471-4914(03)00138-2; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; GROSVENOR M, 1989, CANCER, V63, P330, DOI 10.1002/1097-0142(19890115)63:2<330::AID-CNCR2820630221>3.0.CO;2-U; Guida Michele, 2003, J Transl Med, V1, P13, DOI 10.1186/1479-5876-1-13; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Jeschke MG, 2008, ANN SURG, V248, P387, DOI 10.1097/SLA.0b013e3181856241; Jin X, 2009, GUT; Jin X, 2007, HEPATOLOGY, V46, P802, DOI 10.1002/hep.21728; Jin XL, 2006, HEPATOLOGY, V43, P474, DOI 10.1002/hep.21087; JUAN TSC, 1993, P NATL ACAD SCI USA, V90, P2584, DOI 10.1073/pnas.90.7.2584; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; KUSHNER I, 1993, PERSPECT BIOL MED, V36, P611; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Libonati JR, 2001, J STRENGTH COND RES, V15, P362; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; MietusSnyder M, 1997, ARTERIOSCL THROM VAS, V17, P969, DOI 10.1161/01.ATV.17.5.969; Mirka GA, 2000, J BIOMECH, V33, P1701, DOI 10.1016/S0021-9290(00)00151-2; Mitterhuemer S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-138; MORRISON SD, 1976, PHYSIOL BEHAV, V17, P705, DOI 10.1016/0031-9384(76)90173-6; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Oh YM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006911; OHE Y, 1993, BRIT J CANCER, V67, P939, DOI 10.1038/bjc.1993.174; Pavey SJ, 2001, BLOOD COAGUL FIBRIN, V12, P51, DOI 10.1097/00001721-200101000-00008; Preston T, 1998, J NUTR, V128, P1355, DOI 10.1093/jn/128.8.1355; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scott HR, 1996, BRIT J CANCER, V73, P1560, DOI 10.1038/bjc.1996.294; Snyder M, 2008, J BIOL CHEM, V283, P3791, DOI 10.1074/jbc.M706976200; SODA K, 1995, INT J CANCER, V62, P332, DOI 10.1002/ijc.2910620317; SODA K, 1994, JPN J CANCER RES, V85, P1124, DOI 10.1111/j.1349-7006.1994.tb02917.x; Stephens Nathan A, 2008, Curr Opin Support Palliat Care, V2, P267, DOI 10.1097/SPC.0b013e3283186be2; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; STRASSMANN G, 1993, J CLIN INVEST, V92, P2152, DOI 10.1172/JCI116816; STRASSMANN G, 1995, CYTOKINES MOL THER, V1, P107; STRASSMANN G, 1992, J CLIN INVEST, V89, P1681, DOI 10.1172/JCI115767; Tamura S, 1995, CLIN CANCER RES, V1, P1353; Tan BHL, 2008, CURR OPIN CLIN NUTR, V11, P400, DOI 10.1097/MCO.0b013e328300ecc1; TANAKA Y, 1990, CANCER RES, V50, P2290; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; TSUJINAKA T, 1995, BIOCHEM BIOPH RES CO, V207, P168, DOI 10.1006/bbrc.1995.1168; Tsujinaka T, 1996, J CLIN INVEST, V97, P244, DOI 10.1172/JCI118398; Vallania F, 2009, P NATL ACAD SCI USA, V106, P5117, DOI 10.1073/pnas.0900473106; Ventadour S, 2006, CURR OPIN RHEUMATOL, V18, P631, DOI 10.1097/01.bor.0000245731.25383.de; Vernooy JHJ, 2005, EXP LUNG RES, V31, P855, DOI 10.1080/01902140600611645; Weil WM, 2007, BULL HOSP JT DIS, V65, P72; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525; Zimmers TA, 2006, J SURG RES, V130, P45, DOI 10.1016/j.jss.2005.07.036; Zimmers TA, 2005, SHOCK, V23, P543, DOI 10.1097/01.shk.0000163393.55350.70; Zimmers TA, 2003, HEPATOLOGY, V38, P1590, DOI 10.1016/j.hep.2003.09.021; Zimmers TA, 2003, HEPATOLOGY, V38, P326, DOI 10.1053/jhep.2003.50318	83	232	233	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22538	10.1371/journal.pone.0022538	http://dx.doi.org/10.1371/journal.pone.0022538			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799891	Green Submitted, Green Published, gold			2022-12-25	WOS:000292931200061
J	Guilford, T; Freeman, R; Boyle, D; Dean, B; Kirk, H; Phillips, R; Perrins, C				Guilford, Tim; Freeman, Robin; Boyle, Dave; Dean, Ben; Kirk, Holly; Phillips, Richard; Perrins, Chris			A Dispersive Migration in the Atlantic Puffin and Its Implications for Migratory Navigation	PLOS ONE			English	Article							SURVIVAL; ECOLOGY	Navigational control of avian migration is understood, largely from the study of terrestrial birds, to depend on either genetically or culturally inherited information. By tracking the individual migrations of Atlantic Puffins, Fratercula arctica, in successive years using geolocators, we describe migratory behaviour in a pelagic seabird that is apparently incompatible with this view. Puffins do not migrate to a single overwintering area, but follow a dispersive pattern of movements changing through the non-breeding period, showing great variability in travel distances and directions. Despite this within-population variability, individuals show remarkable consistency in their own migratory routes among years. This combination of complex population dispersion and individual route fidelity cannot easily be accounted for in terms of genetic inheritance of compass instructions, or cultural inheritance of traditional routes. We suggest that a mechanism of individual exploration and acquired navigational memory may provide the dominant control over Puffin migration, and potentially some other pelagic seabirds, despite the apparently featureless nature of the ocean.	[Guilford, Tim; Freeman, Robin; Dean, Ben; Kirk, Holly] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Freeman, Robin] Microsoft Res Cambridge, Computat Ecol & Environm Sci, Cambridge, England; [Boyle, Dave; Perrins, Chris] Univ Oxford, Edward Grey Inst Field Ornithol, Oxford, England; [Phillips, Richard] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	University of Oxford; Microsoft; University of Oxford; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Guilford, T (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	tim.guilford@zoo.ox.ac.uk	Kirk, Holly/HHC-6449-2022	Kirk, Holly/0000-0002-8724-3210	Microsoft Research Cambridge; Oxford University; Natural Environment Research Council; Natural Environment Research Council [bas0100025] Funding Source: researchfish; NERC [bas0100025] Funding Source: UKRI	Microsoft Research Cambridge(Microsoft); Oxford University; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded with the help of Microsoft Research Cambridge, Oxford University, and a Natural Environment Research Council studentship (Ben Dean). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able KP, 1991, ORIENTATION BIRDS, P166; Akesson S, 2001, J NAVIGATION, V54, P419, DOI 10.1017/S0373463301001473; Alerstam T, 1991, ORIENTATION BIRDS, P202; Alerstam T, 2006, SCIENCE, V313, P791, DOI 10.1126/science.1129048; ASHCROFT RE, 1979, ORNIS SCAND, V10, P100, DOI 10.2307/3676349; Benhamou S, 2003, ANIM BEHAV, V65, P729, DOI 10.1006/anbe.2003.2092; Berthold P, 1996, CONTROL BIRD MIGRATI; Bonadonna F, 2003, AVIAN MIGRATION, P367; Bonadonna F, 2005, P ROY SOC B-BIOL SCI, V272, P489, DOI 10.1098/rspb.2004.2984; Croxall JP, 2005, SCIENCE, V307, P249, DOI 10.1126/science.1106042; Dias MP, 2011, P ROY SOC B-BIOL SCI, V278, P1786, DOI 10.1098/rspb.2010.2114; Freeman R, 2011, BIOL LETTERS, V7, P63, DOI 10.1098/rsbl.2010.0627; GWINNER E, 1978, J COMP PHYSIOL, V125, P267, DOI 10.1007/BF00656605; Harris MP, 2010, MAR BIOL, V157, P827, DOI 10.1007/s00227-009-1365-0; Harris MP, 2005, MAR ECOL PROG SER, V297, P283, DOI 10.3354/meps297283; Harris MP, 1984, PUFFIN; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; Mouritsen H, 2003, AVIAN MIGRATION, P493; Nevitt GA, 2008, J EXP BIOL, V211, P1706, DOI 10.1242/jeb.015412; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Phillips RA, 2005, ECOLOGY, V86, P2386, DOI 10.1890/04-1885; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Stone C.J., 1995, ATLAS SEABIRD DISTRI; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013	24	103	105	1	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e21336	10.1371/journal.pone.0021336	http://dx.doi.org/10.1371/journal.pone.0021336			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799734	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000292931200007
J	Ligon, RA; Siefferman, L; Hill, GE				Ligon, Russell A.; Siefferman, Lynn; Hill, Geoffrey E.			Invasive Fire Ants Reduce Reproductive Success and Alter the Reproductive Strategies of a Native Vertebrate Insectivore	PLOS ONE			English	Article							TREECREEPER CERTHIA-FAMILIARIS; BLACK-LEGGED KITTIWAKES; SOLENOPSIS-INVICTA; SEX-RATIO; EURASIAN TREECREEPERS; ARTHROPOD-COMMUNITY; DESERT ECOSYSTEMS; HABITAT QUALITY; CLUTCH SIZE; WOOD ANTS	Background: Introduced organisms can alter ecosystems by disrupting natural ecological relationships. For example, red imported fire ants (Solenopsis invicta) have disrupted native arthropod communities throughout much of their introduced range. By competing for many of the same food resources as insectivorous vertebrates, fire ants also have the potential to disrupt vertebrate communities. Methodology/Principal Findings: To explore the effects of fire ants on a native insectivorous vertebrate, we compared the reproductive success and strategies of eastern bluebirds (Sialia sialis) inhabiting territories with different abundances of fire ants. We also created experimental dyads of adjacent territories comprised of one territory with artificially reduced fire ant abundance (treated) and one territory that was unmanipulated (control). We found that more bluebird young fledged from treated territories than from adjacent control territories. Fire ant abundance also explained significant variation in two measures of reproductive success across the study population: number of fledglings and hatching success of second clutches. Furthermore, the likelihood of bluebird parents re-nesting in the same territory was negatively influenced by the abundance of foraging fire ants, and parents nesting in territories with experimentally reduced abundances of fire ants produced male-biased broods relative to pairs in adjacent control territories. Conclusions/Significance: Introduced fire ants altered both the reproductive success (number of fledglings, hatching success) and strategies (decision to renest, offspring sex-ratio) of eastern bluebirds. These results illustrate the negative effects that invasive species can have on native biota, including species from taxonomically distant groups.	[Ligon, Russell A.; Hill, Geoffrey E.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Siefferman, Lynn] Appalachian State Univ, Dept Biol Sci, Boone, NC 28608 USA	Auburn University System; Auburn University; University of North Carolina; Appalachian State University	Ligon, RA (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	russell.ligon@gmail.com	Hill, Geoffrey E./R-7354-2019; Ligon, Russell/M-1233-2013	Hill, Geoffrey E./0000-0001-8864-6495; Ligon, Russell/0000-0002-0195-8275; Siefferman, Lynn/0000-0002-9600-2902	National Institute of Allergy and Infectious Diseases [R01AI049724]; Birmingham Audubon Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049724] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Birmingham Audubon Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a grant from the National Institute of Allergy and Infectious Diseases, Project n. R01AI049724 to GEH and by a grant from the Birmingham Audubon Society to RAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho T, 1997, ANIM BEHAV, V54, P1283, DOI 10.1006/anbe.1997.0547; Aho T, 1999, ECOLOGY, V80, P998, DOI 10.1890/0012-9658(1999)080[0998:RSOETC]2.0.CO;2; Allen CR, 2004, AM MIDL NAT, V152, P88, DOI 10.1674/0003-0031(2004)152[0088:RIFAIO]2.0.CO;2; Allen CR, 2001, J AGR URBAN ENTOMOL, V18, P249; Angelier F, 2007, HORM BEHAV, V52, P482, DOI 10.1016/j.yhbeh.2007.07.003; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BROWN JH, 1977, SCIENCE, V196, P880, DOI 10.1126/science.196.4292.880; BROWN JH, 1979, ANNU REV ECOL SYST, V10, P201, DOI 10.1146/annurev.es.10.110179.001221; BUREN WF, 1974, J NEW YORK ENTOMOL S, V82, P113; Butcher GS, 2007, COMBINING DATA CHRIS; CARPENTER FL, 1979, AM ZOOL, V19, P1105; Catzeflis F., 1979, Nos Oiseaux, V35, P75; Cavitt J.F., 2000, BIRDS N AM ONLINE; CHARNOV E L, 1982; Clutton-Brock T.H., 1988, REPROD SUCCESS STUDI; Cook JL, 2002, TEXAS PEST ANT IDENT; Costa AN, 2008, J VEG SCI, V19, P849, DOI 10.3170/2008-8-18461; Darwin C., 1877, DIFFERENT FORMS FLOW; Davis NE, 2008, CONSERV BIOL, V22, P1165, DOI 10.1111/j.1523-1739.2008.00984.x; Derrickson K. C., 1992, BIRDS N AM ONLINE; Djerdali S, 2008, ACTA ORNITHOL, V43, P145, DOI 10.3161/000164508X395252; Eubanks MD, 2002, ENVIRON ENTOMOL, V31, P1168, DOI 10.1603/0046-225X-31.6.1168; GILL F.B., 2006, ORNITHOLOGY; Gill VA, 2002, J AVIAN BIOL, V33, P113, DOI 10.1034/j.1600-048X.2002.330201.x; Gowaty P., 1998, BIRDS N AM ONLINE; Haemig PD, 1996, BEHAV ECOL SOCIOBIOL, V38, P25, DOI 10.1007/s002650050213; HAEMIG PD, 1992, OIKOS, V65, P479, DOI 10.2307/3545565; Jantti A, 2007, J AVIAN BIOL, V38, P619, DOI 10.1111/j.2007.0908-8857.03926.x; Krieg D. C., 1971, BEHAV PATTERNS E BLU; Lach L, 2003, ANN MO BOT GARD, V90, P91, DOI 10.2307/3298529; Langkilde T, 2009, ECOLOGY, V90, P208, DOI 10.1890/08-0355.1; Lewis KP, 2004, OIKOS, V104, P305, DOI 10.1111/j.0030-1299.2004.12636.x; Ligon RA, 2009, THESIS AUBURN U; Marone L, 1998, FUNCT ECOL, V12, P640, DOI 10.1046/j.1365-2435.1998.00226.x; MARQUET PA, 1990, REV CHIL HIST NAT, V63, P149; Morrison LW, 2004, BIOL INVASIONS, V6, P183, DOI 10.1023/B:BINV.0000022135.96042.90; Morrison LW, 2002, ECOLOGY, V83, P2337, DOI 10.1890/0012-9658(2002)083[2337:LTIOAA]2.0.CO;2; Phillips BL, 2004, P NATL ACAD SCI USA, V101, P17150, DOI 10.1073/pnas.0406440101; Pike TW, 2003, BIOL REV, V78, P553, DOI 10.1017/S1464793103006146; Pinkowski B.C., 1974, Inland Bird Banding Newsetter, V46, P88; PORTER SD, 1990, ECOLOGY, V71, P2095, DOI 10.2307/1938623; PORTER SD, 1987, ENVIRON ENTOMOL, V16, P802, DOI 10.1093/ee/16.3.802; Salomons HM, 2008, BEHAV ECOL, V19, P417, DOI 10.1093/beheco/arm149; Schmidt JB, 2009, POULTRY SCI, V88, P1352, DOI 10.3382/ps.2008-00513; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; Siefferman L, 2008, IBIS, V150, P32; SMITH CC, 1979, AM ZOOL, V19, P1065; Stauss M, 2005, OIKOS, V109, P367, DOI 10.1111/j.0030-1299.2005.13333.x; Suorsa P, 2003, P ROY SOC B-BIOL SCI, V270, P2215, DOI 10.1098/rspb.2003.2490; Tremblay I, 2005, IBIS, V147, P17, DOI 10.1111/j.1474-919x.2004.00312.x; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; VINSON SB, 1994, WESTV STUD, P240; Williamson M., 1996, BIOL INVASIONS; YOMTOV Y, 1974, J ANIM ECOL, V43, P479, DOI 10.2307/3378	54	4	4	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22578	10.1371/journal.pone.0022578	http://dx.doi.org/10.1371/journal.pone.0022578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799904	Green Published, gold			2022-12-25	WOS:000292931200064
J	Nyberg, F; Ogiwara, A; Harbron, CG; Kawakami, T; Nagasaka, K; Takami, S; Wada, K; Tu, HK; Otsuji, M; Kyono, Y; Dobashi, T; Komatsu, Y; Kihara, M; Akimoto, S; Peers, IS; South, MC; Higenbottam, T; Fukuoka, M; Nakata, K; Ohe, Y; Kudoh, S; Clausen, IG; Nishimura, T; Marko-Varga, G; Kato, H				Nyberg, Fredrik; Ogiwara, Atsushi; Harbron, Chris G.; Kawakami, Takao; Nagasaka, Keiko; Takami, Sachiko; Wada, Kazuya; Tu, Hsiao-Kun; Otsuji, Makiko; Kyono, Yutaka; Dobashi, Tae; Komatsu, Yasuhiko; Kihara, Makoto; Akimoto, Shingo; Peers, Ian S.; South, Marie C.; Higenbottam, Tim; Fukuoka, Masahiro; Nakata, Koichiro; Ohe, Yuichiro; Kudoh, Shoji; Clausen, Ib Groth; Nishimura, Toshihide; Marko-Varga, Gyorgy; Kato, Harubumi			Proteomic Biomarkers for Acute Interstitial Lung Disease in Gefitinib-Treated Japanese Lung Cancer Patients	PLOS ONE			English	Article							MASS-SPECTROMETRY; PHASE-III; PROTEIN; EXPRESSION; IDENTIFICATION; PNEUMONIA; ABUNDANCE; NF-IL6; TRIAL	Interstitial lung disease (ILD) events have been reported in Japanese non-small-cell lung cancer (NSCLC) patients receiving EGFR tyrosine kinase inhibitors. We investigated proteomic biomarkers for mechanistic insights and improved prediction of ILD. Blood plasma was collected from 43 gefitinib-treated NSCLC patients developing acute ILD (confirmed by blinded diagnostic review) and 123 randomly selected controls in a nested case-control study within a pharmacoepidemiological cohort study in Japan. We generated similar to 7 million tandem mass spectrometry (MS/MS) measurements with extensive quality control and validation, producing one of the largest proteomic lung cancer datasets to date, incorporating rigorous study design, phenotype definition, and evaluation of sample processing. After alignment, scaling, and measurement batch adjustment, we identified 41 peptide peaks representing 29 proteins best predicting ILD. Multivariate peptide, protein, and pathway modeling achieved ILD prediction comparable to previously identified clinical variables; combining the two provided some improvement. The acute phase response pathway was strongly represented (17 of 29 proteins, p = 1.0 x 10(-25)), suggesting a key role with potential utility as a marker for increased risk of acute ILD events. Validation by Western blotting showed correlation for identified proteins, confirming that robust results can be generated from an MS/MS platform implementing strict quality control.	[Nyberg, Fredrik] AstraZeneca R&D, Global Epidemiol, Molndal, Sweden; [Nyberg, Fredrik] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Ogiwara, Atsushi; Kawakami, Takao; Nagasaka, Keiko; Takami, Sachiko; Wada, Kazuya; Tu, Hsiao-Kun; Otsuji, Makiko; Kyono, Yutaka; Dobashi, Tae; Komatsu, Yasuhiko; Kihara, Makoto; Akimoto, Shingo; Nishimura, Toshihide] Med ProteoScope Co, Div Res & Dev, Tokyo, Japan; [Ogiwara, Atsushi; Kawakami, Takao; Akimoto, Shingo; Nishimura, Toshihide] Tokyo Med Univ, Clin Proteome Ctr, Tokyo, Japan; [Harbron, Chris G.; Peers, Ian S.; South, Marie C.] AstraZeneca R&D, Discovery Stat, Macclesfield, Cheshire, England; [Higenbottam, Tim; Marko-Varga, Gyorgy] AstraZeneca R&D, AstraZeneca Resp Biol Sci, Lund, Sweden; [Fukuoka, Masahiro] Kinki Univ, Sch Med, Dept Med Oncol, Osaka 589, Japan; [Nakata, Koichiro] Nakata Clin, Tokyo, Japan; [Ohe, Yuichiro] Natl Canc Ctr Hosp E, Dept Thorac Oncol, Chiba, Japan; [Kudoh, Shoji] Japan Anti TB Assoc Fukujuji Hosp, Tokyo, Japan; [Kudoh, Shoji] Nippon Med Sch, Div Pulm Med Infect Dis & Oncol, Dept Internal Med, Tokyo 113, Japan; [Clausen, Ib Groth] AstraZeneca R&D, Resp Biol Sci, Lund, Sweden; [Marko-Varga, Gyorgy; Kato, Harubumi] Tokyo Med Univ, Dept Surg, Tokyo, Japan; [Kato, Harubumi] Niizashiki Cent Gen Hosp, Saitama, Japan	AstraZeneca; Karolinska Institutet; Tokyo Medical University; AstraZeneca; AstraZeneca; Kindai University (Kinki University); National Cancer Center - Japan; Fukujuji Hospital; Nippon Medical School; AstraZeneca; Tokyo Medical University	Nyberg, F (corresponding author), AstraZeneca R&D, Global Epidemiol, Molndal, Sweden.	Fredrik.Nyberg@astrazeneca.com		Nyberg, Fredrik/0000-0003-0892-5668; Komatsu, Yasuhiko/0000-0003-1739-8222	AstraZeneca	AstraZeneca(AstraZeneca)	This study was funded by AstraZeneca and conducted in collaboration by researchers from Academia, AstraZeneca and Medical Proteoscope Company. All collaborating parties participated in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abid SH, 2001, CURR OPIN ONCOL, V13, P242, DOI 10.1097/00001622-200107000-00006; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Ando M, 2006, J CLIN ONCOL, V24, P2549, DOI 10.1200/JCO.2005.04.9866; Azuma A., 2007, JMAJ - Japan Medical Association Journal, V50, P405; BETTS JC, 1993, J BIOL CHEM, V268, P25624; Brancia FL, 2006, EXPERT REV PROTEOMIC, V3, P143, DOI 10.1586/14789450.3.1.143; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; Danson S, 2005, DRUG SAFETY, V28, P103, DOI 10.2165/00002018-200528020-00002; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Fontana V, 2007, HEMATOLOGY, V12, P75, DOI 10.1080/10245330600938281; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Huang YCT, 2006, CHEST, V129, P1565, DOI 10.1378/chest.129.6.1565; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Inoue A, 2003, LANCET, V361, P137, DOI 10.1016/S0140-6736(03)12190-3; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; ISSHIKI H, 1991, NEW BIOL, V3, P63; Koo LC, 2005, PHARMACOEPIDEM DR S, V14, P775, DOI 10.1002/pds.1071; Kudoh S, 2006, J CLIN ONCOL, V24, P3657, DOI 10.1200/JCO.2006.06.1044; Kudoh S, 2008, AM J RESP CRIT CARE, V177, P1348, DOI 10.1164/rccm.200710-1501OC; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Listgarten J, 2005, MOL CELL PROTEOMICS, V4, P419, DOI 10.1074/mcp.R500005-MCP200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marko-Varga G, 2007, J PROTEOME RES, V6, P2925, DOI 10.1021/pr070046s; McDonald WH, 2003, CURR OPIN MOL THER, V5, P302; Nielsen NPV, 1998, J CHROMATOGR A, V805, P17, DOI 10.1016/S0021-9673(98)00021-1; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Oikonomou N, 2009, THORAX, V64, P467, DOI 10.1136/thx.2008.107946; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pieper R, 2003, PROTEOMICS, V3, P1345, DOI 10.1002/pmic.200300449; Pravdova V, 2002, ANAL CHIM ACTA, V456, P77, DOI 10.1016/S0003-2670(02)00008-9; Raghu G, 2004, BRIT J CANCER, V91, pS3, DOI 10.1038/sj.bjc.6602061; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Rossi SE, 2000, RADIOGRAPHICS, V20, P1245, DOI 10.1148/radiographics.20.5.g00se081245; Sandler AB, 2000, J CLIN ONCOL, V18, P122, DOI 10.1200/JCO.2000.18.1.122; Schwartz JC, 2002, J AM SOC MASS SPECTR, V13, P659, DOI 10.1016/S1044-0305(02)00384-7; Seferovic MD, 2008, J CHROMATOGR B, V865, P147, DOI 10.1016/j.jchromb.2008.01.052; Shi W, 2009, RESPIROLOGY, V14, P656, DOI 10.1111/j.1440-1843.2009.01565.x; Silliman CC, 2006, BLOOD REV, V20, P139, DOI 10.1016/j.blre.2005.11.001; Wells AU, 2007, AM J RESP CRIT CARE, V175, P655, DOI 10.1164/rccm.200701-052UP	43	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22062	10.1371/journal.pone.0022062	http://dx.doi.org/10.1371/journal.pone.0022062			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799770	Green Submitted, gold, Green Published			2022-12-25	WOS:000292931200023
J	Ott, A; Trautschold, B; Sandhu, D				Ott, Alina; Trautschold, Brian; Sandhu, Devinder			Using Microsatellites to Understand the Physical Distribution of Recombination on Soybean Chromosomes	PLOS ONE			English	Article							GENETIC-LINKAGE MAP; GENOME SEQUENCE; WHEAT GENOMES; MAIZE GENOME; SSR MARKERS; DNA; POLYMORPHISMS; REGIONS; CENTROMERE; DIVERSITY	Soybean is a major crop that is an important source of oil and proteins. A number of genetic linkage maps have been developed in soybean. Specifically, hundreds of simple sequence repeat (SSR) markers have been developed and mapped. Recent sequencing of the soybean genome resulted in the generation of vast amounts of genetic information. The objectives of this investigation were to use SSR markers in developing a connection between genetic and physical maps and to determine the physical distribution of recombination on soybean chromosomes. A total of 2,188 SSRs were used for sequence-based physical localization on soybean chromosomes. Linkage information was used from different maps to create an integrated genetic map. Comparison of the integrated genetic linkage maps and sequence based physical maps revealed that the distal 25% of each chromosome was the most marker-dense, containing an average of 47.4% of the SSR markers and 50.2% of the genes. The proximal 25% of each chromosome contained only 7.4% of the markers and 6.7% of the genes. At the whole genome level, the marker density and gene density showed a high correlation (R-2) of 0.64 and 0.83, respectively with the physical distance from the centromere. Recombination followed a similar pattern with comparisons indicating that recombination is high in telomeric regions, though the correlation between crossover frequency and distance from the centromeres is low (R-2 = 0.21). Most of the centromeric regions were low in recombination. The crossover frequency for the entire soybean genome was 7.2%, with extremes much higher and lower than average. The number of recombination hotspots varied from 1 to 12 per chromosome. A high correlation of 0.83 between the distribution of SSR markers and genes suggested close association of SSRs with genes. The knowledge of distribution of recombination on chromosomes may be applied in characterizing and targeting genes.	[Ott, Alina; Trautschold, Brian; Sandhu, Devinder] Univ Wisconsin, Dept Biol, Stevens Point, WI 54481 USA	University of Wisconsin System; University of Wisconsin Stevens Point	Sandhu, D (corresponding author), Univ Wisconsin, Dept Biol, Stevens Point, WI 54481 USA.	dsandhu@uwsp.edu		Sandhu, Devinder/0000-0003-4193-3408; Ott, Alina/0000-0003-4830-8509	UWSP L&S undergraduate education initiative	UWSP L&S undergraduate education initiative	The project is supported by UWSP L&S undergraduate education initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov ED, 2003, GENOME RES, V13, P753, DOI 10.1101/gr.808603; Akhunov ED, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-702; AKKAYA MS, 1992, GENETICS, V132, P1131; Anderson LK, 2006, GENOME RES, V16, P115, DOI [10.1101/gr.4249906, 10.1101/gr4249906]; APUYAN R, 1988, THEOR APPL GENET, V75, P889; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Barakat A, 1997, P NATL ACAD SCI USA, V94, P6857, DOI 10.1073/pnas.94.13.6857; BERNATZKY R, 1986, GENETICS, V112, P887; CARELS N, 1995, P NATL ACAD SCI USA, V92, P11057, DOI 10.1073/pnas.92.24.11057; Chen MS, 2002, PLANT CELL, V14, P537, DOI 10.1105/tpc.010485; Choi IY, 2007, GENETICS, V176, P685, DOI 10.1534/genetics.107.070821; Cregan PB, 1999, CROP SCI, V39, P1464, DOI 10.2135/cropsci1999.3951464x; Drouaud J, 2006, GENOME RES, V16, P106, DOI 10.1101/gr.4319006; Erayman M, 2004, NUCLEIC ACIDS RES, V32, P3546, DOI 10.1093/nar/gkh639; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Hisano H, 2007, DNA RES, V14, P271, DOI 10.1093/dnares/dsm025; Hwang TY, 2009, DNA RES, V16, P213, DOI 10.1093/dnares/dsp010; KEIM P, 1990, GENETICS, V126, P735; Kunzel G, 2000, GENETICS, V154, P397; Liu SZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000733; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Mudge J, 2004, GENOME, V47, P361, DOI [10.1139/g03-141, 10.1139/G03-141]; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; Mutti JS, 2010, MOL BREEDING, V26, P177, DOI 10.1007/s11032-009-9389-1; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Saintenac C, 2009, GENETICS, V181, P393, DOI 10.1534/genetics.108.097469; Sandhu D, 2002, PLANT PHYSIOL, V128, P803, DOI 10.1104/pp.010745; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Song QJ, 2010, CROP SCI, V50, P1950, DOI 10.2135/cropsci2009.10.0607; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Walling JG, 2006, GENETICS, V172, P1893, DOI 10.1534/genetics.105.051466; Wei FS, 1999, GENETICS, V153, P1929; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Xia Z, 2007, DNA RES, V14, P257, DOI 10.1093/dnares/dsm027; Yamanaka N, 2001, DNA RES, V8, P61, DOI 10.1093/dnares/8.2.61; Yu QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-371; Zhu YL, 2003, GENETICS, V163, P1123	40	23	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22306	10.1371/journal.pone.0022306	http://dx.doi.org/10.1371/journal.pone.0022306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799819	Green Published, Green Submitted, gold			2022-12-25	WOS:000292931200045
J	Wang, LG; Yang, HK; Zhao, SG; Sato, H; Konishi, Y; Beach, TG; Abdelalim, EM; Bisem, NJ; Tooyama, I				Wang, Ligang; Yang, Hongkuan; Zhao, Shiguang; Sato, Haruhisa; Konishi, Yoshihiro; Beach, Thomas G.; Abdelalim, Essam Mohamed; Bisem, Naomi J.; Tooyama, Ikuo			Expression and Localization of Mitochondrial Ferritin mRNA in Alzheimer's Disease Cerebral Cortex	PLOS ONE			English	Article							IRON TRAFFICKING; TOXICITY; PLAQUES; PROTEIN; ZINC; A-BETA(1-42); PARKINSONS; METABOLISM; COPPER; DEATH	Mitochondrial ferritin (MtF) has been identified as a novel ferritin encoded by an intron-lacking gene with specific mitochondrial localization located on chromosome 5q23.1. MtF has been associated with neurodegenerative disorders such as Friedreich ataxia and restless leg syndrome. However, little information is available about MtF in Alzheimer's disease (AD). In this study, therefore, we investigated the expression and localization of MtF messenger RNA (mRNA) in the cerebral cortex of AD and control cases using real-time polymerase chain reaction (PCR) as well as in situ hybridization histochemistry. We also examined protein expression using western-blot assay. In addition, we used in vitro methods to further explore the effect of oxidative stress and beta-amyloid peptide (A beta) on MtF expression. To do this we examined MtF mRNA and protein expression changes in the human neuroblastoma cell line, IMR-32, after treatment with A beta, H2O2, or both. The neuroprotective effect of MtF on oxidative stress induced by H2O2 was measured by MTT assay. The in situ hybridization studies revealed that MtF mRNA was detected mainly in neurons to a lesser degree in glial cells in the cerebral cortex. The staining intensity and the number of positive cells were increased in the cerebral cortex of AD patients. Real-time PCR and western-blot confirmed that MtF expression levels in the cerebral cortex were significantly higher in AD cases than that in control cases at both the mRNA and the protein level. Cell culture experiments demonstrated that the expression of both MtF mRNA and protein were increased by treatment with H2O2 or a combination of A beta and H2O2, but not with A beta alone. Finally, MtF expression showed a significant neuroprotective effect against H2O2-induced oxidative stress (p<0.05). The present study suggests that MtF is involved in the pathology of AD and may play a neuroprotective role against oxidative stress.	[Wang, Ligang; Abdelalim, Essam Mohamed; Bisem, Naomi J.; Tooyama, Ikuo] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Otsu, Shiga 52021, Japan; [Wang, Ligang; Yang, Hongkuan; Zhao, Shiguang] Harbin Med Univ, Affiliated Hosp 1, Dept Neurosurg, Harbin, Peoples R China; [Sato, Haruhisa] Marutamachi Hosp, Dept Pathol, Kyoto, Japan; [Konishi, Yoshihiro] Nishi Tottori Natl Hosp, Dept Clin Res, Tottori, Japan; [Beach, Thomas G.] Civin Lab Neuropathol, Banner Sun City, AZ USA	Shiga University of Medical Science; Harbin Medical University; Banner Research; Banner Health; Banner Sun Health Research Institute	Wang, LG (corresponding author), Shiga Univ Med Sci, Mol Neurosci Res Ctr, Otsu, Shiga 52021, Japan.	guangsz@hotmail.com; kinchan@belle.shiga-med.ac.jp	Abdelalim, Essam M./Q-8275-2019	Abdelalim, Essam M./0000-0001-7764-6772; Tooyama, Ikuo/0000-0001-8054-9666	JST; JSPS [22300153]; National Institute on Aging [P30 AG19610]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE ON AGING [P30AG019610] Funding Source: NIH RePORTER	JST(Japan Science & Technology Agency (JST)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services; Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by the JST Practical Application Research Program and by JSPS KAKENHI (22300153). The Brain and Body Donation Program is supported by the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901 and 1001 to the Arizona Parkinson's Disease Consortium) and the Michael J. Fox Foundation for Parkinson's Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura S, 2009, J ALZHEIMERS DIS, V16, P879, DOI 10.3233/JAD-2009-1010; An L, 2009, NEUROSCI LETT, V452, P277, DOI 10.1016/j.neulet.2009.01.071; Arosio P, 2010, BBA-GEN SUBJECTS, V1800, P783, DOI 10.1016/j.bbagen.2010.02.005; Beach TG, 1998, ALZHEIMERS REP, V1, P375; Beach TG, 2008, CELL TISSUE BANK, V9, P229, DOI 10.1007/s10561-008-9067-2; Bush AI, 2003, ALZ DIS ASSOC DIS, V17, P147, DOI 10.1097/00002093-200307000-00005; Campanella A, 2009, HUM MOL GENET, V18, P1, DOI 10.1093/hmg/ddn308; Castellani RJ, 2007, NEUROCHEM RES, V32, P1640, DOI 10.1007/s11064-007-9360-7; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; CONNOR JR, 1992, J NEUROSCI RES, V31, P75, DOI 10.1002/jnr.490310111; Corsi B, 2002, J BIOL CHEM, V277, P22430, DOI 10.1074/jbc.M105372200; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; Drysdale J, 2002, BLOOD CELL MOL DIS, V29, P376, DOI 10.1006/bcmd.2002.0577; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Duce JA, 2010, PROG NEUROBIOL, V92, P1, DOI 10.1016/j.pneurobio.2010.04.003; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Jefferies WA, 1996, BRAIN RES, V712, P122, DOI 10.1016/0006-8993(95)01407-1; KAWAMATA T, 1993, AM J PATHOL, V142, P1574; Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Levi S, 2004, INT J BIOCHEM CELL B, V36, P1887, DOI 10.1016/j.biocel.2003.10.020; Levi S, 2001, J BIOL CHEM, V276, P24437, DOI 10.1074/jbc.C100141200; LeVine SM, 1997, BRAIN RES, V760, P298, DOI 10.1016/S0006-8993(97)00470-8; Napier I, 2005, BLOOD, V105, P1867, DOI 10.1182/blood-2004-10-3856; Nie GJ, 2005, BLOOD, V105, P2161, DOI 10.1182/blood-2004-07-2722; Pandolfo M, 2009, J NEUROL, V256, P1, DOI 10.1007/s00415-009-1001-4; Ponka P, 1997, BLOOD, V89, P1; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Saeki M, 2000, NEUROSCI RES, V38, P213, DOI 10.1016/S0168-0102(00)00138-3; Santambrogio P, 2007, J HISTOCHEM CYTOCHEM, V55, P1129, DOI 10.1369/jhc.7A7273.2007; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Snyder AM, 2009, J NEUROPATH EXP NEUR, V68, P1193, DOI 10.1097/NEN.0b013e3181bdc44f; Tooyama I, 2001, DEMENT GERIATR COGN, V12, P237, DOI 10.1159/000051265; Wang LG, 2010, NEUROSCI LETT, V481, P164, DOI 10.1016/j.neulet.2010.06.079; Yamamoto A, 2002, J NEUROCHEM, V82, P1137; YANAGISAWA D, 2011, J ALZHEIMER IN PRESS	43	39	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22325	10.1371/journal.pone.0022325	http://dx.doi.org/10.1371/journal.pone.0022325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799823	gold, Green Published, Green Submitted			2022-12-25	WOS:000292931200047
J	Chen, SCY; Stern, P; Guo, ZY; Chen, JZ				Chen, Steve C. -Y.; Stern, Patrick; Guo, Zhuyan; Chen, Jianzhu			Expression of Multiple Artificial MicroRNAs from a Chicken miRNA126-Based Lentiviral Vector	PLOS ONE			English	Article							REGULATED RNA INTERFERENCE; MAMMALIAN-CELLS; IN-VIVO; SYSTEM; HIV-1; INHIBITION	Background: The use of RNAi in both basic and translational research often requires expression of multiple siRNAs from the same vector. Methods/Principal Findings: We have developed a novel chicken miR126-based artificial miRNA expression system that can express one, two or three miRNAs from a single cassette in a lentiviral vector. We show that each of the miRNAs expressed from the same lentiviral vector is capable of potent inhibition of reporter gene expression in transient transfection and stable integration assays in chicken fibroblast DF-1 cells. Transduction of Vero cells with lentivirus expressing two or three different anti-influenza miRNAs leads to inhibition of influenza virus production. In addition, the chicken miR126-based expression system effectively inhibits reporter gene expression in human, monkey, dog and mouse cells. These results demonstrate that the flanking regions of a single primary miRNA can support processing of three different stem-loops in a single vector. Conclusions/Significance: This novel design expands the means to express multiple miRNAs from the same vector for potent and effective silencing of target genes and influenza virus.	[Chen, Steve C. -Y.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Chen, SCY (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jchen@mit.edu			National Institutes of Health [R01AI056267]; Cobb-Vantress, Inc; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cobb-Vantress, Inc; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from National Institutes of Health (R01AI056267) and Cobb-Vantress, Inc (http://www.cobb-vantress.com/). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer M, 2009, GENE THER, V16, P142, DOI 10.1038/gt.2008.123; Boudreau RL, 2009, MOL THER, V17, P169, DOI 10.1038/mt.2008.231; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Chen JZ, 2008, J INFECT DIS, V197, pS25, DOI 10.1086/524987; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Cockrell AS, 2007, MOL BIOTECHNOL, V36, P184, DOI 10.1007/s12033-007-0010-8; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Liu YP, 2008, NUCLEIC ACIDS RES, V36, P2811, DOI 10.1093/nar/gkn109; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Manjunath N, 2009, ADV DRUG DELIVER REV, V61, P732, DOI 10.1016/j.addr.2009.03.004; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Stern P, 2008, P NATL ACAD SCI USA, V105, P13895, DOI 10.1073/pnas.0806907105; Sun DQ, 2006, BIOTECHNIQUES, V41, P59, DOI 10.2144/000112203; ter Brake O, 2008, MOL THER, V16, P557, DOI 10.1038/sj.mt.6300382; ter Brake O, 2006, MOL THER, V14, P883, DOI 10.1016/j.ymthe.2006.07.007; Tseng YC, 2009, ADV DRUG DELIVER REV, V61, P721, DOI 10.1016/j.addr.2009.03.003; Wang J, 2007, P NATL ACAD SCI USA, V104, P20850, DOI 10.1073/pnas.0710565105; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xia XG, 2006, BIOTECHNIQUES, V41, P64, DOI 10.2144/000112198; Xu HT, 2006, FEBS LETT, V580, P3610, DOI 10.1016/j.febslet.2006.05.044; Zhou HX, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni061; Zhu XC, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-98	26	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22437	10.1371/journal.pone.0022437	http://dx.doi.org/10.1371/journal.pone.0022437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789258	Green Published, gold, Green Submitted			2022-12-25	WOS:000292812400050
J	Bolte, C; Zhang, YF; Wang, IC; Kalin, TV; Molkentin, JD; Kalinichenko, VV				Bolte, Craig; Zhang, Yufang; Wang, I-Ching; Kalin, Tanya V.; Molkentin, Jeffrey D.; Kalinichenko, Vladimir V.			Expression of Foxm1 Transcription Factor in Cardiomyocytes Is Required for Myocardial Development	PLOS ONE			English	Article							CARDIAC GENE-EXPRESSION; SERUM RESPONSE FACTOR; FACTOR TRIDENT; LUNG INJURY; DNA-DAMAGE; S PHASE; BOX; CELLS; DIFFERENTIATION; PROLIFERATION	Forkhead Box M1 (Foxm1) is a transcription factor essential for organ morphogenesis and development of various cancers. Although complete deletion of Foxm1 in Foxm1(-/-) mice caused embryonic lethality due to severe abnormalities in multiple organ systems, requirements for Foxm1 in cardiomyocytes remain to be determined. This study was designed to elucidate the cardiomyocyte-autonomous role of Foxm1 signaling in heart development. We generated a new mouse model in which Foxm1 was specifically deleted from cardiomyocytes (Nkx2.5-Cre/Foxm1(fl/f) mice). Deletion of Foxm1 from cardiomyocytes was sufficient to disrupt heart morphogenesis and induce embryonic lethality in late gestation. Nkx2.5-Cre/Foxm1(fl/fl) hearts were dilated with thinning of the ventricular walls and interventricular septum, as well as disorganization of the myocardium which culminated in cardiac fibrosis and decreased capillary density. Cardiomyocyte proliferation was diminished in Nkx2.5-Cre/Foxm1(fl/fl) hearts owing to altered expression of multiple cell cycle regulatory genes, such as Cdc25B, Cyclin B(1), Plk-1, nMyc and p21(cip1). In addition, Foxm1 deficient hearts displayed reduced expression of CaMKII delta, Hey2 and myocardin, which are critical mediators of cardiac function and myocardial growth. Our results indicate that Foxm1 expression in cardiomyocytes is critical for proper heart development and required for cardiomyocyte proliferation and myocardial growth.	[Bolte, Craig; Zhang, Yufang; Wang, I-Ching; Kalin, Tanya V.; Kalinichenko, Vladimir V.] Cincinnati Childrens Hosp Res Fdn, Div Pulm Biol, Cincinnati, OH USA; [Molkentin, Jeffrey D.] Cincinnati Childrens Hosp Res Fdn, Div Mol Cardiovasc Biol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Bolte, C (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Pulm Biol, Cincinnati, OH USA.	Craig.Bolte@cchmc.org; Vladimir.Kalinichenko@cchmc.org		Wang, I-Ching/0000-0003-4398-2975; Molkentin, Jeffery/0000-0002-3558-6529	National Institute of Health [HL 84151-04]; NATIONAL CANCER INSTITUTE [R01CA142724] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084151] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the National Institute of Health (HL 84151-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bushdid PB, 2003, CIRC RES, V92, P1305, DOI 10.1161/01.RES.0000077045.84609.9F; Chen JF, 2008, ANAT REC, V291, P1200, DOI 10.1002/ar.20756; De Falco Maria, 2009, Front Biosci (Elite Ed), V1, P528; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; HEMPEL P, 2002, BASIC RES CARDIOL S1, V97, P96; Horsthuis T, 2009, CLIN ANAT, V22, P4, DOI 10.1002/ca.20723; Hwang MW, 2001, J AM COLL CARDIOL, V38, P1546, DOI 10.1016/S0735-1097(01)01591-1; Kalin TV, 2008, P NATL ACAD SCI USA, V105, P19330, DOI 10.1073/pnas.0806748105; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2003, J BIOL CHEM, V278, P37888, DOI 10.1074/jbc.M305555200; Kalinichenko VV, 2001, AM J PHYSIOL-LUNG C, V280, pL695, DOI 10.1152/ajplung.2001.280.4.L695; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Kim IM, 2005, J BIOL CHEM, V280, P22278, DOI 10.1074/jbc.M500936200; Koibuchi N, 2007, CIRC RES, V100, P850, DOI 10.1161/01.RES.0000261693.13269.bf; Korver W, 1998, CURR BIOL, V8, P1327, DOI 10.1016/S0960-9822(07)00563-5; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Murakami M, 2008, DEV GROWTH DIFFER, V50, P121, DOI [10.1111/j.1440-169x.2007.00982.x, 10.1111/j.1440-169X.2007.00982.x]; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Ramakrishna S, 2007, DEV DYNAM, V236, P1000, DOI 10.1002/dvdy.21113; Ren XM, 2010, MOL CELL BIOL, V30, P5381, DOI 10.1128/MCB.00876-10; Rojas A, 2008, MOL CELL BIOL, V28, P5420, DOI 10.1128/MCB.00717-08; Savolainen SM, 2009, TOXICOL PATHOL, V37, P395, DOI 10.1177/0192623309335060; Schuller U, 2007, MOL CELL BIOL, V27, P8259, DOI 10.1128/MCB.00707-07; Takeda M, 2009, LAB INVEST, V89, P983, DOI 10.1038/labinvest.2009.59; Tang RH, 2008, P NATL ACAD SCI USA, V105, P3362, DOI 10.1073/pnas.0705842105; Ueno H, 2008, DEVELOPMENT, V135, P2023, DOI 10.1242/dev.019893; Ueyama T, 2003, MOL CELL BIOL, V23, P9222, DOI 10.1128/MCB.23.24.9222-9232.2003; Ustiyan V, 2009, DEV BIOL, V336, P266, DOI 10.1016/j.ydbio.2009.10.007; Vichalkovski A, 2010, ONCOGENE, V29, P3554, DOI 10.1038/onc.2010.115; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang IC, 2008, ONCOGENE, V27, P4137, DOI 10.1038/onc.2008.60; Wang IC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006609; Xin M, 2007, P NATL ACAD SCI USA, V104, P7975, DOI 10.1073/pnas.0702447104; Xue L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009229; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036; Zhang HJ, 2006, MOL ENDOCRINOL, V20, P1853, DOI 10.1210/me.2006-0056; Zhang H, 2010, DIABETES, V59, P143, DOI 10.2337/db09-0050; Zhang T, 2004, RECENT PROG HORM RES, V59, P141, DOI 10.1210/rp.59.1.141; Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154	46	47	48	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22217	10.1371/journal.pone.0022217	http://dx.doi.org/10.1371/journal.pone.0022217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779394	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811300048
J	Zandt, BJ; ten Haken, B; van Dijk, JG; van Putten, MJAM				Zandt, Bas-Jan; ten Haken, Bennie; van Dijk, J. Gert; van Putten, Michel J. A. M.			Neural Dynamics during Anoxia and the "Wave of Death''	PLOS ONE			English	Article							RAT HIPPOCAMPUS; SPREADING DEPRESSION; CEREBRAL-CORTEX; BRAIN; DEPOLARIZATION; MECHANISMS; ISCHEMIA; SEIZURES; EEG	Recent experiments in rats have shown the occurrence of a high amplitude slow brain wave in the EEG approximately 1 minute after decapitation, with a duration of 5-15 s (van Rijn et al, PLoS One 6, e16514, 2011) that was presumed to signify the death of brain neurons. We present a computational model of a single neuron and its intra- and extracellular ion concentrations, which shows the physiological mechanism for this observation. The wave is caused by membrane potential oscillations, that occur after the cessation of activity of the sodium-potassium pumps has lead to an excess of extracellular potassium. These oscillations can be described by the Hodgkin-Huxley equations for the sodium and potassium channels, and result in a sudden change in mean membrane voltage. In combination with a high-pass filter, this sudden depolarization leads to a wave in the EEG. We discuss that this process is not necessarily irreversible.	[Zandt, Bas-Jan; ten Haken, Bennie] Univ Twente, Neuroimaging MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands; [van Dijk, J. Gert] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [van Putten, Michel J. A. M.] Med Spectrum Twente, Dept Clin Neurophysiol, Enschede, Netherlands; [van Putten, Michel J. A. M.] Univ Twente, Clin Neurophysiol MIRA Inst Biomed Technol & Tech, NL-7500 AE Enschede, Netherlands	University of Twente; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Medical Spectrum Twente; University of Twente	Zandt, BJ (corresponding author), Univ Twente, Neuroimaging MIRA Inst Biomed Technol & Tech Med, POB 217, NL-7500 AE Enschede, Netherlands.	b.zandt@utwente.nl	Haken, Bennie ten/AAI-9083-2020; van Putten, Michel J.A.M./D-6519-2018	van Putten, Michel J.A.M./0000-0001-8319-3626	Ministerie van Economische Zaken, Provincie Overijssel; Provincie Gelderland through the ViP-BrainNetworks	Ministerie van Economische Zaken, Provincie Overijssel; Provincie Gelderland through the ViP-BrainNetworks	This work was financially supported by Ministerie van Economische Zaken, Provincie Overijssel and Provincie Gelderland through the ViP-BrainNetworks project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken PG, 1998, J NEUROPHYSIOL, V80, P1514, DOI 10.1152/jn.1998.80.3.1514; Barreto E, 2011, J BIOL PHYS, V37, P361, DOI 10.1007/s10867-010-9212-6; Bolay H, 2002, STROKE, V33, P1369, DOI 10.1161/01.STR.0000013708.54623.DE; Cressman JR, 2009, J COMPUT NEUROSCI, V26, P159, DOI 10.1007/s10827-008-0132-4; CRESSMAN JR, 2011, J COMPUT NEUROSCI; Dzhala V, 2001, J PHYSIOL-LONDON, V536, P521, DOI 10.1111/j.1469-7793.2001.0521c.xd; GJEDDE A, 2007, BRAIN ENERGETICS INT, P351; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; Kager H, 2000, J NEUROPHYSIOL, V84, P495, DOI 10.1152/jn.2000.84.1.495; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Mazel T, 1998, NEUROREPORT, V9, P1299; Plonsey R., 2007, BIOELECTRICITY, V3; SIEMKOWICZ E, 1981, STROKE, V12, P236, DOI 10.1161/01.STR.12.2.236; Somjen G.G., 2004, IONS BRAIN NORMAL FU; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Sun MK, 2002, J PHARMACOL EXP THER, V300, P408, DOI 10.1124/jpet.300.2.408; SWAAB DF, 1972, J NEUROCHEM, V19, P2843, DOI 10.1111/j.1471-4159.1972.tb03822.x; van Putten MJAM, 2010, CLIN NEUROPHYSIOL, V121, P1213, DOI 10.1016/j.clinph.2010.02.162; van Rijn CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016514; Verwer RWH, 2002, J CELL MOL MED, V6, P429, DOI 10.1111/j.1582-4934.2002.tb00522.x	21	35	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22127	10.1371/journal.pone.0022127	http://dx.doi.org/10.1371/journal.pone.0022127			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21779384	Green Published, gold			2022-12-25	WOS:000292781500036
J	Chen, SC; Chang, LY; Wang, YW; Chen, YC; Weng, KF; Shih, SR; Shih, HM				Chen, Shu-Chuan; Chang, Luan-Yin; Wang, Yi-Wei; Chen, Yi-Chun; Weng, Kuo-Feng; Shih, Shin-Ru; Shih, Hsiu-Ming			Sumoylation-promoted Enterovirus 71 3C Degradation Correlates with a Reduction in Viral Replication and Cell Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO PATHWAY; IN-VIVO; PROTEIN; PML; CLEAVAGE; BINDING; VIRUS; INFECTION; DISEASE; TARGETS	Enterovirus 71 (EV71), a member of the Picornaviridae family, may cause serious clinical manifestations associated with the central nervous system. Enterovirus 3C protease is required for virus replication and can trigger host cell apoptosis via cleaving viral polyprotein precursor and cellular proteins, respectively. Although the role of the 3C protease in processing viral and cellular proteins has been established, very little is known about the modulation of EV71 3C function by host cellular factors. Here, we show that sumoylation promotes EV71 3C protein ubiquitination for degradation, correlating with a decrease of EV71 in virus replication and cell apoptosis. SUMO E2-conjugating enzyme Ubc9 was identified as an EV71 3C-interacting protein. Further studies revealed that EV71 3C can be SUMO (small ubiquitin-like modifier)-modified at residue Lys-52. Sumoylation down-regulated 3C protease activity in vitro and also 3C protein stability in cells, in agreement with data suggesting 3C K52R protein induced greater substrate cleavage and apoptosis in cells. More importantly, the recombinant EV71 3C K52R virus infection conferred more apoptotic phenotype and increased virus levels in culture cells, which also correlated with a mouse model showing increased levels of viral VP1 protein in intestine and neuron loss in the spinal cord with EV71 3C K52R recombinant viral infection. Finally, we show that EV71 3C amino acid residues 45-52 involved in Ubc9 interaction determined the extent of 3C sumoylation and protein stability. Our results uncover a previously undescribed cellular regulatory event against EV71 virus replication and host cell apoptosis by sumoylation at 3C protease.	[Chen, Shu-Chuan; Wang, Yi-Wei; Chen, Yi-Chun; Shih, Hsiu-Ming] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Chen, Shu-Chuan; Wang, Yi-Wei; Shih, Hsiu-Ming] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 11529, Taiwan; [Chang, Luan-Yin] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Pediat, Taipei 11529, Taiwan; [Weng, Kuo-Feng; Shih, Shin-Ru] Chang Gung Univ, Dept Med Biotechnol, Tao Yuan 33302, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; National Taiwan University; National Taiwan University Hospital; Chang Gung University	Shih, HM (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan.	hmshih@ibms.sinica.edu.tw	Shih, Hsiu-Ming/S-7023-2018; Shih, Shin-Ru/M-9711-2016	CHANG, LUAN-YIN/0000-0003-2632-1956; Shih, Shin-Ru/0000-0003-4874-401X; Chen, Yi-Chun/0000-0001-6031-8414	National Science Council [NSC99-2321-B-002-025]; Frontier [NSC99-2321-B-001-007]; Academia Sinica Investigator Award	National Science Council(Ministry of Science and Technology, Taiwan); Frontier; Academia Sinica Investigator Award(Academia Sinica - Taiwan)	This work was supported by National Science Council Grant NSC99-2321-B-002-025, Frontier Grant NSC99-2321-B-001-007, and an Academia Sinica Investigator Award (to H.-M. S.).	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; Adamson AL, 2001, J VIROL, V75, P2388, DOI 10.1128/JVI.75.5.2388-2399.2001; Armer H, 2008, J VIROL, V82, P10556, DOI 10.1128/JVI.00907-08; Bailey D, 2002, J GEN VIROL, V83, P2951, DOI 10.1099/0022-1317-83-12-2951; Boggio R, 2004, MOL CELL, V16, P549, DOI 10.1016/j.molcel.2004.11.007; Boggio R, 2006, CURR OPIN MICROBIOL, V9, P430, DOI 10.1016/j.mib.2006.06.008; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Calandria C, 2004, VIRUS RES, V104, P39, DOI 10.1016/j.virusres.2004.02.042; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; Chang SC, 2004, J NEUROVIROL, V10, P338, DOI 10.1080/13550280490521032; Chen YC, 2004, J GEN VIROL, V85, P69, DOI 10.1099/vir.0.19423-0; Chiocca S, 2007, BIOCHEM SOC T, V35, P1419, DOI 10.1042/BST0351419; CLARK ME, 1993, MOL CELL BIOL, V13, P1232, DOI 10.1128/MCB.13.2.1232; DOWNLOADED F, THOMSON; Gao CZ, 2008, MOL CELL BIOL, V28, P5658, DOI 10.1128/MCB.00874-08; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Hunter T, 2009, ERNST SCHERING FOUND, V1, P1, DOI 10.1007/2789_2008_098; JOACHIMS M, 1995, VIROLOGY, V211, P451, DOI 10.1006/viro.1995.1427; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kehle J, 2003, J NEUROVIROL, V9, P126, DOI 10.1080/13550280390173364; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Li ML, 2002, VIROLOGY, V293, P386, DOI 10.1006/viro.2001.1310; Li Z, 2004, CANCER RES, V64, P9080, DOI 10.1158/0008-5472.CAN-04-2419; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; LIU JH, 1995, J EXP MED, V181, P1965, DOI 10.1084/jem.181.6.1965; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Muller S, 1999, J VIROL, V73, P5137; Nishida T, 2002, J BIOL CHEM, V277, P41311, DOI 10.1074/jbc.M206741200; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; RUBINSTEIN SJ, 1992, J VIROL, V66, P3062, DOI 10.1128/JVI.66.5.3062-3068.1992; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Shih SR, 2008, J NEUROVIROL, V14, P53, DOI 10.1080/13550280701798980; Shih SR, 2004, ANTIMICROB AGENTS CH, V48, P3523, DOI 10.1128/AAC.48.9.3523-3529.2004; Shih SR, 2004, J BIOMED SCI, V11, P239, DOI 10.1159/000076036; Spengler ML, 2002, J VIROL, V76, P2990, DOI 10.1128/JVI.76.6.2990-2996.2002; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; van Hagen M, 2010, NUCLEIC ACIDS RES, V38, P1922, DOI 10.1093/nar/gkp1157; Votteler J, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-11; Wang HY, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-294; Weng KF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000593; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; Wong TW, 2010, J ANTIMICROB CHEMOTH, V65, P2176, DOI 10.1093/jac/dkq301; Wotton D, 2007, BIOCHEM SOC T, V35, P1401, DOI 10.1042/BST0351401; Xu K, 2011, J VIROL, V85, P1086, DOI 10.1128/JVI.00877-10; Yalamanchili P, 1997, J VIROL, V71, P1220, DOI 10.1128/JVI.71.2.1220-1226.1997; Yang ML, 2006, J BIOL CHEM, V281, P8264, DOI 10.1074/jbc.M510364200; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	55	38	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31373	31384		10.1074/jbc.M111.254896	http://dx.doi.org/10.1074/jbc.M111.254896			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21784861	Green Published, hybrid			2022-12-25	WOS:000294487500032
J	Franklin, TB; Linder, N; Russig, H; Thony, B; Mansuy, IM				Franklin, Tamara B.; Linder, Natacha; Russig, Holger; Thoeny, Beat; Mansuy, Isabelle M.			Influence of Early Stress on Social Abilities and Serotonergic Functions across Generations in Mice	PLOS ONE			English	Article							DORSAL RAPHE NUCLEUS; MOUSE MODEL; ANXIETY; RECEPTOR; DEFEAT; LIFE; PSYCHOPATHOLOGY; PSYCHOBIOLOGY; CONSEQUENCES; EXPERIENCES	Exposure to adverse environments during early development is a known risk factor for several psychiatric conditions including antisocial behavior and personality disorders. Here, we induced social anxiety and altered social recognition memory in adult mice using unpredictable maternal separation and maternal stress during early postnatal life. We show that these social defects are not only pronounced in the animals directly subjected to stress, but are also transmitted to their offspring across two generations. The defects are associated with impaired serotonergic signaling, in particular, reduced 5HT1A receptor expression in the dorsal raphe nucleus, and increased serotonin level in a dorsal raphe projection area. These findings underscore the susceptibility of social behaviors and serotonergic pathways to early stress, and the persistence of their perturbation across generations.	[Franklin, Tamara B.; Linder, Natacha; Russig, Holger; Mansuy, Isabelle M.] Univ Zurich, Brain Res Inst, Fac Med, Zurich, Switzerland; [Franklin, Tamara B.; Linder, Natacha; Russig, Holger; Mansuy, Isabelle M.] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland; [Thoeny, Beat] Univ Childrens Hosp, Div Clin Chem & Biochem, Zurich, Switzerland	University of Geneva; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University Children's Hospital Zurich	Franklin, TB (corresponding author), European Mol Biol Lab Monterotondo, Mouse Biol Unit, Rome, Italy.	mansuy@hifo.uzh.ch	Mansuy, Isabelle M/N-3042-2015; Franklin, Tamara/W-3909-2019; Franklin, Tamara/AAD-3576-2020	Mansuy, Isabelle M/0000-0001-7785-5371; Franklin, Tamara/0000-0002-8733-8228; Thony, Beat/0000-0002-8420-4769	University of Zurich; Swiss Federal Institute of Technology; Swiss National Science Foundation; National Center for Competence in Research 'Neural Plasticity and Repair'; Roche	University of Zurich; Swiss Federal Institute of Technology; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center for Competence in Research 'Neural Plasticity and Repair'; Roche(Roche Holding)	The lab is supported by the University of Zurich, the Swiss Federal Institute of Technology, the Swiss National Science Foundation, and the National Center for Competence in Research 'Neural Plasticity and Repair', Roche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project is partially funded by Roche. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abrams JK, 2004, ANN NY ACAD SCI, V1018, P46, DOI 10.1196/annals.1296.005; Akimova E, 2009, BIOL PSYCHIAT, V66, P627, DOI 10.1016/j.biopsych.2009.03.012; Amat J, 2010, NEUROSCIENCE, V165, P1031, DOI 10.1016/j.neuroscience.2009.11.005; Ase AR, 1999, J NEURAL TRANSM, V106, P75, DOI 10.1007/s007020050142; BECKER C, 2007, MOL PSYCHIAT; Beesdo K, 2009, PSYCHIAT CLIN N AM, V32, P483, DOI 10.1016/j.psc.2009.06.002; Beitia G, 2005, BRAIN BEHAV IMMUN, V19, P530, DOI 10.1016/j.bbi.2004.11.002; Blau N, 1999, J INHERIT METAB DIS, V22, P216, DOI 10.1023/A:1005584627797; Bonanno GA, 2008, PEDIATRICS, V121, P369, DOI 10.1542/peds.2007-1648; BUWALDA B, 2010, NEUROSCI BIOBEHAV RE; Carola V, 2008, BIOL PSYCHIAT, V63, P840, DOI 10.1016/j.biopsych.2007.08.013; Champagne FA, 2010, DEV PSYCHOBIOL, V52, P299, DOI 10.1002/dev.20436; Christianson JP, 2010, BIOL PSYCHIAT, V67, P339, DOI 10.1016/j.biopsych.2009.09.011; Cooper MA, 2008, PSYCHONEUROENDOCRINO, V33, P1236, DOI 10.1016/j.psyneuen.2008.06.009; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; GEARY WA, 1983, J PHARMACOL EXP THER, V225, P234; Kim HK, 2009, CRIM BEHAV MENT HEAL, V19, P125, DOI 10.1002/cbm.708; Knappe S, 2009, DEPRESS ANXIETY, V26, P363, DOI 10.1002/DA.20527; Kranz GS, 2010, NEUROSCIENCE, V166, P1023, DOI 10.1016/j.neuroscience.2010.01.036; Lanzenberger RR, 2007, BIOL PSYCHIAT, V61, P1081, DOI 10.1016/j.biopsych.2006.05.022; Lim CE, 2007, SEIZURE-EUR J EPILEP, V16, P59, DOI 10.1016/j.seizure.2006.10.006; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McGowan ML, 2009, AM J BIOETHICS, V9, P21, DOI 10.1080/15265160902893908; McGowan PO, 2010, NEUROBIOL DIS, V39, P66, DOI 10.1016/j.nbd.2009.12.026; Merikangas KR, 1998, J AFFECT DISORDERS, V51, P63, DOI 10.1016/S0165-0327(98)00157-8; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; PETTY F, 1994, PSYCHIAT RES, V52, P285, DOI 10.1016/0165-1781(94)90074-4; Schiller L, 2006, BRAIN RES, V1103, P76, DOI 10.1016/j.brainres.2006.05.051; Susman EJ, 2006, NEUROSCI BIOBEHAV R, V30, P376, DOI 10.1016/j.neubiorev.2005.08.002; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Watt MJ, 2009, BEHAV NEUROSCI, V123, P564, DOI 10.1037/a0015752; Weaver ICG, 2009, BIRTH DEFECTS RES C, V87, P314, DOI 10.1002/bdrc.20164; Weiss IC, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00003; Wood M, 2000, EUR J PHARMACOL, V396, P1, DOI 10.1016/S0014-2999(00)00213-2; Yoshio R, 2001, JPN J PHARMACOL, V86, P189, DOI 10.1254/jjp.86.189; Zanettini C, 2010, GENES BRAIN BEHAV, V9, P26, DOI 10.1111/j.1601-183X.2009.00531.x	37	143	147	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e21842	10.1371/journal.pone.0021842	http://dx.doi.org/10.1371/journal.pone.0021842			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799751	Green Published, gold, Green Accepted			2022-12-25	WOS:000293172900007
J	Gade, TP; Motley, MW; Beattie, BJ; Bhakta, R; Boskey, AL; Koutcher, JA; Mayer-Kuckuk, P				Gade, Terence P.; Motley, Matthew W.; Beattie, Bradley J.; Bhakta, Roshni; Boskey, Adele L.; Koutcher, Jason A.; Mayer-Kuckuk, Philipp			Imaging of Alkaline Phosphatase Activity in Bone Tissue	PLOS ONE			English	Article							NONINVASIVE OPTICAL-DETECTION; IN-VIVO; MINERALIZATION; VITRO; HYPOPHOSPHATASIA; DIFFERENTIATION; MICE	The purpose of this study was to develop a paradigm for quantitative molecular imaging of bone cell activity. We hypothesized the feasibility of non-invasive imaging of the osteoblast enzyme alkaline phosphatase (ALP) using a small imaging molecule in combination with (19)Flourine magnetic resonance spectroscopic imaging ((FMRSI)-F-19). 6, 8-difluoro-4-methylumbelliferyl phosphate (DiFMUP), a fluorinated ALP substrate that is activatable to a fluorescent hydrolysis product was utilized as a prototype small imaging molecule. The molecular structure of DiFMUP includes two Fluorine atoms adjacent to a phosphate group allowing it and its hydrolysis product to be distinguished using (19)Fluorine magnetic resonance spectroscopy ((FMRS)-F-19) and (FMRSI)-F-19. ALP-mediated hydrolysis of DiFMUP was tested on osteoblastic cells and bone tissue, using serial measurements of fluorescence activity. Extracellular activation of DiFMUP on ALP-positive mouse bone precursor cells was observed. Concurringly, DiFMUP was also activated on bone derived from rat tibia. Marked inhibition of the cell and tissue activation of DiFMUP was detected after the addition of the ALP inhibitor levamisole. (FMRS)-F-19 and (FMRSI)-F-19 were applied for the non-invasive measurement of DiFMUP hydrolysis. (FMRS)-F-19 revealed a two-peak spectrum representing DiFMUP with an associated chemical shift for the hydrolysis product. Activation of DiFMUP by ALP yielded a characteristic pharmacokinetic profile, which was quantifiable using non-localized (FMRS)-F-19 and enabled the development of a pharmacokinetic model of ALP activity. Application of (FMRSI)-F-19 facilitated anatomically accurate, non-invasive imaging of ALP concentration and activity in rat bone. Thus, (FMRSI)-F-19 represents a promising approach for the quantitative imaging of bone cell activity during bone formation with potential for both preclinical and clinical applications.	[Gade, Terence P.; Bhakta, Roshni; Mayer-Kuckuk, Philipp] Hosp Special Surg, Bone Cell Biol & Imaging Lab, New York, NY 10021 USA; [Boskey, Adele L.] Hosp Special Surg, Mineralized Tissue Lab, New York, NY 10021 USA; [Gade, Terence P.; Motley, Matthew W.; Beattie, Bradley J.; Koutcher, Jason A.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Gade, TP (corresponding author), Hosp Univ Penn, Dept Radiol, 3400 Spruce St, Philadelphia, PA 19104 USA.	mayerkuckukp@hss.edu	Beattie, Bradley J/K-8981-2012	Beattie, Bradley J/0000-0001-9891-8271; Boskey, Adele/0000-0002-6181-2219	National Institutes of Health [R01AR055294, R03AR052069, R24CA083084]; NATIONAL CANCER INSTITUTE [R24CA083084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR052069, R01AR055294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the National Institutes of Health R01AR055294 (to Dr. Mayer-Kuckuk), R03AR052069 (to Dr. Mayer-Kuckuk), and R24CA083084 (to Dr. Koutcher). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augat P, 2008, ANNU REV BIOMED ENG, V10, P369, DOI [10.1146/annurev.bioeng.10.061807.160533, 10.1146/annurev.bioeng.10.061807.16053]; BALLON D, 1993, MAGNET RESON MED, V30, P754, DOI 10.1002/mrm.1910300615; Bar I, 2003, J BONE MINER RES, V18, P570, DOI 10.1359/jbmr.2003.18.3.570; Biswal S, 2007, RADIOLOGY, V244, P651, DOI 10.1148/radiol.2443060295; Biswal Sandip, 2003, Semin Musculoskelet Radiol, V7, P317; de Boer J, 2006, BIOMATERIALS, V27, P1851, DOI 10.1016/j.biomaterials.2005.09.034; Erickson SJ, 1997, RADIOLOGY, V205, P593, DOI 10.1148/radiology.205.3.9393511; Fedde KN, 1999, J BONE MINER RES, V14, P2015, DOI 10.1359/jbmr.1999.14.12.2015; Gade TPF, 2008, CANCER RES, V68, P2878, DOI 10.1158/0008-5472.CAN-07-6028; Gade TPF, 2004, MAGN RESON MED, V52, P169, DOI 10.1002/mrm.20131; GENANT HK, 1974, RADIOLOGY, V113, P373, DOI 10.1148/113.2.373; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Honigman A, 2001, MOL THER, V4, P239, DOI 10.1006/mthe.2001.0437; JONES A G, 1976, Seminars in Nuclear Medicine, V6, P3, DOI 10.1016/S0001-2998(76)80032-3; Kaijzel EL, 2006, CURR OPIN MOL THER, V8, P477; KAPLAN MM, 1972, NEW ENGL J MED, V286, P200, DOI 10.1056/NEJM197201272860407; KAYE M, 1975, J NUCL MED, V16, P40; Kozloff KM, 2007, J BONE MINER RES, V22, P1208, DOI 10.1359/JBMR.070504; Kozloff KM, 2010, J BONE MINER RES, V25, P1748, DOI 10.1002/jbmr.66; Kozloff KM, 2009, BONE, V44, P190, DOI 10.1016/j.bone.2008.10.036; Mayer-Kuckuk P, 2006, BONE, V39, P965, DOI 10.1016/j.bone.2006.05.009; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Pagani F, 2005, J Endocrinol Invest, V28, P8; Pelled G., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P362; Pichler BJ, 2008, SEMIN NUCL MED, V38, P199, DOI 10.1053/j.semnuclmed.2008.02.001; Reumann MK, 2010, TRENDS BIOTECHNOL, V28, P93, DOI 10.1016/j.tibtech.2009.11.004; Sauter AW, 2010, TRENDS MOL MED, V16, P508, DOI 10.1016/j.molmed.2010.08.003; SEIBEL MJ, 2002, PRINCIPLES BONE BIOL, P1543; Thompson DL, 1998, J BONE MINER RES, V13, P195, DOI 10.1359/jbmr.1998.13.2.195; Thornton M. M., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P364; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wehrl HF, 2009, EUR J NUCL MED MOL I, V36, P56, DOI 10.1007/s00259-009-1078-0; WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439; Zaheer A, 2001, NAT BIOTECHNOL, V19, P1148, DOI 10.1038/nbt1201-1148	35	19	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22608	10.1371/journal.pone.0022608	http://dx.doi.org/10.1371/journal.pone.0022608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799916	Green Published, Green Submitted, gold			2022-12-25	WOS:000293172900057
J	Yu, YM; Miller, J; Leventhal, JR; Tambur, AR; Chandrasekaran, D; Levitsky, J; Luo, XR; Mathew, JM				Yu, Yuming; Miller, Joshua; Leventhal, Joseph R.; Tambur, Anat R.; Chandrasekaran, Dhivya; Levitsky, Josh; Luo, Xunrong; Mathew, James M.			Requirement of Cognate CD4(+) T-Cell Recognition for the Regulation of Allospecific CTL by Human CD4(+)CD127(-)CD25(+)FOXP3(+) Cells Generated in MLR	PLOS ONE			English	Article							IN-VITRO PROLIFERATION; C VIRUS-INFECTION; TGF-BETA; TRANSPLANTATION TOLERANCE; SECONDARY EXPANSION; PERIPHERAL-BLOOD; DENDRITIC CELLS; CUTTING EDGE; MEMORY; HEPATITIS	Although immunoregulation of alloreactive human CTLs has been described, the direct influence of CD4(+) Tregs on CD8(+) cytotoxicity and the interactive mechanisms have not been well clarified. Therefore, human CD4(+)CD127(-)CD25(+)FOXP3(+) Tregs were generated in MLR, immunoselected and their allospecific regulatory functions and associated mechanisms were then tested using modified (51)Chromium release assays (Micro-CML), MLRs and CFSE-based multi-fluorochrome flow cytometry proliferation assays. It was observed that increased numbers of CD4(+)CD127(-)CD25(+)FOXP3(+) cells were generated after a 7 day MLR. After immunoselection for CD4(+)CD127(-)CD25(+) cells, they were designated as MLR-Tregs. When added as third component modulators, MLR-Tregs inhibited the alloreactive proliferation of autologous PBMC in a concentration dependent manner. The inhibition was quasi-antigen specific, in that the inhibition was non-specific at higher MLR-Treg modulator doses, but non-specificity disappeared with lower numbers at which specific inhibition was still significant. When tested in micro-CML assays CTL inhibition occurred with PBMC and purified CD8(+) responders. However, antigen specificity of CTL inhibition was observed only with unpurified PBMC responders and not with purified CD8(+) responders or even with CD8(+) responders plus Non-T "APC". However, allospecificity of CTL regulation was restored when autologous purified CD4(+) T cells were added to the CD8(+) responders. Proliferation of CD8(+) cells was suppressed by MLR-Tregs in the presence or absence of IL-2. Inhibition by MLR-Tregs was mediated through down-regulation of intracellular perforin, granzyme B and membrane-bound CD25 molecules on the responding CD8(+) cells. Therefore, it was concluded that human CD4(+)CD127(-)CD25(+)FOXP3(+) MLR-Tregs down-regulate alloreactive cytotoxic responses. Regulatory allospecificity, however, requires the presence of cognate responding CD4(+) T cells. CD8(+) CTL regulatory mechanisms include impaired proliferation, reduced expression of cytolytic molecules and CD25(+) activation epitopes.	[Yu, Yuming; Miller, Joshua; Leventhal, Joseph R.; Tambur, Anat R.; Chandrasekaran, Dhivya; Levitsky, Josh; Luo, Xunrong; Mathew, James M.] Northwestern Univ, Dept Surg, Comprehens Transplant Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Yu, Yuming] So Med Univ, Nanfang Hosp, Dept Organ Transplantat, Guangzhou, Guangdong, Peoples R China; [Miller, Joshua; Mathew, James M.] Jesse Brown VA Med Ctr, Chicago, IL USA; [Levitsky, Josh] Northwestern Univ, Div Hepatol, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Luo, Xunrong] Northwestern Univ, Div Nephrol & Hypertens, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Mathew, James M.] Northwestern Univ, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Southern Medical University - China; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Yu, YM (corresponding author), Northwestern Univ, Dept Surg, Comprehens Transplant Ctr, Feinberg Sch Med, Chicago, IL 60611 USA.	james-mathew@northwestern.edu	Levitsky, Josh/AAF-8662-2019	Levitsky, Josh/0000-0001-7527-6093; Mathew, James/0000-0002-5667-750X	National Institutes of Health (NIH) [2R01DK25243-25A2]; VA Merit review [5723.07]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025243] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit review(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) Grant 2R01DK25243-25A2 and VA Merit review funding 5723.07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Billerbeck E, 2007, WORLD J GASTROENTERO, V13, P4858, DOI 10.3748/wjg.v13.i36.4858; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Boettler T, 2005, J VIROL, V79, P7860, DOI 10.1128/JVI.79.12.7860-7867.2005; Buhlmann JE, 1999, J IMMUNOL, V162, P4373; Camara NOS, 2003, EUR J IMMUNOL, V33, P3473, DOI 10.1002/eji.200323966; Carvalho-Gaspar M, 2008, J IMMUNOL, V180, P6640, DOI 10.4049/jimmunol.180.10.6640; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobbold Stephen P, 2002, Expert Opin Ther Targets, V6, P583, DOI 10.1517/14728222.6.5.583; Gorantla VS, 2010, TRANSPLANT REV-ORLAN, V24, P147, DOI 10.1016/j.trre.2010.04.002; Graziotto R, 2006, TRANSPLANTATION, V81, P1125, DOI 10.1097/01.tp.0000208573.16839.67; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Jones ND, 2010, EUR J IMMUNOL, V40, P3107, DOI 10.1002/eji.201040671; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Lee BO, 2003, J EXP MED, V198, P1759, DOI 10.1084/jem.20031440; Levitsky J, 2009, TRANSPLANTATION, V88, P1303, DOI 10.1097/TP.0b013e3181bbee98; Li S, 2008, J VIROL, V82, P21, DOI 10.1128/JVI.01768-07; Lin CY, 2002, NAT IMMUNOL, V3, P1208, DOI 10.1038/ni853; Luo XR, 2007, P NATL ACAD SCI USA, V104, P2821, DOI 10.1073/pnas.0611646104; Mathew JM, 2010, HUM IMMUNOL, V71, P566, DOI 10.1016/j.humimm.2010.02.008; Mathew JM, 2003, J IMMUNOL METHODS, V272, P67, DOI 10.1016/S0022-1759(02)00432-5; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Miller J, 2011, AM J TRANSPLANT, V11, P92; Miqueu P, 2010, EUR J IMMUNOL, V40, P3280, DOI 10.1002/eji.201040301; Muthukumar T, 2005, NEW ENGL J MED, V353, P2342, DOI 10.1056/NEJMoa051907; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Peters JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002233; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Rushbrook SM, 2005, J VIROL, V79, P7852, DOI 10.1128/JVI.79.12.7852-7859.2005; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Satterwhite T, 2003, PEDIATR TRANSPLANT, V7, P53, DOI 10.1034/j.1399-3046.2003.02053.x; Selvaraj RK, 2007, J IMMUNOL, V178, P7667, DOI 10.4049/jimmunol.178.12.7667; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Sturm N, 2010, J HEPATOL, V53, P25, DOI 10.1016/j.jhep.2010.02.024; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Veronese F, 2007, AM J TRANSPLANT, V7, P914, DOI 10.1111/j.1600-6143.2006.01704.x; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Yang ZZ, 2006, CANCER RES, V66, P10145, DOI 10.1158/0008-5472.CAN-06-1822; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018	41	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22450	10.1371/journal.pone.0022450	http://dx.doi.org/10.1371/journal.pone.0022450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799858	gold, Green Published, Green Submitted			2022-12-25	WOS:000293097300048
J	Mugwanya, KK; Whalen, C; Celum, C; Nakku-Joloba, E; Katabira, E; Baeten, JM				Mugwanya, Kenneth K.; Whalen, Christopher; Celum, Connie; Nakku-Joloba, Edith; Katabira, Elly; Baeten, Jared M.			Circumcision of Male Children for Reduction of Future Risk for HIV: Acceptability among HIV Serodiscordant Couples in Kampala, Uganda	PLOS ONE			English	Article							PREVENTION; TRIAL; MEN; PREVALENCE; INFECTION; AFRICA; KENYA	Introduction: The ultimate success of medical male circumcision for HIV prevention may depend on targeting male infants and children as well as adults, in order to maximally reduce new HIV infections into the future. Methods: We conducted a cross-sectional study among heterosexual HIV serodiscordant couples (a population at high risk for HIV transmission) attending a research clinic in Kampala, Uganda on perceptions and attitudes about medical circumcision for male children for HIV prevention. Correlates of willingness to circumcise male children were assessed using generalized estimating equations methods. Results: 318 HIV serodiscordant couples were interviewed, 51.3% in which the female partner was HIV uninfected. Most couples were married and cohabiting, and almost 50% had at least one uncircumcised male child of <= 18 years of age. Overall, 90.2% of male partners and 94.6% of female partners expressed interest in medical circumcision for their male children for reduction of future risk for HIV infection, including 79.9% of men and 87.6% of women who had an uncircumcised male child. Among both men and women, those who were knowledgeable that circumcision reduces men's risk for HIV (adjusted prevalence ratio [APR] 1.34 and 1.14) and those who had discussed the HIV prevention effects of medical circumcision with their partner (APR 1.08 and 1.07) were significantly (p <= 0.05) more likely to be interested in male child circumcision for HIV prevention. Among men, those who were circumcised (APR 1.09, p = 0.004) and those who were HIV seropositive (APR 1.09, p = 0.03) were also more likely to be interested in child circumcision for HIV prevention. Conclusions: A high proportion of men and women in Ugandan heterosexual HIV serodiscordant partnerships were willing to have their male children circumcised for eventual HIV prevention benefits. Engaging both parents may increase interest in medical male circumcision for HIV prevention.	[Mugwanya, Kenneth K.] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Mugwanya, Kenneth K.] Makerere Univ, Sch Med, Infect Dis Inst, Kampala, Uganda; [Mugwanya, Kenneth K.] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA; [Whalen, Christopher] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Celum, Connie; Baeten, Jared M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Celum, Connie; Baeten, Jared M.] Univ Washington, Dept Med, Seattle, WA USA; [Celum, Connie; Baeten, Jared M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Nakku-Joloba, Edith] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Katabira, Elly] Makerere Univ, Sch Med, Dept Med, Kampala, Uganda	Case Western Reserve University; Makerere University; University System of Georgia; University of Georgia; Makerere University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Makerere University; Makerere University	Mugwanya, KK (corresponding author), Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	kmugwanya@gmail.com			Fogarty International Center of the National Institutes of Health [D43-TW000011]; Bill & Melinda Gates Foundation [26469]; FOGARTY INTERNATIONAL CENTER [D43TW000011] Funding Source: NIH RePORTER	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This project was supported by the AIDS International Training and Research Program (AIRTP) at Case Western Reserve University, Grant #D43-TW000011, funded by the Fogarty International Center of the National Institutes of Health, and by the Partners in Prevention HSV/HIV Transmission Study (Bill & Melinda Gates Foundation grant #26469, to the University of Washington). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahaghotu C, 2009, J NATL MED ASSOC, V101, P325, DOI 10.1016/S0027-9684(15)30879-8; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Binagwaho A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000211; Castro JG, 2010, INT J STD AIDS, V21, P591, DOI 10.1258/ijsa.2010.010201; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Kalichman SC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000219; Lagarde E, 2003, AIDS, V17, P89, DOI 10.1097/00002030-200301030-00012; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Madhivanan P, 2008, AIDS, V22, P983, DOI 10.1097/QAD.0b013e3282ffde52; Mattson CL, 2005, AIDS CARE, V17, P182, DOI 10.1080/09540120512331325671; Mugwanya KK, 2010, AIDS BEHAV, V14, P1190, DOI 10.1007/s10461-010-9696-x; Petersen MR, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-9; Plank RM, 2010, AIDS BEHAV, V14, P1198, DOI 10.1007/s10461-009-9632-0; Singh-Grewal D, 2005, ARCH DIS CHILD, V90, P853, DOI 10.1136/adc.2004.049353; WAIRAGALA W, 2010, LANCET, V376, P757; WHO/UNAIDS, 2007, REC EXP CONS MAL CIR; 2004, MOH UGANDA HIV AIDS	19	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22254	10.1371/journal.pone.0022254	http://dx.doi.org/10.1371/journal.pone.0022254			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799805	Green Submitted, Green Published, gold			2022-12-25	WOS:000292931200040
J	Smits, THM; Rezzonico, F; Kamber, T; Blom, J; Goesmann, A; Ishimaru, CA; Frey, JE; Stockwell, VO; Duffy, B				Smits, Theo H. M.; Rezzonico, Fabio; Kamber, Tim; Blom, Jochen; Goesmann, Alexander; Ishimaru, Carol A.; Frey, Juerg E.; Stockwell, Virginia O.; Duffy, Brion			Metabolic Versatility and Antibacterial Metabolite Biosynthesis Are Distinguishing Genomic Features of the Fire Blight Antagonist Pantoea vagans C9-1	PLOS ONE			English	Article							ERWINIA-AMYLOVORA; VI SECRETION; ANTIBIOTIC PRODUCTION; BIOLOGICAL-CONTROL; APPLE FRUIT; PLANT; IDENTIFICATION; HERBICOLA; SORBITOL; SEQUENCE	Background: Pantoea vagans is a commercialized biological control agent used against the pome fruit bacterial disease fire blight, caused by Erwinia amylovora. Compared to other biocontrol agents, relatively little is currently known regarding Pantoea genetics. Better understanding of antagonist mechanisms of action and ecological fitness is critical to improving efficacy. Principal Findings: Genome analysis indicated two major factors contribute to biocontrol activity: competition for limiting substrates and antibacterial metabolite production. Pathways for utilization of a broad diversity of sugars and acquisition of iron were identified. Metabolism of sorbitol by P. vagans C9-1 may be a major metabolic feature in biocontrol of fire blight. Biosynthetic genes for the antibacterial peptide pantocin A were found on a chromosomal 28-kb genomic island, and for dapdiamide E on the plasmid pPag2. There was no evidence of potential virulence factors that could enable an animal or phytopathogenic lifestyle and no indication of any genetic-based biosafety risk in the antagonist. Conclusions: Identifying key determinants contributing to disease suppression allows the development of procedures to follow their expression in planta and the genome sequence contributes to rationale risk assessment regarding the use of the biocontrol strain in agricultural systems.	[Smits, Theo H. M.; Rezzonico, Fabio; Kamber, Tim; Frey, Juerg E.; Duffy, Brion] Swiss Natl Competence Ctr Fire Blight, Div Plant Protect, Wadenswil, Switzerland; [Blom, Jochen; Goesmann, Alexander] Univ Bielefeld, CeBiTec, Bielefeld, Germany; [Ishimaru, Carol A.] Univ Minnesota, Dept Plant Pathol, St Paul, MN USA; [Stockwell, Virginia O.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	University of Bielefeld; University of Minnesota System; University of Minnesota Twin Cities; Oregon State University	Smits, THM (corresponding author), Swiss Natl Competence Ctr Fire Blight, Div Plant Protect, Wadenswil, Switzerland.	duffy@acw.admin.ch		Goesmann, Alexander/0000-0002-7086-2568; Rezzonico, Fabio/0000-0002-1280-3084; Smits, Theo H.M./0000-0002-1237-235X	Swiss Federal Office of Agriculture; Swiss Secretariat for Education and Research [SBF C06.0069]; Swiss Federal Office for the Environment; European Science Foundation [873]	Swiss Federal Office of Agriculture; Swiss Secretariat for Education and Research; Swiss Federal Office for the Environment; European Science Foundation(European Science Foundation (ESF)European Commission)	Financial support was provided by the Swiss Federal Office of Agriculture, the Swiss Secretariat for Education and Research (COST SBF C06.0069), and the Swiss Federal Office for the Environment. This work was conducted within the European Science Foundation supported research network COST Action 873 (www.cost873.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge P, 1997, MOL GEN GENET, V256, P611, DOI 10.1007/s004380050609; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson LM, 2004, PHYTOPATHOLOGY, V94, P1228, DOI 10.1094/PHYTO.2004.94.11.1228; Armstrong GA, 1996, FASEB J, V10, P228, DOI 10.1096/fasebj.10.2.8641556; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Barash I, 2009, ANNU REV PHYTOPATHOL, V47, P133, DOI 10.1146/annurev-phyto-080508-081803; Berner I, 1988, Biol Met, V1, P51, DOI 10.1007/BF01128017; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Bonn WG, 2000, FIRE BLIGHT, P37, DOI 10.1079/9780851992945.0037; Brady CL, 2009, INT J SYST EVOL MICR, V59, P2339, DOI 10.1099/ijs.0.009241-0; Brandl MT, 1996, APPL ENVIRON MICROB, V62, P4121, DOI 10.1128/AEM.62.11.4121-4128.1996; Calvin L, 1998, J AGR RESOUR ECON, V23, P351; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Chalupowicz L, 2008, MOL PLANT MICROBE IN, V21, P1094, DOI 10.1094/MPMI-21-8-1094; CHIOU CS, 1995, PHYTOPATHOLOGY, V85, P324, DOI 10.1094/Phyto-85-324; Coplin D. L., 1996, Acta Horticulturae, P251; Coutinho TA, 2002, PLANT DIS, V86, P20, DOI 10.1094/PDIS.2002.86.1.20; Coutinho TA, 2009, MOL PLANT PATHOL, V10, P325, DOI [10.1111/j.1364-3703.2009.00542.x, 10.1111/J.1364-3703.2009.00542.X]; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; De Maayer P, 2010, J BACTERIOL, V192, P2936, DOI 10.1128/JB.00060-10; Deiss K, 1998, BIOMETALS, V11, P131, DOI 10.1023/A:1009230012577; Dellagi A, 1998, MOL PLANT MICROBE IN, V11, P734, DOI 10.1094/MPMI.1998.11.8.734; Dennis JJ, 1998, APPL ENVIRON MICROB, V64, P2710; Duffy B, 2008, ACTA HORTIC, V793, P279; Duffy B., 2005, EPPO Bulletin, V35, P239, DOI 10.1111/j.1365-2338.2005.00820.x; Duffy B, 2003, ANNU REV PHYTOPATHOL, V41, P501, DOI 10.1146/annurev.phyto.41.052002.095606; Expert D, 1999, ANNU REV PHYTOPATHOL, V37, P307, DOI 10.1146/annurev.phyto.37.1.307; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Feistner GJ, 1996, BIOMETALS, V9, P337, DOI 10.1007/BF00140602; GAVINI F, 1989, INT J SYST BACTERIOL, V39, P337, DOI 10.1099/00207713-39-3-337; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Grimont PAD, 2005, BERGEYS MANUAL SYSTE, V2, P713; ISHIMARU CA, 1988, PHYTOPATHOLOGY, V78, P746, DOI 10.1094/Phyto-78-746; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Jin M, 2003, ANGEW CHEM INT EDIT, V42, P2898, DOI 10.1002/anie.200351053; Jin M, 2003, ANGEW CHEM INT EDIT, V42, P2902, DOI 10.1002/anie.200351054; Jock S, 2002, ENVIRON MICROBIOL, V4, P106, DOI 10.1046/j.1462-2920.2002.00277.x; Johnson KB, 1998, ANNU REV PHYTOPATHOL, V36, P227, DOI 10.1146/annurev.phyto.36.1.227; KAMBER T, 2011, APPL ENV MICRO UNPUB; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; LICHTER A, 1995, J BACTERIOL, V177, P4457, DOI 10.1128/jb.177.15.4457-4465.1995; Lindow SE, 1998, PHYTOPATHOLOGY, V88, P1149, DOI 10.1094/PHYTO.1998.88.11.1149; McHardy AC, 2004, BIOINFORMATICS, V20, P1622, DOI 10.1093/bioinformatics/bth137; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Poppe L, 2003, EUR J PLANT PATHOL, V109, P963, DOI 10.1023/B:EJPP.0000003747.41051.9f; Pusey PL, 2008, PHYTOPATHOLOGY, V98, P1136, DOI 10.1094/PHYTO-98-10-1136; Pusey PL, 1999, PHYTOPATHOLOGY, V89, P39, DOI 10.1094/PHYTO.1999.89.1.39; Rezzonico F, 2010, APPL ENVIRON MICROB, V76, P4497, DOI 10.1128/AEM.03112-09; Rezzonico F, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-204; Roberts RG, 1998, CROP PROT, V17, P19, DOI 10.1016/S0261-2194(98)80008-2; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sammer UF, 2009, APPL ENVIRON MICROB, V75, P7710, DOI 10.1128/AEM.01244-09; SANDMANN G, 1990, FEMS MICROBIOL LETT, V71, P77, DOI 10.1111/j.1574-6968.1990.tb03801.x; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Smits THM, 2010, J BACTERIOL, V192, P6486, DOI 10.1128/JB.01122-10; Smits THM, 2010, FEMS MICROBIOL LETT, V308, P48, DOI 10.1111/j.1574-6968.2010.01994.x; Smits THM, 2010, MOL PLANT MICROBE IN, V23, P384, DOI 10.1094/MPMI-23-4-0384; Smits THM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-2; Smits THM, 2011, J BIOTECHNO IN PRESS, DOI [10.1016/j.jbiotec.2010.1010.1075, DOI 10.1016/J.JBIOTEC.2010.1010.1075]; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Stockwell VO, 2010, PHYTOPATHOLOGY, V100, P1330, DOI 10.1094/PHYTO-03-10-0097; Stockwell VO, 1996, PHYTOPATHOLOGY, V86, P834, DOI 10.1094/Phyto-86-834; Stockwell VO, 2002, PHYTOPATHOLOGY, V92, P1202, DOI 10.1094/PHYTO.2002.92.11.1202; Taylor DE, 2002, J BACTERIOL, V184, P4690, DOI 10.1128/JB.184.17.4690-4698.2002; Temple TN, 2004, PHYTOPATHOLOGY, V94, P1286, DOI 10.1094/PHYTO.2004.94.12.1286; Teo G, 2006, P NATL ACAD SCI USA, V103, P18842, DOI 10.1073/pnas.0605873103; Vanneste JL, 2008, ACTA HORTIC, V793, P391; VANNESTE JL, 1992, J BACTERIOL, V174, P2785, DOI 10.1128/JB.174.9.2785-2796.1992; WALLAART RAM, 1980, PHYTOCHEMISTRY, V19, P2603, DOI 10.1016/S0031-9422(00)83927-8; WILSON M, 1994, APPL ENVIRON MICROB, V60, P4468, DOI 10.1128/AEM.60.12.4468-4477.1994	74	36	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22247	10.1371/journal.pone.0022247	http://dx.doi.org/10.1371/journal.pone.0022247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789243	gold, Green Published, Green Submitted			2022-12-25	WOS:000292811700037
J	Zhang, JY; Ma, ZN; Dong, NZ; Liu, F; Su, J; Zhao, YM; Shen, F; Wang, AY; Ruan, CG				Zhang, Jingyu; Ma, Zhenni; Dong, Ningzheng; Liu, Fang; Su, Jian; Zhao, Yiming; Shen, Fei; Wang, Anyou; Ruan, Changgeng			A Conformation-Sensitive Monoclonal Antibody against the A2 Domain of von Willebrand Factor Reduces Its Proteolysis by ADAMTS13	PLOS ONE			English	Article							FACTOR-VIII; VONWILLEBRAND-FACTOR; GLYCOPROTEIN-IB; CLEAVAGE; BINDING; VWF; MUTATIONS; PROTEASE; THROMBOSPONDIN-1; COMPLEXES	The size of von Willebrand factor (VWF), controlled by ADAMTS13-dependent proteolysis, is associated with its hemostatic activity. Many factors regulate ADAMTS13-dependent VWF proteolysis through their interaction with VWF. These include coagulation factor VIII, platelet glycoprotein 1b alpha, and heparin sulfate, which accelerate the cleavage of VWF. Conversely, thrombospondin-1 decreases the rate of VWF proteolysis by ADAMTS13 by competing with ADAMTS13 for the A3 domain of VWF. To investigate whether murine monoclonal antibodies (mAbs) against human VWF affect the susceptibility of VWF to proteolysis by ADAMTS13 in vitro, eight mAbs to different domains of human VWF were used to evaluate the effects on VWF cleavage by ADAMTS13 under fluid shear stress and static/denaturing conditions. Additionally, the epitope of anti-VWF mAb (SZ34) was mapped using recombinant proteins in combination with enzyme-linked immunosorbent assay and Western blot analysis. The results indicate that mAb SZ34 inhibited proteolytic cleavage of VWF by ADAMTS13 in a concentration-dependent manner under fluid shear stress, but not under static/denaturing conditions. The binding epitope of SZ34 mAb is located between A1555 and G1595 in the central A2 domain of VWF. These data show that an anti-VWF mAb against the VWF-A2 domain (A1555-G1595) reduces the proteolytic cleavage of VWF by ADAMTS13 under shear stress, suggesting the role of this region in interaction with ADAMTS13.	[Zhang, Jingyu; Ma, Zhenni; Dong, Ningzheng; Su, Jian; Zhao, Yiming; Shen, Fei; Wang, Anyou; Ruan, Changgeng] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suzhou, Peoples R China; [Zhang, Jingyu] Hebei Med Univ, Hosp 2, Hebei Inst Hematol, Dept Hematol, Shijiazhuang, Peoples R China; [Liu, Fang] Emory Univ, Sch Med, Atlanta, GA USA; [Zhang, Jingyu; Ma, Zhenni; Dong, Ningzheng; Su, Jian; Zhao, Yiming; Shen, Fei; Wang, Anyou; Ruan, Changgeng] Soochow Univ, Affiliated Hosp 1, Key Lab Thrombosis & Hemostasis, Minist Hlth, Suzhou, Peoples R China	Soochow University - China; Hebei Medical University; Emory University; Soochow University - China	Zhang, JY (corresponding author), Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Suzhou, Peoples R China.	changgengruan@hotmail.com	Patience, Gregory/I-3434-2019	Patience, Gregory/0000-0001-6593-7986	Nature Science Foundations of China [30670904, 30971287]	Nature Science Foundations of China(National Natural Science Foundation of China (NSFC))	Nature Science Foundations of China (grant numbers 30670904 and 30971287). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnefoy A, 2006, BLOOD, V107, P955, DOI 10.1182/blood-2004-12-4856; Cao WJ, 2008, P NATL ACAD SCI USA, V105, P7416, DOI 10.1073/pnas.0801735105; Cruz MA, 2003, THROMB HAEMOSTASIS, V90, P1204, DOI 10.1160/TH03-06-0398; DENT JA, 1990, P NATL ACAD SCI USA, V87, P6306, DOI 10.1073/pnas.87.16.6306; Dong JF, 2005, J THROMB HAEMOST, V3, P1710, DOI 10.1111/j.1538-7836.2005.01360.x; FEDERICI AB, 1989, BRIT J HAEMATOL, V73, P93, DOI 10.1111/j.1365-2141.1989.tb00226.x; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Hassenpflug WA, 2006, BLOOD, V107, P2339, DOI 10.1182/blood-2005-04-1758; Hoylaerts M F, 2001, J Thromb Thrombolysis, V12, P249, DOI 10.1023/A:1015279109247; JORIEUX S, 1992, BLOOD, V79, P563; Kokame K, 2004, BLOOD, V103, P607, DOI 10.1182/blood-2003-08-2861; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Liang YF, 2005, CLIN CHEM, V51, P1382, DOI 10.1373/clinchem.2005.051045; McKinnon TAJ, 2008, BLOOD, V111, P3042, DOI 10.1182/blood-2007-06-095042; Nishio K, 2004, P NATL ACAD SCI USA, V101, P10578, DOI 10.1073/pnas.0402041101; Pimanda JE, 2004, J BIOL CHEM, V279, P21439, DOI 10.1074/jbc.M313560200; Rayes J, 2007, J THROMB HAEMOST, V5, P321, DOI 10.1111/j.1538-7836.2007.02296.x; Ruan C G, 1986, Zhonghua Nei Ke Za Zhi, V25, P547; RUGGERI ZM, 1991, MAYO CLIN PROC, V66, P847, DOI 10.1016/S0025-6196(12)61204-X; Sadler JE, 2008, BLOOD, V112, P11, DOI 10.1182/blood-2008-02-078170; SHEN F, 2008, SUZHOU U J MED SCI, V28, P234; Shim K, 2008, BLOOD, V111, P651, DOI 10.1182/blood-2007-05-093021; Skipwith CG, 2010, J BIOL CHEM, V285, P28596, DOI 10.1074/jbc.M110.131227; Su Jian, 2005, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V13, P1090; Tao ZY, 2005, BLOOD, V106, P4139, DOI 10.1182/blood-2005-05-2029; Tsai HM, 1997, BLOOD, V89, P1954, DOI 10.1182/blood.V89.6.1954; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; Zanardelli S, 2009, BLOOD, V114, P2819, DOI 10.1182/blood-2009-05-224915; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905; Zhao Y, 2007, J THROMB HAEMOST, V5, P1963, DOI 10.1111/j.1538-7836.2007.02682.x	33	4	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2011	6	7							e22157	10.1371/journal.pone.0022157	http://dx.doi.org/10.1371/journal.pone.0022157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791QY	21779388	Green Published, Green Submitted, gold			2022-12-25	WOS:000292680900033
J	Chanroj, S; Lu, YX; Padmanaban, S; Nanatani, K; Uozumi, N; Rao, R; Sze, H				Chanroj, Salil; Lu, Yongxian; Padmanaban, Senthilkumar; Nanatani, Kei; Uozumi, Nobuyuki; Rao, Rajini; Sze, Heven			Plant-Specific Cation/H+ Exchanger 17 and Its Homologs Are Endomembrane K+ Transporters with Roles in Protein Sorting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; RECTIFYING POTASSIUM CHANNEL; VACUOLAR H+-ATPASE; PLASMA-MEMBRANE; ESCHERICHIA-COLI; TRANSLOCATING ATPASES; EVOLUTIONARY ORIGINS; VESICLE TRAFFICKING; NA+/H+ ANTIPORTERS; ION HOMEOSTASIS	The complexity of intracellular compartments in eukaryotic cells evolved to provide distinct environments to regulate processes necessary for cell proliferation and survival. A large family of predicted cation/proton exchangers (CHX), represented by 28 genes in Arabidopsis thaliana, are associated with diverse endomembrane compartments and tissues in plants, although their roles are poorly understood. We expressed a phylogenetically related cluster of CHX genes, encoded by CHX15-CHX20, in yeast and bacterial cells engineered to lack multiple cation-handling mechanisms. Of these, CHX16-CHX20 were implicated in pH homeostasis because their expression rescued the alkaline pH-sensitive growth phenotype of the host yeast strain. A smaller subset, CHX17-CHX19, also conferred tolerance to hygromycin B. Further differences were observed in K+ - and low pH-dependent growth phenotypes. Although CHX17 did not alter cytoplasmic or vacuolar pH in yeast, CHX20 elicited acidification and alkalization of the cytosol and vacuole, respectively. Using heterologous expression in Escherichia coli strains lacking K+ uptake systems, we provide evidence for K+ (Rb-86) transport mediated by CHX17 and CHX20. Finally, we show that CHX17 and CHX20 affected protein sorting as measured by carboxypeptidase Y secretion in yeast mutants grown at alkaline pH. In plant cells, CHX20-RFP co-localized with an endoplasmic reticulum marker, whereas RFP-tagged CHX17-CHX19 co-localized with prevacuolar compartment and endosome markers. Together, these results suggest that in response to environmental cues, multiple CHX transporters differentially modulate K+ and pH homeostasis of distinct intracellular compartments, which alter membrane trafficking events likely to be critical for adaptation and survival.	[Chanroj, Salil; Lu, Yongxian; Padmanaban, Senthilkumar; Sze, Heven] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Chanroj, Salil; Lu, Yongxian; Padmanaban, Senthilkumar; Sze, Heven] Univ Maryland, Maryland Agr Expt Stn, College Pk, MD 20742 USA; [Rao, Rajini] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Nanatani, Kei; Uozumi, Nobuyuki] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Johns Hopkins University; Tohoku University	Sze, H (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, 0120 Biosci Res Bldg 413, College Pk, MD 20742 USA.	hsze@umd.edu	Lu, Yongxian/I-4286-2012; Uozumi, Nobuyuki/AAG-3252-2019	Uozumi, Nobuyuki/0000-0003-4268-1126	National Institutes of Health [R01DK054214]; National Science Foundation [IBN0209788]; United States Department of Energy [BES DEFG0207ER15883]; Japan Society for the Promotion of Science [22020002, 22380056]; Royal Thai Government; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054214] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23780073] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); United States Department of Energy(United States Department of Energy (DOE)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Royal Thai Government; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK054214 (to R. R.). This work was also supported by National Science Foundation Grant IBN0209788 and United States Department of Energy Grant BES DEFG0207ER15883 (to H. S.), Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research 22020002 and 22380056 (to N. U.), and a Royal Thai Government Fellowship (to S. C.).	Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Banuelos MG, 2010, CURR GENET, V56, P121, DOI 10.1007/s00294-009-0285-3; Bassil E, 2011, PLANT CELL, V23, P224, DOI 10.1105/tpc.110.079426; Bock KW, 2006, PLANT PHYSIOL, V140, P1151, DOI 10.1104/pp.105.074708; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; BUURMAN ET, 1995, J BIOL CHEM, V270, P6678, DOI 10.1074/jbc.270.12.6678; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Cellier F, 2004, PLANT J, V39, P834, DOI 10.1111/j.1365-313X.2004.02177.x; DeFelice LJ, 2007, ANNU REV PHYSIOL, V69, P87, DOI 10.1146/annurev.physiol.69.031905.164816; Flis K, 2005, BIOCHEM J, V390, P655, DOI 10.1042/BJ20050480; Fujisawa M, 2007, P NATL ACAD SCI USA, V104, P13289, DOI 10.1073/pnas.0703709104; Gaxiola RA, 1999, P NATL ACAD SCI USA, V96, P1480, DOI 10.1073/pnas.96.4.1480; Gietz RD, 2007, NAT PROTOC, V2, P1, DOI 10.1038/nprot.2007.17; Jurgens G, 2004, ANNU REV CELL DEV BI, V20, P481, DOI 10.1146/annurev.cellbio.20.082503.103057; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kanter U, 2010, J EXP BOT, V61, P3995, DOI 10.1093/jxb/erq213; Kinclova-Zimmermannova O, 2006, FEMS YEAST RES, V6, P792, DOI 10.1111/j.1567-1364.2006.00062.x; Li XY, 2008, PLANT PHYSIOL, V147, P1675, DOI 10.1104/pp.108.119909; Lu YX, 2011, PLANT CELL, V23, P81, DOI 10.1105/tpc.110.080499; Maresova L, 2005, MOL MICROBIOL, V55, P588, DOI 10.1111/j.1365-2958.2004.04410.x; Maresova L, 2006, YEAST, V23, P1167, DOI 10.1002/yea.1424; Maresova L, 2006, FEMS YEAST RES, V6, P1039, DOI 10.1111/j.1567-1364.2006.00140.x; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mukherjee S, 2006, BIOCHEM J, V398, P97, DOI 10.1042/BJ20060388; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Orlowski J, 2007, CURR OPIN CELL BIOL, V19, P483, DOI 10.1016/j.ceb.2007.06.001; Padmanaban S, 2007, PLANT PHYSIOL, V144, P82, DOI 10.1104/pp.106.092155; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; PERLIN DS, 1988, J BIOL CHEM, V263, P18118; Plant PJ, 1999, J BIOL CHEM, V274, P37270, DOI 10.1074/jbc.274.52.37270; Rose JKC, 2010, PLANT PHYSIOL, V153, P433, DOI 10.1104/pp.110.154872; Sandoval RM, 2004, AM J PHYSIOL-RENAL, V286, pF617, DOI 10.1152/ajprenal.00130.2003; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; Schulte A, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-7; Schumacher K, 2010, CURR OPIN PLANT BIOL, V13, P724, DOI 10.1016/j.pbi.2010.07.003; Serrano R, 2004, J BIOL CHEM, V279, P19698, DOI 10.1074/jbc.M313746200; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Stumpe S, 1997, ARCH MICROBIOL, V167, P126, DOI 10.1007/s002030050425; Sze H, 2004, PLANT PHYSIOL, V136, P2532, DOI 10.1104/pp.104.046003; SZE H, 1992, J BIOENERG BIOMEMBR, V24, P371, DOI 10.1007/BF00762530; SZE H, 1985, ANNU REV PLANT PHYS, V36, P175, DOI 10.1146/annurev.pp.36.060185.001135; Tsunekawa K, 2009, J BIOL CHEM, V284, P16513, DOI 10.1074/jbc.M109.001875; UOZUMI N, 1995, J BIOL CHEM, V270, P24276, DOI 10.1074/jbc.270.41.24276; Uozumi N, 1998, P NATL ACAD SCI USA, V95, P9773, DOI 10.1073/pnas.95.17.9773; Uozumi N, 2001, AM J PHYSIOL-CELL PH, V281, pC733, DOI 10.1152/ajpcell.2001.281.3.C733; Venema K, 2003, J BIOL CHEM, V278, P22453, DOI 10.1074/jbc.M210794200; Venema K, 2002, J BIOL CHEM, V277, P2413, DOI 10.1074/jbc.M105043200; Wagner MC, 2006, ANTIMICROB AGENTS CH, V50, P587, DOI 10.1128/AAC.50.2.587-595.2006; Walker DJ, 1996, P NATL ACAD SCI USA, V93, P10510, DOI 10.1073/pnas.93.19.10510; WEGNER LH, 1994, J MEMBRANE BIOL, V142, P363, DOI 10.1007/BF00233442; Xiang MH, 2007, P NATL ACAD SCI USA, V104, P18677, DOI 10.1073/pnas.0707120104; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	58	63	71	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33931	33941		10.1074/jbc.M111.252650	http://dx.doi.org/10.1074/jbc.M111.252650			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21795714	hybrid, Green Published			2022-12-25	WOS:000295159200025
J	Miller, M; Shi, J; Zhu, YM; Kustov, M; Tian, JB; Stevens, A; Wu, M; Xu, J; Long, SY; Yang, P; Zholos, AV; Salovich, JM; Weaver, CD; Hopkins, CR; Lindsley, CW; McManus, O; Li, M; Zhu, MX				Miller, Melissa; Shi, Jie; Zhu, Yingmin; Kustov, Maksym; Tian, Jin-bin; Stevens, Amy; Wu, Meng; Xu, Jia; Long, Shunyou; Yang, Pu; Zholos, Alexander V.; Salovich, James M.; Weaver, C. David; Hopkins, Corey R.; Lindsley, Craig W.; McManus, Owen; Li, Min; Zhu, Michael X.			Identification of ML204, a Novel Potent Antagonist That Selectively Modulates Native TRPC4/C5 Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSELECTIVE CATION CHANNELS; CALCIUM-ENTRY; SMOOTH-MUSCLE; ESSENTIAL COMPONENT; TRPC5 CHANNELS; G-PROTEIN; ACTIVATION; CELLS; DIACYLGLYCEROL; EXPRESSION	Transient receptor potential canonical (TRPC) channels are Ca2+-permeable nonselective cation channels implicated in diverse physiological functions, including smooth muscle contractility and synaptic transmission. However, lack of potent selective pharmacological inhibitors for TRPC channels has limited delineation of the roles of these channels in physiological systems. Here we report the identification and characterization of ML204 as a novel, potent, and selective TRPC4 channel inhibitor. A high throughput fluorescent screen of 305,000 compounds of the Molecular Libraries Small Molecule Repository was performed for inhibitors that blocked intracellular Ca2+ rise in response to stimulation of mouse TRPC4 beta by mu-opioid receptors. ML204 inhibited TRPC4 beta-mediated intracellular Ca2+ rise with an IC50 value of 0.96 mu M and exhibited 19-fold selectivity against muscarinic receptor-coupled TRPC6 channel activation. In whole-cell patch clamp recordings, ML204 blocked TRPC4 beta currents activated through either mu-opioid receptor stimulation or intracellular dialysis of guanosine 5'-3-O-(thio)triphosphate (GTP gamma S), suggesting a direct interaction of ML204 with TRPC4 channels rather than any interference with the signal transduction pathways. Selectivity studies showed no appreciable block by 10-20 mu M ML204 of TRPV1, TRPV3, TRPA1, and TRPM8, as well as KCNQ2 and native voltage-gated sodium, potassium, and calcium channels in mouse dorsal root ganglion neurons. In isolated guinea pig ileal myocytes, ML204 blocked muscarinic cation currents activated by bath application of carbachol or intracellular infusion of GTP gamma S, demonstrating its effectiveness on native TRPC4 currents. Therefore, ML204 represents an excellent novel tool for investigation of TRPC4 channel function and may facilitate the development of therapeutics targeted to TRPC4.	[Salovich, James M.; Weaver, C. David; Hopkins, Corey R.; Lindsley, Craig W.] Vanderbilt Univ, Dept Pharmacol, Med Ctr, Nashville, TN 37232 USA; [Salovich, James M.; Hopkins, Corey R.; Lindsley, Craig W.] Vanderbilt Univ, Vanderbilt Ctr Neurosci Drug Discovery, Med Ctr, Nashville, TN 37232 USA; [Salovich, James M.; Hopkins, Corey R.; Lindsley, Craig W.] Mol Lib Probe Prod Ctr Network, Dept Chem, Vanderbilt Specialized Chem Ctr Accelerated Probe, Nashville, TN 37232 USA; [Miller, Melissa; Shi, Jie; Stevens, Amy; Wu, Meng; Xu, Jia; Long, Shunyou; McManus, Owen; Li, Min] Johns Hopkins Univ, Dept Neurosci, High Throughput Biol Ctr, Sch Med, Baltimore, MD 21205 USA; [Miller, Melissa; Shi, Jie; Stevens, Amy; Wu, Meng; Xu, Jia; Long, Shunyou; McManus, Owen; Li, Min] Johns Hopkins Univ, Johns Hopkins Ion Channel Ctr, Sch Med, Baltimore, MD 21205 USA; [Zhu, Yingmin; Tian, Jin-bin; Yang, Pu; Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Sch Med, Houston, TX 77030 USA; [Kustov, Maksym; Zholos, Alexander V.] Queens Univ Belfast, Ctr Vis & Vasc Sci, Sch Med Dent & Biomed Sci, Belfast BT12 6BA, Antrim, North Ireland	Vanderbilt University; Vanderbilt University; Vanderbilt University; Johns Hopkins University; Johns Hopkins University; University of Texas System; University of Texas Health Science Center Houston; Queens University Belfast	Hopkins, CR (corresponding author), Vanderbilt Univ, Dept Pharmacol, Med Ctr, Nashville, TN 37232 USA.	corey.r.hopkins@vanderbilt.edu; minli@jhmi.edu	tian, jinbin/L-6006-2019; Tian, JinBin/B-7001-2019; Wu, Meng/F-3958-2010; Zholos, Alexander/A-7017-2011	Tian, JinBin/0000-0002-5516-7778; Zholos, Alexander/0000-0002-4320-149X; Wu, Meng/0000-0003-2222-0736	National Institutes of Health; MLPCN;  [U54MH084691];  [U54MH084659];  [R21NS056942]; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084659, U54MH084691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS056942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MLPCN; ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, MLPCN, Grants U54MH084691 (to M. L.), U54MH084659 (C. W. L.), and R21NS056942 (to M. X. Z.). Vanderbilt is a member of the MLPCN and houses the Vanderbilt Specialized Chemistry Center for Accelerated Probe Development. Johns Hopkins is a member of the MLPCN and houses the Johns Hopkins Ion Channel Center.	Beech DJ, 2004, J PHYSIOL-LONDON, V559, P685, DOI 10.1113/jphysiol.2004.068734; Blair NT, 2009, J GEN PHYSIOL, V133, P525, DOI 10.1085/jgp.200810153; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Fowler MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000573; Freichel M, 2005, J PHYSIOL-LONDON, V567, P59, DOI 10.1113/jphysiol.2005.092999; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Gross SA, 2009, J BIOL CHEM, V284, P34423, DOI 10.1074/jbc.M109.018192; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Hu HZ, 2010, PFLUG ARCH EUR J PHY, V459, P579, DOI 10.1007/s00424-009-0749-9; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Huang JH, 2010, CURR BIOL, V20, P189, DOI 10.1016/j.cub.2009.12.019; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; INOUE R, 1990, J PHYSIOL-LONDON, V424, P73, DOI 10.1113/jphysiol.1990.sp018056; Inoue Ryuji, 1998, Journal of Smooth Muscle Research, V34, P69; Jeon JP, 2008, BIOCHEM BIOPH RES CO, V377, P538, DOI 10.1016/j.bbrc.2008.10.012; Ju M, 2010, J PHYSIOL-LONDON, V588, P1419, DOI 10.1113/jphysiol.2009.185256; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Lee KP, 2005, MOL CELLS, V20, P435; Lintschinger B, 2000, J BIOL CHEM, V275, P27799; Liu XB, 2005, J BIOL CHEM, V280, P21600, DOI 10.1074/jbc.c400492200; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Miller M, 2011, TRP CHANNELS, P1; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Munsch T, 2003, P NATL ACAD SCI USA, V100, P16065, DOI 10.1073/pnas.2535311100; Otsuguro KI, 2008, J BIOL CHEM, V283, P10026, DOI 10.1074/jbc.M707306200; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; Plant TD, 2003, CELL CALCIUM, V33, P441, DOI 10.1016/S0143-4160(03)00055-1; Poteser M, 2006, J BIOL CHEM, V281, P13588, DOI 10.1074/jbc.M512205200; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Tsvilovskyy VV, 2009, GASTROENTEROLOGY, V137, P1415, DOI 10.1053/j.gastro.2009.06.046; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zeng FN, 2004, J PHYSIOL-LONDON, V559, P739, DOI 10.1113/jphysiol.2004.065391; Zholos AV, 2004, J GEN PHYSIOL, V123, P581, DOI 10.1085/jgp.200309002; Zholos AV, 1997, BRIT J PHARMACOL, V122, P885, DOI 10.1038/sj.bjp.0701438	39	154	161	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33436	33446		10.1074/jbc.M111.274167	http://dx.doi.org/10.1074/jbc.M111.274167			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795696	Green Published, hybrid			2022-12-25	WOS:000294968800061
J	Wines, BD; Ramsland, PA; Trist, HM; Gardam, S; Brink, R; Fraser, JD; Hogarth, PM				Wines, Bruce D.; Ramsland, Paul A.; Trist, Halina M.; Gardam, Sandra; Brink, Robert; Fraser, John D.; Hogarth, P. Mark			Interaction of Human, Rat, and Mouse Immunoglobulin A (IgA) with Staphylococcal Superantigen-like 7 (SSL7) Decoy Protein and Leukocyte IgA Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-ALPHA-RI; SECRETORY COMPONENT; STRUCTURAL BASIS; COMPLEMENT C5; CD89; BINDING; NEUTROPHILS; IMMUNITY; IDENTIFICATION; DOMAIN	Host survival depends on an effective immune system and pathogen survival on the effectiveness of immune evasion mechanisms. Staphylococcus aureus utilizes a number of molecules to modulate host immunity, including the SSL family of which SSL7 binds IgA and inhibits Fc alpha receptor I (Fc alpha RI)-mediated function. Other Gram-positive bacterial pathogens produce IgA binding proteins, which, similar to SSL7, also bind the Fc at the CH2/CH3 interface (the junction between constant domains 2 and 3 of the heavy chain). The opposing activities of the host Fc alpha RI-IgA receptor ligand pair and the pathogen decoy proteins select for host and pathogen variants, which exert stronger protection or evasion, respectively. Curiously, mouse but not rat IgA contains a putative N-linked glycosylation site in the center of this host receptor and pathogen-binding site. Here, we demonstrate that this site is glycosylated and that the effect of amino acid changes and glycosylation of the CH2/CH3 interface inhibits interaction with the pathogen IgA binding protein SSL7, while maintaining binding of pIgR, essential to the biosynthesis and transport of SIgA.	[Wines, Bruce D.; Ramsland, Paul A.; Trist, Halina M.; Hogarth, P. Mark] Burnet Inst, Ctr Immunol, Melbourne, Vic 3004, Australia; [Gardam, Sandra; Brink, Robert] St Vincents Hosp, Garvan Inst Med Res, Immunol Res Program, Darlinghurst, NSW 2010, Australia; [Fraser, John D.] Univ Auckland, Maurice Wilkins Ctr, Auckland 1020, New Zealand; [Fraser, John D.] Univ Auckland, Sch Med Sci, Auckland 1020, New Zealand	Burnet Institute; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of Auckland; University of Auckland	Hogarth, PM (corresponding author), Burnet Inst, Ctr Immunol, 85 Commercial Rd, Melbourne, Vic 3004, Australia.	bwines@burnet.edu.au	Brink, Robert/B-7910-2010	Brink, Robert/0000-0002-9586-3655; Hogarth, Mark/0000-0002-0360-7890; Ramsland, Paul/0000-0002-2107-2738	National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a National Health and Medical Research Council project grant.	Abi-Rached L, 2007, J IMMUNOL, V178, P7943, DOI 10.4049/jimmunol.178.12.7943; Areschoug T, 2004, VACCINE, V22, pS9, DOI 10.1016/j.vaccine.2004.08.010; Areschoug T, 2002, J BIOL CHEM, V277, P12642, DOI 10.1074/jbc.M112072200; Balu S, 2011, J IMMUNOL, V186, P3113, DOI 10.4049/jimmunol.1003189; Bohne A, 1999, BIOINFORMATICS, V15, P767, DOI 10.1093/bioinformatics/15.9.767; Bonner A, 2009, MUCOSAL IMMUNOL, V2, P74, DOI 10.1038/mi.2008.68; CHINTALACHARUVU KR, 1994, HEPATOLOGY, V19, P162, DOI 10.1016/0270-9139(94)90068-X; Falkowska E, 2007, J VIROL, V81, P8072, DOI 10.1128/JVI.00459-07; Francica JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001098; Hellwig SMM, 2001, INFECT IMMUN, V69, P4846, DOI 10.1128/IAI.69.8.4846-4850.2001; Herr AB, 2003, J MOL BIOL, V327, P645, DOI 10.1016/S0022-2836(03)00149-9; Herr AB, 2003, NATURE, V423, P614, DOI 10.1038/nature01685; Hexham JM, 1999, J EXP MED, V189, P747, DOI 10.1084/jem.189.4.747; Kobayashi T, 2004, VACCINE, V23, P585, DOI 10.1016/j.vaccine.2004.07.015; Kragten EA, 1995, J MASS SPECTROM, V30, P1679, DOI 10.1002/jms.1190301207; Langley R, 2005, J IMMUNOL, V174, P2926, DOI 10.4049/jimmunol.174.5.2926; Laursen NS, 2010, P NATL ACAD SCI USA, V107, P3681, DOI 10.1073/pnas.0910565107; Lewis MJ, 2005, J IMMUNOL, V175, P6694, DOI 10.4049/jimmunol.175.10.6694; MALISZEWSKI CR, 1990, J EXP MED, V172, P1665, DOI 10.1084/jem.172.6.1665; Maruoka T, 2004, IMMUNOGENETICS, V55, P712, DOI 10.1007/s00251-003-0626-1; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; MOSTOV KE, 1982, J BIOL CHEM, V257, P1816; Otten MA, 2004, IMMUNOL LETT, V92, P23, DOI 10.1016/j.imlet.2003.11.018; Otten MA, 2005, J IMMUNOL, V174, P5472, DOI 10.4049/jimmunol.174.9.5472; Pleass RJ, 1999, J BIOL CHEM, V274, P23508, DOI 10.1074/jbc.274.33.23508; Pleass RJ, 2001, J BIOL CHEM, V276, P8197, DOI 10.1074/jbc.M009396200; Pleass RJ, 1997, BIOCHEM SOC T, V25, pS327, DOI 10.1042/bst025327s; Ramsland PA, 2007, P NATL ACAD SCI USA, V104, P15051, DOI 10.1073/pnas.0706028104; Reljic R, 2004, IMMUNOL LETT, V93, P51, DOI 10.1016/j.imlet.2004.01.015; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; SHEN L, 1992, IMMUNOL RES, V11, P273, DOI 10.1007/BF02919133; Stockmeyer B, 2000, J IMMUNOL, V165, P5954, DOI 10.4049/jimmunol.165.10.5954; van der Pol WL, 2000, J INFECT DIS, V182, P1139, DOI 10.1086/315825; van der Steen L, 2009, GASTROENTEROLOGY, V137, P2018, DOI 10.1053/j.gastro.2009.06.047; van Egmond M, 2000, NAT MED, V6, P680, DOI 10.1038/76261; van Egmond M, 2001, TRENDS IMMUNOL, V22, P205, DOI 10.1016/S1471-4906(01)01873-7; van Spriel AB, 1999, J INFECT DIS, V179, P661, DOI 10.1086/314643; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wines B. D., 2011, ADV EXP MED IN PRESS; Wines BD, 2006, J BIOL CHEM, V281, P1389, DOI 10.1074/jbc.M509334200; Wines BD, 1999, J IMMUNOL, V162, P2146; Wines BD, 2001, J IMMUNOL, V166, P1781, DOI 10.4049/jimmunol.166.3.1781; Wines BD, 2006, TISSUE ANTIGENS, V68, P103, DOI 10.1111/j.1399-0039.2006.00613.x; Woof JM, 2006, J PATHOL, V208, P270, DOI 10.1002/path.1877; Yel L, 2010, J CLIN IMMUNOL, V30, P10, DOI 10.1007/s10875-009-9357-x	46	12	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33118	33124		10.1074/jbc.M111.272252	http://dx.doi.org/10.1074/jbc.M111.272252			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21784854	Green Published, hybrid			2022-12-25	WOS:000294968800030
J	Chen, YJ; Fujita, T; Zhang, D; Doan, H; Pinkaew, D; Liu, ZH; Wu, JX; Koide, Y; Chiu, A; Lin, CCJ; Chang, JY; Ruan, KH; Fujise, K				Chen, Yanjie; Fujita, Takayuki; Zhang, Di; Doan, Hung; Pinkaew, Decha; Liu, Zhihe; Wu, Jiaxin; Koide, Yuichi; Chiu, Andrew; Lin, Curtis Chen-Jen; Chang, Jui-Yoa; Ruan, Ke-He; Fujise, Ken			Physical and Functional Antagonism between Tumor Suppressor Protein p53 and Fortilin, an Anti-apoptotic Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; CALCIUM-BINDING; IN-VIVO; ANTIAPOPTOTIC PROTEIN; TRANSCRIPTION FACTOR; GENE-EXPRESSION; MESSENGER-RNA; MUTANT P53; MDM2; ACTIVATION	Tumor suppressor protein p53, our most critical defense against tumorigenesis, can be made powerless by mechanisms such as mutations and inhibitors. Fortilin, a 172-amino acid polypeptide with potent anti-apoptotic activity, is up-regulated in many human malignancies. However, the exact mechanism by which fortilin exerts its anti-apoptotic activity remains unknown. Here we present significant insight. Fortilin binds specifically to the sequence-specific DNA binding domain of p53. The interaction of fortilin with p53 blocks p53-induced transcriptional activation of Bax. In addition, fortilin, but not a double point mutant of fortilin lacking p53 binding, inhibits p53-dependent apoptosis. Furthermore, cells with wild-type p53 and fortilin, but not cells with wild-type p53 and the double point mutant of fortilin lacking p53 binding, fail to induce Bax gene and apoptosis, leading to the formation of large tumor in athymic mice. Our results suggest that fortilin is a novel p53-interacting molecule and p53 inhibitor and that it is a logical molecular target in cancer therapy.	[Chen, Yanjie; Doan, Hung; Pinkaew, Decha; Liu, Zhihe; Chiu, Andrew; Fujise, Ken] Univ Texas Med Branch, Div Cardiol, Dept Internal Med, Galveston, TX 77555 USA; [Fujise, Ken] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Fujita, Takayuki; Zhang, Di; Wu, Jiaxin; Koide, Yuichi; Lin, Curtis Chen-Jen; Chang, Jui-Yoa; Ruan, Ke-He; Fujise, Ken] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis, Houston, TX 77030 USA; [Fujita, Takayuki; Koide, Yuichi] Yokohama City Univ, Dept Internal Med 2, Yokohama, Kanagawa 2360004, Japan; [Wu, Jiaxin; Ruan, Ke-He] Univ Houston, Coll Pharm, Houston, TX 77004 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health Science Center Houston; Yokohama City University; University of Houston System; University of Houston	Fujise, K (corresponding author), 301 Univ Blvd,Ste JSA5-106G, Galveston, TX 77555 USA.	Ken.Fujise@utmb.edu	Wu, Jiaxin/GVT-3486-2022; Lin, Curtis Chun-Jen/G-5571-2012; Pinkaew, Decha/AAD-3335-2022	Pinkaew, Decha/0000-0001-8334-1545	National Institutes of Health [HL68024]; National Heart, Blood, and Lung Institute; American Heart Association [0540054N]; MacDonald General Research Fund [04RDM013]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); MacDonald General Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL68024 (to K. F.) from National Heart, Blood, and Lung Institute. This work was also supported by American Heart Association Grant 0540054N (to K. F.) and MacDonald General Research Fund Grant 04RDM013 (to K. F.).	Arcuri F, 2004, PROSTATE, V60, P130, DOI 10.1002/pros.20054; Bensaad K, 2005, NAT MED, V11, P1278, DOI 10.1038/nm1205-1278; Bottger V, 1999, ONCOGENE, V18, P189, DOI 10.1038/sj.onc.1202281; Budhram-Mahadeo V, 1999, J BIOL CHEM, V274, P15237, DOI 10.1074/jbc.274.21.15237; Budram-Mahadeo V, 2002, ONCOGENE, V21, P6123, DOI 10.1038/sj.onc.1205842; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; CHITPATIMA ST, 1988, NUCLEIC ACIDS RES, V16, P2350, DOI 10.1093/nar/16.5.2350; Chung S, 2000, CANCER LETT, V156, P185, DOI 10.1016/S0304-3835(00)00460-2; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Feng YG, 2007, ARCH BIOCHEM BIOPHYS, V467, P48, DOI 10.1016/j.abb.2007.08.021; FLORENES VA, 1994, J NATL CANCER I, V86, P1297, DOI 10.1093/jnci/86.17.1297; FRITSCHE M, 1993, ONCOGENE, V8, P307; Fujise K, 2000, J BIOL CHEM, V275, P39458, DOI 10.1074/jbc.M006626200; Gnanasekar M, 2009, INT J ONCOL, V34, P1241, DOI 10.3892/ijo_00000252; Gong LM, 1997, J BIOL CHEM, V272, P28198, DOI 10.1074/jbc.272.45.28198; Graidist P, 2004, J BIOL CHEM, V279, P40868, DOI 10.1074/jbc.M401454200; Graidist P, 2007, BIOCHEM J, V408, P181, DOI 10.1042/BJ20070679; GROSS B, 1989, NUCLEIC ACIDS RES, V17, P8367, DOI 10.1093/nar/17.20.8367; Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585; HAGHIGHAT NG, 1992, MOL BIOCHEM PARASIT, V51, P99, DOI 10.1016/0166-6851(92)90205-X; Hainaut P, 1997, NUCLEIC ACIDS RES, V25, P151, DOI 10.1093/nar/25.1.151; Hansen S, 1998, J MOL BIOL, V275, P575, DOI 10.1006/jmbi.1997.1507; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Iwabuchi K, 1998, J BIOL CHEM, V273, P26061, DOI 10.1074/jbc.273.40.26061; Kim M, 2000, ARCH PHARM RES, V23, P633, DOI 10.1007/BF02975253; Koide Y, 2009, BBA-GEN SUBJECTS, V1790, P326, DOI 10.1016/j.bbagen.2009.01.012; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lee JH, 2008, FEBS LETT, V582, P1210, DOI 10.1016/j.febslet.2008.01.066; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li F, 2001, J BIOL CHEM, V276, P47542, DOI 10.1074/jbc.M108954200; Lu BY, 2002, BIOCHEM J, V364, P81, DOI 10.1042/bj3640081; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; Merched AJ, 2003, ARTERIOSCL THROM VAS, V23, P1608, DOI 10.1161/01.ATV.0000084825.88022.53; MIYASHITA T, 1995, CELL, V80, P293; Mnjoyan ZH, 2003, CIRCULATION, V108, P464, DOI 10.1161/01.CIR.0000080339.49212.49; Moll UM, 2001, BBA-REV CANCER, V1552, P47, DOI 10.1016/S0304-419X(01)00036-1; Monia BP, 1996, NAT MED, V2, P668, DOI 10.1038/nm0696-668; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Okamoto T, 2000, ONCOGENE, V19, P6194, DOI 10.1038/sj.onc.1204029; Pellegrini M, 2001, EUR J BIOCHEM, V268, P3313, DOI 10.1046/j.1432-1327.2001.02235.x; Rao KVN, 2002, J BIOL CHEM, V277, P31207, DOI 10.1074/jbc.M204114200; Rho SB, 2011, FEBS LETT, V585, P29, DOI 10.1016/j.febslet.2010.11.014; Salamanca S, 2005, BIOCHEMISTRY-US, V44, P744, DOI 10.1021/bi048182n; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Sanchez JC, 1997, ELECTROPHORESIS, V18, P150, DOI 10.1002/elps.1150180127; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Susini L, 2008, CELL DEATH DIFFER, V15, P1211, DOI 10.1038/cdd.2008.18; Tian C, 2009, NAT CELL BIOL, V11, P580, DOI 10.1038/ncb1864; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; van Vlijmen BJM, 2001, CIRC RES, V88, P780, DOI 10.1161/hh0801.089261; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2005, SCIENCE, V309, P1685, DOI 10.1126/science.1118232; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Zalcenstein A, 2003, ONCOGENE, V22, P5667, DOI 10.1038/sj.onc.1206724; Zhang D, 2002, J BIOL CHEM, V277, P37430, DOI 10.1074/jbc.M207413200	69	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32575	32585		10.1074/jbc.M110.217836	http://dx.doi.org/10.1074/jbc.M110.217836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795694	Green Published, hybrid			2022-12-25	WOS:000294726800067
J	Leotoing, L; Chereau, F; Baron, S; Hube, F; Valencia, HJ; Bordereaux, D; Demmers, JA; Strouboulis, J; Baud, V				Leotoing, Laurent; Chereau, Fanny; Baron, Silvere; Hube, Florent; Valencia, Hugo J.; Bordereaux, Didier; Demmers, Jeroen A.; Strouboulis, John; Baud, Veronique			A20-binding Inhibitor of Nuclear Factor-kappa B (NF-kappa B)-2 (ABIN-2) Is an Activator of Inhibitor of NF-kappa B (I kappa B) Kinase alpha (IKK alpha)-mediated NF-kappa B Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IKK-ALPHA; GENE-EXPRESSION; IMMUNE-SYSTEM; PHOSPHORYLATION; BETA; PATHWAY; COMPLEX; PROTEIN; SUBUNIT; CELLS	NF-kappa B transcription factors are pivotal players in controlling inflammatory and immune responses, as well as cell proliferation and apoptosis. Aberrant regulation of NF-kappa B and the signaling pathways that regulate its activity have been involved in various pathologies, particularly cancers, as well as inflammatory and autoimmune diseases. NF-kappa B activation is tightly regulated by the I kappa B kinase (IKK) complex, which is composed of two catalytic subunits IKK alpha and IKK beta, and a regulatory subunit IKK gamma/NEMO. Although IKK alpha and IKK beta share structural similarities, IKK alpha has been shown to have distinct biological functions. However, the molecular mechanisms that modulate IKK alpha activity have not yet been fully elucidated. To understand better the regulation of IKK alpha activity, we purified IKK alpha-associated proteins and identified ABIN-2. Here, we demonstrate that IKK alpha and IKK beta Both interact with ABIN-2 and impair its constitutive degradation by the proteasome. Nonetheless, ABIN-2 enhances IKK alpha- but not IKK beta-mediated NF-kappa B activation by specifically inducing IKK alpha autophosphorylation and kinase activity. Furthermore, we found that ABIN-2 serine 146 is critical for the ABIN-2-dependent IKK alpha transcriptional up-regulation of specific NF-kappa B target genes. These results imply that ABIN-2 acts as a positive regulator of NF-kappa B-dependent transcription by activating IKK alpha.	[Baud, Veronique] INSERM, U1016, Inst Cochin, Dept Immunol Hematol, F-75014 Paris, France; [Leotoing, Laurent; Chereau, Fanny; Valencia, Hugo J.; Bordereaux, Didier; Baud, Veronique] CNRS, UMR 8104, Paris, France; [Leotoing, Laurent; Chereau, Fanny; Valencia, Hugo J.; Bordereaux, Didier; Baud, Veronique] Univ Paris 05, Paris, France; [Baron, Silvere] Univ Clermont Ferrand, Clermont Univ, F-63000 Clermont Ferrand, France; [Baron, Silvere] GReD, CNRS, UMR 6247, F-63177 Aubiere, France; [Hube, Florent] Univ Paris 07, CNRS, UMR7216, Paris, France; [Demmers, Jeroen A.] Erasmus MC, Dept Biochem, NL-3015 GE Rotterdam, Netherlands; [Demmers, Jeroen A.] Erasmus MC, Prote Ctr, NL-3015 GE Rotterdam, Netherlands; [Strouboulis, John] Erasmus MC, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Baud, V (corresponding author), INSERM, U1016, Inst Cochin, Dept Immunol Hematol, 123 Blvd Port Royal, F-75014 Paris, France.	veronique.baud@inserm.fr	Valencia, Hugo/HHC-4835-2022; Demmers, Jeroen AA/F-4046-2016; HUBE, Florent/G-1174-2011; Strouboulis, John/U-4459-2019; Baud, Veronique/AAL-3950-2020; Baud, Veronique/F-7699-2013	Demmers, Jeroen AA/0000-0002-8757-9611; HUBE, Florent/0000-0001-7560-2530; Baud, Veronique/0000-0002-4090-718X; Baud, Veronique/0000-0002-4090-718X; Chereau, Fanny/0000-0002-5651-9800; Strouboulis, John/0000-0002-6133-2872	Agence Nationale pour la Recherche; Association pour la Recherche sur le Cancer; Belgian InterUniversity Attraction Pole; Canceropole Ile-de-France; Institut National du Cancer; Universite Paris Descartes; Agence Nationale de la Recherche; Ligue Nationale contre le Cancer; Ministere de la Recherche et des Technologies	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Belgian InterUniversity Attraction Pole(Belgian Federal Science Policy Office); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer(Institut National du Cancer (INCA) France); Universite Paris Descartes; Agence Nationale de la Recherche(French National Research Agency (ANR)); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Ministere de la Recherche et des Technologies	This work was supported by grants from the Agence Nationale pour la Recherche, Association pour la Recherche sur le Cancer, Belgian InterUniversity Attraction Pole, Canceropole Ile-de-France, Institut National du Cancer, and Universite Paris Descartes (to V.B.), postdoctoral funding from the Agence Nationale de la Recherche (to L.L.), grants from the Ligue Nationale contre le Cancer (to S.B. and F.H.), and a doctoral fellowship from the Ministere de la Recherche et des Technologies (to F.C.).	Adli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009428; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Baud V, 2011, CURR TOP MICROBIOL, V349, P97, DOI 10.1007/82_2010_101; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Chien CY, 2003, FEBS LETT, V543, P55, DOI 10.1016/S0014-5793(03)00401-0; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; Dong GH, 2011, CLIN CANCER RES, V17, P1440, DOI 10.1158/1078-0432.CCR-10-1859; Fan YJ, 2008, ADV EXP MED BIOL, V615, P223, DOI 10.1007/978-1-4020-6554-5_11; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hinz M, 2007, J BIOL CHEM, V282, P32311, DOI 10.1074/jbc.M705785200; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hu WH, 2005, J BIOL CHEM, V280, P29233, DOI 10.1074/jbc.M501670200; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Huang L, 2008, ONCOGENE, V27, P6131, DOI 10.1038/onc.2008.208; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kieusseian A, 2006, BLOOD, V107, P492, DOI 10.1182/blood-2005-02-0529; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li QT, 2005, P NATL ACAD SCI USA, V102, P12425, DOI 10.1073/pnas.0505997102; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Liu WK, 2004, BIOCHEM J, V378, P867, DOI 10.1042/BJ20031736; Luo JL, 2005, J CLIN IMMUNOL, V25, P541, DOI 10.1007/s10875-005-8217-6; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Papoutsopoulou S, 2006, NAT IMMUNOL, V7, P606, DOI 10.1038/ni1334; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Schomer-Miller B, 2006, J BIOL CHEM, V281, P15268, DOI 10.1074/jbc.M513793200; Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1; Sun SC, 2008, TRENDS IMMUNOL, V29, P469, DOI 10.1016/j.it.2008.07.003; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Van Huffel S, 2001, J BIOL CHEM, V276, P30216, DOI 10.1074/jbc.M100048200; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Verstrepen L, 2009, BIOCHEM PHARMACOL, V78, P105, DOI 10.1016/j.bcp.2009.02.009; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576	55	26	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32277	32288		10.1074/jbc.M111.236448	http://dx.doi.org/10.1074/jbc.M111.236448			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784860	hybrid, Green Published			2022-12-25	WOS:000294726800038
J	Chao, C; Joyce-Shaikh, B; Grein, J; Moshrefi, M; Raoufi, F; Laface, DM; McClanahan, TK; Bourne, PA; Pierce, RH; Gorman, DM; Pflanz, S				Chao, Connie; Joyce-Shaikh, Barbara; Grein, Jeff; Moshrefi, Mehrdad; Raoufi, Fahimeh; Laface, Drake M.; McClanahan, Terril K.; Bourne, Patricia A.; Pierce, Robert H.; Gorman, Daniel M.; Pflanz, Stefan			C17 Prevents Inflammatory Arthritis and Associated Joint Destruction in Mice	PLOS ONE			English	Article							EXPRESSION IN-VIVO; HELICAL CYTOKINES; CELLS; DNA; OSTEOARTHRITIS; PERSISTENT; ADAMTS5; ROLES	C17 was first described about ten years ago as a gene expressed in CD34+ cells. A more recent study has suggested a role for C17 in chondrogenesis and development of cartilage. However, based on sequence analysis, we believe that C17 has homology to IL-2 and hence we present the hypothesis that C17 is a cytokine possessing immune-regulatory properties. We provide evidence that C17 is a secreted protein preferentially expressed in chondrocytes, hence in cartilage-rich tissues. Systemic expression of C17 in vivo reduces disease in a collagen antibody-induced arthritis model in mice (CAIA). Joint protection is evident by delayed disease onset, minimal edema, bone protection and absence of diverse histological features of disease. Expression of genes typically associated with acute joint inflammation and erosion of cartilage or bone is blunted in the presence of C17. Consistent with the observed reduction in bone erosion, we demonstrate reduced levels of RANKL in the paws and sera of mice over-expressing C17. Administration of C17 at the peak of disease, however, had no effect on disease progression, indicating that C17's immune-regulatory activity must be most prominent prior to or at the onset of severe joint inflammation. Based on this data we propose C17 as a cytokine that contributes to immune homeostasis systemically or in a tissue-specific manner in the joint.	[Chao, Connie; Joyce-Shaikh, Barbara; Laface, Drake M.; Pflanz, Stefan] Merck Res Labs, Dept Immunol, Palo Alto, CA USA; [Grein, Jeff; McClanahan, Terril K.] Merck Res Labs, Dept Translat Res & Pharmacol, Palo Alto, CA USA; [Moshrefi, Mehrdad; Gorman, Daniel M.] Merck Res Labs, Dept Antibody Technol, Palo Alto, CA USA; [Raoufi, Fahimeh] Merck Res Labs, Dept Bioanalyt, Palo Alto, CA USA; [Bourne, Patricia A.; Pierce, Robert H.] Merck Res Labs, Dept Anat Pathol, Palo Alto, CA USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company	Chao, C (corresponding author), Merck Res Labs, Dept Immunol, Palo Alto, CA USA.	stefanpflanz@gmail.com		Pierce, MD, Robert Hamilton/0000-0002-2677-144X	Schering-Plough/Merck	Schering-Plough/Merck(Merck & CompanySchering Plough Corporation)	All authors were employed by Schering-Plough/Merck Research Labs. As such, Schering-Plough/Merck funded this research, and had a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; Begley LA, 2008, CYTOKINE, V43, P194, DOI 10.1016/j.cyto.2008.05.012; Chen ZY, 2005, HUM GENE THER, V16, P126, DOI 10.1089/hum.2005.16.126; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Hermansson M, 2004, J BIOL CHEM, V279, P43514, DOI 10.1074/jbc.M407041200; Kagari T, 2002, J IMMUNOL, V169, P1459, DOI 10.4049/jimmunol.169.3.1459; Kim JS, 2007, J BIOL CHEM, V282, P29359, DOI 10.1074/jbc.M700965200; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu X, 2000, GENOMICS, V65, P283, DOI 10.1006/geno.2000.6170; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Noh EM, 2009, RHEUMATOLOGY, V48, P45, DOI 10.1093/rheumatology/ken417; Okamoto M, 2006, J BONE MINER RES, V21, P1022, DOI 10.1359/JBMR.060411; Rankin AL, 2010, J IMMUNOL, V184, P1526, DOI 10.4049/jimmunol.0903306; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; ROZWARSKI DA, 1994, STRUCTURE, V2, P159, DOI 10.1016/S0969-2126(00)00018-6; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; WELLS JA, 1993, ANNU REV BIOPH BIOM, V22, P329, DOI 10.1146/annurev.bb.22.060193.001553	19	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22256	10.1371/journal.pone.0022256	http://dx.doi.org/10.1371/journal.pone.0022256			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799806	Green Published, Green Submitted, gold			2022-12-25	WOS:000293172900019
J	He, ZY; Eichel, K; Ruvinsky, I				He, Zhengying; Eichel, Kelsie; Ruvinsky, Ilya			Functional Conservation of Cis-Regulatory Elements of Heat-Shock Genes over Long Evolutionary Distances	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; DROSOPHILA-MELANOGASTER; BINDING-PROTEIN; C-ELEGANS; EXPRESSION; STRESS; COEVOLUTION; SPECIFICITY; ACTIVATION; PROMOTER	Transcriptional control of gene regulation is an intricate process that requires precise orchestration of a number of molecular components. Studying its evolution can serve as a useful model for understanding how complex molecular machines evolve. One way to investigate evolution of transcriptional regulation is to test the functions of cis-elements from one species in a distant relative. Previous results suggested that few, if any, tissue-specific promoters from Drosophila are faithfully expressed in C. elegans. Here we show that, in contrast, promoters of fly and human heat-shock genes are upregulated in C. elegans upon exposure to heat. Inducibility under conditions of heat shock may represent a relatively simple "on-off" response, whereas complex expression patterns require integration of multiple signals. Our results suggest that simpler aspects of regulatory logic may be retained over longer periods of evolutionary time, while more complex ones may be diverging more rapidly.	[He, Zhengying; Eichel, Kelsie; Ruvinsky, Ilya] Univ Chicago, Dept Ecol & Evolut, Inst Genom & Syst Biol, Chicago, IL 60637 USA	University of Chicago	He, ZY (corresponding author), Univ Chicago, Dept Ecol & Evolut, Inst Genom & Syst Biol, 940 E 57Th St, Chicago, IL 60637 USA.	ruvinsky@uchicago.edu	He, Zhengying/A-5635-2014	Eichel, Kelsie/0000-0003-4507-5949	National Science Foundation (NSF) [IOS-0843504]; National Institutes of Health (NIH) [P50 GM081892]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081892] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was made possible by grant support, awarded to Dr. Ruvinsky, from the National Science Foundation (NSF) (IOS-0843504) and the National Institutes of Health (NIH) (P50 GM081892). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Athanikar JN, 1998, P NATL ACAD SCI USA, V95, P4935, DOI 10.1073/pnas.95.9.4935; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; BOORSTEIN WR, 1990, MOL CELL BIOL, V10, P3262, DOI 10.1128/MCB.10.6.3262; COHEN RS, 1985, CELL, V43, P737, DOI 10.1016/0092-8674(85)90247-8; CORCES V, 1981, P NATL ACAD SCI-BIOL, V78, P7038, DOI 10.1073/pnas.78.11.7038; Crocker J, 2008, PLOS BIOL, V6, P2576, DOI 10.1371/journal.pbio.0060263; Fernandes M, 1995, NUCLEIC ACIDS RES, V23, P4799, DOI 10.1093/nar/23.23.4799; Fukushige T, 2006, GENE DEV, V20, P3395, DOI 10.1101/gad.1481706; GALLO GJ, 1993, MOL CELL BIOL, V13, P749, DOI 10.1128/MCB.13.2.749; GLASER RL, 1986, EMBO J, V5, P747, DOI 10.1002/j.1460-2075.1986.tb04277.x; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Grens A, 1995, DEVELOPMENT, V121, P4027; Guertin MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001114; GuhaThakurta D, 2002, GENOME RES, V12, P701, DOI 10.1101/gr.228902; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Hare EE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000106; ISHHOROWICZ D, 1979, CELL, V18, P1351, DOI 10.1016/0092-8674(79)90245-9; Ishihara K, 1999, BBA-GENE STRUCT EXPR, V1444, P138, DOI 10.1016/S0167-4781(98)00254-1; Kirienko NV, 2010, EMBO J, V29, P727, DOI 10.1038/emboj.2009.387; Lakhotia SC, 2002, J EXP BIOL, V205, P345; Li VC, 2009, MOL BIOL EVOL, V26, P1103, DOI 10.1093/molbev/msp030; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu QX, 2007, MOL BIOL EVOL, V24, P1458, DOI 10.1093/molbev/msm073; Liu XD, 1997, EMBO J, V16, P6466, DOI 10.1093/emboj/16.21.6466; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; McGregor AP, 2001, EVOL DEV, V3, P397, DOI 10.1046/j.1525-142X.2001.01043.x; MCMAHON AP, 1984, P NATL ACAD SCI-BIOL, V81, P7490, DOI 10.1073/pnas.81.23.7490; MIRAULT ME, 1982, EMBO J, V1, P1279, DOI 10.1002/j.1460-2075.1982.tb00025.x; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; PAULI D, 1990, J CELL BIOL, V111, P817, DOI 10.1083/jcb.111.3.817; RIDDIHOUGH G, 1986, EMBO J, V5, P1653, DOI 10.1002/j.1460-2075.1986.tb04408.x; Ruvinsky I, 2003, DEVELOPMENT, V130, P5133, DOI 10.1242/dev.00711; Sakurai H, 2007, J BIOL CHEM, V282, P13334, DOI 10.1074/jbc.M611801200; SANDALTZOPOULOS R, 1995, NUCLEIC ACIDS RES, V23, P2479, DOI 10.1093/nar/23.13.2479; Shaw PJ, 2002, EVOL DEV, V4, P265, DOI 10.1046/j.1525-142X.2002.02016.x; Shilova VY, 2006, GENETICS, V173, P809, DOI 10.1534/genetics.105.053959; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; SIMON JA, 1987, NUCLEIC ACIDS RES, V15, P2971, DOI 10.1093/nar/15.7.2971; Tian SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010669; Trinklein ND, 2004, CELL STRESS CHAPERON, V9, P21, DOI 10.1379/1466-1268(2004)009<0021:TRABOH>2.0.CO;2; VUISTER GW, 1994, NAT STRUCT BIOL, V1, P605, DOI 10.1038/nsb0994-605; Westmoreland JJ, 2001, J NEUROSCI, V21, P6810, DOI 10.1523/JNEUROSCI.21-17-06810.2001; WIEDERRECHT G, 1987, CELL, V48, P507, DOI 10.1016/0092-8674(87)90201-7; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140	45	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22677	10.1371/journal.pone.0022677	http://dx.doi.org/10.1371/journal.pone.0022677			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799932	Green Published, Green Submitted, gold			2022-12-25	WOS:000293172900066
J	Xu, QP; Rawlings, ND; Farr, CL; Chiu, HJ; Grant, JC; Jaroszewski, L; Klock, HE; Knuth, MW; Miller, MD; Weekes, D; Elsliger, MA; Deacon, AM; Godzik, A; Lesley, SA; Wilson, IA				Xu, Qingping; Rawlings, Neil D.; Farr, Carol L.; Chiu, Hsiu-Ju; Grant, Joanna C.; Jaroszewski, Lukasz; Klock, Heath E.; Knuth, Mark W.; Miller, Mitchell D.; Weekes, Dana; Elsliger, Marc-Andre; Deacon, Ashley M.; Godzik, Adam; Lesley, Scott A.; Wilson, Ian A.			Structural and Sequence Analysis of Imelysin-Like Proteins Implicated in Bacterial Iron Uptake	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; GENERATION; LIPOPROTEINS; TRANSPORTER; MUTAGENESIS; REFINEMENT; GENOMICS; BIOLOGY; CLONING; LRUA	Imelysin-like proteins define a superfamily of bacterial proteins that are likely involved in iron uptake. Members of this superfamily were previously thought to be peptidases and were included in the MEROPS family M75. We determined the first crystal structures of two remotely related, imelysin-like proteins. The Psychrobacter arcticus structure was determined at 2.15 angstrom resolution and contains the canonical imelysin fold, while higher resolution structures from the gut bacteria Bacteroides ovatus, in two crystal forms (at 1.25 angstrom and 1.44 angstrom resolution), have a circularly permuted topology. Both structures are highly similar to each other despite low sequence similarity and circular permutation. The all-helical structure can be divided into two similar four-helix bundle domains. The overall structure and the GxHxxE motif region differ from known HxxE metallopeptidases, suggesting that imelysin-like proteins are not peptidases. A putative functional site is located at the domain interface. We have now organized the known homologous proteins into a superfamily, which can be separated into four families. These families share a similar functional site, but each has family-specific structural and sequence features. These results indicate that imelysin-like proteins have evolved from a common ancestor, and likely have a conserved function.	[Xu, Qingping; Farr, Carol L.; Chiu, Hsiu-Ju; Grant, Joanna C.; Jaroszewski, Lukasz; Klock, Heath E.; Knuth, Mark W.; Miller, Mitchell D.; Weekes, Dana; Elsliger, Marc-Andre; Deacon, Ashley M.; Godzik, Adam; Lesley, Scott A.; Wilson, Ian A.] Joint Ctr Struct Genom, La Jolla, CA USA; [Xu, Qingping; Chiu, Hsiu-Ju; Miller, Mitchell D.; Deacon, Ashley M.] SLAC Natl Accelerator Lab, Menlo Pk, CA USA; [Rawlings, Neil D.] Wellcome Trust Sanger Inst, Hinxton, England; [Farr, Carol L.; Elsliger, Marc-Andre; Lesley, Scott A.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Grant, Joanna C.; Klock, Heath E.; Knuth, Mark W.; Lesley, Scott A.] Novartis Res Fdn, Genom Inst, Prot Sci Dept, San Diego, CA USA; [Jaroszewski, Lukasz; Godzik, Adam] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Jaroszewski, Lukasz; Weekes, Dana; Godzik, Adam] Sanford Burnham Med Res Inst, Program Bioinformat & Syst Biol, La Jolla, CA USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Wellcome Trust Sanger Institute; Scripps Research Institute; Novartis; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute	Xu, QP (corresponding author), Joint Ctr Struct Genom, La Jolla, CA USA.	wilson@scripps.edu	Rawlings, Neil/M-5566-2013; Godzik, Adam/AAW-1467-2020; Rawlings, Neil D./I-4867-2012; Godzik, Adam/A-7279-2009	Rawlings, Neil/0000-0001-5557-7665; Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; Elsliger, Marc Andre/0000-0002-1989-7626; Miller, Mitchell/0000-0003-1626-4943	National Institutes of Health; National Institute of General Medical Sciences, Protein Structure Initiative [U54 GM094586, U54 GM074898]; Department of Energy, Office of Biological and Environmental Research; National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074898, U54GM094586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences, Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, National Institute of General Medical Sciences, Protein Structure Initiative grants U54 GM094586 and U54 GM074898. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the members of the JCSG high-throughput structural biology pipeline for their contribution to this work. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL). The SSRL is a national user facility operated by Stanford University on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health (National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences). Portions of this research were conducted at the Advanced Light Source a national user facility operated by Lawrence Berkeley National Laboratory, on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences. The Berkeley Center for Structural Biology is supported in part by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences. Genomic DNA from B. ovatus ATCC 8483 was extracted from cells (ATCC # 8483T) obtained from ATCC. Genomic DNA from P. articum (P. articum 273-4) was a gift of Dr. Tamara Cole and Dr. Jim Tiedje, Michigan State University, East Lansing, MI, USA.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cao J, 2007, MOL MICROBIOL, V65, P857, DOI 10.1111/j.1365-2958.2007.05802.x; CHRISTIANSON DW, 1986, P NATL ACAD SCI USA, V83, P7568, DOI 10.1073/pnas.83.20.7568; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; Cornelis P, 2009, BIOMETALS, V22, P15, DOI 10.1007/s10534-008-9193-0; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Elsliger MA, 2010, ACTA CRYSTALLOGR F, V66, P1137, DOI 10.1107/S1744309110038212; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fricke B, 1999, BBA-MOL BASIS DIS, V1454, P236, DOI 10.1016/S0925-4439(99)00040-X; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Grosse C, 2006, MOL MICROBIOL, V62, P120, DOI 10.1111/j.1365-2958.2006.05326.x; HAYASHI S, 1990, J BIOENERG BIOMEMBR, V22, P451, DOI 10.1007/BF00763177; He JS, 2008, FEMS MICROBIOL LETT, V288, P221, DOI 10.1111/j.1574-6968.2008.01354.x; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kleywegt GJ, 1999, J MOL BIOL, V285, P1887, DOI 10.1006/jmbi.1998.2393; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Maruyama Y, 2011, BIOCHEM BIOPH RES CO, V405, P411, DOI 10.1016/j.bbrc.2011.01.043; Mey AR, 2005, INFECT IMMUN, V73, P8167, DOI 10.1128/IAI.73.12.8167-8178.2005; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Quezada CM, 2004, J MOL BIOL, V341, P1283, DOI 10.1016/j.jmb.2004.06.061; Rajasekaran MB, 2010, BIOMETALS, V23, P1, DOI 10.1007/s10534-009-9262-z; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; REDDY KJ, 1988, J BACTERIOL, V170, P4466, DOI 10.1128/jb.170.10.4466-4476.1988; Santarsiero BD, 2002, J APPL CRYSTALLOGR, V35, P278, DOI 10.1107/S0021889802001474; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Verma A, 2005, INFECT IMMUN, V73, P7259, DOI 10.1128/IAI.73.11.7259-7266.2005; Verma A, 2008, CLIN VACCINE IMMUNOL, V15, P1019, DOI 10.1128/CVI.00203-07; Vishnivetskaya T, 2000, EXTREMOPHILES, V4, P165, DOI 10.1007/s007920070031; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	40	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e21875	10.1371/journal.pone.0021875	http://dx.doi.org/10.1371/journal.pone.0021875			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799754	gold, Green Submitted, Green Published			2022-12-25	WOS:000293172900008
J	Bailey, JA; Ray, B; Greig, NH; Lahiri, DK				Bailey, Jason A.; Ray, Balmiki; Greig, Nigel H.; Lahiri, Debomoy K.			Rivastigmine Lowers A beta and Increases sAPP alpha Levels, Which Parallel Elevated Synaptic Markers and Metabolic Activity in Degenerating Primary Rat Neurons	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; CHOLINESTERASE-INHIBITORS; PRESYNAPTIC PROTEINS; HIPPOCAMPAL-NEURONS; GLUCOSE-METABOLISM; PEPTIDE LEVELS; MESSENGER-RNA; BRAIN; EXPRESSION	Overproduction of amyloid-beta (A beta) protein in the brain has been hypothesized as the primary toxic insult that, via numerous mechanisms, produces cognitive deficits in Alzheimer's disease (AD). Cholinesterase inhibition is a primary strategy for treatment of AD, and specific compounds of this class have previously been demonstrated to influence A beta precursor protein (APP) processing and A beta production. However, little information is available on the effects of rivastigmine, a dual acetylcholinesterase and butyrylcholinesterase inhibitor, on APP processing. As this drug is currently used to treat AD, characterization of its various activities is important to optimize its clinical utility. We have previously shown that rivastigmine can preserve or enhance neuronal and synaptic terminal markers in degenerating primary embryonic cerebrocortical cultures. Given previous reports on the effects of APP and A beta on synapses, regulation of APP processing represents a plausible mechanism for the synaptic effects of rivastigmine. To test this hypothesis, we treated degenerating primary cultures with rivastigmine and measured secreted APP (sAPP) and A beta. Rivastigmine treatment increased metabolic activity in these cultured cells, and elevated APP secretion. Analysis of the two major forms of APP secreted by these cultures, attributed to neurons or glia based on molecular weight showed that rivastigmine treatment significantly increased neuronal relative to glial secreted APP. Furthermore, rivastigmine treatment increased a-secretase cleaved sAPP alpha and decreased A beta secretion, suggesting a therapeutic mechanism wherein rivastigmine alters the relative activities of the secretase pathways. Assessment of sAPP levels in rodent CSF following once daily rivastigmine administration for 21 days confirmed that elevated levels of APP in cell culture translated in vivo. Taken together, rivastigmine treatment enhances neuronal sAPP and shifts APP processing toward the a-secretase pathway in degenerating neuronal cultures, which mirrors the trend of synaptic proteins, and metabolic activity.	[Bailey, Jason A.; Ray, Balmiki; Lahiri, Debomoy K.] Indiana Univ Sch Med, Inst Psychiat Res, Dept Psychiat, Indianapolis, IN USA; [Greig, Nigel H.] NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA	Indiana University System; Indiana University Bloomington; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Bailey, JA (corresponding author), Indiana Univ Sch Med, Inst Psychiat Res, Dept Psychiat, Indianapolis, IN USA.	dlahiri@iupui.edu	Lahiri, Debomoy/AAZ-3322-2020		National Institutes of Health [R01-AG18379, R01-AG18884]; National Institute on Aging; Novartis; NATIONAL INSTITUTE ON AGING [R01AG018379, R01AG018884, ZIAAG000311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Novartis(Novartis); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research is supported by National Institutes of Health grants (R01-AG18379 and R01-AG18884) to DKL and the Intramural Research Program of the National Institute on Aging (NHG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I have read the journal's policy and have the following conflict: Dr. Lahiri is a member of the scientific advisory board of QR Pharma, Inc, Randon, PA. He was previously a receipient of a grant from Novartis. Currently, he and the other co-authors of this study are declaring no financial relationship with Novartis, and this past relationship does not interfere with the PLoS ONE policies on sharing of data and materials.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alley GM, 2010, J NEUROSCI RES, V88, P143, DOI 10.1002/jnr.22172; Bailey JA, 2010, J NEUROCHEM, V112, P843, DOI 10.1111/j.1471-4159.2009.06490.x; Barrachina M, 2005, NEUROCHEM INT, V46, P253, DOI 10.1016/j.neuint.2004.08.006; Bejar C, 1999, EUR J PHARMACOL, V383, P231, DOI 10.1016/S0014-2999(99)00643-3; Boyle PA, 2010, ARCH GEN PSYCHIAT, V67, P304, DOI 10.1001/archgenpsychiatry.2009.208; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Catalano SM, 2006, CURR TOP MED CHEM, V6, P597, DOI 10.2174/156802606776743066; Copanaki E, 2010, MOL CELL NEUROSCI, V44, P386, DOI 10.1016/j.mcn.2010.04.007; CROMMELIN DJA, 2007, PHARM BIOTECHNOLOGY, P67; Desai A, 2001, Expert Opin Pharmacother, V2, P653, DOI 10.1517/14656566.2.4.653; DESILVA HAR, 1997, BRAIN RES MOL BRAIN, V47, P147, DOI DOI 10.1016/S0169-328X(97)00045-4; Evans NA, 2008, J NEUROSCI METH, V175, P96, DOI 10.1016/j.jneumeth.2008.08.001; Farlow MR, 1996, ANN NY ACAD SCI, V802, P101, DOI 10.1111/j.1749-6632.1996.tb32603.x; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hendrie HC, 2004, CAN J PSYCHIAT, V49, P92, DOI 10.1177/070674370404900203; Kadir A, 2007, PSYCHOPHARMACOLOGY, V191, P1005, DOI 10.1007/s00213-007-0725-z; Lahiri D K, 1997, Ann N Y Acad Sci, V826, P416, DOI 10.1111/j.1749-6632.1997.tb48495.x; Lahiri DK, 2009, MOL PSYCHIATR, V14, P992, DOI 10.1038/mp.2009.82; Lahiri DK, 2010, EXP GERONTOL, V45, P291, DOI 10.1016/j.exger.2010.01.001; Lahiri DK, 2007, J PHARMACOL EXP THER, V320, P386, DOI 10.1124/jpet.106.112102; Lahiri DK, 2007, NEUROMOL MED, V9, P157, DOI 10.1385/NMM:9:2:157; Lahiri DK, 2003, CURR DRUG TARGETS, V4, P97, DOI 10.2174/1389450033346957; Lahiri DK, 1996, J MOL NEUROSCI, V7, P41, DOI 10.1007/BF02736847; LAHIRI DK, 1994, J NEUROSCI RES, V37, P777, DOI 10.1002/jnr.490370612; Long JM, 2011, BIOCHEM BIOPH RES CO, V404, P889, DOI 10.1016/j.bbrc.2010.12.053; Matsui T, 2007, BRAIN RES, V1161, P116, DOI 10.1016/j.brainres.2007.05.050; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Mosconi L, 2005, EUR J NUCL MED MOL I, V32, P486, DOI [10.1007/s00259-008-1039-z, 10.1007/s00259-005-1762-7]; Mosconi L, 2008, ANN NY ACAD SCI, V1147, P180, DOI 10.1196/annals.1427.007; Nizri E, 2008, J NEUROIMMUNOL, V203, P12, DOI 10.1016/j.jneuroim.2008.06.018; Paco S, 2009, J NEUROCHEM, V110, P143, DOI 10.1111/j.1471-4159.2009.06116.x; Panegyres PK, 1998, J NEURAL TRANSM, V105, P463, DOI 10.1007/s007020050070; Pepeu G, 2010, CHEM-BIOL INTERACT, V187, P403, DOI 10.1016/j.cbi.2009.11.018; Pepeu G, 2009, CURR ALZHEIMER RES, V6, P86, DOI 10.2174/156720509787602861; Proctor DT, 2010, J ALZHEIMERS DIS, V21, P795, DOI 10.3233/JAD-2010-100090; Ray B, 2011, NEUROSCIENCE, V184, P139, DOI 10.1016/j.neuroscience.2011.03.067; Ray B, 2011, J NEUROCHEM, V117, P388, DOI 10.1111/j.1471-4159.2010.07145.x; Ray B, 2009, CURR OPIN PHARMACOL, V9, P434, DOI 10.1016/j.coph.2009.06.012; Sambamurti K, 2002, NEUROMOL MED, V1, P1, DOI 10.1385/NMM:1:1:1; Sandbrink R, 1996, ANN NY ACAD SCI, V777, P281, DOI 10.1111/j.1749-6632.1996.tb34433.x; Sando SB, 2008, INT J GERIATR PSYCH, V23, P1156, DOI 10.1002/gps.2043; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Shaw KTY, 2001, P NATL ACAD SCI USA, V98, P7605, DOI 10.1073/pnas.131152998; Stefanova E, 2006, J NEURAL TRANSM, V113, P205, DOI 10.1007/s00702-005-0312-6; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Townsend M, 2006, ANN NEUROL, V60, P668, DOI 10.1002/ana.21051; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Weinstock M, 2001, ANN NY ACAD SCI, V939, P148; WELLER M, 1993, BRAIN RES, V613, P143, DOI 10.1016/0006-8993(93)90464-X; Wu J, 2008, J NEUROSCI, V28, P3, DOI 10.1523/JNEUROSCI.4405-07.2008; Yogev-Falach M, 2002, FASEB J, V16, P1674, DOI 10.1096/fj.02-0198fje; Youdim MBH, 2001, CELL MOL NEUROBIOL, V21, P555, DOI 10.1023/A:1015131516649; Zhang WW, 2009, J NEURAL TRANSM, V116, P1643, DOI 10.1007/s00702-009-0297-7	62	68	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e21954	10.1371/journal.pone.0021954	http://dx.doi.org/10.1371/journal.pone.0021954			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799757	Green Published, Green Submitted, gold			2022-12-25	WOS:000293097300008
J	Pietrzak, M; Rempala, G; Nelson, PT; Zheng, JJ; Hetman, M				Pietrzak, Maciej; Rempala, Grzegorz; Nelson, Peter T.; Zheng, Jing-Juan; Hetman, Michal			Epigenetic Silencing of Nucleolar rRNA Genes in Alzheimer's Disease	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; DNA METHYLATION; NEURONAL HYPERTROPHY; LIFE-SPAN; BRAIN; AGE; MOUSE; RDNA; HYPERMETHYLATION; INACTIVATION	Background: Ribosomal deficits are documented in mild cognitive impairment (MCI), which often represents an early stage Alzheimer's disease (AD), as well as in advanced AD. The nucleolar rRNA genes (rDNA), transcription of which is critical for ribosomal biogenesis, are regulated by epigenetic silencing including promoter CpG methylation. Methodology/Principal Findings: To assess whether CpG methylation of the rDNA promoter was dysregulated across the AD spectrum, we analyzed brain samples from 10 MCI-, 23 AD-, and, 24 age-matched control individuals using bisulfite mapping. The rDNA promoter became hypermethylated in cerebro-cortical samples from MCI and AD groups. In parietal cortex, the rDNA promoter was hypermethylated more in MCI than in advanced AD. The cytosine methylation of total genomic DNA was similar in AD, MCI, and control samples. Consistent with a notion that hypermethylation-mediated silencing of the nucleolar chromatin stabilizes rDNA loci, preventing their senescence-associated loss, genomic rDNA content was elevated in cerebrocortical samples from MCI and AD groups. Conclusions/Significance: In conclusion, rDNA hypermethylation could be a new epigenetic marker of AD. Moreover, silencing of nucleolar chromatin may occur during early stages of AD pathology and play a role in AD-related ribosomal deficits and, ultimately, dementia.	[Pietrzak, Maciej; Zheng, Jing-Juan; Hetman, Michal] Univ Louisville, Dept Neurol Surg, Louisville, KY 40292 USA; [Pietrzak, Maciej; Zheng, Jing-Juan; Hetman, Michal] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; [Hetman, Michal] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Rempala, Grzegorz] Med Coll Georgia, Dept Biostat, Augusta, GA 30912 USA; [Nelson, Peter T.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA	University of Louisville; University of Louisville; University of Louisville; University System of Georgia; Augusta University; University of Kentucky	Pietrzak, M (corresponding author), Univ Louisville, Dept Neurol Surg, Louisville, KY 40292 USA.	michal.hetman@louisville.edu	Pietrzak, Maciej/GNH-5768-2022; Rempala, Grzegorz/C-3576-2013	Pietrzak, Maciej/0000-0001-5768-7884	National Institutes of Health (NIH) [NS047341, RR015576, R01DE019243]; National Science Foundation (NSF) [IOS1021860, DMS0840695]; Commonwealth of Kentucky Challenge for Excellence; Norton Healthcare; NATIONAL CANCER INSTITUTE [R01CA152158] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028383] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1021860] Funding Source: National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Commonwealth of Kentucky Challenge for Excellence; Norton Healthcare; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The funders include National Institutes of Health (NIH) (NS047341 and RR015576 to MH; R01DE019243 to GR), National Science Foundation (NSF) (IOS1021860 to MH; DMS0840695 to GR), The Commonwealth of Kentucky Challenge for Excellence, and Norton Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul HM, 2009, J NEUROSCI, V29, P12957, DOI 10.1523/JNEUROSCI.1064-09.2009; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chouliaras L, 2010, PROG NEUROBIOL, V90, P498, DOI 10.1016/j.pneurobio.2010.01.002; Ding QX, 2006, NEUROCHEM RES, V31, P705, DOI 10.1007/s11064-006-9071-5; Ding QX, 2005, J NEUROSCI, V25, P9171, DOI 10.1523/JNEUROSCI.3040-05.2005; GAUBATZ J, 1976, BIOCHIM BIOPHYS ACTA, V418, P358, DOI 10.1016/0005-2787(76)90297-5; Guetg C, 2010, EMBO J, V29, P2135, DOI 10.1038/emboj.2010.17; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Honda K, 2005, J BIOL CHEM, V280, P20978, DOI 10.1074/jbc.M500526200; Iacono D, 2009, NEUROLOGY, V73, P665, DOI 10.1212/WNL.0b013e3181b01077; Iacono D, 2008, J NEUROPATH EXP NEUR, V67, P578, DOI 10.1097/NEN.0b013e3181772794; Kalita K, 2008, J NEUROCHEM, V105, P2286, DOI 10.1111/j.1471-4159.2008.05316.x; Kastner P, 2003, PEDIATR RES, V53, P62, DOI 10.1203/01.PDR.0000041516.10799.14; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; Machwe A, 2000, FASEB J, V14, P1715, DOI 10.1096/fj.99-0926com; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Mokarram P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007012; Morgan AR, 2008, AM J MED GENET B, V147B, P727, DOI 10.1002/ajmg.b.30670; Nelson PT, 2007, J NEUROPATH EXP NEUR, V66, P1136, DOI 10.1097/nen.0b013e31815c5efb; Nelson PT, 2007, J NEUROPATH EXP NEUR, V66, P461, DOI 10.1097/01.jnen.0000240474.27791.f3; Oakes CC, 2003, P NATL ACAD SCI USA, V100, P1775, DOI 10.1073/pnas.0437971100; Paredes S, 2009, GENETICS, V181, P1661, DOI 10.1534/genetics.108.099093; Parlato R, 2008, J NEUROSCI, V28, P12759, DOI 10.1523/JNEUROSCI.2439-08.2008; Rieker C, 2011, J NEUROSCI, V31, P453, DOI 10.1523/JNEUROSCI.0590-10.2011; Santoro R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006653; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; SINGERSAM J, 1990, MOL CELL BIOL, V10, P4987, DOI 10.1128/MCB.10.9.4987; Speranca MA, 2008, ALZHEIMERS DEMENT, V4, P438, DOI 10.1016/j.jalz.2008.03.010; STREHLER BL, 1979, MECH AGEING DEV, V11, P379, DOI 10.1016/0047-6374(79)90013-7; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; SWISSHELM K, 1990, MUTAT RES, V237, P131, DOI 10.1016/0921-8734(90)90019-N; Szyf M, 2009, ANNU REV PHARMACOL, V49, P243, DOI 10.1146/annurev-pharmtox-061008-103102; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002698; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Zafiropoulos A, 2005, INT J BIOCHEM CELL B, V37, P409, DOI 10.1016/j.biocel.2004.07.007	37	101	106	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22585	10.1371/journal.pone.0022585	http://dx.doi.org/10.1371/journal.pone.0022585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799908	Green Published, gold			2022-12-25	WOS:000293097300068
J	Racca, AC; Camolotto, SA; Ridano, ME; Bocco, JL; Genti-Raimondi, S; Panzetta-Dutari, GM				Racca, Ana C.; Camolotto, Soledad A.; Ridano, Magali E.; Bocco, Jose L.; Genti-Raimondi, Susana; Panzetta-Dutari, Graciela M.			Kruppel-Like Factor 6 Expression Changes during Trophoblast Syncytialization and Transactivates beta hCG and PSG Placental Genes	PLOS ONE			English	Article							PREGNANCY-SPECIFIC GLYCOPROTEINS; HUMAN CHORIONIC-GONADOTROPIN; TRANSCRIPTION FACTOR KLF6; TUMOR-SUPPRESSOR GENE; ZINC-FINGER PROTEIN; CELL; DIFFERENTIATION; CANCER; GROWTH; ONCOPROTEIN	Background: Kruppel-like factor-6 (KLF6) is a widely expressed member of the Sp1/KLF family of transcriptional regulators involved in differentiation, cell cycle control and proliferation in several cell systems. Even though the highest expression level of KLF6 has been detected in human and mice placenta, its function in trophoblast physiology is still unknown. Methodology/Principal Findings: Herein, we explored KLF6 expression and sub-cellular distribution in human trophoblast cells differentiating into the syncytial pathway, and its role in the regulation of genes associated with placental development and pregnancy maintenance. Confocal immunofluorescence microscopy demonstrated that KLF6 is expressed throughout human cytotrophoblast differentiation showing no evident modifications in its nuclear and cytoplasmic localization pattern. KLF6 transcript and protein peaked early during the syncytialization process as determined by qRT-PCR and western blot assays. Overexpression of KLF6 in trophoblast-derived JEG-3 cells showed a preferential nuclear signal correlating with enhanced expression of human beta-chorionic gonadotropin (beta hCG) and pregnancy-specific glycoprotein (PSG) genes. Moreover, KLF6 transactivated beta hCG5, PSG5 and PSG3 gene promoters. Deletion of KLF6 Zn-finger DNA binding domain or mutation of the consensus KLF6 binding site abolished transactivation of the PSG5 promoter. Conclusions/Significance: Results are consistent with KLF6 playing a role as transcriptional regulator of relevant genes for placental differentiation and physiology such as beta hCG and PSG, in agreement with an early and transient increase of KLF6 expression during trophoblast syncytialization.	[Racca, Ana C.; Camolotto, Soledad A.; Ridano, Magali E.; Bocco, Jose L.; Genti-Raimondi, Susana; Panzetta-Dutari, Graciela M.] Univ Nacl Cordoba, Fac Ciencias Quim, CIBICI, CONICET,Dept Bioquim Clin, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Racca, AC (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, CIBICI, CONICET,Dept Bioquim Clin, RA-5000 Cordoba, Argentina.	gpan@fcq.unc.edu.ar		Racca, Ana Cristina/0000-0002-5909-2451; Bocco, Jose Luis/0000-0002-9682-1270	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Argentina [6352, 919]; Agencia Nacional de Promocion Ciencia y Tecnologica (FONCyT) [PICT-2006-00147]; Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba; Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba, Argentina [SECyT-UNC: 05/C479]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Ciencia y Tecnologica (FONCyT)(FONCyT); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba, Argentina(Secretaria de Ciencia y Tecnologia (SECYT))	This work was funded by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET: PIP No 6352, PIP No 919), Argentina; Agencia Nacional de Promocion Ciencia y Tecnologica (FONCyT: PICT-2006-00147); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba; and Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba, Argentina (SECyT-UNC: 05/C479). ACR, SC and MER acknowledge CONICET for their fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agell L, 2008, MODERN PATHOL, V21, P1470, DOI 10.1038/modpathol.2008.145; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreoli V, 2010, IUBMB LIFE, V62, P896, DOI 10.1002/iub.396; Angeletti S, 2008, PLACENTA, V29, P396, DOI 10.1016/j.placenta.2008.02.011; Baczyk D, 2004, PLACENTA, V25, P553, DOI 10.1016/j.placenta.2003.12.004; Baczyk D, 2009, CELL DEATH DIFFER, V16, P719, DOI 10.1038/cdd.2009.1; Bentov I, 2008, ENDOCRINOLOGY, V149, P1890, DOI 10.1210/en.2007-0844; Blanchon L, 2001, MECH DEVELOP, V105, P185, DOI 10.1016/S0925-4773(01)00391-4; BOCCO JL, 1989, BIOCHEM INT, V18, P999; Botella LM, 2002, BLOOD, V100, P4001, DOI 10.1182/blood.V100.12.4001; Botella LM, 2009, BIOCHEM J, V419, P485, DOI 10.1042/BJ20081434; Boyault S, 2005, HEPATOLOGY, V41, P681, DOI 10.1002/hep.20588; Camolotto S, 2010, PLACENTA, V31, P312, DOI 10.1016/j.placenta.2010.01.004; Chiambaretta F, 2004, MOL VIS, V10, P901; Cole LA, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-8; Difeo A, 2009, DRUG RESIST UPDATE, V12, P1, DOI 10.1016/j.drup.2008.11.001; ElRouby S, 1997, GENOMICS, V43, P395; Fischer EA, 2001, J AM SOC NEPHROL, V12, P726, DOI 10.1681/ASN.V124726; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Gehrau RC, 2005, BBA-GENE STRUCT EXPR, V1730, P137, DOI 10.1016/j.bbaexp.2005.06.006; Gehrau RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008929; Huppertz Berthold, 2008, V475, P135, DOI 10.1007/978-1-59745-250-2_8; Inuzuka H, 1999, BBA-GENE STRUCT EXPR, V1447, P199, DOI 10.1016/S0167-4781(99)00161-X; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Knofler M, 2004, ENDOCRINOLOGY, V145, P1685, DOI 10.1210/en.2003-0954; Koritschoner NP, 1997, J BIOL CHEM, V272, P9573; Koritschoner NP, 1996, EUR J BIOCHEM, V236, P365, DOI 10.1111/j.1432-1033.1996.00365.x; Laub F, 2001, MECH DEVELOP, V106, P167, DOI 10.1016/S0925-4773(01)00419-1; Li D, 2005, J BIOL CHEM, V280, P26941, DOI 10.1074/jbc.M500463200; Lievre A, 2005, ONCOGENE, V24, P7253, DOI 10.1038/sj.onc.1208867; Lin FY, 2011, NUCLEIC ACIDS RES, V39, P848, DOI 10.1093/nar/gkq838; Liu J, 2010, MOL CELL BIOCHEM, V335, P29, DOI 10.1007/s11010-009-0237-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Diaz F, 2007, PLACENTA, V28, P898, DOI 10.1016/j.placenta.2007.03.002; Matsumoto N, 2006, BLOOD, V107, P1357, DOI 10.1182/blood-2005-05-1916; Morrish DW, 1997, PLACENTA, V18, P577, DOI 10.1016/0143-4004(77)90013-3; Nakamura H, 2004, INVEST OPHTH VIS SCI, V45, P4327, DOI 10.1167/iovs.04-0353; Narla G, 2005, CANCER RES, V65, P1213, DOI 10.1158/0008-5472.CAN-04-4249; Nores R, 2004, PLACENTA, V25, P9, DOI 10.1016/S0143-4004(03)00213-3; Panzetta-Dutari GM, 2000, BIOCHEM J, V350, P511, DOI 10.1042/0264-6021:3500511; Ratziu V, 1998, P NATL ACAD SCI USA, V95, P9500, DOI 10.1073/pnas.95.16.9500; Rodriguez E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012639; Slavin D, 1999, BIOL REPROD, V61, P1586, DOI 10.1095/biolreprod61.6.1586; Slavin DA, 2004, ONCOGENE, V23, P8196, DOI 10.1038/sj.onc.1208020; Stecca B, 2002, MECH DEVELOP, V115, P27, DOI 10.1016/S0925-4773(02)00095-3; Yang M, 2003, ENDOCRINOLOGY, V144, P1108, DOI 10.1210/en.2002-220922; Zhao XA, 2010, DEV BIOL, V344, P79, DOI 10.1016/j.ydbio.2010.04.018	47	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22438	10.1371/journal.pone.0022438	http://dx.doi.org/10.1371/journal.pone.0022438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799854	Green Published, Green Submitted, gold			2022-12-25	WOS:000293097300047
J	Mellmann, A; Harmsen, D; Cummings, CA; Zentz, EB; Leopold, SR; Rico, A; Prior, K; Szczepanowski, R; Ji, YM; Zhang, WL; McLaughlin, SF; Henkhaus, JK; Leopold, B; Bielaszewska, M; Prager, R; Brzoska, PM; Moore, RL; Guenther, S; Rothberg, JM; Karch, H				Mellmann, Alexander; Harmsen, Dag; Cummings, Craig A.; Zentz, Emily B.; Leopold, Shana R.; Rico, Alain; Prior, Karola; Szczepanowski, Rafael; Ji, Yongmei; Zhang, Wenlan; McLaughlin, Stephen F.; Henkhaus, John K.; Leopold, Benjamin; Bielaszewska, Martina; Prager, Rita; Brzoska, Pius M.; Moore, Richard L.; Guenther, Simone; Rothberg, Jonathan M.; Karch, Helge			Prospective Genomic Characterization of the German Enterohemorrhagic Escherichia coli O104:H4 Outbreak by Rapid Next Generation Sequencing Technology	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ACID RESISTANCE; ADHERENCE; O157-H7; STRAINS; DISEASE; GENES	An ongoing outbreak of exceptionally virulent Shiga toxin (Stx)-producing Escherichia coli O104:H4 centered in Germany, has caused over 830 cases of hemolytic uremic syndrome (HUS) and 46 deaths since May 2011. Serotype O104:H4, which has not been detected in animals, has rarely been associated with HUS in the past. To prospectively elucidate the unique characteristics of this strain in the early stages of this outbreak, we applied whole genome sequencing on the Life Technologies Ion Torrent PGM (TM) sequencer and Optical Mapping to characterize one outbreak isolate (LB226692) and a historic O104:H4 HUS isolate from 2001 (01-09591). Reference guided draft assemblies of both strains were completed with the newly introduced PGM (TM) within 62 hours. The HUS-associated strains both carried genes typically found in two types of pathogenic E. coli, enteroaggregative E. coli (EAEC) and enterohemorrhagic E. coli (EHEC). Phylogenetic analyses of 1,144 core E. coli genes indicate that the HUS-causing O104:H4 strains and the previously published sequence of the EAEC strain 55989 show a close relationship but are only distantly related to common EHEC serotypes. Though closely related, the outbreak strain differs from the 2001 strain in plasmid content and fimbrial genes. We propose a model in which EAEC 55989 and EHEC O104:H4 strains evolved from a common EHEC O104:H4 progenitor, and suggest that by stepwise gain and loss of chromosomal and plasmid-encoded virulence factors, a highly pathogenic hybrid of EAEC and EHEC emerged as the current outbreak clone. In conclusion, rapid next-generation technologies facilitated prospective whole genome characterization in the early stages of an outbreak.	[Mellmann, Alexander; Leopold, Shana R.; Zhang, Wenlan; Leopold, Benjamin; Bielaszewska, Martina; Karch, Helge] Univ Munster, Inst Hyg, Munster, Germany; [Harmsen, Dag; Prior, Karola; Szczepanowski, Rafael] Univ Munster, Dept Periodontol, Munster, Germany; [Cummings, Craig A.; Ji, Yongmei; McLaughlin, Stephen F.; Brzoska, Pius M.] Life Technol, Foster City, CA USA; [Zentz, Emily B.; Henkhaus, John K.; Moore, Richard L.] OpGen, Gaithersburg, MD USA; [Rico, Alain; Guenther, Simone] Life Technol, Darmstadt, Germany; [Prager, Rita] Robert Koch Inst, Wernigerode Branch, Wernigerode, Germany; [Rothberg, Jonathan M.] Ion Torrent, Guilford, CT USA	University of Munster; University of Munster; Thermo Fisher Scientific; Thermo Fisher Scientific; Robert Koch Institute	Mellmann, A (corresponding author), Univ Munster, Inst Hyg, Munster, Germany.	dharmsen@uni-muenster.de	Leopold, Shana/ABA-2797-2020; Bielaszewska, Martina/AAC-9812-2022; Weinstock, George M/C-6314-2013; Harmsen, Dag/J-3041-2012	Leopold, Shana/0000-0001-5830-1955; Weinstock, George M/0000-0002-2997-4592; Mellmann, Alexander/0000-0002-0649-5185	BMBF [01KI1020]; Medical Faculty Muenster [BD9817044]	BMBF(Federal Ministry of Education & Research (BMBF)); Medical Faculty Muenster	Funding for this work was provided by the BMBF (no. 01KI1020 to AM, DH, HK) and the Medical Faculty Muenster (grant BD9817044 to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askar M, 2011, EURO SURVEILL, V16; Bae WK, 2006, YONSEI MED J, V47, P437, DOI 10.3349/ymj.2006.47.3.437; Beijing Genome Institute ( BGI), 2011, SEQ DAT ESCH COL TY; Bielaszewska M, 2011, LANCET INFE IN PRESS; Bielaszewska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001024; Bielaszewska M, 2011, MOL MICROBIOL, V79, P1024, DOI 10.1111/j.1365-2958.2010.07499.x; Bonnet R, 1998, J CLIN MICROBIOL, V36, P1777, DOI 10.1128/JCM.36.6.1777-1780.1998; Brzuszkiewicz E, 2011, ARCH MICROBIOL  0629; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Dudley EG, 2006, INFECT IMMUN, V74, P2102, DOI 10.1128/IAI.74.4.2102-2114.2006; DYTOC MT, 1994, INFECT IMMUN, V62, P3494, DOI 10.1128/IAI.62.8.3494-3505.1994; Elias J, 2006, EMERG INFECT DIS, V12, P1689, DOI 10.3201/eid1211.060682; European Food Safety Authority (EFSA), JOINT EFSA ECDC TECH; Federal Institute for Risk Assessment (BfR) Germany, 2011, EHEC OUTBR BFR CONF; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Frank C, 2011, N ENGL J ME IN PRESS; Gilmour MW, 2007, J MED MICROBIOL, V56, P620, DOI 10.1099/jmm.0.47053-0; GORDEN J, 1993, INFECT IMMUN, V61, P364, DOI 10.1128/IAI.61.1.364-367.1993; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Homer N, ION TORRENT COMMUNIT; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Janies DA, 2011, CLADISTICS, V27, P61, DOI 10.1111/j.1096-0031.2010.00314.x; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; Kotewicz ML, 2008, MICROBIOL-SGM, V154, P3518, DOI 10.1099/mic.0.2008/019026-0; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lienau EK, 2011, NEW ENGL J MED, V364, P981, DOI 10.1056/NEJMc1100443; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Mellmann A, 2008, APPL ENVIRON MICROB, V74, P67, DOI 10.1128/AEM.01906-07; Mellmann A, 2009, GASTROENTEROLOGY, V136, P1925, DOI 10.1053/j.gastro.2008.12.072; Morabito S, 1998, J CLIN MICROBIOL, V36, P840, DOI 10.1128/JCM.36.3.840-842.1998; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Rothberg J, 2011, NATURE IN PRESS; Schwan WR, 2010, MICROBIOL-SGM, V156, P2124, DOI 10.1099/mic.0.033977-0; Smet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011202; Tarr PI, 2000, INFECT IMMUN, V68, P1400, DOI 10.1128/IAI.68.3.1400-1407.2000; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; WHO, 2011, EHEC OUTBR UPD 13; Wilson K, 1997, CURRENT PROTOCOLS MO, p2 4 1; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Zhang WL, 2007, INT J MED MICROBIOL, V297, P17, DOI 10.1016/j.ijmm.2006.10.004	43	541	567	4	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22751	10.1371/journal.pone.0022751	http://dx.doi.org/10.1371/journal.pone.0022751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799941	Green Published, gold, Green Submitted			2022-12-25	WOS:000292931200065
J	Portiansky, EL; Nishida, F; Barbeito, CG; Gimeno, EJ; Goya, RG				Portiansky, Enrique L.; Nishida, Fabian; Barbeito, Claudio G.; Gimeno, Eduardo J.; Goya, Rodolfo G.			Increased Number of Neurons in the Cervical Spinal Cord of Aged Female Rats	PLOS ONE			English	Article							OLD-AGE; ADULT; NEUROGENESIS; BRAIN; CELLS; PROLIFERATION; ASTROCYTES; EXPRESSION; RESPONSES; PITUITARY	In the brain, specific signaling pathways localized in highly organized regions called niches allow the persistence of a pool of stem and progenitor cells that generate new neurons in adulthood. Much less is known about the spinal cord where a sustained adult neurogenesis is not observed. Moreover, there is scarce information concerning cell proliferation in the adult mammalian spinal cord and virtually none in aging animals or humans. We performed a comparative morphometric and immunofluorescence study of the entire cervical region (C1-C8) in young (5 mo.) and aged (30 mo.) female rats. Serum prolactin (PRL), a neurogenic hormone, was also measured. Gross anatomy showed a significant age-related increase in size of all of the cervical segments. Morphometric analysis of cresyl violet stained segments also showed a significant increase in the area occupied by the gray matter of some cervical segments of aged rats. The most interesting finding was that both the total area occupied by neurons and the number of neurons increased significantly with age, the latter increase ranging from 16% (C6) to 34% (C2). Taking the total number of cervical neurons the age-related increase ranged from 19% (C6) to 51% (C3), C3 being the segment that grew most in length in the aged animals. Some bromodeoxyuridine positive-neuron specific enolase negative (BrdU(+)-NSE-) cells were observed and, occasionally, double positive (BrdU(+)-NSE+) cells were detected in some cervical segments of both young and aged rats groups. As expected, serum PRL increased markedly with age. We propose that in the cervical spinal cord of female rats, both maturation of pre-existing neuroblasts and/or possible neurogenesis occur during the entire life span, in a process in which PRL may play a role.	[Portiansky, Enrique L.; Nishida, Fabian; Barbeito, Claudio G.; Gimeno, Eduardo J.] Natl Univ La Plata, Sch Vet Sci, Lab Anal Imagenes, La Plata, Buenos Aires, Argentina; [Goya, Rodolfo G.] Natl Univ La Plata, Sch Med, INIBIOLP Histol B, La Plata, Buenos Aires, Argentina	National University of La Plata; National University of La Plata	Portiansky, EL (corresponding author), Natl Univ La Plata, Sch Vet Sci, Lab Anal Imagenes, La Plata, Buenos Aires, Argentina.	elporti@fcv.unlp.edu.ar	Barbeito, Claudio/AAM-5227-2020	Barbeito, Claudio/0000-0001-9459-138X; Nishida, Fabian/0000-0002-5295-5605	National Agency for the Promotion of Science and Technology (ANPCyT) [PICT 2006-583]; CONICET	National Agency for the Promotion of Science and Technology (ANPCyT)(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was financed by grant # PICT 2006-583 from the National Agency for the Promotion of Science and Technology (ANPCyT) to ELP. FN holds a fellowship from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fontana PA, 2009, J CHEM NEUROANAT, V37, P98, DOI 10.1016/j.jchemneu.2008.11.001; Bauer S, 2005, NEUROSCIENCE, V130, P75, DOI 10.1016/j.neuroscience.2004.08.047; BRODAL A, 1969, NEUROLOGICAL ANATOMY; Burek J.D., 1978, PATHOLOGY AGING RATS; Carptenter MB, 1990, HUMAN NEUROANATOMY, P210; DAS GD, 1977, EXPERIENTIA, V33, P1179, DOI 10.1007/BF01922313; DAVIS RK, 1956, CANCER RES, V16, P194; Engesser-Cesar C, 2007, NEUROSCIENCE, V144, P1033, DOI 10.1016/j.neuroscience.2006.10.016; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; GOYA RG, 1990, MECH AGEING DEV, V56, P77, DOI 10.1016/0047-6374(90)90116-W; Grant G., 2004, RAT NERVOUS SYSTEM, P121; HASHIZUME K, 1995, NEUROSCI RES, V22, P189, DOI 10.1016/0168-0102(95)00889-3; Horner P, 2002, ARCH NEUROL-CHICAGO, V59, P1717, DOI 10.1001/archneur.59.11.1717; Horner PJ, 2000, J NEUROSCI, V20, P2218; HUANG HH, 1978, ENDOCRINOLOGY, V103, P1855, DOI 10.1210/endo-103-5-1855; Hugnot JP, 2011, FRONT BIOSCI-LANDMRK, V16, P1044, DOI 10.2741/3734; Kane CJM, 1997, BRAIN RES, V759, P163, DOI 10.1016/S0006-8993(97)00359-4; KIM U, 1960, J NATL CANCER I, V24, P1031; Krityakiarana W, 2010, INT J NEUROSCI, V120, P280, DOI 10.3109/00207450903222741; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lang B, 2004, NEUROSCIENCE, V128, P775, DOI 10.1016/j.neuroscience.2004.06.033; Larsen CM, 2010, ENDOCRINOLOGY, V151, P3805, DOI 10.1210/en.2009-1385; Portiansky EL, 2006, ACTA NEUROPATHOL, V112, P647, DOI 10.1007/s00401-006-0139-8; Lozza FA, 2009, NEUROPATHOLOGY, V29, P258, DOI 10.1111/j.1440-1789.2008.00974.x; LU JKH, 1980, BIOL REPROD, V23, P345, DOI 10.1095/biolreprod23.2.345; LU KH, 1979, BIOL REPROD, V21, P193, DOI 10.1095/biolreprod21.1.193; Marichal N, 2009, J NEUROSCI, V29, P10010, DOI 10.1523/JNEUROSCI.6183-08.2009; MCKENNA KE, 1986, J COMP NEUROL, V248, P532, DOI 10.1002/cne.902480406; MILLER MW, 1990, J COMP NEUROL, V293, P92, DOI 10.1002/cne.902930108; Peinado MA, 1997, ANAT REC, V247, P420; Portiansky EL, 2006, EXP NEUROL, V202, P519, DOI 10.1016/j.expneurol.2006.07.014; Radmilovich M, 2003, J EXP BIOL, V206, P3085, DOI 10.1242/jeb.00515; de Amorim MAR, 2010, EXP GERONTOL, V45, P457, DOI 10.1016/j.exger.2010.03.015; Russ J. C., 2006, IMAGE PROCESSING HDB; Sanchez HL, 2003, J COMP NEUROL, V458, P319, DOI 10.1002/cne.10564; Sarkisian MR, 2001, CEREB CORTEX, V11, P734, DOI 10.1093/cercor/11.8.734; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647	40	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22537	10.1371/journal.pone.0022537	http://dx.doi.org/10.1371/journal.pone.0022537			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799890	Green Published, Green Submitted, gold			2022-12-25	WOS:000292931200060
J	Boudinot, P; van der Aa, LM; Jouneau, L; Du Pasquier, L; Pontarotti, P; Briolat, V; Benmansour, A; Levraud, JP				Boudinot, Pierre; van der Aa, Lieke M.; Jouneau, Luc; Du Pasquier, Louis; Pontarotti, Pierre; Briolat, Valerie; Benmansour, Abdenour; Levraud, Jean-Pierre			Origin and Evolution of TRIM Proteins: New Insights from the Complete TRIM Repertoire of Zebrafish and Pufferfish	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MHC CLASS-I; E3 UBIQUITIN-LIGASE; RETROVIRAL RESTRICTION; POSITIVE SELECTION; MOLECULAR-CLONING; GENOMIC ANALYSIS; STRUCTURAL BASIS; FAMILY PROTEINS; MESSENGER-RNA	Tripartite motif proteins (TRIM) constitute a large family of proteins containing a RING-Bbox-Coiled Coil motif followed by different C-terminal domains. Involved in ubiquitination, TRIM proteins participate in many cellular processes including antiviral immunity. The TRIM family is ancient and has been greatly diversified in vertebrates and especially in fish. We analyzed the complete sets of trim genes of the large zebrafish genome and of the compact pufferfish genome. Both contain three large multigene subsets - adding the hsl5/trim35-like genes (hltr) to the ftr and the btr that we previously described - all containing a B30.2 domain that evolved under positive selection. These subsets are conserved among teleosts. By contrast, most human trim genes of the other classes have only one or two orthologues in fish. Loss or gain of C-terminal exons generated proteins with different domain organizations; either by the deletion of the ancestral domain or, remarkably, by the acquisition of a new C-terminal domain. Our survey of fish trim genes in fish identifies subsets with different evolutionary dynamics. trims encoding RBCC-B30.2 proteins show the same evolutionary trends in fish and tetrapods: they evolve fast, often under positive selection, and they duplicate to create multigenic families. We could identify new combinations of domains, which epitomize how new trim classes appear by domain insertion or exon shuffling. Notably, we found that a cyclophilin-A domain replaces the B30.2 domain of a zebrafish fintrim gene, as reported in the macaque and owl monkey antiretroviral TRIM5 alpha. Finally, trim genes encoding RBCC-B30.2 proteins are preferentially located in the vicinity of MHC or MHC gene paralogues, which suggests that such trim genes may have been part of the ancestral MHC.	[Boudinot, Pierre; van der Aa, Lieke M.; Jouneau, Luc; Benmansour, Abdenour] INRA, Virol & Immunol Mol, Jouy En Josas, France; [van der Aa, Lieke M.] Wageningen Univ, Cell Biol & Immunol Grp, Wageningen, Netherlands; [Du Pasquier, Louis] Univ Basel, Inst Zool & Evolutionary Biol, Basel, Switzerland; [Pontarotti, Pierre] Univ Aix Marseille 1, CNRS, Ctr St Charles, Equipe Evolut Biol & Modelisat,UMR 6632, Marseille, France; [Briolat, Valerie; Levraud, Jean-Pierre] Inst Pasteur, Unite Macrophages & Dev Immun, Paris, France; [Briolat, Valerie; Levraud, Jean-Pierre] CNRS, URA 2578, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Wageningen University & Research; University of Basel; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Boudinot, P (corresponding author), INRA, Virol & Immunol Mol, Jouy En Josas, France.	pierre.boudinot@jouy.inra.fr; jlevraud@pasteur.fr	Jouneau, Luc/AAC-4711-2020; , pontarotti/ABB-1753-2021; boudinot, pierre/L-4246-2016	Pierre, Pontarotti/0000-0001-7202-3648; boudinot, pierre/0000-0002-7490-9677	Institut National de la Recherche Agronomique (INRA); Wageningen University (WUR); Agence Nationale de la Recherche [ANR-07-MIME-029-01]	Institut National de la Recherche Agronomique (INRA); Wageningen University (WUR); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work has been funded by the Institut National de la Recherche Agronomique (INRA) and by the Wageningen University (WUR), and by a grant from Agence Nationale de la Recherche (ANR-07-MIME-029-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2004, J MOL EVOL, V59, P177, DOI 10.1007/s00239-004-2612-0; Baranova A, 2003, GENE, V321, P103, DOI 10.1016/j.gene.2003.08.007; Bielawski Joseph P., 2003, Journal of Structural and Functional Genomics, V3, P201, DOI 10.1023/A:1022642807731; Brennan G, 2008, P NATL ACAD SCI USA, V105, P3569, DOI 10.1073/pnas.0709511105; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Chang RY, 2002, GENE, V291, P241, DOI 10.1016/S0378-1119(02)00603-0; Crollius HR, 2006, GENOME DYN, V2, P154, DOI 10.1159/000095102; Danchin E, 2004, IMMUNOL REV, V198, P216, DOI 10.1111/j.0105-2896.2004.00132.x; Darbo E, 2008, IMMUNOGENETICS, V60, P423, DOI 10.1007/s00251-008-0301-7; Diaz-Griffero F, 2007, VIROLOGY, V369, P400, DOI 10.1016/j.virol.2007.08.032; Diaz-Griffero F, 2009, J VIROL, V83, P10737, DOI 10.1128/JVI.01307-09; Dijkstra JM, 2007, IMMUNOGENETICS, V59, P305, DOI 10.1007/s00251-007-0198-6; Du Pasquier L, 2004, IMMUNOL REV, V198, P233, DOI 10.1111/j.0105-2896.2004.00122.x; Du Pasquier Louis, 2009, Journal of Biology (London), V8, P50, DOI 10.1186/jbiol150; Du Pasquier L, 2009, FRONT BIOSCI-LANDMRK, V14, P177, DOI 10.2741/3239; Flajnik MF, 2001, IMMUNITY, V15, P351, DOI 10.1016/S1074-7613(01)00198-4; FURNES C, 2010, FISH SHELLFISH IMMUN; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Georgescu SP, 2005, MOL ENDOCRINOL, V19, P2491, DOI 10.1210/me.2004-0311; Henry J, 1998, MOL BIOL EVOL, V15, P1696, DOI 10.1093/oxfordjournals.molbev.a025896; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Higgs R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011776; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Javanbakht H, 2005, J BIOL CHEM, V280, P26933, DOI 10.1074/jbc.M502145200; Kasahara M, 2004, TRENDS IMMUNOL, V25, P105, DOI 10.1016/j.it.2003.11.005; Kasahara M, 1996, P NATL ACAD SCI USA, V93, P9096, DOI 10.1073/pnas.93.17.9096; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Lassot I, 2010, CELL DEATH DIFFER, V17, P1928, DOI 10.1038/cdd.2010.73; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Lutfalla G, 2006, METHOD ENZYMOL, V410, P386, DOI 10.1016/S0076-6879(06)10019-1; Mallery DL, 2010, P NATL ACAD SCI USA, V107, P19985, DOI 10.1073/pnas.1014074107; Matsuo MY, 2002, IMMUNOGENETICS, V53, P930, DOI 10.1007/s00251-001-0427-3; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Mehta RB, 2009, IMMUNOGENETICS, V61, P385, DOI 10.1007/s00251-009-0371-1; Meyer M, 2003, TISSUE ANTIGENS, V61, P63, DOI 10.1034/j.1399-0039.2003.610105.x; Muffato M, 2010, BIOINFORMATICS, V26, P1119, DOI 10.1093/bioinformatics/btq079; Newman RM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000003; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Nisole S, 2004, P NATL ACAD SCI USA, V101, P13324, DOI 10.1073/pnas.0404640101; O'Farrell C, 2002, J VIROL, V76, P8040, DOI 10.1128/JVI.76.16.8040-8049.2002; Ohkura S, 2006, J VIROL, V80, P8554, DOI 10.1128/JVI.00688-06; Ohta Y, 2006, J IMMUNOL, V176, P3674, DOI 10.4049/jimmunol.176.6.3674; ORIMO A, 1995, J BIOL CHEM, V270, P24406, DOI 10.1074/jbc.270.41.24406; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Perry J, 1999, GENOMICS, V62, P385, DOI 10.1006/geno.1999.6043; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Rajsbaum R, 2008, EUR J IMMUNOL, V38, P619, DOI 10.1002/eji.200737916; REDDY BA, 1992, TRENDS BIOCHEM SCI, V17, P344, DOI 10.1016/0968-0004(92)90308-V; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; Rold CJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000074; Ruby T, 2005, IMMUNOGENETICS, V57, P116, DOI 10.1007/s00251-005-0770-x; Sakuma R, 2007, NAT MED, V13, P631, DOI 10.1038/nm1562; Sambrook JG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-152; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Sawyer SL, 2007, PLOS PATHOG, V3, P1918, DOI 10.1371/journal.ppat.0030197; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Scheffler K, 2006, BIOINFORMATICS, V22, P2493, DOI 10.1093/bioinformatics/btl427; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; Simons C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-470; Sonnhammer ELL, 2002, TRENDS GENET, V18, P619, DOI 10.1016/S0168-9525(02)02793-2; Spencer JA, 2000, J CELL BIOL, V150, P771, DOI 10.1083/jcb.150.4.771; Stafford JL, 2006, IMMUNOGENETICS, V58, P758, DOI 10.1007/s00251-006-0134-1; Stein C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r251; Steinke D, 2006, J MOL EVOL, V62, P772, DOI 10.1007/s00239-005-0170-8; Stremlau M, 2005, J VIROL, V79, P3139, DOI 10.1128/JVI.79.5.3139-3145.2005; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tuoc TC, 2008, GENE DEV, V22, P1972, DOI 10.1101/gad.471708; van der Aa LM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-7; Viertlboeck BC, 2005, J IMMUNOL, V175, P385, DOI 10.4049/jimmunol.175.1.385; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Virgen CA, 2008, P NATL ACAD SCI USA, V105, P3563, DOI 10.1073/pnas.0709258105; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Wilson SJ, 2008, P NATL ACAD SCI USA, V105, P3557, DOI 10.1073/pnas.0709003105; Woo JS, 2006, MOL CELL, V24, P967, DOI 10.1016/j.molcel.2006.11.009; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yan KP, 2004, GENE, V334, P3, DOI 10.1016/j.gene.2004.02.056; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yergeau DA, 2005, DEV BIOL, V283, P97, DOI 10.1016/j.ydbio.2005.04.006; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Zha FK, 2006, J IMMUNOL, V176, P1072, DOI 10.4049/jimmunol.176.2.1072	85	80	83	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22022	10.1371/journal.pone.0022022	http://dx.doi.org/10.1371/journal.pone.0022022			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789205	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811700014
J	Kapina, MA; Shepelkova, GS; Avdeenko, VG; Guseva, AN; Kondratieva, TK; Evstifeev, VV; Apt, AS				Kapina, Marina A.; Shepelkova, Galina S.; Avdeenko, Vadim G.; Guseva, Anna N.; Kondratieva, Tatiana K.; Evstifeev, Vladimir V.; Apt, Alexander S.			Interleukin-11 Drives Early Lung Inflammation during Mycobacterium tuberculosis Infection in Genetically Susceptible Mice	PLOS ONE			English	Article							DOWN-REGULATION; NITRIC-OXIDE; RESPONSES; THERAPY; BINDING; MODEL; GP130	IL-11 is multifunctional cytokine whose physiological role in the lungs during pulmonary tuberculosis (TB) is poorly understood. Here, using in vivo administration of specific antibodies against IL-11, we demonstrate for the first time that blocking IL-11 diminishes histopathology and neutrophilic infiltration of the lung tissue in TB-infected genetically susceptible mice. Antibody treatment decreased the pulmonary levels of IL-11 and other key inflammatory cytokines not belonging to the Th1 axis, and down-regulated IL-11 mRNA expression. This suggests the existence of a positive feedback loop at the transcriptional level, which is further supported by up-regulation of IL-11 mRNA expression in the presence of rIL-11 in in vitro cultures of lung cells. These findings imply a pathogenic role for IL-11 during the early phase of Mycobacterium tuberculosis-triggered disease in a genetically susceptible host.	[Kapina, Marina A.; Shepelkova, Galina S.; Avdeenko, Vadim G.; Guseva, Anna N.; Kondratieva, Tatiana K.; Evstifeev, Vladimir V.; Apt, Alexander S.] Cent Inst TB, Dept Immunol, Moscow, Russia		Kapina, MA (corresponding author), Cent Inst TB, Dept Immunol, Moscow, Russia.	asapt@aha.ru	Shepelkova, Galina/F-3059-2017	Shepelkova, Galina/0000-0001-6854-7932; Apt, Alexander/0000-0002-3683-3085	NIH [AI078864]; Russian Foundation for Basic Research [09-04-91321, 10-04-00053]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078864] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was financially supported by the NIH R01 grant AI078864 (to ASA), and the Russian Foundation for Basic Research grants 09-04-91321 (to GSS) and 10-04-00053 (to TKK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartz H, 2002, CLIN EXP IMMUNOL, V129, P438, DOI 10.1046/j.1365-2249.2002.01927.x; Beisiegel M, 2009, J INFECT DIS, V199, P1222, DOI 10.1086/597421; Bosani M, 2009, BIOL-TARGETS THER, V3, P77; Bozza M, 2001, J INTERF CYTOK RES, V21, P21, DOI 10.1089/107999001459123; Du XX, 1997, BLOOD, V89, P3897, DOI 10.1182/blood.V89.11.3897; Einarsson O, 1996, J CLIN INVEST, V97, P915, DOI 10.1172/JCI118514; ELIAS JA, 1994, J IMMUNOL, V152, P2421; Eruslanov EB, 2005, INFECT IMMUN, V73, P1744, DOI 10.1128/IAI.73.3.1744-1753.2005; Eruslanov EB, 2004, CLIN EXP IMMUNOL, V135, P19, DOI 10.1111/j.1365-2249.2004.02328.x; Feinglass S, 2001, ARTHRITIS RHEUM, V44, P170, DOI 10.1002/1529-0131(200101)44:1<170::AID-ANR22>3.0.CO;2-T; Glatman-Freedman A, 1998, CLIN MICROBIOL REV, V11, P514, DOI 10.1128/CMR.11.3.514; Herllinger KR, 2006, AM J GASTROENTEROL, V101, P793, DOI 10.1111/j.1572-0241.2005.00356.x; Keller C, 2006, INFECT IMMUN, V74, P4295, DOI 10.1128/IAI.00057-06; Kondratieva E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010515; Kuhn C, 2000, AM J RESP CELL MOL, V22, P289, DOI 10.1165/ajrcmb.22.3.3690; Lee CG, 2008, AM J RESP CELL MOL, V39, P739, DOI 10.1165/rcmb.2008-0053OC; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyadova IV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010469; NICKONENKO BV, 1985, PROGR LEUKOCYTE BIOL, V3, P291; Nikonenko BV, 2000, TUBERCLE LUNG DIS, V80, P15, DOI 10.1054/tuld.1999.0225; Orlova MO, 2006, INFECT IMMUN, V74, P3668, DOI 10.1128/IAI.00196-06; Peterson RL, 1998, LAB INVEST, V78, P1503; PFEIFFER NE, 1987, J IMMUNOL METHODS, V97, P1, DOI 10.1016/0022-1759(87)90098-6; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Sims NA, 2010, BMB REP, V43, P513, DOI 10.5483/BMBRep.2010.43.8.513; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Torroella-Kouri M, 2003, INT J ONCOL, V22, P439; Trepicchio WL, 1999, J CLIN INVEST, V104, P1527, DOI 10.1172/JCI6910; Trepicchio WL, 1996, J IMMUNOL, V157, P3627; Ulrichs T, 2005, J INFECT DIS, V192, P89, DOI 10.1086/430621; Wang JM, 2000, J IMMUNOL, V165, P2222, DOI 10.4049/jimmunol.165.4.2222; Wong PKK, 2005, CYTOKINE, V29, P72, DOI 10.1016/j.cyto.2004.09.011; ZHENG T, 1994, J IMMUNOL, V153, P4742	34	18	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e21878	10.1371/journal.pone.0021878	http://dx.doi.org/10.1371/journal.pone.0021878			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789190	Green Submitted, Green Published, gold			2022-12-25	WOS:000292811700008
J	Reuter, T; Renner, B				Reuter, Tabea; Renner, Britta			Who Takes Precautionary Action in the Face of the New H1N1 Influenza? Prediction of Who Collects a Free Hand Sanitizer Using a Health Behavior Model	PLOS ONE			English	Article							RISK PERCEPTIONS; SWINE FLU; WORRY; CONSEQUENCES; DETERMINANTS; COGNITION; METAANALYSIS; INFORMATION; RESPONSES; ANXIETY	Background: In order to fight the spread of the novel H1N1 influenza, health authorities worldwide called for a change in hygiene behavior. Within a longitudinal study, we examined who collected a free bottle of hand sanitizer towards the end of the first swine flu pandemic wave in December 2009. Methods: 629 participants took part in a longitudinal study assessing perceived likelihood and severity of an H1N1 infection, and H1N1 influenza related negative affect (i.e., feelings of threat, concern, and worry) at T1 (October 2009, week 43-44) and T2 (December 2009, week 51-52). Importantly, all participants received a voucher for a bottle of hand sanitizer at T2 which could be redeemed in a university office newly established for this occasion at T3 (ranging between 1-4 days after T2). Results: Both a sequential longitudinal model (M2) as well as a change score model (M3) showed that greater perceived likelihood and severity at T1 (M2) or changes in perceived likelihood and severity between T1 and T2 (M3) did not directly drive protective behavior (T3), but showed a significant indirect impact on behavior through H1N1 influenza related negative affect. Specifically, increases in perceived likelihood (beta = .12), severity (beta = .24) and their interaction (beta = .13) were associated with a more pronounced change in negative affect (M3). The more threatened, concerned and worried people felt (T2), the more likely they were to redeem the voucher at T3 (OR = 1.20). Conclusions: Affective components need to be considered in health behavior models. Perceived likelihood and severity of an influenza infection represent necessary but not sufficient self-referential knowledge for paving the way for preventive behaviors.	[Reuter, Tabea; Renner, Britta] Univ Konstanz, Dept Psychol, Constance, Baden Wurttembe, Germany	University of Konstanz	Reuter, T (corresponding author), Univ Konstanz, Dept Psychol, Constance, Baden Wurttembe, Germany.	tabea.reuter@uni-konstanz.de	Renner, Britta/AAW-1895-2020	Renner, Britta/0000-0001-8385-2839	German Research Foundation [RE 1583/3-1]	German Research Foundation(German Research Foundation (DFG))	This research was supported by the German Research Foundation (RE 1583/3-1; http://www.dfg.de/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L.S., 1991, MULTIPLE REGRESSION; [Anonymous], 2009, PAND H1N1 2009 UPD 7; Arbuckle J. L., 1996, ADV STRUCTURAL EQUAT, V243, P243, DOI DOI 10.4324/9781315827414; Armitage CJ, 2000, PSYCHOL HEALTH, V15, P173, DOI 10.1080/08870440008400299; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7; Brown SL, 2005, BRIT J PSYCHOL, V96, P155, DOI 10.1348/000712605X36703; Cameron LD, 2001, J HEALTH PSYCHOL, V6, P47, DOI 10.1177/135910530100600104; Cameron LD, 2009, HEALTH PSYCHOL, V28, P307, DOI 10.1037/a0013947; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Consedine NS, 2004, CANCER EPIDEM BIOMAR, V13, P501; CROYLE RT, 1988, J APPL SOC PSYCHOL, V18, P473, DOI 10.1111/j.1559-1816.1988.tb00030.x; Ditto PH, 2006, J BEHAV DECIS MAKING, V19, P99, DOI 10.1002/bdm.520; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Hall S, 2009, HEALTH PSYCHOL, V28, P258, DOI 10.1037/a0013425; Harris PR, 2008, J PERS SOC PSYCHOL, V95, P1225, DOI 10.1037/a0013315; Hay JL, 2006, PREV MED, V42, P401, DOI 10.1016/j.ypmed.2006.03.002; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Ibuka Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-296; Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032; Klein WMP, 2009, ANN BEHAV MED, V38, P256, DOI 10.1007/s12160-009-9143-2; Lawton R, 2007, HEALTH PSYCHOL, V26, P259, DOI 10.1037/0278-6133.26.3.259; Liao QY, 2011, INT J BEHAV MED, V18, P93, DOI 10.1007/s12529-010-9123-8; Liao QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013350; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Mathieu JE, 2006, J ORGAN BEHAV, V27, P1031, DOI 10.1002/job.406; McCaul KD, 1996, BASIC APPL SOC PSYCH, V18, P183, DOI 10.1207/s15324834basp1802_5; Peters E, 1996, J APPL SOC PSYCHOL, V26, P1427, DOI 10.1111/j.1559-1816.1996.tb00079.x; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Renner B, 2003, BLACKW SER HLTH PSYC, P169; Renner B., 2011, OXFORD HDB HLTH PSYC, P639; RENNER B, 2011, HLTH PSYCHO IN PRESS; Renner B, 2008, RISK ANAL, V28, P741, DOI 10.1111/j.1539-6924.2008.01047.x; Rubin G., 2009, BMJ-BRIT MED J, V339, P2651, DOI DOI 10.1136/BMJ.B2651; Rubin GJ, 2010, HEALTH TECHNOL ASSES, V14, P183, DOI 10.3310/hta14340-03; SCHMALZLE R, 2011, FRONTIERS H IN PRESS, V5; Seale H, 2009, MED J AUSTRALIA, V191, P267, DOI 10.5694/j.1326-5377.2009.tb02781.x; Slovic P, 2000, PERCEPTION RISK; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Van D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-130; Van Gelder JL, 2009, J BEHAV DECIS MAKING, V22, P45, DOI 10.1002/bdm.610; Weinstein ND, 2003, BLACKW SER HLTH PSYC, P22; Weinstein ND, 1998, PSYCHOL HEALTH, V13, P479, DOI 10.1080/08870449808407305; Weinstein ND., 1983, HEAL PSYCHOL, V2, P11, DOI [10.1037/0278-6133.2.1.11, DOI 10.1037/0278-6133.2.1.11]; Weinstein ND, 2007, HEALTH PSYCHOL, V26, P146, DOI 10.1037/0278-6133.26.2.146; *WHO, 2010, WHAT CAN I DO PROT M; Wichmann O, 2010, EURO SURVEILL, V15; WILKING H, 2010, EURO SURVEILL, V15	51	19	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22130	10.1371/journal.pone.0022130	http://dx.doi.org/10.1371/journal.pone.0022130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	793HT	21789224	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811700027
J	George, D; Blieck, A				George, David; Blieck, Alain			Rise of the Earliest Tetrapods: An Early Devonian Origin from Marine Environment	PLOS ONE			English	Article							ATMOSPHERIC OXYGEN; CYTOCHROME-B; FISH; COELACANTH; EVOLUTION; BIODIVERSIFICATION; DIVERSIFICATION; DIVERSITY; TRACKWAYS; LUNGFISH	Tetrapod fossil tracks are known from the Middle Devonian (Eifelian at ca. 397 million years ago - MYA), and their earliest bony remains from the Upper Devonian (Frasnian at 375-385 MYA). Tetrapods are now generally considered to have colonized land during the Carboniferous (i.e., after 359 MYA), which is considered to be one of the major events in the history of life. Our analysis on tetrapod evolution was performed using molecular data consisting of 13 proteins from 17 species and different paleontological data. The analysis on the molecular data was performed with the program TreeSAAP and the results were analyzed to see if they had implications on the paleontological data collected. The results have shown that tetrapods evolved from marine environments during times of higher oxygen levels. The change in environmental conditions played a major role in their evolution. According to our analysis this evolution occurred at about 397-416 MYA during the Early Devonian unlike previously thought. This idea is supported by various environmental factors such as sea levels and oxygen rate, and biotic factors such as biodiversity of arthropods and coral reefs. The molecular data also strongly supports lungfish as tetrapod's closest living relative.	[George, David] St Peters Engn Coll, Dept Biotechnol, Madras, Tamil Nadu, India; [Blieck, Alain] Univ Lille 1, FRE 3298, CNRS Geosyst, F-59655 Villeneuve Dascq, France	St. Peter's Institute of Higher Education & Research; Universite de Lille - ISITE; Universite de Lille	George, D (corresponding author), St Peters Engn Coll, Dept Biotechnol, Madras, Tamil Nadu, India.	davetigerland@yahoo.com						Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; [Anonymous], 2004, ACTA U LATVIENSIS; Bambach Richard K., 2002, Paleontological Society Papers, V8, P319; Bambach RK, 1999, GEOBIOS-LYON, V32, P131, DOI 10.1016/S0016-6995(99)80025-4; Beckstead WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005836; Berner RA, 2009, AM J SCI, V309, P603, DOI 10.2475/07.2009.03; Blieck A, 2010, GEOL SOC SPEC PUBL, V339, P129, DOI 10.1144/SP339.11; Blieck A, 2007, GEOL SOC SPEC PUBL, V278, P219, DOI 10.1144/SP278.10; Blieck A, 2011, GEOL BELG, V14, P203; Brinkmann H, 2004, P NATL ACAD SCI USA, V101, P4900, DOI 10.1073/pnas.0400609101; Butterfield NJ, 2011, P NATL ACAD SCI USA, V108, pE28, DOI 10.1073/pnas.1018072108; Butterfield NJ, 2009, GEOBIOLOGY, V7, P1, DOI 10.1111/j.1472-4669.2009.00188.x; Clack JA, 2006, PALAEOGEOGR PALAEOCL, V232, P167, DOI 10.1016/j.palaeo.2005.07.019; Clack JA, 1997, PALAEOGEOGR PALAEOCL, V130, P227, DOI 10.1016/S0031-0182(96)00142-3; Clack JA., 2012, GAINING GROUND ORIGI; Clack JA, 2007, INTEGR COMP BIOL, V47, P510, DOI 10.1093/icb/icm055; Copper P, 2002, PALAEOGEOGR PALAEOCL, V181, P27, DOI 10.1016/S0031-0182(01)00472-2; COPPER P, 1994, CORAL REEFS, V13, P3, DOI 10.1007/BF00426428; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Dahl TW, 2010, P NATL ACAD SCI USA, V107, P17911, DOI 10.1073/pnas.1011287107; Flugel E., 2002, PHANEROZOIC REEF PAT, V72, P691; Gensel PG, 2008, ANNU REV ECOL EVOL S, V39, P459, DOI 10.1146/annurev.ecolsys.39.110707.173526; Haq BU, 2008, SCIENCE, V322, P64, DOI 10.1126/science.1161648; HEDGES SB, 1993, NATURE, V363, P501, DOI 10.1038/363501b0; Joachimski MM, 2009, EARTH PLANET SC LETT, V284, P599, DOI 10.1016/j.epsl.2009.05.028; Kiessling W, 1999, AAPG BULL, V83, P1552; Klug C, 2010, LETHAIA, V43, P465, DOI 10.1111/j.1502-3931.2009.00206.x; Laurin M, 2007, J PALEONTOL, V81, P143, DOI 10.1666/0022-3360(2007)81[143:AMAHSO]2.0.CO;2; Long JA, 2006, NATURE, V444, P199, DOI 10.1038/nature05243; Lucifora LO, 2002, BIOL J LINN SOC, V77, P35, DOI 10.1046/j.1095-8312.2002.00085.x; McClellan DA, 2005, MOL BIOL EVOL, V22, P437, DOI 10.1093/molbev/msi028; McGowan AJ, 2008, PALEOBIOLOGY, V34, P80, DOI 10.1666/07019.1; MEYER A, 1992, J MOL EVOL, V35, P102; Niedzwiedzki G, 2010, NATURE, V463, P43, DOI 10.1038/nature08623; Novack-Gottshall PM, 2008, PALEOBIOLOGY, V34, P210, DOI 10.1666/0094-8373(2008)034[0210:EBTICM]2.0.CO;2; Payne JL, 2009, P NATL ACAD SCI USA, V106, P24, DOI 10.1073/pnas.0806314106; Pridmore Peter A., 1995, Zoology (Jena), V98, P278; ROMER AS, 1958, EVOLUTION, V12, P365, DOI 10.2307/2405858; Schultze H. -P., 1998, INTERTIDAL FISHES LI, P373; Schultze Hans-Peter, 1997, Sitzungsberichte der Gesellschaft Naturforschender Freunde zu Berlin N F, V36, P59; SEPKOSKI JJ, 1981, PALEOBIOLOGY, V7, P36, DOI 10.1017/S0094837300003778; Servais T, 2010, PALAEOGEOGR PALAEOCL, V294, P99, DOI 10.1016/j.palaeo.2010.05.031; Takezaki N, 2004, MOL BIOL EVOL, V21, P1512, DOI 10.1093/molbev/msh150; Ward P, 2006, P NATL ACAD SCI USA, V103, P16818, DOI 10.1073/pnas.0607824103; WARREN A, 1986, ALCHERINGA, V10, P183, DOI 10.1080/03115518608619153; Webby B.D., 2004, GREAT ORDOVICIAN BIO, DOI DOI 10.7312/WEBB12678; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; YOUNG GC, 2006, ALCHERINGA, P409; Zardoya R, 1996, P NATL ACAD SCI USA, V93, P5449, DOI 10.1073/pnas.93.11.5449	50	35	36	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22136	10.1371/journal.pone.0022136	http://dx.doi.org/10.1371/journal.pone.0022136			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779385	Green Submitted, Green Published, gold			2022-12-25	WOS:000292811300041
J	Mutti, NS; Wang, Y; Kaftanoglu, O; Amdam, GV				Mutti, Navdeep S.; Wang, Ying; Kaftanoglu, Osman; Amdam, Gro V.			Honey Bee PTEN - Description, Developmental Knockdown, and Tissue-Specific Expression of Splice-Variants Correlated with Alternative Social Phenotypes	PLOS ONE			English	Article							APIS-MELLIFERA WORKERS; INSULIN-LIKE PEPTIDES; DIVISION-OF-LABOR; TUMOR-SUPPRESSOR; BEHAVIORAL-DEVELOPMENT; SIGNALING PATHWAY; JUVENILE-HORMONE; RNA INTERFERENCE; LIFE-SPAN; DIFFERENTIAL EXPRESSION	Background: Phosphatase and TENsin (PTEN) homolog is a negative regulator that takes part in IIS (insulin/insulin-like signaling) and Egfr (epidermal growth factor receptor) activation in Drosophila melanogaster. IIS and Egfr signaling events are also involved in the developmental process of queen and worker differentiation in honey bees (Apis mellifera). Here, we characterized the bee PTEN gene homologue for the first time and begin to explore its potential function during bee development and adult life. Results: Honey bee PTEN is alternatively spliced, resulting in three splice variants. Next, we show that the expression of PTEN can be down-regulated by RNA interference (RNAi) in the larval stage, when female caste fate is determined. Relative to controls, we observed that RNAi efficacy is dependent on the amount of PTEN dsRNA that is delivered to larvae. For larvae fed queen or worker diets containing a high amount of PTEN dsRNA, PTEN knockdown was significant at a whole-body level but lethal. A lower dosage did not result in a significant gene down-regulation. Finally, we compared same-aged adult workers with different behavior: nursing vs. foraging. We show that between nurses and foragers, PTEN isoforms were differentially expressed within brain, ovary and fat body tissues. All isoforms were expressed at higher levels in the brain and ovaries of the foragers. In fat body, isoform B was expressed at higher level in the nurse bees. Conclusion: Our results suggest that PTEN plays a central role during growth and development in queen- and worker-destined honey bees. In adult workers, moreover, tissue-specific patterns of PTEN isoform expression are correlated with differences in complex division of labor between same-aged individuals. Therefore, we propose that knowledge on the roles of IIS and Egfr activity in developmental and behavioral control may increase through studies of how PTEN functions can impact bee social phenotypes.	[Mutti, Navdeep S.; Wang, Ying; Kaftanoglu, Osman; Amdam, Gro V.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Amdam, Gro V.] Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway	Arizona State University; Arizona State University-Tempe; Norwegian University of Life Sciences	Mutti, NS (corresponding author), DuPont Expt Stn, Wilmington, DE USA.	nsmutti@gmail.com	Wang, Ying/H-1172-2012		NSF [0615502]; Norwegian Research Council [180504, 185306, 191699]; PEW Charitable Trust; National Institute on Aging [NIA P01 AG22500]; Wissenschaftskolleg zu Berlin; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Norwegian Research Council(Research Council of NorwayEuropean Commission); PEW Charitable Trust; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Wissenschaftskolleg zu Berlin(Austrian Science Fund (FWF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the NSF grant #0615502 and Norwegian Research Council grants 180504, 185306, and 191699, and the PEW Charitable Trust to GVA. YW was supported by the National Institute on Aging (NIA P01 AG22500), and the Wissenschaftskolleg zu Berlin grants also supported GVA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addepalli MK, 2010, GENE THER, V17, P352, DOI 10.1038/gt.2009.155; Agrawal S, 2006, HUM MOL GENET, V15, P777, DOI 10.1093/hmg/ddi492; Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Amdam GV, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1003; Amdam GV, 2007, AM NAT, V170, P37, DOI 10.1086/518183; Amdam GV, 2006, BEHAV BRAIN RES, V169, P201, DOI 10.1016/j.bbr.2006.01.006; Amdam GV, 2005, AGEING RES REV, V4, P398, DOI 10.1016/j.arr.2005.03.007; Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; Amdam GV, 2003, J THEOR BIOL, V223, P451, DOI 10.1016/S0022-5193(03)00121-8; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; AMDAM GV, AGING CELL; Ament SA, 2008, P NATL ACAD SCI USA, V105, P4226, DOI 10.1073/pnas.0800630105; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; Beye M, 2002, INSECT MOL BIOL, V11, P527, DOI 10.1046/j.1365-2583.2002.00361.x; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broue F, 2007, AGING CELL, V6, P87, DOI 10.1111/j.1474-9726.2006.00268.x; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cheng CL, 2005, WORLD J GASTROENTERO, V11, P1891; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; CRAILSHEIM K, 1989, J INSECT PHYSIOL, V35, P595, DOI 10.1016/0022-1910(89)90121-2; Crawford D, 2007, AGING CELL, V6, P715, DOI 10.1111/j.1474-9726.2007.00327.x; Dann CT, 2006, P NATL ACAD SCI USA, V103, P11246, DOI 10.1073/pnas.0604657103; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; de Azevedo SV, 2008, J INSECT PHYSIOL, V54, P1064, DOI 10.1016/j.jinsphys.2008.04.009; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Elekonich MM, 2001, J INSECT PHYSIOL, V47, P1119, DOI 10.1016/S0022-1910(01)00090-7; FAHRBACH SE, 1995, NEUROSCI LETT, V197, P145, DOI 10.1016/0304-3940(95)11913-H; Fahrbach SE, 1995, LEARN MEMORY, V2, P199, DOI 10.1101/lm.2.5.199; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; Fukuyama M, 2006, CURR BIOL, V16, P773, DOI 10.1016/j.cub.2006.02.073; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Gericke A, 2006, GENE, V374, P1, DOI 10.1016/j.gene.2006.02.024; Gil EB, 1999, P NATL ACAD SCI USA, V96, P2925, DOI 10.1073/pnas.96.6.2925; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; Guidugli KR, 2005, FEBS LETT, V579, P4961, DOI 10.1016/j.febslet.2005.07.085; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; Huang H, 1999, DEVELOPMENT, V126, P5365; HUANG ZY, 1992, P NATL ACAD SCI USA, V89, P11726, DOI 10.1073/pnas.89.24.11726; Huang ZY, 1998, J COMP PHYSIOL A, V183, P143, DOI 10.1007/s003590050242; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Ismail N, 2006, P NATL ACAD SCI USA, V103, P207, DOI 10.1073/pnas.0508318102; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jee SH, 2005, YONSEI MED J, V46, P449, DOI 10.3349/ymj.2005.46.4.449; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Kobayashi N, 2004, J PHARMACOL EXP THER, V308, P688, DOI 10.1124/jpet.103.059931; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lin HR, 1999, CAN ENTOMOL, V131, P695, DOI 10.4039/Ent131695-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maehama T, 2006, SEIKAGAKU, V78, P133; Antonio DSM, 2008, NATURWISSENSCHAFTEN, V95, P953, DOI 10.1007/s00114-008-0413-9; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Nijhout HF, 1999, P NATL ACAD SCI USA, V96, P5348, DOI 10.1073/pnas.96.10.5348; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Oldham S, 2002, DEVELOPMENT, V129, P4103; Page DT, 2009, P NATL ACAD SCI USA, V106, P1989, DOI 10.1073/pnas.0804428106; Page RE, 2007, BIOESSAYS, V29, P334, DOI 10.1002/bies.20549; Page RE, 2006, CURR TOP DEV BIOL, V74, P253, DOI 10.1016/S0070-2153(06)74008-X; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; Pinto LZ, 2000, J INSECT PHYSIOL, V46, P153, DOI 10.1016/S0022-1910(99)00111-0; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Riehle MA, 2007, INSECT MOL BIOL, V16, P277, DOI 10.1111/j.1365-2583.2007.00724.x; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rual JF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-106; Scheiner R, 2001, BEHAV BRAIN RES, V120, P67, DOI 10.1016/S0166-4328(00)00359-4; Schinner S, 2005, DIABETIC MED, V22, P674, DOI 10.1111/j.1464-5491.2005.01566.x; Schulz DJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P295, DOI 10.1007/s002650050442; Smith A, 1999, BBA-GENE STRUCT EXPR, V1447, P313, DOI 10.1016/S0167-4781(99)00172-4; Soares CAG, 2005, INSECT MOL BIOL, V14, P443, DOI 10.1111/j.1365-2583.2005.00575.x; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Walshe DP, 2009, INSECT MOL BIOL, V18, P11, DOI 10.1111/j.1365-2583.2008.00839.x; Wang Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000896; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wessels D, 2007, J CELL SCI, V120, P2517, DOI 10.1242/jcs.010876; Wheeler DE, 2006, INSECT MOL BIOL, V15, P597, DOI 10.1111/j.1365-2583.2006.00681.x; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103; WINSTON ML, BIOL HONEY BEE; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; WOLSCHIN F, 2010, BIOL LETT; Wolschin F, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-10; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005	94	25	25	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22195	10.1371/journal.pone.0022195	http://dx.doi.org/10.1371/journal.pone.0022195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779392	gold, Green Published, Green Submitted			2022-12-25	WOS:000292811300046
J	Lenz, LS; Marx, J; Chamulitrat, W; Kaiser, I; Grone, HJ; Liebisch, G; Schmitz, G; Elsing, C; Straub, BK; Fullekrug, J; Stremmel, W; Herrmann, T				Lenz, Lena-Solveig; Marx, Jana; Chamulitrat, Walee; Kaiser, Iris; Groene, Hermann-Josef; Liebisch, Gerhard; Schmitz, Gerd; Elsing, Christoph; Straub, Beate K.; Fuellekrug, Joachim; Stremmel, Wolfgang; Herrmann, Thomas			Adipocyte-specific Inactivation of Acyl-CoA Synthetase Fatty Acid Transport Protein 4 (Fatp4) in Mice Causes Adipose Hypertrophy and Alterations in Metabolism of Complex Lipids under High Fat Diet	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; RAT ADIPOCYTES; OBESITY; TISSUE; GENE; DISRUPTION; DISEASE; FAMILY	Fatp4 exhibits acyl-CoA synthetase activity and is thereby able to catalyze the activation of fatty acids for further metabolism. However, its actual function in most tissues remains unresolved, and its role in cellular fatty acid uptake is still controversial. To characterize Fatp4 functions in adipocytes in vivo, we generated a mouse line with adipocyte-specific inactivation of the Fatp4 gene (Fatp4(A-/-)). Under standard conditions mutant mice showed no phenotypical aberrance. Uptake of radiolabeled palmitic and lignoceric acid into adipose tissue of Fatp4(A-/-) mice was unchanged. When exposed to a diet enriched in long chain fatty acids, Fatp4(A-/-) mice gained more body weight compared with control mice, although they were not consuming more food. Pronounced obesity was accompanied by a thicker layer of subcutaneous fat and greater adipocyte circumference, although expression of genes involved in de novo lipogenesis was not changed. However, the increase in total fat mass was contrasted by a significant decrease in various phospholipids, sphingomyelin, and cholesteryl esters in adipocytes. Livers of Fatp4-deficient animals under a high fat diet exhibited a higher degree of fatty degeneration. Nonetheless, no evidence for changes in insulin sensitivity and adipose inflammation was found. In summary, the results of this study confirm that Fatp4 is not crucial for fatty acid uptake into adipocytes. Instead, under the condition of a diet enriched in long chain fatty acids, adipocyte-specific Fatp4 deficiency results in adipose hypertrophy and profound alterations in the metabolism of complex lipids.	[Lenz, Lena-Solveig; Marx, Jana; Chamulitrat, Walee; Kaiser, Iris; Fuellekrug, Joachim; Stremmel, Wolfgang; Herrmann, Thomas] Univ Heidelberg, Dept Internal Med 4, D-69120 Heidelberg, Germany; [Groene, Hermann-Josef] German Canc Res Ctr, Dept Cellular & Mol Pathol, D-69120 Heidelberg, Germany; [Liebisch, Gerhard; Schmitz, Gerd] Univ Regensburg, Inst Clin Chem, D-93042 Regensburg, Germany; [Elsing, Christoph] St Elizabeth Hosp, Dept Internal Med, D-46225 Dorsten, Germany; [Straub, Beate K.] Inst Pathol, Dept Gen Pathol, D-69120 Heidelberg, Germany; [Herrmann, Thomas] Klinikum Idar Oberstein, Dept Internal Med 1, D-55743 Idar Oberstein, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Regensburg	Herrmann, T (corresponding author), Univ Heidelberg, Dept Internal Med 4, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.	dr._thomas_herrmann@email.de	Füllekrug, Joachim/A-6581-2008; Liebisch, Gerhard/G-6130-2010	Liebisch, Gerhard/0000-0003-4886-0811; Stremmel, Wolfgang/0000-0002-8545-1753; Schmitz, Gerd/0000-0002-1325-1007; Straub, Beate/0000-0002-4857-1561	Deutsche Forschungsgemeinschaft [HE 5521/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant HE 5521/1-1 (to T. H.).	Caro JF, 1996, LANCET, V348, P159, DOI 10.1016/S0140-6736(96)03173-X; Cernkovich ER, 2008, ENDOCRINOLOGY, V149, P1581, DOI 10.1210/en.2007-1148; Chen HC, 2002, DIABETES, V51, P3189, DOI 10.2337/diabetes.51.11.3189; Ehehalt R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-45; Fernandis AZ, 2007, CURR OPIN LIPIDOL, V18, P121, DOI 10.1097/MOL.0b013e328082e4d5; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Gimeno RE, 2003, J BIOL CHEM, V278, P16039, DOI 10.1074/jbc.M211412200; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Havel PJ, 2004, DIABETES, V53, pS143, DOI 10.2337/diabetes.53.2007.S143; Herrmann T, 2005, J INVEST DERMATOL, V125, P1228, DOI 10.1111/j.0022-202X.2005.23972.x; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; Herrmann T, 2001, GENE, V270, P31, DOI 10.1016/S0378-1119(01)00489-9; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Jia ZZ, 2007, J MOL NEUROSCI, V33, P25, DOI 10.1007/s12031-007-0038-z; Jia ZZ, 2007, J BIOL CHEM, V282, P20573, DOI 10.1074/jbc.M700568200; Kage-Nakadai E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008857; Klar J, 2009, AM J HUM GENET, V85, P248, DOI 10.1016/j.ajhg.2009.06.021; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; Kunos G, 2008, J BIOL CHEM, V283, P33021, DOI 10.1074/jbc.R800012200; Lobo S, 2007, J LIPID RES, V48, P609, DOI 10.1194/jlr.M600441-JLR200; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Muller G, 2010, BRIT J PHARMACOL, V160, P878, DOI 10.1111/j.1476-5381.2010.00724.x; Mueller Guenter, 2010, Archives of Physiology and Biochemistry, V116, P28, DOI 10.3109/13813450903508812; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; Shim J, 2009, J LIPID RES, V50, P491, DOI 10.1194/jlr.M800400-JLR200; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang X, 2007, DIABETOLOGIA, V50, P1127, DOI 10.1007/s00125-007-0640-1	31	36	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2011	286	41					35578	35587		10.1074/jbc.M111.226530	http://dx.doi.org/10.1074/jbc.M111.226530			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	834AG	21808061	Green Published, hybrid			2022-12-25	WOS:000295927100030
J	Morrison, C; Mancini, S; Cipollone, J; Kappelhoff, R; Roskelley, C; Overall, C				Morrison, Charlotte; Mancini, Stephanie; Cipollone, Jane; Kappelhoff, Reinhild; Roskelley, Calvin; Overall, Christopher			Microarray and Proteomic Analysis of Breast Cancer Cell and Osteoblast Co-cultures ROLE OF OSTEOBLAST MATRIX METALLOPROTEINASE (MMP)-13 IN BONE METASTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; C-TERMINAL DOMAIN; GELATINASE-A; COLLAGENASE-3 MMP-13; TUMOR MICROENVIRONMENT; 72-KDA GELATINASE; HUMAN FIBROBLASTS; TISSUE INHIBITOR; GENE-EXPRESSION; BONE METASTASES	Dynamic reciprocal interactions between a tumor and its microenvironment impact both the establishment and progression of metastases. These interactions are mediated, in part, through proteolytic sculpting of the microenvironment, particularly by the matrix metalloproteinases, with both tumors and stroma contributing to the proteolytic milieu. Because bone is one of the predominant sites of breast cancer metastases, we used a co-culture system in which a subpopulation of the highly invasive human breast cancer cell line MDA-MB-231, with increased propensity to metastasize to bone, was overlaid onto a monolayer of differentiated osteoblast MC3T3-E1 cells in a mineralized osteoid matrix. CLIP-CHIP (R) microarrays identified changes in the complete protease and inhibitor expression profile of the breast cancer and osteoblast cells that were induced upon co-culture. A large increase in osteoblast-derived MMP-13 mRNA and protein was observed. Affymetrix analysis and validation showed induction of MMP-13 was initiated by soluble factors produced by the breast tumor cells, including oncostatin M and the acute response apolipoprotein SAA3. Significant changes in the osteoblast secretomes upon addition of MMP-13 were identified by degradomics from which six novel MMP-13 substrates with the potential to functionally impact breast cancer metastasis to bone were identified and validated. These included inactivation of the chemokines CCL2 and CCL7, activation of platelet-derived growth factor-C, and cleavage of SAA3, osteoprotegerin, CutA, and antithrombin III. Hence, the influence of breast cancer metastases on the bone microenvironment that is executed via the induction of osteoblast MMP-13 with the potential to enhance metastases growth by generating a microenvironmental amplifying feedback loop is revealed.	[Overall, Christopher] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Morrison, Charlotte; Kappelhoff, Reinhild; Overall, Christopher] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; [Overall, Christopher] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Mancini, Stephanie; Cipollone, Jane; Roskelley, Calvin] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Overall, C (corresponding author), Univ British Columbia, Ctr Blood Res, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	chris.overall@ubc.ca	Roskelley, Calvin D/F-4630-2011		Canadian Institutes of Health Research; National Cancer Institute of Canada (Canadian Cancer Association); Canadian Breast Cancer Research Alliance Metastasis; Michael Smith Research Foundation; Canada Research Chair in Metalloproteinase Proteomics and Systems Biology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada (Canadian Cancer Association); Canadian Breast Cancer Research Alliance Metastasis; Michael Smith Research Foundation(Michael Smith Foundation for Health Research); Canada Research Chair in Metalloproteinase Proteomics and Systems Biology(Canada Research Chairs)	This work was supported in part by grants from the Canadian Institutes of Health Research, the National Cancer Institute of Canada (with funds raised by the Canadian Cancer Association), a Special Program Grant from the Canadian Breast Cancer Research Alliance Metastasis, and a Centre Grant from the Michael Smith Research Foundation to the University of British Columbia Centre of Blood Research.; Supported by a Canada Research Chair in Metalloproteinase Proteomics and Systems Biology. To whom correspondence should be addressed: Centre for Blood Research, University of British Columbia, 2350 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada. E-mail: chris.overall@ubc.ca.	Acuff HB, 2006, CANCER RES, V66, P259, DOI 10.1158/0008-5472.CAN-05-2502; Andarawewa KL, 2003, CANCER RES, V63, P5844; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Bar-Shavit Z, 2007, J CELL BIOCHEM, V102, P1130, DOI 10.1002/jcb.21553; Bisson C, 2003, INT J CANCER, V105, P7, DOI 10.1002/ijc.11012; Butler GS, 2008, MOL CELL BIOL, V28, P4896, DOI 10.1128/MCB.01775-07; Butler GS, 2010, METHODS MOL BIOL, V622, P451, DOI 10.1007/978-1-60327-299-5_26; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Butler GS, 2004, J BIOL CHEM, V279, P15615, DOI 10.1074/jbc.M312727200; Chabottaux V, 2007, CLIN EXP METASTAS, V24, P647, DOI 10.1007/s10585-007-9113-7; Chen HT, 2010, J CELL PHYSIOL, V223, P737, DOI 10.1002/jcp.22083; Cowell S, 1998, BIOCHEM J, V331, P453, DOI 10.1042/bj3310453; Cox Jennifer H., 2008, P519, DOI 10.1007/978-0-387-69057-5_26; D'Angelo M, 2001, J BONE MINER RES, V16, P2339, DOI 10.1359/jbmr.2001.16.12.2339; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; El Mabrouk M, 2007, BBA-MOL CELL RES, V1773, P309, DOI 10.1016/j.bbamcr.2006.11.018; Filanti C, 2000, J BONE MINER RES, V15, P2154, DOI 10.1359/jbmr.2000.15.11.2154; Fosang AJ, 1996, FEBS LETT, V380, P17, DOI 10.1016/0014-5793(95)01539-6; Franchimont N, 1997, J BIOL CHEM, V272, P12144, DOI 10.1074/jbc.272.18.12144; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; Gonzalez LO, 2007, BRIT J CANCER, V97, P957, DOI 10.1038/sj.bjc.6603963; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Han G, 2008, ONCOL REP, V20, P929, DOI 10.3892/or_00000093; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Jinushi M, 2008, CANCER RES, V68, P8889, DOI 10.1158/0008-5472.CAN-08-2147; Jost M, 2006, CANCER RES, V66, P5234, DOI 10.1158/0008-5472.CAN-05-4315; Kahai S, 2004, MATRIX BIOL, V23, P445, DOI 10.1016/j.matbio.2004.09.004; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kappelhoff R., 2009, CURRENT PROTOCOLS S, P1; Kappelhoff R, 2010, METHODS MOL BIOL, V622, P175, DOI 10.1007/978-1-60327-299-5_10; Katagiri T, 2002, ORAL DIS, V8, P147, DOI 10.1034/j.1601-0825.2002.01829.x; Keller UAD, 2010, CANCER RES, V70, P7562, DOI 10.1158/0008-5472.CAN-10-1584; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Knauper V, 1997, EUR J BIOCHEM, V248, P369, DOI 10.1111/j.1432-1033.1997.00369.x; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Koo BH, 2009, J BIOL CHEM, V284, P23375, DOI 10.1074/jbc.M109.036848; Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338; Lafleur MA, 2005, INT J CANCER, V114, P544, DOI 10.1002/ijc.20763; Lafleur MA, 2001, BIOCHEM J, V357, P107, DOI 10.1042/0264-6021:3570107; Lee J, 2001, EUR J CANCER, V37, P106, DOI 10.1016/S0959-8049(00)00363-4; Li XR, 2003, CYTOKINE GROWTH F R, V14, P91, DOI 10.1016/S1359-6101(02)00090-4; Liang D, 2009, FEBS J, V276, P4473, DOI 10.1111/j.1742-4658.2009.07154.x; Liang D, 2009, J BIOL CHEM, V284, P5195, DOI 10.1074/jbc.M806260200; Lin Y, 2001, J BIOL CHEM, V276, P42077, DOI 10.1074/jbc.M107101200; Lynch CC, 2007, CANCER RES, V67, P6760, DOI 10.1158/0008-5472.CAN-07-0026; MAST AE, 1991, J BIOL CHEM, V266, P15810; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; MITCHELL TI, 1993, BIOCHIM BIOPHYS ACTA, V1156, P245, DOI 10.1016/0304-4165(93)90038-A; Mizutani A, 2001, J BONE MINER RES, V16, P2043, DOI 10.1359/jbmr.2001.16.11.2043; Monfort J, 2008, OSTEOARTHR CARTILAGE, V16, P749, DOI 10.1016/j.joca.2007.11.007; Monfort J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2042; Morrison CJ, 2001, J BIOL CHEM, V276, P47402, DOI 10.1074/jbc.M108643200; Nagaraja GM, 2006, ONCOGENE, V25, P2328, DOI 10.1038/sj.onc.1209265; Nakano Y, 2010, J CELL PHYSIOL, V223, P260, DOI 10.1002/jcp.22034; Nam JS, 2006, CANCER RES, V66, P7176, DOI 10.1158/0008-5472.CAN-06-0825; Nannuru KC, 2010, CANCER RES, V70, P3494, DOI 10.1158/0008-5472.CAN-09-3251; Navaratnam DS, 2000, J NEUROCHEM, V74, P2146, DOI 10.1046/j.1471-4159.2000.0742146.x; Naylor MJ, 2005, MOL ENDOCRINOL, V19, P1868, DOI 10.1210/me.2004-0254; Neutzner M, 2007, CANCER RES, V67, P6777, DOI 10.1158/0008-5472.CAN-07-0165; Orbe J, 2009, ARTERIOSCL THROM VAS, V29, P2109, DOI 10.1161/ATVBAHA.109.194589; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; OVERALL CM, 1990, J BIOL CHEM, V265, P21141; Ozaki N, 2009, MOL CANCER RES, V7, P1572, DOI 10.1158/1541-7786.MCR-08-0567; Pendas AM, 2004, MOL CELL BIOL, V24, P5304, DOI 10.1128/MCB.24.12.5304-5313.2004; Pendas AM, 2000, CLIN CHIM ACTA, V291, P137, DOI 10.1016/S0009-8981(99)00225-9; Perrier AL, 2000, J BIOL CHEM, V275, P34260, DOI 10.1074/jbc.M004289200; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Radjabi AR, 2008, J BIOL CHEM, V283, P2822, DOI 10.1074/jbc.M704855200; Roemisch J, 2002, BLOOD COAGUL FIBRIN, V13, P657, DOI 10.1097/00001721-200212000-00001; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Rozanov DV, 2002, J BIOL CHEM, V277, P9318, DOI 10.1074/jbc.M110711200; Schneeweis LA, 2005, J BIOL CHEM, V280, P41155, DOI 10.1074/jbc.M506366200; Schwarz E. M., 2007, ARTHRITIS RES THE S1, V9, P7; Selvamurugan N, 2000, J CELL BIOCHEM, V79, P182, DOI 10.1002/1097-4644(20001101)79:2<182::AID-JCB20>3.0.CO;2-0; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Szabova L, 2008, ONCOGENE, V27, P3274, DOI 10.1038/sj.onc.1210982; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; Tarin C, 2009, ARTERIOSCL THROM VAS, V29, P27, DOI 10.1161/ATVBAHA.108.169623; Terpos E, 2009, EXPERT OPIN BIOL TH, V9, P465, DOI [10.1517/14712590902845610, 10.1517/14712590902845610 ]; Uria JA, 1998, J BIOL CHEM, V273, P9769, DOI 10.1074/jbc.273.16.9769; Vallon R, 2001, J IMMUNOL, V166, P2801, DOI 10.4049/jimmunol.166.4.2801; Varghese S, 1999, AM J PHYSIOL-ENDOC M, V276, pE465, DOI 10.1152/ajpendo.1999.276.3.E465; Vizoso FJ, 2007, BRIT J CANCER, V96, P903, DOI 10.1038/sj.bjc.6603666; Wagsater D, 2009, ATHEROSCLEROSIS, V202, P415, DOI 10.1016/j.atherosclerosis.2008.04.050; Yang CM, 2009, J BIOL CHEM, V284, P26040, DOI 10.1074/jbc.M109.040154; Yang JC, 2009, MOL BIOL REP, V36, P63, DOI 10.1007/s11033-007-9152-9; Yu XF, 2004, J BONE MINER RES, V19, P2065, DOI 10.1359/JBMR.040910; Zhang J, 2004, CANCER RES, V64, P6957, DOI 10.1158/0008-5472.CAN-04-0819; Zigrino P, 2009, J INVEST DERMATOL, V129, P2686, DOI 10.1038/jid.2009.130	101	45	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					34271	34285		10.1074/jbc.M111.222513	http://dx.doi.org/10.1074/jbc.M111.222513			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21784845	hybrid, Green Published			2022-12-25	WOS:000295159200057
J	Kolandaivelu, S; Chang, B; Ramamurthy, V				Kolandaivelu, Saravanan; Chang, Bo; Ramamurthy, Visvanathan			Rod Phosphodiesterase-6 (PDE6) Catalytic Subunits Restore Cone Function in a Mouse Model Lacking Cone PDE6 Catalytic Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-GMP PHOSPHODIESTERASE; INHIBITORY GAMMA-SUBUNIT; CGMP-PHOSPHODIESTERASE; PHOTORECEPTOR CELLS; VISUAL TRANSDUCTION; GENE; NRL; PHOTOTRANSDUCTION; DEGENERATION; MUTATIONS	Rod and cone photoreceptor neurons utilize discrete PDE6 enzymes that are crucial for phototransduction. Rod PDE6 is composed of heterodimeric catalytic subunits (alpha beta), while the catalytic core of cone PDE6 (alpha') is a homodimer. It is not known if variations between PDE6 subunits preclude rod PDE6 catalytic subunits from coupling to the cone phototransduction pathway. To study this issue, we generated a cone-dominated mouse model lacking cone PDE6 (Nrl(-/-) cpfl1). In this animal model, using several independent experimental approaches, we demonstrated the expression of rod PDE6 (alpha beta) and the absence of cone PDE6 (alpha') catalytic subunits. The rod PDE6 enzyme expressed in cone cells is active and contributes to the hydrolysis of cGMP in response to light. In addition, rod PDE6 expressed in cone cells couples to the light signaling pathway to produce S-cone responses. However, S-cone responses and light-dependent cGMP hydrolysis were eliminated when the beta-subunit of rod PDE6 was removed (Nrl(-/-) cpfl1 rd). We conclude that either rod or cone PDE6 can effectively couple to the cone phototransduction pathway to mediate visual signaling. Interestingly, we also found that functional PDE6 is required for trafficking of M-opsin to cone outer segments.	[Ramamurthy, Visvanathan] W Virginia Univ, Inst Eye, Ctr Neurosci, Dept Ophthalmol, Morgantown, WV 26506 USA; [Kolandaivelu, Saravanan; Ramamurthy, Visvanathan] W Virginia Univ, Ctr Neurosci, Dept Biochem, Morgantown, WV 26506 USA; [Chang, Bo] Jackson Lab, Bar Harbor, ME 04609 USA	West Virginia University; West Virginia University; Jackson Laboratory	Ramamurthy, V (corresponding author), W Virginia Univ, Inst Eye, Ctr Neurosci, Dept Ophthalmol, 1 Stadium Dr,E-363, Morgantown, WV 26506 USA.	ramamurthyv@wvuhealthcare.com		Ramamurthy, Visvanathan/0000-0003-0289-3685; Chang, Bo/0000-0001-8259-7290	National Institutes of Health [R01EY017035]; WV Lions Eye Bank; Lions Club International Foundation; Research to Prevent Blindness (RPB); NATIONAL EYE INSTITUTE [R01EY019943, R01EY017035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WV Lions Eye Bank; Lions Club International Foundation; Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01EY017035 (to V. R.), WV Lions Eye Bank, Lions Club International Foundation, and Research to Prevent Blindness (RPB) challenge grant to West Virginia University.	ANANT JS, 1992, J BIOL CHEM, V267, P687; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Chang B, 2009, P NATL ACAD SCI USA, V106, P19581, DOI 10.1073/pnas.0907720106; Chen CK, 2010, J PHYSIOL-LONDON, V588, P3231, DOI 10.1113/jphysiol.2010.191221; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; Deng WT, 2009, P NATL ACAD SCI USA, V106, P17681, DOI 10.1073/pnas.0901382106; FARBER DB, 1995, INVEST OPHTH VIS SCI, V36, P263; FARBER DB, 1982, METHOD ENZYMOL, V81, P551; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; GILLESPIE PG, 1989, P NATL ACAD SCI USA, V86, P4311, DOI 10.1073/pnas.86.11.4311; GILLESPIE PG, 1988, J BIOL CHEM, V263, P8133; HAMILTON SE, 1990, J BIOL CHEM, V265, P11259; HURWITZ RL, 1984, J BIOL CHEM, V259, P8612; Kefalov V, 2003, NATURE, V425, P526, DOI 10.1038/nature01992; Kirschman LT, 2010, HUM MOL GENET, V19, P1076, DOI 10.1093/hmg/ddp571; Kolandaivelu S, 2009, J BIOL CHEM, V284, P30853, DOI 10.1074/jbc.M109.036780; LI T, 1990, P NATL ACAD SCI USA, V87, P293, DOI 10.1073/pnas.87.1.293; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Muradov H, 2004, VISION RES, V44, P2437, DOI 10.1016/j.visres.2004.05.013; Muradov H, 2010, J BIOL CHEM, V285, P39828, DOI 10.1074/jbc.M110.170068; Nikonov SS, 2005, J GEN PHYSIOL, V125, P287, DOI 10.1085/jgp.200409208; PITTLER SJ, 1991, PROG CLIN BIOL RES, V362, P33; Pittler SJ, 2004, J BIOL CHEM, V279, P19800, DOI 10.1074/jbc.M401864200; PUGH EN, 1986, VISION RES, V26, P1613, DOI 10.1016/0042-6989(86)90051-9; Ramamurthy V, 2004, P NATL ACAD SCI USA, V101, P13897, DOI 10.1073/pnas.0404197101; Sakamoto K, 2009, HUM MOL GENET, V18, P178, DOI 10.1093/hmg/ddn327; Trifunovic D, 2010, J COMP NEUROL, V518, P3604, DOI 10.1002/cne.22416; Wensel TG, 2008, VISION RES, V48, P2052, DOI 10.1016/j.visres.2008.03.010; Zhang XJ, 2008, J BIOL CHEM, V283, P29699, DOI 10.1074/jbc.M803948200; Zhang XJ, 2005, FRONT BIOSCI-LANDMRK, V10, P1191, DOI 10.2741/1612	33	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33252	33259		10.1074/jbc.M111.259101	http://dx.doi.org/10.1074/jbc.M111.259101			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21799013	Green Published, hybrid			2022-12-25	WOS:000294968800044
J	Sancar, F; Touroutine, D; Gao, SB; Oh, HJ; Gendrel, M; Bessereau, JL; Kim, H; Zhen, M; Richmond, JE				Sancar, Feyza; Touroutine, Denis; Gao, Shangbang; Oh, Hyun J.; Gendrel, Marie; Bessereau, Jean-Louis; Kim, Hongkyun; Zhen, Mei; Richmond, Janet E.			The Dystrophin-associated Protein Complex Maintains Muscle Excitability by Regulating Ca2+-dependent K+ (BK) Channel Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS DYSTROPHIN; GLYCOPROTEIN COMPLEX; POTASSIUM CHANNELS; GENETIC-EVIDENCE; SKELETAL-MUSCLE; DYSTROBREVIN; RECEPTOR; BLADDER; REPOLARIZATION; DYSTROGLYCAN	The dystrophin-associated protein complex (DAPC) consists of several transmembrane and intracellular scaffolding elements that have been implicated in maintaining the structure and morphology of the vertebrate neuromuscular junction (NMJ). Genetic linkage analysis has identified loss-of-function mutations in DAPC genes that give rise to degenerative muscular dystrophies. Although much is known about the involvement of the DAPC in maintaining muscle integrity, less is known about the precise contribution of the DAPC in cell signaling events. To better characterize the functional role of the DAPC at the NMJ, we used electrophysiology, immunohistochemistry, and fluorescent labeling to directly assess cholinergic synaptic transmission, ion channel localization, and muscle excitability in loss-of-function (lf) mutants of Caenorhabditis elegans DAPC homologues. We found that all DAPC mutants consistently display mislocalization of the Ca2+-gated K+ channel, SLO-1, in muscle cells, while ionotropic acetylcholine receptor (AChR) expression and localization at the NMJ remained unaltered. Synaptic cholinergic signaling was also not significantly impacted across DAPC(lf) mutants. Consistent with these findings and the postsynaptic mislocalization of SLO-1, we observed an increase in muscle excitability downstream of cholinergic signaling. Based on our results, we conclude that the DAPC is not involved in regulating AChR architecture at the NMJ, but rather functions to control muscle excitability, in an activity-dependent manner, through the proper localization of SLO-1 channels.	[Sancar, Feyza; Richmond, Janet E.] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; [Touroutine, Denis] Univ Massachusetts, Dept Neurobiol, Sch Med, Worcester, MA 01605 USA; [Gao, Shangbang; Zhen, Mei] Univ Toronto, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Oh, Hyun J.; Kim, Hongkyun] Rosalind Franklin Univ Sci & Med, Dept Cell Biol & Anat, N Chicago, IL 60064 USA; [Gendrel, Marie; Bessereau, Jean-Louis] Ecole Normale Super, Dept Biol, Inst Biol, F-75005 Paris, France; [Bessereau, Jean-Louis] INSERM, Unite 1024, F-75005 Paris, France; [Bessereau, Jean-Louis] Ctr Natl Rech Sci, Unit Mixte Rech 8197, F-75005 Paris, France	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Rosalind Franklin University Medical & Science; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)	Richmond, JE (corresponding author), Univ Illinois, Dept Biol Sci, 840 W Taylor St, Chicago, IL 60607 USA.	jer@uic.edu	Zhen, Mei/A-4967-2012; Bessereau, Jean-Louis/M-2988-2017	Zhen, Mei/0000-0003-0086-9622; Bessereau, Jean-Louis/0000-0002-3088-7621; Gao, Shangbang/0000-0001-5431-4628; Gendrel, Marie/0000-0002-0991-0479; Oh, Kelly/0000-0001-8203-5247; Kim, Hongkyun/0000-0002-4879-7122	National Institutes of Health [R01 MH073156, R01 NS058814]; Canadian Institute Health Research [MOP-93619, MOP-74530]; INSERM; Fondation pour la Recherche Medicale; Association Francaise contre les Myopathies; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute Health Research(Canadian Institutes of Health Research (CIHR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported, in whole or in part, by National Institutes of Health Grants R01 MH073156 (to J. E. R.), and R01 NS058814 (to H. K.); the Canadian Institute Health Research Grants (MOP-93619 and MOP-74530) (to M. Z.); and INSERM, the Fondation pour la Recherche Medicale and the Association Francaise contre les Myopathies (to J.-L. B.).	Abraham LS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001077; Adams ME, 2000, J CELL BIOL, V150, P1385, DOI 10.1083/jcb.150.6.1385; Alderton JM, 2000, J BIOL CHEM, V275, P9452, DOI 10.1074/jbc.275.13.9452; Allen DG, 2005, J PHYSIOL-LONDON, V567, P723, DOI 10.1113/jphysiol.2005.091694; Bessou C, 1998, NEUROGENETICS, V2, P61, DOI 10.1007/s100480050053; Bingham JP, 2006, BIOCONJUGATE CHEM, V17, P689, DOI 10.1021/bc060002u; Carlson CG, 1998, NEUROBIOL DIS, V5, P3, DOI 10.1006/nbdi.1998.0188; Carre-Pierrat M, 2006, J MOL BIOL, V358, P387, DOI 10.1016/j.jmb.2006.02.037; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gao SB, 2011, P NATL ACAD SCI USA, V108, P2557, DOI 10.1073/pnas.1012346108; Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430; Gieseler K, 1999, FEBS LETT, V461, P59, DOI 10.1016/S0014-5793(99)01421-0; Gieseler K, 1999, NEUROGENETICS, V2, P87, DOI 10.1007/s100480050057; Gieseler K, 2000, CURR BIOL, V10, P1092, DOI 10.1016/S0960-9822(00)00691-6; Gieseler K, 2001, J MOL BIOL, V307, P107, DOI 10.1006/jmbi.2000.4480; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Grisoni K, 2002, GENE, V294, P77, DOI 10.1016/S0378-1119(02)00762-X; Grisoni K, 2003, J MOL BIOL, V332, P1037, DOI 10.1016/j.jmb.2003.08.021; Hashitani H, 2003, BRIT J PHARMACOL, V140, P159, DOI 10.1038/sj.bjp.0705320; Heppner TJ, 1997, AM J PHYSIOL-CELL PH, V273, pC110; Herrera GM, 2002, J PHYSIOL-LONDON, V541, P483, DOI 10.1113/jphysiol.2002.017707; Hopf F. W., 2007, V45, P429; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Jacobson C, 2001, J CELL BIOL, V152, P435, DOI 10.1083/jcb.152.3.435; Kanagawa M, 2006, J HUM GENET, V51, P915, DOI 10.1007/s10038-006-0056-7; Kim H, 2004, NATURE, V430, P891, DOI 10.1038/nature02798; Kim H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000780; Kong JM, 1999, BRAIN RES, V839, P298, DOI 10.1016/S0006-8993(99)01737-0; Lecroisey C, 2008, MOL BIOL CELL, V19, P785, DOI 10.1091/mbc.E07-05-0497; Liewald JF, 2008, NAT METHODS, V5, P895, DOI 10.1038/NMETH.1252; Liu P, 2011, J PHYSIOL-LONDON, V589, P101, DOI 10.1113/jphysiol.2010.200683; MCMANUS OB, 1991, J PHYSIOL-LONDON, V443, P739, DOI 10.1113/jphysiol.1991.sp018861; Meier T, 2000, NEWS PHYSIOL SCI, V15, P255; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Nimigean CM, 1999, J GEN PHYSIOL, V113, P425, DOI 10.1085/jgp.113.3.425; Pilgram GSK, 2010, MOL NEUROBIOL, V41, P1, DOI 10.1007/s12035-009-8089-5; Richmond Janet, 2005, WormBook, P1; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; Tricarico D, 2005, NEUROBIOL DIS, V20, P296, DOI 10.1016/j.nbd.2005.03.011; Vainzof M, 2008, J MOL NEUROSCI, V34, P241, DOI 10.1007/s12031-007-9023-9; Wang YJ, 2008, LIFE SCI, V82, P11, DOI 10.1016/j.lfs.2007.10.015; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; Willmann R, 2002, CELL MOL LIFE SCI, V59, P1296, DOI 10.1007/s00018-002-8509-4	49	18	23	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33501	33510		10.1074/jbc.M111.227678	http://dx.doi.org/10.1074/jbc.M111.227678			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795674	hybrid, Green Published			2022-12-25	WOS:000294968800067
J	Long, JX; Bushnell, RV; Tobin, JK; Pan, KY; Deem, MW; Nara, PL; Tobin, GJ				Long, Jinxue; Bushnell, Ruth V.; Tobin, John K.; Pan, Keyao; Deem, Michael W.; Nara, Peter L.; Tobin, Gregory J.			Evolution of H3N2 Influenza Virus in a Guinea Pig Model	PLOS ONE			English	Article							A VIRUS; TRANSMISSION MODEL; ANTIGENIC DISTANCE; VACCINE DESIGN; HEMAGGLUTININ; GLYCOSYLATION; EPITOPE; NEUTRALIZATION; MECHANISMS; SELECTION	Studies of influenza virus evolution under controlled experimental conditions can provide a better understanding of the consequences of evolutionary processes with and without immunological pressure. Characterization of evolved strains assists in the development of predictive algorithms for both the selection of subtypes represented in the seasonal influenza vaccine and the design of novel immune refocused vaccines. To obtain data on the evolution of influenza in a controlled setting, naive and immunized Guinea pigs were infected with influenza A/Wyoming/2003 (H3N2). Virus progeny from nasal wash samples were assessed for variation in the dominant and other epitopes by sequencing the hemagglutinin (HA) gene to quantify evolutionary changes. Viral RNA from the nasal washes from infection of naive and immune animals contained 6% and 24.5% HA variant sequences, respectively. Analysis of mutations relative to antigenic epitopes indicated that adaptive immunity played a key role in virus evolution. HA mutations in immunized animals were associated with loss of glycosylation and changes in charge and hydrophobicity in and near residues within known epitopes. Four regions of HA-1 (75-85, 125-135, 165-170, 225-230) contained residues of highest variability. These sites are adjacent to or within known epitopes and appear to play an important role in antigenic variation. Recognition of the role of these sites during evolution will lead to a better understanding of the nature of evolution which help in the prediction of future strains for selection of seasonal vaccines and the design of novel vaccines intended to stimulated broadened cross-reactive protection to conserved sites outside of dominant epitopes.	[Long, Jinxue; Bushnell, Ruth V.; Tobin, John K.; Nara, Peter L.; Tobin, Gregory J.] Biol Mimet Inc, Frederick, MD USA; [Pan, Keyao; Deem, Michael W.] Rice Univ, Dept Bioengn & Phys & Astron, Houston, TX USA; [Nara, Peter L.; Tobin, Gregory J.] Iowa State Univ, Coll Vet Med, Dept Biol Sci, Ames, IA USA	Rice University; Iowa State University	Long, JX (corresponding author), Shanghai Vet Res Inst, Dept Swine Infect Dis, Shanghai, Peoples R China.	tobin@bmi-md.com	Dr. Peter L. Nara, M.Sc./I-7432-2019; Deem, Michael W/P-3595-2014	Deem, Michael W/0000-0002-4298-3450	Defense Advanced Research Projects Agency (DARPA)	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The work was funded, in part, by the Defense Advanced Research Projects Agency (DARPA, http://www.darpa.mil/). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alymova IV, 2008, J VIROL, V82, P8400, DOI 10.1128/JVI.00474-08; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P77; BATSCHELET E, 1976, GENE, V1, P27, DOI 10.1016/0378-1119(76)90004-4; Bouvier NM, 2008, J VIROL, V82, P10052, DOI 10.1128/JVI.01226-08; Brammer L., 2008, Morbidity and Mortality Weekly Report, V57, P179; Bushnell RV, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-200; Caporale LH, 2003, ANNU REV MICROBIOL, V57, P467, DOI 10.1146/annurev.micro.57.030502.090855; Earl DJ, 2004, P NATL ACAD SCI USA, V101, P11531, DOI 10.1073/pnas.0404656101; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fleury D, 1998, NAT STRUCT BIOL, V5, P119, DOI 10.1038/nsb0298-119; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Grebe KM, 2008, MICROBES INFECT, V10, P1024, DOI 10.1016/j.micinf.2008.07.002; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; Herlocher ML, 2001, J INFECT DIS, V184, P542, DOI 10.1086/322801; Holmes EC, 2003, TRENDS MICROBIOL, V11, P543, DOI 10.1016/j.tim.2003.10.006; INKSTER MD, 1993, J VIROL, V67, P7436, DOI 10.1128/JVI.67.12.7436-7443.1993; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Keleta L, 2008, J VIROL, V82, P11599, DOI 10.1128/JVI.01393-08; KILBOURN.ED, 1969, B WORLD HEALTH ORGAN, V41, P643; Laddy DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002517; LAMBKIN R, 1994, J GEN VIROL, V75, P3493, DOI 10.1099/0022-1317-75-12-3493; Langley JM, 2010, J INFECT DIS, V201, P1644, DOI 10.1086/652701; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Manrubia SC, 2006, PHYS LIFE REV, V3, P65, DOI 10.1016/j.plrev.2005.11.002; MirShekari SY, 1997, J BIOL CHEM, V272, P4027, DOI 10.1074/jbc.272.7.4027; Mishin VP, 2005, J VIROL, V79, P12416, DOI 10.1128/JVI.79.19.12416-12424.2005; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Munoz ET, 2005, VACCINE, V23, P1144, DOI 10.1016/j.vaccine.2004.08.028; Nara PL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000571; Nara PL, 1998, VACCINE, V16, P1780, DOI 10.1016/S0264-410X(98)00168-6; Nara PL, 1999, ADV VET MED-ACAD PR, V41, P115; Palmer DF, 1975, HAEMAGGLUTINATION IN; Pan K, 2011, PROTEIN ENG DES SEL, V24, P291, DOI 10.1093/protein/gzq105; Pan KY, 2011, J MOL EVOL, V72, P90, DOI 10.1007/s00239-010-9405-4; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Tobin GJ, 2008, VACCINE, V26, P6189, DOI 10.1016/j.vaccine.2008.09.080; Vigerust DJ, 2007, J VIROL, V81, P8593, DOI 10.1128/JVI.00769-07; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07	42	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e20130	10.1371/journal.pone.0020130	http://dx.doi.org/10.1371/journal.pone.0020130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799726	gold, Green Published, Green Submitted			2022-12-25	WOS:000293097300001
J	Pothukuchi, M; Nagaraja, SB; Kelamane, S; Satyanarayana, S; Shashidhar; Babu, S; Dewan, P; Wares, F				Pothukuchi, Madhavi; Nagaraja, Sharath Burugina; Kelamane, Santosha; Satyanarayana, Srinath; Shashidhar; Babu, Sai; Dewan, Puneet; Wares, Fraser			Tuberculosis Contact Screening and Isoniazid Preventive Therapy in a South Indian District: Operational Issues for Programmatic Consideration	PLOS ONE			English	Article							MALAWI	Background: Under India's Revised National Tuberculosis Control Programme (RNTCP), all household contacts of sputum smear positive Pulmonary Tuberculosis (PTB) patients are screened for TB. In the absence of active TB disease, household contacts aged <6 years are eligible for Isoniazid Preventive Therapy (IPT) (5 milligrams/kilogram body weight/day) for 6 months. Objectives: To estimate the number of household contacts aged <6 years, of sputum smear positive PTB patients registered for treatment under RNTCP from April to June'2008 in Krishna District, to assess the extent to which they are screened for TB disease and in its absence initiated on IPT. Methods: A cross sectional study was conducted. Households of all smear positive PTB cases (n = 848) registered for treatment from April to June'2008 were included. Data on the number of household contacts aged <6 years, the extent to which they were screened for TB disease, and the status of initiation of IPT, was collected. Results: Households of 825 (97%) patients were visited, and 172 household contacts aged <6 years were identified. Of them, 116 (67%) were evaluated for TB disease; none were found to be TB diseased and 97 (84%) contacts were initiated on IPT and 19 (16%) contacts were not initiated on IPT due to shortage of INH tablets in peripheral health centers. The reasons for non-evaluation of the remaining eligible children (n = 56, 33%) include no home visit by the health staff in 25 contacts, home visit done but not evaluated in 31 contacts. House-hold contacts in rural areas were less likely to be evaluated and initiated on IPT [risk ratio 6.65 (95% CI; 3.06-14.42)]. Conclusion: Contact screening and IPT implementation under routine programmatic conditions is sub-optimal. There is an urgent need to sensitize all concerned programme staff on its importance and establishment of mechanisms for rigorous monitoring.	[Pothukuchi, Madhavi] Siddhartha Med Coll, Dept Community Med, Vijayawada, Andhra Pradesh, India; [Satyanarayana, Srinath] Int Union TB & Lung Dis, Ctr Operat Res, New Delhi, India; [Shashidhar] Dist TB Ctr, Machilipatnam, Andhra Pradesh, India; [Babu, Sai] Govt Andhra Pradesh, State TB Off, Directorate Hlth, Hyderabad, Andhra Pradesh, India; [Dewan, Puneet; Wares, Fraser] World Hlth Org, Off WHO Representat India, New Delhi, India	World Health Organization	Pothukuchi, M (corresponding author), Siddhartha Med Coll, Dept Community Med, Vijayawada, Andhra Pradesh, India.	ssrinath@theunion.org	Nagaraja, Sharath Burugina/ABD-7748-2021; Nagaraja, Sharath Burugina/ABD-7238-2021	Nagaraja, Sharath Burugina/0000-0002-6599-5753; Nagaraja, Sharath Burugina/0000-0002-6599-5753; Satyanarayana, Srinath/0000-0002-5420-2551	Revised National TB Control Programme	Revised National TB Control Programme	The study was conducted with an operational research grant from the Revised National TB Control Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*CENTR TUB DIV, 2006, GUID US PED PAT WIS; Central Tuberculosis Division, 2005, TECHN OP GUID TUB CO; Chauhan L S, 2004, Indian Pediatr, V41, P901; Donabedian P., 2007, RENAISSANCE ARCHITEC, P124; Marais BJ, 2006, ARCH DIS CHILD, V91, P762, DOI 10.1136/adc.2006.097220; Nair N, 2001, Paediatr Respir Rev, V2, P97, DOI 10.1053/prrv.2000.0116; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; Nguyen TH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-96; RAMAKRISHNA C, 1961, B WORLD HEALTH ORGAN, V25, P361; Rekha VVB, 2009, INT J TUBERC LUNG D, V13, P1507; Sinfield R, 2006, ANN TROP PAEDIATR, V26, P205, DOI 10.1179/146532806X120291; Van Wyk SS, 2010, INT J TUBERC LUNG D, V14, P650; van Zyl S, 2006, INT J TUBERC LUNG D, V10, P13; WHO, 2007, INT J TUBERC LUNG D, V11, P12; World Health Organisation, 2006, GUID NAT TUB PROGR M; Zachariah R, 2003, INT J TUBERC LUNG D, V7, P1033	16	46	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22500	10.1371/journal.pone.0022500	http://dx.doi.org/10.1371/journal.pone.0022500			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799875	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000293097300055
J	Ranjith-Kumar, CT; Wen, YH; Baxter, N; Bhardwaj, K; Kao, CC				Ranjith-Kumar, C. T.; Wen, Yahong; Baxter, Nielson; Bhardwaj, Kanchan; Kao, C. Cheng			A Cell-Based Assay for RNA Synthesis by the HCV Polymerase Reveals New Insights on Mechanism of Polymerase Inhibitors and Modulation by NS5A	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; NONSTRUCTURAL PROTEIN 5A; DOUBLE-STRANDED-RNA; DE-NOVO INITIATION; INDUCIBLE GENE-I; RIG-I; ADAPTER PROTEIN; RECEPTOR-3 ECTODOMAIN; CRYSTAL-STRUCTURE; INNATE IMMUNITY	RNA synthesis by the genotype 1b hepatitis C virus (HCV) polymerase (NS5B) transiently expressed in Human embryonic kidney 293T cells or liver hepatocytes was found to robustly stimulate RIG-I-dependent luciferase production from the interferon beta promoter in the absence of exogenously provided ligand. This cell-based assay, henceforth named the 5BR assay, could be used to examine HCV polymerase activity in the absence of other HCV proteins. Mutations that decreased de novo initiated RNA synthesis in biochemical assays decreased activation of RIG-I signaling. In addition, NS5B that lacks the C-terminal transmembrane helix but remains competent for RNA synthesis could activate RIG-I signaling. The addition of cyclosporine A to the cells reduced luciferase levels without affecting agonist-induced RIG-I signaling. Furthermore, non-nucleoside inhibitor benzothiadiazines (BTDs) that bind within the template channel of the 1b NS5B were found to inhibit the readout from the 5BR assay. Mutation M414T in NS5B that rendered the HCV replicon resistant to BTD was also resistant to BTDs in the 5BR assay. Co-expression of the HCV NS5A protein along with NS5B and RIG-I was found to inhibit the readout from the 5BR assay. The inhibition by NS5A was decreased with the removal of the transmembrane helix in NS5B. Lastly, NS5B from all six major HCV genotypes showed robust activation of RIG-I in the 5BR assay. In summary, the 5BR assay could be used to validate inhibitors of the HCV polymerase as well as to elucidate requirements for HCV-dependent RNA synthesis.	[Ranjith-Kumar, C. T.; Wen, Yahong; Baxter, Nielson; Bhardwaj, Kanchan; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Ranjith-Kumar, CT (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA.	ctrkumar@indiana.edu; ckao@indiana.edu	Bhardwaj, Kanchan/CAH-2291-2022; Kumar CT, Ranjith/J-5701-2016	Bhardwaj, Kanchan/0000-0002-7331-7717; Baxter, Nielson/0000-0003-2513-7444	National Institute of Allergy and Infectious Diseases [1RO1AI073335, RA0750150]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073335] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institute of Allergy and Infectious Diseases grant 1RO1AI073335 and RA0750150 to CCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Appel N, 2005, J VIROL, V79, P896, DOI 10.1128/JVI.79.2.896-909.2005; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Chinnaswamy S., 2010, VIRUS ADAP TREAT, V2, P73, DOI DOI 10.2147/VAAT.S9641; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Deore RR, 2010, CURR MED CHEM, V17, P3806; Dhanak D, 2002, J BIOL CHEM, V277, P38322, DOI 10.1074/jbc.M205566200; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; Flisiak R, 2010, EXPERT OPIN INV DRUG, V19, P63, DOI 10.1517/13543780903431034; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; GOSWAMI BB, 1979, BIOCHEM BIOPH RES CO, V89, P830, DOI 10.1016/0006-291X(79)91853-9; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Legrand-Abravanel F, 2010, EXPERT OPIN INV DRUG, V19, P963, DOI 10.1517/13543784.2010.500285; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Liu Z, 2009, HEPATOLOGY, V50, P25, DOI 10.1002/hep.22987; Lo Iacono O, 2000, ALIMENT PHARM THER, V14, P463; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Ma S, 2006, ANTIMICROB AGENTS CH, V50, P2976, DOI 10.1128/AAC.00310-06; McHutchison JG, 2004, AM J MANAG CARE, V10, pS21; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Moreno-Monteagudo JA, 2002, ALIMENT PHARM THER, V16, P243, DOI 10.1046/j.1365-2036.2002.01162.x; Moriyama M, 2007, HEPATOL INT, V1, P302, DOI 10.1007/s12072-007-9003-8; Munakata T, 2005, P NATL ACAD SCI USA, V102, P18159, DOI 10.1073/pnas.0505605102; Oh JW, 1999, J VIROL, V73, P7694, DOI 10.1128/JVI.73.9.7694-7702.1999; Pockros P, 2008, HEPATOLOGY, V48, P1349, DOI 10.1002/hep.22593; Pockros Paul J, 2007, Expert Rev Gastroenterol Hepatol, V1, P145, DOI 10.1586/17474124.1.1.145; Qi RS, 2010, J BIOL CHEM, V285, P36635, DOI 10.1074/jbc.M110.144402; Quezada Elizabeth M, 2009, Open Biochem J, V3, P39, DOI 10.2174/1874091X00903010039; Ramsby ML, 1999, METH MOL B, V112, P53; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P7668, DOI 10.1074/jbc.M610946200; Ranjith-Kumar CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012878; Ranjith-Kumar CT, 2009, J BIOL CHEM, V284, P1155, DOI 10.1074/jbc.M806219200; Ranjith-Kumar CT, 2004, J VIROL, V78, P12207, DOI 10.1128/JVI.78.22.12207-12217.2004; Ranjith-Kumar CT, 2003, J MOL BIOL, V330, P675, DOI 10.1016/S0022-2836(03)00613-2; Ranjith-Kumar CT, 2002, J VIROL, V76, P12513, DOI 10.1128/JVI.76.24.12513-12525.2002; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shaw AN, 2009, BIOORG MED CHEM LETT, V19, P4350, DOI 10.1016/j.bmcl.2009.05.091; Shimakami T, 2004, J VIROL, V78, P2738, DOI 10.1128/JVI.78.6.2738-2748.2004; Shirota Y, 2002, J BIOL CHEM, V277, P11149, DOI 10.1074/jbc.M111392200; Simister P, 2009, J VIROL, V83, P11926, DOI 10.1128/JVI.01008-09; Sintchak MD, 2000, IMMUNOPHARMACOLOGY, V47, P163, DOI 10.1016/S0162-3109(00)00193-4; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Tam RC, 1999, J HEPATOL, V30, P376, DOI 10.1016/S0168-8278(99)80093-2; Tomei L, 2004, J VIROL, V78, P938, DOI 10.1128/JVI.78.2.938-946.2004; Tong X, 2006, VIRUS RES, V115, P122, DOI 10.1016/j.virusres.2005.07.012; Vermehren J, 2011, CLIN MICROBIOL INFEC, V17, P122, DOI 10.1111/j.1469-0691.2010.03430.x; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2007, CYTOKINE GROWTH F R, V18, P545, DOI 10.1016/j.cytogfr.2007.06.023; You SY, 2004, J VIROL, V78, P1352, DOI 10.1128/JVI.78.3.1352-1366.2004; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301	60	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22575	10.1371/journal.pone.0022575	http://dx.doi.org/10.1371/journal.pone.0022575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799903	Green Published, Green Submitted, gold			2022-12-25	WOS:000293097300067
J	Chandra, V; Holla, P; Ghosh, D; Chakrabarti, D; Padigaru, M; Jameel, S				Chandra, Vivek; Holla, Prasida; Ghosh, Dhrubaa; Chakrabarti, Debarshi; Padigaru, Muralidhara; Jameel, Shahid			The Hepatitis E Virus ORF3 Protein Regulates the Expression of Liver-Specific Genes by Modulating Localization of Hepatocyte Nuclear Factor 4	PLOS ONE			English	Article							VIRAL-HEPATITIS; IN-VITRO; TRANSCRIPTION; CELLS; RECEPTORS; INFECTION; REPLICATION; ENCODES; HNF4	The hepatitis E virus (HEV) is a small RNA virus and the cause of acute viral hepatitis E. The open reading frame 3 protein (pORF3) of HEV appears to be a pleiotropic regulatory protein that helps in the establishment, propagation and progression of viral infection. However, the global cellular effects of this protein remain to be explored. In the absence of traditional in vitro viral infection systems or efficient replicon systems, we made an adenovirus based ORF3 protein expression system to study its effects on host cell gene expression. We infected Huh7 hepatoma cells with recombinant adenoviruses expressing pORF3 and performed microarray-based gene expression analyses. Several genes down regulated in pORF3-expressing cells were found to be under regulation of the liver-enriched hepatocyte nuclear factor 4 (HNF4), which regulates hepatocyte-specific gene expression. While HNF4 localizes to the nucleus, its phosphorylation results in impaired nuclear localization of HNF4. Here we report that pORF3 increases HNF4 phosphorylation through the ERK and Akt kinases, which results in impaired nuclear translocation of HNF4 and subsequently the down modulation of HNF4-responsive genes in pORF3-expressing cells. We propose that modulation of several hepatocyte specific genes by pORF3 will create an environment favorable for viral replication and pathogenesis.	[Chandra, Vivek; Holla, Prasida; Ghosh, Dhrubaa; Jameel, Shahid] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi, India; [Chakrabarti, Debarshi; Padigaru, Muralidhara] Piramal Life Sci Ltd, Dept Biomarker Discovery, Bombay, Maharashtra, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Piramal Life Sciences Ltd	Chandra, V (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, Aruna Asaf Ali Marg, New Delhi, India.	shahid@icgeb.res.in	Chandra, Vivek/D-2121-2017	Chandra, Vivek/0000-0002-4047-015X	Wellcome Trust; NIH [5R01AI076192]; Indian Council for Medical Research; Department of Biotechnology, Government of India; Council for Scientific and Industrial Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076192] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indian Council for Medical Research(Indian Council of Medical Research (ICMR)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially support by an International Senior Research Fellowship of the Wellcome Trust and NIH grant 5R01AI076192 to SJ. VC and PH were supported by fellowships from the Indian Council for Medical Research and Council for Scientific and Industrial Research, respectively. ICGEB receives core funding from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2008, HEPATOL INT, V2, P308, DOI 10.1007/s12072-008-9071-4; Ahmad I, 2011, VIRUS RES       0221; Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Biswas SM, 2010, J MED VIROL, V82, P304, DOI 10.1002/jmv.21688; Chandra V, 2008, J BIOSCIENCES, V33, P451, DOI 10.1007/s12038-008-0064-1; Chandra V, 2008, J VIROL, V82, P7100, DOI 10.1128/JVI.00403-08; Chandra V, 2010, J VIROL, V84, P3857, DOI 10.1128/JVI.01994-09; Emerson SU, 2004, J VIROL, V78, P4838, DOI 10.1128/JVI.78.9.4838-4846.2004; Emerson SU, 2006, J VIROL, V80, P10457, DOI 10.1128/JVI.00892-06; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Gonzalez FJ, 2008, DRUG METAB PHARMACOK, V23, P2, DOI 10.2133/dmpk.23.2; Graff J, 2005, J VIROL, V79, P6680, DOI 10.1128/JVI.79.11.6680-6689.2005; Graff J, 2006, J VIROL, V80, P5919, DOI 10.1128/JVI.00046-06; Hirota K, 2003, J BIOL CHEM, V278, P13056, DOI 10.1074/jbc.C200553200; Huang YW, 2007, J VIROL, V81, P3018, DOI 10.1128/JVI.02259-06; Inoue Y, 2006, J MOL MED, V84, P334, DOI 10.1007/s00109-005-0013-5; Jameel S, 1999, Expert Rev Mol Med, V1999, P1, DOI 10.1017/S1462399499001271; Kalia M, 2009, J VIROL, V83, P12714, DOI 10.1128/JVI.00717-09; KHUROO MS, 1981, AM J MED, V70, P252, DOI 10.1016/0002-9343(81)90758-0; Korkaya H, 2001, J BIOL CHEM, V276, P42389, DOI 10.1074/jbc.M101546200; KRAWCZYNSKI K, 1993, HEPATOLOGY, V17, P932, DOI 10.1002/hep.1840170525; Li JX, 2000, GENE DEV, V14, P464; Ma L, 2001, J VIROL METHODS, V93, P181, DOI 10.1016/S0166-0934(01)00257-9; Moin SM, 2009, CELL MICROBIOL, V11, P1409, DOI 10.1111/j.1462-5822.2009.01340.x; Moin SM, 2007, J BIOL CHEM, V282, P21124, DOI 10.1074/jbc.M701696200; Qadri I, 2006, MOL PHARMACOL, V70, P627, DOI 10.1124/mol.106.023499; RAMALINGASWAMI V, 1988, LANCET, V1, P571; Reddy S, 1999, J BIOL CHEM, V274, P33050, DOI 10.1074/jbc.274.46.33050; Roy AK, 2004, J BIOL CHEM, V279, P28345, DOI 10.1074/jbc.M400457200; Schena M, 1996, BIOESSAYS, V18, P427, DOI 10.1002/bies.950180513; Sun K, 2007, MOL ENDOCRINOL, V21, P1297, DOI 10.1210/me.2006-0300; Surjit M, 2006, J BIOL CHEM, V281, P8135, DOI 10.1074/jbc.M509568200; Taneja S, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-39; Yamada K, 2009, J GEN VIROL, V90, P1880, DOI 10.1099/vir.0.010561-0; Yu XM, 2003, J VIROL, V77, P2489, DOI 10.1128/JVI.77.4.2489-2499.2003; Zafrullah M, 1997, J VIROL, V71, P9045, DOI 10.1128/JVI.71.12.9045-9053.1997	36	34	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22412	10.1371/journal.pone.0022412	http://dx.doi.org/10.1371/journal.pone.0022412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799848	Green Submitted, Green Published, gold			2022-12-25	WOS:000292931200053
J	Lakhashe, SK; Wang, W; Siddappa, NB; Hemashettar, G; Polacino, P; Hu, SL; Villinger, F; Else, JG; Novembre, FJ; Yoon, JK; Lee, SJ; Montefiori, DC; Ruprecht, RM; Rasmussen, RA				Lakhashe, Samir K.; Wang, Wendy; Siddappa, Nagadenahalli B.; Hemashettar, Girish; Polacino, Patricia; Hu, Shiu-Lok; Villinger, Francois; Else, James G.; Novembre, Francis J.; Yoon, John K.; Lee, Sandra J.; Montefiori, David C.; Ruprecht, Ruth M.; Rasmussen, Robert A.			Vaccination against Heterologous R5 Clade C SHIV: Prevention of Infection and Correlates of Protection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELLS; HIV-1 INFECTION; ANTIBODY ACTIVITIES; IMMUNE-RESPONSE; RHESUS MACAQUES; SUBTYPE-C; NEUTRALIZATION; EFFICACY; REPLICATION	A safe, efficacious vaccine is required to stop the AIDS pandemic. Disappointing results from the STEP trial implied a need to include humoral anti-HIV-1 responses, a notion supported by RV144 trial data even though correlates of protection are unknown. We vaccinated rhesus macaques with recombinant simian immunodeficiency virus (SIV) Gag-Pol particles, HIV-1 Tat and trimeric clade C (HIV-C) gp160, which induced cross-neutralizing antibodies (nAbs) and robust cellular immune responses. After five low-dose mucosal challenges with a simian-human immunodeficiency virus (SHIV) that encoded a heterologous R5 HIV-C envelope (22.1% divergence from the gp160 immunogen), 94% of controls became viremic, whereas one third of vaccinees remained virus-free. Upon high-dose SHIV rechallenge, all controls became infected, whereas some vaccinees remained aviremic. Peak viremia was inversely correlated with both cellular immunity (p<0.001) and cross-nAb titers (p<0.001). These data simultaneously linked cellular as well as humoral immune responses with the degree of protection for the first time.	[Lakhashe, Samir K.; Wang, Wendy; Siddappa, Nagadenahalli B.; Hemashettar, Girish; Yoon, John K.; Lee, Sandra J.; Ruprecht, Ruth M.; Rasmussen, Robert A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Lakhashe, Samir K.; Siddappa, Nagadenahalli B.; Lee, Sandra J.; Ruprecht, Ruth M.; Rasmussen, Robert A.] Harvard Univ, Sch Med, Boston, MA USA; [Polacino, Patricia; Hu, Shiu-Lok] Univ Washington, Seattle, WA 98195 USA; [Villinger, Francois; Else, James G.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Novembre, Francis J.] Emory Univ, Sch Med, Dept Microbiol, Atlanta, GA USA; [Villinger, Francois; Else, James G.; Novembre, Francis J.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Montefiori, David C.] Duke Univ, Durham, NC USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Emory University; Emory University; Emory University; Duke University	Lakhashe, SK (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	ruth_ruprecht@dfci.harvard.edu	Lakhashe, Samir/F-1150-2014; Hu, Shiu-Lok/A-3196-2008	Hu, Shiu-Lok/0000-0003-4336-7964; Byrareddy, Siddappa/0000-0002-7423-1763	National Institutes of Health [PO1 AI048240];  [RR-00165]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI048240, P30AI060354] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant PO1 AI048240 to RMR, SLH, RAR and JLE. Base grant RR-00165 provided support to the Yerkes National Primate Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balfe P, 2004, VIROLOGY, V318, P267, DOI 10.1016/j.virol.2003.09.022; Barnetta SW, 2008, AIDS, V22, P339, DOI 10.1097/QAD.0b013e3282f3ca57; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; BOMSEL M, 2011, IMMUNITY IN PRESS; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Chenine AL, 2010, J INFECT DIS, V201, P1155, DOI 10.1086/651274; Cline AN, 2005, J MED PRIMATOL, V34, P303; D'Souza MP, 2010, AIDS, V24, P803, DOI 10.1097/QAD.0b013e3283379712; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Dreja H, 2010, J GEN VIROL, V91, P2794, DOI 10.1099/vir.0.024224-0; Duvall MG, 2008, EUR J IMMUNOL, V38, P350, DOI 10.1002/eji.200737768; Florese RH, 2009, J IMMUNOL, V182, P3718, DOI 10.4049/jimmunol.0803115; Forsell MNE, 2009, CURR OPIN HIV AIDS, V4, P380, DOI 10.1097/COH.0b013e32832edc19; Forthal DN, 2009, CURR OPIN HIV AIDS, V4, P388, DOI 10.1097/COH.0b013e32832f0a89; Grisson RD, 2004, J VIROL, V78, P14066, DOI 10.1128/JVI.78.24.14066-14069.2004; Hladik Florian, 2009, Curr HIV/AIDS Rep, V6, P20, DOI 10.1007/s11904-009-0004-1; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hofmann-Lehmann R, 2000, AIDS RES HUM RETROV, V16, P1247, DOI 10.1089/08892220050117014; Humbert M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-94; Koopman G, 2008, J GEN VIROL, V89, P540, DOI 10.1099/vir.0.83384-0; Koup RA, 2011, NAT REV IMMUNOL, V11, P65, DOI 10.1038/nri2890; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Lin JP, 2008, HUM GENE THER, V19, P663, DOI 10.1089/hum.2008.033; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Lu YC, 1998, J ACQ IMMUN DEF SYND, V19, P6, DOI 10.1097/00042560-199809010-00002; Mann AM, 2009, AIDS, V23, P1659, DOI 10.1097/QAD.0b013e32832e9408; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Montano MA, 2000, J INFECT DIS, V181, P76, DOI 10.1086/315185; Nishimura Y, 2004, P NATL ACAD SCI USA, V101, P12324, DOI 10.1073/pnas.0404620101; Perreau M, 2008, J EXP MED, V205, P2717, DOI 10.1084/jem.20081786; Polonis VR, 2008, VIROLOGY, V375, P315, DOI 10.1016/j.virol.2008.02.007; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Rasmussen RA, 2006, VACCINE, V24, P2324, DOI 10.1016/j.vaccine.2005.11.063; Rasmussen RA, 2007, AIDS, V21, P1841, DOI 10.1097/QAD.0b013e32828684ea; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sacha JB, 2009, P NATL ACAD SCI USA, V106, P9791, DOI 10.1073/pnas.0813106106; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Siddappa NB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011689; Siddappa NB, 2009, J VIROL, V83, P1422, DOI 10.1128/JVI.02066-08; Song RJ, 2006, J VIROL, V80, P8729, DOI 10.1128/JVI.00558-06; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Villadangos JA, 2010, J EXP MED, V207, P1131, DOI 10.1084/jem.20100985; Vlasak J, 2006, AIDS, V20, P2135, DOI 10.1097/QAD.0b013e328010beb5; Xiao P, 2010, J VIROL, V84, P7161, DOI 10.1128/JVI.00410-10	50	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22010	10.1371/journal.pone.0022010	http://dx.doi.org/10.1371/journal.pone.0022010			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799765	Green Published, Green Submitted, gold			2022-12-25	WOS:000292931200020
J	Sellamuthu, S; Shin, BH; Han, HE; Park, SM; Oh, HJ; Rho, SH; Lee, YJ; Park, WJ				Sellamuthu, Saravanan; Shin, Bae Hyun; Han, Hye-Eun; Park, Sang Min; Oh, Hye Jin; Rho, Seong-Hwan; Lee, Yong Jae; Park, Woo Jin			An Engineered Viral Protease Exhibiting Substrate Specificity for a Polyglutamine Stretch Prevents Polyglutamine-Induced Neuronal Cell Death	PLOS ONE			English	Article							SITE-SPECIFIC PROTEOLYSIS; HUNTINGTONS-DISEASE; EXPANDED POLYGLUTAMINE; IN-VIVO; 3C PROTEINASE; GENETIC ASSAY; AGGREGATION; INHIBITION; SUPPRESSES; NEURODEGENERATION	Background: Polyglutamine (polyQ)-induced protein aggregation is the hallmark of a group of neurodegenerative diseases, including Huntington's disease. We hypothesized that a protease that could cleave polyQ stretches would intervene in the initial events leading to pathogenesis in these diseases. To prove this concept, we aimed to generate a protease possessing substrate specificity for polyQ stretches. Methodology/Principal Findings: Hepatitis A virus (HAV) 3C protease (3CP) was subjected to engineering using a yeast-based method known as the Genetic Assay for Site-specific Proteolysis (GASP). Analysis of the substrate specificity revealed that 3CP can cleave substrates containing glutamine at positions P5, P4, P3, P1, P2', or P3', but not substrates containing glutamine at the P2 or P1' positions. To accommodate glutamine at P2 and P1', key residues comprising the active sites of the S2 or S1' pockets were separately randomized and screened. The resulting sets of variants were combined by shuffling and further subjected to two rounds of randomization and screening using a substrate containing glutamines from positions P5 through P3'. One of the selected variants (Var26) reduced the expression level and aggregation of a huntingtin exon1-GFP fusion protein containing a pathogenic polyQ stretch (HttEx1(97Q)-GFP) in the neuroblastoma cell line SH-SY5Y. Var26 also prevented cell death and caspase 3 activation induced by HttEx1(97Q)-GFP. These protective effects of Var26 were proteolytic activity-dependent. Conclusions/Significance: These data provide a proof-of-concept that proteolytic cleavage of polyQ stretches could be an effective modality for the treatment of polyQ diseases.	[Sellamuthu, Saravanan; Shin, Bae Hyun; Han, Hye-Eun; Park, Sang Min; Oh, Hye Jin; Park, Woo Jin] Gwangju Inst Sci & Technol, Coll Life Sci, Kwangju, South Korea; [Rho, Seong-Hwan] Univ Freiburg, Inst Phys, Freiburg, Germany; [Lee, Yong Jae] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Gwangju Institute of Science & Technology (GIST); University of Freiburg; Yale University	Sellamuthu, S (corresponding author), Gwangju Inst Sci & Technol, Coll Life Sci, Kwangju, South Korea.	wjpark@gist.ac.kr		Rho, Seong-Hwan/0000-0002-8650-8205	National Research Foundation of Korea [2009-0085747]; Korean government (MEST) [M6-0605-00-0001]; Gwangju Institute of Science and Technology (GIST)	National Research Foundation of Korea(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Gwangju Institute of Science and Technology (GIST)	This work was supported by a grant from the National Research Foundation of Korea (No. 2009-0085747), a grant from the Global Research Laboratory Program (M6-0605-00-0001) funded by the Korean government (MEST), and a grant from the "Systems biology infrastructure establishment grant" provided by Gwangju Institute of Science and Technology (GIST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIRE M, 1994, NATURE, V369, P72, DOI 10.1038/369072a0; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bergmann EM, 1999, VIROLOGY, V265, P153, DOI 10.1006/viro.1999.9968; Chun W, 2002, FEBS LETT, V515, P61, DOI 10.1016/S0014-5793(02)02436-5; Colby DW, 2004, P NATL ACAD SCI USA, V101, P17616, DOI 10.1073/pnas.0408134101; Han HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015645; Heiser V, 2000, P NATL ACAD SCI USA, V97, P6739, DOI 10.1073/pnas.110138997; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Kang H, 2001, J GEN VIROL, V82, P3115, DOI 10.1099/0022-1317-82-12-3115; Kang H, 2001, MOL CELLS, V11, P263; Kazantsev A, 2002, NAT GENET, V30, P367, DOI 10.1038/ng864; Kim SY, 2000, ANAL BIOCHEM, V284, P42, DOI 10.1006/abio.2000.4662; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Lecerf JM, 2001, P NATL ACAD SCI USA, V98, P4764, DOI 10.1073/pnas.071058398; MALCOLM BA, 1995, PROTEIN SCI, V4, P1439, DOI 10.1002/pro.5560040801; Marr RA, 2003, J NEUROSCI, V23, P1992; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Mitsui K, 2002, J NEUROSCI, V22, P9267; Nagai Y, 2000, J BIOL CHEM, V275, P10437, DOI 10.1074/jbc.275.14.10437; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nagai Y, 2008, CURR PHARM DESIGN, V14, P3267, DOI 10.2174/138161208786404164; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sellamuthu S, 2008, BIOCHEM BIOPH RES CO, V371, P122, DOI 10.1016/j.bbrc.2008.04.026; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Suhr ST, 2001, J CELL BIOL, V153, P283, DOI 10.1083/jcb.153.2.283; Varadarajan N, 2005, P NATL ACAD SCI USA, V102, P6855, DOI 10.1073/pnas.0500063102; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Yano T, 2001, P NATL ACAD SCI USA, V98, P903, DOI 10.1073/pnas.031442298; Ye CF, 2008, NEUROSCI LETT, V442, P63, DOI 10.1016/j.neulet.2008.05.119; Yin J, 2006, J MOL BIOL, V361, P673, DOI 10.1016/j.jmb.2006.06.047; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	34	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22554	10.1371/journal.pone.0022554	http://dx.doi.org/10.1371/journal.pone.0022554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799895	Green Submitted, Green Published, gold			2022-12-25	WOS:000292931200063
J	Xie, H; Lin, LP; Tong, LJ; Jiang, Y; Zheng, MY; Chen, Z; Jiang, XY; Zhang, XW; Ren, XW; Qu, WC; Yang, Y; Wan, H; Chen, Y; Zuo, JP; Jiang, HL; Geng, MY; Ding, J				Xie, Hua; Lin, Liping; Tong, Linjiang; Jiang, Yong; Zheng, Mingyue; Chen, Zhuo; Jiang, Xiaoyan; Zhang, Xiaowei; Ren, Xiaowei; Qu, Wenchao; Yang, Yang; Wan, Hua; Chen, Yi; Zuo, Jianping; Jiang, Hualiang; Geng, Meiyu; Ding, Jian			AST1306, A Novel Irreversible Inhibitor of the Epidermal Growth Factor Receptor 1 and 2, Exhibits Antitumor Activity Both In Vitro and In Vivo	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; CELL LUNG-CANCER; ADVANCED SOLID TUMORS; ACQUIRED-RESISTANCE; PHASE-I; T790M MUTATION; ERBB RECEPTORS; EGF RECEPTOR; GEFITINIB; HER2	Despite the initial response to the reversible, ATP-competitive quinazoline inhibitors that target ErbB-family, such a subset of cancer patients almost invariably develop resistance. Recent studies have provided compelling evidence that irreversible ErbB inhibitors have the potential to override this resistance. Here, we found that AST1306, a novel anilino-quinazoline compound, inhibited the enzymatic activities of wild-type epidermal growth factor receptor (EGFR) and ErbB2 as well as EGFR resistant mutant in both cell-free and cell-based systems. Importantly, AST1306 functions as an irreversible inhibitor, most likely through covalent interaction with Cys797 and Cys805 in the catalytic domains of EGFR and ErbB2, respectively. Further studies showed that AST1306 inactivated pathways downstream of these receptors and thereby inhibited the proliferation of a panel of cancer cell lines. Although the activities of EGFR and ErbB2 were similarly sensitive to AST1306, ErbB2-overexpressing cell lines consistently exhibited more sensitivity to AST1306 antiproliferative effects. Consistent with this, knockdown of ErbB2, but not EGFR, decreased the sensitivity of SK-OV-3 cells to AST1306. In vivo, AST1306 potently suppressed tumor growth in ErbB2-overexpressing adenocarcinoma xenograft and FVB-2/N(ne)u transgenic breast cancer mouse models, but weakly inhibited the growth of EGFR-overexpressing tumor xenografts. Tumor growth inhibition induced by a single dose of AST1306 in the SK-OV-3 xenograft model was accompanied by a rapid (within 2 h) and sustained (>= 24 h) inhibition of both EGFR and ErbB2, consistent with an irreversible inhibition mechanism. Taken together, these results establish AST1306 as a selective, irreversible ErbB2 and EGFR inhibitor whose growth-inhibitory effects are more potent in ErbB2-overexpressing cells.	[Xie, Hua; Lin, Liping; Tong, Linjiang; Chen, Zhuo; Zhang, Xiaowei; Chen, Yi; Geng, Meiyu; Ding, Jian] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 200031, Peoples R China; [Jiang, Yong; Ren, Xiaowei] Shanghai Allist Pharmaceut, Shanghai, Peoples R China; [Zheng, Mingyue; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, Shanghai 200031, Peoples R China; [Yang, Yang; Zuo, Jianping] Chinese Acad Sci, Shanghai Inst Mat Med, Lab Immunopharmacol, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Jiang, Xiaoyan; Qu, Wenchao; Wan, Hua] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai University of Traditional Chinese Medicine	Xie, H (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Div Antitumor Pharmacol, Shanghai 200031, Peoples R China.	suozhang@mail.shcnc.ac.cn	Zheng, Mingyue/HHZ-4062-2022; Zheng, Mingyue/Z-3582-2019; Zheng, Mingyue/AAJ-8027-2020; Zheng, Mingyue/B-4860-2010; lin, liping/HGE-0871-2022	Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092; 	Key New Drug Creation and Manufacturing Program [2009ZX09103-001, 2009ZX09103-102]; National Natural Science Foundation of China [81021062]; Shanghai Committee of Science and Technology [10431902600]; Shanghai Key Lab of Chemical Biology [SKLCB-2008-03]	Key New Drug Creation and Manufacturing Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Shanghai Key Lab of Chemical Biology	This work was supported with funding from the Key New Drug Creation and Manufacturing Program 2009ZX09103-001 and 2009ZX09103-102, National Natural Science Foundation of China 81021062, Shanghai Committee of Science and Technology 10431902600, and Shanghai Key Lab of Chemical Biology SKLCB-2008-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; EGAN SE, 1993, NATURE, V365, P781, DOI 10.1038/365781a0; Engelman JA, 2006, CLIN CANCER RES, V12, p4372S, DOI 10.1158/1078-0432.CCR-06-0795; Eskens F, 2008, BRIT J CANCER, V98, P80, DOI 10.1038/sj.bjc.6604108; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Godin-Heymann N, 2008, MOL CANCER THER, V7, P874, DOI 10.1158/1535-7163.MCT-07-2387; Gonzales AJ, 2008, MOL CANCER THER, V7, P1880, DOI 10.1158/1535-7163.MCT-07-2232; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; HU P, 1992, MOL CELL BIOL, V12, P981, DOI 10.1128/MCB.12.3.981; Hug B, 2010, CLIN CANCER RES, V16, P4016, DOI 10.1158/1078-0432.CCR-10-0280; Kelly RJ, 2010, J CLIN ONCOL, V28, pE507, DOI 10.1200/JCO.2010.29.3126; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Laheru D, 2008, CLIN CANCER RES, V14, P5602, DOI 10.1158/1078-0432.CCR-08-0433; Lin LG, 2008, J MED CHEM, V51, P4419, DOI 10.1021/jm701501x; Liu B, 2006, PROTEINS, V65, P331, DOI 10.1002/prot.21111; Liu XF, 2010, J MED CHEM, V53, P2661, DOI 10.1021/jm901798e; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Moasser MM, 2001, CANCER RES, V61, P7184; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Rabindran SK, 2004, CANCER RES, V64, P3958, DOI 10.1158/0008-5472.CAN-03-2868; Reshma S, 2007, CANCER IMMUNOL IMMUN, V56, P927, DOI 10.1007/s00262-006-0237-4; Rusnak DW, 2001, MOL CANCER THER, V1, P85; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Sharma SV, 2006, CANCER CELL, V10, P425, DOI 10.1016/j.ccr.2006.09.014; Slichenmyer WJ, 2001, SEMIN ONCOL, V28, P80, DOI 10.1016/S0093-7754(01)90285-4; Takezawa K, 2010, MOL CANCER THER, V9, P1647, DOI 10.1158/1535-7163.MCT-09-1009; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Wissner A, 2003, J MED CHEM, V46, P49, DOI 10.1021/jm020241c; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Xie H, 2009, ACTA PHARMACOL SIN, V30, P346, DOI 10.1038/aps.2009.3; Yap TA, 2010, J CLIN ONCOL, V28, P3965, DOI 10.1200/JCO.2009.26.7278; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zhang DW, 2008, MOL CANCER THER, V7, P1846, DOI 10.1158/1535-7163.MCT-08-0168	37	33	34	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e21487	10.1371/journal.pone.0021487	http://dx.doi.org/10.1371/journal.pone.0021487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789172	gold, Green Published, Green Submitted			2022-12-25	WOS:000292812400009
J	Mazzanti, ML; Walvick, RP; Zhou, X; Sun, YP; Shah, N; Mansour, J; Gereige, J; Albert, MS				Mazzanti, Mary L.; Walvick, Ronn P.; Zhou, Xin; Sun, Yanping; Shah, Niral; Mansour, Joey; Gereige, Jessica; Albert, Mitchell S.			Distribution of Hyperpolarized Xenon in the Brain Following Sensory Stimulation: Preliminary MRI Findings	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; LASER-POLARIZED XE-129; POSITRON-EMISSION-TOMOGRAPHY; FUNCTIONAL MRI; SOMATOSENSORY STIMULATION; FOREPAW STIMULATION; RELAXATION-TIMES; CARRIER AGENTS; RAT; NMR	In hyperpolarized xenon magnetic resonance imaging (HP Xe-129 MRI), the inhaled spin-1/2 isotope of xenon gas is used to generate the MR signal. Because hyperpolarized xenon is an MR signal source with properties very different from those generated from water-protons, HP Xe-129 MRI may yield structural and functional information not detectable by conventional proton-based MRI methods. Here we demonstrate the differential distribution of HP Xe-129 in the cerebral cortex of the rat following a pain stimulus evoked in the animal's forepaw. Areas of higher HP Xe-129 signal corresponded to those areas previously demonstrated by conventional functional MRI (fMRI) methods as being activated by a forepaw pain stimulus. The percent increase in HP Xe-129 signal over baseline was 13-28%, and was detectable with a single set of pre and post stimulus images. Recent innovations in the production of highly polarized Xe-129 should make feasible the emergence of HP Xe-129 MRI as a viable adjunct method to conventional MRI for the study of brain function and disease.	[Mazzanti, Mary L.; Walvick, Ronn P.; Zhou, Xin; Sun, Yanping; Shah, Niral; Mansour, Joey; Gereige, Jessica; Albert, Mitchell S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Zhou, Xin] Chinese Acad Sci, Wuhan Inst Phys & Math, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Ctr Magnet Resonance, Wuhan, Peoples R China; [Sun, Yanping] Dana Farber Canc Inst, Ctr Biomed Imaging Oncol, Lurie Family Imaging Ctr, Boston, MA 02115 USA; [Albert, Mitchell S.] Thunder Bay Reg Res Inst, Thunder Bay, ON, Canada	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Harvard University; Dana-Farber Cancer Institute; Northern Ontario School of Medicine	Mazzanti, ML (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA.	xinzhou@wipm.ac.cn; albertmi@tbh.net	Zhou, Xin/D-9987-2016	Zhou, Xin/0000-0002-5580-7907; Gereige, Jessica/0000-0003-0755-1131	Amersham Health Inc.	Amersham Health Inc.	Amersham Health Inc., provided funding for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2000, NMR BIOMED, V13, P407, DOI 10.1002/1099-1492(200011)13:7<407::AID-NBM661>3.0.CO;2-1; ALBERT MS, 1994, NATURE, V370, P199, DOI 10.1038/370199a0; BETZ E, 1972, PHYSIOL REV, V52, P595, DOI 10.1152/physrev.1972.52.3.595; Bock C, 1998, MAGNET RESON MED, V39, P457, DOI 10.1002/mrm.1910390316; CULLEN SC, 1951, SCIENCE, V113, P580, DOI 10.1126/science.113.2942.580; Driehuys B, 1996, APPL PHYS LETT, V69, P1668, DOI 10.1063/1.117022; Duhamel G, 2002, ACAD RADIOL, V9, pS498, DOI 10.1016/S1076-6332(03)80275-1; Duhamel G, 2001, MAGN RESON MED, V46, P208, DOI 10.1002/mrm.1180; Duong TQ, 2000, MAGN RESON MED, V43, P383, DOI 10.1002/(SICI)1522-2594(200003)43:3<383::AID-MRM10>3.0.CO;2-Q; Goodson BM, 1997, P NATL ACAD SCI USA, V94, P14725, DOI 10.1073/pnas.94.26.14725; Governo RJM, 2006, PAIN, V126, P35, DOI 10.1016/j.pain.2006.06.012; GUR D, 1982, SCIENCE, V215, P1267, DOI 10.1126/science.7058347; HAPPER W, 1984, PHYS REV A, V29, P3092, DOI 10.1103/PhysRevA.29.3092; Homi HM, 2003, ANESTHESIOLOGY, V99, P876, DOI 10.1097/00000542-200310000-00020; Kilian W, 2004, MAGNET RESON MED, V51, P843, DOI 10.1002/mrm.10726; Laitio RM, 2007, ANESTHESIOLOGY, V106, P1128, DOI 10.1097/01.anes.0000267596.57497.92; Liotti M, 1997, JMRI-J MAGN RESON IM, V7, P761, DOI 10.1002/jmri.1880070424; Liu ZHM, 2004, MAGN RESON MED, V52, P277, DOI 10.1002/mrm.20148; Lowe AS, 2008, NMR BIOMED, V21, P53, DOI 10.1002/nbm.1165; Lowery TJ, 2003, MAGN RESON IMAGING, V21, P1235, DOI 10.1016/j.mri.2003.08.025; Malisza KL, 2001, J MAGN RESON IMAGING, V14, P341, DOI 10.1002/jmri.1192; Mandeville JB, 1999, MAGN RESON MED, V42, P944, DOI 10.1002/(SICI)1522-2594(199911)42:5<944::AID-MRM15>3.0.CO;2-W; MARKS EC, 1992, NEURORADIOLOGY, V34, P297, DOI 10.1007/BF00588185; Nakamura K, 2005, MAGN RESON MED, V53, P528, DOI 10.1002/mrm.20399; Ngai AC, 1999, BRAIN RES, V837, P221, DOI 10.1016/S0006-8993(99)01649-2; Oregioni A, 2003, MAGNET RESON MED, V49, P1028, DOI 10.1002/mrm.10476; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Ramirez MP, 2000, NMR BIOMED, V13, P253, DOI 10.1002/1099-1492(200006)13:4<253::AID-NBM636>3.0.CO;2-9; Rex S, 2006, ANESTHESIOLOGY, V105, P936, DOI 10.1097/00000542-200611000-00014; Ruset IC, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.053002; Schroder L, 2006, SCIENCE, V314, P446, DOI 10.1126/science.1131847; Silva AC, 1999, J CEREBR BLOOD F MET, V19, P871, DOI 10.1097/00004647-199908000-00006; Swanson SD, 1997, MAGNET RESON MED, V38, P695, DOI 10.1002/mrm.1910380503; Tuor UI, 2000, PAIN, V87, P315, DOI 10.1016/S0304-3959(00)00293-1; Venkatesh AK, 2000, NMR BIOMED, V13, P245, DOI 10.1002/1099-1492(200006)13:4<245::AID-NBM635>3.0.CO;2-7; Wilson GJ, 1999, MAGNET RESON MED, V41, P933, DOI 10.1002/(SICI)1522-2594(199905)41:5<933::AID-MRM12>3.0.CO;2-Z; Wolber J, 2000, MAGNET RESON MED, V43, P491, DOI 10.1002/(SICI)1522-2594(200004)43:4<491::AID-MRM1>3.0.CO;2-6; YONAS H, 1995, AM J NEURORADIOL, V16, P219; Zhou X, 2008, NMR BIOMED, V21, P217, DOI 10.1002/nbm.1184; Zhou X, 2011, NMR BIOMED, V24, P170, DOI 10.1002/nbm.1568; Zhou X, 2009, P NATL ACAD SCI USA, V106, P16903, DOI 10.1073/pnas.0909147106	41	60	63	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e21607	10.1371/journal.pone.0021607	http://dx.doi.org/10.1371/journal.pone.0021607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789173	gold, Green Published, Green Submitted			2022-12-25	WOS:000292811700001
J	Miskei, M; Adam, C; Kovacs, L; Karanyi, Z; Dombradi, V				Miskei, Marton; Adam, Csaba; Kovacs, Laszlo; Karanyi, Zsolt; Dombradi, Viktor			Molecular Evolution of Phosphoprotein Phosphatases in Drosophila	PLOS ONE			English	Article							PROTEIN SERINE/THREONINE PHOSPHATASES; GENE; MELANOGASTER; MITOSIS; DNA; 2A; SACCHAROMYCES; CONSERVATION; MICROTUBULES; CHROMOSOME	Phosphoprotein phosphatases (PPP), these ancient and important regulatory enzymes are present in all eukaryotic organisms. Based on the genome sequences of 12 Drosophila species we traced the evolution of the PPP catalytic subunits and noted a substantial expansion of the gene family. We concluded that the 18-22 PPP genes of Drosophilidae were generated from a core set of 8 indispensable phosphatases that are present in most of the insects. Retropositons followed by tandem gene duplications extended the phosphatase repertoire, and sporadic gene losses contributed to the species specific variations in the PPP complement. During the course of these studies we identified 5, up till now uncharacterized phosphatase retrogenes: PpY+, PpD5+, PpD6+, Pp4+, and Pp6+ which are found only in some ancient Drosophila. We demonstrated that all of these new PPP genes exhibit a distinct male specific expression. In addition to the changes in gene numbers, the intron-exon structure and the chromosomal localization of several PPP genes was also altered during evolution. The G-C content of the coding regions decreased when a gene moved into the heterochromatic region of chromosome Y. Thus the PPP enzymes exemplify the various types of dynamic rearrangements that accompany the molecular evolution of a gene family in Drosophilidae.	[Miskei, Marton] Univ Debrecen, Dept Plant Biotechnol, Inst Hort Sci, Ctr Agr & Appl Econ Sci, Debrecen, Hungary; [Adam, Csaba; Kovacs, Laszlo; Dombradi, Viktor] Univ Debrecen, Dept Med Chem, Res Ctr Mol Med, Med & Hlth Sci Ctr, Debrecen, Hungary; [Karanyi, Zsolt] Univ Debrecen, Fac Med, Dept Med 1, Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen	Miskei, M (corresponding author), Univ Debrecen, Dept Plant Biotechnol, Inst Hort Sci, Ctr Agr & Appl Econ Sci, Debrecen, Hungary.	dombradi@med.unideb.hu			TAMOP project [4.2.1/B-09/1/KONV-2010-0007]; European Union; European Social Fund	TAMOP project; European Union(European Commission); European Social Fund(European Social Fund (ESF))	This work was supported by the TAMOP 4.2.1/B-09/1/KONV-2010-0007 project. The project was co-financed by the European Union and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam C, 2010, DEV GENES EVOL, V220, P123, DOI 10.1007/s00427-010-0332-6; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ASZTALOS Z, 1993, J NEUROSCI, V13, P924; AXTON JM, 1990, CELL, V63, P33, DOI 10.1016/0092-8674(90)90286-N; Bai YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r11; BAKSA K, 1993, GENETICS, V135, P117; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; BARTON GJ, 1994, EUR J BIOCHEM, V220, P225, DOI 10.1111/j.1432-1033.1994.tb18618.x; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; BREWIS ND, 1993, EMBO J, V12, P987, DOI 10.1002/j.1460-2075.1993.tb05739.x; Bronstein AM, 2006, P NATL ACAD SCI USA, V103, P1168, DOI 10.1073/pnas.0508601103; Brown L, 2000, BBA-GENE STRUCT EXPR, V1492, P470, DOI 10.1016/S0167-4781(00)00105-6; BROWN L, 1994, FEBS LETT, V339, P124, DOI 10.1016/0014-5793(94)80398-6; Casso DJ, 2008, GENETICS, V178, P1399, DOI 10.1534/genetics.107.081638; Chen F, 2007, CURR BIOL, V17, P293, DOI 10.1016/j.cub.2007.01.068; CHEN MX, 1992, FEBS LETT, V306, P54, DOI 10.1016/0014-5793(92)80836-6; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cohen PTW, 2004, TOP CURR GENET, V5, P1; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Davidson FF, 1998, NATURE, V391, P587, DOI 10.1038/35385; Diaz-Castillo C, 2007, GENETICS, V177, P359, DOI 10.1534/genetics.107.077081; Dijkers PF, 2007, CURR BIOL, V17, P2087, DOI 10.1016/j.cub.2007.11.001; DOMBRADI V, 1990, FEBS LETT, V275, P39, DOI 10.1016/0014-5793(90)81434-P; DOMBRADI V, 1993, EUR J BIOCHEM, V212, P177, DOI 10.1111/j.1432-1033.1993.tb17648.x; Farnum MA, 2003, PROTEIN SCI, V12, P1604, DOI 10.1110/ps.0379403; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gloor G. B., 1992, DROSOPHILA INFORMATI, V71, P148; GUERINI D, 1992, J BIOL CHEM, V267, P22542; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Helps NR, 1998, J CELL SCI, V111, P1331; Jia H, 2009, DEVELOPMENT, V136, P307, DOI 10.1242/dev.030015; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Kennelly PJ, 2002, FEMS MICROBIOL LETT, V206, P1, DOI 10.1016/S0378-1097(01)00479-7; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kirchner J, 2007, GENETICS, V176, P273, DOI 10.1534/genetics.106.069914; Koerich LB, 2008, NATURE, V456, P949, DOI 10.1038/nature07463; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lee SJ, 2001, NEURON, V32, P1097, DOI 10.1016/S0896-6273(01)00538-4; MANN DJ, 1993, EMBO J, V12, P4833, DOI 10.1002/j.1460-2075.1993.tb06173.x; Miskei M, 2009, FUNGAL GENET BIOL, V46, pS105, DOI 10.1016/j.fgb.2008.07.013; Moorhead GBG, 2009, BIOCHEM J, V417, P401, DOI 10.1042/BJ20081986; Morrison DK, 2000, J CELL BIOL, V150, pF57, DOI 10.1083/jcb.150.2.F57; Nei M, 2000, MOL EVOLUTION PHYLOG; Raghavan S, 2000, CURR BIOL, V10, P269, DOI 10.1016/S0960-9822(00)00364-X; Roy SW, 2009, TRENDS GENET, V25, P67, DOI 10.1016/j.tig.2008.11.004; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Schwarz R, 1979, ATLAS PROTEIN SEQUEN, P353, DOI DOI 10.2307/2408678; Snaith HA, 1996, J CELL SCI, V109, P3001; Sousa-Nunes R, 2009, GENE DEV, V23, P359, DOI 10.1101/gad.1723609; STEELE FR, 1992, CELL, V69, P669, DOI 10.1016/0092-8674(92)90230-A; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Sullivan KMC, 2002, GENETICS, V161, P183; Takeo S, 2006, CURR BIOL, V16, P1435, DOI 10.1016/j.cub.2006.05.058; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Vibranovski MD, 2009, GENOME RES, V19, P897, DOI 10.1101/gr.088609.108; Vicario S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-226; Vinckenbosch N, 2006, P NATL ACAD SCI USA, V103, P3220, DOI 10.1073/pnas.0511307103; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; Wang N, 2008, J NEUROSCI, V28, P1444, DOI 10.1523/JNEUROSCI.5134-07.2008; Wassarman DA, 1996, GENE DEV, V10, P272, DOI 10.1101/gad.10.3.272; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108	65	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22218	10.1371/journal.pone.0022218	http://dx.doi.org/10.1371/journal.pone.0022218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789237	Green Submitted, gold, Green Published			2022-12-25	WOS:000292811700034
J	Lakshmanan, I; Ponnusamy, MP; Das, S; Chakraborty, S; Haridas, D; Mukhopadhyay, P; Lele, SM; Batra, SK				Lakshmanan, I.; Ponnusamy, M. P.; Das, S.; Chakraborty, S.; Haridas, D.; Mukhopadhyay, P.; Lele, S. M.; Batra, S. K.			MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells	ONCOGENE			English	Article						MUC16; JNK; Aurora kinase; Cyclin B1; G2/M arrest and breast cancer	N-TERMINAL DOMAIN; AURORA-A; C-JUN; TRANSCRIPTION FACTORS; CYCLE INHIBITORS; EPITHELIAL-CELLS; TYROSINE KINASE; MITOTIC ENTRY; DNA-DAMAGE; PHOSPHORYLATION	MUC16/CA125 is a tumor marker currently used in clinics for the follow-up of patients with ovarian cancer. However, MUC16 expression is not entirely restricted to ovarian malignancies and has been reported in other cancers including breast cancer. Although it is well established as a biomarker, function of MUC16 in cancer remains to be elucidated. In the present study, we investigated the role of MUC16 in breast cancer and its underlying mechanisms. Interestingly, our results showed that MUC16 is overexpressed in breast cancer tissues whereas not expressed in non-neoplastic ducts. Further, stable knockdown of MUC16 in breast cancer cells (MDA MB 231 and HBL100) resulted in significant decrease in the rate of cell growth, tumorigenicity and increased apoptosis. In search of a mechanism for breast cancer cell proliferation we found that MUC16 interacts with the ezrin/radixin/moesin domain-containing protein of Janus kinase ( JAK2) as demonstrated by the reciprocal immunoprecipitation method. These interactions mediate phosphorylation of STAT3 (Tyr705), which might be a potential mechanism for MUC16-induced proliferation of breast cancer cells by a subsequent co-transactivation of transcription factor c-Jun. Furthermore, silencing of MUC16 induced G2/M arrest in breast cancer cells through downregulation of Cyclin B1 and decreased phosphorylation of Aurora kinase A. This in turn led to enhanced apoptosis in the MUC16-knockdown breast cancer cells through Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated extrinsic apoptotic pathway with the help of c-Jun N-terminal kinase signaling. Collectively, our results suggest that MUC16 has a dual role in breast cancer cell proliferation by interacting with JAK2 and by inhibiting the apoptotic process through downregulation of TRAIL. Oncogene (2012) 31, 805-817; doi: 10.1038/onc.2011.297; published online 25 July 2011	[Batra, S. K.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Lele, S. M.; Batra, S. K.] Univ Nebraska, Med Ctr, Dept Pathol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Batra, SK (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	sbatra@unmc.edu		Palanimuthu Ponnusamy, Moorthy/0000-0001-5744-193X; Mukhopadhyay, Partha/0000-0001-5817-0174; lakshmanan, Imayavaramban/0000-0003-1733-2223	National Institutes of Health [CA78590, CA111294, CA133774, CA131944]; Department of Defense [BC101014]; NATIONAL CANCER INSTITUTE [R01CA133774, R01CA078590, U01CA111294, R01CA131944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are supported by grants from the National Institutes of Health (CA78590, CA111294, CA133774 and CA131944) and Department of Defense (BC101014). We thank Dr Jessica Mercer, Editorial Grants Associate at UNMC, for carefully editing this manuscript. We also acknowledge Erik Moore and Kavita Mallya for their technical support. We also thank Janice A Tayor and James R Talaska of the confocal laser scanning microscope core facility at UNMC for their support.	Bafna S, 2008, CANCER RES, V68, P9231, DOI 10.1158/0008-5472.CAN-08-3135; Bast RC, 1998, INT J BIOL MARKER, V13, P179, DOI 10.1177/172460089801300402; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Blalock TD, 2007, INVEST OPHTH VIS SCI, V48, P4509, DOI 10.1167/iovs.07-0430; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Chaturvedi P, 2008, CANCER RES, V68, P2065, DOI 10.1158/0008-5472.CAN-07-6041; Chen M, 1997, P NATL ACAD SCI USA, V94, P6910, DOI 10.1073/pnas.94.13.6910; Chinnaiyan AM, 2000, P NATL ACAD SCI USA, V97, P1754, DOI 10.1073/pnas.030545097; Clevenger CV, 2004, AM J PATHOL, V165, P1449, DOI 10.1016/S0002-9440(10)63403-7; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Fendrick JL, 1997, TUMOR BIOL, V18, P278, DOI 10.1159/000218041; FIRMBACHKRAFT I, 1990, ONCOGENE, V5, P1329; Fujimoto K, 1999, INT J CANCER, V81, P637, DOI 10.1002/(SICI)1097-0215(19990517)81:4<637::AID-IJC21>3.0.CO;2-4; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Ginsberg M, 2007, MOL CELL BIOL, V27, P6300, DOI 10.1128/MCB.00613-07; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; He LL, 2008, J BIOL CHEM, V283, P31012, DOI 10.1074/jbc.M803547200; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Huang YL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005397; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; Johnson R, 1996, MOL CELL BIOL, V16, P4504; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Korgun ET, 2006, HISTOCHEM CELL BIOL, V125, P615, DOI 10.1007/s00418-006-0160-y; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Lee S, 2004, J BIOL CHEM, V279, P1885, DOI 10.1074/jbc.M306968200; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; Lin HH, 2007, INT J CANCER, V120, P2306, DOI 10.1002/ijc.22571; Marumoto T, 2002, GENES CELLS, V7, P1173, DOI 10.1046/j.1365-2443.2002.00592.x; Moritani S, 2008, HUM PATHOL, V39, P666, DOI 10.1016/j.humpath.2007.09.009; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Munro EG, 2009, INT J GYNECOL PATHOL, V28, P127, DOI 10.1097/PGP.0b013e318184f3e0; O'Brien TJ, 2002, TUMOR BIOL, V23, P154, DOI 10.1159/000064032; Orren DK, 1997, MOL BIOL CELL, V8, P1129, DOI 10.1091/mbc.8.6.1129; Ouchi M, 2004, J BIOL CHEM, V279, P19643, DOI 10.1074/jbc.M311780200; Perez BH, 2008, EXP EYE RES, V87, P400, DOI 10.1016/j.exer.2007.12.008; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Rahman M, 2009, BREAST CANCER RES TR, V113, P217, DOI 10.1007/s10549-008-9924-5; Rakha EA, 2005, MODERN PATHOL, V18, P1295, DOI 10.1038/modpathol.3800445; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Singh AP, 2004, CANCER RES, V64, P622, DOI 10.1158/0008-5472.CAN-03-2636; Singh PK, 2007, CANCER RES, V67, P5201, DOI 10.1158/0008-5472.CAN-06-4647; Tanaka H, 2002, J CELL BIOL, V158, P321, DOI 10.1083/jcb.200202071; Tong W, 1999, MOL CELL BIOL, V19, P2251; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Watson CJ, 2001, J MAMMARY GLAND BIOL, V6, P115, DOI 10.1023/A:1009524817155; Wu YM, 2009, J PROTEOME RES, V8, P1876, DOI 10.1021/pr8008379; Yin BWT, 2002, INT J CANCER, V98, P737, DOI 10.1002/ijc.10250; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 ; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8; Zhao LQ, 2010, BIOCHEM J, V426, P91, DOI 10.1042/BJ20090615	59	95	105	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2012	31	7					805	817		10.1038/onc.2011.297	http://dx.doi.org/10.1038/onc.2011.297			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	897BL	21785467	Green Accepted			2022-12-25	WOS:000300615800001
J	Cohen, B; Dai, MJ; Ogorodnikov, D; Laurens, J; Raphan, T; Muller, P; Athanasios, A; Edmaier, J; Grossenbacher, T; Stadtmuller, K; Brugger, U; Hauser, G; Straumann, D				Cohen, Bernard; Dai, Mingjia; Ogorodnikov, Dmitri; Laurens, Jean; Raphan, Theodore; Mueller, Philippe; Athanasios, Alexiou; Edmaier, Juergen; Grossenbacher, Thomas; Stadtmueller, Klaus; Brugger, Ueli; Hauser, Gerald; Straumann, Dominik			Motion sickness on tilting trains	FASEB JOURNAL			English	Article						linear acceleration; angular acceleration; roll while rotating	VESTIBULOOCULAR REFLEX; ROLL OSCILLATION	Trains that tilt on curves can go faster, but passengers complain of motion sickness. We studied the control signals and tilts to determine why this occurs and how to maintain speed while eliminating motion sickness. Accelerometers and gyros monitored train and passenger yaw and roll, and a survey evaluated motion sickness. The experimental train had 3 control configurations: an untilted mode, a reactive mode that detected curves from sensors on the front wheel set, and a predictive mode that determined curves from the train's position on the tracks. No motion sickness was induced in the untilted mode, but the train ran 21% slower than when it tilted 8 degrees in either the reactive or predictive modes (113 vs. 137 km/h). Roll velocities rose and fell faster in the predictive than the reactive mode when entering and leaving turns (0.4 vs. 0.8 s for a 4 degrees/s roll tilt, P<0.001). Concurrently, motion sickness was greater (P<0.001) in the reactive mode. We conclude that the slower rise in roll velocity during yaw rotations on entering and leaving curves had induced the motion sickness. Adequate synchronization of roll tilt with yaw velocity on curves will reduce motion sickness and improve passenger comfort on tilting trains.-Cohen, B., Dai, M., Ogorodnikov, D., Laurens, J., Raphan, T., Muller, P., Athanasios, A., Edmaier, J., Grossenbacher, T., Stadtmuller, K., Brugger, U., Hauser, G., Straumann, D. Motion sickness on tilting trains. FASEB J. 25, 3765-3774 (2011). www.fasebj.org	[Cohen, Bernard; Dai, Mingjia; Ogorodnikov, Dmitri] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Laurens, Jean; Straumann, Dominik] Univ Zurich Hosp, Dept Neurol, Zurich, Switzerland; [Raphan, Theodore] CUNY Brooklyn Coll, Dept Comp & Informat Sci, Brooklyn, NY 11210 USA; [Mueller, Philippe; Athanasios, Alexiou; Edmaier, Juergen; Grossenbacher, Thomas; Stadtmueller, Klaus] Schweizer Bundesbahnen, Bern, Switzerland; [Brugger, Ueli; Hauser, Gerald] Alstom Schienenfahrzeuge AG, Neuhausen, Switzerland	Icahn School of Medicine at Mount Sinai; University of Zurich; University Zurich Hospital; City University of New York (CUNY) System; Brooklyn College (CUNY); Alstom	Cohen, B (corresponding author), Mt Sinai Sch Med, Dept Neurol, Box 1135,1 Gustav L Levy Pl, New York, NY 10029 USA.	bernard.cohen@mssm.edu			Schweizerische Bundes-bahnen; U.S. National Institute on Deafness and Other Communciation Disorders [DC007847, DC05204]; Swiss National Science Foundation; Center for Integrative Human Physiology, University of Zurich; Koetser Foundation for Brain Research; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005204, R01DC007847] Funding Source: NIH RePORTER	Schweizerische Bundes-bahnen; U.S. National Institute on Deafness and Other Communciation Disorders; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Center for Integrative Human Physiology, University of Zurich; Koetser Foundation for Brain Research; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by the Schweizerische Bundes-bahnen; U.S. National Institute on Deafness and Other Communciation Disorders grants DC007847 and DC05204; the Swiss National Science Foundation; the Center for Integrative Human Physiology, University of Zurich; and the Koetser Foundation for Brain Research. The authors thank the following colleagues for their help in performing these experiments and preparing the manuscript: Christopher J. Bockisch (Department of Neurology, Otolaryngology, and Ophthalmology, Zurich University Hospital, Zurich, Switzerland) and Marco Penner (Department of Neurology, Zurich University Hospital). The authors also thank Mildred Mora and Sergey Tarasenko for their technical support.	Andersson E, 1995, P I MECH ENG F-J RAI, V209, P93, DOI 10.1243/PIME_PROC_1995_209_261_02; Andersson E, 1996, VEHICLE SYST DYN, V25, P37, DOI 10.1080/00423119608969186; Barnett R., 1992, 113 U CAL TRANSP CTR; Cohen B., 2010, J VESTIBUL RES-EQUIL, V20, P212; Dai MJ, 2011, EXP BRAIN RES, V210, P503, DOI 10.1007/s00221-011-2548-8; Dai MJ, 2010, EXP BRAIN RES, V204, P207, DOI 10.1007/s00221-010-2305-4; Dai MJ, 2009, EXP BRAIN RES, V195, P553, DOI 10.1007/s00221-009-1825-2; Dai MJ, 2003, EXP BRAIN RES, V151, P173, DOI 10.1007/s00221-003-1479-4; Donohew B. E., 2008, AVIAT SPACE ENV MED, V75, P649; Donohew BE, 2010, AVIAT SPACE ENVIR MD, V81, P22, DOI 10.3357/ASEM.2555.2010; Donohew BE, 2009, AVIAT SPACE ENVIR MD, V80, P94, DOI 10.3357/ASEM.2345.2009; Ebeling K., 2005, JAPAN RAILWAY TRANSP, V40, P36; Forstberg J, 1998, BRAIN RES BULL, V47, P525, DOI 10.1016/S0361-9230(98)00097-5; Forstberg J, 2000, MOTION RELATED COMFO; Forstberg J., 2005, NORDIC FIELD TEST TI; Golding JF, 1997, AVIAT SPACE ENVIR MD, V68, P396; GOLDING JF, 1995, AVIAT SPACE ENVIR MD, V66, P1046; Golding JF, 2005, CURR OPIN NEUROL, V18, P29, DOI 10.1097/00019052-200502000-00007; GOLDING JF, 1992, AVIAT SPACE ENVIR MD, V63, P491; Goodall R.M., 2000, P RAILW TECHN C IMEC, P231; Guedry F. E., 1974, VESTIBULAR SYSTEM PA, VVI, P3; Hauser G, 2006, LERAIL, V129, P6; Joseph JA, 2007, AVIAT SPACE ENVIR MD, V78, P944, DOI 10.3357/ASEM.2043.2007; Kortum W., 1993, MECHANTRONIC DEV RAI; Lyne L., 1997, THESIS MIT BOSTON; MILLER EF, 1970, ACTA OTO-LARYNGOL, P1; MILLER EF, 1970, AEROSPACE MED, V41, P1180; Neimer J, 2001, CURR BIOL, V11, pR549, DOI 10.1016/S0960-9822(01)00339-6; Persson R., 2008, 614A VTI; Raphan T, 2002, EXP BRAIN RES, V145, P1, DOI 10.1007/s00221-002-1067-z; Raphan T, 1996, ANN NY ACAD SCI, V781, P348, DOI 10.1111/j.1749-6632.1996.tb15712.x; Sasaki K., 2000, RAILWAY TECH RES I, V41, P11; Union Internationale des Chemins de Fer, 1998, TILT TRAIN TECHN STA; Wearne S, 1999, J NEUROPHYSIOL, V81, P2175, DOI 10.1152/jn.1999.81.5.2175; Young LR, 2003, J VESTIBUL RES-EQUIL, V13, P65; Young-Jae Han, 2008, 2008 International Conference on Control, Automation and Systems (ICCAS), P1518, DOI 10.1109/ICCAS.2008.4694382; Zaidi K., 2007, TEMP J SCI TECH ENV, V26, P301; Zolotas A, 2006, P AMER CONTR CONF, V1-12, P1796, DOI 10.1109/ACC.2006.1656480	38	12	12	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2011	25	11					3765	3774		10.1096/fj.11-184887	http://dx.doi.org/10.1096/fj.11-184887			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	844BT	21788449	Green Published			2022-12-25	WOS:000296723100003
J	Singleton, RS; Trudgian, DC; Fischer, R; Kessler, BM; Ratcliffe, PJ; Cockman, ME				Singleton, Rachelle S.; Trudgian, David C.; Fischer, Roman; Kessler, Benedikt M.; Ratcliffe, Peter J.; Cockman, Matthew E.			Quantitative Mass Spectrometry Reveals Dynamics of Factor-inhibiting Hypoxia-inducible Factor-catalyzed Hydroxylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYRIN REPEAT DOMAIN; ASPARAGINYL HYDROXYLASE; FACTOR HIF; BETA-HYDROXYLATION; STATISTICAL-MODEL; FIH; PROTEIN; SUBSTRATE; NOTCH; IDENTIFICATIONS	The asparaginyl hydroxylase, factor-inhibiting hypoxia-inducible factor (HIF), is central to the oxygen-sensing pathway that controls the activity of HIF. Factor-inhibiting HIF (FIH) also catalyzes the hydroxylation of a large set of proteins that share a structural motif termed the ankyrin repeat domain (ARD). In vitro studies have defined kinetic properties of FIH with respect to different substrates and have suggested FIH binds more tightly to certain ARD proteins than HIF and that ARD hydroxylation may have a lower K-m value for oxygen than HIF hydroxylation. However, regulation of asparaginyl hydroxylation on ARD substrates has not been systematically studied in cells. To address these questions, we employed isotopic labeling and mass spectrometry to monitor the accrual, inhibition, and decay of hydroxylation under defined conditions. Under the conditions examined, hydroxylation was not reversed but increased as the protein aged. The extent of hydroxylation on ARD proteins was increased by addition of ascorbate, whereas iron and 2-oxoglutarate supplementation had no significant effect. Despite preferential binding of FIH to ARD substrates in vitro, when expressed as fusion proteins in cells, hydroxylation was found to be more complete on HIF polypeptides compared with sites within the ARD. Furthermore, comparative studies of hydroxylation in graded hypoxia revealed ARD hydroxylation was suppressed in a site-specific manner and was as sensitive as HIF to hypoxic inhibition. These findings suggest that asparaginyl hydroxylation of HIF-1 and ARD proteins is regulated by oxygen over a similar range, potentially tuning the HIF transcriptional response through competition between the two types of substrate.	[Singleton, Rachelle S.; Trudgian, David C.; Fischer, Roman; Kessler, Benedikt M.; Ratcliffe, Peter J.; Cockman, Matthew E.] Univ Oxford, Ctr Cellular & Mol Physiol, Oxford OX3 7BN, England	University of Oxford	Cockman, ME (corresponding author), Univ Oxford, Ctr Cellular & Mol Physiol, Henry Wellcome Bldg Mol Physiol, Oxford OX3 7BN, England.	matthew@well.ox.ac.uk	Trudgian, David/D-4785-2012; Fischer, Roman/N-4408-2017; Cockman, Matthew/V-9619-2019; Kessler, Benedikt/AAY-8614-2021	Trudgian, David/0000-0002-7084-6787; Fischer, Roman/0000-0002-9715-5951; Cockman, Matthew/0000-0002-3310-4821; Kessler, Benedikt/0000-0002-8160-2446; Singleton, Rachelle/0000-0001-7337-5688; Ratcliffe, Peter/0000-0002-2853-806X	Biotechnology and Biological Sciences Research Council; European Union; Wellcome Trust; Action Medical Research Charity [208701, SC039284]; Biomedical Research Centre (National Institute for Health Research), Oxford, UK; Biotechnology and Biological Sciences Research Council [BB/G014124/1] Funding Source: researchfish; British Heart Foundation [RG/11/1/28684] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Action Medical Research Charity; Biomedical Research Centre (National Institute for Health Research), Oxford, UK(National Institute for Health Research (NIHR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This work was supported in part by the Biotechnology and Biological Sciences Research Council, the European Union (7th Framework), and the Wellcome Trust (to P.J.R.).; Supported by Action Medical Research Charity Grants 208701 and SC039284.; Supported by the Biomedical Research Centre (National Institute for Health Research), Oxford, UK.	Bendall SC, 2008, MOL CELL PROTEOMICS, V7, P1587, DOI 10.1074/mcp.M800113-MCP200; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Deutsch EW, 2010, PROTEOMICS, V10, P1190, DOI 10.1002/pmic.200900567; Devries IL, 2010, FEBS LETT, V584, P4725, DOI 10.1016/j.febslet.2010.10.060; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Ferguson JE, 2007, MOL CELL BIOL, V27, P6407, DOI 10.1128/MCB.00511-07; Flashman E, 2010, BIOCHEM J, V427, P135, DOI 10.1042/BJ20091609; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Hardy AP, 2009, J MOL BIOL, V392, P994, DOI 10.1016/j.jmb.2009.07.070; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kelly L, 2009, MOL BIOSYST, V5, P52, DOI 10.1039/b815271c; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lee SH, 2008, J BIOMOL SCREEN, V13, P494, DOI 10.1177/1087057108318800; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pasa-Tolic L, 2004, BIOTECHNIQUES, V37, P621, DOI 10.2144/04374RV01; Robinson N. E, 2004, MOL CLOCKS DEAMIDATI, P1; Schmierer B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-139; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Trudgian DC, 2010, BIOINFORMATICS, V26, P1131, DOI 10.1093/bioinformatics/btq081; Webb JD, 2009, BIOCHEM J, V420, P327, DOI 10.1042/BJ20081905; Wilkins SE, 2009, INT J BIOCHEM CELL B, V41, P1563, DOI 10.1016/j.biocel.2009.01.005; Xu DM, 2008, MOL CELL PROTEOMICS, V7, P2215, DOI 10.1074/mcp.M800095-MCP200; Yang M, 2011, FEBS J, V278, P1086, DOI 10.1111/j.1742-4658.2011.08022.x; Yang M, 2011, J BIOL CHEM, V286, P7648, DOI 10.1074/jbc.M110.193540; Zhang N, 2010, CELL METAB, V11, P364, DOI 10.1016/j.cmet.2010.03.001; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	39	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33784	33794		10.1074/jbc.M111.262808	http://dx.doi.org/10.1074/jbc.M111.262808			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21808058	hybrid, Green Published			2022-12-25	WOS:000295159200009
J	Honsa, ES; Fabian, M; Cardenas, AM; Olson, JS; Maresso, AW				Honsa, Erin Sarah; Fabian, Marian; Cardenas, Ana Maria; Olson, John S.; Maresso, Anthony William			The Five Near-iron Transporter (NEAT) Domain Anthrax Hemophore, IsdX2, Scavenges Heme from Hemoglobin and Transfers Heme to the Surface Protein IsdC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY BINDING; UPTAKE SYSTEM; ACQUISITION; RECEPTOR; STREPTOCOCCUS; ANTIBODY; IDENTIFICATION; SIDEROPHORES; COORDINATION; HAPTOGLOBIN	Pathogenic bacteria require iron to replicate inside mammalian hosts. Recent studies indicate that heme acquisition in Gram-positive bacteria is mediated by proteins containing one or more near-iron transporter (NEAT) domains. Bacillus anthracis is a spore-forming, Gram-positive pathogen and the causative agent of anthrax disease. The rapid, extensive, and efficient replication of B. anthracis in host tissues makes this pathogen an excellent model organism for the study of bacterial heme acquisition. B. anthracis secretes two NEAT hemophores, IsdX1 and IsdX2. IsdX1 contains a single NEAT domain, whereas IsdX2 has five, a novel property among hemophores. To understand the functional significance of harboring multiple, non-identical NEAT domains, we purified each individual NEAT domain of IsdX2 as a GST fusion and analyzed the specific function of each domain as it relates to heme acquisition and transport. NEAT domains 1, 3, 4, and 5 all bind heme, with domain 5 having the highest affinity. All NEATs associate with hemoglobin, but only NEAT1 and -5 can extract heme from hemoglobin, seemingly by a specific and active process. NEAT1, -3, and -4 transfer heme to IsdC, a cell wall-anchored anthrax NEAT protein. These results indicate that IsdX2 has all the features required to acquire heme from the host and transport heme to the bacterial cell wall. Additionally, these results suggest that IsdX2 may accelerate iron import rates by acting as a "heme sponge" that enhances B. anthracis replication in ironstarved environments.	[Honsa, Erin Sarah; Cardenas, Ana Maria; Maresso, Anthony William] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Fabian, Marian; Olson, John S.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77096 USA	Baylor College of Medicine; Rice University	Maresso, AW (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, 1 Baylor Plaza, Houston, TX 77030 USA.	maresso@bcm.edu		Olson, John/0000-0002-0760-5403	National Institutes of Health [AI069697, GM035649, HL047020, GM84348]; Robert A. Welch Foundation [C0612]; Baylor College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI096314, R21AI088329, K22AI079165, F32AI069697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084348, R01GM035649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Baylor College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI069697 (to A. W. M.), GM035649 and HL047020 (to J. S. O.), and GM84348 (to M. F.).; Supported by Robert A. Welch Foundation Grant C0612.; Supported by seed funds from Baylor College of Medicine. To whom correspondence should be addressed: Dept. of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030. Tel.: 713-798-7368; Fax: 713-798-7375; E-mail: maresso@bcm.edu.	Abramova A. A., 1993, Arkhiv Patologii, V55, P18; Andrade MA, 2002, GENOME BIOL, V3; Ascoli F, 1981, Methods Enzymol, V76, P72; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carlson PE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006988; Cescau S, 2007, BIOMETALS, V20, P603, DOI 10.1007/s10534-006-9050-y; Chitlaru T, 2007, INFECT IMMUN, V75, P2841, DOI 10.1128/IAI.02029-06; Crosa JH., 2004, IRON TRANSPORT BACTE; Culbertson DS, 2010, BIOCHEMISTRY-US, V49, P6052, DOI 10.1021/bi1006942; Daou N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000675; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Dementieva IS, 2009, J MOL BIOL, V387, P175, DOI 10.1016/j.jmb.2009.01.030; Dixon TC, 2000, CELL MICROBIOL, V2, P453, DOI 10.1046/j.1462-5822.2000.00067.x; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Ebert Tim, 2010, Human Antibodies, V19, P113, DOI 10.3233/HAB-2010-0235; Fabian M, 2009, J BIOL CHEM, V284, P32138, DOI 10.1074/jbc.M109.040915; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Gao JL, 2010, J BIOL CHEM, V285, P40028, DOI 10.1074/jbc.M110.163535; Gat O, 2008, MOL MICROBIOL, V70, P983, DOI 10.1111/j.1365-2958.2008.06460.x; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Grigg JC, 2007, J BIOL CHEM, V282, P28815, DOI 10.1074/jbc.M704602200; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Guidi-Rontani C, 1999, MOL MICROBIOL, V31, P9, DOI 10.1046/j.1365-2958.1999.01137.x; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; HILLIER J, 1953, J CELL COMPAR PHYSL, V42, P203, DOI 10.1002/jcp.1030420205; Honsa ES, 2011, BIOMETALS, V24, P533, DOI 10.1007/s10534-011-9413-x; Howell S, 1998, J MOL RECOGNIT, V11, P200, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<200::AID-JMR423>3.0.CO;2-7; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Izadi-Pruneyre N, 2006, J BIOL CHEM, V281, P25541, DOI 10.1074/jbc.M603698200; Kim HK, 2010, VACCINE, V28, P6382, DOI 10.1016/j.vaccine.2010.02.097; Klichko VI, 2003, BIOCHEM BIOPH RES CO, V303, P855, DOI 10.1016/S0006-291X(03)00440-6; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; LETOFFE S, 1994, P NATL ACAD SCI USA, V91, P9876, DOI 10.1073/pnas.91.21.9876; Letoffe S, 1999, MOL MICROBIOL, V33, P546, DOI 10.1046/j.1365-2958.1999.01499.x; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Meehan M, 2010, MICROBIOL-SGM, V156, P1824, DOI 10.1099/mic.0.036087-0; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Murphy Michael, 2006, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471142301.ps1914s45; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Ouattara M, 2010, MOL MICROBIOL, V78, P739, DOI 10.1111/j.1365-2958.2010.07367.x; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Pluym M, 2008, J INORG BIOCHEM, V102, P480, DOI 10.1016/j.jinorgbio.2007.11.011; ROSS JM, 1955, BRIT J EXP PATHOL, V36, P336; Shannon JG, 2003, INFECT IMMUN, V71, P3183, DOI 10.1128/IAI.71.6.3183-3189.2003; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Tarlovsky Y, 2010, J BACTERIOL, V192, P3503, DOI 10.1128/JB.00054-10; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Vermeiren CL, 2006, BIOCHEMISTRY-US, V45, P12867, DOI 10.1021/bi0607711; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Yukl ET, 2010, BIOCHEMISTRY-US, V49, P6646, DOI 10.1021/bi100692f; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200; Zhu H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-15	65	40	41	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33652	33660		10.1074/jbc.M111.241687	http://dx.doi.org/10.1074/jbc.M111.241687			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21808055	hybrid, Green Published			2022-12-25	WOS:000294968800081
J	Zhang, JZ; Yarov-Yarovoy, V; Scheuer, T; Karbat, I; Cohen, L; Gordon, D; Gurevitz, M; Catterall, WA				Zhang, Joel Z.; Yarov-Yarovoy, Vladimir; Scheuer, Todd; Karbat, Izhar; Cohen, Lior; Gordon, Dalia; Gurevitz, Michael; Catterall, William A.			Structure-Function Map of the Receptor Site for beta-Scorpion Toxins in Domain II of Voltage-gated Sodium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT K+ CHANNEL; PROTEIN-PROTEIN DOCKING; GATING MODIFIER; ALPHA-SUBUNIT; SENSOR; ACTIVATION; ROSETTA; BINDING; CONFORMATIONS; INACTIVATION	Voltage-gated sodium (Na-v) channels are the molecular targets of beta-scorpion toxins, which shift the voltage dependence of activation to more negative membrane potentials by a voltage sensor-trapping mechanism. Molecular determinants of beta-scorpion toxin (CssIV) binding and action on rat brain sodium channels are located in the S1-S2 (IIS1-S2) and S3-S4 (IIS3-S4) extracellular linkers of the voltage-sensing module in domain II. In IIS1-S2, mutations of two amino acid residues (Glu(779) and Pro(782)) significantly altered the toxin effect by reducing binding affinity. In IIS3-S4, six positions surrounding the key binding determinant, Gly(845), define a hot spot of high-impact residues. Two of these substitutions (A841N and L846A) reduced voltage sensor trapping. The other three substitutions (N842R, V843A, and E844N) increased voltage sensor trapping. These bidirectional effects suggest that the IIS3-S4 loop plays a primary role in determining both toxin affinity and efficacy. A high resolution molecular model constructed with the Rosetta-Membrane modeling system reveals interactions of amino acid residues in sodium channels that are crucial for toxin action with residues in CssIV that are required for its effects. In this model, the wedge-shaped CssIV inserts between the IIS1-S2 and IIS3-S4 loops of the voltage sensor, placing key amino acid residues in position to interact with binding partners in these extracellular loops. These results provide new molecular insights into the voltage sensor-trapping model of toxin action and further define the molecular requirements for the development of antagonists that can prevent or reverse toxicity of scorpion toxins.	[Zhang, Joel Z.; Yarov-Yarovoy, Vladimir; Scheuer, Todd; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Karbat, Izhar; Cohen, Lior; Gordon, Dalia; Gurevitz, Michael] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Plant Mol Biol & Ecol, IL-69978 Tel Aviv, Israel	University of Washington; University of Washington Seattle; Tel Aviv University	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@uw.edu	Yarov-Yarovoy, Vladimir/ABE-5454-2020	Yarov-Yarovoy, Vladimir/0000-0002-2325-4834	National Institutes of Health [U01 NS058039]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant U01 NS058039 (to W. A. C. and M. G.).	Banerjee A, 2008, J MOL BIOL, V381, P569, DOI 10.1016/j.jmb.2008.06.010; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; CAHALAN MD, 1975, J PHYSIOL-LONDON, V244, P511, DOI 10.1113/jphysiol.1975.sp010810; Campos FV, 2008, J GEN PHYSIOL, V132, P251, DOI 10.1085/jgp.200809995; Campos FV, 2007, J GEN PHYSIOL, V130, P257, DOI 10.1085/jgp.200609719; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2001, J GEN PHYSIOL, V118, P291, DOI 10.1085/jgp.118.3.291; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Cohen L, 2007, J BIOL CHEM, V282, P29424, DOI 10.1074/jbc.M704651200; Cohen L, 2006, J BIOL CHEM, V281, P20673, DOI 10.1074/jbc.M603212200; COURAUD F, 1982, TOXICON, V20, P9, DOI 10.1016/0041-0101(82)90138-6; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeCaen PG, 2008, P NATL ACAD SCI USA, V105, P15142, DOI 10.1073/pnas.0806486105; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Gurevitz M, 2007, TOXICON, V49, P473, DOI 10.1016/j.toxicon.2006.11.015; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Karbat I, 2010, J BIOL CHEM, V285, P30531, DOI 10.1074/jbc.M110.150888; Leipold E, 2005, FEBS LETT, V579, P3881, DOI 10.1016/j.febslet.2005.05.077; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mantegazza M, 2005, J PHYSIOL-LONDON, V568, P13, DOI 10.1113/jphysiol.2005.093484; Marcotte P, 1997, CIRC RES, V80, P363, DOI 10.1161/01.RES.80.3.363; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Smith JJ, 2007, J BIOL CHEM, V282, P12687, DOI 10.1074/jbc.M610462200; Sokolov S, 2008, MOL PHARMACOL, V73, P1020, DOI 10.1124/mol.107.041046; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103	43	61	64	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33641	33651		10.1074/jbc.M111.282509	http://dx.doi.org/10.1074/jbc.M111.282509			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795675	hybrid, Green Published			2022-12-25	WOS:000294968800080
J	Kishi, S; Abe, H; Akiyama, H; Tominaga, T; Murakami, T; Mima, A; Nagai, K; Kishi, F; Matsuura, M; Matsubara, T; Iehara, N; Ueda, O; Fukushima, N; Jishage, K; Doi, T				Kishi, Seiji; Abe, Hideharu; Akiyama, Haruhiko; Tominaga, Tatsuya; Murakami, Taichi; Mima, Akira; Nagai, Kojiro; Kishi, Fumi; Matsuura, Motokazu; Matsubara, Takeshi; Iehara, Noriyuki; Ueda, Otoya; Fukushima, Naoshi; Jishage, Kou-ichi; Doi, Toshio			SOX9 Protein Induces a Chondrogenic Phenotype of Mesangial Cells and Contributes to Advanced Diabetic Nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH MUSCLE ACTIN; LOW-OXYGEN TENSION; END-PRODUCTS; CHONDROCYTE DIFFERENTIATION; MATRIX EXPANSION; EXPRESSION; HYPOXIA; COLLAGEN; SMAD1; RAT	Diabetic nephropathy (DN) is the most important chronic kidney disease. We previously reported that Smad1 transcriptionally regulates the expression of extracellular matrix in DN. Phenotypic change in mesangial cells (MCs) is a key pathologic event in the progression of DN. The aim of this study is to investigate a novel mechanism underlying chondrogenic phenotypic change in MCs that results in the development of DN. MCs showed chondrogenic potential in a micromass culture, and BMP4 induced the expression of chondrocyte markers (SRY-related HMG Box 9 (SOX9) and type II collagen (COL2)). Advanced glycation end products induced the expression of chondrocyte marker proteins downstream from the BMP4-Smad1 signaling pathway in MCs. In addition, hypoxia also induced the expression of BMP4, hypoxia-inducible factor-1 alpha (HIF-1 alpha), and chondrocyte markers. Overexpression of SOX9 caused ectopic expression of proteoglycans and COL2 in MCs. Furthermore, forced expression of Smad1 induced chondrocyte markers as well. Dorsomorphin inhibited these inductions. Glomerular expressions of HIF-1 alpha, BMP4, and chondrocyte markers were observed in diabetic nephropathy mice. These positive stainings were observed in mesangial sclerotic lesions. SOX9 was partially colocalized with HIF-1 alpha and BMP4 in diabetic glomeruli. BMP4 knock-in transgenic mice showed not only similar pathological lesions to DN, but also the induction of chondrocyte markers in the sclerotic lesions. Here we demonstrate that HIF-1 alpha and BMP4 induce SOX9 expression and subsequent chondrogenic phenotype change in DN. The results suggested that the transdifferentiation of MCs into chondrocyte-like cells in chronic hypoxic stress may result in irreversible structural change in DN.	[Kishi, Seiji; Abe, Hideharu; Tominaga, Tatsuya; Murakami, Taichi; Mima, Akira; Nagai, Kojiro; Kishi, Fumi; Matsuura, Motokazu; Doi, Toshio] Univ Tokushima, Hlth Biosci Inst, Grad Sch Med, Dept Nephrol, Tokushima 7708503, Japan; [Matsubara, Takeshi; Iehara, Noriyuki] Kyoto Univ, Dept Orthoped Surg, Sakyo Ku, Kyoto 6068503, Japan; [Akiyama, Haruhiko] Kyoto Univ, Dept Nephrol, Sakyo Ku, Kyoto 6068503, Japan; [Ueda, Otoya; Jishage, Kou-ichi] Chugai Res Inst Med Sci Inc, Shizuoka 4128513, Japan; [Fukushima, Naoshi] Chugai Pharmaceut Co Ltd, Tokyo 1030092, Japan	Tokushima University; Kyoto University; Kyoto University; Chugai Pharmaceutical Co., Ltd.; Chugai Research Institute for Medical Science, Inc.; Chugai Pharmaceutical Co., Ltd.; Roche Holding	Abe, H (corresponding author), Univ Tokushima, Hlth Biosci Inst, Grad Sch Med, Dept Nephrol, Tokushima 7708503, Japan.	abeabe@clin.med.tokushima-u.ac.jp			Japan Society for the Promotion of Science [21591033, 19590973]; Mitsui Sumitomo Welfare Foundation; Kidney Foundation, Japan [JKFB09-41]; Grants-in-Aid for Scientific Research [21591032] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsui Sumitomo Welfare Foundation; Kidney Foundation, Japan(Kidney Foundation, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grants-in-Aid for Scientific Research of the Japan Society for the Promotion of Science (21591033 and 19590973), Mitsui Sumitomo Welfare Foundation, and The Kidney Foundation, Japan (JKFB09-41).	Abe H, 2004, J BIOL CHEM, V279, P14201, DOI 10.1074/jbc.M310427200; AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Chen JH, 2009, AM J PATHOL, V174, P1109, DOI 10.2353/ajpath.2009.080750; Chen W, 2002, CHINESE MED J-PEKING, V115, P446; Cramer T, 2004, OSTEOARTHR CARTILAGE, V12, P433, DOI 10.1016/j.joca.2004.02.003; DAVIES M, 1994, KIDNEY INT, V45, P320, DOI 10.1038/ki.1994.41; Denker AE, 1999, DIFFERENTIATION, V64, P67, DOI 10.1046/j.1432-0436.1999.6420067.x; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; DOI T, 1992, P NATL ACAD SCI USA, V89, P2873, DOI 10.1073/pnas.89.7.2873; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Farrington-Rock C, 2004, CIRCULATION, V110, P2226, DOI 10.1161/01.CIR.0000144457.55518.E5; Fornoni A, 2002, DIABETES, V51, P499, DOI 10.2337/diabetes.51.2.499; Garin G, 2003, AM J PATHOL, V163, P2485, DOI 10.1016/S0002-9440(10)63603-6; Hanley KP, 2008, J BIOL CHEM, V283, P14063, DOI 10.1074/jbc.M707390200; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200; Iehara N, 1996, KIDNEY INT, V50, P1166, DOI 10.1038/ki.1996.424; Isner JM, 2000, J CLIN INVEST, V106, P615, DOI 10.1172/JCI10961; JOHNSON RJ, 1991, J CLIN INVEST, V87, P847, DOI 10.1172/JCI115089; JOHNSON RJ, 1994, KIDNEY INT, V45, P1769, DOI 10.1038/ki.1994.230; Lenz O, 1998, J AM SOC NEPHROL, V9, P2040; Lupia E, 1999, DIABETES, V48, P1638, DOI 10.2337/diabetes.48.8.1638; Makino H, 1995, J DIABETES COMPLICAT, V9, P282, DOI 10.1016/1056-8727(95)80022-7; Malladi P, 2006, AM J PHYSIOL-CELL PH, V290, pC1139, DOI 10.1152/ajpcell.00415.2005; Manotham K, 2004, J AM SOC NEPHROL, V15, P1277, DOI 10.1097/01.ASN.0000125614.35046.10; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Matsubara T, 2006, LAB INVEST, V86, P357, DOI 10.1038/labinvest.3700400; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; Mima A, 2008, DIABETES, V57, P1712, DOI 10.2337/db07-1726; Myint KM, 2006, DIABETES, V55, P2510, DOI 10.2337/db06-0221; Naitoh M, 2005, GENES CELLS, V10, P1081, DOI 10.1111/j.1365-2443.2005.00902.x; Neusser MA, 2010, AM J PATHOL, V176, P594, DOI 10.2353/ajpath.2010.090268; Neven E, 2007, KIDNEY INT, V72, P574, DOI 10.1038/sj.ki.5002353; Nishi H, 2008, J AM SOC NEPHROL, V19, P1500, DOI 10.1681/ASN.2007101085; Ohashi S, 2004, J BIOL CHEM, V279, P19816, DOI 10.1074/jbc.M310428200; Pfander D, 2003, J CELL SCI, V116, P1819, DOI 10.1242/jcs.00385; Rajpurohit R, 1996, J CELL PHYSIOL, V168, P424, DOI 10.1002/(SICI)1097-4652(199608)168:2<424::AID-JCP21>3.0.CO;2-1; SCHLONDORFF D, 1987, FASEB J, V1, P272, DOI 10.1096/fasebj.1.4.3308611; Semba I, 2000, DEV DYNAM, V217, P401, DOI 10.1002/(SICI)1097-0177(200004)217:4<401::AID-DVDY7>3.0.CO;2-D; Simonson MS, 2007, KIDNEY INT, V71, P846, DOI 10.1038/sj.ki.5002180; Sumi E, 2007, AM J PATHOL, V170, P1854, DOI 10.2353/ajpath.2007.060899; Takamura T, 1998, J BIOL CHEM, V273, P2493, DOI 10.1074/jbc.273.5.2493; Tintut Y, 2003, CIRCULATION, V108, P2505, DOI 10.1161/01.CIR.0000096485.64373.C5; Tominaga T, 2011, J BIOL CHEM, V286, P20109, DOI 10.1074/jbc.M110.179382; VLASSARA H, 1994, P NATL ACAD SCI USA, V91, P11704, DOI 10.1073/pnas.91.24.11704; Xia L, 2007, AM J PHYSIOL-ENDOC M, V293, pE1280, DOI 10.1152/ajpendo.00223.2007; Xia L, 2008, AM J PHYSIOL-RENAL, V295, pF1705, DOI 10.1152/ajprenal.00043.2008; Xu Y, 2007, TISSUE ENG, V13, P2981, DOI 10.1089/ten.2007.0050; Yamamoto Y, 2001, J CLIN INVEST, V108, P261, DOI 10.1172/JCI11771; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zehentner BK, 1999, J BONE MINER RES, V14, P1734, DOI 10.1359/jbmr.1999.14.10.1734	56	25	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32162	32169		10.1074/jbc.M111.244541	http://dx.doi.org/10.1074/jbc.M111.244541			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795715	Green Published, hybrid			2022-12-25	WOS:000294726800026
J	Cattell, M; Lai, S; Cerny, R; Medeiros, DM				Cattell, Maria; Lai, Su; Cerny, Robert; Medeiros, Daniel Meulemans			A New Mechanistic Scenario for the Origin and Evolution of Vertebrate Cartilage	PLOS ONE			English	Article							NEURAL CREST EVOLUTION; EMBRYONIC SEA LAMPREY; PETROMYZON-MARINUS L; II COLLAGEN GENE; CHONDROCYTE DIFFERENTIATION; CRANIOFACIAL DEVELOPMENT; HOMEODOMAIN PROTEINS; EXPRESSION PATTERNS; LIMB DEVELOPMENT; XENOPUS-LAEVIS	The appearance of cellular cartilage was a defining event in vertebrate evolution because it made possible the physical expansion of the vertebrate "new head". Despite its central role in vertebrate evolution, the origin of cellular cartilage has been difficult to understand. This is largely due to a lack of informative evolutionary intermediates linking vertebrate cellular cartilage to the acellular cartilage of invertebrate chordates. The basal jawless vertebrate, lamprey, has long been considered key to understanding the evolution of vertebrate cartilage. However, histological analyses of the lamprey head skeleton suggest it is composed of modern cellular cartilage and a putatively unrelated connective tissue called mucocartilage, with no obvious transitional tissue. Here we take a molecular approach to better understand the evolutionary relationships between lamprey cellular cartilage, gnathostome cellular cartilage, and lamprey mucocartilage. We find that despite overt histological similarity, lamprey and gnathostome cellular cartilage utilize divergent gene regulatory networks (GRNs). While the gnathostome cellular cartilage GRN broadly incorporates Runx, Barx, and Alx transcription factors, lamprey cellular cartilage does not express Runx or Barx, and only deploys Alx genes in certain regions. Furthermore, we find that lamprey mucocartilage, despite its distinctive mesenchymal morphology, deploys every component of the gnathostome cartilage GRN, albeit in different domains. Based on these findings, and previous work, we propose a stepwise model for the evolution of vertebrate cellular cartilage in which the appearance of a generic neural crest-derived skeletal tissue was followed by a phase of skeletal tissue diversification in early agnathans. In the gnathostome lineage, a single type of rigid cellular cartilage became dominant, replacing other skeletal tissues and evolving via gene cooption to become the definitive cellular cartilage of modern jawed vertebrates.	[Cattell, Maria; Lai, Su; Medeiros, Daniel Meulemans] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Lai, Su] Charles Univ Prague, Dept Zool, Prague, Czech Republic	University of Colorado System; University of Colorado Boulder; Charles University Prague	Cattell, M (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	daniel.medeiros@colorado.edu	Cerny, Robert/H-3801-2017	Cerny, Robert/0000-0002-0022-0199; MEDEIROS, DANIEL/0000-0002-8182-6028	Grant Agency of the Academy of Sciences of the Czech Republic [206/07/P257]; Ministry of Education Youth and Sports [0021620828]; National Science Foundation [IOS0920751]; University of Colorado	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Ministry of Education Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); National Science Foundation(National Science Foundation (NSF)); University of Colorado	RC was supported by the Grant Agency of the Academy of Sciences of the Czech Republic (206/07/P257) and by the Ministry of Education Youth and Sports (project 0021620828). MVC and DMM were supported by National Science Foundation grant IOS0920751 to DMM. SL was supported by an Undergraduate Research Opportunities Program Assistantship from the University of Colorado. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow AJ, 1999, DEV DYNAM, V214, P291, DOI 10.1002/(SICI)1097-0177(199904)214:4<291::AID-AJA2>3.0.CO;2-E; Bassham S, 2005, DEVELOPMENT, V132, P4259, DOI 10.1242/dev.01973; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Beverdam A, 2001, MECH DEVELOP, V107, P163, DOI 10.1016/S0925-4773(01)00450-6; Beverdam A, 2001, DEVELOPMENT, V128, P3975; BIEKER JJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1117, DOI 10.1177/40.8.1619277; Braun T, 2009, BLOOD CELL MOL DIS, V43, P43, DOI 10.1016/j.bcmd.2009.05.001; Cerny R, 2010, P NATL ACAD SCI USA, V107, P17262, DOI 10.1073/pnas.1009304107; Chen JY, 1999, NATURE, V402, P518, DOI 10.1038/990080; DHORDAIN P, 1995, MECH DEVELOP, V50, P17, DOI 10.1016/0925-4773(94)00322-E; Eames BF, 2004, DEV BIOL, V274, P188, DOI 10.1016/j.ydbio.2004.07.006; Endo T, 2010, MOL ENDOCRINOL, V24, P1267, DOI 10.1210/me.2010-0056; Ettensohn CA, 2003, DEVELOPMENT, V130, P2917, DOI 10.1242/dev.00511; Flores MV, 2006, DEV DYNAM, V235, P3166, DOI 10.1002/dvdy.20957; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Gaskell W. H., 1908, ORIGIN VERTEBRATES; Haldin CE, 2010, INT J BIOCHEM CELL B, V42, P441, DOI 10.1016/j.biocel.2009.11.014; Hardisty M.W., 1979, BIOL CYCLOSTOMES; Hecht J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000025; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Ishii M, 2003, DEVELOPMENT, V130, P6131, DOI 10.1242/dev.00793; Jeffery WR, 2004, NATURE, V431, P696, DOI 10.1038/nature02975; Johnels AG, 1948, ACTA ZOOL-STOCKHOLM, V29, P140; Jones FS, 1997, P NATL ACAD SCI USA, V94, P2632, DOI 10.1073/pnas.94.6.2632; Kee Y, 2007, GENE DEV, V21, P6; Kerney R, 2007, DEV DYNAM, V236, P1650, DOI 10.1002/dvdy.21175; Kimmel CB, 1998, DEV BIOL, V203, P245, DOI 10.1006/dbio.1998.9016; Kimmel CB, 2001, DEV BIOL, V233, P239, DOI 10.1006/dbio.2001.0201; Lakhwani S, 2010, DEV BIOL, V344, P869, DOI 10.1016/j.ydbio.2010.06.002; LANGILLE RM, 1988, DEVELOPMENT, V102, P301; Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447; Mallatt J, 1996, ZOOL J LINN SOC-LOND, V117, P329, DOI 10.1111/j.1096-3642.1996.tb01658.x; Mallatt J, 2003, J MORPHOL, V258, P1, DOI 10.1002/jmor.10081; Manni L, 1999, J COMP NEUROL, V412, P527, DOI 10.1002/(SICI)1096-9861(19990927)412:3<527::AID-CNE11>3.0.CO;2-U; Martin WM, 2009, DEV DYNAM, V238, P3126, DOI 10.1002/dvdy.22164; Martinez-Morales JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r36; Martinsen BJ, 1998, SCIENCE, V281, P988, DOI 10.1126/science.281.5379.988; Mazet F, 2005, DEV BIOL, V282, P494, DOI 10.1016/j.ydbio.2005.02.021; McBurney KM, 1996, ANAT EMBRYOL, V193, P419; McCauley DW, 2006, NATURE, V441, P750, DOI 10.1038/nature04691; McCauley DW, 2003, DEVELOPMENT, V130, P2317, DOI 10.1242/dev.00451; Meech R, 2005, DEVELOPMENT, V132, P2135, DOI 10.1242/dev.01811; Meulemans D, 2003, DEV BIOL, V264, P430, DOI 10.1016/j.ydbio.2003.09.006; Meulemans D, 2002, DEVELOPMENT, V129, P4953; Meulemans D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000787; Meulemans D, 2007, INT J BIOL SCI, V3, P356; Mori-Akiyama Y, 2003, P NATL ACAD SCI USA, V100, P9360, DOI 10.1073/pnas.1631288100; Morrison SL, 2000, ANAT REC, V260, P252, DOI 10.1002/1097-0185(20001101)260:3<252::AID-AR50>3.0.CO;2-4; Nikitina N, 2009, CSH PROTOC, V2009; Nikitina N, 2008, P NATL ACAD SCI USA, V105, P20083, DOI 10.1073/pnas.0806009105; Ohtanii K, 2008, J EXP ZOOL PART B, V310B, P596, DOI 10.1002/jez.b.21231; Park BY, 2010, GENE EXPR PATTERNS, V10, P159, DOI 10.1016/j.gep.2010.04.004; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Robertson AJ, 2002, MECH DEVELOP, V117, P327, DOI 10.1016/S0925-4773(02)00201-0; ROBSON P, 1993, J BIOL CHEM, V268, P1440; Rodrigo I, 2004, MOL CELL BIOL, V24, P2757, DOI 10.1128/MCB.24.7.2757-2766.2004; Rodrigo I, 2003, DEVELOPMENT, V130, P473, DOI 10.1242/dev.00240; Rychel AL, 2007, J EXP ZOOL PART B, V308B, P325, DOI 10.1002/jez.b.21157; Sauka-Spengler T, 2007, DEV CELL, V13, P405, DOI 10.1016/j.devcel.2007.08.005; Schaffer J., 1896, Z WISS ZOOL, V61, P606; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Schwend T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-59; SEUFERT DW, 1994, ANAT EMBRYOL, V189, P81; Shimeld SM, 1999, DEV GENES EVOL, V209, P40, DOI 10.1007/s004270050225; Simoes B, 2006, CALCIFIED TISSUE INT, V79, P230, DOI 10.1007/s00223-006-0111-6; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Sperber SM, 2008, DEV BIOL, V321, P101, DOI 10.1016/j.ydbio.2008.06.004; STOCK DW, 1992, SCIENCE, V257, P787, DOI 10.1126/science.1496398; Stricker S, 2002, DEV BIOL, V245, P95, DOI 10.1006/dbio.2002.0640; TAHARA Y, 1988, ZOOL SCI, V5, P109; Takahashi T, 2004, DEVELOPMENT, V131, P3285, DOI 10.1242/dev.01201; Takio Y, 2007, DEV BIOL, V308, P606, DOI 10.1016/j.ydbio.2007.05.009; ten Berge D, 1998, DEV BIOL, V199, P11, DOI 10.1006/dbio.1998.8921; Wada H, 1998, DEVELOPMENT, V125, P1113; Walshe J, 2003, DEV BIOL, V264, P522, DOI 10.1016/j.ydbio.2003.08.010; Wang CQ, 2010, BLOOD CELL MOL DIS, V44, P275, DOI 10.1016/j.bcmd.2010.01.006; Wenke AK, 2006, BIOCHEM BIOPH RES CO, V345, P495, DOI 10.1016/j.bbrc.2006.04.123; WRIGHT GM, 1982, AM J ANAT, V165, P39, DOI 10.1002/aja.1001650105; WRIGHT GM, 1988, AM J ANAT, V182, P1, DOI 10.1002/aja.1001820102; Yamashita S, 2009, EXP CELL RES, V315, P2231, DOI 10.1016/j.yexcr.2009.03.008; YAN YL, 1995, DEV DYNAM, V203, P363, DOI 10.1002/aja.1002030308; Yan YL, 2005, DEVELOPMENT, V132, P1069, DOI 10.1242/dev.01674; Yan YL, 2002, DEVELOPMENT, V129, P5065; Yoshida CA, 2005, CRIT REV EUKAR GENE, V15, P243, DOI 10.1615/CritRevEukarGeneExpr.v15.i3.60; Zhang GJ, 2006, P NATL ACAD SCI USA, V103, P3180, DOI 10.1073/pnas.0508313103; Zhang GJ, 2006, P NATL ACAD SCI USA, V103, P16829, DOI 10.1073/pnas.0605630103; ZHAO GQ, 1994, MECH DEVELOP, V48, P245, DOI 10.1016/0925-4773(94)90063-9; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F	88	37	37	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22474	10.1371/journal.pone.0022474	http://dx.doi.org/10.1371/journal.pone.0022474			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799866	gold, Green Submitted, Green Published			2022-12-25	WOS:000293097300051
J	Lasek, AW; Lim, J; Kliethermes, CL; Berger, KH; Joslyn, G; Brush, G; Xue, LQ; Robertson, M; Moore, MS; Vranizan, K; Morris, SW; Schuckit, MA; White, RL; Heberlein, U				Lasek, Amy W.; Lim, Jana; Kliethermes, Christopher L.; Berger, Karen H.; Joslyn, Geoff; Brush, Gerry; Xue, Liquan; Robertson, Margaret; Moore, Monica S.; Vranizan, Karen; Morris, Stephan W.; Schuckit, Marc A.; White, Raymond L.; Heberlein, Ulrike			An Evolutionary Conserved Role for Anaplastic Lymphoma Kinase in Behavioral Responses to Ethanol	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; RECOMBINANT INBRED MICE; NEURONAL DIFFERENTIATION; DROSOPHILA-MELANOGASTER; ACTIVATING MUTATIONS; NERVOUS-SYSTEM; C57BL/6J MICE; ALK KINASE; ALCOHOL; GENE	Anaplastic lymphoma kinase (Alk) is a gene expressed in the nervous system that encodes a receptor tyrosine kinase commonly known for its oncogenic function in various human cancers. We have determined that Alk is associated with altered behavioral responses to ethanol in the fruit fly Drosophila melanogaster, in mice, and in humans. Mutant flies containing transposon insertions in dAlk demonstrate increased resistance to the sedating effect of ethanol. Database analyses revealed that Alk expression levels in the brains of recombinant inbred mice are negatively correlated with ethanol-induced ataxia and ethanol consumption. We therefore tested Alk gene knockout mice and found that they sedate longer in response to high doses of ethanol and consume more ethanol than wild-type mice. Finally, sequencing of human ALK led to the discovery of four polymorphisms associated with a low level of response to ethanol, an intermediate phenotype that is predictive of future alcohol use disorders (AUDs). These results suggest that Alk plays an evolutionary conserved role in ethanol-related behaviors. Moreover, ALK may be a novel candidate gene conferring risk for AUDs as well as a potential target for pharmacological intervention.	[Lasek, Amy W.; Lim, Jana; Kliethermes, Christopher L.; Berger, Karen H.; Joslyn, Geoff; Brush, Gerry; Robertson, Margaret; Moore, Monica S.; White, Raymond L.; Heberlein, Ulrike] Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA; [Xue, Liquan; Morris, Stephan W.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Xue, Liquan; Morris, Stephan W.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Vranizan, Karen] Univ Calif Berkeley, Funct Genom Lab, Berkeley, CA 94720 USA; [Schuckit, Marc A.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Heberlein, Ulrike] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Heberlein, Ulrike] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of California System; University of California Berkeley; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lasek, AW (corresponding author), Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA.	alasek@gallo.ucsf.edu; Ulrike.Heberlein@ucsf.edu	Lasek, Amy/AAV-7606-2020	Lasek, Amy/0000-0002-7099-2442	State of California through the University of California San Francisco; National Institutes of Health (NIAAA) through the Alcohol Center for Translational Genetics at the Ernest Gallo Clinic and Research Center; National Institute on Alcohol Abuse and Alcoholism [AA16654-INIA]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010035, U01AA016654] Funding Source: NIH RePORTER	State of California through the University of California San Francisco; National Institutes of Health (NIAAA) through the Alcohol Center for Translational Genetics at the Ernest Gallo Clinic and Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding was provided by the State of California for medical research on alcohol and substance abuse through the University of California San Francisco and the National Institutes of Health (NIAAA), through the Alcohol Center for Translational Genetics at the Ernest Gallo Clinic and Research Center. Additional funding was provided by National Institute on Alcohol Abuse and Alcoholism (AA16654-INIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazigou E, 2007, CELL, V128, P961, DOI 10.1016/j.cell.2007.02.024; Bilsland JG, 2008, NEUROPSYCHOPHARMACOL, V33, P685, DOI 10.1038/sj.npp.1301446; Browman KE, 2000, ALCOHOL CLIN EXP RES, V24, P17, DOI 10.1111/j.1530-0277.2000.tb04547.x; Camicella S, 2009, ALCOHOL, V43, P35, DOI 10.1016/j.alcohol.2008.12.001; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Corl AB, 2009, CELL, V137, P949, DOI 10.1016/j.cell.2009.03.020; Crabbe JC, 2005, NEUROSCI BIOBEHAV R, V28, P785, DOI 10.1016/j.neubiorev.2004.08.002; Ducci F, 2008, ADDICTION, V103, P1414, DOI 10.1111/j.1360-0443.2008.02203.x; Englund C, 2003, NATURE, V425, P512, DOI 10.1038/nature01950; Faccidomo S, 2009, PSYCHOPHARMACOLOGY, V204, P135, DOI 10.1007/s00213-008-1444-9; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Gill K, 1996, ALCOHOL CLIN EXP RES, V20, P185, DOI 10.1111/j.1530-0277.1996.tb01063.x; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Gouzi JY, 2005, J CELL SCI, V118, P5811, DOI 10.1242/jcs.02695; Hansson AC, 2008, EUR J NEUROSCI, V27, P1912, DOI 10.1111/j.1460-9568.2008.06159.x; Heath AC, 1999, PSYCHOL MED, V29, P1069, DOI 10.1017/S0033291799008909; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Kong EC, 2010, ALCOHOL CLIN EXP RES, V34, P302, DOI 10.1111/j.1530-0277.2009.01093.x; Kunugi H, 2006, J NEURAL TRANSM, V113, P1569, DOI 10.1007/s00702-006-0436-3; Lasek AW, 2010, GENES BRAIN BEHAV, V9, P817, DOI 10.1111/j.1601-183X.2010.00620.x; Lasek AW, 2011, LMO GENES R IN PRESS; Loren CE, 2003, EMBO REP, V4, P781, DOI 10.1038/sj.embor.embor897; Loren CE, 2001, GENES CELLS, V6, P531, DOI 10.1046/j.1365-2443.2001.00440.x; Lu L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-444; Mayfield RD, 2008, BRIT J PHARMACOL, V154, P275, DOI 10.1038/bjp.2008.88; Milan M, 1998, GENE DEV, V12, P2912, DOI 10.1101/gad.12.18.2912; Moog-Lutz C, 2005, J BIOL CHEM, V280, P26039, DOI 10.1074/jbc.M501972200; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Mosse YP, 2008, NATURE; Motegi A, 2004, J CELL SCI, V117, P3319, DOI 10.1242/jcs.01183; Mulligan MK, 2006, P NATL ACAD SCI USA, V103, P6368, DOI 10.1073/pnas.0510188103; Overall RW, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.15.003.2009; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Retaux S, 2002, MOL NEUROBIOL, V26, P269, DOI 10.1385/MN:26:2-3:269; Rhodes JS, 2005, PHYSIOL BEHAV, V84, P53, DOI 10.1016/j.physbeh.2004.10.007; Rohrbough J, 2010, DEVELOPMENT, V137, P3523, DOI 10.1242/dev.047878; Rossner MJ, 2006, J NEUROSCI, V26, P9956, DOI 10.1523/JNEUROSCI.0468-06.2006; Rothenfluh A, 2006, CELL, V127, P199, DOI 10.1016/j.cell.2006.09.010; Salomonis N, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r12; Schuckit MA, 2000, ALCOHOL ALCOHOLISM, V35, P242, DOI 10.1093/alcalc/35.3.242; Schuckit MA, 2005, ALCOHOL CLIN EXP RES, V29, P1976, DOI 10.1097/01.alc.0000187598.82921.27; SCHUCKIT MA, 1991, ALCOHOL ALCOHOLISM, P147; Shoresh M, 1998, GENETICS, V150, P283; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Souttou B, 2001, J BIOL CHEM, V276, P9526, DOI 10.1074/jbc.M007333200; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun Y, 2006, MOL CELL BIOL, V26, P5809, DOI 10.1128/MCB.00024-06; Tsai LTY, 2004, PLOS BIOL, V2, P2122, DOI 10.1371/journal.pbio.0020408; Vernersson E, 2006, GENE EXPR PATTERNS, V6, P448, DOI 10.1016/j.modgep.2005.11.006; Wilhelmsen KC, 2003, ALCOHOL CLIN EXP RES, V27, P1041, DOI 10.1097/01.ALC.0000075551.02714.63; Wolf FW, 2002, J NEUROSCI, V22, P11035; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963	54	67	67	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22636	10.1371/journal.pone.0022636	http://dx.doi.org/10.1371/journal.pone.0022636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799923	Green Published, gold, Green Submitted			2022-12-25	WOS:000293097300077
J	Gibbs, BF; Yasinska, IM; Oniku, AE; Sumbayev, VV				Gibbs, Bernhard F.; Yasinska, Inna M.; Oniku, Abraham E.; Sumbayev, Vadim V.			Effects of Stem Cell Factor on Hypoxia-Inducible Factor 1 Alpha Accumulation in Human Acute Myeloid Leukaemia and LAD2 Mast Cells	PLOS ONE			English	Article							SIGNAL-REGULATING KINASE-1; FC-EPSILON-RI; HIF-1-ALPHA PROTEIN; XANTHINE-OXIDASE; DOWN-REGULATION; NADPH-OXIDASE; APOPTOSIS; ACTIVATION; INVOLVEMENT; GLUTATHIONE	Stem cell factor (SCF) is a hematopoietic growth factor that exerts its activity by signalling through the tyrosine kinase receptor known as Kit or CD117. SCF-Kit signalling is crucial for the survival, proliferation and differentiation of hematopoietic cells of myeloid lineage. Furthermore, since myeloid leukaemia cells express the Kit receptor, SCF may play an important role in myeloid leukaemia progression too. However, the mechanisms of this pathophysiological effect remain unclear. Recent evidence shows that SCF triggers accumulation of the inducible alpha subunit of hypoxia-inducible factor 1 (HIF-1) in hematopoietic cells-a transcription complex that plays a pivotal role in cellular adaptation to low oxygen availability. However, it is unknown how SCF impacts on HIF-1 alpha accumulation in human myeloid leukaemia and mast cells. Here we show that SCF induces HIF-1 alpha accumulation in THP-1 human myeloid leukaemia cells but not in LAD2 mast cells. We demonstrated that LAD2 cells have a more robust glutathione (GSH)-dependent antioxidative system compared to THP-1 cells and are therefore protected against the actions of ROS generated in an SCF-dependent manner. BSO-induced GSH depletion led to a significant decrease in HIF-1 alpha prolyl hydroxylase (PHD) activity in THP-1 cells and to near attenuation of it in LAD2 cells. In THP-1 cells, SCF-induced HIF-1 alpha accumulation is controlled via ERK, PI3 kinase/PKC-delta/mTOR-dependent and to a certain extent by redox-dependent mechanisms. These results demonstrate for the first time an important cross-talk of signalling pathways associated with HIF-1 activation-an important stage of the myeloid leukaemia cell life cycle.	[Gibbs, Bernhard F.; Yasinska, Inna M.; Oniku, Abraham E.; Sumbayev, Vadim V.] Univ Kent, Medway Sch Pharm, Canterbury CT2 7NZ, Kent, England	University of Kent	Gibbs, BF (corresponding author), Univ Kent, Medway Sch Pharm, Canterbury CT2 7NZ, Kent, England.	B.F.Gibbs@kent.ac.uk; V.Sumbayev@kent.ac.uk	Sumbayev, Vadim/HCH-7696-2022	Yasinska, Inna/0000-0002-0775-1689	Asthma UK [10/065]	Asthma UK	Work was supported by the Asthma UK Grant (Grant number 10/065 - to Drs. B. F. Gibbs and V. Sumbayev). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2007, GENE, V401, P38, DOI 10.1016/j.gene.2007.06.017; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; George J, 2009, VASC HEALTH RISK MAN, V5, P265, DOI 10.2147/VHRM.S4265; Jelacic T, 2005, BLOOD, V105, P1923, DOI 10.1182/blood-2004-04-1450; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Kim MS, 2008, J IMMUNOL, V180, P4586, DOI 10.4049/jimmunol.180.7.4586; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Kitahata Y, 2010, INT ARCH ALLERGY IMM, V152, P22, DOI 10.1159/000312122; Lall H, 2008, MOL IMMUNOL, V45, P3045, DOI 10.1016/j.molimm.2008.03.014; Lee SJ, 2007, BIOCHEM PHARMACOL, V74, P215, DOI 10.1016/j.bcp.2007.04.011; Maraldi T, 2007, ANTIOXID REDOX SIGN, V9, P271, DOI 10.1089/ars.2007.9.271; Nicholas SA, 2011, CELL MOL LIFE SCI, V68, P151, DOI 10.1007/s00018-010-0450-3; Nicholas SA, 2010, MOL IMMUNOL, V48, P240, DOI 10.1016/j.molimm.2010.08.004; Nicholas SA, 2010, IMMUNOL CELL BIOL, V88, P180, DOI 10.1038/icb.2009.76; Nicholas SA, 2009, CELL RES, V19, P973, DOI 10.1038/cr.2009.44; Oehme F, 2004, ANAL BIOCHEM, V330, P74, DOI 10.1016/j.ab.2004.03.066; Pedersen M, 2008, BIOCHEM BIOPH RES CO, V377, P98, DOI 10.1016/j.bbrc.2008.09.102; Pendleton A, 2003, J BIOL CHEM, V278, P14394, DOI 10.1074/jbc.M206393200; Plo I, 2001, ONCOGENE, V20, P6752, DOI 10.1038/sj.onc.1204877; Pyatt DW, 1996, MOL PHARMACOL, V49, P1097; Rahman A, 2007, FASEB J, V21, pA861; Schwarzer E, 1996, BBA-MOL BASIS DIS, V1316, P169, DOI 10.1016/0925-4439(96)00021-X; Singh A, 2005, BIOCHEM BIOPH RES CO, V331, P1069, DOI 10.1016/j.bbrc.2005.03.235; Sumbayev VV, 2008, FEBS LETT, V582, P319, DOI 10.1016/j.febslet.2007.12.024; Sumbayev VV, 2008, IMMUNOL LETT, V115, P126, DOI 10.1016/j.imlet.2007.10.013; Sumbayev VV, 2010, ARCH IMMUNOL THER EX, V58, P287, DOI 10.1007/s00005-010-0083-0; Sumbayev VV, 2003, FEBS LETT, V535, P106, DOI 10.1016/S0014-5793(02)03887-5; Sumbayev VV, 2002, EUR J PHARMACOL, V444, P1, DOI 10.1016/S0014-2999(02)01555-8; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Welker P, 2004, EXP DERMATOL, V13, P535, DOI 10.1111/j.0906-6705.2004.00193.x; Ye JL, 2009, J NEUROCHEM, V111, P441, DOI 10.1111/j.1471-4159.2009.06328.x; Yuan G, 2008, J CELL PHYSIOL, V217, P674, DOI 10.1002/jcp.21537; Zarember KA, 2005, J CLIN INVEST, V115, P1702, DOI 10.1172/JCI25740; Zhou GF, 2004, J BIOL CHEM, V279, P46595, DOI 10.1074/jbc.M408320200	35	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22502	10.1371/journal.pone.0022502	http://dx.doi.org/10.1371/journal.pone.0022502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799876	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000292931200058
J	Kurokawa, H; Kato, K; Iwanaga, T; Sugi, T; Sudo, A; Kobayashi, K; Gong, HY; Takemae, H; Recuenco, FC; Horimoto, T; Akashi, H				Kurokawa, Hitomi; Kato, Kentaro; Iwanaga, Tatsuya; Sugi, Tatsuki; Sudo, Atsushi; Kobayashi, Kyousuke; Gong, Haiyan; Takemae, Hitoshi; Recuenco, Frances C.; Horimoto, Taisuke; Akashi, Hiroomi			Identification of Toxoplasma gondii cAMP Dependent Protein Kinase and Its Role in the Tachyzoite Growth	PLOS ONE			English	Article							CATALYTIC SUBUNIT; PLASMODIUM-FALCIPARUM; REGULATORY SUBUNIT; TRYPANOSOMA-CRUZI; INHIBITOR; FAMILY; PHOSPHORYLATION; GENE; CLASSIFICATION; EXPRESSION	Background: cAMP-dependent protein kinase (PKA) has been implicated in the asexual stage of the Toxoplasma gondii life cycle through assaying the effect of a PKA-specific inhibitor on its growth rate. Since inhibition of the host cell PKA cannot be ruled out, a more precise evaluation of the role of PKA, as well as characterization of the kinase itself, is necessary. Methodology/Principal Finding: The inhibitory effects of two PKA inhibitors, H89, an ATP-competitive chemical inhibitor, and PKI, a substrate-competitive mammalian natural peptide inhibitor, were estimated. In the in vitro kinase assay, the inhibitory effect of PKI on a recombinant T. gondii PKA catalytic subunit (TgPKA-C) was weaker compared to that on mammalian PKA-C. In a tachyzoite growth assay, PKI had little effect on the growth of tachyzoites, whereas H89 strongly inhibited it. Moreover, T. gondii PKA regulatory subunit (TgPKA-R)-overexpressing tachyzoites showed a significant growth defect. Conclusions/Significance: Our data suggest that PKA plays an important role in the growth of tachyzoites, and the inhibitory effect of substrate-competitive inhibitor PKI on T. gondii PKA was low compared to that of the ATP competitive inhibitor H89.	[Kurokawa, Hitomi; Kato, Kentaro; Iwanaga, Tatsuya; Sugi, Tatsuki; Kobayashi, Kyousuke; Gong, Haiyan; Takemae, Hitoshi; Recuenco, Frances C.; Horimoto, Taisuke; Akashi, Hiroomi] Univ Tokyo, Fac Agr, Dept Vet Microbiol, Bunkyo Ku, Tokyo 113, Japan; [Sudo, Atsushi] Kobe Univ, Sch Med, Chuo Ku, Kobe, Hyogo 650, Japan	University of Tokyo; Kobe University	Kurokawa, H (corresponding author), Univ Tokyo, Fac Agr, Dept Vet Microbiol, Bunkyo Ku, Tokyo 113, Japan.	akkato@mail.ecc.u-tokyo.ac.jp	Sugi, Tatsuki/A-9110-2012; Takemae, Hitoshi/AEP-5503-2022	Recuenco, Frances/0000-0002-0065-3218; Kobayashi, Kyousuke/0000-0001-5501-8396	Bio-Oriented Technology Research Advancement Institution; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Mochida Memorial Foundation for Medical and Pharmaceutical Research	Bio-Oriented Technology Research Advancement Institution; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research	This work was support by the Bio-Oriented Technology Research Advancement Institution, a grant-in-aid for young scientists from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and the Mochida Memorial Foundation for Medical and Pharmaceutical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ES, 2001, J BIOL CHEM, V276, P10320, DOI 10.1074/jbc.M006589200; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bao Y, 2008, INFECT IMMUN, V76, P4757, DOI 10.1128/IAI.00527-08; Bao Y, 2010, MICROBES INFECT, V12, P716, DOI 10.1016/j.micinf.2010.04.014; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; Canaves JM, 2002, J MOL EVOL, V54, P17, DOI 10.1007/s00239-001-0013-1; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Dalton GD, 2006, NEUROPEPTIDES, V40, P23, DOI 10.1016/j.npep.2005.10.002; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Eaton MS, 2006, INT J PARASITOL, V36, P107, DOI 10.1016/j.ijpara.2005.08.014; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; FANTOZZI DA, 1994, J BIOL CHEM, V269, P2676; Filisetti Denis, 2004, Ann Ist Super Sanita, V40, P71; FLOCKHART DA, 1980, J BIOL CHEM, V255, P4435; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Kato K, 2003, J GEN VIROL, V84, P3381, DOI 10.1099/vir.0.19454-0; Kato K, 2001, J GEN VIROL, V82, P1457, DOI 10.1099/0022-1317-82-6-1457; Kato K, 2009, PARASITOL INT, V58, P394, DOI 10.1016/j.parint.2009.08.001; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; KAUSHAL DC, 1980, NATURE, V286, P490, DOI 10.1038/286490a0; Kirkman LA, 2001, INFECT IMMUN, V69, P148, DOI 10.1128/IAI.69.1.148-153.2001; LEVIN LR, 1990, MOL CELL BIOL, V10, P1066, DOI 10.1128/MCB.10.3.1066; Leykauf K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000941; Li JL, 2000, MOL BIOCHEM PARASIT, V109, P157, DOI 10.1016/S0166-6851(00)00242-5; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; LUFT BJ, 1984, JAMA-J AM MED ASSOC, V252, P913, DOI 10.1001/jama.252.7.913; Malki-Feldman L, 2009, EXP PARASITOL, V123, P39, DOI 10.1016/j.exppara.2009.05.010; Merckx A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040019; Nishikawa Y, 2003, INT J PARASITOL, V33, P1525, DOI 10.1016/S0020-7519(03)00204-2; SimanTov MM, 1996, MOL BIOCHEM PARASIT, V77, P201, DOI 10.1016/0166-6851(96)02601-1; Skariah S, 2010, PARASITOL RES, V107, P253, DOI 10.1007/s00436-010-1899-6; Sonda S, 2006, TRENDS PARASITOL, V22, P41, DOI 10.1016/j.pt.2005.11.001; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; Sudo A, 2008, MOL BIOCHEM PARASIT, V160, P138, DOI 10.1016/j.molbiopara.2008.03.011; Sugi T, 2010, EUKARYOT CELL, V9, P667, DOI 10.1128/EC.00351-09; Swierczewski BE, 2010, INT J PARASITOL, V40, P929, DOI 10.1016/j.ijpara.2010.01.001; Swierczewski BE, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000505; Syin C, 2001, EUR J BIOCHEM, V268, P4842, DOI 10.1046/j.1432-1327.2001.02403.x; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; TONERWEBB J, 1992, J BIOL CHEM, V267, P25174; vanderVen AJAM, 1996, J ANTIMICROB CHEMOTH, V38, P75, DOI 10.1093/jac/38.1.75; WEN W, 1994, J BIOL CHEM, V269, P32214; WONG SY, 1993, AIDS, V7, P299, DOI 10.1097/00002030-199303000-00001	45	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22492	10.1371/journal.pone.0022492	http://dx.doi.org/10.1371/journal.pone.0022492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799871	Green Submitted, Green Published, gold			2022-12-25	WOS:000292931200057
J	Prentice, JS; Homann, J; Simmons, KD; Tkacik, G; Balasubramanian, V; Nelson, PC				Prentice, Jason S.; Homann, Jan; Simmons, Kristina D.; Tkacik, Gasper; Balasubramanian, Vijay; Nelson, Philip C.			Fast, Scalable, Bayesian Spike Identification for Multi-Electrode Arrays	PLOS ONE			English	Article							GANGLION-CELLS; NEURONAL SIGNALS; NEURAL SIGNALS; ALPHA-GANGLION; RABBIT RETINA; RAT RETINA; CLASSIFICATION; POPULATION; SIZE	We present an algorithm to identify individual neural spikes observed on high-density multi-electrode arrays (MEAs). Our method can distinguish large numbers of distinct neural units, even when spikes overlap, and accounts for intrinsic variability of spikes from each unit. As MEAs grow larger, it is important to find spike-identification methods that are scalable, that is, the computational cost of spike fitting should scale well with the number of units observed. Our algorithm accomplishes this goal, and is fast, because it exploits the spatial locality of each unit and the basic biophysics of extracellular signal propagation. Human interaction plays a key role in our method; but effort is minimized and streamlined via a graphical interface. We illustrate our method on data from guinea pig retinal ganglion cells and document its performance on simulated data consisting of spikes added to experimentally measured background noise. We present several tests demonstrating that the algorithm is highly accurate: it exhibits low error rates on fits to synthetic data, low refractory violation rates, good receptive field coverage, and consistency across users.	[Prentice, Jason S.; Homann, Jan; Tkacik, Gasper; Balasubramanian, Vijay; Nelson, Philip C.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Simmons, Kristina D.; Balasubramanian, Vijay] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Prentice, JS (corresponding author), Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.	jprentic@sas.upenn.edu	Tkacik, Gasper/C-3510-2011; Nelson, Philip/I-6251-2015	Tkacik, Gasper/0000-0002-6699-1455; Simmons, Kristina/0000-0002-1197-6127; Nelson, Philip/0000-0002-1782-3076	National Science Foundation (NSF) [IBN-0344678, EF-0928048]; National Institutes of Health (NIH) [RO1 EY08124]; NIH [T32-07035, 5T90DA022763-04]; NATIONAL EYE INSTITUTE [R01EY008124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022763] Funding Source: NIH RePORTER; Emerging Frontiers [0928048] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation (NSF) grants IBN-0344678, EF-0928048, National Institutes of Health (NIH) grant RO1 EY08124, NIH training grant T32-07035, and NIH training grant 5T90DA022763-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankerst M, 1999, SIGMOD RECORD, VOL 28, NO 2 - JUNE 1999, P49; ATIYA AF, 1992, IEEE T BIO-MED ENG, V39, P723, DOI 10.1109/10.142647; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; DACEY DM, 1992, P NATL ACAD SCI USA, V89, P9666, DOI 10.1073/pnas.89.20.9666; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; DONASCIMENTO JLM, 1991, BRAZ J MED BIOL RES, V24, P199; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; LEWICKI MS, 1994, NEURAL COMPUT, V6, P1005, DOI 10.1162/neco.1994.6.5.1005; Litke AM, 2004, IEEE T NUCL SCI, V51, P1434, DOI 10.1109/TNS.2004.832706; MALLAT SG, 1993, IEEE T SIGNAL PROCES, V41, P3397, DOI 10.1109/78.258082; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; PEICHL L, 1989, J COMP NEUROL, V286, P120, DOI 10.1002/cne.902860108; PEICHL L, 1987, J COMP NEUROL, V263, P25, DOI 10.1002/cne.902630103; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Quian Quiroga R., 2007, SCHOLARPEDIA, V2, P3583, DOI DOI 10.4249/SCHOLARPEDIA.3583; Ratliff CP, 2010, P NATL ACAD SCI USA, V107, P17368, DOI 10.1073/pnas.1005846107; Sahani M., 1999, THESIS CALIFORNIA I; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; Shoham S, 2003, J NEUROSCI METH, V127, P111, DOI 10.1016/S0165-0270(03)00120-1; Sterlng P, 2004, VISUAL NEUROSCIENCES; TAUCHI M, 1992, EXP BRAIN RES, V88, P67, DOI 10.1007/BF02259129; Tkaficik G, 2010, P NATL ACAD SCI USA, V107, P14419; Ventura V, 2009, P NATL ACAD SCI USA, V106, P6921, DOI 10.1073/pnas.0901771106	29	48	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e19884	10.1371/journal.pone.0019884	http://dx.doi.org/10.1371/journal.pone.0019884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799725	Green Published, Green Submitted, gold			2022-12-25	WOS:000292931200001
J	Kluza, J; Jendoubi, M; Ballot, C; Dammak, A; Jonneaux, A; Idziorek, T; Joha, S; Dauphin, V; Malet-Martino, M; Balayssac, S; Maboudou, P; Briand, G; Formstecher, P; Quesnel, B; Marchetti, P				Kluza, Jerome; Jendoubi, Manel; Ballot, Caroline; Dammak, Abir; Jonneaux, Aurelie; Idziorek, Thierry; Joha, Sami; Dauphin, Veronique; Malet-Martino, Myriam; Balayssac, Stephane; Maboudou, Patrice; Briand, Gilbert; Formstecher, Pierre; Quesnel, Bruno; Marchetti, Philippe			Exploiting Mitochondrial Dysfunction for Effective Elimination of Imatinib-Resistant Leukemic Cells	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; GLUCOSE-TRANSPORT REGULATION; KINASE DOMAIN MUTATIONS; ABL-POSITIVE CELLS; BCR-ABL; CANCER-CELLS; SUPEROXIDE-PRODUCTION; AEROBIC GLYCOLYSIS; MEDIATED MECHANISM; APOPTOSIS	Challenges today concern chronic myeloid leukemia (CML) patients resistant to imatinib. There is growing evidence that imatinib-resistant leukemic cells present abnormal glucose metabolism but the impact on mitochondria has been neglected. Our work aimed to better understand and exploit the metabolic alterations of imatinib-resistant leukemic cells. Imatinib-resistant cells presented high glycolysis as compared to sensitive cells. Consistently, expression of key glycolytic enzymes, at least partly mediated by HIF-1 alpha, was modified in imatinib-resistant cells suggesting that imatinib-resistant cells uncouple glycolytic flux from pyruvate oxidation. Interestingly, mitochondria of imatinib-resistant cells exhibited accumulation of TCA cycle intermediates, increased NADH and low oxygen consumption. These mitochondrial alterations due to the partial failure of ETC were further confirmed in leukemic cells isolated from some imatinib-resistant CML patients. As a consequence, mitochondria generated more ROS than those of imatinib-sensitive cells. This, in turn, resulted in increased death of imatinib-resistant leukemic cells following in vitro or in vivo treatment with the pro-oxidants, PEITC and Trisenox, in a syngeneic mouse tumor model. Conversely, inhibition of glycolysis caused derepression of respiration leading to lower cellular ROS. In conclusion, these findings indicate that imatinib-resistant leukemic cells have an unexpected mitochondrial dysfunction that could be exploited for selective therapeutic intervention.	[Kluza, Jerome; Jendoubi, Manel; Ballot, Caroline; Dammak, Abir; Jonneaux, Aurelie; Formstecher, Pierre; Marchetti, Philippe] Univ Lille 2, Equipe UMR Inserm 4 837, Fac Med, Lille, France; [Idziorek, Thierry; Joha, Sami; Dauphin, Veronique; Quesnel, Bruno] Equipe 3 UMR 837, Lille, France; [Idziorek, Thierry; Joha, Sami; Dauphin, Veronique; Quesnel, Bruno] Inst Rech Canc Lille, Lille, France; [Malet-Martino, Myriam; Balayssac, Stephane] Univ Toulouse 3, Lab Synth & Physicochim Mol Interet Biol, UMR CNRS 5068, F-31062 Toulouse, France; [Maboudou, Patrice; Briand, Gilbert; Marchetti, Philippe] Ctr Hosp Reg Univ, Ctr Biopathol Plate Forme Biotherapie & Banque Ti, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; CHU Lille	Kluza, J (corresponding author), Univ Lille 2, Equipe UMR Inserm 4 837, Fac Med, Lille, France.	philippe.marchetti@inserm.fr	Quesnel, Bruno/D-5533-2018; Kluza, Jérome/B-6312-2012	Quesnel, Bruno/0000-0002-6563-2709; Kluza, Jérome/0000-0002-7346-1305; MARCHETTI, Philippe/0000-0002-4663-6800; Jendoubi, Manel/0000-0002-1047-1274	Fondation de France; Ligue contre le cancer (Comite de l'Aisne); ARC; INSERM-Region Nord Pas de Calais	Fondation de France(Fondation de France); Ligue contre le cancer (Comite de l'Aisne); ARC(Australian Research Council); INSERM-Region Nord Pas de Calais(Institut National de la Sante et de la Recherche Medicale (Inserm)Region Hauts-de-France)	This work received financial support from the Fondation de France and Ligue contre le cancer (Comite de l'Aisne) to PM. JK received a fellowship from ARC. CB was the recipient of a grant from INSERM-Region Nord Pas de Calais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballot C, 2010, APOPTOSIS, V15, P769, DOI 10.1007/s10495-010-0471-2; Barnes K, 2005, ONCOGENE, V24, P3257, DOI 10.1038/sj.onc.1208461; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bentley J, 2003, J BIOL CHEM, V278, P39337, DOI 10.1074/jbc.M305689200; Bentley J, 2001, BRIT J HAEMATOL, V112, P212, DOI 10.1046/j.1365-2141.2001.02428.x; Boag JM, 2006, LEUKEMIA, V20, P1731, DOI 10.1038/sj.leu.2404365; Boren J, 2001, J BIOL CHEM, V276, P37747; Castera L, 2009, J CELL MOL MED, V13, P1321, DOI 10.1111/j.1582-4934.2008.00358.x; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Gottschalk S, 2004, CLIN CANCER RES, V10, P6661, DOI 10.1158/1078-0432.CCR-04-0039; Kim JH, 2005, BLOOD, V105, P1717, DOI 10.1182/blood-2004-03-0849; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Klawitter J, 2009, BRIT J CANCER, V100, P923, DOI 10.1038/sj.bjc.6604946; Klawitter J, 2009, BRIT J PHARMACOL, V158, P588, DOI 10.1111/j.1476-5381.2009.00345.x; Kluza J, 2006, CANCER RES, V66, P3177, DOI 10.1158/0008-5472.CAN-05-1929; Kluza J, 2004, ONCOGENE, V23, P7018, DOI 10.1038/sj.onc.1207936; Kominsky DJ, 2009, CLIN CANCER RES, V15, P3442, DOI 10.1158/1078-0432.CCR-08-3291; Koptyra M, 2006, BLOOD, V108, P319, DOI 10.1182/blood-2005-07-2815; Liu J, 2008, LEUKEMIA, V22, P791, DOI 10.1038/leu.2008.3; Mahon FX, 2008, CANCER RES, V68, P9809, DOI 10.1158/0008-5472.CAN-08-1008; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Mason EF, 2010, CANCER RES, V70, P8066, DOI 10.1158/0008-5472.CAN-10-0608; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Naughton R, 2009, LEUKEMIA, V23, P1432, DOI 10.1038/leu.2009.49; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Sattler M, 2000, J BIOL CHEM, V275, P24273, DOI 10.1074/jbc.M002094200; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vereecque R, 1999, LEUKEMIA RES, V23, P415; Walz C, 2006, CRIT REV ONCOL HEMAT, V57, P145, DOI 10.1016/j.critrevonc.2005.06.007; WARBURG O, 1956, SCIENCE, V124, P269; Wei Y, 2006, ANN HEMATOL, V85, P841, DOI 10.1007/s00277-006-0171-8; Xu RH, 2005, CANCER RES, V65, P613; Zhang H, 2008, LEUKEMIA, V22, P1191, DOI 10.1038/leu.2008.74; Zhao F, 2010, ONCOGENE, V29, P2962, DOI 10.1038/onc.2010.67	44	44	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e21924	10.1371/journal.pone.0021924	http://dx.doi.org/10.1371/journal.pone.0021924			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789194	Green Published, Green Submitted, gold			2022-12-25	WOS:000292812400020
J	Oster, M; Murani, E; Metges, CC; Ponsuksili, S; Wimmers, K				Oster, Michael; Murani, Eduard; Metges, Cornelia C.; Ponsuksili, Siriluck; Wimmers, Klaus			A High Protein Diet during Pregnancy Affects Hepatic Gene Expression of Energy Sensing Pathways along Ontogenesis in a Porcine Model	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; FOLIC-ACID SUPPLEMENTATION; MATERNAL LOW; METABOLIC SYNDROME; RESTRICTION LEADS; MAMMALIAN TARGET; RAPAMYCIN MTOR; FETAL-RAT; IGF-I; KINASE	In rodent models and in humans the impact of gestational diets on the offspring's phenotype was shown experimentally and epidemiologically. The underlying programming of fetal development was shown to be associated with an increased risk of degenerative diseases in adulthood, including the metabolic syndrome. There are clues that diet-dependent modifications of the metabolism during fetal life can persist until adulthood. This leads to the hypothesis that the offspring's transcriptomes show short-term and long-term changes depending on the maternal diet. To this end pregnant German landrace gilts were fed either a high protein diet (HP, 30% CP) or an adequate protein diet (AP, 12% CP) throughout pregnancy. Hepatic transcriptome profiles of the offspring were analyzed at prenatal (94 dpc) and postnatal stages (1, 28, 188 dpn). Depending on the gestational dietary exposure, mRNA expression levels of genes related to energy metabolism, N-metabolism, growth factor signaling pathways, lipid metabolism, nucleic acid metabolism and stress/immune response were affected either in a short-term or in a long-term manner. Gene expression profiles at fetal stage 94 dpc were almost unchanged between the diets. The gestational HP diet affected the hepatic expression profiles at prenatal and postnatal stages. The effects encompassed a modulation of the genome in terms of an altered responsiveness of energy and nutrient sensing pathways. Differential expression of genes related to energy production and nutrient utilization contribute to the maintenance of development and growth performance within physiological norms, however the modulation of these pathways may be accompanied by a predisposition for metabolic disturbances up to adult stages.	[Oster, Michael; Murani, Eduard; Wimmers, Klaus] Leibniz Inst Farm Anim Biol FBN, Res Unit Mol Biol, Dummerstorf, Germany; [Metges, Cornelia C.] Leibniz Inst Farm Anim Biol FBN, Res Unit Physiol Nutr, Dummerstorf, Germany; [Ponsuksili, Siriluck] Leibniz Inst Farm Anim Biol FBN, Res Grp Funct Genom, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN)	Oster, M (corresponding author), Leibniz Inst Farm Anim Biol FBN, Res Unit Mol Biol, Dummerstorf, Germany.	wimmers@fbn-dummerstorf.de	Wimmers, Klaus/AAF-9434-2020	Wimmers, Klaus/0000-0002-9523-6790	German Federal Ministry of Education and Research [FKZ 0315132A]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study is part of the project FEPROeXPRESS (FUGATOplus (http://www.fugato-forschung.de/), FKZ 0315132A), which is funded by the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasyan K, 2007, EUR J CLIN NUTR, V61, P498, DOI 10.1038/sj.ejcn.1602552; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bertram C, 2001, ENDOCRINOLOGY, V142, P2841, DOI 10.1210/en.142.7.2841; CAMPBELLBROWN M, 1986, P NUTR SOC, V45, pA90; Chmurzynska A, 2010, NUTR REV, V68, P87, DOI 10.1111/j.1753-4887.2009.00265.x; Ciciarello M, 2007, CELL MOL LIFE SCI, V64, P1891, DOI 10.1007/s00018-007-6568-2; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; Coupe B, 2009, AM J PHYSIOL-REG I, V297, pR813, DOI 10.1152/ajpregu.00201.2009; Daenzer M, 2002, J NUTR, V132, P142, DOI 10.1093/jn/132.2.142; Desai M, 1996, BRIT J NUTR, V76, P591, DOI 10.1079/BJN19960065; El Khattabi I, 2003, AM J PHYSIOL-ENDOC M, V285, pE991, DOI 10.1152/ajpendo.00037.2003; Fernandez-Twinn DS, 2005, AM J PHYSIOL-REG I, V288, pR368, DOI 10.1152/ajpregu.00206.2004; Fernandez-Twinn DS, 2003, BRIT J NUTR, V90, P815, DOI 10.1079/BJN2003967; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gotea V, 2008, NUCLEIC ACIDS RES, V36, pW133, DOI 10.1093/nar/gkn300; Graziewicz MA, 2002, NUCLEIC ACIDS RES, V30, P2817, DOI 10.1093/nar/gkf392; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hetzer M, 2002, NAT CELL BIOL, V4, pE177, DOI 10.1038/ncb0702-e177; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kuhla B, 2010, PROTEOMICS, V10, P2573, DOI 10.1002/pmic.200900789; LANGLEY SC, 1994, CLIN SCI, V86, P217, DOI 10.1042/cs0860217; Liebermann DA, 2003, BLOOD CELL MOL DIS, V31, P213, DOI 10.1016/S1079-9796(03)00160-8; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lillycrop KA, 2010, BRIT J NUTR, V103, P1711, DOI 10.1017/S0007114509993795; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Mathers JC, 2009, ADV EXP MED BIOL, V646, P119, DOI 10.1007/978-1-4020-9173-5_13; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; McNeil CJ, 2009, GENES NUTR, V4, P189, DOI 10.1007/s12263-009-0125-6; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Naraballobh W, 2010, ARCH TIERZUCHT, V53, P230, DOI 10.5194/aab-53-230-2010; Nijland MJ, 2007, J PHYSIOL-LONDON, V579, P643, DOI 10.1113/jphysiol.2006.122101; Olson M., 2001, Current Molecular Medicine (Hilversum), V1, P91, DOI 10.2174/1566524013364239; Ozanne SE, 2003, J ENDOCRINOL, V177, P235, DOI 10.1677/joe.0.1770235; Petry C J, 2001, Int J Exp Diabetes Res, V2, P139; Pluske JR, 1997, LIVEST PROD SCI, V51, P215, DOI 10.1016/S0301-6226(97)00057-2; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; Rehfeldt C, 2011, J ANIM SCI, V89, P329, DOI 10.2527/jas.2010-2970; Rehfeldt C, 2008, P INT C MEAT SCI TEC; Rehfeldt C, 2011, EUR J NUTR; Ren J, 2010, J MOL MED, V88, P993, DOI 10.1007/s00109-010-0663-9; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; RUSH D, 1989, EFFECTS CHANGES MATE, P203; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sarr O, 2010, J ANIM SCI, V88, P1626, DOI 10.2527/jas.2009-2542; Shepherd PR, 1997, BRIT J NUTR, V78, P121, DOI 10.1079/BJN19970124; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sutherland LN, 2008, AM J PHYSIOL-ENDOC M, V295, pE1076, DOI 10.1152/ajpendo.90408.2008; Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1; Theys N, 2009, AM J PHYSIOL-REG I, V297, pR1516, DOI 10.1152/ajpregu.00280.2009; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Wu GY, 2008, ARCH TIERZUCHT, V51, P4; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	67	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e21691	10.1371/journal.pone.0021691	http://dx.doi.org/10.1371/journal.pone.0021691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789176	Green Published, gold, Green Submitted			2022-12-25	WOS:000292812400012
J	Parczewski, M; Bander, D; Leszczyszyn-Pynka, M; Urbanska, A; Kaczmarczyk, M; Ciechanowicz, A; Boron-Kaczmarska, A				Parczewski, Milosz; Bander, Dorota; Leszczyszyn-Pynka, Magdalena; Urbanska, Anna; Kaczmarczyk, Mariusz; Ciechanowicz, Andrzej; Boron-Kaczmarska, Anna			Risk of All-Cause Mortality in HIV Infected Patients Is Associated with Clinical, Immunologic Predictors and the CCR5 Delta 32 Deletion	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; CCR5 DELTA-32 DELETION; AIDS-FREE SURVIVAL; DISEASE PROGRESSION; HIV-1-INFECTED PATIENTS; INTERNATIONAL METAANALYSIS; VIROLOGICAL RESPONSE; CCR2-64I ALLELES; NAIVE PATIENTS; VIRAL LOAD	Objective: Investigation of the interplay between the CCR5 Delta 32/wt genotype and demographic, epidemiological, clinical and immunological factors associated with mortality in the cART era. Design: Longitudinal data from 507 HIV-infected patients following the Delta 32 allele detection were analyzed. Methods: Cumulative 15 years mortality was calculated using Kaplan-Meyer methodology. Hazard ratios were estimated using univariate Cox models. Basing on Akakie information criteria and statistical significance multivariate Cox model was constructed and effect plots presenting adjusted hazard ratio time-dependency were drawn. Analysis of the association of all-cause mortality and CCR5 Delta 32/wt genotype prior to the antiretroviral treatment (cART) initiation (n = 507) and on the therapy (n = 422) was also performed. Results: A mortality rate of 2.66 (CI 2.57-3.19) per 100 person-years was observed. Univariate analysis factors modifying the risk of death included the CCR5 genotype, gender, history of cART, AIDS diagnosis and also CD4 lymphocyte nadir, zenith, the latest CD4 count and stable levels >500 cells/mu l. For multivariate analysis the following predictors were selected: CCR5 genotype (HR for wt/wt 2.53, CI 1.16-5.53, p = 0.02), gender (HR for males 1.91, 95% CI 1.1-3.36, p = 0.023), introduction of combined antiretroviral treatment (HR 4.85, CI 3.0-7.89, if untreated or treated <1 month, p<0.0001) CD4 count of 500 cells/mu l for six months or more (HR 4.16, CI 1.95-8.88 if not achieved, p = 0.028), the latest CD4 count (HR 5.44, CI 3.39-8.74 for <100 cells/mu l, p<0.0001) and history of AIDS (HR 1.69, CI 1.03-2.79, p = 0.039). Among untreated individuals the Delta 32/wt genotype was associated with notably better survival (p = 0.026), while among cART treated individuals the D32 mutation did not correlate significantly with higher survival rates (p = 0.23). Conclusions: The Delta 32 CCR5 allele is associated with a reduction of the risk of all-cause mortality in HIV (+) patients alongside clinical and immunologic predictors such as AIDS, history of cART, lymphocyte CD4 cell count and gender.	[Parczewski, Milosz; Bander, Dorota; Leszczyszyn-Pynka, Magdalena; Urbanska, Anna; Boron-Kaczmarska, Anna] Pomeranian Med Univ, Dept Infect Dis & Hepatol, Szczecin, Poland; [Kaczmarczyk, Mariusz; Ciechanowicz, Andrzej] Pomeranian Med Univ, Dept Mol Med, Szczecin, Poland	Pomeranian Medical University; Pomeranian Medical University	Parczewski, M (corresponding author), Pomeranian Med Univ, Dept Infect Dis & Hepatol, Szczecin, Poland.	mparczewski@yahoo.co.uk	Ciechanowicz, Andrzej/W-8594-2018; Parczewski, Milosz/I-1869-2014; Parczewski, Milosz/AAV-4280-2021; Kaczmarczyk, Mariusz/M-7809-2016	Ciechanowicz, Andrzej/0000-0002-3804-440X; Parczewski, Milosz/0000-0003-1869-1084; Parczewski, Milosz/0000-0003-1869-1084; Bander, Dorota/0000-0002-1717-6198; Kaczmarczyk, Mariusz/0000-0002-0180-644X	Polish Ministry of Science and Higher Education;  [PBZ-KBN-119/P05/2005/06]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); 	Funding for this study was obtained from the research grant of Polish Ministry of Science and Higher Education "Iuventus Plus'' and grant number PBZ-KBN-119/P05/2005/06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achhra AC, 2010, AIDS, V24, P1877, DOI 10.1097/QAD.0b013e32833b1b26; Adler A, 2009, AIDS CARE, V21, P284, DOI 10.1080/09540120802183537; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alexander M, 2010, J VIROL, V84, P4100, DOI 10.1128/JVI.02068-09; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; ANTINORI A, 2010, LATE PRESENTATION HI; Bander Dorota, 2009, Przegl Epidemiol, V63, P61; Bratt G, 1998, AIDS, V12, P2193, DOI 10.1097/00002030-199816000-00015; Bron R, 1997, J VIROL, V71, P8405, DOI 10.1128/JVI.71.11.8405-8415.1997; Brumme ZL, 2005, ANTIVIR THER, V10, P849; Brumme ZL, 2001, AIDS, V15, P2259, DOI 10.1097/00002030-200111230-00007; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; EugenOlsen J, 1997, AIDS, V11, P305, DOI 10.1097/00002030-199703110-00007; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Gatell JM, 2010, J ANTIMICROB CHEMOTH, V65, P383, DOI 10.1093/jac/dkp487; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Guerin S, 2000, AIDS, V14, P2788, DOI 10.1097/00002030-200012010-00020; Hendrickson SL, 2008, JAIDS-J ACQ IMM DEF, V48, P263, DOI 10.1097/QAI.0b013e31816fdc5f; Ioannidis JPA, 2003, AIDS, V17, P1631, DOI 10.1097/00002030-200307250-00007; Ioannidis JPA, 2001, ANN INTERN MED, V135, P782, DOI 10.7326/0003-4819-135-9-200111060-00008; Laurichesse JJ, 2007, HIV MED, V8, P213, DOI 10.1111/j.1468-1293.2007.00455.x; Laurichesse JJ, 2010, HIV MED, V11, P239, DOI 10.1111/j.1468-1293.2009.00769.x; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Lodwick RK, 2010, LANCET, V376, P340, DOI 10.1016/S0140-6736(10)60932-4; Mahajan SD, 2010, BIOCHEM BIOPH RES CO, V396, P348, DOI 10.1016/j.bbrc.2010.04.095; McKinnon LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011434; Meyer L, 1997, AIDS, V11, pF73, DOI 10.1097/00002030-199711000-00001; Mulherin SA, 2003, AIDS, V17, P377, DOI 10.1097/00002030-200302140-00012; Neuhaus J, 2010, AIDS, V24, P697, DOI 10.1097/QAD.0b013e3283365356; O'Brien TR, 2000, AIDS, V14, P821, DOI 10.1097/00002030-200005050-00008; Parczewski M, 2009, J APPL GENET, V50, P159, DOI 10.1007/BF03195668; Philpott S, 2003, J INFECT DIS, V187, P569, DOI 10.1086/367995; Rector A, 2001, HUM GENET, V108, P190, DOI 10.1007/s004390100462; Simon B, 2010, AIDS, V24, P2051, DOI 10.1097/QAD.0b013e32833c93e6; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681	35	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22215	10.1371/journal.pone.0022215	http://dx.doi.org/10.1371/journal.pone.0022215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789236	Green Submitted, gold, Green Published			2022-12-25	WOS:000292812400039
J	Vilas, JS; Pannell, JR				Vilas, Julia Sanchez; Pannell, John R.			Sex-Differential Herbivory in Androdioecious Mercurialis annua	PLOS ONE			English	Article							BIASED HERBIVORY; PLANT; DEFENSE; EVOLUTION; COSTS; REPRODUCTION; METAANALYSIS; ALLOCATION; HEMIPTERA; FITNESS	Males of plants with separate sexes are often more prone to attack by herbivores than females. A common explanation for this pattern is that individuals with a greater male function suffer more from herbivory because they grow more quickly, drawing more heavily on resources for growth that might otherwise be allocated to defence. Here, we test this 'faster-sex' hypothesis in a species in which males in fact grow more slowly than hermaphrodites, the wind-pollinated annual herb Mercurialis annua. We expected greater herbivory in the faster-growing hermaphrodites. In contrast, we found that males, the slower sex, were significantly more heavily eaten by snails than hermaphrodites. Our results thus reject the faster-sex hypothesis and point to the importance of a trade-off between defence and reproduction rather than growth.	[Vilas, Julia Sanchez; Pannell, John R.] Univ Oxford, Dept Plant Sci, Oxford, England	University of Oxford	Vilas, JS (corresponding author), Univ Oxford, Dept Plant Sci, Oxford, England.	julia.sanchezvilas@gmail.com	VILAS, JULIA SANCHEZ/AAA-7475-2020	VILAS, JULIA SANCHEZ/0000-0002-4049-8443; Pannell, John/0000-0002-0098-7074	Xunta de Galicia (Spain)	Xunta de Galicia (Spain)(Xunta de Galicia)	JSV was supported by a postdoctoral fellowship from Xunta de Galicia (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren J., 1999, GENDER SEXUAL DIMORP, P217, DOI DOI 10.1007/978-3-662-03908-3_8; Ashman TL, 2004, ECOLOGY, V85, P2550, DOI 10.1890/03-0495; Ashman TL, 2002, ECOLOGY, V83, P1175, DOI 10.1890/0012-9658(2002)083[1175:TROHIT]2.0.CO;2; BOECKLEN WJ, 1993, OECOLOGIA, V96, P49, DOI 10.1007/BF00318030; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Cook CDK., 1968, FLORA EUROPAEA, P295; Cornelissen T, 2005, OIKOS, V111, P488, DOI 10.1111/j.1600-0706.2005.14075.x; DANELL K, 1985, OIKOS, V44, P82, DOI 10.2307/3544047; Dorken ME, 2008, AM NAT, V171, P824, DOI 10.1086/587524; Durand B, 1963, ANN SCI NAT BOT BIOL, V12, P579, DOI DOI 10.1080/01811797.1992.10824974; Friedman J, 2009, ANN BOT-LONDON, V103, P1515, DOI 10.1093/aob/mcp035; Geber MA, 1999, GENDER SEXUAL DIMORP; Harris MS, 2008, P ROY SOC B-BIOL SCI, V275, P2595, DOI 10.1098/rspb.2008.0585; Hendricks BJ, 2003, ECOL RES, V18, P247, DOI 10.1046/j.1440-1703.2003.00551.x; JING SW, 1990, OIKOS, V58, P369, DOI 10.2307/3545228; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Lorenz P, 2010, PHYTOCHEM ANALYSIS, V21, P234, DOI 10.1002/pca.1190; MUENCHOW G, 1992, AM MIDL NAT, V127, P355, DOI 10.2307/2426542; Muenchow GE, 1998, AM J BOT, V85, P513, DOI 10.2307/2446435; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; OSTROZHENKOVA E, 2010, BIOSYNTHESIS HERMIDI, P33; PALO RT, 1984, J CHEM ECOL, V10, P499, DOI 10.1007/BF00988096; Pannell J, 1997, BIOL J LINN SOC, V61, P95, DOI 10.1006/bijl.1996.0117; Pannell J, 1997, J ECOL, V85, P57, DOI 10.2307/2960627; Pannell JR, 2002, ANNU REV ECOL SYST, V33, P397, DOI 10.1146/annurev.ecolsys.33.010802.150419; POLHEMUS DA, 1988, ANN ENTOMOL SOC AM, V81, P742, DOI 10.1093/aesa/81.5.742; PRICE PW, 1989, J CHEM ECOL, V15, P1117, DOI 10.1007/BF01014816; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Vilas JS, 2011, ANN BOT-LONDON, V107, P119, DOI 10.1093/aob/mcq209	31	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22083	10.1371/journal.pone.0022083	http://dx.doi.org/10.1371/journal.pone.0022083			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21779379	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000292781500030
J	Lee, KM; Choi, WI; Koh, DI; Kim, YJ; Jeon, BN; Yoon, JH; Lee, CE; Kim, SH; Oh, J; Hur, MW				Lee, K. M.; Choi, W. I.; Koh, D. I.; Kim, Y. J.; Jeon, B. N.; Yoon, J. H.; Lee, C. E.; Kim, S. H.; Oh, J.; Hur, M. W.			The proto-oncoprotein KR-POK represses transcriptional activation of CDKN1A by MIZ-1 through competitive binding	ONCOGENE			English	Article						MIZ-1; Kr-pok; CDKN1A; p21; competition; cell proliferation	ACUTE PROMYELOCYTIC LEUKEMIA; INTERACTION MOTIF; P53 PATHWAY; STEM-CELLS; GENE; DOMAIN; P21CIP1; BCL-6; SP1; P21	The BTB/POZ family of proteins has been implicated in multiple biological processes, including tumourigenesis, DNA damage responses and cell cycle progression and development. MIZ-1 (Myc-interacting zinc-finger protein 1) is known to activate transcription of CDKN1A. We recently found that a kidney cancer-related POK transcription factor, KR-POK, is highly expressed in kidney, brain and bone marrow cancer tissues and is a potential proto-oncoprotein. Mouse Kr-pok represses transcription of the CDKN1A by acting on the proximal promoter. The BiFC/FRET assay, co-immunoprecipitation and glutathione S-transferase-fusion protein pull-down assay indicate that MIZ-1 and Kr-pok interact via their POZ domains. Oligoucleotide pull-down assays and chromatin immunoprecipitation assays revealed that MIZ-1 binds to the proximal GC-box#3 (bp, -55 to -63) and the MIZ-1-binding elements, MRE-A (bp, -90 to -64) and MRE-B (bp, -27 to -17). Interestingly, MIZ-1 also binds to the distal p53-binding elements. Kr-pok binds to the proximal GC-box#1 (bp, -95 to -100) and #3 (bp, -55 to -63) relatively strongly. It also shows weak binding to the MREs and the distal p53-binding elements. Kr-pok competes with MIZ-1 in binding to these elements and represses transcription by inhibiting MIZ-1/p300 recruitment, which decreases the acetylation of histones H3 and H4. Our data indicate that Kr-pok stimulates cell proliferation by interfering with the function of MIZ-1 in CDKN1A gene transcription using a mechanism that is radically different from other MIZ-1-interacting proteins, such as B-cell lymphoma 6, c-Myc and Gfi-1. Oncogene (2012) 31, 1442-1458; doi:10.1038/onc.2011.331; published online 1 August 2011	[Lee, K. M.; Choi, W. I.; Koh, D. I.; Kim, Y. J.; Jeon, B. N.; Yoon, J. H.; Hur, M. W.] Yonsei Univ, Brain Korea Project Med Sci 21, Dept Biochem & Mol Biol, Severance Biomed Res Inst,Sch Med, Seoul 120752, South Korea; [Lee, C. E.; Kim, S. H.; Oh, J.] Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea	Yonsei University; Sungkyunkwan University (SKKU)	Hur, MW (corresponding author), Yonsei Univ, Brain Korea Project Med Sci 21, Dept Biochem & Mol Biol, Severance Biomed Res Inst,Sch Med, 134 ShinChon Dong, Seoul 120752, South Korea.	mwhur2@yuhs.ac		Hur, Man-Wook/0000-0002-3416-1334; CHOI, WONIL/0000-0002-4837-0436	Basic Science Research Grant [314-2008-1-E00030]; MRC from the National Research Foundation of Korea [R13-2002-054-05002-0]; Yonsei University School of Medicine	Basic Science Research Grant; MRC from the National Research Foundation of Korea(National Research Foundation of Korea); Yonsei University School of Medicine	This work was mainly funded by a Basic Science Research Grant (314-2008-1-E00030 to M-W Hur and C-E Lee), and MRC (R13-2002-054-05002-0) from the National Research Foundation of Korea, and also by a Faculty Research Grant from Yonsei University School of Medicine.	ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Aravind L, 1999, J MOL BIOL, V285, P1353, DOI 10.1006/jmbi.1998.2394; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Basu S, 2009, P NATL ACAD SCI USA, V106, P1433, DOI 10.1073/pnas.0804863106; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Choi WI, 2008, J BIOL CHEM, V283, P29341, DOI 10.1074/jbc.M802477200; Choi WI, 2009, J BIOL CHEM, V284, P12633, DOI 10.1074/jbc.M809794200; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dong S, 1996, P NATL ACAD SCI USA, V93, P3624, DOI 10.1073/pnas.93.8.3624; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gartel AL, 2009, BIOFACTORS, V35, P161, DOI 10.1002/biof.26; He X, 2010, ANNU REV IMMUNOL, V28, P295, DOI 10.1146/annurev.immunol.25.022106.141715; Huynh KD, 2000, GENE DEV, V14, P1810; Issa JPJ, 1997, CANCER RES, V57, P1678; Jeon BN, 2009, J BIOL CHEM, V284, P17935, DOI 10.1074/jbc.M809559200; Jeon BN, 2008, J BIOL CHEM, V283, P33199, DOI 10.1074/jbc.M802935200; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; Kim MH, 2007, CELL PHYSIOL BIOCHEM, V20, P703, DOI 10.1159/000110431; Koh DI, 2009, J BIOL CHEM, V284, P19856, DOI 10.1074/jbc.M109.025817; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P213, DOI 10.1016/0968-0004(92)90379-N; Koutsodontis G, 2001, J BIOL CHEM, V276, P29116, DOI 10.1074/jbc.M104130200; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Liu Q, 2010, ONCOGENE, V29, P2843, DOI 10.1038/onc.2010.48; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Piluso D, 2002, J BIOL CHEM, V277, P46799, DOI 10.1074/jbc.M206226200; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Weber A, 2008, EMBO J, V27, P1563, DOI 10.1038/emboj.2008.85; Willenbring H, 2008, CANCER CELL, V14, P59, DOI 10.1016/j.ccr.2008.05.004; Yamochi T, 1999, ONCOGENE, V18, P487, DOI 10.1038/sj.onc.1202334; Zhan FH, 2007, BLOOD, V109, P1692, DOI 10.1182/blood-2006-07-037077	44	11	11	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	11					1442	1458		10.1038/onc.2011.331	http://dx.doi.org/10.1038/onc.2011.331			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	912FL	21804610				2022-12-25	WOS:000301780000011
J	Kanagasabai, R; Krishnamurthy, K; Druhan, LJ; Ilangovan, G				Kanagasabai, Ragu; Krishnamurthy, Karthikeyan; Druhan, Lawrence J.; Ilangovan, Govindasamy			Forced Expression of Heat Shock Protein 27 (Hsp27) Reverses P-Glycoprotein (ABCB1)-mediated Drug Efflux and MDR1 Gene Expression in Adriamycin-resistant Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; TUMOR-SUPPRESSOR P53; MUTANT P53; MULTIDRUG-RESISTANCE; INDUCED APOPTOSIS; WILD-TYPE; TRANSCRIPTIONAL REPRESSION; ANTICANCER AGENTS; BINDING PROTEIN	Mutant p53 accumulation has been shown to induce the multidrug resistance gene (MDR1) and ATP binding cassette (ABC)-based drug efflux in human breast cancer cells. In the present work, we have found that transcriptional activation of the oxidative stress-responsive heat shock factor 1 (HSF-1) and expression of heat shock proteins, including Hsp27, which is normally known to augment proteasomal p53 degradation, are inhibited in Adriamycin (doxorubicin)-resistant MCF-7 cells (MCF-7/adr). Such an endogenous inhibition of HSF-1 and Hsp27 in turn results in p53 mutation with gain of function in its transcriptional activity and accumulation in MCF-7/adr. Also, lack of HSF-1 enhances nuclear factor kappa B (NF-kappa B) DNA binding activity together with mutant p53 and induces MDR1 gene and P-glycoprotein (P-gp, ABCB1), resulting in a multidrug-resistant phenotype. Ectopic expression of Hsp27, however, significantly depleted both mutant p53 and NF-kappa B (p65), reversed the drug resistance by inhibiting MDR1/P-gp expression in MCF-7/adr cells, and induced cell death by increased G(2)/M population and apoptosis. We conclude from these results that HSF-1 inhibition and depletion of Hsp27 is a trigger, at least in part, for the accumulation of transcriptionally active mutant p53, which can either directly or NF-kappa B-dependently induce an MDR1/P-gp phenotype in MCF-7 cells. Upon Hsp27 overexpression, this pathway is abrogated, and the acquired multidrug resistance is significantly abolished so that MCF-7/adr cells are sensitized to Dox. Thus, clinical alteration in Hsp27 or NF-kappa B level will be a potential approach to circumvent drug resistance in breast cancer.	[Kanagasabai, Ragu; Krishnamurthy, Karthikeyan; Ilangovan, Govindasamy] Ohio State Univ, Dept Internal Med, Davis Heart & Lung Res Inst, Div Cardiovasc Med, Columbus, OH 43210 USA; [Druhan, Lawrence J.] Ohio State Univ, Dept Anesthesiol, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Ilangovan, G (corresponding author), Ohio State Univ, Dept Internal Med, Davis Heart & Lung Res Inst, Div Cardiovasc Med, 392 Biomed Res Tower,460 W 12th Ave, Columbus, OH 43210 USA.	Govindasamy.Ilangovan@osumc.edu	Druhan, Lawrence/E-2994-2011		National Institutes of Health [R21 HL094881, R01 HL078796-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078796, R21HL094881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 HL094881 and R01 HL078796-02.	Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Bahr O, 2001, J CLIN INVEST, V107, P643, DOI 10.1172/JCI12415; Bradshaw TD, 2000, BRIT J CANCER, V83, P270; CIOCCA DR, 1992, CANCER RES, V52, P3648; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Deng L, 2001, J BIOL CHEM, V276, P413, DOI 10.1074/jbc.M004551200; Deppert W, 1996, J CELL BIOCHEM, V62, P172, DOI 10.1002/(SICI)1097-4644(199608)62:2<172::AID-JCB5>3.0.CO;2-P; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; Fang L, 1999, ONCOGENE, V18, P2789, DOI 10.1038/sj.onc.1202615; Farmer G, 1996, NUCLEIC ACIDS RES, V24, P4281, DOI 10.1093/nar/24.21.4281; Gabai VL, 2002, J APPL PHYSIOL, V92, P1743, DOI 10.1152/japplphysiol.01101.2001; Gao CL, 2000, INT J CANCER, V88, P191, DOI 10.1002/1097-0215(20001015)88:2<191::AID-IJC7>3.3.CO;2-1; Garrido C, 1996, EUR J BIOCHEM, V237, P653, DOI 10.1111/j.1432-1033.1996.0653p.x; Gulati AP, 2006, MOL CARCINOGEN, V45, P26, DOI 10.1002/mc.20149; Hansen RK, 1999, BREAST CANCER RES TR, V56, P187; Hansen RK, 2001, BIOCHEM BIOPH RES CO, V282, P186, DOI 10.1006/bbrc.2001.4548; HORIKOSHI N, 1995, MOL CELL BIOL, V15, P227, DOI 10.1128/MCB.15.1.227; HUOT J, 1991, CANCER RES, V51, P5245; Kamada M, 2007, MOL CANCER THER, V6, P299, DOI 10.1158/1535-7163.MCT-06-0417; KAMESAKI S, 1993, CANCER RES, V53, P4251; Kanagasabai R, 2010, MOL CANCER RES, V8, P1399, DOI 10.1158/1541-7786.MCR-10-0181; Kim E, 2007, ONCOGENE, V26, P2185, DOI 10.1038/sj.onc.1210312; Knowlton AA, 2006, CARDIOVASC RES, V69, P7, DOI 10.1016/j.cardiores.2005.10.009; Kuo MT, 2002, ONCOGENE, V21, P1945, DOI 10.1038/sj.onc.1205117; Ling YH, 1996, MOL PHARMACOL, V49, P832; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Mendoza-Alvarez H, 2001, J BIOL CHEM, V276, P36425, DOI 10.1074/jbc.M105215200; Morii T, 2010, ANTICANCER RES, V30, P3565; O'Callaghan-Sunol C, 2007, CANCER RES, V67, P11779, DOI 10.1158/0008-5472.CAN-07-2441; OESTERREICH S, 1993, CANCER RES, V53, P4443; Ogretmen B, 1997, ONCOGENE, V14, P499, DOI 10.1038/sj.onc.1200855; Ogretmen B, 1999, BIOCHEMISTRY-US, V38, P2189, DOI 10.1021/bi982236+; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Park KJ, 2003, J BIOL CHEM, V278, P35272, DOI 10.1074/jbc.M305095200; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Putt KS, 2005, CHEMBIOCHEM, V6, P53, DOI 10.1002/cbic.200400330; Richards EH, 1996, CANCER RES, V56, P2446; Robert J, 1998, BIOCHIMIE, V80, P247, DOI 10.1016/S0300-9084(98)80007-2; Ros JE, 2001, HEPATOLOGY, V33, P1425, DOI 10.1053/jhep.2001.24667; Sampath J, 2001, J BIOL CHEM, V276, P39359, DOI 10.1074/jbc.M103429200; Satou R, 2010, AM J PHYSIOL-CELL PH, V299, pC750, DOI 10.1152/ajpcell.00078.2010; Schett G, 1999, FASEB J, V13, P833, DOI 10.1096/fasebj.13.8.833; Schneider G, 2010, ONCOGENE, V29, P2795, DOI 10.1038/onc.2010.46; Schneider J, 1998, ANTICANCER RES, V18, P2967; Schwabedissen HEMZ, 2011, HANDB EXP PHARMACOL, V201, P325, DOI 10.1007/978-3-642-14541-4_9; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; Shabbits JA, 2002, MOL CANCER THER, V1, P205; Sigal A, 2000, CANCER RES, V60, P6788; Song MC, 2008, J CRIT CARE, V23, P406, DOI 10.1016/j.jcrc.2007.09.007; Srivastava SK, 2009, EXP EYE RES, V88, P2, DOI 10.1016/j.exer.2008.03.012; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tagashira M, 2000, CHEM PHARM BULL, V48, P575; Tchenio T, 2006, MOL CELL BIOL, V26, P580, DOI 10.1128/MCB.26.2.580-591.2006; Vedam K, 2010, AM J PHYSIOL-HEART C, V298, pH1832, DOI 10.1152/ajpheart.01047.2009; Vilaboa NE, 2000, J BIOL CHEM, V275, P24970, DOI 10.1074/jbc.M909136199; Weisz L, 2004, CANCER RES, V64, P8318, DOI 10.1158/0008-5472.CAN-04-1145; Weisz L, 2007, CANCER RES, V67, P2396, DOI 10.1158/0008-5472.CAN-06-2425; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wirth D, 2004, AM J PHYSIOL-LUNG C, V287, pL953, DOI 10.1152/ajplung.00184.2003; Wu Chung-Pu, 2008, Curr Mol Pharmacol, V1, P93; Wuerzberger-Davis SM, 2005, MOL CANCER RES, V3, P345, DOI 10.1158/1541-7786.MCR-05-0028; ZAMBETTI GP, 1993, FASEB J, V7, P855, DOI 10.1096/fasebj.7.10.8344485; ZASTAWNY RL, 1993, ONCOGENE, V8, P1529	64	60	66	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33289	33300		10.1074/jbc.M111.249102	http://dx.doi.org/10.1074/jbc.M111.249102			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21784846	hybrid, Green Published			2022-12-25	WOS:000294968800048
J	Nagatoshi, M; Terasaka, K; Nagatsu, A; Mizukami, H				Nagatoshi, Mai; Terasaka, Kazuyoshi; Nagatsu, Akito; Mizukami, Hajime			Iridoid-specific Glucosyltransferase from Gardenia jasminoides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDICAGO-TRUNCATULA; CATHARANTHUS-ROSEUS; F GRANDIFLORA; GLUCOSIDES; GLYCOSYLTRANSFERASES; BIOSYNTHESIS; CULTURES; GLUCOSYLATION; SECOIRIDOIDS; METABOLISM	Iridoids are one of the most widely distributed secondary metabolites in higher plants. They are pharmacologically active principles in various medicinal plants and key intermediates in the biosynthesis of monoterpenoid indole alkaloids as well as quinoline alkaloids. Although most iridoids are present as 1-O-glucosides, the glucosylation step in the biosynthetic pathway has remained obscure. We isolated a cDNA coding for UDPglucose: iridoid glucosyltransferase (UGT85A24) from Gardenia jasminoides. UGT85A24 preferentially glucosylated the 1-O-hydroxyl group of 7-deoxyloganetin and genipin but exhibited only weak activity toward loganetin and no activity toward 7-deoxyloganetic acid. This suggests that, in the biosynthetic pathway of geniposide, a major iridoid compound in G. jasminoides, glucosylation occurs after methylation of 7-deoxyloganetic acid. UGT85A24 showed negligible activity toward any acceptor substrates other than iridoid aglycones. Thus, UGT85A24 has a remarkable specificity for iridoid aglycones. The mRNA level of UGT85A24 overlaps with the marked increase in genipin glucosylation activity in the methyl jasmonate-treated cell cultures of G. jasminoides and is related to iridoid accumulation in G. jasminoides fruits.	[Mizukami, Hajime] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Nagatsu, Akito] Kinjo Gakuin Univ, Sch Pharm, Nagoya, Aichi 4638521, Japan	Nagoya City University	Mizukami, H (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	hajimem@phar.nagoya-cu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22710218] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research and a grant-in-aid for young scientists from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Achnine L, 2005, PLANT J, V41, P875, DOI 10.1111/j.1365-313X.2005.02344.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; CHAUDHURI RK, 1980, TETRAHEDRON, V36, P2317, DOI 10.1016/0040-4020(80)80128-1; Dinda B, 2007, CHEM PHARM BULL, V55, P689, DOI 10.1248/cpb.55.689; Dinda B, 2007, CHEM PHARM BULL, V55, P159, DOI 10.1248/cpb.55.159; El-Sayed Magdi, 2007, Phytochemistry Reviews, V6, P277, DOI 10.1007/s11101-006-9047-8; Franks TK, 2008, FUNCT PLANT BIOL, V35, P236, DOI 10.1071/FP07275; Gachon CMM, 2005, TRENDS PLANT SCI, V10, P542, DOI 10.1016/j.tplants.2005.09.007; Ghisalberti EL, 1998, PHYTOMEDICINE, V5, P147, DOI 10.1016/S0944-7113(98)80012-3; Harvey JA, 2005, J CHEM ECOL, V31, P287, DOI 10.1007/s10886-005-1341-1; Hasada K, 2010, J NAT MED-TOKYO, V64, P161, DOI 10.1007/s11418-010-0393-x; Hou BK, 2004, J BIOL CHEM, V279, P47822, DOI 10.1074/jbc.M409569200; HUGHES J, 1994, DNA SEQUENCE, V5, P41, DOI 10.3109/10425179409039703; INOUE K, 1992, HETEROCYCLES, V33, P673; Li LN, 2007, J MOL BIOL, V370, P951, DOI 10.1016/j.jmb.2007.05.036; Lim EK, 2004, EMBO J, V23, P2915, DOI 10.1038/sj.emboj.7600295; LINSMAIER EM, 1965, PHYSIOL PLANTARUM, V18, P100, DOI 10.1111/j.1399-3054.1965.tb06874.x; Masada S, 2009, PLANT CELL PHYSIOL, V50, P1401, DOI 10.1093/pcp/pcp088; MEIJER AH, 1993, J PLANT RES, P145; Nakatsuka T, 2008, J EXP BOT, V59, P1241, DOI 10.1093/jxb/ern031; Naoumkina MA, 2010, PLANT CELL, V22, P850, DOI 10.1105/tpc.109.073270; Noguchi A, 2008, PLANT J, V54, P415, DOI 10.1111/j.1365-313X.2008.03428.x; Noguchi A, 2009, PLANT CELL, V21, P1556, DOI 10.1105/tpc.108.063826; Offen W, 2006, EMBO J, V25, P1396, DOI 10.1038/sj.emboj.7600970; Ono M, 2005, CHEM PHARM BULL, V53, P1342, DOI 10.1248/cpb.53.1342; Oudin Audrey, 2007, Phytochemistry Reviews, V6, P259, DOI 10.1007/s11101-006-9054-9; UEDA S, 1981, PLANTA MED, V41, P186, DOI 10.1055/s-2007-971697; UESATO S, 1983, CHEM PHARM BULL, V31, P4185; UESATO S, 1984, TETRAHEDRON LETT, V25, P573, DOI 10.1016/S0040-4039(00)99941-6; Vogt T, 2000, TRENDS PLANT SCI, V5, P380, DOI 10.1016/S1360-1385(00)01720-9; Yamamoto H., 2002, PLANT BIOTECHNOL-NAR, V19, P295; Yu Y, 2009, J NAT PROD, V72, P1459, DOI 10.1021/np900176q	33	54	67	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32866	32874		10.1074/jbc.M111.242586	http://dx.doi.org/10.1074/jbc.M111.242586			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21799001	hybrid, Green Published			2022-12-25	WOS:000294726800093
J	Alvergne, A; Gibson, MA; Gurmu, E; Mace, R				Alvergne, Alexandra; Gibson, Mhairi A.; Gurmu, Eshetu; Mace, Ruth			Social Transmission and the Spread of Modern Contraception in Rural Ethiopia	PLOS ONE			English	Article							PARENTAL INVESTMENT; FERTILITY; NETWORKS; EVOLUTIONARY; WOMEN; TIME	Socio-economic development has proven to be insufficient to explain the time and pace of the human demographic transition. Shifts to low fertility norms have thus been thought to result from social diffusion, yet to date, micro-level studies are limited and are often unable to disentangle the effect of social transmission from that of extrinsic factors. We used data which included the first ever use of modern contraception among a population of over 900 women in four villages in rural Ethiopia, where contraceptive prevalence is still low (<20%). We investigated whether the time of adoption of modern contraception is predicted by (i) the proportion of ever-users/non ever-users within both women and their husbands' friendships networks and (ii) the geographic distance to contraceptive ever-users. Using a model comparison approach, we found that individual socio-demographic characteristics (e.g. parity, education) and a religious norm are the most likely explanatory factors of temporal and spatial patterns of contraceptive uptake, while the role of person-to-person contact through either friendship or spatial networks remains marginal. Our study has broad implications for understanding the processes that initiate transitions to low fertility and the uptake of birth control technologies in the developing world.	[Alvergne, Alexandra; Mace, Ruth] UCL, Dept Anthropol, London, England; [Gibson, Mhairi A.] Univ Bristol, Dept Archaeol & Anthropol, Bristol, Avon, England; [Gurmu, Eshetu] Univ Addis Ababa, Inst Populat Studies, Coll Dev Studies, Addis Ababa, Ethiopia	University of London; University College London; University of Bristol; Addis Ababa University	Alvergne, A (corresponding author), UCL, Dept Anthropol, London, England.	a.alvergne@ucl.ac.uk	Gibson, Mhairi A/D-4726-2009	Gibson, Mhairi A/0000-0001-7963-4759; Alvergne, Alexandra/0000-0002-3151-9919; Mace, Ruth/0000-0002-6137-7739; Gurmu, Eshetu/0000-0001-7487-0058	Royal Society; British Academy; European Research Council	Royal Society(Royal Society of London); British Academy; European Research Council(European Research Council (ERC)European Commission)	AA is a Newton fellow funded by the Royal Society and the British Academy. RM is funded by the European Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addai I, 1999, REV RELIG RES, V40, P259, DOI 10.2307/3512371; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Anderson DR, 2001, J WILDLIFE MANAGE, V65, P373, DOI 10.2307/3803088; Bathia S, 1982, STUD FAMILY PLANN, V13, P4; Behrman JR, 2002, DEMOGRAPHY, V39, P713, DOI 10.2307/3180828; Bongaarts J, 1996, POPUL DEV REV, V22, P639, DOI 10.2307/2137804; Boyd R., 2005, ORIGIN EVOLUTION CUL; Casterline JB, 2001, DIFFUSION PROCESSES AND FERTILITY TRANSITION: SELECTED PERSPECTIVES, P1; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Coale Ansley., 1986, DECLINE FERTILITY EU; Cohen-Cole E, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2533; Gayen K, 2010, SOC SCI MED, V71, P1584, DOI 10.1016/j.socscimed.2010.08.002; Gibson MA, 2011, P NAT AC SC IN PRESS; Gibson MA, 2002, THESIS U COLL LONDON; Gibson MA, 2006, PLOS MED, V3, P476, DOI 10.1371/journal.pmed.0030087; Godley J, 2001, INT FAMILY PLANNING, V27, P4; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Hill SE, 2005, BEHAV ECOL, V16, P398, DOI 10.1093/beheco/ari001; Jejeebhoy S., 1995, WOMENS ED AUTONOMY R; Kaplan H, 2002, AM J HUM BIOL, V14, P233, DOI 10.1002/ajhb.10041; Kaplan H, 1996, YEARB PHYS ANTHROPOL, V39, P91; KAPLAN HS, 1995, HUM NATURE-INT BIOS, V6, P325, DOI 10.1007/BF02734205; Kendal JR, 2005, MORRISON I WORKING P; Kincaid DL, 2000, SOC SCI MED, V50, P215, DOI 10.1016/S0277-9536(99)00276-2; Kohler HP, 2001, DEMOGRAPHY, V38, P43, DOI 10.1353/dem.2001.0005; Kohler HP, 1997, DEMOGRAPHY, V34, P369, DOI 10.2307/3038290; Lawson DW, 2011, PHILOS T R SOC B, V366, P333, DOI 10.1098/rstb.2010.0297; Lee R, 2003, J ECON PERSPECT, V17, P167, DOI 10.1257/089533003772034943; Lummaa V, 2002, TRENDS ECOL EVOL, V17, P141, DOI 10.1016/S0169-5347(01)02414-4; Mace R, 2006, SOCIAL INFORM TRANSM, P191; Mace R, 2009, AM J HUM BIOL, V21, P472, DOI 10.1002/ajhb.20940; Macro CSAEaO, 2006, ETH DEM HLTH SURV 20; Madhavan S, 2003, INT FAM PLAN PERSPEC, V29, P58, DOI 10.2307/3181059; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; Mason KO, 1997, DEMOGRAPHY, V34, P443, DOI 10.2307/3038299; Montgomery MR, 1996, POPUL DEV REV, V22, P151, DOI 10.2307/2808010; MONTGOMERY MR, 1993, POP STUD-J DEMOG, V47, P457, DOI 10.1080/0032472031000147246; Mulder MB, 1998, TRENDS ECOL EVOL, V13, P266, DOI 10.1016/S0169-5347(98)01357-3; Mulder MB, 2009, AM J HUM BIOL, V21, P478, DOI 10.1002/ajhb.20885; Newson L, 2005, PERS SOC PSYCHOL REV, V9, P360, DOI 10.1207/s15327957pspr0904_5; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; POLLAK RA, 1993, POPUL DEV REV, V19, P467, DOI 10.2307/2938463; Potter JE, 2004, POPUL DEV REV, V25, P703; Rob A K, 1988, Asia Pac Popul J, V3, P55; Rogers E.M., 2010, DIFFUSION INNOVATION, V4th ed; Samandari G, 2010, INT PERSPECT SEX R H, V36, P122, DOI 10.1363/ipsrh.36.122.10; Shalizi CR, 2011, SOCIOL METHOD RES, V40, P211, DOI 10.1177/0049124111404820; Singer JD, 2003, APPL LONGITUDINAL AN; Stephenson R, 2007, AM J PUBLIC HEALTH, V97, P1; Valente TW, 1997, SOC SCI MED, V45, P677, DOI 10.1016/S0277-9536(96)00385-1; Valente TW, 1994, NETWORK MODELS DIFFU	54	41	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22515	10.1371/journal.pone.0022515	http://dx.doi.org/10.1371/journal.pone.0022515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	797BJ	21799882	Green Published, Green Submitted, gold			2022-12-25	WOS:000293097300059
J	Aran-Matero, D; Amico, P; Aran-Fernandez, C; Gobet, B; Izazola-Licea, JA; Avila-Figueroa, C				Aran-Matero, Daniel; Amico, Peter; Aran-Fernandez, Christian; Gobet, Benjamin; Antonio Izazola-Licea, Jose; Avila-Figueroa, Carlos			Levels of Spending and Resource Allocation to HIV Programs and Services in Latin America and the Caribbean	PLOS ONE			English	Article							HIV/AIDS; MEXICO	Background: An estimated 1.86 million people are living with HIV in Latin America and the Caribbean (LAC). The region is comprised of mainly middle-income countries with steady economic growth while simultaneously there are enormous social inequalities and several concentrated AIDS epidemics. This paper describes HIV spending patterns in LAC countries including analysis of the levels and patterns of domestic HIV spending from both public and international sources. Methods and Findings: We conducted an extensive analysis of the most recently available data from LAC countries using the National AIDS Spending Assessment tool. The LAC countries spent a total of US$ 1.59 billion on HIV programs and services during the latest reported year. Countries providing detailed information on spending showed that high percentages are allocated to treatment and care (75.1%) and prevention (15.0%). Domestic sources accounted for 93.6 percent of overall spending and 79 percent of domestic funds were directed to treatment and care. International funds represented 5.4 percent of total HIV funding in the region, but they supplied the majority of the effort to reach most-at-risk-populations (MARPs). However, prevalence rates among men who have sex with men (MSM) still reached over 25 percent in some countries. Conclusions: Although countries in the region have increasingly sustained their response from domestic sources, still there are future challenges: 1) The growing number of new HIV infections and more people-living-with-HIV (PLWH) eligible to receive antiretroviral treatment (ART); 2) Increasing ART coverage along with high prices of antiretroviral drugs; and 3) The funding for prevention activities among MARPs rely almost exclusively on external donors. These threats call for strengthened actions by civil society and governments to protect and advance gains against HIV in LAC.	[Aran-Matero, Daniel] Promot Econ Dev PROMODE, Joao Pessoa, Paraiba, Brazil; [Amico, Peter] Brandeis Univ, Heller Sch Social Policy & Management, Boston, MA USA; [Aran-Fernandez, Christian; Gobet, Benjamin; Avila-Figueroa, Carlos] Joint United Nations Programme AIDS UNAIDS, Geneva, Switzerland; [Antonio Izazola-Licea, Jose] Minist Hlth, Natl AIDS Control Programme, Mexico City, DF, Mexico	Brandeis University; UNAIDS	Aran-Matero, D (corresponding author), Promot Econ Dev PROMODE, Joao Pessoa, Paraiba, Brazil.	avilac@unaids.org						Aldridge RW, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-352; *ALL PART PARL GRO, 2010, TREATM TIM; Amico P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012997; [Anonymous], [No title captured]; Bastos FI, 2008, INT J EPIDEMIOL, V37, P729, DOI 10.1093/ije/dyn127; BLISS K, KEY PLAYERS GLOBAL H; Moreno JGB, 2010, LANCET, V376, P493, DOI 10.1016/S0140-6736(10)60883-5; *CIT MAYORS, 2006, WORLDS LARG CIT URB; Garcia-Calleja JM, 2009, JAIDS-J ACQ IMM DEF, V51, pS1, DOI 10.1097/QAI.0b013e3181a1f255; *GLOB FUND, 2011, BRAZ GRANT PORTF; Global Fund, 2011, GRANT PORTF; HORSTMAN R, 2007, CAN WE PREDICT OUT O; HOTEZ PJ, 2008, PLOS NEGLECTED TROPI, V2; *ILO, 1999, OV EXCL SOC PROT HLT; ILO, 2010, EXT SOC SEC ALL; Izazola-Licea JA, 2002, AIDS, V16, pS66, DOI 10.1097/00002030-200212003-00010; Kates J, 2010, FINANCING RESPONSE A; Leive A, 2008, B WORLD HEALTH ORGAN, V86, P849, DOI 10.2471/BLT.07.049403; Montano SM, 2005, JAIDS-J ACQ IMM DEF, V40, P57, DOI 10.1097/01.qai.0000159667.72584.8b; Musgrove P, 2002, B WORLD HEALTH ORGAN, V80, P134; Organization for Economic Cooperation and Development, 2000, SYST HLTH ACC; *PARL OFF SCI TECH, 2001, ACC MED DEV WORLD; RENAUDTHERY F, 2011, AIDS RES TR IN PRESS; Rodriguez CM, 2002, AIDS, V16, pS34, DOI 10.1097/00002030-200212003-00006; Smith RD, 2009, LANCET, V373, P684, DOI 10.1016/S0140-6736(08)61779-1; Soto-Ramirez LE, 2008, SCIENCE, V321, P465, DOI 10.1126/science.1162896; UNAIDS, 2010, 2010 GLOB REP UNAIDS; UNAIDS, 2009, NAT AIDS SPEND ASS N; *UNAIDS, 2009, CAR FACT SHEET; UNAIDS, 2009, WHAT COUNTR NEED INV; *UNAIDS, 2009, LAT AM FACT SHEET; UNDP, 2009, HUM DEV REP; *WHO, 2008, AG AM 2008 2017; Wirtz VJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S6; *WORLD BANK, 2010, GROSS NAT INC CAP 20; World Bank, 2008, GROSS NAT INC CAP 20; World Bank WHO and The United States Agency for International Development, 2003, GUID PROD NAT HLTH A; World Health Organization, 2009, HLTH SIT AM BAS IND; World Health Organization, 2010, UN ACC SCAL PRIOR HI; 2009, LANCET, V374, P266; 2008, LANCET, V372, P263	41	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22373	10.1371/journal.pone.0022373	http://dx.doi.org/10.1371/journal.pone.0022373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799839	Green Published, Green Submitted, gold			2022-12-25	WOS:000293097300041
J	Hemphill, MA; Dabiri, BE; Gabriele, S; Kerscher, L; Franck, C; Goss, JA; Alford, PW; Parker, KK				Hemphill, Matthew A.; Dabiri, Borna E.; Gabriele, Sylvain; Kerscher, Lucas; Franck, Christian; Goss, Josue A.; Alford, Patrick W.; Parker, Kevin Kit			A Possible Role for Integrin Signaling in Diffuse Axonal Injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; FOCAL ADHESION KINASE; RHO-ASSOCIATED KINASE; MECHANICAL STRETCH; ACTIVATION; CELLS; CALCIUM; NEURONS; MECHANOTRANSDUCTION; RETRACTION	Over the past decade, investigators have attempted to establish the pathophysiological mechanisms by which non-penetrating injuries damage the brain. Several studies have implicated either membrane poration or ion channel dysfunction pursuant to neuronal cell death as the primary mechanism of injury. We hypothesized that traumatic stimulation of integrins may be an important etiological contributor to mild Traumatic Brain Injury. In order to study the effects of forces at the cellular level, we utilized two hierarchical, in vitro systems to mimic traumatic injury to rat cortical neurons: a high velocity stretcher and a magnetic tweezer system. In one system, we controlled focal adhesion formation in neurons cultured on a stretchable substrate loaded with an abrupt, one dimensional strain. With the second system, we used magnetic tweezers to directly simulate the abrupt injury forces endured by a focal adhesion on the neurite. Both systems revealed variations in the rate and nature of neuronal injury as a function of focal adhesion density and direct integrin stimulation without membrane poration. Pharmacological inhibition of calpains did not mitigate the injury yet the inhibition of Rho-kinase immediately after injury reduced axonal injury. These data suggest that integrin-mediated activation of Rho may be a contributor to the diffuse axonal injury reported in mild Traumatic Brain Injury.	[Hemphill, Matthew A.; Dabiri, Borna E.; Gabriele, Sylvain; Kerscher, Lucas; Franck, Christian; Goss, Josue A.; Alford, Patrick W.; Parker, Kevin Kit] Harvard Univ, Dis Biophys Grp, Sch Engn & Appl Sci, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Harvard University	Hemphill, MA (corresponding author), Harvard Univ, Dis Biophys Grp, Sch Engn & Appl Sci, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.	kkparker@seas.harvard.edu	GABRIELE, Sylvain/N-6412-2014; Franck, Christian/C-6077-2012	GABRIELE, Sylvain/0000-0001-8696-8052; Franck, Christian/0000-0002-2347-620X	Defense Advance Research Projects Agency (Office of Naval) [N66001-09-c-2064]; Harvard School of Engineering and Applied Sciences	Defense Advance Research Projects Agency (Office of Naval); Harvard School of Engineering and Applied Sciences	Financial support from the Defense Advance Research Projects Agency's PREVENT Program (Office of Naval Research SPAWAR N66001-09-c-2064) and the Harvard School of Engineering and Applied Sciences. The authors acknowledge Harvard University's Center for Nanoscale Systems (CNS) for the use of cleanroom facilities. S.G. is Charge de Recherches of the F.R.S.-FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford PW, 2003, J BIOMECH, V36, P1135, DOI 10.1016/S0021-9290(03)00089-7; Amano M, 2003, J NEUROCHEM, V87, P780, DOI 10.1046/j.1471-4159.2003.02054.x; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chan CS, 2003, J NEUROSCI, V23, P7107, DOI 10.1523/JNEUROSCI.23-18-07107.2003; Cullen DK, 2007, ANN BIOMED ENG, V35, P835, DOI 10.1007/s10439-007-9292-z; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Fass JN, 2004, BIOPHYS J, V87, P2099, DOI 10.1529/biophysj.104.900105; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hashimoto R, 1998, BIOCHEM BIOPH RES CO, V245, P407, DOI 10.1006/bbrc.1998.8446; Hoang B, 1998, J NEUROSCI, V18, P7847; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Kam Z, 2001, TRENDS CELL BIOL, V11, P329, DOI 10.1016/S0962-8924(01)02067-0; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Lemons ML, 2006, EXP NEUROL, V202, P324, DOI 10.1016/j.expneurol.2006.06.008; Lin CY, 2008, MOL CELL NEUROSCI, V37, P770, DOI 10.1016/j.mcn.2008.01.001; Lin YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004293; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Meyer CJ, 2000, NAT CELL BIOL, V2, P666, DOI 10.1038/35023621; Milner R, 2002, J NEUROSCI RES, V69, P286, DOI 10.1002/jnr.10321; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Nakayama K, 2008, NEUROSCI LETT, V444, P127, DOI 10.1016/j.neulet.2008.08.034; Nishimura SL, 1998, BRAIN RES, V791, P271, DOI 10.1016/S0006-8993(98)00118-8; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pinkstaff JK, 1999, J NEUROSCI, V19, P1541; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762; Rodriguez MA, 2000, P NATL ACAD SCI USA, V97, P3550, DOI 10.1073/pnas.050589797; Schmid RS, 2003, CEREB CORTEX, V13, P219, DOI 10.1093/cercor/13.3.219; SCHMIDT CE, 1995, J NEUROSCI, V15, P3400; Schwartz MA, 2000, TRENDS BIOCHEM SCI, V25, P388, DOI 10.1016/S0968-0004(00)01605-4; Shi Y, 2006, J NEUROSCI, V26, P1813, DOI 10.1523/JNEUROSCI.4091-05.2006; Spaethling JM, 2008, J NEUROTRAUM, V25, P1207, DOI 10.1089/neu.2008.0532; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Staubli U, 1998, J NEUROSCI, V18, P3460; Stevens GR, 1996, J NEUROSCI RES, V46, P445, DOI 10.1002/(SICI)1097-4547(19961115)46:4<445::AID-JNR6>3.3.CO;2-D; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Su L, 2008, NEUROMOL MED, V10, P316, DOI 10.1007/s12017-008-8042-1; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; UPTON GJG, 1992, J ROY STAT SOC A STA, V155, P395, DOI 10.2307/2982890; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; Watson PMD, 2007, MOL CELL NEUROSCI, V34, P147, DOI 10.1016/j.mcn.2006.10.007; Webb DJ, 2007, J BIOL CHEM, V282, P6929, DOI 10.1074/jbc.M610981200; Wernig F, 2003, HYPERTENSION, V41, P903, DOI 10.1161/01.HYP.0000062882.42265.88; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Zamir E, 1999, J CELL SCI, V112, P1655	67	81	83	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22899	10.1371/journal.pone.0022899	http://dx.doi.org/10.1371/journal.pone.0022899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799943	Green Published, gold, Green Submitted			2022-12-25	WOS:000293097300082
J	Puech, PH; Nevoltris, D; Robert, P; Limozin, L; Boyer, C; Bongrand, P				Puech, Pierre-Henri; Nevoltris, Damien; Robert, Philippe; Limozin, Laurent; Boyer, Claude; Bongrand, Pierre			Force Measurements of TCR/pMHC Recognition at T Cell Surface	PLOS ONE			English	Article							RECEPTOR-LIGAND INTERACTIONS; CD8 CORECEPTOR FUNCTION; PEPTIDE-MHC; ANTIGEN RECEPTOR; ADHESION FORCES; STRUCTURAL BASIS; SINGLE-MOLECULE; KINETICS; BINDING; TCR	The rupture forces and adhesion frequencies of single recognition complexes between an affinity selected peptide/MHC complex and a TCR at a murine hybridoma surface were measured using Atomic Force Microscopy. When the CD8 coreceptor is absent, the adhesion frequency depends on the nature of the peptide but the rupture force does not. When CD8 is present, no effect of the nature of the peptide is observed. CD8 is proposed to act as a time and distance lock, enabling the shorter TCR molecule to bridge the pMHC and have time to finely read the peptide. Ultimately, such experiments could help the dissection of the sequential steps by which the TCR reads the peptide/MHC complex in order to control T cell activation.	[Puech, Pierre-Henri; Nevoltris, Damien; Robert, Philippe; Limozin, Laurent; Bongrand, Pierre] LAI, Marseille, France; [Puech, Pierre-Henri; Nevoltris, Damien; Robert, Philippe; Limozin, Laurent; Bongrand, Pierre] INSERM, UMR 600, F-13258 Marseille, France; [Puech, Pierre-Henri; Nevoltris, Damien; Robert, Philippe; Limozin, Laurent; Bongrand, Pierre] CNRS, UMR 6212, Marseille, France; [Boyer, Claude] Univ Aix Marseille 2, UMR 6546, CIML, Marseille, France; [Robert, Philippe; Bongrand, Pierre] Hop Conception, Serv Immunol, Marseille, France; [Boyer, Claude] INSERM, UMR 631, F-13258 Marseille, France; [Boyer, Claude] CNRS, UMR 6102, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)	Puech, PH (corresponding author), LAI, Parc Sci & Technol Luminy, Marseille, France.	pierre-henri.puech@inserm.fr	Limozin, Laurent/P-7134-2016; Robert, Philippe/P-9597-2016; Bongrand, Pierre/C-4456-2013; Puech, Pierre-henri/G-1744-2013	Limozin, Laurent/0000-0001-9523-8086; Robert, Philippe/0000-0002-1343-994X; Bongrand, Pierre/0000-0001-6185-6572; Puech, Pierre-henri/0000-0002-8521-0685	ANR JCJC AdheKon; ANR JCJC DissecTion; HFSP short term grant; CNRS Prise de risques program; JPK Instruments company (Berlin, Germany)	ANR JCJC AdheKon(French National Research Agency (ANR)); ANR JCJC DissecTion(French National Research Agency (ANR)); HFSP short term grant; CNRS Prise de risques program; JPK Instruments company (Berlin, Germany)	ANR JCJC AdheKon, ANR JCJC DissecTion, an HFSP short term grant and CNRS Prise de risques programs are acknowledged for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge Claude Gregoire (CIML, Marseille) for his skilful help in the hybridoma preparation; A. Guimezanes (CIML, Marseille), Marion Scillier (ESIL, Marseille) and Thomas Biederman (ECM, Marseille) for providing materials and establishing experimental conditions; Annemarie Lellouch (Inserm UMR600) for proofreading and helpful suggestions to the manuscript; K. Kinoshita, A. Leung and E. Evans for fruitful discussions about the complexity of rupture events of bio-molecular bonds and preliminary experiments using Biomembrane Force Probe; and JPK Instruments company (Berlin, Germany) for its continuous support.	Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Arcaro A, 2000, J IMMUNOL, V165, P2068, DOI 10.4049/jimmunol.165.4.2068; Auphan-Anezin N, 2006, EUR J IMMUNOL, V36, P1856, DOI 10.1002/eji.200635895; Bongrand P, 1998, BIOESSAYS, V20, P412; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; BUFERNE M, 1992, J IMMUNOL, V148, P657; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Chen AL, 2002, METHOD CELL BIOL, V68, P301; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Delon J, 1998, IMMUNITY, V9, P467, DOI 10.1016/S1074-7613(00)80630-5; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Franz CM, 2008, CELL MOL BIOENG, V1, P289, DOI 10.1007/s12195-008-0037-3; FRANZ CM, 2007, SCI STKE, V2007; Gakamsky DM, 2005, BIOPHYS J, V89, P2121, DOI 10.1529/biophysj.105.061671; Gakamsky DM, 2004, P NATL ACAD SCI USA, V101, P9063, DOI 10.1073/pnas.0402840101; GOLSTEIN P, 1982, IMMUNOL REV, V68, P5, DOI 10.1111/j.1600-065X.1982.tb01058.x; Guimezanes A, 2003, EUR J IMMUNOL, V33, P3060, DOI 10.1002/eji.200324249; Guimezanes A, 2001, EUR J IMMUNOL, V31, P421, DOI 10.1002/1521-4141(200102)31:2<421::AID-IMMU421>3.0.CO;2-4; Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477; Hoffmann S, 2011, IMMUNOL LETT, V136, P13, DOI 10.1016/j.imlet.2010.11.005; Hosseini BH, 2009, P NATL ACAD SCI USA, V106, P17852, DOI 10.1073/pnas.0905384106; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Huang J, 2007, J IMMUNOL, V179, P7653, DOI 10.4049/jimmunol.179.11.7653; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; Ma ZY, 2008, FASEB J, V22, P1002, DOI 10.1096/fj.07-9331hyp; Marshall BT, 2005, BIOPHYS J, V88, P1458, DOI 10.1529/biophysj.104.050567; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; Pincet F, 2005, BIOPHYS J, V89, P4374, DOI 10.1529/biophysj.105.067769; Puech PH, 2005, J CELL SCI, V118, P4199, DOI 10.1242/jcs.02547; Puech PH, 2006, ULTRAMICROSCOPY, V106, P637, DOI 10.1016/j.ultramic.2005.08.003; Radmacher M, 2002, METHOD CELL BIOL, V68, P67; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Robert P, 2007, J MOL RECOGNIT, V20, P432, DOI 10.1002/jmr.827; Robert P, 2009, BIOPHYS J, V96, P4642, DOI 10.1016/j.bpj.2009.03.020; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Taubenberger A, 2007, MOL BIOL CELL, V18, P1634, DOI 10.1091/mbc.E06-09-0777; Tees DFJ, 2001, BIOPHYS J, V80, P668, DOI 10.1016/S0006-3495(01)76047-X; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Varghese JC, 2008, J IMMUNOL, V181, P6002, DOI 10.4049/jimmunol.181.9.6002; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Wang R, 2009, J IMMUNOL, V183, P2554, DOI 10.4049/jimmunol.0901276; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9	59	36	37	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22344	10.1371/journal.pone.0022344	http://dx.doi.org/10.1371/journal.pone.0022344			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799834	Green Published, Green Submitted, gold			2022-12-25	WOS:000293097300038
J	Rajadas, J; Liu, CW; Novick, P; Kelley, NW; Inayathullah, M; LeMieux, MC; Pande, VS				Rajadas, Jayakumar; Liu, Corey W.; Novick, Paul; Kelley, Nicholas W.; Inayathullah, Mohammed; LeMieux, Melburne C.; Pande, Vijay S.			Rationally Designed Turn Promoting Mutation in the Amyloid-beta Peptide Sequence Stabilizes Oligomers in Solution	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; HAIRPIN PEPTIDE; PROTEIN; FIBRILS; NMR; STATE; WATER; A-BETA(1-40); SIMULATIONS; NUCLEATION	Enhanced production of a 42-residue beta amyloid peptide (A beta(42)) in affected parts of the brain has been suggested to be the main causative factor for the development of Alzheimer's Disease (AD). The severity of the disease depends not only on the amount of the peptide but also its conformational transition leading to the formation of oligomeric amyloid-derived diffusible ligands (ADDLs) in the brain of AD patients. Despite being significant to the understanding of AD mechanism, no atomic-resolution structures are available for these species due to the evanescent nature of ADDLs that hinders most structural biophysical investigations. Based on our molecular modeling and computational studies, we have designed Met35Nle and G37p mutations in the A beta(42) peptide (A beta(42)Nle35p37) that appear to organize A beta(42) into stable oligomers. 2D NMR on the A beta(42)Nle35p37 peptide revealed the occurrence of two beta-turns in the V24-N27 and V36-V39 stretches that could be the possible cause for the oligomer stability. We did not observe corresponding NOEs for the V24-N27 turn in the A beta(21-43)Nle35p37 fragment suggesting the need for the longer length amyloid peptide to form the stable oligomer promoting conformation. Because of the presence of two turns in the mutant peptide which were absent in solid state NMR structures for the fibrils, we propose, fibril formation might be hindered. The biophysical information obtained in this work could aid in the development of structural models for toxic oligomer formation that could facilitate the development of therapeutic approaches to AD.	[Rajadas, Jayakumar] Stanford Univ, Biomat & Adv Drug Delivery Lab, Stanford, CA 94305 USA; [Rajadas, Jayakumar; Novick, Paul; Pande, Vijay S.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Liu, Corey W.] Stanford Univ, Stanford Magnet Resonance Lab, Stanford, CA 94305 USA; [Kelley, Nicholas W.; Pande, Vijay S.] Stanford Univ, Dept Biophys, Stanford, CA 94305 USA; [LeMieux, Melburne C.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Inayathullah, Mohammed] Cent Leather Res Inst, Bioorgan & Neurochem Lab, Madras 600020, Tamil Nadu, India	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Leather Research Institute (CLRI)	Rajadas, J (corresponding author), Stanford Univ, Biomat & Adv Drug Delivery Lab, Stanford, CA 94305 USA.	pande@stanford.edu	Rajadas, Jayakumar/AHC-0630-2022; Inayathullah, Mohammed/C-6953-2015; Pande, Vijay/ABE-8145-2020	Inayathullah, Mohammed/0000-0001-7646-1709; Rajadas, Jayakumar/0000-0001-6520-3923	National Institutes of Health (NIH) [R01-GM062868]; National Institutes of Health NDC Nanomedicine Center [PN1 EY016525]; NATIONAL EYE INSTITUTE [PN1EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062868] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NDC Nanomedicine Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge support from the National Institutes of Health via an R01 grant to VSP (NIH R01-GM062868) and the National Institutes of Health NDC Nanomedicine Center (PN1 EY016525). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Baumketner A, 2006, PROTEIN SCI, V15, P1239, DOI 10.1110/ps.062076806; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Ciccotosto GD, 2004, J BIOL CHEM, V279, P42528, DOI 10.1074/jbc.M406465200; de Vega MJP, 2008, BIOORG MED CHEM LETT, V18, P2078, DOI 10.1016/j.bmcl.2008.01.092; Dong JJ, 2005, BIOORGAN MED CHEM, V13, P5213, DOI 10.1016/j.bmc.2005.05.052; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Griffiths-Jones SR, 1998, J MOL BIOL, V284, P1597, DOI 10.1006/jmbi.1998.2264; Griffiths-Jones SR, 1999, J MOL BIOL, V292, P1051, DOI 10.1006/jmbi.1999.3119; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Karsai A, 2006, J STRUCT BIOL, V155, P316, DOI 10.1016/j.jsb.2005.12.015; Kelley NW, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3010881; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Klyubin I, 2004, EUR J NEUROSCI, V19, P2839, DOI 10.1111/j.1460-9568.2004.03389.x; Kneller, 2003, SPARKY 3; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lobanov MY, 2008, MOL BIOL+, V42, P623, DOI 10.1134/S0026893308040195; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; McLaurin J, 2000, J BIOL CHEM, V275, P18495, DOI 10.1074/jbc.M906994199; Nilsson KPR, 2007, ACS CHEM BIOL, V2, P553, DOI 10.1021/cb700116u; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; Paparcone R, 2010, BIOCHEMISTRY-US, V49, P8967, DOI 10.1021/bi100953t; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Stromer T, 2005, MICROSC RES TECHNIQ, V67, P210, DOI 10.1002/jemt.20190; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Williams AD, 2005, P NATL ACAD SCI USA, V102, P7115, DOI 10.1073/pnas.0408582102; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; Wu C, 2009, J MOL BIOL, V387, P492, DOI 10.1016/j.jmb.2009.01.029; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Yong W, 2002, P NATL ACAD SCI USA, V99, P150, DOI 10.1073/pnas.012584899; Yoshiike Y, 2007, BIOCHEMISTRY-US, V46, P9805, DOI 10.1021/bi700455c; Zhang S, 2000, J STRUCT BIOL, V130, P130, DOI 10.1006/jsbi.2000.4288; Zhang XC, 2005, BIOCHEMISTRY-US, V44, P8117, DOI 10.1021/bi0501939	42	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e21776	10.1371/journal.pone.0021776	http://dx.doi.org/10.1371/journal.pone.0021776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799748	gold, Green Submitted, Green Published			2022-12-25	WOS:000293097300006
J	Woo, J; Miletich, I; Kim, BM; Sharpe, PT; Shivdasani, RA				Woo, Janghee; Miletich, Isabelle; Kim, Byeong-Moo; Sharpe, Paul T.; Shivdasani, Ramesh A.			Barx1-Mediated Inhibition of Wnt Signaling in the Mouse Thoracic Foregut Controls Tracheo-Esophageal Septation and Epithelial Differentiation	PLOS ONE			English	Article							ESOPHAGEAL ATRESIA; MULTIPLE ROLES; LUNG; MORPHOGENESIS; TRACHEA; STOMACH; BARX1; MECHANISMS; IDENTITY; PLAYERS	Mesenchymal cells underlying the definitive endoderm in vertebrate animals play a vital role in digestive and respiratory organogenesis. Although several signaling pathways are implicated in foregut patterning and morphogenesis, and despite the clinical importance of congenital tracheal and esophageal malformations in humans, understanding of molecular mechanisms that allow a single tube to separate correctly into the trachea and esophagus is incomplete. The homoebox gene Barx1 is highly expressed in prospective stomach mesenchyme and required to specify this organ. We observed lower Barx1 expression extending contiguously from the proximal stomach domain, along the dorsal anterior foregut mesenchyme and in mesenchymal cells between the nascent esophagus and trachea. This expression pattern exactly mirrors the decline in Wnt signaling activity in late development of the adjacent dorsal foregut endoderm and medial mainstem bronchi. The hypopharynx in Barx1(-/-) mouse embryos is abnormally elongated and the point of esophagotracheal separation shows marked caudal displacement, resulting in a common foregut tube that is similar to human congenital tracheo-esophageal fistula and explains neonatal lethality. Moreover, the Barx1(-/-) esophagus displays molecular and cytologic features of respiratory endoderm, phenocopying abnormalities observed in mouse embryos with activated beta-catenin. The zone of canonical Wnt signaling is abnormally prolonged and expanded in the proximal Barx1(-/-) foregut. Thus, as in the developing stomach, but distinct from the spleen, Barx1 control of thoracic foregut specification and tracheo-esophageal septation is tightly associated with down-regulation of adjacent Wnt pathway activity.	[Woo, Janghee; Kim, Byeong-Moo; Shivdasani, Ramesh A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Woo, Janghee] Harvard Univ, Grad Program Biol & Biomed Sci, Cambridge, MA 02138 USA; [Miletich, Isabelle; Sharpe, Paul T.] Kings Coll London, Dept Craniofacial Dev, Inst Dent, London WC2R 2LS, England; [Shivdasani, Ramesh A.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Shivdasani, Ramesh A.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; University of London; King's College London; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Woo, J (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	ramesh_shivdasani@dfci.harvard.edu	woo, janghee/CAG-2114-2022	Sharpe, Paul/0000-0003-2116-9561; Miletich, Isabelle/0000-0003-2817-7492	National Institutes of Health [R01DK081113]; Harvard Stem Cell Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081113] Funding Source: NIH RePORTER; Medical Research Council [G0600698B] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by National Institutes of Health grant R01DK081113 (RAS) and a graduate fellowship from the Harvard Stem Cell Institute (JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunner HG, 2005, CURR OPIN GENET DEV, V15, P341, DOI 10.1016/j.gde.2005.04.010; DasGupta R, 1999, DEVELOPMENT, V126, P4557; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Harris-Johnson KS, 2009, P NATL ACAD SCI USA, V106, P16287, DOI 10.1073/pnas.0902274106; Kaufman MH., 1992, ATLAS MOUSE DEV, P512; Kim BM, 2005, DEV CELL, V8, P611, DOI 10.1016/j.devcel.2005.01.015; Kim BM, 2007, DEVELOPMENT, V134, P3603, DOI 10.1242/dev.009308; Li Y, 2007, DEV DYNAM, V236, P746, DOI 10.1002/dvdy.21075; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Minoo P, 1995, DEV BIOL, V172, P694, DOI 10.1006/dbio.1995.8080; Mitsiadis TA, 2003, DEVELOPMENT, V130, P4451, DOI 10.1242/dev.00631; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Que JW, 2006, DIFFERENTIATION, V74, P422, DOI 10.1111/j.1432-0436.2006.00096.x; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; TISSIERSETA JP, 1995, MECH DEVELOP, V51, P3, DOI 10.1016/0925-4773(94)00343-L; Tucker AS, 1998, SCIENCE, V282, P1136, DOI 10.1126/science.282.5391.1136; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786	22	46	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22493	10.1371/journal.pone.0022493	http://dx.doi.org/10.1371/journal.pone.0022493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799872	gold, Green Published, Green Submitted			2022-12-25	WOS:000293097300054
J	Akesson, CP; McGovern, G; Dagleish, MP; Espenes, A; Press, CM; Landsverk, T; Jeffrey, M				Akesson, Caroline Piercey; McGovern, Gillian; Dagleish, Mark P.; Espenes, Arild; Press, Charles McL; Landsverk, Thor; Jeffrey, Martin			Exosome-Producing Follicle Associated Epithelium Is Not Involved in Uptake of PrPd from the Gut of Sheep (Ovis aries): An Ultrastructural Study	PLOS ONE			English	Article							ILEAL PEYERS PATCH; PRION PROTEIN; M-CELLS; SCRAPIE INFECTION; CARBONIC-ANHYDRASE; EARLY ACCUMULATION; BLOOD-TRANSFUSION; DENDRITIC CELLS; SUFFOLK SHEEP; TRANSPORT	In natural or experimental oral scrapie infection of sheep, disease associated prion protein (PrPd) often first accumulates in Peyer's patch (PP) follicles. The route by which infectivity reaches the follicles is unknown, however, intestinal epithelial cells may participate in intestinal antigenic presentation by delivering exosomes as vehicles of luminal antigens. In a previous study using an intestinal loop model, following inoculation of scrapie brain homogenate, inoculum associated PrPd was detected by light microscopy shortly (15 minutes to 3.5 hours) after inoculation in the villous lacteals and sub-mucosal lymphatics. No PrPd was located within the follicle-associated epithelium (FAE), sub-FAE domes or the PP follicles. To evaluate this gut loop model and the transportation routes in more detail, we used electron microscopy (EM) to study intestinal tissues exposed to scrapie or control homogenates for 15 minutes to 10 days. In addition, immuno-EM was used to investigate whether exosomes produced in the FAE may possess small amounts of PrPd that were not detectable by light microscopy. This study showed that the integrity of the intestinal epithelium was sustained in the intestinal loop model. Despite prominent transcytotic activity and exosome release from the FAE of the ileal PP in sheep, these structures were not associated with transportation of PrPd across the mucosa. The study did not determine how infectivity reaches the follicles of PPs. The possibility that the infectious agent is transported across the FAE remains a possibility if it occurs in a form that is undetectable by the methods used in this study. Infectivity may also be transported via lymph to the blood and further to all other lymphoid tissues including the PP follicles, but the early presence of PrPd in the PP follicles during scrapie infection argues against such a mechanism.	[Akesson, Caroline Piercey; Espenes, Arild; Press, Charles McL; Landsverk, Thor] Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway; [McGovern, Gillian; Jeffrey, Martin] Lasswade Lab, AHVLA, Penicuik, Midlothian, Scotland; [Dagleish, Mark P.] Moredun Res Inst, Dept Pathol, Penicuik, Midlothian, Scotland	Norwegian University of Life Sciences; Moredun Research Institute	Akesson, CP (corresponding author), Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway.	carolinepiercey.akesson@nvh.no	Jeffrey, Martin/D-2251-2009; McGOVERN, GILLIAN/C-3441-2011	McGOVERN, GILLIAN/0000-0001-5344-5909	Defra (UK) [Se1951]; Norwegian School of Veterinary Science	Defra (UK)(Department for Environment, Food & Rural Affairs (DEFRA)); Norwegian School of Veterinary Science	The study was partly funded by Defra (UK) under project Se1951 and partly funded by The Norwegian School of Veterinary Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2000, J GEN VIROL, V81, P3115, DOI 10.1099/0022-1317-81-12-3115; Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; Beekes M, 2000, NEUROSCI LETT, V278, P181, DOI 10.1016/S0304-3940(99)00934-9; Collas P, 2002, EUR J CELL BIOL, V81, P69, DOI 10.1078/0171-9335-00225; Corr SC, 2008, FEMS IMMUNOL MED MIC, V52, P2, DOI 10.1111/j.1574-695X.2007.00359.x; Defaweux V, 2005, MICROSC RES TECHNIQ, V66, P1, DOI 10.1002/jemt.20135; Eaton SL, 2009, VET IMMUNOL IMMUNOP, V131, P105, DOI 10.1016/j.vetimm.2009.02.012; FARQUHAR CF, 1993, P CONS BSE SCI VET C, P301; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Foster N, 2010, J INFECT DIS, V202, P1916, DOI 10.1086/657415; Gerdts V, 2001, J IMMUNOL METHODS, V256, P19, DOI 10.1016/S0022-1759(01)00429-X; Ghosh S, 2004, ADV DRUG DELIVER REV, V56, P915, DOI 10.1016/j.addr.2003.10.035; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; HALLERAKER M, 1990, VET IMMUNOL IMMUNOP, V26, P93, DOI 10.1016/0165-2427(90)90135-F; Hazzard RA, 1996, J ANAT, V189, P265; Heggebo R, 2000, J GEN VIROL, V81, P2327, DOI 10.1099/0022-1317-81-9-2327; Heppner FL, 2001, NAT MED, V7, P976, DOI 10.1038/nm0901-976; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; Huang FP, 2002, J GEN VIROL, V83, P267, DOI 10.1099/0022-1317-83-1-267; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Jeffrey M, 2006, J PATHOL, V209, P4, DOI 10.1002/path.1962; Jeffrey M, 2004, CURR TOP MICROBIOL, V284, P65; Jeffrey M, 2004, ANN NEUROL, V55, P781, DOI 10.1002/ana.20093; Jeffrey M, 2000, ARCH VIROL, P23; Jeffrey M, 2001, J COMP PATHOL, V125, P48, DOI 10.1053/jcpa.2001.0476; Jeffrey M, 2009, BRAIN PATHOL, V19, P1, DOI 10.1111/j.1750-3639.2008.00150.x; LANDSVERK T, 1981, ACTA VET SCAND, V22, P198; LANDSVERK T, 1990, CELL TISSUE RES, V261, P239, DOI 10.1007/BF00318665; LANDSVERK T, 1987, IMMUNOL CELL BIOL, V65, P251, DOI 10.1038/icb.1987.28; LANDSVERK T, 1988, IMMUNOL CELL BIOL, V66, P261, DOI 10.1038/icb.1988.35; LANDSVERK T, 1991, VET IMMUNOL IMMUNOP, V28, P1, DOI 10.1016/0165-2427(91)90038-E; LANDSVERK T, 1987, IMMUNOL CELL BIOL, V65, P425, DOI 10.1038/icb.1987.49; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; McGovern G, 2004, J COMP PATHOL, V130, P181, DOI 10.1016/j.jcpa.2003.11.001; McGovern G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001304; Owen RL, 1999, SEMIN IMMUNOL, V11, P157, DOI 10.1006/smim.1999.0171; PAAR M, 1992, VET PATHOL, V29, P120, DOI 10.1177/030098589202900204; Piccardo P, 2007, P NATL ACAD SCI USA, V104, P4712, DOI 10.1073/pnas.0609241104; Prusiner SB, 1999, COLD SPRING HARBOR M, V38, P67; Race R, 2002, J INFECT DIS, V186, pS166, DOI 10.1086/344267; RHODES RS, 1971, LAB INVEST, V25, P220; Ryder SJ, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-9; Sassa Y, 2010, VET IMMUNOL IMMUNOP, V133, P33, DOI 10.1016/j.vetimm.2009.06.018; Siso S, 2009, NEUROPATH APPL NEURO, V35, P232, DOI 10.1111/j.1365-2990.2008.00978.x; van Keulen LJM, 2002, APMIS, V110, P23, DOI 10.1034/j.1600-0463.2002.100104.x; WOLF JL, 1981, SCIENCE, V212, P471, DOI 10.1126/science.6259737	47	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22180	10.1371/journal.pone.0022180	http://dx.doi.org/10.1371/journal.pone.0022180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789232	Green Published, Green Submitted, gold			2022-12-25	WOS:000292812400036
J	Smith, CA; Kortemme, T				Smith, Colin A.; Kortemme, Tanja			Predicting the Tolerated Sequences for Proteins and Protein Interfaces Using RosettaBackrub Flexible Backbone Design	PLOS ONE			English	Article							SIDE-CHAIN; PHAGE-DISPLAY; CONFORMATIONAL VARIABILITY; DOMAIN; FLEXIBILITY; SPECIFICITY; DIVERSITY; ENSEMBLES; ALGORITHMS; STABILITY	Predicting the set of sequences that are tolerated by a protein or protein interface, while maintaining a desired function, is useful for characterizing protein interaction specificity and for computationally designing sequence libraries to engineer proteins with new functions. Here we provide a general method, a detailed set of protocols, and several benchmarks and analyses for estimating tolerated sequences using flexible backbone protein design implemented in the Rosetta molecular modeling software suite. The input to the method is at least one experimentally determined three-dimensional protein structure or high-quality model. The starting structure(s) are expanded or refined into a conformational ensemble using Monte Carlo simulations consisting of backrub backbone and side chain moves in Rosetta. The method then uses a combination of simulated annealing and genetic algorithm optimization methods to enrich for low-energy sequences for the individual members of the ensemble. To emphasize certain functional requirements (e. g. forming a binding interface), interactions between and within parts of the structure (e.g. domains) can be reweighted in the scoring function. Results from each backbone structure are merged together to create a single estimate for the tolerated sequence space. We provide an extensive description of the protocol and its parameters, all source code, example analysis scripts and three tests applying this method to finding sequences predicted to stabilize proteins or protein interfaces. The generality of this method makes many other applications possible, for example stabilizing interactions with small molecules, DNA, or RNA. Through the use of within-domain reweighting and/or multistate design, it may also be possible to use this method to find sequences that stabilize particular protein conformations or binding interactions over others.	[Smith, Colin A.; Kortemme, Tanja] Univ Calif San Francisco, Grad Program Biol & Med Informat, San Francisco, CA 94143 USA; [Smith, Colin A.; Kortemme, Tanja] Calif Inst Quantitat Biosci, San Francisco, CA USA; [Smith, Colin A.; Kortemme, Tanja] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Smith, CA (corresponding author), Univ Calif San Francisco, Grad Program Biol & Med Informat, San Francisco, CA 94143 USA.	kortemme@cgl.ucsf.edu	Smith, Colin A/E-5713-2012; Kortemme, Tanja/AAN-3180-2021	Smith, Colin A/0000-0002-4651-167X; Kortemme, Tanja/0000-0002-8494-680X	NSF [EF-0849400]; Synthetic Biology Engineering Research Center (SynBERC) [NSF-EEC-0540879]	NSF(National Science Foundation (NSF)); Synthetic Biology Engineering Research Center (SynBERC)	C. A. S. was supported by the NSF Graduate Research Fellowship Program. This work was supported by the Synthetic Biology Engineering Research Center (SynBERC, NSF-EEC-0540879), and an NSF award to T. K. (EF-0849400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroggio XI, 2006, CURR OPIN STRUC BIOL, V16, P525, DOI 10.1016/j.sbi.2006.05.014; Ambroggio XI, 2006, J AM CHEM SOC, V128, P1154, DOI 10.1021/ja054718w; Bloom JD, 2009, P NATL ACAD SCI USA, V106, P9995, DOI 10.1073/pnas.0901522106; Clackson T, 1998, J MOL BIOL, V277, P1111, DOI 10.1006/jmbi.1998.1669; Davis IW, 2006, STRUCTURE, V14, P265, DOI 10.1016/j.str.2005.10.007; Desjarlais JR, 1999, J MOL BIOL, V290, P305, DOI 10.1006/jmbi.1999.2866; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Distefano MD, 2002, J MOL BIOL, V322, P179, DOI 10.1016/S0022-2836(02)00738-6; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Ernst A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000416; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Frey KM, 2010, P NATL ACAD SCI USA, V107, P13707, DOI 10.1073/pnas.1002162107; Friedland GD, 2008, J MOL BIOL, V380, P757, DOI 10.1016/j.jmb.2008.05.006; Friedland GD, 2010, CURR OPIN STRUC BIOL, V20, P377, DOI 10.1016/j.sbi.2010.02.004; Friedland GD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000393; Fu XR, 2007, J MOL BIOL, V371, P1099, DOI 10.1016/j.jmb.2007.04.069; Fuh G, 2000, J BIOL CHEM, V275, P21486, DOI 10.1074/jbc.275.28.21486; Georgiev I, 2008, BIOINFORMATICS, V24, pI196, DOI 10.1093/bioinformatics/btn169; Georgiev I, 2008, J COMPUT CHEM, V29, P1527, DOI 10.1002/jcc.20909; Georgiev I, 2007, BIOINFORMATICS, V23, pI185, DOI 10.1093/bioinformatics/btm197; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Hu XZ, 2007, P NATL ACAD SCI USA, V104, P17668, DOI 10.1073/pnas.0707977104; Humphris EL, 2007, PLOS COMPUT BIOL, V3, P1591, DOI 10.1371/journal.pcbi.0030164; Humphris EL, 2008, STRUCTURE, V16, P1777, DOI 10.1016/j.str.2008.09.012; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Kotz JD, 2004, EUR J BIOCHEM, V271, P1623, DOI 10.1111/j.1432-1033.2004.04076.x; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Larson SM, 2002, PROTEIN SCI, V11, P2804, DOI 10.1110/ps.0203902; Laura RP, 2002, J BIOL CHEM, V277, P12906, DOI 10.1074/jbc.M200818200; Leaver-Fay A, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P16; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Mandell DJ, 2009, CURR OPIN BIOTECH, V20, P420, DOI 10.1016/j.copbio.2009.07.006; Marini NJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000968; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Ollikainen Noah, 2009, Proceedings of the 2009 IEEE/ACM International Conference on Computer-Aided Design (ICCAD 2009), P128; Pal G, 2006, J BIOL CHEM, V281, P22378, DOI 10.1074/jbc.M603826200; Pokala N, 2001, J STRUCT BIOL, V134, P269, DOI 10.1006/jsbi.2001.4349; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; SAUERERIKSSON AE, 1995, STRUCTURE, V3, P265, DOI 10.1016/S0969-2126(01)00157-5; Saunders CT, 2005, J MOL BIOL, V346, P631, DOI 10.1016/j.jmb.2004.11.062; Schmidt HLF, 2007, J PHYS CHEM B, V111, P14362, DOI 10.1021/jp075531p; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Smith CA, 2010, J MOL BIOL, V402, P460, DOI 10.1016/j.jmb.2010.07.032; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Treynor TP, 2007, P NATL ACAD SCI USA, V104, P48, DOI 10.1073/pnas.0609647103; Voigt CA, 2000, J MOL BIOL, V299, P789, DOI 10.1006/jmbi.2000.3758	50	55	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e20451	10.1371/journal.pone.0020451	http://dx.doi.org/10.1371/journal.pone.0020451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789164	Green Submitted, gold, Green Published			2022-12-25	WOS:000292812400003
J	Avital, A; Dolev, T; Aga-Mizrachi, S; Zubedat, S				Avital, Avi; Dolev, Talya; Aga-Mizrachi, Shlomit; Zubedat, Salman			Environmental Enrichment Preceding Early Adulthood Methylphenidate Treatment Leads to Long Term Increase of Corticosterone and Testosterone in the Rat	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NEGATIVE FEEDBACK ACTION; PREPULSE INHIBITION; EXPERIENCE OVERCOMES; EARLY EXPOSURE; BEHAVIOR; CHILDREN; STRESS; AGGRESSION; MEMORY	Attention-deficit/hyperactivity disorder (ADD/ADHD) has been emerging as a world-wide psychiatric disorder. There appears to be an increasing rate of stimulant drug abuse, specifically methylphenidate (MPH) which is the most common treatment for ADHD, among individuals who do not meet the criteria for ADHD and particularly for cognitive enhancement among university students. However, the long term effects of exposure to MPH are unknown. Thus, in light of a developmental approach in humans, we aimed to test the effects of adolescence exposure to enriched environment (EE) followed by MPH administration during early adulthood, on reactions to stress in adulthood. Specifically, at approximate adolescence [post natal days (PND) 30-60] rats were reared in EE and were treated with MPH during early adulthood (PND 60-90). Adult (PND 90-92) rats were exposed to mild stress and starting at PND 110, the behavioral and endocrine effects of the combined drug and environmental conditions were assessed. Following adolescence EE, long term exposure to MPH led to decreased locomotor activity and increased sucrose preference. EE had a beneficial effect on PPI (attentive abilities), which was impaired by long term exposure to MPH. Finally, the interaction between EE and, exposure to MPH led to long-term elevated corticosterone and testosterone levels. In view of the marked increase in MPH consumption over the past decade, vigilance is crucial in order to prevent potential drug abuse and its long term detrimental consequences.	[Avital, Avi; Dolev, Talya; Aga-Mizrachi, Shlomit; Zubedat, Salman] Yezreel Valley Coll, Dept Psychol, Yezreel Valley, Israel; [Avital, Avi; Dolev, Talya; Aga-Mizrachi, Shlomit; Zubedat, Salman] Yezreel Valley Coll, Ctr Psychobiol Res, Yezreel Valley, Israel; [Avital, Avi] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Avital, A (corresponding author), Yezreel Valley Coll, Dept Psychol, Yezreel Valley, Israel.	avia@yvc.ac.il	Avital, Avraham/I-2163-2016	Avital, Avraham/0000-0002-0691-153X				Abikoff H, 2004, J AM ACAD CHILD PSY, V43, P802, DOI 10.1097/01.chi.0000128791.10014.ac; Amaral OB, 2008, PHYSIOL BEHAV, V93, P388, DOI 10.1016/j.physbeh.2007.09.009; Anderson VR, 2006, DRUGS, V66, P1117, DOI 10.2165/00003495-200666080-00007; Angold A, 2000, J AM ACAD CHILD PSY, V39, P975, DOI 10.1097/00004583-200008000-00009; Aron AR, 2003, BIOL PSYCHIAT, V54, P1465, DOI 10.1016/S0006-3223(03)00609-7; Avital A, 2006, BRAIN RES BULL, V68, P419, DOI 10.1016/j.brainresbull.2005.09.015; Avital A, 2001, NEUROPSYCHOPHARMACOL, V25, P669, DOI 10.1016/S0893-133X(01)00286-X; Avital A, 2006, J NEUROSCI, V26, P9130, DOI 10.1523/JNEUROSCI.1628-06.2006; Basu P, 2006, NAT MED, V12, P374, DOI 10.1038/nm0406-374a; Belz EE, 2003, PHARMACOL BIOCHEM BE, V76, P481, DOI 10.1016/j.pbb.2003.09.005; Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x; Bogle Kristin E, 2009, Curr Drug Abuse Rev, V2, P157; Bolanos CA, 2003, BIOL PSYCHIAT, V54, P1317, DOI 10.1016/S0006-3223(03)00570-5; Bolanos CA, 2008, BIOL PSYCHIAT, V63, P309, DOI 10.1016/j.biopsych.2007.06.024; Bonilla-Jaime H, 2003, NEUROPSYCHOBIOLOGY, V48, P55, DOI 10.1159/000072877; Branchi I, 2006, BEHAV BRAIN RES, V172, P299, DOI 10.1016/j.bbr.2006.05.019; Bright George M, 2008, Medscape J Med, V10, P111; Britton GB, 2007, DEV PSYCHOBIOL, V49, P265, DOI 10.1002/dev.20213; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Buitelaar J, 2010, EUR CHILD ADOLES PSY, V19, P325, DOI 10.1007/s00787-009-0056-1; Carlezon WA, 2003, BIOL PSYCHIAT, V54, P1330, DOI 10.1016/j.biopsych.2003.08.020; Carre JM, 2010, BIOL PSYCHOL, V84, P346, DOI 10.1016/j.biopsycho.2010.04.001; Chapillon P, 1999, BEHAV GENET, V29, P41, DOI 10.1023/A:1021437905913; Cui MH, 2006, NEUROSCI LETT, V404, P208, DOI 10.1016/j.neulet.2006.05.048; Degroot A, 2005, NEUROREPORT, V16, P63, DOI 10.1097/00001756-200501190-00015; Ferguson SA, 2010, NEUROTOXICOL TERATOL, V32, P432, DOI 10.1016/j.ntt.2010.03.007; Forrester MB, 2006, J TOXICOL ENV HEAL A, V69, P1145, DOI 10.1080/15287390500360273; Frahm KA, 2011, PHARMACOL BIOCHEM BE, V97, P416, DOI 10.1016/j.pbb.2010.09.015; Frick KM, 2003, NEUROBIOL AGING, V24, P615, DOI 10.1016/S0197-4580(02)00138-0; Golubchik P, 2008, INT CLIN PSYCHOPHARM, V23, P228, DOI 10.1097/YIC.0b013e3282f94ae2; GRAHAM FK, 1975, PSYCHOPHYSIOLOGY, V12, P238, DOI 10.1111/j.1469-8986.1975.tb01284.x; Hannestad J, 2010, BIOL PSYCHIAT, V68, P854, DOI 10.1016/j.biopsych.2010.06.017; Hart S, 1998, PHARMACOL BIOCHEM BE, V61, P113, DOI 10.1016/S0091-3057(98)00079-3; Hawk LW, 2003, PSYCHOPHARMACOLOGY, V165, P118, DOI 10.1007/s00213-002-1235-7; Hermans EJ, 2008, BIOL PSYCHIAT, V63, P263, DOI 10.1016/j.biopsych.2007.05.013; Ilin Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004329; Jensen PS, 1999, J AM ACAD CHILD PSY, V38, P797, DOI 10.1097/00004583-199907000-00008; King S, 2009, J ABNORM CHILD PSYCH, V37, P579, DOI 10.1007/s10802-008-9294-9; Kirby K, 2002, CURR OPIN PEDIATR, V14, P236, DOI 10.1097/00008480-200204000-00017; Kohl Z, 2002, GENES BRAIN BEHAV, V1, P46, DOI 10.1046/j.1601-1848.2001.00009.x; Lagace DC, 2006, BIOL PSYCHIAT, V60, P1121, DOI 10.1016/j.biopsych.2006.04.009; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; Lumia AR, 2010, PHYSIOL BEHAV, V100, P199, DOI 10.1016/j.physbeh.2010.01.007; Mague SD, 2005, BIOL PSYCHIAT, V57, P120, DOI 10.1016/j.biopsych.2004.10.037; MARCO EM, 2011, NEUROSCI BIOBEHAV RE; Mehta MA, 2004, J CHILD PSYCHOL PSYC, V45, P293, DOI 10.1111/j.1469-7610.2004.00221.x; Mehta PH, 2010, J COGNITIVE NEUROSCI, V22, P2357, DOI 10.1162/jocn.2009.21389; Miller K J, 1998, Pediatr Rev, V19, P373; Morley-Fletcher S, 2003, EUR J NEUROSCI, V18, P3367, DOI 10.1111/j.1460-9568.2003.03070.x; Nass Ruth D, 2005, Semin Pediatr Neurol, V12, P200, DOI 10.1016/j.spen.2005.12.002; Palsson E, 2011, PSYCHOPHARMACOLOGY, V214, P675, DOI 10.1007/s00213-010-2074-6; Pham TM, 1999, NEUROSCIENCE, V94, P279, DOI 10.1016/S0306-4522(99)00316-4; Poulin C, 2001, CAN MED ASSOC J, V165, P1039; Quinn R, 2005, NUTRITION, V21, P775, DOI 10.1016/j.nut.2005.04.002; Rey JM, 2003, BRIT J PSYCHIAT, V182, P284, DOI 10.1192/bjp.182.4.284; Rose S, 2008, NATURE, V451, P521, DOI 10.1038/451521a; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Sanchez-Martin JR, 2011, PSYCHONEUROENDOCRINO, V36, P750, DOI 10.1016/j.psyneuen.2010.10.011; Schaefer TL, 2006, J NEUROCHEM, V98, P1369, DOI 10.1111/j.1471-4159.2006.04034.x; Scholes KE, 2010, PSYCHOPHYSIOLOGY, V47, P223, DOI 10.1111/j.1469-8986.2009.00927.x; Sinzig J, 2007, J CHILD ADOL PSYCHOP, V17, P421, DOI 10.1089/cap.2007.0011; Smith C, 2011, J ETHNOPHARMACOL, V133, P31, DOI 10.1016/j.jep.2010.08.058; Soma KK, 2006, J NEUROENDOCRINOL, V18, P543, DOI 10.1111/j.1365-2826.2006.01440.x; Spear L, 2000, ALCOHOL RES HEALTH, V24, P115; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Svetlov SI, 2007, J ADDICT DIS, V26, P1, DOI 10.1300/J069v26n04_01; Swanson JM, 2008, NATURE, V453, P586, DOI 10.1038/453586a; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Teicher MH, 1996, J AM ACAD CHILD PSY, V35, P334, DOI 10.1097/00004583-199603000-00015; Teter CJ, 2006, PHARMACOTHERAPY, V26, P1501, DOI 10.1592/phco.26.10.1501; van Bokhoven I, 2006, HORM BEHAV, V50, P118, DOI 10.1016/j.yhbeh.2006.02.002; Varty GB, 2000, BIOL PSYCHIAT, V47, P864, DOI 10.1016/S0006-3223(99)00269-3; Veena J, 2009, NEUROSCI LETT, V455, P178, DOI 10.1016/j.neulet.2009.03.059; Volkow ND, 1998, AM J PSYCHIAT, V155, P1325, DOI 10.1176/ajp.155.10.1325; VREEBURG JTM, 1988, J STEROID BIOCHEM, V29, P93, DOI 10.1016/0022-4731(88)90381-0; VREEBURG JTM, 1984, ENDOCRINOLOGY, V115, P977, DOI 10.1210/endo-115-3-977; Waite E, 2009, J NEUROENDOCRINOL, V21, P737, DOI 10.1111/j.1365-2826.2009.01900.x; Weiss IC, 2001, BEHAV BRAIN RES, V121, P207, DOI 10.1016/S0166-4328(01)00166-8; Williams RJ, 2004, AM J ADDICTION, V13, P381, DOI 10.1080/10550490490483053; Zhang H, 2010, NEUROPEDIATRICS, V41, P55, DOI 10.1055/s-0030-1261893; Zito JM, 2000, JAMA-J AM MED ASSOC, V283, P1025, DOI 10.1001/jama.283.8.1025	82	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22059	10.1371/journal.pone.0022059	http://dx.doi.org/10.1371/journal.pone.0022059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789212	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811700019
J	Huang, YH; Lee, MH; Chen, WJ; Hsiao, CK				Huang, Yung-Hsiang; Lee, Mei-Hsien; Chen, Wei J.; Hsiao, Chuhsing Kate			Using an Uncertainty-Coding Matrix in Bayesian Regression Models for Haplotype-Specific Risk Detection in Family Association Studies	PLOS ONE			English	Article							GENETIC ASSOCIATION; CONTINUOUS TRAITS; SCHIZOPHRENIA; EVOLUTION; DISCRETE; GENOTYPE; LINKAGE; SAMPLES; TESTS	Haplotype association studies based on family genotype data can provide more biological information than single marker association studies. Difficulties arise, however, in the inference of haplotype phase determination and in haplotype transmission/non-transmission status. Incorporation of the uncertainty associated with haplotype inference into regression models requires special care. This task can get even more complicated when the genetic region contains a large number of haplotypes. To avoid the curse of dimensionality, we employ a clustering algorithm based on the evolutionary relationship among haplotypes and retain for regression analysis only the ancestral core haplotypes identified by it. To integrate the three sources of variation, phase ambiguity, transmission status and ancestral uncertainty, we propose an uncertainty-coding matrix which combines these three types of variability simultaneously. Next we evaluate haplotype risk with the use of such a matrix in a Bayesian conditional logistic regression model. Simulation studies and one application, a schizophrenia multiplex family study, are presented and the results are compared with those from other family based analysis tools such as FBAT. Our proposed method (Bayesian regression using uncertainty-coding matrix, BRUCM) is shown to perform better and the implementation in R is freely available.	[Huang, Yung-Hsiang; Chen, Wei J.; Hsiao, Chuhsing Kate] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lee, Mei-Hsien] Taipei Municipal Univ Educ, Dept Math & Comp Sci Educ, Taipei, Taiwan; [Chen, Wei J.; Hsiao, Chuhsing Kate] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Chen, Wei J.; Hsiao, Chuhsing Kate] Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan; [Hsiao, Chuhsing Kate] Natl Taiwan Univ, NTU Ctr Genom Med, Taipei 10764, Taiwan	National Taiwan University; University of Taipei; National Taiwan University; National Taiwan University; National Taiwan University	Huang, YH (corresponding author), Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	ckhsiao@ntu.edu.tw		Chen, Wei Jen/0000-0001-5899-5870; hsiao, chuhsing kate/0000-0003-4905-8484	National Science Council [NSC97-2314-B-002-040-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	Part of this study was supported by a grant (number: NSC97-2314-B-002-040-MY3) from the National Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Becker T, 2004, GENET EPIDEMIOL, V27, P21, DOI 10.1002/gepi.10323; Cordell HJ, 2006, GENET EPIDEMIOL, V30, P259, DOI 10.1002/gepi.20142; Guo W, 2009, GENET EPIDEMIOL, V33, P308, DOI 10.1002/gepi.20382; Herold C, 2009, BIOINFORMATICS, V25, P134, DOI 10.1093/bioinformatics/btn581; Holliday EG, 2006, TWIN RES HUM GENET, V9, P531, DOI 10.1375/twin.9.4.531; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Hwu HG, 2005, AM J MED GENET B, V134B, P30, DOI 10.1002/ajmg.b.30139; Igo RP, 2009, GENET EPIDEMIOL, V33, P16, DOI 10.1002/gepi.20352; Krishna A, 2009, J STAT PLAN INFER, V139, P2665, DOI 10.1016/j.jspi.2008.12.004; Lee MH, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-48; Lin DY, 2006, J AM STAT ASSOC, V101, P89, DOI 10.1198/016214505000000808; Lin SH, 2009, GENES BRAIN BEHAV, V8, P785, DOI 10.1111/j.1601-183X.2009.00523.x; Liu CM, 2007, SCHIZOPHR RES, V93, P391, DOI 10.1016/j.schres.2007.02.003; Mensah FK, 2007, GENET EPIDEMIOL, V31, P348, DOI 10.1002/gepi.20215; Morris AP, 2005, GENET EPIDEMIOL, V29, P91, DOI 10.1002/gepi.20080; Purcell S, 2007, BIOINFORMATICS, V23, P255, DOI 10.1093/bioinformatics/btl580; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Seltman H, 2003, GENET EPIDEMIOL, V25, P48, DOI 10.1002/gepi.10246; Seltman H, 2001, AM J HUM GENET, V68, P1250, DOI 10.1086/320110; Sham PC, 2004, BEHAV GENET, V34, P207, DOI 10.1023/B:BEGE.0000013734.39266.a3; SOOFI ES, 1990, J ECONOMETRICS, V43, P255, DOI 10.1016/0304-4076(90)90120-I; Tsuang HC, 2006, SCHIZOPHR RES, V87, P172, DOI 10.1016/j.schres.2006.03.045; Tsuang M, 2000, BIOL PSYCHIAT, V47, P210, DOI 10.1016/S0006-3223(99)00289-9; Tzeng JY, 2005, GENET EPIDEMIOL, V28, P220, DOI 10.1002/gepi.20063; Walker E, 2004, ANNU REV PSYCHOL, V55, P401, DOI 10.1146/annurev.psych.55.090902.141950; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986	28	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e21890	10.1371/journal.pone.0021890	http://dx.doi.org/10.1371/journal.pone.0021890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789192	Green Submitted, Green Published, gold			2022-12-25	WOS:000292811700009
J	Sepp, M; Kannike, K; Eesmaa, A; Urb, M; Timmusk, T				Sepp, Mari; Kannike, Kaja; Eesmaa, Ave; Urb, Mari; Timmusk, Tonis			Functional Diversity of Human Basic Helix-Loop-Helix Transcription Factor TCF4 Isoforms Generated by Alternative 5 ' Exon Usage and Splicing	PLOS ONE			English	Article							PITT-HOPKINS-SYNDROME; LYMPHOCYTE DEVELOPMENT; MENTAL-RETARDATION; FACTOR E2-2; IMMUNOGLOBULIN ENHANCER; ACTIVATE TRANSCRIPTION; TRANSPOSABLE ELEMENTS; NEURONAL PLASTICITY; NEGATIVE REGULATOR; BRAIN-DEVELOPMENT	Background: Transcription factor 4 (TCF4 alias ITF2, E2-2, ME2 or SEF2) is a ubiquitous class A basic helix-loop-helix protein that binds to E-box DNA sequences (CANNTG). While involved in the development and functioning of many different cell types, recent studies point to important roles for TCF4 in the nervous system. Specifically, human TCF4 gene is implicated in susceptibility to schizophrenia and TCF4 haploinsufficiency is the cause of the Pitt-Hopkins mental retardation syndrome. However, the structure, expression and coding potential of the human TCF4 gene have not been described in detail. Principal Findings: In the present study we used human tissue samples to characterize human TCF4 gene structure and TCF4 expression at mRNA and protein level. We report that although widely expressed, human TCF4 mRNA expression is particularly high in the brain. We demonstrate that usage of numerous 5' exons of the human TCF4 gene potentially yields in TCF4 protein isoforms with 18 different N-termini. In addition, the diversity of isoforms is increased by alternative splicing of several internal exons. For functional characterization of TCF4 isoforms, we overexpressed individual isoforms in cultured human cells. Our analysis revealed that subcellular distribution of TCF4 isoforms is differentially regulated: Some isoforms contain a bipartite nuclear localization signal and are exclusively nuclear, whereas distribution of other isoforms relies on heterodimerization partners. Furthermore, the ability of different TCF4 isoforms to regulate E-box controlled reporter gene transcription is varied depending on whether one or both of the two TCF4 transcription activation domains are present in the protein. Both TCF4 activation domains are able to activate transcription independently, but act synergistically in combination. Conclusions: Altogether, in this study we have described the inter-tissue variability of TCF4 expression in human and provided evidence about the functional diversity of the alternative TCF4 protein isoforms.	[Sepp, Mari; Kannike, Kaja; Eesmaa, Ave; Urb, Mari; Timmusk, Tonis] Tallinn Univ Technol, Dept Gene Technol, Tallinn, Estonia	Tallinn University of Technology	Sepp, M (corresponding author), Tallinn Univ Technol, Dept Gene Technol, Tallinn, Estonia.	tonis.timmusk@ttu.ee	Sepp, Mari/F-5987-2012; Timmusk, Tonis/H-4889-2015	Sepp, Mari/0000-0003-1733-8385; Nurm, Kaja/0000-0002-0739-0414; Timmusk, Tonis/0000-0002-1015-3348; Eesmaa, Ave/0000-0002-3397-3330	Estonian Ministry of Education and Research [0140143]; Estonian Science Foundation [7257, 8844]	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation	This work was supported by Estonian Ministry of Education and Research (Grant 0140143) and Estonian Science Foundation (Grants 7257 and 8844). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2007, AM J HUM GENET, V80, P988, DOI 10.1086/515582; ARTANDI SE, 1995, NUCLEIC ACIDS RES, V23, P3865, DOI 10.1093/nar/23.19.3865; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bergqvist I, 2000, EUR J IMMUNOL, V30, P2857, DOI 10.1002/1521-4141(200010)30:10<2857::AID-IMMU2857>3.0.CO;2-G; Brockschmidt A, 2007, HUM MOL GENET, V16, P1488, DOI 10.1093/hmg/ddm099; Brzozka MM, 2010, BIOL PSYCHIAT, V68, P33, DOI 10.1016/j.biopsych.2010.03.015; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; CAUDY M, 1988, GENE DEV, V2, P843, DOI 10.1101/gad.2.7.843; CHIARAMELLO A, 1995, MOL BRAIN RES, V29, P107, DOI 10.1016/0169-328X(94)00236-8; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; CORNELIUSSEN B, 1991, J VIROL, V65, P6084, DOI 10.1128/JVI.65.11.6084-6093.1991; CRONMILLER C, 1986, DEV GENET, V7, P205, DOI 10.1002/dvg.1020070406; de Pontual L, 2009, HUM MUTAT, V30, P669, DOI 10.1002/humu.20935; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; Flora A, 2007, P NATL ACAD SCI USA, V104, P15382, DOI 10.1073/pnas.0707456104; Furumura M, 2001, J BIOL CHEM, V276, P28147, DOI 10.1074/jbc.M101626200; Gustincich S, 2006, J PHYSIOL-LONDON, V575, P321, DOI 10.1113/jphysiol.2006.115568; Hauser J, 2008, P NATL ACAD SCI USA, V105, P1267, DOI 10.1073/pnas.0708220105; HENTHORN P, 1990, SCIENCE, V247, P467, DOI 10.1126/science.2105528; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Kalscheuer VM, 2008, AM J MED GENET A, V146A, P2053, DOI 10.1002/ajmg.a.32419; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kurooka H, 2005, J BIOL CHEM, V280, P4313, DOI 10.1074/jbc.M412614200; Lingbeck JM, 2005, ONCOGENE, V24, P6376, DOI 10.1038/sj.onc.1208789; Liu Y, 1998, J BIOL CHEM, V273, P19269, DOI 10.1074/jbc.273.30.19269; MARUYAMA K, 1994, GENE, V138, P171; Massari ME, 1999, MOL CELL, V4, P63, DOI 10.1016/S1097-2765(00)80188-4; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Massari ME, 1996, MOL CELL BIOL, V16, P121; Muir T, 2006, MOL REPROD DEV, V73, P491, DOI 10.1002/mrd.20397; Murre C, 2005, NAT IMMUNOL, V6, P1079, DOI 10.1038/ni1260; Nagasawa M, 2008, EUR J IMMUNOL, V38, P2389, DOI 10.1002/eji.200838470; Pscherer A, 1996, EMBO J, V15, P6680, DOI 10.1002/j.1460-2075.1996.tb01058.x; Qiu Y, 1998, MOL CELL BIOL, V18, P2957, DOI 10.1128/MCB.18.5.2957; QUONG MW, 1993, MOL CELL BIOL, V13, P792, DOI 10.1128/MCB.13.2.792; Ravanpay AC, 2008, J NEUROSCI RES, V86, P1472, DOI 10.1002/jnr.21615; Saarikettu J, 2004, J BIOL CHEM, V279, P41004, DOI 10.1074/jbc.M408120200; Skerjanc IS, 1996, J BIOL CHEM, V271, P3555, DOI 10.1074/jbc.271.7.3555; Sobrado VR, 2009, J CELL SCI, V122, P1014, DOI 10.1242/jcs.028241; SOOSAAR A, 1994, MOL BRAIN RES, V25, P176, DOI 10.1016/0169-328X(94)90297-6; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; TANAKA M, 1994, MOL CELL BIOL, V14, P6046, DOI 10.1128/MCB.14.9.6046; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Uittenbogaard M, 2000, NEUROSCI LETT, V280, P95, DOI 10.1016/S0304-3940(00)00761-8; van de Lagemaat LN, 2003, TRENDS GENET, V19, P530, DOI 10.1016/j.tig.2003.08.004; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang DC, 2006, J IMMUNOL, V177, P109, DOI 10.4049/jimmunol.177.1.109; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Wu M, 2007, GENE, V401, P165, DOI 10.1016/j.gene.2007.07.012; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; YOON SO, 1994, J BIOL CHEM, V269, P18453; Zamudio N, HEREDITY, V105, P92; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898; Zweier C, 2007, AM J HUM GENET, V80, P994, DOI 10.1086/515583	57	87	90	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22138	10.1371/journal.pone.0022138	http://dx.doi.org/10.1371/journal.pone.0022138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789225	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811700028
J	Cooper, KG; Winfree, S; Malik-Kale, P; Jolly, C; Ireland, R; Knodler, LA; Steele-Mortimer, O				Cooper, Kendal G.; Winfree, Seth; Malik-Kale, Preeti; Jolly, Carrie; Ireland, Robin; Knodler, Leigh A.; Steele-Mortimer, Olivia			Activation of Akt by the Bacterial Inositol Phosphatase, SopB, is Wortmannin Insensitive	PLOS ONE			English	Article							PROTEIN-KINASE B; PLECKSTRIN-HOMOLOGY DOMAINS; EPITHELIAL-CELLS; SALMONELLA-TYPHIMURIUM; SUSTAINED ACTIVATION; PLASMA-MEMBRANE; PATHWAY; PTDINS(4,5)P-2; IDENTIFICATION; INHIBITORS	Salmonella enterica uses effector proteins translocated by a Type III Secretion System to invade epithelial cells. One of the invasion-associated effectors, SopB, is an inositol phosphatase that mediates sustained activation of the pro-survival kinase Akt in infected cells. Canonical activation of Akt involves membrane translocation and phosphorylation and is dependent on phosphatidyl inositide 3 kinase (PI3K). Here we have investigated these two distinct processes in Salmonella infected HeLa cells. Firstly, we found that SopB-dependent membrane translocation and phosphorylation of Akt are insensitive to the PI3K inhibitor wortmannin. Similarly, depletion of the PI3K regulatory subunits p85 alpha and p85 beta by RNAi had no inhibitory effect on SopB-dependent Akt phosphorylation. Nevertheless, SopB-dependent phosphorylation does depend on the Akt kinases, PDK1 and rictor-mTOR. Membrane translocation assays revealed a dependence on SopB for Akt recruitment to Salmonella ruffles and suggest that this is mediated by phosphoinositide (3,4) P-2 rather than phosphoinositide (3,4,5) P-3. Altogether these data demonstrate that Salmonella activates Akt via a wortmannin insensitive mechanism that is likely a class I PI3K-independent process that incorporates some essential elements of the canonical pathway.	[Cooper, Kendal G.; Winfree, Seth; Malik-Kale, Preeti; Jolly, Carrie; Ireland, Robin; Knodler, Leigh A.; Steele-Mortimer, Olivia] NIAID, Intracellular Parasites Lab, NIH, Rocky Mt Labs, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Cooper, KG (corresponding author), Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	omortimer@niaid.nih.gov		Winfree, Seth/0000-0002-2396-5871; Knodler, Leigh/0000-0002-3028-2198	National Institutes of Allergy and Infectious Disease, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001111] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Disease, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work in the laboratory was supported by the Intramural Research Program of the National Institutes of Allergy and Infectious Disease, National Institutes of Health. No other current external funding sources supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; BALLA T, 2009, CURR PROTOC CELL BIO, V4; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bertelsen LS, 2004, AM J PHYSIOL-CELL PH, V287, pC939, DOI 10.1152/ajpcell.00413.2003; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; Downing GJ, 1996, BIOCHEMISTRY-US, V35, P3587, DOI 10.1021/bi9517493; Drecktrah D, 2006, TRAFFIC, V7, P39, DOI 10.1111/j.1600-0854.2005.00360.x; Drecktrah D, 2005, CELL MICROBIOL, V7, P105, DOI 10.1111/j.1462-5822.2004.00436.x; Drecktrah D, 2008, TRAFFIC, V9, P2117, DOI 10.1111/j.1600-0854.2008.00830.x; Dyson JM, 2005, INT J BIOCHEM CELL B, V37, P2260, DOI 10.1016/j.biocel.2005.05.003; Edwards JL, 2006, CELL MICROBIOL, V8, P1253, DOI 10.1111/j.1462-5822.2006.00707.x; Filippa N, 1999, MOL CELL BIOL, V19, P4989; FINLAY BB, 1991, J CELL SCI, V99, P283; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Gharbi SI, 2007, BIOCHEM J, V404, P15, DOI 10.1042/BJ20061489; Gills JJ, 2007, J BIOL CHEM, V282, P27020, DOI 10.1074/jbc.M701108200; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Ivetac I, 2009, EMBO REP, V10, P487, DOI 10.1038/embor.2009.28; Kierbel A, 2005, MOL BIOL CELL, V16, P2577, DOI 10.1091/mbc.E04-08-0717; Knodler LA, 2005, J BIOL CHEM, V280, P9058, DOI 10.1074/jbc.M412588200; Knodler LA, 2006, MOL MICROBIOL, V62, P928, DOI 10.1111/j.1365-2958.2006.05418.x; Knodler LA, 2009, CELL MICROBIOL, V11, P1652, DOI 10.1111/j.1462-5822.2009.01356.x; Konishi H, 1997, FEBS LETT, V410, P493, DOI 10.1016/S0014-5793(97)00541-3; Krech T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-287; Li YP, 2011, VET MICROBIOL, V148, P75, DOI 10.1016/j.vetmic.2010.08.009; Maira SM, 2001, SCIENCE, V294, P374, DOI 10.1126/science.1062030; Mallo GV, 2008, J CELL BIOL, V182, P741, DOI 10.1083/jcb.200804131; Mao S, 2007, CELL MICROBIOL, V9, P1997, DOI 10.1111/j.1462-5822.2007.00931.x; Marcus SL, 2002, CELL MICROBIOL, V4, P435, DOI 10.1046/j.1462-5822.2002.00202.x; Marcus SL, 2001, FEBS LETT, V494, P201, DOI 10.1016/S0014-5793(01)02356-0; Marshall AJ, 2002, MOL CELL BIOL, V22, P5479, DOI 10.1128/MCB.22.15.5479-5491.2002; Mason D, 2007, J GEN PHYSIOL, V129, P267, DOI 10.1085/jgp.200609656; Niebuhr K, 2002, EMBO J, V21, P5069, DOI 10.1093/emboj/cdf522; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Ono H, 2007, AM J PHYSIOL-CELL PH, V293, pC1576, DOI 10.1152/ajpcell.00570.2006; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Pendaries C, 2006, EMBO J, V25, P1024, DOI 10.1038/sj.emboj.7601001; Ramel D, 2009, BIOCHEM BIOPH RES CO, V387, P127, DOI 10.1016/j.bbrc.2009.06.139; Roxas JL, 2007, INFECT IMMUN, V75, P2316, DOI 10.1128/IAI.01690-06; Sable CL, 1997, FEBS LETT, V409, P253, DOI 10.1016/S0014-5793(97)00518-8; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sarkaria JN, 1998, CANCER RES, V58, P4375; Steele-Mortimer O, 2000, J BIOL CHEM, V275, P37718, DOI 10.1074/jbc.M008187200; Stender S, 2000, MOL MICROBIOL, V36, P1206, DOI 10.1046/j.1365-2958.2000.01933.x; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Terebiznik MR, 2002, NAT CELL BIOL, V4, P766, DOI 10.1038/ncb854; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Verbeke Philippe, 2006, PLoS Pathog, V2, pe45, DOI 10.1371/journal.ppat.0020045; Voth DE, 2009, INFECT IMMUN, V77, P205, DOI 10.1128/IAI.01124-08; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Zhou DG, 2001, MICROBES INFECT, V3, P1293, DOI 10.1016/S1286-4579(01)01489-7; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	65	29	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22260	10.1371/journal.pone.0022260	http://dx.doi.org/10.1371/journal.pone.0022260			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779406	gold, Green Published, Green Submitted			2022-12-25	WOS:000292811300059
J	Nishihara, E; Hiyama, TY; Noda, M				Nishihara, Eri; Hiyama, Takeshi Y.; Noda, Masaharu			Osmosensitivity of Transient Receptor Potential Vanilloid 1 Is Synergistically Enhanced by Distinct Activating Stimuli Such as Temperature and Protons	PLOS ONE			English	Article							NORMAL THIRST RESPONSES; CAPSAICIN RECEPTOR; MICE LACKING; ION-CHANNEL; PERMEABILITY; OSMORECEPTOR; CLONING; KIDNEY	In animals, body-fluid osmolality is continuously monitored to keep it within a narrow range around a set point (similar to 300 mOsm/kg). Transient receptor potential vanilloid 1 (TRPV1), a cation channel, has been implicated in body-fluid homeostasis in vivo based on studies with the TRPV1-knockout mouse. However, the response of TRPV1 to hypertonic stimuli has not been demonstrated with heterologous expression systems so far, despite intense efforts by several groups. Thus, the molecular entity of the hypertonic sensor in vivo still remains controversial. Here we found that the full-length form of TRPV1 is sensitive to an osmotic increase exclusively at around body temperature using HEK293 cells stably expressing rat TRPV1. At an ambient temperature of 24 degrees C, a slight increase in the intracellular calcium concentration ([Ca2+](i)) was rarely observed in response to hypertonic stimuli. However, the magnitude of the osmosensitive response markedly increased with temperature, peaking at around 36 degrees C. Importantly, the response at 36 degrees C showed a robust increase over a hypertonic range, but a small decrease over a hypotonic range. A TRPV1 antagonist, capsazepine, and a nonspecific TRP channel inhibitor, ruthenium red, completely blocked the increase in [Ca2+](i). These results endorse the view that the full-length form of TRPV1 is able to function as a sensor of hypertonic stimuli in vivo. Furthermore, we found that protons and capsaicin likewise synergistically potentiated the response of TRPV1 to hypertonic stimuli. Of note, HgCl2, which blocks aquaporins and inhibits cell-volume changes, significantly reduced the osmosensitive response. Our findings thus indicate that TRPV1 integrates multiple different types of activating stimuli, and that TRPV1 is sensitive to hypertonic stimuli under physiologically relevant conditions.	[Nishihara, Eri; Hiyama, Takeshi Y.; Noda, Masaharu] Grad Univ Adv Studies, Natl Inst Basic Biol, Div Mol Neurobiol, Aichi, Japan; [Hiyama, Takeshi Y.; Noda, Masaharu] Grad Univ Adv Studies, Sch Life Sci, Aichi, Japan	Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Nishihara, E (corresponding author), Grad Univ Adv Studies, Natl Inst Basic Biol, Div Mol Neurobiol, Aichi, Japan.	madon@nibb.ac.jp	Hiyama, Takeshi/X-4134-2018; Noda, Masaharu/D-7146-2016	Hiyama, Takeshi/0000-0001-8612-8707; Noda, Masaharu/0000-0002-3796-524X	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON B, 1978, PHYSIOL REV, V58, P582, DOI 10.1152/physrev.1978.58.3.582; ANDERSSON B, 1977, ANNU REV PHYSIOL, V39, P185, DOI 10.1146/annurev.ph.39.030177.001153; ARIEFF AI, 1993, BRIT MED J, V307, P305, DOI 10.1136/bmj.307.6899.305; Ayus JC, 1996, J PHYSIOL-LONDON, V492, P243, DOI 10.1113/jphysiol.1996.sp021305; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Ciura S, 2006, J NEUROSCI, V26, P9069, DOI 10.1523/JNEUROSCI.0877-06.2006; Guler AD, 2002, J NEUROSCI, V22, P6408; Hamamoto DT, 2000, BRAIN RES, V862, P217, DOI 10.1016/S0006-8993(00)02138-7; ISHIBASHI K, 1994, P NATL ACAD SCI USA, V91, P6269, DOI 10.1073/pnas.91.14.6269; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; Kitabchi AE, 2006, ENDOCRIN METAB CLIN, V35, P725, DOI 10.1016/j.ecl.2006.09.006; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liu LJ, 2007, J NEUROPHYSIOL, V97, P2001, DOI 10.1152/jn.00887.2006; Liu XB, 2006, J BIOL CHEM, V281, P15485, DOI 10.1074/jbc.M600549200; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Naeini RS, 2006, NAT NEUROSCI, V9, P93, DOI 10.1038/nn1614; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Oliet SHR, 1996, NEURON, V16, P175, DOI 10.1016/S0896-6273(00)80034-3; SHUTTLEWORTH TJ, 1991, J BIOL CHEM, V266, P1410; SPECTOR WG, 1956, J PATHOL BACTERIOL, V72, P367, DOI 10.1002/path.1700720203; Sprague J, 2001, EUR J PHARMACOL, V423, P121, DOI 10.1016/S0014-2999(01)01123-2; Stiefel D, 2007, NEUROCRIT CARE, V6, P67, DOI 10.1385/NCC:6:1:67; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 1999, J BIOL CHEM, V274, P6330, DOI 10.1074/jbc.274.10.6330; Taylor AC, 2008, AM J PHYSIOL-REG I, V294, pR1285, DOI 10.1152/ajpregu.00003.2008; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; VAKILI C, 1970, Surgical Forum (Chicago), V21, P227; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Xue Q, 2001, GENOMICS, V76, P14, DOI 10.1006/geno.2001.6582; Zhang ZZ, 2006, EUR J NEUROSCI, V23, P1491, DOI 10.1111/j.1460-9568.2006.04670.x	33	41	43	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22246	10.1371/journal.pone.0022246	http://dx.doi.org/10.1371/journal.pone.0022246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779403	gold, Green Published, Green Submitted			2022-12-25	WOS:000292811300056
J	Chaudhuri, L; Nicholson, AM; Kalen, AL; Goswami, PC				Chaudhuri, L.; Nicholson, A. M.; Kalen, A. L.; Goswami, P. C.			Preferential selection of MnSOD transcripts in proliferating normal and cancer cells	ONCOGENE			English	Article						MnSOD; 3 '-untranslated region; radiation; polyadenylation; quiescence	MANGANESE SUPEROXIDE-DISMUTASE; MESSENGER-RNA DEGRADATION; IRON-RESPONSIVE ELEMENT; 3' UNTRANSLATED REGION; MALIGNANT PHENOTYPE; 3'-UNTRANSLATED REGION; HUMAN FIBROBLASTS; BINDING; POLYADENYLATION; OVEREXPRESSION	Manganese superoxide dismutase (MnSOD) is a nuclear encoded and mitochondrial matrix-localized redox enzyme that is known to regulate the cellular redox environment. Cellular redox environment changes during transitions between quiescent and proliferative cycles. Human MnSOD has two poly(A) sites resulting in two transcripts: 1.5 and 4.2 kb. The present study investigates if the 3'-untranslated region (UTR) of MnSOD regulates its expression during transitions between quiescent and proliferating cycles, and in response to radiation. A preferential increase in the levels of the 1.5-kb MnSOD transcript was observed in quiescent cells, whereas the abundance of the longer transcript showed a direct correlation with the percentage of S-phase cells. The log-transformed expression ratio of the longer to the shorter transcript was also higher in proliferating normal and cancer cells. Deletion and reporter assays showed a significant decrease in reporter activity in constructs carrying multiple AU-rich sequence that are present in the 3'-UTR of the longer MnSOD transcript. Overexpression of the MnSOD 3'-UTR representing the longer transcript enhanced endogenous MnSOD mRNA levels, which was associated with an increase in MnSOD protein levels and a decrease in the percentage of S-phase cells. Irradiation increases the mRNA levels of the 1.5-kb MnSOD transcript, which was consistent with a significant increase in the reporter activity of the construct carrying the 3'-UTR of the shorter transcript. We conclude that the 3'-UTR of MnSOD regulates MnSOD expression in response to different growth states and radiation. Oncogene (2012) 31, 1207-1216; doi: 10.1038/onc.2011.325; published online 1 August 2011	[Chaudhuri, L.] Mayo Clin, Div Hematol Oncol, Scottsdale, AZ USA; [Goswami, P. C.] Univ Iowa, Dept Radiat Oncol, Free Rad & Radiat Biol Div, Med Labs B180, Iowa City, IA 52242 USA	Mayo Clinic; Mayo Clinic Phoenix; University of Iowa	Goswami, PC (corresponding author), Univ Iowa, Dept Radiat Oncol, Free Rad & Radiat Biol Div, Med Labs B180, Iowa City, IA 52242 USA.	prabhat-goswami@uiowa.edu	Kalen, Amanda/AAJ-7531-2020	Goswami, Prabhat/0000-0002-5700-2096	NIH [CA111365]; NIEHS [P42 ES 013661]; NATIONAL CANCER INSTITUTE [R01CA111365, P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES013661] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Dr Ehab H Sarsour and Maneesh G Kumar at the Free Radical and Radiation Biology Division, and Amy Dubinsky and Dr Beverly L Davidson at the Department of Internal Medicine, for technical assistance with the UTR cloning and luciferase reporter assay; Drs Ann Simons and Melissa Fath for human oral squamous and lung cancer cells; Mr Gareth Smith with editorial assistance and the staff at the Flow Cytometry and Radiation and Free Radical Research Core Facilities. Funding from NIH CA111365 and NIEHS P42 ES 013661 supported this work.	AKASHI M, 1995, J BIOL CHEM, V270, P15864, DOI 10.1074/jbc.270.26.15864; Chaudhuri L, 2010, ENVIRON INT, V36, P924, DOI 10.1016/j.envint.2010.01.001; Chaudhuri L, 2010, FREE RADICAL BIO MED, V49, P40, DOI 10.1016/j.freeradbiomed.2010.03.012; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chivukula RR, 2008, TRENDS BIOCHEM SCI, V33, P474, DOI 10.1016/j.tibs.2008.06.008; CHURCH SL, 1990, BIOCHIM BIOPHYS ACTA, V1087, P250, DOI 10.1016/0167-4781(90)90213-L; CHURCH SL, 1993, P NATL ACAD SCI USA, V90, P3113, DOI 10.1073/pnas.90.7.3113; Clerch LB, 2000, ANN NY ACAD SCI, V899, P103; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Goswami PC, 2000, J BIOL CHEM, V275, P38384, DOI 10.1074/jbc.M005298200; GUO B, 1994, J BIOL CHEM, V269, P24252; Jupe ER, 1996, EXP CELL RES, V224, P128, DOI 10.1006/excr.1996.0120; Jupe ER, 1996, CELL GROWTH DIFFER, V7, P871; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; Martincic K, 1998, P NATL ACAD SCI USA, V95, P11095, DOI 10.1073/pnas.95.19.11095; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; McCord J, 1969, J BIOL CHEM, V244, P6049; Menon SG, 2005, ANTIOXID REDOX SIGN, V7, P711, DOI 10.1089/ars.2005.7.711; Oberley LW, 2001, ANTIOXID REDOX SIGN, V3, P461, DOI 10.1089/15230860152409095; OBERLEY LW, 1989, FREE RADICAL BIO MED, V6, P379, DOI 10.1016/0891-5849(89)90083-X; OBERLEY TD, 1995, FREE RADICAL BIO MED, V19, P53, DOI 10.1016/0891-5849(95)00012-M; ROUAULT TA, 1988, SCIENCE, V241, P1207, DOI 10.1126/science.3413484; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sarsour EH, 2005, J BIOL CHEM, V280, P18033, DOI 10.1074/jbc.M501939200; Sarsour EH, 2008, AGING CELL, V7, P405, DOI 10.1111/j.1474-9726.2008.00384.x; Sarsour EH, 2010, MITOCHONDRION, V10, P342, DOI 10.1016/j.mito.2010.02.004; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SPITZ DR, 1989, ANAL BIOCHEM, V179, P8, DOI 10.1016/0003-2697(89)90192-9; STCLAIR DK, 1991, FREE RADICAL RES COM, V12-3, P771; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; WAN XS, 1994, DNA CELL BIOL, V13, P1127, DOI 10.1089/dna.1994.13.1127; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309; Weydert C, 2003, MOL CANCER THER, V2, P361; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; Zhong WX, 1997, ONCOGENE, V14, P481, DOI 10.1038/sj.onc.1200852	38	16	17	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAR	2012	31	10					1207	1216		10.1038/onc.2011.325	http://dx.doi.org/10.1038/onc.2011.325			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	906KS	21804600	Green Accepted			2022-12-25	WOS:000301344600001
J	Mao, JH; Wu, D; Kim, IJ; Kang, HC; Wei, G; Climent, J; Kumar, A; Pelorosso, FG; DelRosario, R; Huang, EJ; Balmain, A				Mao, J-H; Wu, D.; Kim, I-J; Kang, H. C.; Wei, G.; Climent, J.; Kumar, A.; Pelorosso, F. G.; DelRosario, R.; Huang, E. J.; Balmain, A.			Hipk2 cooperates with p53 to suppress gamma-ray radiation-induced mouse thymic lymphoma	ONCOGENE			English	Article						Hipk2; p53; radiation; tumorigenesis	INTERACTING PROTEIN KINASE-2; TRANSCRIPTION; TUMORS; GENE	A genome-wide screen for genetic alterations in radiation-induced thymic lymphomas generated from p53+/- and p53-/- mice showed frequent loss of heterozygosity (LOH) on chromosome 6. Fine mapping of these LOH regions revealed three non-overlapping regions, one of which was refined to a 0.2 Mb interval that contained only the gene encoding homeobox-interacting protein kinase 2 (Hipk2). More than 30% of radiation-induced tumors from both p53+/- and p53-/- mice showed heterozygous loss of one Hipk2 allele. Mice carrying a single inactive allele of Hipk2 in the germline were susceptible to induction of tumors by gamma-radiation, but most tumors retained and expressed the wild-type allele, suggesting that Hipk2 is a haploinsufficient tumor suppressor gene for mouse lymphoma development. Heterozygous loss of both Hipk2 and p53 confers strong sensitization to radiation-induced lymphoma. We conclude that Hipk2 is a haploinsufficient lymphoma suppressor gene. Oncogene (2012) 31, 1176-1180; doi:10.1038/onc.2011.306; published online 25 July 2011	[Wu, D.; Kim, I-J; Kang, H. C.; Climent, J.; Kumar, A.; Pelorosso, F. G.; DelRosario, R.; Balmain, A.] Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Mao, J-H] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Wei, G.; Huang, E. J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Wei, G.; Huang, E. J.] Vet Affairs Med Ctr, Pathol Serv 113B, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Balmain, A (corresponding author), Helen Diller Family Comprehens Canc Ctr, 1450 3rd St, San Francisco, CA 94158 USA.	abalmain@cc.ucsf.edu	Climent, Joan/O-5877-2017; Mao, Jian-Hua/EIZ-8595-2022; Wei, Grace/GPX-0836-2022; Huang, Eric J./AAH-7997-2019	Climent, Joan/0000-0002-8927-6614; Mao, Jian-Hua/0000-0001-9320-6021; Huang, Eric J./0000-0002-5381-3801	NIH/NCI [U01 CA84244R, 01 CA116481]; DOE [DE-FG02-03ER63630]; Office of Biological and Environmental Research of the US Department of Energy [DE-AC02-05CH11231]; Laboratory Directed Research and Development Program (LDRD); UCSF Genome Analysis Core; Barbara Bass Bakar Chair of Cancer Genetics; NATIONAL CANCER INSTITUTE [R01CA116481, U01CA084244] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOE(United States Department of Energy (DOE)); Office of Biological and Environmental Research of the US Department of Energy(United States Department of Energy (DOE)); Laboratory Directed Research and Development Program (LDRD); UCSF Genome Analysis Core; Barbara Bass Bakar Chair of Cancer Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by NIH/NCI grant U01 CA84244 and the DOE (DE-FG02-03ER63630) to AB, and NIH/NCI grant R01 CA116481, Office of Biological and Environmental Research of the US Department of Energy under Contract No DE-AC02-05CH11231 and Laboratory Directed Research and Development Program (LDRD) to JHM. AB acknowledges support from the UCSF Genome Analysis Core and the Barbara Bass Bakar Chair of Cancer Genetics.	Cai WW, 2002, NAT BIOTECHNOL, V20, P393, DOI 10.1038/nbt0402-393; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dauth I, 2007, CANCER RES, V67, P2274, DOI 10.1158/0008-5472.CAN-06-2884; Deshmukh H, 2008, ONCOGENE, V27, P4745, DOI 10.1038/onc.2008.110; Di Stefano V, 2004, ONCOGENE, V23, P5185, DOI 10.1038/sj.onc.1207656; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Kanei-Ishii C, 2004, J BIOL CHEM, V279, P44582, DOI 10.1074/jbc.M407831200; Li XL, 2007, ONCOGENE, V26, P7231, DOI 10.1038/sj.onc.1210523; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mao JH, 2007, CANCER CELL, V11, P161, DOI 10.1016/j.ccr.2006.11.025; Mitelman F, 2010, MITELMAN DATABASE CH; Pierantoni GM, 2007, J CLIN INVEST, V117, P693, DOI 10.1172/JCI29852; Pierantoni GM, 2001, ONCOGENE, V20, P6132, DOI 10.1038/sj.onc.1204635; Pistritto G, 2007, CELL DEATH DIFFER, V14, P1837, DOI 10.1038/sj.cdd.4402186; Trapasso F, 2009, DNA CELL BIOL, V28, P161, DOI 10.1089/dna.2008.0778; Wei GW, 2007, P NATL ACAD SCI USA, V104, P13040, DOI 10.1073/pnas.0703213104; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X	17	32	33	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2012	31	9					1176	1180		10.1038/onc.2011.306	http://dx.doi.org/10.1038/onc.2011.306			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	901EW	21785465	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000300945900010
J	Johansson, BB; Torsvik, J; Bjorkhaug, L; Vesterhus, M; Ragvin, A; Tjora, E; Fjeld, K; Hoem, D; Johansson, S; Raeder, H; Lindquist, S; Hernell, O; Cnop, M; Saraste, J; Flatmark, T; Molven, A; Njolstad, PR				Johansson, Bente B.; Torsvik, Janniche; Bjorkhaug, Lise; Vesterhus, Mette; Ragvin, Anja; Tjora, Erling; Fjeld, Karianne; Hoem, Dag; Johansson, Stefan; Raeder, Helge; Lindquist, Susanne; Hernell, Olle; Cnop, Miriam; Saraste, Jaakko; Flatmark, Torgeir; Molven, Anders; Njolstad, Pal R.			Diabetes and Pancreatic Exocrine Dysfunction Due to Mutations in the Carboxyl Ester Lipase Gene-Maturity Onset Diabetes of the Young (CEL-MODY) A PROTEIN MISFOLDING DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT-DEPENDENT LIPASE; AMINO-ACID-SEQUENCES; STIMULATED LIPASE; HUMAN-MILK; ACTIVATED LIPASE; CDNA CLONING; INSULIN GENE; SECRETION; AGGREGATION; HYDROLASE	CEL-maturity onset diabetes of the young (MODY), diabetes with pancreatic lipomatosis and exocrine dysfunction, is due to dominant frameshift mutations in the acinar cell carboxyl ester lipase gene (CEL). As Cel knock-out mice do not express the phenotype and the mutant protein has an altered and intrinsically disordered tandem repeat domain, we hypothesized that the disease mechanism might involve a negative effect of the mutant protein. In silico analysis showed that the pI of the tandem repeat was markedly increased from pH 3.3 in wild-type (WT) to 11.8 in mutant (MUT) human CEL. By stably over-expressing CEL-WT and CEL-MUT in HEK293 cells, we found similar glycosylation, ubiquitination, constitutive secretion, and quality control of the two proteins. The CEL-MUT protein demonstrated, however, a high propensity to form aggregates found intracellularly and extracellularly. Different physicochemical properties of the intrinsically disordered tandem repeat domains of WT and MUT proteins may contribute to different short and long range interactions with the globular core domain and other macromolecules, including cell membranes. Thus, we propose that CEL-MODY is a protein misfolding disease caused by a negative gain-of-function effect of the mutant proteins in pancreatic tissues.	[Njolstad, Pal R.] Univ Bergen, Haukeland Univ Hosp, Sect Pediat, Dept Pediat, N-5021 Bergen, Norway; [Johansson, Bente B.; Torsvik, Janniche; Bjorkhaug, Lise; Vesterhus, Mette; Ragvin, Anja; Tjora, Erling; Fjeld, Karianne; Johansson, Stefan; Raeder, Helge; Njolstad, Pal R.] Univ Bergen, Dept Clin Med, N-5020 Bergen, Norway; [Johansson, Bente B.; Torsvik, Janniche; Bjorkhaug, Lise; Ragvin, Anja; Fjeld, Karianne; Johansson, Stefan] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Hoem, Dag] Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway; [Hoem, Dag; Molven, Anders] Univ Bergen, Gade Inst, Sect Pathol, N-5021 Bergen, Norway; [Lindquist, Susanne; Hernell, Olle] Umea Univ, Dept Clin Sci, SE-90187 Umea, Sweden; [Cnop, Miriam] Univ Libre Brussels, Expt Med Lab, B-1070 Brussels, Belgium; [Cnop, Miriam] Erasmus Hosp, Div Endocrinol, B-1070 Brussels, Belgium; [Saraste, Jaakko; Flatmark, Torgeir] Univ Bergen, Dept Biomed, N-5020 Bergen, Norway; [Molven, Anders] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Umea University; Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Bergen; University of Bergen; Haukeland University Hospital	Njolstad, PR (corresponding author), Univ Bergen, Haukeland Univ Hosp, Sect Pediat, Dept Pediat, N-5021 Bergen, Norway.	pal.njolstad@uib.no	Raeder, Helge/AFQ-6279-2022; Johansson, Stefan/C-4394-2011; Johansson, Bente Berg/AAE-7666-2022; Raeder, Helge/ABE-3601-2020; Fjeld, Karianne/Q-7122-2018; Bjørkhaug, Lise/AAA-4356-2021; Vesterhus, Mette/AAX-8767-2020	Johansson, Stefan/0000-0002-2298-7008; Fjeld, Karianne/0000-0003-0441-1475; Bjørkhaug, Lise/0000-0002-9695-4559; Vesterhus, Mette/0000-0003-1493-2303; Johansson, Bente Berg/0000-0001-8893-1915; Cnop, Miriam/0000-0002-5112-1692	Bergen Medical Research Foundation; University of Bergen; Haukeland University Hospital; Helse Vest; Innovest; Research Council of Norway; Fonds National de la Recherche Scientifique-Fonds de la Recherche Scientifique Medicale	Bergen Medical Research Foundation; University of Bergen; Haukeland University Hospital; Helse Vest; Innovest; Research Council of Norway(Research Council of Norway); Fonds National de la Recherche Scientifique-Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS)	The work was supported by a grant from the Translational Fund of the Bergen Medical Research Foundation (to A. M. and P. R. N.), the University of Bergen, Haukeland University Hospital, Helse Vest, Innovest, the FUGE Program at the Research Council of Norway (to P. R. N.), and Fonds National de la Recherche Scientifique-Fonds de la Recherche Scientifique Medicale (to M. C.).	ABOUAKIL N, 1993, J BIOL CHEM, V268, P25755; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; BLACKBERG L, 1981, FEBS LETT, V136, P284, DOI 10.1016/0014-5793(81)80636-9; Broersen K, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt36; Brown W. J., 1999, IMMUNOPEROXIDASE MET, V4.6.1-4.6.17; Bruneau N, 1998, J CELL SCI, V111, P2665; BRUNEAU N, 1995, J BIOL CHEM, V270, P13524, DOI 10.1074/jbc.270.22.13524; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Chin LS, 2010, BIOCHEM SOC T, V38, P144, DOI 10.1042/BST0380144; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Higuchi S, 2002, J HUM GENET, V47, P213, DOI 10.1007/s100380200027; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kagan BL, 2004, J MEMBRANE BIOL, V202, P1, DOI 10.1007/s00232-004-0709-4; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Le Petit-Thevenin J, 2001, BBA-MOL CELL BIOL L, V1530, P184, DOI 10.1016/S1388-1981(00)00181-5; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Lindquist S, 2002, EUR J BIOCHEM, V269, P759, DOI 10.1046/j.0014-2956.2001.02666.x; LOMBARDO D, 1978, BIOCHIM BIOPHYS ACTA, V527, P142, DOI 10.1016/0005-2744(78)90263-2; LOMBARDO D, 1980, BIOCHIM BIOPHYS ACTA, V611, P147, DOI 10.1016/0005-2744(80)90050-9; Lombardo D, 2001, BBA-MOL CELL BIOL L, V1533, P1, DOI 10.1016/S1388-1981(01)00130-5; MARIANNE T, 1987, BIOCHEM J, V248, P189, DOI 10.1042/bj2480189; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Molven A, 2008, DIABETES, V57, P1131, DOI 10.2337/db07-1467; Munishkina LA, 2008, BIOCHEMISTRY-US, V47, P8993, DOI 10.1021/bi8008399; NILSSON J, 1990, EUR J BIOCHEM, V192, P543, DOI 10.1111/j.1432-1033.1990.tb19259.x; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Pasqualini E, 2000, BIOCHEM J, V345, P121, DOI 10.1042/0264-6021:3450121; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Raeder H, 2007, DIABETES, V56, P444, DOI 10.2337/db06-0859; REUE K, 1991, J LIPID RES, V32, P267; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; ROSE MC, 1984, BIOCHEM J, V222, P371, DOI 10.1042/bj2220371; ROUDANI S, 1995, BBA-GENE STRUCT EXPR, V1264, P141, DOI 10.1016/0167-4781(95)00141-3; Sannerud Ragna, 2008, V457, P253, DOI 10.1007/978-1-59745-261-8_19; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Terzyan S, 2000, PROTEIN SCI, V9, P1783, DOI 10.1110/ps.9.9.1783; Torsvik J, 2010, HUM GENET, V127, P55, DOI 10.1007/s00439-009-0740-8; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Uversky VN, 2009, FRONT BIOSCI-LANDMRK, V14, P5188, DOI 10.2741/3594; Verine A, 2001, J BIOL CHEM, V276, P12356, DOI 10.1074/jbc.M008658200; Vesterhus M, 2008, DIABETES CARE, V31, P306, DOI 10.2337/dc07-1002; Vesterhus M, 2010, PANCREATOLOGY, V10, P467, DOI 10.1159/000266284; WANG CS, 1995, BIOCHEMISTRY-US, V34, P10639, DOI 10.1021/bi00033a039; Weise K, 2010, CHEMBIOCHEM, V11, P1280, DOI 10.1002/cbic.201000039; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797	48	60	70	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34593	34605		10.1074/jbc.M111.222679	http://dx.doi.org/10.1074/jbc.M111.222679			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21784842	hybrid, Green Published			2022-12-25	WOS:000295406300014
J	Bulat, E; Garrett, TA				Bulat, Evgeny; Garrett, Teresa A.			Putative N-Acylphosphatidylethanolamine Synthase from Arabidopsis thaliana Is a Lysoglycerophospholipid Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; ESCHERICHIA-COLI; ELECTROSPRAY-IONIZATION; SALMONELLA-TYPHIMURIUM; RAT-BRAIN; IDENTIFICATION; BIOSYNTHESIS; MECHANISMS; PRECURSORS; ANANDAMIDE	AT1G78690, a gene found in Arabidopsis thaliana, has been reported to encode a N-acyltransferase that transfers an acyl chain from acyl-CoA to the headgroup of phosphatidylethanolamine (PE) to form N-acylphosphatidylethanolamine (N-acyl-PE). Our investigation suggests that At1g78690p is not a PE-dependent N-acyltransferase but is instead a lysoglycerophospholipid O-acyltransferase. We overexpressed AT1G78690 in Escherichia coli, extracted the cellular lipids, and identified the accumulating glycerophospholipid as acylphosphatidylglycerol (acyl-PG). Electrospray ionization quadrupole time-of-flight mass spectrometry (ESI-MS) analysis yielded [M - H](-) ions, corresponding by exact mass to acyl-PG rather than N-acyl-PE. Collision-induced dissociation mass spectrometry (MS/MS) yielded product ions consistent with acyl-PG. In addition, in vitro enzyme assays using both P-32- and C-14-radiolabeled substrates showed that AT1G78690 acylates 1-acyllysophosphatidylethanolamine (1-acyllyso-PE) and 1-acyllysophosphatidylglycerol (1-acyllyso-PG), but not PE or phosphatidylglycerol (PG), to form a diacylated product that co-migrates with PE and PG, respectively. We analyzed the diacylated product formed by AT1G78690 using a combination of base hydrolysis, phospholipase D treatment, ESI-MS, and MS/MS to show that AT1G78690 acylates the sn-2-position of 1-acyllyso-PE and 1-acyllyso-PG.	[Bulat, Evgeny; Garrett, Teresa A.] Vassar Coll, Dept Chem, Poughkeepsie, NY 12604 USA	Vassar College	Garrett, TA (corresponding author), Box 580,124 Raymond Ave, Poughkeepsie, NY 12604 USA.	tegarrett@vassar.edu		Bulat, Evgeny/0000-0002-8444-0067	National Institutes of Health [GM 069338]; National Science Foundation [1039659]; Research Corporation for Science Advancement Cottrell College [7914]; Direct For Mathematical & Physical Scien [1039659] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Research Corporation for Science Advancement Cottrell College(Research Corporation for Science Advancement); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health LIPID MAPS Large Scale Collaborative Grant GM 069338 (to Christian R.H. Raetz). This work was also supported by National Science Foundation Major Research Instrumentation Award 1039659 and Research Corporation for Science Advancement Cottrell College Science Single Investigator Award 7914.	Astarita G, 2008, J LIPID RES, V49, P48, DOI 10.1194/jlr.M700354-JLR200; Bishop RE, 2005, MOL MICROBIOL, V57, P900, DOI 10.1111/j.1365-2958.2005.04711.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cadas H, 1997, J NEUROSCI, V17, P1226; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Chapman KD, 1997, PLANT CELL PHYSIOL, V38, P1359, DOI 10.1093/oxfordjournals.pcp.a029130; Chapman KD, 2000, CHEM PHYS LIPIDS, V108, P221, DOI 10.1016/S0009-3084(00)00198-5; CHAPMAN KD, 1993, ARCH BIOCHEM BIOPHYS, V301, P21, DOI 10.1006/abbi.1993.1110; CHAPMAN KD, 1993, PLANT PHYSIOL, V102, P761, DOI 10.1104/pp.102.3.761; Coulon D., 2011, J BIOCH IN PRESS; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Faure L, 2009, J BIOL CHEM, V284, P18734, DOI 10.1074/jbc.M109.005744; Garrett T. A., 2011, BIOCH BIOPH IN PRESS; Garrett TA, 1997, J BIOL CHEM, V272, P21855, DOI 10.1074/jbc.272.35.21855; Garrett TA, 1998, J BIOL CHEM, V273, P12457, DOI 10.1074/jbc.273.20.12457; Garrett TA, 2009, J LIPID RES, V50, P1589, DOI 10.1194/jlr.M800549-JLR200; Guo LL, 2010, ANAL BIOCHEM, V405, P236, DOI 10.1016/j.ab.2010.06.027; GUPTA SD, 1993, J BIOL CHEM, V268, P16551; Holmback J, 2001, LIPIDS, V36, P153, DOI 10.1007/s11745-001-0702-z; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P892, DOI 10.1016/S1044-0305(00)00159-8; Hsu FF, 2004, J AM SOC MASS SPECTR, V15, P1, DOI 10.1016/j.jasms.2003.08.006; Hsu FF, 2009, J CHROMATOGR B, V877, P2673, DOI 10.1016/j.jchromb.2009.02.033; IMAMURA S, 1978, J BIOCHEM-TOKYO, V83, P677, DOI 10.1093/oxfordjournals.jbchem.a131960; Janssen MJW, 1999, PROTEIN ENG, V12, P497, DOI 10.1093/protein/12.6.497; Jin XH, 2007, J BIOL CHEM, V282, P3614, DOI 10.1074/jbc.M606369200; Jin XH, 2009, BBA-MOL CELL BIOL L, V1791, P32, DOI 10.1016/j.bbalip.2008.09.006; KARASAWA K, 1985, J BIOCHEM, V98, P1117, DOI 10.1093/oxfordjournals.jbchem.a135360; Kilaru A, 2007, CHEM BIODIVERS, V4, P1933, DOI 10.1002/cbdv.200790161; KOBAYASHI T, 1984, J BIOCHEM, V96, P137, DOI 10.1093/oxfordjournals.jbchem.a134805; KOBAYASHI T, 1985, J BIOCHEM-TOKYO, V98, P1017, DOI 10.1093/oxfordjournals.jbchem.a135347; Lands WEM, 2000, BBA-MOL CELL BIOL L, V1483, P1, DOI 10.1016/S1388-1981(99)00177-8; Merkel O, 2005, BBA-MOL CELL BIOL L, V1734, P215, DOI 10.1016/j.bbalip.2005.03.004; Metzger LE, 2009, BIOCHEMISTRY-US, V48, P11559, DOI 10.1021/bi901750f; Mileykovskaya E, 2009, J BIOL CHEM, V284, P2990, DOI 10.1074/jbc.M805189200; Miller J.H., 1972, EXPT MOL GENETICS; NAGGERT J, 1991, J BIOL CHEM, V266, P11044; NATARAJAN V, 1982, BIOCHIM BIOPHYS ACTA, V712, P342, DOI 10.1016/0005-2760(82)90352-6; Petersen G, 2006, BBA-MOL CELL BIOL L, V1761, P143, DOI 10.1016/j.bbalip.2005.12.011; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Rawyler AJ, 2001, PLANT PHYSIOL, V127, P240, DOI 10.1104/pp.127.1.240; Schmid HHO, 2000, CHEM PHYS LIPIDS, V108, P71, DOI 10.1016/S0009-3084(00)00188-2; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Stalberg K, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-60; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491; Ueda N, 2010, BBA-MOL CELL BIOL L, V1801, P1274, DOI 10.1016/j.bbalip.2010.08.010; WANG AY, 1994, MOL MICROBIOL, V11, P1009, DOI 10.1111/j.1365-2958.1994.tb00379.x; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200	48	21	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33819	33831		10.1074/jbc.M111.269779	http://dx.doi.org/10.1074/jbc.M111.269779			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21803774	Green Published, hybrid			2022-12-25	WOS:000295159200013
J	Bai, HD; Baik, N; Kiosses, WB; Krajewski, S; Miles, LA; Parmer, RJ				Bai, Hongdong; Baik, Nagyung; Kiosses, William B.; Krajewski, Stan; Miles, Lindsey A.; Parmer, Robert J.			The Novel Plasminogen Receptor, Plasminogen Receptor(KT) (Plg-R-KT), Regulates Catecholamine Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; ACTIVATOR T-PA; CHROMOGRANIN-A; NEURONAL DEGENERATION; SYMPATHETIC AXONS; BINDING-SITES; CELL-DEATH; LATE-PHASE; SURFACE; SECRETION	Neurotransmitter release by catecholaminergic cells is negatively regulated by prohormone cleavage products formed from plasmin-mediated proteolysis. Here, we investigated the expression and subcellular localization of Plg-R-KT, a novel plasminogen receptor, and its role in catecholaminergic cell plasminogen activation and regulation of catecholamine release. Prominent staining with anti-Plg-R-KT mAb was observed in adrenal medullary chromaffin cells in murine and human tissue. In Western blotting, Plg-R-KT was highly expressed in bovine adrenomedullary chromaffin cells, human pheochromocytoma tissue, PC12 pheochromocytoma cells, and murine hippocampus. Expression of Plg-R-KT fused in-frame to GFP resulted in targeting of the GFP signal to the cell membrane. Phase partitioning, co-immunoprecipitation with urokinase-type plasminogen activator receptor (uPAR), and FACS analysis with antibody directed against the C terminus of Plg-R-KT were consistent with Plg-R-KT being an integral plasma membrane protein on the surface of catecholaminergic cells. Cells stably overexpressing Plg-R-KT exhibited substantial enhancement of plasminogen activation, and antibody blockade of non-transfected PC12 cells suppressed plasminogen activation. In functional secretion assays, nicotine-evoked [H-3] norepinephrine release from cells overexpressing Plg-R-KT was markedly decreased (by 51 +/- 2%, p < 0.001) when compared with control transfected cells, and anti-body blockade increased [H-3] norepinephrine release from non-transfected PC12 cells. In summary, Plg-R-KT is present on the surface of catecholaminergic cells and functions to stimulate plasminogen activation and modulate catecholamine release. Plg-R-KT thus represents a new mechanism and novel control point for regulating the interface between plasminogen activation and neurosecretory cell function.	[Bai, Hongdong; Parmer, Robert J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92037 USA; [Bai, Hongdong; Parmer, Robert J.] Vet Adm San Diego Healthcare Syst, San Diego, CA 92161 USA; [Baik, Nagyung; Kiosses, William B.; Miles, Lindsey A.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Krajewski, Stan] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Scripps Research Institute; Sanford Burnham Prebys Medical Discovery Institute	Parmer, RJ (corresponding author), Univ Calif San Diego, Dept Med 9111H, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	rparmer@ucsd.edu			National Institutes of Health [HL050398, HL081046]; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081046, R01HL050398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL050398 (to R. J. P.) and HL081046 (to L. A. M.). This work was also supported by a grant from the Department of Veterans Affairs (to R. J. P.).	Andronicos NM, 2010, BLOOD, V115, P1319, DOI 10.1182/blood-2008-11-188938; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Blasi F, 2010, FEBS LETT, V584, P1923, DOI 10.1016/j.febslet.2009.12.039; BORDIER C, 1981, J BIOL CHEM, V256, P1604; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; ESTREICHER A, 1989, J BIOL CHEM, V264, P1180; Felez J, 1996, THROMB HAEMOSTASIS, V76, P577; Frey U, 1996, J NEUROSCI, V16, P2057; FRIEDMAN GC, 1995, J COMP NEUROL, V360, P658; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gualandris A, 1996, J NEUROSCI, V16, P2220; Gutierrez-Fernandez A, 2009, J NEUROSCI, V29, P12393, DOI 10.1523/JNEUROSCI.3553-09.2009; Hao ZF, 2006, BLOOD, V108, P200, DOI 10.1182/blood-2005-12-4884; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Jiang QJ, 2002, ANN NY ACAD SCI, V971, P445, DOI 10.1111/j.1749-6632.2002.tb04506.x; Jiang QJ, 2001, J BIOL CHEM, V276, P25022, DOI 10.1074/jbc.M101545200; Jiang X, 2002, MICROVASC RES, V64, P438, DOI 10.1006/mvre.2002.2441; Krajewska M, 2009, J HISTOCHEM CYTOCHEM, V57, P649, DOI 10.1369/jhc.2009.952812; Miles LA, 2002, ANN NY ACAD SCI, V971, P454, DOI 10.1111/j.1749-6632.2002.tb04508.x; Miles LA, 2006, J NEUROSCI, V26, P13017, DOI 10.1523/JNEUROSCI.2070-06.2006; Odegaard JI, 2007, J LEUKOCYTE BIOL, V81, P711, DOI 10.1189/jlb.0906590; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; PARMER RJ, 1993, J CLIN INVEST, V92, P1042, DOI 10.1172/JCI116609; Parmer RJ, 2000, J CLIN INVEST, V106, P907, DOI 10.1172/JCI7394; Parmer RJ, 1997, J BIOL CHEM, V272, P1976, DOI 10.1074/jbc.272.3.1976; Parmer RJ, 1998, TRENDS CARDIOVAS MED, V8, P306, DOI 10.1016/S1050-1738(98)00025-5; PITTMAN RN, 1995, J NEUROCHEM, V64, P566; PITTMAN RN, 1989, J NEUROSCI, V9, P4269; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Ranson M, 1998, BRIT J CANCER, V77, P1586, DOI 10.1038/bjc.1998.261; Salles FJ, 2002, J NEUROSCI, V22, P2125, DOI 10.1523/JNEUROSCI.22-06-02125.2002; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; Seeds NW, 2003, J NEUROSCI, V23, P7368; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Tsirka SE, 1996, NATURE, V384, P123, DOI 10.1038/384123b0; Tsirka SE, 1997, J NEUROSCI, V17, P543; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Wang N, 2004, J THROMB HAEMOST, V2, P785, DOI 10.1111/j.1538-7836.2004.00694.x; Wang YF, 1998, J NEUROSCI RES, V53, P443, DOI 10.1002/(SICI)1097-4547(19980815)53:4<443::AID-JNR6>3.3.CO;2-L; Zhang L, 2002, THROMB HAEMOSTASIS, V87, P493	41	19	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33125	33133		10.1074/jbc.M111.218693	http://dx.doi.org/10.1074/jbc.M111.218693			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21795689	hybrid, Green Published			2022-12-25	WOS:000294968800031
J	Dang, HQ; Li, ZY				Dang, Hung Quang; Li, Ziyin			The Cdc45.Mcm2-7.GINS Protein Complex in Trypanosomes Regulates DNA Replication and Interacts with Two Orc1-like Proteins in the Origin Recognition Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; S-PHASE PROGRESSION; CELL-CYCLE; BUDDING YEAST; CHROMOSOMAL DNA; SACCHAROMYCES-CEREVISIAE; EUKARYOTIC DNA; NUCLEAR EXPORT; PROCYCLIC FORM; MULTIPROTEIN COMPLEX	Accurate DNA replication requires a complex interplay of many regulatory proteins at replication origins. The CMG (Cdc45.Mcm2-7.GINS) complex, which is composed of Cdc45, Mcm2-7, and the GINS (Go-Ichi-Ni-San) complex consisting of Sld5 and Psf1 to Psf3, is recruited by Cdc6 and Cdt1 onto origins bound by the heterohexameric origin recognition complex (ORC) and functions as a replicative helicase. Trypanosoma brucei, an early branched microbial eukaryote, appears to express an archaea-like ORC consisting of a single Orc1/Cdc6-like protein. However, unlike archaea, trypanosomes possess components of the eukaryote-like CMG complex, but whether they form an active helicase complex, associate with the ORC, and regulate DNA replication remains unknown. Here, we demonstrated that the CMG complex is formed in vivo in trypanosomes and thatMcm2-7 helicase activity is activated by the association with Cdc45 and the GINS complex in vitro. Mcm2-7 and GINS proteins are confined to the nucleus throughout the cell cycle, whereas Cdc45 is exported out of the nucleus after DNA replication, indicating that nuclear exclusion of Cdc45 constitutes one mechanism for preventing DNA re-replication in trypanosomes. With the exception of Mcm4, Mcm6, and Psf1, knockdown of individual CMG genes inhibits DNA replication and cell proliferation. Finally, we identified a novel Orc1-like protein, Orc1b, as an additional component of the ORC and showed that both Orc1b and Orc1/Cdc6 associate with Mcm2-7 via interactions with Mcm3. All together, we identified the Cdc45.Mcm2-7.GINS complex as the replicative helicase that interacts with two Orc1-like proteins in the unusual origin recognition complex in trypanosomes.	[Dang, Hung Quang; Li, Ziyin] Univ Texas Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Li, ZY (corresponding author), Univ Texas Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	Ziyin.Li@uth.tmc.edu		Li, Ziyin/0000-0002-3960-9716	National Institutes of Health [AI090070]; University of Texas Medical School at Houston; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI090070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Medical School at Houston; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI090070 (to Z. L.) and by start-up funds from the University of Texas Medical School at Houston (to Z. L.).	Akita M, 2010, GENES CELLS, V15, P537, DOI 10.1111/j.1365-2443.2010.01402.x; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Barry ER, 2006, MICROBIOL MOL BIOL R, V70, P876, DOI 10.1128/MMBR.00029-06; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Godoy PDD, 2009, EUKARYOT CELL, V8, P1592, DOI 10.1128/EC.00161-09; Devault A, 2008, MOL BIOL CELL, V19, P2267, DOI 10.1091/mbc.E07-06-0614; Drury LS, 2000, CURR BIOL, V10, P231, DOI 10.1016/S0960-9822(00)00355-9; Elsasser S, 1999, MOL BIOL CELL, V10, P3263, DOI 10.1091/mbc.10.10.3263; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gourguechon S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-68; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; Hammarton TC, 2004, J BIOL CHEM, V279, P24757, DOI 10.1074/jbc.M401276200; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; Hellman K, 2007, EUKARYOT CELL, V6, P2206, DOI 10.1128/EC.00176-07; Huang HK, 2005, MOL CELL BIOL, V25, P9000, DOI 10.1128/MCB.25.20.9000-9015.2005; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Jallepalli PV, 1997, GENE DEV, V11, P2767, DOI 10.1101/gad.11.21.2767; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2003, NATURE, V423, P720, DOI 10.1038/nature01692; Kosugi S, 2008, TRAFFIC, V9, P2053, DOI 10.1111/j.1600-0854.2008.00825.x; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Li Y, 2003, MOL MICROBIOL, V49, P251, DOI 10.1046/j.1365-2958.2003.03575.x; Li ZY, 2008, EUKARYOT CELL, V7, P1941, DOI 10.1128/EC.00249-08; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000575; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003814; Li ZY, 2003, J BIOL CHEM, V278, P20652, DOI 10.1074/jbc.M301635200; Liku ME, 2005, MOL BIOL CELL, V16, P5026, DOI 10.1091/mbc.E05-05-0412; MacNeill SA, 2010, BIOCHEM J, V425, P489, DOI 10.1042/BJ20091531; Marinsek N, 2006, EMBO REP, V7, P539, DOI 10.1038/sj.embor.7400649; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Nigg Erich A., 1993, Trends in Cell Biology, V3, P296, DOI 10.1016/0962-8924(93)90011-O; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Nougarede R, 2000, MOL CELL BIOL, V20, P3795, DOI 10.1128/MCB.20.11.3795-3806.2000; Ogbadoyi E, 2000, CHROMOSOMA, V108, P501, DOI 10.1007/s004120050402; Sanchez-Pulido L, 2011, BIOINFORMATICS, V27, P1885, DOI 10.1093/bioinformatics/btr332; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tu XM, 2004, J BIOL CHEM, V279, P20519, DOI 10.1074/jbc.M312862200; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	65	38	38	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32424	32435		10.1074/jbc.M111.240143	http://dx.doi.org/10.1074/jbc.M111.240143			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21799014	Green Published, hybrid			2022-12-25	WOS:000294726800052
J	de Groot, T; van der Hagen, EAE; Verkaart, S; Boekhorst, VAMT; Bindels, RJM; Hoenderop, JGJ				de Groot, Theun; van der Hagen, Eline A. E.; Verkaart, Sjoerd; Boekhorst, Veronika A. M. Te; Bindels, Rene J. M.; Hoenderop, Joost G. J.			Role of the Transient Receptor Potential Vanilloid 5 (TRPV5) Protein N Terminus in Channel Activity, Tetramerization, and Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYRIN REPEAT; MOLECULAR DETERMINANTS; ENDOPLASMIC-RETICULUM; CATION CHANNELS; PLASMA-MEMBRANE; KINASE DOMAIN; CELL-SURFACE; TRPM8; COLD; ARCHITECTURE	The epithelial Ca2+ channel transient receptor potential vanilloid 5 (TRPV5) constitutes the apical entry site for active Ca2+ reabsorption in the kidney. The TRPV5 channel is a member of the TRP family of cation channels, which are composed of four subunits together forming a central pore. Regulation of channel activity is tightly controlled by the intracellular N and C termini. The TRPV5 C terminus regulates channel activity by various mechanisms, but knowledge regarding the role of the N terminus remains scarce. To study the role of the N terminus in TRPV5 regulation, we generated different N-terminal deletion constructs. We found that deletion of the first 32 residues did not affect TRPV5-mediated Ca-45(2+) uptake, whereas deletion up to residue 34 and 75 abolished channel function. Immunocytochemistry demonstrated that these mutant channels were retained in the endoplasmic reticulum and in contrast to wildtype TRPV5 did not reach the Golgi apparatus, explaining the lack of complex glycosylation of the mutants. A limited amount of mutant channels escaped the endoplasmic reticulum and reached the plasma membrane, as shown by cell surface biotinylation. These channels did not internalize, explaining the reduced but significant amount of these mutant channels at the plasma membrane. Wild-type TRPV5 channels, despite significant plasma membrane internalization, showed higher plasma membrane levels compared with the mutant channels. The assembly into tetramers was not affected by the N-terminal deletions. Thus, the N-terminal residues 34-75 are critical in the formation of a functional TRPV5 channel because the deletion mutants were present at the plasma membrane as tetramers, but lacked channel activity.	[de Groot, Theun; van der Hagen, Eline A. E.; Verkaart, Sjoerd; Boekhorst, Veronika A. M. Te; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Nijmegen Ctr Mol Life Sci, POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.hoenderop@fysiol.umcn.nl	Bindels, René JM/B-9824-2013; Groot, Theun/A-2596-2015; Hoenderop, Joost G.J./H-8047-2014; te Boekhorst, Veronika/C-5430-2017	Bindels, René JM/0000-0003-1167-1339; Hoenderop, Joost G.J./0000-0002-1816-8544; te Boekhorst, Veronika/0000-0002-9473-5926	Dutch Kidney Foundation [C03.6017, C06.2170]; Netherlands Organization for Scientific Research [NWO-ALW 814.02.001, NWO 819.02.012, NWO-CW 700.55.302]; European Young Investigator Award	Dutch Kidney Foundation; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Young Investigator Award	This work was supported by Dutch Kidney Foundation Grants C03.6017 and C06.2170 and The Netherlands Organization for Scientific Research Grants NWO-ALW 814.02.001, NWO 819.02.012, and NWO-CW 700.55.302.; Supported by an European Young Investigator Award.	Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; Cao G, 2008, CURR BIOL, V18, P168, DOI 10.1016/j.cub.2007.12.058; Cha SK, 2008, AM J PHYSIOL-RENAL, V294, pF1212, DOI 10.1152/ajprenal.00007.2008; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chang Q, 2004, J BIOL CHEM, V279, P54304, DOI 10.1074/jbc.M406222200; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Engelke M, 2002, FEBS LETT, V523, P193, DOI 10.1016/S0014-5793(02)02971-X; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; Erler I, 2006, J BIOL CHEM, V281, P38396, DOI 10.1074/jbc.M607756200; Farhan H, 2006, HANDB EXP PHARM, V175, P233; Gaudet R, 2008, J PHYSIOL-LONDON, V586, P3565, DOI 10.1113/jphysiol.2008.155812; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Gaudet Rachelle, 2007, P349; Gkika D, 2006, EMBO J, V25, P4707, DOI 10.1038/sj.emboj.7601357; GREEN WN, 1995, TRENDS NEUROSCI, V18, P280, DOI 10.1016/0166-2236(95)93915-K; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Jung J, 2002, J BIOL CHEM, V277, P44448, DOI 10.1074/jbc.M207103200; Kamsteeg EJ, 1999, EMBO J, V18, P2394, DOI 10.1093/emboj/18.9.2394; Lambers TT, 2007, MOL CELL BIOL, V27, P1486, DOI 10.1128/MCB.01468-06; Lambers TT, 2004, J BIOL CHEM, V279, P28855, DOI 10.1074/jbc.M313637200; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nilius B, 2000, J PHYSIOL-LONDON, V527, P239, DOI 10.1111/j.1469-7793.2000.00239.x; Nilius B, 2005, PFLUG ARCH EUR J PHY, V451, P1, DOI 10.1007/s00424-005-1462-y; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Phelps CB, 2007, J BIOL CHEM, V282, P36474, DOI 10.1074/jbc.M707205200; Schlingmann KP, 2007, BBA-MOL BASIS DIS, V1772, P813, DOI 10.1016/j.bbadis.2007.03.009; Schulteis CT, 1998, J BIOL CHEM, V273, P26210, DOI 10.1074/jbc.273.40.26210; Takezawa R, 2004, P NATL ACAD SCI USA, V101, P6009, DOI 10.1073/pnas.0307565101; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; van de Graaf SFJ, 2008, J BIOL CHEM, V283, P4077, DOI 10.1074/jbc.M706959200; van den Berghe PVE, 2009, HEPATOLOGY, V50, P1783, DOI 10.1002/hep.23209; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x	40	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32132	32139		10.1074/jbc.M111.226878	http://dx.doi.org/10.1074/jbc.M111.226878			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795703	Green Published, hybrid			2022-12-25	WOS:000294726800023
J	Mukherjee, M; Ge, GQ; Zhang, NG; Huang, EY; Nakamura, LV; Minor, M; Fofanov, V; Rao, PH; Herron, A; Pati, D				Mukherjee, Malini; Ge, Gouqing; Zhang, Nenggang; Huang, Eryong; Nakamura, Lanelle V.; Minor, Marissa; Fofanov, Viacheslav; Rao, Pullivarthi H.; Herron, Alan; Pati, Debananda			Separase Loss of Function Cooperates with the Loss of p53 in the Initiation and Progression of T- and B-Cell Lymphoma, Leukemia and Aneuploidy in Mice	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; DOUBLE-STRAND BREAKS; LI-FRAUMENI-SYNDROME; DNA-DAMAGE; SACCHAROMYCES-CEREVISIAE; HUMAN CANCERS; ANAPHASE; REPAIR; YEAST; GENE	Background: Cohesin protease Separase plays a key role in faithful segregation of sister chromatids by cleaving the cohesin complex at the metaphase to anaphase transition. Homozygous deletion of ESPL1 gene that encodes Separase protein results in embryonic lethality in mice and Separase overexpression lead to aneuploidy and tumorigenesis. However, the effect of Separase haploinsufficiency has not been thoroughly investigated. Methodology/Principal Findings: Here we examined the effect of ESPL1 heterozygosity using a hypomorphic mouse model that has reduced germline Separase activity. We report that while ESPL1 mutant (ESPL1(+/hyp)) mice have a normal phenotype, in the absence of p53, these mice develop spontaneous T- and B-cell lymphomas, and leukemia with a significantly shortened latency as compared to p53 null mice. The ESPL1 hypomorphic, p53 heterozygous transgenic mice (ESPL1(+/hyp), p53(+/-)) also show a significantly reduced life span with an altered tumor spectrum of carcinomas and sarcomas compared to p53(+/-) mice alone. Furthermore, ESPL1(+/hyp), p53(-/-) mice display significantly higher levels of genetic instability and aneuploidy in normal cells, as indicated by the abnormal metaphase counts and SKY analysis of primary splenocytes. Conclusions/Significance: Our results indicate that reduced levels of Separase act synergistically with loss of p53 in the initiation and progression of B-and T-cell lymphomas, which is aided by increased chromosomal missegregation and accumulation of genomic instability. ESPL1(+/hyp), p53(-/-) mice provide a new animal model for mechanistic study of aggressive lymphoma and also for preclinical evaluation of new agents for its therapy.	[Mukherjee, Malini; Ge, Gouqing; Zhang, Nenggang; Huang, Eryong; Nakamura, Lanelle V.; Minor, Marissa; Rao, Pullivarthi H.; Pati, Debananda] Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pediat Hematol Oncol, Houston, TX 77030 USA; [Herron, Alan] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Herron, Alan] Baylor Coll Med, Ctr Comparat Med, Houston, TX 77030 USA; [Fofanov, Viacheslav] Eureka Genom Corp, Houston, TX USA	Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine	Mukherjee, M (corresponding author), Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pediat Hematol Oncol, Houston, TX 77030 USA.	pati@bcm.tmc.edu			National Cancer Institute [1RO1 CA109478, 1RO1 CA109330]; NATIONAL CANCER INSTITUTE [R01CA109478, R01CA109330] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants awarded to D. Pati from the National Cancer Institute (1RO1 CA109478 and 1RO1 CA109330). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Viacheslav Fofanov is an employee of Eureka Genomics (R), Corp and contributed to the statistical analysis of the data for this study.	Adachi Y, 2008, CELL CYCLE, V7, P765, DOI 10.4161/cc.7.6.5530; Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Bauerschmidt C, 2010, NUCLEIC ACIDS RES, V38, P477, DOI 10.1093/nar/gkp976; Bausch C, 2007, MOL CELL BIOL, V27, P8522, DOI 10.1128/MCB.01007-07; BERNS A, 1991, J CELL BIOCHEM, V47, P130, DOI 10.1002/jcb.240470206; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Cohen-Fix O, 1999, GENE DEV, V13, P1950, DOI 10.1101/gad.13.15.1950; Covo S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001006; CURTIS HJ, 1971, ADV GENET, V16, P305, DOI 10.1016/S0065-2660(08)60361-2; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DONEHOWER LA, 1993, BIOCHIM BIOPHYS ACTA, V1155, P181, DOI 10.1016/0304-419X(93)90004-V; Dorsett D, 2009, CHROMOSOME RES, V17, P185, DOI 10.1007/s10577-009-9022-5; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Haering CH, 2003, BIOESSAYS, V25, P1178, DOI 10.1002/bies.10361; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hornig NCD, 2002, CURR BIOL, V12, P973, DOI 10.1016/S0960-9822(02)00847-3; Horsfield JA, 2007, DEVELOPMENT, V134, P2639, DOI 10.1242/dev.002485; Huang XX, 2008, PLOS BIOL, V6, P52, DOI 10.1371/journal.pbio.0060015; HUNTER T, 1991, CELL, V66, P1071, DOI 10.1016/0092-8674(91)90028-W; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; JESSBERGER R, 1993, J BIOL CHEM, V268, P15070; Jessberger R, 2009, EMBO J, V28, P2491, DOI 10.1038/emboj.2009.217; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Kumada K, 2006, J CELL BIOL, V172, P835, DOI 10.1083/jcb.200511126; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Liu JL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000119; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Meyer R, 2009, CLIN CANCER RES, V15, P2703, DOI 10.1158/1078-0432.CCR-08-2454; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nagao K, 2004, NATURE, V430, P1044, DOI 10.1038/nature02803; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Panigrahi AK, 2009, CRIT REV ONCOL HEMAT, V72, P181, DOI 10.1016/j.critrevonc.2008.12.002; Pati D, 2004, CANCER RES, V64, P5608, DOI 10.1158/0008-5472.CAN-03-0629; Pfleghaar K, 2005, PLOS BIOL, V3, P2127, DOI 10.1371/journal.pbio.0030416; Post SM, 2010, ONCOGENE, V29, P1260, DOI 10.1038/onc.2009.423; PURDIE CA, 1994, ONCOGENE, V9, P603; Rao PH, 1998, BLOOD, V92, P1743; Shepard JL, 2007, GENE DEV, V21, P55, DOI 10.1101/gad.1470407; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Waizenegger IC, 2002, CURR BIOL, V12, P1368, DOI 10.1016/S0960-9822(02)01073-4; Watrin E, 2006, EXP CELL RES, V312, P2687, DOI 10.1016/j.yexcr.2006.06.024; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; Xu HL, 2011, NAT REV CANCER, V11, P199, DOI 10.1038/nrc3018; Xu HL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2814; Xu HL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012112; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang NG, 2008, P NATL ACAD SCI USA, V105, P13033, DOI 10.1073/pnas.0801610105; Zhang NG, 2009, CELL CYCLE, V8, P399, DOI 10.4161/cc.8.3.7586; Zhou YL, 2003, J BIOL CHEM, V278, P462, DOI 10.1074/jbc.M203793200	59	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22167	10.1371/journal.pone.0022167	http://dx.doi.org/10.1371/journal.pone.0022167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799785	gold, Green Published, Green Submitted			2022-12-25	WOS:000293172900014
J	Baune, BT; Unwin, SJ; Quirk, F; Golledge, J				Baune, Bernhard T.; Unwin, Steven J.; Quirk, Frances; Golledge, Jonathan			Neuropsychiatric Symptoms in Patients with Aortic Aneurysms	PLOS ONE			English	Article							ELDERLY GENERAL-POPULATION; MILD COGNITIVE IMPAIRMENT; NECROSIS-FACTOR-ALPHA; DEPRESSIVE SYMPTOMS; SICKNESS BEHAVIOR; VASCULAR-DISEASE; RATING-SCALE; RISK-FACTORS; ASSOCIATION; PERFORMANCE	Background: Emerging evidence suggests that vascular disease confers vulnerability to a late-onset of depressive illness and the impairment of specific cognitive functions, most notably in the domains of memory storage and retrieval. Lower limb athero-thrombosis and abdominal aortic aneurysm (AAA) have both been previously associated with neuropsychiatric symptoms possibly due to associated intracerebral vascular disease or systemic inflammation, hence suggesting that these illnesses may be regarded as models to investigate the vascular genesis of neuropsychiatric symptoms. The aim of this study was to compare neuropsychiatric symptoms such as depression, anxiety and a variety of cognitive domains in patients who had symptoms of peripheral athero-thrombosis (intermittent claudication) and those who had an asymptomatic abdominal aortic aneurysm AAA. Methodology/Principal Findings: In a cross-sectional study, 26 participants with either intermittent claudication or AAA were assessed using a detailed neuropsychiatric assessment battery for various cognitive domains and depression and anxiety symptoms (Hamilton Depression and Anxiety Scales). Student t test and linear regression analyses were applied to compare neuropsychiatric symptoms between patient groups. AAA participants showed greater levels of cognitive impairment in the domains of immediate and delayed memory as compared to patients who had intermittent claudication. Cognitive dysfunction was best predicted by increasing aortic diameter. CRP was positively related to AAA diameter, but not to cognitive function. AAA and aortic diameter in particular were associated with cognitive dysfunction in this study. Conclusions/Significance: AAA patients are at a higher risk for cognitive impairment than intermittent claudication patients. Validation of this finding is required in a larger study, but if confirmed could suggest that systemic factors peculiar to AAA may impact on cognitive function.	[Baune, Bernhard T.] Univ Adelaide, Discipline Psychiat, Adelaide, SA, Australia; [Unwin, Steven J.; Quirk, Frances] James Cook Univ, Discipline Psychiat, Townsville, Qld 4811, Australia; [Golledge, Jonathan] James Cook Univ, Vasc Biol Unit, Townsville, Qld 4811, Australia	University of Adelaide; James Cook University; James Cook University	Baune, BT (corresponding author), Univ Adelaide, Discipline Psychiat, Adelaide, SA, Australia.	bernhard.baune@adelaide.edu.au	golledge, jonathan/I-2371-2013	Quirk, Frances/0000-0002-4177-0461	Discipline of Psychiatry, James Cook University	Discipline of Psychiatry, James Cook University	The study was funded by internal funds form the Discipline of Psychiatry, James Cook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos GS, 2006, BIOL PSYCHIAT, V60, P1304, DOI 10.1016/j.biopsych.2006.09.006; Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915; Alexopoulos GS, 2003, J AM GERIATR SOC, V51, P1178, DOI 10.1046/j.1532-5415.2003.51373.x; Alexopoulos GS, 1996, AM J PSYCHIAT, V153, P877; ALEXOPOULOS GS, 1992, BIOL PSYCHIAT, V31, P591, DOI 10.1016/0006-3223(92)90245-U; Barnes DE, 2006, ARCH GEN PSYCHIAT, V63, P273, DOI 10.1001/archpsyc.63.3.273; Baune BT, 2008, NEUROBIOL AGING, V29, P937, DOI 10.1016/j.neurobiolaging.2006.12.003; Baune BT, 2008, PSYCHONEUROENDOCRINO, V33, P68, DOI 10.1016/j.psyneuen.2007.10.002; Baune BT, 2007, J PSYCHIATR RES, V41, P247, DOI 10.1016/j.jpsychires.2006.06.004; Baune BT, 2006, DEMENT GERIATR COGN, V22, P142, DOI 10.1159/000093745; Beatty WW, 2003, J CLIN EXP NEUROPSYC, V25, P1065, DOI 10.1076/jcen.25.8.1065.16732; Benoit AG, 2005, J VASC SURG, V42, P884, DOI 10.1016/j.jvs.2005.07.032; Bowler JV, 2007, BRIT MED BULL, V83, P291, DOI 10.1093/bmb/ldm021; Brebner K, 2000, NEUROPSYCHOPHARMACOL, V22, P566, DOI 10.1016/S0893-133X(99)00166-9; CARROLL BJ, 1968, LANCET, V1, P1373; COFFEY CE, 1988, BIOL PSYCHIAT, V24, P143, DOI 10.1016/0006-3223(88)90270-3; de Ceniga MV, 2009, EUR J VASC ENDOVASC, V37, P297, DOI 10.1016/j.ejvs.2008.11.014; Dunn AJ, 2005, NEUROSCI BIOBEHAV R, V29, P891, DOI 10.1016/j.neubiorev.2005.03.023; Filipovic M, 2005, BRIT J SURG, V92, P968, DOI 10.1002/bjs.5118; Frasure-Smith N, 1999, PSYCHOSOM MED, V61, P26, DOI 10.1097/00006842-199901000-00006; Geroldi C, 2003, J AM GERIATR SOC, V51, P1064, DOI 10.1046/j.1532-5415.2003.51353.x; GOLD PW, 1988, NEW ENGL J MED, V319, P348, DOI 10.1056/NEJM198808113190606; Golledge J, 2007, CIRCULATION, V116, P2275, DOI 10.1161/CIRCULATIONAHA.107.717926; Golledge J, 2007, ARTERIOSCL THROM VAS, V27, P655, DOI 10.1161/01.ATV.0000255560.49503.4e; Golledge J, 2011, EUR HEART J, V32, P354, DOI 10.1093/eurheartj/ehq171; Golledge J, 2010, ARTERIOSCL THROM VAS, V30, P1075, DOI 10.1161/ATVBAHA.110.206573; Golledge J, 2008, CIRCULATION, V118, P2382, DOI 10.1161/CIRCULATIONAHA.108.802074; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Hippisley-Cox J, 1998, BMJ-BRIT MED J, V316, P1714, DOI 10.1136/bmj.316.7146.1714; Iwanaga Y, 2008, NEUROPATH APPL NEURO, V34, P145, DOI 10.1111/j.1365-2990.2007.00877.x; KENT S, 1992, TRENDS PHARMACOL SCI, V13, P24, DOI 10.1016/0165-6147(92)90012-U; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Kos K, 2007, J CLIN ENDOCR METAB, V92, P1129, DOI 10.1210/jc.2006-1841; Leonard B, 2000, World J Biol Psychiatry, V1, P17, DOI 10.3109/15622970009150562; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Mangan SH, 2007, CARDIOVASC RES, V76, P494, DOI 10.1016/j.cardiores.2007.07.017; McAfoose J, 2009, NEUROSCI BIOBEHAV R, V33, P355, DOI 10.1016/j.neubiorev.2008.10.005; Merino JG, 2008, STROKE, V39, P739, DOI 10.1161/STROKEAHA.107.510289; Miller GE, 2002, AM J CARDIOL, V90, P1279, DOI 10.1016/S0002-9149(02)02863-1; Moran CS, 2005, CIRCULATION, V111, P3119, DOI 10.1161/CIRCULATIONAHA.104.464727; Nordlund A, 2007, NEUROPSYCHOLOGY, V21, P706, DOI 10.1037/0894-4105.21.6.706; Norman PE, 2007, CONNECT TISSUE RES, V48, P125, DOI 10.1080/03008200701331524; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Pucak ML, 2006, INT REV PSYCHIATR, V17, P477, DOI 10.1080/02646830500381757; Putnam S, 1990, CLIN NEUROPSYCHOL, V4, P199, DOI DOI 10.1080/13854049008401906; Rafnsson SB, 2007, J AM GERIATR SOC, V55, P700, DOI 10.1111/j.1532-5415.2007.01158.x; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Randolph C., 1998, REPEATABLE BATTERY A; Reynolds WM, 1995, PSYCHOL ASSESSMENT, V7, P472; Stott DJ, 2010, ARTERIOSCL THROM VAS, V30, P605, DOI 10.1161/ATVBAHA.109.199448; TROXLER RG, 1977, ATHEROSCLEROSIS, V26, P151, DOI 10.1016/0021-9150(77)90098-3	53	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22632	10.1371/journal.pone.0022632	http://dx.doi.org/10.1371/journal.pone.0022632			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799922	gold, Green Published, Green Accepted			2022-12-25	WOS:000293097300076
J	Godlewski, AE; Veyrune, JL; Nicolas, E; Ciangura, CA; Chaussain, CC; Czernichow, S; Basdevant, A; Hennequin, M				Godlewski, Anne Esperance; Veyrune, Jean Luc; Nicolas, Emmanuel; Ciangura, Cecile A.; Chaussain, Catherine C.; Czernichow, Sebastien; Basdevant, Arnaud; Hennequin, Martine			Effect of Dental Status on Changes in Mastication in Patients with Obesity following Bariatric Surgery	PLOS ONE			English	Article							CEPHALIC-PHASE RESPONSES; MUSCLE-ACTIVITY; FOOD; HUMANS; ELECTROMYOGRAPHY; METAANALYSIS; PERFORMANCE; VALIDATION; METABOLISM; DENTURE	Background: Patients scheduled for bariatric surgery (BS) are encouraged to chew slowly in order to optimise the digestion process. The influence of dental status on patients' ability to comply with advice on chewing behaviour is poorly documented. This study aims to compare modifications of chewing function before and after BS in three groups of obese patients differing in dental status. Method and Findings: A cohort of 46 obese women provided three groups: FD group: fully dentate (7-10 functional dental units [FU]); PD group: partially dentate (4-6 FU) without partial dentures; DW group: partial and complete denture wearers. Chewing time (CT), number of chewing cycles (CC), and chewing frequency (CF) were measured before and after surgery during mastication of standardised samples of raw carrot, peanuts, banana, apple and jelly. The median particle-size distribution (D50) of the pre-swallowed bolus was also evaluated for peanut and carrot. Before surgery, the PD and DW groups exhibited greater mean CCs and CTs than the FD group (SNK p<0.05) and produced a bolus with higher granulometry (SNK, p<0.05) than the FD group. After surgery, CT and CC increased for all groups and for all foods, but not statistically significant for jelly. The resulting changes in bolus granulometry observed depended on both food and dental status. The granulometry of carrot bolus remained as fine or as coarse in FD and DW groups respectively as it was before surgery while it was significantly decreased in the PD group (Student's test, p<0.001). Conclusions: After bariatric surgery, all the obese patients, regardless of dental status modified their chewing kinematics. The effects of this chewing behaviour on bolus granulometry depended on dental status and type of food. Further studies are needed to understand better the impact of dental status on feeding behaviour and nutrition in patients with obesity.	[Godlewski, Anne Esperance; Veyrune, Jean Luc; Nicolas, Emmanuel; Hennequin, Martine] Univ Auvergne, Clermont Univ, EA 3847, Clermont Ferrand, France; [Godlewski, Anne Esperance; Veyrune, Jean Luc; Nicolas, Emmanuel; Hennequin, Martine] CHU Clermont Ferrand, Clermont Ferrand, France; [Ciangura, Cecile A.] Hop La Pitie Salpetriere, AP HP, Paris, France; [Chaussain, Catherine C.] Univ Paris 05, EA 2496, Paris, France; [Chaussain, Catherine C.] Hop Bretonneau, AP HP, Serv Odontol, Paris, France; [Czernichow, Sebastien] Univ Versailles, Dept Nutr, Hop Ambroise Pare, Boulogne, France; [Czernichow, Sebastien] INSERM, Ctr Rech Epidemiol & Sante Populat, U1018, Villejuif, France; [Basdevant, Arnaud] Univ Paris 06, INSERM, U755, IFR58, Paris, France	Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bretonneau - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Godlewski, AE (corresponding author), Univ Auvergne, Clermont Univ, EA 3847, Clermont Ferrand, France.	martine.hennequin@u-clermont1.fr	Hennequin, Martine/AAB-3004-2021	Hennequin, Martine/0000-0001-8173-2606; Chaussain, Catherine/0000-0002-3463-3936	Assistance Publique/Hopitaux de Paris (Paris, France); University of Auvergne (Clermont-Ferrand, France) [3847]; Conference of the Heads of French hospital dental departments	Assistance Publique/Hopitaux de Paris (Paris, France); University of Auvergne (Clermont-Ferrand, France); Conference of the Heads of French hospital dental departments	This project was funded by Assistance Publique/Hopitaux de Paris (Paris, France) and Equipe d'Accueil 3847, University of Auvergne (Clermont-Ferrand, France). The project received a grant from the Benjamin Delessert Foundation in 2006 and from the "Conference of the Heads of French hospital dental departments" in 2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AG NAT ACCR EV EN, 2001, CHIR OB MORB AD; Agrawal KR, 1998, J DENT RES, V77, P1931, DOI 10.1177/00220345980770111101; Andrade AM, 2008, J AM DIET ASSOC, V108, P1186, DOI 10.1016/j.jada.2008.04.026; BELLISLE F, 1981, PHYSIOL BEHAV, V27, P649, DOI 10.1016/0031-9384(81)90237-7; BELLISLE F, 1988, APPETITE, V11, P111, DOI 10.1016/S0195-6663(88)80010-2; BRAND JG, 1982, ANNU REV NUTR, V2, P249, DOI 10.1146/annurev.nu.02.070182.001341; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Buchwald H, 2009, OBES SURG, V19, P1605, DOI 10.1007/s11695-009-0014-5; Buddeberg-Fischer B, 2006, OBES SURG, V16, P321, DOI 10.1381/096089206776116471; Cassady BA, 2009, AM J CLIN NUTR, V89, P794, DOI 10.3945/ajcn.2008.26669; de Araujo IE, 2004, J NEUROSCI, V24, P3086, DOI 10.1523/JNEUROSCI.0130-04.2004; de Jonge L, 1997, OBES RES, V5, P622, DOI 10.1002/j.1550-8528.1997.tb00584.x; de Saint Pol T, 2009, ECON HUM BIOL, V7, P398, DOI 10.1016/j.ehb.2009.06.002; DeJonge L, 1997, AM J PHYSIOL-ENDOC M, V272, pE775, DOI 10.1152/ajpendo.1997.272.5.E775; Dixon JB, 2009, WORLD J SURG, V33, P2014, DOI 10.1007/s00268-009-0062-y; Farella M, 1999, ARCH ORAL BIOL, V44, P835, DOI 10.1016/S0003-9969(99)00074-6; Fontijn-Tekamp FA, 2004, PHYSIOL BEHAV, V83, P431, DOI 10.1016/j.physbeh.2004.08.026; GIDUCK SA, 1987, J NUTR, V117, P1191, DOI 10.1093/jn/117.7.1191; Harthoorn LF, 2008, EUR J APPL PHYSIOL, V102, P601, DOI 10.1007/s00421-007-0622-5; Hasegawa Y, 2009, EUR J ORAL SCI, V117, P470, DOI 10.1111/j.1600-0722.2009.00637.x; Hashkes PJ, 1997, INT J OBESITY, V21, P608, DOI 10.1038/sj.ijo.0800449; Hennequin M, 2005, CLIN NUTR, V24, P314, DOI 10.1016/j.clnu.2004.11.010; Ibrahima P, 2002, J PROSTHET DENT, V87, P667, DOI 10.1067/mpr.2002.123229; KANEKO H, 1995, AM J GASTROENTEROL, V90, P603; Kikutani Takeshi, 2006, Gerodontology, V23, P93, DOI 10.1111/j.1741-2358.2006.00104.x; Klineberg I, 1999, Adv Dent Res, V13, P120; LeBlanc J, 1996, AM J PHYSIOL-REG I, V271, pR936, DOI 10.1152/ajpregu.1996.271.4.R936; LIPSITZ LA, 1993, CIRCULATION, V87, P391, DOI 10.1161/01.CIR.87.2.391; Maggard MA, 2005, ANN INTERN MED, V142, P547, DOI 10.7326/0003-4819-142-7-200504050-00013; Mattes RD, 1997, J AM DIET ASSOC, V97, P406, DOI 10.1016/S0002-8223(97)00101-6; Mishellany A, 2006, DYSPHAGIA, V21, P87, DOI 10.1007/s00455-006-9014-y; Mishellany-Dutour A, 2008, BRIT J NUTR, V99, P121, DOI 10.1017/S0007114507795284; Momose T, 1997, ARCH ORAL BIOL, V42, P57, DOI 10.1016/S0003-9969(96)00081-7; Nicolas E, 2007, J ORAL REHABIL, V34, P566, DOI 10.1111/j.1365-2842.2007.01696.x; *NIH, 1991, GASTR SURG SEV OB; Pera P, 2002, J DENT RES, V81, P179, DOI 10.1177/154405910208100307; Peyron MA, 2004, J DENT RES, V83, P578, DOI 10.1177/154405910408300713; Peyron MA, 2004, J NEUROPHYSIOL, V92, P773, DOI 10.1152/jn.01122.2003; Peyron MA, 2002, EXP BRAIN RES, V142, P41, DOI 10.1007/s00221-001-0916-5; Power ML, 2008, APPETITE, V50, P194, DOI 10.1016/j.appet.2007.10.006; Powley TL, 2000, APPETITE, V34, P184, DOI 10.1006/appe.1999.0279; Prinz JF, 1997, P ROY SOC B-BIOL SCI, V264, P1715, DOI 10.1098/rspb.1997.0238; PRINZ JF, 1995, ARCH ORAL BIOL, V40, P401, DOI 10.1016/0003-9969(94)00185-E; Remond D, 2007, AM J CLIN NUTR, V85, P1286, DOI 10.1093/ajcn/85.5.1286; Sakata T, 2003, EXP BIOL MED, V228, P1106, DOI 10.1177/153537020322801002; Santry HP, 2005, JAMA-J AM MED ASSOC, V294, P1909, DOI 10.1001/jama.294.15.1909; Seo HS, 2007, J FOOD SCI, V72, pS707, DOI 10.1111/j.1750-3841.2007.00544.x; SLAGTER AP, 1993, ARCH ORAL BIOL, V38, P195, DOI 10.1016/0003-9969(93)90028-K; VANDERBILT A, 2011, J ORAL REHABIL  0117; Vernay M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-215; Veyrune JL, 2008, OBES SURG, V18, P1467, DOI 10.1007/s11695-008-9443-9; *WHO, 1995, US INT ANTH; Woda A, 2006, PHYSIOL BEHAV, V89, P28, DOI 10.1016/j.physbeh.2006.02.013; Woda A, 2006, J ORAL REHABIL, V33, P840, DOI 10.1111/j.1365-2842.2006.01626.x; Woda A, 2010, J DENT RES, V89, P281, DOI 10.1177/0022034509357022; Yven C, 2010, J FOOD ENG, V101, P85, DOI 10.1016/j.jfoodeng.2010.06.012; Zijlstra N, 2009, AM J CLIN NUTR, V90, P269, DOI 10.3945/ajcn.2009.27694	57	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22324	10.1371/journal.pone.0022324	http://dx.doi.org/10.1371/journal.pone.0022324			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799822	Green Published, gold, Green Submitted			2022-12-25	WOS:000292931200046
J	Wang, H; Fewer, DP; Sivonen, K				Wang, Hao; Fewer, David P.; Sivonen, Kaarina			Genome Mining Demonstrates the Widespread Occurrence of Gene Clusters Encoding Bacteriocins in Cyanobacteria	PLOS ONE			English	Article							MICROCIN B17; PEPTIDE; SEQUENCE; PRODUCT; BIOSYNTHESIS; LANTIBIOTICS; DIVERSITY; LEADER	Cyanobacteria are a rich source of natural products with interesting biological activities. Many of these are peptides and the end products of a non-ribosomal pathway. However, several cyanobacterial peptide classes were recently shown to be produced through the proteolytic cleavage and post-translational modification of short precursor peptides. A new class of bacteriocins produced through the proteolytic cleavage and heterocyclization of precursor proteins was recently identified from marine cyanobacteria. Here we show the widespread occurrence of bacteriocin gene clusters in cyanobacteria through comparative analysis of 58 cyanobacterial genomes. A total of 145 bacteriocin gene clusters were discovered through genome mining. These clusters encoded 290 putative bacteriocin precursors. They ranged in length from 28 to 164 amino acids with very little sequence conservation of the core peptide. The gene clusters could be classified into seven groups according to their gene organization and domain composition. This classification is supported by phylogenetic analysis, which further indicated independent evolutionary trajectories of gene clusters in different groups. Our data suggests that cyanobacteria are a prolific source of low-molecular weight post-translationally modified peptides.	[Wang, Hao; Fewer, David P.; Sivonen, Kaarina] Univ Helsinki, Dept Food & Environm Sci, Div Microbiol, Helsinki, Finland	University of Helsinki	Wang, H (corresponding author), Univ Helsinki, Dept Food & Environm Sci, Div Microbiol, Helsinki, Finland.	kaarina.sivonen@helsinki.fi	Fewer, David P/A-8704-2008	Fewer, David P/0000-0003-3978-4845; Sivonen, Kaarina/0000-0002-2904-0458; Wang, Hao/0000-0001-7475-0136	Academy of Finland; University of Helsinki [118637, 214457]; Viikki Doctoral Programme in Molecular Biosciences	Academy of Finland(Academy of Finland); University of Helsinki; Viikki Doctoral Programme in Molecular Biosciences	This work was financially supported by the Academy of Finland and the University of Helsinki to K.S. (Research Center of Excellence grant 118637 and Academy Professors grant 214457), and by Viikki Doctoral Programme in Molecular Biosciences to H.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Begley M, 2009, APPL ENVIRON MICROB, V75, P5451, DOI 10.1128/AEM.00730-09; Behrens-Kneip S, 2010, INT J MED MICROBIOL, V300, P421, DOI 10.1016/j.ijmm.2010.04.012; Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; Bode HB, 2005, ANGEW CHEM INT EDIT, V44, P6828, DOI 10.1002/anie.200501080; Brown LCW, 2009, P NATL ACAD SCI USA, V106, P2549, DOI [10.1073/pnas.0900008105, 10.1073/pnas.0900008106]; Burja AM, 2002, J MICROBIOL METH, V48, P207, DOI 10.1016/S0167-7012(01)00324-4; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Jong A, 2006, NUCLEIC ACIDS RES, V34, pW273, DOI 10.1093/nar/gkl237; de Jong A, 2010, NUCLEIC ACIDS RES, V38, pW647, DOI 10.1093/nar/gkq365; Dirix G, 2004, PEPTIDES, V25, P1425, DOI 10.1016/j.peptides.2003.10.028; FERNANDEZPINAS F, 1994, J BACTERIOL, V176, P5277; Galvez A, 2008, CRIT REV BIOTECHNOL, V28, P125, DOI [10.1080/07388550802107202, 10.1080/07388550802107202 ]; Goto Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000339; Haft DH, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-70; HAVARSTEIN LS, 1995, MOL MICROBIOL, V16, P229, DOI 10.1111/j.1365-2958.1995.tb02295.x; Kodani S, 2004, P NATL ACAD SCI USA, V101, P11448, DOI 10.1073/pnas.0404220101; Lee SW, 2008, P NATL ACAD SCI USA, V105, P5879, DOI 10.1073/pnas.0801338105; Li B, 2010, P NATL ACAD SCI USA, V107, P10430, DOI 10.1073/pnas.0913677107; Li YM, 1996, SCIENCE, V274, P1188, DOI 10.1126/science.274.5290.1188; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Michiels J, 2001, TRENDS MICROBIOL, V9, P164, DOI 10.1016/S0966-842X(01)01979-5; Milne JC, 1999, BIOCHEMISTRY-US, V38, P4768, DOI 10.1021/bi982975q; Nes IF, 2007, J BACTERIOL, V189, P1189, DOI 10.1128/JB.01254-06; O'Sullivan O, 2011, PROBIOTICS ANTIMICRO, V3, P27, DOI 10.1007/s12602-011-9062-y; Oman TJ, 2010, NAT CHEM BIOL, V6, P9, DOI [10.1038/NCHEMBIO.286, 10.1038/nchembio.286]; Onaka H, 2005, MICROBIOL-SGM, V151, P3923, DOI 10.1099/mic.0.28420-0; Pimenta AL, 2005, J BACTERIOL, V187, P7471, DOI 10.1128/JB.187.21.7471-7480.2005; Piper Clare, 2009, Curr Drug Discov Technol, V6, P1; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Riley MA, 2002, BIOCHIMIE, V84, P357, DOI 10.1016/S0300-9084(02)01421-9; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Shi YX, 2011, J AM CHEM SOC, V133, P2338, DOI 10.1021/ja109044r; Sivonen Kaarina, 2008, P159; Sivonen K, 2010, APPL MICROBIOL BIOT, V86, P1213, DOI 10.1007/s00253-010-2482-x; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00; Velasquez JE, 2011, CURR OPIN CHEM BIOL, V15, P11, DOI 10.1016/j.cbpa.2010.10.027; Welker M, 2006, FEMS MICROBIOL REV, V30, P530, DOI 10.1111/j.1574-6976.2006.00022.x; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Zuckerkandl E., 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	43	63	66	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2011	6	7							e22384	10.1371/journal.pone.0022384	http://dx.doi.org/10.1371/journal.pone.0022384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794WE	21799841	Green Submitted, gold, Green Published			2022-12-25	WOS:000292931200051
J	Gorecki, RK; Koryszewska-Baginska, A; Golebiewski, M; Zylinska, J; Grynberg, M; Bardowski, JK				Gorecki, Roman K.; Koryszewska-Baginska, Anna; Golebiewski, Marcin; Zylinska, Joanna; Grynberg, Marcin; Bardowski, Jacek K.			Adaptative Potential of the Lactococcus Lactis IL594 Strain Encoded in Its 7 Plasmids	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; OLIGOPEPTIDE TRANSPORT-SYSTEM; BACTERIOCIN-PRODUCING PLASMID; ACID BACTERIA; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; OXALOBACTER-FORMIGENES; STREPTOCOCCUS-LACTIS; THETA-REPLICATION; GENETIC-ANALYSIS	The extrachromosomal gene pool plays a significant role both in evolution and in the environmental adaptation of bacteria. The L. lactis subsp. lactis IL594 strain contains seven plasmids, named pIL1 to pIL7, and is the parental strain of the plasmid-free L. lactis IL1403, which is one of the best characterized lactococcal strains of LAB. Complete nucleotide sequences of pIL1 (6,382 bp), pIL2 (8,277 bp), pIL3 (19,244 bp), pIL4 (48,979), pIL5 (23,395), pIL6 (28,435 bp) and pIL7 (28,546) were established and deposited in the generally accessible database (GeneBank). Nine highly homologous repB-containing replicons, belonging to the lactococcal theta-type replicons, have been identified on the seven plasmids. Moreover, a putative region involved in conjugative plasmid mobilization was found on four plasmids, through identification of the presence of mob genes and/or oriT sequences. Detailed bioinformatic analysis of the plasmid nucleotide sequences provided new insight into the repertoire of plasmid-encoded functions in L. lactis, and indicated that plasmid genes from IL594 strain can be important for L. lactis adaptation to specific environmental conditions (e. g. genes coding for proteins involved in DNA repair or cold shock response) as well as for technological processes (e. g. genes encoding citrate and lactose utilization, oligopeptide transport, restriction-modification system). Moreover, global gene analysis indicated cooperation between plasmid-and chromosome-encoded metabolic pathways.	[Gorecki, Roman K.; Koryszewska-Baginska, Anna; Golebiewski, Marcin; Zylinska, Joanna; Grynberg, Marcin; Bardowski, Jacek K.] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Golebiewski, Marcin] Nicholas Copernicus Univ, Dept Biotechnol, Torun, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Nicolaus Copernicus University	Gorecki, RK (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	jacek@ibb.waw.pl	Koryszewska-Baginska, Anna/AAQ-9491-2021; Golebiewski, Marcin/G-4579-2014; Koryszewska-Bagińska, Anna/W-7484-2018	Koryszewska-Baginska, Anna/0000-0002-4367-2961; Golebiewski, Marcin/0000-0003-2039-8733; Koryszewska-Bagińska, Anna/0000-0002-4367-2961; Grynberg, Marcin/0000-0003-1887-7209; Zylinska -Urban, Joanna/0000-0003-1565-0615	EU [QLK3-2001-010473]; Ministry of Science and Higher Education [MNiSW NN 303017833]	EU(European Commission); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the EU research programme "Quality of Life and Management of Living Resources'' QLK3-2001-010473 (Express-Fingerprints) and partially financed by the Ministry of Science and Higher Education (MNiSW NN 303017833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk-Poplawska M, 2003, MICROBIOL-SGM, V149, P3311, DOI 10.1099/mic.0.26497-0; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; CHOPIN A, 1984, PLASMID, V11, P260, DOI 10.1016/0147-619X(84)90033-7; Courville P, 2006, BIOCHEM CELL BIOL, V84, P960, DOI 10.1139/O06-193; Crutz-Le Coq AM, 2002, MICROBIOL-SGM, V148, P985, DOI 10.1099/00221287-148-4-985; DALY C, 1983, A VAN LEEUW J MICROB, V49, P297, DOI 10.1007/BF00399505; Davidson BE, 1996, ANTON LEEUW INT J G, V70, P161, DOI 10.1007/BF00395932; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dougherty BA, 1998, MOL MICROBIOL, V29, P1029, DOI 10.1046/j.1365-2958.1998.00988.x; Drider Djamel, 2004, Genet Mol Res, V3, P273; Emond E, 2001, APPL ENVIRON MICROB, V67, P1700, DOI 10.1128/AEM.67.4.1700-1709.2001; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Forde A, 1999, ANTON LEEUW INT J G, V76, P89, DOI 10.1023/A:1002027321171; Garcia-Quintans N, 1998, APPL ENVIRON MICROB, V64, P850; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gravesen A, 1997, PLASMID, V38, P115, DOI 10.1006/plas.1997.1302; Grohmann E, 2003, MICROBIOL MOL BIOL R, V67, P277, DOI 10.1128/MMBR.67.2.277-301.2003; HAYES F, 1991, PLASMID, V25, P16, DOI 10.1016/0147-619X(91)90003-F; Janion C, 2008, INT J BIOL SCI, V4, P338; Janscak P, 1998, J MOL BIOL, V284, P937, DOI 10.1006/jmbi.1998.2250; Kehres DG, 2000, MOL MICROBIOL, V36, P1085, DOI 10.1046/j.1365-2958.2000.01922.x; KEMPLER GM, 1981, J DAIRY SCI, V64, P1527, DOI 10.3168/jds.S0022-0302(81)82721-X; KIEWIET R, 1993, MOL MICROBIOL, V10, P319, DOI 10.1111/j.1365-2958.1993.tb01958.x; KUNJI ERS, 1995, J BIOL CHEM, V270, P1569, DOI 10.1074/jbc.270.4.1569; Liu CQ, 1997, PLASMID, V38, P79, DOI 10.1006/plas.1997.1301; LUCEY M, 1993, J BACTERIOL, V175, P6002, DOI 10.1128/JB.175.18.6002-6009.1993; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Mills S, 2006, FEMS MICROBIOL REV, V30, P243, DOI 10.1111/j.1574-6976.2005.00011.x; O'Driscoll J, 2006, J BACTERIOL, V188, P6629, DOI 10.1128/JB.00672-06; O'Sullivan D, 2000, MOL MICROBIOL, V36, P866, DOI 10.1046/j.1365-2958.2000.01901.x; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; RUAN ZS, 1992, J BIOL CHEM, V267, P10537; SAHLSTROM S, 1993, APPL ENVIRON MICROB, V59, P3076; SALAMA MS, 1995, J DAIRY SCI, V78, P1004, DOI 10.3168/jds.S0022-0302(95)76716-9; Sambrook J, 1989, MOL CLONING LAB MANU, P2; Sanchez C, 2000, PLASMID, V44, P239, DOI 10.1006/plas.2000.1482; SANDERS ME, 1981, APPL ENVIRON MICROB, V42, P944, DOI 10.1128/AEM.42.6.944-950.1981; SCHOULER C, 1994, MICROBIOL-UK, V140, P3061, DOI 10.1099/13500872-140-11-3061; Seegers JFML, 2000, MICROBIOL-UK, V146, P435, DOI 10.1099/00221287-146-2-435; Siegele DA, 2005, J BACTERIOL, V187, P6253, DOI 10.1128/JB.187.18.6253-6254.2005; Siezen RJ, 2005, APPL ENVIRON MICROB, V71, P8371, DOI 10.1128/AEM.71.12.8371-8382.2005; Siezen RJ, 2010, J BACTERIOL, V192, P2649, DOI 10.1128/JB.00276-10; Smith MA, 2001, J MOL BIOL, V314, P41, DOI 10.1006/jmbi.2001.5123; Tanous C, 2007, MICROBIOL-SGM, V153, P1664, DOI 10.1099/mic.0.2006/002246-0; TYNKKYNEN S, 1993, J BACTERIOL, V175, P7523, DOI 10.1128/JB.175.23.7523-7532.1993; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; Wouters JA, 2001, APPL ENVIRON MICROB, V67, P5171, DOI 10.1128/AEM.67.11.5171-5178.2001; Ye LW, 2002, J BIOL CHEM, V277, P20372, DOI 10.1074/jbc.M111140200; Yonezawa H, 2005, ANTIMICROB AGENTS CH, V49, P541, DOI 10.1128/AAC.49.2.541-548.2005; Zielenkiewicz U, 2001, ACTA BIOCHIM POL, V48, P1003	55	34	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22238	10.1371/journal.pone.0022238	http://dx.doi.org/10.1371/journal.pone.0022238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789242	Green Submitted, Green Published, gold			2022-12-25	WOS:000292812400042
J	Macdonald-Wallis, C; Lawlor, DA; Heron, J; Fraser, A; Nelson, SM; Tilling, K				Macdonald-Wallis, Corrie; Lawlor, Debbie A.; Heron, Jon; Fraser, Abigail; Nelson, Scott M.; Tilling, Kate			Relationships of Risk Factors for Pre-Eclampsia with Patterns of Occurrence of Isolated Gestational Proteinuria during Normal Term Pregnancy	PLOS ONE			English	Article							BODY-MASS INDEX; HYPERTENSIVE DISORDERS; SMOKING; INTERVENTION; ECLAMPSIA; ADULTS; IMPACT	Background: Isolated gestational proteinuria may be part of the pre-eclampsia disease spectrum. Confirmation of its association with established pre-eclampsia risk factors and higher blood pressure in uncomplicated pregnancies would support this concept. Methods: Data from 11,651 women from the Avon Longitudinal Study of Parents and Children who had a term live birth but did not have pre-existing hypertension or diabetes or develop gestational diabetes or preeclampsia were used. Proteinuria was assessed repeatedly (median 12 measurements per woman) by dipstick and latent class analysis was used to identify subgroups of the population with different patterns of proteinuria in pregnancy. Results: Higher maternal pre-pregnancy body mass index (BMI), younger age, nulliparity and twin pregnancy were independently associated with increased odds of any proteinuria in pregnancy. Women who experienced proteinuria showed five patterns: proteinuria in early pregnancy only (<= 20 weeks gestation), and onset at 21-28 weeks, 29-32 weeks, 33-36 weeks and >= 37 weeks gestation. There were higher odds of proteinuria onset after 33 weeks in obese women and after 37 weeks in nulliparous women compared with normal weight and multiparous women respectively. Smoking in pregnancy was weakly negatively associated with odds of proteinuria onset after 37 weeks. Twin pregnancies had higher odds of proteinuria onset from 29 weeks. In women with proteinuria onset after 33 weeks blood pressure was higher in early pregnancy and at the end of pregnancy. Conclusions: Established pre-eclampsia risk factors were related to proteinuria occurrence in late gestation in healthy term pregnancies, supporting the hypothesis that isolated gestational proteinuria may represent an early manifestation of preeclampsia.	[Macdonald-Wallis, Corrie; Lawlor, Debbie A.; Fraser, Abigail] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Nelson, Scott M.] Univ Glasgow, Ctr Populat & Hlth Sci, Glasgow, Lanark, Scotland	University of Bristol; University of Glasgow	Macdonald-Wallis, C (corresponding author), Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England.	C.Macdonald-Wallis@bristol.ac.uk	Heron, Jon/D-5884-2011; Tilling, Kate/AAY-1578-2021	Heron, Jon/0000-0001-6199-5644; Lawlor, Debbie A/0000-0002-6793-2262; Tilling, Kate/0000-0002-1010-8926; Nelson, Scott/0000-0002-9099-3047; Fraser, Abigail/0000-0002-7741-9470; Macdonald-Wallis, Corrie/0000-0002-4447-3817	United States National Institutes of Health [R01 DK077659]; UK Wellcome Trust [WT087997MA]; UK Medical Research Council [G0600705]; MRC [G0600705, G0701594] Funding Source: UKRI; Medical Research Council [G9815508, G0701594, G0600705] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077659] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Wellcome Trust(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the United States National Institutes of Health [grant number R01 DK077659] and UK Wellcome Trust [grant number WT087997MA]. Core support for ALSPAC was provided by the UK Medical Research Council, the Wellcome Trust and the University of Bristol. The UK Medical Research Council provided funding for the MRC Centre for Causal Analyses in Translational Epidemiology [grant number G0600705]. AF is funded by a UK MRC research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth CV, 1995, ACTA OBSTET GYN SCAN, V74, P788, DOI 10.3109/00016349509021198; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Chadban SJ, 2003, J AM SOC NEPHROL, V14, pS131, DOI 10.1097/01.ASN.0000070152.11927.4A; Chen XK, 2006, HYPERTENS PREGNANCY, V25, P217, DOI 10.1080/10641950600912992; Cirillo M, 1998, ARCH INTERN MED, V158, P1933, DOI 10.1001/archinte.158.17.1933; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; DOUGLAS KA, 1994, BMJ-BRIT MED J, V309, P1395, DOI 10.1136/bmj.309.6966.1395; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Dunn KM, 2006, AM J EPIDEMIOL, V163, P754, DOI 10.1093/aje/kwj100; England L, 2007, FRONT BIOSCI-LANDMRK, V12, P2471, DOI 10.2741/2248; GRIBBLE RK, 1995, AM J OBSTET GYNECOL, V173, P214, DOI 10.1016/0002-9378(95)90193-0; Henderson J, 2008, THORAX, V63, P974, DOI 10.1136/thx.2007.093187; HOLSTON AM, 2009, AM J OBSTET GYNECOL, V392, pE1; Knight M, 2007, BJOG-INT J OBSTET GY, V114, P1072, DOI 10.1111/j.1471-0528.2007.01423.x; Lewis G., 2007, 7 CONFIDENTIAL ENQUI; Lindheimer MD, 2010, OBSTET GYNECOL, V115, P365, DOI 10.1097/AOG.0b013e3181cb9644; MACDONALDWALLIS C, 2011, J HYPERTENS IN PRESS; Masuyama H, 2006, AM J OBSTET GYNECOL, V194, P551, DOI 10.1016/j.ajog.2005.08.034; Morikawa M, 2009, CURR OPIN OBSTET GYN, V21, P491, DOI 10.1097/GCO.0b013e32833040bf; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Sattar N, 2002, BMJ-BRIT MED J, V325, P157, DOI 10.1136/bmj.325.7356.157; Smith NA, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.013; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Tozawa M, 2002, KIDNEY INT, V62, P956, DOI 10.1046/j.1523-1755.2002.00506.x; Voigt M, 2011, Z GEBURTSH NEONATOL, V215, P23, DOI 10.1055/s-0030-1254142; Wang CP, 2005, J AM STAT ASSOC, V100, P1054, DOI 10.1198/016214505000000501	27	28	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22115	10.1371/journal.pone.0022115	http://dx.doi.org/10.1371/journal.pone.0022115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789220	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000292812400031
J	Rodriguez, F; Bustos, MA; Zanetti, MN; Ruete, MC; Mayorga, LS; Tomes, CN				Rodriguez, Facundo; Bustos, Matias A.; Zanetti, Maria N.; Ruete, Maria C.; Mayorga, Luis S.; Tomes, Claudia N.			alpha-SNAP Prevents Docking of the Acrosome during Sperm Exocytosis because It Sequesters Monomeric Syntaxin	PLOS ONE			English	Article							ETHYLMALEIMIDE-SENSITIVE FACTOR; SYNAPTIC VESICLE FUSION; NSF ATPASE ACTIVITY; MEMBRANE-FUSION; MAMMALIAN SPERM; NEUROTRANSMITTER RELEASE; REGULATED EXOCYTOSIS; SECRETORY VESICLES; PHOSPHOLIPASE A(2); HUMAN SPERMATOZOA	alpha-SNAP has an essential role in membrane fusion that consists of bridging cis SNARE complexes to NSF. alpha-SNAP stimulates NSF, which releases itself, alpha-SNAP, and individual SNAREs that subsequently re-engage in the trans arrays indispensable for fusion. alpha-SNAP also binds monomeric syntaxin and NSF disengages the alpha-SNAP/syntaxin dimer. Here, we examine why recombinant alpha-SNAP blocks secretion in permeabilized human sperm despite the fact that the endogenous protein is essential for membrane fusion. The only mammalian organism with a genetically modified alpha-SNAP is the hyh mouse strain, which bears a M105I point mutation; males are subfertile due to defective sperm exocytosis. We report here that recombinant alpha-SNAP-M105I has greater affinity for the cytosolic portion of immunoprecipitated syntaxin than the wild type protein and in consequence NSF is less efficient in releasing the mutant. alpha-SNAP-M105I is a more potent sperm exocytosis blocker than the wild type and requires higher concentrations of NSF to rescue its effect. Unlike other fusion scenarios where SNAREs are subjected to an assembly/disassembly cycle, the fusion machinery in sperm is tuned so that SNAREs progress uni-directionally from a cis configuration in resting cells to monomeric and subsequently trans arrays in cells challenged with exocytosis inducers. By means of functional and indirect immunofluorescense assays, we show that recombinant alpha-SNAPs - wild type and M105I - inhibit exocytosis because they bind monomeric syntaxin and prevent this SNARE from assembling with its cognates in trans. Sequestration of free syntaxin impedes docking of the acrosome to the plasma membrane assessed by transmission electron microscopy. The N-terminal deletion mutant alpha-SNAP-(160-295), unable to bind syntaxin, affects neither docking nor secretion. The implications of this study are twofold: our findings explain the fertility defect of hyh mice and indicate that assembly of SNAREs in trans complexes is essential for docking.	[Rodriguez, Facundo; Bustos, Matias A.; Zanetti, Maria N.; Ruete, Maria C.; Mayorga, Luis S.; Tomes, Claudia N.] Univ Nacl Cuyo, Lab Biol Celular & Mol, Inst Histol & Embriol, Fac Ciencias Med, RA-5500 Mendoza, Argentina	University Nacional Cuyo Mendoza	Rodriguez, F (corresponding author), Univ Nacl Cuyo, Lab Biol Celular & Mol, Inst Histol & Embriol, Fac Ciencias Med, RA-5500 Mendoza, Argentina.	ctomes@fcm.uncu.edu.ar		Mayorga, Luis S/0000-0002-5995-0671; Zanetti, Maria Natalia/0000-0002-3992-7167; Ruete, Maria Celeste/0000-0002-8183-5637; Bustos, Matias A./0000-0001-9625-1127; Rodriguez Ayala, Juan Facundo/0000-0003-3165-2186	CONICET [PIP 5951]; Secretaria de Ciencia y Tecnica-Universidad Nacional de Cuyo [06/J342]; ANPCYT [PICT-2006-01036]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia y Tecnica-Universidad Nacional de Cuyo(Secretaria de Ciencia y Tecnologia (SECYT)); ANPCYT(ANPCyT)	This work was supported by grants from CONICET (grant # PIP 5951; http://www.conicet.gov.ar), Secretaria de Ciencia y Tecnica-Universidad Nacional de Cuyo (grant # 06/J342; http://www.uncu.edu.ar/categoria/item/investigacion) and ANPCYT (grant # PICT-2006-01036; http://www.agencia.mincyt.gov.ar/) (all from Argentina) to CT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann F, 2008, J CELL PHYSIOL, V214, P757, DOI 10.1002/jcp.21272; Barnard RJO, 1996, MOL BIOL CELL, V7, P693, DOI 10.1091/mbc.7.5.693; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; BARROS C, 1967, J CELL BIOL, V34, pC1, DOI 10.1083/jcb.34.3.C1; Barszczewski M, 2008, MOL BIOL CELL, V19, P776, DOI 10.1091/mbc.E07-05-0498; Branham MT, 2009, J BIOL CHEM, V284, P24825, DOI 10.1074/jbc.M109.015362; Branham MAT, 2006, J BIOL CHEM, V281, P8656, DOI 10.1074/jbc.M508854200; Burgalossi A, 2010, NEURON, V68, P473, DOI 10.1016/j.neuron.2010.09.019; Burgoyne RD, 2009, ANN NY ACAD SCI, V1152, P76, DOI 10.1111/j.1749-6632.2008.03987.x; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; Chae TH, 2004, NAT GENET, V36, P264, DOI 10.1038/ng1302; Costello S, 2009, REPRODUCTION, V138, P425, DOI 10.1530/REP-09-0134; Darszon A, 2005, INT REV CYTOL, V243, P79, DOI 10.1016/S0074-7696(05)43002-8; De Blas G, 2002, J BIOL CHEM, V277, P49326, DOI 10.1074/jbc.M208587200; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; Batiz LF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004963; Garde J, 2000, J REPROD FERTIL, V118, P57, DOI 10.1530/reprod/118.1.57; Garde J, 1996, FEBS LETT, V391, P263, DOI 10.1016/0014-5793(96)00749-1; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Haynes LP, 1998, FEBS LETT, V436, P1, DOI 10.1016/S0014-5793(98)01088-6; Herrick SB, 2005, J CELL PHYSIOL, V202, P663, DOI 10.1002/jcp.20172; Hong HK, 2004, P NATL ACAD SCI USA, V101, P1748, DOI 10.1073/pnas.0308268100; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; Izumi T, 2007, DIABETES OBES METAB, V9, P109, DOI 10.1111/j.1463-1326.2007.00789.x; Jahn R, 2000, NEURON, V27, P201, DOI 10.1016/S0896-6273(00)00029-5; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; KEE Y, 1995, NEURON, V14, P991, DOI 10.1016/0896-6273(95)90337-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang T, 2002, J CELL BIOL, V158, P751, DOI 10.1083/jcb.200203088; Lang Thorsten, 2008, V184, P107; Lopez CI, 2007, FASEB J, V21, P4121, DOI 10.1096/fj.06-7716com; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Marz KE, 2003, J BIOL CHEM, V278, P27000, DOI 10.1074/jbc.M302003200; Mayorga LS, 2007, IUBMB LIFE, V59, P286, DOI 10.1080/15216540701222872; MCMAHON HT, 1995, J BIOL CHEM, V270, P2213, DOI 10.1074/jbc.270.5.2213; Michaut M, 2000, P NATL ACAD SCI USA, V97, P9996, DOI 10.1073/pnas.180206197; Ramalho-Santos J, 2000, DEV BIOL, V223, P54, DOI 10.1006/dbio.2000.9745; Ramalho-Santos J, 2004, ARCH ANDROLOGY, V50, P163, DOI 10.1080/01485010490425502; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Roggero CM, 2007, J BIOL CHEM, V282, P26335, DOI 10.1074/jbc.M700854200; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schweizer FE, 1998, SCIENCE, V279, P1203, DOI 10.1126/science.279.5354.1203; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Sorensen JB, 2004, PFLUG ARCH EUR J PHY, V448, P347, DOI 10.1007/s00424-004-1247-8; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; TOMES C, 2006, MOL MECH EXOCYTOSIS, P117; Tomes Claudia Nora, 2007, Soc Reprod Fertil Suppl, V65, P275; Tomes CN, 2005, MOL HUM REPROD, V11, P43, DOI 10.1093/molehr/gah126; Tomes CN, 2002, DEV BIOL, V243, P326, DOI 10.1006/dbio.2002.0567; Tsai PS, 2007, MOL MEMBR BIOL, V24, P313, DOI 10.1080/09687860701228692; Tsai PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011204; Vaidyanathan VV, 1999, J NEUROCHEM, V72, P327, DOI 10.1046/j.1471-4159.1999.0720327.x; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Verhage M, 2009, P NATL ACAD SCI USA, V106, P19745, DOI 10.1073/pnas.0911425106; Wang L, 2000, J BIOL CHEM, V275, P22862, DOI 10.1074/jbc.M001447200; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; YUDIN AI, 1988, GAMETE RES, V20, P11, DOI 10.1002/mrd.1120200103; Yunes R, 2000, BIOL REPROD, V62, P1084, DOI 10.1095/biolreprod62.4.1084; Zanetti N, 2009, BIOL REPROD, V81, P396, DOI 10.1095/biolreprod.109.076166; Zarelli VEP, 2009, J BIOL CHEM, V284, P10491, DOI 10.1074/jbc.M807614200; Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032; Zhao L, 2007, DEV BIOL, V309, P236, DOI 10.1016/j.ydbio.2007.07.009	67	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e21925	10.1371/journal.pone.0021925	http://dx.doi.org/10.1371/journal.pone.0021925			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789195	Green Published, Green Submitted, gold			2022-12-25	WOS:000292812400021
J	He, HP; Yu, FX; Sun, C; Luo, Y				He, Hongpeng; Yu, Fa-Xing; Sun, Chi; Luo, Yan			CBP/p300 and SIRT1 Are Involved in Transcriptional Regulation of S-Phase Specific Histone Genes	PLOS ONE			English	Article							CREB-BINDING PROTEIN; CYCLIN E/CDK2 SUBSTRATE; NF-KAPPA-B; CELL-CYCLE; DNA-DAMAGE; ACETYLTRANSFERASE ACTIVITY; CHROMATIN-STRUCTURE; COACTIVATORS P300; METABOLIC CYCLE; EXPRESSION	Background: Histones constitute a type of essential nuclear proteins important for chromatin structure and functions. The expression of major histones is strictly confined to the S phase of a cell cycle and tightly coupled to DNA replication. Methodology/Principal Findings: With RT-qPCR and ChIP assays, we investigated transcriptional regulation of the S-phase specific histone genes and found that the acetylation level of histones on core histone gene promoters fluctuated during cell cycle in a pattern similar to RNA polymerase II association. Further, we showed that CBP/p300 and SIRT1 were recruited to histone gene promoters in an NPAT-dependent manner, knockdown of which affected histone acetylation on histone gene promoters and histone gene transcription. Significance: These observations contribute to further understanding of the mechanism by which the expression of canonical histone genes is regulated, and also implicate a link between histone expression and DNA damage repair and cell metabolism.	[He, Hongpeng; Yu, Fa-Xing; Sun, Chi; Luo, Yan] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	He, HP (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 10 Kent Ridge Crescent, Singapore 117548, Singapore.	yluo@imcb.a-star.edu.sg	Sun, Chi/AAV-6284-2021	Yu, Fa-Xing/0000-0003-4834-9335	ASTAR (Agency for Science, Technology and Research), Singapore	ASTAR (Agency for Science, Technology and Research), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by ASTAR (Agency for Science, Technology and Research), Singapore. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Si-Ali S, 2000, ONCOGENE, V19, P2430, DOI 10.1038/sj.onc.1203562; Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; Albig W, 1997, HUM GENET, V101, P284, DOI 10.1007/s004390050630; Bhakat KK, 2006, MOL CELL BIOL, V26, P1654, DOI 10.1128/MCB.26.5.1654-1665.2006; Blobel GA, 2000, BLOOD, V95, P745, DOI 10.1182/blood.V95.3.745.003k05_745_755; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Castillo AG, 2007, PLOS GENET, V3, P1264, DOI 10.1371/journal.pgen.0030121; Cazzalini O, 2008, NUCLEIC ACIDS RES, V36, P1713, DOI 10.1093/nar/gkn014; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; CHRYSOGELOS S, 1985, P NATL ACAD SCI USA, V82, P7535, DOI 10.1073/pnas.82.22.7535; Crowe DL, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1362; Dai RP, 2008, J BIOL CHEM, V283, P26894, DOI 10.1074/jbc.M804307200; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Deran M, 2008, MOL CELL BIOL, V28, P435, DOI 10.1128/MCB.00607-07; Ewen ME, 2000, GENE DEV, V14, P2265, DOI 10.1101/gad.842100; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Gao G, 2003, MOL CELL BIOL, V23, P2821, DOI 10.1128/MCB.23.8.2821-2833.2003; Ghule PN, 2007, J CELL PHYSIOL, V213, P9, DOI 10.1002/jcp.21119; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HAN M, 1987, CELL, V48, P589, DOI 10.1016/0092-8674(87)90237-6; HARRIS ME, 1991, MOL CELL BIOL, V11, P2416, DOI 10.1128/MCB.11.5.2416; HEINTZ N, 1991, BIOCHIM BIOPHYS ACTA, V1088, P327, DOI 10.1016/0167-4781(91)90122-3; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Kingsley-Kallesen ML, 1999, J BIOL CHEM, V274, P34020, DOI 10.1074/jbc.274.48.34020; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kraus WL, 1999, MOL CELL BIOL, V19, P8123; LABELLA F, 1988, GENE DEV, V2, P32, DOI 10.1101/gad.2.1.32; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lee MC, 2010, J BIOL CHEM, V285, P9041, DOI 10.1074/jbc.M109.075358; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; Mariadason JM, 2008, EPIGENETICS-US, V3, P28, DOI 10.4161/epi.3.1.5736; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Miele A, 2005, MOL CELL BIOL, V25, P6140, DOI 10.1128/MCB.25.14.6140-6153.2005; Mizzen C, 1998, COLD SPRING HARB SYM, V63, P469, DOI 10.1101/sqb.1998.63.469; MORENO ML, 1986, BIOCHEMISTRY-US, V25, P5364, DOI 10.1021/bi00367a003; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Stauffer D, 2007, J BIOL CHEM, V282, P9678, DOI 10.1074/jbc.M609261200; STEIN GS, 1994, J CELL BIOCHEM, V54, P393, DOI 10.1002/jcb.240540406; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Su C, 2004, EMBO J, V23, P1133, DOI 10.1038/sj.emboj.7600120; Sun YL, 2010, CELL CYCLE, V9, P930, DOI 10.4161/cc.9.5.10931; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Vempati RK, 2010, J BIOL CHEM, V285, P28553, DOI 10.1074/jbc.M110.149393; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang A, 2004, BIOCHEM BIOPH RES CO, V325, P1509, DOI 10.1016/j.bbrc.2004.10.198; Wei Y, 2003, MOL CELL BIOL, V23, P3669, DOI 10.1128/MCB.23.10.3669-3680.2003; Yamagata K, 2009, BIOCHEM BIOPH RES CO, V390, P1355, DOI 10.1016/j.bbrc.2009.10.156; Ye X, 2003, MOL CELL BIOL, V23, P8586, DOI 10.1128/MCB.23.23.8586-8600.2003; Yu FX, 2009, CELL CYCLE, V8, P773, DOI 10.4161/cc.8.5.7880; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zhao JY, 2004, CELL CYCLE, V3, P695; Zhao JY, 1998, GENE DEV, V12, P456, DOI 10.1101/gad.12.4.456; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	73	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22088	10.1371/journal.pone.0022088	http://dx.doi.org/10.1371/journal.pone.0022088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789216	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811700021
J	Boistel, R; Aubin, T; Cloetens, P; Langer, M; Gillet, B; Josset, P; Pollet, N; Herrel, A				Boistel, Renaud; Aubin, Thierry; Cloetens, Peter; Langer, Max; Gillet, Brigitte; Josset, Patrice; Pollet, Nicolas; Herrel, Anthony			Whispering to the Deaf: Communication by a Frog without External Vocal Sac or Tympanum in Noisy Environments	PLOS ONE			English	Article							PHASE RETRIEVAL; MIDDLE-EAR; PATTERNS; CALLS; VOCALIZATIONS; TRANSMISSION; TOADS	Atelopus franciscus is a diurnal bufonid frog that lives in South-American tropical rain forests. As in many other frogs, males produce calls to defend their territories and attract females. However, this species is a so-called "earless'' frog lacking an external tympanum and is thus anatomically deaf. Moreover, A. franciscus has no external vocal sac and lives in a sound constraining environment along river banks where it competes with other calling frogs. Despite these constraints, male A. franciscus reply acoustically to the calls of conspecifics in the field. To resolve this apparent paradox, we studied the vocal apparatus and middle-ear, analysed signal content of the calls, examined sound and signal content propagation in its natural habitat, and performed playback experiments. We show that A. franciscus males can produce only low intensity calls that propagate a short distance (< 8 m) as a result of the lack of an external vocal sac. The species-specific coding of the signal is based on the pulse duration, providing a simple coding that is efficient as it allows discrimination from calls of sympatric frogs. Moreover, the signal is redundant and consequently adapted to noisy environments. As such a coding system can be efficient only at short-range, territory holders established themselves at short distances from each other. Finally, we show that the middle-ear of A. franciscus does not present any particular adaptations to compensate for the lack of an external tympanum, suggesting the existence of extra-tympanic pathways for sound propagation.	[Boistel, Renaud; Aubin, Thierry] Univ Paris 06, CNRS, CNPS, UMR8195, Orsay, France; [Boistel, Renaud] Univ Poitiers, CNRS, Inst Int Paleoprimatol & Paleontol Humaine IPHEP, UMR 6046, Poitiers, France; [Cloetens, Peter; Langer, Max] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Langer, Max] Univ Lyon 1, CNRS, Inst Natl Sci Appl Lyon, CREATIS,INSERM,UMR 5220,U630, F-69622 Villeurbanne, France; [Gillet, Brigitte] Univ Paris 11, CNRS, UMR8081, F-91405 Orsay, France; [Josset, Patrice] Hop Enfants Armand Trousseau, Paris, France; [Pollet, Nicolas] Univ Evry, CNRS, Inst Syst & Synthet Biol, Evry, France; [Herrel, Anthony] Museum Natl Hist Nat, CNRS, Dept Ecol & Gest Biodiversite EGB, UMR 7179, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; European Synchrotron Radiation Facility (ESRF); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Boistel, R (corresponding author), Univ Paris 06, CNRS, CNPS, UMR8195, Orsay, France.	renaud.boistel@univ-poitiers.fr	Pollet, Nicolas/A-4746-2013; Langer, Max/E-1408-2013; Herrel, Anthony/C-3712-2013; Cloetens, Peter/AAJ-6131-2020	Pollet, Nicolas/0000-0002-9975-9644; Langer, Max/0000-0002-5821-9617; Herrel, Anthony/0000-0003-0991-4434; Cloetens, Peter/0000-0002-4129-9091	RB; ESRF	RB; ESRF	The authors declare that no funders supported this work, except for RB's parents and ESRF, which provided beamtime in the framework of proposal SC-1593. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, PRINCIPLES ANIMAL CO; AUBIN T, 1994, BIOACOUSTICS, V6, P80; Bennet-Clark HC, 1999, J EXP BIOL, V202, P3347; Cloetens P, 1999, APPL PHYS LETT, V75, P2912, DOI 10.1063/1.125225; COCROFT RB, 1990, COPEIA, P631; COCROFT RB, 1995, ANIM BEHAV, V49, P283, DOI 10.1006/anbe.1995.0043; Coleman MN, 2004, ANAT REC PART A, V281A, P1123, DOI 10.1002/ar.a.20118; DUBOIS A, 1984, J ORNITHOL, V125, P455, DOI 10.1007/BF01640137; Feng AS, 2006, NATURE, V440, P333, DOI 10.1038/nature04416; Fletcher N. H., 1992, ACOUSTIC SYSTEMS BIO; GERHARDT HC, 1975, J COMP PHYSIOL, V102, P1, DOI 10.1007/BF00657481; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Guigay JP, 2007, OPT LETT, V32, P1617, DOI 10.1364/OL.32.001617; Jaslow A.P., 1988, P69; Jorgensen MB, 1998, J COMP PHYSIOL A, V182, P59; Langer M, 2010, IEEE T IMAGE PROCESS, V19, P2428, DOI 10.1109/TIP.2010.2048608; LESCURE J, 1981, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V3, P893; LIU CH'ENG CHAO, 1935, PROC BOSTON SOC NAT HIST, V41, P19; LOTTERS S, 1996, NEOTROPICAL TOAD GEN; Mbu Nyamsi Ruben G., 1994, Bioacoustics, V5, P187; NARINS PM, 1988, P NATL ACAD SCI USA, V85, P1508, DOI 10.1073/pnas.85.5.1508; PASSMORE NI, 1981, HERPETOLOGICA, V37, P166; Randal RB., 1987, FREQUENCY ANAL; Romeis B., 1989, MIKROSKOPISCHE TECHN; RYAN MJ, 1989, ETHOLOGY, V80, P182; RYAN MJ, 1992, AM NAT, V139, pS4, DOI 10.1086/285303; RYAN MJ, 1991, TRENDS ECOL EVOL, V6, P351, DOI 10.1016/0169-5347(91)90224-L; Scherrer B, 1984, BIOSTATISTIQUE; SIMMONS AM, 1993, J ACOUST SOC AM, V93, P3374, DOI 10.1121/1.405693; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WELLS KD, 1982, HERPETOLOGICA, V38, P449; Werner YL, 2003, HEARING RES, V175, P54, DOI 10.1016/S0378-5955(02)00709-8; Wever E. G., 1985, AMPHIBIAN EAR; Yu ZL, 2006, J COMP PHYSIOL A, V192, P801, DOI 10.1007/s00359-006-0125-6; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	40	26	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2011	6	7							e22080	10.1371/journal.pone.0022080	http://dx.doi.org/10.1371/journal.pone.0022080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792WQ	21779377	gold, Green Published			2022-12-25	WOS:000292781500029
J	Nordstrom, T; Movert, E; Olin, AI; Ali, SR; Nizet, V; Varki, A; Areschoug, T				Nordstrom, Therese; Movert, Elin; Olin, Anders I.; Ali, Syed R.; Nizet, Victor; Varki, Ajit; Areschoug, Thomas			Human Siglec-5 Inhibitory Receptor and Immunoglobulin A (IgA) Have Separate Binding Sites in Streptococcal beta Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-B STREPTOCOCCI; PROLINE-RICH REGION; PHOSPHATASES SHP-1; SURFACE-PROTEINS; IDENTIFICATION; SEQUENCE; MOTIF; RECOGNITION; MONOCYTES; STRAINS	Sialic acid-binding immunoglobulin-like lectins (Siglecs) are receptors believed to be important for regulation of cellular activation and inflammation. Several pathogenic microbes bind specific Siglecs via sialic acid-containing structures at the microbial surface, interactions that may result in modulation of host responses. Recently, it was shown that the group B Streptococcus (GBS) binds to human Siglec-5 (hSiglec-5), an inhibitory receptor expressed on macrophages and neutrophils, via the IgA-binding surface beta protein, providing the first example of a protein/protein interaction between a pathogenic microbe and a Siglec. Here we show that the hSiglec-5-binding part of beta resides in the N-terminal half of the protein, which also harbors the previously determined IgA-binding region. We constructed bacterial mutants expressing variants of the beta protein with non-overlapping deletions in the N-terminal half of the protein. Using these mutants and recombinant beta fragments, we showed that the hSiglec-5-binding site is located in the most N-terminal part of beta (B6N region; amino acids 1-152) and that the hSiglec-5-and IgA-binding domains in beta are completely separate. We showed with BIAcore (TM) analysis that tandem variants of the hSiglec-5-and IgA-binding domains bind to their respective ligands with high affinity. Finally, we showed that the B6N region, but not the IgA-binding region of beta, triggers recruitment of the tyrosine phosphatase SHP-2 to hSiglec-5 in U937 monocytes. Taken together, we have identified and isolated the first microbial non-sialic acid Siglec-binding region that can be used as a tool in studies of the beta/hSiglec-5 interaction.	[Nordstrom, Therese; Movert, Elin; Areschoug, Thomas] Lund Univ, Dept Lab Med, Div Med Microbiol, S-22362 Lund, Sweden; [Olin, Anders I.] Lund Univ, Dept Clin Sci, Div Infect Med, S-22184 Lund, Sweden; [Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Ali, Syed R.; Varki, Ajit] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ali, Syed R.; Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ali, Syed R.; Nizet, Victor; Varki, Ajit] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Lund University; Lund University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Areschoug, T (corresponding author), Lund Univ, Dept Lab Med, Div Med Microbiol, Solvegatan 23, S-22362 Lund, Sweden.	Thomas.areschoug@med.lu.se	Ali, Syed/M-7418-2013; Nizet, Victor/AAF-3190-2019	Nizet, Victor/0000-0003-3847-0422	Royal Physiographic Society; Swedish Government; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER	Royal Physiographic Society; Swedish Government; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Royal Physiographic Society, the Swedish Government Funding for Clinical Research (ALF), and the Foundations Crafoord, Ake Wibergs, Cornell, Zoegas, Ollie och Elof Ericsson, Osterlund, Goljes, and Hierta.	Ando M, 2008, BIOCHEM BIOPH RES CO, V369, P878, DOI 10.1016/j.bbrc.2008.02.111; Angata T, 2006, FASEB J, V20, P1964, DOI 10.1096/fj.06-5800com; Areschoug T, 2002, J BACTERIOL, V184, P6376, DOI 10.1128/JB.184.22.6376-6393.2002; Areschoug T, 2002, J BIOL CHEM, V277, P12642, DOI 10.1074/jbc.M112072200; Avril T, 2004, J IMMUNOL, V173, P6841, DOI 10.4049/jimmunol.173.11.6841; Avril T, 2005, J BIOL CHEM, V280, P19843, DOI 10.1074/jbc.M502041200; Avril T, 2006, INFECT IMMUN, V74, P4133, DOI 10.1128/IAI.02094-05; BRADY LJ, 1989, INFECT IMMUN, V57, P1573, DOI 10.1128/IAI.57.5.1573-1581.1989; Carlin AF, 2009, J EXP MED, V206, P1691, DOI 10.1084/jem.20090691; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; Cornish AL, 1998, BLOOD, V92, P2123, DOI 10.1182/blood.V92.6.2123.418k20_2123_2132; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Edwards MS, 2011, INFECT DIS FETUS NEW, P419, DOI DOI 10.1016/B978-1-4160-6400-8.00012-2; HEDEN LO, 1991, EUR J IMMUNOL, V21, P1481, DOI 10.1002/eji.1830210623; JERLSTROM PG, 1991, MOL MICROBIOL, V5, P843, DOI 10.1111/j.1365-2958.1991.tb00757.x; Jerlstrom PG, 1996, INFECT IMMUN, V64, P2787; Jones C, 2003, MOL MICROBIOL, V49, P1213, DOI 10.1046/j.1365-2958.2003.03634.x; Lanier LL, 2000, IMMUNOL TODAY, V21, P611, DOI 10.1016/S0167-5699(00)01745-X; Larsson C, 1996, INFECT IMMUN, V64, P3518, DOI 10.1128/IAI.64.9.3518-3523.1996; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; LINDAHL G, 1990, EUR J IMMUNOL, V20, P2241, DOI 10.1002/eji.1830201013; Nguyen DH, 2006, P NATL ACAD SCI USA, V103, P7765, DOI 10.1073/pnas.0510484103; Paul SP, 2000, BLOOD, V96, P483; Pleass RJ, 2001, J BIOL CHEM, V276, P8197, DOI 10.1074/jbc.M009396200; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rempel H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001967; RUSSELLJONES GJ, 1984, J EXP MED, V160, P1467, DOI 10.1084/jem.160.5.1467; STALHAMMARCARLEMALM M, 1993, J EXP MED, V177, P1593, DOI 10.1084/jem.177.6.1593; STENBERG L, 1992, MOL MICROBIOL, V6, P1185, DOI 10.1111/j.1365-2958.1992.tb01557.x; Ulyanova T, 2001, J BIOL CHEM, V276, P14451, DOI 10.1074/jbc.M011650200; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Vimr E, 2002, TRENDS MICROBIOL, V10, P254, DOI 10.1016/S0966-842X(02)02361-2; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Zhang M, 2007, BLOOD, V109, P4280, DOI 10.1182/blood-2006-08-039255; Zhuravleva MA, 2008, J MOL BIOL, V375, P437, DOI 10.1016/j.jmb.2007.10.009	35	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2011	286	39					33981	33991		10.1074/jbc.M111.251728	http://dx.doi.org/10.1074/jbc.M111.251728			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	823WW	21795693	Green Published, hybrid			2022-12-25	WOS:000295159200030
J	Huang, HP; Chen, PH; Yu, CY; Chuang, CY; Stone, L; Hsiao, WC; Li, CL; Tsai, SC; Chen, KY; Chen, HF; Ho, HN; Kuo, HC				Huang, Hsiang-Po; Chen, Pin-Hsun; Yu, Chun-Ying; Chuang, Ching-Yu; Stone, Lee; Hsiao, Wen-Chu; Li, Chung-Leung; Tsai, Shih-Chih; Chen, Kai-Yun; Chen, Hsin-Fu; Ho, Hong-Nerng; Kuo, Hung-Chih			Epithelial Cell Adhesion Molecule (EpCAM) Complex Proteins Promote Transcription Factor-mediated Pluripotency Reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; CD44 VARIANT ISOFORMS; CARCINOMA-CELLS; E-CADHERIN; EP-CAM; DEFINED FACTORS; ANTIGEN EPCAM; SELF-RENEWAL; EXPRESSION; FIBROBLASTS	Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein that is highly expressed in embryonic stem cells (ESCs) and its role in maintenance of pluripotency has been suggested previously. In epithelial cancer cells, activation of the EpCAM surface-to-nucleus signaling transduction pathway involves a number of membrane proteins. However, their role in somatic cell reprogramming is still unknown. Here we demonstrate that EpCAM and its associated protein, Cldn7, play a critical role in reprogramming. Quantitative RT-PCR analysis of Oct4, Sox2, Klf4, and c-Myc (OSKM) infected mouse embryonic fibroblasts (MEFs) indicated that EpCAM and Cldn7 were up-regulated during reprogramming. Analysis of numbers of alkaline phosphatase-and Nanog-positive clones, and the expression level of pluripotency-related genes demonstrated that inhibition of either EpCAM or Cldn7 expression resulted in impairment in reprogramming efficiency, whereas overexpression of EpCAM, EpCAM plus Cldn7, or EpCAM intercellular domain (EpICD) significantly enhanced reprogramming efficiency in MEFs. Furthermore, overexpression of EpCAM or EpICD significantly repressed the expression of p53 and p21 in the reprogramming MEFs, and both EpCAM and EpICD activated the promoter activity of Oct4. These observations suggest that EpCAM signaling may enhance reprogramming through up-regulation of Oct4 and possible suppression of the p53-p21 pathway. In vitro and in vivo characterization indicated that the EpCAM-reprogrammed iPSCs exhibited similar molecular and functional features to the mouse ESCs. In summary, our studies provide additional insight into the molecular mechanisms of reprogramming and suggest a more effective means of induced pluripotent stem cell generation.	[Huang, Hsiang-Po; Chen, Kai-Yun] Natl Taiwan Univ Hosp, Dept Med Res, Taipei 100, Taiwan; [Chen, Hsin-Fu; Ho, Hong-Nerng] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Taipei 100, Taiwan; [Chen, Pin-Hsun; Chuang, Ching-Yu; Li, Chung-Leung; Kuo, Hung-Chih] Acad Sinica, Stem Cell Program, Genom Res Ctr, Taipei 115, Taiwan; [Yu, Chun-Ying; Stone, Lee; Li, Chung-Leung; Tsai, Shih-Chih; Kuo, Hung-Chih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Chen, Pin-Hsun] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan; [Hsiao, Wen-Chu] Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 106, Taiwan; [Chen, Hsin-Fu; Ho, Hong-Nerng] Natl Taiwan Univ, Grad Inst Clin Genom, Taipei 106, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Defense Medical Center; National Taiwan University; National Taiwan University	Kuo, HC (corresponding author), 128,Sec 2,Acad Rd, Taipei, Taiwan.	kuohuch@gate.sinica.edu.tw	yu, chun ying/ABB-3212-2020; Yu, Chun-ying/AAE-8368-2020; Kuo, Hung-Chih/H-7810-2014; NTU, Ref07/AAX-7890-2021	yu, chun ying/0000-0002-7320-7876; Yu, Chun-ying/0000-0002-7320-7876; Kuo, Hung-Chih/0000-0003-1336-1203; HUANG, HSIANG-PO/0000-0002-3382-305X; Ho, Hong-Nerng/0000-0002-7207-0089; CHEN, HSIN-FU/0000-0002-7748-4440	Academia Sinica, Stem Cell Priority [97-3111-B-001-009, 98-2811-B-001-022]; National Science Council, Taiwan [97-2321-B-002-020-MY3]; National RNAi Core Facility [NSC 97-3112-B-001-016]	Academia Sinica, Stem Cell Priority(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National RNAi Core Facility	This work was supported by an intramural grant from Academia Sinica, Stem Cell Priority Grants 97-3111-B-001-009 and 98-2811-B-001-022, and National Science Council, Taiwan, Grant 97-2321-B-002-020-MY3.; We thank the National RNAi Core Facility supported by Grant NSC 97-3112-B-001-016 for lentiviral shRNA clones and Dr. Wei Cui for providing the human OCT4 promoter-containing plasmid.	Akutsu H, 2009, DIFFERENTIATION, V78, P137, DOI 10.1016/j.diff.2009.08.005; Cerretti DP, 1999, CYTOKINE, V11, P541, DOI 10.1006/cyto.1998.0466; Chen HF, 2009, HUM REPROD, V24, P1114, DOI 10.1093/humrep/dep003; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Claas C, 2005, BIOCHEM J, V389, P99, DOI 10.1042/BJ20041287; Edel MJ, 2010, GENE DEV, V24, P561, DOI 10.1101/gad.1876710; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; Gires O, 2009, NAT REV CANCER, V9, P143, DOI 10.1038/nrc2499-c1; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huang HP, 2010, J BIOL CHEM, V285, P33510, DOI 10.1074/jbc.M110.122093; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Kolle G, 2009, STEM CELLS, V27, P2446, DOI 10.1002/stem.182; Kuhn S, 2007, MOL CANCER RES, V5, P553, DOI 10.1158/1541-7786.MCR-06-0384; Ladwein M, 2005, EXP CELL RES, V309, P345, DOI 10.1016/j.yexcr.2005.06.013; Le Naour F, 2006, MOL CELL PROTEOMICS, V5, P845, DOI 10.1074/mcp.M500330-MCP200; Lee MK, 1996, J NEUROSCI, V16, P7513, DOI 10.1523/jneurosci.16-23-07513.1996; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lioni M, 2007, AM J PATHOL, V170, P709, DOI 10.2353/ajpath.2007.060343; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Maaser K, 2008, BRIT J CANCER, V99, P1635, DOI 10.1038/sj.bjc.6604725; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; MOMBURG F, 1987, CANCER RES, V47, P2883; MORRISH DW, 1991, IN VITRO CELL DEV B, V27, P303; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Ng VY, 2010, STEM CELLS, V28, P29, DOI 10.1002/stem.221; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; Nubel T, 2009, MOL CANCER RES, V7, P285, DOI 10.1158/1541-7786.MCR-08-0200; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sankpal NV, 2009, CANCER RES, V69, P753, DOI 10.1158/0008-5472.CAN-08-2708; Schmidt DS, 2004, EXP CELL RES, V297, P329, DOI 10.1016/j.yexcr.2004.02.023; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Sundberg M, 2009, STEM CELL RES, V2, P113, DOI 10.1016/j.scr.2008.08.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Trzpis M, 2008, J PATHOL, V216, P201, DOI 10.1002/path.2396; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Winter MJ, 2003, AM J PATHOL, V163, P2139, DOI 10.1016/S0002-9440(10)63570-5; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001	53	70	70	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					33520	33532		10.1074/jbc.M111.256164	http://dx.doi.org/10.1074/jbc.M111.256164			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21799003	Green Published, hybrid			2022-12-25	WOS:000294968800069
J	Lefrancois-Martinez, AM; Blondet-Trichard, A; Binart, N; Val, P; Chambon, C; Sahut-Barnola, I; Pointud, JC; Martinez, A				Lefrancois-Martinez, Anne-Marie; Blondet-Trichard, Antonine; Binart, Nadine; Val, Pierre; Chambon, Celine; Sahut-Barnola, Isabelle; Pointud, Jean-Christophe; Martinez, Antoine			Transcriptional Control of Adrenal Steroidogenesis NOVEL CONNECTION BETWEEN JANUS KINASE (JAK) 2 PROTEIN AND PROTEIN KINASE A (PKA) THROUGH STABILIZATION OF cAMP RESPONSE ELEMENT-BINDING PROTEIN (CREB) TRANSCRIPTION FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE REGULATORY PROTEIN; MULTIPLE SIGNALING PATHWAYS; MAMMARY EPITHELIAL-CELLS; PROLACTIN RECEPTOR; LUTEINIZING-HORMONE; CORTICOSTERONE SECRETION; ADRENOCORTICAL-CELLS; SOMATOSTATIN GENE; PRL RECEPTOR; MALE RATS	In the adrenal gland, adrenocorticotropin (ACTH) acting through the cAMP protein kinase (PKA) transduction pathway is the main regulator of genes involved in glucocorticoid synthesis. The prolactin (PRL) receptor is expressed in the adrenal cortex of most mammals, but experimental proof that PRL ensures direct control on glucocorticoid synthesis in rodents remains elusive. To unravel the physiological importance of PRL in adrenocortical functions, we measured steroidogenic capacity of Prlr-deficient mice (Prlr(-/-)) and explored the influence of JAK/STAT signaling, the major PRL transduction pathway, on the steroidogenic activity of adrenocortical cell cultures. We demonstrate that lack of Prlr does not affect basal (nor stress-induced) corticosterone levels in mice. PRL triggers JAK2/STAT5-dependent transcription in adrenal cells, but this does not influence corticosterone release. In contrast, pharmacological or siRNA-mediated inhibition of JAK2 reveals its essential role in both basal and ACTH/cAMP-induced steroidogenesis. We demonstrate that nuclear JAK2 regulates the amount of active transcription factor CREB (cAMP response element-binding protein) through tyrosine phosphorylation and prevention of proteasomal degradation, which in turn leads to transcriptional activation of the rate-limiting steroidogenic Star gene. Hence, we describe a novel link between PKA and JAK2 by which nuclear JAK2 signaling controls adrenal steroidogenesis by increasing the stability of CREB.	[Lefrancois-Martinez, Anne-Marie; Blondet-Trichard, Antonine; Val, Pierre; Chambon, Celine; Sahut-Barnola, Isabelle; Pointud, Jean-Christophe; Martinez, Antoine] Clermont Univ, CNRS, UMR6247, F-63171 Aubiere, France; [Binart, Nadine] Univ Paris 11, Fac Med Paris Sud, F-94276 Le Kremlin Bicetre, France; [Binart, Nadine] Univ Paris 11, INSERM 693, F-94276 Le Kremlin Bicetre, France	Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Lefrancois-Martinez, AM (corresponding author), Clermont Univ, CNRS, UMR6247, BP80026,24 Ave Landais, F-63171 Aubiere, France.	a-marie.lefrancois-martinez@univ-bpclermont.fr; antoine.martinez@univ-bpclermont.fr	Binart, Nadine/F-2949-2013	Binart, Nadine/0000-0002-5606-3866; Val, Pierre/0000-0001-7648-5567	Centre National de la Recherche Scientifique (CNRS); Universite Blaise Pascal; Universite d'Auvergne and Agence Nationale pour la Recherche [ANR06-MRAR-007, ANR08-GENOPAT-002]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Blaise Pascal; Universite d'Auvergne and Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by grants from the Centre National de la Recherche Scientifique (CNRS), Universite Blaise Pascal, and Universite d'Auvergne and Agence Nationale pour la Recherche Grants ANR06-MRAR-007 and ANR08-GENOPAT-002, Region Auvergne.	Aigueperse C, 2001, MOL ENDOCRINOL, V15, P93, DOI 10.1210/me.15.1.93; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Binart N, 2000, ENDOCRINOLOGY, V141, P2691, DOI 10.1210/en.141.7.2691; Blume A, 2009, ENDOCRINOLOGY, V150, P1841, DOI 10.1210/en.2008-1023; Boer AK, 2002, BLOOD, V100, P467, DOI 10.1182/blood.V100.2.467; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Boscaro M, 2001, LANCET, V357, P783, DOI 10.1016/S0140-6736(00)04172-6; Carvalho CRO, 2003, ENDOCRINOLOGY, V144, P638, DOI 10.1210/en.2002-220706; Chang LL, 1999, J CELL BIOCHEM, V73, P563; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; Clevenger CV, 2009, TRENDS ENDOCRIN MET, V20, P223, DOI 10.1016/j.tem.2009.03.001; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; de Santa Barbara P, 1998, J BIOL CHEM, V273, P29654; Ehrhart-Bornstein M, 1998, ENDOCR REV, V19, P101, DOI 10.1210/er.19.2.101; Glasow A, 1996, J CLIN ENDOCR METAB, V81, P3103, DOI 10.1210/jc.81.8.3103; GOEBEL S, 1992, ENDOCRINOLOGY, V130, P914, DOI 10.1210/en.130.2.914; Goffin V, 1996, J BIOL CHEM, V271, P16573, DOI 10.1074/jbc.271.28.16573; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Imrich R, 2002, INT J TISSUE REACT, V24, P73; Jaroenporn S, 2007, ENDOCR J, V54, P703, DOI 10.1507/endocrj.K07-003; Jaroenporn S, 2009, LIFE SCI, V85, P172, DOI 10.1016/j.lfs.2009.05.011; Kaminska B, 2000, DOMEST ANIM ENDOCRIN, V19, P147, DOI 10.1016/S0739-7240(00)00076-X; Kan SF, 2003, EUR J PHARMACOL, V468, P141, DOI 10.1016/S0014-2999(03)01663-7; Kau MM, 2002, J INVEST MED, V50, P101, DOI 10.2310/6650.2002.31271; Kawamura M, 2007, INTERNAL MED, V46, P1117, DOI 10.2169/internalmedicine.46.6436; Kero J, 2000, J CLIN INVEST, V105, P633, DOI 10.1172/JCI7716; KLEMCKE HG, 1990, P SOC EXP BIOL MED, V195, P100, DOI 10.3181/00379727-195-43125; Li JH, 2003, J BIOL CHEM, V278, P52355, DOI 10.1074/jbc.M305232200; Lobie PE, 1996, ENDOCRINOLOGY, V137, P4037, DOI 10.1210/en.137.9.4037; Manna PR, 2003, STEROIDS, V68, P1125, DOI 10.1016/j.steroids.2003.07.009; Manna PR, 2003, J MOL ENDOCRINOL, V30, P381, DOI 10.1677/jme.0.0300381; Manna PR, 2002, MOL ENDOCRINOL, V16, P184, DOI 10.1210/me.16.1.184; MIMOU N, 1992, ENDOCRINOL JAPON, V39, P185; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MOREL G, 1994, NEUROENDOCRINOLOGY, V59, P78, DOI 10.1159/000126641; Mynard V, 2004, MOL ENDOCRINOL, V18, P2997, DOI 10.1210/me.2003-0417; Nilsson J, 2006, MOL CELL BIOL, V26, P5663, DOI 10.1128/MCB.02095-05; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; OUHTIT A, 1993, ENDOCRINOLOGY, V133, P135, DOI 10.1210/en.133.1.135; Pivonello R, 2004, J CLIN ENDOCR METAB, V89, P4493, DOI 10.1210/jc.2003-031746; Ragazzon B, 2006, ENDOCRINOLOGY, V147, P1805, DOI 10.1210/en.2005-1279; Ragazzon B, 2004, ENDOCR RES, V30, P945, DOI 10.1081/ERC-200044168; Rane SG, 2000, ONCOGENE, V19, P5662, DOI 10.1038/sj.onc.1203925; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Sakamoto K, 2007, MOL ENDOCRINOL, V21, P1877, DOI 10.1210/me.2006-0316; Sautin YuYu, 1992, Endocr Regul, V26, P35; Shraga-Slutzky Ilana, 2006, Pituitary, V9, P151, DOI 10.1007/s11102-006-9290-4; Stocco DM, 2005, MOL ENDOCRINOL, V19, P2647, DOI 10.1210/me.2004-0532	50	34	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2011	286	38					32976	32985		10.1074/jbc.M111.218016	http://dx.doi.org/10.1074/jbc.M111.218016			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	821IR	21808064	hybrid, Green Published			2022-12-25	WOS:000294968800015
J	Alvira, D; Naughton, R; Bhatt, L; Tedesco, S; Landry, WD; Cotter, TG				Alvira, Daniel; Naughton, Ruth; Bhatt, Lavinia; Tedesco, Sara; Landry, William D.; Cotter, Thomas G.			Inhibition of Protein-tyrosine Phosphatase 1B (PTP1B) Mediates Ubiquitination and Degradation of Bcr-Abl Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOID-LEUKEMIA; HUMAN BREAST-CANCER; MOLECULAR-BIOLOGY; EXPRESSION; TRANSFORMATION; KINASES; FIBROBLASTS; RECEPTOR; CELLS; SRC	Chronic myelogenous leukemia (CML) is a myeloproliferative disorder characterized at the molecular level by the expression of Bcr-Abl, a chimeric protein with deregulated tyrosine kinase activity. The protein-tyrosine phosphatase 1B (PTP1B) is up-regulated in Bcr-Abl-expressing cells, suggesting a regulatory link between the two proteins. To investigate the interplay between these two proteins, we inhibited the activity of PTP1B in Bcr-Abl-expressing TonB.210 cells by either pharmacological or siRNA means and examined the effects of such inhibition on Bcr-Abl expression and function. Herein we describe a novel mechanism by which the phosphatase activity of PTP1B is required for Bcr-Abl protein stability. Inhibition of PTP1B elicits tyrosine phosphorylation of Bcr-Abl that triggers the degradation of Bcr-Abl through ubiquitination via the lysosomal pathway. The degradation of Bcr-Abl consequently inhibits tyrosine phosphorylation of Bcr-Abl substrates and the downstream production of intracellular reactive oxygen species. Furthermore, PTP1B inhibition reduces cell viability and the IC50 of the Bcr-Abl inhibitor imatinib mesylate. Degradation of Bcr-Abl via PTP1B inhibition is also observed in human CML cell lines K562 and LAMA-84. These results suggest that inhibition of PTP1B may be a useful strategy to explore in the development of novel therapeutic agents for the treatment of CML, particularly because host drugs currently used in CML such as imatinib focus on inhibiting the kinase activity of Bcr-Abl.	[Alvira, Daniel; Naughton, Ruth; Bhatt, Lavinia; Tedesco, Sara; Landry, William D.; Cotter, Thomas G.] Univ Coll Cork, Biosci Res Inst, Dept Biochem, Tumour Biol Lab, Cork, Ireland	University College Cork	Cotter, TG (corresponding author), Univ Coll Cork, Biosci Res Inst, Dept Biochem, Tumour Biol Lab, Cork, Ireland.	t.cotter@ucc.ie		Cotter, Thomas/0000-0003-4626-5613	Health Research Board of Ireland; Children's Leukemia Research Project; Irish Cancer Society	Health Research Board of Ireland; Children's Leukemia Research Project; Irish Cancer Society	This work was supported by grants from the Health Research Board of Ireland, the Children's Leukemia Research Project, and the Irish Cancer Society.	Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; Bhatt L, 2007, BIOCHEM BIOPH RES CO, V359, P277, DOI 10.1016/j.bbrc.2007.05.100; Bjorge JD, 2000, J BIOL CHEM, V275, P41439, DOI 10.1074/jbc.M004852200; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; BROWNSHIMER S, 1992, CANCER RES, V52, P478; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chen J, 2007, BLOOD, V109, P778, DOI 10.1182/blood-2006-04-019141; Dadke S, 2003, J BIOL CHEM, V278, P40607, DOI 10.1074/jbc.M306772200; de Pril R, 2004, HUM MOL GENET, V13, P1803, DOI 10.1093/hmg/ddh188; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Dube N, 2004, P NATL ACAD SCI USA, V101, P1834, DOI 10.1073/pnas.0304242101; Fukada T, 2001, J BIOL CHEM, V276, P25512, DOI 10.1074/jbc.M101354200; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Junttila MR, 2008, CELL CYCLE, V7, P592, DOI 10.4161/cc.7.5.5492; Kakazu A, 2008, INVEST OPHTH VIS SCI, V49, P2927, DOI 10.1167/iovs.07-0709; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Khoudoli G.A., 2004, PROTEOME SCI, V2, P6, DOI DOI 10.1186/1477-5956-2-6; Klucher KM, 1998, BLOOD, V91, P3927, DOI 10.1182/blood.V91.10.3927.3927_3927_3934; LaMontagne KR, 1998, MOL CELL BIOL, V18, P2965, DOI 10.1128/MCB.18.5.2965; LaMontagne KR, 1998, P NATL ACAD SCI USA, V95, P14094, DOI 10.1073/pnas.95.24.14094; Liu F, 1998, MOL CELL BIOL, V18, P250, DOI 10.1128/MCB.18.1.250; Lu ZM, 2009, ANNU REV BIOCHEM, V78, P435, DOI 10.1146/annurev.biochem.013008.092711; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Melo JV, 1996, LEUKEMIA, V10, P751; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; Monteiro HP, 2008, ANTIOXID REDOX SIGN, V10, P843, DOI 10.1089/ars.2007.1853; Nanney LB, 1997, J CUTAN PATHOL, V24, P521, DOI 10.1111/j.1600-0560.1997.tb01456.x; Naughton R, 2009, LEUKEMIA, V23, P1432, DOI 10.1038/leu.2009.49; Nimmanapalli R, 2001, CANCER RES, V61, P1799; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Perego RA, 2000, EUR J CANCER, V36, P1395, DOI 10.1016/S0959-8049(00)00128-3; Tartaglia M, 2004, CURR OPIN HEMATOL, V11, P44, DOI 10.1097/00062752-200401000-00007; Tedesco S, 2010, COMP BIOCHEM PHYS C, V151, P167, DOI 10.1016/j.cbpc.2009.10.002; Warabi M, 2000, EXP MOL PATHOL, V68, P187, DOI 10.1006/exmp.2000.2303; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; WIENER JR, 1994, AM J OBSTET GYNECOL, V170, P1177, DOI 10.1016/S0002-9378(94)70118-0; WIENER JR, 1994, J NATL CANCER I, V86, P372, DOI 10.1093/jnci/86.5.372; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401	42	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32313	32323		10.1074/jbc.M111.249060	http://dx.doi.org/10.1074/jbc.M111.249060			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795709	hybrid, Green Published			2022-12-25	WOS:000294726800041
J	Kirkpatrick, CL; Wiederkehr, A; Baquie, M; Akhmedov, D; Wang, HY; Gauthier, BR; Akerman, I; Ishihara, H; Ferrer, J; Wollheim, CB				Kirkpatrick, Clare L.; Wiederkehr, Andreas; Baquie, Mathurin; Akhmedov, Dmitry; Wang, Haiyan; Gauthier, Benoit R.; Akerman, Ildem; Ishihara, Hisamitsu; Ferrer, Jorge; Wollheim, Claes B.			Hepatic Nuclear Factor 1 alpha (HNF1 alpha) Dysfunction Down-regulates X-box-binding Protein 1 (XBP1) and Sensitizes beta-Cells to Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT-NEGATIVE SUPPRESSION; DEFECTIVE INSULIN-SECRETION; TRANSCRIPTION FACTOR; MITOCHONDRIAL DYSFUNCTION; MESSENGER-RNA; ER STRESS; TARGETED EXPRESSION; PANCREATIC-ISLETS; INS-1 CELLS; GENE	Correct endoplasmic reticulum (ER) function is critical for the health of secretory cells, such as the pancreatic beta-cell, and ER stress is often a contributory factor to beta-cell death in type 2 diabetes. We have used an insulin-secreting cell line with inducible expression of dominant negative (DN) HNF1 alpha, a transcription factor vital for correct beta-cell development and function, to show that HNF1 alpha is required for Xbp1 transcription and maintenance of the normal ER stress response. DN HNF1 alpha expression sensitizes the beta-cell to ER stress by directly down-regulating Xbp1 transcription, whereas Atf6 is unaffected. Furthermore, DN HNF1 alpha alters calcium homeostasis, resulting in elevated cytoplasmic calcium and increased store-operated calcium entry, whereas mitochondrial calcium uptake is normal. Loss of function of XBP1 is toxic to the beta-cell and decreases production of the ER chaperone BiP, even in the absence of ER stress. DN HNF1 alpha-induced sensitivity to cyclopiazonic acid can be partially rescued with the chemical chaperone tauroursodeoxycholate. Rat insulin 2 promoter-DN HNF1 alpha mouse islets express lower levels of BiP mRNA, synthesize less insulin, and are sensitized to ER stress relative to matched control mouse islets, suggesting that this mechanism is also operating in vivo.	[Kirkpatrick, Clare L.; Baquie, Mathurin; Akhmedov, Dmitry; Wollheim, Claes B.] Univ Geneva, Ctr Med Univ, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland; [Gauthier, Benoit R.] Andalusian Ctr Mol Biol & Regenerat Med, Seville 41092, Spain; [Wiederkehr, Andreas] Nestle Inst Hlth Sci, CH-1015 Lausanne, Switzerland; [Akerman, Ildem; Ferrer, Jorge] Inst Invest Biomediques August Pi i Sunyer, Genom Programming Beta Cells Lab, Barcelona 08036, Spain; [Akerman, Ildem; Ferrer, Jorge] Hosp Clin Barcelona, E-08036 Barcelona, Spain; [Akerman, Ildem; Ferrer, Jorge] CIBER Diabet & Enfermedades Metab Asociadas, Barcelona 08036, Spain; [Ishihara, Hisamitsu] Nihon Univ, Sch Med, Div Diabet & Metab Med, Tokyo 1738610, Japan; [Wang, Haiyan] F Hoffmann La Roche & Cie AG, PRBD Metab Dis, CH-4070 Basel, Switzerland	University of Geneva; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Nestle SA; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Nihon University; Roche Holding	Wollheim, CB (corresponding author), Univ Geneva, Ctr Med Univ, Dept Cell Physiol & Metab, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	claes.wollheim@unige.ch	Gauthier, Benoit R/C-3138-2017; Ferrer, Jorge/A-3176-2012; Kirkpatrick, Clare L/M-1890-2018	Gauthier, Benoit R/0000-0001-8146-7486; Ferrer, Jorge/0000-0002-5959-5729; Kirkpatrick, Clare L/0000-0001-8564-8559; Akerman, Ildem/0000-0002-9875-1421	European Foundation for the Study of Diabetes/Lilly; Swiss National Science Foundation [310000-116750/1]; EuroDia 6th Framework Programme [LSHM-CT-2006-518153]	European Foundation for the Study of Diabetes/Lilly(Eli Lilly); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EuroDia 6th Framework Programme	This work was supported by an European Foundation for the Study of Diabetes/Lilly grant, Swiss National Science Foundation Grant 310000-116750/1, and EuroDia 6th Framework Programme Grant LSHM-CT-2006-518153.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Allagnat F, 2010, DIABETOLOGIA, V53, P1120, DOI 10.1007/s00125-010-1699-7; BLUMENFELD M, 1991, DEVELOPMENT, V113, P589; Brewer JW, 1997, EMBO J, V16, P7207, DOI 10.1093/emboj/16.23.7207; Brun T, 2007, ONCOGENE, V26, P4261, DOI 10.1038/sj.onc.1210205; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; EMENS LA, 1992, P NATL ACAD SCI USA, V89, P7300, DOI 10.1073/pnas.89.16.7300; Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002; Hagenfeldt-Johansson KA, 2001, ENDOCRINOLOGY, V142, P5311, DOI 10.1210/en.142.12.5311; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Kennedy J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011211; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kutlu B, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-3; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2011, P NATL ACAD SCI USA, V108, P8885, DOI 10.1073/pnas.1105564108; Lee AH, 2009, CELL MOL LIFE SCI, V66, P2835, DOI 10.1007/s00018-009-0049-8; Luco RF, 2006, DIABETES, V55, P2202, DOI 10.2337/db05-1534; Maechler P, 1999, J BIOL CHEM, V274, P12583, DOI 10.1074/jbc.274.18.12583; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; MIQUEROL L, 1994, J BIOL CHEM, V269, P8944; NICOSIA A, 1990, CELL, V61, P1225, DOI 10.1016/0092-8674(90)90687-A; Nozaki J, 2004, GENES CELLS, V9, P261, DOI 10.1111/j.1356-9597.2004.00721.x; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Okita K, 1999, BIOCHEM BIOPH RES CO, V263, P566, DOI 10.1006/bbrc.1999.1412; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Park KS, 2008, J BIOL CHEM, V283, P33347, DOI 10.1074/jbc.M806251200; Pirot P, 2006, DIABETOLOGIA, V49, P1229, DOI 10.1007/s00125-006-0214-7; Pongratz RL, 2009, J BIOL CHEM, V284, P16808, DOI 10.1074/jbc.M807723200; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; SCHREIBER E, 1988, EMBO J, V7, P4221, DOI 10.1002/j.1460-2075.1988.tb03319.x; Servitja JM, 2009, MOL CELL BIOL, V29, P2945, DOI 10.1128/MCB.01389-08; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Wang HY, 1998, EMBO J, V17, P6701, DOI 10.1093/emboj/17.22.6701; Wang HY, 2000, EMBO J, V19, P4257, DOI 10.1093/emboj/19.16.4257; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wicksteed B, 2001, J BIOL CHEM, V276, P22553, DOI 10.1074/jbc.M011214200; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302; Winzell MS, 2004, DIABETES, V53, pS92, DOI 10.2337/diabetes.53.suppl_3.S92; Wobser H, 2002, J BIOL CHEM, V277, P6413, DOI 10.1074/jbc.M108390200; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamagata K, 1998, DIABETES, V47, P1231, DOI 10.2337/diabetes.47.8.1231; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Yamaguchi S, 2008, CELL METAB, V7, P269, DOI 10.1016/j.cmet.2008.01.008; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	58	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32300	32312		10.1074/jbc.M111.247866	http://dx.doi.org/10.1074/jbc.M111.247866			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784843	Green Published, hybrid			2022-12-25	WOS:000294726800040
J	Suzuki-Anekoji, M; Suzuki, M; Kobayashi, T; Sato, Y; Nakayama, J; Suzuki, A; Bao, XF; Angata, K; Fukuda, M				Suzuki-Anekoji, Misa; Suzuki, Masami; Kobayashi, Tatsuya; Sato, Yoshiko; Nakayama, Jun; Suzuki, Atsushi; Bao, Xingfeng; Angata, Kiyohiko; Fukuda, Minoru			HNK-1 Glycan Functions as a Tumor Suppressor for Astrocytic Tumor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; MYELIN-ASSOCIATED GLYCOPROTEIN; CARBOHYDRATE EPITOPE HNK-1; MONOCLONAL-ANTIBODY HNK-1; NERVOUS-SYSTEM; L2/HNK-1 CARBOHYDRATE; EXPRESSION CLONING; ALPHA-DYSTROGLYCAN; MICE DEFICIENT; BRAIN-TUMORS	Astrocytic tumor is the most prevalent primary brain tumor. However, the role of cell surface carbohydrates in astrocytic tumor invasion is not known. In a previous study, we showed that polysialic acid facilitates astrocytic tumor invasion and thereby tumor progression. Here, we examined the role of HNK-1 glycan in astrocytic tumor invasion. A Kaplan-Meier analysis of 45 patients revealed that higher HNK-1 expression levels were positively associated with increased survival of patients. To determine the role of HNK-1 glycan, we transfected C6 glioma cells, which lack HNK-1 glycan expression, with beta 1,3-glucuronyltransferase-P cDNA, generating HNK-1-positive cells. When these cells were injected into the mouse brain, the resultant tumors were 60% smaller than tumors emerging from injection of the mock-transfected HNK-1-negative C6 cells. HNK-1-positive C6 cells also grew more slowly than mock-transfected C6 cells in anchorage-dependent and anchorage-independent assays. C6-HNK-1 cells migrated well after treatment of anti-beta 1 integrin antibody, whereas the same treatment inhibited cell migration of mock-transfected C6 cells. Similarly, alpha-dystroglycan containing HNK-1 glycan is different from those containing the laminin-binding glycans, supporting the above conclusion that C6-HNK-1 cells migrate independently from beta 1-integrin-mediated signaling. Moreover, HNK-1-positive cells exhibited attenuated activation of ERK 1/2 compared with mock-transfected C6 cells, whereas focal adhesion kinase activation was equivalent in both cell types. Overall, these results indicate that HNK-1 glycan functions as a tumor suppressor.	[Suzuki-Anekoji, Misa; Suzuki, Masami; Suzuki, Atsushi; Bao, Xingfeng; Angata, Kiyohiko; Fukuda, Minoru] Sanford Burnham Med Res Inst, Tumor Microenvironm Program, Canc Res Ctr, La Jolla, CA 92037 USA; [Kobayashi, Tatsuya] Shinshu Univ, Sch Med, Dept Neurosurg, Matsumoto, Nagano 3908621, Japan; [Sato, Yoshiko; Nakayama, Jun] Shinshu Univ, Grad Sch Med, Dept Mol Pathol, Matsumoto, Nagano 3908621, Japan	Sanford Burnham Prebys Medical Discovery Institute; Shinshu University; Shinshu University	Fukuda, M (corresponding author), Sanford Burnham Med Res Inst, Tumor Microenvironm Program, Canc Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	minoru@sanfordburnham.org	Angata, Kiyohiko/M-2749-2018	Angata, Kiyohiko/0000-0001-5561-1368	National Institutes of Health [CA33895, P0l CA71932]; NATIONAL CANCER INSTITUTE [P01CA071932, R01CA033895] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21390104] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA33895 and P0l CA71932.	Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; ABO T, 1981, J IMMUNOL, V127, P1024; Amoureux MC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-91; Andac Z, 1999, J MOL BIOL, V287, P253, DOI 10.1006/jmbi.1999.2606; ARIGA T, 1987, J BIOL CHEM, V262, P848; Ariga T, 2008, NEUROSIGNALS, V16, P226, DOI 10.1159/000111565; Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; Bao XF, 2009, P NATL ACAD SCI USA, V106, P12109, DOI 10.1073/pnas.0904515106; Bhunia A, 2010, J AM CHEM SOC, V132, P96, DOI 10.1021/ja904334s; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Bleckmann C, 2009, BIOL CHEM, V390, P627, DOI 10.1515/BC.2009.044; CHOU DKH, 1986, J BIOL CHEM, V261, P1717; FIGARELLABRANGER DF, 1990, CANCER RES, V50, P6364; Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735; GENNARINI G, 1989, J NEUROSCI RES, V22, P1, DOI 10.1002/jnr.490220102; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; He H, 2010, J PROTEOME RES, V9, P2098, DOI 10.1021/pr900793a; Kawataki T, 2007, EXP CELL RES, V313, P3819, DOI 10.1016/j.yexcr.2007.07.038; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Klinowska TCM, 1999, DEV BIOL, V215, P13, DOI 10.1006/dbio.1999.9435; KRUSE J, 1984, NATURE, V311, P153, DOI 10.1038/311153a0; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; Lee SH, 2009, J BIOL CHEM, V284, P17157, DOI 10.1074/jbc.M109.010934; LIZARDNACOL S, 1989, AM J PATHOL, V135, P847; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MARTINI R, 1992, EUR J NEUROSCI, V4, P628, DOI 10.1111/j.1460-9568.1992.tb00171.x; MCGARRY RC, 1983, NATURE, V306, P376, DOI 10.1038/306376a0; Morita I, 2009, J BIOL CHEM, V284, P30209, DOI 10.1074/jbc.M109.024208; Ong E, 1998, J BIOL CHEM, V273, P5190, DOI 10.1074/jbc.273.9.5190; PAULUS W, 1993, AM J PATHOL, V143, P154; PEEHL DM, 1981, P NATL ACAD SCI-BIOL, V78, P3053, DOI 10.1073/pnas.78.5.3053; Petridis AK, 2009, ACTA NEUROCHIR, V151, P601, DOI 10.1007/s00701-009-0324-3; REIFENBERGER G, 1989, ACTA NEUROPATHOL, V78, P270, DOI 10.1007/BF00687757; Satz JS, 2010, J NEUROSCI, V30, P14560, DOI 10.1523/JNEUROSCI.3247-10.2010; SCHACHNER M, 1995, TRENDS NEUROSCI, V18, P183, DOI 10.1016/0166-2236(95)93899-9; Senn C, 2002, MOL CELL NEUROSCI, V20, P712, DOI 10.1006/mcne.2002.1142; Soriano P, 2004, VIRCHOWS ARCH, V445, P292, DOI 10.1007/s00428-004-1041-1; Suzuki M, 2005, GLYCOBIOLOGY, V15, P887, DOI 10.1093/glycob/cwi071; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; Thies A, 2004, J PATHOL, V203, P933, DOI 10.1002/path.1595; Todaro L, 2007, J NEURO-ONCOL, V83, P135, DOI 10.1007/s11060-006-9312-0; Watters JJ, 2005, J NEUROSCI RES, V81, P447, DOI 10.1002/jnr.20485; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yanagisawa M, 2005, J NEUROCHEM, V95, P1311, DOI 10.1111/j.1471-4159.2005.03452.x; Yoshihara T, 2009, J BIOL CHEM, V284, P12550, DOI 10.1074/jbc.M809188200; Yuen CT, 1997, J BIOL CHEM, V272, P8924; ZHU W, 1992, J NEUROSCI RES, V31, P745, DOI 10.1002/jnr.490310418	47	12	12	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32824	32833		10.1074/jbc.M111.245886	http://dx.doi.org/10.1074/jbc.M111.245886			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21784847	hybrid, Green Published			2022-12-25	WOS:000294726800089
J	Thom, SR; Bhopale, VM; Yang, M; Bogush, M; Huang, SH; Milovanova, TN				Thom, Stephen R.; Bhopale, Veena M.; Yang, Ming; Bogush, Marina; Huang, Shaohui; Milovanova, Tatyana N.			Neutrophil beta(2) Integrin Inhibition by Enhanced Interactions of Vasodilator-stimulated Phosphoprotein with S-Nitrosylated Actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERBARIC-OXYGEN THERAPY; LEUKOCYTE B-2 INTEGRINS; INTACT HUMAN PLATELETS; MYOCARDIAL-INFARCTION; FUNCTIONAL INHIBITION; MEDIATED ADHESION; VASP; KINASE; RAC; CGMP	Production of reactive species in neutrophils exposed to hyperoxia causes S-nitrosylation of beta-actin, which increases formation of short actin filaments, leading to alterations in the cytoskeletal network that inhibit beta(2) integrin-dependent adherence (Thom, S. R., Bhopale, V. M., Mancini, D. J., and Milovanova, T. N. (2008) J. Biol. Chem. 283, 10822-10834). In this study, we found that vasodilator-stimulated protein (VASP) exhibits high affinity for S-nitrosylated short filamentous actin, which increases actin polymerization. VASP bundles Rac1, Rac2, cyclic AMP-dependent, and cyclic GMP-dependent protein kinases in close proximity to short actin filaments, and subsequent Rac activation increases actin free barbed end formation. Using specific chemical inhibitors or reducing cell concentrations of any of these proteins with small inhibitory RNA abrogates enhanced free barbed end formation, increased actin polymerization, and beta(2) integrin inhibition by hyperoxia. Alternatively, incubating neutrophils with formylmethionylleucylphenylalanine or 8-bromo-cyclic GMP activates either cyclic AMP-dependent or cyclic GMP-dependent protein kinase, respectively, outside of the short F-actin pool and phosphorylates VASP on serine 153. Phosphorylated VASP abrogates the augmented polymerization normally observed with S-nitrosylated actin, VASP binding to actin, elevated Rac activity, and elevated formation of actin free barbed ends, thus restoring normal beta(2) integrin function.	[Thom, Stephen R.; Bhopale, Veena M.; Yang, Ming; Bogush, Marina; Huang, Shaohui; Milovanova, Tatyana N.] Univ Penn, Inst Environm Med, Med Ctr, Philadelphia, PA 19104 USA; [Thom, Stephen R.] Univ Penn, Dept Emergency Med, Med Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Thom, SR (corresponding author), Univ Penn, Inst Environm Med, Med Ctr, 1 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	sthom@mail.med.upenn.edu	Shaohui Huang, Shaohui Huang Huang Shaohui/AAW-4531-2021		Office of Naval Research	Office of Naval Research(Office of Naval Research)	This work was supported by a grant from the Office of Naval Research.	Alex J, 2005, J THORAC CARDIOV SUR, V130, P1623, DOI 10.1016/j.jtcvs.2005.08.018; Anderson SI, 2003, CELL MOTIL CYTOSKEL, V54, P135, DOI 10.1002/cm.10091; Arcaro A, 1998, J BIOL CHEM, V273, P805, DOI 10.1074/jbc.273.2.805; Arguinzonis MIG, 2002, J BIOL CHEM, V277, P45604, DOI 10.1074/jbc.M202873200; Aszodi A, 1999, EMBO J, V18, P37, DOI 10.1093/emboj/18.1.37; Atochin DN, 2000, UNDERSEA HYPERBAR M, V27, P185; Banick PD, 1997, J CELL PHYSIOL, V172, P12, DOI 10.1002/(SICI)1097-4652(199707)172:1<12::AID-JCP2>3.0.CO;2-G; Brown EJ, 1996, ANN MED, V28, P201, DOI 10.3109/07853899609033121; BUTT E, 1994, EUR J PHARM-MOLEC PH, V269, P265, DOI 10.1016/0922-4106(94)90095-7; BUTT E, 1994, J BIOL CHEM, V269, P14509; Chen QP, 1996, J PHARMACOL EXP THER, V276, P929; Deevi RK, 2010, J IMMUNOL, V184, P6575, DOI 10.4049/jimmunol.0903910; Dib K, 2003, J BIOL CHEM, V278, P24181, DOI 10.1074/jbc.M302300200; Eckert RE, 2007, J LEUKOCYTE BIOL, V82, P1311, DOI 10.1189/jlb.0206107; Glogauer M, 2000, J CELL BIOL, V150, P785, DOI 10.1083/jcb.150.4.785; Goldberg N D, 1975, Adv Cyclic Nucleotide Res, V5, P307; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; HORSTRUP K, 1994, EUR J BIOCHEM, V225, P21, DOI 10.1111/j.1432-1033.1994.00021.x; Huttelmaier S, 1999, FEBS LETT, V451, P68, DOI 10.1016/S0014-5793(99)00546-3; Huttelmaier S, 1998, CURR BIOL, V8, P479, DOI 10.1016/S0960-9822(98)70199-X; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Martin JD, 2002, AVIAT SPACE ENVIR MD, V73, P565; Miranti CK, 1998, CURR BIOL, V8, P1289, DOI 10.1016/S0960-9822(07)00559-3; Pai SY, 2010, DIS MARKERS, V29, P177, DOI [10.1155/2010/380291, 10.3233/DMA-2010-0738]; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Schlegel N, 2009, J CELL PHYSIOL, V220, P357, DOI 10.1002/jcp.21772; Schlegel N, 2009, AM J PHYSIOL-CELL PH, V296, pC453, DOI 10.1152/ajpcell.00360.2008; Selvatici R, 2006, EUR J PHARMACOL, V534, P1, DOI 10.1016/j.ejphar.2006.01.034; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Shandling AH, 1997, AM HEART J, V134, P544, DOI 10.1016/S0002-8703(97)70093-0; Sharifi M, 2004, AM J CARDIOL, V93, P1533, DOI 10.1016/j.amjcard.2004.03.009; Sharifi Mohsen, 2002, Cardiovasc Radiat Med, V3, P124, DOI 10.1016/S1522-1865(03)00104-5; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Stavitsky Y, 1998, CARDIOLOGY, V90, P131, DOI 10.1159/000006832; Sun CX, 2007, J CELL BIOL, V179, P239, DOI 10.1083/jcb.200705122; Tahepold P, 2003, J THORAC CARDIOV SUR, V125, P650, DOI 10.1067/mtc.2003.36; Tahepold P, 2001, LIFE SCI, V68, P1629, DOI 10.1016/S0024-3205(01)00964-X; THOM SR, 1993, TOXICOL APPL PHARM, V123, P248, DOI 10.1006/taap.1993.1243; Thom SR, 1997, AM J PHYSIOL-CELL PH, V272, pC770, DOI 10.1152/ajpcell.1997.272.3.C770; Thom SR, 2008, J BIOL CHEM, V283, P10822, DOI 10.1074/jbc.M709200200; Thom SR, 2009, J APPL PHYSIOL, V106, P988, DOI 10.1152/japplphysiol.91004.2008; Ueno S, 1999, HEPATO-GASTROENTEROL, V46, P1798; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; WONG HP, 1996, SURG FORUM, P705; Worner R, 2007, AM J PHYSIOL-HEART C, V292, pH237, DOI 10.1152/ajpheart.00079.2006; Yang ZJ, 2001, EUR J APPL PHYSIOL, V85, P96, DOI 10.1007/s004210100391; Yogaratnam JZ, 2010, CARDIOVASC REVASCULA, V11, P8, DOI 10.1016/j.carrev.2009.03.004; ZAMBONI WA, 1993, PLAST RECONSTR SURG, V91, P1110, DOI 10.1097/00006534-199305000-00022	50	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32854	32865		10.1074/jbc.M111.255778	http://dx.doi.org/10.1074/jbc.M111.255778			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795685	hybrid, Green Published			2022-12-25	WOS:000294726800092
J	Yao, SYM; Ng, AML; Cass, CE; Baldwin, SA; Young, JD				Yao, Sylvia Y. M.; Ng, Amy M. L.; Cass, Carol E.; Baldwin, Stephen A.; Young, James D.			Nucleobase Transport by Human Equilibrative Nucleoside Transporter 1 (hENT1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; HIGH-AFFINITY; RECOMBINANT HUMAN; EPITHELIAL-CELLS; CELLULAR UPTAKE; GUINEA-PIG; NITROBENZYLTHIOINOSINE; IDENTIFICATION; PURINE	The human equilibrative nucleoside transporters hENT1 and hENT2 (each with 456 residues) are 40% identical in amino acid sequence and contain 11 putative transmembrane helices. Both transport purine and pyrimidine nucleosides and are distinguished functionally by a difference in sensitivity to inhibition by nanomolar concentrations of nitrobenzylmercaptopurine ribonucleoside (NBMPR), hENT1 being NBMPR-sensitive. Previously, we used heterologous expression in Xenopus oocytes to demonstrate that recombinant hENT2 and its rat ortholog rENT2 also transport purine and pyrimidine bases, h/rENT2 representing the first identified mammalian nucleobase transporter proteins (Yao, S. Y., Ng, A. M., Vickers, M. F., Sundaram, M., Cass, C. E., Baldwin, S. A., and Young, J. D. (2002) J. Biol. Chem. 277, 24938-24948). The same study also revealed lower, but significant, transport of hypoxanthine by h/rENT1. In the present investigation, we have used the enhanced Xenopus oocyte expression vector pGEMHE to demonstrate that hENT1 additionally transports thymine and adenine and, to a lesser extent, uracil and guanine. Fluxes of hypoxanthine, thymine, and adenine by hENT1 were saturable and inhibited by NBMPR. Ratios of Vmax (pmol/oocyte.min(-1)): K-m (mM), a measure of transport efficiency, were 86, 177, and 120 for hypoxantine, thymine, and adenine, respectively, compared with 265 for uridine. Hypoxanthine influx was competitively inhibited by uridine, indicating common or overlapping nucleobase and nucleoside permeant binding pockets, and the anticancer nucleobase drugs 5-fluorouracil and 6-mercaptopurine were also transported. Nucleobase transport activity was absent from an engineered cysteine-less version hENT1 (hENT1C-) in which all 10 endogenous cysteine residues were mutated to serine. Site-directed mutagenesis identified Cys-414 in transmembrane helix 10 of hENT1 as the residue conferring nucleobase transport activity to the wild-type transporter.	[Yao, Sylvia Y. M.; Ng, Amy M. L.; Young, James D.] Univ Alberta, Dept Physiol, Membrane Prot Dis Res Grp, Edmonton, AB T6G 2H7, Canada; [Cass, Carol E.] Univ Alberta, Dept Oncol, Membrane Prot Dis Res Grp, Edmonton, AB T6G 2H7, Canada; [Cass, Carol E.] Cross Canc Inst, Edmonton, AB T6G 2H7, Canada; [Baldwin, Stephen A.] Univ Leeds, Astbury Ctr Struct Mol Biol, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England	University of Alberta; University of Alberta; University of Alberta; University of Leeds	Young, JD (corresponding author), Univ Alberta, Dept Physiol, Membrane Prot Dis Res Grp, 7-55 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	james.young@ualberta.ca			Canadian Institutes of Health Research; Alberta Cancer Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation	This work was supported in part by the Canadian Institutes of Health Research and the Alberta Cancer Foundation.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Arastu-Kapur S, 2005, J BIOL CHEM, V280, P2213, DOI 10.1074/jbc.M408224200; ARONOW B, 1986, J BIOL CHEM, V261, P2014; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Baldwin SA, 2007, CURR PHARM DESIGN, V13, P569, DOI 10.2174/138161207780162845; Barnes K, 2006, CIRC RES, V99, P510, DOI 10.1161/01.RES.0000238359.18495.42; BARROS LF, 1994, AM J OBSTET GYNECOL, V171, P111, DOI 10.1016/S0002-9378(94)70086-9; BELT JA, 1985, BIOCHEM J, V232, P681, DOI 10.1042/bj2320681; Cabrita MA, 2002, BIOCHEM CELL BIOL, V80, P623, DOI 10.1139/O02-153; Caulfield MJ, 2008, PLOS MED, V5, P1509, DOI 10.1371/journal.pmed.0050197; Crawford CR, 1998, J BIOL CHEM, V273, P5288, DOI 10.1074/jbc.273.9.5288; de Koning H, 2000, MOL MEMBR BIOL, V17, P75; Engel K, 2004, J BIOL CHEM, V279, P50042, DOI 10.1074/jbc.M407913200; GATI WP, 1992, J BIOL CHEM, V267, P22272; Govindarajan R, 2009, AM J PHYSIOL-GASTR L, V296, pG910, DOI 10.1152/ajpgi.90672.2008; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; GRIFFITH DA, 1992, BIOCHIM BIOPHYS ACTA, V1106, P303, DOI 10.1016/0005-2736(92)90010-J; GRIFFITH DA, 1994, BIOCHEM J, V303, P901, DOI 10.1042/bj3030901; GRIFFITH DA, 1993, J BIOL CHEM, V268, P20085; Griffiths M, 1997, NAT MED, V3, P89, DOI 10.1038/nm0197-89; Griffiths M, 1997, BIOCHEM J, V328, P739, DOI 10.1042/bj3280739; Hoque KM, 2008, AM J PHYSIOL-REG I, V294, pR1988, DOI 10.1152/ajpregu.00016.2008; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Kato R, 2006, AM J PHYSIOL-ENDOC M, V290, pE968, DOI 10.1152/ajpendo.00160.2005; Kato R, 2009, BIOL PHARM BULL, V32, P450, DOI 10.1248/bpb.32.450; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Landfear SM, 2004, EUKARYOT CELL, V3, P245, DOI 10.1128/EC.3.2.245-254.2004; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Nagai K, 2007, INT J PHARM, V333, P56, DOI 10.1016/j.ijpharm.2006.09.044; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Pantazopoulou A, 2007, FEMS MICROBIOL REV, V31, P657, DOI 10.1111/j.1574-6976.2007.00083.x; Papageorgiou I, 2008, INT J PARASITOL, V38, P641, DOI 10.1016/j.ijpara.2007.10.005; Parker MD, 2000, BIOCHEM J, V349, P67, DOI 10.1042/0264-6021:3490067; Parkinson FE, 2011, CURR TOP MED CHEM, V11, P948; PLAGEMANN PGW, 1988, BIOCHIM BIOPHYS ACTA, V947, P405, DOI 10.1016/0304-4157(88)90002-0; Ritzel MWL, 1998, MOL MEMBR BIOL, V15, P203; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; Shayeghi M, 1999, BBA-BIOMEMBRANES, V1416, P109, DOI 10.1016/S0005-2736(98)00213-2; Smith KM, 2004, J PHYSIOL-LONDON, V558, P807, DOI 10.1113/jphysiol.2004.068189; Stein WD, 1986, TRANSPORT DIFFUSION, P231; Sundaram M, 2001, J BIOL CHEM, V276, P45270, DOI 10.1074/jbc.M107169200; ULLMAN B, 1987, MOL CELL BIOL, V7, P97, DOI 10.1128/MCB.7.1.97; Valdes R, 2009, J BIOL CHEM, V284, P19067, DOI 10.1074/jbc.M109.017947; Ward JL, 2000, J BIOL CHEM, V275, P8375, DOI 10.1074/jbc.275.12.8375; WASHINGTON CB, 1995, J BIOL CHEM, V270, P22816, DOI 10.1074/jbc.270.39.22816; Yamamoto S, 2010, J BIOL CHEM, V285, P6522, DOI 10.1074/jbc.M109.032961; Yao SYM, 2000, PRACT APPROACH SER, P47; Yao SYM, 2002, J BIOL CHEM, V277, P24938, DOI 10.1074/jbc.M200966200; Yao SYM, 2001, BIOCHEM J, V353, P387, DOI 10.1042/0264-6021:3530387; Yao SYM, 1997, J BIOL CHEM, V272, P28423, DOI 10.1074/jbc.272.45.28423; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]; Young J. D., 2000, CURRENT TOPICS MEMBR, P329; YOUNG JD, 2003, EQUILIBRATIVE NUCLEO, P321; Zhang J, 2007, CANCER METAST REV, V26, P85, DOI 10.1007/s10555-007-9044-4	57	85	86	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32552	32562		10.1074/jbc.M111.236117	http://dx.doi.org/10.1074/jbc.M111.236117			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21795683	hybrid, Green Published			2022-12-25	WOS:000294726800065
J	Carrington, LB; Lipkowitz, JR; Hoffmann, AA; Turelli, M				Carrington, Lauren B.; Lipkowitz, Jeremy R.; Hoffmann, Ary A.; Turelli, Michael			A Re-Examination of Wolbachia-Induced Cytoplasmic Incompatibility in California Drosophila simulans	PLOS ONE			English	Article							UNIDIRECTIONAL INCOMPATIBILITY; NATURAL-POPULATIONS; EVOLUTION; DYNAMICS; HOST; ENDOSYMBIONTS; RESISTANCE; MICROBES	Background: In California Drosophila simulans, the maternally inherited Riverside strain Wolbachia infection (wRi) provides a paradigm for rapid spread of Wolbachia in nature and rapid evolutionary change. wRi induces cytoplasmic incompatibility (CI), where crosses between infected males and uninfected females produce reduced egg-hatch. The three parameters governing wRi infection-frequency dynamics quantify: the fidelity of maternal transmission, the level of cytoplasmic incompatibility, and the relative fecundity of infected females. We last estimated these parameters in nature in 1993. Here we provide new estimates, under both field and laboratory conditions. Five years ago, we found that wRi had apparently evolved over 15 years to enhance the fecundity of infected females; here we examine whether CI intensity has also evolved. Methodology/Principal Findings: New estimates using wild-caught flies indicate that the three key parameters have remained relatively stable since the early 1990s. As predicted by our three-parameter model using field-estimated parameter values, population infection frequencies remain about 93%. Despite this relative stability, laboratory data based on reciprocal crosses and introgression suggest that wRi may have evolved to produce less intense CI (i.e., higher egg hatch from incompatible crosses). In contrast, we find no evidence that D. simulans has evolved to lower the susceptibility of uninfected females to CI. Conclusions/Significance: Evolution of wRi that reduces CI is consistent with counterintuitive theoretical predictions that within-population selection on CI-causing Wolbachia does not act to increase CI. Within taxa, CI is likely to evolve mainly via pleiotropic effects associated with the primary targets of selection on Wolbachia, i.e., host fecundity and transmission fidelity. Despite continuous, strong selection, D. simulans has not evolved appreciably to suppress CI. Our data demonstrate a lack of standing genetic variation for CI resistance in the host.	[Carrington, Lauren B.; Hoffmann, Ary A.] Univ Melbourne, Dept Genet, Parkville, Vic 3052, Australia; [Carrington, Lauren B.; Hoffmann, Ary A.] Univ Melbourne, Inst Bio21, Parkville, Vic 3052, Australia; [Carrington, Lauren B.; Lipkowitz, Jeremy R.; Turelli, Michael] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA	University of Melbourne; University of Melbourne; University of California System; University of California Davis	Carrington, LB (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.	mturelli@ucdavis.edu	Hoffmann, Ary/R-2972-2019; Hoffmann, Ary/C-2961-2011; Carrington, Lauren/B-8269-2013	Hoffmann, Ary/0000-0001-9497-7645; Carrington, Lauren Bree/0000-0001-9273-7912	Foundation for the National Institutes of Health, through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; National Science Foundation [DEB 0815145]; Australian Research Council	Foundation for the National Institutes of Health, through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; National Science Foundation(National Science Foundation (NSF)); Australian Research Council(Australian Research Council)	This research was supported by grants from the Foundation for the National Institutes of Health, through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation (MT), the National Science Foundation (DEB 0815145 to MT) and a Laureate Fellowship from the Australian Research Council (AAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINNINGTON KC, 1989, J INVERTEBR PATHOL, V54, P344, DOI 10.1016/0022-2011(89)90118-3; Casper-Lindley C, 2011, APPL ENVIRON MICROB, V77, P4788, DOI 10.1128/AEM.00215-11; Efron B., 1994, INTRO BOOTSTRAP; Frank SA, 1997, J THEOR BIOL, V184, P327, DOI 10.1006/jtbi.1996.0276; Haygood R, 2009, EVOLUTION, V63, P432, DOI 10.1111/j.1558-5646.2008.00550.x; Hercus MJ, 1999, GENETICS, V151, P1493; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; HOFFMANN AA, 1988, GENETICS, V119, P435; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; HOFFMANN AA, 1990, GENETICS, V126, P933; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Hornett EA, 2006, PLOS BIOL, V4, P1643, DOI 10.1371/journal.pbio.0040283; Hornett EA, 2009, CURR BIOL, V19, P1628, DOI 10.1016/j.cub.2009.07.071; HURST LD, 1991, J THEOR BIOL, V148, P269, DOI 10.1016/S0022-5193(05)80344-3; Jaenike J, 2008, J EVOLUTION BIOL, V21, P1570, DOI 10.1111/j.1420-9101.2008.01607.x; Jaenike J, 2007, EVOLUTION, V61, P2244, DOI 10.1111/j.1558-5646.2007.00180.x; Jaenike J, 2009, OIKOS, V118, P353, DOI 10.1111/j.1600-0706.2008.17110.x; Karr TL, 1998, P ROY SOC B-BIOL SCI, V265, P391, DOI 10.1098/rspb.1998.0307; Klasson L, 2009, P NATL ACAD SCI USA, V106, P5725, DOI 10.1073/pnas.0810753106; Poinsot D, 2003, BIOESSAYS, V25, P259, DOI 10.1002/bies.10234; PROUT T, 1994, EVOLUTION, V48, P909, DOI 10.1111/j.1558-5646.1994.tb01371.x; Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827; TURELLI M, 1992, GENETICS, V132, P713; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x; TURELLI M, 1995, GENETICS, V140, P1319; Turelli M, 2010, EVOLUTION, V64, P232, DOI 10.1111/j.1558-5646.2009.00822.x; Unckless RL, 2009, P ROY SOC B-BIOL SCI, V276, P2805, DOI 10.1098/rspb.2009.0287; VOELKER RA, 1991, MOL CELL BIOL, V11, P894, DOI 10.1128/MCB.11.2.894; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	33	30	31	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22565	10.1371/journal.pone.0022565	http://dx.doi.org/10.1371/journal.pone.0022565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799900	Green Published, gold			2022-12-25	WOS:000293172900048
J	Kennedy, BA; Deatherage, DE; Gu, F; Tang, BH; Chan, MWY; Nephew, KP; Huang, THM; Jin, VX				Kennedy, Brian A.; Deatherage, Daniel E.; Gu, Fei; Tang, Binhua; Chan, Michael W. Y.; Nephew, Kenneth P.; Huang, Tim H-M.; Jin, Victor X.			ChIP-seq Defined Genome-Wide Map of TGF beta/SMAD4 Targets: Implications with Clinical Outcome of Ovarian Cancer	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; WEB APPLICATION TOOL; GROWTH-FACTOR-BETA; C-MYC; CHROMATIN IMMUNOPRECIPITATION; SYNEXPRESSION GROUP; REGULATORY MODULES; CELL-MEMBRANE; BREAST-CANCER; PATHWAYS	Deregulation of the transforming growth factor-beta (TGF beta) signaling pathway in epithelial ovarian cancer has been reported, but the precise mechanism underlying disrupted TGF beta signaling in the disease remains unclear. We performed chromatin immunoprecipitation followed by sequencing (ChIP-seq) to investigate genome-wide screening of TGF beta-induced SMAD4 binding in epithelial ovarian cancer. Following TGF beta stimulation of the A2780 epithelial ovarian cancer cell line, we identified 2,362 SMAD4 binding loci and 318 differentially expressed SMAD4 target genes. Comprehensive examination of SMAD4-bound loci, revealed four distinct binding patterns: 1) Basal; 2) Shift; 3) Stimulated Only; 4) Unstimulated Only. TGF beta stimulated SMAD4-bound loci were primarily classified as either Stimulated only (74%) or Shift (25%), indicating that TGF beta-stimulation alters SMAD4 binding patterns in epithelial ovarian cancer cells. Furthermore, based on gene regulatory network analysis, we determined that the TGF beta-induced, SMAD4-dependent regulatory network was strikingly different in ovarian cancer compared to normal cells. Importantly, the TGF beta/SMAD4 target genes identified in the A2780 epithelial ovarian cancer cell line were predictive of patient survival, based on in silico mining of publically available patient data bases. In conclusion, our data highlight the utility of next generation sequencing technology to identify genome-wide SMAD4 target genes in epithelial ovarian cancer and link aberrant TGF beta/SMAD signaling to ovarian tumorigenesis. Furthermore, the identified SMAD4 binding loci, combined with gene expression profiling and in silico data mining of patient cohorts, may provide a powerful approach to determine potential gene signatures with biological and future translational research in ovarian and other cancers.	[Kennedy, Brian A.; Gu, Fei; Tang, Binhua; Jin, Victor X.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Deatherage, Daniel E.; Huang, Tim H-M.] Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA; [Chan, Michael W. Y.] Natl Chung Cheng Univ, Dept Life Sci, Chiayi, Taiwan; [Nephew, Kenneth P.] Indiana Univ Sch Med, Bloomington, IN USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; National Chung Cheng University; Indiana University System; Indiana University Bloomington	Kennedy, BA (corresponding author), Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA.	Victor.Jin@osumc.edu	Tang, Binhua/M-9468-2019; Chan, Michael/F-9615-2018; Tang, Binhua/B-7642-2014	Tang, Binhua/0000-0003-4744-5835; Chan, Michael/0000-0003-1431-322X; Tang, Binhua/0000-0003-4744-5835; Chan, Michael/0000-0003-0314-2437	National Institutes of Health [U54CA113001, R01CA069065]; National Cancer Institute [CA85289]; Ohio State University Comprehensive Cancer Center; Ohio State University Biomedical Informatics; NATIONAL CANCER INSTITUTE [R01CA069065, U54CA113001, R01CA085289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ohio State University Comprehensive Cancer Center; Ohio State University Biomedical Informatics(Ohio State University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from National Institutes of Health U54CA113001, R01CA069065 and National Cancer Institute CA85289 and by funds from the Ohio State University Comprehensive Cancer Center and The Ohio State University Biomedical Informatics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin RL, 2003, CANCER RES, V63, P1413; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BERCHUCK A, 1992, AM J OBSTET GYNECOL, V166, P676, DOI 10.1016/0002-9378(92)91697-9; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bleuming SA, 2007, CANCER RES, V67, P8149, DOI 10.1158/0008-5472.CAN-06-4659; BREIMAN L., 1984, CRC PRESS; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chan M, 2008, NEOPLASIA, V10, P908, DOI 10.1593/neo.08540; Cheng ASL, 2006, MOL CELL, V21, P393, DOI 10.1016/j.molcel.2005.12.016; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; Chou JL, 2010, LAB INVEST, V90, P414, DOI 10.1038/labinvest.2009.138; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fei T, 2010, GENOME RES, V20, P36, DOI 10.1101/gr.092114.109; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Frietze S, 2010, J BIOL CHEM, V285, P1393, DOI 10.1074/jbc.M109.063032; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Gu F, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-170; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikushima H, 2008, EMBO J, V27, P2955, DOI 10.1038/emboj.2008.218; Jin VX, 2006, GENOME RES, V16, P1585, DOI 10.1101/gr.5520206; Jin VX, 2009, BIOINFORMATICS, V25, P3191, DOI 10.1093/bioinformatics/btp570; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kodach LL, 2008, GASTROENTEROLOGY, V134, P1332, DOI 10.1053/j.gastro.2008.02.059; Koinuma D, 2009, CANCER SCI, V100, P2133, DOI 10.1111/j.1349-7006.2009.01299.x; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Lan X, 2011, BIOINFORMATICS, V27, P428, DOI 10.1093/bioinformatics/btq669; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; Lim SK, 2006, P NATL ACAD SCI USA, V103, P18580, DOI 10.1073/pnas.0604773103; Lu KH, 2004, CLIN CANCER RES, V10, P3291, DOI 10.1158/1078-0432.CCR-03-0409; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Milano F, 2007, GASTROENTEROLOGY, V132, P2412, DOI 10.1053/j.gastro.2007.03.026; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nilsson Eric E, 2002, Reprod Biomed Online, V5, P254; Qin HX, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-73; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tanaka Y, 2004, J BIOL CHEM, V279, P8567, DOI 10.1074/jbc.M309131200; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Wong AST, 2007, J OBSTET GYNAECOL RE, V33, P3, DOI 10.1111/j.1447-0756.2007.00478.x; Yamada SD, 1999, GYNECOL ONCOL, V75, P72, DOI 10.1006/gyno.1999.5535	48	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22606	10.1371/journal.pone.0022606	http://dx.doi.org/10.1371/journal.pone.0022606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799915	Green Submitted, Green Published, gold			2022-12-25	WOS:000293172900056
J	Li, J; Hu, DM; Ding, XX; Chen, Y; Pan, YX; Qiu, LW; Che, XY				Li, Jie; Hu, Dong-mei; Ding, Xi-xia; Chen, Yue; Pan, Yu-xian; Qiu, Li-wen; Che, Xiao-yan			Enzyme-Linked Immunosorbent Assay-Format Tissue Culture Infectious Dose-50 Test for Titrating Dengue Virus	PLOS ONE			English	Article							REDUCTION; ANTIBODIES; CELLS	A dengue nonstructural protein 1 (NS1) antigen capture enzyme-linked immunosorbent assay (ELISA)-based tissue culture infectious dose-50 (TCID(50)) test (TCID(50)-ELISA) was developed as an alternative to the standard plaque assay for titrating dengue virus. Virus titers obtained by TCID(50)-ELISA were comparable to those obtained by the plaque assay and by the traditional TCID(50)-cytopathic effect (CPE) test (TCID(50)-CPE), with a better reproducibility and a lower coefficient of variation. Quantitative comparison of TCID(50)-ELISA and TCID(50)-CPE resulted in a correlation coefficient of 0.976. Moreover, this new method showed a wider application to C6/36, Vero E6, BHK-21, and Vero cells compared with other titration methods. In summary, the novel TCID(50)-ELISA method described here provides a more reliable and more accurate alternative compared to the plaque assay and TCID(50)-CPE for titration of dengue virus.	[Li, Jie; Hu, Dong-mei; Ding, Xi-xia; Chen, Yue; Pan, Yu-xian; Qiu, Li-wen; Che, Xiao-yan] So Med Univ, Ctr Clin Lab, Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China; [Li, Jie; Hu, Dong-mei; Ding, Xi-xia; Chen, Yue; Pan, Yu-xian; Qiu, Li-wen; Che, Xiao-yan] Guangdong Higher Educ Inst, Key Lab Prevent & Control Emerging Infect Dis, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Li, J (corresponding author), So Med Univ, Ctr Clin Lab, Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China.	chexiaoyan@126.com			National Outstanding Young Scientist Foundation of China [30725031]; National Science and Technology Major Project of China [2009ZX10004-306]; National Natural Science Foundation of China [30671874]	National Outstanding Young Scientist Foundation of China; National Science and Technology Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant 30725031 from the National Outstanding Young Scientist Foundation of China, grant 2009ZX10004-306 of the National Science and Technology Major Project of China, and grant 30671874 of the Research Program of the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; De Paula Sérgio Oliveira, 2004, Braz J Infect Dis, V8, P390, DOI 10.1590/S1413-86702004000600002; DING X, 2011, CLIN VACCINE IMMUNOL; Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999; George Rebecca, 1997, P89; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Krishna VD, 2009, J VIROL, V83, P4766, DOI 10.1128/JVI.01850-08; Lambeth CR, 2005, J CLIN MICROBIOL, V43, P3267, DOI 10.1128/JCM.43.7.3267-3272.2005; Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007; SCHOEPP RJ, 1984, J CLIN MICROBIOL, V20, P1017, DOI 10.1128/JCM.20.5.1017-1019.1984; TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053; Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625	14	19	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22553	10.1371/journal.pone.0022553	http://dx.doi.org/10.1371/journal.pone.0022553			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799894	Green Published, Green Submitted, gold			2022-12-25	WOS:000293172900045
J	Mild, M; Hedskog, C; Jernberg, J; Albert, J				Mild, Mattias; Hedskog, Charlotte; Jernberg, Johanna; Albert, Jan			Performance of Ultra-Deep Pyrosequencing in Analysis of HIV-1 pol Gene Variation	PLOS ONE			English	Article							PCR-MEDIATED RECOMBINATION; RESISTANT VIRAL VARIANTS; MINORITY VARIANTS; POLYMERASE; SUBTYPE; IMPACT	Introduction: Ultra-deep pyrosequencing (UDPS) has been used to detect minority variants within HIV-1 populations. Some aspects of the quality and reproducibility of UDPS have been previously evaluated, but comprehensive studies are still needed. Principal Finding: In this study the UDPS technology (FLX platform) was evaluated by analyzing a 120 base pair fragment of the HIV-1 pol gene from plasma samples from two patients and artificial mixtures of molecular clones. UDPS was performed using an optimized experimental protocol and an in-house data cleaning strategy. Nine samples and mixtures were analyzed and the average number of reads per sample was 19,404 (range 8,858-26,846). The two patient plasma samples were analyzed twice and quantification of viral variants was found to be highly repeatable for variants representing >0.27% of the virus population, whereas some variants representing 0.11-0.27% were detected in only one of the two UDPS runs. Bland-Altman analysis showed that a repeated measurement would have a 95% likelihood to lie approximately within +/- 0.5 log(10) of the initial estimate. A similar level of agreement was observed for variant frequency estimates in forward vs. reverse sequencing direction, but here the agreement was higher for common variants than for rare variants. UDPS following PCR amplification with alternative primers indicated that some variants may be incorrectly quantified due to primer-related selective amplification. Finally, the in vitro recombination rate during PCR was evaluated using artificial mixtures of clones and was found to be low. The most abundant in vitro recombinant represented 0.25% of all UDPS reads. Conclusion: This study demonstrates that this UDPS protocol results in low experimental noise and high repeatability, which is relevant for future research and clinical use of the UDPS technology. The low rate of in vitro recombination suggests that this UDPS system can be used to study genetic variants and mutational linkage.	[Mild, Mattias; Hedskog, Charlotte; Jernberg, Johanna; Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Albert, Jan] Karolinska Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Mild, M (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	mattias.mild@smi.se		Hedskog, Charlotte/0000-0003-0512-7767	Swedish Research Council [2007-1131-49460-36]; Swedish International Development Cooperation Agency [SWE-2006-018]; EU [LSHP-CT-2006-518211, FP7/2007-2013, 223131]; Swedish Parliament and Government	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency; EU(European Commission); Swedish Parliament and Government	Mattias Mild was funded by a post doctoral fellowship grant from The Swedish Research Council. The research leading to these results has received funding from the Swedish Research Council (grant no. 2007-1131-49460-36); Swedish International Development Cooperation Agency (grant no. SWE-2006-018), a non-commercial organization working according to directives of the Swedish Parliament and Government (http://www.sida.se/English/); and the EU projects Europe HIV Resistance (EHR) (LSHP-CT-2006-518211) and CHAIN (FP7/2007-2013) "Collaborative HIV and Anti-HIV Drug Resistance Network" grant agreement no 223131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaeus A, 1997, AIDS, V11, P859, DOI 10.1097/00002030-199707000-00004; Archer J, 2009, AIDS, V23, P1209, DOI 10.1097/QAD.0b013e32832b4399; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; De Grassi A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000275; Esbjornsson J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23; GIANELLA S, 2011, J VIROL; Hedskog C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011345; Judo MSB, 1998, NUCLEIC ACIDS RES, V26, P1819, DOI 10.1093/nar/26.7.1819; Kanagawa T, 2003, J BIOSCI BIOENG, V96, P317, DOI 10.1263/jbb.96.317; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; Mitsuya Y, 2008, J VIROL, V82, P10747, DOI 10.1128/JVI.01827-07; POON AF, 2009, MOL BIOL EVOL; Rozera G, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-15; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Varghese V, 2009, JAIDS-J ACQ IMM DEF, V52, P309, DOI 10.1097/QAI.0b013e3181bca669; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655	24	36	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2011	6	7							e22741	10.1371/journal.pone.0022741	http://dx.doi.org/10.1371/journal.pone.0022741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	798AP	21799940	Green Submitted, gold, Green Published			2022-12-25	WOS:000293172900072
J	Remigereau, MS; Lakis, G; Rekima, S; Leveugle, M; Fontaine, MC; Langin, T; Sarr, A; Robert, T				Remigereau, Marie-Stanislas; Lakis, Ghayas; Rekima, Samah; Leveugle, Magalie; Fontaine, Michael C.; Langin, Thierry; Sarr, Aboubakry; Robert, Thierry			Cereal Domestication and Evolution of Branching: Evidence for Soft Selection in the Tb1 Orthologue of Pearl Millet (Pennisetum glaucum [L.] R. Br.)	PLOS ONE			English	Article							MAIZE DOMESTICATION; GENETIC-VARIATION; PLANT DOMESTICATION; MOLECULAR EVOLUTION; DNA POLYMORPHISM; FOXTAIL MILLET; ADAPTATION; TEOSINTE; TRAITS; GRASSES	Background: During the Neolithic revolution, early farmers altered plant development to domesticate crops. Similar traits were often selected independently in different wild species; yet the genetic basis of this parallel phenotypic evolution remains elusive. Plant architecture ranks among these target traits composing the domestication syndrome. We focused on the reduction of branching which occurred in several cereals, an adaptation known to rely on the major gene Teosinte-branched1 (Tb1) in maize. We investigate the role of the Tb1 orthologue (Pgtb1) in the domestication of pearl millet (Pennisetum glaucum), an African outcrossing cereal. Methodology/Principal Findings: Gene cloning, expression profiling, QTL mapping and molecular evolution analysis were combined in a comparative approach between pearl millet and maize. Our results in pearl millet support a role for PgTb1 in domestication despite important differences in the genetic basis of branching adaptation in that species compared to maize (e.g. weaker effects of PgTb1). Genetic maps suggest this pattern to be consistent in other cereals with reduced branching (e.g. sorghum, foxtail millet). Moreover, although the adaptive sites underlying domestication were not formerly identified, signatures of selection pointed to putative regulatory regions upstream of both Tb1 orthologues in maize and pearl millet. However, the signature of human selection in the pearl millet Tb1 is much weaker in pearl millet than in maize. Conclusions/Significance: Our results suggest that some level of parallel evolution involved at least regions directly upstream of Tb1 for the domestication of pearl millet and maize. This was unanticipated given the multigenic basis of domestication traits and the divergence of wild progenitor species for over 30 million years prior to human selection. We also hypothesized that regular introgression of domestic pearl millet phenotypes by genes from the wild gene pool could explain why the selective sweep in pearl millet is softer than in maize.	[Remigereau, Marie-Stanislas; Lakis, Ghayas; Rekima, Samah; Leveugle, Magalie; Fontaine, Michael C.; Sarr, Aboubakry; Robert, Thierry] Univ Paris 11, Lab Ecol Systemat & Evolut, Orsay, France; [Remigereau, Marie-Stanislas; Langin, Thierry] Univ Paris 11, Inst Biotechnol Plantes, Orsay, France; [Sarr, Aboubakry; Robert, Thierry] Univ Paris 06, Paris, France	AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Remigereau, MS (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	thierry.robert@u-psud.fr	Fontaine, Michael/G-5350-2011	Fontaine, Michael/0000-0003-1156-4154	ANR (Agence Nationale pour la Recherche Scientifique) [ANR-06-BDIV-003-01]; Centre National de la Recherche Scientifique (CNRS)	ANR (Agence Nationale pour la Recherche Scientifique)(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was funded by the ANR (Agence Nationale pour la Recherche Scientifique) Biodiversity program (ANR-06-BDIV-003-01) - project Transbiodiv, and by the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Martinez JA, 2007, PLANT CELL, V19, P458, DOI 10.1105/tpc.106.048934; Allinne C, 2008, GENETICA, V133, P167, DOI 10.1007/s10709-007-9197-7; Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; [Anonymous], 1989, AFR ARCHAEOL REV, DOI DOI 10.1007/BF01116840; Arendt J, 2008, TRENDS ECOL EVOL, V23, P26, DOI 10.1016/j.tree.2007.09.011; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; D'Andrea AC, 2001, ANTIQUITY, V75, P341, DOI 10.1017/S0003598X00060993; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DOEBLEY J, 1991, GENETICS, V129, P285; DOEBLEY J, 1995, GENETICS, V141, P333; DOEBLEY J, 1999, MAIZE GENETICS COOPE, V73, P82; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Doust AN, 2006, MOL ECOL, V15, P1335, DOI 10.1111/j.1365-294X.2005.02791.x; Doust AN, 2004, P NATL ACAD SCI USA, V101, P9045, DOI 10.1073/pnas.0402892101; Doust A, 2007, ANN BOT-LONDON, V100, P941, DOI 10.1093/aob/mcm040; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; Finlayson SA, 2010, PLANT PHYSIOL, V152, P1914, DOI 10.1104/pp.109.148833; Frary A, 2003, THEOR APPL GENET, V107, P359, DOI 10.1007/s00122-003-1257-5; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; FU YX, 1993, GENETICS, V133, P693; Gompel N, 2009, DEV BIOL, V332, P36, DOI 10.1016/j.ydbio.2009.04.040; Harlan J.R., 1975, CROPS MAN; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Hubbard L, 2002, GENETICS, V162, P1927; HUDSON RR, 1987, GENETICS, V116, P153; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; Kebrom TH, 2006, PLANT PHYSIOL, V140, P1109, DOI 10.1104/pp.105.074856; Kim Y, 2006, GENETICS, V172, P1967, DOI 10.1534/genetics.105.048447; Kim Y, 2003, GENETICS, V164, P389; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lauter N, 2002, GENETICS, V160, P333; Lukens L, 2001, MOL BIOL EVOL, V18, P627, DOI 10.1093/oxfordjournals.molbev.a003843; Mariac C, 2006, THEOR APPL GENET, V113, P1003, DOI 10.1007/s00122-006-0360-9; Martin C, 2010, PLANT PHYSIOL, V154, P506, DOI 10.1104/pp.110.161331; McSteen P, 2005, ANNU REV PLANT BIOL, V56, P353, DOI 10.1146/annurev.arplant.56.032604.144122; McSteen P, 2009, PLANT PHYSIOL, V149, P46, DOI 10.1104/pp.108.129056; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; Poncet V, 2002, THEOR APPL GENET, V104, P965, DOI 10.1007/s00122-002-0889-1; Poncet V, 2000, THEOR APPL GENET, V100, P147, DOI 10.1007/s001220050020; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Qi X, 2001, BIOTECHNIQUES, V31, P355, DOI 10.2144/01312st08; Ramirez-Soriano A, 2008, BIOINFORMATICS, V24, P2790, DOI 10.1093/bioinformatics/btn531; Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745; ROBERT T, 2003, ACT 4 C NAT BRG PATR; Robert T, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: MILLETS AND GRASSES, P217, DOI 10.1007/978-3-642-14255-0_13; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; TAJIMA F, 1989, GENETICS, V123, P585; Takeda T, 2003, PLANT J, V33, P513, DOI 10.1046/j.1365-313X.2003.01648.x; Tenaillon MI, 2004, MOL BIOL EVOL, V21, P1214, DOI 10.1093/molbev/msh102; Wallace B., 1968, TOPICS POPULATION GE; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Westerbergh A, 2004, THEOR APPL GENET, V109, P1544, DOI 10.1007/s00122-004-1778-6; Wood TE, 2005, GENETICA, V123, P157, DOI 10.1007/s10709-003-2738-9; Zhai WW, 2009, MOL BIOL EVOL, V26, P273, DOI 10.1093/molbev/msn231	58	28	29	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22404	10.1371/journal.pone.0022404	http://dx.doi.org/10.1371/journal.pone.0022404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799845	Green Submitted, Green Published, gold			2022-12-25	WOS:000293097300044
J	Smutny, M; Wu, SK; Gomez, GA; Mangold, S; Yap, AS; Hamilton, NA				Smutny, Michael; Wu, Selwin K.; Gomez, Guillermo A.; Mangold, Sabine; Yap, Alpha S.; Hamilton, Nicholas A.			Multicomponent Analysis of Junctional Movements Regulated by Myosin II Isoforms at the Epithelial Zonula Adherens	PLOS ONE			English	Article							CELL-ADHESION; E-CADHERIN; LOCAL CONCENTRATION; ACTIN; VI	The zonula adherens (ZA) of epithelial cells is a site of cell-cell adhesion where cellular forces are exerted and resisted. Increasing evidence indicates that E-cadherin adhesion molecules at the ZA serve to sense force applied on the junctions and coordinate cytoskeletal responses to those forces. Efforts to understand the role that cadherins play in mechanotransduction have been limited by the lack of assays to measure the impact of forces on the ZA. In this study we used 4D imaging of GFP-tagged E-cadherin to analyse the movement of the ZA. Junctions in confluent epithelial monolayers displayed prominent movements oriented orthogonal (perpendicular) to the ZA itself. Two components were identified in these movements: a relatively slow unidirectional (translational) component that could be readily fitted by least-squares regression analysis, upon which were superimposed more rapid oscillatory movements. Myosin IIB was a dominant factor responsible for driving the unilateral translational movements. In contrast, frequency spectrum analysis revealed that depletion of Myosin IIA increased the power of the oscillatory movements. This implies that Myosin IIA may serve to dampen oscillatory movements of the ZA. This extends our recent analysis of Myosin II at the ZA to demonstrate that Myosin IIA and Myosin IIB make distinct contributions to junctional movement at the ZA.	[Smutny, Michael; Wu, Selwin K.; Gomez, Guillermo A.; Mangold, Sabine; Yap, Alpha S.] Univ Queensland, Mol Cell Biol Div, Inst Mol Biosci, St Lucia, Qld, Australia; [Hamilton, Nicholas A.] Univ Queensland, Div Genom & Computat Biol, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Smutny, M (corresponding author), Univ Queensland, Mol Cell Biol Div, Inst Mol Biosci, St Lucia, Qld, Australia.	michael.smutny@ist.ac.at; a.yap@uq.edu.au; n.hamilton@imb.uq.edu.au	Hamilton, Nicholas A/A-6033-2010; Gomez, Guillermo/J-2993-2014; Yap, Alpha S./J-1554-2014; Wu, Selwin/V-3464-2019	Hamilton, Nicholas A/0000-0003-0331-3427; Gomez, Guillermo/0000-0002-0494-2404; Yap, Alpha S./0000-0002-1038-8956; Wu, Selwin/0000-0002-5185-8467; Smutny, Michael/0000-0002-5920-9090	National Health and Medical Research Council (NHMRC) of Australia; UQ International Research Tuition Award and Research Scholarship; ANZ Trustees PhD Scholarship	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); UQ International Research Tuition Award and Research Scholarship; ANZ Trustees PhD Scholarship	This work was funded by the National Health and Medical Research Council (NHMRC) of Australia. M.S. was an Erwin Schroedinger postdoctoral fellow of the Austrian Science Fund (FWF), S.K.W. is supported by a UQ International Research Tuition Award and Research Scholarship, S.M. by an ANZ Trustees PhD Scholarship. A.S.Y. is a Research Fellow of the NHMRC. Confocal imaging was performed at the Australian Cancer Research Foundation (ACRF) Cancer Biology Imaging Centre at the Institute for Molecular Bioscience, established with the generous support of the ACRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghamohammadzadeh S, 2009, NAT CELL BIOL, V11, P1039, DOI 10.1038/ncb1918; Bi Yanli, 2008, Weishengwu Xuebao, V48, P1115; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; BOLLER K, 1985, J CELL BIOL, V100, P327, DOI 10.1083/jcb.100.1.327; Brigham E, 2002, FAST FOURIER TRANSFO; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Geisbrecht ER, 2002, NAT CELL BIOL, V4, P616, DOI 10.1038/ncb830; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; He L, 2010, NAT CELL BIOL; Ishiwata S, 2010, HFSP J, V4, P100, DOI 10.2976/1.3390455; Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Maddugoda MP, 2007, J CELL BIOL, V178, P529, DOI 10.1083/jcb.200612042; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Monier B, 2010, NAT CELL BIOL, V12, P60, DOI 10.1038/ncb2005; Placais PY, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.158102; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sawyer JK, 2011, MOL BIOL CELL; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Smutny M, 2010, J CELL BIOL, V189, P1075, DOI 10.1083/jcb.201005151; Stehbens SJ, 2006, J CELL SCI, V119, P1801, DOI 10.1242/jcs.02903; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Vitriol EA, 2007, P NATL ACAD SCI USA, V104, P6702, DOI 10.1073/pnas.0701801104; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0; Yap AS, 2003, J CELL BIOL, V160, P11, DOI 10.1083/jcb.200208156; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	35	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2011	6	7							e22458	10.1371/journal.pone.0022458	http://dx.doi.org/10.1371/journal.pone.0022458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	797BJ	21799860	gold, Green Submitted, Green Published			2022-12-25	WOS:000293097300049
J	Guariento, RD; Carneiro, LS; Caliman, A; Leal, JJF; Bozelli, RL; Esteves, FA				Guariento, Rafael D.; Carneiro, Luciana S.; Caliman, Adriano; Leal, Joao J. F.; Bozelli, Reinaldo L.; Esteves, Francisco A.			Food Web Architecture and Basal Resources Interact to Determine Biomass and Stoichiometric Cascades along a Benthic Food Web	PLOS ONE			English	Article							ECOLOGICAL STOICHIOMETRY; FRESH-WATER; NUTRIENT LIMITATION; TOP-DOWN; LIGHT; PERIPHYTON; STREAM; PRODUCTIVITY; CONSUMER; QUALITY	Understanding the effects of predators and resources on primary producers has been a major focus of interest in ecology. Within this context, the trophic cascade concept especially concerning the pelagic zone of lakes has been the focus of the majority of these studies. However, littoral food webs could be especially interesting because base trophic levels may be strongly regulated by consumers and prone to be light limited. In this study, the availability of nutrients and light and the presence of an omnivorous fish (Hyphessobrycon bifasciatus) were manipulated in enclosures placed in a humic coastal lagoon (Cabiunas Lagoon, Macae - RJ) to evaluate the individual and interactive effects of resource availability (nutrients and light) and food web configuration on the biomass and stoichiometry of periphyton and benthic grazers. Our findings suggest that light and nutrients interact to determine periphyton biomass and stoichiometry, which propagates to the consumer level. We observed a positive effect of the availability of nutrients on periphytic biomass and grazers' biomass, as well as a reduction of periphytic C:N:P ratios and an increase of grazers' N and P content. Low light availability constrained the propagation of nutrient effects on periphyton biomass and induced higher periphytic C:N:P ratios. The effects of fish presence strongly interacted with resource availability. In general, a positive effect of fish presence was observed for the total biomass of periphyton and grazer's biomass, especially with high resource availability, but the opposite was found for periphytic autotrophic biomass. Fish also had a significant effect on periphyton stoichiometry, but no effect was observed on grazers' stoichiometric ratios. In summary, we observed that the indirect effect of fish predation on periphyton biomass might be dependent on multiple resources and periphyton nutrient stoichiometric variation can affect consumers' stoichiometry.	[Guariento, Rafael D.; Carneiro, Luciana S.; Caliman, Adriano; Leal, Joao J. F.; Bozelli, Reinaldo L.; Esteves, Francisco A.] Univ Fed Rio de Janeiro, Dept Ecol, Rio De Janeiro, Brazil; [Leal, Joao J. F.] Ctr Fed Educ Tecnol Quim, Rio De Janeiro, Brazil; [Esteves, Francisco A.] Nucleo Ecol & Desenvolvimento Socioambiental Maca, Rio De Janeiro, Brazil; [Carneiro, Luciana S.; Caliman, Adriano] Univ Fed Rio Grande do Norte, Dept Bot Ecol & Zool, BR-59072970 Natal, RN, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio Grande do Norte	Guariento, RD (corresponding author), Univ Fed Rio de Janeiro, Dept Ecol, Rio De Janeiro, Brazil.	dettogni@biologia.ufrj.br	Guariento, Rafael Dettogni/Q-3602-2019; Habe, Neusa K/D-6316-2011; Bozelli, Reinaldo/S-6414-2019; Bozelli, Reinaldo L/G-1805-2012; Caliman, Adriano/A-8668-2008; GUARIENTO, RAFAEL DETTOGNI/J-1211-2014	Guariento, Rafael Dettogni/0000-0003-2035-2030; Bozelli, Reinaldo L/0000-0001-9916-1629; Caliman, Adriano/0000-0001-9218-5601; Leal, Joao/0000-0002-9295-2062	Brazilian National Council of Scientific and Technological Development (CNPq)	Brazilian National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study received funding from the Brazilian National Council of Scientific and Technological Development (CNPq - www.cnpq.br) by supporting RDG, LSC and AC with scholarships and providing the financial support to conduct the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2007, ECOLOGY, V88, P2555, DOI 10.1890/06-1381.1; American Public Health Association, 1989, STAND METH EX WAT WA, V17th; Ask J, 2009, LIMNOL OCEANOGR, V54, P2034, DOI 10.4319/lo.2009.54.6.2034; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Bertrand KN, 2007, OECOLOGIA, V151, P69, DOI 10.1007/s00442-006-0569-y; Boersma M, 2008, INT REV HYDROBIOL, V93, P479, DOI 10.1002/iroh.200811066; BRETT MT, 1996, P NATL ACAD SCI; BRONMARK C, 1994, ECOLOGY, V75, P1818, DOI 10.2307/1939640; Carr GM, 2005, FRESHWATER BIOL, V50, P1337, DOI 10.1111/j.1365-2427.2005.01401.x; Carvalho TP, 2006, NEOTROP ICHTHYOL, V4, P301, DOI 10.1590/S1679-62252006000300001; Chase JM, 2003, OIKOS, V101, P187, DOI 10.1034/j.1600-0706.2003.12062.x; Cross WF, 2003, ECOL LETT, V6, P721, DOI 10.1046/j.1461-0248.2003.00481.x; Cruz-Rivera E, 2000, ECOLOGY, V81, P201; Danger M, 2008, FRESHWATER BIOL, V53, P2089, DOI 10.1111/j.1365-2427.2008.02031.x; Darcy-Hall TL, 2006, OECOLOGIA, V148, P660, DOI 10.1007/s00442-006-0405-4; Dickman EM, 2008, P NATL ACAD SCI USA, V105, P18408, DOI 10.1073/pnas.0805566105; Elser JJ, 1999, ECOLOGY, V80, P735, DOI 10.2307/177013; Eriksson BK, 2006, ECOLOGY, V87, P246, DOI 10.1890/05-0090; Esteves FA, 2008, BRAZ J BIOL, V68, P967, DOI 10.1590/S1519-69842008000500006; Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015; Fanta SE, 2010, FRESHWATER BIOL, V55, P931, DOI 10.1111/j.1365-2427.2009.02309.x; Fink P, 2006, OIKOS, V115, P484, DOI 10.1111/j.2006.0030-1299.14951.x; Flecker AS, 2002, ECOLOGY, V83, P1831, DOI 10.2307/3071768; GELWICK FP, 1992, ECOLOGY, V73, P1630, DOI 10.2307/1940016; Gruner DS, 2008, ECOL LETT, V11, P740, DOI 10.1111/j.1461-0248.2008.01192.x; Guariento RD, 2010, AQUAT BIOL, V10, P273, DOI 10.3354/ab00287; Hall SR, 2007, OIKOS, V116, P1128, DOI 10.1111/j.0030-1299.2007.15875.x; Hall SR, 2007, ECOLOGY, V88, P1142, DOI 10.1890/06-0923; Hargrave CW, 2006, OECOLOGIA, V149, P123, DOI 10.1007/s00442-006-0435-y; Hessen DO, 2002, ECOLOGY, V83, P1886, DOI 10.2307/3071772; Hill WR, 2010, ECOLOGY, V91, P518, DOI 10.1890/09-0703.1; Hillebrand H, 2004, OIKOS, V106, P93, DOI 10.1111/j.0030-1299.2004.13166.x; Hillebrand H, 2008, OECOLOGIA, V155, P619, DOI 10.1007/s00442-007-0930-9; Hutchinson G.E., 1978, INTRO POPULATION ECO; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; Liess A, 2006, J N AM BENTHOL SOC, V25, P632, DOI 10.1899/0887-3593(2006)25[632:RONSIG]2.0.CO;2; Mackereth F.J.H., 1978, WATER ANAL SOME REVI; McCollum EW, 1998, ECOLOGY, V79, P1980; McIntosh AR, 1996, OECOLOGIA, V108, P174, DOI 10.1007/BF00333229; Nunez V, 2010, IHERINGIA SER ZOOL, V100, P275, DOI 10.1590/S0073-47212010000300014; Passarge J, 2006, ECOL MONOGR, V76, P57, DOI 10.1890/04-1824; POWER ME, 1992, ECOLOGY, V73, P733, DOI 10.2307/1940153; Preisser EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002465; Qin PB, 2007, LIMNOL OCEANOGR, V52, P1728, DOI 10.4319/lo.2007.52.4.1728; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; Sanches LF, 2011, HYDROBIOLOGIA, V669, P35, DOI 10.1007/s10750-011-0661-0; Sanchez-Botero JI, 2008, J COASTAL RES, V24, P225, DOI 10.2112/06-0752.1; Schindler DE, 2002, OIKOS, V98, P177, DOI 10.1034/j.1600-0706.2002.980201.x; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; Sommer U, 1999, ECOL LETT, V2, P65, DOI 10.1046/j.1461-0248.1999.22052.x; Stelzer RS, 2002, ECOLOGY, V83, P1039, DOI 10.1890/0012-9658(2002)083[1039:ESIRWP]2.0.CO;2; Thiengo SC, 2002, MEM I OSWALDO CRUZ, V97, P621, DOI 10.1590/S0074-02762002000500004; Vadeboncoeur Y, 2003, LIMNOL OCEANOGR, V48, P1408, DOI 10.4319/lo.2003.48.4.1408; Vadeboncoeur Y, 2005, ECOSYSTEMS, V8, P682, DOI 10.1007/s10021-003-0149-5; Vadeboncoeur Y, 2002, BIOSCIENCE, V52, P44, DOI 10.1641/0006-3568(2002)052[0044:PTLBTR]2.0.CO;2; Vadeboncoeur Y, 2008, ECOLOGY, V89, P2542, DOI 10.1890/07-1058.1; Vanni MJ, 1997, ECOLOGY, V78, P1	57	9	13	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e22205	10.1371/journal.pone.0022205	http://dx.doi.org/10.1371/journal.pone.0022205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789234	Green Published, Green Submitted, gold			2022-12-25	WOS:000292812400037
J	Rochira, JA; Matluk, NN; Adams, TL; Karaczyn, AA; Oxburgh, L; Hess, ST; Verdi, JM				Rochira, Jennifer A.; Matluk, Nicholas N.; Adams, Tamara L.; Karaczyn, Aldona A.; Oxburgh, Leif; Hess, Samuel T.; Verdi, Joseph M.			A Small Peptide Modeled after the NRAGE Repeat Domain Inhibits XIAP-TAB1-TAK1 Signaling for NF-kappa B Activation and Apoptosis in P19 Cells	PLOS ONE			English	Article							P75 NEUROTROPHIN RECEPTOR; EMBRYONAL CARCINOMA-CELLS; X-LINKED INHIBITOR; INTERACTING PROTEIN; RETINOIC ACID; CYTOCHROME-C; DEATH; INDUCTION; XIAP; UPSTREAM	In normal growth and development, apoptosis is necessary to shape the central nervous system and to eliminate excess neurons which are not required for innervation. In some diseases, however, apoptosis can be either overactive as in some neurodegenerative disorders or severely attenuated as in the spread of certain cancers. Bone morphogenetic proteins (BMPs) transmit signals for regulating cell growth, differentiation, and apoptosis. Responding to BMP receptors stimulated from BMP ligands, neurotrophin receptor-mediated MAGE homolog (NRAGE) binds and functions with the XIAP-TAK1-TAB1 complex to activate p38(MAPK) and induces apoptosis in cortical neural progenitors. NRAGE contains a unique repeat domain that is only found in human, mouse, and rat homologs that we theorize is pivotal in its BMP MAPK role. Previously, we showed that deletion of the repeat domain inhibits apoptosis, p38(MAPK) phosphorylation, and caspase-3 cleavage in P19 neural progenitor cells. We also showed that the XIAP-TAB1-TAK1 complex is dependent on NRAGE for IKK-alpha/beta phosphorylation and NF-kappa B activation. XIAP is a major inhibitor of caspases, the main executioners of apoptosis. Although it has been shown previously that NRAGE binds to the RING domain of XIAP, it has not been determined which NRAGE domain binds to XIAP. Here, we used fluorescence resonance energy transfer (FRET) to determine that there is a strong likelihood of a direct interaction between NRAGE and XIAP occurring at NRAGE's unique repeat domain which we also attribute to be the domain responsible for downstream signaling of NF-kappa B and activating IKK subunits. From these results, we designed a small peptide modeled after the NRAGE repeat domain which we have determined inhibits NF-kappa B activation and apoptosis in P19 cells. These intriguing results illustrate that the paradigm of the NRAGE repeat domain may hold promising therapeutic strategies in developing pharmaceutical solutions for combating harmful diseases involving excessive downstream BMP signaling, including apoptosis.	[Rochira, Jennifer A.] Univ Maine, IGERT Funct Genom Ph D Program, Orono, ME USA; [Rochira, Jennifer A.; Matluk, Nicholas N.; Adams, Tamara L.; Karaczyn, Aldona A.; Oxburgh, Leif; Verdi, Joseph M.] Maine Med Ctr, Ctr Mol Med, Res Inst, Scarborough, ME USA; [Rochira, Jennifer A.; Hess, Samuel T.] Univ Maine, Dept Phys & Astron, Orono, ME 04469 USA; [Matluk, Nicholas N.] Univ Maine, Grad Sch Biomed Sci, Orono, ME USA	University of Maine System; University of Maine Orono; Maine Medical Center; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono	Rochira, JA (corresponding author), Rhode Isl Hosp, Div Cardiol, Cardiovasc Res Ctr, Providence, RI 02903 USA.	verdij@mmc.org			National Institutes of Health (NIH) [R01NS055304, NIH K25-AI65459]; National Science Foundation (NSF) [0722759, 0221625]; NIH Center of Biomedical Research Excellence (COBRE) [P20RR018789]; Maine Medical Center Research Institute (Scarborough, Maine); Jackson Laboratory (Bar Harbor, Maine); Graduate School of Biomedical Sciences at University of Maine, Orono, Maine; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K25AI065459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055304] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NIH Center of Biomedical Research Excellence (COBRE); Maine Medical Center Research Institute (Scarborough, Maine); Jackson Laboratory (Bar Harbor, Maine); Graduate School of Biomedical Sciences at University of Maine, Orono, Maine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grant R01NS055304 awarded to JMV, grants NIH K25-AI65459 and National Science Foundation (NSF) 0722759 awarded to STH, and NIH Center of Biomedical Research Excellence (COBRE) grant P20RR018789 in Stem Cell Biology and Regenerative Medicine to Maine Medical Center (Portland, Maine). JAR was funded by the Integrative Graduate Education Research Training (IGERT) Functional Genomics Ph.D. program through a fellowship from NSF grant 0221625 awarded to the University of Maine (Orono, Maine), Maine Medical Center Research Institute (Scarborough, Maine), and the Jackson Laboratory (Bar Harbor, Maine). NNM was funded by the Graduate School of Biomedical Sciences Ph.D. program at the University of Maine, Orono, Maine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett GL, 2005, NEUROSCIENCE, V133, P381, DOI 10.1016/j.neuroscience.2005.01.067; Bertrand MJM, 2008, CELL DEATH DIFFER, V15, P1921, DOI 10.1038/cdd.2008.127; Bragason BT, 2005, MOL CELL NEUROSCI, V29, P232, DOI 10.1016/j.mcn.2005.02.013; Chu CS, 2007, CANCER LETT, V250, P268, DOI 10.1016/j.canlet.2006.10.020; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Di Certo MG, 2007, J CELL SCI, V120, P1852, DOI 10.1242/jcs.03454; Friedman WJ, 2000, J NEUROSCI, V20, P6340, DOI 10.1523/JNEUROSCI.20-17-06340.2000; Gautschi OP, 2009, J MUSCULOSKEL NEURON, V9, P53; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Glozak MA, 1996, DEV BIOL, V179, P458, DOI 10.1006/dbio.1996.0275; Glozak MA, 2001, EXP CELL RES, V268, P128, DOI 10.1006/excr.2001.5281; Hofer-Warbinek R, 2000, J BIOL CHEM, V275, P22064, DOI 10.1074/jbc.M910346199; Jordan BWM, 2001, J BIOL CHEM, V276, P39985, DOI 10.1074/jbc.C100171200; Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1; Kendall SE, 2005, MOL CELL BIOL, V25, P7711, DOI 10.1128/MCB.25.17.7711-7724.2005; Kendall SE, 2002, MECH DEVELOP, V117, P187, DOI 10.1016/S0925-4773(02)00204-6; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P3873, DOI 10.1093/nar/12.9.3873; Kusumoto K, 2009, IN VITRO CELL DEV-AN, V45, P55, DOI 10.1007/s11626-008-9153-6; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Lu M, 2007, MOL CELL, V26, P689, DOI 10.1016/j.molcel.2007.05.006; Maatouk DM, 2009, DEV BIOL, V327, P516, DOI 10.1016/j.ydbio.2009.01.004; Matluk N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-7; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Neil JR, 2009, J BIOL CHEM, V284, P21209, DOI 10.1074/jbc.M109.018374; Nikopoulos GN, 2009, MECH DEVELOP, V126, P337, DOI 10.1016/j.mod.2009.02.005; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Resch U, 2009, J CELL SCI, V122, P2651, DOI 10.1242/jcs.049940; Rochira JA, 2010, APOPTOSIS, V15, P63, DOI 10.1007/s10495-009-0427-6; Salehi AH, 2000, NEURON, V27, P279, DOI 10.1016/S0896-6273(00)00036-2; Salehi AH, 2002, J BIOL CHEM, V277, P48043, DOI 10.1074/jbc.M205324200; Shibuya H, 1998, EMBO J, V17, P1019, DOI 10.1093/emboj/17.4.1019; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200; Splan KE, 2007, BIOCHEMISTRY-US, V46, P11938, DOI 10.1021/bi061938t; Srinivasula SM, 2000, J BIOL CHEM, V275, P36152, DOI 10.1074/jbc.C000533200; URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601; Walpole RE, 1985, PROBABILITY STAT ENG; Xue B, 2005, BIOCHEM BIOPH RES CO, V336, P247, DOI 10.1016/j.bbrc.2005.08.069; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179; Yoon SO, 1998, J NEUROSCI, V18, P3273	49	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2011	6	7							e20659	10.1371/journal.pone.0020659	http://dx.doi.org/10.1371/journal.pone.0020659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HY	21789165	gold, Green Submitted, Green Published			2022-12-25	WOS:000292812400004
J	Frasch, MG; Keen, AE; Gagnon, R; Ross, MG; Richardson, BS				Frasch, Martin G.; Keen, Ashley E.; Gagnon, Robert; Ross, Michael G.; Richardson, Bryan S.			Monitoring Fetal Electrocortical Activity during Labour for Predicting Worsening Acidemia: A Prospective Study in the Ovine Fetus Near Term	PLOS ONE			English	Article							UMBILICAL-CORD OCCLUSION; CEREBRAL-BLOOD-FLOW; HEART-RATE; ACUTE-HYPOXIA; SLEEP; METABOLISM; RESPONSES; CONTRACTILITY; INHIBITION; PARAMETERS	Background: Severe fetal acidemia during labour with arterial pH below 7.00 is associated with increased risk of hypoxic-ischemic brain injury. Electronic fetal heart rate (FHR) monitoring, the mainstay of intrapartum surveillance, has poor specificity for detecting fetal acidemia. We studied brain electrical activity measured with electrocorticogram (ECOG) in the near term ovine fetus subjected to repetitive umbilical cord occlusions (UCO) inducing FHR decelerations, as might be seen in human labour, to delineate the time-course for ECOG changes with worsening acidemia and thereby assess the potential clinical utility of fetal ECOG. Methodology/Principal Findings: Ten chronically catheterized fetal sheep were studied through a series of mild, moderate and severe UCO until the arterial pH was below 7.00. At a pH of 7.24 +/- 0.04, 52 +/- 13 min prior to the pH dropping <7.00, spectral edge frequency (SEF) increased to 23 +/- 2 Hz from 3 +/- 1 Hz during each FHR deceleration (p<0.001) and was correlated to decreases in FHR and in fetal arterial blood pressure during each FHR deceleration (p<0.001). Conclusions/Significance: The UCO-related changes in ECOG occurred in advance of the pH decreasing below 7.00. These ECOG changes may be a protective mechanism suppressing non-essential energy needs when oxygen supply to the fetal brain is decreased acutely. By detecting such "adaptive brain shutdown,'' the need for delivery in high risk pregnant patients may be more accurately predicted than with FHR monitoring alone. Therefore, monitoring fetal electroencephalogram (EEG, the human equivalent of ECOG) during human labour may be a useful adjunct to FHR monitoring.	[Frasch, Martin G.; Keen, Ashley E.; Richardson, Bryan S.] Univ Western Ontario, Lawson Hlth Res Inst, Dept Obstet & Gynecol, London, ON, Canada; [Keen, Ashley E.; Richardson, Bryan S.] Univ Western Ontario, Lawson Hlth Res Inst, Dept Physiol & Pharmacol, London, ON, Canada; [Gagnon, Robert] McGill Univ, Dept Obstet & Gynecol, Quebec City, PQ, Canada; [Ross, Michael G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Frasch, Martin G.] Univ Montreal, CHU St Justine Res Ctr, Dept Obstet & Gynecol, Quebec City, PQ, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); McGill University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Frasch, MG (corresponding author), Univ Western Ontario, Lawson Hlth Res Inst, Dept Obstet & Gynecol, London, ON, Canada.	mg.frasch@umontreal.ca	Frasch, Martin G/B-3539-2014; Frasch, Martin/AAN-8507-2020	Frasch, Martin G/0000-0003-3159-6321; Frasch, Martin/0000-0003-3159-6321	Child Health Research Institute; John Patrick Foundation; Department of Obstetrics and Gynaecology, London; CIHR funded Strategic Training Initiative in Research in Reproductive Health Sciences (STIRRHS), Canada	Child Health Research Institute; John Patrick Foundation; Department of Obstetrics and Gynaecology, London; CIHR funded Strategic Training Initiative in Research in Reproductive Health Sciences (STIRRHS), Canada(Canadian Institutes of Health Research (CIHR))	The study was supported by grants to BSR, RG and MR from the Child Health Research Institute, John Patrick Foundation and Department of Obstetrics and Gynaecology Academic Enrichment Fund, London, and to MGF from CIHR funded Strategic Training Initiative in Research in Reproductive Health Sciences (STIRRHS), Canada (http://www.stirrhs.ca/fr/user/frasch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM COLL OBST GYN, 1996, US AB APG SCOR; *AM COLL OBST GYN, 1995, TECHN B AM COLL OBST, V207; American College of Obstetricians and Gynecologists, 2010, OBSTET GYNECOL, V116, P1232; ASTRUP J, 1982, J NEUROSURG, V56, P482, DOI 10.3171/jns.1982.56.4.0482; DeHaan HH, 1997, PEDIATR RES, V41, P96, DOI 10.1203/00006450-199701000-00015; deHaan HH, 1997, AM J OBSTET GYNECOL, V176, P8, DOI 10.1016/S0002-9378(97)80004-X; FISHER DJ, 1986, J DEV PHYSIOL, V8, P23; Frasch MG, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.022; Gardner DS, 2002, CIRCULATION, V106, P2278, DOI 10.1161/01.CIR.0000033827.48974.C8; Giussani D, 1994, FETAL MED REV, V6, P17; GIUSSANI DA, 1993, J PHYSIOL-LONDON, V461, P431, DOI 10.1113/jphysiol.1993.sp019521; GOLDABER KG, 1991, OBSTET GYNECOL, V78, P1103; Green LR, 1999, J SOC GYNECOL INVEST, V6, P56, DOI 10.1016/S1071-5576(98)00055-0; GUNN AJ, 1992, PEDIATR RES, V31, P486, DOI 10.1203/00006450-199205000-00016; Hunter CJ, 2003, J PHYSIOL-LONDON, V552, P241, DOI 10.1113/jphysiol.2003.048082; Hunter CJ, 2003, STROKE, V34, P2240, DOI 10.1161/01.STR.0000083623.77327.CE; IOFFE S, 1980, PFLUG ARCH EUR J PHY, V388, P149, DOI 10.1007/BF00584121; ITSKOVITZ J, 1983, AM J OBSTET GYNECOL, V147, P451, DOI 10.1016/S0002-9378(16)32243-8; Kaneko M, 2003, AM J OBSTET GYNECOL, V188, P961, DOI 10.1067/mob.2003.219; Kawagoe Y, 1999, AM J OBSTET GYNECOL, V181, P1520, DOI 10.1016/S0002-9378(99)70399-6; KREBS HB, 1983, AM J OBSTET GYNECOL, V145, P297, DOI 10.1016/0002-9378(83)90714-7; LEWINSKY RM, 1994, BAILLIERE CLIN OB GY, V8, P663, DOI 10.1016/S0950-3552(05)80204-4; Liston R, 2007, J OBSTET GYNAECOL CA, V29, pS3, DOI 10.1016/S1701-2163(16)32615-9; Liston Robert, 2002, J Obstet Gynaecol Can, V24, P342; Liston Robert, 2002, J Obstet Gynaecol Can, V24, P250; LOU HC, 1979, ACTA PAEDIATR SCAND, V68, P57, DOI 10.1111/j.1651-2227.1979.tb04430.x; LOW JA, 1984, AM J OBSTET GYNECOL, V148, P533, DOI 10.1016/0002-9378(84)90742-7; MALLARD EC, 1995, PEDIATR RES, V37, P707, DOI 10.1203/00006450-199506000-00006; Ozden S, 1999, ARCH GYNECOL OBSTET, V262, P141, DOI 10.1007/s004040050242; Parer JT, 1997, AM J OBSTET GYNECOL, V177, P1385; Prout AP, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.020; Richardson B, 2008, MATERNAL FETAL MED, P171; RICHARDSON BS, 1989, J DEV PHYSIOL, V11, P37; RUCKEBUSCH Y, 1977, ELECTROEN CLIN NEURO, V42, P226, DOI 10.1016/0013-4694(77)90029-3; Sejnowski TJ, 2006, J NEUROSCI, V26, P1673, DOI 10.1523/JNEUROSCI.3737-05d.2006; SOKOL RJ, 1977, AM J OBSTET GYNECOL, V127, P329, DOI 10.1016/0002-9378(77)90481-1; SZETO HH, 1985, SLEEP, V8, P347, DOI 10.1093/sleep/8.4.347; Thaler I, 2000, PEDIATR RES, V48, P340, DOI 10.1203/00006450-200009000-00013; TORTOSA MN, 1990, EUR J OBSTET GYN R B, V34, P235, DOI 10.1016/0028-2243(90)90077-E; Waldvogel D, 2000, NATURE, V406, P995, DOI 10.1038/35023171; WINKLER CL, 1991, AM J OBSTET GYNECOL, V164, P637, DOI 10.1016/S0002-9378(11)80038-4	41	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22100	10.1371/journal.pone.0022100	http://dx.doi.org/10.1371/journal.pone.0022100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789218	Green Submitted, Green Published, gold			2022-12-25	WOS:000292811700023
J	He, YG; Li, C; Amos, CI; Xiong, MM; Ling, H; Jin, L				He, Yungang; Li, Cong; Amos, Christopher I.; Xiong, Momiao; Ling, Hua; Jin, Li			Accelerating Haplotype-Based Genome-Wide Association Study Using Perfect Phylogeny and Phase-Known Reference Data	PLOS ONE			English	Article							GENOTYPE DATA; RECONSTRUCTION; RECOMBINATION; INFERENCE; TESTS	The genome-wide association study (GWAS) has become a routine approach for mapping disease risk loci with the advent of large-scale genotyping technologies. Multi-allelic haplotype markers can provide superior power compared with single-SNP markers in mapping disease loci. However, the application of haplotype-based analysis to GWAS is usually bottlenecked by prohibitive time cost for haplotype inference, also known as phasing. In this study, we developed an efficient approach to haplotype-based analysis in GWAS. By using a reference panel, our method accelerated the phasing process and reduced the potential bias generated by unrealistic assumptions in phasing process. The haplotype-based approach delivers great power and no type I error inflation for association studies. With only a medium-size reference panel, phasing error in our method is comparable to the genotyping error afforded by commercial genotyping solutions.	[He, Yungang; Li, Cong; Jin, Li] Chinese Acad Sci, Shanghai Inst Biol Sci, Dept Computat Genom, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [He, Yungang; Li, Cong; Jin, Li] Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai, Peoples R China; [Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Xiong, Momiao] Univ Texas Sch Publ Hlth, Ctr Human Genet, Houston, TX USA; [Xiong, Momiao; Jin, Li] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Xiong, Momiao; Jin, Li] Fudan Univ, Sch Life Sci, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Xiong, Momiao; Jin, Li] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Ling, Hua] Johns Hopkins Univ, Ctr Inherited Dis Res, Baltimore, MD USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Fudan University; Fudan University; Fudan University; Johns Hopkins University	He, YG (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Dept Computat Genom, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China.	heyungang@gmail.com; lijin.fudan@gmail.com	Jin, Li/M-5063-2019; Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415; He, Yungang/0000-0002-2931-2871	Science and Technology Committee of Shanghai Municipality [09ZR1437000, 09540704300, 09XD1400200]; Shanghai Institutes of Biological Sciences [2010KIP206]; National Natural Science Foundation of China [30890034, 30625016]; Shanghai Leading Academic Discipline Project [B111]; Center for Evolutionary Biology at Fudan University;  [AR44422];  [AR57120]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057120, R01AR044422] Funding Source: NIH RePORTER	Science and Technology Committee of Shanghai Municipality(Shanghai Science & Technology Committee); Shanghai Institutes of Biological Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Center for Evolutionary Biology at Fudan University; ; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the Science and Technology Committee of Shanghai Municipality (09ZR1437000 to Y.H., 09540704300 and 09XD1400200 to L.J.), Shanghai Institutes of Biological Sciences (2010KIP206 to Y.H.) and National Natural Science Foundation of China (30890034 and 30625016 to L.J.). C.I.A. was supported by AR44422 and AR57120. L.J. was also supported by Shanghai Leading Academic Discipline Project (B111) and the Center for Evolutionary Biology at Fudan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Amos Christopher I, 2009, BMC Proc, V3 Suppl 7, pS2; Beuten J, 2006, NEUROPSYCHOPHARMACOL, V31, P675, DOI 10.1038/sj.npp.1300997; Bray NJ, 2003, AM J HUM GENET, V73, P152, DOI 10.1086/376578; Brinza D, 2006, BIOINFORMATICS, V22, P371, DOI 10.1093/bioinformatics/bti785; Browning BL, 2008, HUM GENET, V123, P273, DOI 10.1007/s00439-008-0472-1; Browning BL, 2007, GENET EPIDEMIOL, V31, P365, DOI 10.1002/gepi.20216; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Chen GK, 2009, GENOME RES, V19, P136, DOI 10.1101/gr.083634.108; Curtis D, 2006, AM J HUM GENET, V78, P729, DOI 10.1086/502666; Durrant C, 2004, AM J HUM GENET, V75, P35, DOI 10.1086/422174; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Gordon D, 2001, Pac Symp Biocomput, P18; Gusfield D., 2002, P 6 ANN INT C COMP B, P166; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Halperin E, 2004, BIOINFORMATICS, V20, P1842, DOI 10.1093/bioinformatics/bth149; Kim KK, 2009, GENOMICS, V94, P89, DOI 10.1016/j.ygeno.2009.04.005; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Mailund T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-454; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Minichiello MJ, 2006, AM J HUM GENET, V79, P910, DOI 10.1086/508901; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Su SY, 2008, BIOINFORMATICS, V24, P972, DOI 10.1093/bioinformatics/btn071; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398	29	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2011	6	7							e22097	10.1371/journal.pone.0022097	http://dx.doi.org/10.1371/journal.pone.0022097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HT	21789217	Green Published, Green Submitted, gold			2022-12-25	WOS:000292811700022
J	Francois-Newton, V; Almeida, GMD; Payelle-Brogard, B; Monneron, D; Pichard-Garcia, L; Piehler, J; Pellegrini, S; Uze, G				Francois-Newton, Veronique; Almeida, Gabriel Magno de Freitas; Payelle-Brogard, Beatrice; Monneron, Daniele; Pichard-Garcia, Lydiane; Piehler, Jacob; Pellegrini, Sandra; Uze, Gilles			USP18-Based Negative Feedback Control Is Induced by Type I and Type III Interferons and Specifically Inactivates Interferon alpha Response	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; UBIQUITIN-SPECIFIC PROTEASE; GENE-EXPRESSION SIGNATURE; DIFFERENTIAL EXPRESSION; ANTIVIRAL ACTIVITY; RECEPTOR COMPLEX; VIRAL-INFECTION; DENDRITIC CELLS; UBP43 USP18; IFN-LAMBDA	Type I interferons (IFN) are cytokines that are rapidly secreted upon microbial infections and regulate all aspects of the immune response. In humans 15 type I IFN subtypes exist, of which IFN alpha 2 and IFN beta are used in the clinic for treatment of different pathologies. IFN alpha 2 and IFN beta are non redundant in their expression and in their potency to exert specific bioactivities. The more recently identified type III IFNs (3 IFN lambda or IL-28/IL-29) bind an unrelated cell-type restricted receptor. Downstream of these two receptor complexes is a shared Jak/Stat pathway. Several mechanisms that contribute to the shut down of the IFN-induced signaling have been described at the molecular level. In particular, it has long been known that type I IFN induces the establishment of a desensitized state. In this work we asked how the IFN-induced desensitization integrates into the network built by the multiple type I IFN subtypes and type III IFNs. We show that priming of cells with either type I IFN or type III IFN interferes with the cell's ability to further respond to all IFN alpha subtypes. Importantly, primed cells are differentially desensitized in that they retain sensitivity to IFN beta. We show that USP18 is necessary and sufficient to induce differential desensitization, by impairing the formation of functional binding sites for IFN alpha 2. Our data highlight a new type of differential between IFNs alpha and IFN beta and underline a cross-talk between type I and type III IFN. This cross-talk could shed light on the reported genetic variation in the IFN lambda loci, which has been associated with persistence of hepatitis C virus and patient's response to IFN alpha 2 therapy.	[Francois-Newton, Veronique; Payelle-Brogard, Beatrice; Pellegrini, Sandra] Inst Pasteur, CNRS, Cytokine Signaling Unit, Unite Rech Associee 1961, Paris, France; [Almeida, Gabriel Magno de Freitas; Monneron, Daniele; Uze, Gilles] Univ Montpellier 2, CNRS, UMR 5235, Montpellier, France; [Pichard-Garcia, Lydiane] Univ Montpellier 1, Hop St Eloi, Inst Natl Sante & Rech Med, Inst Rech Biotherapie,Unite 1040, Montpellier, France; [Piehler, Jacob] Univ Osnabruck, Div Biophys, Osnabruck, Germany	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; University Osnabruck	Francois-Newton, V (corresponding author), Inst Pasteur, CNRS, Cytokine Signaling Unit, Unite Rech Associee 1961, Paris, France.	uze@univ-montp2.fr	Almeida, Gabriel MF/I-8910-2012; Pellegrini, Sandra/Y-6351-2019; Uzé, Gilles/O-6383-2019; Pellegrini, Sandra -/G-5546-2015	Almeida, Gabriel MF/0000-0003-2317-5092; Pellegrini, Sandra/0000-0001-5837-7589; Pellegrini, Sandra -/0000-0001-5837-7589; Uze, Gilles/0000-0002-4150-5772	European Community [223608]; Institut Pasteur, Association pour la Recherche sur le Cancer [3158]; Centre National pour la Recherche Scientifique; Ministere de l' Education Nationale, de la Recherche et de la Technologie	European Community(European Commission); Institut Pasteur, Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Centre National pour la Recherche Scientifique; Ministere de l' Education Nationale, de la Recherche et de la Technologie	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2010) under grant agreement no 223608 (SP, GU and JP). Also supported by grants from Institut Pasteur, Association pour la Recherche sur le Cancer (grant 3158 to SP and GU) and Centre National pour la Recherche Scientifique. VFN was supported by the Ministere de l' Education Nationale, de la Recherche et de la Technologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 2010, J HEPATOL; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Asselah T, 2008, GUT, V57, P516, DOI 10.1136/gut.2007.128611; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Chen LM, 2010, GASTROENTEROLOGY, V138, P1123, DOI 10.1053/j.gastro.2009.10.046; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Coccia EM, 2006, CELL MOL BIOL, V52, P77, DOI 10.1170/T701; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Coelho LFL, 2005, P NATL ACAD SCI USA, V102, P11917, DOI 10.1073/pnas.0502188102; Dill MT, 2010, GASTROENTEROLOGY; Dondi E, 2001, J BIOL CHEM, V276, P47004, DOI 10.1074/jbc.M104316200; Duex JE, 2009, MOL BIOL CELL, V20, P1833, DOI 10.1091/mbc.E08-08-0880; Durfee LA, 2008, J BIOL CHEM, V283, P23895, DOI 10.1074/jbc.M804069200; Ferrantini M, 2008, CYTOKINE GROWTH F R, V19, P93, DOI 10.1016/j.cytogfr.2007.10.003; Ferrini J B, 1998, Methods Mol Biol, V107, P341; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; Kalie E, 2008, J BIOL CHEM, V283, P32925, DOI 10.1074/jbc.M806019200; Kim KI, 2006, MOL CELL BIOL, V26, P472, DOI 10.1128/MCB.26.2.472-479.2006; Knobeloch KP, 2005, MOL CELL BIOL, V25, P11030, DOI 10.1128/MCB.25.24.11030-11034.2005; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Liu LQ, 1999, MOL CELL BIOL, V19, P3029; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Marijanovic Z, 2007, BIOCHEM J, V407, P141, DOI 10.1042/BJ20070605; MOGENSEN KE, 1986, METHOD ENZYMOL, V119, P267; Moraga I, 2009, MOL CELL BIOL, V29, P4778, DOI 10.1128/MCB.01808-08; Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005; Potu H, 2010, CANCER RES, V70, P655, DOI 10.1158/0008-5472.CAN-09-1942; Randall G, 2006, GASTROENTEROLOGY, V131, P1584, DOI 10.1053/j.gastro.2006.08.043; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Schwer H, 2000, GENOMICS, V65, P44, DOI 10.1006/geno.2000.6148; Severa M, 2006, J LEUKOCYTE BIOL, V79, P1286, DOI 10.1189/jlb.1205742; Slutzki M, 2006, J MOL BIOL, V360, P1019, DOI 10.1016/j.jmb.2006.05.069; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; Uze G, 2007, BIOCHIMIE, V89, P729, DOI 10.1016/j.biochi.2007.01.008; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	46	179	182	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2011	6	7							e22200	10.1371/journal.pone.0022200	http://dx.doi.org/10.1371/journal.pone.0022200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	793HP	21779393	Green Published, gold, Green Submitted			2022-12-25	WOS:000292811300047
J	Liu, Y; McNevin, JP; Holte, S; McElrath, MJ; Mullins, JI				Liu, Yi; McNevin, John P.; Holte, Sarah; McElrath, M. Juliana; Mullins, James I.			Dynamics of Viral Evolution and CTL Responses in HIV-1 Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CYTOTOXIC T-LYMPHOCYTES; ESCAPE; CELLS; VIREMIA; SELECTION; ANTIGEN; REPLICATION; VARIANTS; EPITOPES	Improved understanding of the dynamics of host immune responses and viral evolution is critical for effective HIV-1 vaccine design. We comprehensively analyzed Cytotoxic T-lymphocyte (CTL)-viral epitope dynamics in an antiretroviral therapy-naive subject over the first four years of HIV-1 infection. We found that CTL responses developed sequentially and required constant antigenic stimulation for maintenance. CTL responses exerting strong selective pressure emerged early and led to rapid escape, proliferated rapidly and were predominant during acute/early infection. Although CTL responses to a few persistent epitopes developed over the first two months of infection, they proliferated slowly. As CTL epitopes were replaced by mutational variants, the corresponding responses immediately declined, most rapidly in the cases of strongly selected epitopes. CTL recognition of epitope variants, via cross-reactivity and de novo responses, was common throughout the period of study. Our data demonstrate that HIV-specific CTL responses, especially in the critical acute/early stage, were focused on regions that are prone to escape. Failure of CTL responses to strongly target functional or structurally critical regions of the virus, as well as the sequential cascade of CTL responses, followed closely by viral escape and decline of the corresponding responses, likely contribute to a lack of sustainable viral suppression. Focusing early and rapidly proliferating CTL on persistent epitopes may be essential for durable viral control in HIV-1 infection.	[Liu, Yi; Mullins, James I.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [McElrath, M. Juliana; Mullins, James I.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Mullins, James I.] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; [McNevin, John P.; McElrath, M. Juliana] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98104 USA; [Holte, Sarah] Fred Hutchinson Canc Res Ctr, Program Biostat & Biomath, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Liu, Y (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.	jmullins@uw.edu		mcnevin, john paul/0000-0002-9893-9256; Li, Yong/0000-0003-2651-8791	United States Public Health Service [P01 AI57005, R01 AI055343]; University of Washington Center for AIDS Research Computational Biology Core [P30 AI27757];  [M01-RR-00037]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005, R01AI055343, P30AI027757] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University of Washington Center for AIDS Research Computational Biology Core; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the United States Public Health Service to JIM (P01 AI57005), to SH (R01 AI055343) and the University of Washington Center for AIDS Research Computational Biology Core (P30 AI27757), and by grant M01-RR-00037 for leukapheresis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bennett MS, 2007, J VIROL, V81, P4973, DOI 10.1128/JVI.02362-06; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Buseyne F, 2001, INT IMMUNOL, V13, P941, DOI 10.1093/intimm/13.7.941; Cao JH, 2003, J VIROL, V77, P6867, DOI 10.1128/JVI.77.12.6867-6878.2003; Cao JH, 2003, J IMMUNOL, V171, P3837, DOI 10.4049/jimmunol.171.7.3837; Feeney ME, 2005, J IMMUNOL, V174, P7524, DOI 10.4049/jimmunol.174.12.7524; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Fujiwara M, 2008, J VIROL, V82, P138, DOI 10.1128/JVI.01452-07; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Jamieson BD, 2003, J IMMUNOL, V171, P5372, DOI 10.4049/jimmunol.171.10.5372; Jones NA, 2004, J EXP MED, V200, P1243, DOI 10.1084/jem.20040511; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; LEITNER TF, 2006, HIV SEQUENCE COMPEND; Lichterfeld M, 2007, J VIROL, V81, P4199, DOI 10.1128/JVI.01388-06; Lieberman J, 2001, BLOOD, V98, P1667, DOI 10.1182/blood.V98.6.1667; Liu Y, 2007, J VIROL, V81, P12179, DOI 10.1128/JVI.01277-07; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Liu Y, 2009, J INFECT DIS, V200, P1825, DOI 10.1086/648401; NOWAK MA, 1995, NATURE, V375, P606, DOI 10.1038/375606a0; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Streeck H, 2006, J INFECT DIS, V194, P734, DOI 10.1086/503811; Tomiyama H, 2000, EUR J IMMUNOL, V30, P2521, DOI 10.1002/1521-4141(200009)30:9<2521::AID-IMMU2521>3.0.CO;2-Q; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; Welsh RM, 2001, J EXP MED, V193, pF19, DOI 10.1084/jem.193.5.F19; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101	34	121	129	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e15639	10.1371/journal.pone.0015639	http://dx.doi.org/10.1371/journal.pone.0015639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21283794	Green Published, Green Submitted, gold			2022-12-25	WOS:000286522200010
